PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Disease Control Priorities, 3rd edition-from theory to practice	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London EC2Y 5AS, England		Das, P (corresponding author), The Lancet, London EC2Y 5AS, England.							Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2017, LANCET	2	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					E9	E10		10.1016/S0140-6736(17)32905-7	http://dx.doi.org/10.1016/S0140-6736(17)32905-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ4TP	29221644				2022-12-28	WOS:000427585100001
J	Weintraub, AS; Li, CH; Zamudio, AV; Sigova, AA; Hannett, NM; Day, DS; Abraham, BJ; Cohen, MA; Nabet, B; Buckley, DL; Guo, YE; Hnisz, D; Jaenisch, R; Bradner, JE; Gray, NS; Young, RA				Weintraub, Abraham S.; Li, Charles H.; Zamudio, Alicia V.; Sigova, Alla A.; Hannett, Nancy M.; Day, Daniel S.; Abraham, Brian J.; Cohen, Malkiel A.; Nabet, Behnam; Buckley, Dennis L.; Guo, Yang Eric; Hnisz, Denes; Jaenisch, Rudolf; Bradner, James E.; Gray, Nathanael S.; Young, Richard A.			YY1 Is a Structural Regulator of Enhancer-Promoter Loops	CELL			English	Article							TRANSCRIPTION FACTOR YY1; YIN YANG 1; GENE-REGULATION; INSULATED NEIGHBORHOODS; BINDING PROTEIN; HUMAN GENOME; 3D GENOME; CTCF; MEDIATOR; ELEMENTS	There is considerable evidence that chromosome structure plays important roles in gene control, but we have limited understanding of the proteins that contribute to structural interactions between gene promoters and their enhancer elements. Large DNA loops that encompass genes and their regulatory elements depend on CTCF-CTCF interactions, but most enhancer-promoter interactions do not employ this structural protein. Here, we show that the ubiquitously expressed transcription factor Yin Yang 1 (YY1) contributes to enhancer-promoter structural interactions in a manner analogous to DNA interactions mediated by CTCF. YY1 binds to active enhancers and promoter-proximal elements and forms dimers that facilitate the interaction of these DNA elements. Deletion of YY1 binding sites or depletion of YY1 protein disrupts enhancer-promoter looping and gene expression. We propose that YY1-mediated enhancer-promoter interactions are a general feature of mammalian gene control.	[Weintraub, Abraham S.; Li, Charles H.; Zamudio, Alicia V.; Sigova, Alla A.; Hannett, Nancy M.; Day, Daniel S.; Abraham, Brian J.; Cohen, Malkiel A.; Guo, Yang Eric; Hnisz, Denes; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weintraub, Abraham S.; Li, Charles H.; Zamudio, Alicia V.; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Nabet, Behnam; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nabet, Behnam] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Buckley, Dennis L.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Sigova, Alla A.] Marauder Therapeut, Cambridge, MA 02139 USA; [Buckley, Dennis L.; Bradner, James E.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Novartis	Young, RA (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.; Young, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Abraham, Brian/C-2230-2019; Cohen, Malkiel/AAE-1115-2020; Hnisz, Denes/AAE-9592-2019; Nabet, Behnam/AAZ-4987-2020	Young, Richard A/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; Hnisz, Denes/0000-0002-6256-1693; Nabet, Behnam/0000-0002-6738-4200; Li, Charles/0000-0001-8091-6112; Cohen, Malkiel/0000-0002-4187-691X	NIH [HG002668/GM123511, R37HD045022/R01-NS088538/R01-MH104610]; Ludwig Graduate Fellowship funds; NSF GRFP; American Cancer Society New England Division Postdoctoral Fellowship [PF-16-146-01-DMC]; Margaret and Herman Sokol Postdoctoral Award; ACS [PF-17-010-01-CDD]; Merck Fellow of the Damon Runyon Cancer Research Foundation [DRG-2196-14]; Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship; Emerald Foundation; Cancer Research Institute Irvington Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123511, T32GM007287, T32GM087237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Graduate Fellowship funds; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); American Cancer Society New England Division Postdoctoral Fellowship(American Cancer Society); Margaret and Herman Sokol Postdoctoral Award; ACS(American Cancer Society); Merck Fellow of the Damon Runyon Cancer Research Foundation; Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship; Emerald Foundation; Cancer Research Institute Irvington Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Whitehead Institute Genome Technology Core, FACS facility, and Johanna Goldmann for their assistance. This work is supported by NIH grants HG002668/GM123511 (R.A.Y.), R37HD045022/R01-NS088538/R01-MH104610 (R.J.), Ludwig Graduate Fellowship funds (A.S.W.), NSF GRFP (A.V.Z.), American Cancer Society New England Division Postdoctoral Fellowship PF-16-146-01-DMC (D.S.D.), Margaret and Herman Sokol Postdoctoral Award (D.H.), ACS Postdoctoral Fellowship PF-17-010-01-CDD (B.N.), Merck Fellow of the Damon Runyon Cancer Research Foundation DRG-2196-14 (D.L.B.), Hope Funds for Cancer Research Grillo-Marxuach Family Fellowship (B.J.A.), Emerald Foundation (M.A.C.), and Cancer Research Institute Irvington Fellowship (Y.E.G.). The Whitehead Institute filed a patent application based on this study. R.A.Y., J.E.B., and N.S.G. are the founders of Syros Pharmaceuticals. B.J.A. is a shareholder in Syros. R.A.Y. is a founder of Syros Pharmaceuticals, Marauder Therapeutics, and Omega Therapeutics. J.E.B. is a Scientific Founder of SHAPE Pharmaceuticals, Acetylon Pharmaceuticals, Tensha Therapeutics (now Roche), and C4 Therapeutics. J.E.B. is now an executive and shareholder in Novartis AG. N.S.G. is a founder and member of the Scientific Advisory Board of C4 and Petra Therapeutics. R.J. is a cofounder of Fate Therapeutics, Fulcrum Therapeutics, and Omega Therapeutics.	ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Arnold R, 1996, NUCLEIC ACIDS RES, V24, P2640, DOI 10.1093/nar/24.14.2640; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Beagan JA, 2017, GENOME RES, V27, P1139, DOI 10.1101/gr.215160.116; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bonev B, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.147; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Filippova G., 1998, WIDELY EXPRESSED TRA; Filippova GN, 2002, CANCER RES, V62, P48; Fraser J, 2015, MICROBIOL MOL BIOL R, V79, P347, DOI 10.1128/MMBR.00006-15; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gabriele M, 2017, AM J HUM GENET, V100, P907, DOI 10.1016/j.ajhg.2017.05.006; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Huang H., 2017, ELIFE; Hwang SS, 2013, P NATL ACAD SCI USA, V110, P276, DOI 10.1073/pnas.1214682110; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jeronimo C, 2016, MOL CELL, V64, P455, DOI 10.1016/j.molcel.2016.09.002; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kleiman E, 2016, P NATL ACAD SCI USA, V113, pE3911, DOI 10.1073/pnas.1606297113; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; KOHNE AC, 1993, J MOL BIOL, V232, P747, DOI 10.1006/jmbi.1993.1428; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lopez-Perrote A, 2014, J BIOL CHEM, V289, P22614, DOI 10.1074/jbc.M114.567040; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Muerdter F, 2016, CURR BIOL, V26, pR895, DOI 10.1016/j.cub.2016.08.031; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; Nora E., 2016, TARGETED DEGRADATION; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Petrenko N, 2016, MOL CELL, V64, P443, DOI 10.1016/j.molcel.2016.09.015; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ren B, 2015, COLD SH Q B, V80, P17, DOI 10.1101/sqb.2015.80.027219; Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Spitz F, 2016, SEMIN CELL DEV BIOL, V57, P57, DOI 10.1016/j.semcdb.2016.06.017; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	116	421	431	9	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1573	+		10.1016/j.cell.2017.11.008	http://dx.doi.org/10.1016/j.cell.2017.11.008			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29224777	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000418044000014
J	Mohan, D; Farris, C; Fischhoff, B; Rosengart, MR; Angus, DC; Yealy, DM; Wallace, DJ; Barnato, AE				Mohan, Deepika; Farris, Coreen; Fischhoff, Baruch; Rosengart, Matthew R.; Angus, Derek C.; Yealy, Donald M.; Wallace, David J.; Barnato, Amber E.			Efficacy of educational video game versus traditional educational apps at improving physician decision making in trauma triage: randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE PHYSICIANS; EMERGENCY-DEPARTMENTS; OUTCOMES; GUIDELINES; CASELOAD; JUDGMENT; CENTERS; SYSTEMS; ERROR; COSTS	OBJECTIVE To determine whether a behavioral intervention delivered through a video game can improve the appropriateness of trauma triage decisions in the emergency department of non-trauma centers. DESIGN Randomized clinical trial. SETTING Online intervention in national sample of emergency medicine physicians who make triage decisions at US hospitals. PARTICIPANTS 368 emergency medicine physicians primarily working at non-trauma centers. A random sample (n=200) of those with primary outcome data was reassessed at six months. INTERVENTIONS Physicians were randomized in a 1: 1 ratio to one hour of exposure to an adventure video game (Night Shift) or apps based on traditional didactic education (myATLS and Trauma Life Support MCQ Review), both on iPads. Night Shift was developed to recalibrate the process of using pattern recognition to recognize moderate-severe injuries (representativeness heuristics) through the use of stories to promote behavior change (narrative engagement). Physicians were randomized with a 2x2 factorial design to intervention (game v traditional education apps) and then to the experimental condition under which they completed the outcome assessment tool (low v high cognitive load). Blinding could not be maintained after allocation but group assignment was masked during the analysis phase. MAIN OUTCOME MEASURES Outcomes of a virtual simulation that included 10 cases; in four of these the patients had severe injuries. Participants completed the simulation within four weeks of their intervention. Decisions to admit, discharge, or transfer were measured. The proportion of patients under-triaged (patients with severe injuries not transferred to a trauma center) was calculated then (primary outcome) and again six months later, with a different set of cases (primary outcome of follow-up study). The secondary outcome was effect of cognitive load on under-triage. RESULTS 149 (81%) physicians in the game arm and 148 (80%) in the traditional education arm completed the trial. Of these, 64/100 (64%) and 58/100 (58%), respectively, completed reassessment at six months. The mean age was 40 (SD 8.9), 283 (96%) were trained in emergency medicine, and 207 (70%) were ATLS (advanced trauma life support) certified. Physicians exposed to the game under-triaged fewer severely injured patients than those exposed to didactic education (316/596 (0.53) v 377/592 (0.64), estimated difference 0.11, 95% confidence interval 0.05 to 0.16; P<0.001). Cognitive load did not influence under-triage (161/308 (0.53) v 155/288 (0.54) in the game arm; 197/300 (0.66) v 180/292 (0.62) in the traditional educational apps arm; P=0.66). At six months, physicians exposed to the game remained less likely to under-triage patients (146/256 (0.57) v 172/232 (0.74), estimated difference 0.17, 0.09 to 0.25; P<0.001). No physician reported side effects. The sample might not reflect all emergency medicine physicians, and a small set of cases was used to assess performance. CONCLUSIONS Compared with apps based on traditional didactic education, exposure of physicians to a theoretically grounded video game improved triage decision making in a validated virtual simulation. Though the observed effect was large, the wide confidence intervals include the possibility of a small benefit, and the real world efficacy of this intervention remains uncertain.	[Mohan, Deepika; Angus, Derek C.; Wallace, David J.] Univ Pittsburgh, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Farris, Coreen] RAND Corp, 4570 Fifth Ave,Suite 600, Pittsburgh, PA 15213 USA; [Fischhoff, Baruch] Carnegie Mellon Univ, Porter Hall 219E,5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Rosengart, Matthew R.] Univ Pittsburgh, F1266 Presbyterian Hosp, Pittsburgh, PA 15213 USA; [Yealy, Donald M.] Univ Pittsburgh, 3600 Meyran Ave, Pittsburgh, PA 15260 USA; [Barnato, Amber E.] Dartmouth Inst, Williamson Translat Bldg,5th Floor,One Med Ctr Dr, Lebanon, NH 03756 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Mohan, D (corresponding author), Univ Pittsburgh, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mohand@upmc.edu	Angus, Derek C/E-9671-2012; Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874	National Institutes of Health [DP2 LM012339, NHLBI-K08-HL122478]; RAND Center for Gaming; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL122478] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP2LM012339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RAND Center for Gaming; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health through grants DP2 LM012339 (DM) and NHLBI-K08-HL122478 (DJW). RAND Center for Gaming provided funds to recruit physicians for the six month assessment. The funding agencies reviewed the study but played no role in its design or in the collection, analysis or interpretation of data. Schell Games performed work for hire and does not retain any property rights to Night Shift.	American College of Surgeons - Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; ARKES HR, 1991, PSYCHOL BULL, V110, P486, DOI 10.1037/0033-2909.110.3.486; BIRNBAUM MH, 1983, AM J PSYCHOL, V96, P85, DOI 10.2307/1422211; Bliss SJ, 2004, NEW ENGL J MED, V350, P1037, DOI 10.1056/NEJMcps032253; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Committee on Trauma - American College of Surgeons, RES OPT CAR INJ PAT; Delgado MK, 2014, JAMA SURG, V149, P422, DOI 10.1001/jamasurg.2013.4398; Drapkin MS, 2012, NEW ENGL J MED, V367, P754, DOI 10.1056/NEJMcpc1200087; Elstein AS, 2009, ADV HEALTH SCI EDUC, V14, P7, DOI 10.1007/s10459-009-9184-0; Entertainment Software Association, ESS FACTS COMP VID G; Gillard E, 2009, EXP PSYCHOL, V56, P92, DOI 10.1027/1618-3169.56.2.92; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Graafland M, 2012, BRIT J SURG, V99, P1322, DOI 10.1002/bjs.8819; Graber ML, 2012, BMJ QUAL SAF, V21, P535, DOI 10.1136/bmjqs-2011-000149; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Idson LC, 2004, J BEHAV DECIS MAKING, V17, P159, DOI 10.1002/bdm.467; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D, 2003, JUDGMENT UNCERTAINTY, P3; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kapoor R, 2014, NEW ENGL J MED, V371, P2218, DOI 10.1056/NEJMcps1212211; Kassam, 2015, POLICY INSIGHTS BEHA, V2, P129, DOI [10.1177/2372732215600886, DOI 10.1177/2372732215600886]; Lale A, 2017, JAMA SURG, V152, P467, DOI 10.1001/jamasurg.2016.5049; LICHTENSTEIN S, 1980, ORGAN BEHAV HUM PERF, V26, P149, DOI 10.1016/0030-5073(80)90052-5; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Madigan J, 2016, THE PSYCHOLOGY OF IM; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Milkman KL, 2009, PERSPECT PSYCHOL SCI, V4, P379, DOI 10.1111/j.1745-6924.2009.01142.x; Miller-Day M, 2013, HEALTH COMMUN, V28, P657, DOI 10.1080/10410236.2012.762861; Mohan D, 2016, BMC EMERG MED, V16, P1, DOI 10.1186/s12873-016-0108-z; Mohan D, 2015, ANN SURG, V261, P383, DOI 10.1097/SLA.0000000000000603; Mohan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105445; Mohan D, 2013, J TRAUMA ACUTE CARE, V74, P1541, DOI 10.1097/TA.0b013e31828c3f75; Mohan D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-103; Mohan D, 2010, ANN SURG, V251, P946, DOI 10.1097/SLA.0b013e3181d76cb5; Moyer-Guse E, 2010, HUM COMMUN RES, V36, P26, DOI 10.1111/j.1468-2958.2009.01367.x; Nabi RL, 2015, MEDIA PSYCHOL, V18, P137, DOI 10.1080/15213269.2014.912585; National Academies of Sciences, 2015, ENG MED IMPR DIAGN H; National Academies of Sciences Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; Nyweide DJ, 2009, JAMA-J AM MED ASSOC, V302, P2444, DOI 10.1001/jama.2009.1810; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Raab SS, 2008, AM J CLIN PATHOL, V130, P905, DOI 10.1309/AJCPPIA5D7MYKDWF; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Ramnarayan Padmanabhan, 2006, BMC Med Inform Decis Mak, V6, P37, DOI 10.1186/1472-6947-6-37; Safdar N, 2015, NEW ENGL J MED, V372, P2218, DOI 10.1056/NEJMcps1413402; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Todd P.M., 1999, SIMPLE HEURISTICS MA; Tsai TT, 2009, NEW ENGL J MED, V361, P1010, DOI 10.1056/NEJMcps0903023; Tudor GR, 2001, CLIN RADIOL, V56, P751, DOI 10.1053/crad.2001.0760; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Wolpaw T, 2009, ACAD MED, V84, P517, DOI 10.1097/ACM.0b013e31819a8cbf; Zhou QH, 2017, JAMA SURG, V152, P369, DOI 10.1001/jamasurg.2016.4976	57	27	27	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5416	10.1136/bmj.j5416	http://dx.doi.org/10.1136/bmj.j5416			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KY	29233854	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000418327500002
J	Brown, PT; Caldeira, K				Brown, Patrick T.; Caldeira, Ken			Greater future global warming inferred from Earth's recent energy budget	NATURE			English	Article							CLIMATE SENSITIVITY; RADIATION BUDGET; CONSTRAINTS; CLOUDS; SPREAD; TEMPERATURE; FEEDBACKS; CMIP5	Climate models provide the principal means of projecting global warming over the remainder of the twenty-first century but modelled estimates of warming vary by a factor of approximately two even under the same radiative forcing scenarios. Across-model relationships between currently observable attributes of the climate system and the simulated magnitude of future warming have the potential to inform projections. Here we show that robust across-model relationships exist between the global spatial patterns of several fundamental attributes of Earth's top-of-atmosphere energy budget and the magnitude of projected global warming. When we constrain the model projections with observations, we obtain greater means and narrower ranges of future global warming across the major radiative forcing scenarios, in general. In particular, we find that the observationally informed warming projection for the end of the twenty-first century for the steepest radiative forcing scenario is about 15 per cent warmer (+0.5 degrees Celsius) with a reduction of about a third in the two-standard-deviation spread (-1.2 degrees Celsius) relative to the raw model projections reported by the Intergovernmental Panel on Climate Change. Our results suggest that achieving any given global temperature stabilization target will require steeper greenhouse gas emissions reductions than previously calculated.	[Brown, Patrick T.; Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	Carnegie Institution for Science	Brown, PT (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	pbrown@carnegiescience.edu	Keyes, Dennis/AAZ-9285-2021; Caldeira, Ken/E-7914-2011	Caldeira, Ken/0000-0002-4591-643X; Brown, Patrick/0000-0002-5058-1718	Fund for Innovative Climate and Energy Research; Carnegie Institution for Science endowment	Fund for Innovative Climate and Energy Research; Carnegie Institution for Science endowment	We thank Z. Hausfather for discussions. This study was supported by the Fund for Innovative Climate and Energy Research and the Carnegie Institution for Science endowment. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for the Coupled Modelled Intercomparison Project (CMIP), and we thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Armour KC, 2013, J CLIMATE, V26, P4518, DOI 10.1175/JCLI-D-12-00544.1; Baker MB, 2009, J CLIMATE, V22, P4574, DOI 10.1175/2009JCLI2647.1; Brient F, 2016, J CLIMATE, V29, P5821, DOI 10.1175/JCLI-D-15-0897.1; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Caldwell PM, 2016, J CLIMATE, V29, P513, DOI 10.1175/JCLI-D-15-0352.1; Caldwell PM, 2014, GEOPHYS RES LETT, V41, P1803, DOI 10.1002/2014GL059205; Ceppi P, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.465; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Curry J. A., 2017, CLIMATE MODELS LAYMA; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; DelSole T, 2009, J CLIMATE, V22, P331, DOI 10.1175/2008JCLI2414.1; Dessler AE, 2010, SCIENCE, V330, P1523, DOI 10.1126/science.1192546; Dessler AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035333; Fasullo JT, 2012, SCIENCE, V338, P792, DOI 10.1126/science.1227465; Feldl N, 2013, J CLIMATE, V26, P8289, DOI 10.1175/JCLI-D-12-00631.1; Flato G., 2013, CLIMATE CHANGE 2013, P741; Gordon ND, 2014, J GEOPHYS RES-ATMOS, V119, P6052, DOI 10.1002/2013JD021052; Gregory JM, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0417; Grise KM, 2015, J CLIMATE, V28, P9298, DOI 10.1175/JCLI-D-15-0031.1; Hall A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025127; Hansen J, 2016, ATMOS CHEM PHYS, V16, P3761, DOI 10.5194/acp-16-3761-2016; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hu XM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04623-7; Huber M, 2011, J CLIMATE, V24, P1034, DOI 10.1175/2010JCLI3403.1; Hwang YT, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045440; Klein SA, 2015, CURR CLIM CHANGE REP, V1, P276, DOI 10.1007/s40641-015-0027-1; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Myers TA, 2016, GEOPHYS RES LETT, V43, P2144, DOI 10.1002/2015GL067416; Myhre G., 2013, CONTRIBUTION WORKING; Qu X, 2014, CLIM DYNAM, V42, P69, DOI 10.1007/s00382-013-1774-0; Roe GH, 2015, NAT GEOSCI, V8, P135, DOI [10.1038/NGEO2346, 10.1038/ngeo2346]; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/gigs.1000101, DOI 10.4172/2327-4581.1000101]; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Rugenstein MAA, 2016, GEOPHYS RES LETT, V43, P9877, DOI 10.1002/2016GL070907; Schmidt G. A., 2017, GEOSCI MODEL DEV DIS, V2017, P1; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Smoliak BV, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041478; Su H, 2014, J GEOPHYS RES-ATMOS, V119, P5787, DOI 10.1002/2014JD021642; Tan I, 2016, SCIENCE, V352, P224, DOI 10.1126/science.aad5300; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Tebaldi C, 2014, CLIMATIC CHANGE, V122, P459, DOI 10.1007/s10584-013-1032-9; Tian BJ, 2015, GEOPHYS RES LETT, V42, P4133, DOI 10.1002/2015GL064119; Tignor M., 2013, CLIMATE CHANGE 2013; Trenberth KE, 2015, J GEOPHYS RES-ATMOS, V120, P3642, DOI 10.1002/2014JD022887; Trenberth KE, 2013, J CLIMATE, V26, P7837, DOI 10.1175/JCLI-D-13-00008.1; Trenberth KE, 2010, J CLIMATE, V23, P440, DOI 10.1175/2009JCLI3152.1; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Volodin EM, 2008, IZV ATMOS OCEAN PHY+, V44, P288, DOI 10.1134/S0001433808030043; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Zhai CX, 2015, GEOPHYS RES LETT, V42, P8729, DOI 10.1002/2015GL065911; Zhou C, 2015, GEOPHYS RES LETT, V42, P10463, DOI 10.1002/2015GL066698	56	157	161	24	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					45	+		10.1038/nature24672	http://dx.doi.org/10.1038/nature24672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219964				2022-12-28	WOS:000417560500040
J	Darrow, JJ; Avorn, J; Kesselheim, AS				Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.			Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL DEVELOPMENT; SURVIVAL; APPROVAL; DRUGS; RISK; ACT		[Darrow, Jonathan J.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Darrow, J J/R-8365-2019	Darrow, J J/0000-0002-7351-4243	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Supported by the Laura and John Arnold Foundation, with additional support from the Engelberg Foundation. Dr. Kesselheim has also received funding from the Harvard Program in Therapeutic Science.	Abola MV, 2016, MAYO CLIN PROC, V91, P1668, DOI 10.1016/j.mayocp.2016.08.015; [Anonymous], 2017, FED REGISTER, V82, P41026; [Anonymous], 2017, FED REGISTER, V82, P43241; [Anonymous], 1980, 8064 HRD; [Anonymous], 2017, FED REGISTER, V82, P43244; [Anonymous], 2017, FED REGISTER, V82, P41029; Avorn Jerry, 2004, POWERFUL MED; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Carpenter D, 2014, PREVENTING REGULATORY CAPTURE: SPECIAL INTEREST INFLUENCE AND HOW TO LIMIT IT, P152; Center for Drug Evaluation and Research, 2016, MAN POL PROC 5240 3; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Ciani O, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f457; Darrow Jonathan J., 2013, WASH LEE L REV, V70, P2073; Food and Drug Administration, 2010, AD DES CLIN IN PRESS; Food and Drug Administration, 2017, FEE REL QUEST; Food and Drug Administration, 2017, BSUFA M; Food and Drug Administration, 2017, GDUFA REAUTH PUBL M; Food and Drug Administration, 2017, MULT ENDP C IN PRESS; Forum on Drug Discovery Development and Translation Board on Health Sciences Policy Health and Medicine Division, 2022, ENV TRANSF CLIN TRIA; Frank C, 2014, HEALTH AFFAIR, V33, P1453, DOI 10.1377/hlthaff.2014.0122; Gilhooley M., 2011, NM L REV, V41, P327; Government Accountability Office, 1995, PEMD961 GOV ACC OFF; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Hutt PB, 2008, ADMIN LAW REV, V60, P431; Hwang TJ, 2016, JAMA INTERN MED, V176, P1826, DOI 10.1001/jamainternmed.2016.6008; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V315, P1516, DOI 10.1001/jama.2015.16984; Kusserow RP, 1990, IMPLEMENTING USER FE; Kwak J, 2014, PREVENTING REGULATORY CAPTURE: SPECIAL INTEREST INFLUENCE AND HOW TO LIMIT IT, P71; O'Leary P, 2013, HARVARD J LEGIS, V50, P239; Office of the Inspector General, 2003, USITC PUBL; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Prescription Drug User Fee Act (PDUFA), 2005, CISC VIS NETW IND GL; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443; Stern AD, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0013; Tan A, 2017, J CLIN ONCOL, V35, P1686, DOI 10.1200/JCO.2016.71.2109; THOMPSON L, 2000, FDA CONSUMER MAGAZIN; Union of Concerned Scientists, 2006, VOIC SCI FDA PROT PU; Wolfe S, 1998, FDA MED OFFICERS REP; Woloshin S, 2017, NEW ENGL J MED, V377, P1114, DOI 10.1056/NEJMp1705800; Woodcock J, PDUFA LAYS FDN LAUNC; Zelenay JL, 2005, FOOD DRUG LAW J, V60, P261	44	29	29	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2278	2286		10.1056/NEJMhle1710706	http://dx.doi.org/10.1056/NEJMhle1710706			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211663				2022-12-28	WOS:000417201100014
J	Germano, G; Lamba, S; Rospo, G; Barault, L; Magri, A; Maione, F; Russo, M; Crisafulli, G; Bartolini, A; Lerda, G; Siravegna, G; Mussolin, B; Frapolli, R; Montone, M; Morano, F; de Braud, F; Amirouchene-Angelozzi, N; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Sartore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A				Germano, Giovanni; Lamba, Simona; Rospo, Giuseppe; Barault, Ludovic; Magri, Alessandro; Maione, Federica; Russo, Mariangela; Crisafulli, Giovanni; Bartolini, Alice; Lerda, Giulia; Siravegna, Giulia; Mussolin, Benedetta; Frapolli, Roberta; Montone, Monica; Morano, Federica; de Braud, Filippo; Amirouchene-Angelozzi, Nabil; Marsoni, Silvia; D'Incalci, Maurizio; Orlandi, Armando; Giraudo, Enrico; Sartore-Bianchi, Andrea; Siena, Salvatore; Pietrantonio, Filippo; Di Nicolantonio, Federica; Bardelli, Alberto			Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth	NATURE			English	Article							METASTATIC COLORECTAL-CANCER; MISMATCH-REPAIR; PD-1 BLOCKADE; MUTATIONS; TEMOZOLOMIDE; BLOOD; GLIOBLASTOMAS; SENSITIVITY; PROGRESSION; RESISTANCE	Molecular alterations in genes involved in DNA mismatch repair (MMR) promote cancer initiation and foster tumour progression(1). Cancers deficient in MMR frequently show favourable prognosis and indolent progression(2). The functional basis of the clinical outcome of patients with tumours that are deficient in MMR is not clear. Here we genetically inactivate MutL homologue 1 (MLH1) in colorectal, breast and pancreatic mouse cancer cells. The growth of MMR-deficient cells was comparable to their proficient counterparts in vitro and on transplantation in immunocompromised mice. By contrast, MMR-deficient cancer cells grew poorly when transplanted in syngeneic mice. The inactivation of MMR increased the mutational burden and led to dynamic mutational profiles, which resulted in the persistent renewal of neoantigens in vitro and in vivo, whereas MMR-proficient cells exhibited stable mutational load and neoantigen profiles over time. Immune surveillance improved when cancer cells, in which MLH1 had been inactivated, accumulated neoantigens for several generations. When restricted to a clonal population, the dynamic generation of neoantigens driven by MMR further increased immune surveillance. Inactivation of MMR, driven by acquired resistance to the clinical agent temozolomide, increased mutational load, promoted continuous renewal of neoantigens in human colorectal cancers and triggered immune surveillance in mouse models. These results suggest that targeting DNA repair processes can increase the burden of neoantigens in tumour cells; this has the potential to be exploited in therapeutic approaches.	[Germano, Giovanni; Lamba, Simona; Rospo, Giuseppe; Barault, Ludovic; Magri, Alessandro; Maione, Federica; Russo, Mariangela; Crisafulli, Giovanni; Bartolini, Alice; Lerda, Giulia; Siravegna, Giulia; Mussolin, Benedetta; Montone, Monica; Amirouchene-Angelozzi, Nabil; Marsoni, Silvia; Giraudo, Enrico; Di Nicolantonio, Federica; Bardelli, Alberto] IRCCS, Candiolo Canc Inst FPO, I-10060 Turin, Italy; [Germano, Giovanni; Barault, Ludovic; Magri, Alessandro; Russo, Mariangela; Crisafulli, Giovanni; Lerda, Giulia; Siravegna, Giulia; Di Nicolantonio, Federica; Bardelli, Alberto] Univ Turin, Dept Oncol, I-10060 Turin, Italy; [Frapolli, Roberta; D'Incalci, Maurizio] IRCCS Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy; [Morano, Federica; de Braud, Filippo; Pietrantonio, Filippo] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, I-20133 Milan, Italy; [de Braud, Filippo; Siena, Salvatore] Univ Milan, Dept Oncol & Hemat Oncol, I-20122 Milan, Italy; [Amirouchene-Angelozzi, Nabil] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy; [Orlandi, Armando] Policlin Univ A Gemelli, I-00168 Rome, Italy; [Giraudo, Enrico] Univ Torino, Dept Sci & Drug Technol, I-10125 Turin, Italy; [Sartore-Bianchi, Andrea; Siena, Salvatore] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, I-20142 Milan, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; IFOM - FIRC Institute of Molecular Oncology; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Turin	Bardelli, A (corresponding author), IRCCS, Candiolo Canc Inst FPO, I-10060 Turin, Italy.; Bardelli, A (corresponding author), Univ Turin, Dept Oncol, I-10060 Turin, Italy.	alberto.bardelli@unito.it	Di Nicolantonio, Federica/A-2503-2011; Maione, Federica/K-6679-2016; SIENA, SALVATORE/AAC-5806-2019; Russo, Mariangela/K-1900-2018; Giraudo, Enrico/K-6441-2019; Morano, Federica/B-7910-2018; D'Incalci, Maurizio/AAA-9021-2020; Rospo, Giuseppe/AAC-4523-2020; Crisafulli, Giovanni/AAB-6256-2019; Sartore-Bianchi, Andrea/AAB-9848-2019; Frapolli, Roberta/AAA-6729-2020; Pietrantonio, Filippo/C-2180-2017; Germano, Giovanni/AAB-6672-2020; Orlandi, Armando/A-1517-2015; Barault, Ludovic/J-2472-2016; Giraudo, Enrico/K-3192-2016; Siravegna, Giulia/Z-2826-2019; BARTOLINI, ALICE/K-2534-2018; de Braud, Filippo Guglielmo Maria/B-9997-2017; BARDELLI, Alberto/J-9721-2018	Di Nicolantonio, Federica/0000-0001-9618-2010; Maione, Federica/0000-0003-2789-799X; SIENA, SALVATORE/0000-0002-2681-2846; Russo, Mariangela/0000-0003-4625-1449; Giraudo, Enrico/0000-0003-4128-4786; Morano, Federica/0000-0002-5306-3596; D'Incalci, Maurizio/0000-0001-8784-1360; Rospo, Giuseppe/0000-0002-1757-9085; Crisafulli, Giovanni/0000-0002-5511-1555; Sartore-Bianchi, Andrea/0000-0003-0780-0409; Frapolli, Roberta/0000-0003-2907-273X; Pietrantonio, Filippo/0000-0002-8530-8420; Germano, Giovanni/0000-0003-1688-8684; Orlandi, Armando/0000-0001-5253-4678; Barault, Ludovic/0000-0001-5227-5047; Giraudo, Enrico/0000-0003-4128-4786; Siravegna, Giulia/0000-0002-7132-6484; Lamba, Simona Elena/0000-0003-3207-1594; MUSSOLIN, BENEDETTA/0000-0001-5723-5685; BARTOLINI, ALICE/0000-0003-3492-0772; de Braud, Filippo Guglielmo Maria/0000-0003-0103-730X; BARDELLI, Alberto/0000-0003-1647-5070; Marsoni, Silvia/0000-0002-5361-7122; MONTONE, MONICA/0000-0001-7907-4333	European Community's Seventh Framework Programme [602901 MErCuRIC, 635342-2 MoTriColor]; IMI contract [115749 CANCER-ID]; AIRC Special Program Molecular Clinical Oncology 5 per mille [9970]; AIRC IG [16788, 17707]; Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille Ministero della Salute; AIRC-IG Grant [15645]; Swiss National Science Foundation SNSF), Sinergia Grant [CRSII3 160742/1]; AIRC; EU under a Marie Curie COFUND; AIRC 3-year fellowship; grant Terapia Molecolare Tumori by Fondazione Oncologia Niguarda Onlus; Merck grant for Oncology Innovation -GOI-	European Community's Seventh Framework Programme(European Commission); IMI contract; AIRC Special Program Molecular Clinical Oncology 5 per mille; AIRC IG(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille Ministero della Salute; AIRC-IG Grant(Fondazione AIRC per la ricerca sul cancro); Swiss National Science Foundation SNSF), Sinergia Grant(Swiss National Science Foundation (SNSF)); AIRC; EU under a Marie Curie COFUND; AIRC 3-year fellowship; grant Terapia Molecolare Tumori by Fondazione Oncologia Niguarda Onlus; Merck grant for Oncology Innovation -GOI-	We thank B. Van Emburgh, A. Sogari, C. Falcomata, V. Amodio and C. Cancelliere for assistance with in vitro experiments; F. Sassi and S. Giove for help with the immunohistochemistry; M. Buscarino for suggestions on MSI analysis; D. Cantarella for performing RNA-seq; G. Corti and L. Novara for bioinformatic analysis and comments; D. Sangiolo and M. Rescigno for discussion; D. Hananhan and K. Shchors for providing the PDAC cell model; and C. Torrance and J. Roix for scientific support, suggestions and critically reading the manuscript. This study was supported by European Community's Seventh Framework Programme under grant agreement no. 602901 MErCuRIC (A. Bard. and G. G.); no. 635342-2 MoTriColor (A. Bard. and S. S.); IMI contract no. 115749 CANCER-ID (A. Bard.); AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille, Project no. 9970 (A. Bard. and S. S.); AIRC IG no. 16788 (A. Bard.); AIRC IG no. 17707 (F.D.N.); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille 2011 Ministero della Salute (A. Bard. and F.D.N.); AIRC-IG Grant no. 15645 and Swiss National Science Foundation SNSF), Sinergia Grant (CRSII3 160742/1) (E.G.); AIRC and the EU under a Marie Curie COFUND (G.G.); AIRC 3-year fellowship (G.S.); grant Terapia Molecolare Tumori by Fondazione Oncologia Niguarda Onlus (A.S.-B. and S.S.); and Merck grant for Oncology Innovation -GOI- 2016 (A. Bard.).	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Bailey JM, 2016, ONCOGENE, V35, P4282, DOI 10.1038/onc.2015.441; Bardelli A, 2001, P NATL ACAD SCI USA, V98, P5770, DOI 10.1073/pnas.081082898; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cahill Daniel P, 2008, Clin Neurosurg, V55, P165; Calegari MA, 2017, BRIT J CANCER, V116, P1279, DOI 10.1038/bjc.2017.109; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; CORBETT TH, 1975, CANCER RES, V35, P2434; Fink D, 1998, CLIN CANCER RES, V4, P1; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gilles ME, 2016, CANCER RES, V76, P7181, DOI 10.1158/0008-5472.CAN-16-0300; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Jiricny J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012633; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee SY, 2016, GENES DIS, V3, P198, DOI 10.1016/j.gendis.2016.04.007; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maione F, 2012, J CLIN INVEST, V122, P1832, DOI 10.1172/JCI58976; Maletzki C, 2013, EUR J CANCER, V49, P2587, DOI 10.1016/j.ejca.2013.02.035; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ponti G, 2015, CLIN GENET, V87, P507, DOI 10.1111/cge.12529; Rayner E, 2016, NAT REV CANCER, V16, P71, DOI 10.1038/nrc.2015.12; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sartore-Bianchi A, 2017, EUR J CANCER, V71, P43, DOI 10.1016/j.ejca.2016.10.032; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Woerner SM, 2015, MOL CARCINOGEN, V54, P1376, DOI 10.1002/mc.22213; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	44	325	331	9	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					116	+		10.1038/nature24673	http://dx.doi.org/10.1038/nature24673			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186113				2022-12-28	WOS:000417560500054
J	McKellar, S				McKellar, Shelley			Clinical Firsts - Christiaan Barnard's Heart Transplantations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McKellar, Shelley] Western Univ, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	McKellar, S (corresponding author), Western Univ, Schulich Sch Med & Dent, London, ON, Canada.							BARNARD C N, 1967, South African Medical Journal, V41, P1271; BARNARD CN, 1968, AM J CARDIOL, V22, P584, DOI 10.1016/0002-9149(68)90166-5; Fox R., 1974, COURAGE FAIL SOCIAL; Fye, 2015, CARING HEART MAYO CL; McKellar Shelley., 2018, ARTIFICIAL HEARTS AL	5	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2211	2213		10.1056/NEJMp1707919	http://dx.doi.org/10.1056/NEJMp1707919			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211673				2022-12-28	WOS:000417201100004
J	Le, LH; Badgett, RG				Le, Lisa H.; Badgett, Robert G.			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter							DOUBLE-BLIND		[Le, Lisa H.; Badgett, Robert G.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center	Le, LH (corresponding author), Univ Kansas, Sch Med, Wichita, KS 67214 USA.		Badgett, Robert/AAD-3429-2021	Badgett, Robert/0000-0003-2888-3303				Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub4; Kaplan RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132382; Lee JH, 2013, CLIN THER, V35, P1830, DOI 10.1016/j.clinthera.2013.09.017; Prasad V, 2015, MAYO CLIN PROC, V90, P1171, DOI 10.1016/j.mayocp.2015.05.006; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	5	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					834	834		10.7326/L17-0472	http://dx.doi.org/10.7326/L17-0472			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204613				2022-12-28	WOS:000417135900022
J	Cohen, JB; Townsend, RR				Cohen, Jordana B.; Townsend, Raymond R.			The ACC/AHA 2017 Hypertension Guidelines: Both Too Much and Not Enough of a Good Thing?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIANS		[Cohen, Jordana B.; Townsend, Raymond R.] Univ Penn, 3400 Spruce St, Philadelphia, PA 19103 USA	University of Pennsylvania	Cohen, JB (corresponding author), Univ Penn, 3400 Spruce St, Philadelphia, PA 19103 USA.	jco@pennmedicine.upenn.edu	Cohen, Jordana/S-5435-2016	Cohen, Jordana/0000-0003-4649-079X				Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Whelton PK, 2018, J AM COLL CARDIOL, V71, P1, DOI [10.22141/2307-1257.7.1.2018.122220, 10.1161/HYP.0000000000000065, DOI 10.1161/HYP.0000000000000065]	10	20	20	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					287	+		10.7326/M17-3103	http://dx.doi.org/10.7326/M17-3103			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29204627				2022-12-28	WOS:000425434000018
J	Karliner, M; Rosner, JL				Karliner, Marek; Rosner, Jonathan L.			Quark-level analogue of nuclear fusion with doubly heavy baryons (vol 551, pg 89, 2017)	NATURE			English	Correction																		Karliner M, 2017, NATURE, V551, P89, DOI 10.1038/nature24289	1	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687								10.1038/nature25141	http://dx.doi.org/10.1038/nature25141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29186121	Bronze			2022-12-28	WOS:000419794800044
J	Youngblood, B; Hale, JS; Kissick, HT; Ahn, E; Xu, XJ; Wieland, A; Araki, K; West, EE; Ghoneim, HE; Fan, YP; Dogra, P; Davis, CW; Konieczny, BT; Antia, R; Cheng, XD; Ahmed, R				Youngblood, Ben; Hale, J. Scott; Kissick, Haydn T.; Ahn, Eunseon; Xu, Xiaojin; Wieland, Andreas; Araki, Koichi; West, Erin E.; Ghoneim, Hazem E.; Fan, Yiping; Dogra, Pranay; Davis, Carl W.; Konieczny, Bogumila T.; Antia, Rustom; Cheng, Xiaodong; Ahmed, Rafi			Effector CD8 T cells dedifferentiate into long-lived memory cells	NATURE			English	Article							VIRAL PERSISTENCE; DNA METHYLATION; EXPRESSION; FATES; DEMETHYLATION; PRECURSOR; DNMT3A; VIRUS; BET; ID2	Memory CD8 T cells that circulate in the blood and are present in lymphoid organs are an essential component of long-lived T cell immunity. These memory CD8 T cells remain poised to rapidly elaborate effector functions upon re-exposure to pathogens, but also have many properties in common with naive cells, including pluripotency and the ability to migrate to the lymph nodes and spleen. Thus, memory cells embody features of both naive and effector cells, fuelling a long-standing debate centred on whether memory T cells develop from effector cells or directly from naive cells(1-4). Here we show that long-lived memory CD8 T cells are derived from a subset of effector T cells through a process of dedifferentiation. To assess the developmental origin of memory CD8 T cells, we investigated changes in DNA methylation programming at naive and effector cell-associated genes in virus-specific CD8 T cells during acute lymphocytic choriomeningitis virus infection in mice. Methylation profiling of terminal effector versus memory-precursor CD8 T cell subsets showed that, rather than retaining a naive epigenetic state, the subset of cells that gives rise to memory cells acquired de novo DNA methylation programs at naive-associated genes and became demethylated at the loci of classically defined effector molecules. Conditional deletion of the de novo methyltransferase Dnmt3a at an early stage of effector differentiation resulted in reduced methylation and faster re-expression of naive-associated genes, thereby accelerating the development of memory cells. Longitudinal phenotypic and epigenetic characterization of the memory-precursor effector subset of virus-specific CD8 T cells transferred into antigen-free mice revealed that differentiation to memory cells was coupled to erasure of de novo methylation programs and re-expression of naive-associated genes. Thus, epigenetic repression of naive-associated genes in effector CD8 T cells can be reversed in cells that develop into long-lived memory CD8 T cells while key effector genes remain demethylated, demonstrating that memory T cells arise from a subset of fate-permissive effector T cells.	[Youngblood, Ben; Hale, J. Scott; Ahn, Eunseon; Xu, Xiaojin; Wieland, Andreas; Araki, Koichi; West, Erin E.; Davis, Carl W.; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Youngblood, Ben; Hale, J. Scott; Ahn, Eunseon; Xu, Xiaojin; Wieland, Andreas; Araki, Koichi; West, Erin E.; Davis, Carl W.; Konieczny, Bogumila T.; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA; [Youngblood, Ben; Ghoneim, Hazem E.; Dogra, Pranay] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	Emory University; Emory University; St Jude Children's Research Hospital; Emory University; St Jude Children's Research Hospital; Emory University; Emory University; University of Texas System; UTMD Anderson Cancer Center	Youngblood, B; Ahmed, R (corresponding author), Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA.; Youngblood, B; Ahmed, R (corresponding author), Emory Univ, Dept Microbiol & Immunol, Sch Med, Atlanta, GA 30322 USA.; Youngblood, B (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	benjamin.youngblood@stjude.org; rahmed@emory.edu	Kissick, Haydn/AAS-6292-2021; Youngblood, Benjamin/N-2508-2018	Kissick, Haydn/0000-0001-7624-5598; Youngblood, Benjamin/0000-0002-1261-9957; Dogra, Pranay/0000-0003-2031-9855; Araki, Koichi/0000-0003-3478-6315	National Institutes of Health (NIH) [U19 AI117891, R01AI030048, U19AI057266, R01AI114442]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114442, R01AI030048, U19AI117891, P01AI080192, U19AI057266, R37AI030048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Karaffa and S. Durham at the Emory University School of Medicine Flow Cytometry Core Facility and R. Cross and G. Lennon in the St Jude Flow Cytometry Core Facility for FACS sorting. Whole-genome sequencing was performed by the St Jude Hartwell Sequencing facility. This work was supported by the National Institutes of Health (NIH) grant U19 AI117891 (to R.An.), R01AI030048 (to R.Ah.), U19AI057266 (to R.Ah.), R01AI114442(to B.Y.), and funds from American Lebanese Syrian Associated Charities (ALSAC) (to B.Y.).	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Akondy R. S., 2017, NATURE; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Cannarile MA, 2006, NAT IMMUNOL, V7, P1317, DOI 10.1038/ni1403; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Dang XT, 2009, BBA-GENE REGUL MECH, V1789, P146, DOI 10.1016/j.bbagrm.2008.10.004; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Furukawa Y, 2008, J BIOL CHEM, V283, P12112, DOI 10.1074/jbc.M801745200; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kersh EN, 2006, J IMMUNOL, V177, P3821, DOI 10.4049/jimmunol.177.6.3821; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Ladle BH, 2016, P NATL ACAD SCI USA, V113, P10631, DOI 10.1073/pnas.1524490113; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Youngblood B, 2013, IMMUNOLOGY, V139, P277, DOI 10.1111/imm.12074; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015	38	250	262	12	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					404	+		10.1038/nature25144	http://dx.doi.org/10.1038/nature25144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236683	Green Accepted			2022-12-28	WOS:000418559800059
J	Wallace, DV; Dykewicz, MS; Oppenheimer, J; Portnoy, JM; Lang, DM				Wallace, Dana V.; Dykewicz, Mark S.; Oppenheimer, John; Portnoy, Jay M.; Lang, David M.			Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters	ANNALS OF INTERNAL MEDICINE			English	Article							AQUEOUS NASAL SPRAY; CLINICALLY IMPORTANT DIFFERENCE; PLACEBO-CONTROLLED TRIAL; ADD-ON THERAPY; FLUTICASONE PROPIONATE; AZELASTINE HYDROCHLORIDE; DOUBLE-BLIND; MONTELUKAST; COMBINATION; LORATADINE	Description: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care providers on the initial pharmacologic treatment of seasonal allergic rhinitis in patients aged 12 years or older. Methods: To update a prior systematic review, the workgroup searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from 18 July 2012 to 29 July 2016 to identify studies that addressed efficacy and adverse effects of single or combination pharmacotherapy for seasonal allergic rhinitis. In conjunction with the Joint Task Force, the workgroup reviewed the evidence and developed recommendations about initial treatment approaches by using the Grading of Recommendations Assessment, Development and Evaluation approach. Members of the AAAAI, the ACAAI, and the general public provided feedback on the draft document, which the Joint Task Force reviewed before finalizing the guideline. Recommendation 1: For initial treatment of seasonal allergic rhinitis in persons aged 12 years or older, routinely prescribe monotherapy with an intranasal corticosteroid rather than an intranasal corticosteroid in combination with an oral antihistamine. (Strong recommendation) Recommendation 2: For initial treatment of seasonal allergic rhinitis in persons aged 15 years or older, recommend an intranasal corticosteroid over a leukotriene receptor antagonist. (Strong recommendation) Recommendation 3: For treatment of moderate to severe seasonal allergic rhinitis in persons aged 12 years or older, the clinician may recommend the combination of an intranasal corticosteroid and an intranasal antihistamine for initial treatment. (Weak recommendation)	[Wallace, Dana V.] 1240 SW 14th Ave, Ft Lauderdale, FL 33312 USA; [Dykewicz, Mark S.] St Louis Univ Allergy & Immunol, 1402 S Grand Blvd,M157, St Louis, MO 63104 USA; [Oppenheimer, John] Care of Pulm & Allergy Assoc, UMDNJ Rutgers, 1 Springfield Ave, Summit, NJ 07901 USA; [Portnoy, Jay M.] Univ Missouri Kansas City, Sch Med, Childrens Mercy Hosp, Sect Allergy Asthma & Immunol, 2401 Gillham Rd, Kansas City, MO 64108 USA; [Lang, David M.] Resp Inst, Cleveland Clin, Dept Allergy & Clin Immunol, 9500 Euclid Ave A90, Cleveland, OH 44195 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Cleveland Clinic Foundation	Wallace, DV (corresponding author), Care of Amer Acad Allergy, 555 E Wells St,Suite 1100, Milwaukee, WI 53202 USA.	naumann@aaaai.org						Anolik R, 2008, ANN ALLERG ASTHMA IM, V100, P264, DOI 10.1016/S1081-1206(10)60452-8; Barnes ML, 2010, CLIN EXP ALLERGY, V40, P242, DOI 10.1111/j.1365-2222.2009.03381.x; Barnes ML, 2006, CLIN EXP ALLERGY, V36, P676, DOI 10.1111/j.1365-2222.2006.02478.x; BENINCASA C, 1994, DRUG INVEST, V8, P225, DOI 10.1007/BF03258482; Brooks CD, 1996, AM J RHINOL, V10, P193, DOI 10.2500/105065896781794941; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050; Can D, 2006, ALLERGY ASTHMA PROC, V27, P248, DOI 10.2500/aap.2006.27.2856; Carr W, 2012, J ALLERGY CLIN IMMUN, V129, P1282, DOI 10.1016/j.jaci.2012.01.077; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Devillier P, 2014, ALLERGY, V69, P1689, DOI 10.1111/all.12518; Di Lorenzo G, 2004, CLIN EXP ALLERGY, V34, P259, DOI 10.1111/j.1365-2222.2004.01877.x; Dykewicz MS, 2017, ANN ALLERG ASTHMA IM, V119, P489, DOI 10.1016/j.anai.2017.08.012; Dykewicz MS, 1998, ANN ALLERG ASTHMA IM, V81, P478, DOI 10.1016/S1081-1206(10)63155-9; Forbes Consulting Group, 2005, UND DYN SURR ALL SUF; Glacy J, 2013, AHRQ PUBLICATION; Greenhawt M, 2017, ANN ALLERG ASTHMA IM, V118, P276, DOI 10.1016/j.anai.2016.12.009; Hampel FC, 2010, ANN ALLERG ASTHMA IM, V105, P168, DOI 10.1016/j.anai.2010.06.008; Hellings Peter W, 2012, Clin Transl Allergy, V2, P9; Lu S, 2009, J ASTHMA, V46, P878, DOI 10.3109/02770900903104540; Martin BG, 2006, ANN ALLERG ASTHMA IM, V96, P851, DOI 10.1016/S1081-1206(10)61349-X; Meda Pharmaceuticals, DYMISTA FULL PRESCR; Meltzer EO, 2016, J ALLER CL IMM-PRACT, V4, P682, DOI 10.1016/j.jaip.2016.02.006; Meltzer EO, 2012, ALLERGY ASTHMA PROC, V33, P324, DOI 10.2500/aap.2012.33.3587; Modgill V, 2010, METHOD FIND EXP CLIN, V32, P669, DOI 10.1358/mf.2010.32.9.1533686; Nathan RA, 2005, CHEST, V128, P1910, DOI 10.1378/chest.128.4.1910; National Asthma Education and Prevention Program Third Expert Panel on the Diagnosis and Management of Asthma, 2007, 3 NAT HEART LUNG BLO; Pullerits T, 2002, J ALLERGY CLIN IMMUN, V109, P949, DOI 10.1067/mai.2002.124467; Ratner PH, 2008, ANN ALLERG ASTHMA IM, V100, P74, DOI 10.1016/S1081-1206(10)60408-5; Ratner PH, 2003, ANN ALLERG ASTHMA IM, V90, P536, DOI 10.1016/S1081-1206(10)61847-9; Ratner PH, 1998, J FAM PRACTICE, V47, P118; Seidman MD, 2015, OTOLARYNG HEAD NECK, V152, P197, DOI 10.1177/0194599814562166; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; The National Academies of Sciences Engineering and Medicine, 2003, CONFL INT POL COMM U; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003	35	29	32	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					876	+		10.7326/M17-2203	http://dx.doi.org/10.7326/M17-2203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29181536				2022-12-28	WOS:000418276000016
J	Sheth, RU; Yim, SS; Wu, FL; Wang, HH				Sheth, Ravi U.; Yim, Sung Sun; Wu, Felix L.; Wang, Harris H.			Multiplex recording of cellular events over time on CRISPR biological tape	SCIENCE			English	Article							IMMUNE-RESPONSE; LIVING BACTERIA; CAS SYSTEMS; ACQUISITION; ADAPTATION; GENOME; CELLS; DNA; PROKARYOTES; INTEGRATION	Although dynamics underlie many biological processes, our ability to robustly and accurately profile time-varying biological signals and regulatory programs remains limited. Here we describe a framework for storing temporal biological information directly in the genomes of a cell population. We developed a "biological tape recorder" in which biological signals trigger intracellular DNA production that is then recorded by the CRISPR-Cas adaptation system. This approach enables stable recording over multiple days and accurate reconstruction of temporal and lineage information by sequencing CRISPR arrays. We further demonstrate a multiplexing strategy to simultaneously record the temporal availability of three metabolites (copper, trehalose, and fucose) in the environment of a cell population over time. This work enables the temporal measurement of dynamic cellular states and environmental changes and suggests new applications for chronicling biological events on a large scale.	[Sheth, Ravi U.; Yim, Sung Sun; Wu, Felix L.; Wang, Harris H.] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Sheth, Ravi U.; Wu, Felix L.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY USA; [Wang, Harris H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Wang, HH (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Wang, HH (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	hw2429@columbia.edu		Wang, Harris/0000-0003-2164-4318	Department of Defense Office of Naval Research [N00014-17-1-2353, N00014-15-1-2704]; NIH Director's Early Independence Award [DP50D009172-02]; Sloan Foundation [FR-2015-65795]; Fannie and John Hertz Foundation; NSF [DGE 16-44869]; NIH [T32GM008224]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER	Department of Defense Office of Naval Research(Office of Naval ResearchUnited States Department of Defense); NIH Director's Early Independence Award; Sloan Foundation(Alfred P. Sloan Foundation); Fannie and John Hertz Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Blazejewski, C. Munck, and members of the Wang laboratory for advice and comments on the manuscript. Sequencing data associated with this study are available in the National Center for Biotechnology Information Sequence Read Archive under PRJNA417866 and plasmids are available through Addgene. H.H.W. acknowledges specific funding support from the Department of Defense Office of Naval Research (N00014-17-1-2353 and N00014-15-1-2704), an NIH Director's Early Independence Award DP50D009172-02), and the Sloan Foundation (FR-2015-65795) for this work. R.U.S. is supported by a Fannie and John Hertz Foundation Graduate Fellowship and an NSF Graduate Research Fellowship (DGE 16-44869). F.L.W. is supported by an NIH training grant (T32GM008224). R.U.S., S.S.Y., and H.H.W. developed the initial concept; R.U.S., S.SY. and FUN. performed experiments; R.U.S. and F.L.W. analyzed the sequencing data: R.U.S. and H.H.W. wrote the manuscript; and. all authors discussed results and commented on and approved the manuscript. H.H.W. and R.U.S. are inventors or, a provisional patent application, filed by the Trustees of Columbia University in the City of New York regarding this work.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Elbaz J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11179; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Heler R, 2017, MOL CELL, V65, P168, DOI 10.1016/j.molcel.2016.11.031; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Pei W., 2011, NATURE, V548, P456; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Schmidt ST, 2017, ACS SYNTH BIOL, V6, P936, DOI 10.1021/acssynbio.6b00309; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	30	71	77	7	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1457	+		10.1126/science.aao0958	http://dx.doi.org/10.1126/science.aao0958			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29170279	Green Accepted			2022-12-28	WOS:000417918500047
J	Rubin, R				Rubin, Rita			Illicit Fentanyl Driving Opioid Overdose Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2174	2174		10.1001/jama.2017.18602	http://dx.doi.org/10.1001/jama.2017.18602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234815				2022-12-28	WOS:000417822700008
J	Holme, C				Holme, Chris			The bright spark who lit up Glasgow	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cholme@outlook.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2017	359								j5597	10.1136/bmj.j5597	http://dx.doi.org/10.1136/bmj.j5597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8OI	29222173				2022-12-28	WOS:000417904000003
J	Barbieri, I; Tzelepis, K; Pandolfini, L; Shi, JW; Millan-Zambrano, G; Robson, SC; Aspris, D; Migliori, V; Bannister, AJ; Han, N; De Braekeleer, E; Ponstingl, H; Hendrick, A; Vakoc, CR; Vassiliou, GS; Kouzarides, T				Barbieri, Isaia; Tzelepis, Konstantinos; Pandolfini, Luca; Shi, Junwei; Millan-Zambrano, Gonzalo; Robson, Samuel C.; Aspris, Demetrios; Migliori, Valentina; Bannister, Andrew J.; Han, Namshik; De Braekeleer, Etienne; Ponstingl, Hannes; Hendrick, Alan; Vakoc, Christopher R.; Vassiliou, George S.; Kouzarides, Tony			Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control	NATURE			English	Article							MESSENGER-RNA TRANSLATION; TRANSCRIPTION FACTORS; N-6-METHYLADENOSINE; BINDING; METHYLATION; INHIBITION; ELEMENTS; TARGETS; MURINE; ATLAS	N-6-methyladenosine (m(6)A) is an abundant internal RNA modification in both coding(1) and non-coding RNAs2,3 that is catalysed by the METTL3-METTL14 methyltransferase complex4. However, the specific role of these enzymes in cancer is still largely unknown. Here we define a pathway that is specific for METTL3 and is implicated in the maintenance of a leukaemic state. We identify METTL3 as an essential gene for growth of acute myeloid leukaemia cells in two distinct genetic screens. Downregulation of METTL3 results in cell cycle arrest, differentiation of leukaemic cells and failure to establish leukaemia in immunodeficient mice. We show that METTL3, independently of METTL14, associates with chromatin and localizes to the transcriptional start sites of active genes. The vast majority of these genes have the CAATT-box binding protein CEBPZ present at the transcriptional start site(5), and this is required for recruitment of METTL3 to chromatin. Promoterbound METTL3 induces m(6)A modification within the coding region of the associated mRNA transcript, and enhances its translation by relieving ribosome stalling. We show that genes regulated by METTL3 in this way are necessary for acute myeloid leukaemia. Together, these data define METTL3 as a regulator of a chromatinbased pathway that is necessary for maintenance of the leukaemic state and identify this enzyme as a potential therapeutic target for acute myeloid leukaemia.	[Barbieri, Isaia; Pandolfini, Luca; Millan-Zambrano, Gonzalo; Robson, Samuel C.; Migliori, Valentina; Bannister, Andrew J.; Han, Namshik; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Barbieri, Isaia; Pandolfini, Luca; Millan-Zambrano, Gonzalo; Robson, Samuel C.; Migliori, Valentina; Bannister, Andrew J.; Han, Namshik; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QN, England; [Tzelepis, Konstantinos; Aspris, Demetrios; De Braekeleer, Etienne; Ponstingl, Hannes; Vassiliou, George S.] Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge CB10 1SA, England; [Shi, Junwei; Vakoc, Christopher R.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Hendrick, Alan] Storm Therapeut Ltd, Moneta Bldg B280,Babraham Res Campus, Cambridge CB22 3AT, England; [Vassiliou, George S.] Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England; [Vassiliou, George S.] Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge CB2 0QQ, England; [Shi, Junwei] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA; [Robson, Samuel C.] Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth, Hants, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cold Spring Harbor Laboratory; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Portsmouth	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.; Kouzarides, T (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QN, England.; Vassiliou, GS (corresponding author), Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge CB10 1SA, England.; Vassiliou, GS (corresponding author), Univ Cambridge, Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England.; Vassiliou, GS (corresponding author), Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge CB2 0QQ, England.	gsv20@sanger.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Pandolfini, Luca/AAK-4213-2021; Millan-Zambrano, Gonzalo/AAA-5562-2020; Barbieri, Isaia/AAW-8263-2020	Millan-Zambrano, Gonzalo/0000-0002-4530-6359; Tzelepis, Konstantinos/0000-0002-4865-7648; Migliori, Valentina/0000-0003-4978-2245; Kouzarides, Tony/0000-0002-8918-4162; Pandolfini, Luca/0000-0003-1444-8167; Hendrick, Alan/0000-0002-8604-0462; Vassiliou, George/0000-0003-4337-8022; De Braekeleer, Etienne/0000-0003-4659-023X; Han, Namshik/0000-0002-7741-6384; Bannister, Andrew/0000-0002-6312-4436	Cancer Research UK [RG17001, C6946/A14492]; ERC [268569]; Wellcome Trust [092096]; Kay Kendall Leukaemia Fund project grant [RG88664]; EMBO fellowship [ALTF907-2014]; Wellcome Trust Senior Fellowship in Clinical Science [WT095663MA]; Cancer Research UK Senior Cancer Research Fellowship [C22324/A23015]; Kay Kendall Leukemia Fund; Bloodwise; Sanger Institute [WT098051]; Northwell Health; Cancer Research UK [10827, 23015, 17001] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukaemia Fund project grant; EMBO fellowship(European Molecular Biology Organization (EMBO)); Wellcome Trust Senior Fellowship in Clinical Science(Wellcome Trust); Cancer Research UK Senior Cancer Research Fellowship(Cancer Research UK); Kay Kendall Leukemia Fund; Bloodwise; Sanger Institute; Northwell Health; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K.H. Che for help generating the RNA enzyme list. The Kouzarides laboratory is supported by grants from Cancer Research UK (grant reference RG17001) and ERC (project number 268569), in addition to benefiting from core support from the Wellcome Trust (Core Grant reference 092096) and Cancer Research UK (grant reference C6946/A14492). I.B. is funded by a Kay Kendall Leukaemia Fund project grant (grant reference RG88664). G.M.-Z. is funded by an EMBO fellowship (ALTF907-2014). G.S.V. was funded by a Wellcome Trust Senior Fellowship in Clinical Science (WT095663MA) and Cancer Research UK Senior Cancer Research Fellowship (C22324/A23015). The Vassiliou laboratory is supported by grants from the Kay Kendall Leukemia Fund and Bloodwise, as well as core funding from the Sanger Institute (WT098051). C.R.V. and J.S. are funded by a translational research grant from Northwell Health.	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cui X., 2015, IEEE ACM T COMPUT BI; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunn JG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3278-x; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Geltinger C, 1996, GENE EXPRESSION, V6, P113; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; O'Connor Leigh, 2016, Yale Journal of Biology and Medicine, V89, P513; Panda AC, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2126; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripperger T, 2015, BBA-GENE REGUL MECH, V1849, P1145, DOI 10.1016/j.bbagrm.2015.07.005; RONCHI AE, 1995, J BIOL CHEM, V270, P21934, DOI 10.1074/jbc.270.37.21934; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wyspianska BS, 2014, LEUKEMIA, V28, P88, DOI 10.1038/leu.2013.234; Xiao ZT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11194; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	546	567	12	166	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					126	+		10.1038/nature24678	http://dx.doi.org/10.1038/nature24678			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186125	Green Submitted, Green Accepted			2022-12-28	WOS:000417560500056
J	Abouk, R; Grosse, SD; Ailes, EC; Oster, ME				Abouk, Rahi; Grosse, Scott D.; Ailes, Elizabeth C.; Oster, Matthew E.			Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULSE OXIMETRY; UNITED-STATES; DEFECTS; DIAGNOSIS; HEALTH	IMPORTANCE In 2011, critical congenital heart disease was added to the US Recommended Uniform Screening Panel for newborns, but whether state implementation of screening policies has been associated with infant death rates is unknown. OBJECTIVE To assess whether there was an association between implementation of state newborn screening policies for critical congenital heart disease and infant death rates. DESIGN, SETTING, AND PARTICIPANTS Observational study with group-level analyses. A difference-in-differences analysis was conducted using the National Center for Health Statistics' period linked birth/infant death data set files for 2007-2013 for 26 546 503 US births through June 30, 2013, aggregated by month and state of birth. EXPOSURES State policies were classified as mandatory or nonmandatory (including voluntary policies and mandates that were not yet implemented). As of June 1, 2013, 8 states had implemented mandatory screening policies, 5 states had voluntary screening policies, and 9 states had adopted but not yet implemented mandates. MAIN OUTCOMES AND MEASURES Numbers of early infant deaths (between 24 hours and 6 months of age) coded for critical congenital heart disease or other/unspecified congenital cardiac causes for each state-month birth cohort. RESULTS Between 2007 and 2013, there were 2734 deaths due to critical congenital heart disease and 3967 deaths due to other/unspecified causes. Critical congenital heart disease death rates in states with mandatory screening policies were 8.0 (95% CI, 5.4-10.6) per 100 000 births (n = 37) in 2007 and 6.4 (95% CI, 2.9-9.9) per 100 000 births (n = 13) in 2013 (for births by the end of July); for other/unspecified cardiac causes, death rates were 11.7 (95% CI, 8.6-14.8) per 100 000 births in 2007 (n = 54) and 10.3 (95% CI, 5.9-14.8) per 100 000 births (n = 21) in 2013. Early infant deaths from critical congenital heart disease through December 31, 2013, decreased by 33.4%(95% CI, 10.6%-50.3%), with an absolute decline of 3.9 (95% CI, 3.6-4.1) deaths per 100 000 births after states implemented mandatory screening compared with prior periods and states without screening policies. Early infant deaths from other/unspecified cardiac causes declined by 21.4%(95% CI, 6.9%-33.7%), with an absolute decline of 3.5 (95% CI, 3.2-3.8) deaths per 100 000 births. No significant decrease was associated with nonmandatory screening policies. CONCLUSIONS AND RELEVANCE Statewide implementation of mandatory policies for newborn screening for critical congenital heart disease was associated with a significant decrease in infant cardiac deaths between 2007 and 2013 compared with states without these policies.	[Abouk, Rahi] William Paterson Univ, Cotsakos Coll Business, 300 Pompton Rd, Wayne, NJ 07470 USA; [Grosse, Scott D.; Ailes, Elizabeth C.; Oster, Matthew E.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Oster, Matthew E.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Children's Healthcare of Atlanta (CHOA); Emory University	Abouk, R (corresponding author), William Paterson Univ, Cotsakos Coll Business, 300 Pompton Rd, Wayne, NJ 07470 USA.	aboukr@wpunj.edu	Abouk, Rahi/ABG-3944-2021	Abouk, Rahi/0000-0002-8920-4055; Grosse, Scott/0000-0003-1078-6855	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ailes EC, 2015, PEDIATRICS, V135, P1000, DOI 10.1542/peds.2014-3662; American Academy of Pediatrics, 2016, NEWB SCREEN CRIT CON; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Chang RKR, 2008, ARCH PEDIAT ADOL MED, V162, P969, DOI 10.1001/archpedi.162.10.969; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Ewer AK, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1206; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Glidewell J, 2015, MMWR-MORBID MORTAL W, V64, P625; Grosse SD, 2017, MMWR-MORBID MORTAL W, V66, P888, DOI 10.15585/mmwr.mm6633a4; Grosse SD, 2005, AM J PUBLIC HEALTH, V95, P1917, DOI 10.2105/AJPH.2004.058859; Hill GD, 2015, PRENATAL DIAG, V35, P859, DOI 10.1002/pd.4622; Ismail AQT, 2017, ARCH DIS CHILDHOOD-E, V102, P155, DOI 10.1136/archdischild-2016-311047; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Martin GR, 2013, PEDIATRICS, V132, pE185, DOI 10.1542/peds.2012-3926; Oster ME, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4573; Oster ME, 2013, PEDIATRICS, V131, pE1502, DOI 10.1542/peds.2012-3435; Peterson C, 2013, PEDIATRICS, V132, pE595, DOI 10.1542/peds.2013-0332; Quartermain MD, 2015, PEDIATRICS, V136, pE378, DOI 10.1542/peds.2014-3783; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Simeone RM, 2015, BIRTH DEFECTS RES A, V103, P814, DOI 10.1002/bdra.23379; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Song D., 2012, NEOREVIEWS, V13, pE724, DOI DOI 10.1542/NE0.13-12-E724; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X	25	76	76	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2111	2118		10.1001/jama.2017.17627	http://dx.doi.org/10.1001/jama.2017.17627			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO7XT	29209720	Green Accepted, Bronze			2022-12-28	WOS:000417093500016
J	Bridoux, F; Carron, PL; Pegourie, B; Alamartine, E; Augeul-Meunier, K; Karras, A; Joly, B; Peraldi, MN; Arnulf, B; Vigneau, C; Lamy, T; Wynckel, A; Kolb, B; Royer, B; Rabot, N; Benboubker, L; Combe, C; Jaccard, A; Moulin, B; Knebelmann, B; Chevret, S; Fermand, JP				Bridoux, Frank; Carron, Pierre-Louis; Pegourie, Brigitte; Alamartine, Eric; Augeul-Meunier, Karine; Karras, Alexandre; Joly, Bertrand; Peraldi, Marie-Noelle; Arnulf, Bertrand; Vigneau, Cecile; Lamy, Thierry; Wynckel, Alain; Kolb, Brigitte; Royer, Bruno; Rabot, Nolwenn; Benboubker, Lotfi; Combe, Christian; Jaccard, Arnaud; Moulin, Bruno; Knebelmann, Bertrand; Chevret, Sylvie; Fermand, Jean-Paul		MYRE Study Group	Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FREE LIGHT-CHAINS; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; DIAGNOSED MULTIPLE-MYELOMA; BORTEZOMIB-BASED REGIMENS; PLASMA-EXCHANGE; IMPAIRMENT; RECOVERY; SERUM; CHEMOTHERAPY	IMPORTANCE Cast nephropathy is the main cause of acute kidney injury in multiple myeloma and persistent reduction in kidney function strongly affects prognosis. Strategies to rapidly remove nephrotoxic serum-free light chains combined with novel antimyeloma agents have not been evaluated prospectively. OBJECTIVE To compare the hemodialysis independence rate among patients newly diagnosed with myeloma cast nephropathy treated with hemodialysis using a high-cutoff dialyzer (with very large membrane pores and high permeability to immunoglobulin light chains) or a conventional high-flux dialyzer (with small pores and lower permeability). DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial involving 98 patients with biopsy-proven myeloma cast nephropathy requiring hemodialysis treated at 48 French centers between July 2011 and June 2016; the final date of follow-up was June 29, 2016. INTERVENTIONS Intensive hemodialysis (eight 5-hour sessions over 10 days) with either a high-cutoff dialyzer (46 patients) or a conventional high-flux dialyzer (48 patients). All patients received the same chemotherapy regimen of bortezomib and dexamethasone. MAIN OUTCOMES AND MEASURES Primary end point was hemodialysis independence at 3 months; secondary end points: hemodialysis independence rates at 6 and 12 months, hemodialysis- and chemotherapy-related adverse events, and death. RESULTS Among 98 randomized patients, 94 (96%) (median age, 68.8 years [interquartile range, 61.2-75.3 years]; 45% women) were included in the modified intent-to-treat analysis. The hemodialysis independence rate at 3 months was 41.3%(n = 19) in the high-cutoff hemodialysis group vs 33.3%(n = 16) in the conventional hemodialysis group (between-group difference, 8.0%[95% CI, -12.0% to 27.9%], P =.42); at 6 months, the rate was 56.5%(n = 26) vs 35.4%(n = 17), respectively (between-group difference, 21.1% [95% CI, 0.9% to 41.3%], P =.04); and at 12 months, the rate was 60.9%(n = 28) vs 37.5%(n = 18) (between-group difference, 23.4%[95% CI, 3.2% to 43.5%], P =.02). The incidence of hemodialysis-related adverse events was 43% in the high-cutoff hemodialysis group vs 39% in the conventional hemodialysis group; chemotherapy-related serious adverse events, 39% vs 37%, respectively; and at 12 months, 9 patients vs 10 patients died. CONCLUSIONS AND RELEVANCE Among patients with myeloma cast nephropathy treated with a bortezomib-based chemotherapy regimen, the use of high-cutoff hemodialysis compared with conventional hemodialysis did not result in a statistically significant difference in hemodialysis independence at 3 months. However, the study may have been underpowered to identify an early clinically important difference.	[Bridoux, Frank] Ctr Hosp Univ, Ctr Invest Clin 1402, Inst Natl Sante & Rech Med, Dept Nephrol, Poitiers, France; [Bridoux, Frank; Jaccard, Arnaud] Ctr Reference Malad Rares, Poitiers, France; [Bridoux, Frank; Jaccard, Arnaud] Univ Limoges, Unite Mixte Rech 7276, Ctr Natl Rech Sci, Limoges, France; [Carron, Pierre-Louis] Ctr Hosp Univ, Dept Nephrol, Grenoble, France; [Pegourie, Brigitte] Ctr Hosp Univ, Dept Hematol, Grenoble, France; [Alamartine, Eric] Ctr Hosp Univ, Dept Nephrol, St Etienne, France; [Augeul-Meunier, Karine] Ctr Hosp Univ, Dept Hematol, St Etienne, France; [Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, Paris, France; [Joly, Bertrand] Ctr Hosp Sud Francilien, Dept Hematol, Corbeil Essonnes, France; [Peraldi, Marie-Noelle] Hop St Louis, AP HP, Dept Nephrol, Paris, France; [Arnulf, Bertrand; Fermand, Jean-Paul] Hop St Louis, AP HP, Dept Hematol & Immunol, Inst Natl Sante & Rech Med,Unite Mixte Rech 1126, Paris, France; [Vigneau, Cecile] Ctr Hosp Univ, Dept Nephrol, Rennes, France; [Lamy, Thierry] Ctr Hosp Univ, Dept Hematol, Rennes, France; [Wynckel, Alain] Ctr Hosp Univ, Dept Nephrol, Reims, France; [Kolb, Brigitte] Ctr Hosp Univ, Dept Hematol, Reims, France; [Royer, Bruno] Ctr Hosp Univ, Dept Hematol, Amiens, France; [Rabot, Nolwenn] Ctr Hosp Univ, Dept Nephrol, Tours, France; [Benboubker, Lotfi] Ctr Hosp Univ, Dept Hematol, Tours, France; [Combe, Christian] Ctr Hosp Univ, Dept Nephrol, Bordeaux, France; [Jaccard, Arnaud] Ctr Hosp Univ, Dept Hematol, Limoges, France; [Moulin, Bruno] Ctr Hosp Univ, Dept Nephrol, Strasbourg, France; [Knebelmann, Bertrand] Hop Necker Enfants Malad, AP HP, Dept Nephrol, Paris, France; [Chevret, Sylvie] Paris Diderot Univ, Hop St Louis, AP HP,Unite Mixte Rech ECSTRA Team 1153, Dept Biostat & Med Informat,Inst Natl Sante & Rec, Paris, France	CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU de St Etienne; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Sud Francilien; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; CHU Rennes; CHU de Reims; CHU de Reims; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Tours; CHU Tours; CHU Bordeaux; CHU Limoges; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Bridoux, F (corresponding author), Ctr Hosp Univ, Dept Nephrol, 2 Rue Miletrie, F-86021 Poitiers, France.	f.bridoux@chu-poitiers.fr	DECONINCK, ERIC/AAF-3647-2021; vigneau, cecile/I-3178-2015; Herbrecht, Raoul/AAT-1763-2021; Combe, Christian/N-3726-2015	DECONINCK, ERIC/0000-0002-6006-8088; Herbrecht, Raoul/0000-0002-9381-4876; Bridoux, Frank/0000-0002-2005-8424; Maillard, Nicolas/0000-0002-3073-7252; MOULIN, Bruno/0000-0001-6772-7165; Combe, Christian/0000-0002-0360-573X; Delmer, Alain/0000-0002-1430-2574; Alamartine, Eric/0000-0001-7720-8297; burtey, stephane/0000-0003-1813-7884	Programme Hospitalier de Recherche Clinique-Cancer 2009 grant from the French Ministry of Health, French National Hospital Program for Clinical Research Cancer	Programme Hospitalier de Recherche Clinique-Cancer 2009 grant from the French Ministry of Health, French National Hospital Program for Clinical Research Cancer	The study was funded by the Programme Hospitalier de Recherche Clinique-Cancer 2009 grant from the French Ministry of Health, French National Hospital Program for Clinical Research Cancer, 2009. Gambro Dialyzatoren provided the high-cutoff dialyzers used in the study. Janssen France provided bortezomib. The Binding Site company provided kits for measurement of serum-free light chains.	Blade J, 1998, ARCH INTERN MED, V158, P1889, DOI 10.1001/archinte.158.17.1889; Bridoux F, 2015, KIDNEY INT, V87, P698, DOI 10.1038/ki.2014.408; Burnette BL, 2011, NEW ENGL J MED, V364, P2365, DOI 10.1056/NEJMc1101834; Campbell JP, 2013, J IMMUNOL METHODS, V391, P1, DOI 10.1016/j.jim.2013.01.014; Chanan-Khan AA, 2007, BLOOD, V109, P2604, DOI 10.1182/blood-2006-09-046409; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Curti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159942; Dimopoulos MA, 2016, AM J HEMATOL, V91, P499, DOI 10.1002/ajh.24335; Dimopoulos MA, 2016, J CLIN ONCOL, V34, P1544, DOI 10.1200/JCO.2015.65.0044; Dimopoulos MA, 2009, CLIN LYMPHOMA MYELOM, V9, P302, DOI 10.3816/CLM.2009.n.059; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Ecotiere L, 2016, NEPHROL DIAL TRANSPL, V31, P64, DOI 10.1093/ndt/gfv283; Gerth HU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154993; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Heyne N, 2012, ANN HEMATOL, V91, P729, DOI 10.1007/s00277-011-1383-0; Hutchison CA, 2016, J AM SOC NEPHROL, V27, p8A, DOI [10.1681/ASN.2015050576, DOI 10.1681/ASN.2015050576]; Hutchison CA, 2007, J AM SOC NEPHROL, V18, P886, DOI 10.1681/ASN.2006080821; Hutchison CA, 2012, NEPHROL DIAL TRANSPL, V27, P3823, DOI 10.1093/ndt/gfr773; Hutchison CA, 2012, NAT REV NEPHROL, V8, P43, DOI 10.1038/nrneph.2011.168; Hutchison CA, 2011, J AM SOC NEPHROL, V22, P1129, DOI 10.1681/ASN.2010080857; Hutchison CA, 2009, CLIN J AM SOC NEPHRO, V4, P745, DOI 10.2215/CJN.04590908; Knudsen LM, 2000, EUR J HAEMATOL, V65, P175, DOI 10.1034/j.1600-0609.2000.90221.x; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Lameire N, 2013, CRIT CARE, V17, DOI 10.1186/cc11455; Leung N, 2008, KIDNEY INT, V73, P1282, DOI 10.1038/ki.2008.108; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lodhi A, 2015, CLIN KIDNEY J, V8, P632, DOI 10.1093/ckj/sfv059; Ludwig H, 2010, J CLIN ONCOL, V28, P4635, DOI 10.1200/JCO.2010.28.1238; Magarotto V, 2016, BLOOD, V127, P1102, DOI 10.1182/blood-2015-08-662627; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morabito F, 2010, EUR J HAEMATOL, V84, P223, DOI 10.1111/j.1600-0609.2009.01385.x; Nasr SH, 2012, AM J KIDNEY DIS, V59, P786, DOI 10.1053/j.ajkd.2011.12.028; Oiwa K, 2016, ANTICANCER RES, V36, P6655, DOI 10.21873/anticanres.11274; Yadav P, 2016, EUR J HAEMATOL, V96, P610, DOI 10.1111/ejh.12644; Zand L, 2015, LEUKEMIA LYMPHOMA, V56, P3357, DOI 10.3109/10428194.2015.1040011; Zannetti BA, 2015, AM J HEMATOL, V90, P647, DOI 10.1002/ajh.24035	37	77	81	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2099	2110		10.1001/jama.2017.17924	http://dx.doi.org/10.1001/jama.2017.17924			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209721	Green Published, Bronze			2022-12-28	WOS:000417093500015
J	Clay, PL; Burgess, R; Busemann, H; Ruzie-Hamilton, L; Joachim, B; Day, JMD; Ballentine, CJ				Clay, Patricia L.; Burgess, Ray; Busemann, Henner; Ruzie-Hamilton, Lorraine; Joachim, Bastian; Day, James M. D.; Ballentine, Christopher J.			Halogens in chondritic meteorites and terrestrial accretion	NATURE			English	Article							SOLAR-SYSTEM ABUNDANCES; X-RAY-DIFFRACTION; CHEMICAL-COMPOSITION; NOBLE-GAS; MODAL MINERALOGY; HIGHLY SIDEROPHILE; FLUID INCLUSIONS; TRACE-ELEMENTS; MANTLE; IODINE	Volatile element delivery and retention played a fundamental part in Earth's formation and subsequent chemical differentiation. The heavy halogens-chlorine (Cl), bromine (Br) and iodine (I)-are key tracers of accretionary processes owing to their high volatility and incompatibility, but have low abundances in most geological and planetary materials. However, noble gas proxy isotopes produced during neutron irradiation provide a high-sensitivity tool for the determination of heavy halogen abundances. Using such isotopes, here we show that Cl, Br and I abundances in carbonaceous, enstatite, Rumuruti and primitive ordinary chondrites are about 6 times, 9 times and 15-37 times lower, respectively, than previously reported and usually accepted estimates1. This is independent of the oxidation state or petrological type of the chondrites. The ratios Br/Cl and I/Cl in all studied chondrites show a limited range, indistinguishable from bulk silicate Earth estimates. Our results demonstrate that the halogen depletion of bulk silicate Earth relative to primitive meteorites is consistent with the depletion of lithophile elements of similar volatility. These results for carbonaceous chondrites reveal that late accretion, constrained to a maximum of 0.5 +/- 0.2 per cent of Earth's silicate mass(2-5), cannot solely account for present-day terrestrial halogen inventories(6,7). It is estimated that 80-90 per cent of heavy halogens are concentrated in Earth's surface reservoirs(7,8) and have not undergone the extreme early loss observed in atmosphere-forming elements(9). Therefore, in addition to late-stage terrestrial accretion of halogens and mantle degassing, which has removed less than half of Earth's dissolved mantle gases(10), the efficient extraction of halogen-rich fluids(6) from the solid Earth during the earliest stages of terrestrial differentiation is also required to explain the presence of these heavy halogens at the surface. The hydropilic nature of halogens, whereby they track with water, supports this requirement, and is consistent with volatile-rich or water-rich late-stage terrestrial accretion(5,11-14).	[Clay, Patricia L.; Burgess, Ray; Ruzie-Hamilton, Lorraine] Univ Manchester, Sch Earth & Environm Sci, Manchester M13 9PL, Lancs, England; [Busemann, Henner] ETH, Inst Geochem & Petrol, Clausiusstr 25, CH-8092 Zurich, Switzerland; [Joachim, Bastian] Univ Innsbruck, Inst Mineral & Petrog, Innrain 52, A-6020 Innsbruck, Austria; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ballentine, Christopher J.] Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England	University of Manchester; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Innsbruck; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford	Clay, PL (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Manchester M13 9PL, Lancs, England.	patricia.clay@manchester.ac.uk	Clay, Patricia L/F-2638-2013; Burgess, Ray/A-5767-2009; Ruzie-Hamilton, Lorraine/GXZ-4903-2022; Ruzie-Hamilton, Lorraine/G-2416-2018; Joachim-Mrosko, Bastian/AAQ-9868-2020; Day, James/A-5099-2010	Clay, Patricia L/0000-0002-6175-9761; Burgess, Ray/0000-0001-7674-8718; Ruzie-Hamilton, Lorraine/0000-0002-2802-8123; Joachim-Mrosko, Bastian/0000-0003-2134-004X; Busemann, Henner/0000-0002-0867-6908; Ballentine, Chris/0000-0001-9382-070X; Day, James/0000-0001-9520-3465	PlanetS National Center of Competence in Research (NCCR) of the Swiss National Science Foundation; European Research Council [267692]; STFC [ST/L002957/1] Funding Source: UKRI	PlanetS National Center of Competence in Research (NCCR) of the Swiss National Science Foundation; European Research Council(European Research Council (ERC)European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the following organisations and individuals for the provision of samples: NASA Antarctic Meteorite Working Group (MIL 07139, MIL 07028 and ALH 77295); P. Heck, Chicago Field Museum (Indarch); Izikio Museum of South Africa (St Marks); M. Boyet (SAH 97096); M. Schonbachler (GRA 06100, EET 92159, Murray, Orgueil); and A. Ruzicka (NWA 753 and NWA 755). We thank J. Cowpe for assistance with noble gas measurements, K. J. Theis for laboratory assistance and W. Akram for help with sample preparation. H. B. acknowledges support from the PlanetS National Center of Competence in Research (NCCR) of the Swiss National Science Foundation. This project was funded by the European Research Council FP7 'NOBLE' grant number 267692.	Aiuppa A, 2009, CHEM GEOL, V263, P1, DOI 10.1016/j.chemgeo.2008.10.005; Allegre C, 2001, EARTH PLANET SC LETT, V185, P49, DOI 10.1016/S0012-821X(00)00359-9; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; Allen R. O. J., 1965, EOS, V46, P123; ANDERS E, 1982, GEOCHIM COSMOCHIM AC, V46, P2363, DOI 10.1016/0016-7037(82)90208-3; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDERSON DL, 1983, J GEOPHYS RES, V88, pB41, DOI 10.1029/JB088iS01p00B41; Armytage RMG, 2013, EARTH PLANET SC LETT, V373, P140, DOI 10.1016/j.epsl.2013.04.031; Barrat JA, 2012, GEOCHIM COSMOCHIM AC, V83, P79, DOI 10.1016/j.gca.2011.12.011; Bischoff A, 2011, CHEM ERDE-GEOCHEM, V71, P101, DOI 10.1016/j.chemer.2011.02.005; Bland PA, 2004, METEORIT PLANET SCI, V39, P3, DOI 10.1111/j.1945-5100.2004.tb00046.x; BOHLKE JK, 1992, EARTH PLANET SC LETT, V110, P51, DOI 10.1016/0012-821X(92)90038-W; Brazzle RH, 1999, GEOCHIM COSMOCHIM AC, V63, P739, DOI 10.1016/S0016-7037(98)00314-7; Burgess R, 2002, EARTH PLANET SC LETT, V197, P193, DOI 10.1016/S0012-821X(02)00480-6; Burgess R, 2009, GEOCHIM COSMOCHIM AC, V73, P1779, DOI 10.1016/j.gca.2008.12.025; Cartwright JA, 2013, GEOCHIM COSMOCHIM AC, V105, P255, DOI 10.1016/j.gca.2012.11.046; Chou CL., 1978, P 9 LUN SCI C, V1, P219; Clay PL, 2014, AM MINERAL, V99, P1683, DOI 10.2138/am.2014.4700; Day JMD, 2016, REV MINERAL GEOCHEM, V81, P161, DOI 10.2138/rmg.2016.81.04; DERUELLE B, 1992, EARTH PLANET SC LETT, V108, P217, DOI 10.1016/0012-821X(92)90024-P; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; DREIBUS G, 1977, PHILOS T R SOC A, V285, P49, DOI 10.1098/rsta.1977.0042; Dreibus G., 1979, PHYS CHEM EARTH, V11, P33; Dreibus G., 1986, INT WORKSHOP ANTARCT, P34; Dreibus G., 2006, LUNAR PLANET SCI C, VXXXVII; Ebel DS, 2013, CONTRIB MINERAL PETR, V166, P923, DOI 10.1007/s00410-013-0898-x; El Goresy A., 1988, P NIPR S ANTARCTIC M, V1, P65; Elkins-Tanton LT, 2011, ASTROPHYS SPACE SCI, V332, P359, DOI 10.1007/s10509-010-0535-3; ENDRESS M, 1994, METEORITICS, V29, P462; GOLES GG, 1962, GEOCHIM COSMOCHIM AC, V26, P723, DOI 10.1016/0016-7037(62)90035-2; GOLES GG, 1967, GEOCHIM COSMOCHIM AC, V31, P1771, DOI 10.1016/0016-7037(67)90121-4; GOLES GG, 1966, ASTRON J, V71, P162, DOI 10.1086/110128; Goswami JN, 1998, METEORIT PLANET SCI, V33, P527, DOI 10.1111/j.1945-5100.1998.tb01657.x; GREENLAND L, 1965, GEOCHIM COSMOCHIM AC, V29, P821, DOI 10.1016/0016-7037(65)90082-7; GREENLAND LP, 1963, J GEOPHYS RES, V68, P6507, DOI 10.1029/JZ068i024p06507; Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Hammerli J, 2013, CHEM GEOL, V337, P75, DOI 10.1016/j.chemgeo.2012.12.002; HART SR, 1986, CHEM GEOL, V57, P247, DOI 10.1016/0009-2541(86)90053-7; HEUMANN KG, 1990, GEOCHIM COSMOCHIM AC, V54, P2503, DOI 10.1016/0016-7037(90)90236-E; Howard K.T., 2011, METEOR PLANET SCI S, V74, P5256; Humayun M, 2000, ORIGIN EARTH MOON, P3; Izawa MRM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003452; Jagoutz E., 1979, LUNAR PLANETARY SCI, V11, P2031; JAMBON A, 1985, EARTH PLANET SC LETT, V73, P255, DOI 10.1016/0012-821X(85)90074-3; John T, 2011, EARTH PLANET SC LETT, V308, P65, DOI 10.1016/j.epsl.2011.05.038; Jones RH, 2014, GEOCHIM COSMOCHIM AC, V132, P120, DOI 10.1016/j.gca.2014.01.027; JOVANOVIS, 1973, EOS, V54, P595; Kadlag Y, 2016, METEORIT PLANET SCI, V51, P1136, DOI 10.1111/maps.12653; KALLEMEYN GW, 1981, GEOCHIM COSMOCHIM AC, V45, P1217, DOI 10.1016/0016-7037(81)90145-9; KARGEL JS, 1993, ICARUS, V105, P1, DOI 10.1006/icar.1993.1108; Kendrick MA, 2017, NAT GEOSCI, V10, P222, DOI [10.1038/NGEO2902, 10.1038/ngeo2902]; Kendrick MA, 2014, EARTH PLANET SC LETT, V400, P165, DOI 10.1016/j.epsl.2014.05.021; Kendrick MA, 2013, GEOCHIM COSMOCHIM AC, V123, P150, DOI 10.1016/j.gca.2013.09.012; Kendrick MA, 2013, EARTH PLANET SC LETT, V365, P86, DOI 10.1016/j.epsl.2013.01.006; Kendrick MA, 2012, GEOLOGY, V40, P1075, DOI 10.1130/G33265.1; Kendrick MA, 2012, GEOCHIM COSMOCHIM AC, V81, P82, DOI 10.1016/j.gca.2011.12.004; Kendrick MA, 2012, CHEM GEOL, V292, P116, DOI 10.1016/j.chemgeo.2011.11.021; Kendrick MA, 2011, NAT GEOSCI, V4, P807, DOI [10.1038/ngeo1270, 10.1038/NGEO1270]; King AJ, 2015, GEOCHIM COSMOCHIM AC, V165, P148, DOI 10.1016/j.gca.2015.05.038; King A. J., 2013, LUNAR PLANET SCI C, VXLIV; KRAHENBUHL U, 1973, GEOCHIM COSMOCHIM AC, V37, P1353, DOI 10.1016/0016-7037(73)90066-5; Kramers JD, 2003, PRECAMBRIAN RES, V126, P379, DOI 10.1016/S0301-9268(03)00106-2; LI YH, 1982, GEOCHIM COSMOCHIM AC, V46, P2671, DOI 10.1016/0016-7037(82)90386-6; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lodders K., 1998, PLANETARY SCI COMPAN, V371; Lyubetskaya T, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004223; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; MCDONOUGH WF, 1992, GEOCHIM COSMOCHIM AC, V56, P1001, DOI 10.1016/0016-7037(92)90043-I; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Menzies ON, 2005, METEORIT PLANET SCI, V40, P1023, DOI 10.1111/j.1945-5100.2005.tb00171.x; MORGAN JW, 1980, P NATL ACAD SCI USA, V77, P6973, DOI 10.1073/pnas.77.12.6973; Muramatsu Y, 1998, CHEM GEOL, V147, P201, DOI 10.1016/S0009-2541(98)00013-8; PALME H, 1985, GEOCHIM COSMOCHIM AC, V49, P2123, DOI 10.1016/0016-7037(85)90070-5; Palme H., 1993, METHODS CONSTANTS SO, V2a, P257; Palme H., 1993, ASTRON ASTROPHYS, V3a, P198; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; REED GW, 1973, GEOCHIM COSMOCHIM AC, V37, P1007, DOI 10.1016/0016-7037(73)90196-8; REED GW, 1966, GEOCHIM COSMOCHIM AC, V30, P779, DOI 10.1016/0016-7037(66)90132-3; REED GW, 1970, SCIENCE, V167, P501, DOI 10.1126/science.167.3918.501; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; RINGWOOD AE, 1962, J GEOPHYS RES, V67, P857, DOI 10.1029/JZ067i002p00857; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Rubin AE, 2009, EARTH MOON PLANETS, V105, P41, DOI 10.1007/s11038-009-9316-9; Ruzie-Hamilton L, 2016, CHEM GEOL, V437, P77, DOI 10.1016/j.chemgeo.2016.05.003; SCHILLING JG, 1980, PHILOS T R SOC A, V297, P147, DOI 10.1098/rsta.1980.0208; SCHILLING JG, 1978, NATURE, V273, P631, DOI 10.1038/273631a0; Schonbachler M, 2010, SCIENCE, V328, P884, DOI 10.1126/science.1186239; Sharp ZD, 2007, NATURE, V446, P1062, DOI 10.1038/nature05748; Sharp ZD, 2013, EARTH PLANET SC LETT, V369, P71, DOI 10.1016/j.epsl.2013.03.005; Sharp ZD, 2013, GEOCHIM COSMOCHIM AC, V107, P189, DOI 10.1016/j.gca.2013.01.003; SUN SS, 1982, GEOCHIM COSMOCHIM AC, V46, P179, DOI 10.1016/0016-7037(82)90245-9; Tucker JM, 2014, EARTH PLANET SC LETT, V393, P254, DOI 10.1016/j.epsl.2014.02.050; Tucker JM, 2012, EARTH PLANET SC LETT, V355, P244, DOI 10.1016/j.epsl.2012.08.025; Vetter W, 2002, ENVIRON TOXICOL CHEM, V21, P2014, DOI 10.1897/1551-5028(2002)021<2014:SHNPFA>2.0.CO;2; Vogt R, 1996, NATURE, V383, P327, DOI 10.1038/383327a0; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; Wanke H., 1973, LPSC, V4, P1461; Wanke H., 1984, ARCHAEAN GEOCHEMISTR, P1, DOI [10.1007/978-3-642-70001-9_1, DOI 10.1007/978-3-642-70001-9_1]; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; Weisberg M.K., 2006, METEORITES EARLY SOL, P19; Whitby JA, 2002, GEOCHIM COSMOCHIM AC, V66, P347, DOI 10.1016/S0016-7037(01)00783-9; Zolotov M. Y., 2007, LUNAR PLANET SCI C, VXXXVIII	107	44	46	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					614	+		10.1038/nature24625	http://dx.doi.org/10.1038/nature24625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189777	Green Submitted			2022-12-28	WOS:000416520400040
J	Gaertner, F; Ahmad, Z; Rosenberger, G; Fan, SX; Nicolai, L; Busch, B; Yavuz, G; Luckner, M; Ishikawa-Ankerhold, H; Hennel, R; Benechet, A; Lorenz, M; Chandraratne, S; Schubert, I; Helmer, S; Striednig, B; Stark, K; Janko, M; Bottcher, RT; Verschoor, A; Leon, C; Gachet, C; Gudermann, T; Schnitzler, MMY; Pincus, Z; Iannacone, M; Haas, R; Wanner, G; Lauber, K; Sixt, M; Massberg, S				Gaertner, Florian; Ahmad, Zerkah; Rosenberger, Gerhild; Fan, Shuxia; Nicolai, Leo; Busch, Benjamin; Yavuz, Goekce; Luckner, Manja; Ishikawa-Ankerhold, Hellen; Hennel, Roman; Benechet, Alexandre; Lorenz, Michael; Chandraratne, Sue; Schubert, Irene; Helmer, Sebastian; Striednig, Bianca; Stark, Konstantin; Janko, Marek; Boettcher, Ralph T.; Verschoor, Admar; Leon, Catherine; Gachet, Christian; Gudermann, Thomas; Mederos y Schnitzler, Michael; Pincus, Zachary; Iannacone, Matteo; Haas, Rainer; Wanner, Gerhard; Lauber, Kirsten; Sixt, Michael; Massberg, Steffen			Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria	CELL			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; CELL-MIGRATION; STAPHYLOCOCCUS-AUREUS; MONOCLONAL-ANTIBODY; THROMBUS GROWTH; HOST-DEFENSE; MOTILITY; ACTIN; ACTIVATION; CHANNELS	Blood platelets are critical for hemostasis and thrombosis and play diverse roles during immune responses. Despite these versatile tasks in mammalian biology, their skills on a cellular level are deemed limited, mainly consisting in rolling, adhesion, and aggregate formation. Here, we identify an unappreciated asset of platelets and show that adherent platelets use adhesion receptors to mechanically probe the adhesive substrate in their local microenvironment. When actomyosin-dependent traction forces overcome substrate resistance, platelets migrate and pile up the adhesive substrate together with any bound particulate material. They use this ability to act as cellular scavengers, scanning the vascular surface for potential invaders and collecting deposited bacteria. Microbe collection by migrating platelets boosts the activity of professional phagocytes, exacerbating inflammatory tissue injury in sepsis. This assigns platelets a central role in innate immune responses and identifies them as potential targets to dampen inflammatory tissue damage in clinical scenarios of severe systemic infection.	[Gaertner, Florian; Ahmad, Zerkah; Rosenberger, Gerhild; Fan, Shuxia; Nicolai, Leo; Yavuz, Goekce; Ishikawa-Ankerhold, Hellen; Lorenz, Michael; Chandraratne, Sue; Schubert, Irene; Helmer, Sebastian; Striednig, Bianca; Stark, Konstantin; Massberg, Steffen] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany; [Luckner, Manja; Wanner, Gerhard] Ludwig Maximilians Univ Munchen, Ultrastruct Res, Dept Biol 1, Biozentrum, D-82152 Martinsried, Germany; [Busch, Benjamin; Haas, Rainer] LMU, Fac Med, Max von Pettenkofer Inst, Chair Med Microbiol & Hosp Epidemiol, D-80336 Munich, Germany; [Benechet, Alexandre; Iannacone, Matteo] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Expt Imaging Ctr, I-20132 Milan, Italy; [Hennel, Roman; Lauber, Kirsten] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, D-81377 Munich, Germany; [Janko, Marek] Tech Univ, Dept Mat Sci, D-64287 Darmstadt, Germany; [Boettcher, Ralph T.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Verschoor, Admar] Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany; [Leon, Catherine; Gachet, Christian] Univ Strasbourgh, INSERM, UMR S949, Etab Francais Sang Alsace, F-67065 Strasbourg, France; [Gudermann, Thomas; Mederos y Schnitzler, Michael] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Pincus, Zachary] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA; [Pincus, Zachary] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Sixt, Michael] IST Austria, A-3400 Klosterneuburg, Austria; [Gaertner, Florian; Stark, Konstantin; Boettcher, Ralph T.; Gudermann, Thomas; Mederos y Schnitzler, Michael; Massberg, Steffen] DZHK, D-13347 Berlin, Germany; [Haas, Rainer] German Ctr Infect Res DZIF, Munich Site, D-80336 Munich, Germany	University of Munich; University of Munich; University of Munich; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Munich; Technical University of Darmstadt; Max Planck Society; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich; Washington University (WUSTL); Washington University (WUSTL); Institute of Science & Technology - Austria; German Centre for Cardiovascular Research; German Center for Infection Research	Gaertner, F; Massberg, S (corresponding author), Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 1, D-81377 Munich, Germany.; Gaertner, F; Massberg, S (corresponding author), DZHK, D-13347 Berlin, Germany.	f.gaertner@med.uni-muenchen.de; steffen.massberg@med.uni-muenchen.de	Gaertner, Florian/AAY-1420-2021; Massberg, Steffen/AAN-6054-2021; leon, catherine/ABB-5242-2020; Léon, Catherine/G-6473-2015; Stark, Konstantin/AAJ-2815-2020; Iannacone, Matteo/I-8507-2018; Schubert, Irene/M-7230-2019; Gaertner, Florian/GXG-7213-2022; Gachet, Christian/H-9156-2016	leon, catherine/0000-0002-8597-9929; Léon, Catherine/0000-0002-8597-9929; Stark, Konstantin/0000-0002-5369-8399; Iannacone, Matteo/0000-0002-9370-2671; Gaertner, Florian/0000-0001-6120-3723; Benechet, Alexandre/0000-0001-8746-2459; Schubert, Irene/0000-0003-3344-5324; Luckner, Manja/0000-0002-9915-2842; Sixt, Michael/0000-0002-6620-9179	DFG [SFB 914, SFB 1123, FOR 2033]; German Centre for Cardiovascular Research (DZHK); FP7 program [260309]; FoFoLe project [947]; Friedrich-Baur-Stiftung project [41/16]; Marie Sklodowska Curie Individual Fellowship (EU project) [747687]	DFG(German Research Foundation (DFG)); German Centre for Cardiovascular Research (DZHK); FP7 program; FoFoLe project; Friedrich-Baur-Stiftung project; Marie Sklodowska Curie Individual Fellowship (EU project)	We thank Christin Lehmann, Anja Titova, Nicole Blount, and Cornelia Niemann for excellent technical assistance. We thank Reinhard Fassler, Barbara Walzog, Eva Kiermaier, and Joachim Pilcher for helpful discussions. This study was supported by the DFG SFB 914 (S.M. [B02 and Z01], K.S. [B02], R.T.B. [A05], A.V. [B04], and R. Haas [B05]), the DFG SFB 1123 (S.M. [B06]), the DFG FOR 2033 (S.M. and F.G.), the German Centre for Cardiovascular Research (DZHK) (MHA 1.4VD [S.M.]), FP7 program (project 260309, PRESTIGE [S.M.]), FoFoLe project 947 (F.G.), the Friedrich-Baur-Stiftung project 41/16 (F.G.), Marie Sklodowska Curie Individual Fellowship (EU project 747687, LamelliActin [F.G.]).	Ali RA, 2017, J IMMUNOL, V198, P344, DOI 10.4049/jimmunol.1601178; [Anonymous], 2014, R LANG ENV STAT COMP; Auger JM, 2008, ARTERIOSCL THROM VAS, V28, P1499, DOI 10.1161/ATVBAHA.108.167296; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; BELAMARI.FA, 1966, NATURE, V212, P1579, DOI 10.1038/2121579a0; Benechet AP, 2017, METHODS MOL BIOL, V1514, P49, DOI 10.1007/978-1-4939-6548-9_4; BETTEXGALLAND M, 1959, NATURE, V184, P276, DOI 10.1038/184276b0; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Brass LF, 2005, J CLIN INVEST, V115, P3385, DOI 10.1172/JCI26869; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Clark A. M., 1942, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V20, P241, DOI 10.1038/icb.1942.40; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Feng D, 1998, INT ARCH ALLERGY IMM, V116, P188, DOI 10.1159/000023944; Grebecka L, 1997, PROTOPLASMA, V197, P174, DOI 10.1007/BF01288026; Greenlee-Wacker M, 2015, CURR OPIN HEMATOL, V22, P30, DOI 10.1097/MOH.0000000000000096; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jung CJ, 2012, J INFECT DIS, V205, P1066, DOI 10.1093/infdis/jis021; Kanaji T, 2002, BLOOD, V100, P2102, DOI 10.1182/blood-2002-03-0997; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Levin J., 1988, Progress in Clinical and Biological Research, V272, P3; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mazharian A, 2011, BLOOD, V117, P5198, DOI 10.1182/blood-2010-12-326850; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendoza M.C., 2012, CURR PROTOC CYTOM; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Ono A, 2008, BLOOD, V112, P90, DOI 10.1182/blood-2007-12-127001; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prasad JM, 2015, BLOOD, V126, P2047, DOI 10.1182/blood-2015-04-639849; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Wanner G, 2013, J STRUCT BIOL, V184, P203, DOI 10.1016/j.jsb.2013.10.003; White JG, 2005, PLATELETS, V16, P121, DOI 10.1080/09537100400007390; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yount G, 2007, J NEURO-ONCOL, V81, P113, DOI 10.1007/s11060-006-9211-4	64	167	176	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1368	+		10.1016/j.cell.2017.11.001	http://dx.doi.org/10.1016/j.cell.2017.11.001			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195076	Bronze			2022-12-28	WOS:000417362700018
J	Hodaei, H; Hassan, AU; Wittek, S; Garcia-Gracia, H; El-Ganainy, R; Christodoulides, DN; Khajavikhan, M				Hodaei, Hossein; Hassan, Absar U.; Wittek, Steffen; Garcia-Gracia, Hipolito; El-Ganainy, Ramy; Christodoulides, Demetrios N.; Khajavikhan, Mercedeh			Enhanced sensitivity at higher-order exceptional points (vol 548, pg 187, 2017)	NATURE			English	Correction																		Hodaei H, 2017, NATURE, V548, P187, DOI 10.1038/nature23280	1	10	10	7	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682								10.1038/nature24024	http://dx.doi.org/10.1038/nature24024			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189779	Bronze			2022-12-28	WOS:000416520400050
J	Topper, MJ; Vaz, M; Chiappinelli, KB; Shields, CED; Niknafs, N; Yen, RWC; Wenzel, A; Hicks, J; Ballew, M; Stone, M; Tran, PT; Zahnow, CA; Hellmann, MD; Anagnostou, V; Strissel, PL; Strick, R; Velculescu, VE; Baylin, SB				Topper, Michael J.; Vaz, Michelle; Chiappinelli, Katherine B.; Shields, Christina E. DeStefano; Niknafs, Noushin; Yen, Ray-Whay Chiu; Wenzel, Alyssa; Hicks, Jessica; Ballew, Matthew; Stone, Meredith; Tran, Phuoc T.; Zahnow, Cynthia A.; Hellmann, Matthew D.; Anagnostou, Valsamo; Strissel, Pamela L.; Strick, Reiner; Velculescu, Victor E.; Baylin, Stephen B.			Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer	CELL			English	Article							HISTONE DEACETYLASE INHIBITOR; REFRACTORY SOLID TUMORS; T-CELL EXHAUSTION; LARGE GENE LISTS; NF-KAPPA-B; DNA METHYLATION; PD-1 BLOCKADE; INTERFERON RESPONSE; PHASE-I; EXPRESSION	Combining DNA-demethylating agents (DNA methyltransferase inhibitors [DNMTis]) with histone deacetylase inhibitors (HDACis) holds promise for enhancing cancer immune therapy. Herein, pharmacologic and isoform specificity of HDACis are investigated to guide their addition to a DNMTi, thus devising a new, low-dose, sequential regimen that imparts a robust anti-tumor effect for non-small-cell lung cancer (NSCLC). Using in-vitro-treated NSCLC cell lines, we elucidate an interferon alpha/beta-based transcriptional program with accompanying upregulation of antigen presentation machinery, mediated in part through double-stranded RNA (dsRNA) induction. This is accompanied by suppression of MYC signaling and an increase in the T cell chemoattractant CCL5. Use of this combination treatment schema in mouse models of NSCLC reverses tumor immune evasion and modulates T cell exhaustion state towards memory and effector T cell phenotypes. Key correlative science metrics emerge for an upcoming clinical trial, testing enhancement of immune checkpoint therapy for NSCLC.	[Topper, Michael J.; Vaz, Michelle; Shields, Christina E. DeStefano; Niknafs, Noushin; Yen, Ray-Whay Chiu; Stone, Meredith; Zahnow, Cynthia A.; Anagnostou, Valsamo; Velculescu, Victor E.; Baylin, Stephen B.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Topper, Michael J.; Stone, Meredith] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Ballew, Matthew; Tran, Phuoc T.] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA; [Chiappinelli, Katherine B.] George Washington Univ, Canc Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Strissel, Pamela L.; Strick, Reiner] Univ Clin Erlangen, Lab Mol Med, Dept Gynecol & Obstet, D-91054 Erlangen, Germany; [Hicks, Jessica] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Urol Pathol, Baltimore, MD 21287 USA; [Wenzel, Alyssa] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; George Washington University; Memorial Sloan Kettering Cancer Center; University of Erlangen Nuremberg; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA.	sbaylin@jhmi.edu	Tran, Phuoc/W-2084-2019; Velculescu, Victor/ABF-4846-2020	Tran, Phuoc/0000-0002-0147-0376; Velculescu, Victor/0000-0003-1195-438X; DeStefano Shields, Christina/0000-0003-4714-3423	Hodson Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Commonwealth Foundation; Stand Up To Cancer Jim Toth Sr. Breakthrough Prize in Lung Cancer; SWCRF Collaboration for a Cure; Defense Health Program (DOD0), through the Department of Defense Ovarian Cancer Research Program, Teal Innovator Award [OC130454/W81XWH-14-1-0385]; National Cancer Institute [CA121113, CA006973, CA180950]; Van Andel Research Institute through the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; NATIONAL CANCER INSTITUTE [R00CA204592, R01CA121113, R01CA166348, P30CA008748, U10CA180950, P30CA006973] Funding Source: NIH RePORTER	Hodson Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Commonwealth Foundation; Stand Up To Cancer Jim Toth Sr. Breakthrough Prize in Lung Cancer; SWCRF Collaboration for a Cure; Defense Health Program (DOD0), through the Department of Defense Ovarian Cancer Research Program, Teal Innovator Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Van Andel Research Institute through the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from The Hodson Trust, The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, The Commonwealth Foundation, Stand Up To Cancer Jim Toth Sr. Breakthrough Prize in Lung Cancer, and the SWCRF Collaboration for a Cure. This work is also supported by The Defense Health Program (DOD0), through the Department of Defense Ovarian Cancer Research Program, Teal Innovator Award No. OC130454/W81XWH-14-1-0385 (opinions, interpretations, conclusions, and recommendations are those of the author and not necessarily endorsed by the Department of Defense). Research reported in this publication was supported by the National Cancer Institute under award numbers CA121113, CA006973, and CA180950. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Research funding was also provided by the Van Andel Research Institute through the Van Andel Research Institute - Stand Up To Cancer Epigenetics Dream Team. Stand Up To Cancer is a program of the Entertainment Industry Foundation, administered by AACR. We acknowledge Mrs. Elizabeth Stiegler and Lauren Murphy for expert technical help. We thank Kathy Bender for help with manuscript preparation. V.E.V. is a founder of Personal Genome Diagnostics, a member of its Scientific Advisory Board and Board of Directors, and owns Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. V.E.V. is also on the Scientific Advisory Board for Ignyta.	Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Cai Y, 2014, ONCOGENE, V33, P2157, DOI 10.1038/onc.2013.178; Cai Y, 2017, GENOME RES, V27, P533, DOI 10.1101/gr.208108.116; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Gore L, 2008, CLIN CANCER RES, V14, P4517, DOI 10.1158/1078-0432.CCR-07-1461; Hong M, 2011, CANCER RES, V71, P6997, DOI 10.1158/0008-5472.CAN-11-1466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kellar A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621324; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Lavergne E, 2004, J IMMUNOL, V173, P3755, DOI 10.4049/jimmunol.173.6.3755; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Moreno-Bost A, 2011, CYTOTHERAPY, V13, P618, DOI 10.3109/14653249.2010.529893; Oi S, 2009, J NEURO-ONCOL, V92, P15, DOI 10.1007/s11060-008-9732-0; Okayama H, 2013, INT J CANCER, V132, P9, DOI 10.1002/ijc.27644; Rasheed WK, 2007, EXPERT OPIN INV DRUG, V16, P659, DOI 10.1517/13543784.16.5.659; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Schlee M, 2007, ADV CANCER RES, V97, P167, DOI 10.1016/S0065-230X(06)97007-9; Schlee M, 2007, INT J CANCER, V120, P1387, DOI 10.1002/ijc.22372; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Stengel S, 2010, GENE CHROMOSOME CANC, V49, P401, DOI 10.1002/gcc.20751; Strissel PL, 2012, ONCOTARGET, V3, P1204; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Zahnow CA, 2016, ADV CANCER RES, V130, P55, DOI 10.1016/bs.acr.2016.01.007; Zehn D, 2015, ADV EXP MED BIOL, V850, P137, DOI 10.1007/978-3-319-15774-0_10	55	235	244	8	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1284	+		10.1016/j.cell.2017.10.022	http://dx.doi.org/10.1016/j.cell.2017.10.022			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195073	Green Accepted, Bronze			2022-12-28	WOS:000417362700012
J	White, C				White, Caroline			INVESTIGATION Sexual health services on the brink	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												carolinew_health@hotmail.com	King, Carina/C-8883-2016					All Parliamentary Group on Sexual and Reproductive Health, 2015, ALL PARLIAMENTARY GR, P49; Croxford S, 2017, BRIT HIV ASS C LIV A; London Councils, LOND SEX HLTH TRANSF; McCall H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5790; National AIDS Trust, 2017, HIV SUPP SERV STAT N; Public Health England, 2014, MAK IT WORK GUID WHO; Public Health England, SEX TRANSM INF CHLAM; Public Health England, 2017, HIV UK DECL NEW HIV; Public Health England, 2011, SEX TRANSM INF STIS; Robertson R, 2017, UNDERSTANDING NHS FI	10	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5395	10.1136/bmj.j5395	http://dx.doi.org/10.1136/bmj.j5395			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29192020				2022-12-28	WOS:000417211800005
J	Zeiser, R; Blazar, BR				Zeiser, Robert; Blazar, Bruce R.			Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; PHASE 1/2 TRIAL; ACUTE GVHD; MURINE RECIPIENTS; NLRP3 INFLAMMASOME; DENDRITIC CELLS; TUMOR ACTIVITY; TISSUE-DAMAGE		[Zeiser, Robert] Freiburg Univ, Med Ctr, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities	Blazar, BR (corresponding author), Dept Pediat, Div Blood & Marrow Transplantat, MMC 366,420 Delaware St SE, Minneapolis, MN 55455 USA.	blaza001@umn.edu		Zeiser, Robert/0000-0001-6565-3393	NCI NIH HHS [P01 CA142106, P01 CA065493] Funding Source: Medline; NHLBI NIH HHS [R01 HL056067] Funding Source: Medline; NIAID NIH HHS [R37 AI034495, P01 AI056299] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA142106, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299, R37AI034495] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Asai O, 1998, J CLIN INVEST, V101, P1835, DOI 10.1172/JCI1268; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarod S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00056; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Baker MB, 1996, J EXP MED, V183, P2645, DOI 10.1084/jem.183.6.2645; Betts BC, 2011, BLOOD, V118, P5330, DOI 10.1182/blood-2011-06-363408; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Blazar BR, 1999, J IMMUNOL, V162, P6368; Blazar BR, 1997, J IMMUNOL, V159, P3460; BLAZAR BR, 1993, J IMMUNOL, V151, P5726; Bleakley M, 2015, J CLIN INVEST, V125, P2677, DOI 10.1172/JCI81229; Borsotti C, 2007, BLOOD, V110, P783, DOI 10.1182/blood-2006-10-054510; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Bruce DW, 2017, J CLIN INVEST, V127, P1813, DOI 10.1172/JCI91816; Brunstein CG, 2016, BLOOD, V127, P1044, DOI 10.1182/blood-2015-06-653667; Byersdorfer CA, 2013, BLOOD, V122, P3230, DOI 10.1182/blood-2013-04-495515; Carapito R, 2016, BLOOD, V128, P1979, DOI 10.1182/blood-2016-05-719070; Chen BJ, 2007, BLOOD, V109, P3115, DOI 10.1182/blood-2006-04-016410; Chen YB, 2017, BIOL BLOOD MARROW TR, V23, P625, DOI 10.1016/j.bbmt.2017.01.069; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; Chopra M, 2016, J EXP MED, V213, P1881, DOI 10.1084/jem.20151563; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Fischer JC, 2017, CELL IMMUNOL, V316, P70, DOI 10.1016/j.cellimm.2017.04.003; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Forman SJ., 2015, THOMAS HEMATOPOIETIC; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Furlan SN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3231; Ganguly S, 2014, BLOOD, V124, P2131, DOI 10.1182/blood-2013-10-525873; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Giroux M, 2011, BLOOD, V117, P1734, DOI 10.1182/blood-2010-05-287649; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Gratwohl A, 2015, LANCET HAEMATOL, V2, pE91, DOI 10.1016/S2352-3026(15)00028-9; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; Gungor T, 2014, LANCET, V383, P436, DOI [10.1016/s0140-6736(13)62069-3, 10.1016/S0140-6736(13)62069-3]; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Harris AC, 2016, BIOL BLOOD MARROW TR, V22, P4, DOI 10.1016/j.bbmt.2015.09.001; Hartwell MJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89798; Hayase E, 2017, J EXP MED; Iyengar S, 2014, BIOL BLOOD MARROW TR, V20, P1104, DOI 10.1016/j.bbmt.2014.04.029; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kakihana K, 2016, BLOOD, V128, P2083, DOI 10.1182/blood-2016-05-717652; Kennedy GA, 2014, LANCET ONCOL, V15, P1451, DOI 10.1016/S1470-2045(14)71017-4; Klambt V, 2015, J IMMUNOL, V195, P5795, DOI 10.4049/jimmunol.1501357; Koch LK, 2009, BLOOD, V114, P5062, DOI 10.1182/blood-2009-06-227587; Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41; Koreth J, 2009, BLOOD, V114, P3956, DOI 10.1182/blood-2009-07-231092; Koura DT, 2013, BIOL BLOOD MARROW TR, V19, P1638, DOI 10.1016/j.bbmt.2013.09.003; Koyama M, 2015, J EXP MED, V212, P1303, DOI 10.1084/jem.20150329; Koyama M, 2012, NAT MED, V18, P135, DOI 10.1038/nm.2597; Kroger N, 2016, NEW ENGL J MED, V374, P43, DOI 10.1056/NEJMoa1506002; Lang P, 2015, BONE MARROW TRANSPL, V50, pS6, DOI 10.1038/bmt.2015.87; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li HM, 2012, J IMMUNOL, V188, P3804, DOI 10.4049/jimmunol.1102795; Li LQ, 2009, CELL CYCLE, V8, P1794, DOI 10.4161/cc.8.11.8738; Li XF, 2012, J IMMUNOL, V188, P724, DOI 10.4049/jimmunol.1102630; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Loiseau P, 2007, BIOL BLOOD MARROW TR, V13, P965, DOI 10.1016/j.bbmt.2007.04.010; Luznik L, 2010, BLOOD, V115, P3224, DOI 10.1182/blood-2009-11-251595; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995; Martelli MF, 2014, BLOOD, V124, P638, DOI 10.1182/blood-2014-03-564401; Martin PJ, 2017, BLOOD, V129, P791, DOI 10.1182/blood-2016-09-737700; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Matta BM, 2016, BLOOD, V128, P427, DOI 10.1182/blood-2015-12-684142; Matte-Martone C, 2008, BLOOD, V111, P3884, DOI 10.1182/blood-2007-11-125294; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mielcarek M, 2015, HAEMATOLOGICA, V100, P842, DOI 10.3324/haematol.2014.118471; Nguyen HD, 2016, J CLIN INVEST, V126, P1337, DOI 10.1172/JCI82587; Nishikii H, 2016, BLOOD, V128, P2846, DOI 10.1182/blood-2016-06-723783; Pasquini MC, 2015, CURRENT USE OUTCOME; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Penack O, 2010, JNCI-J NATL CANCER I, V102, P894, DOI 10.1093/jnci/djq172; Reichenbach DK, 2015, BLOOD, V125, P3183, DOI 10.1182/blood-2014-10-606830; Reinhardt K, 2014, J IMMUNOL, V193, P3355, DOI 10.4049/jimmunol.1400983; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Riesner K, 2017, BLOOD, V129, P2021, DOI 10.1182/blood-2016-08-736314; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Saha A, 2016, J CLIN INVEST, V126, P2642, DOI 10.1172/JCI85796; Saha A, 2013, BLOOD, V122, P3062, DOI 10.1182/blood-2013-05-500801; Santos N, 2016, BONE MARROW TRANSPL, V51, P79, DOI 10.1038/bmt.2015.207; Schwab L, 2014, NAT MED, V20, P648, DOI 10.1038/nm.3517; Shindo T, 2013, BLOOD, V121, P4617, DOI 10.1182/blood-2012-12-476218; Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Socie G, 2017, BLOOD, V129, P643, DOI 10.1182/blood-2016-09-738625; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Spoerl S, 2014, BLOOD, V123, P3832, DOI 10.1182/blood-2013-12-543736; Stickel N, 2017, LEUKEMIA; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; STORB R, 1986, NEW ENGL J MED, V314, P729, DOI 10.1056/NEJM198603203141201; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Taylor PA, 2007, BLOOD, V110, P3480, DOI 10.1182/blood-2007-05-087940; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Toubai T, 2014, BLOOD, V123, P3512, DOI 10.1182/blood-2013-12-545335; Tsukamoto H, 2012, BLOOD, V119, P4554, DOI 10.1182/blood-2011-09-375899; UrbanoIspizua A, 1997, BLOOD, V89, P3967, DOI 10.1182/blood.V89.11.3967; Uryu H, 2015, BLOOD, V125, P3014, DOI 10.1182/blood-2014-12-615781; VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Veenstra RG, 2015, BLOOD, V125, P3335, DOI 10.1182/blood-2014-09-603357; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058397; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wolf D, 2017, BIOL BLOOD MARROW TR, V23, P757, DOI 10.1016/j.bbmt.2017.02.013; Wysocki CA, 2004, J IMMUNOL, V173, P845, DOI 10.4049/jimmunol.173.2.845; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Zeiser R, 2015, LEUKEMIA, V29, P2062, DOI 10.1038/leu.2015.212; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeiser R, 2016, BLOOD, V127, P3117, DOI 10.1182/blood-2016-02-699082; Zhang JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0166; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	122	523	542	7	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2167	2179		10.1056/NEJMra1609337	http://dx.doi.org/10.1056/NEJMra1609337			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO1VI	29171820	Green Accepted			2022-12-28	WOS:000416555000010
J	Sousa, AMM; Zhu, Y; Raghanti, MA; Kitchen, RR; Onorati, M; Tebbenkamp, ATN; Stutz, B; Meyer, KA; Li, MF; Kawasawa, YI; Liu, FC; Perez, RG; Mele, M; Carvalho, T; Skarica, M; Gulden, FO; Pletikos, M; Shibata, A; Stephenson, AR; Edler, MK; Ely, JJ; Elsworth, JD; Horvath, TL; Hof, PR; Hyde, TM; Kleinman, JE; Weinberger, DR; Reimers, M; Lifton, RP; Mane, SM; Noonan, JP; State, MW; Lein, ES; Knowles, JA; Marques-Bonet, T; Sherwood, CC; Gerstein, MB; Sestan, N				Sousa, Andre M. M.; Zhu, Ying; Raghanti, Mary Ann; Kitchen, Robert R.; Onorati, Marco; Tebbenkamp, Andrew T. N.; Stutz, Bernardo; Meyer, Kyle A.; Li, Mingfeng; Kawasawa, Yuka Imamura; Liu, Fuchen; Perez, Raquel Garcia; Mele, Marta; Carvalho, Tiago; Skarica, Mario; Gulden, Forrest O.; Pletikos, Mihovil; Shibata, Akemi; Stephenson, Alexa R.; Edler, Melissa K.; Ely, John J.; Elsworth, John D.; Horvath, Tamas L.; Hof, Patrick R.; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.; Reimers, Mark; Lifton, Richard P.; Mane, Shrikant M.; Noonan, James P.; State, Matthew W.; Lein, Ed S.; Knowles, James A.; Marques-Bonet, Tomas; Sherwood, Chet C.; Gerstein, Mark B.; Sestan, Nenad			Molecular and cellular reorganization of neural circuits in the human lineage	SCIENCE			English	Article							HYDROXYLASE-IMMUNOREACTIVE NEURONS; GENE-EXPRESSION LEVELS; TYROSINE-HYDROXYLASE; CEREBRAL-CORTEX; HUMAN BRAIN; EVOLUTION; PRIMATE; TRANSCRIPTOME; DIVERSITY; NUMBER	To better understand the molecular and cellular differences in brain organization between human and nonhuman primates, we performed transcriptome sequencing of 16 regions of adult human, chimpanzee, and macaque brains. Integration with human single-cell transcriptomic data revealed global, regional, and cell-type-specific species expression differences in genes representing distinct functional categories. We validated and further characterized the human specificity of genes enriched in distinct cell types through histological and functional analyses, including rare subpallial-derived interneurons expressing dopamine biosynthesis genes enriched in the human striatum and absent in the nonhuman African ape neocortex. Our integrated analysis of the generated data revealed diverse molecular and cellular features of the phylogenetic reorganization of the human brain across multiple levels, with relevance for brain function and disease.	[Sousa, Andre M. M.; Zhu, Ying; Onorati, Marco; Tebbenkamp, Andrew T. N.; Meyer, Kyle A.; Li, Mingfeng; Kawasawa, Yuka Imamura; Liu, Fuchen; Skarica, Mario; Gulden, Forrest O.; Pletikos, Mihovil; Shibata, Akemi; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT USA; [Sousa, Andre M. M.; Zhu, Ying; Onorati, Marco; Tebbenkamp, Andrew T. N.; Meyer, Kyle A.; Li, Mingfeng; Kawasawa, Yuka Imamura; Liu, Fuchen; Skarica, Mario; Gulden, Forrest O.; Pletikos, Mihovil; Shibata, Akemi; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT USA; [Raghanti, Mary Ann; Stephenson, Alexa R.; Edler, Melissa K.] Kent State Univ, Dept Anthropol, Kent, OH 44242 USA; [Raghanti, Mary Ann; Stephenson, Alexa R.; Edler, Melissa K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Kitchen, Robert R.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, Dept Mol Biophys, New Haven, CT USA; [Kitchen, Robert R.; Gerstein, Mark B.] Yale Univ, Dept Biochem, Program Computat Biol & Bioinformat, New Haven, CT USA; [Kitchen, Robert R.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Kitchen, Robert R.; Elsworth, John D.; Sestan, Nenad] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Onorati, Marco] Univ Pisa, Dept Biol, Unit Cell & Dev Biol, Pisa, Italy; [Stutz, Bernardo; Horvath, Tamas L.; Sestan, Nenad] Program Integrat Cell Signaling & Neurobiol Metab, Dept Comparat Med, New Haven, CT USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Dept Pharmacol, Hershey, PA USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Dept Biochem, Inst Personalized Med, Hershey, PA USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Dept Mol Biol, Hershey, PA USA; [Perez, Raquel Garcia; Mele, Marta; Carvalho, Tiago; Marques-Bonet, Tomas] Univ Pompeu Fabra, Consejo Super Invest Cient, Barcelona Biomed Res Pk, Inst Biol Evolut, Barcelona, Catalonia, Spain; [Ely, John J.] Alamogordo Primate Facil, Holloman AFB, NM USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.] Johns Hopkins Univ Med Campus, Lieber Inst Brain Dev, Baltimore, MD USA; [Reimers, Mark] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Lifton, Richard P.; Noonan, James P.; Sestan, Nenad] Yale Sch Med, Dept Genet, New Haven, CT USA; [Lifton, Richard P.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Genom, 1230 York Ave, New York, NY 10065 USA; [Mane, Shrikant M.] Yale Sch Med, Yale Ctr Genom Anal, New Haven, CT USA; [State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [State, Matthew W.] Univ Calif San Francisco, Langley Porter Psychiat Inst, San Francisco, CA USA; [Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA USA; [Knowles, James A.] Univ Southern Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA USA; [Knowles, James A.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Marques-Bonet, Tomas] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Marques-Bonet, Tomas] Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain; [Sherwood, Chet C.] George Washington Univ, Dept Anthropol, Washington, DC USA; [Sestan, Nenad] Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA; [Sestan, Nenad] Yale Sch Med, Yale Child Study Ctr, New Haven, CT USA	Yale University; Yale University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Yale University; Yale University; Yale University; Yale University; University of Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine; Michigan State University; Yale University; Howard Hughes Medical Institute; Yale University; Rockefeller University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Allen Institute for Brain Science; University of Southern California; University of Southern California; ICREA; George Washington University; Yale University; Yale University	Sestan, N (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT USA.; Sestan, N (corresponding author), Yale Sch Med, Kavli Inst Neurosci, New Haven, CT USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT USA.; Sestan, N (corresponding author), Program Integrat Cell Signaling & Neurobiol Metab, Dept Comparat Med, New Haven, CT USA.; Sestan, N (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT USA.; Sestan, N (corresponding author), Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT USA.; Sestan, N (corresponding author), Yale Sch Med, Yale Child Study Ctr, New Haven, CT USA.	nenad.sestan@yale.edu	Zhu, Ying/T-2268-2019; Onorati, Marco/K-3919-2018; Noonan, James/ABF-1320-2021; Marques-Bonet, Tomas/ABF-3734-2020; Onorati, Marco/T-7190-2019; State, Matthew/W-2256-2019; Sousa, Andre M. M./C-1203-2015	Onorati, Marco/0000-0001-8517-930X; Marques-Bonet, Tomas/0000-0002-5597-3075; Sousa, Andre M. M./0000-0003-1740-5066; Imamura Kawasawa, Yuka/0000-0002-8638-6738; Edler, Melissa/0000-0002-9084-9539; Kitchen, Robert/0000-0003-1443-8559; Garcia Perez, Raquel/0000-0002-2573-6984; Stutz, Bernardo/0000-0001-5282-6400; mele, marta/0000-0001-8874-6453; Tebbenkamp, Andrew/0000-0002-9015-3427; Zhu, Ying/0000-0002-6594-3734; State, Matthew/0000-0003-1624-8302	NIH [MH109904, MH106874, AG048918, DK111178, NS092988]; Kavli Foundation; James S. McDonnell Foundation; NSF [BCS-1316829]; MINECO [BFU2014-55090-P]; Howard Hughes International Early Career; Secretaria d'Universitats i Recerca del Department d'Economia i Coneixement de la Generalitat de Catalunya;  [MH103339];  [MH106934];  [MH110926]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106934, R01MH110926, U01MH103339, RF1MH114126, U01MH106874, R01MH109904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS092988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048918] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); MINECO(Spanish Government); Howard Hughes International Early Career; Secretaria d'Universitats i Recerca del Department d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Data are available at National Center for Biotechnology Information BioProjects (accession number PRJNA236446). We thank A. Bauernfeind, M. Horn, D. Singh, G. Terwilliger, I. B. Toxopeus, B. Wicinski, and S. Wilson for assistance with tissue acquisition and processing, and the Alamogordo Primate Facility and the Primate Brain Bank, Netherlands Institute for Neuroscience, for providing primate tissue. Data was generated as part of the PsychENCODE Consortium, supported by MH103339, MH106934, and MH110926. Additional support was provided by NIH grants MH109904, MH106874, AG048918, DK111178, and NS092988 (National Chimpanzee Brain Resource), the Kavli Foundation, the James S. McDonnell Foundation, NSF grant BCS-1316829, MINECO BFU2014-55090-P (FEDER), Howard Hughes International Early Career, and Secretaria d'Universitats i Recerca del Department d'Economia i Coneixement de la Generalitat de Catalunya. The supplementary materials contain additional data.	Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035; Benavides-Piccione R, 2007, J ANAT, V211, P212, DOI 10.1111/j.1469-7580.2007.00760.x; BERGER B, 1985, DEV BRAIN RES, V23, P141, DOI 10.1016/0165-3806(85)90013-6; Boudreau RL, 2014, NEURON, V81, P294, DOI 10.1016/j.neuron.2013.10.062; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Close JL, 2017, NEURON, V93, P1035, DOI [10.1016/j.neuron.2017.10.024, 10.1016/j.neuron.2017.02.014]; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Dehorter N, 2015, SCIENCE, V349, P1216, DOI 10.1126/science.aab3415; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fukuda T, 1999, NEUROPATHOLOGY, V19, P10, DOI 10.1046/j.1440-1789.1999.00196.x; Gabi M, 2016, P NATL ACAD SCI USA, V113, P9617, DOI 10.1073/pnas.1610178113; GASPAR P, 1989, J COMP NEUROL, V279, P249, DOI 10.1002/cne.902790208; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lein ES, 2017, ANNU REV NEUROSCI, V40, P629, DOI 10.1146/annurev-neuro-070815-013858; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Marui W, 2003, NEUROSCI LETT, V340, P185, DOI 10.1016/S0304-3940(03)00101-0; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Preuss T. M., 2004, THE COGNITIVE NEUROS, P5; Raghanti MA, 2009, NEUROSCIENCE, V158, P1551, DOI 10.1016/j.neuroscience.2008.10.058; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Silver DL, 2016, BIOESSAYS, V38, P162, DOI 10.1002/bies.201500108; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Vermunt MW, 2016, NAT NEUROSCI, V19, P494, DOI 10.1038/nn.4229	40	116	118	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1027	1032		10.1126/science.aan3456	http://dx.doi.org/10.1126/science.aan3456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170230	Green Accepted, Green Submitted			2022-12-28	WOS:000416590400034
J	Williams, JG; Bachman, MW; Lyons, MD; Currie, BB; Brown, LH; Jones, AW; Cabanas, JG; Kronhaus, AK; Myers, JB				Williams, J. G.; Bachman, M. W.; Lyons, M. D.; Currie, B. B.; Brown, L. H.; Jones, A. W.; Cabanas, J. G.; Kronhaus, A. K.; Myers, J. B.			Transport to the Emergency Department for Assisted Living Residents Who Fall	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													jones, wayne/Q-9508-2019						0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					I26	I26		10.7326/P17-9051	http://dx.doi.org/10.7326/P17-9051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29230471				2022-12-28	WOS:000424224300003
J	Xiang, Y; Laurent, B; Hsu, CH; Nachtergaele, S; Lu, ZK; Sheng, WQ; Xu, CY; Chen, H; Ouyang, J; Wang, SQ; Ling, D; Hsu, PH; Zou, L; Jambhekar, A; He, C; Shi, Y				Xiang, Yang; Laurent, Benoit; Hsu, Chih-Hung; Nachtergaele, Sigrid; Lu, Zhike; Sheng, Wanqiang; Xu, Chuanyun; Chen, Hao; Ouyang, Jian; Wang, Siqing; Ling, Dominic; Hsu, Pang-Hung; Zou, Lee; Jambhekar, Ashwini; He, Chuan; Shi, Yang			RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response (vol 543, pg 573, 2017)	NATURE			English	Correction													Hsu, Pang-Hung/C-5587-2018; Wang, Siqing/K-6662-2019	Hsu, Pang-Hung/0000-0001-6873-6434; Wang, Siqing/0000-0002-6665-298X				Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671	1	10	10	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					430	430		10.1038/nature24007	http://dx.doi.org/10.1038/nature24007			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29186122	Bronze			2022-12-28	WOS:000418559800064
J	Sabo, JL; Ruhi, A; Holtgrieve, GW; Elliott, V; Arias, ME; Ngor, PB; Rasanen, TA; Nam, S				Sabo, J. L.; Ruhi, A.; Holtgrieve, G. W.; Elliott, V.; Arias, M. E.; Ngor, Peng Bun; Rasanen, T. A.; Nam, So			Designing river flows to improve food security futures in the Lower Mekong Basin	SCIENCE			English	Article							CHANGE-POINT ANALYSIS; FLOOD PULSE; HYDROLOGIC ALTERATION; DENSITY-DEPENDENCE; MULTIVARIATE DATA; HYDROPOWER; BIODIVERSITY; DAMS; OPTIMIZATION; ECOSYSTEM	Rivers provide unrivaled opportunity for clean energy via hydropower, but little is known about the potential impact of dam-building on the food security these rivers provide. In tropical rivers, rainfall drives a periodic flood pulse fueling fish production and delivering nutrition to more than 150 million people worldwide. Hydropower will modulate this flood pulse, thereby threatening food security. We identified variance components of the Mekong River flood pulse that predict yield in one of the largest freshwater fisheries in the world. We used these variance components to design an algorithm for a managed hydrograph to explore future yields. This algorithm mimics attributes of discharge variance that drive fishery yield: prolonged low flows followed by a short flood pulse. Designed flows increased yield by a factor of 3.7 relative to historical hydrology. Managing desired components of discharge variance will lead to greater efficiency in the Lower Mekong Basin food system.	[Sabo, J. L.] Arizona State Univ, Future H2O Knowledge Enterprise Dev, Tempe, AZ 85287 USA; [Sabo, J. L.; Ruhi, A.] Arizona State Univ, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ 85287 USA; [Sabo, J. L.] Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; [Ruhi, A.] Univ Maryland, Natl Social Ecol Synth Ctr SESYNC, Annapolis, MD 21401 USA; [Holtgrieve, G. W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98105 USA; [Elliott, V.] Conservat Int, Betty & Gordon Moore Ctr Sci, Arlington, VA 22202 USA; [Arias, M. E.] Univ S Florida, Dept Civil & Environm Engn, Tampa, FL 33620 USA; [Rasanen, T. A.] Aalto Univ, Dept Built Environm, Aalto 00076, Finland; [Ngor, Peng Bun] Univ Toulouse III Paul Sabatier, ENFA, CNRS, EDB Lab Evolut & Diversite Biol UMR5174, F-31062 Toulouse, France	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle; Conservation International; State University System of Florida; University of South Florida; Aalto University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Sabo, JL (corresponding author), Arizona State Univ, Future H2O Knowledge Enterprise Dev, Tempe, AZ 85287 USA.; Sabo, JL (corresponding author), Arizona State Univ, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ 85287 USA.; Sabo, JL (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA.	john.l.sabo@asu.edu	Arias, Mauricio/H-5667-2013; Holtgrieve, Gordon/C-5371-2009; Ruhi, Albert/L-4207-2017	Arias, Mauricio/0000-0002-8805-6353; Rasanen, Timo A./0000-0003-0839-3155; Holtgrieve, Gordon/0000-0002-4451-3567; Elliott, Vittoria/0000-0001-8230-489X; Ngor, Peng Bun/0000-0002-3659-6577; Ruhi, Albert/0000-0003-4011-6457	MacArthur Foundation [100717, 100718, 15-108455-000-CSD]; NSF [DEB-1541694, CBET-1204478, EAR-1740042, DBI-1052875]; National Socio-Environmental Synthesis Center (SESYNC); MAA-Ja Vesitekniikan Tuki; Div Of Chem, Bioeng, Env, & Transp Sys [1204478] Funding Source: National Science Foundation	MacArthur Foundation; NSF(National Science Foundation (NSF)); National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MAA-Ja Vesitekniikan Tuki; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Supported by MacArthur Foundation award 100717 and NSF grant DEB-1541694 (G.W.H.); NSF grant CBET-1204478 (J.L.S.); NSF grant EAR-1740042 (J.L.S. and G.W.H.); the National Socio-Environmental Synthesis Center (SESYNC) with funding from NSF grant DBI-1052875 (A.R.); MAA-Ja Vesitekniikan Tuki (T.A.R.); and MacArthur Foundation awards 100718 and 15-108455-000-CSD to Conservation International. All authors thank the Mekong River Commission and the Inland Fisheries Research and Development Institute (IFReDI) of Cambodia for access to data, and C. Phen, T. Cochrane, M. Cooperman, C. Costello, T. Farrell, L. Hannah, L. Kauffman, K. McCann, E. Moody, T. Pool, N. Rooney, and S. Lim for helpful comments on the design of the research or previous versions of the manuscript. Illustrations were created by S. Deviche (Fig. 1) and M. Northrop (Fig. 6), Arizona State University. Data used in this analysis are presented in the supplementary materials and are available in raw form by request from the Mekong River Commission by writing to S. N. (sonam@mrcmekong.org).	Acreman M, 2014, FRONT ECOL ENVIRON, V12, P466, DOI 10.1890/130134; [Anonymous], 1979, FISHERIES ECOLOGY FL; Arias ME, 2014, HYDROL EARTH SYST SC, V18, P5303, DOI 10.5194/hess-18-5303-2014; Barbour EJ, 2016, ENVIRON MODELL SOFTW, V83, P167, DOI 10.1016/j.envsoft.2016.04.029; Bartle A, 2002, ENERG POLICY, V30, P1231, DOI 10.1016/S0301-4215(02)00084-8; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CGIAR, 2017, MEK RIV FACTS; Chang XL, 2010, ENERGY, V35, P4400, DOI 10.1016/j.energy.2009.06.051; Cochrane TA, 2014, HYDROL EARTH SYST SC, V18, P4529, DOI 10.5194/hess-18-4529-2014; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; De Graaf G, 2003, FISHERIES MANAG ECOL, V10, P241; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Graf WL, 1999, WATER RESOUR RES, V35, P1305, DOI 10.1029/1999WR900016; Grumbine RE, 2012, FRONT ECOL ENVIRON, V10, P91, DOI 10.1890/110146; Halls AS, 2013, 32 MRC; Hampton SE, 2013, ECOLOGY, V94, P2663, DOI 10.1890/13-0996.1; Harms TK, 2010, ECOHYDROLOGY, V3, P349, DOI 10.1002/eco.119; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Holmes E. E., 2014, MARSS MULTIVARIATE A; Hori H., 2000, MEKONG ENV DEV; Horne A, 2017, ENVIRON MODELL SOFTW, V88, P188, DOI 10.1016/j.envsoft.2016.11.020; Horne A, 2016, ENVIRON MODELL SOFTW, V84, P326, DOI 10.1016/j.envsoft.2016.06.028; Hortle K.G., 2007, CONSUMPTION YIELD FI; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jager HI, 2008, RIVER RES APPL, V24, P340, DOI 10.1002/rra.1069; James NA, 2014, J STAT SOFTW, V62, P1; Johnson P. T. J., 2008, FRONT ECOL ENVIRON, V6, P357, DOI DOI 10.1890/070156; Kalitsi E. A. K., 2003, UN WORKSH AFR EN EXP, P1; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Kuby MJ, 2005, ADV WATER RESOUR, V28, P845, DOI 10.1016/j.advwatres.2004.12.015; Kummu M, 2008, AMBIO, V37, P185, DOI 10.1579/0044-7447(2008)37[185:IOTMRF]2.0.CO;2; Larnberts D, 2008, AMBIO, V37, P178, DOI 10.1579/0044-7447(2008)37[178:FPAAPO]2.0.CO;2; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Matteson DS, 2014, J AM STAT ASSOC, V109, P334, DOI 10.1080/01621459.2013.849605; Meixner T, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000266; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 2016, NAT CLIM CHANGE, V6, P25, DOI [10.1038/nclimate2765, 10.1038/NCLIMATE2765]; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Rasanen TA, 2013, HYDROL EARTH SYST SC, V17, P2069, DOI 10.5194/hess-17-2069-2013; Rasanen TA, 2017, J HYDROL, V545, P28, DOI 10.1016/j.jhydrol.2016.12.023; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Ruhi A., 2016, Frontiers in Ecology and the Environment, V14, P465; Ruhi A, 2015, GLOBAL CHANGE BIOL, V21, P1482, DOI 10.1111/gcb.12780; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; SEEGRIST DW, 1972, T AM FISH SOC, V101, P478, DOI 10.1577/1548-8659(1972)101<478:EOFOTI>2.0.CO;2; Stone R, 2011, SCIENCE, V333, P814, DOI 10.1126/science.333.6044.814; Suzuki HI, 2009, BRAZ J BIOL, V69, P649, DOI 10.1590/S1519-69842009000300019; Szemis JM, 2013, WATER RESOUR RES, V49, P6393, DOI 10.1002/wrcr.20518; U.S. Agency for International Development, 2014, CAMB COUNTR DEV COOP; U.S. EIA, 2016, INT EN OUTL 2016; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Welter JR, 2005, BIOGEOCHEMISTRY, V76, P421, DOI 10.1007/s10533-005-6997-7; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	62	132	138	12	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368							eaao1053	10.1126/science.aao1053	http://dx.doi.org/10.1126/science.aao1053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217541				2022-12-28	WOS:000417254700050
J	Vijan, S; Manaker, S; Qaseem, A				Vijan, Sandeep; Manaker, Scott; Qaseem, Amir			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Vijan, Sandeep] Ann Arbor Vet Affairs Hlth Serv, Ann Arbor, MI 48105 USA; [Manaker, Scott] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	University of Pennsylvania; American College of Physicians	Vijan, S (corresponding author), Ann Arbor Vet Affairs Hlth Serv, Ann Arbor, MI 48105 USA.							Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	2	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					835	836		10.7326/L17-0475	http://dx.doi.org/10.7326/L17-0475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204616				2022-12-28	WOS:000417135900024
J	Song, BJ; Rogulja, D				Song, Bryan J.; Rogulja, Dragana			SnapShot: Circadian Clock	CELL			English	Editorial Material							DROSOPHILA-MELANOGASTER; PERIOD PROTEIN; GENE; TIMELESS		[Song, Bryan J.; Rogulja, Dragana] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Song, BJ (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.							Aryal RP, 2017, MOL CELL, V67, P770, DOI 10.1016/j.molcel.2017.07.017; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	9	6	7	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	1					1224	+	1224.e1	10.1016/j.cell.2017.11.021	http://dx.doi.org/10.1016/j.cell.2017.11.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW8TV	29195079	Bronze			2022-12-28	WOS:000425610800001
J	Lyon, J				Lyon, Jeff			Map of DNA Sites Governing Gene Expression Finalized	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1967	1967		10.1001/jama.2017.17062	http://dx.doi.org/10.1001/jama.2017.17062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183054				2022-12-28	WOS:000416317600002
J	Mokhlesi, B; Cifu, AS				Mokhlesi, Babak; Cifu, Adam S.			Diagnostic Testing for Obstructive Sleep Apnea in Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; PREVALENCE		[Mokhlesi, Babak; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P407, DOI [10.1001/jama.2016.20325, 10.1001/jama.2016.19635]; Chen XL, 2015, SLEEP, V38, P877, DOI 10.5665/sleep.4732; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kushida CA, 2008, J CLIN SLEEP MED, V4, P157; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Qaseem A, 2014, ANN INTERN MED, V161, P210, DOI 10.7326/M12-3187	8	7	8	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2035	2036		10.1001/jama.2017.16722	http://dx.doi.org/10.1001/jama.2017.16722			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183053				2022-12-28	WOS:000416317600025
J	Deshpande, A				Deshpande, Aditi			Learning to be a mentor	SCIENCE			English	Editorial Material									[Deshpande, Aditi] Allena Pharmaceut, Newton, MA 02462 USA		Deshpande, A (corresponding author), Allena Pharmaceut, Newton, MA 02462 USA.	SciCareerEditor@aaas.org							0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1098	1098		10.1126/science.358.6366.1098	http://dx.doi.org/10.1126/science.358.6366.1098			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2FN	29170240	Bronze			2022-12-28	WOS:000416590400049
J	Conrad, N; Judge, A; Tran, J; Mohseni, H; Hedgecott, D; Crespillo, AP; Allison, M; Hemingway, H; Cleland, JG; McMurray, JJV; Rahimi, K				Conrad, Nathalie; Judge, Andrew; Tran, Jenny; Mohseni, Hamid; Hedgecott, Deborah; Crespillo, Abel Perez; Allison, Moira; Hemingway, Harry; Cleland, John G.; McMurray, John J. V.; Rahimi, Kazem			Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals	LANCET			English	Article							LONG-TERM TRENDS; SURVIVAL; RISK; EPIDEMIOLOGY; ASSOCIATIONS; INEQUALITIES; PROFILE; CARE	Background Large-scale and contemporary population-based studies of heart failure incidence are needed to inform resource planning and research prioritisation but current evidence is scarce. We aimed to assess temporal trends in incidence and prevalence of heart failure in a large general population cohort from the UK, between 2002 and 2014. Methods For this population-based study, we used linked primary and secondary electronic health records of 4 million individuals from the Clinical Practice Research Datalink (CPRD), a cohort that is representative of the UK population in terms of age and sex. Eligible patients were aged 16 years and older, had contributed data between Jan 1, 2002, and Dec 31, 2014, had an acceptable record according to CPRD quality control, were approved for CPRD and Hospital Episodes Statistics linkage, and were registered with their general practice for at least 12 months. For patients with incident heart failure, we extracted the most recent measurement of baseline characteristics (within 2 years of diagnosis) from electronic health records, as well as information about comorbidities, socioeconomic status, ethnicity, and region. We calculated standardised rates by applying direct age and sex standardisation to the 2013 European Standard Population, and we inferred crude rates by applying year-specific, age-specific, and sex-specific incidence to UK census mid-year population estimates. We assumed no heart failure for patients aged 15 years or younger and report total incidence and prevalence for all ages (>0 years). Findings From 2002 to 2014, heart failure incidence (standardised by age and sex) decreased, similarly for men and women, by 7% (from 358 to 332 per 100 000 person-years; adjusted incidence ratio 0.93, 95% CI 0.91-0.94). However, the estimated absolute number of individuals with newly diagnosed heart failure in the UK increased by 12% (from 170 727 in 2002 to 190 798 in 2014), largely due to an increase in population size and age. The estimated absolute number of prevalent heart failure cases in the UK increased even more, by 23% (from 750 127 to 920 616). Over the study period, patient age and multi-morbidity at first presentation of heart failure increased (mean age 76.5 years [SD 12.0] to 77.0 years [12.9], adjusted difference 0.79 years, 95% CI 0.37-1.20; mean number of comorbidities 3.4 [SD 1.9] vs 5.4 [2.5]; adjusted difference 2.0, 95% CI 1.9-2.1). Socioeconomically deprived individuals were more likely to develop heart failure than were affluent individuals (incidence rate ratio 1.61, 95% CI 1.58-1.64), and did so earlier in life than those from the most affluent group (adjusted difference -3.51 years, 95% CI -3.77 to -3.25). From 2002 to 2014, the socioeconomic gradient in age at first presentation with heart failure widened. Socioeconomically deprived individuals also had more comorbidities, despite their younger age. Interpretation Despite a moderate decline in standardised incidence of heart failure, the burden of heart failure in the UK is increasing, and is now similar to the four most common causes of cancer combined. The observed socioeconomic disparities in disease incidence and age at onset within the same nation point to a potentially preventable nature of heart failure that still needs to be tackled. Copyright (c) The Author(s). Published by Elsevier Ltd.	[Conrad, Nathalie; Tran, Jenny; Mohseni, Hamid; Hedgecott, Deborah; Crespillo, Abel Perez; Allison, Moira; Rahimi, Kazem] Univ Oxford, George Inst Global Hlth, Oxford, England; [Rahimi, Kazem] Univ Oxford, Oxford Martin Sch, Deep Med, Oxford, England; [Judge, Andrew] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Nuffield Orthopaed Ctr, Oxford, England; [Judge, Andrew] Univ Bristol, Southmead Hosp, Bristol Natl Inst Hlth Res, Biomed Res Ctr,Musculoskeletal Res Unit, Bristol, Avon, England; [Judge, Andrew] Univ Southampton, Southampton Gen Hosp, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Hemingway, Harry] UCL, Inst Hlth Informat Res, London, England; [Hemingway, Harry] UCL, Univ Coll London Hosp NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Cleland, John G.] Univ Glasgow, Robertson Ctr Biostat & Clin Trials, Glasgow, Lanark, Scotland; [McMurray, John J. V.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Cleland, John G.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Rahimi, Kazem] Oxford Univ Hosp NHS Fdn Trust, Oxford, England	University of Oxford; University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Southmead Hospital; University of Bristol; University of Southampton; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Glasgow; University of Glasgow; Imperial College London; Oxford University Hospitals NHS Foundation Trust	Rahimi, K (corresponding author), Univ Oxford, Oxford Martin Sch, George Inst Global Hlth, Oxford OX1 3QX, England.	kazem.rahimi@georgeinstitute.ox.ac.uk	Conrad, Nathalie/ACZ-2107-2022; Cleland, John G./AAZ-4185-2020; Rahimi, Kazem/AAA-4250-2022; mcmurray, John/B-2467-2013; Rahimi, Kazem/Q-1279-2015; Hemingway, Harry/C-1219-2009	Conrad, Nathalie/0000-0001-5027-5481; Cleland, John G./0000-0002-1471-7016; mcmurray, John/0000-0002-6317-3975; Judge, Andrew/0000-0003-3015-0432; Rahimi, Kazem/0000-0002-4807-4610; Hemingway, Harry/0000-0003-2279-0624	British Heart Foundation; National Institute for Health Research; Medical Research Council [MR/K006584/1, HDR-9003, HDR-9006, MC_PC_13041, HDR-9002] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	British Heart Foundation and National Institute for Health Research.	[Anonymous], 2015, J EPIDEMIOL COMMUNIT, V69, P1000; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Callender T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001699; Cancer Research UK, CANC INC STAT; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Department for Communities and Local Government (DCLG), 2015, ENGL IND MULT DEPR 2; Eurostat, 2013, REP EUR TASK FORC; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Gerber Y, 2013, AM J EPIDEMIOL, V178, P1272, DOI 10.1093/aje/kwt109; Hawkins NM, 2012, CIRCULATION, V126, P1050, DOI 10.1161/CIRCULATIONAHA.111.088047; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; HERRETT E, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Johansson S, 2001, EUR J HEART FAIL, V3, P225, DOI 10.1016/S1388-9842(00)00131-8; Kershaw KN, 2013, EUR J EPIDEMIOL, V28, P807, DOI 10.1007/s10654-013-9847-2; Kirkwood BR, 2003, ESSENTIAL MED STAT; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; McMurray JJV, 2002, EUR HEART J SUPPL, V4, pD50, DOI 10.1016/S1520-765X(02)90160-4; Mitchell P, 2015, NATL HEART FAILURE A; Ponikowski P, 2014, PREVENTING DIS DEATH; Primary Care Domain ND, 2016, QUAL OUTC FRAM REP E; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Rahimi K, MORTALITY HEART FAIL; Ramsay SE, 2014, EUR HEART J, V35, P442, DOI 10.1093/eurheartj/eht449; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Townsend N, 2015, CARDIOVASCULAR DIS S; United Nations, 2015, WORLD POP AG 2015; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zarrinkoub R, 2013, EUR J HEART FAIL, V15, P995, DOI 10.1093/eurjhf/hft064	40	473	477	6	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					572	580		10.1016/S0140-6736(17)32520-5	http://dx.doi.org/10.1016/S0140-6736(17)32520-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV5VB	29174292	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000424649400034
J	Martinez-Leo, B; Garcia-Cabello, LM				Martinez-Leo, Bruno; Garcia-Cabello, Luis M.			Caterpillar Sign in Infantile Hypertrophic Pyloric Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Martinez-Leo, Bruno; Garcia-Cabello, Luis M.] Hosp Pediat Moctezuma, Mexico City, DF, Mexico		Martinez-Leo, B (corresponding author), Hosp Pediat Moctezuma, Mexico City, DF, Mexico.	bruno.martinezleo@gmail.com	Martinez-Leo, Bruno/J-7518-2019	Martinez-Leo, Bruno/0000-0001-7056-5128					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					E33	E33		10.1056/NEJMicm1614216	http://dx.doi.org/10.1056/NEJMicm1614216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP8VG	29236645				2022-12-28	WOS:000417923600010
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Davidson, K; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, KarinaW.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; INITIATIVE RANDOMIZED-TRIALS; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; ESTROGEN/PROGESTIN REPLACEMENT; CLINICAL ENDOCRINOLOGISTS; CARDIOVASCULAR-DISEASE; AMERICAN ASSOCIATION; URINARY-INCONTINENCE; HEALTH OUTCOMES	IMPORTANCE Menopause occurs at a median age of 51.3 years, and the average US woman who reaches menopause is expected to live another 30 years. The prevalence and incidence of most chronic conditions, such as coronary heart disease, dementia, stroke, fractures, and breast cancer, increase with age; however, the excess risk for these conditions that can be attributed to menopause alone is uncertain. Since the publication of findings from the Women's Health Initiative that hormone therapy use is associated with serious adverse health effects in postmenopausal women, use of menopausal hormone therapy has declined. OBJECTIVE To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on the use of menopausal hormone therapy for the primary prevention of chronic conditions. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of systemic (ie, oral or transdermal) hormone therapy for the prevention of chronic conditions in postmenopausal women and whether outcomes vary among women in different subgroups or by timing of intervention after menopause. The review did not address hormone therapy for preventing or treating menopausal symptoms. FINDINGS Although the use of hormone therapy to prevent chronic conditions in postmenopausal women is associated with some benefits, there are also well-documented harms. The USPSTF determined that the magnitude of both the benefits and the harms of hormone therapy in postmenopausal women is small to moderate. Therefore, the USPSTF concluded with moderate certainty that combined estrogen and progestin has no net benefit for the primary prevention of chronic conditions for most postmenopausal women with an intact uterus and that estrogen alone has no net benefit for the primary prevention of chronic conditions for most postmenopausal women who have had a hysterectomy. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women. (D recommendation) The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal women who have had a hysterectomy. (D recommendation)	[Grossman, David C.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, KarinaW.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA USA; [Epling, John W., Jr.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.	david.c.grossman@kp.org	Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, 2012, CLIN PREV SERV REC H; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; [Anonymous], 2013, Obstet Gynecol, V121, P1407, DOI 10.1097/01.AOG.0000431053.33593.2d; [Anonymous], 2014, TOT NUMB DISCH AG GR; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Cherry N, 2014, BJOG-INT J OBSTET GY, V121, P700, DOI 10.1111/1471-0528.12598; Cherry N, 2002, LANCET, V360, P2001; Chlebowski RT, 2012, JNCI-J NATL CANCER I, V104, P517, DOI 10.1093/jnci/djs014; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Cobin RH, 2017, ENDOCR PRACT, V23, P869, DOI 10.4158/EP171828.PS; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; Gartlehner G, 2017, AHRQ PUBLICATION; Goodman NF, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S6.1; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; McKinlay SM, 1996, MATURITAS, V23, P137, DOI 10.1016/0378-5122(95)00985-X; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI [10.7326/0003-4819-159-10-201311190-00717, 10.7326/0003-4819-159-10-201311190-00718]; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Social Security Administration, 2014, ACT LIF TABL PER LIF; Steinauer JE, 2005, OBSTET GYNECOL, V106, P940, DOI 10.1097/01.AOG.0000180394.08406.15; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Tierney MC, 2009, PSYCHONEUROENDOCRINO, V34, P1065, DOI 10.1016/j.psyneuen.2009.02.009; Veerus P, 2006, MATURITAS, V55, P162, DOI 10.1016/j.maturitas.2006.01.012; Vickers MR, 2007, BMJ-BRIT MED J, V335, P239; Waetjen LE, 2005, OBSTET GYNECOL, V106, P946, DOI 10.1097/01.AOG.0000182576.48290.6d; Wathen CN, 2004, CAN MED ASSOC J, V170, P1535, DOI 10.1503/cmaj.1030756; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1	39	96	99	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2224	2233		10.1001/jama.2017.18261	http://dx.doi.org/10.1001/jama.2017.18261			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234814	Bronze			2022-12-28	WOS:000417822700020
J	Born, DA; Ulrich, EC; Ju, KS; Peck, SC; van der Donk, WA; Drennan, CL				Born, David A.; Ulrich, Emily C.; Ju, Kou-San; Peck, Spencer C.; van der Donk, Wilfred A.; Drennan, Catherine L.			Structural basis for methylphosphonate biosynthesis	SCIENCE			English	Article							METHANE; CLEAVAGE; OCEAN	Methylphosphonate synthase (MPnS) produces methylphosphonate, a metabolic precursor to methane in the upper ocean. Here, we determine a 2.35-angstrom resolution structure of MPnS and discover that it has an unusual 2-histidine-1-glutamine iron-coordinating triad. We further solve the structure of a related enzyme, hydroxyethylphosphonate dioxygenase from Streptomyces albus (SaHEPD), and find that it displays the same motif. SaHEPD can be converted into an MPnS by mutation of glutamine-adjacent residues, identifying the molecular requirements for methylphosphonate synthesis. Using these sequence markers, we find numerous putative MPnSs in marine microbiomes and confirm that MPnS is present in the abundant Pelagibacter ubique. The ubiquity of MPnS-containing microbes supports the proposal that methylphosphonate is a source of methane in the upper, aerobic ocean, where phosphorus-starved microbes catabolize methylphosphonate for its phosphorus.	[Born, David A.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Born, David A.; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA USA; [Ulrich, Emily C.; Peck, Spencer C.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Ulrich, Emily C.; Ju, Kou-San; Peck, Spencer C.; van der Donk, Wilfred A.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Ju, Kou-San] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Ju, Kou-San] Ohio State Univ, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Peck, Spencer C.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University	Drennan, CL (corresponding author), MIT, Dept Biol, Cambridge, MA USA.; van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, Urbana, IL USA.; van der Donk, WA (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA.; van der Donk, WA (corresponding author), Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA.; Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA USA.	vddonk@illinois.edu; cdrennan@mit.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071; Peck, Spencer/0000-0002-1599-6635; Born, David/0000-0003-3507-9022; Drennan, Catherine/0000-0001-5486-2755; Ju, Kou-San/0000-0003-0438-6740	National Institutes of Health [GM 077596]; NIH Molecular Biophysics Training Grant [T32 GM008313]; NIH [S10-RR028833]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, P01GM077596, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Giovannoni laboratory for genomic DNA from P. ubique HTCC7217 and H. Cooke for the plasmids for NmMPnS-Q<SUP>152</SUP>A and Q<SUP>152</SUP>E. This work was supported by the National Institutes of Health (GM 077596 to W.A.V.). An NIH Molecular Biophysics Training Grant T32 GM008313 supported D.A.B. C.L.D. and W.A.V. are Howard Hughes Medical Institute Investigators. <SUP>31</SUP>P NMR data were collected on a 600-MHz NMR spectrometer funded by NIH (S10-RR028833). This work used Northeastern Collaborative Access Team beamlines (GM103403) and a Pilatus detector (RR029205) at the Advanced Photon Source (DE-AC02-06CH11357). Structures of 2-HEP-bound Fe(II)-SaHEPD, substrate-free MPnS, and 2-HEP-bound Fe(II)-MPnS are available through the Protein Data Bank under accession codes 6B9R, 6B9S, and 6B9T, respectively.	Carini P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5346; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Cooke HA, 2012, J AM CHEM SOC, V134, P15660, DOI 10.1021/ja306777w; DAUGHTON CG, 1979, FEMS MICROBIOL LETT, V5, P91, DOI 10.1016/0378-1097(79)90191-5; DeLano W.L, PYMOL MOL GRAPHICS S; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Holmes ME, 2000, GLOBAL BIOGEOCHEM CY, V14, P1, DOI 10.1029/1999GB001209; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; KARL DM, 1994, NATURE, V368, P732, DOI 10.1038/368732a0; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Peck SC, 2015, J AM CHEM SOC, V137, P3217, DOI 10.1021/jacs.5b00282; Repeta DJ, 2016, NAT GEOSCI, V9, P884, DOI [10.1038/ngeo2837, 10.1038/NGEO2837]; Rogers J.E., 1991, MICROBIAL PRODUCTION; SCRANTON MI, 1977, DEEP-SEA RES, V24, P127, DOI 10.1016/0146-6291(77)90548-3; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Whitteck JT, 2011, J AM CHEM SOC, V133, P4236, DOI 10.1021/ja1113326	20	26	27	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1336	1338		10.1126/science.aao3435	http://dx.doi.org/10.1126/science.aao3435			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217579	Green Accepted			2022-12-28	WOS:000417254700066
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Scottish GP contract-responsibility without power?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				McCartney M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4745; McCartney M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i693; [National Institute for Health Research University of York Centre for Reviews and Dissemination], 2014, ADV CAR PLANN EV BRI; Weathers E, 2016, MATURITAS, V91, P101, DOI 10.1016/j.maturitas.2016.06.016	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2017	359								j5628	10.1136/bmj.j5628	http://dx.doi.org/10.1136/bmj.j5628			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AQ	29212663	Bronze, Green Published			2022-12-28	WOS:000417559500009
J	Zhang, Y; Ptacin, JL; Fischer, EC; Aerni, HR; Caffaro, CE; Jose, KS; Feldman, AW; Turner, CR; Romesberg, FE				Zhang, Yorke; Ptacin, Jerod L.; Fischer, Emil C.; Aerni, Hans R.; Caffaro, Carolina E.; Jose, Kristine San; Feldman, Aaron W.; Turner, Court R.; Romesberg, Floyd E.			A semi-synthetic organism that stores and retrieves increased genetic information	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; CLICK CHEMISTRY; CODE; PROTEOMICS; PURIFICATION; MUTAGENESIS; EXPANSION; PLATFORM; PEPTIDE	Since at least the last common ancestor of all life on Earth, genetic information has been stored in a four-letter alphabet that is propagated and retrieved by the formation of two base pairs. The central goal of synthetic biology is to create new life forms and functions(1), and the most general route to this goal is the creation of semi-synthetic organisms whose DNA harbours two additional letters that form a third, unnatural base pair. Previous efforts to generate such semi-synthetic organisms(2) culminated in the creation of a strain of Escherichia coli that, by virtue of a nucleoside triphosphate transporter from Phaeodactylum tricornutum, imports the requisite unnatural triphosphates from its medium and then uses them to replicate a plasmid containing the unnatural base pair dNaM-dTPT3. Although the semi-synthetic organism stores increased information when compared to natural organisms, retrieval of the information requires in vivo transcription of the unnatural base pair into mRNA and tRNA, aminoacylation of the tRNA with a non-canonical amino acid, and efficient participation of the unnatural base pair in decoding at the ribosome. Here we report the in vivo transcription of DNA containing dNaM and dTPT3 into mRNAs with two different unnatural codons and tRNAs with cognate unnatural anticodons, and their efficient decoding at the ribosome to direct the site-specific incorporation of natural or non-canonical amino acids into superfolder green fluorescent protein. The results demonstrate that interactions other than hydrogen bonding can contribute to every step of information storage and retrieval. The resulting semi-synthetic organism both encodes and retrieves increased information and should serve as a platform for the creation of new life forms and functions.	[Zhang, Yorke; Fischer, Emil C.; Feldman, Aaron W.; Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ptacin, Jerod L.; Aerni, Hans R.; Caffaro, Carolina E.; Jose, Kristine San; Turner, Court R.] Synthorx Inc, La Jolla, CA 92037 USA	Scripps Research Institute	Romesberg, FE (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	floyd@scripps.edu	Romesberg, Floyd/M-2821-2017	Romesberg, Floyd/0000-0001-6317-1315; Fischer, Emil Christian/0000-0002-0438-6719	National Institutes of Health [GM118178]; National Science Foundation [NSF/DGE-1346837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118178, R01GM060005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. G. Schultz for the pEVOL-pAzF plasmid. This work was supported by the National Institutes of Health (GM118178 to F.E.R.). A.W.F. was supported by a National Science Foundation Graduate Research Fellowship (NSF/DGE-1346837).	Aerni HR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1087; Beck S, 2015, MOL CELL PROTEOMICS, V14, P2014, DOI 10.1074/mcp.M114.047407; Chan WT, 2013, BIOSCIENCE REP, V33, P931, DOI 10.1042/BSR20130098; Chatterjee A, 2013, BIOCHEMISTRY-US, V52, P1828, DOI 10.1021/bi4000244; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gorochowski TE, 2016, ACS SYNTH BIOL, V5, P710, DOI 10.1021/acssynbio.6b00040; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Leduc S., 1911, MECHANISMS LIFE; Link A. J., 2001, CURR PROT PROTEIN SC, V78; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Moini M, 1998, J AM SOC MASS SPECTR, V9, P977, DOI 10.1016/S1044-0305(98)00079-8; Mukai T, 2017, ANNU REV MICROBIOL, V71, P557, DOI 10.1146/annurev-micro-090816-093247; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pirman NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9130; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SHIMIZU M, 1992, J MOL EVOL, V35, P436; Smith PA, 2012, ANTIMICROB AGENTS CH, V56, P5054, DOI 10.1128/AAC.00785-12; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Wandrey G, 2016, J BIOL ENG, V10, DOI 10.1186/s13036-016-0031-6; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhang YK, 2017, P NATL ACAD SCI USA, V114, P1317, DOI 10.1073/pnas.1616443114	28	188	201	18	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					644	+		10.1038/nature24659	http://dx.doi.org/10.1038/nature24659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189780	Green Accepted			2022-12-28	WOS:000416520400046
J	Nochomovitz, M; Sharma, R				Nochomovitz, Michael; Sharma, Rahul			Is It Time for a New Medical Specialty? The Medical Virtualist	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nochomovitz, Michael] New York Presbyterian, New York, NY 10021 USA; [Sharma, Rahul] Weill Cornell Med, New York Presbyterian, New York, NY USA	NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital	Nochomovitz, M (corresponding author), New York Presbyterian, Phys Serv Div, 525 E 68th St,POB 182, New York, NY 10021 USA.	mnochomovitz@nyp.org						[Anonymous], 2016, MODERN HEALTHCARE; Dare F., VOTING VIRTUAL HLTH; Eveleth R., 2014, BBC; Reddy S., 2017, WALL STREET J; Ripton JT, 2016, BECKERS HOSP REV; Vaidya A., 2017, BECKERS HOSP REV	6	31	31	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					437	438		10.1001/jama.2017.17094	http://dx.doi.org/10.1001/jama.2017.17094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29181539				2022-12-28	WOS:000424224500007
J	Banados, E; Venemans, BP; Mazzucchelli, C; Farina, EP; Walter, F; Wang, FG; Decarli, R; Stern, D; Fan, XH; Davies, FB; Hennawi, JF; Simcoe, RA; Turner, ML; Rix, HW; Yang, JY; Kelson, DD; Rudie, GC; Winters, JM				Banados, Eduardo; Venemans, Bram P.; Mazzucchelli, Chiara; Farina, Emanuele P.; Walter, Fabian; Wang, Feige; Decarli, Roberto; Stern, Daniel; Fan, Xiaohui; Davies, Frederick B.; Hennawi, Joseph F.; Simcoe, Robert A.; Turner, Monica L.; Rix, Hans-Walter; Yang, Jinyi; Kelson, Daniel D.; Rudie, Gwen C.; Winters, Jan Martin			An 800-million-solar-mass black hole in a significantly neutral Universe at a redshift of 7.5	NATURE			English	Article							INTERGALACTIC MEDIUM; QUASAR; REIONIZATION; EVOLUTION; GROWTH; SAMPLE; EPOCH; GAS	Quasars are the most luminous non-transient objects known and as a result they enable studies of the Universe at the earliest cosmic epochs. Despite extensive efforts, however, the quasar ULAS J1120 + 0641 at redshift z = 7.09 has remained the only one known at z > 7 for more than half a decade(1). Here we report observations of the quasar ULAS J134208.10 + 092838.61 (hereafter J1342 + 0928) at redshift z = 7.54. This quasar has a bolometric luminosity of 4 x 10(13) times the luminosity of the Sun and a black-hole mass of 8 x 10(8) solar masses. The existence of this supermassive black hole when the Universe was only 690 million years old-just five per cent of its current age-reinforces models of early black-hole growth that allow black holes with initial masses of more than about 10(4) solar masses(2,3) or episodic hyper-Eddington accretion(4,5). We see strong evidence of absorption of the spectrum of the quasar redwards of the Lyman alpha emission line (the Gunn-Peterson damping wing), as would be expected if a significant amount (more than 10 per cent) of the hydrogen in the intergalactic medium surrounding J1342 + 0928 is neutral. We derive such a significant fraction of neutral hydrogen, although the exact fraction depends on the modelling. However, even in our most conservative analysis we find a fraction of more than 0.33 (0.11) at 68 per cent (95 per cent) probability, indicating that we are probing well within the reionization epoch of the Universe.	[Banados, Eduardo; Kelson, Daniel D.; Rudie, Gwen C.] Observ Carnegie Inst Sci, 813 Santa Barbara St, Pasadena, CA 91101 USA; [Venemans, Bram P.; Mazzucchelli, Chiara; Farina, Emanuele P.; Walter, Fabian; Decarli, Roberto; Rix, Hans-Walter] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Wang, Feige; Yang, Jinyi] Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China; [Wang, Feige; Yang, Jinyi] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Decarli, Roberto] INAF Osservatorio Astron Bologna, Via Gobetti 93-3, I-40129 Bologna, Italy; [Stern, Daniel] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Fan, Xiaohui] Univ Arizona, Steward Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Davies, Frederick B.; Hennawi, Joseph F.] Univ Calif Santa Barbara, Dept Phys, Broida Hall, Santa Barbara, CA 93106 USA; [Simcoe, Robert A.; Turner, Monica L.] MIT Kavli Ctr Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Turner, Monica L.] Las Cumbres Observ, 6740 Cortona Dr, Goleta, CA 93117 USA; [Winters, Jan Martin] Inst Radioastron Millimetr IRAM, 300 Rue Piscine, F-38406 St Martin Dheres, France	Carnegie Institution for Science; Max Planck Society; Peking University; Peking University; Istituto Nazionale Astrofisica (INAF); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; University of California System; University of California Santa Barbara	Banados, E (corresponding author), Observ Carnegie Inst Sci, 813 Santa Barbara St, Pasadena, CA 91101 USA.	ebanados@carnegiescience.edu	Yang, Jinyi/AAG-1344-2022; Mazzucchelli, Chiara/GQB-5613-2022; Yang, Jinyi/AFK-2958-2022; Farina, Emanuele Paolo/AAB-2899-2020	Farina, Emanuele Paolo/0000-0002-6822-2254; Mazzucchelli, Chiara/0000-0002-5941-5214; Davies, Frederick/0000-0003-0821-3644; Wang, Feige/0000-0002-7633-431X; Walter, Fabian/0000-0003-4793-7880; Banados, Eduardo/0000-0002-2931-7824; Stern, Daniel/0000-0003-2686-9241	Gemini North telescope [GN-2017A-DD-4]	Gemini North telescope	We thank D. Ossip for support with the FIRE echellette observations and A. Stephens for help preparing the GNIRS observations. This work is based on data collected with the Magellan Baade telescope, the Gemini North telescope (programme GN-2017A-DD-4), the Large Binocular Telescope and the IRAM/NOEMA interferometer. We are grateful for the support provided by the staff of these observatories. We acknowledge the use of the UKIDSS, WISE and DECaLS surveys.	Adam R, 2016, ASTRON ASTROPHYS, V596, DOI 10.1051/0004-6361/201628897; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Alexander T, 2014, SCIENCE, V345, P1330, DOI 10.1126/science.1251053; Alvarez MA, 2007, MON NOT R ASTRON SOC, V380, pL30, DOI 10.1111/j.1745-3933.2007.00342.x; Banados E, 2016, ASTROPHYS J SUPPL S, V227, DOI 10.3847/0067-0049/227/1/11; Becker GD, 2015, MON NOT R ASTRON SOC, V447, P3402, DOI 10.1093/mnras/stu2646; Bosman SEI, 2015, MON NOT R ASTRON SOC, V452, P1105, DOI 10.1093/mnras/stv1336; Davies FB, 2016, MON NOT R ASTRON SOC, V457, P3006, DOI 10.1093/mnras/stw055; Eilers AC, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6c60; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Gallerani S, 2017, PUBL ASTRON SOC AUST, V34, P1, DOI 10.1017/pasa.2017.14; Greig B., 2016, MON NOT R ASTRON SOC, P4239; Inayoshi K, 2016, MON NOT R ASTRON SOC, V459, P3738, DOI 10.1093/mnras/stw836; Latif MA, 2013, MON NOT R ASTRON SOC, V433, P1607, DOI 10.1093/mnras/stt834; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Lukic Z, 2015, MON NOT R ASTRON SOC, V446, P3697, DOI 10.1093/mnras/stu2377; Mejia-Restrepo J. E., 2017, NAT ASTRON; Mesinger A, 2011, MON NOT R ASTRON SOC, V411, P955, DOI 10.1111/j.1365-2966.2010.17731.x; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Pacucci F, 2015, MON NOT R ASTRON SOC, V452, P1922, DOI 10.1093/mnras/stv1465; Paris I, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016233; Paris I, 2017, ASTRON ASTROPHYS, V597, DOI 10.1051/0004-6361/201527999; Richards GT, 2006, ASTROPHYS J SUPPL S, V166, P470, DOI 10.1086/506525; Simcoe RA, 2012, NATURE, V492, P79, DOI 10.1038/nature11612; Songaila A, 2010, ASTROPHYS J, V721, P1448, DOI 10.1088/0004-637X/721/2/1448; Suzuki N, 2005, ASTROPHYS J, V618, P592, DOI 10.1086/426062; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Venemans BP, 2017, ASTROPHYS J LETT, V851, DOI 10.3847/2041-8213/aa943a; Venemans BP, 2016, ASTROPHYS J, V816, DOI 10.3847/0004-637X/816/1/37; Vestergaard M, 2009, ASTROPHYS J, V699, P800, DOI 10.1088/0004-637X/699/1/800; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Wu XB, 2015, NATURE, V518, P512, DOI 10.1038/nature14241	37	529	531	1	33	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					473	+		10.1038/nature25180	http://dx.doi.org/10.1038/nature25180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29211709	Green Submitted			2022-12-28	WOS:000423971100034
J	Autzen, HE; Myasnikov, AG; Campbell, MG; Asarnow, D; Julius, D; Cheng, YF				Autzen, Henriette E.; Myasnikov, Alexander G.; Campbell, Melody G.; Asarnow, Daniel; Julius, David; Cheng, Yifan			Structure of the human TRPM4 ion channel in a lipid nanodisc	SCIENCE			English	Article							TRPV1 STRUCTURES; N-TERMINUS; CATION; REVEALS; DOMAIN	Transient receptor potential (TRP) melastatin 4 (TRPM4) is a widely expressed cation channel associated with a variety of cardiovascular disorders. TRPM4 is activated by increased intracellular calcium in a voltage-dependent manner but, unlike many other TRP channels, is permeable to monovalent cations only. Here we present two structures of full-length human TRPM4 embedded in lipid nanodiscs at similar to 3-angstrom resolution, as determined by single-particle cryo-electron microscopy. These structures, with and without calcium bound, reveal a general architecture for this major subfamily of TRP channels and a well-defined calcium-binding site within the intracellular side of the S1-S4 domain. The structures correspond to two distinct closed states. Calcium binding induces conformational changes that likely prime the channel for voltage-dependent opening.	[Autzen, Henriette E.; Myasnikov, Alexander G.; Campbell, Melody G.; Asarnow, Daniel; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Autzen, Henriette E.] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Julius, David] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Aarhus University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.; Cheng, YF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	david.julius@ucsf.edu; yifan.cheng@ucsf.edu	Myasnikov, Alexander/T-4654-2018; Autzen, Henriette Elisabeth/AAI-1084-2019	Autzen, Henriette Elisabeth/0000-0003-3691-5010; Asarnow, Daniel/0000-0001-7870-5308; Cheng, Yifan/0000-0001-9535-0369; Myasnikov, Alexander/0000-0003-2607-7121; Campbell, Melody/0000-0003-1909-5751	Danish Council of Independent Research [DFF-5051-00085]; NIH [R01NS047723, R01GM098672, S10OD020054, S10OD021741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105038, R01NS047723] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021741, S10OD020054] Funding Source: NIH RePORTER	Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Diver, P. Dominik, A. Kintzer, and R. Stroud for valuable discussions; M. Diver and E. Green for reading the manuscript; and Y. Jiang for coordinating cosubmission of our studies. H.E.A. is supported by a postdoctoral fellowship from the Danish Council of Independent Research (grant DFF-5051-00085). This work was supported by grants from the NIH (R01NS047723 to D.J.; R01GM098672, S10OD020054, and S10OD021741 to Y.C.). Y.C. is an investigator of the Howard Hughes Medical Institute. Accession numbers for the human TRPM4 structures in EDTA and CaCl<INF>2</INF>, respectively, are as follows: 6BQR and 6BQV (coordinates of atomic models; Protein Data Bank), EMD-7132 and EMD-7133 (density maps; Electron Microscopy Data Bank), and EMPIAR-10126 and EMPIAR-10127 (raw particle stacks; Electron Microscopy Public Image Archive).	Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Bousova K, 2015, BIOPHYS CHEM, V205, P24, DOI 10.1016/j.bpc.2015.06.004; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen QF, 2017, NATURE, V550, DOI 10.1038/nature24035; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hirschi M, 2017, NATURE, V550, P411, DOI 10.1038/nature24055; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, J PHYSIOL-LONDON, V560, P753, DOI 10.1113/jphysiol.2004.070839; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Shin Sung H, 2015, Open Biochem J, V9, P24, DOI 10.2174/1874091X01509010024; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Yamaguchi S, 2014, J BIOL CHEM, V289, P35265, DOI 10.1074/jbc.M114.606087; Zocher M, 2012, P NATL ACAD SCI USA, V109, pE3463, DOI 10.1073/pnas.1210373109	28	151	155	5	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					228	+		10.1126/science.aar4510	http://dx.doi.org/10.1126/science.aar4510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29217581	Green Submitted, Green Accepted			2022-12-28	WOS:000419816600049
J	Liao, HK; Hatanaka, F; Araoka, T; Reddy, P; Wu, MZ; Sui, YH; Yamauchi, T; Sakurai, M; O'Keefe, DD; Nunez-Delicado, E; Guillen, P; Campistol, JM; Wu, CJ; Lu, LF; Esteban, CR; Belmonte, JCI				Liao, Hsin-Kai; Hatanaka, Fumiyuki; Araoka, Toshikazu; Reddy, Pradeep; Wu, Min-Zu; Sui, Yinghui; Yamauchi, Takayoshi; Sakurai, Masahiro; O'Keefe, David D.; Nunez-Delicado, Estrella; Guillen, Pedro; Campistol, Josep M.; Wu, Cheng-Jang; Lu, Li-Fan; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos			In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation	CELL			English	Article							MOUSE MODEL; MUSCULAR-DYSTROPHY; MDX MOUSE; EXPRESSION; CAS9; TRANSCRIPTION; CRISPR; MUSCLE; MICE; UTROPHIN	Current genome-editing systems generally rely on inducing DNA double-strand breaks (DSBs). This may limit their utility in clinical therapies, as unwanted mutations caused by DSBs can have deleterious effects. CRISPR/Cas9 system has recently been repurposed to enable target gene activation, allowing regulation of endogenous gene expression without creating DSBs. However, in vivo implementation of this gain-of-function system has proven difficult. Here, we report a robust system for in vivo activation of endogenous target genes through trans-epigenetic remodeling. The system relies on recruitment of Cas9 and transcriptional activation complexes to target loci by modified single guide RNAs. As proof-of-concept, we used this technology to treat mouse models of diabetes, muscular dystrophy, and acute kidney disease. Results demonstrate that CRISPR/Cas9-mediated target gene activation can be achieved in vivo, leading to measurable phenotypes and amelioration of disease symptoms. This establishes new avenues for developing targeted epigenetic therapies against human diseases.	[Liao, Hsin-Kai; Hatanaka, Fumiyuki; Araoka, Toshikazu; Reddy, Pradeep; Wu, Min-Zu; Yamauchi, Takayoshi; Sakurai, Masahiro; O'Keefe, David D.; Rodriguez Esteban, Concepcion; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Araoka, Toshikazu; Wu, Min-Zu; Yamauchi, Takayoshi; Nunez-Delicado, Estrella] Univ Catolica San Antonio de Murcia, Campus Jeronimos 135, Guadalupe 30107, Spain; [Sui, Yinghui] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA; [Guillen, Pedro] Fdn Pedro Guillen, Clin CEMTRO, Ave Ventisquero de la Condesa 42, Madrid 28035, Spain; [Campistol, Josep M.] Hosp Clin Barcelona, Carrer Villarroel 170, E-08036 Barcelona, Spain; [Wu, Cheng-Jang; Lu, Li-Fan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; Universidad Catolica de Murcia; University of California System; University of California San Diego; University of Barcelona; Hospital Clinic de Barcelona; University of California System; University of California San Diego	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	belmonte@salk.edu	Núñez-Delicado, Estrella/AAR-9438-2021; Reddy, Pradeep/G-1770-2014; Núñez-Delicado, Estrella/F-7053-2012; Liao, Hsin-Kai/H-9608-2015	Núñez-Delicado, Estrella/0000-0002-0554-2365; Reddy, Pradeep/0000-0002-9173-3845; Núñez-Delicado, Estrella/0000-0002-0554-2365; Lu, Li-Fan/0000-0002-9727-0036; Sakurai, Masahiro/0000-0002-6376-0299; Josep M, Campistol/0000-0001-6244-0253	Uehara Memorial Foundation; MDA; Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Dr. Pedro Guillen; AFE; UCAM; NIH [R01 HL123755]; NIH-NCI [CCSG: P30 014195]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108651] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); MDA(Muscular Dystrophy Association); Moxie Foundation; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Dr. Pedro Guillen; AFE; UCAM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to J. Naughton and J. Marlett for AAV production, C.-C. Liao, W.-M. Hsu, B. Li and C.-Y. Chung for programming script of CRISPR data mining, M.C. Ku, N. Hah and T. Nguyen for high-throughput sequencing, J. Wu for critical reading of the manuscript, and M. Schwarz for administrative help. F.H. was partially supported by the Uehara Memorial Foundation. P.R. was partially supported by the MDA. This work was supported by The Moxie Foundation, The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), the G. Harold and Leila Y. Mathers Charitable Foundation, Fundacion Dr. Pedro Guillen, AFE, UCAM, NIH (R01 HL123755) and NIH-NCI CCSG: P30 014195.	Altucci L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0222-5; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/NMETH.3871, 10.1038/nmeth.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/NMETH.3312, 10.1038/nmeth.3312]; Chen M, 2017, ADV EXP MED BIOL, V983, P147, DOI [10.1007/978-981-10-4310-9_10, 10.1007/978-981-10-6020-5_7]; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Hunter P, 2015, EMBO REP, V16, P276, DOI 10.15252/embr.201540121; Janghra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150818; Jin YM, 2013, LAB INVEST, V93, P801, DOI 10.1038/labinvest.2013.64; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jurkowski TP, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0044-x; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim Ji-Yoen, 2014, J Vis Exp, P51863, DOI 10.3791/51863; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; La Russa MF, 2015, MOL CELL BIOL, V35, P3800, DOI 10.1128/MCB.00512-15; Lampe SEG, 2014, JOVE-J VIS EXP, DOI 10.3791/52037; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Ling GS, 2011, RHEUMATOLOGY, V50, P1773, DOI 10.1093/rheumatology/ker198; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pfister SX, 2017, NAT REV DRUG DISCOV, V16, P241, DOI 10.1038/nrd.2016.256; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Sienkiewicz D, 2015, THER ADV NEUROL DISO, V8, P166, DOI 10.1177/1756285615586123; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/nmeth.3733, 10.1038/NMETH.3733]; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Vora S, 2016, FEBS J, V283, P3181, DOI 10.1111/febs.13768; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	55	241	261	3	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1495	+		10.1016/j.cell.2017.10.025	http://dx.doi.org/10.1016/j.cell.2017.10.025			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29224783	Green Accepted, Bronze			2022-12-28	WOS:000418044000008
J	Pangala, SR; Enrich-Prast, A; Basso, LS; Peixoto, RB; Bastviken, D; Hornibrook, ERC; Gatti, LV; Marotta, H; Calazans, LSB; Sakuragui, CM; Bastos, WR; Malm, O; Gloor, E; Miller, JB; Gauci, V				Pangala, Sunitha R.; Enrich-Prast, Alex; Basso, Luana S.; Peixoto, Roberta Bittencourt; Bastviken, David; Hornibrook, Edward R. C.; Gatti, Luciana V.; Marotta, Humberto; Braucks Calazans, Luana Silva; Sakuragui, Cassia Monica; Bastos, Wanderley Rodrigues; Malm, Olaf; Gloor, Emanuel; Miller, John Bharat; Gauci, Vincent			Large emissions from floodplain trees close the Amazon methane budget	NATURE			English	Article							ATMOSPHERIC METHANE; BASIN; RIVERS; FOREST; FLUX; SOIL	Wetlands are the largest global source of atmospheric methane (CH4)(1), a potent greenhouse gas. However, methane emission inventories from the Amazon floodplain(2,3), the largest natural geographic source of CH4 in the tropics, consistently underestimate the atmospheric burden of CH4 determined via remote sensing and inversion modelling(4,5), pointing to a major gap in our understanding of the contribution of these ecosystems to CH4 emissions. Here we report CH4 fluxes from the stems of 2,357 individual Amazonian floodplain trees from 13 locations across the central Amazon basin. We find that escape of soil gas through wetland trees is the dominant source of regional CH4 emissions. Methane fluxes from Amazon tree stems were up to 200 times larger than emissions reported for temperate wet forests(6) and tropical peat swamp forests(7), representing the largest non-ebullitive wetland fluxes observed. Emissions from trees had an average stable carbon isotope value (delta C-13) of -66.2 +/- 6.4 per mil, consistent with a soil biogenic origin. We estimate that floodplain trees emit 15.1 +/- 1.8 to 21.2 +/- 2.5 teragrams of CH4 a year, in addition to the 20.5 +/- 5.3 teragrams a year emitted regionally from other sources. Furthermore, we provide a 'topdown' regional estimate of CH4 emissions of 42.7 +/- 5.6 teragrams of CH4 a year for the Amazon basin, based on regular vertical lower-troposphere CH4 profiles covering the period 2010-2013. We find close agreement between our 'top-down' and combined 'bottom-up' estimates, indicating that large CH4 emissions from trees adapted to permanent or seasonal inundation can account for the emission source that is required to close the Amazon CH4 budget. Our findings demonstrate the importance of tree stem surfaces in mediating approximately half of all wetland CH4 emissions in the Amazon floodplain, a region that represents up to one-third of the global wetland CH4 source when trees are combined with other emission sources.	[Pangala, Sunitha R.; Gauci, Vincent] Open Univ, Sch Environm Earth & Ecosyst Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England; [Enrich-Prast, Alex; Bastviken, David] Linkoping Univ, Dept Themat Studies, Environm Change, SE-58183 Linkoping, Sweden; [Enrich-Prast, Alex; Peixoto, Roberta Bittencourt; Braucks Calazans, Luana Silva; Sakuragui, Cassia Monica] Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil; [Basso, Luana S.; Gatti, Luciana V.] IPEN, CNEN, Atmospher Chem Lab, 2242 Ave Prof Lineu Prestes, BR-05508000 Sao Paulo, Brazil; [Hornibrook, Edward R. C.] Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England; [Hornibrook, Edward R. C.] Univ British Columbia, Dept Earth Environm & Geog Sci, Irving K Barber Sch Arts & Sci, Okanagan Campus,1177 Res Rd, Kelowna, BC V1V 1V7, Canada; [Gatti, Luciana V.] Natl Inst Space Res INPE, Ctr Earth Syst Sci CCST, Greenhouse Gas Lab LaGEE, Av Dos Astronautas 1758, BR-12227010 Sao Jose Dos Campos, Brazil; [Marotta, Humberto] Univ Fed Fluminense, Ecosyst & Global Change Lab LEMG UFF, Int Lab Global Change LINCGlobal, Biomass & Water Management Res Ctr NAB UFF, Ave Edmundo March, BR-24210310 Niteroi, RJ, Brazil; [Marotta, Humberto] Univ Fed Fluminense, Sedimentary & Environm Proc Lab LAPSA UFF, Dept Geog, Ave Gen Milton Tavares de Souza, BR-24210346 Niteroi, RJ, Brazil; [Bastos, Wanderley Rodrigues] Fed Univ Rondonia, Environm Biogeochem Lab, Rondonia, Brazil; [Malm, Olaf] Univ Fed Rio de Janeiro, Biophys Inst, Radioisotopes Lab, Rio De Janeiro, Brazil; [Gloor, Emanuel] Univ Leeds, Sch Geog, Woodhouse Lane, Leeds LS9 2JT, W Yorkshire, England; [Miller, John Bharat] NOAA, Earth Syst Res Lab, Global Monitoring Div, 325 Broadway, Boulder, CO 80305 USA; [Pangala, Sunitha R.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England	Open University - UK; Linkoping University; Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); University of Bristol; University of British Columbia; Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade Federal de Rondonia; Universidade Federal do Rio de Janeiro; University of Leeds; National Oceanic Atmospheric Admin (NOAA) - USA; Lancaster University	Pangala, SR; Gauci, V (corresponding author), Open Univ, Sch Environm Earth & Ecosyst Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.; Pangala, SR (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England.	s.pangala@lancaster.ac.uk; Vincent.Gauci@open.ac.uk	Sakuragui, Cassia/J-8603-2014; Bastos, Wanderley/AAQ-5875-2020; Bastos, Wanderley R/E-9856-2013; Miller, John B./AAE-7714-2019; Marotta, Humberto/F-9554-2012; Peixoto, Roberta B/P-6303-2017; Basso, Luana/E-3290-2014; Gatti, Luciana Vanni/J-8569-2012; Malm, Olaf/H-1724-2012; Calazans, Luana S.B./I-1442-2012	Miller, John B./0000-0001-8630-1610; Marotta, Humberto/0000-0002-2828-6595; Peixoto, Roberta B/0000-0002-8053-2730; Gatti, Luciana Vanni/0000-0003-4908-8974; Calazans, Luana S.B./0000-0002-3308-3725; Gauci, Vincent/0000-0002-2452-7291; Basso, Luana/0000-0002-4208-6039; Malm, Olaf/0000-0002-4116-7160; Bastos, Wanderley/0000-0002-2105-9947; Pangala, Sunitha/0000-0002-0650-7721	UK Natural Environment Research Council [NE/J010928/1, NE/J009032/1]; CNPq (Brazil National Council of Research and Development); FAPERJ (Science Foundation from the State of Rio de Janeiro); Swedish Research Council, VR [2012-00048]; Swedish-Brazilian collaboration STINT/CAPES [2012-2085]; NERC consortium AMAZONICA [NE/F005806/1]; FAPESP (State of Sao Paulo Science Foundation) via the Carbon Tracker project; FAPESP-NERC via the ACO project [08/58120-3, 11/51841-0]; EU via the 7th-Framework Programme project GEOCARBON [283080]; CNPq [403241/2012-3]; FAPESP-NERC ACO project; NERC consortium MOYA [NE/N015606/1]; Swedish Research Council (VR); AXA Research Fund; NERC [NE/J009032/1, NE/N015606/1, NE/N015657/1, NE/J010928/1] Funding Source: UKRI; Natural Environment Research Council [NE/J009032/1, NE/J010928/1, NE/N015606/1, NE/N015657/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CNPq (Brazil National Council of Research and Development); FAPERJ (Science Foundation from the State of Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swedish Research Council, VR(Swedish Research Council); Swedish-Brazilian collaboration STINT/CAPES; NERC consortium AMAZONICA; FAPESP (State of Sao Paulo Science Foundation) via the Carbon Tracker project(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-NERC via the ACO project; EU via the 7th-Framework Programme project GEOCARBON; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP-NERC ACO project; NERC consortium MOYA; Swedish Research Council (VR)(Swedish Research Council); AXA Research Fund(AXA Research Fund); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The bottom-up measurement study was funded by grants from the following bodies: UK Natural Environment Research Council to V.G. (Principal Investigator, grant NE/J010928/1) and E.R.C.H. (co-investigator, NE/J009032/1); several CNPq (Brazil National Council of Research and Development) and FAPERJ (Science Foundation from the State of Rio de Janeiro) grants to A. E.-P.; Swedish Research Council, VR (grant 2012-00048) to D.B.; and the Swedish-Brazilian collaboration STINT/CAPES to D.B. and A.E.-P. (grant 2012-2085). Atmospheric CH<INF>4</INF> vertical profile measurements were funded by the following agencies: NERC consortium AMAZONICA, which is led by E.G. (grant NE/F005806/1) and includes L.V.G. and J.B.M.; FAPESP (State of Sao Paulo Science Foundation) via the Carbon Tracker project and FAPESP-NERC via the ACO project (grants 08/58120-3, 11/51841-0); the EU via the 7th-Framework Programme project GEOCARBON (grant 283080); and CNPq (grant 403241/2012-3, awarded to L.V.G.). NASA, NOAA, IPEN and INPE contributed to the construction and maintenance of the GHG laboratory in Brazil. We also acknowledge support from the FAPESP-NERC ACO project for a workshop that brought bottom-up and top-down data together. V.G. and E.G. thank the NERC consortium MOYA (grant NE/N015606/1) and D.B. thanks the Swedish Research Council (VR) for salary contributions. V.G. and S.R.P. acknowledge support from the AXA Research Fund. We thank T. Silva for assistance with tree species identification and A. Breves, E. Cristina, F. M. Silva, J. Valle, J. P. Felizardo, L. Rodrigues, L. Valladares, P. Souto, R. Pollery and V. Figueiredo for field work assistance. We thank A. Dwarakanath for data analysis and P. Monaghan and A. McAleer for performing delta<SUP>13</SUP>C-CH<INF>4</INF> analyses.	BARTLETT KB, 1988, J GEOPHYS RES-ATMOS, V93, P1571, DOI 10.1029/JD093iD02p01571; Bastviken D, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000608; Beck V, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017345; Belger L, 2011, BIOGEOCHEMISTRY, V105, P171, DOI 10.1007/s10533-010-9536-0; Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; Bloom AA, 2012, BIOGEOSCIENCES, V9, P2821, DOI 10.5194/bg-9-2821-2012; Bloom AA, 2010, NEW PHYTOL, V187, P417, DOI 10.1111/j.1469-8137.2010.03259.x; Chou WW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001295; Covey KR, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052361; DEVOL AH, 1990, J GEOPHYS RES-ATMOS, V95, P16417, DOI 10.1029/JD095iD10p16417; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Fisher R, 2006, RAPID COMMUN MASS SP, V20, P200, DOI 10.1002/rcm.2300; Frankenberg C, 2008, ATMOS CHEM PHYS, V8, P5061, DOI 10.5194/acp-8-5061-2008; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Hess LL, 2015, WETLANDS, V35, P745, DOI 10.1007/s13157-015-0666-y; Hess LL, 2003, REMOTE SENS ENVIRON, V87, P404, DOI 10.1016/j.rse.2003.04.001; Keppler F, 2010, ENVIRON SCI TECHNOL, V44, P5067, DOI 10.1021/es100460d; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Martinson GO, 2010, NAT GEOSCI, V3, P766, DOI 10.1038/NGEO980; Melack J. M., 2011, LBAECO LC07 OAK RIDG; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Pangala SR, 2015, GLOBAL CHANGE BIOL, V21, P2642, DOI 10.1111/gcb.12891; Pangala SR, 2014, NEW PHYTOL, V201, P887, DOI 10.1111/nph.12561; Pangala SR, 2013, NEW PHYTOL, V197, P524, DOI 10.1111/nph.12031; Pitz S, 2017, NEW PHYTOL, V214, P1432, DOI 10.1111/nph.14559; Ringeval B, 2014, BIOGEOSCIENCES, V11, P1519, DOI 10.5194/bg-11-1519-2014; Rusch H, 1998, PLANT SOIL, V201, P1, DOI 10.1023/A:1004331521059; Santiago LS, 2000, TREE PHYSIOL, V20, P673; Sawakuchi HO, 2014, GLOBAL CHANGE BIOL, V20, P2829, DOI 10.1111/gcb.12646; Schaefer H, 2016, SCIENCE, V352, P80, DOI 10.1126/science.aad2705; Siegenthaler A, 2016, BIOGEOSCIENCES, V13, P1197, DOI 10.5194/bg-13-1197-2016; Wang ZP, 2016, NEW PHYTOL, V211, P429, DOI 10.1111/nph.13909; Webb AJ, 2016, J GEOPHYS RES-ATMOS, V121, P11006, DOI 10.1002/2016JD025263; Wilson C, 2016, GLOBAL BIOGEOCHEM CY, V30, P400, DOI 10.1002/2015GB005300	36	135	137	19	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					230	+		10.1038/nature24639	http://dx.doi.org/10.1038/nature24639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211724	Green Accepted, Green Published			2022-12-28	WOS:000418029500042
J	Semrau, KEA; Hirschhorn, LR; Delaney, MM; Singh, VP; Saurastri, R; Sharma, N; Tuller, DE; Firestone, R; Lipsitz, S; Dhingra-Kumar, N; Kodkany, BS; Kumar, V; Gawande, AA				Semrau, Katherine E. A.; Hirschhorn, Lisa R.; Delaney, Megan Marx; Singh, Vinay P.; Saurastri, Rajiv; Sharma, Narender; Tuller, Danielle E.; Firestone, Rebecca; Lipsitz, Stuart; Dhingra-Kumar, Neelam; Kodkany, Bhalachandra S.; Kumar, Vishwajeet; Gawande, Atul A.		BetterBirth Trial Grp	Outcomes of a Coaching-Based WHO Safe Childbirth Checklist Program in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PUBLIC-HEALTH FACILITIES; MIDDLE-INCOME COUNTRIES; UTTAR-PRADESH; OBSTETRIC COMPLICATIONS; NEWBORN MORTALITY; MATERNITY CARE; IMPLEMENTATION; STILLBIRTH; BETTERBIRTH	BACKGROUND The prevalence of facility-based childbirth in low-resource settings has increased dramatically during the past two decades, yet gaps in the quality of care persist and mortality remains high. The World Health Organization (WHO) Safe Childbirth Checklist, a quality-improvement tool, promotes systematic adherence to practices that have been associated with improved childbirth outcomes. METHODS We conducted a matched-pair, cluster-randomized, controlled trial in 60 pairs of facilities across 24 districts of Uttar Pradesh, India, testing the effect of the BetterBirth program, an 8-month coaching-based implementation of the Safe Childbirth Checklist, on a composite outcome of perinatal death, maternal death, or maternal severe complications within 7 days after delivery. Outcomes - assessed 8 to 42 days after delivery - were compared between the intervention group and the control group with adjustment for clustering and matching. We also compared birth attendants' adherence to 18 essential birth practices in 15 matched pairs of facilities at 2 and 12 months after the initiation of the intervention. RESULTS Of 161,107 eligible women, we enrolled 157,689 (97.9%) and determined 7-day outcomes for 157,145 (99.7%) mother-newborn dyads. Among 4888 observed births, birth attendants' mean practice adherence was significantly higher in the intervention group than in the control group (72.8% vs. 41.7% at 2 months; 61.7% vs. 43.9% at 12 months; P<0.001 for both comparisons). However, there was no significant difference between the trial groups either in the composite primary outcome (15.1% in the intervention group and 15.3% in the control group; relative risk, 0.99; 95% confidence interval, 0.83 to 1.18; P = 0.90) or in secondary maternal or perinatal adverse outcomes. CONCLUSIONS Birth attendants' adherence to essential birth practices was higher in facilities that used the coaching-based WHO Safe Childbirth Checklist program than in those that did not, but maternal and perinatal mortality and maternal morbidity did not differ significantly between the two groups.	[Semrau, Katherine E. A.; Delaney, Megan Marx; Tuller, Danielle E.; Lipsitz, Stuart; Gawande, Atul A.] Harvard TH Chan Sch Publ Hlth, Ariadne Labs, Brigham & Womens Hosp, Boston, MA USA; [Semrau, Katherine E. A.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Lipsitz, Stuart] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Semrau, Katherine E. A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Gawande, Atul A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Hirschhorn, Lisa R.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Singh, Vinay P.; Saurastri, Rajiv; Sharma, Narender] Populat Serv Int, Lucknow, Uttar Pradesh, India; [Kumar, Vishwajeet] Community Empowerment Lab, Lucknow, Uttar Pradesh, India; [Kodkany, Bhalachandra S.] Jawaharlal Nehru Med Coll, Belgaum, India; [Firestone, Rebecca] Populat Serv Int, Washington, DC USA; [Dhingra-Kumar, Neelam] WHO, Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; World Health Organization	Semrau, KEA (corresponding author), Ariadne Labs, 401 Pk Dr,3rd Flr E, Boston, MA 02215 USA.	ksemrau@ariadnelabs.org	Singh, Shambhavi/AAQ-7609-2021	Semrau, Katherine/0000-0002-8360-1391; Gass, Jonathon/0000-0002-0515-9091	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funded by the Bill and Melinda Gates Foundation;	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; [Anonymous], ANN HLTH SURV 2012 1; [Anonymous], 2009, STAF CHILDB CHECKL P; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Bhattacharyya S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1077-8; Bradley J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1933-1; Carter RE, 2005, BIOSTATISTICS, V6, P39, DOI 10.1093/biostatistics/kxh016; Delaney MM, 2017, GLOB HEALTH-SCI PRAC, V5, P217, DOI 10.9745/GHSP-D-16-00410; Dettrick Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083070; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; Gass JD, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2159-1; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Hirschhorn LR, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0309-y; Kara N, 2017, GLOB HEALTH-SCI PRAC, V5, P232, DOI 10.9745/GHSP-D-16-00411; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kumar S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1139-x; LIPSITZ SR, 1994, BIOMETRICS, V50, P842, DOI 10.2307/2532797; Magge H, 2015, ARCH DIS CHILD, V100, P565, DOI 10.1136/archdischild-2013-305863; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Office of the Registrar General and Census Commissioner, 2 GOV IND OFF REG GE, V1; Office of the Registrar General & Census Commissioner, 2015, SAMPL REG SYST STAT; Patabendige M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0436-0; Rader KA, 2017, STAT METHODS MED RES, V26, P2257, DOI 10.1177/0962280215596550; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Salam RA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S3; Sarin E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1318-4; Semmelweis I., 1983, ETIOLOGY CONCEPT PRO; Semrau KEA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1673-x; Souza JP, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-16; Spector JM, 2013, INT J GYNECOL OBSTET, V122, P164, DOI 10.1016/j.ijgo.2013.03.022; Spector JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035151; Stanton CK, 2014, INT J GYNECOL OBSTET, V127, P25, DOI 10.1016/j.ijgo.2014.04.014; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1124-4; Sudhinaraset M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0942-8; Taljaard M, 2008, PAEDIATR PERINAT EP, V22, P117, DOI 10.1111/j.1365-3016.2007.00901.x; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	43	138	140	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2313	2324		10.1056/NEJMoa1701075	http://dx.doi.org/10.1056/NEJMoa1701075			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	29236628	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000417923600004
J	DeForest, A				DeForest, Anna			A Fair Interpretation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeForest, Anna] Yale Sch Med, Yale New Haven Hosp, 20 York St, New Haven, CT USA	Yale University	DeForest, A (corresponding author), Yale Sch Med, Yale New Haven Hosp, 20 York St, New Haven, CT USA.	anna.deforest@yale.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2183	2183		10.1001/jama.2017.17563	http://dx.doi.org/10.1001/jama.2017.17563			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234811				2022-12-28	WOS:000417822700014
J	Leslie, M				Leslie, Mitch			BIOMEDICINE To help save the heart, is it time to retire cholesterol tests?	SCIENCE			English	News Item																			0	2	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1237	1238		10.1126/science.358.6368.1237	http://dx.doi.org/10.1126/science.358.6368.1237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217551				2022-12-28	WOS:000417254700015
J	Simon, L				Simon, Lisa			My Real Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Simon, Lisa] Harvard Med Sch, Boston, MA 02115 USA; [Simon, Lisa] Harvard Sch Dent Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine	Simon, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Simon, L (corresponding author), Harvard Sch Dent Med, Boston, MA 02115 USA.			Simon, Lisa/0000-0003-4870-1052					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2109	2111		10.1056/NEJMp1711277	http://dx.doi.org/10.1056/NEJMp1711277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO1VI	29171819				2022-12-28	WOS:000416555000004
J	Stevenson, DR; Hashim, H; Salman, M; Mouyis, M				Stevenson, Daniel R.; Hashim, Hasnain; Salman, Mohammed; Mouyis, Maria			CASE REVIEW A non-cardiac cause of bilateral leg swelling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stevenson, Daniel R.; Hashim, Hasnain; Salman, Mohammed; Mouyis, Maria] Northwick Pk Hosp & Clin Res Ctr, Harrow, Middx, England	Imperial College London	Stevenson, DR (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Harrow, Middx, England.	danny.r.stevenson@gmail.com						Corradi D, 2007, KIDNEY INT, V72, P742, DOI 10.1038/sj.ki.5002427; Hao MJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003785; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Khosroshahi A, 2015, ARTHRITIS RHEUMATOL, V67, P1688, DOI 10.1002/art.39132; Neild GH, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-23; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Vaglio A, 2016, J AM SOC NEPHROL, V27, P1880, DOI 10.1681/ASN.2015101110; Vaglio A, 2011, LANCET, V378, P338, DOI 10.1016/S0140-6736(11)60934-3; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; van Bommel EFH, 2002, NETH J MED, V60, P231	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5306	10.1136/bmj.j5306	http://dx.doi.org/10.1136/bmj.j5306			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29191853				2022-12-28	WOS:000417211800004
J	Maslove, DM				Maslove, David M.			Medical Preprints-A Debate Worth Having	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Maslove, David M.] Queens Univ, Fac Hlth Sci, Kingston, ON, Canada; [Maslove, David M.] Kingston Hlth Sci Ctr, Kingston, ON, Canada	Queens University - Canada	Maslove, DM (corresponding author), Kingston Gen Hosp, Davies 2,76 Stuart St, Kingston, ON K7L 2V7, Canada.	david.maslove@queensu.ca	Maslove, David M/H-4645-2019	Maslove, David M/0000-0002-0765-7158				Bauchner H, 2017, JAMA-J AM MED ASSOC, V318, P1109, DOI 10.1001/jama.2017.11816; Berg JM, 2016, SCIENCE, V352, P899, DOI 10.1126/science.aaf9133; Callaway E, 2013, NATURE, V503, P180, DOI 10.1038/503180a; Callaway E, 2013, NAT MED, V19, P512, DOI 10.1038/nm0513-512; Cold Spring Harbor Laboratory, BIORXIV BET PREPR SE; Cornell University Library, ARXIV US STAT; Desjardins-Proulx P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001563; Enserink M, 2017, SCIENCE, DOI [10.1126/science.aap9443, DOI 10.1126/SCIENCE.AAP9443]	8	31	31	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					443	444		10.1001/jama.2017.17566	http://dx.doi.org/10.1001/jama.2017.17566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29192310				2022-12-28	WOS:000424224500010
J	Castle, PE; Kinney, WK; Xue, XN; Cheung, LC; Gage, JC; Zhao, FH; Fetterman, B; Poitras, NE; Lorey, TS; Wentzensen, N; Katki, HA; Schiffman, M				Castle, Philip E.; Kinney, Walter K.; Xue, Xiaonan; Cheung, Li C.; Gage, Julia C.; Zhao, Fang-Hui; Fetterman, Barbara; Poitras, Nancy E.; Lorey, Thomas S.; Wentzensen, Nicolas; Katki, Hormuzd A.; Schiffman, Mark			Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTRAEPITHELIAL NEOPLASIA; INCIDENCE TRENDS; CONSENSUS GUIDELINES; AMERICAN SOCIETY; NATURAL-HISTORY; UNITED-STATES; FOLLOW-UP; WOMEN; RISK; ADENOCARCINOMA	Background: Current U. S. cervical cancer screening and management guidelines do not consider previous screening history, because data on multiple-round human papillomavirus (HPV) and cytology "co-testing" have been unavailable. Objective: To measure cervical cancer risk in routine practice after successive negative screening co-tests at 3-year intervals. Design: Observational cohort study. Setting: Integrated health care system (Kaiser Permanente Northern California, Oakland, California). Patients: 990 013 women who had 1 or more co-tests from 2003 to 2014. Measurements: 3-and 5-year cumulative detection of (risk for) cervical intraepithelial neoplasia grade 3, adenocarcinoma in situ, and cervical cancer (>= CIN3) in women with different numbers of negative co-tests, overall and within subgroups defined by previous co-test results or baseline age. Results: Five-year >= CIN3 risks decreased after each successive negative co-test screening round (0.098%, 0.052%, and 0.035%). Five-year >= CIN3 risks for an HPV-negative co-test, regardless of the cytology result, nearly matched the performance (reassurance) of a negative co-test for each successive round of screening (0.114%, 0.061%, and 0.041%). By comparison, >= CIN3 risks for the cytology-negative co-test, regardless of the HPV result, also decreased with each successive round, but 3-year risks were as high as 5-year risks after an HPV-negative co-test (0.199%, 0.065%, and 0.043%). No interval cervical cancer cases were diagnosed after the second negative co-test. Independently, >= CIN3 risks decreased with age. Length of previous screening interval did not influence future >= CIN3 risks. Limitation: Interval-censored observational data. Conclusion: After 1 or more negative cervical co-tests (or HPV tests), longer screening intervals (every 5 years or more) might be feasible and safe.	Albert Einstein Coll Med, Bronx, NY 10467 USA; Permanente Med Grp Inc, Oakland, CA USA; NCI, Bethesda, MD 20892 USA; Peking Univ, Beijing, Peoples R China; [Castle, Philip E.] 1300 Morris Pk Ave,Belfer Bldg,Room 1308C, Bronx, NY 10461 USA; [Kinney, Walter K.] 2589 Garden Highway, Sacramento, CA 95833 USA; [Xue, Xiaonan] 1300 Morris Pk Ave,Room 1303C, Bronx, NY 10461 USA; [Cheung, Li C.] Room 7E612,9609 Med Ctr Dr, Rockville, MD 20850 USA; [Gage, Julia C.] Room 6E546,9609 Med Ctr Dr, Rockville, MD 20850 USA; [Zhao, Fang-Hui] Chinese Acad Med Sci, Canc Inst Hosp, 17 South Panjiayuan Lane,POB 2258, Beijing 100021, Peoples R China; [Fetterman, Barbara] TPMG Reg Lab, Cytol Dept, 1725 Eastshore Highway, Berkeley, CA 94710 USA; [Poitras, Nancy E.] Kaiser Permanente, 501 Lennon Lane, Walnut Creek, CA 94597 USA; [Lorey, Thomas S.] Kaiser Permanente Reg Labs, 1725 Eastshore Highway, Berkeley, CA 94710 USA; [Wentzensen, Nicolas] Room 6E448,9609 Med Ctr Dr, Rockville, MD 20850 USA; [Katki, Hormuzd A.] Room 7E606,9609 Med Ctr Dr, Rockville, MD 20850 USA; [Schiffman, Mark] Room 6E544,9609 Med Ctr Dr, Rockville, MD 20850 USA	Yeshiva University; Albert Einstein College of Medicine; Permanente Medical Groups; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Kaiser Permanente; Kaiser Permanente	Castle, PE (corresponding author), 1300 Morris Pk Ave,Belfer Bldg,Room 1308C, Bronx, NY 10461 USA.	castle.philip@gmail.com	Schiffman, Mark/B-9766-2015; Castle, Philip/AAP-6395-2020; Cheung, Li/AAY-3594-2020; Gage, Julia/ABE-9405-2021; Wentzensen, Nicolas/AAG-8522-2019	Castle, Philip/0000-0003-1082-6554; Gage, Julia/0000-0001-5259-6385; Cheung, Li/0000-0003-1625-4331; Zhao, Fang-Hui/0000-0001-9294-0005	National Institutes of Health/National Cancer Institute	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Castle was supported in part by an Intergovernmental Personnel Act assignment from the National Institutes of Health/National Cancer Institute.	Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Burger EA, 2017, CLIN INFECT DIS, V65, P893, DOI 10.1093/cid/cix475; Castanon A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6223; Castle PE, 2015, NAT REV CLIN ONCOL, V12, DOI 10.1038/nrclinonc.2015.37; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Castle PE, 2008, J LOW GENIT TRACT DI, V12, P1, DOI 10.1097/lgt.0b013e31815ea58b; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Cheung LC, 2017, STAT MED, V36, P3583, DOI 10.1002/sim.7380; Committee on Practice BulletinsGynecology, 2012, Obstet Gynecol, V120, P1222, DOI http://10.1097/AOG.0b013e318277c92a; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Dijkstra MG, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4924; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Habbema D, 2017, INT J CANCER, V140, P1215, DOI 10.1002/ijc.30524; Herbert A, 2017, CYTOPATHOLOGY, V28, P9, DOI 10.1111/cyt.12334; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Jeronimo J, 2017, J GLOB ONCOL, V3, P635, DOI 10.1200/JGO.2016.006577; Jeronimo J, 2017, J ONCOL PRACT, V13, P129, DOI 10.1200/JOP.2016.017889; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kinney W, 2015, OBSTET GYNECOL, V125, P311, DOI 10.1097/AOG.0000000000000632; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Liu S, 2001, INT J GYNECOL CANCER, V11, P24, DOI 10.1046/j.1525-1438.2001.011001024.x; Liu SL, 2001, CAN MED ASSOC J, V164, P1151; Lonnberg S, 2015, INT J CANCER, V137, P1758, DOI 10.1002/ijc.29541; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sasieni P, 2016, BJOG-INT J OBSTET GY, V123, P1426, DOI 10.1111/1471-0528.13839; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2017, J LOW GENIT TRACT DI, V21, P87, DOI 10.1097/LGT.0000000000000300; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon, 2006, J LOW GENIT TRACT DI, V11, P223; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Trimble CL, 2005, CLIN CANCER RES, V11, P4717, DOI 10.1158/1078-0432.CCR-04-2599; U. S. Preventive Services Task Force, 2017, PUBL COMM DRAFT REC; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; WHO, 2013, WHO GUID SCREEN TREA; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	48	34	37	2	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					20	+		10.7326/M17-1609	http://dx.doi.org/10.7326/M17-1609			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5SO	29181509				2022-12-28	WOS:000419126700004
J	Chung, JJ; Shaw, AS				Chung, Jun-Jae; Shaw, Andrey S.			TRP'ing up chronic kidney disease Blockade of a specific calcium channel can slow chronic kidney disease progression	SCIENCE			English	Editorial Material							TRPC5; PODOCYTES		[Chung, Jun-Jae; Shaw, Andrey S.] Genentech Inc, Res Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Shaw, AS (corresponding author), Genentech Inc, Res Biol, San Francisco, CA 94080 USA.	shaw.andrey@gene.com		Chung, Jun-Jae/0000-0002-3053-5693				Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48; Glassock RJ, 2017, NAT REV NEPHROL, V13, P104, DOI [10.1038/nmeph.2016.163, 10.1038/nrneph.2016.163]; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Kikuchi M, 2015, SEMIN NEPHROL, V35, P245, DOI 10.1016/j.semnephrol.2015.04.004; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; United States Renal Data System, 2017, USRDS ANN DAT REP EP; Wang XX, 2018, J AM SOC NEPHROL, V29, P409, DOI 10.1681/ASN.2017060682; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhou Y, 2017, SCIENCE, V358, P1332, DOI 10.1126/science.aal4178	13	4	4	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1256	1257		10.1126/science.aar3572	http://dx.doi.org/10.1126/science.aar3572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217557				2022-12-28	WOS:000417254700039
J	Nowakowski, TJ; Bhaduri, A; Pollen, AA; Alvarado, B; Mostajo-Radji, MA; Di Lullo, E; Haeussler, M; Sandoval-Espinosa, C; Liu, SJ; Velmeshev, D; Ounadjela, JR; Shuga, J; Wang, XH; Lim, DA; West, JA; Leyrat, AA; Kent, WJ; Kriegstein, AR				Nowakowski, Tomasz J.; Bhaduri, Aparna; Pollen, Alex A.; Alvarado, Beatriz; Mostajo-Radji, Mohammed A.; Di Lullo, Elizabeth; Haeussler, Maximilian; Sandoval-Espinosa, Carmen; Liu, Siyuan John; Velmeshev, Dmitry; Ounadjela, Johain Ryad; Shuga, Joe; Wang, Xiaohui; Lim, Daniel A.; West, Jay A.; Leyrat, Anne A.; Kent, W. James; Kriegstein, Arnold R.			Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex	SCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; HUMAN BRAIN; CORTICAL AREAS; RADIAL GLIA; CELL-TYPES; NEOCORTEX; DIVERSITY; NEURONS; ORIGIN	Systematic analyses of spatiotemporal gene expression trajectories during organogenesis have been challenging because diverse cell types at different stages of maturation and differentiation coexist in the emerging tissues. We identified discrete cell types as well as temporally and spatially restricted trajectories of radial glia maturation and neurogenesis in developing human telencephalon. These lineage-specific trajectories reveal the expression of neurogenic transcription factors in early radial glia and enriched activation of mammalian target of rapamycin signaling in outer radial glia. Across cortical areas, modest transcriptional differences among radial glia cascade into robust typological distinctions among maturing neurons. Together, our results support a mixed model of topographical, typological, and temporal hierarchies governing cell-type diversity in the developing human telencephalon, including distinct excitatory lineages emerging in rostral and caudal cerebral cortex.	[Nowakowski, Tomasz J.; Bhaduri, Aparna; Pollen, Alex A.; Alvarado, Beatriz; Mostajo-Radji, Mohammed A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Velmeshev, Dmitry; Kriegstein, Arnold R.] UCSF, Dept Neurol, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.; Bhaduri, Aparna; Pollen, Alex A.; Alvarado, Beatriz; Mostajo-Radji, Mohammed A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Velmeshev, Dmitry; Ounadjela, Johain Ryad; Lim, Daniel A.; Kriegstein, Arnold R.] UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.; Ounadjela, Johain Ryad; Kriegstein, Arnold R.] UCSF, Dept Anat, San Francisco, CA 94143 USA; [Haeussler, Maximilian; Kent, W. James] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA; [Liu, Siyuan John; Lim, Daniel A.] UCSF, Dept Neurosurg, Santa Cruz, CA 95064 USA; [Shuga, Joe; Wang, Xiaohui; West, Jay A.; Leyrat, Anne A.] Fluidigm, New Technol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Nowakowski, TJ; Kriegstein, AR (corresponding author), UCSF, Dept Neurol, San Francisco, CA 94143 USA.; Nowakowski, TJ; Kriegstein, AR (corresponding author), UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Nowakowski, TJ; Kriegstein, AR (corresponding author), UCSF, Dept Anat, San Francisco, CA 94143 USA.	tomasz.nowakowski@ucsf.edu; arnold.kriegstein@ucsf.edu	Haeussler, Maximilian/AAY-1649-2021	Lim, Daniel/0000-0001-7221-3425; Velmeshev, Dmitry/0000-0002-6491-7307; Pollen, Alex/0000-0003-3263-8634	Damon Runyon Cancer Research Foundation [DRG-2166-13]; NIH [U01 MH105989, R35NS097305, R01NS091544]; California Institute for Regenerative Medicine [GC1R-06673-C]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH114825, U01MH105989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097305, R01NS091544] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank S. Wang, O. Meyerson, R. N. Delgado, A. Diaz, J. H. Lui, M. Paredes, E. Huang, W. Walantus, and members of the A. R. K. laboratory for providing research resources, technical help, and helpful comments during manuscript preparation. RNA-sequencing data has been deposited at dbGaP: phs000989.v3. This study was supported by the Damon Runyon Cancer Research Foundation (grant DRG-2166-13 to A.A.P.), NIH awards U01 MH105989 and R35NS097305 to A. R. K., R01NS091544 to D.A.L., and by a gift from B. Osher. M. H. and J. K. are funded by California Institute for Regenerative Medicine grants GC1R-06673-C and GC1R-06673-C, respectively. J. A. W. is an inventor on patent application 15/055,252, 20150337295, 20130302884, 20130302883, 20130302807, 20130296196, 20130295602, 20160025761 held/submitted by Fluidigm that covers single-cell nucleic acids for high-throughput sudies, methods and devices for analysis of defined multicellular combinations, and methods, systems, and devices for multiple single-cell capturing and processing using microfluidics. The supplementary materials contain additional data. T.J.N. and A.A.P. designed the study. Single-cell experiments were performed by T.J.N., A.A.P., B. A., J. S., A.A.L., C.S.E., and E.D.L., with input from D.A.L. and J. A. W. Validation experiments and immunohistochemistry were performed by T.J.N., M. A. M. R., J. R. O., and E.D.L. Data management and read processing was performed by A. B., with initial contribution from D.V. Data analysis was performed by A. B., T.J.N., C.S.E., S.J.L., A.A.P., and X.W. Data viewer was designed by M. H. and W. J. K. The study was supervised by T.J.N., A.A.P., A. B., and A. R. K. This manuscript was prepared by T.J.N., A. B., and A.A.P., with feedback from all authors.	Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Bayer S.A., 1991, NEOCORTICAL DEV; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cederquist GY, 2013, J NEUROSCI, V33, P6321, DOI 10.1523/JNEUROSCI.5140-12.2013; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; CONEL JL, 1939, POSTNATAL DEV HUMAN, V1; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mirzaa GM, 2016, JAMA NEUROL, V73, P836, DOI 10.1001/jamaneurol.2016.0363; MOUNTCASTLE VB, 1978, J ROY SOC MED, V71, P14; Nishino J, 2013, ELIFE, V2, DOI 10.7554/eLife.00924; Nowakowski TJ, 2016, NEURON, V91, P1219, DOI 10.1016/j.neuron.2016.09.005; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/NMETH.3629, 10.1038/nmeth.3629]; Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	31	384	386	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1318	1323		10.1126/science.aap8809	http://dx.doi.org/10.1126/science.aap8809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217575	Green Accepted			2022-12-28	WOS:000417254700062
J	Miles, A; Harding, NJ; Botta, G; Clarkson, CS; Antao, T; Kozak, K; Schrider, DR; Kern, AD; Redmond, S; Sharakhov, I; Pearson, RD; Bergey, C; Fontaine, MC; Donnelly, MJ; Lawniczak, MKN; Kwiatkowski, DP; Ayala, D; Besensky, NJ; Burt, A; Caputo, B; della Torre, A; Fontaine, MC; Godfray, HCJ; Hahn, MW; Midega, J; Neafsey, DE; O'Loughlin, S; Pinto, J; Riehle, MM; Vernick, KD; Weetman, D; Wilding, CS; White, BJ; Troco, AD; Diabate, A; Costantini, C; Rohatgi, KR; Besansky, NJ; Elissa, N; Coulibaly, B; Dinis, J; Midegal, J; Mbogo, C; Bejon, P; Mawejje, HD; Stalker, J; Rockett, K; Drury, E; Mead, D; Jeffreys, A; Hubbard, C; Rowlands, K; Isaacs, AT; Jyothi, D; Malangone, C; Vauterin, P; Jeffery, B; Wright, I; Hart, L; Kluczyriski, K; Cornelius, V; MacInnisn, B; Henrichs, C; Giacomantonio, R				Miles, Alistair; Harding, Nicholas J.; Botta, Giordano; Clarkson, Chris S.; Antao, Tiago; Kozak, Krzysztof; Schrider, Daniel R.; Kern, Andrew D.; Redmond, Seth; Sharakhov, Igor; Pearson, Richard D.; Bergey, Christina; Fontaine, Michael C.; Donnelly, Martin J.; Lawniczak, Mara K. N.; Kwiatkowski, Dominic P.; Ayala, Diego; Besensky, Nora J.; Burt, Austin; Caputo, Beniamino; della Torre, Alessandra; Fontaine, Michael C.; Godfray, H. Charles J.; Hahn, Matthew W.; Midega, Janet; Neafsey, Daniel E.; O'Loughlin, Samantha; Pinto, Joao; Riehle, Michelle M.; Vernick, Kenneth D.; Weetman, David; Wilding, Craig S.; White, Bradley J.; Troco, Arlete D.; Diabate, Abdoulaye; Costantini, Carlo; Rohatgi, Kyanne R.; Besansky, Nora J.; Elissa, Nohal; Coulibaly, Bouhacar; Dinis, Joao; Midegal, Janet; Mbogo, Charles; Bejon, Philip; Mawejje, Henry D.; Stalker, Jim; Rockett, Kirk; Drury, Eleanor; Mead, Daniel; Jeffreys, Anna; Hubbard, Christina; Rowlands, Kate; Isaacs, Alison T.; Jyothi, Dushyanth; Malangone, Cinzia; Vauterin, Paul; Jeffery, Ben; Wright, Ian; Hart, Lee; Kluczyriski, Krzysztof; Cornelius, Victoria; MacInnisn, Bronwyn; Henrichs, Christa; Giacomantonio, Rachel		Anopheles Gombioe 1000 Genomes	Genetic diversity of the African malaria vector Anopheles gambiae	NATURE			English	Article							POPULATION-STRUCTURE; INCIPIENT SPECIATION; POSITIVE SELECTION; MOSQUITO; FLOW; INTROGRESSION; DIVERGENCE; RESISTANCE; CULICIDAE; SUGGESTS	The sustainability of malaria control in Africa is threatened by the rise of insecticide resistance in Anopheles mosquitoes, which transmit the disease(1). To gain a deeper understanding of how mosquito populations are evolving, here we sequenced the genomes of 765 specimens of Anopheles gambiae and Anopheles coluzzii sampled from 15 locations across Africa, and identified over 50 million single nucleotide polymorphisms within the accessible genome. These data revealed complex population structure and patterns of gene flow, with evidence of ancient expansions, recent bottlenecks, and local variation in effective population size. Strong signals of recent selection were observed in insecticide-resistance genes, with several sweeps spreading over large geographical distances and between species. The design of new tools for mosquito control using gene-drive systems will need to take account of high levels of genetic diversity in natural mosquito populations.	[Miles, Alistair; Clarkson, Chris S.; Kozak, Krzysztof; Pearson, Richard D.; Donnelly, Martin J.; Lawniczak, Mara K. N.; Kwiatkowski, Dominic P.; Stalker, Jim; Drury, Eleanor; Mead, Daniel; Jyothi, Dushyanth; Malangone, Cinzia; Giacomantonio, Rachel] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Miles, Alistair; Harding, Nicholas J.; Botta, Giordano; Antao, Tiago; Pearson, Richard D.; Kwiatkowski, Dominic P.; Rockett, Kirk; Jeffreys, Anna; Hubbard, Christina; Rowlands, Kate; Vauterin, Paul; Jeffery, Ben; Wright, Ian; Hart, Lee; Kluczyriski, Krzysztof; Cornelius, Victoria; Henrichs, Christa] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford OX3 7BN, England; [Botta, Giordano; Caputo, Beniamino; della Torre, Alessandra] Univ Roma SAPIENZA, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur Italia Fdn Cenci Bolognetti, Rome, Italy; [Clarkson, Chris S.; Antao, Tiago; Donnelly, Martin J.; Isaacs, Alison T.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England; [Antao, Tiago] Univ Montana, Missoula, MT 59812 USA; [Schrider, Daniel R.] Rutgers State Univ, Dept Genet, 604 Alison Rd, Piscataway, NJ 08854 USA; [Redmond, Seth; Neafsey, Daniel E.] Broad Inst, Genome Sequencing & Anal Program, 415 Main St, Cambridge, MD 02142 USA; [Sharakhov, Igor] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk 634050, Russia; [Bergey, Christina; Besensky, Nora J.; Rohatgi, Kyanne R.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Fontaine, Michael C.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Ayala, Diego; Elissa, Nohal] Ctr Int Rech Med Franceville, Unite Ecol Syst Vectoriels, Franceville, Gabon; [Ayala, Diego; Costantini, Carlo] UM2, UM1, CNRS 5290, IRD,UMR MIVEGEC,IRD 224, Montpellier, France; Imperial Coll, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England; [Godfray, H. Charles J.] Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England; [Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Midega, Janet; Midegal, Janet; Mbogo, Charles; Bejon, Philip] KEMRI Wellcome Trust Res Programme, POB 230, Kilifi, Kenya; Univ Nova Lisboa, IHMT, GHTM, Rua Junqueira 100, P-1349008 Lisbon, Portugal; Univ Minnesota, Microbial & Plant Genom Inst, Dept Microbiol & Immunol, St Paul, MN 55108 USA; Inst Pasteur, Unit Genet & Genom Insect Vectors, Paris, France; Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [White, Bradley J.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Troco, Arlete D.] Minist Saude, Direccao Nacl Sude Publ, Programa Nacl Controle Malaria, Luanda, Angola; [Diabate, Abdoulaye] IRSS, Bobo Dioulasso, Burkina Faso; [Costantini, Carlo] OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Coulibaly, Bouhacar] Univ Bamako, MRTC, Bamako, Mali; [Dinis, Joao] Minist Saude Publ, Inst Nacl Saude Publ, Bissau, Guinea Bissau; [Mawejje, Henry D.] Infect Dis Res Collaborat, 2C Nakasero Hill Rd,POB 7475, Kampala, Uganda; [MacInnisn, Bronwyn] Broad Inst Massachusetts Inst Technol & Harvard, 415 Main St, Cambridge, MA 02142 USA	Wellcome Trust Sanger Institute; University of Oxford; Sapienza University Rome; Liverpool School of Tropical Medicine; University of Liverpool; University of Montana System; University of Montana; Rutgers State University New Brunswick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Tomsk State University; University of Notre Dame; University of Groningen; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Imperial College London; University of Oxford; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Liverpool John Moores University; University of California System; University of California Riverside; University of Bamako; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Miles, A; Donnelly, MJ; Lawniczak, MKN; Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England.; Miles, A; Kwiatkowski, DP (corresponding author), Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford OX3 7BN, England.; Donnelly, MJ (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	alistairmiles@bdi.ox.ac.uk; Martin.Donnelly@Istmed.ac.uk; mara@sangerac.uk; dominic@sangerac.uk	Sharakhov, Igor/B-1972-2008; Mead, Daniel/AAE-6629-2019; Bergey, Christina/ADV-1840-2022; Wilding, Craig S/C-5500-2012; Costantini, Carlo/F-3470-2012; Ayala, Diego/J-6788-2016; Kozak, Krzysztof M./G-4182-2012; Pinto, Joao/C-2208-2012; Fontaine, Michael/G-5350-2011; Antao, Tiago/C-3615-2009; Weetman, David/M-1261-2014; Jyothi, Dushyanth/H-9517-2014	Sharakhov, Igor/0000-0003-0752-3747; Mead, Daniel/0000-0001-7717-4330; Bergey, Christina/0000-0001-8336-8078; Wilding, Craig S/0000-0001-5818-2706; Costantini, Carlo/0000-0003-1016-129X; Ayala, Diego/0000-0003-4726-580X; Kozak, Krzysztof M./0000-0001-8980-3173; Pinto, Joao/0000-0001-8572-7708; Wright, Ian/0000-0003-2858-7045; Fontaine, Michael/0000-0003-1156-4154; Kwiatkowski, Dominic/0000-0002-5023-0176; Antao, Tiago/0000-0002-7269-5513; Miles, Alistair/0000-0001-9018-4680; Weetman, David/0000-0002-5820-1388; redmond, seth/0000-0003-2653-760X; Hart, Lee/0000-0002-6473-0964; Lawniczak, Mara/0000-0002-3006-2080; Burt, Austin/0000-0001-5146-9640; Donnelly, Martin/0000-0001-5218-1497; Harding, Nicholas/0000-0001-5907-0773; Jyothi, Dushyanth/0000-0002-0448-5303; Hahn, Matthew/0000-0002-5731-8808; Vauterin, Paul/0000-0003-3665-4519	Wellcome Trust [090770/Z/09/Z, 090532/Z/09/Z, 098051]; Medical Research Council UK; Department for International Development (DFID) [MR/M006212/1]; MRC [G1100339]; Foundation for the National Institutes of Health through Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill AMP; Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID) [U19AI089674, R01AI082734]; Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674, R01AI082734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117241] Funding Source: NIH RePORTER; Medical Research Council [G0600718, G1002624, MR/M006212/1, G0600718B, G1100339] Funding Source: researchfish; Wellcome Trust [204911/Z/16/Z] Funding Source: researchfish; MRC [G0600718, MR/M006212/1, G1002624] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Foundation for the National Institutes of Health through Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill AMP; Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the staff of the Wellcome Trust Sanger Institute Sample Logistics, Sequencing and Informatics facilities for their contributions. This work was supported by the Wellcome Trust (090770/Z/09/Z; 090532/Z/09/Z; 098051) and Medical Research Council UK and the Department for International Development (DFID) (MR/M006212/1). M.K.N.L. was supported by MRC grant G1100339. S.O.'L. and A.B. were supported by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation. D.W., C.S.W., H.D.M. and M.J.D. were supported by Award Numbers U19AI089674 and R01AI082734 from the National Institute of Allergy and Infectious Diseases (NIAID). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH. T.A. was supported by a Sir Henry Wellcome Postdoctoral Fellowship.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2013, AFRICAN GEOGRAPHICAL; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Browning BL, 2013, AM J HUM GENET, V93, P840, DOI 10.1016/j.ajhg.2013.09.014; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diabate A, 2005, J MED ENTOMOL, V42, P548, DOI 10.1603/0022-2585(2005)042[0548:LDOTMF]2.0.CO;2; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Fossog BT, 2015, EVOL APPL, V8, P326, DOI 10.1111/eva.12242; Garud NR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005004; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1448; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Norris LC, 2015, P NATL ACAD SCI USA, V112, P815, DOI 10.1073/pnas.1418892112; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; Ross R, 1899, Br Med J, V2, P1; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schrider DR, 2013, GENETICS, V194, P937, DOI 10.1534/genetics.113.151670; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-459; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vicente JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46451	50	159	160	3	118	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					96	+		10.1038/nature24995	http://dx.doi.org/10.1038/nature24995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186111	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000417560500050
J	Ong, LL; Hanikel, N; Yaghi, OK; Grun, C; Strauss, MT; Bron, P; Lai-Kee-Him, J; Schueder, F; Wang, B; Wang, PF; Kishi, JY; Myhrvold, C; Zhu, A; Jungmann, R; Bellot, G; Ke, YG; Yin, P				Ong, Luvena L.; Hanikel, Nikita; Yaghi, Omar K.; Grun, Casey; Strauss, Maximilian T.; Bron, Patrick; Lai-Kee-Him, Josephine; Schueder, Florian; Wang, Bei; Wang, Pengfei; Kishi, Jocelyn Y.; Myhrvold, Cameron; Zhu, Allen; Jungmann, Ralf; Bellot, Gaetan; Ke, Yonggang; Yin, Peng			Programmable self-assembly of three-dimensional nanostructures from 10,000 unique components	NATURE			English	Article							SINGLE-STRANDED-DNA; NANOSCALE SHAPES; RATIONAL DESIGN; IMAGE-ANALYSIS; ORIGAMI; RECONSTRUCTION; MICROSCOPY; PATTERNS; PAINT	Nucleic acids (DNA and RNA) are widely used to construct nanometre-scale structures with ever increasing complexity(1-14), with possible application in fields such as structural biology, biophysics, synthetic biology and photonics. The nanostructures are formed through one-pot self-assembly, with early kilodalton-scale examples containing typically tens of unique DNA strands. The introduction of DNA origami(4), which uses many staple strands to fold one long scaffold strand into a desired structure, has provided access to megadalton-scale nanostructures that contain hundreds of unique DNA strands(6,7,10-14). Even larger DNA origami structures are possible(15,16), but manufacturing and manipulating an increasingly long scaffold strand remains a challenge. An alternative and more readily scalable approach involves the assembly of DNA bricks, which each consist of four short binding domains arranged so that the bricks can interlock(8,9). This approach does not require a scaffold; instead, the short DNA brick strands self-assemble according to specific inter-brick interactions. First-generation bricks used to create three-dimensional structures are 32 nucleotides long, consisting of four eight-nucleotide binding domains. Protocols have been designed to direct the assembly of hundreds of distinct bricks into well formed structures, but attempts to create larger structures have encountered practical challenges and had limited success(9). Here we show that DNA bricks with longer, 13-nucleotide binding domains make it possible to self-assemble 0.1-1-gigadalton, three-dimensional nanostructures from tens of thousands of unique components, including a 0.5-gigadalton cuboid containing about 30,000 unique bricks and a 1-gigadalton rotationally symmetric tetramer. We also assembled a cuboid that contains around 10,000 bricks and about 20,000 uniquely addressable, 13-base-pair 'voxels' that serves as a molecular canvas for three-dimensional sculpting. Complex, user-prescribed, three-dimensional cavities can be produced within this molecular canvas, enabling the creation of shapes such as letters, a helicoid and a teddy bear. We anticipate that with further optimization of structure design, strand synthesis and assembly procedure even larger structures could be accessible, which could be useful for applications such as positioning functional components.	[Ong, Luvena L.; Hanikel, Nikita; Yaghi, Omar K.; Grun, Casey; Strauss, Maximilian T.; Schueder, Florian; Wang, Bei; Kishi, Jocelyn Y.; Myhrvold, Cameron; Zhu, Allen; Yin, Peng] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Ong, Luvena L.] MIT, Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA; [Strauss, Maximilian T.; Schueder, Florian; Jungmann, Ralf] Max Planck Inst Biochem, D-82152 Martinsried Munich, Germany; [Strauss, Maximilian T.; Schueder, Florian; Jungmann, Ralf] Ludwig Maximilians Univ Munchen, Dept Phys, D-80539 Munich, Germany; [Strauss, Maximilian T.; Schueder, Florian; Jungmann, Ralf] Ludwig Maximilians Univ Munchen, Ctr Nanosci, D-80539 Munich, Germany; [Bron, Patrick; Lai-Kee-Him, Josephine] Ctr Biochim Struct, CNRS, INSERM, UMR 5048,U1054, F-34000 Montpellier, France; [Wang, Bei] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China; [Wang, Pengfei; Ke, Yonggang] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Wang, Pengfei; Ke, Yonggang] Georgia Inst Technol, Atlanta, GA 30322 USA; [Kishi, Jocelyn Y.; Myhrvold, Cameron; Yin, Peng] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Bellot, Gaetan] Inst Genom Fonct, CNRS, INSERM, U1191,UMR 5203, F-34000 Montpellier, France; [Ke, Yonggang] Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Harvard University; Massachusetts Institute of Technology (MIT); Max Planck Society; University of Munich; University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Emory University; University System of Georgia; Georgia Institute of Technology; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Emory University	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.; Ke, YG (corresponding author), Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA.; Ke, YG (corresponding author), Georgia Inst Technol, Atlanta, GA 30322 USA.; Yin, P (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Bellot, G (corresponding author), Inst Genom Fonct, CNRS, INSERM, U1191,UMR 5203, F-34000 Montpellier, France.; Ke, YG (corresponding author), Emory Univ, Dept Chem, Atlanta, GA 30322 USA.	gaetan.bellot@igf.cnrs.fr; yonggang.ke@emory.edu; py@hms.harvard.edu	Strauss, Maximilian/GRR-3068-2022; Jungmann, Ralf/A-6357-2015; Grun, Casey/M-2475-2014	Strauss, Maximilian/0000-0003-3320-6833; Jungmann, Ralf/0000-0003-4607-3312; LAI KEE HIM, Josephine/0000-0001-6303-1224; Grun, Casey/0000-0002-4563-6358; Bellot, Gaetan/0000-0002-2671-6723; bron, patrick/0000-0002-3354-9513; Schueder, Florian/0000-0003-3412-5066	Office of Naval Research grants [N000141010827, N000141310593, N000141410610, N000141612182, N000141612410]; Army Research Office grant [W911NF1210238]; National Science Foundation [CCF-1054898, CCF-1162459, CCF-1317291, CMMI-1333215, CMMI-1334109, CMMI-1344915]; Air Force Office of Scientific Research grant [AFA9550-15- 1-0514]; National Institute of Health [1DP2OD007292, 1R01EB018659, 167814]; Emory Biomedical Engineering Department Startup Fund; Emory Winship Cancer Institute Billi and Bernie Marcus Research Award; Winship Cancer Institute from American Cancer Society [IRG-14-188-0]; National Science Foundation CAREER Award [DMR-1654485]; French National Research Agency [ANR-16- CE09-0004-01, ANR-15-CE09-0003-02, ANR-10-INBS-05]; NSF graduate research fellowship; German National Academic Foundation; German Academic Exchange Service; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER; Directorate For Engineering [1333215] Funding Source: National Science Foundation	Office of Naval Research grants(Office of Naval Research); Army Research Office grant; National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Biomedical Engineering Department Startup Fund; Emory Winship Cancer Institute Billi and Bernie Marcus Research Award; Winship Cancer Institute from American Cancer Society; National Science Foundation CAREER Award(National Science Foundation (NSF)); French National Research Agency(French National Research Agency (ANR)); NSF graduate research fellowship(National Science Foundation (NSF)); German National Academic Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank N. Ponnuswamy, R. Sorensen, J. Hahn, J. Lara, L. Chou, N. Garreau, S. Saka, H. Sasaki, J. B. Woehrstein and C. B. Marks for experimental help. We also thank B. Wei, W. Sun and W.M. Shih for discussions, M. Beatty and J. Cheng for help in developing the Nanobricks platform, and C. Chen for assistance with draft preparation. The work was funded by Office of Naval Research grants N000141010827, N000141310593, N000141410610, N000141612182 and N000141612410, an Army Research Office grant W911NF1210238, National Science Foundation grants CCF-1054898, CCF-1162459, CCF-1317291, CMMI-1333215, CMMI-1334109 and CMMI-1344915, an Air Force Office of Scientific Research grant AFA9550-15- 1-0514, and National Institute of Health grants 1DP2OD007292 and 1R01EB018659, 167814 (P.Y.); an Emory Biomedical Engineering Department Startup Fund, an Emory Winship Cancer Institute Billi and Bernie Marcus Research Award, a Winship Cancer Institute grant number IRG-14-188-0 from the American Cancer Society, and a National Science Foundation CAREER Award DMR-1654485 (Y.K.); French National Research Agency grants ANR-16- CE09-0004-01 and ANR-15-CE09-0003-02 (G.B.); and a French National Research Agency grant ANR-10-INBS-05 (P.B.). L.L.O. was funded by an NSF graduate research fellowship. N. H. was funded by the German National Academic Foundation and German Academic Exchange Service. M.T.S. acknowledges support from the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS).	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; El Beheiry M, 2013, NAT METHODS, V10, P689, DOI 10.1038/nmeth.2566; Fu JL, 2014, NAT NANOTECHNOL, V9, P531, DOI [10.1038/nnano.2014.100, 10.1038/NNANO.2014.100]; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Jacobs WM, 2015, P NATL ACAD SCI USA, V112, P6313, DOI 10.1073/pnas.1502210112; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Knudsen JB, 2015, NAT NANOTECHNOL, V10, P892, DOI [10.1038/NNANO.2015.190, 10.1038/nnano.2015.190]; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Liu Y, 2005, J AM CHEM SOC, V127, P17140, DOI 10.1021/ja055614o; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Myhrvold C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14698; Nickels PC, 2016, SCIENCE, V354, P305, DOI 10.1126/science.aah5974; Nickels PC, 2014, SMALL, V10, P1765, DOI 10.1002/smll.201303442; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9634; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Sun W, 2014, SCIENCE, V346, P717, DOI 10.1126/science.1258361; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	37	239	247	20	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					72	+		10.1038/nature24648	http://dx.doi.org/10.1038/nature24648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219968	Green Accepted, Green Submitted			2022-12-28	WOS:000417560500045
J	Aso, T				Aso, Taro			Crucial role of finance ministry in achieving universal health coverage	LANCET			English	Editorial Material									[Aso, Taro] Govt Japan, Minist Finance, Chiyoda Ku, Tokyo 1008940, Japan		Aso, T (corresponding author), Govt Japan, Minist Finance, Chiyoda Ku, Tokyo 1008940, Japan.	akihiko.yoshida@mof.go.jp						Abe S, 2015, LANCET, V386, P2367, DOI 10.1016/S0140-6736(15)01172-1; [Anonymous], 2011, LANCET, V378, P1049, DOI 10.1016/S0140-6736(11)61223-3; Barroy H, 2017, HLTH SYST REFORM; Claeson M, 2017, LANCET, V389, P1588, DOI 10.1016/S0140-6736(17)31000-0; Ezoe S, 2017, HEALTH SYST REFORM, V3, P268, DOI 10.1080/23288604.2017.1347125; Fukawa T, 2002, PUBLIC HLTH INSURANC; Ikegami N., 2014, UNIVERSAL HLTH COVER; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Ministry of Health Labour and Welfare Government of Japan, 2016, 2014 SURV INC RED; World Bank, 2016, UNIV HLTH COV UH AFR; World Bank, 2016, PAND EM FIN FAC GLOB; World Bank, 2016, IDA18 WORLD BANK; World Bank, 2017, GLOB FIN FAC ANN REP	13	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2415	2417		10.1016/S0140-6736(17)33077-5	http://dx.doi.org/10.1016/S0140-6736(17)33077-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO6UL	29208296				2022-12-28	WOS:000417003400008
J	Roushan, P; Neill, C; Tangpanitanon, J; Bastidas, VM; Megrant, A; Barends, R; Chen, Y; Chen, Z; Chiaro, B; Dunsworth, A; Fowler, A; Foxen, B; Giustina, M; Jeffrey, E; Kelly, J; Lucero, E; Mutus, J; Neeley, M; Quintana, C; Sank, D; Vainsencher, A; Wenner, J; White, T; Neven, H; Angelakis, DG; Martinis, J				Roushan, P.; Neill, C.; Tangpanitanon, J.; Bastidas, V. M.; Megrant, A.; Barends, R.; Chen, Y.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Fowler, A.; Foxen, B.; Giustina, M.; Jeffrey, E.; Kelly, J.; Lucero, E.; Mutus, J.; Neeley, M.; Quintana, C.; Sank, D.; Vainsencher, A.; Wenner, J.; White, T.; Neven, H.; Angelakis, D. G.; Martinis, J.			Spectroscopic signatures of localization with interacting photons in superconducting qubits	SCIENCE			English	Article							MANY-BODY LOCALIZATION; DIRAC FERMIONS; QUANTUM; THERMALIZATION	Quantized eigenenergies and their associated wave functions provide extensive information for predicting the physics of quantum many-body systems. Using a chain of nine superconducting qubits, we implement a technique for resolving the energy levels of interacting photons. We benchmark this method by capturing the main features of the intricate energy spectrum predicted for two-dimensional electrons in a magnetic field-the Hofstadter butterfly. We introduce disorder to study the statistics of the energy levels of the system as it undergoes the transition from a thermalized to a localized phase. Our work introduces a many-body spectroscopy technique to study quantum phases of matter.	[Roushan, P.; Megrant, A.; Barends, R.; Chen, Y.; Fowler, A.; Giustina, M.; Jeffrey, E.; Kelly, J.; Lucero, E.; Mutus, J.; Neeley, M.; Sank, D.; Vainsencher, A.; White, T.; Neven, H.; Martinis, J.] Google Inc, Santa Barbara, CA 93117 USA; [Neill, C.; Chen, Z.; Chiaro, B.; Dunsworth, A.; Foxen, B.; Quintana, C.; Wenner, J.; Martinis, J.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Tangpanitanon, J.; Bastidas, V. M.; Angelakis, D. G.] Natl Univ Singapore, CQT, Singapore, Singapore; [Angelakis, D. G.] Tech Univ Crete, Sch Elect & Comp Engn, Khania, Crete, Greece	Google Incorporated; University of California System; University of California Santa Barbara; National University of Singapore; Technical University of Crete	Roushan, P (corresponding author), Google Inc, Santa Barbara, CA 93117 USA.; Angelakis, DG (corresponding author), Natl Univ Singapore, CQT, Singapore, Singapore.; Angelakis, DG (corresponding author), Tech Univ Crete, Sch Elect & Comp Engn, Khania, Crete, Greece.	pedramr@google.com; dimitris.angelakis@gmail.com	Wenner, James/G-3777-2014	Wenner, James/0000-0001-7107-4734; Angelakis, Dimitris/0000-0001-6763-6060; Bastidas, Victor M./0000-0001-8091-7860; Tangpanitanon, Jirawat/0000-0003-0435-0422	Singapore Ministry of Education Academic Research Fund Tier 3 [MOE2012-T3-1-009]; National Research Foundation (NRF) Singapore; Ministry of Education, Singapore under the Research Centres of Excellence Program	Singapore Ministry of Education Academic Research Fund Tier 3(Ministry of Education, Singapore); National Research Foundation (NRF) Singapore(National Research Foundation, Singapore); Ministry of Education, Singapore under the Research Centres of Excellence Program(Ministry of Education, Singapore)	We acknowledge discussions with Y. Bahri, E. Kapit, O. Kyriienko, M. F. Maghrebi, V. Oganesyan, V. N. Smelyanskiy, and G. Zhu. P. R. and C. N. performed the experiment. J. T., V. M. B., and D. G. A. provided theoretical assistance. P. R., C. N., J. T., V. M. B., and D. G. A. analyzed the data and cowrote the manuscript. All of the UCSB and Google team members contributed to the experimental setup. At CQT, this research was supported by Singapore Ministry of Education Academic Research Fund Tier 3 (grant no. MOE2012-T3-1-009); National Research Foundation (NRF) Singapore; and the Ministry of Education, Singapore under the Research Centres of Excellence Program. The data that support the plots presented in this paper and other findings of this study are available from the corresponding author upon reasonable request. The authors declare no competing financial interests.	Abrahams E., 2010, 50 YEARS ANDERSON LO; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Altman E, 2015, ANNU REV CONDEN MA P, V6, P383, DOI 10.1146/annurev-conmatphys-031214-014701; Angelakis D. G., 2017, SERIES QUANTUM SCI T; Atas YY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.084101; Bahri Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8341; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Chandran A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.144201; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; De Roeck W, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.014203; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Iemini F, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.214206; Imbrie JZ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.027201; Iyer S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134202; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Johri S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.117401; Jurcevic P, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.100501; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Kjall JA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.107204; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Nandkishore R, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.064203; Noh C, 2017, REP PROG PHYS, V80, DOI 10.1088/0034-4885/80/1/016401; Oganesyan V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155111; Pal A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174411; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Senko C, 2014, SCIENCE, V345, P430, DOI 10.1126/science.1251422; Serbyn M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.147204; Serbyn M, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041047; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; Yao NY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.243002	35	237	238	4	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1175	1178		10.1126/science.aao1401	http://dx.doi.org/10.1126/science.aao1401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191906	Green Submitted			2022-12-28	WOS:000416584000039
J	Wang, XJ; Ran, TT; Zhang, X; Xin, JY; Zhang, ZH; Wu, TW; Wang, WW; Cai, G				Wang, Xuejuan; Ran, Tingting; Zhang, Xuan; Xin, Jiyu; Zhang, Zhihui; Wu, Tengwei; Wang, Weiwu; Cai, Gang			3.9 angstrom structure of the yeast Mec1-Ddc2 complex, a homolog of human ATR-ATRIP	SCIENCE			English	Article							STALLED REPLICATION FORKS; ATAXIA-TELANGIECTASIA; CHECKPOINT ACTIVATION; DNA-DAMAGE; PROTEIN; KINASE; ARCHITECTURE; MEC1(ATR)	The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase is a master regulator of DNA damage response and replication stress in humans, but the mechanism of its activation remains unclear. ATR acts together with its partner ATRIP. Using cryo-electron microscopy, we determined the structure of intact Mec1-Ddc2 (the yeast homolog of ATR-ATRIP), which is poised for catalysis, at a resolution of 3.9 angstroms. Mec1-Ddc2 forms a dimer of heterodimers through the PRD and FATdomains of Mec1 and the coiled-coil domain of Ddc2. The PRD and Bridge domains in Mec1 constitute critical regulatory sites. The activation loop of Mec1 is inhibited by the PRD, revealing an allosteric mechanism of kinase activation. Our study clarifies the architecture of ATR-ATRIP and provides a structural framework for the understanding of ATR regulation.	[Wang, Xuejuan; Zhang, Xuan; Xin, Jiyu; Zhang, Zhihui; Wu, Tengwei; Cai, Gang] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Wang, Xuejuan; Zhang, Xuan; Xin, Jiyu; Zhang, Zhihui; Wu, Tengwei; Cai, Gang] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wang, Xuejuan; Cai, Gang] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Hefei 230026, Anhui, Peoples R China; [Ran, Tingting; Wang, Weiwu] Nanjing Agr Univ, Key Lab Agr & Environm Microbiol, Minist Agr, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Cai, G (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Cai, G (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.; Cai, G (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Hefei 230026, Anhui, Peoples R China.	gcai@ustc.edu.cn	Cai, Gang/AAA-4439-2020; zhang, zh/GWV-4677-2022; wang, weiwu/AAD-1490-2022; Wang, Xuejuan/G-5093-2018; Cai, Gang/B-1103-2012	Cai, Gang/0000-0001-8622-3907; Wang, Xuejuan/0000-0001-6493-9971; Cai, Gang/0000-0001-8622-3907; , Tingting/0000-0002-5541-3553; , weiwu/0000-0001-6922-9207	National Basic Research Program [2014CB910700, 2013CB910200]; National Natural Science Foundation of China [31222017, 31770808]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The 3D cryo-EM density map reported in this paper has been deposited in the EM Databank under accession number EMD-6708 and the corresponding model in the Protein Data Bank as PDB ID 5X6O. EM data were collected at the Center for Bio-imaging, Institute of Biophysics, Chinese Academy of Sciences. We thank G. Ji and X. Huang for technical help and support with electron microscopy, X. Shen (University of Texas M. D. Anderson Cancer Center) for providing the N-terminal Mec1 tagged yeast strain MEC1-FLAG (MATa MEC1-FLAG his3 Delta 1 leu2 Delta 0 met15 Delta 0 ura3 Delta 0), and S. Ma and H. Wu (Shanghai Chenglan Technology Co.) for help with GPU computation. Supported by National Basic Research Program grants 2014CB910700 and 2013CB910200 and National Natural Science Foundation of China grants 31222017 and 31770808. Author contributions: X. W. ran the kinase assay, froze the grids, performed the 3D reconstructions, analyzed the cryo-EM reconstruction of the Mec1-Ddc2 complex, and built the models with W. W. and T.R.; X.Z. and T.W. purified the Mec1-Ddc2; J.X. prepared the Dpb11; Z.Z. and X. W. collected the cryo-EM data; and G.C. designed experiments, analyzed data, and wrote the manuscript with X.W.	Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Bandhu A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004136; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Baretic D, 2014, SEMIN CELL DEV BIOL, V36, P91, DOI 10.1016/j.semcdb.2014.09.024; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Kapoor P, 2015, GENE DEV, V29, P591, DOI 10.1101/gad.257626.114; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Luzwick JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099397; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nam EA, 2011, J BIOL CHEM, V286, P37320, DOI 10.1074/jbc.M111.276113; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Wanrooij PH, 2016, J BIOL CHEM, V291, P393, DOI 10.1074/jbc.M115.687145; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Yang HR, 2016, PROTEIN CELL, V7, P878, DOI 10.1007/s13238-016-0346-6; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	27	41	44	7	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1206	1209		10.1126/science.aan8414	http://dx.doi.org/10.1126/science.aan8414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191911				2022-12-28	WOS:000416584000046
J	Kao, D; Roach, B; Silva, M; Beck, P; Rioux, K; Kaplan, GG; Chang, HJ; Coward, S; Goodman, KJ; Xu, HP; Madsen, K; Mason, A; Wong, GKS; Jovel, J; Patterson, J; Louie, T				Kao, Dina; Roach, Brandi; Silva, Marisela; Beck, Paul; Rioux, Kevin; Kaplan, Gilaad G.; Chang, Hsiu-Ju; Coward, Stephanie; Goodman, Karen J.; Xu, Huiping; Madsen, Karen; Mason, Andrew; Wong, Gane Ka-Shu; Jovel, Juan; Patterson, Jordan; Louie, Thomas			Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLAMMATORY-BOWEL-DISEASE; FROZEN; METAANALYSIS; PREVENTION; VANCOMYCIN; RESOLUTION; DIARRHEA	IMPORTANCE Fecal microbiota transplantation (FMT)is effective in preventing recurrent Clostridium difficile infection (RCDI). However, it is not known whether clinical efficacy differs by route of delivery. OBJECTIVE To determine whether FMT by oral capsule is noninferior to colonoscopy delivery in efficacy. DESIGN, SETTING, AND PARTICIPANTS Noninferiority, unblinded, randomized trial conducted in 3 academic centers in Alberta, Canada. A total of 116 adult patients with RCDI were enrolled between October 2014 and September 2016, with follow-up to December 2016. The noninferiority margin was 15%. INTERVENTIONS Participants were randomly assigned to FMT by capsule or by colonoscopy at a 1: 1 ratio. MAIN OUTCOMES AND MEASURES The primary outcomewas the proportion of patients without RCDI 12 weeks after FMT. Secondary outcomes included (1) serious and minor adverse events, (2) changes in quality of life by the 36-Item Short Form Survey on a scale of 0 (worst possible quality of life) to 100 (best quality of life), and (3) patient perception on a scale of 1 (not at all unpleasant) to 10 (extremely unpleasant) and satisfaction on a scale of 1 (best) to 10 (worst). RESULTS Among 116 patients randomized (mean [SD] age, 58 [19] years; 79 women [68%]), 105 (91%) completed the trial, with 57 patients randomized to the capsule group and 59 to the colonoscopy group. In per-protocol analysis, prevention of RCDI after a single treatment was achieved in 96.2% in both the capsule group (51/53) and the colonoscopy group (50/52) (difference, 0%; 1-sided 95% CI, -6.1% to infinity; P < .001), meeting the criterion for noninferiority. One patient in each group died of underlying cardiopulmonary illness unrelated to FMT. Rates of minor adverse events were 5.4% for the capsule group vs 12.5% for the colonoscopy group. There was no significant between-group difference in improvement in quality of life. A significantly greater proportion of participants receiving capsules rated their experience as "not at all unpleasant" (66% vs 44%; difference, 22% [95% CI, 3%-40%]; P = .01). CONCLUSIONS AND RELEVANCE Among adults with RCDI, FMT via oral capsules was not inferior to delivery by colonoscopy for preventing recurrent infection over 12 weeks. Treatment with oral capsulesmay be an effective approach to treating RCDI.	[Kao, Dina; Roach, Brandi; Goodman, Karen J.; Madsen, Karen; Mason, Andrew] Univ Alberta, Div Gastroenterol, Dept Med, Edmonton, AB, Canada; [Silva, Marisela; Louie, Thomas] Univ Calgary, Div Infect Dis, Dept Med, Calgary, AB, Canada; [Beck, Paul; Kaplan, Gilaad G.] Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB, Canada; [Rioux, Kevin] Univ Victoria, Div Gastroenterol, Dept Med, Victoria, BC, Canada; [Chang, Hsiu-Ju] Univ Alberta, Edmonton, AB, Canada; [Coward, Stephanie] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Xu, Huiping] Indiana Univ, Dept Biostat, Indianapolis, IN 46204 USA; [Wong, Gane Ka-Shu; Jovel, Juan; Patterson, Jordan] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wong, Gane Ka-Shu] BGI Shenzhen, Shenzhen, Peoples R China	University of Alberta; University of Calgary; University of Calgary; University of Victoria; University of Alberta; University of Calgary; Indiana University System; Indiana University-Purdue University Indianapolis; University of Alberta; University of Alberta; Beijing Genomics Institute (BGI)	Kao, D (corresponding author), Univ Alberta, Dept Med, Zeidler Ledcor Ctr, 130 Univ Campus, Edmonton, AB T6G 2X8, Canada.	dkao@ualberta.ca	Madsen, Karen L/H-5898-2011; Kaplan, Gil/AAH-2335-2021; WONG, Gane Ka-Shu/G-5784-2013; Goodman, Karen/D-6823-2013	Kaplan, Gil/0000-0003-2719-0556; WONG, Gane Ka-Shu/0000-0001-6108-5560; Goodman, Karen/0000-0002-3790-3217	Alberta Health Services; University of Alberta Hospital Foundation	Alberta Health Services; University of Alberta Hospital Foundation(University of Alberta)	The study was funded by a grant from Alberta Health Services and University of Alberta Hospital Foundation.	Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; Bafeta A, 2017, ANN INTERN MED, V167, P34, DOI 10.7326/M16-2810; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Dubberke ER, 2016, OPEN FORUM INFECT DI, V3, P1341; Fischer M, 2016, INFLAMM BOWEL DIS, V22, P2402, DOI 10.1097/MIB.0000000000000908; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; Khoruts A, 2016, CLIN GASTROENTEROL H, V14, P1433, DOI 10.1016/j.cgh.2016.02.018; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Negron ME, 2014, INFLAMM BOWEL DIS, V20, P2046, DOI 10.1097/MIB.0000000000000181; Postigo R, 2012, INFECTION, V40, P643, DOI 10.1007/s15010-012-0307-9; Staley C, 2017, AM J GASTROENTEROL, V112, P940, DOI 10.1038/ajg.2017.6; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	26	303	318	3	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1985	1993		10.1001/jama.2017.17077	http://dx.doi.org/10.1001/jama.2017.17077			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183074	Green Published, Bronze			2022-12-28	WOS:000416317600019
J	Lyon, J				Lyon, Jeff			NIH Partners With Drug Makers to Advance Cancer Immunotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1967	1967		10.1001/jama.2017.17931	http://dx.doi.org/10.1001/jama.2017.17931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183056				2022-12-28	WOS:000416317600004
J	Avorn, J				Avorn, Jerry			Engaging With Patients on Health Policy Changes An Urgent Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Avorn, Jerry] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste3030, Boston, MA 02120 USA.	avorn@post.harvard.edu						Bauchner H, 2017, JAMA-J AM MED ASSOC, V317, P29, DOI 10.1001/jama.2016.19687; Mackenbach JP, 2009, J EPIDEMIOL COMMUN H, V63, P181, DOI 10.1136/jech.2008.077032; Sullivan Peter, 2017, HILL; Tavernise S, 2017, NY TIMES, pA11; Whittier JG, MAUD MULLER	5	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					233	234		10.1001/jama.2017.20257	http://dx.doi.org/10.1001/jama.2017.20257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29222542				2022-12-28	WOS:000423022300014
J	Lata, S; Marasa, M; Li, YF; Fasel, DA; Groopman, E; Jobanputra, V; Rasouly, H; Mitrotti, A; Westland, R; Verbitsky, M; Nestor, J; Slater, LM; D'Agati, V; Zaniew, M; Materna-Kiryluk, A; Lugani, F; Caridi, G; Rampoldi, L; Mattoo, A; Newton, CA; Rao, MK; Radhakrishnan, J; Ahn, W; Canetta, PA; Bomback, AS; Appel, GB; Antignac, C; Markowitz, GS; Garcia, CK; Kiryluk, K; Sanna-Cherchi, S; Gharavi, AG				Lata, Sneh; Marasa, Maddalena; Li, Yifu; Fasel, David A.; Groopman, Emily; Jobanputra, Vaidehi; Rasouly, Hila; Mitrotti, Adele; Westland, Rik; Verbitsky, Miguel; Nestor, Jordan; Slater, Lindsey M.; D'Agati, Vivette; Zaniew, Marcin; Materna-Kiryluk, Anna; Lugani, Francesca; Caridi, Gianluca; Rampoldi, Luca; Mattoo, Aditya; Newton, Chad A.; Rao, Maya K.; Radhakrishnan, Jai; Ahn, Wooin; Canetta, Pietro A.; Bomback, Andrew S.; Appel, Gerald B.; Antignac, Corinne; Markowitz, Glen S.; Garcia, Christine K.; Kiryluk, Krzysztof; Sanna-Cherchi, Simone; Gharavi, Ali G.			Whole-Exome Sequencing in Adults With Chronic Kidney Disease A Pilot Study	ANNALS OF INTERNAL MEDICINE			English	Article							POLY(A)-SPECIFIC RIBONUCLEASE PARN; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RESISTANT NEPHROTIC SYNDROME; STAGE RENAL-DISEASE; GENETIC-VARIATION; CONGENITAL-ANOMALIES; MENDELIAN DISORDERS; PULMONARY-FIBROSIS; MEDICAL GENETICS; AMERICAN-COLLEGE	Background: The utility of whole-exome sequencing (WES) for the diagnosis and management of adult-onset constitutional disorders has not been adequately studied. Genetic diagnostics may be advantageous in adults with chronic kidney disease (CKD), in whom the cause of kidney failure often remains unknown. Objective: To study the diagnostic utility of WES in a selected referral population of adults with CKD. Design: Observational cohort. Setting: A major academic medical center. Patients: 92 adults with CKD of unknown cause or familial nephropathy or hypertension. Measurements: The diagnostic yield of WES and its potential effect on clinical management. Results: Whole-exome sequencing provided a diagnosis in 22 of 92 patients (24%), including 9 probands with CKD of unknown cause and encompassing 13 distinct genetic disorders. Among these, loss-of-function mutations were identified in PARN in 2 probands diagnosed respectively with tubulointerstitial fibrosis and CKD of unknown cause. PARN mutations have been implicated in a short telomere syndrome characterized by lung, bone marrow, and liver fibrosis; these findings extend the phenotype of PARN mutations to renal fibrosis. In addition, review of the American College of Medical Genetics actionable genes identified a pathogenic BRCA2 mutation in a proband who was diagnosed with breast cancer on follow-up. The results affected clinical management in most identified cases, including initiation of targeted surveillance, familial screening to guide donor selection for transplantation, and changes in therapy. Limitation: The small sample size and recruitment at a tertiary care academic center limit generalizability of findings among the broader CKD population. Conclusion: Whole-exome sequencing identified diagnostic mutations in a substantial number of adults with CKD of many causes. Further study of the utility of WES in the evaluation and care of patients with CKD in additional settings is warranted.	[Lata, Sneh] Claritas Genom, 99 Erie St, Cambridge, MA 02139 USA; [Marasa, Maddalena; Rao, Maya K.; Radhakrishnan, Jai; Ahn, Wooin; Canetta, Pietro A.; Bomback, Andrew S.; Appel, Gerald B.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, 622 West 168th St, New York, NY 10032 USA; [Fasel, David A.; Rasouly, Hila; Mitrotti, Adele; Westland, Rik; Verbitsky, Miguel; Nestor, Jordan; Kiryluk, Krzysztof; Sanna-Cherchi, Simone; Gharavi, Ali G.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, 1150 St Nicholas Ave, New York, NY 10032 USA; [Jobanputra, Vaidehi] New York Genome Ctr, 101 Ave Amer, New York, NY 10013 USA; [Slater, Lindsey M.] Nephrol Associates, 4923 Ogletown Stanton Rd 200, Newark, DE 19713 USA; [D'Agati, Vivette; Markowitz, Glen S.] Columbia Univ, Coll Phys & Surg, Dept Pathol, Room VC14-224,630 West 168th St, New York, NY 10032 USA; [Zaniew, Marcin] Osiedle Zwyciestwa 5H-27, PL-61644 Poznan, Poland; [Materna-Kiryluk, Anna] Poznan Univ Med Sci, Dept Med Genet, 8 Rokietnicka St, PL-60806 Poznan, Poland; [Lugani, Francesca; Caridi, Gianluca] Ist Giannina Gaslini, Largo G Gaslini 5, I-16148 Genoa, Italy; [Rampoldi, Luca] Ist Sci San Raffaele, Div Genet & Cell Biol, Via Olgettina 58, I-20132 Milan, Italy; [Mattoo, Aditya] NYU, Div Nephrol, 560 1st Ave 251, New York, NY 10016 USA; [Newton, Chad A.] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Div Pulm & Crit Care Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Antignac, Corinne] Imagine Inst, 24 Blvd Montparnasse, F-75015 Paris, France	Columbia University; Columbia University; Columbia University; Poznan University of Medical Sciences; University of Genoa; IRCCS Istituto Giannina Gaslini; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; UDICE-French Research Universities; Universite Paris Cite	Gharavi, AG (corresponding author), Columbia Univ, Div Nephrol, Dept Med, 1150 St Nicholas Ave,Russ Berrie Pavil 413, New York, NY 10032 USA.	ag2239@columbia.edu	ANTIGNAC, Corinne/H-8945-2017; Newton, Chad/AFS-1146-2022; Nestor, Jordan Gabriela/AAX-7362-2021; Caridi, Gianluca/F-7052-2010; Rampoldi, Luca/AAN-6228-2020	ANTIGNAC, Corinne/0000-0002-9934-4940; Caridi, Gianluca/0000-0001-6700-3001; Rampoldi, Luca/0000-0002-0544-7042; Nestor, Jordan/0000-0003-1418-3103; Canetta, Pietro/0000-0003-1130-5486; LI, YIFU/0000-0002-7077-7689; Newton, Chad/0000-0001-5256-9029; Milo Rasouly, Hila/0000-0002-0770-2190; Westland, Rik/0000-0003-4960-4078	New York State Empire Clinical Research Investigator Program; Renal Research Institute; National Human Genome Research Institute of the National Institutes of Health [U01HG008680]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [1R01DK103184]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK108741, R01DK103184] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009223] Funding Source: NIH RePORTER	New York State Empire Clinical Research Investigator Program; Renal Research Institute; National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	By a New York State Empire Clinical Research Investigator Program grant, a research grant from the Renal Research Institute, and grant U01HG008680 from the National Human Genome Research Institute of the National Institutes of Health. Dr. Sanna-Cherchi is supported by grant 1R01DK103184 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bekheirnia MR, 2017, GENET MED, V19, P412, DOI 10.1038/gim.2016.131; Bierzynska A, 2017, KIDNEY INT, V91, P937, DOI 10.1016/j.kint.2016.10.013; Bowdin S, 2016, GENET MED, V18, P1075, DOI 10.1038/gim.2016.17; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Deltas C, 2015, NEPHRON, V130, P271, DOI 10.1159/000435789; Dhanraj S, 2015, J MED GENET, V52, P738, DOI 10.1136/jmedgenet-2015-103292; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Freedman BI, 1999, AM J KIDNEY DIS, V34, P254, DOI 10.1016/S0272-6386(99)70352-5; Freedman BI, 1997, AM J KIDNEY DIS, V29, P729, DOI 10.1016/S0272-6386(97)90126-8; Gast C, 2016, NEPHROL DIAL TRANSPL, V31, P961, DOI 10.1093/ndt/gfv325; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Green RC, 2016, AM J HUM GENET, V99, P246, DOI 10.1016/j.ajhg.2016.06.002; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Katsanis SH, 2013, NAT REV GENET, V14, P415, DOI 10.1038/nrg3493; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kropski JA, 2017, AM J RESP CRIT CARE, V196, P1481, DOI 10.1164/rccm.201703-0635LE; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lata S, 2018, ANN INTERN MED, V168, P100, DOI 10.7326/M17-1319; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lovric S, 2014, CLIN J AM SOC NEPHRO, V9, P1109, DOI 10.2215/CJN.09010813; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; Moon DH, 2015, NAT GENET, V47, P1482, DOI 10.1038/ng.3423; Newton CA, 2016, EUR RESPIR J, V48, P1710, DOI 10.1183/13993003.00308-2016; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Petrovski S, 2017, AM J RESP CRIT CARE, V196, P82, DOI [10.1164/rccm.201610-2088OC, 10.1164/rccm.201610-2088oc]; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Savage SA, 1993, GENEREVIEWS; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sifrim A, 2016, NAT GENET, V48, P1060, DOI 10.1038/ng.3627; Skrunes R, 2014, CLIN J AM SOC NEPHRO, V9, P1692, DOI 10.2215/CJN.01680214; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; US Renal Data System, 2016, USRDS 2016 ANN DAT R; Vassy JL, 2017, ANN INTERN MED, V167, P159, DOI 10.7326/M17-0188; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	55	109	110	2	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					100	+		10.7326/M17-1319	http://dx.doi.org/10.7326/M17-1319			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29204651	Green Accepted			2022-12-28	WOS:000424096600014
J	Barnett, ML; Gray, J; Zink, A; Jena, AB				Barnett, Michael L.; Gray, Josh; Zink, Anna; Jena, Anupam B.			Coupling Policymaking with Evaluation - The Case of the Opioid Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RATES		[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gray, Josh] athenahealth, Watertown, MA USA; [Zink, Anna] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; National Bureau of Economic Research	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Barnett, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.		Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609				Buchmueller TC, 2017, EFFECT PRESCRIPTION; Larochelle MR, 2015, JAMA INTERN MED, V175, P978, DOI 10.1001/jamainternmed.2015.0914; Meara E, 2016, NEW ENGL J MED, V375, P44, DOI 10.1056/NEJMsa1514387; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Sacarny A, 2016, HEALTH AFFAIR, V35, P471, DOI 10.1377/hlthaff.2015.1025	5	30	31	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2306	2309		10.1056/NEJMp1710014	http://dx.doi.org/10.1056/NEJMp1710014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP8VG	29236636	Bronze			2022-12-28	WOS:000417923600002
J	Puram, SV; Tirosh, I; Parikh, AS; Patel, AP; Yizhak, K; Gillespie, S; Rodman, C; Luo, CL; Mroz, EA; Emerick, KS; Deschler, DG; Varvares, MA; Mylvaganam, R; Rozenblatt-Rosen, O; Rocco, JW; Faquin, WC; Lin, DT; Regev, A; Bernstein, BE				Puram, Sidharth V.; Tirosh, Itay; Parikh, Anuraag S.; Patel, Anoop P.; Yizhak, Keren; Gillespie, Shawn; Rodman, Christopher; Luo, Christina L.; Mroz, Edmund A.; Emerick, Kevin S.; Deschler, Daniel G.; Varvares, Mark A.; Mylvaganam, Ravi; Rozenblatt-Rosen, Orit; Rocco, James W.; Faquin, William C.; Lin, Derrick T.; Regev, Aviv; Bernstein, Bradley E.			Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DNA-SEQUENCING DATA; RNA-SEQ; CARCINOMA; HETEROGENEITY; FRAMEWORK; GENOME; GLIOBLASTOMA; EXPRESSION; PLASTICITY	The diverse malignant, stromal, and immune cells in tumors affect growth, metastasis, and response to therapy. We profiled transcriptomes of similar to 6,000 single cells from 18 head and neck squamous cell carcinoma (HNSCC) patients, including five matched pairs of primary tumors and lymph node metastases. Stromal and immune cells had consistent expression programs across patients. Conversely, malignant cells varied within and between tumors in their expression of signatures related to cell cycle, stress, hypoxia, epithelial differentiation, and partial epithelial-to-mesenchymal transition (p-EMT). Cells expressing the p-EMT program spatially localized to the leading edge of primary tumors. By integrating single-cell transcriptomes with bulk expression profiles for hundreds of tumors, we refined HNSCC sub-types by their malignant and stromal composition and established p-EMT as an independent predictor of nodal metastasis, grade, and adverse pathologic features. Our results provide insight into the HNSCC ecosystem and define stromal interactions and a p-EMT program associated with metastasis.	[Puram, Sidharth V.; Parikh, Anuraag S.; Patel, Anoop P.; Yizhak, Keren; Gillespie, Shawn; Luo, Christina L.; Mylvaganam, Ravi; Faquin, William C.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Puram, Sidharth V.; Parikh, Anuraag S.; Patel, Anoop P.; Yizhak, Keren; Gillespie, Shawn; Luo, Christina L.; Mylvaganam, Ravi; Faquin, William C.; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02114 USA; [Puram, Sidharth V.; Tirosh, Itay; Parikh, Anuraag S.; Patel, Anoop P.; Yizhak, Keren; Gillespie, Shawn; Rodman, Christopher; Rozenblatt-Rosen, Orit; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Puram, Sidharth V.; Parikh, Anuraag S.; Mroz, Edmund A.; Emerick, Kevin S.; Deschler, Daniel G.; Varvares, Mark A.; Rocco, James W.; Lin, Derrick T.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Puram, Sidharth V.; Parikh, Anuraag S.; Emerick, Kevin S.; Deschler, Daniel G.; Varvares, Mark A.; Rocco, James W.; Lin, Derrick T.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA; [Tirosh, Itay] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Patel, Anoop P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Rocco, James W.] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA; [Regev, Aviv] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Koch Inst, Cambridge, MA 02142 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; University System of Ohio; Ohio State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Tirosh, I; Regev, A; Bernstein, BE (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Lin, DT (corresponding author), Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.; Lin, DT (corresponding author), Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA.; Tirosh, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.; Regev, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Koch Inst, Cambridge, MA 02142 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	itay.tirosh@weizmann.ac.il; derrick_lin@meei.harvard.edu; aregev@broadinstitute.org; bernstein.bradley@mgh.harvard.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022	Deschler-Baier, Barbara/0000-0001-5831-5150; Mroz, Edmund/0000-0002-1014-7853	American Academy of Otolaryngology Resident Grant; New England Otolaryngology Society Resident Grant; Human Frontiers Science Program; NRSA; Massachusetts Eye and Ear Infirmary; National Cancer Institute; NIH Common Fund; Broad Institute; Klarman Cell Observatory; Starr Foundation; Ludwig Center; NIH; NATIONAL CANCER INSTITUTE [DP1CA216873, P30CA016058, R33CA202820, P30CA014051, U24CA180922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022087] Funding Source: NIH RePORTER	American Academy of Otolaryngology Resident Grant; New England Otolaryngology Society Resident Grant; Human Frontiers Science Program(Human Frontier Science Program); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Eye and Ear Infirmary; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Klarman Cell Observatory; Starr Foundation; Ludwig Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank P. van Galen and members of the Bernstein and Regev laboratories for critical review of the manuscript. We also thank H. Ravichandran, P. Della Pelle, N. Hayes, and K. Hoadley for technical assistance. This research was supported by an American Academy of Otolaryngology Resident Grant (S.V.P.), a New England Otolaryngology Society Resident Grant (S.V.P.), the Human Frontiers Science Program (I.T.), a NRSA T32 Training Grant (A.S.P.), the Massachusetts Eye and Ear Infirmary, the National Cancer Institute, the NIH Common Fund, the Broad Institute, the Klarman Cell Observatory, the Starr Foundation, the Ludwig Center, and an NIH Shared Instrumentation grant for cytometry. B.E.B. is the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and an American Cancer Society Research Professor. A.R. is a Howard Hughes Medical Institute Investigator. S.V.P., I.T., A.S.P., D.T.L., A.R., and B.E.B. are co-inventors on United States provisional patent application no. 62/484,709 relating to advances described in this manuscript filed by the Broad Institute. A.R. is a member of the scientific advisory board for ThermoFisher Scientific, Syros Pharmaceuticals, and Driver Group. B.E.B is an advisor and equity holder for HiFiBio and 1CellBio.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bacher R, 2017, NAT METHODS, V14, P584, DOI 10.1038/nmeth.4263; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Colella S, 2008, HEAD NECK-J SCI SPEC, V30, P1273, DOI 10.1002/hed.20871; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kim KT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0945-9; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Lundgren K, 2009, BRIT J CANCER, V101, P1769, DOI 10.1038/sj.bjc.6605369; Madar S, 2013, TRENDS MOL MED, V19, P447, DOI 10.1016/j.molmed.2013.05.004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Monroe MM, 2012, OTOLARYNG CLIN N AM, V45, P1181, DOI 10.1016/j.otc.2012.06.016; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Muller S, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166969; Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Puram SV, 2015, HEMATOL ONCOL CLIN N, V29, P971, DOI 10.1016/j.hoc.2015.07.003; Puram SV, 2012, J NEUROSCI, V32, P7806, DOI 10.1523/JNEUROSCI.3243-11.2012; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Ranieri D, 2016, ONCOTARGET, V7, P5440, DOI 10.18632/oncotarget.6706; Rockey DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077166; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ting DT, 2014, CELL REP, V8, P1905, DOI 10.1016/j.celrep.2014.08.029; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Dijk D., 2017, BIORXIV, DOI [10.1101/111591, DOI 10.1101/111591]; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinberg RA, 2014, CELL, V157, P267, DOI 10.1016/j.cell.2014.03.004; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	52	943	967	28	202	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1611	+		10.1016/j.cell.2017.10.044	http://dx.doi.org/10.1016/j.cell.2017.10.044			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29198524	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000418044000017
J	Truong, DM; Boeke, JD				Truong, David M.; Boeke, Jef D.			Resetting the Yeast Epigenome with Human Nucleosomes	CELL			English	Article							HISTONE VARIANT H3.3; CHROMATIN-STRUCTURE; GENE-EXPRESSION; GENOMIC INSTABILITY; PHO5 PROMOTER; TRANSCRIPTION; REVEALS; COMPLEX; DNA; RESIDUES	Humans and yeast are separated by a billion years of evolution, yet their conserved histones retain central roles in gene regulation. Here, we "reset'' yeast to use core human nucleosomes in lieu of their own (a rare event taking 20 days), which initially only worked with variant H3.1. The cells adapt by acquiring suppressor mutations in cell-division genes or by acquiring certain aneuploid states. Converting five histone residues to their yeast counterparts restored robust growth. We reveal that humanized nucleosomes are positioned according to endogenous yeast DNA sequence and chromatin-remodeling network, as judged by a yeast-like nucleosome repeat length. However, human nucleosomes have higher DNA occupancy, globally reduce RNA content, and slow adaptation to new conditions by delaying chromatin remodeling. These humanized yeasts (including H3.3) pose fundamental new questions about how chromatin is linked to many cell processes and provide a platform to study histone variants via yeast epigenome reprogramming.	[Truong, David M.; Boeke, Jef D.] NYU Langone Hlth, Inst Syst Genet, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	NYU Langone Medical Center	Truong, DM; Boeke, JD (corresponding author), NYU Langone Hlth, Inst Syst Genet, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	davemtruong@gmail.com; jef.boeke@nyumc.org		Boeke, Jef/0000-0001-5322-4946; Truong, David/0000-0002-5121-5111	NIH (NIGMS) [F32GM116411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM116411] Funding Source: NIH RePORTER	NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Junbiao Dai for plasmids and strains and Michael Shen for the Gal1-EGFP plasmid. We thank Leslie Mitchell, Liam Holt, and Karim-Jean Armache for comments on the manuscript. This work was supported by NIH (NIGMS) fellowship F32GM116411 to D.M.T. J.D.B. is a founder and director of Neochromosome and serves as a scientific adviser to Modern Meadow, Recombinetics, and Sample6. These arrangements are reviewed and managed by the committee on conflict of interest at NYULMC. The topic of this paper is the subject of a patent application.	Acker J, 2013, BBA-GENE REGUL MECH, V1829, P283, DOI 10.1016/j.bbagrm.2012.10.002; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Budhavarapu VN, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-32; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Campos EI, 2014, TRENDS CELL BIOL, V24, P664, DOI 10.1016/j.tcb.2014.08.004; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Deaton AM, 2016, ELIFE, V5, DOI 10.7554/eLife.15316; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; El Hage A, 2013, METHODS MOL BIOL, V1054, P195, DOI 10.1007/978-1-62703-565-1_13; Eriksson PR, 2012, GENETICS, V191, P7, DOI 10.1534/genetics.112.140145; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Hamza A, 2015, GENETICS, V201, P1263, DOI 10.1534/genetics.115.181099; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Hyland EM, 2011, GENE DEV, V25, P1306, DOI 10.1101/gad.2050311; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Laurent JM, 2016, BRIEF FUNCT GENOMICS, V15, P155, DOI 10.1093/bfgp/elv041; LEE KP, 1982, CAN J BIOCHEM CELL B, V60, P379, DOI 10.1139/o82-045; LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Macadangdang BR, 2014, ELIFE, V3, DOI 10.7554/eLife.02792; McBurney KL, 2016, GENETICS, V202, P341, DOI 10.1534/genetics.115.180810; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mitchell LA, 2015, JOVE-J VIS EXP, DOI 10.3791/52941; Musladin S, 2014, NUCLEIC ACIDS RES, V42, P4270, DOI 10.1093/nar/gkt1395; Nagai S, 2017, P NATL ACAD SCI USA, V114, P1536, DOI 10.1073/pnas.1620312114; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Osborn Michael J., 2007, Briefings in Functional Genomics & Proteomics, V6, P104, DOI 10.1093/bfgp/elm017; Panday A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0062-8; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Santenard A, 2009, EPIGENETICS-US, V4, P80, DOI 10.4161/epi.4.2.7838; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Small EC, 2014, P NATL ACAD SCI USA, V111, pE2462, DOI 10.1073/pnas.1400517111; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	58	25	25	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1508	+		10.1016/j.cell.2017.10.043	http://dx.doi.org/10.1016/j.cell.2017.10.043			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29198523	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000418044000009
J	Wang, HN; Gao, HW; Chi, HB; Zeng, L; Xiao, WH; Wang, YR; Li, R; Liu, P; Wang, C; Tian, Q; Zhou, ZH; Yang, J; Liu, Y; Wei, R; Mol, BJ; Hong, TP; Qiao, J				Wang, Haining; Gao, Hongwei; Chi, Hongbin; Zeng, Lin; Xiao, Wenhua; Wang, Yanrong; Li, Rong; Liu, Ping; Wang, Chen; Tian, Qing; Zhou, Zehong; Yang, Jin; Liu, Ye; Wei, Rui; Mol, Ben Willem J.; Hong, Tianpei; Qiao, Jie			Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED REPRODUCTION TECHNOLOGIES; ANTIBODY-POSITIVE WOMEN; EUTHYROID WOMEN; SUBCLINICAL HYPOTHYROIDISM; PREGNANT-WOMEN; RECURRENT MISCARRIAGE; DISEASE; METAANALYSIS; TSH; ASSOCIATION	IMPORTANCE Presence of thyroid autoantibodies in women with normal thyroid function is associated with increased risk of miscarriage. Whether levothyroxine treatment improves pregnancy outcomes among women undergoing in vitro fertilization and embryo transfer (IVF-ET) is unknown. OBJECTIVE To determine the effect of levothyroxine on miscarriage among women undergoing IVF-ET who had normal thyroid function and tested positive for thyroid autoantibodies. DESIGN, SETTING, AND PARTICIPANTS An open-label, randomized clinical trial involving 600 women who tested positive for the antithyroperoxidase antibody and were being treated for infertility at Peking University Third Hospital from September 2012 to March 2017. INTERVENTIONS The intervention group (n = 300) received either a 25-mu g/d or 50-mu g/d dose of levothyroxine at study initiation that was titrated according to the level of thyroid-stimulating hormone during pregnancy. The women in the control group (n = 300) did not receive levothyroxine. All participants received the same IVF-ET and follow-up protocols. MAIN OUTCOMES AND MEASURES The primary outcome was the miscarriage rate (pregnancy loss before 28 weeks of gestation, which was calculated among women who became pregnant). The secondary outcomes were clinical intrauterine pregnancy rate (fetal cardiac activity seen at sonography observation on the 30th day after the embryo transfer), and live-birth rate (at least 1 live birth after 28 weeks of gestation). RESULTS Among the 600 women (mean [SD] age, 31.6 [3.8] years) randomized in this trial, 567 women (94.5%) underwent IVF-ET and 565 (94.2%) completed the study. Miscarriage rates were 10.3%(11 of 107) in the intervention group and 10.6%(12 of 113) in the control group, with the absolute rate difference (RD) of -0.34%(95% CI, -8.65% to 8.12%) over the 4.5-year study period. Clinical intrauterine pregnancy rates were 35.7%(107 of 300) in the intervention group and 37.7%(113 of 300) in the control group, with an absolute RD of -2.00% (95% CI, -9.65% to 5.69%). Live-birth rates were 31.7%(95 of 300) in the intervention group and 32.3%(97 of 300) in the control group, with an absolute RD of -0.67%(95% CI, -8.09% to 6.77%). CONCLUSIONS AND RELEVANCE Among women in China who had intact thyroid function and tested positive for antithyroperoxidase antibodies and were undergoing IVF-ET, treatment with levothyroxine, compared with no levothyroxine treatment, did not reduce miscarriage rates or increase live-birth rates.	[Wang, Haining; Gao, Hongwei; Chi, Hongbin; Xiao, Wenhua; Wang, Yanrong; Li, Rong; Liu, Ping; Wang, Chen; Tian, Qing; Zhou, Zehong; Yang, Jin; Liu, Ye; Wei, Rui; Hong, Tianpei; Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med, Dept Endocrinol & Metab, Beijing, Peoples R China; [Zeng, Lin] Peking Univ, Hosp 3, Clin Epidemiol Res Ctr, Beijing, Peoples R China; [Mol, Ben Willem J.] Univ Adelaide, Sch Pediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Mol, Ben Willem J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Peking University; Peking University; Robinson Research Institute; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Qiao, J (corresponding author), Peking Univ, Hosp 3, Ctr Reprod Med, 49 N Garden Rd, Beijing 100191, Peoples R China.; Hong, TP (corresponding author), Peking Univ, Hosp 3, Dept Endocrinol & Metab, 49 N Garden Rd, Beijing 100191, Peoples R China.	tpho66@bjmu.edu.cn; jie.qiao@263.net	Zeng, Lin/AEQ-2252-2022	Qiao, Jie/0000-0003-2126-1376; Wei, Rui/0000-0002-8838-703X; Hong, Tianpei/0000-0002-5744-5129	National Key Technology R&D Program from the Ministry of Science and Technology of China [2015BAI13B06]; Chinese National 973 Program from the Ministry of Science and Technology of China [2012CB517502]	National Key Technology R&D Program from the Ministry of Science and Technology of China(National Key Technology R&D Program); Chinese National 973 Program from the Ministry of Science and Technology of China	This study was supported by grants 2015BAI13B06 from the National Key Technology R&D Program and 2012CB517502 and from the Chinese National 973 Program, both from the Ministry of Science and Technology of China.	Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; BROMWICH P, 1987, BRIT MED J, V294, P527, DOI 10.1136/bmj.294.6571.527; Busnelli A, 2016, HUM REPROD UPDATE, V22, P775, DOI 10.1093/humupd/dmw019; Bussen S, 2000, HUM REPROD, V15, P545, DOI 10.1093/humrep/15.3.545; Chen LL, 2011, CLIN ENDOCRINOL, V74, P513, DOI 10.1111/j.1365-2265.2010.03974.x; Chi HB, 2010, REPROD BIOMED ONLINE, V20, P504, DOI 10.1016/j.rbmo.2010.01.005; Colicchia M, 2014, HUM REPROD UPDATE, V20, P884, DOI 10.1093/humupd/dmu028; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; El Hachem H, 2017, INT J WOMENS HEALTH, V9, P331, DOI 10.2147/IJWH.S100817; Geva E, 1996, HUM REPROD, V11, P1627; Gingold JA, 2016, GYNECOL ENDOCRINOL, V32, P973, DOI 10.1080/09513590.2016.1200553; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Green KA, 2015, J ASSIST REPROD GEN, V32, P1469, DOI 10.1007/s10815-015-0549-4; Guan HX, 2008, CLIN ENDOCRINOL, V69, P136, DOI 10.1111/j.1365-2265.2007.03150.x; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kutteh WH, 1999, HUM REPROD, V14, P2886, DOI 10.1093/humrep/14.11.2886; Maraka S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6865; Medenica S, 2015, EUR REV MED PHARMACO, V19, P977; Nazarpour S, 2017, EUR J ENDOCRINOL, V176, P253, DOI 10.1530/EJE-16-0548; Negro R, 2007, J ENDOCRINOL INVEST, V30, P3, DOI 10.1007/BF03347388; Negro R, 2005, HUM REPROD, V20, P1529, DOI 10.1093/humrep/deh843; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2016, J CLIN ENDOCR METAB, V101, P3685, DOI 10.1210/jc.2016-1803; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pfeifer S, 2015, FERTIL STERIL, V104, P545, DOI 10.1016/j.fertnstert.2015.05.028; Poppe K, 2003, J CLIN ENDOCR METAB, V88, P4149, DOI 10.1210/jc.2003-030268; Poppe K, 2008, NAT CLIN PRACT ENDOC, V4, P394, DOI 10.1038/ncpendmet0846; Promberger R, 2017, IRAN J ALLERGY ASTHM, V16, P72; Rahman AHA, 2010, ENDOCR PRACT, V16, P792, DOI 10.4158/EP09365.OR; Stagnaro-Green A, 2004, BEST PRACT RES CL EN, V18, P167, DOI 10.1016/j.beem.2004.03.007; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Thangaratinam S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2616; Toulis KA, 2010, EUR J ENDOCRINOL, V162, P643, DOI 10.1530/EJE-09-0850; Velkeniers B, 2013, HUM REPROD UPDATE, V19, P251, DOI 10.1093/humupd/dms052; Vissenberg R, 2015, CONTEMP CLIN TRIALS, V44, P134, DOI 10.1016/j.cct.2015.08.005; Vissenberg R, 2015, HUM REPROD UPDATE, V21, P378, DOI 10.1093/humupd/dmv004; Wu Z, 2012, REPROD BIOMED ONLINE, V24, P511, DOI 10.1016/j.rbmo.2012.02.003	38	104	121	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2190	2198		10.1001/jama.2017.18249	http://dx.doi.org/10.1001/jama.2017.18249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234808	Bronze			2022-12-28	WOS:000417822700017
J	[Anonymous]				[Anonymous]			The Banana Again	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1912, J A M A         0127, P276; Pease MC, 1917, AM J DIS CHILD, V14, P379	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2261	2261		10.1001/jama.2017.10498	http://dx.doi.org/10.1001/jama.2017.10498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234796				2022-12-28	WOS:000417822700032
J	Liang, Q; Strahan, SE; Fleming, EL				Liang, Qing; Strahan, Susan E.; Fleming, Eric L.			Concerns for ozone recovery Climate change mitigation and compliance with the Montreal Protocol are crucial for ozone layer recovery	SCIENCE			English	Editorial Material							STRATOSPHERIC OZONE; DICHLOROMETHANE; EMISSIONS; TRANSPORT; THREAT		[Liang, Qing; Strahan, Susan E.; Fleming, Eric L.] NASA, Goddard Space Flight Ctr, Atmospher Chem & Dynam Lab, Greenbelt, MD 20771 USA; [Liang, Qing; Strahan, Susan E.] Univ Space Res Assoc, GESTAR, Columbia, MD 21046 USA; [Fleming, Eric L.] Sci Syst & Applicat Inc, Lanham, MD USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); Science Systems and Applications Inc	Liang, Q (corresponding author), NASA, Goddard Space Flight Ctr, Atmospher Chem & Dynam Lab, Greenbelt, MD 20771 USA.; Liang, Q (corresponding author), Univ Space Res Assoc, GESTAR, Columbia, MD 21046 USA.	qing.liang-1@nasa.gov	Strahan, Susan E/H-1965-2012; , Qing/GPX-8988-2022; Liang, Qing/B-1276-2011	Strahan, Susan E/0000-0002-7511-4577; , Qing/0000-0002-8430-0515; Liang, Qing/0000-0002-8430-0515				Carpenter L. J., 2014, SCI ASSESSMENT OZONE; Chipperfield MP, 2017, NATURE, V549, P211, DOI 10.1038/nature23681; Elvidge ECL, 2015, ATMOS CHEM PHYS, V15, P1939, DOI 10.5194/acp-15-1939-2015; Hossaini R, 2016, ATMOS CHEM PHYS, V16, P9163, DOI 10.5194/acp-16-9163-2016; Hossaini R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15962; Liang Q, 2014, ATMOS CHEM PHYS, V14, P5781, DOI 10.5194/acp-14-5781-2014; Liang Q., 2016, 7 SPARC; Newman PA, 2007, ATMOS CHEM PHYS, V7, P4537, DOI 10.5194/acp-7-4537-2007; Oram DE, 2017, ATMOS CHEM PHYS, V17, P11929, DOI 10.5194/acp-17-11929-2017; Tegtmeier S, 2015, ATMOS CHEM PHYS, V15, P13647, DOI 10.5194/acp-15-13647-2015; World Meteorological Organization/UNEP, 2011, SCI ASS OZ DEPL 2010; Yvon-Lewis SA, 2009, ATMOS CHEM PHYS, V9, P5963, DOI 10.5194/acp-9-5963-2009	12	13	13	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1257	1258		10.1126/science.aaq0145	http://dx.doi.org/10.1126/science.aaq0145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217558				2022-12-28	WOS:000417254700040
J	Marcus, DM				Marcus, Donald M.			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter									[Marcus, Donald M.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Marcus, DM (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.							Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Greenfield S, 2017, JAMA-J AM MED ASSOC, V317, P594, DOI 10.1001/jama.2016.19969; Marcus DM, 2010, RHEUMATOLOGIST, V4, P28; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					832	832		10.7326/L17-0469	http://dx.doi.org/10.7326/L17-0469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204610				2022-12-28	WOS:000417135900019
J	Klaeger, S; Heinzlmeir, S; Wilhelm, M; Polzer, H; Vick, B; Koenig, PA; Reinecke, M; Ruprecht, B; Petzoldt, S; Meng, C; Zecha, J; Reiter, K; Qiao, HC; Helm, D; Koch, H; Schoof, M; Canevari, G; Casale, E; Depaolini, SR; Feuchtinger, A; Wu, ZX; Schmidt, T; Rueckert, L; Becker, W; Huenges, J; Garz, AK; Gohlke, BO; Zolg, DP; Kayser, G; Vooder, T; Preissner, R; Hahne, H; Tonisson, N; Kramer, K; Gotze, K; Bassermann, F; Schlegl, J; Ehrlich, HC; Aiche, S; Walch, A; Greif, PA; Schneider, S; Felder, ER; Ruland, J; Medard, G; Jeremias, I; Spiekermann, K; Kuster, B				Klaeger, Susan; Heinzlmeir, Stephanie; Wilhelm, Mathias; Polzer, Harald; Vick, Binje; Koenig, Paul-Albert; Reinecke, Maria; Ruprecht, Benjamin; Petzoldt, Svenja; Meng, Chen; Zecha, Jana; Reiter, Katrin; Qiao, Huichao; Helm, Dominic; Koch, Heiner; Schoof, Melanie; Canevari, Giulia; Casale, Elena; Depaolini, Stefania Re; Feuchtinger, Annette; Wu, Zhixiang; Schmidt, Tobias; Rueckert, Lars; Becker, Wilhelm; Huenges, Jan; Garz, Anne-Kathrin; Gohlke, Bjoern-Oliver; Zolg, Daniel Paul; Kayser, Gian; Vooder, Tonu; Preissner, Robert; Hahne, Hannes; Tonisson, Neeme; Kramer, Karl; Goetze, Katharina; Bassermann, Florian; Schlegl, Judith; Ehrlich, Hans-Christian; Aiche, Stephan; Walch, Axel; Greif, Philipp A.; Schneider, Sabine; Felder, Eduard Rudolf; Ruland, Juergen; Medard, Guillaume; Jeremias, Irmela; Spiekermann, Karsten; Kuster, Bernhard			The target landscape of clinical kinase drugs	SCIENCE			English	Article							INTEGRATIVE GENOMICS VIEWER; SALT-INDUCIBLE KINASES; CHEMICAL PROTEOMICS; INHIBITOR SELECTIVITY; COMPREHENSIVE ANALYSIS; DATA QUALITY; PROTEIN; QUANTIFICATION; REFINEMENT; CANCER	Kinase inhibitors are important cancer therapeutics. Polypharmacology is commonly observed, requiring thorough target deconvolution to understand drug mechanism of action. Using chemical proteomics, we analyzed the target spectrum of 243 clinically evaluated kinase drugs. The data revealed previously unknown targets for established drugs, offered a perspective on the "druggable" kinome, highlighted (non)kinase off-targets, and suggested potential therapeutic applications. Integration of phosphoproteomic data refined drug-affected pathways, identified response markers, and strengthened rationale for combination treatments. We exemplify translational value by discovering SIK2 (salt-inducible kinase 2) inhibitors that modulate cytokine production in primary cells, by identifying drugs against the lung cancer survival marker MELK (maternal embryonic leucine zipper kinase), and by repurposing cabozantinib to treat FLT3-ITD-positive acute myeloid leukemia. This resource, available via the ProteomicsDB database, should facilitate basic, clinical, and drug discovery research and aid clinical decision-making.	[Klaeger, Susan; Heinzlmeir, Stephanie; Wilhelm, Mathias; Reinecke, Maria; Ruprecht, Benjamin; Petzoldt, Svenja; Meng, Chen; Zecha, Jana; Qiao, Huichao; Helm, Dominic; Koch, Heiner; Schoof, Melanie; Wu, Zhixiang; Schmidt, Tobias; Zolg, Daniel Paul; Hahne, Hannes; Kramer, Karl; Medard, Guillaume; Kuster, Bernhard] TUM, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [Klaeger, Susan; Heinzlmeir, Stephanie; Polzer, Harald; Vick, Binje; Reinecke, Maria; Petzoldt, Svenja; Zecha, Jana; Reiter, Katrin; Koch, Heiner; Garz, Anne-Kathrin; Gohlke, Bjoern-Oliver; Preissner, Robert; Goetze, Katharina; Bassermann, Florian; Greif, Philipp A.; Ruland, Juergen; Jeremias, Irmela; Spiekermann, Karsten; Kuster, Bernhard] German Canc Consortium DKTK, Heidelberg, Germany; [Klaeger, Susan; Heinzlmeir, Stephanie; Polzer, Harald; Vick, Binje; Reinecke, Maria; Petzoldt, Svenja; Zecha, Jana; Reiter, Katrin; Koch, Heiner; Garz, Anne-Kathrin; Gohlke, Bjoern-Oliver; Preissner, Robert; Goetze, Katharina; Bassermann, Florian; Greif, Philipp A.; Ruland, Juergen; Spiekermann, Karsten; Kuster, Bernhard] German Canc Res Ctr, Heidelberg, Germany; [Polzer, Harald; Reiter, Katrin; Greif, Philipp A.; Spiekermann, Karsten] Ludwig Maximilians Univ LMU Munchen, Univ Hosp, Dept Internal Med 3, Munich, Germany; [Vick, Binje; Jeremias, Irmela] German Ctr Environm Hlth HMGU, Helmholtz Ctr Munich, Dept Apoptosis Hematopoiet Stem Cells, Munich, Germany; [Koenig, Paul-Albert; Ruland, Juergen] TUM, Inst Klin Chem & Pathobiochem, Munich, Germany; [Canevari, Giulia; Casale, Elena; Depaolini, Stefania Re; Felder, Eduard Rudolf] Nerviano Med Sci Srl, Oncol, Milan, Italy; [Feuchtinger, Annette; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany; [Rueckert, Lars; Becker, Wilhelm; Huenges, Jan; Ehrlich, Hans-Christian; Aiche, Stephan] SAP SE, Potsdam, Germany; [Garz, Anne-Kathrin; Goetze, Katharina; Bassermann, Florian] TUM, Klinikum Rechts Isar, Dept Med 3, Munich, Germany; [Gohlke, Bjoern-Oliver; Preissner, Robert] Charite, Struct Bioinformat Grp, Berlin, Germany; [Kayser, Gian] Univ Freiburg, Univ Med Ctr Freiburg, Inst Surg Pathol, Fac Med, Freiburg, Germany; [Vooder, Tonu] Ctr Thorac Surg, Krefeld, Germany; [Vooder, Tonu; Tonisson, Neeme] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Vooder, Tonu; Tonisson, Neeme] Tartu Univ Hosp, Tartu, Estonia; [Schlegl, Judith] SAP SE, Walldorf, Germany; [Schneider, Sabine] TUM, Dept Chem, Garching, Germany; [Schneider, Sabine; Kuster, Bernhard] CIPSM, Munich, Germany; [Jeremias, Irmela] LMU, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Kuster, Bernhard] TUM, Bavarian Biomol Mass Spectrometry Ctr BayBioMS, Freising Weihenstephan, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Nerviano Medical Sciences S.r.l; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; University of Tartu; Technical University of Munich; University of Munich; Technical University of Munich	Kuster, B (corresponding author), TUM, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany.; Kuster, B (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.; Kuster, B (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Kuster, B (corresponding author), CIPSM, Munich, Germany.; Kuster, B (corresponding author), TUM, Bavarian Biomol Mass Spectrometry Ctr BayBioMS, Freising Weihenstephan, Germany.	kuster@tum.de	Meng, Chen/AAV-1140-2020; Jeremias, Irmela/Q-5934-2019; Feuchtinger, Annette/O-4569-2014; Schneider, Sabine/G-2908-2013; Koenig, Paul-Albert/AAH-1595-2021; Walch, Axel/B-4554-2012; Médard, Guillaume/HGC-8366-2022; Ruland, Jürgen/Q-6680-2018	Meng, Chen/0000-0002-5968-6719; Jeremias, Irmela/0000-0003-1773-7677; Schneider, Sabine/0000-0003-1054-8689; Koenig, Paul-Albert/0000-0001-5995-2557; Walch, Axel/0000-0001-5578-4023; Médard, Guillaume/0000-0002-4782-4029; Ruland, Jürgen/0000-0002-8381-3597; preissner, robert/0000-0002-2407-1087; Aiche, Stephan/0000-0001-9601-8229; Heinzlmeir, Stephanie/0000-0002-1066-6565; Klaeger, Susan/0000-0002-0074-5163; Wilhelm, Mathias/0000-0002-9224-3258; Wiechmann (Petzoldt), Svenja/0000-0003-1324-0743; Greif, Philipp/0000-0002-3744-7936; Schoof, Melanie/0000-0002-1373-8130; Schmidt, Tobias/0000-0002-1883-6514; Helm, Dominic/0000-0001-9321-2069; Gohlke, Bjoern/0000-0003-3094-1031; Vick, Binje/0000-0003-1956-2778; Zecha, Jana/0000-0002-8767-6294; Zolg, Daniel Paul/0000-0002-1692-6102	Bundesministerium EP-Bildung and Forschung (BMBF) [03110008A-ProteomeTools]; Deutsche Forschungsgemeinschaft (DFG) [SFB 824 TP Z02]; BMBF [01ZX1310B.01KT16015]; Deutsche Krebshilfe [70112617]; European Research Council (ERC) Advanced Grant [322865]; DFG [SIB1243]; Estonian Research Council [IUT60-20, PUT/36]; ERC Consolidator Grant [681524]; CLerthan Research Foundation [Collaborative Research Center 1243]; German Cancer Aid	Bundesministerium EP-Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); European Research Council (ERC) Advanced Grant(European Research Council (ERC)); DFG(German Research Foundation (DFG)); Estonian Research Council(Estonian Research Council); ERC Consolidator Grant(European Research Council (ERC)); CLerthan Research Foundation; German Cancer Aid(Deutsche Krebshilfe)	The data reported here are tabulated in the main paper and the supplementary materials. We want to thank J. Mergner, F. Seefried, D. Warig, A. Hubarier, M. Kroetz-Fahning, A. Klaus, S. Silingas, L.-H. Li, L. Wanat (all from TUM), B. Tizazu (LEM), and M. AbuJarour (SAP) for technical assistance. M. Fritschle is acknowledged for animal handling. E. Kunold and S. Sieber am acknowledged for measurement of phosphosamples. A.F. arid A.W. thank U. Buchholz, C.-M. Flinger, and A. Voss for technical assistance. D.P.Z. gratefully acknowledges funding from the Bundesministerium EP-Bildung and Forschung (BMBF) (grant 03110008A-ProteomeTools). A.W. and A.E. gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (DFG) (SFB 824 TP Z02), BMBF (grant 01ZX1310B.01KT16015), and Deutsche Krebshilfe (grant 70112617). IR. is grateful for European Research Council (ERC) Advanced Grant (FP7, grant agreement 322865). KG K.S., arid H.P. are grateful for funding through DFG SIB1243. N.T. is funded by Institutional grant IUT60-20 and personal grant PUT/36 from the Estonian Research Council. S.S. thanks Fonds der Chemischen Industrie. I.J. is thankful for ERC Consolidator Grant 681524, CLerthan Research Foundation, Collaborative Research Center 1243 "Genetic and epigenetic evolution of hernatopoietic neoplasms," and the Mildred Scheel Professorship from German Cancer Aid. B.K. is an inventor on the patent EP20060763568 held by GlaxoSmithKline that covers the kinobeads technology. The proteornic data are available at the ProteorneXchange Consortium (http://eroteorrecentral.proteornexchange.org) via the PRIDE partner repository with the data set identifier PXD005336, as well as at ProteomicsDB (www.proteomicsdb.org) with the data set identifier PRDB004257. Compound selectivity data can also be explored at http://129.187.44.58:7575/. Crystal data are available at PDB protein database at www.rcsb.org/pdb with the following PDB accession codes: 5LBW, 5LBY, 5LBZ, 5M5A, 5MAF, 5MAG, 5MAH, and 5MAI. Supplementary materials are available as part of this Research Article, in the ProteomeXchange repository, and in the ProtearricsDB. Tables Si and 52 contain direct links to the summary PDFs, containing the results of each drug profiling and the interactive visualizations in ProteomicsDB. N.H. is the cofounder, shareholder, and chief executive officer of OrnicScouts: a company providing proteorric and chemical proteamic services. M.W. and B.K. are cofounders and shareholders of OmicScouts. They have no operational role in the company.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Ardini E, 2014, MOL ONCOL, V8, P1495, DOI 10.1016/j.molonc.2014.06.001; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Borgo C, 2015, BBA-MOL CELL RES, V1853, P1693, DOI 10.1016/j.bbamcr.2015.04.004; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Canevari G, 2013, BIOCHEMISTRY-US, V52, P6380, DOI 10.1021/bi4005864; Cheng AC, 2010, J MED CHEM, V53, P4502, DOI 10.1021/jm100301x; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Cook PJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15987; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Elkins JM, 2016, NAT BIOTECHNOL, V34, P95, DOI 10.1038/nbt.3374; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ermolayev V, 2015, INT J CANCER, V137, P1107, DOI 10.1002/ijc.29372; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Fabbro D, 2015, BRIT J PHARMACOL, V172, P2675, DOI 10.1111/bph.13096; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fauster A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.130; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Hahne H, 2013, NAT METHODS, V10, P989, DOI [10.1038/nmeth.2610, 10.1038/NMETH.2610]; Heinzlmeir S, 2016, ACS CHEM BIOL, V11, P3400, DOI 10.1021/acschembio.6b00709; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Janke H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089560; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kayser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056333; Klaeger S, 2016, ACS CHEM BIOL, V11, P1245, DOI 10.1021/acschembio.5b01063; Knapp S, 2013, NAT CHEM BIOL, V9, P3, DOI 10.1038/nchembio.1113; Koch H, 2016, J PROTEOME RES, V15, P4490, DOI 10.1021/acs.jproteome.6b00621; Kooistra AJ, 2016, NUCLEIC ACIDS RES, V44, pD365, DOI 10.1093/nar/gkv1082; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lemeer S, 2013, J PROTEOME RES, V12, P1723, DOI 10.1021/pr301073j; Li YF, 2013, LUNG CANCER, V80, P91, DOI 10.1016/j.lungcan.2012.12.022; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lu JW, 2016, CANCER LETT, V376, P218, DOI 10.1016/j.canlet.2016.04.004; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medard G, 2015, J PROTEOME RES, V14, P1574, DOI 10.1021/pr5012608; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Polzer H., 2015, J CLIN CASE REP, V5, P622, DOI [10.4172/2165-7920.1000622, DOI 10.4172/2165-7920.1000622]; Polzer H, 2013, EXP HEMATOL, V41, P271, DOI 10.1016/j.exphem.2012.10.016; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudolf AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098800; Ruprecht B, 2015, MOL CELL PROTEOMICS, V14, P205, DOI 10.1074/mcp.M114.043109; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Terziyska N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052798; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uitdehaag JCM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-94; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	87	414	417	8	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367							eaan4368	10.1126/science.aan4368	http://dx.doi.org/10.1126/science.aan4368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191878	Green Submitted, Green Accepted			2022-12-28	WOS:000416584000032
J	den Heijer, M; Bakker, A; Gooren, L				den Heijer, Martin; Bakker, Alex; Gooren, Louis			THERAPEUTICS Long term hormonal treatment for transgender people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPY		[den Heijer, Martin] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [den Heijer, Martin; Gooren, Louis] Vrije Univ Amsterdam Med Ctr, Ctr Expertise Gender Dysphoria, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	den Heijer, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands.; den Heijer, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Ctr Expertise Gender Dysphoria, Amsterdam, Netherlands.	m.denheijer@vumc.nl	den Heijer, Martin/J-8036-2015	den Heijer, Martin/0000-0003-3620-5617				Arnold JD, 2016, J SEX MED, V13, P1773, DOI 10.1016/j.jsxm.2016.09.001; Asscheman H, 2014, ANDROLOGIA, V46, P791, DOI 10.1111/and.12150; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Brown GR, 2015, BREAST CANCER RES TR, V149, P191, DOI 10.1007/s10549-014-3213-2; Cauley JA, 2015, STEROIDS, V99, P11, DOI 10.1016/j.steroids.2014.12.010; Coleman E, 2012, INT J TRANSGENDERISM, V13, P165, DOI 10.1080/15532739.2011.700873; Collin L, 2016, J SEX MED, V13, P613, DOI 10.1016/j.jsxm.2016.02.001; Deutsch MB, 2015, OBSTET GYNECOL, V125, P605, DOI 10.1097/AOG.0000000000000692; Elamin MB, 2010, CLIN ENDOCRINOL, V72, P1, DOI 10.1111/j.1365-2265.2009.03632.x; Gava G, 2016, CLIN ENDOCRINOL, V85, P239, DOI 10.1111/cen.13050; Gil M, 2011, BRIT J CLIN PHARMACO, V72, P965, DOI 10.1111/j.1365-2125.2011.04031.x; Gomez-Gil E, 2012, PSYCHONEUROENDOCRINO, V37, P662, DOI 10.1016/j.psyneuen.2011.08.010; Gooren L, 2015, ANDROLOGIA, V47, P1202, DOI 10.1111/and.12399; Gooren L, 2014, ANDROLOGIA, V46, P1156, DOI 10.1111/and.12208; Gooren L, 2014, J SEX MED, V11, P2012, DOI 10.1111/jsm.12563; Gooren LJ, 2014, EUR J ENDOCRINOL, V170, P809, DOI 10.1530/EJE-14-0011; Gooren LJ, 2011, NEW ENGL J MED, V364, P1251, DOI 10.1056/NEJMcp1008161; Gorin-Lazard A, 2013, J NERV MENT DIS, V201, P996, DOI 10.1097/NMD.0000000000000046; Hembree WC, 2018, J CLIN ENDOCR METAB, V103, P699, DOI [10.1210/jc.2017-02548, 10.1210/jc.2017-01658]; Irwig MS, 2017, LANCET DIABETES ENDO, V5, P301, DOI 10.1016/S2213-8587(16)00036-X; Klaver M, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12660; Mohammed K, 2015, J CLIN ENDOCR METAB, V100, P4012, DOI 10.1210/jc.2015-2237; Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x; Nota NM, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12666; Roberts TK, 2014, AM J MED, V127, P159, DOI 10.1016/j.amjmed.2013.10.009; Tangpricha V, 2016, LANCET DIABETES ENDO, V359, P1; Turo R, 2013, CUAJ-CAN UROL ASSOC, V7, pE544, DOI 10.5489/cuaj.175; Van Caenegem E, 2013, BONE, V54, P92, DOI 10.1016/j.bone.2013.01.039; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Weinand JD, 2015, J CLIN TRANSL ENDOCR, V2, P55, DOI 10.1016/j.jcte.2015.02.003; Wiepjes CM, 2017, J BONE MINER RES, V32, P1252, DOI 10.1002/jbmr.3102; Wierckx K, 2014, J SEX MED, V11, P1999, DOI 10.1111/jsm.12571	32	17	17	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5027	10.1136/bmj.j5027	http://dx.doi.org/10.1136/bmj.j5027			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29192092				2022-12-28	WOS:000417211800001
J	Shan, JJ; Li, MW; Allard, LF; Lee, SS; Flytzani-Stephanopoulos, M				Shan, Junjun; Li, Mengwei; Allard, Lawrence F.; Lee, Sungsik; Flytzani-Stephanopoulos, Maria			Mild oxidation of methane to methanol or acetic acid on supported isolated rhodium catalysts	NATURE			English	Article							EXCHANGED ZEOLITES; CARBON-MONOXIDE; CONVERSION; OXYGEN; ZSM-5; CO; CARBONYLATION; TEMPERATURE; SELECTIVITY; MORDENITE	An efficient and direct method of catalytic conversion of methane to liquid methanol and other oxygenates would be of considerable practical value. However, it remains an unsolved problem in catalysis, as typically it involves expensive(1-4) or corrosive oxidants or reaction media(5-8) that are not amenable to commercialization. Although methane can be directly converted to methanol using molecular oxygen under mild conditions in the gas phase, the process is either stoichiometric (and therefore requires a water extraction step)(9-15) or is too slow and low-yielding(16) to be practical. Methane could, in principle, also be transformed through direct oxidative carbonylation to acetic acid, which is commercially obtained through methane steam reforming, methanol synthesis, and subsequent methanol carbonylation on homogeneous catalysts(17,18). However, an effective catalyst for the direct carbonylation of methane to acetic acid, which might enable the economical small-scale utilization of natural gas that is currently flared or stranded, has not yet been reported. Here we show that mononuclear rhodium species, anchored on a zeolite or titanium dioxide support suspended in aqueous solution, catalyse the direct conversion of methane to methanol and acetic acid, using oxygen and carbon monoxide under mild conditions. We find that the two products form through independent pathways, which allows us to tune the conversion: three-hour-long batch-reactor tests conducted at 150 degrees Celsius, using either the zeolitesupported or the titanium-dioxide-supported catalyst, yield around 22,000 micromoles of acetic acid per gram of catalyst, or around 230 micromoles of methanol per gram of catalyst, respectively, with selectivities of 60-100 per cent. We anticipate that these unusually high activities, despite still being too low for commercial application, may guide the development of optimized catalysts and practical processes for the direct conversion of methane to methanol, acetic acid and other useful chemicals.	[Shan, Junjun; Li, Mengwei; Flytzani-Stephanopoulos, Maria] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Allard, Lawrence F.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Lee, Sungsik] Argonne Natl Lab, Xray Sci Div, 9700 South Cass Ave, Argonne, IL 60439 USA; [Shan, Junjun] NICE Amer Res Inc, Mountain View, CA 94043 USA	Tufts University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Flytzani-Stephanopoulos, M (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	maria.flytzani-stephanopoulos@tufts.edu		Shan, Junjun/0000-0002-9295-8667; Lee, Sungsik/0000-0002-1425-9852	Department of Energy, DOE/ARPA-e from MIT [DE-AR0000433]; DOE Office of Science [DE-AC02-06CH11357]; US Department of Energy, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office	Department of Energy, DOE/ARPA-e from MIT; DOE Office of Science(United States Department of Energy (DOE)); US Department of Energy, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office	The financial support of this work by the Department of Energy, DOE/ARPA-e grant DE-AR0000433, under subcontract from MIT, is gratefully acknowledged. The XAS work used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science, User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Aberration-corrected electron microscopy research at Oak Ridge National Laboratory was sponsored by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office, Propulsion Materials Program.	Beznis NV, 2011, MICROPOR MESOPOR MAT, V138, P176, DOI 10.1016/j.micromeso.2010.09.009; Cavell KJ, 1996, COORDIN CHEM REV, V155, P209; Chepaikin EG, 2001, J MOL CATAL A-CHEM, V169, P89, DOI 10.1016/S1381-1169(01)00046-2; Forde MM, 2014, CHEM SCI, V5, P3603, DOI 10.1039/c4sc00545g; Fu WQ, 2015, CHEM COMMUN, V51, P5890, DOI 10.1039/c4cc10417j; GOLDSHLEGER NF, 1969, RUSS J PHYS CHEM+, V43, P1222; Groothaert MH, 2005, J AM CHEM SOC, V127, P1394, DOI 10.1021/ja047158u; Grundner S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8546; Hammond C, 2013, ACS CATAL, V3, P689, DOI 10.1021/cs3007999; Hammond C, 2012, ANGEW CHEM INT EDIT, V51, P5129, DOI 10.1002/anie.201108706; Ivanova E, 2003, PHYS CHEM CHEM PHYS, V5, P655, DOI 10.1039/b210711b; Kroner AB, 2014, CHEMPHYSCHEM, V15, P3049, DOI 10.1002/cphc.201402122; Lee W., 2011, THESIS; Lepage M, 2008, J PHYS CHEM C, V112, P9394, DOI 10.1021/jp711743g; LIN M, 1994, NATURE, V368, P613, DOI 10.1038/368613a0; Linh NH, 2015, J PHYS CHEM C, V119, P21547, DOI 10.1021/acs.jpcc.5b06660; Liu CC, 2016, ENERG ENVIRON SCI, V9, P1361, DOI 10.1039/c5ee03372a; Martinez-Macias C, 2015, ACS CATAL, V5, P5647, DOI 10.1021/acscatal.5b00995; Matsubu JC, 2015, J AM CHEM SOC, V137, P3076, DOI 10.1021/ja5128133; Mavila S, 2014, CHEM SCI, V5, P4196, DOI 10.1039/c4sc01231c; McFarland E, 2012, SCIENCE, V338, P340, DOI 10.1126/science.1226840; Narsimhan K, 2016, ACS CENTRAL SCI, V2, P424, DOI 10.1021/acscentsci.6b00139; Narsimhan K, 2015, J AM CHEM SOC, V137, P1825, DOI 10.1021/ja5106927; Olivos-Suarez AI, 2016, ACS CATAL, V6, P2965, DOI 10.1021/acscatal.6b00428; Pardue DB, 2014, INORG CHEM, V53, P2968, DOI 10.1021/ic402759w; PAULIK FE, 1968, CHEM COMMUN, P1578; Periana RA, 2003, SCIENCE, V301, P814, DOI 10.1126/science.1086466; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Ravenelle RM, 2010, J PHYS CHEM C, V114, P19582, DOI 10.1021/jp104639e; Robin TF, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2015.00051; Shan JJ, 2014, LANGMUIR, V30, P8558, DOI 10.1021/la501184b; Starokon EV, 2011, J PHYS CHEM C, V115, P2155, DOI 10.1021/jp109906j; Su JC, 2013, NANOSCALE, V5, P9720, DOI 10.1039/c3nr02916f; Sushkevich VL, 2017, SCIENCE, V356, P523, DOI 10.1126/science.aam9035; Wang L, 2015, ACS CATAL, V5, P2727, DOI 10.1021/acscatal.5b00083; Wang XM, 2012, ANGEW CHEM INT EDIT, V51, P3850, DOI 10.1002/anie.201108634; Xu JY, 2017, P NATL ACAD SCI USA, V114, pE5308, DOI 10.1073/pnas.1703321114; Yang M, 2013, J AM CHEM SOC, V135, P3768, DOI 10.1021/ja312646d; Zapata PA, 2012, J AM CHEM SOC, V134, P8570, DOI 10.1021/ja3015082; Zhu Y, 2013, ACS CATAL, V3, P2627, DOI 10.1021/cs400070y	40	369	375	82	868	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					605	+		10.1038/nature24640	http://dx.doi.org/10.1038/nature24640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189776	Green Submitted			2022-12-28	WOS:000416520400038
J	Ward, ZJ; Long, MW; Resch, SC; Giles, CM; Cradock, AL; Gortmaker, SL				Ward, Zachary J.; Long, Michael W.; Resch, Stephen C.; Giles, Catherine M.; Cradock, Angie L.; Gortmaker, Steven L.			Simulation of Growth Trajectories of Childhood Obesity into Adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; UNITED-STATES; CARDIOVASCULAR RISK; OVERWEIGHT STATUS; ADOLESCENCE; COST; TRACKING; HEALTH; PREVALENCE; CHILDREN	BACKGROUND Although the current obesity epidemic has been well documented in children and adults, less is known about long-term risks of adult obesity for a given child at his or her present age and weight. We developed a simulation model to estimate the risk of adult obesity at the age of 35 years for the current population of children in the United States. METHODS We pooled height and weight data from five nationally representative longitudinal studies totaling 176,720 observations from 41,567 children and adults. We simulated growth trajectories across the life course and adjusted for secular trends. We created 1000 virtual populations of 1 million children through the age of 19 years that were representative of the 2016 population of the United States and projected their trajectories in height and weight up to the age of 35 years. Severe obesity was defined as a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 35 or higher in adults and 120% or more of the 95th percentile in children. RESULTS Given the current level of childhood obesity, the models predicted that a majority of today's children (57.3%; 95% uncertainly interval [UI], 55.2 to 60.0) will be obese at the age of 35 years, and roughly half of the projected prevalence will occur during childhood. Our simulations indicated that the relative risk of adult obesity increased with age and BMI, from 1.17 (95% UI, 1.09 to 1.29) for overweight 2-year-olds to 3.10 (95% UI, 2.43 to 3.65) for 19-year-olds with severe obesity. For children with severe obesity, the chance they will no longer be obese at the age of 35 years fell from 21.0% (95% UI, 7.3 to 47.3) at the age of 2 years to 6.1% (95% UI, 2.1 to 9.9) at the age of 19 years. CONCLUSIONS On the basis of our simulation models, childhood obesity and overweight will continue to be a major health problem in the United States. Early development of obesity predicted obesity in adulthood, especially for children who were severely obese.	[Ward, Zachary J.; Resch, Stephen C.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA; [Giles, Catherine M.; Cradock, Angie L.; Gortmaker, Steven L.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Long, Michael W.] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Prevent & Community Hlth, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; George Washington University	Ward, ZJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	zward@hsph.harvard.edu		Ward, Zachary/0000-0002-4007-2207; Long, Michael/0000-0002-3953-3424	JPB Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052646, R01HD069609, R01HD059779] Funding Source: NIH RePORTER	JPB Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the JPB Foundation and others.	Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Cheung PC, 2016, CHILD OBES, V12, P1, DOI 10.1089/chi.2015.0055; Cradock AL, 2017, PREV MED, V95, pS17, DOI 10.1016/j.ypmed.2016.10.017; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Dietz WH, 1998, PEDIATRICS, V101, P518; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Evensen E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0599-5; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Goldhaber-Fiebert JD, 2013, MED DECIS MAKING, V33, P163, DOI 10.1177/0272989X12447240; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Gortmaker SL, 2015, HEALTH AFFAIR, V34, P1932, DOI 10.1377/hlthaff.2015.0631; Institute of Medicine, 2012, ACCELERATING PROGR O; Janssen I, 2005, OBES RES, V13, P1106, DOI 10.1038/oby.2005.129; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Kim KR, 2008, EUR J CLIN NUTR, V62, P748, DOI 10.1038/sj.ejcn.1602783; Li L, 2008, AM J EPIDEMIOL, V168, P1008, DOI 10.1093/aje/kwn227; Long MW, 2016, INT J OBESITY, V40, P1523, DOI 10.1038/ijo.2016.130; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Rao G, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3616; Stovitz SD, 2010, AM J PREV MED, V38, P74, DOI 10.1016/j.amepre.2009.09.033; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85; Temple JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060947; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Thompson N, 2016, J AM ASSOC NURSE PRA, V28, P559, DOI 10.1002/2327-6924.12369; Tran MK, 2016, AM J EPIDEMIOL, V183, P643, DOI 10.1093/aje/kwv233; Venn AJ, 2007, MED J AUSTRALIA, V186, P458, DOI 10.5694/j.1326-5377.2007.tb00997.x; Wang LY, 2008, J ADOLESCENT HEALTH, V42, P512, DOI 10.1016/j.jadohealth.2007.10.010; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wang YC, 2015, HEALTH AFFAIR, V34, P1923, DOI 10.1377/hlthaff.2015.0633; Wang YC, 2012, AM J PREV MED, V42, P437, DOI 10.1016/j.amepre.2012.01.018; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang YC, 2011, INT J PEDIATR OBES, V6, P12, DOI 10.3109/17477161003587774; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Ward ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150735	44	315	324	9	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2145	2153		10.1056/NEJMoa1703860	http://dx.doi.org/10.1056/NEJMoa1703860			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO1VI	29171811	Bronze, Green Accepted			2022-12-28	WOS:000416555000008
J	Slomski, A				Slomski, Anita			Romosozumab Prevents Fractures in Women With Osteoporosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1968	1968		10.1001/jama.2017.17272	http://dx.doi.org/10.1001/jama.2017.17272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183069				2022-12-28	WOS:000416317600005
J	Slomski, A				Slomski, Anita			Primary Care Treatment of Substance Use Disorder Reaches More Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1968	1968		10.1001/jama.2017.17949	http://dx.doi.org/10.1001/jama.2017.17949			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183070				2022-12-28	WOS:000416317600006
J	Horton, R				Horton, Richard			Offline: Who is Peter Sands?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2336	2336		10.1016/S0140-6736(17)33040-4	http://dx.doi.org/10.1016/S0140-6736(17)33040-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	29185426	Bronze			2022-12-28	WOS:000416118700010
J	Modjarrad, K; Lin, L; George, SL; Stephenson, KE; Eckels, KH; De La Barrera, RA; Jarman, RG; Sondergaard, E; Tennant, J; Ansel, JL; Mills, K; Koren, M; Robb, ML; Barrett, J; Thompson, J; Kosel, AE; Dawson, P; Hale, A; Tan, CS; Walsh, SR; Meyer, KE; Brien, J; Crowell, TA; Blazevic, A; Mosby, K; Larocca, RA; Abbink, P; Boyd, M; Bricault, CA; Seaman, MS; Basil, A; Walsh, M; Tonwe, V; Hoft, DF; Thomas, SJ; Barouch, DH; Michael, NL				Modjarrad, Kayvon; Lin, Leyi; George, Sarah L.; Stephenson, Kathryn E.; Eckels, Kenneth H.; De La Barrera, Rafael A.; Jarman, Richard G.; Sondergaard, Erica; Tennant, Janice; Ansel, Jessica L.; Mills, Kristin; Koren, Michael; Robb, Merlin L.; Barrett, Jill; Thompson, Jason; Kosel, Alison E.; Dawson, Peter; Hale, Andrew; Tan, C. Sabrina; Walsh, Stephen R.; Meyer, Keith E.; Brien, James; Crowell, Trevor A.; Blazevic, Azra; Mosby, Karla; Larocca, Rafael A.; Abbink, Peter; Boyd, Michael; Bricault, Christine A.; Seaman, Michael S.; Basil, Anne; Walsh, Melissa; Tonwe, Veronica; Hoft, Daniel F.; Thomas, Stephen J.; Barouch, Dan H.; Michael, Nelson L.			Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials	LANCET			English	Article							GUILLAIN-BARRE-SYNDROME; PROTECTIVE EFFICACY; INFECTION; PREGNANCY	Background A safe, effective, and rapidly scalable vaccine against Zika virus infection is needed. We developed a purified formalin-inactivated Zika virus vaccine (ZPIV) candidate that showed protection in mice and non-human primates against viraemia after Zika virus challenge. Here we present the preliminary results in human beings. Methods We did three phase 1, placebo-controlled, double-blind trials of ZPIV with aluminium hydroxide adjuvant. In all three studies, healthy adults were randomly assigned by a computer-generated list to receive 5 mu g ZPIV or saline placebo, in a ratio of 4:1 at Walter Reed Army Institute of Research, Silver Spring, MD, USA, or of 5:1 at Saint Louis University, Saint Louis, MO, USA, and Beth Israel Deaconess Medical Center, Boston, MA, USA. Vaccinations were given intramuscularly on days 1 and 29. The primary objective was safety and immunogenicity of the ZPIV candidate. We recorded adverse events and Zika virus envelope microneutralisation titres up to day 57. These trials are registered at ClinicalTrials.gov, numbers NCT02963909, NCT02952833, and NCT02937233. Findings We enrolled 68 participants between Nov 7, 2016, and Jan 25, 2017. One was excluded and 67 participants received two injections of Zika vaccine (n=55) or placebo (n=12). The vaccine caused only mild to moderate adverse events. The most frequent local effects were pain (n=40 [60%]) or tenderness (n=32 [47%]) at the injection site, and the most frequent systemic reactogenic events were fatigue (29 [43%]), headache (26 [39%]), and malaise (15 [22%]). By day 57, 52 (92%) of vaccine recipients had seroconverted (micro-neutralisation titre >= 1:10), with peak geometric mean titres seen at day 43 and exceeding protective thresholds seen in animal studies. Interpretation The ZPIV candidate was well tolerated and elicited robust neutralising antibody titres in healthy adults.	[Modjarrad, Kayvon; Lin, Leyi; Eckels, Kenneth H.; De La Barrera, Rafael A.; Jarman, Richard G.; Sondergaard, Erica; Mills, Kristin; Koren, Michael; Thomas, Stephen J.; Michael, Nelson L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [George, Sarah L.; Tennant, Janice; Meyer, Keith E.; Blazevic, Azra; Mosby, Karla; Hoft, Daniel F.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA; [Brien, James] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [George, Sarah L.; Hoft, Daniel F.] St Louis VA Med Ctr, St Louis, MO USA; [Stephenson, Kathryn E.; Ansel, Jessica L.; Tan, C. Sabrina; Walsh, Stephen R.; Larocca, Rafael A.; Abbink, Peter; Boyd, Michael; Bricault, Christine A.; Seaman, Michael S.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, E CLS 1043, Boston, MA 02115 USA; [Stephenson, Kathryn E.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Robb, Merlin L.; Crowell, Trevor A.; Basil, Anne; Walsh, Melissa; Tonwe, Veronica] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Barrett, Jill; Thompson, Jason; Kosel, Alison E.; Dawson, Peter] Emmes Corp, Rockville, MD USA; [Hale, Andrew] Univ Vermont, Med Ctr, Burlington, VT USA; [Hale, Andrew] Larner Coll Med, Burlington, VT USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Saint Louis University; Saint Louis University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Emmes Corporation; University of Vermont; University of Vermont Medical Center	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, E CLS 1043, Boston, MA 02115 USA.; Michael, NL (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.	dbarouch@bidmc.harvard.edu; nelson.l.michael2.mil@mail.mil	Barouch, Dan/Y-3918-2019; Crowell, Trevor A./W-3904-2019	Crowell, Trevor A./0000-0001-5947-265X; Walsh, Stephen/0000-0002-0817-9370; Thomas, Stephen/0000-0002-8368-7682; Stephenson, Kathryn/0000-0002-3440-4105; Tonwe, Veronica/0000-0002-4175-2546; George, Sarah/0000-0002-9699-1042	Department of the Army; Department of the Defense; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI104794] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003714] Funding Source: NIH RePORTER	Department of the Army; Department of the Defense(United States Department of Defense); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Departments of the Army and Defense and National Institute of Allergy and Infectious Diseases.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Muthumani K, VIVO PROTECTION ZIKV; Pardi N., 2017, NATURE; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Richner J. M., 2017, CELL; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375; Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120; US Food and Drug Administration, 2017, TITL 21 FOOD DRUGS	26	129	131	2	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					563	571		10.1016/S0140-6736(17)33106-9	http://dx.doi.org/10.1016/S0140-6736(17)33106-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV5VB	29217375	Green Accepted, Bronze			2022-12-28	WOS:000424649400033
J	Akondy, RS; Fitch, M; Edupuganti, S; Yang, S; Kissick, HT; Li, KW; Youngblood, BA; Abdelsamed, HA; McGuire, DJ; Cohen, KW; Alexe, G; Nagar, S; McCausland, MM; Gupta, S; Tata, P; Haining, WN; McElrath, MJ; Zhang, D; Hu, B; Greenleaf, WJ; Goronzy, JJ; Mulligan, MJ; Hellerstein, M; Ahmed, R				Akondy, Rama S.; Fitch, Mark; Edupuganti, Srilatha; Yang, Shu; Kissick, Haydn T.; Li, Kelvin W.; Youngblood, Ben A.; Abdelsamed, Hossam A.; McGuire, Donald J.; Cohen, Kristen W.; Alexe, Gabriela; Nagar, Shashi; McCausland, Megan M.; Gupta, Satish; Tata, Pramila; Haining, W. Nicholas; McElrath, M. Juliana; Zhang, David; Hu, Bin; Greenleaf, William J.; Goronzy, Jorg J.; Mulligan, Mark J.; Hellerstein, Marc; Ahmed, Rafi			Origin and differentiation of human memory CD8 T cells after vaccination	NATURE			English	Article							VIRAL-INFECTION; LIFE-SPAN; EFFECTOR; TURNOVER; LYMPHOCYTES; EXHAUSTION	The differentiation of human memory CD8 T cells is not well understood. Here we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-term immunity in humans. We used in vivo deuterium labelling to mark CD8 T cells that proliferated in response to the virus and then assessed cellular turnover and longevity by quantifying deuterium dilution kinetics in YFV-specific CD8 T cells using mass spectrometry. This longitudinal analysis showed that the memory pool originates from CD8 T cells that divided extensively during the first two weeks after infection and is maintained by quiescent cells that divide less than once every year (doubling time of over 450 days). Although these long-lived YFV-specific memory CD8 T cells did not express effector molecules, their epigenetic landscape resembled that of effector CD8 T cells. This open chromatin profile at effector genes was maintained in memory CD8 T cells isolated even a decade after vaccination, indicating that these cells retain an epigenetic fingerprint of their effector history and remain poised to respond rapidly upon re-exposure to the pathogen.	[Akondy, Rama S.; Yang, Shu; Youngblood, Ben A.; McGuire, Donald J.; McCausland, Megan M.; Mulligan, Mark J.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Akondy, Rama S.; Yang, Shu; Youngblood, Ben A.; McCausland, Megan M.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Fitch, Mark; Hellerstein, Marc] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Edupuganti, Srilatha; Nagar, Shashi; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA; [Li, Kelvin W.; Hellerstein, Marc] KineMed Inc, Emeryville, CA 94608 USA; [Youngblood, Ben A.; Abdelsamed, Hossam A.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Cohen, Kristen W.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Alexe, Gabriela; Haining, W. Nicholas] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Alexe, Gabriela; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gupta, Satish; Tata, Pramila] Strand Lifesci, Bangalore, Karnataka, India; [Zhang, David; Hu, Bin; Goronzy, Jorg J.] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Yang, Shu] Cent S Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Tata, Pramila] Syngene Int, Bangalore, Karnataka, India	Emory University; Emory University; University of California System; University of California Berkeley; Emory University; Emory University; St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Stanford University; Central South University; Syngene International Limited	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Hellerstein, M (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.; Hellerstein, M (corresponding author), KineMed Inc, Emeryville, CA 94608 USA.	march@berkeley.edu; rahmed@emory.edu	Youngblood, Benjamin/N-2508-2018; Mulligan, Mark/V-9275-2019; Kissick, Haydn/AAS-6292-2021; Akondy, Rama/AAC-4656-2020	Youngblood, Benjamin/0000-0002-1261-9957; Kissick, Haydn/0000-0001-7624-5598; McGuire, Donald/0000-0002-3742-9594; Goronzy, Jorg/0000-0001-7670-1856	NIH [U19AI057266, R01-AI43866-07]; NIAID [UM1 AI068618, UM1 AI069481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069481, UM1AI068618, U19AI057266, R01AI129191, R01AI043866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants U19AI057266 (R.A.), R01-AI43866-07 (M.H.), NIAID UM1 AI068618 (M.J.Mc.) and NIAID UM1 AI069481 (M.J.Mc.). The authors acknowledge technical support from R. Karaffa and S. Durham for cell sorting.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ahmed R, 2016, CELL REP, V17, P2811, DOI 10.1016/j.celrep.2016.11.037; Ahmed R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004355; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Busch R, 2007, NAT PROTOC, V2, P3045, DOI 10.1038/nprot.2007.420; Choo DK, 2010, J IMMUNOL, V185, P3436, DOI 10.4049/jimmunol.1001421; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DEMKOWICZ WE, 1993, J VIROL, V67, P1538, DOI 10.1128/JVI.67.3.1538-1544.1993; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Nanan R, 2000, J GEN VIROL, V81, P1313, DOI 10.1099/0022-1317-81-5-1313; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sellars M, 2015, NAT IMMUNOL, V16, P746, DOI 10.1038/ni.3198; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Westera L, 2013, BLOOD, V122, P2205, DOI 10.1182/blood-2013-03-488411; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Youngblood B., 2017, NATURE	31	261	266	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					362	+		10.1038/nature24633	http://dx.doi.org/10.1038/nature24633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236685	Green Accepted			2022-12-28	WOS:000418559800050
J	He, KM; Marsland, R; Upadhyayula, S; Song, E; Dang, S; Capraro, BR; Wang, WM; Skillern, W; Gaudin, R; Ma, MH; Kirchhausen, T				He, Kangmin; Marsland, Robert, III; Upadhyayula, Srigokul; Song, Eli; Dang, Song; Capraro, Benjamin R.; Wang, Weiming; Skillern, Wesley; Gaudin, Raphael; Ma, Minghe; Kirchhausen, Tom			Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic	NATURE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE; LOWE-SYNDROME; COATED PITS; AUXILIN; CELL; RECRUITMENT; REVEALS; 5-PHOSPHATASE; 3-PHOSPHATE; METABOLISM	Vesicular carriers transport proteins and lipids from one organelle to another, recognizing specific identifiers for the donor and acceptor membranes. Two important identifiers are phosphoinositides and GTP-bound GTPases, which provide well-defined but mutable labels. Phosphatidylinositol and its phosphorylated derivatives are present on the cytosolic faces of most cellular membranes(1,2). Reversible phosphorylation of its headgroup produces seven distinct phosphoinositides. In endocytic traffic, phosphatidylinositol-4,5-biphosphate marks the plasma membrane, and phosphatidylinositol-3-phosphate and phosphatidylinositol-4-phosphate mark distinct endosomal compartments(2,3). It is unknown what sequence of changes in lipid content confers on the vesicles their distinct identity at each intermediate step. Here we describe 'coincidence-detecting' sensors that selectively report the phosphoinositide composition of clathrin-associated structures, and the use of these sensors to follow the dynamics of phosphoinositide conversion during endocytosis. The membrane of an assembling coated pit, in equilibrium with the surrounding plasma membrane, contains phosphatidylinositol-4,5-biphosphate and a smaller amount of phosphatidylinositol-4-phosphate. Closure of the vesicle interrupts free exchange with the plasma membrane. A substantial burst of phosphatidylinositol-4-phosphate immediately after budding coincides with a burst of phosphatidylinositol-3-phosphate, distinct from any later encounter with the phosphatidylinositol-3-phosphate pool in early endosomes; phosphatidylinositol-3,4-biphosphate and the GTPase Rab5 then appear and remain as the uncoating vesicles mature into Rab5-positive endocytic intermediates. Our observations show that a cascade of molecular conversions, made possible by the separation of a vesicle from its parent membrane, can label membrane-traffic intermediates and determine their destinations.	[He, Kangmin; Upadhyayula, Srigokul; Capraro, Benjamin R.; Wang, Weiming; Gaudin, Raphael; Kirchhausen, Tom] Harvard Med Sch, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA; [He, Kangmin; Upadhyayula, Srigokul; Song, Eli; Dang, Song; Capraro, Benjamin R.; Wang, Weiming; Skillern, Wesley; Gaudin, Raphael; Ma, Minghe; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, 200 Longwood Ave, Boston, MA 02115 USA; [He, Kangmin; Upadhyayula, Srigokul; Kirchhausen, Tom] Harvard Med Sch, Dept Pediat, 200 Longwood Ave, Boston, MA 02115 USA; [Marsland, Robert, III] MIT, Phys Living Syst Grp, 400 Technol Sq, Cambridge, MA 02139 USA; [Marsland, Robert, III] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Song, Eli] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Gaudin, Raphael] INSERM, U1110, Inst Viral & Liver Dis, 3 Rue Koeberle, F-67000 Strasbourg, France	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Boston University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	He, KM; Kirchhausen, T (corresponding author), Harvard Med Sch, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.; He, KM; Kirchhausen, T (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, 200 Longwood Ave, Boston, MA 02115 USA.; He, KM; Kirchhausen, T (corresponding author), Harvard Med Sch, Dept Pediat, 200 Longwood Ave, Boston, MA 02115 USA.	Kangmin.He@childrens.harvard.edu; kirchhausen@crystal.harvard.edu	Capraro, Benjamin R/C-6090-2009	gaudin, raphael/0000-0002-8558-8143	National Defense Science and Engineering Graduate (NDSEG) Fellowship from the DoD Air Force Office of Scientific Research; National Natural Science Foundation of China [31770900, 31270884, 30900268]; Beijing Natural Science Foundation [5122026, 5092017]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2011087]; NIH [GM103792, NIH R01 GM075252]; Janelia Visitor Program; Biogen; Ionis Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate (NDSEG) Fellowship from the DoD Air Force Office of Scientific Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Youth Innovation Promotion Association of the Chinese Academy of Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janelia Visitor Program; Biogen(Biogen); Ionis Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Alessi, T. Balla, P. De Camilli, O. Gozani, L. Lavis, H. Stenmark, T. Takenawa and Y. Takuwa for reagents; J. R. Houser for maintaining the TIRF and spinning-disk microscopes; J. England for advice and support; members of our laboratory for help and encouragement; and in particular S. C. Harrison for discussions and editorial help. R.M. was supported by a National Defense Science and Engineering Graduate (NDSEG) Fellowship from the DoD Air Force Office of Scientific Research and E.S. by the National Natural Science Foundation of China (31770900, 31270884, 30900268), the Beijing Natural Science Foundation (5122026, 5092017) and the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2011087). S.U. is a Fellow at the Image and Data Analysis core at Harvard Medical School and thanks H. Elliott and D. Richmond for discussions, and acknowledges the MATLAB code repository received from the Computational Image Analysis Workshop supported by NIH grant GM103792. T.K. acknowledges support from the Janelia Visitor Program and thanks E. Betzig, E. Marino, T. Liu and W. Legant for help and advice in constructing and installing the lattice light-sheet microscope. Construction of the lattice light-sheet microscope was supported by grants from Biogen and Ionis Pharmaceuticals to T.K. The research was supported by NIH grant NIH R01 GM075252 to T.K.	Aguet F, 2016, MOL BIOL CELL, V27, P3418, DOI 10.1091/mbc.E16-03-0164; Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chou YY, 2016, J VIROL, V90, P4494, DOI 10.1128/JVI.00103-16; Cocucci E, 2014, MOL BIOL CELL, V25, P3595, DOI 10.1091/mbc.E14-07-1240; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Matteis MA, 2017, NAT REV NEPHROL, V13, P455, DOI 10.1038/nrneph.2017.83; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Guan R, 2010, STRUCTURE, V18, P1191, DOI 10.1016/j.str.2010.06.016; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kadlecova Z, 2017, J CELL BIOL, V216, P167, DOI 10.1083/jcb.201608071; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Villasenor R, 2016, CURR OPIN CELL BIOL, V39, P53, DOI 10.1016/j.ceb.2016.02.002; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhang Kai, 2015, Methods Mol Biol, V1298, P319, DOI 10.1007/978-1-4939-2569-8_27; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	47	83	83	2	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					410	+		10.1038/nature25146	http://dx.doi.org/10.1038/nature25146			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236694	Green Accepted			2022-12-28	WOS:000418559800060
J	Wang, YG; Guo, YR; Liu, K; Yin, Z; Liu, R; Xia, Y; Tan, L; Yang, PY; Lee, JH; Li, XJ; Hawke, D; Zheng, YH; Qian, X; Lyu, JX; He, J; Xing, DM; Tao, YJ; Lu, ZM				Wang, Yugang; Guo, Yusong R.; Liu, Ke; Yin, Zheng; Liu, Rui; Xia, Yan; Tan, Lin; Yang, Peiying; Lee, Jong-Ho; Li, Xin-jian; Hawke, David; Zheng, Yanhua; Qian, Xu; Lyu, Jianxin; He, Jie; Xing, Dongming; Tao, Yizhi Jane; Lu, Zhimin			KAT2A coupled with the alpha-KGDH complex acts as a histone H3 succinyltransferase	NATURE			English	Article							LYSINE SUCCINYLATION; STRUCTURAL BASIS; GCN5; GENERATION; DOMAIN; SAGA; COA	Histone modifications, such as the frequently occurring lysine succinylation(1,2), are central to the regulation of chromatin-based processes. However, the mechanism and functional consequences of histone succinylation are unknown. Here we show that the alpha-ketoglutarate dehydrogenase (alpha-KGDH) complex is localized in the nucleus in human cell lines and binds to lysine acetyltransferase 2A (KAT2A, also known as GCN5) in the promoter regions of genes. We show that succinyl-coenzyme A (succinyl-CoA) binds to KAT2A. The crystal structure of the catalytic domain of KAT2A in complex with succinyl-CoA at 2.3 angstrom resolution shows that succinyl-CoA binds to a deep cleft of KAT2A with the succinyl moiety pointing towards the end of a flexible loop 3, which adopts different structural conformations in succinyl-CoA-bound and acetyl-CoA-bound forms. Site-directed mutagenesis indicates that tyrosine 645 in this loop has an important role in the selective binding of succinylCoA over acetyl-CoA. KAT2A acts as a succinyltransferase and succinylates histone H3 on lysine 79, with a maximum frequency around the transcription start sites of genes. Preventing the alpha-KGDH complex from entering the nucleus, or expression of KAT2A(Tyr645Ala), reduces gene expression and inhibits tumour cell proliferation and tumour growth. These findings reveal an important mechanism of histone modification and demonstrate that local generation of succinyl-CoA by the nuclear alpha-KGDH complex coupled with the succinyltransferase activity of KAT2A is instrumental in histone succinylation, tumour cell proliferation, and tumour development.	[Wang, Yugang; Liu, Rui; Xia, Yan; Lee, Jong-Ho; Li, Xin-jian; Zheng, Yanhua; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Brain Tumor Ctr, Houston, TX 77030 USA; [Guo, Yusong R.; Tao, Yizhi Jane] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Liu, Ke] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Yin, Zheng] Houston Methodist Res Inst, Dept Syst Med & Bioengn, Houston, TX 77030 USA; [Tan, Lin; Yang, Peiying] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Gen Oncol, Houston, TX 77054 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Qian, Xu; Lyu, Jianxin] Hangzhou Med Coll, Peoples Hosp, Hangzhou 310014, Zhejiang, Peoples R China; [Lyu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou 325035, Zhejiang, Peoples R China; [He, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, Peking Union Med Coll, Lab Thorac Surg, Beijing 100021, Peoples R China; [Xing, Dongming] Qingdao Univ, Canc Inst, Affiliated Hosp, Qingdao 266061, Shandong, Peoples R China; [Xing, Dongming] Qingdao Canc Inst, Qingdao 266061, Shandong, Peoples R China; [Xing, Dongming] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas Houston, MD Anderson Canc Ctr UTHlth, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; University of California System; University of California Berkeley; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Hangzhou Medical College; Ministry of Education, China; Wenzhou Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Qingdao University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Brain Tumor Ctr, Houston, TX 77030 USA.; Tao, YJ (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Xing, DM (corresponding author), Qingdao Univ, Canc Inst, Affiliated Hosp, Qingdao 266061, Shandong, Peoples R China.; Xing, DM (corresponding author), Qingdao Canc Inst, Qingdao 266061, Shandong, Peoples R China.; Xing, DM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Lu, ZM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr UTHlth, Grad Sch Biomed Sci, Houston, TX 77030 USA.	pharm@mail.tsinghua.edu.cn; ytao@rice.edu; zhiminlu@mdanderson.org	QIAN, XU/AAR-1867-2021; Yin, Zheng/J-9307-2015; yang, zheng/HGC-7753-2022	Yin, Zheng/0000-0002-3547-0606; Guo, Yusong/0000-0002-8563-3397	National Institute of Neurological Disorders and Stroke [R01 NS089754]; National Cancer Institute [2R01 CA109035, R01 CA169603]; MD Anderson Support Grant [P30CA016672]; Welch Foundation [C-1565]; National Institutes of Health Brain Cancer Specialized Program of Research Excellence [2P50 CA127001]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001, R01CA109035, R01CA169603] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089754] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Support Grant; Welch Foundation(The Welch Foundation); National Institutes of Health Brain Cancer Specialized Program of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Li at the University of Texas Health Science at Houston for technical support and D. Norwood and T. Locke for critical reading of this manuscript. This work was supported by National Institute of Neurological Disorders and Stroke grant R01 NS089754 (Z.L.), National Cancer Institute grants 2R01 CA109035 (Z.L.), R01 CA169603 (Z.L.), MD Anderson Support Grant P30CA016672, Welch Foundation grant C-1565 (Y.J.T.), and the National Institutes of Health Brain Cancer Specialized Program of Research Excellence (2P50 CA127001). Z.L. is a Ruby E. Rutherford Distinguished Professor.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Jiang YH, 2015, NAT CELL BIOL, V17, P1158, DOI 10.1038/ncb3209; Kaczmarska Z, 2017, NAT CHEM BIOL, V13, P21, DOI [10.1038/NCHEMBIO.2217, 10.1038/nchembio.2217]; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Schuetz A, 2007, PROTEINS, V68, P403, DOI 10.1002/prot.21407; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Wang L, 2014, EPIGENOMICS-UK, V6, P329, DOI [10.2217/EPI.14.22, 10.2217/epi.14.22]; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495	19	178	189	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					273	+		10.1038/nature25003	http://dx.doi.org/10.1038/nature25003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211711	Green Accepted			2022-12-28	WOS:000418029500051
J	Bejnordi, BE; Veta, M; van Diest, PJ; van Ginneken, B; Karssemeijer, N; Litjens, G; van der Laak, JAWM				Bejnordi, Babak Ehteshami; Veta, Mitko; van Diest, Paul Johannes; van Ginneken, Bram; Karssemeijer, Nico; Litjens, Geert; van der Laak, Jeroen A. W. M.		CAMELYON16 Consortium	Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIGITAL PATHOLOGY; CLASSIFICATION; MULTIREADER; FEATURES; SCALE; ROC	IMPORTANCE Application of deep learning algorithms to whole-slide pathology images can potentially improve diagnostic accuracy and efficiency. OBJECTIVE Assess the performance of automated deep learning algorithms at detecting metastases in hematoxylin and eosin-stained tissue sections of lymph nodes of women with breast cancer and compare it with pathologists' diagnoses in a diagnostic setting. DESIGN, SETTING, AND PARTICIPANTS Researcher challenge competition (CAMELYON16) to develop automated solutions for detecting lymph node metastases (November 2015-November 2016). A training data set of whole-slide images from 2 centers in the Netherlands with (n = 110) and without (n = 160) nodal metastases verified by immunohistochemical staining were provided to challenge participants to build algorithms. Algorithm performance was evaluated in an independent test set of 129 whole-slide images (49 with and 80 without metastases). The same test set of corresponding glass slides was also evaluated by a panel of 11 pathologists with time constraint (WTC) from the Netherlands to ascertain likelihood of nodal metastases for each slide in a flexible 2-hour session, simulating routine pathology workflow, and by 1 pathologist without time constraint (WOTC). EXPOSURES Deep learning algorithms submitted as part of a challenge competition or pathologist interpretation. MAIN OUTCOMES AND MEASURES The presence of specific metastatic foci and the absence vs presence of lymph node metastasis in a slide or image using receiver operating characteristic curve analysis. The 11 pathologists participating in the simulation exercise rated their diagnostic confidence as definitely normal, probably normal, equivocal, probably tumor, or definitely tumor. RESULTS The area under the receiver operating characteristic curve (AUC) for the algorithms ranged from 0.556 to 0.994. The top-performing algorithm achieved a lesion-level, true-positive fraction comparable with that of the pathologist WOTC (72.4%[95% CI, 64.3%-80.4%]) at a mean of 0.0125 false-positives per normal whole-slide image. For the whole-slide image classification task, the best algorithm (AUC, 0.994 [95% CI, 0.983-0.999]) performed significantly better than the pathologists WTC in a diagnostic simulation (mean AUC, 0.810 [range, 0.738-0.884]; P<.001). The top 5 algorithms had a mean AUC that was comparable with the pathologist interpreting the slides in the absence of time constraints (mean AUC, 0.960 [range, 0.923-0.994] for the top 5 algorithms vs 0.966 [95% CI, 0.927-0.998] for the pathologist WOTC). CONCLUSIONS AND RELEVANCE In the setting of a challenge competition, some deep learning algorithms achieved better diagnostic performance than a panel of 11 pathologists participating in a simulation exercise designed to mimic routine pathology workflow; algorithm performance was comparable with an expert pathologist interpreting whole-slide images without time constraints. Whether this approach has clinical utility will require evaluation in a clinical setting.	[Bejnordi, Babak Ehteshami; van Ginneken, Bram; Karssemeijer, Nico] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Diagnost Image Anal Grp, Nijmegen, Netherlands; [Veta, Mitko] Eindhoven Univ Technol, Med Image Anal Grp, Eindhoven, Netherlands; [van Diest, Paul Johannes] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Litjens, Geert; van der Laak, Jeroen A. W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands	Radboud University Nijmegen; Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Bejnordi, BE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.	ehteshami@babakint.com	RACOCEANU, Daniel/F-4576-2011; Halici, Ugur/ABA-4356-2020; Karssemeijer, N./H-8058-2014; Bult, Peter/L-4236-2015; van Ginneken, Bram/A-3728-2012; Bueno, Gloria/K-6286-2014; Shaban, Muhammad/AEV-0783-2022; Liauchuk, Vitali/AAZ-3813-2020; Litjens, Geert JS/A-2319-2016; Albarqouni, Shadi/H-5441-2019; van der Laak, Jeroen AWM/D-3057-2015; Bejnordi, Babak Ehteshami/P-9534-2015; Balkenhol, Maschenka CA/D-1005-2015; Oner, Mustafa Umit/AAS-7132-2021; Albarqouni, Shadi/GSN-5618-2022; Seno, Shigeto/W-1426-2019; Cetin-Atalay, Rengul/O-9826-2014; Chen, Hao/V-4299-2019; Latonen, Leena/C-8787-2016	RACOCEANU, Daniel/0000-0002-9416-1803; Halici, Ugur/0000-0002-2469-1163; Bult, Peter/0000-0001-6427-9889; van Ginneken, Bram/0000-0003-2028-8972; Bueno, Gloria/0000-0002-7345-4869; Shaban, Muhammad/0000-0001-6115-1505; Liauchuk, Vitali/0000-0001-9686-3705; Litjens, Geert JS/0000-0003-1554-1291; Albarqouni, Shadi/0000-0003-2157-2211; van der Laak, Jeroen AWM/0000-0001-7982-0754; Bejnordi, Babak Ehteshami/0000-0002-6258-5687; Balkenhol, Maschenka CA/0000-0001-9457-618X; Oner, Mustafa Umit/0000-0003-4252-9167; Albarqouni, Shadi/0000-0003-2157-2211; Seno, Shigeto/0000-0003-3861-6444; Cetin-Atalay, Rengul/0000-0003-2408-6606; Heng, Pheng Ann/0000-0003-3055-5034; Lin, Huangjing/0000-0002-6799-9352; Dou, Qi/0000-0002-3416-9950; Wang, Dayong/0000-0002-5904-6156; Deniz, Oscar/0000-0002-0841-4131; Hufnagl, Peter/0000-0001-6810-586X; Beca, Francisco/0000-0002-4409-012X; Rajpoot, Nasir/0000-0002-4706-1308; Sirinukunwattana, Korsuk/0000-0002-3603-4435; Ahmady Phoulady, Hady/0000-0002-3215-7630; Matsuda, Hideo/0000-0002-4701-3779; Stathonikos, Nikolas/0000-0002-5457-7580; Chen, Hao/0000-0002-8400-3780; Kartasalo, Kimmo/0000-0002-9470-4783; Liimatainen, Kaisa Maria/0000-0002-9893-0278; Fernandez-Carrobles/0000-0003-0213-6473; Latonen, Leena/0000-0003-4502-2193; Ruusuvuori, Pekka/0000-0001-9086-9591; Hermsen, Meyke/0000-0002-2531-7077	Stichting IT Projecten; Fonds Economische Structuurversterking (tEPIS/TRAIT project); Fonds Economische Structuurversterking (LSH-FES Program); Fonds Economische Structuurversterking [DFES1029161, FES1103JJT8U]; Fonds Economische Structuurversterking; Seventh Framework Programme for Research [601040]	Stichting IT Projecten; Fonds Economische Structuurversterking (tEPIS/TRAIT project); Fonds Economische Structuurversterking (LSH-FES Program); Fonds Economische Structuurversterking; Fonds Economische Structuurversterking; Seventh Framework Programme for Research	Data collection and annotation were funded by Stichting IT Projecten and by the Fonds Economische Structuurversterking (tEPIS/TRAIT project; LSH-FES Program 2009; DFES1029161 and FES1103JJT8U). Fonds Economische Structuurversterking also supported (in kind) web-access to whole-slide images. This work was supported by grant 601040 from the Seventh Framework Programme for Research-funded VPH-PRISM project of the European Union (Mr Ehteshami Bejnordi).	Albarqouni S, 2016, IEEE T MED IMAGING, V35, P1313, DOI 10.1109/TMI.2016.2528120; Bejnordi BE, 2016, IEEE T MED IMAGING, V35, P404, DOI 10.1109/TMI.2015.2476509; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chagpar A, 2005, CANCER-AM CANCER SOC, V103, P1581, DOI 10.1002/cncr.20934; Chakraborty DP, 2011, NUCL INSTRUM METH A, V648, pS297, DOI 10.1016/j.nima.2010.11.042; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gallas BD, 2012, ACAD RADIOL, V19, P463, DOI 10.1016/j.acra.2011.12.016; Griffin J, 2017, HISTOPATHOLOGY, V70, P134, DOI 10.1111/his.12993; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hillis SL, 2011, ACAD RADIOL, V18, P129, DOI 10.1016/j.acra.2010.09.007; Kendall A, BAYESIAN SEGNET MODE; Krizhevsky A., P 25 INT C NEUR INF, P1097; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Obuchowski NA, 2004, ACAD RADIOL, V11, P980, DOI 10.1016/j.arca.2004.04.014; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pendas S, 1999, AM SURGEON, V65, P500; Reed J, 2009, J AM COLL SURGEONS, V208, P333, DOI 10.1016/j.jamcollsurg.2008.10.036; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Simonyan K., VERY DEEP CONVOLUTIO; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Upton G., 2014, DICT STAT 3E; Vestjens JHMJ, 2012, ANN ONCOL, V23, P2561, DOI 10.1093/annonc/mds072; Viola P, 2002, ADV NEUR INF PROC SY, V15; Zheng S, 2015, IEEE I CONF COMP VIS, P1529, DOI 10.1109/ICCV.2015.179	32	1191	1231	46	294	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2199	2210		10.1001/jama.2017.14585	http://dx.doi.org/10.1001/jama.2017.14585			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234806	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000417822700018
J	Gulland, A				Gulland, Anne			CHRISTMAS 2017: THE LIVES OF DOCTORS From app developer to WhatsApp queen-stereotypes of 21st century doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5663	10.1136/bmj.j5663	http://dx.doi.org/10.1136/bmj.j5663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229754				2022-12-28	WOS:000418327000007
J	Harris, K				Harris, Kelley			Reading the genome like a history book Mathematical modeling sheds light on the evolution of human genetic variation	SCIENCE			English	Editorial Material							MUTATIONS; DNA		[Harris, Kelley] Univ Washington, Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Harris, K (corresponding author), Univ Washington, Genome Sci, Seattle, WA 98195 USA.							Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Harris K, 2015, P NATL ACAD SCI USA, V112, P3439, DOI 10.1073/pnas.1418652112; Harris K, 2014, GENOME RES, V24, P1445, DOI 10.1101/gr.170696.113; Harris K, 2014, LECT N BIOINFORMAT, V8394, P100, DOI 10.1007/978-3-319-05269-4_8; Harris K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003521; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Seplyarskiy VB, 2015, MOL BIOL EVOL, V32, P3158, DOI 10.1093/molbev/msv184; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Stone JE, 2012, ENVIRON MOL MUTAGEN, V53, P777, DOI 10.1002/em.21728; Wright S., 1942, Bull Amer Math Soc, V48, P223, DOI 10.1090/S0002-9904-1942-07641-5	13	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368								10.1126/science.aar2003	http://dx.doi.org/10.1126/science.aar2003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217565				2022-12-28	WOS:000417254700047
J	Cannon, KM; Parman, SW; Mustard, JF				Cannon, Kevin M.; Parman, Stephen W.; Mustard, John F.			Primordial clays on Mars formed beneath a steam or supercritical atmosphere	NATURE			English	Article							HYDROUS MINERALS; HISTORY; WATER; DIFFERENTIATION; DIVERSITY; COMPONENT; IMPACTS; ORIGIN; GROWTH; MODEL	On Mars, clay minerals are widespread in terrains that date back to the Noachian period (4.1 billion to 3.7 billion years ago)(1-5). It is thought that the Martian basaltic crust reacted with liquid water during this time to form hydrated clay minerals(3,6). Here we propose, however, that a substantial proportion of these clays was formed when Mars' primary crust reacted with a dense steam or supercritical atmosphere of water and carbon dioxide that was outgassed during magma ocean cooling(7-9). We present experimental evidence that shows rapid clay formation under conditions that would have been present at the base of such an atmosphere and also deeper in the porous crust. Furthermore, we explore the fate of a primordial clay-rich layer with the help of a parameterized crustal evolution model; we find that the primordial clay is locally disrupted by impacts and buried by impact-ejected material and by erupted volcanic material, but that it survives as a mostly coherent layer at depth, with limited surface exposures. These exposures are similar to those observed in remotely sensed orbital data from Mars(1-5). Our results can explain the present distribution of many clays on Mars, and the anomalously low density of the Martian crust in comparison with expectations.	[Cannon, Kevin M.; Parman, Stephen W.; Mustard, John F.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Cannon, Kevin M.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	Brown University; State University System of Florida; University of Central Florida	Cannon, KM (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA.; Cannon, KM (corresponding author), Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.	cannon@ucf.edu						ABE Y, 1993, LITHOS, V30, P223, DOI 10.1016/0024-4937(93)90037-D; Abramov O, 2012, ICARUS, V218, P906, DOI 10.1016/j.icarus.2011.12.022; Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Baratoux D, 2014, J GEOPHYS RES-PLANET, V119, P1707, DOI 10.1002/2014JE004642; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Bottke WF, 2017, NAT GEOSCI, V10, P344, DOI [10.1038/NGEO2937, 10.1038/ngeo2937]; Breuer D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001999; Cannon KM, 2015, ICARUS, V252, P150, DOI 10.1016/j.icarus.2015.01.016; Carter J, 2013, J GEOPHYS RES-PLANET, V118, P831, DOI 10.1029/2012JE004145; Carter J, 2015, ICARUS, V248, P373, DOI 10.1016/j.icarus.2014.11.011; Chemtob S. M., 2017, LUNAR PLANET SCI C, VXLVII; Clark R. N., 1993, US GEOL SURV OPEN FI; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; CROFT SK, 1985, J GEOPHYS RES, V90, pC828, DOI 10.1029/JB090iS02p0C828; Dauphas N, 2011, NATURE, V473, P489, DOI 10.1038/nature10077; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Elkins-Tanton LT, 2008, EARTH PLANET SC LETT, V271, P181, DOI 10.1016/j.epsl.2008.03.062; Garvin JB, 2000, ICARUS, V144, P329, DOI 10.1006/icar.1999.6298; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Kruijer TS, 2017, EARTH PLANET SC LETT, V474, P345, DOI 10.1016/j.epsl.2017.06.047; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Marinova MM, 2008, NATURE, V453, P1216, DOI 10.1038/nature07070; McCubbin FM, 2016, J GEOPHYS RES-PLANET, V121, P2120, DOI 10.1002/2016JE005143; Meunier A, 2012, NAT GEOSCI, V5, P739, DOI [10.1038/NGEO1572, 10.1038/ngeo1572]; Michalski JR, 2015, EARTH PLANET SC LETT, V427, P215, DOI 10.1016/j.epsl.2015.06.020; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Morschhauser A, 2011, ICARUS, V212, P541, DOI 10.1016/j.icarus.2010.12.028; Mustard Architects, 2017, CUR HOM; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Petford N, 2003, GEOL SOC SPEC PUBL, V214, P93, DOI 10.1144/GSL.SP.2003.214.01.06; PIETERS CM, 1983, J GEOPHYS RES, V88, P9534, DOI 10.1029/JB088iB11p09534; Robbins S.J., 2012, GEOPHYS RES, V117, P1, DOI DOI 10.1029/2011JE003967V; Robbins SJ, 2013, ICARUS, V225, P173, DOI 10.1016/j.icarus.2013.03.019; Sun VZ, 2015, J GEOPHYS RES-PLANET, V120, P2293, DOI 10.1002/2015JE004918; Tornabene LL, 2013, J GEOPHYS RES-PLANET, V118, P994, DOI 10.1002/jgre.20082; Viviano-Beck CE, 2017, ICARUS, V284, P43, DOI 10.1016/j.icarus.2016.09.005; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wordsworth RD, 2015, J GEOPHYS RES-PLANET, V120, P1201, DOI 10.1002/2015JE004787	40	30	30	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					88	+		10.1038/nature24657	http://dx.doi.org/10.1038/nature24657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219967				2022-12-28	WOS:000417560500048
J	Simicevic, V				Simicevic, Vedrana			CONSERVATION BIOLOGY Poachers threaten Balkans' underground biodiversity	SCIENCE			English	News Item																			0	8	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1116	1117		10.1126/science.358.6367.1116	http://dx.doi.org/10.1126/science.358.6367.1116			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191884				2022-12-28	WOS:000416584000012
J	Ryskina, KL; Polsky, D; Werner, RM				Ryskina, Kira L.; Polsky, Daniel; Werner, Rachel M.			Physicians and Advanced Practitioners Specializing in Nursing Home Care, 2012-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ryskina, Kira L.] Univ Penn, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Polsky, Daniel] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Ryskina, KL (corresponding author), 1230 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	ryskina@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221	National Institute on Aging [K08AG052572, K24-AG047908]; NATIONAL INSTITUTE ON AGING [K24AG047908, K08AG052572] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Career Development Award K08AG052572 (Dr Ryskina) and K24-AG047908 (DrWerner) from the National Institute on Aging.	Dartmouth Atlas Group, HOSP REF REG ZIP COD; Medicare Payment Advisory Commission, C MED HEALTHC DEL SY; Neuman MD, 2014, JAMA-J AM MED ASSOC, V312, P1542, DOI 10.1001/jama.2014.13513; Research Data Assistance Center, MED DAT PROV PRACT S; Wachter RM, 2016, NEW ENGL J MED, V375, P1009, DOI 10.1056/NEJMp1607958	5	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2040	2042		10.1001/jama.2017.13378	http://dx.doi.org/10.1001/jama.2017.13378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183059	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000416317600026
J	Medaglia, C; Giladi, A; Stoler-Barak, L; De Giovanni, M; Salame, TM; Biram, A; David, E; Li, HJ; Iannacone, M; Shulman, Z; Amit, I				Medaglia, Chiara; Giladi, Amir; Stoler-Barak, Liat; De Giovanni, Marco; Salame, Tomer Meir; Biram, Adi; David, Eyal; Li, Hanjie; Iannacone, Matteo; Shulman, Ziv; Amit, Ido			Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq	SCIENCE			English	Article							GENE-EXPRESSION; SINGLE CELLS; HETEROGENEITY	Cellular functions are strongly dependent on surrounding cells and environmental factors. Current technologies are limited in their ability to characterize the spatial location and gene programs of cells in poorly structured and dynamic niches. We developed a method, NICHE-seq, that combines photoactivatable fluorescent reporters, two-photon microscopy, and single-cell RNA sequencing (scRNA-seq) to infer the cellular and molecular composition of niches. We applied NICHE-seq to examine the high-order assembly of immune cell networks. NICHE-seq is highly reproducible in spatial tissue reconstruction, enabling identification of rare niche-specific immune subpopulations and gene programs, including natural killer cells within infected B cell follicles and distinct myeloid states in the spleen and tumor. This study establishes NICHE-seq as a broadly applicable method for elucidating high-order spatial organization of cell types and their molecular pathways.	[Medaglia, Chiara; Giladi, Amir; Stoler-Barak, Liat; Biram, Adi; David, Eyal; Li, Hanjie; Shulman, Ziv; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [De Giovanni, Marco; Iannacone, Matteo] Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [De Giovanni, Marco; Iannacone, Matteo] Ist Sci San Raffaele, IRCCS, Expt Imaging Ctr, I-20132 Milan, Italy; [De Giovanni, Marco; Iannacone, Matteo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Salame, Tomer Meir] Weizmann Inst Sci, Dept Biol Serv, Flow Cytometry Unit, Rehovot, Israel	Weizmann Institute of Science; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Weizmann Institute of Science	Shulman, Z; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.; Iannacone, M (corresponding author), Ist Sci San Raffaele, IRCCS, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.; Iannacone, M (corresponding author), Ist Sci San Raffaele, IRCCS, Expt Imaging Ctr, I-20132 Milan, Italy.; Iannacone, M (corresponding author), Univ Vita Salute San Raffaele, I-20132 Milan, Italy.	iannacone.matteo@hsr.it; ziv.shulman@weizmann.ac.il; ido.amit@weizmann.ac.il	Li, Hanjie/G-6185-2019; Shulman, Ziv/AAE-2654-2020; Iannacone, Matteo/I-8507-2018	Li, Hanjie/0000-0002-4052-8366; Shulman, Ziv/0000-0002-9604-212X; Iannacone, Matteo/0000-0002-9370-2671; Salame, Tomer Meir/0000-0003-4260-8738; David, Eyal/0000-0002-9020-2364; De Giovanni, Marco/0000-0001-7521-3092	Chan Zuckerberg Initiative; Howard Hughes Medical Institute; European Research Council [724471-HemTree2.0, 677713, 725038]; Melanoma Research Alliance [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; Minerva Stiftung; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center; Abramson Family Center for Young Scientists; Morris Kahn Institute for Human Immunology and Human Frontiers of Science Program [CDA-00023/2016]; Azrieli Foundation; Rising Tide Foundation; Benoziyo Endowment Fund for the Advancement of Science; Comisaroff Family Trust; Irma and Jacques Ber-Lehmsdorf Foundation; Gerald O. Mann Charitable Foundation; David M. Polen Charitable Trust; Italian Association for Cancer Research [15350]; Italian Ministry of Health [GR-2011-02347925]; Fondazione Regionale per la Ricerca Biomedica [2015-0010]; European Molecular Biology Organization; Giovanni Armenise-Harvard Foundation; Clore Fellowship; Marie Curie Individual Fellowship (European Union) (SCALTIE) [746382]	Chan Zuckerberg Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Melanoma Research Alliance; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; Minerva Stiftung; Israeli Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center(German Research Foundation (DFG)); Abramson Family Center for Young Scientists; Morris Kahn Institute for Human Immunology and Human Frontiers of Science Program; Azrieli Foundation; Rising Tide Foundation; Benoziyo Endowment Fund for the Advancement of Science; Comisaroff Family Trust; Irma and Jacques Ber-Lehmsdorf Foundation; Gerald O. Mann Charitable Foundation; David M. Polen Charitable Trust; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Regionale per la Ricerca Biomedica; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Giovanni Armenise-Harvard Foundation; Clore Fellowship; Marie Curie Individual Fellowship (European Union) (SCALTIE)	I.A. is supported by the Chan Zuckerberg Initiative; the Howard Hughes Medical Institute International Scholar Award; European Research Council Consolidator Grant 724471-HemTree2.0; a Melanoma Research Alliance Established Investigator Award (509044); the Israel Science Foundation (703/15); the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; the Helen and Martin Kimmel Award for Innovative Investigation; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology, and Space; the David and Fela Shapell Family Foundation; the NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center Grant; and the Abramson Family Center for Young Scientists. Z.S. is supported by European Research Council grant 677713, the Morris Kahn Institute for Human Immunology and Human Frontiers of Science Program (CDA-00023/2016), the Azrieli Foundation, the Rising Tide Foundation, grants from the Benoziyo Endowment Fund for the Advancement of Science, the Sir Charles Clore Research Prize, the Comisaroff Family Trust, the Irma and Jacques Ber-Lehmsdorf Foundation, the Gerald O. Mann Charitable Foundation, and the David M. Polen Charitable Trust. M. I. is supported by European Research Council Consolidator Grant 725038, Italian Association for Cancer Research grant 15350, Italian Ministry of Health grant GR-2011-02347925, Fondazione Regionale per la Ricerca Biomedica grant 2015-0010, the European Molecular Biology Organization Young Investigator Program, and a Career Development Award from the Giovanni Armenise-Harvard Foundation. A.G. is a recipient of the Clore Fellowship. H.L. is funded by a Marie Curie Individual Fellowship (European Union project 746382, SCALTIE). The data reported in this manuscript are presented in the main paper and the supplementary materials. Raw and processed scRNA-seq data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus with accession number GSE104054.	Duhan V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19191; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lovatt D, 2014, NAT METHODS, V11, P190, DOI [10.1038/NMETH.2804, 10.1038/nmeth.2804]; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shah S, 2017, NEURON, V94, P752, DOI 10.1016/j.neuron.2017.05.008; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032	19	113	115	10	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1622	1626		10.1126/science.aao4277	http://dx.doi.org/10.1126/science.aao4277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29217582	Green Accepted			2022-12-28	WOS:000418448000067
J	Milner, JJ; Toma, C; Yu, BF; Zhang, K; Omilusik, K; Phan, AT; Wang, DP; Getzler, AJ; Nguyen, T; Crotty, S; Wang, W; Pipkin, ME; Goldrath, AW				Milner, J. Justin; Toma, Clara; Yu, Bingfei; Zhang, Kai; Omilusik, Kyla; Phan, Anthony T.; Wang, Dapeng; Getzler, Adam J.; Nguyen, Toan; Crotty, Shane; Wang, Wei; Pipkin, Matthew E.; Goldrath, Ananda W.			Runx3 programs CD8(+) T cell residency in non-lymphoid tissues and tumours	NATURE			English	Article							TRANSCRIPTION FACTORS; INFILTRATING LYMPHOCYTES; LUNG-CANCER; RNA-SEQ; MEMORY; DIFFERENTIATION; INFECTION; CD4(+); POPULATION; EXPRESSION	Tissue-resident memory CD8(+) T (T-RM) cells are found at common sites of pathogen exposure, where they elicit rapid and robust protective immune responses(1,2). However, the molecular signals that control T-RM cell differentiation and homeostasis are not fully understood. Here we show that mouse T-RM precursor cells represent a unique CD8(+) T cell subset that is distinct from the precursors of circulating memory cell populations at the levels of gene expression and chromatin accessibility. Using computational and pooled in vivo RNA interference screens, we identify the transcription factor Runx3 as a key regulator of T-RM cell differentiation and homeostasis. Runx3 was required to establish T-RM cell populations in diverse tissue environments, and supported the expression of crucial tissue-residency genes while suppressing genes associated with tissue egress and recirculation. Furthermore, we show that human and mouse tumour-infiltrating lymphocytes share a core tissue-residency gene-expression signature with T-RM cells that is associated with Runx3 activity. In a mouse model of adoptive T cell therapy for melanoma, Runx3-deficient CD8(+) tumour-infiltrating lymphocytes failed to accumulate in tumours, resulting in greater rates of tumour growth and mortality. Conversely, overexpression of Runx3 enhanced tumour-specific CD8(+) T cell abundance, delayed tumour growth, and prolonged survival. In addition to establishing Runx3 as a central regulator of T-RM cell differentiation, these results provide insight into the signals that promote T cell residency in non-lymphoid sites, which could be used to enhance vaccine efficacy or adoptive cell therapy treatments that target cancer.	[Milner, J. Justin; Toma, Clara; Yu, Bingfei; Omilusik, Kyla; Phan, Anthony T.; Nguyen, Toan; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zhang, Kai; Wang, Wei] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Wang, Dapeng; Getzler, Adam J.; Pipkin, Matthew E.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.; Pipkin, ME (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.	mpipkin@scripps.edu; agoldrath@ucsd.edu	Zhang, Kai/E-5426-2010; Zhang, Kai/D-6501-2016; Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019; Wang, Dapeng/HGD-4818-2022; Getzler, Adam/U-9845-2017	Zhang, Kai/0000-0003-3454-7357; Zhang, Kai/0000-0003-3454-7357; Crotty, Shane/0000-0002-6484-6262; Omilusik, Kyla/0000-0003-3675-048X; Pipkin, Matthew/0000-0002-9688-0190; Phan, Anthony/0000-0003-2935-6070; Goldrath, Ananda/0000-0002-5900-508X; Getzler, Adam/0000-0001-8091-3851	UCSD Molecular Biology Cancer Fellowship; US National Institutes of Health [U19AI109976, R01 AI095634]; California Institute for Regenerative Medicine [RB5-07012]; Kimmelman Family Foundation; San Diego Center for Precision Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095634, U19AI109976] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016262] Funding Source: NIH RePORTER	UCSD Molecular Biology Cancer Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Kimmelman Family Foundation; San Diego Center for Precision Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all the members of the Goldrath and Pipkin laboratories for their contributions. We also thank the Flow Cytometry Core at the La Jolla Institute for Allergy and Immunology. This study was funded in part by the UCSD Molecular Biology Cancer Fellowship (J.J.M.), the US National Institutes of Health U19AI109976 (S.C., M.E.P., A.W.G) and R01 AI095634 (M.E.P.), California Institute for Regenerative Medicine RB5-07012 (W.W.), the Kimmelman Family Foundation and the San Diego Center for Precision Immunotherapy (A.W.G.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 1998, TECHNICAL REPORT; Benck CJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53638; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Doedens AL, 2016, CANCER IMMUNOL RES, V4, P799, DOI 10.1158/2326-6066.CIR-15-0178; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Grueter B, 2005, J IMMUNOL, V175, P1694, DOI 10.4049/jimmunol.175.3.1694; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Knott SRV, 2014, MOL CELL, V56, P796, DOI 10.1016/j.molcel.2014.10.025; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706	37	300	306	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					253	+		10.1038/nature24993	http://dx.doi.org/10.1038/nature24993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211713	Green Accepted			2022-12-28	WOS:000418029500047
J	Gomez, AM				Gomez, Anu Manchikanti			Availability of Pharmacist-Prescribed Contraception in California, 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PROVISION		[Gomez, Anu Manchikanti] Univ Calif Berkeley, Sch Social Welf, Sexual Hlth & Reprod Equ Program, 110 Haviland Hall MC 7400, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gomez, AM (corresponding author), Univ Calif Berkeley, Sch Social Welf, Sexual Hlth & Reprod Equ Program, 110 Haviland Hall MC 7400, Berkeley, CA 94720 USA.	anugomez@berkeley.edu		Gomez, Anu Manchikanti/0000-0002-9461-4411				California State Board of Pharmacy, 2016, SELF ADM HORM CONTR; Gonsalves L, 2017, CONTRACEPTION, V95, P339, DOI 10.1016/j.contraception.2016.12.002; National Alliance of State Pharmacy Associations (NASPA), 2017, PHARM AUTH PRESCR BI; Rodriguez MI, 2016, J AM PHARM ASSOC, V56, P521, DOI 10.1016/j.japh.2016.05.003	4	41	41	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2253	2254		10.1001/jama.2017.15674	http://dx.doi.org/10.1001/jama.2017.15674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234797	Bronze, Green Published			2022-12-28	WOS:000417822700023
J	Bell, C				Bell, Catherine			CHRISTMAS 2017: ALL CREATURES GREAT AND SMALL Does Peppa Pig encourage inappropriate use of primary care resources?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bell, Catherine] Valleys Med Partnership, Moss Valley Med Practice, Sheffield, S Yorkshire, England		Bell, C (corresponding author), Valleys Med Partnership, Moss Valley Med Practice, Sheffield, S Yorkshire, England.	catherine.gray@doctors.org.uk							0	1	1	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5397	10.1136/bmj.j5397	http://dx.doi.org/10.1136/bmj.j5397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229662				2022-12-28	WOS:000418327000004
J	Redelmeier, DA; Shafir, E				Redelmeier, Donald A.; Shafir, Eldar			The full moon and motorcycle related mortality: population based double control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRIVING FATALITIES; INJURY PATTERNS; UNITED-STATES; BIAS; US; CHALLENGE; INCIDENTS; LUMINANCE; CAPTURE; DEATHS	OBJECTIVE To test whether a full moon contributes to motorcycle related deaths. DESIGN Population based, individual level, double control, cross sectional analysis. SETTING Nighttime (4 pm to 8 am), United States. PARTICIPANTS 13 029 motorcycle fatalities throughout the United States, 1975 to 2014 (40 years). MAIN OUTCOME MEASURE Motorcycle fatalities during a full moon. RESULTS 13 029 motorcyclists were in fatal crashes during 1482 relevant nights. The typical motorcyclist was a middle aged man (mean age 32 years) riding a street motorcycle with a large engine in a rural location who experienced a head-on frontal impact and was not wearing a helmet. 4494 fatal crashes occurred on the 494 nights with a full moon (9.10/night) and 8535 on the 988 control nights without a full moon (8.64/night). Comparisons yielded a relative risk of 1.05 associated with the full moon (95% confidence interval 1.02 to 1.09, P=0.005), a conditional odds ratio of 1.26 (95% confidence interval 1.17 to 1.37, P<0.001), and an absolute increase of 226 additional deaths over the study interval. The increase extended to diverse types of motorcyclists, vehicles, and crashes; was accentuated during a supermoon; and replicated in analyses from the United Kingdom, Canada, and Australia. CONCLUSION The full moon is associated with an increased risk of fatal motorcycle crashes, although potential confounders cannot be excluded. An awareness of the risk might encourage motorcyclists to ride with extra care during a full moon and, more generally, to appreciate the power of seemingly minor distractions at all times.	[Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada; [Shafir, Eldar] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Shafir, Eldar] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Princeton University; Princeton University	Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca	Sutter, Raoul/J-7747-2019; Shafir, Eldar/H-9957-2014	Sutter, Raoul/0000-0002-6575-356X; 	Canada research chair in medical decision sciences; Canadian Institute for Advanced Research; Canadian Institutes of Health Research; Ontario Ministry of Transportation	Canada research chair in medical decision sciences(Canada Research Chairs); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Transportation	This project was supported by a Canada research chair in medical decision sciences, the Canadian Institute for Advanced Research, the Canadian Institutes of Health Research, and the Ontario Ministry of Transportation. The views are those of the authors and do not necessarily reflect the Ontario Ministry of Health.	ALONSO Y, 1993, PERCEPT MOTOR SKILL, V77, P371, DOI 10.2466/pms.1993.77.2.371; [Anonymous], FAT AN REP SYST ENC; [Anonymous], 2012, NATL VITAL STAT REPO, V61; BALLING RC, 1995, SCIENCE, V267, P1481, DOI 10.1126/science.267.5203.1481; BRADLEY DA, 1962, SCIENCE, V137, P748, DOI 10.1126/science.137.3532.748; Burns W., 2013, CORONA SHOOTS MOON L; Busko A, 2017, NEW ENGL J MED, V376, P1208, DOI 10.1056/NEJMp1615621; Cheung B, 2013, AVIAT SPACE ENVIR MD, V84, P1211, DOI 10.3357/ASEM.3657.2013; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e612; Coffee P., 2012, HAAGEN DAZS ICE MOON; Dunn J, 2009, J PSYCHOSOC ONCOL, V27, P119, DOI 10.1080/07347330802616084; Evans L., 2004, TRAFFIC SAFETY; Evans L, 2014, AM J PUBLIC HEALTH, V104, P1501, DOI 10.2105/AJPH.2014.301922; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; Galera C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8105; Government of Canada, TRANSP CAN NAT COLL; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5565; Hershenson M., 1989, THE MOON ILLUSION; Hulley SB, 2007, DESIGNING CLIN RES; Irwin DE, 2000, VISION RES, V40, P1443, DOI 10.1016/S0042-6989(00)00030-4; JONIDES J, 1981, COGNITION, V10, P145, DOI 10.1016/0010-0277(81)90038-X; Klauer SG, 2014, NEW ENGL J MED, V370, P54, DOI 10.1056/NEJMsa1204142; Kohyama T, 2016, GEOPHYS RES LETT, V43, P918, DOI 10.1002/2015GL067342; Lastfogel J, 2016, JAMA SURG, V151, P88, DOI 10.1001/jamasurg.2015.3225; LEIBOWITZ HW, 1977, SCIENCE, V197, P422, DOI 10.1126/science.197.4302.422-a; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Liu BS, 2007, ACCIDENT ANAL PREV, V39, P216, DOI 10.1016/j.aap.2006.07.005; McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3799; Morris BA, 2012, SUPPORT CARE CANCER, V20, P1849, DOI 10.1007/s00520-011-1287-5; Muratore S, 2016, AM J SURG, V212, P670, DOI 10.1016/j.amjsurg.2016.06.011; National Aeronautics and Space Administration, SUP FULL MOON; National Highway Traffic Safety Administration, 2002, 812035 US DOT HS NAT; National Highway Traffic Safety Administration, FAT AN REP SYST FARS; National Highway Traffic Safety Administration, 2002, 809242 US DOT HS NAT; National Highway Traffic Safety Administration, TRAFF SAF FACTS 2012; Nolle R, SUPERMOON; Nudd T., 2013, CRESCENT MOON BECOME; Proulx MJ, 2008, PSYCHOL RES-PSYCH FO, V72, P106, DOI 10.1007/s00426-006-0077-z; Proulx MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015293; Redelmeier DA, 1997, J CLIN EPIDEMIOL, V50, P1281, DOI 10.1016/S0895-4356(97)00196-0; Redelmeier DA, 2003, NEW ENGL J MED, V348, P368, DOI 10.1056/NEJM200301233480423; Redelmeier DA, 2008, JAMA-J AM MED ASSOC, V300, P1518, DOI 10.1001/jama.300.13.1518; Redelmeier DA, 2017, J CLIN EPIDEMIOL, V81, P51, DOI 10.1016/j.jclinepi.2016.08.006; Redelmeier DA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005710; Redelmeier DA, 2014, MED DECIS MAKING, V34, P940, DOI 10.1177/0272989X14526642; Redelmeier DA, 2012, JAMA-J AM MED ASSOC, V307, P1486, DOI 10.1001/jama.2012.450; Redelmeier DA, 2012, J CLIN EPIDEMIOL, V65, P467, DOI 10.1016/j.jclinepi.2011.09.007; Redelmeier DA, 2010, MED DECIS MAKING, V30, pE12, DOI 10.1177/0272989X09357476; Retting R, 2017, MOTORCYCLE TRAFFIC F; Riotte-Lambert L, 2013, J THEOR BIOL, V317, P238, DOI 10.1016/j.jtbi.2012.10.026; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sarton G., 1939, ISIS, V30, P495, DOI [10.1086/347530, DOI 10.1086/347530]; Schafer JA, 2010, J CRIM JUST, V38, P359, DOI 10.1016/j.jcrimjus.2010.04.003; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; SHAH GM, 1972, NATURE, V237, P275, DOI 10.1038/237275a0; Simpson JC, 2015, TRAFFIC INJ PREV, V16, P159, DOI 10.1080/15389588.2014.911852; Smith AP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011461; Smith MP, 2017, J SLEEP RES, V26, P371, DOI 10.1111/jsr.12472; TANNER JC, 1952, NATURE, V169, P107, DOI 10.1038/169107a0; US Department of Transportation, TRAFF SAF FACTS; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson FA, 2010, AM J PUBLIC HEALTH, V100, P2213, DOI 10.2105/AJPH.2009.187179; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95	65	8	8	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5367	10.1136/bmj.j5367	http://dx.doi.org/10.1136/bmj.j5367			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KT	29229755	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000418327000003
J	Aigner, H; Wilson, RH; Bracher, A; Calisse, L; Bhat, JY; Hartl, FU; Hayer-Hartl, M				Aigner, H.; Wilson, R. H.; Bracher, A.; Calisse, L.; Bhat, J. Y.; Hartl, F. U.; Hayer-Hartl, M.			Plant RuBisCo assembly in E. coli with five chloroplast chaperones including BSD2	SCIENCE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; TEMPERATURE RESPONSE; RBCX; PROTEIN; PHOTOSYNTHESIS; BIOGENESIS; PROSPECTS; GENE; EXPRESSION; FUTURE	Plant RuBisCo, a complex of eight large and eight small subunits, catalyzes the fixation of CO2 in photosynthesis. The low catalytic efficiency of RuBisCo provides strong motivation to reengineer the enzyme with the goal of increasing crop yields. However, genetic manipulation has been hampered by the failure to express plant RuBisCo in a bacterial host. We achieved the functional expression of Arabidopsis thaliana RuBisCo in Escherichia coli by coexpressing multiple chloroplast chaperones. These include the chaperonins Cpn60/Cpn20, RuBisCo accumulation factors 1 and 2, RbcX, and bundle-sheath defective-2 (BSD2). Our structural and functional analysis revealed the role of BSD2 in stabilizing an end-state assembly intermediate of eight RuBisCo large subunits until the small subunits become available. The ability to produce plant RuBisCo recombinantly will facilitate efforts to improve the enzyme through mutagenesis.	[Aigner, H.; Wilson, R. H.; Bracher, A.; Calisse, L.; Bhat, J. Y.; Hartl, F. U.; Hayer-Hartl, M.] Max Planck Inst Biochem, Dept Cellular Biochem, Martinsried, Germany	Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Martinsried, Germany.	mhartl@biochem.mpg.de	Wilson, Robbie/AAP-7650-2020; Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017; Wilson, Robert H/C-3593-2019	Wilson, Robbie/0000-0003-4168-2805; Hayer-Hartl, Manajit/0000-0001-8213-6742; Wilson, Robert H/0000-0003-4168-2805; Hartl, F. Ulrich/0000-0002-7941-135X; BHAT, JAVAID/0000-0002-7153-6035; Calisse, Lorenzo/0000-0001-5125-7277	European Synchrotron Radiation Facility (ESRF) in Grenoble, France; Minerva Foundation of the Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft [SFB1035]	European Synchrotron Radiation Facility (ESRF) in Grenoble, France; Minerva Foundation of the Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Expert technical assistance by S. Gartner, A. Jungclaus, and A. Ries is acknowledged. Antibodies against Raf2 were a kind gift from S. Merchant (University of California, Los Angeles). We thank the immunization facility of the Max Planck Institute of Biochemistry (MPIB) for the generation of primary rabbit antibodies. We thank the staff at the MPIB Crystallization facility and at beamline X10SA of the Swiss Light Source in Villigen, Switzerland, and the European Synchrotron Radiation Facility (ESRF) in Grenoble, France, for their support. M.H.-H. acknowledges funding by the Minerva Foundation of the Max Planck Gesellschaft and a grant of the Deutsche Forschungsgemeinschaft (SFB1035) to M.H.-H. and F.U.H. X-ray structure factors and refined coordinates have been deposited in the Protein Data Bank (www.wwpdb.org) under accession numbers 6EKB and 6EKC for AtBSD2 and TeRbcL(IA)<INF>8</INF>:AtBSD2<INF>8</INF>, respectively. H.A. generated the plasmids and the E. coli strain for AtRuBisCo expression. H.A. and R.H.W designed and performed most of the in vivo and in vitro experiments. H.A. performed mass spectrometry proteomics and generated antibodies. R.H.W. kinetically characterized recombinant AtRuBisCo, crystallized RuBisCo complexes, and performed native-MS with assistance from J.Y.B. L.C. assisted in BSD2 crystallization and mutagenic analysis. A.B. solved the crystal structures. F.U.H. and M.H.-H. supervised the experimental design and wrote the manuscript, with contributions from the other authors.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; Bishop KA, 2015, PLANT CELL ENVIRON, V38, P1765, DOI 10.1111/pce.12443; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Bracher A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135448; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; CLONEY LP, 1992, J BIOL CHEM, V267, P23333; Doron L, 2014, PLANT J, V80, P345, DOI 10.1111/tpj.12638; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Erb TJ, 2016, CURR OPIN CHEM BIOL, V34, P72, DOI 10.1016/j.cbpa.2016.06.026; Evans JR, 2013, PLANT PHYSIOL, V162, P1780, DOI 10.1104/pp.113.219006; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; Furbank RT, 2015, FIELD CROP RES, V182, P19, DOI 10.1016/j.fcr.2015.04.009; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gruber AV, 2013, TRENDS PLANT SCI, V18, P688, DOI 10.1016/j.tplants.2013.08.001; Hauser T, 2015, NAT STRUCT MOL BIOL, V22, P720, DOI 10.1038/nsmb.3062; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Kolesinski P, 2014, FEBS J, V281, P3920, DOI 10.1111/febs.12928; Kolesinski P, 2013, BBA-GEN SUBJECTS, V1830, P2899, DOI 10.1016/j.bbagen.2012.12.025; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Orr DJ, 2016, PLANT PHYSIOL, V172, P707, DOI 10.1104/pp.16.00750; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Sharwood RE, 2017, NEW PHYTOL, V213, P494, DOI 10.1111/nph.14351; Sharwood RE, 2016, CURR OPIN PLANT BIOL, V31, P135, DOI 10.1016/j.pbi.2016.04.002; Sjuts I, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00168; Tanaka S, 2007, ACTA CRYSTALLOGR D, V63, P1109, DOI 10.1107/S090744490704228X; Tarnawski M, 2011, ACTA CRYSTALLOGR F, V67, P851, DOI 10.1107/S1744309111018860; Tarnawski M, 2008, ACTA BIOCHIM POL, V55, P777; Trosch R, 2015, BBA-BIOENERGETICS, V1847, P872, DOI 10.1016/j.bbabio.2015.01.002; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Whitney SM, 2015, P NATL ACAD SCI USA, V112, P3564, DOI 10.1073/pnas.1420536112; Wilson R. H., 2017, J BIOL CHEM; Wilson RH., 2017, DIRECTED ENZYME EVOL, P101, DOI [10.1007/978-3-319-50413-1_4, DOI 10.1007/978-3-319-50413-1_4]; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6	42	114	121	9	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1272	+		10.1126/science.aap9221	http://dx.doi.org/10.1126/science.aap9221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217567	Green Submitted			2022-12-28	WOS:000417254700052
J	Poff, NL; Olden, JD				Poff, N. Leroy; Olden, Julian D.			Can dams be designed for sustainability? Dam design on the Mekong River can help to support water, energy, and fisheries needs	SCIENCE			English	Editorial Material							HYDROPOWER; BIODIVERSITY; SECURITY		[Poff, N. Leroy] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Poff, N. Leroy] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2617, Australia; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Olden, Julian D.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia	Colorado State University; University of Canberra; University of Washington; University of Washington Seattle; Griffith University	Poff, NL (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.; Poff, NL (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2617, Australia.	poff@lamar.colostate.edu	Olden, Julian D/A-8535-2010	Poff, N LeRoy/0000-0002-1390-8742; Olden, Julian/0000-0003-2143-1187				Acreman M, 2014, FRONT ECOL ENVIRON, V12, P466, DOI 10.1890/130134; Auerbach DA, 2014, ECOSYST SERV, V10, P1, DOI 10.1016/j.ecoser.2014.07.005; Bodin O, 2017, SCIENCE, V357, P659, DOI 10.1126/science.aan1114; Chen W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02226-4; Forsberg BR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182254; Poff NL, 2016, SCIENCE, V353, P1099, DOI 10.1126/science.aah4926; Poff NL, 2016, NAT CLIM CHANGE, V6, P25, DOI [10.1038/nclimate2765, 10.1038/NCLIMATE2765]; Sabo JL, 2017, SCIENCE, V358, DOI 10.1126/science.aao1053; Tickner D, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00004; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wantzen KM, 2016, ECOHYDROL HYDROBIOL, V16, P7, DOI 10.1016/j.ecohyd.2015.12.003; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	14	50	51	9	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1252	1253		10.1126/science.aaq1422	http://dx.doi.org/10.1126/science.aaq1422			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217554				2022-12-28	WOS:000417254700036
J	Ambrosi, G; An, Q; Asfandiyarov, R; Azzarello, P; Bernardini, P; Bertucci, B; Cai, MS; Chang, J; Chen, DY; Chen, HF; Chen, JL; Chen, W; Cui, MY; Cui, TS; D'Amone, A; De Benedittis, A; De Mitri, I; Di Santo, M; Dong, JN; Dong, TK; Dong, YF; Dong, ZX; Donvito, G; Droz, D; Duan, KK; Duan, JL; Duranti, M; D'Urso, D; Fan, RR; Fan, YZ; Fang, F; Feng, CQ; Feng, L; Fusco, P; Gallo, V; Gan, FJ; Gao, M; Gao, SS; Gargano, F; Garrappa, S; Gong, K; Gong, YZ; Guo, DY; Guo, JH; Hu, YM; Huang, GS; Huang, YY; Ionica, M; Jiang, D; Jiang, W; Jin, X; Kong, J; Lei, SJ; Li, S; Li, X; Li, WL; Li, Y; Liang, YF; Liang, YM; Liao, NH; Liu, H; Liu, J; Liu, SB; Liu, WQ; Liu, Y; Loparco, F; Ma, M; Ma, PX; Ma, SY; Ma, T; Ma, XQ; Ma, XY; Marsella, G; Mazziotta, MN; Mo, D; Niu, XY; Peng, XY; Peng, WX; Qiao, R; Rao, JN; Salinas, MM; Shang, GZ; Shen, WH; Shen, ZQ; Shen, ZT; Song, JX; Su, H; Su, M; Sun, ZY; Surdo, A; Teng, XJ; Tian, XB; Tykhonov, A; Vagelli, V; Vitillo, S; Wang, C; Wang, H; Wang, HY; Wang, JZ; Wang, LG; Wang, Q; Wang, S; Wang, XH; Wang, XL; Wang, YF; Wang, YP; Wang, YZ; Wen, SC; Wang, ZM; Wei, DM; Wei, JJ; Wei, YF; Wu, D; Wu, J; Wu, LB; Wu, SS; Wu, X; Xi, K; Xia, ZQ; Xin, YL; Xu, HT; Xu, ZL; Xu, ZZ; Xue, GF; Yang, HB; Yang, P; Yang, YQ; Yang, ZL; Yao, HJ; Yu, YH; Yuan, Q; Yue, C; Zang, JJ; Zhang, C; Zhang, DL; Zhang, F; Zhang, JB; Zhang, JY; Zhang, JZ; Zhang, L; Zhang, PF; Zhang, SX; Zhang, WZ; Zhang, Y; Zhang, YJ; Zhang, YQ; Zhang, YL; Zhang, YP; Zhang, Z; Zhang, ZY; Zhao, H; Zhao, HY; Zhao, XF; Zhou, CY; Zhou, Y; Zhu, X; Zhu, Y; Zimmer, S				Ambrosi, G.; An, Q.; Asfandiyarov, R.; Azzarello, P.; Bernardini, P.; Bertucci, B.; Cai, M. S.; Chang, J.; Chen, D. Y.; Chen, H. F.; Chen, J. L.; Chen, W.; Cui, M. Y.; Cui, T. S.; D'Amone, A.; De Benedittis, A.; De Mitri, I.; Di Santo, M.; Dong, J. N.; Dong, T. K.; Dong, Y. F.; Dong, Z. X.; Donvito, G.; Droz, D.; Duan, K. K.; Duan, J. L.; Duranti, M.; D'Urso, D.; Fan, R. R.; Fan, Y. Z.; Fang, F.; Feng, C. Q.; Feng, L.; Fusco, P.; Gallo, V.; Gan, F. J.; Gao, M.; Gao, S. S.; Gargano, F.; Garrappa, S.; Gong, K.; Gong, Y. Z.; Guo, D. Y.; Guo, J. H.; Hu, Y. M.; Huang, G. S.; Huang, Y. Y.; Ionica, M.; Jiang, D.; Jiang, W.; Jin, X.; Kong, J.; Lei, S. J.; Li, S.; Li, X.; Li, W. L.; Li, Y.; Liang, Y. F.; Liang, Y. M.; Liao, N. H.; Liu, H.; Liu, J.; Liu, S. B.; Liu, W. Q.; Liu, Y.; Loparco, F.; Ma, M.; Ma, P. X.; Ma, S. Y.; Ma, T.; Ma, X. Q.; Ma, X. Y.; Marsella, G.; Mazziotta, M. N.; Mo, D.; Niu, X. Y.; Peng, X. Y.; Peng, W. X.; Qiao, R.; Rao, J. N.; Salinas, M. M.; Shang, G. Z.; Shen, W. H.; Shen, Z. Q.; Shen, Z. T.; Song, J. X.; Su, H.; Su, M.; Sun, Z. Y.; Surdo, A.; Teng, X. J.; Tian, X. B.; Tykhonov, A.; Vagelli, V.; Vitillo, S.; Wang, C.; Wang, H.; Wang, H. Y.; Wang, J. Z.; Wang, L. G.; Wang, Q.; Wang, S.; Wang, X. H.; Wang, X. L.; Wang, Y. F.; Wang, Y. P.; Wang, Y. Z.; Wen, S. C.; Wang, Z. M.; Wei, D. M.; Wei, J. J.; Wei, Y. F.; Wu, D.; Wu, J.; Wu, L. B.; Wu, S. S.; Wu, X.; Xi, K.; Xia, Z. Q.; Xin, Y. L.; Xu, H. T.; Xu, Z. L.; Xu, Z. Z.; Xue, G. F.; Yang, H. B.; Yang, P.; Yang, Y. Q.; Yang, Z. L.; Yao, H. J.; Yu, Y. H.; Yuan, Q.; Yue, C.; Zang, J. J.; Zhang, C.; Zhang, D. L.; Zhang, F.; Zhang, J. B.; Zhang, J. Y.; Zhang, J. Z.; Zhang, L.; Zhang, P. F.; Zhang, S. X.; Zhang, W. Z.; Zhang, Y.; Zhang, Y. J.; Zhang, Y. Q.; Zhang, Y. L.; Zhang, Y. P.; Zhang, Z.; Zhang, Z. Y.; Zhao, H.; Zhao, H. Y.; Zhao, X. F.; Zhou, C. Y.; Zhou, Y.; Zhu, X.; Zhu, Y.; Zimmer, S.		Dampe Collaboration	Direct detection of a break in the teraelectronvolt cosmic-ray spectrum of electrons and positrons	NATURE			English	Article							PARTICLE DARK-MATTER; PROPAGATION; CANDIDATES; SIGNATURE; ENERGIES	High-energy cosmic-ray electrons and positrons (CREs), which lose energy quickly during their propagation, provide a probe of Galactic high-energy processes(1-7) and may enable the observation of phenomena such as dark-matter particle annihilation or decay(8-10). The CRE spectrum has been measured directly up to approximately 2 teraelectronvolts in previous balloon-or space-borne experiments(11-16), and indirectly up to approximately 5 teraelectronvolts using ground-based Cherenkov gamma-ray telescope arrays(17,18). Evidence for a spectral break in the teraelectronvolt energy range has been provided by indirect measurements(17,18), although the results were qualified by sizeable systematic uncertainties. Here we report a direct measurement of CREs in the energy range 25 gigaelectronvolts to 4.6 teraelectronvolts by the Dark Matter Particle Explorer (DAMPE)(19) with unprecedentedly high energy resolution and low background. The largest part of the spectrum can be well fitted by a 'smoothly broken power-law' model rather than a single power-law model. The direct detection of a spectral break at about 0.9 teraelectronvolts confirms the evidence found by previous indirect measurements(17,18), clarifies the behaviour of the CRE spectrum at energies above 1 teraelectronvolt and sheds light on the physical origin of the sub-teraelectronvolt CREs.	[Ambrosi, G.; Bertucci, B.; Duranti, M.; D'Urso, D.; Garrappa, S.; Ionica, M.; Vagelli, V.] Ist Nazl Fis Nucl INFN, Sez Perugia, I-06123 Perugia, Italy; [An, Q.; Chen, H. F.; Dong, J. N.; Feng, C. Q.; Gan, F. J.; Gao, S. S.; Huang, G. S.; Jiang, D.; Jin, X.; Liu, S. B.; Ma, S. Y.; Shen, Z. T.; Wang, C.; Wang, Q.; Wang, X. L.; Wang, Y. F.; Wei, Y. F.; Wu, L. B.; Xu, Z. Z.; Zhang, D. L.; Zhang, J. B.; Zhang, Y. L.; Zhang, Z. Y.; Zhu, X.] Univ Sci & Technol China, State Key Lab Particle Detect & Elect, Hefei 230026, Anhui, Peoples R China; [An, Q.; Chen, H. F.; Dong, J. N.; Feng, C. Q.; Gan, F. J.; Gao, S. S.; Huang, G. S.; Jiang, D.; Jin, X.; Liu, S. B.; Ma, S. Y.; Shen, Z. T.; Wang, C.; Wang, Q.; Wang, X. L.; Wang, Y. F.; Wei, Y. F.; Wu, L. B.; Xu, Z. Z.; Zhang, D. L.; Zhang, J. B.; Zhang, Y. L.; Zhang, Z. Y.; Zhu, X.] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Asfandiyarov, R.; Azzarello, P.; Droz, D.; Gallo, V.; Salinas, M. M.; Tykhonov, A.; Vitillo, S.; Wu, X.; Zimmer, S.] Univ Geneva, Dept Nucl & Particle Phys, CH-1211 Geneva, Switzerland; [Bernardini, P.; D'Amone, A.; De Benedittis, A.; De Mitri, I.; Marsella, G.] Univ Salento, Dipartimento Matemat & Fis E De Giorgi, I-73100 Lecce, Italy; [Bernardini, P.; D'Amone, A.; De Benedittis, A.; De Mitri, I.; Marsella, G.] Ist Nazl Fis Nucl INFN, Sez Lecce, I-73100 Lecce, Italy; [Bertucci, B.; Duranti, M.; Garrappa, S.; Vagelli, V.] Univ Perugia, Dipartimento Fis & Geol, I-06123 Perugia, Italy; [Cai, M. S.; Chang, J.; Chen, D. Y.; Chen, W.; Cui, M. Y.; Dong, T. K.; Duan, K. K.; Fan, Y. Z.; Feng, L.; Gong, Y. Z.; Guo, J. H.; Hu, Y. M.; Huang, Y. Y.; Jiang, W.; Lei, S. J.; Li, S.; Li, X.; Liang, Y. F.; Liao, N. H.; Liu, H.; Liu, Y.; Ma, P. X.; Ma, T.; Peng, X. Y.; Shen, Z. Q.; Su, M.; Wang, S.; Wang, Y. P.; Wang, Y. Z.; Wen, S. C.; Wei, D. M.; Wei, J. J.; Wu, J.; Xia, Z. Q.; Xin, Y. L.; Xu, Z. L.; Yuan, Q.; Yue, C.; Zang, J. J.; Zhang, C.; Zhang, L.; Zhang, P. F.; Zhang, Y.; Zhang, Y. Q.; Zhang, Z.] Chinese Acad Sci, Purple Mt Observ, Key Lab Dark Matter & Space Astron, Nanjing 210008, Jiangsu, Peoples R China; [Cai, M. S.; Chang, J.; Fan, Y. Z.; Jiang, W.; Ma, P. X.; Wei, D. M.; Wu, J.; Xia, Z. Q.; Yuan, Q.] Univ Sci & Technol China, Sch Astron & Space Sci, Hefei 230026, Anhui, Peoples R China; [Chen, D. Y.; Chen, W.; Duan, K. K.; Li, S.; Liang, Y. F.; Shen, Z. Q.; Wang, S.; Wang, Y. P.; Wang, Y. Z.; Wen, S. C.; Xu, Z. L.; Yue, C.; Zhang, L.; Zhang, Y.; Zhang, Y. Q.] Univ Chinese Acad Sci, Yuquan Rd 19, Beijing 100049, Peoples R China; [Chen, J. L.; Duan, J. L.; Fang, F.; Kong, J.; Li, Y.; Liu, J.; Liu, W. Q.; Mo, D.; Niu, X. Y.; Su, H.; Sun, Z. Y.; Wang, X. H.; Wang, Z. M.; Xi, K.; Yang, H. B.; Yang, P.; Yang, Y. Q.; Yang, Z. L.; Yao, H. J.; Yu, Y. H.; Zhang, J. Z.; Zhang, S. X.; Zhang, Y. J.; Zhang, Y. P.; Zhao, H. Y.; Zhou, Y.] Chinese Acad Sci, Inst Modern Phys, Nanchang Rd 509, Lanzhou 730000, Gansu, Peoples R China; [Cui, T. S.; Dong, Z. X.; Li, W. L.; Liang, Y. M.; Ma, M.; Ma, X. Q.; Ma, X. Y.; Rao, J. N.; Shang, G. Z.; Shen, W. H.; Song, J. X.; Teng, X. J.; Tian, X. B.; Wang, H.; Wang, L. G.; Wu, S. S.; Xu, H. T.; Xue, G. F.; Zhang, W. Z.; Zhao, X. F.; Zhou, C. Y.; Zhu, Y.] Chinese Acad Sci, Natl Space Sci Ctr, Nanertiao 1, Beijing 100190, Peoples R China; [Dong, Y. F.; Fan, R. R.; Gao, M.; Gong, K.; Guo, D. Y.; Peng, W. X.; Qiao, R.; Wang, H. Y.; Wang, J. Z.; Wu, D.; Zhang, F.; Zhang, J. Y.; Zhao, H.] Chinese Acad Sci, Inst High Energy Phys, YuquanLu 19B, Beijing 100049, Peoples R China; [Donvito, G.; Fusco, P.; Gargano, F.; Loparco, F.; Mazziotta, M. N.] Ist Nazl Fis Nucl INFN, Sez Bari, I-70125 Bari, Italy; [D'Urso, D.] ASI Space Sci Data Ctr SSDC, I-00133 Rome, Italy; [Fusco, P.; Loparco, F.] Univ Politecn Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Su, M.] Univ Hong Kong, Dept Phys, Pok Fu Lam, Hong Kong, Peoples R China; [Su, M.] Univ Hong Kong, Lab Space Res, Pok Fu Lam, Hong Kong, Peoples R China	Istituto Nazionale di Fisica Nucleare (INFN); Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Geneva; University of Salento; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; National Space Science Center, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Istituto Nazionale di Fisica Nucleare (INFN); Politecnico di Bari; University of Hong Kong; University of Hong Kong	Ambrosi, G (corresponding author), Ist Nazl Fis Nucl INFN, Sez Perugia, I-06123 Perugia, Italy.		Yang, Zhan/GQG-9995-2022; Duranti, Matteo/I-7691-2013; Tykhonov, Andrii/Q-8688-2018; Sun, Zhiyu/B-3922-2012; D'Urso, Domenico/I-5325-2012; Gargano, Fabio/AAD-5121-2021; Donvito, Giacinto/AAC-9872-2020; Duan, Jinglai/B-8561-2012; Vagelli, Valerio/J-9425-2016; Wu, Xin/ABH-1729-2020; Gao, Shanshan/AAI-5302-2021; Surdo, Antonio/H-2303-2017; De Mitri, Ivan/C-1728-2017; Mazziotta, Mario Nicola/O-8867-2015	Duranti, Matteo/0000-0003-0980-6425; Tykhonov, Andrii/0000-0003-2908-7915; Sun, Zhiyu/0000-0002-7667-3178; D'Urso, Domenico/0000-0002-8215-4542; Gargano, Fabio/0000-0002-5055-6395; Donvito, Giacinto/0000-0002-0628-1080; Duan, Jinglai/0000-0002-9019-5088; Vagelli, Valerio/0000-0002-4495-9331; Wu, Xin/0000-0001-7655-389X; Gao, Shanshan/0000-0003-4721-7795; Cui, Mingyang/0000-0002-8937-4388; Xi, Kai/0000-0002-3092-906X; Zhao, Hao/0000-0001-8135-0616; Shen, Zhaoqiang/0000-0003-3722-0966; Surdo, Antonio/0000-0003-2715-589X; De Mitri, Ivan/0000-0002-8665-1730; Fusco, Piergiorgio/0000-0002-9383-2425; Di Santo, Margherita/0000-0001-8490-7416; Li, Xiang/0000-0002-5894-3429; xia, ziqing/0000-0003-4963-7275; Feng, Lei/0000-0003-2963-5336; Azzarello, Philipp/0000-0001-8275-5738; Liang, Yunfeng/0000-0002-6316-1616; Ma, PengXiong/0000-0002-8547-9115; Zimmer, Stephan/0000-0002-5735-0082; Marsella, Giovanni/0000-0002-3152-8874; Mazziotta, Mario Nicola/0000-0001-9325-4672; Xin, Yuliang/0000-0001-5135-5942; Wang, Zhaomin/0000-0001-7975-0717	strategic priority science and technology projects in space science of the Chinese Academy of Sciences; National Key R&D Program of China [2016YFA0400200]; National Basic Research Program of China [2013CB837000]; National Natural Science Foundation of China [11525313, 11622327, U1738206]; 100 Talents Program of Chinese Academy of Sciences; Swiss National Science Foundation (SNSF), Switzerland; National Institute for Nuclear Physics (INFN), Italy	strategic priority science and technology projects in space science of the Chinese Academy of Sciences; National Key R&D Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Swiss National Science Foundation (SNSF), Switzerland(Swiss National Science Foundation (SNSF)); National Institute for Nuclear Physics (INFN), Italy	The DAMPE mission is funded by the strategic priority science and technology projects in space science of the Chinese Academy of Sciences. In China the data analysis was supported in part by the National Key R&D Program of China (number 2016YFA0400200), the National Basic Research Program of China (number 2013CB837000), the National Natural Science Foundation of China (numbers 11525313, 11622327 and U1738206) and the 100 Talents Program of Chinese Academy of Sciences. In Europe the activities and the data analysis are supported by the Swiss National Science Foundation (SNSF), Switzerland; the National Institute for Nuclear Physics (INFN), Italy.	Abdo AA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.181101; Abdollahi S, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.082007; Abdollahi S, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.091103; Accardo L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.121101; Ackermann M, 2013, SCIENCE, V339, P807, DOI 10.1126/science.1231160; Adare A., 2008, Physical Review Letters, V101, DOI 10.1103/PhysRevLett.101.232301; Adriani O, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.201101; Adriani O, 2009, NATURE, V458, P607, DOI 10.1038/nature07942; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Aguilar M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.221102; Aharonian F, 2009, ASTRON ASTROPHYS, V508, P561, DOI 10.1051/0004-6361/200913323; AHARONIAN FA, 1995, ASTRON ASTROPHYS, V294, pL41; Bergstrom L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.031103; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Blasi P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.051104; Chang J, 2008, NATURE, V456, P362, DOI 10.1038/nature07477; Chang J, 2008, ADV SPACE RES, V42, P431, DOI 10.1016/j.asr.2007.06.012; Chang J, 2017, ASTROPART PHYS, V95, P6, DOI 10.1016/j.astropartphys.2017.08.005; Chang J., 1999, P 26 INT COSM RAY C, V5, P37; Fan YZ, 2010, INT J MOD PHYS D, V19, P2011, DOI 10.1142/S0218271810018268; Feng JL, 2010, ANNU REV ASTRON ASTR, V48, P495, DOI 10.1146/annurev-astro-082708-101659; Hooper D, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.103013; Hooper D, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/01/025; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Kobayashi T, 2004, ASTROPHYS J, V601, P340, DOI 10.1086/380431; MEYER P, 1969, ANNU REV ASTRON ASTR, V7, P1, DOI 10.1146/annurev.aa.07.090169.000245; Moskalenko IV, 1998, ASTROPHYS J, V493, P694, DOI 10.1086/305152; NISHIMURA J, 1980, ASTROPHYS J, V238, P394, DOI 10.1086/157997; Roe BP, 2005, NUCL INSTRUM METH A, V543, P577, DOI 10.1016/j.nima.2004.12.018; Schmidt W. K. H., 1999, P 26 INT COSM RAY C, V5, P41; SHEN CS, 1970, ASTROPHYS J, V162, pL181, DOI 10.1086/180650; Strong AW, 2007, ANNU REV NUCL PART S, V57, P285, DOI 10.1146/annurev.nucl.57.090506.123011; TURNER MS, 1990, PHYS REV D, V42, P1001, DOI 10.1103/PhysRevD.42.1001; Wu X., 2015, P SCI, V1192; Yue C, 2017, NUCL INSTRUM METH A, V856, P11, DOI 10.1016/j.nima.2017.03.013; Zang J. J., 2017, P SCI, V197; Zhang ZY, 2016, NUCL INSTRUM METH A, V836, P98, DOI 10.1016/j.nima.2016.08.015; Zhang ZY, 2015, NUCL INSTRUM METH A, V780, P21, DOI 10.1016/j.nima.2015.01.036	38	289	313	7	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					63	+		10.1038/nature24475	http://dx.doi.org/10.1038/nature24475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186110	Green Submitted			2022-12-28	WOS:000417560500043
J	Gunzer, M				Gunzer, Matthias			IMMUNOLOGY Escaping the traps of your own hunters	SCIENCE			English	Editorial Material							NEUTROPHIL EXTRACELLULAR TRAPS; CHROMATIN		[Gunzer, Matthias] Univ Duisburg Essen, Univ Hosp, Inst Expt Immunol & Imaging, Essen, Germany	University of Duisburg Essen	Gunzer, M (corresponding author), Univ Duisburg Essen, Univ Hosp, Inst Expt Immunol & Imaging, Essen, Germany.	matthias.gunzer@uni-due.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055				Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; Gunzer M, 2014, BRIT J HAEMATOL, V164, P189, DOI 10.1111/bjh.12608; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Masias C, 2017, BLOOD, V129, P2857, DOI 10.1182/blood-2016-11-743104; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322	13	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1126	1127		10.1126/science.aar2428	http://dx.doi.org/10.1126/science.aar2428			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191890				2022-12-28	WOS:000416584000018
J	Kim, H; Rao, SR; Narayanan, S; Kapustin, EA; Yang, S; Furukawa, H; Umans, AS; Yaghi, OM; Wang, EN				Kim, Hyunho; Rao, Sameer R.; Narayanan, Shankar; Kapustin, Eugene A.; Yang, Sungwoo; Furukawa, Hiroyasu; Umans, Ari S.; Yaghi, Omar M.; Wang, Evelyn N.			Response to Comment on "Water harvesting from air with metal-organic frameworks powered by natural sunlight"	SCIENCE			English	Editorial Material							ENERGY; OPTIMIZATION; DESALINATION	In their comment, Bui et al. argue that the approach we described in our report is vastly inferior in efficiency to alternative off-the-shelf technologies. Their conclusion is invalid, as they compare efficiencies in completely different operating conditions. Here, using heat transfer and thermodynamics principles, we show how Bui et al.'s conclusions about the efficiencies of off-the-shelf technologies are fundamentally flawed and inaccurate for the operating conditions described in our study.	[Kim, Hyunho; Rao, Sameer R.; Narayanan, Shankar; Yang, Sungwoo; Umans, Ari S.; Wang, Evelyn N.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kapustin, Eugene A.; Furukawa, Hiroyasu; Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kapustin, Eugene A.; Furukawa, Hiroyasu; Yaghi, Omar M.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Kapustin, Eugene A.; Furukawa, Hiroyasu; Yaghi, Omar M.] Kavli Energy NanoSci Inst Berkeley, Berkeley, CA 94720 USA; [Kapustin, Eugene A.; Furukawa, Hiroyasu; Yaghi, Omar M.] Berkeley Global Sci Inst, Berkeley, CA 94720 USA; [Yaghi, Omar M.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia; [Narayanan, Shankar] Rensselaer Polytech Inst, Dept Mech Aerosp & Nucl Engn, Troy, NY 12180 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; King Abdulaziz City for Science & Technology; Rensselaer Polytechnic Institute	Wang, EN (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Kavli Energy NanoSci Inst Berkeley, Berkeley, CA 94720 USA.; Yaghi, OM (corresponding author), Berkeley Global Sci Inst, Berkeley, CA 94720 USA.	yaghi@berkeley.edu; enwang@mit.edu	Yaghi, Omar M/C-6749-2013; Narayan, Shankar/M-8210-2015; Furukawa, Hiroyasu/C-5910-2008; /G-4484-2011	Kapustin, Eugene/0000-0003-4095-9729; Narayan, Shankar/0000-0001-6325-8736; Kim, Hyunho/0000-0002-5290-5560; Yaghi, Omar/0000-0002-5611-3325; Furukawa, Hiroyasu/0000-0002-6082-1738; /0000-0001-8721-3591; /0000-0002-6557-4940; Wang, Evelyn/0000-0001-7045-1200				Bui DT, 2017, ENERGY, V132, P106, DOI 10.1016/j.energy.2017.05.075; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Bui DT, 2017, SCIENCE, V358, DOI 10.1126/science.aao0791; Gordon JM, 2017, NAT PHOTONICS, V11, P70, DOI 10.1038/nphoton.2017.1; Ji JG, 2007, DESALINATION, V212, P176, DOI 10.1016/j.desal.2006.10.008; Kalogirou SA, 2004, PROG ENERG COMBUST, V30, P231, DOI 10.1016/j.pecs.2004.02.001; Kim H, 2017, SCIENCE, V356, P430, DOI 10.1126/science.aam8743; Mistry KH, 2013, ENTROPY-SWITZ, V15, P2046, DOI 10.3390/e15062046; Narayanan S, 2014, INT J HEAT MASS TRAN, V77, P288, DOI 10.1016/j.ijheatmasstransfer.2014.05.022; Nellis G, 2009, HEAT TRANSFER-BOOK, P1; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Ni G, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.126, 10.1038/NENERGY.2016.126]; Ozkan O, 2017, APPL THERM ENG, V118, P224, DOI 10.1016/j.applthermaleng.2017.02.096; Straub AP, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.90, 10.1038/NENERGY.2016.90]; Strobach E, 2017, J NON-CRYST SOLIDS, V462, P72, DOI 10.1016/j.jnoncrysol.2017.02.009; Water-Gen Ltd, 2016, MOD GEN 350G; Wikramanayake ED, 2017, ENERGY, V138, P647, DOI 10.1016/j.energy.2017.07.062; Zhao L, 2016, AIP ADV, V6, DOI 10.1063/1.4943215	18	9	9	12	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367								10.1126/science.aao3139	http://dx.doi.org/10.1126/science.aao3139			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191877				2022-12-28	WOS:000416584000002
J	Karimkhani, C; Reddy, BY; Dellavalle, RP; Sundararajan, S				Karimkhani, Chante; Reddy, Bobby Y.; Dellavalle, Robert P.; Sundararajan, Srinath			THERAPEUTICS Novel therapies for unresectable and metastatic melanoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Karimkhani, Chante; Dellavalle, Robert P.] Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA; [Reddy, Bobby Y.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Dept Dermatol, Boston, MA USA; [Dellavalle, Robert P.] US Dept Vet Affairs, Dermatol Serv, Eastern Colorado Hlth Care Syst, Denver, CO USA; [Dellavalle, Robert P.] Univ Colorado, Colorado Sch Publ Hlth, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Sundararajan, Srinath] Univ Arizona, Dept Med, Div Hematol & Oncol, Tucson, AZ USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Massachusetts General Hospital; US Department of Veterans Affairs; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Arizona	Karimkhani, C (corresponding author), Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.	ck2525@caa.columbia.edu						American Cancer Society, CANC FACTS FIG 2016; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Eton O, 1998, J CLIN ONCOL, V16, P1103, DOI 10.1200/JCO.1998.16.3.1103; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; HALL WH, 1992, JAMA-J AM MED ASSOC, V268, P1314, DOI 10.1001/jama.1992.03490100112037; Hamid O, 2016, ANN ONCOL, V359, P1107, DOI [10.1093/annonc/mdw379.02, DOI 10.1093/ANNONC/MDW379.02]; Hauschild A, 2014, ANN ONCOL         S4, V25, piv378, DOI DOI 10.1093/ANNONC/MDU344.8; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2016, CANCER RES, V76, pCT001, DOI DOI 10.1158/1538-7445.AM2016-CT001; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; James K, 1999, J NATL CANCER I, V91, P523, DOI 10.1093/jnci/91.6.523; Karimkhani C, 2017, BRIT J DERMATOL, V177, P134, DOI 10.1111/bjd.15510; Kink A, 2016, HEALTHCARE RESOURCE; Kohlhapp FJ, 2016, CLIN CANCER RES, V22, P1048, DOI 10.1158/1078-0432.CCR-15-2667; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Larkin J, 2017, J CLIN ONCOL, DOI DOI 10.1200/JCO.2016.71.8023; Liu MD, 2017, ONCOTARGET, V8, P32258, DOI 10.18632/oncotarget.15632; Long GV, 2016, ANN ONCOL, V27, P1940, DOI 10.1093/annonc/mdw265; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Melanoma research foundation, CUT MEL MEL SKIN; National Cancer Institute, NCI DICT CANC TERMS; National Comprehensive Cancer Network, 2016, NCCN GUID PAT VERS 1; National Institute for Health and Care Excellence, 2015, MEL ASS MAN; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel PM, 2011, EUR J CANCER, V47, P1476, DOI 10.1016/j.ejca.2011.04.030; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Robert C, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_supll.9503; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schachter J, 2016, J CLIN ONCOL, V359, P9504; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Shih V, 2015, J SKIN CANCER, V2015, DOI 10.1155/2015/505302; Voskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053745; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8	44	7	7	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5174	10.1136/bmj.j5174	http://dx.doi.org/10.1136/bmj.j5174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29191943				2022-12-28	WOS:000417211800002
J	Langridge, PD; Struhl, G				Langridge, Paul D.; Struhl, Gary			Epsin-Dependent Ligand Endocytosis Activates Notch by Force	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; VON-WILLEBRAND-FACTOR; FOLLICLE-STIMULATING-HORMONE; SIGNAL-TRANSDUCTION; UBIQUITIN LIGASE; A2 DOMAIN; DROSOPHILA; MUTATIONS; RECEPTOR; CLEAVAGE	DSL ligands activate Notch by inducing proteolytic cleavage of the receptor ectodomain, an event that requires ligand to be endocytosed in signal-sending cells by the adaptor protein Epsin. Two classes of explanation for this unusual requirement are (1) recycling models, in which the ligand must be endocytosed to be modified or repositioned before it binds Notch and (2) pulling models, in which the ligand must be endocytosed after it binds Notch to exert force that exposes an otherwise buried site for cleavage. We demonstrate in vivo that ligands that cannot enter the Epsin pathway nevertheless bind Notch but fail to activate the receptor because they cannot exert sufficient force. This argues against recycling models and in favor of pulling models. Our results also suggest that once ligand binds receptor, activation depends on a competition between Epsin-mediated ligand endocytosis, which induces cleavage, and transendocytosis of the ligand by the receptor, which aborts the incipient signal.	[Langridge, Paul D.; Struhl, Gary] Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; [Langridge, Paul D.; Struhl, Gary] Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA	Columbia University	Langridge, PD; Struhl, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA.; Langridge, PD; Struhl, G (corresponding author), Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.	pl2266@columbia.edu; gs20@columbia.edu			NIH [R01 GM109183]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Tao, J. Recio, Y. Chen, G. Saharia and R. De Luca for assistance; T. Springer Q. Fan and B. Zhang for DNAs and antisera; the Bloomington Drosophila Stock Center (NIH P400D018537) for stocks; I. Greenwald, A. Tomlinson, S. Blacklow, M. Zecca, R. Coleman, and J. Parker for advice; and the NIH (R01 GM109183) and HHMI for support.	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Blair SS, 1997, CURR BIOL, V7, pR686, DOI 10.1016/S0960-9822(06)00356-3; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; ELLIS MC, 1994, DEVELOPMENT, V120, P1959; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lee EC, 2000, CURR BIOL, V10, P931, DOI 10.1016/S0960-9822(00)00622-9; Legent K, 2012, GENETICS, V190, P601, DOI 10.1534/genetics.111.133827; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Stephenson NL, 2012, P NATL ACAD SCI USA, V109, pE2757, DOI 10.1073/pnas.1205788109; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; TSAI HM, 1994, BLOOD, V83, P2171; Wang W., 2006, STOCHASTICITY NONLIN; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Xu AJ, 2013, J BIOL CHEM, V288, P6317, DOI 10.1074/jbc.M112.422618; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	51	57	58	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1383	+		10.1016/j.cell.2017.10.048	http://dx.doi.org/10.1016/j.cell.2017.10.048			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195077	Green Accepted, Bronze			2022-12-28	WOS:000417362700019
J	Pachiadaki, MG; Sintes, E; Bergauer, K; Brown, JM; Record, NR; Swan, BK; Mathyer, ME; Hallam, SJ; Lopez-Garcia, P; Takaki, Y; Nunoura, T; Woyke, T; Herndl, GJ; Stepanauskas, R				Pachiadaki, Maria G.; Sintes, Eva; Bergauer, Kristin; Brown, Julia M.; Record, Nicholas R.; Swan, Brandon K.; Mathyer, Mary Elizabeth; Hallam, Steven J.; Lopez-Garcia, Purificacion; Takaki, Yoshihiro; Nunoura, Takuro; Woyke, Tanja; Herndl, Gerhard J.; Stepanauskas, Ramunas			Major role of nitrite-oxidizing bacteria in dark ocean carbon fixation	SCIENCE			English	Article							OXYGEN MINIMUM ZONE; GEN-NOV-SP; NITROSPIRA; OXIDATION; EASTERN; RESPIRATION; AUTOTROPHY; METAGENOME; PHYSIOLOGY; EVOLUTION	Carbon fixation by chemoautotrophic microorganisms in the dark ocean has a major impact on global carbon cycling and ecological relationships in the ocean's interior, but the relevant taxa and energy sources remain enigmatic. We show evidence that nitrite-oxidizing bacteria affiliated with the Nitrospinae phylum are important in dark ocean chemoautotrophy. Single-cell genomics and community metagenomics revealed that Nitrospinae are the most abundant and globally distributed nitrite-oxidizing bacteria in the ocean. Metaproteomics and metatranscriptomics analyses suggest that nitrite oxidation is the main pathway of energy production in Nitrospinae. Microautoradiography, linked with catalyzed reporter deposition fluorescence in situ hybridization, indicated that Nitrospinae fix 15 to 45% of inorganic carbon in the mesopelagic western North Atlantic. Nitrite oxidation may have a greater impact on the carbon cycle than previously assumed.	[Pachiadaki, Maria G.; Brown, Julia M.; Record, Nicholas R.; Swan, Brandon K.; Mathyer, Mary Elizabeth; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Sintes, Eva; Bergauer, Kristin] Univ Vienna, Dept Limnol & Biooceanog, A-1090 Vienna, Austria; [Swan, Brandon K.] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD 21702 USA; [Mathyer, Mary Elizabeth] Washington Univ, Sch Med, Ctr Pharmacogen, Div Dermatol,Dept Internal Med, St Louis, MO 63110 USA; [Mathyer, Mary Elizabeth] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC, Canada; [Hallam, Steven J.] Univ British Columbia, Peter Wall Inst Adv Studies, Vancouver, BC, Canada; [Hallam, Steven J.] Univ British Columbia, ECOSCOPE Training Program, Vancouver, BC, Canada; [Lopez-Garcia, Purificacion] Univ Paris Saclay, Univ Paris Sud, AgroParisTech, Ecol Systemat Evolut,CNRS, F-91400 Orsay, France; [Takaki, Yoshihiro; Nunoura, Takuro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res & Dev Ctr Marine Biosci, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Takaki, Yoshihiro] JAMSTEC, Dept Subsurface Geobiol Anal & Res, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Woyke, Tanja] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Herndl, Gerhard J.] Univ Utrecht, Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, NL-1790 AB Den Burg, Netherlands	Bigelow Laboratory for Ocean Sciences; University of Vienna; Washington University (WUSTL); Washington University (WUSTL); University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Stepanauskas, R (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA.	rstepanauskas@bigelow.org	Sintes, Eva/H-8494-2015; Pachiadaki, Maria/AAW-2640-2021; Herndl, Gerhard J./S-3011-2019; Herndl, Gerhard J./B-1513-2013; Lopez-Garcia, Purificacion/B-6775-2012; Nunoura, Takuro/AAL-6266-2020; Swan, Brandon K/O-9824-2018; Bergauer, Kristin/AAG-3050-2021	Sintes, Eva/0000-0002-7408-5647; Pachiadaki, Maria/0000-0003-2684-7501; Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Lopez-Garcia, Purificacion/0000-0002-0927-0651; Nunoura, Takuro/0000-0003-2323-0880; Swan, Brandon K/0000-0003-0465-1444; Stepanauskas, Ramunas/0000-0003-4458-3108; Takaki, Yoshihiro/0000-0002-1247-4946; Hallam, Steven/0000-0002-4889-6876; Bergauer, Kristin/0000-0003-3018-0711	NSF [OCE-1232982, OCE-1335810, EF-0826924]; U.S. Department of Energy Joint Genome Institute Community Science Program [620]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Austrian Science Fund [1486-B09, Z194-B17]; European Research Council under the European Community [268595]; G. Unger Vetlesen Foundation; Ambrose Monell Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canadian Institute for Advanced Research; Japan Society for the Promotion of Science [24370015]; French ANR	NSF(National Science Foundation (NSF)); U.S. Department of Energy Joint Genome Institute Community Science Program(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Austrian Science Fund(Austrian Science Fund (FWF)); European Research Council under the European Community(European Research Council (ERC)); G. Unger Vetlesen Foundation; Ambrose Monell Foundation; Tula Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); French ANR(French National Research Agency (ANR))	Supported by NSF grant OCE-1232982, OCE-1335810, and EF-0826924 and U.S. Department of Energy Joint Genome Institute Community Science Program grant 620 (R.S.). Work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. Laboratory work was supported by Austrian Science Fund (EWE) projects 1486-B09 and Z194-B17 and by the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement 268595 (MEDEA project) (G.J.H.). Aspects of this work were performed under the auspices of the G. Unger Vetlesen and Ambrose Monell Foundations, the Tula Foundation-funded Centre for Microbial Diversity and Evolution, the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, and the Canadian Institute for Advanced Research through grants awarded to S.H. Also supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) (24370015) (T.N.) and French ANR grant Evoldeep (P.L-G.). We thank the captain and new of the R/V Pelagic and of B/O Sarmiento de Gamboa; the captain, crew, ROV ABISMO operation team and science party of JAMSTEC KR11-11 cruise (R/V Kairei); the scientific team and the crew of the R/V Urania Marmara2010 cruise; M. Varela for her support during the MODUPLAN cruise I. Lekunberri and S. Gonzalez for the collection of MAR-CARD-FISH samples and DIC fixation measurements ruing the Archimedes-IV catise; A.K. Hawley and W.E. Dunne for their role in obtaining the Saanich Inlet SAGs; S. Lucker for providing the curated N. gracilis genome annotations; H. Daims and M. Wagner for discussing the reciprocal feeding concept; J. Garcia and A. Srivastava for providing the metatranscriptomic data; and S. Gonzales Acinas for allowing the use of the Malaspina metagenomic data. All data and code to understand and assess Se conclusions of this research are available in the main text and supplementary materials. The accession links for the SAG assemblies and the accession identifiers for the metagenomes are in tables S3 and S4, respectively.	Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Beman JM, 2013, ISME J, V7, P2192, DOI 10.1038/ismej.2013.96; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dunne JP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002907; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Hawley AK, 2014, P NATL ACAD SCI USA, V111, P11395, DOI 10.1073/pnas.1322132111; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Keuter S, 2011, ENVIRON MICROBIOL, V13, P2536, DOI 10.1111/j.1462-2920.2011.02525.x; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Levipan HA, 2014, ENV MICROBIOL REP, V6, P565, DOI 10.1111/1758-2229.12158; Lucker S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00027; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Madigan MT, 2010, BROCK BIOL MICROORGA; Middelburg JJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049725; Ngugi DK, 2016, ISME J, V10, P1383, DOI 10.1038/ismej.2015.214; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165; Sintes E, 2006, APPL ENVIRON MICROB, V72, P7022, DOI 10.1128/AEM.00763-06; Spieck E, 2014, SYST APPL MICROBIOL, V37, P170, DOI 10.1016/j.syapm.2013.12.005; Spieck E, 2011, METHOD ENZYMOL, V486, P109, DOI [10.1016/S0076-6879(11)86005-2, 10.1016/B978-0-12-381294-0.00005-5]; Swan BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095380; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Tsementzi D, 2016, NATURE, V536, P179, DOI 10.1038/nature19068; Varela MM, 2011, ENVIRON MICROBIOL, V13, P1524, DOI 10.1111/j.1462-2920.2011.02457.x; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; WATSON SW, 1971, ARCH MIKROBIOL, V77, P203, DOI 10.1007/BF00408114; WATSON SW, 1986, ARCH MICROBIOL, V144, P1, DOI 10.1007/BF00454947; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Widner B, 2013, ANAL CHEM, V85, P6661, DOI 10.1021/ac400351c; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	36	118	129	24	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1046	1050		10.1126/science.aan8260	http://dx.doi.org/10.1126/science.aan8260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170234				2022-12-28	WOS:000416590400038
J	McDonald, CM; Henricson, EK; Abresch, RT; Duong, TN; Joyce, NC; Hu, FM; Clemens, PR; Hoffman, EP; Cnaan, A; Gordish-Dressman, H				McDonald, Craig M.; Henricson, Erik K.; Abresch, Richard T.; Duong, Tina; Joyce, Nanette C.; Hu, Fengming; Clemens, Paula R.; Hoffman, Eric P.; Cnaan, Avital; Gordish-Dressman, Heather		CINRG Investigators	Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study	LANCET			English	Article							NATURAL-HISTORY; THERAPY; CORTICOSTEROIDS; DEFLAZACORT; PROGRESSION; PREDNISONE; MILESTONES; MORTALITY; TRIAL	Background Glucocorticoid treatment is recommended as a standard of care in Duchenne muscular dystrophy; however, few studies have assessed the long-term benefits of this treatment. We examined the long-term effects of glucocorticoids on milestone-related disease progression across the lifespan and survival in patients with Duchenne muscular dystrophy. Methods For this prospective cohort study, we enrolled male patients aged 2-28 years with Duchenne muscular dystrophy at 20 centres in nine countries. Patients were followed up for 10 years. We compared no glucocorticoid treatment or cumulative treatment duration of less than 1 month versus treatment of 1 year or longer with regard to progression of nine disease-related and clinically meaningful mobility and upper limb milestones. We used Kaplan-Meier analyses to compare glucocorticoid treatment groups for time to stand from supine of 5 s or longer and 10 s or longer, and loss of stand from supine, four-stair climb, ambulation, full overhead reach, hand-to-mouth function, and hand function. Risk of death was also assessed. This study is registered with ClinicalTrials. gov, number NCT00468832. Findings 440 patients were enrolled during two recruitment periods (2006-09 and 2012-16). Time to all disease progression milestone events was significantly longer in patients treated with glucocorticoids for 1 year or longer than in patients treated for less than 1 month or never treated (log-rank p<0.0001). Glucocorticoid treatment for 1 year or longer was associated with increased median age at loss of mobility milestones by 2.1-4.4 years and upper limb milestones by 2.8-8.0 years compared with treatment for less than 1 month. Deflazacort was associated with increased median age at loss of three milestones by 2.1-2.7 years in comparison with prednisone or prednisolone (log-rank p<0.012). 45 patients died during the 10-year follow-up. 39 (87%) of these deaths were attributable to Duchenne-related causes in patients with known duration of glucocorticoids usage. 28 (9%) deaths occurred in 311 patients treated with glucocorticoids for 1 year or longer compared with 11 (19%) deaths in 58 patients with no history of glucocorticoid use (odds ratio 0.47, 95% CI 0.22-1.00; p=0.0501). Interpretation In patients with Duchenne muscular dystrophy, glucocorticoid treatment is associated with reduced risk of losing clinically meaningful mobility and upper limb disease progression milestones across the lifespan as well as reduced risk of death.	[McDonald, Craig M.; Henricson, Erik K.; Abresch, Richard T.; Joyce, Nanette C.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Duong, Tina] Stanford Univ, Stanford, CA 94305 USA; [Hu, Fengming; Cnaan, Avital; Gordish-Dressman, Heather] Childrens Natl Hlth Syst, Ctr Genet Med, Washington, DC USA; [Hu, Fengming; Cnaan, Avital; Gordish-Dressman, Heather] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Clemens, Paula R.] Univ Pittsburgh, Pittsburgh, PA USA; [Hoffman, Eric P.] Binghamton Univ, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA	University of California System; University of California Davis; Stanford University; Children's National Health System; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	McDonald, CM (corresponding author), Univ Calif Davis, Sch Med, UC Davis Childrens Hosp, Lawrence J Ellison Ambulatory Care Ctr,Phys Med &, Sacramento, CA 95817 USA.	cmmcdonald@ucdavis.edu		Duong, Tina/0000-0003-3177-4722; Tesi Rocha, Carolina/0000-0002-7224-0754; Kuntz, Nancy L/0000-0003-2253-5156; Hoffman, Eric/0000-0001-6470-5139; Day, John/0000-0002-0086-9529; McDonald, Craig/0000-0002-8779-3220; , Chidambaranathan/0000-0003-2491-4651	US Department of Education/National Institute on Disability and Rehabilitation Research; US Department of Defense; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases; Parent Project Muscular Dystrophy	US Department of Education/National Institute on Disability and Rehabilitation Research(US Department of Education); US Department of Defense(United States Department of Defense); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Parent Project Muscular Dystrophy	US Department of Education/National Institute on Disability and Rehabilitation Research; US Department of Defense; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases; and Parent Project Muscular Dystrophy.	Barber BJ, 2013, J PEDIATR-US, V163, P1080, DOI 10.1016/j.jpeds.2013.05.060; Bello L, 2015, NEUROLOGY, V85, P1048, DOI 10.1212/WNL.0000000000001950; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Daltroy LH, 1998, J PEDIATR ORTHOPED, V18, P561, DOI 10.1097/00004694-199809000-00001; Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014; Eagle M, 2007, NEUROMUSCULAR DISORD, V17, P470, DOI 10.1016/j.nmd.2007.03.002; FDA, 2015, DUCH MUSC DYSTR REL; Goemans N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164684; Griggs RC, 2016, NEUROLOGY, V87, P2123, DOI 10.1212/WNL.0000000000003217; Griggs RC, 2013, MUSCLE NERVE, V48, P27, DOI 10.1002/mus.23831; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mazzone ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151445; McDonald CM, 2013, NEUROMUSCULAR DISORD, V23, P752, DOI 10.1016/j.nmd.2013.06.416; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Passamano Luigia, 2012, Acta Myol, V31, P121; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; Rall Susanne, 2012, Acta Myol, V31, P117; Schram G, 2013, J AM COLL CARDIOL, V61, P948, DOI 10.1016/j.jacc.2012.12.008	27	203	207	5	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					451	461		10.1016/S0140-6736(17)32160-8	http://dx.doi.org/10.1016/S0140-6736(17)32160-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OL	29174484				2022-12-28	WOS:000424333600034
J	Thurston, GD; Newman, JD				Thurston, George D.; Newman, Jonathan D.			Walking to a pathway for cardiovascular effects of air pollution	LANCET			English	Editorial Material							ARTERIAL STIFFNESS; PARTICULATE MATTER; PHYSICAL-ACTIVITY; DISEASE; METAANALYSIS; ASSOCIATION; STATEMENT; MORTALITY		[Thurston, George D.] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Newman, Jonathan D.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY USA	New York University; New York University	Thurston, GD (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.	george.thurston@nyu.edu	Thurston, George/ABB-1359-2021	Newman, Jonathan/0000-0001-6855-7305	NHLBI NIH HHS [K23 HL125991] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Endes S, 2017, INT J HYG ENVIR HEAL, V220, P1030, DOI 10.1016/j.ijheh.2017.06.001; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; Rao XQ, 2014, CIRC RES, V115, P770, DOI 10.1161/CIRCRESAHA.115.304666; Sinharay R., 2017, LANCET; Spira-Cohen A, 2011, ENVIRON HEALTH PERSP, V119, P559, DOI 10.1289/ehp.1002653; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Thurston G, 2017, AM J RESP CRIT CARE, V196, P6, DOI 10.1164/rccm.201702-0273ED; Upala S, 2017, INT J CARDIOL, V227, P338, DOI 10.1016/j.ijcard.2016.11.073; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Xie WX, 2015, HEART, V101, P257, DOI 10.1136/heartjnl-2014-306165	12	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					291	292		10.1016/S0140-6736(17)33078-7	http://dx.doi.org/10.1016/S0140-6736(17)33078-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU5CE	29221647	hybrid, Green Accepted			2022-12-28	WOS:000423869500010
J	Dang, SY; Feng, SJ; Tien, J; Peters, CJ; Bulkley, D; Lolicato, M; Zhao, JH; Zuberbuhler, K; Ye, WL; Qi, LJ; Chen, TX; Craik, CS; Jan, YN; Minor, DL; Cheng, YF; Jan, LY				Dang, Shangyu; Feng, Shengjie; Tien, Jason; Peters, Christian J.; Bulkley, David; Lolicato, Marco; Zhao, Jianhua; Zuberbuhler, Kathrin; Ye, Wenlei; Qi, Lijun; Chen, Tingxu; Craik, Charles S.; Jan, Yuh Nung; Minor, Daniel L., Jr.; Cheng, Yifan; Jan, Lily Yeh			Cryo-EM structures of the TMEM16A calcium-activated chloride channel	NATURE			English	Article							INDEPENDENT ACTIVATION; ELECTRON-MICROSCOPY; MEMBRANE-PROTEINS; VISUALIZATION; VALIDATION; EXPRESSION; PORES; MODEL	Calcium-activated chloride channels (CaCCs) encoded by TMEM16A(1-3) control neuronal signalling, smooth muscle contraction, airway and exocrine gland secretion, and rhythmic movements of the gastrointestinal system(4-7). To understand how CaCCs mediate and control anion permeation to fulfil these physiological functions, knowledge of the mammalian TMEM16A structure and identification of its pore-lining residues are essential. TMEM16A forms a dimer with two pores(8,9). Previous CaCC structural analyses have relied on homology modelling of a homologue (nhTMEM16) from the fungus Nectria haematococca that functions primarily as a lipid scramblase(10-12), as well as subnanometre-resolution electron cryo-microscopy(12). Here we present de novo atomic structures of the transmembrane domains of mouse TMEM16A in nanodiscs and in lauryl maltose neopentyl glycol as determined by single-particle electron cryo-microscopy. These structures reveal the ion permeation pore and represent different functional states. The structure in lauryl maltose neopentyl glycol has one Ca2+ ion resolved within each monomer with a constricted pore; this is likely to correspond to a closed state, because a CaCC with a single Ca2+ occupancy requires membrane depolarization in order to open (C.J.P.etal., manuscript submitted). The structure in nanodiscs has two Ca2+ ions per monomer and its pore is in a closed conformation; this probably reflects channel rundown, which is the gradual loss of channel activity that follows prolonged CaCC activation in 1 mM Ca2+. Our mutagenesis and electrophysiological studies, prompted by analyses of the structures, identified ten residues distributed along the pore that interact with permeant anions and affect anion selectivity, as well as seven porelining residues that cluster near pore constrictions and regulate channel gating. Together, these results clarify the basis of CaCC anion conduction.	[Dang, Shangyu; Bulkley, David; Zhao, Jianhua; Jan, Yuh Nung; Minor, Daniel L., Jr.; Cheng, Yifan; Jan, Lily Yeh] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Feng, Shengjie; Tien, Jason; Peters, Christian J.; Ye, Wenlei; Qi, Lijun; Chen, Tingxu; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Lolicato, Marco; Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Zuberbuhler, Kathrin; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Jan, Yuh Nung; Cheng, Yifan; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Minor, Daniel L., Jr.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cheng, YF; Jan, LY (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Jan, LY (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Cheng, YF; Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; Lily.Jan@ucsf.edu	Ye, Wenlei/S-1012-2016; Qi, LI/AAF-3389-2019; Lolicato, Marco/ABC-6878-2020; Lolicato, Marco/AAL-3614-2020	Lolicato, Marco/0000-0002-2022-7961; Lolicato, Marco/0000-0002-2022-7961; Tien, Jason/0000-0003-3853-0827; Ye, Wenlei/0000-0002-4694-1493; Cheng, Yifan/0000-0001-9535-0369; Peters, Christian/0000-0002-8794-5394; Bulkley, David/0000-0002-2535-904X; Dang, Shangyu/0000-0001-9141-1865	NIH [R01GM098672, S100D0020054, R01NS069229, R35NS097227, R01HL080050, R01DC007664, P41CA196276, P50GM111126, K99DA041500]; American Heart Association; UCSF Breakthrough Biomedical Research; Human Frontier Science Program (HFSP) Postdoctoral Fellowship; Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE [P41CA196276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672, P01GM111126, P50GM082250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097227, R01NS069229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA041500] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020054] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); UCSF Breakthrough Biomedical Research; Human Frontier Science Program (HFSP) Postdoctoral Fellowship(Human Frontier Science Program); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. MacKinnon, T. Xiao and W. Wang for advice on protein purification; B. Kobilka and A. Koehl for help with the CPM assay; Z. Yu and his colleagues at the HHMI Janelia Cryo-EM Facility for help with data acquisition; J. Wang for discussions on model building; P. Jin for help with data presentation; and colleagues in our laboratories for discussion. This work was supported by grants from the NIH (R01GM098672 and S100D0020054 to Y.C., R01NS069229 to L.Y.J., R35NS097227 to Y.N.J., R01HL080050 and R01DC007664 to D.L.M., P41CA196276 and P50GM111126 to C.S.C., K99DA041500 to C.J.P.) and from the American Heart Association (M.L.), and by UCSF Breakthrough Biomedical Research (Y.C.). S.D. is supported by a Human Frontier Science Program (HFSP) Postdoctoral Fellowship. J.Z. is supported by a Banting Postdoctoral Fellowship from the Canadian Institute of Health Research. L.Y.J., Y.N.J. and Y.C. are Investigators with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Ashok Y, 2016, METHODSX, V3, P212, DOI 10.1016/j.mex.2016.03.009; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Brunner JD, 2016, CURR OPIN STRUC BIOL, V39, P61, DOI 10.1016/j.sbi.2016.05.020; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Duriseti S, 2010, J BIOL CHEM, V285, P26878, DOI 10.1074/jbc.M109.077677; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Jiang Tao, 2017, Elife, V6, DOI 10.7554/eLife.28671; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38788; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	52	182	189	9	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					426	+		10.1038/nature25024	http://dx.doi.org/10.1038/nature25024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236684	Green Submitted, Green Accepted			2022-12-28	WOS:000418559800063
J	Alonso, P; Noor, AM				Alonso, Pedro; Noor, Abdisalan M.			The global fight against malaria is at crossroads	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; AFRICA		[Alonso, Pedro; Noor, Abdisalan M.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland	World Health Organization	Alonso, P (corresponding author), WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland.	alonsop@who.int; anoor@who.int	Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2017, Wkly Epidemiol Rec, V92, P578; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Snow RW, 2017, NATURE, V550, P515, DOI 10.1038/nature24059; WHO, 2016, WORLD MAL REP 2016; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2017, DEPRESSION; World Health Organization, 2017, ANT DRUG RES GREAT M	7	66	67	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2532	2533		10.1016/S0140-6736(17)33080-5	http://dx.doi.org/10.1016/S0140-6736(17)33080-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29195688				2022-12-28	WOS:000417493300007
J	Cook, PJ; Donohue, JJ				Cook, Philip J.; Donohue, John J.			Saving lives by regulating guns: Evidence for policy Despite obstacles, research is clarifying gun-policy impacts	SCIENCE			English	Editorial Material							VIOLENT CRIME; DETERRENCE; DEATH; LAWS		[Cook, Philip J.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Donohue, John J.] Stanford Law Sch, Stanford, CA 94305 USA	Duke University; Stanford University	Cook, PJ (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.	pcook@duke.edu; donohue@law.stanford.edu		Cook, Philip/0000-0001-5094-9052				Abrams DS, 2012, AM ECON J-APPL ECON, V4, P32, DOI 10.1257/app.4.4.32; Alcorn T, 2017, JAMA INTERN MED, V177, P124, DOI 10.1001/jamainternmed.2016.7076; Black DA, 1998, J LEGAL STUD, V27, P209, DOI 10.1086/468019; CDC, FAT INJ REP NAT REG; COOK PJ, 1982, BELL J ECON, V13, P379, DOI 10.2307/3003461; Cook PJ, 2000, GUN VIOLENCE REAL CO; Donohue JJ, 2017, AM J PUBLIC HEALTH, V107, P1864, DOI 10.2105/AJPH.2017.304144; Donohue John J., 2017, 23510 NAT BUR EC RES; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hahn Robert A, 2003, MMWR Recomm Rep, V52, P11; Hemenway David, 2017, Inj Epidemiol, V4, P11, DOI 10.1186/s40621-017-0109-8; Leshner AI, 2013, PRIORITIES RES REDUC; Levine PB, 2017, SCIENCE, V358, P1324, DOI 10.1126/science.aan8179; Levitt SD, 2004, J ECON PERSPECT, V18, P163, DOI 10.1257/089533004773563485; Lott JR, 1997, J LEGAL STUD, V26, P1, DOI 10.1086/467988; Ludwig J, 1998, INT REV LAW ECON, V18, P239, DOI 10.1016/S0144-8188(98)00012-X; MacDonald S., 2012, CHL HOLDER FIRED SHO; McElroy Majorie B., 2017, SEEMINGLY INEXTRICAB; Raissian KM, 2016, J POLICY ANAL MANAG, V35, P67, DOI 10.1002/pam.21857; Siegel M, 2017, AM J PUBLIC HEALTH, V107, P1923, DOI 10.2105/AJPH.2017.304057; Simpson Kevin, 2017, DENVER POST; Stark DE, 2017, JAMA-J AM MED ASSOC, V317, P84, DOI 10.1001/jama.2016.16215; Wadman M, 2017, SCIENCE, V358, P286, DOI 10.1126/science.358.6361.286; Wellford C. F., 2004, FIREARMS VIOLENCE CR; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zimmerman PR, 2014, INT REV LAW ECON, V37, P66, DOI 10.1016/j.irle.2013.06.003	26	12	12	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1259	1261		10.1126/science.aar3067	http://dx.doi.org/10.1126/science.aar3067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217559				2022-12-28	WOS:000417254700041
J	Louca, S				Louca, Stilianos			Probing the metabolism of microorganisms Modeling and genetic analyses reveal insights into microbial metabolic pathways	SCIENCE			English	Editorial Material							GLOBAL OCEAN MICROBIOME		[Louca, Stilianos] Biodivers Res Ctr, Vancouver, BC, Canada		Louca, S (corresponding author), Biodivers Res Ctr, Vancouver, BC, Canada.			Louca, Stilianos/0000-0001-9216-5619				Dawkins Richard, 1976, SELFISH GENE; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Louca S, 2017, ENVIRON MICROBIOL, V19, P3863, DOI 10.1111/1462-2920.13743; Louca S, 2017, ENVIRON MICROBIOL, V19, P3132, DOI 10.1111/1462-2920.13788; Louca S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0015; Louca S, 2016, P NATL ACAD SCI USA, V113, pE5925, DOI 10.1073/pnas.1602897113; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Louca S, 2016, ENVIRON MICROBIOL, V18, P1863, DOI 10.1111/1462-2920.13058; Louca S, 2015, ELIFE, V4, DOI 10.7554/eLife.08208; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359	10	6	7	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1264	1265		10.1126/science.aar2000	http://dx.doi.org/10.1126/science.aar2000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217563				2022-12-28	WOS:000417254700045
J	Praetorius, F; Kick, B; Behler, KL; Honemann, MN; Weuster-Botz, D; Dietz, H				Praetorius, Florian; Kick, Benjamin; Behler, Karl L.; Honemann, Maximilian N.; Weuster-Botz, Dirk; Dietz, Hendrik			Biotechnological mass production of DNA origami	NATURE			English	Article							SINGLE-STRANDED-DNA; NANOSCALE SHAPES; DRUG-RESISTANCE; FOLDING DNA; NANOSTRUCTURES; MECHANISMS; PATTERNS; COMPLEX	DNA nanotechnology, in particular DNA origami, enables the bottom-up self-assembly of micrometre-scale, three-dimensional structures with nanometre-precise features(1-12). These structures are customizable in that they can be site-specifically functionalized(13) or constructed to exhibit machine-like(14,15) or logic-gating behaviour(16). Their use has been limited to applications that require only small amounts of material (of the order of micrograms), owing to the limitations of current production methods. But many proposed applications, for example as therapeutic agents or in complex materials(3,16-22), could be realized if more material could be used. In DNA origami, a nanostructure is assembled from a very long single-stranded scaffold molecule held in place by many short single-stranded staple oligonucleotides. Only the bacteriophage-derived scaffold molecules are amenable to scalable and efficient mass production(23); the shorter staple strands are obtained through costly solid-phase synthesis(24) or enzymatic processes(25). Here we show that single strands of DNA of virtually arbitrary length and with virtually arbitrary sequences can be produced in a scalable and cost-efficient manner by using bacteriophages to generate single-stranded precursor DNA that contains target strand sequences interleaved with self-excising 'cassettes', with each cassette comprising two Zn2+-dependent DNA-cleaving DNA enzymes. We produce all of the necessary single strands of DNA for several DNA origami using shaker-flask cultures, and demonstrate end-to-end production of macroscopic amounts of a DNA origami nanorod in a litre-scale stirred-tank bioreactor. Our method is compatible with existing DNA origami design frameworks and retains the modularity and addressability of DNA origami objects that are necessary for implementing custom modifications using functional groups. With all of the production and purification steps amenable to scaling, we expect that our method will expand the scope of DNA nanotechnology in many areas of science and technology.	[Praetorius, Florian; Kick, Benjamin; Honemann, Maximilian N.; Dietz, Hendrik] Techn Univ Munich, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany; [Praetorius, Florian; Kick, Benjamin; Honemann, Maximilian N.; Dietz, Hendrik] Techn Univ Munich, Inst Adv Study, Coulombwall 4a, D-85748 Garching, Germany; [Kick, Benjamin; Behler, Karl L.; Weuster-Botz, Dirk] Tech Univ Munich, Inst Biochem Engn, Boltzmannstr 15, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Dietz, H (corresponding author), Techn Univ Munich, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany.; Dietz, H (corresponding author), Techn Univ Munich, Inst Adv Study, Coulombwall 4a, D-85748 Garching, Germany.	dietz@tum.de		Weuster-Botz, Dirk/0000-0002-1171-4194; Dietz, Hendrik/0000-0003-1270-3662	European Research Council starting grant [256270]; Deutsche Forschungsgemeinschaft within TUM IGSSE (Biomat 05 PSN); Gottfried-Wilhelm-Leibniz Program; Excellence Cluster CIPSM (Center for Integrated Protein Science Munich); ERASynBio project 'BioOrigami' - Bundesministerium fur Bildung und Forschung grant [031 A 458];  [SFB863]	European Research Council starting grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft within TUM IGSSE (Biomat 05 PSN); Gottfried-Wilhelm-Leibniz Program; Excellence Cluster CIPSM (Center for Integrated Protein Science Munich); ERASynBio project 'BioOrigami' - Bundesministerium fur Bildung und Forschung grant; 	We thank D. Maslak (TUM Research Center for Industrial Biotechnology, Technical University of Munich) for cost estimation in pilot-scale production at the TUM Pilot Plant for Industrial Biotechnology. We thank T. Gerling, E. Meier, M. Schickinger and J. Funke for discussions. This project was supported by European Research Council starting grant 256270, the Deutsche Forschungsgemeinschaft through grants provided within TUM IGSSE (Biomat 05 PSN), the Gottfried-Wilhelm-Leibniz Program, the SFB863, and the Excellence Cluster CIPSM (Center for Integrated Protein Science Munich), the ERASynBio project 'BioOrigami', funded by Bundesministerium fur Bildung und Forschung grant 031 A 458.	Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chasteen L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl772; Clokie M. R., 2008, BACTERIOPHAGES, V8, P77; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Ducani C, 2013, NAT METHODS, V10, P647, DOI [10.1038/NMETH.2503, 10.1038/nmeth.2503]; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Funke JJ, 2016, NAT NANOTECHNOL, V11, P47, DOI [10.1038/NNANO.2015.240, 10.1038/nnano.2015.240]; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Gu HZ, 2013, BIOTECHNIQUES, V54, P337, DOI 10.2144/000114009; Halley PD, 2016, SMALL, V12, P308, DOI 10.1002/smll.201502118; Hong F, 2017, CHEM REV, V117, P12584, DOI 10.1021/acs.chemrev.6b00825; Jiang Q, 2015, SMALL, V11, P5134, DOI 10.1002/smll.201501266; Jiang Q, 2012, J AM CHEM SOC, V134, P13396, DOI 10.1021/ja304263n; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ketterer P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501209; Kick B, 2017, BIOTECHNOL BIOENG, V114, P777, DOI 10.1002/bit.26200; Kick B, 2015, NANO LETT, V15, P4672, DOI 10.1021/acs.nanolett.5b01461; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Knudsen JB, 2015, NAT NANOTECHNOL, V10, P892, DOI [10.1038/NNANO.2015.190, 10.1038/nnano.2015.190]; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Marras AE, 2015, P NATL ACAD SCI USA, V112, P713, DOI 10.1073/pnas.1408869112; Niekamp S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw208; Reese CB, 2005, ORG BIOMOL CHEM, V3, P3851, DOI 10.1039/b510458k; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sambrook J., 2001, MOL CLONING LAB MANU, V1; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Siavashpouri M, 2017, NAT MATER, V16, P849, DOI [10.1038/NMAT4909, 10.1038/nmat4909]; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Stahl E, 2014, ANGEW CHEM INT EDIT, V53, P12735, DOI 10.1002/anie.201405991; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Zhao YX, 2012, ACS NANO, V6, P8684, DOI 10.1021/nn3022662	41	270	278	22	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					84	+		10.1038/nature24650	http://dx.doi.org/10.1038/nature24650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219963				2022-12-28	WOS:000417560500047
J	Mullins, E; Lees, C; Brocklehurst, P				Mullins, Edward; Lees, Christoph; Brocklehurst, Peter			Is continuous electronic fetal monitoring useful for all women in labour?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CEREBRAL-PALSY; HEART-RATE; OUTCOMES; INFANT		[Mullins, Edward; Lees, Christoph] Imperial Coll London, London, England; [Lees, Christoph] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Brocklehurst, Peter] Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham, W Midlands, England	Imperial College London; KU Leuven; University of Birmingham	Lees, C (corresponding author), Imperial Coll London, London, England.; Lees, C (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.; Brocklehurst, P (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham, W Midlands, England.	c.lees@imperial.ac.uk; p.brocklehurst@bham.ac.uk		Mullins, Edward/0000-0003-1886-6358				Alfirevic Z, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub3; Brocklehurst P, 2017, LANCET, V389, P1719, DOI 10.1016/S0140-6736(17)30568-8; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chandraharan E, 2016, BJOG-INT J OBSTET GY, V123, P1770, DOI 10.1111/1471-0528.13980; Chen HY, 2011, AM J OBSTET GYNECOL, V204, pS43, DOI 10.1016/j.ajog.2010.10.091; Dyson C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3120; Evers ACC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5639; Fitzpatrick KE, 2014, BJOG-INT J OBSTET GY, V121, P62, DOI 10.1111/1471-0528.12405; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Fitzpatrick KE, 2014, BJOG, V121, P70; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; GRANT A, 1989, LANCET, V2, P1233; Green L, 2016, BJOG-INT J OBSTET GY, V123, P2164, DOI 10.1111/1471-0528.13831; Knight M, 2008, OBSTET GYNECOL, V111, P97, DOI 10.1097/01.AOG.0000296658.83240.6d; Lees C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j834; Nunes I, 2017, OBSTET GYNECOL, V129, P83, DOI 10.1097/AOG.0000000000001799; Royal College of Obstetricians and Gynaecologists, 2017, EACH BAB COUNTS 2015; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Strijbis EMM, 2006, OBSTET GYNECOL, V107, P1357, DOI 10.1097/01.AOG.0000220544.21316.80	19	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2017	359								j5423	10.1136/bmj.j5423	http://dx.doi.org/10.1136/bmj.j5423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AL	29208652	Green Submitted			2022-12-28	WOS:000417559000003
J	Oh, S; Montgomery, BL				Oh, Sookyung; Montgomery, Beronda L.			Phytochromes: Where to Start?	CELL			English	Editorial Material							ARABIDOPSIS; PHOTOMORPHOGENESIS	Phytochrome signaling allows plants to sense and respond to light through gene regulation. Ushijima et al. (2017) demonstrate a role for phytochromes in widespread regulation of alternative promoter usage, resulting in light-dependent protein isoforms with altered subcellular localization that help the plant respond metabolically to fluctuating light conditions.	[Oh, Sookyung; Montgomery, Beronda L.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Montgomery, Beronda L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Montgomery, Beronda L.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Montgomery, BL (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.; Montgomery, BL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.; Montgomery, BL (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	montg133@msu.edu			National Science Foundation [MCB-1515002]; Office of Science of the US Department of Energy [DE-FG02-91ER20021]; Direct For Biological Sciences [1515002] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research in the lab of B.L.M. on phytochrome-dependent signaling in plants is supported by the National Science Foundation (grant no. MCB-1515002) and by infrastructure support from the Office of Science of the US Department of Energy (grant no. DE-FG02-91ER20021).	Galvao VC, 2015, CURR OPIN NEUROBIOL, V34, P46, DOI 10.1016/j.conb.2015.01.013; Koo SC, 2009, MOL CELLS, V27, P467, DOI 10.1007/s10059-009-0062-7; Montgomery BL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00480; Paik I, 2012, P NATL ACAD SCI USA, V109, P1335, DOI 10.1073/pnas.1109683109; Shikata H, 2014, P NATL ACAD SCI USA, V111, P18781, DOI 10.1073/pnas.1407147112; Shikata H, 2012, PLANT J, V70, P727, DOI 10.1111/j.1365-313X.2012.04937.x; Tsai HL, 2014, PLANT CELL, V26, P2858, DOI 10.1105/tpc.114.126722; Ushijima T, 2017, CELL, V171, P1316, DOI 10.1016/j.cell.2017.10.018	8	6	7	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1254	1256		10.1016/j.cell.2017.11.020	http://dx.doi.org/10.1016/j.cell.2017.11.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195071	Bronze			2022-12-28	WOS:000417362700008
J	Sehgal, A				Sehgal, Amita			Physiology Flies with Time	CELL			English	Editorial Material							CIRCADIAN BEHAVIORAL RHYTHMS; DROSOPHILA CLOCK GENE; PERIOD PROTEIN; MUTATION; AUTOREGULATION; CRYPTOCHROME; MELANOGASTER; FEEDBACK; PRODUCT; MUTANT	The 2017 Nobel Prize in Medicine or Physiology has been awarded to Jeffrey Hall, Michael Rosbash, and Michael Young for elucidating molecular mechanisms of the circadian clock. From studies beginning in fruit flies, we now know that circadian regulation pervades most biological processes and has strong ties to human health and disease.	[Sehgal, Amita] Univ Penn, Chronobiol Program, HHMI, Perelman Sch Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Univ Penn, Chronobiol Program, HHMI, Perelman Sch Med, Philadelphia, PA 19104 USA.	amita@pennmedicine.upenn.edu			NINDS NIH HHS [R37 NS048471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS048471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nohales MA, 2016, NAT STRUCT MOL BIOL, V23, P1061, DOI 10.1038/nsmb.3327; Patke A, 2017, CELL, V169, P203, DOI 10.1016/j.cell.2017.03.027; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	20	27	28	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1232	1235		10.1016/j.cell.2017.11.028	http://dx.doi.org/10.1016/j.cell.2017.11.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195066	Bronze			2022-12-28	WOS:000417362700003
J	Young, MW				Young, Michael W.			As Time Flew By	CELL			English	Editorial Material													, 机智的马小跳和机智的羊不愁/ABC-5169-2020		National Institutes of Health; NIH at Stanford; Calico Life Sciences; NIH R01 grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH at Stanford; Calico Life Sciences; NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Most of my research support has come from the National Institutes of Health. In fact, NIH has supported me continuously since 1971. I was a pre-doctoral NIH trainee from 1971-1975 and had a postdoctoral fellowship from NIH at Stanford, and my first NIH R01 grant arrived shortly after moving to Rockefeller in 1978. This whole pathway of research opportunities was not uncommon in the 1970s. During my time at Rockefeller, I have had unwavering interest and encouragement from many of my colleagues, but especially Norton Zinder, Jim Darnell, Gunter Blobel, and Torsten Wiesel. I also had the good fortune to marry an immunologist in the 1970s, Laurel Eckhardt, now Hesselbach Professor at Hunter College, who has loved discussing the "clock problem'' as it unfolds almost as much as I have. This work was supported in part by a grant from Calico Life Sciences.		0	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1236	1240		10.1016/j.cell.2017.11.022	http://dx.doi.org/10.1016/j.cell.2017.11.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195067	Bronze			2022-12-28	WOS:000417362700004
J	Garrick, DE; Hall, JW; Dobson, A; Damania, R; Grafton, RQ; Hope, R; Hepburn, C; Bark, R; Boltz, F; De Stefano, L; O'Donnell, E; Matthews, N; Money, A				Garrick, Dustin E.; Hall, Jim W.; Dobson, Andrew; Damania, Richard; Grafton, R. Quentin; Hope, Robert; Hepburn, Cameron; Bark, Rosalind; Boltz, Frederick; De Stefano, Lucia; O'Donnell, Erin; Matthews, Nathanial; Money, Alex			Valuing water for sustainable development	SCIENCE			English	Editorial Material							GROUNDWATER; GOVERNANCE; HISTORY; VALUES		[Garrick, Dustin E.; Hall, Jim W.; Hope, Robert; Hepburn, Cameron; Money, Alex] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Dobson, Andrew] Princeton Univ, Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Damania, Richard] World Bank Grp, Global Water Practice, Washington, DC 20433 USA; [Grafton, R. Quentin] Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT 2601, Australia; [Grafton, R. Quentin] Natl Univ Singapore, Inst Water Policy, Singapore 259770, Singapore; [Bark, Rosalind] Univ East Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Boltz, Frederick] Rockefeller Fdn, New York, NY 10018 USA; [De Stefano, Lucia] Univ Complutense Madrid, Madrid 28040, Spain; [De Stefano, Lucia] Botin Fdn, Water Observ, Madrid 28001, Spain; [O'Donnell, Erin] Univ Melbourne, Law Sch, Melbourne, Vic 3010, Australia; [Matthews, Nathanial] Global Resilience Partnership, Nairobi 40612, Kenya	University of Oxford; Princeton University; The World Bank; Australian National University; National University of Singapore; University of East Anglia; Complutense University of Madrid; University of Melbourne	Garrick, DE (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England.	dustin.garrick@ouce.ox.ac.uk	Hall, Jim W/ABF-1407-2020; Grafton, Quentin/AAS-2316-2021; O'Donnell, Erin/AAA-2678-2019; De Stefano, Lucia/H-2085-2015	Hall, Jim W/0000-0002-2024-9191; Grafton, Quentin/0000-0002-0048-9083; De Stefano, Lucia/0000-0002-9612-7051; GARRICK, DUSTIN/0000-0001-6504-6550; Boltz, Frederick/0000-0002-4225-248X; Hepburn, Cameron/0000-0003-0467-7441	Social Sciences and Humanities Research Council of Canada [430-2014-00785]; UK Natural Environment Research Council (NERC) [NE/L010364/1]; UK Department for International Development (DFID) [201880]; NERC; UK Economic and Social Research Council (ESRC); DFID [NE/M008894/1]; NERC [NE/M008894/1, NE/L010364/1] Funding Source: UKRI; Natural Environment Research Council [NE/L010364/1, NE/M008894/1] Funding Source: researchfish	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department for International Development (DFID); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); DFID; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank three anonymous reviewers and E. Schlager for comments. The intellectual support and contribution of the World Bank and the Rockefeller Foundation are gratefully acknowledged. Responsibility for at errors and omissions lies with the authors. D.E.G.. R.D., and A.D. participated in an Expert Advisory Group for The Valuing Water Initiative of the UN/World Bank High Level Panel, and they work for the World Bank in staff or consulting roles. They gratefully acknowledge discussions with ether participants in the expert advisory group in Bellagio (May 2017) and Delft (October 2017). However, this paper does not represent the official view of the expert advisory group, the World Bank, or the UN. The following funding sources supported this work: Social Sciences and Humanities Research Council of Canada, grant 430-2014-00785 (D.E.G., L.D.); the UK Natural Environment Research Council (NERC), grant NE/L010364/1 (J.W.H.); the UK Department for International Development (DFID), grant 201880 (R.H.), and NERC, the UK Economic and Social Research Council (ESRC), and DFID. grant NE/M008894/1 (R.H.).	Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Boyle KJ, 2017, SCIENCE, V358, P49, DOI 10.1126/science.aap8023; Colchester FE, 2017, ENVIRON MODELL SOFTW, V91, P241, DOI 10.1016/j.envsoft.2017.01.026; Cox M, 2010, ECOL SOC, V15; Damania R., 2017, UNCHARTED WATERS NEW; Fenichel EP, 2016, P NATL ACAD SCI USA, V113, P2382, DOI 10.1073/pnas.1513779113; Gerlak AK, 2015, REV POLICY RES, V32, P100, DOI 10.1111/ropr.12114; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Grafton RQ, 2013, NAT CLIM CHANGE, V3, P315, DOI [10.1038/NCLIMATE1746, 10.1038/nclimate1746]; Hanemann WM, 2006, WATER CRISIS: MYTH OR REALITY?, P61; Hutton G., 2016, COSTS M 2030 SUSTAIN, DOI 10.1596/k8543; Karimi P, 2013, HYDROL EARTH SYST SC, V17, P2459, DOI 10.5194/hess-17-2459-2013; Kenter JO, 2016, ECOSYST SERV, V21, P291, DOI 10.1016/j.ecoser.2016.06.010; Lankao PR, 2010, ENVIRON URBAN, V22, P157, DOI 10.1177/0956247809362636; Lorenz C, 2012, J HYDROMETEOROL, V13, P1397, DOI 10.1175/JHM-D-11-088.1; Meehan K, 2013, ENVIRON PLANN D, V31, P319, DOI 10.1068/d20610; Mukherji A, 2014, WATER INT, V39, P671, DOI 10.1080/02508060.2014.955408; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Poff NL, 2016, NAT CLIM CHANGE, V6, P25, DOI [10.1038/nclimate2765, 10.1038/NCLIMATE2765]; Schmidt JJ, 2014, WIRES WATER, V1, P533, DOI 10.1002/wat2.1043	20	89	91	16	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1003	1005		10.1126/science.aao4942	http://dx.doi.org/10.1126/science.aao4942			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2FN	29170225	Green Accepted			2022-12-28	WOS:000416590400026
J	Iacobucci, G				Iacobucci, Gareth			The 2017 Budget and the NHS: experts give their verdict	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gulland A, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5359; Iacobucci G, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5422	2	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2017	359								j5480	10.1136/bmj.j5480	http://dx.doi.org/10.1136/bmj.j5480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WH	29175950				2022-12-28	WOS:000416473300007
J	Ganguli, I; Ferris, TG				Ganguli, Ishani; Ferris, Timothy G.			Accountable Care at the Frontlines of a Health System Bridging Aspiration and Reality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICARE		[Ganguli, Ishani; Ferris, Timothy G.] Harvard Med Sch, Boston, MA USA; [Ganguli, Ishani] Brigham & Womens Hosp, Boston, MA 02120 USA; [Ferris, Timothy G.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Ganguli, I (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	iganguli@bwh.harvard.edu						Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; Mehrotra A, 2017, ANN INTERN MED, V167, P434, DOI 10.7326/M17-0655; Muhlestein D, 2017, HLTH AFFAIRS BLOG; Powers BW, 2017, HEALTHCARE-J DEL SCI, V5, P141, DOI 10.1016/j.hjdsi.2016.04.007; Song ZR, 2016, JAMA-J AM MED ASSOC, V316, P705, DOI 10.1001/jama.2016.9958	7	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2018	319	7					655	656		10.1001/jama.2017.18995	http://dx.doi.org/10.1001/jama.2017.18995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW7MQ	29228143				2022-12-28	WOS:000425508400012
J	Clark, DM; Canvin, L; Green, J; Layard, R; Pilling, S; Janecka, M				Clark, David M.; Canvin, Lauren; Green, John; Layard, Richard; Pilling, Stephen; Janecka, Magdalena			Transparency about the outcomes of mental health services (IAPT approach): an analysis of public data	LANCET			English	Article							PSYCHOLOGICAL TREATMENT; BETA REGRESSION; DEPRESSION; DISORDER; RATES	Background Internationally, the clinical outcomes of routine mental health services are rarely recorded or reported; however, an exception is the English Improving Access to Psychological Therapies (IAPT) service, which delivers psychological therapies recommended by the National Institute for Health and Care Excellence for depression and anxiety disorders to more than 537 000 patients in the UK each year. A session-by-session outcome monitoring system ensures that IAPT obtains symptom scores before and after treatment for 98% of patients. Service outcomes can then be reported, along with contextual information, on public websites. Methods We used publicly available data to identify predictors of variability in clinical performance. Using beta regression models, we analysed the outcome data released by National Health Service Digital and Public Health England for the 2014-15 financial year (April 1, 2014, to March 31, 2015) and developed a predictive model of reliable improvement and reliable recovery. We then tested whether these predictors were also associated with changes in service outcome between 2014-15 and 2015-16. Findings Five service organisation features predicted clinical outcomes in 2014-15. Percentage of cases with a problem descriptor, number of treatment sessions, and percentage of referrals treated were positively associated with outcome. The time waited to start treatment and percentage of appointments missed were negatively associated with outcome. Additive odd ratios suggest that moving from the lowest to highest level on an organisational factor could improve service outcomes by 11-42%, dependent on the factor. Consistent with a causal model, most organisational factors also predicted between-year changes in outcome, together accounting for 33% of variance in reliable improvement and 22% for reliable recovery. Social deprivation was negatively associated with some outcomes, but the effect was partly mitigated by the organisational factors. Interpretation Traditionally, efforts to improve mental health outcomes have largely focused on the development of new and more effective treatments. Our analyses show that the way psychological therapy services are implemented could be similarly important. Mental health services elsewhere in the UK and in other countries might benefit from adopting IAPT's approach to recording and publicly reporting clinical outcomes. Copyright (c) The Author(s). Published by Elsevier Ltd.	[Clark, David M.; Canvin, Lauren] Univ Oxford, Dept Expt Psychol, Oxford, England; [Clark, David M.; Canvin, Lauren] Oxford Acad Hlth Sci Network, Oxford, England; [Green, John] Cent & North West London Natl Hlth Serv Trust, Dept Clin Hlth Psychol, London, England; [Layard, Richard] London Sch Econ, Ctr Econ Performance, London, England; [Pilling, Stephen] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Janecka, Magdalena] Icahn Sch Med Mt Sinai, Dept Psychiat, Seaver Autism Ctr, New York, NY 10029 USA	University of Oxford; University of London; London School Economics & Political Science; University of London; University College London; Icahn School of Medicine at Mount Sinai	Clark, DM (corresponding author), Univ Oxford, Oxford, England.	david.clark@psy.ox.ac.uk		Green, John/0000-0002-5469-973X; Clark, David/0000-0002-8173-6022; Janecka, Magdalena/0000-0001-7406-0776; Canvin, Lauren/0000-0001-5553-0357	Wellcome Trust; ESRC [ES/M010341/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Wellcome Trust.	[Anonymous], SOC ANX DIS REC ASS; Clark DM, 2008, PSYCHOL MED, V38, P629, DOI 10.1017/S0033291707001869; Clark DM, 2011, INT REV PSYCHIATR, V23, P318, DOI 10.3109/09540261.2011.606803; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Delgadillo J., 2015, BRIT J PSYCHIAT, V209, P429, DOI DOI 10.1192/BJP.BP.115.17101; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Department of Health, 2011, IAPT DAT HDB VERS 2; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gillespie K, 2002, BEHAV RES THER, V40, P345, DOI 10.1016/S0005-7967(02)00004-9; Gyani A, 2013, BEHAV RES THER, V51, P597, DOI 10.1016/j.brat.2013.06.004; Health and Social Care Information Centre (HSCIC), 2015, PSYCH THER ANN REP U; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Layard R., 2014, THRIVE POWER PSYCHOL; National Institute for Health and Clinical Excellence (NICE), COMM MENT HLTH DIS I; NHS Digital, 2016, ANN REPORT; Osborne J., 2006, PRACT ASSESS RES EVA, V11, P1; Public Health England, 2017, COMM MENT HLTH DIS P; Roth A., 2005, WHAT WORKS WHOM CRIT, V2nd; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	23	141	141	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					679	686		10.1016/S0140-6736(17)32133-5	http://dx.doi.org/10.1016/S0140-6736(17)32133-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW4MN	29224931	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000425287800027
J	Thornicroft, G				Thornicroft, Graham			Improving access to psychological therapies in England	LANCET			English	Editorial Material							IAPT; DISORDERS; PEOPLE; COST		[Thornicroft, Graham] Kings Coll London, Ctr Global Mental Hlth, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England	University of London; King's College London	Thornicroft, G (corresponding author), Kings Coll London, Ctr Global Mental Hlth, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England.	graham.thornicroft@kcl.ac.uk	Thornicroft, Graham/B-4027-2010	Thornicroft, Graham/0000-0003-0662-0879	Medical Research Council [MR/R023697/1] Funding Source: Medline; MRC [MR/R023697/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker C., 2017, 6988 HOUS COMM LIB; Clark DM, 2009, BEHAV RES THER, V47, P910, DOI 10.1016/j.brat.2009.07.010; Clark DM, 2017, LANCET; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; Department of Health, 2011, WAIT TIM TALK THER; Fornells-Ambrojo M, 2017, BRIT J CLIN PSYCHOL, V56, P253, DOI 10.1111/bjc.12136; Jorm AF, 2017, WORLD PSYCHIATRY, V16, P90, DOI 10.1002/wps.20388; Layard R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01713; McCrone P, 2013, BRIT J PSYCHIAT, V202, P383, DOI 10.1192/bjp.202.5.383; McManus S., 2016, MENTAL HLTH WELLBEIN; Meadows J, 2017, BEHAV COGN PSYCHOTH, V45, P266, DOI 10.1017/S1352465816000485; Radhakrishnan M, 2013, BEHAV RES THER, V51, P37, DOI 10.1016/j.brat.2012.10.001; Singla DR, 2017, ANNU REV CLIN PSYCHO, V13, P149, DOI 10.1146/annurev-clinpsy-032816-045217; Thornicroft G, 2017, BRIT J PSYCHIAT, V210, P119, DOI 10.1192/bjp.bp.116.188078; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; World Health Organization, 2016, MHGAP INT GUID MENT; Wroe AL, 2015, BEHAV COGN PSYCHOTH, V43, P412, DOI 10.1017/S1352465813001227	17	20	21	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2018	391	10121					636	637		10.1016/S0140-6736(17)32158-X	http://dx.doi.org/10.1016/S0140-6736(17)32158-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW4MN	29224933	hybrid			2022-12-28	WOS:000425287800006
J	Ioannidis, JPA; Trepanowski, JF				Ioannidis, John P. A.; Trepanowski, John F.			Disclosures in Nutrition Research Why It Is Different	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROVERSY; OBESITY; FACTS		[Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Trepanowski, John F.] Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA USA; [Trepanowski, John F.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Ioannidis, John P./0000-0003-3118-6859	Laura and John Arnold Foundation; National Institutes of Health at Stanford Prevention Research Center	Laura and John Arnold Foundation; National Institutes of Health at Stanford Prevention Research Center	The Meta-Research Innovation Center at Stanford is receiving grant support from the Laura and John Arnold Foundation. The work of Dr Ioannidis is funded by an unrestricted gift from Sue and Bob O'Donnell. Dr Trepanowski is funded by a T32 fellowship from National Institutes of Health at Stanford Prevention Research Center.	Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; Cope MB, 2010, INT J OBESITY, V34, P84, DOI 10.1038/ijo.2009.239; DariushMozaffarian, 2017, JAMA-J AM MED ASSOC, V317, P1755, DOI 10.1001/jama.2017.3456; de Camargo KR, 2013, GLOB PUBLIC HEALTH, V8, P769, DOI 10.1080/17441692.2013.817599; Holmes-Rovner M, 2003, PATIENT EDUC COUNS, V51, P75, DOI 10.1016/S0738-3991(02)00167-2; IOANNIDIS JPA, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6698; Magni P, 2017, ADV NUTR, V8, P532, DOI 10.3945/an.116.014738	9	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					547	548		10.1001/jama.2017.18571	http://dx.doi.org/10.1001/jama.2017.18571			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29222543				2022-12-28	WOS:000424908400011
J	Inoue, LYT; Lin, DW; Newcomb, LF; Leonardson, AS; Ankerst, D; Gulati, R; Carter, HB; Trock, BJ; Carroll, PR; Cooperberg, MR; Cowan, JE; Klotz, LH; Mamedov, A; Penson, DF; Etzioni, R				Inoue, Lurdes Y. T.; Lin, Daniel W.; Newcomb, Lisa F.; Leonardson, Amy S.; Ankerst, Donna; Gulati, Roman; Carter, H. Ballentine; Trock, Bruce J.; Carroll, Peter R.; Cooperberg, Matthew R.; Cowan, Janet E.; Klotz, Laurence H.; Mamedov, Alexandre; Penson, David F.; Etzioni, Ruth			Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts	ANNALS OF INTERNAL MEDICINE			English	Article							COMPETING RISKS; FOLLOW-UP; TIME; RECURRENCE; OUTCOMES; MODELS	Background: Active surveillance (AS) is increasingly accepted for managing low-risk prostate cancer, yet there is no consensus about implementation. This lack of consensus is due in part to uncertainty about risks for disease progression, which have not been systematically compared or integrated across AS studies with variable surveillance protocols and dropout to active treatment. Objective: To compare risks for upgrading from a Gleason score (GS) of 6 or less to 7 or more across AS studies after accounting for differences in surveillance intervals and competing treatments and to evaluate tradeoffs of more versus less frequent biopsies. Design: Joint statistical model of longitudinal prostate-specific antigen (PSA) levels and risks for biopsy upgrading. Setting: Johns Hopkins University (JHU); Canary Prostate Active Surveillance Study (PASS); University of California, San Francisco (UCSF); and University of Toronto (UT) AS studies. Patients: 2576 men aged 40 to 80 years with a GS between 2 and 6 and clinical stage T1 or T2 prostate cancer enrolled between 1995 and 2014. Measurements: PSA levels and biopsy GSs. Results: After variable surveillance intervals and competing treatments were accounted for, estimated risks for biopsy upgrading were similar in the PASS and UT studies but higher in UCSF and lower in JHU studies. All cohorts had a delay of 3 to 5 months in detecting upgrading with biennial biopsies starting after a first confirmatory biopsy versus annual biopsies. Limitation: The model does not account for possible misclassification of biopsy GS. Conclusion: Men in different AS studies have different risks for biopsy upgrading after variable surveillance protocols and competing treatments are accounted for. Despite these differences, the consequences of more versus less frequent biopsies seem to be similar across cohorts. Biennial biopsies seem to be an acceptable alternative to annual biopsies.	[Inoue, Lurdes Y. T.] Univ Washington, Dept Biostat, 1959 NE Pacific St, Seattle, WA 98195 USA; [Lin, Daniel W.] Univ Washington, Dept Urol, 1959 NE Pacific St, Seattle, WA 98195 USA; [Newcomb, Lisa F.; Leonardson, Amy S.; Gulati, Roman; Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230, Seattle, WA 98109 USA; [Ankerst, Donna] Tech Univ Munich, Boltzmannstr 3, D-85748 Garching, Germany; [Carter, H. Ballentine; Trock, Bruce J.] Johns Hopkins Med Inst, James Buchanan Urol Inst, 600 North Wolfe St, Baltimore, MD 21287 USA; [Carroll, Peter R.; Cooperberg, Matthew R.; Cowan, Janet E.] Univ Calif San Francisco, Dept Urol, 400 Parnassus Ave, San Francisco, CA 94143 USA; [Klotz, Laurence H.; Mamedov, Alexandre] Univ Toronto, Div Urol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Penson, David F.] Vanderbilt Univ, Dept Urol Surg, 1301 Med Ctr Dr, Nashville, TN 37232 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Technical University of Munich; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; University of Toronto; Vanderbilt University	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230, Seattle, WA 98109 USA.	linoue@u.washington.edu; retzioni@fredhutch.org	Cooperberg, Matthew R/G-6249-2017; Gulati, Roman/AAE-4298-2019	Cooperberg, Matthew R/0000-0003-4339-6685; Gulati, Roman/0000-0002-7592-6567; Penson, David/0000-0002-2580-2697; Ankerst, Donna/0000-0003-4229-2462	National Cancer Institute [R01 CA183570, R01 CA160239]; Canary Foundation; Genomic Health; U.S. Department of Defense Translational Impact Award for Prostate Cancer award [W81XWH-13-2-0074]; Prostate Cancer Canada; National Cancer Institute as part of the Pacific Northwest Prostate Cancer Specialized Program of Research Excellence [P50 CA097186]; National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network (CISNET) [U01 CA199338]; NATIONAL CANCER INSTITUTE [R01CA160239, U01CA199338, R01CA183570, P50CA097186] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; Genomic Health; U.S. Department of Defense Translational Impact Award for Prostate Cancer award(United States Department of Defense); Prostate Cancer Canada; National Cancer Institute as part of the Pacific Northwest Prostate Cancer Specialized Program of Research Excellence; National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network (CISNET); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By National Cancer Institute awards R01 CA183570 for the Prostate Modeling to Identify Surveillance Strategies (PROMISS) consortium (all authors), R01 CA160239 for statistical methods to study cancer recurrence using longitudinal multistate models (Dr. Inoue), P50 CA097186 as part of the Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (Ms. Leonardson), and U01 CA199338 as part of the Cancer Intervention and Surveillance Modeling Network (CISNET) (Mr. Gulati and Dr. Etzioni); the Canary Foundation (Drs. Lin and Newcomb); Genomic Health and U.S. Department of Defense Translational Impact Award for Prostate Cancer award W81XWH-13-2-0074 (Drs. Carroll and Cooperberg and Ms. Cowan); and Prostate Cancer Canada (Dr. Klotz).	Alam R, 2015, J UROLOGY, V193, P1950, DOI 10.1016/j.juro.2014.12.091; Ankerst DP, 2015, EUR UROL, V68, P1083, DOI 10.1016/j.eururo.2015.03.023; Boorjian SA, 2005, BJU INT, V96, P773, DOI 10.1111/j.1464-410X.2005.05763.x; Bruinsma SM, 2016, NAT REV UROL, V13, P151, DOI 10.1038/nrurol.2015.313; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Chen RC, 2016, J CLIN ONCOL, V34, P2182, DOI 10.1200/JCO.2015.65.7759; Chiang AJ, 2014, J GYNECOL ONCOL, V25, P51, DOI 10.3802/jgo.2014.25.1.51; Fossati N, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2016.11.010; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Ibrahim JG, 2010, J CLIN ONCOL, V28, P2796, DOI 10.1200/JCO.2009.25.0654; Inoue LYT, 2013, BIOSTATISTICS, V14, P15, DOI 10.1093/biostatistics/kxs018; Inoue LYT, 2014, STAT MED, V33, P930, DOI 10.1002/sim.6003; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Newcomb LF, 2016, J UROLOGY, V195, P313, DOI 10.1016/j.juro.2015.08.087; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Taylor JMG, 2013, BIOMETRICS, V69, P206, DOI 10.1111/j.1541-0420.2012.01823.x; Tosoian JJ, 2016, NAT REV UROL, V13, P205, DOI 10.1038/nrurol.2016.45; Tosoian JJ, 2015, J CLIN ONCOL, V33, P3379, DOI 10.1200/JCO.2015.62.5764; Welty CJ, 2015, J UROLOGY, V193, P807, DOI 10.1016/j.juro.2014.09.094	19	28	29	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					1	+		10.7326/M17-0548	http://dx.doi.org/10.7326/M17-0548			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5SO	29181514	Green Accepted			2022-12-28	WOS:000419126700002
J	Abbasi, J				Abbasi, Jennifer			Emergency Department Opioid Misuse Diagnoses Increasing in Adolescents and Young Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2416	2417		10.1001/jama.2017.16586	http://dx.doi.org/10.1001/jama.2017.16586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29214309				2022-12-28	WOS:000418720700002
J	Cohen, SD; Kopp, JB; Kimmel, PL				Cohen, Scott D.; Kopp, Jeffrey B.; Kimmel, Paul L.			Kidney Diseases Associated with Human Immunodeficiency Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							APOL1 RISK VARIANTS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-ASSOCIATED NEPHROPATHY; ACUTE-RENAL-FAILURE; THROMBOTIC MICROANGIOPATHY; PERITONEAL-DIALYSIS; INJURY; ERA; TRANSPLANTATION		[Cohen, Scott D.; Kimmel, Paul L.] George Washington Univ, Dept Med, Div Renal Dis & Hypertens, Washington, DC USA; [Kopp, Jeffrey B.; Kimmel, Paul L.] NIDDK, NIH, Rm 6707,Democracy Blvd, Bethesda, MD 20892 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kimmel, PL (corresponding author), NIDDK, NIH, Rm 6707,Democracy Blvd, Bethesda, MD 20892 USA.	kimmelp@extra.niddk.nih.gov	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X				[Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1306, DOI 10.15585/mmwr.mm6546a9; Avettand-Fenoel V, 2017, TRANSPLANTATION, V101, P2003, DOI 10.1097/TP.0000000000001674; Barnighausen T, 2015, CURR OPIN HIV AIDS, V10, P391, DOI 10.1097/COH.0000000000000205; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Becker S, 2004, CLIN INFECT DIS, V39, pS267, DOI 10.1086/422363; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Berns JS, 2006, CLIN J AM SOC NEPHRO, V1, P117, DOI 10.2215/CJN.00370705; Bird JE, 1998, J AM SOC NEPHROL, V9, P1441; Booth JW, 2016, NEPHROL DIAL TRANSPL, V31, P2099, DOI 10.1093/ndt/gfv436; Boyarsky BJ, 2015, AM J TRANSPLANT, V15, P2023, DOI 10.1111/ajt.13344; Calvo M, 2014, CURR OPIN HIV AIDS, V9, P332, DOI 10.1097/COH.0000000000000075; Campos P, 2016, CLIN KIDNEY J, V9, P772, DOI 10.1093/ckj/sfw104; Chaudhary SR, 2015, NEPHROL DIAL TRANSPL, V30, P1734, DOI 10.1093/ndt/gfv207; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; Cohen SD, 2008, CURR OPIN CRIT CARE, V14, P647, DOI 10.1097/MCC.0b013e3283186f43; Cohen SD, 2009, NAT CLIN PRACT NEPHR, V5, P22, DOI 10.1038/ncpneph0990; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cooper A, 2017, ELIFE, V6, DOI [10.7554/eLife.25461, 10.7554/elife.25461]; Daugas E, 2006, NAT CLIN PRACT NEPHR, V2, P594, DOI 10.1038/ncpneph0282; DELARCO A, 1993, CLIN INFECT DIS, V17, P360, DOI 10.1093/clinids/17.3.360; Dijkman HBPM, 2006, KIDNEY INT, V70, P338, DOI 10.1038/sj.ki.5001574; Estrella MM, 2010, ADV CHRONIC KIDNEY D, V17, P26, DOI 10.1053/j.ackd.2009.07.014; Eustace JA, 2000, KIDNEY INT, V58, P1253, DOI 10.1046/j.1523-1755.2000.00280.x; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Farzadegan H, 1996, KIDNEY INT, V50, P1659, DOI 10.1038/ki.1996.482; Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Franceschini N, 2005, KIDNEY INT, V67, P1526, DOI 10.1111/j.1523-1755.2005.00232.x; Freedman BI, 2015, KIDNEY INT, V87, P671, DOI 10.1038/ki.2015.16; Fu YL, 2017, J AM SOC NEPHROL, V28, P1106, DOI 10.1681/ASN.2016050550; GARDENSWARTZ MH, 1984, CLIN NEPHROL, V21, P197; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; German P, 2012, JAIDS-J ACQ IMM DEF, V61, P32, DOI 10.1097/QAI.0b013e3182645648; Gervasoni C, 2002, CLIN INFECT DIS, V35, P1534, DOI 10.1086/344778; Ghrenassia E, 2015, J AUTOIMMUN, V59, P19, DOI 10.1016/j.jaut.2015.01.010; Gibson AK, 2016, ANN PHARMACOTHER, V50, P942, DOI 10.1177/1060028016660812; Hadigan C, 2013, AM J NEPHROL, V37, P443, DOI 10.1159/000350384; Hayek SS, 2017, NAT MED, V23, P945, DOI 10.1038/nm.4362; Henry J. Kaiser Family Foundation, HIV AIDS EP US; Heymann J, 2017, NEPHROL DIAL TRANSPL, V32, P65, DOI 10.1093/ndt/gfw402; Izzedine H, 2007, AIDS, V21, P409, DOI 10.1097/QAD.0b013e328011ec40; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Jin A, 2016, CLIN KIDNEY J, V9, P576, DOI 10.1093/ckj/sfw035; Jotwani V, 2016, AM J KIDNEY DIS, V68, P571, DOI 10.1053/j.ajkd.2016.03.430; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; KIMMEL PL, 1993, KIDNEY INT, V44, P1327, DOI 10.1038/ki.1993.386; KIMMEL PL, 1992, NEW ENGL J MED, V327, P702, DOI 10.1056/NEJM199209033271006; Kimmel PL, 2003, ANN INTERN MED, V139, P214, DOI 10.7326/0003-4819-139-3-200308050-00011; Kooman JP, 2017, EXP GERONTOL, V87, P156, DOI 10.1016/j.exger.2016.02.003; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117, DOI 10.1681/ASN.2016050546; Kumar D, 2012, AM J PHYSIOL-RENAL, V303, pF711, DOI 10.1152/ajprenal.00643.2011; Lake JE, 2013, LANCET INFECT DIS, V13, P964, DOI 10.1016/S1473-3099(13)70271-8; Lee FJ, 2012, CURR OPIN HIV AIDS, V7, P422, DOI 10.1097/COH.0b013e328356682a; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; Mallipattu Sandeep K, 2012, J AIDS Clin Res, VSuppl 4, P001; Mallipattu SK, 2014, KIDNEY INT, V86, P259, DOI 10.1038/ki.2014.44; Meehan SM, 2012, VIRCHOWS ARCH, V460, P429, DOI 10.1007/s00428-012-1213-3; Mocroft A, 2014, HIV MED, V15, P144, DOI 10.1111/hiv.12095; Mocroft A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001809; Mpondo BCT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089573; Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896; Nadkarni GN, 2014, CURR OPIN HIV AIDS, V9, P340, DOI 10.1097/COH.0000000000000067; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Nobakht E, 2016, NAT REV NEPHROL, V12, P291, DOI 10.1038/nrneph.2015.216; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; PARDO V, 1984, ANN INTERN MED, V101, P429, DOI 10.7326/0003-4819-101-4-429; Peralta CA, 2014, HIV MED, V15, P291, DOI 10.1111/hiv.12113; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Raper J, 1999, INFECT IMMUN, V67, P1910; Rosenberg AZ, 2015, NAT REV NEPHROL, V11, P150, DOI 10.1038/nrneph.2015.9; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sauter D, 2016, CURR OPIN HIV AIDS, V11, P173, DOI 10.1097/COH.0000000000000233; Sawinski D, 2014, CURR OPIN NEPHROL HY, V23, P619, DOI 10.1097/MNH.0000000000000071; Scherzer R, 2014, AIDS, V28, P1289, DOI 10.1097/QAD.0000000000000258; Shlipak MG, 2012, JAIDS-J ACQ IMM DEF, V61, P565, DOI 10.1097/QAI.0b013e3182737706; Siedner MJ, 2008, JAIDS-J ACQ IMM DEF, V47, P261, DOI 10.1097/QAI.0b013e31815ac4ad; Soleymanian T, 2006, INT UROL NEPHROL, V38, P331, DOI 10.1007/s11255-006-0080-8; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; Stohr W, 2011, ANTIVIR THER, V16, P1011, DOI 10.3851/IMP1832; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; UNAIDS, 2014, UNAIDS FACT SHEET; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wyatt CM, 2016, KIDNEY INT, V89, P5, DOI 10.1016/j.kint.2015.11.014; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601; Wyatt CM, 2009, KIDNEY INT, V75, P428, DOI 10.1038/ki.2008.604	91	53	58	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2363	2374		10.1056/NEJMra1508467	http://dx.doi.org/10.1056/NEJMra1508467			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	29236630				2022-12-28	WOS:000417923600008
J	Ostergaard, L; Vesikari, T; Absalon, J; Beeslaar, J; Ward, BJ; Senders, S; Eiden, JJ; Jansen, KU; Anderson, AS; York, LJ; Jones, TR; Harris, SL; O'Neill, R; Radley, D; Maansson, R; Pregaldien, JL; Ginis, J; Staerke, NB; Perez, JL				Ostergaard, Lars; Vesikari, Timo; Absalon, Judith; Beeslaar, Johannes; Ward, Brian J.; Senders, Shelly; Eiden, Joseph J.; Jansen, Kathrin U.; Anderson, Annaliesa S.; York, Laura J.; Jones, Thomas R.; Harris, Shannon L.; O'Neill, Robert; Radley, David; Maansson, Roger; Pregaldien, Jean-Louis; Ginis, John; Staerke, Nina B.; Perez, John L.		B1971009 B1971016 Trial Investigat	A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; DISEASE RECOMMENDATIONS; RLP2086 VACCINE; IMMUNOGENICITY; SAFETY; TOLERABILITY; COVERAGE; PROTECTION; UNIVERSITY	BACKGROUND MenB-FHbp is a licensed meningococcal B vaccine targeting factor H-binding protein. Two phase 3 studies assessed the safety of the vaccine and its immunogenicity against diverse strains of group B meningococcus. METHODS We randomly assigned 3596 adolescents (10 to 18 years of age) to receive MenB-FHbp or hepatitis A virus vaccine and saline and assigned 3304 young adults (18 to 25 years of age) to receive MenB-FHbp or saline at baseline, 2 months, and 6 months. Immunogenicity was assessed in serum bactericidal assays that included human complement (hSBAs). We used 14 meningococcal B test strains that expressed vaccine-heterologous factor H-binding proteins representative of meningococcal B epidemiologic diversity; an hSBA titer of at least 1:4 is the accepted correlate of protection. The five primary end points were the proportion of participants who had an increase in their hSBA titer for each of 4 primary strains by a factor of 4 or more and the proportion of those who had an hSBA titer at least as high as the lower limit of quantitation (1:8 or 1:16) for all 4 strains combined after dose 3. We also assessed the hSBA responses to the primary strains after dose 2; hSBA responses to the 10 additional strains after doses 2 and 3 were assessed in a subgroup of participants only. Safety was assessed in participants who received at least one dose. RESULTS In the modified intention-to-treat population, the percentage of adolescents who had an increase in the hSBA titer by a factor of 4 or more against each primary strain ranged from 56.0 to 85.3% after dose 2 and from 78.8 to 90.2% after dose 3; the percentages of young adults ranged from 54.6 to 85.6% and 78.9 to 89.7%, after doses 2 and 3, respectively. Composite responses after doses 2 and 3 in adolescents were 53.7% and 82.7%, respectively, and those in young adults were 63.3% and 84.5%, respectively. Responses to the 4 primary strains were predictive of responses to the 10 additional strains. Most of those who received MenB-FHbp reported mild or moderate pain at the vaccination site. CONCLUSIONS MenB-FHbp elicited bactericidal responses against diverse meningococcal B strains after doses 2 and 3 and was associated with more reactions at the injection site than the hepatitis A virus vaccine and saline.	[Ostergaard, Lars; Staerke, Nina B.] Aarhus Univ Hosp, Aarhus, Denmark; [Vesikari, Timo] Univ Tampere, Med Sch, Vaccine Res Ctr, Tampere, Finland; [Absalon, Judith; Eiden, Joseph J.] Pfizer Vaccine Clin Res & Dev, 401 N Middletown Rd, Pearl River, NY 10965 USA; [Jansen, Kathrin U.; Anderson, Annaliesa S.; Jones, Thomas R.; Harris, Shannon L.; O'Neill, Robert] Pfizer Vaccine Res & Dev, Pearl River, NY USA; [Beeslaar, Johannes] Pfizer Vaccine Clin Res & Dev, Hurley, England; [Ward, Brian J.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Senders, Shelly] Senders Pediat, South Euclid, OH USA; [York, Laura J.] Pfizer Vaccine Med Dev, Sci & Clin Affairs, Collegeville, PA USA; [Radley, David; Maansson, Roger; Ginis, John; Perez, John L.] Pfizer Vaccine Clin Res & Dev, Collegeville, PA USA; [Perez, John L.] Pfizer Vaccine Clin Res & Dev, Brussels, Belgium	Aarhus University; Tampere University; Pfizer; Pfizer; Pfizer; McGill University; Pfizer; Pfizer; Pfizer	Absalon, J (corresponding author), Pfizer Vaccine Clin Res & Dev, 401 N Middletown Rd, Pearl River, NY 10965 USA.	judith.absalon@pfizer.com	Ostergaard, Lars/AAA-3020-2020; Faust, Saul/J-9779-2014; Esposito, Susanna/K-3475-2016	Ostergaard, Lars/0000-0003-2459-0511; Faust, Saul/0000-0003-3410-7642; Ostergaard, Lars/0000-0002-7619-605X; Lipko, Nancy/0000-0001-9267-4587; Staerke, Nina Breinholt/0000-0002-5834-2033; Esposito, Susanna/0000-0003-4103-2837; Ramon Torrell, Josep M/0000-0001-5355-4136	Pfizer	Pfizer(Pfizer)	Funded by Pfizer;	[Anonymous], 2016, HAVR HEP A VACC; [Anonymous], 2016, TRUM MEN GROUP B VAC; Basta NE, 2016, NEW ENGL J MED, V375, P220, DOI 10.1056/NEJMoa1514866; Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Centers for Disease Control and Prevention, 2015, MEN DIS TECHN CLIN I; Centers for Disease Control and Prevention, 2012, ACT BACT COR SURV AB; Centers for Disease Control and Prevention, 2016, MEN DIS; Chatt C, 2014, EUROSURVEILLANCE, V19, P25, DOI 10.2807/1560-7917.ES2014.19.44.20949; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Giuntini S, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00430-16; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Horne AD, 2000, VACCINE, V19, P319, DOI 10.1016/S0264-410X(00)00152-3; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Marshall HS, 2013, VACCINE, V31, P1569, DOI 10.1016/j.vaccine.2013.01.021; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Pace D, 2012, VACCINE, V30, pB3, DOI 10.1016/j.vaccine.2011.12.062; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Reiner DM, 2016, VACCINE, V34, P809, DOI 10.1016/j.vaccine.2015.12.016; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Senders S, 2016, PEDIATR INFECT DIS J, V35, P548, DOI 10.1097/INF.0000000000001072; Sheldon EA, 2012, HUM VACC IMMUNOTHER, V8, P888, DOI 10.4161/hv.19983; Stewart A, 2013, PERSPECT PUBLIC HEAL, V133, P104, DOI 10.1177/1757913912439928; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Vesikari T, 2016, J PEDIAT INF DIS SOC, V5, P180, DOI 10.1093/jpids/piv064; Vesikari T, 2016, J PEDIAT INF DIS SOC, V5, P152, DOI 10.1093/jpids/piv039; Wong CA, 2013, J ADOLESCENT HEALTH, V53, P492, DOI 10.1016/j.jadohealth.2013.05.009; World Health Organization, 1999, STAND VAL SER ASS EV; Zlotnick GW, 2015, HUM VACC IMMUNOTHER, V11, P5, DOI 10.4161/hv.34293	38	42	42	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2349	2362		10.1056/NEJMoa1614474	http://dx.doi.org/10.1056/NEJMoa1614474			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	29236639	Bronze, Green Published			2022-12-28	WOS:000417923600007
J	Shahbazi, MN; Scialdone, A; Skorupska, N; Weberling, A; Recher, G; Zhu, M; Jedrusik, A; Devito, LG; Noli, L; Macaulay, IC; Buecker, C; Khalaf, Y; Ilic, D; Voet, T; Marioni, JC; Zernicka-Goetz, M				Shahbazi, Marta N.; Scialdone, Antonio; Skorupska, Natalia; Weberling, Antonia; Recher, Gaelle; Zhu, Meng; Jedrusik, Agnieszka; Devito, Liani G.; Noli, Laila; Macaulay, Iain C.; Buecker, Christa; Khalaf, Yakoub; Ilic, Dusko; Voet, Thierry; Marioni, John C.; Zernicka-Goetz, Magdalena			Pluripotent state transitions coordinate morphogenesis in mouse and human embryos	NATURE			English	Article							STEM-CELL TRANSITION; LUMEN FORMATION; GROUND-STATE; NAIVE; CULTURE; POLARIZATION; OTX2	The foundations of mammalian development lie in a cluster of embryonic epiblast stem cells. In response to extracellular matrix signalling, these cells undergo epithelialization and create an apical surface in contact with a cavity(1,2), a fundamental event for all subsequent development. Concomitantly, epiblast cells transit through distinct pluripotent states(3,4), before lineage commitment at gastrulation. These pluripotent states have been characterized at the molecular level(5), but their biological importance remains unclear. Here we show that exit from an unrestricted naive pluripotent state is required for epiblast epithelialization and generation of the pro-amniotic cavity in mouse embryos. Embryonic stem cells locked in the naive state are able to initiate polarization but fail to undergo lumenogenesis. Mechanistically, exit from naive pluripotency activates an Oct4-governed transcriptional program that results in expression of glycosylated sialomucin proteins and the vesicle tethering and fusion events of lumenogenesis. Similarly, exit of epiblasts from naive pluripotency in cultured human post-implantation embryos triggers amniotic cavity formation and developmental progression. Our results add tissue-level architecture as a new criterion for the characterization of different pluripotent states, and show the relevance of transitions between these states during development of the mammalian embryo.	[Shahbazi, Marta N.; Skorupska, Natalia; Weberling, Antonia; Recher, Gaelle; Zhu, Meng; Jedrusik, Agnieszka; Zernicka-Goetz, Magdalena] Univ Cambridge, Mammalian Embryo & Stem Cell Grp, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Scialdone, Antonio; Marioni, John C.] EMBL EBI, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Devito, Liani G.; Noli, Laila; Khalaf, Yakoub; Ilic, Dusko] Kings Coll London, Guys Hosp, Fac Life Sci & Med, Womens Hlth Acad Ctr,Assisted Concept Unit, London SE1 9RT, England; [Macaulay, Iain C.; Voet, Thierry; Marioni, John C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Buecker, Christa] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Herestr 49, B-3000 Leuven, Belgium; [Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Scialdone, Antonio] Helmholtz Zentrum Munchen, Inst Epigenet & Stem Cells, D-85764 Munich, Germany; [Recher, Gaelle] CNRS, IOGS, Bioimaging & Optofluid Grp, Rue Francois Mitterrand, F-33400 Talence, France; [Recher, Gaelle] Univ Bordeaux, Rue Francois Mitterrand, F-33400 Talence, France; [Macaulay, Iain C.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UG, Norfolk, England; [Buecker, Christa] Vienna Bioctr VBC, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria	University of Cambridge; European Molecular Biology Laboratory (EMBL); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Wellcome Trust Sanger Institute; Stanford University; KU Leuven; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Mammalian Embryo & Stem Cell Grp, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	mz205@cam.ac.uk	Voet, Thierry/E-8877-2017; Shahbazi, Marta/AAM-7365-2020; Recher, Gaelle/AAB-8218-2019	Voet, Thierry/0000-0003-1204-9963; Recher, Gaelle/0000-0001-9004-0118; Marioni, John/0000-0001-9092-0852; Zhu, Meng/0000-0001-6157-8840; Macaulay, Iain/0000-0002-6761-757X; Buecker, Christa/0000-0003-3055-2642; ILIC, DUSKO/0000-0003-1647-0026; Shahbazi, Marta Nasila/0000-0002-1599-5747; Scialdone, Antonio/0000-0002-4956-2843; Weberling, Antonia/0000-0001-8282-5695; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust [098287/Z/12/Z, 105031/D/14/Z]; ERC [669198]; KU Leuven (SymBioSys) [PFV/10/016]; EMBL; Cancer Research UK; Ramon Areces postdoctoral fellowship; EMBO postdoctoral fellowship; Newton fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR9819, BB/P022073/1] Funding Source: researchfish; Cancer Research UK [22231] Funding Source: researchfish; BBSRC [BBS/E/T/000PR9819, BB/P022073/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); KU Leuven (SymBioSys); EMBL; Cancer Research UK(Cancer Research UK); Ramon Areces postdoctoral fellowship; EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Newton fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. McNagny, J. Hanna and R. Jaenisch for reagents and discussions; F. Martin-Belmonte, D. Glover, C. Lynch, M. Serrano, A. Hupalowska, F. Antonica and M. Petruzzelli for feedback; J. N. Skepper for help with electron microscopy; W. Mansfield for help with embryo transfer. This work was supported by Wellcome Trust (098287/Z/12/Z) and ERC (669198) grants to M.Z.-G. Work in the laboratory of T.V. was supported by Wellcome Trust and KU Leuven (SymBioSys PFV/10/016). Work in the laboratory of J. C. M. was supported by EMBL and Cancer Research UK. M.N.S. was supported by Ramon Areces and EMBO postdoctoral fellowships; A.S. by a Wellcome Trust strategic award (105031/D/14/Z) and G.R. by a Newton fellowship.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Blasky AJ, 2015, ANNU REV CELL DEV BI, V31, P575, DOI 10.1146/annurev-cellbio-100814-125323; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; HERTIG AT, 1956, AM J ANAT, V98, P435, DOI 10.1002/aja.1000980306; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Kalkan T, 2017, DEVELOPMENT, V144, P1221, DOI 10.1242/dev.142711; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mangan AJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12426; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Panamarova M, 2016, DEVELOPMENT, V143, P1271, DOI 10.1242/dev.131961; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Taniguchi K, 2015, STEM CELL REP, V5, P954, DOI 10.1016/j.stemcr.2015.10.015; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vallot C, 2017, CELL STEM CELL, V20, P102, DOI 10.1016/j.stem.2016.10.014; Vuoristo S., 2016, PROTOC EXCH; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Yang ZF, 2013, DEVELOPMENT, V140, P1774, DOI 10.1242/dev.087957; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	45	120	121	2	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					239	+		10.1038/nature24675	http://dx.doi.org/10.1038/nature24675			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29186120	Green Accepted, Green Submitted			2022-12-28	WOS:000418029500044
J	Hoag, H				Hoag, Hannah			CLIMATE CHANGE Nations put science before fishing in the Arctic	SCIENCE			English	News Item																			0	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1235	1235		10.1126/science.358.6368.1235	http://dx.doi.org/10.1126/science.358.6368.1235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217549				2022-12-28	WOS:000417254700013
J	Perez, MF; Francesconi, M; Hidalgo-Carcedo, C; Lehner, B				Francisco Perez, Marcos; Francesconi, Mirko; Hidalgo-Carcedo, Cristina; Lehner, Ben			Maternal age generates phenotypic variation in Caenorhabditis elegans	NATURE			English	Article							GENETICALLY IDENTICAL ORGANISMS; REPRODUCTION; VARIABILITY; STARVATION; UNDERLIES; SELECTION; GROWTH; OOCYTE	Genetically identical individuals that grow in the same environment often show substantial phenotypic variation within populations of organisms as diverse as bacteria(1), nematodes(2), rodents(3) and humans(4). With some exceptions(5-7), the causes are poorly understood. Here we show that isogenic Caenorhabditis elegans nematodes vary in their size at hatching, speed of development, growth rate, starvation resistance, fecundity, and also in the rate of development of their germline relative to that of somatic tissues. We show that the primary cause of this variation is the age of an individual's mother, with the progeny of young mothers exhibiting several phenotypic impairments. We identify age-dependent changes in the maternal provisioning of the lipoprotein complex vitellogenin to embryos as the molecular mechanism that underlies the variation in multiple traits throughout the life of an animal. The production of sub-optimal progeny by young mothers may reflect a trade-off between the competing fitness traits of a short generation time and the survival and fecundity of the progeny.	[Francisco Perez, Marcos; Francesconi, Mirko; Hidalgo-Carcedo, Cristina; Lehner, Ben] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Dr Aiguader 88, Barcelona 08003, Spain; [Francisco Perez, Marcos; Francesconi, Mirko; Hidalgo-Carcedo, Cristina; Lehner, Ben] Univ Pompeu Fabra UPF, Barcelona, Spain; [Lehner, Ben] Pg Lluis Co 23, Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Lehner, B (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Dr Aiguader 88, Barcelona 08003, Spain.; Lehner, B (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.; Lehner, B (corresponding author), Pg Lluis Co 23, Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain.	ben.lehner@crg.eu	francesconi, mirko/O-8080-2015; Lehner, Ben/L-3413-2014; Perez, Marcos Francisco/N-8803-2015; Perez, Marcos Francisco/ABA-2387-2021	francesconi, mirko/0000-0002-8702-0877; Lehner, Ben/0000-0002-8817-1124; Perez, Marcos Francisco/0000-0001-5277-1550; Perez, Marcos Francisco/0000-0003-3835-3445	European Research Council Consolidator grant [616434]; Spanish Ministry of Economy and Competitiveness [BFU2011-26206, SEV-2012-0208]; AXA Research Fund; Bettencourt Schueller Foundation; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014 SGR 831]; EMBL-CRG Systems Biology Program; CERCA Program/Generalitat de Catalunya; FPI-Severo Ochoa fellowship; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	European Research Council Consolidator grant(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); AXA Research Fund(AXA Research Fund); Bettencourt Schueller Foundation; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBL-CRG Systems Biology Program; CERCA Program/Generalitat de Catalunya; FPI-Severo Ochoa fellowship; National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a European Research Council Consolidator grant (616434), the Spanish Ministry of Economy and Competitiveness (BFU2011-26206 and SEV-2012-0208), the AXA Research Fund, the Bettencourt Schueller Foundation, Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, 2014 SGR 831), the EMBL-CRG Systems Biology Program, and the CERCA Program/Generalitat de Catalunya. M.F.P. was partially supported by a FPI-Severo Ochoa fellowship. Expression profiling was performed in the CRG Genomics core facility and microscopy in the CRG Advanced Light Microscopy Facility. Some strains were provided by the CGC, which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Artyukhin AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02777; BEGUET B, 1972, EXP GERONTOL, V7, P195, DOI 10.1016/0531-5565(72)90026-5; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Chotard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015662; Coburn Cassandra, 2013, Frontiers in Genetics, V4, P151, DOI 10.3389/fgene.2013.00151; DePina Ana S., 2011, BMC Physiology, V11, P11, DOI 10.1186/1472-6793-11-11; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Fouad AD, 2017, G3-GENES GENOM GENET, V7, P1811, DOI 10.1534/g3.117.040840; Francesconi M, 2014, NATURE, V505, P208, DOI 10.1038/nature12772; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Jobson MA, 2015, GENETICS, V201, P201, DOI 10.1534/genetics.115.178699; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Klapper M, 2011, J LIPID RES, V52, P1281, DOI 10.1194/jlr.D011940; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Klosin A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701143; Klosin A, 2017, SCIENCE, V356, P316, DOI 10.1126/science.aah6412; Lee I., 2013, PLOS ONE, V8; Lee IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032585; Lionaki Eirini, 2013, Methods Mol Biol, V965, P473, DOI 10.1007/978-1-62703-239-1_31; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Mok DZL, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0076-7; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Poullet N, 2016, EVOLUTION, V70, P2357, DOI 10.1111/evo.13032; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115; SHARROCK WJ, 1990, J BIOL CHEM, V265, P14422; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Sterken MG, 2015, TRENDS GENET, V31, P224, DOI 10.1016/j.tig.2015.02.009; Van Rompay L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16381; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wahlby C, 2012, NAT METHODS, V9, P714, DOI [10.1038/nmeth.1984, 10.1038/NMETH.1984]; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Xiao R, 2015, CELL REP, V11, P1123, DOI 10.1016/j.celrep.2015.04.024	53	66	66	2	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					106	+		10.1038/nature25012	http://dx.doi.org/10.1038/nature25012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186117	Green Accepted			2022-12-28	WOS:000417560500052
J	Mulvey, RE				Mulvey, Robert Emmet			Benzene submits to main-group power	SCIENCE			English	Editorial Material							CATALYSIS		[Mulvey, Robert Emmet] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow, Lanark, Scotland	University of Strathclyde	Mulvey, RE (corresponding author), Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow, Lanark, Scotland.	r.e.mulvey@strath.ac.uk						Harder S, 2012, CHEM COMMUN, V48, P11165, DOI 10.1039/c2cc33478j; Harder S, 2010, CHEM REV, V110, P3852, DOI 10.1021/cr9003659; Hill MS, 2016, CHEM SOC REV, V45, P972, DOI 10.1039/c5cs00880h; Okuda J., 2017, ANGEW CHEM INT EDIT, V52, P13155; Rueping M, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.6; Wilson ASS, 2017, SCIENCE, V358, P1168, DOI 10.1126/science.aao5923	6	5	5	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1132	1132		10.1126/science.aaq1314	http://dx.doi.org/10.1126/science.aaq1314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191894	Green Accepted			2022-12-28	WOS:000416584000022
J	Martin, AR; Lin, M; Granka, JM; Myrick, JW; Liu, XM; Sockell, A; Atkinson, EG; Werely, CJ; Moller, M; Sandhu, MS; Kingsley, DM; Hoal, EG; Liu, X; Daly, MJ; Feldman, MW; Gignoux, CR; Bustamante, CD; Henn, BM				Martin, Alicia R.; Lin, Meng; Granka, Julie M.; Myrick, Justin W.; Liu, Xiaomin; Sockell, Alexandra; Atkinson, Elizabeth G.; Werely, Cedric J.; Moller, Marlo; Sandhu, Manjinder S.; Kingsley, David M.; Hoal, Eileen G.; Liu, Xiao; Daly, Mark J.; Feldman, Marcus W.; Gignoux, Christopher R.; Bustamante, Carlos D.; Henn, Brenna M.			An Unexpectedly Complex Architecture for Skin Pigmentation in Africans	CELL			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-DETERMINANTS; TRANSCRIPTION FACTOR; REVEALS ADAPTATION; EYE-COLOR; HAIR; EXPRESSION; SOUTHERN; COMMON; HERITABILITY	Approximately 15 genes have been directly associated with skin pigmentation variation in humans, leading to its characterization as a relatively simple trait. However, by assembling a global survey of quantitative skin pigmentation phenotypes, we demonstrate that pigmentation is more complex than previously assumed, with genetic architecture varying by latitude. We investigate polygenicity in the KhoeSan populations indigenous to southern Africa who have considerably lighter skin than equatorial Africans. We demonstrate that skin pigmentation is highly heritable, butknownpigmentation loci explainonly asmall fraction of the variance. Rather, baseline skin pigmentation is a complex, polygenic trait in the KhoeSan. Despite this, we identify canonical and non-canonical skin pigmentation loci, including near SLC24A5, TYRP1, SMARCA2/VLDLR, and SNX13, using a genome-wide association approach complemented by targeted resequencing. By considering diverse, under-studied African populations, we show how the architecture of skin pigmentation can vary across humans subject to different local evolutionary pressures.	[Martin, Alicia R.; Sockell, Alexandra; Gignoux, Christopher R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martin, Alicia R.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Martin, Alicia R.; Daly, Mark J.] Harvard Med Sch, Boston, MA 02114 USA; [Martin, Alicia R.; Daly, Mark J.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Martin, Alicia R.; Daly, Mark J.] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02141 USA; [Lin, Meng; Myrick, Justin W.; Atkinson, Elizabeth G.; Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Granka, Julie M.; Feldman, Marcus W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Liu, Xiaomin; Liu, Xiao] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Werely, Cedric J.; Moller, Marlo; Hoal, Eileen G.] Stellenbosch Univ, SA MRC Ctr TB Res, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Genome Campus, Hinxton, England; [Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Gignoux, Christopher R.] Univ Colorado, Colorado Ctr Personalized Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Gignoux, Christopher R.] Univ Colorado, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO 80045 USA; [Granka, Julie M.] AncestryDNA, San Francisco, CA 94107 USA	Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University; Beijing Genomics Institute (BGI); National Research Foundation - South Africa; Stellenbosch University; Wellcome Trust Sanger Institute; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Martin, AR (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Martin, AR (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Martin, AR (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Martin, AR (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA.; Martin, AR (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02141 USA.; Henn, BM (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	armartin@broadinstitute.org; brenna.henn@stonybrook.edu	Daly, Mark J/B-2453-2017; Moller, Marlo/AAC-6973-2020; Liu, Xiao/P-2732-2015	Daly, Mark J/0000-0002-0949-8752; Moller, Marlo/0000-0002-0805-6741; Liu, Xiao/0000-0002-8073-0534; Liu, Xiaomin/0000-0003-2155-3627; Bustamante, Carlos D./0000-0002-4187-7920; Atkinson, Elizabeth/0000-0002-6308-776X; Sockell, Alexandra/0000-0002-8725-9415; Martin, Alicia/0000-0003-0241-3522	Stanford University CDEHA seed grant (NIH) [NIA P30 AG017253-12]; Stanford Center for Computational, Evolutionary and Human Genomics; Morrison Institute for Population Studies, Stanford University; NIH Genetics and Developmental Biology Training Program [5T32GM007790]; NIH IRACDA fellowship [NIH K12 GM102778]; Stanford NIH Genome Training Program [5T32HG000044]; South African Medical Research Council; MRC [MR/K013491/1] Funding Source: UKRI; Medical Research Council [MR/K013491/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	Stanford University CDEHA seed grant (NIH); Stanford Center for Computational, Evolutionary and Human Genomics; Morrison Institute for Population Studies, Stanford University; NIH Genetics and Developmental Biology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IRACDA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford NIH Genome Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Beijing Genome Institute and Agilent Technologies for sequencing support. We thank Sandra Beleza, Heather Norton, Esteban Parra, Chandana Basu Mallick, Andres Moreno-Estrada and Karla Sandoval, Richard Cooper, Sophie Candille, George Chaplin, and Nina Jablonski and their colleagues for providing quantitative phenotypes or summaries from their pigmentation work. We thank Catherine Guenther for discussing molecular strategies for functional followup. We also thank the Working Group of Indigenous Minorities in Southern Africa (WIMSA), community leaders, and the South African San Institute (SASI) for their advice and oversight. Finally, we thank Richard Jacobs, Wilhelmina Mondzinger, Hans Padmaker, Willem de Klerk, Hendrik Kaiman, and the communities in which we have sampled; without their support, this study would not have been possible. Funding for this project was provided by a Stanford University CDEHA seed grant (NIH, NIA P30 AG017253-12) to B.M.H. and by a trainee research grant to A.R.M. by the Stanford Center for Computational, Evolutionary and Human Genomics. Funding was also provided by the Morrison Institute for Population Studies, Stanford University. Funding for genotyping additional KhoeSan individuals was provided by the Stanford Center for Computational, Evolutionary and Human Genomics. A.R.M. was funded by NIH Genetics and Developmental Biology Training Program 5T32GM007790. E.G.A. was supported by an NIH IRACDA fellowship to Stony Brook University, NIH K12 GM102778. C.R.G. was supported by the Stanford NIH Genome Training Program 5T32HG000044. C.J.W., M.M., and E.G.H. are partly supported by the South African Medical Research Council. The content is solely the responsibility of the authors and does not necessarily represent the official views of the South African Medical Research Council. C.R.G. and B.M.H. own stock in 23andMe. C.R.G. is a member of the scientific advisory board and academic founder for Encompass Bioscience. J.M.G. is an employee of AncestryDNA. C.D.B. is a member of the scientific advisory board for Liberty Biosecurity, Personalis, 23andMe Roots into the Future, Ancestry.com, IdentifyGenomics, and Etalon and is a founder of CDB Consulting.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Candille SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048294; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chaplin G, 2004, AM J PHYS ANTHROPOL, V125, P292, DOI 10.1002/ajpa.10263; Chaplin G, 2009, AM J PHYS ANTHROPOL, V139, P451, DOI 10.1002/ajpa.21079; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; CLARK P, 1981, ANN HUM BIOL, V8, P529, DOI 10.1080/03014468100005371; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Coussens AK, 2015, P NATL ACAD SCI USA, V112, P8052, DOI 10.1073/pnas.1500909112; Crawford NG, 2017, SCIENCE, V358, P887, DOI 10.1126/science.aan8433; DIFFEY BL, 1984, BRIT J DERMATOL, V111, P663, DOI 10.1111/j.1365-2133.1984.tb14149.x; Duan SW, 2009, PHARMACOGENOMICS, V10, P549, DOI 10.2217/PGS.09.8; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Durazo-Arvizu RA, 2014, AM J CLIN NUTR, V100, P908, DOI 10.3945/ajcn.113.066605; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; FRISANCHO AR, 1981, AM J PHYS ANTHROPOL, V55, P203, DOI 10.1002/ajpa.1330550207; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; HARRISON GA, 1964, ANN HUM GENET, V28, P27, DOI 10.1111/j.1469-1809.1964.tb00457.x; Hart KL, 2013, CROAT MED J, V54, P248, DOI 10.3325/cmj.2013.54.248; Henn BM, 2016, P NATL ACAD SCI USA, V113, pE440, DOI 10.1073/pnas.1510805112; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jablonski NG, 2014, DERMATOL CLIN, V32, P113, DOI 10.1016/j.det.2013.11.003; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Kenny EE, 2012, SCIENCE, V336, P554, DOI 10.1126/science.1217849; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu F, 2015, HUM GENET, V134, P823, DOI 10.1007/s00439-015-1559-0; Mallick CB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003912; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pospiech E, 2014, FORENSIC SCI INT-GEN, V11, P64, DOI 10.1016/j.fsigen.2014.01.012; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shringarpure SS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1082-x; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Spichenok O, 2011, FORENSIC SCI INT-GEN, V5, P472, DOI 10.1016/j.fsigen.2010.10.005; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Uren C, 2016, GENETICS, V204, P303, DOI 10.1534/genetics.116.187369; Vachtenheim J, 2010, BIOCHEM BIOPH RES CO, V392, P454, DOI 10.1016/j.bbrc.2010.01.048; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang ZH, 2016, MOL BIOL EVOL, V33, P1177, DOI 10.1093/molbev/msw003; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zaidi AA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006616; Zaitlen N, 2014, NAT GENET, V46, P1356, DOI 10.1038/ng.3139; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	84	82	84	4	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1340	+		10.1016/j.cell.2017.11.015	http://dx.doi.org/10.1016/j.cell.2017.11.015			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195075	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000417362700016
J	Streit, E; Vogelsang, LE				Streit, Enrico; Vogelsang, Lena E.			ECG-Induced Koebner Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Streit, Enrico; Vogelsang, Lena E.] Heidelberg Univ, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Streit, E (corresponding author), Heidelberg Univ, Heidelberg, Germany.	enrico.streit@med.uniheidelberg.de							0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2180	2180		10.1056/NEJMicm1706993	http://dx.doi.org/10.1056/NEJMicm1706993			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO1VI	29171822				2022-12-28	WOS:000416555000011
J	Frenzel, T; Kadic, M; Wegener, M				Frenzel, Tobias; Kadic, Muamer; Wegener, Martin			Three-dimensional mechanical metamaterials with a twist	SCIENCE			English	Article							NEGATIVE POISSONS RATIO; ARCHITECTED MATERIALS; COMPACT-BONE; DESIGN; MICROLATTICES; NANOLATTICES; LIGHTWEIGHT; ULTRALIGHT	Rationally designed artificial materials enable mechanical properties that are inaccessible with ordinary materials. Pushing on an ordinary linearly elastic bar can cause it to be deformed in many ways. However, a twist, the counter part of optical activity in the static case, is strictly zero. The unavailability of this degree of freedom hinders applications in terms of mode conversion and the realization of advanced mechanical designs using coordinate transformations. Here, we aim at realizing microstructured three-dimensional elastic chiral mechanical metamaterials that overcome this limitation. On overall millimeter-sized samples, we measure twists per axial strain exceeding 2 degrees/%. Scaling up the number of unit cells for fixed sample dimensions, the twist is robust due to metamaterial stiffening, indicating a characteristic length scale and bringing the aforementioned applications into reach.	[Frenzel, Tobias; Kadic, Muamer; Wegener, Martin] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Kadic, Muamer; Wegener, Martin] Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Kadic, Muamer] Univ Bourgogne Franche Comte, CNRS, UMR 6174, Inst Franche Comte Elect Mecan Therm & Opt Sci &, F-25000 Besancon, France	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Franche-Comte	Wegener, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany.; Wegener, M (corresponding author), Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany.	martin.wegener@kit.edu	Wegener, Martin/S-5456-2016; Kadic, Muamer/J-9478-2015; Wegener, Martin/ABD-5353-2021	Wegener, Martin/0000-0002-9770-2441; Kadic, Muamer/0000-0002-4692-5696; Wegener, Martin/0000-0002-9770-2441	Helmholtz program Science; Virtual Materials project; Hector Fellow Academy; Karlsruhe School of Optics and Photonics; Karlsruhe Institute of Technology Nanostructure Service Laboratoty; Labex ACTION program [ANR-11-LABX-0001-01]; French "Investissements d'Avenir" program [ANR-15-IDEX-03]	Helmholtz program Science; Virtual Materials project; Hector Fellow Academy; Karlsruhe School of Optics and Photonics; Karlsruhe Institute of Technology Nanostructure Service Laboratoty; Labex ACTION program; French "Investissements d'Avenir" program(French National Research Agency (ANR))	We acknowledge support by the Helmholtz program Science are Technology of Nanosystems, including the Virtual Materials project, the Hector Fellow Academy, the Karlsruhe School of Optics and Photonics, and the Karlsruhe Institute of Technology Nanostructure Service Laboratoty. M.K. acknowledges support by the Labex ACTION program (contract ANR-11-LABX-0001-01) and the French "Investissements d'Avenir" program, project ISIIE-BFC (contract ANR-15-IDEX-03). Data ate available in the main text and the supplementary materials.	Babaee S, 2013, ADV MATER, V25, P5044, DOI 10.1002/adma.201301986; Bauer J, 2016, NAT MATER, V15, P438, DOI [10.1038/NMAT4561, 10.1038/nmat4561]; Buckmann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5130; Coulais C, 2017, NATURE, V542, P461, DOI 10.1038/nature21044; Coulais C, 2016, NATURE, V535, P529, DOI 10.1038/nature18960; Diatta A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4887454; Eringen A, 1999, MICROCONTINUUM FIELD, VI; Florijn B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175503; Frenzel T, 2016, ADV MATER, V28, P5865, DOI 10.1002/adma.201600610; Fu MH, 2017, COMPOS STRUCT, V176, P442, DOI 10.1016/j.compstruct.2017.05.027; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Ha CS, 2016, PHYS STATUS SOLIDI B, V253, P1243, DOI 10.1002/pssb.201600055; Haghpanah B, 2016, ADV MATER, V28, P7915, DOI 10.1002/adma.201601650; Kweun JM, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.205901; LAKES RS, 1982, J BIOMECH ENG-T ASME, V104, P6, DOI 10.1115/1.3138308; LAKES RS, 1982, INT J ENG SCI, V20, P1161, DOI 10.1016/0020-7225(82)90096-9; Merkel A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.225502; Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Milton GW, 2007, P ROY SOC A-MATH PHY, V463, P855, DOI 10.1098/rspa.2006.1795; Overvelde JTB, 2017, NATURE, V541, P347, DOI 10.1038/nature20824; Pendry JB, 2004, SCIENCE, V306, P1353, DOI 10.1126/science.1104467; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Seppecher P, 2011, J PHYS CONF SER, V319, DOI 10.1088/1742-6596/319/1/012018; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Sommerfeld A, 1950, MECH DEFORMABLE BODI, VII; Wegener M, 2013, SCIENCE, V342, P939, DOI 10.1126/science.1246545; YANG JFC, 1981, J BIOMECH ENG-T ASME, V103, P275, DOI 10.1115/1.3138292; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	29	439	448	68	483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1072	1074		10.1126/science.aao4640	http://dx.doi.org/10.1126/science.aao4640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170236				2022-12-28	WOS:000416590400044
J	Lodato, MA; Rodin, RE; Bohrson, CL; Coulter, ME; Barton, AR; Kwon, M; Sherman, MA; Vitzthum, CM; Luquette, LJ; Yandava, CN; Yang, PW; Chittenden, TW; Hatem, NE; Ryu, SC; Woodworth, MB; Park, PJ; Walsh, CA				Lodato, Michael A.; Rodin, Rachel E.; Bohrson, Craig L.; Coulter, Michael E.; Barton, Alison R.; Kwon, Minseok; Sherman, Maxwell A.; Vitzthum, Carl M.; Luquette, Lovelace J.; Yandava, Chandri N.; Yang, Pengwei; Chittenden, Thomas W.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Park, Peter J.; Walsh, Christopher A.			Aging and neurodegeneration are associated with increased mutations in single human neurons	SCIENCE			English	Article							NUCLEOTIDE EXCISION-REPAIR; SOMATIC MUTATIONS; HUMAN BRAIN; DNA-DAMAGE; DEFICIENT; CANCER; MICE	It has long been hypothesized that aging and neurodegeneration are associated with somatic mutation in neurons; however, methodological hurdles have prevented testing this hypothesis directly. We used single-cell whole-genome sequencing to perform genome-wide somatic single-nucleotide variant (sSNV) identification on DNA from 161 single neurons from the prefrontal cortex and hippocampus of 15 normal individuals (aged 4 months to 82 years), as well as 9 individuals affected by early-onset neurodegeneration due to genetic disorders of DNA repair (Cockayne syndrome and xeroderma pigmentosum). sSNVs increased approximately linearly with age in both areas (with a higher rate in hippocampus) and were more abundant in neurodegenerative disease. The accumulation of somatic mutations with age-which we term genosenium-shows age-related, region-related, and disease-related molecular signatures and may be important in other human age-associated conditions.	[Lodato, Michael A.; Rodin, Rachel E.; Coulter, Michael E.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis, Div Genet & Genom, Boston, MA 02115 USA; [Lodato, Michael A.; Rodin, Rachel E.; Coulter, Michael E.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Walsh, Christopher A.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lodato, Michael A.; Rodin, Rachel E.; Coulter, Michael E.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Walsh, Christopher A.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Lodato, Michael A.; Rodin, Rachel E.; Coulter, Michael E.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Walsh, Christopher A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Lodato, Michael A.; Rodin, Rachel E.; Coulter, Michael E.; Hatem, Nicole E.; Ryu, Steven C.; Woodworth, Mollie B.; Walsh, Christopher A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rodin, Rachel E.; Coulter, Michael E.] Harvard Med Sch, Program Neurosci, Boston, MA USA; [Rodin, Rachel E.; Coulter, Michael E.] Harvard Med Sch, Harvard MIT MD PHD Program, Boston, MA USA; [Bohrson, Craig L.; Barton, Alison R.; Kwon, Minseok; Sherman, Maxwell A.; Vitzthum, Carl M.; Luquette, Lovelace J.; Park, Peter J.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Yandava, Chandri N.; Yang, Pengwei; Chittenden, Thomas W.] WuXi NextCODE, Adv Artificial Intelligence Res Lab, Computat Stat & Bioinformat Grp, Cambridge, MA USA; [Chittenden, Thomas W.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chittenden, Thomas W.] Harvard Med Sch, Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Woodworth, Mollie B.] Canada Coll, Redwood City, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Walsh, CA (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis, Div Genet & Genom, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Walsh, CA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Park, PJ (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Park, PJ (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	peter_park@hms.harvard.edu; christopher.walsh@childrens.harvard.edu	Lodato, Michael/AAX-9211-2021	Lodato, Michael/0000-0003-4175-1073; Woodworth, Mollie/0000-0003-2130-2289; Barton, Alison/0000-0003-0882-0196; Walsh, Christopher/0000-0002-0156-2238; Sherman, Maxwell/0000-0002-5297-9252; Bohrson, Craig/0000-0003-4063-4844; Rodin, Rachel/0000-0001-9826-7827; Vitzthum, Carl/0000-0002-3075-2305	Harvard/MIT MD-PHD program; Stuart H. Q. and Victoria Quan Fellowship in Neurobiology; Paul G. Allen Family Foundation;  [K99 AG054749 01];  [F30 MH102909];  [1S10RR028832-01];  [T32HG002295];  [U01MH106883];  [P50MH106933];  [R01 NS032457 U01 MH106883]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH102909, U01MH106883, P50MH106933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG050749, K99AG054748] Funding Source: NIH RePORTER	Harvard/MIT MD-PHD program; Stuart H. Q. and Victoria Quan Fellowship in Neurobiology; Paul G. Allen Family Foundation; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. S. Hill, M. P. Anderson, J. Gulcher, Z. Chen, I. Cortez, the Dana Farber Cancer Institute Flow Cytometry Core, and the Research Computing group at Harvard Medical School for assistance. Human tissue was obtained from the NIH NeuroBioBank at the University of Maryland, and we thank the donors and their families for their invaluable donations for the advancement of science. This work was supported by K99 AG054749 01, F30 MH102909, 1S10RR028832-01, T32HG002295, U01MH106883, P50MH106933, R01 NS032457 U01 MH106883, the Harvard/MIT MD-PHD program, the Stuart H. Q. and Victoria Quan Fellowship in Neurobiology, and the Paul G. Allen Family Foundation. C.A.W. is an investigator of the Howard Hughes Medical Institute. See the supplementary materials for full acknowledgments. The supplementary materials also contain additional data.	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Bae T, 2018, SCIENCE, V359, P550, DOI 10.1126/science.aan8690; Bohrson C. L., 2017, 211169 BIORXIV; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Dolle MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545; Dumanski JP, 2012, METHODS MOL BIOL, V838, P249, DOI 10.1007/978-1-61779-507-7_12; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404; Hazen JL, 2016, NEURON, V89, P1223, DOI 10.1016/j.neuron.2016.02.004; Hoang ML, 2016, P NATL ACAD SCI USA, V113, P9846, DOI 10.1073/pnas.1607794113; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Lim ET, 2017, NAT NEUROSCI, V20, P1217, DOI 10.1038/nn.4598; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; van Veluw SJ, 2012, BRAIN STRUCT FUNCT, V217, P797, DOI 10.1007/s00429-012-0381-x	23	264	267	5	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					555	558		10.1126/science.aao4426	http://dx.doi.org/10.1126/science.aao4426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29217584	Green Submitted, Green Accepted			2022-12-28	WOS:000423795800037
J	Zajac, DM; Sigillito, AJ; Russ, M; Borjans, F; Taylor, JM; Burkard, G; Petta, JR				Zajac, D. M.; Sigillito, A. J.; Russ, M.; Borjans, F.; Taylor, J. M.; Burkard, G.; Petta, J. R.			Resonantly driven CNOT gate for electron spins	SCIENCE			English	Article							QUANTUM DOTS; SILICON; ENTANGLEMENT; QUBITS	Single-qubit rotations and two-qubit CNOT operations are crucial ingredients for universal quantum computing. Although high-fidelity single-qubit operations have been achieved using the electron spin degree of freedom, realizing a robust CNOT gate has been challenging because of rapid nuclear spin dephasing and charge noise. We demonstrate an efficient resonantly driven CNOT gate for electron spins in silicon. Our platform achieves single-qubit rotations with fidelities greater than 99%, as verified by randomized benchmarking. Gate control of the exchange coupling allows a quantum CNOT gate to be implemented with resonant driving in similar to 200 nanoseconds. We used the CNOT gate to generate a Bell state with 78% fidelity (corrected for errors in state preparation and measurement). Our quantum dot device architecture enables multi-qubit algorithms in silicon.	[Zajac, D. M.; Sigillito, A. J.; Borjans, F.; Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Russ, M.; Burkard, G.] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Taylor, J. M.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA; [Taylor, J. M.] NIST, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Taylor, J. M.] Univ Maryland, College Pk, MD 20742 USA; [Taylor, J. M.] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	Princeton University; University of Konstanz; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University of Tokyo	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu	Taylor, Jacob M/B-7826-2011; Burkard, Guido/A-6949-2008; Taylor, Jacob/O-1670-2019; Burkard, Guido/ABB-9358-2021; Sigillito, Anthony/N-5981-2015; Petta, Jason/J-6663-2013	Taylor, Jacob M/0000-0003-0493-5594; Burkard, Guido/0000-0001-9053-2200; Taylor, Jacob/0000-0003-0493-5594; Burkard, Guido/0000-0001-9053-2200; Zajac, David/0000-0003-1593-5426; Sigillito, Anthony/0000-0002-4765-9414; Rimbach-Russ, Maximilian/0000-0001-9775-0323; Borjans, Felix/0000-0002-9652-097X; Petta, Jason/0000-0002-6416-0789	Army Research Office [W911NF-15-1-0149]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4535]; NSF [DMR-1409556]; Division Of Materials Research [1409556] Funding Source: National Science Foundation	Army Research Office; Gordon and Betty Moore Foundation's EPiQS Initiative; NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank T. Hazard, J. Stehlik, and K. Wang for technical assistance. Research was sponsored by Army Research Office grant W911NF-15-1-0149, the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4535, and NSF grant DMR-1409556. Devices were fabricated in the Princeton University Quantum Device Nanofabrication Laboratory. Any mention of commercial products is for information only; it does not imply recommendation or endorsement by NIST. The data that support the findings of this study are available in the supplementary materials. Additional data can be obtained from the corresponding author upon request.	Bertrand B, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.096801; Brunner R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146801; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Kawakami E, 2014, NAT NANOTECHNOL, V9, P666, DOI [10.1038/nnano.2014.153, 10.1038/NNANO.2014.153]; Liu YX, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014547; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Martins F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.116801; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nowack KC, 2011, SCIENCE, V333, P1269, DOI 10.1126/science.1209524; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Russ M., 2017, ARXIV171100754; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Tokura Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047202; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Watson T.F., 2017, ARXIV170804214; Yoneda J., 2017, ARXIV170801454; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961	27	325	332	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					439	442		10.1126/science.aao5965	http://dx.doi.org/10.1126/science.aao5965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29217586	Green Submitted			2022-12-28	WOS:000423283200042
J	Erwin, GS; Grieshop, MP; Ali, A; Qi, J; Lawlor, M; Kumar, D; Ahmad, I; McNally, A; Teider, N; Worringer, K; Sivasankaran, R; Syed, DN; Eguchi, A; Ashraf, M; Jeffery, J; Xu, MS; Park, PMC; Mukhtar, H; Srivastava, AK; Faruq, M; Bradner, JE; Ansari, AZ				Erwin, Graham S.; Grieshop, Matthew P.; Ali, Asfa; Qi, Jun; Lawlor, Matthew; Kumar, Deepak; Ahmad, Istaq; McNally, Anna; Teider, Natalia; Worringer, Katie; Sivasankaran, Rajeev; Syed, Deeba N.; Eguchi, Asuka; Ashraf, Md.; Jeffery, Justin; Xu, Mousheng; Park, Paul M. C.; Mukhtar, Hasan; Srivastava, Achal K.; Faruq, Mohammed; Bradner, James E.; Ansari, Aseem Z.			Synthetic transcription elongation factors license transcription across repressive chromatin	SCIENCE			English	Article							FRIEDREICH ATAXIA; CELL FATE; GENE; DNA; REPEATS; INHIBITION; MOLECULES; COMPLEX	The release of paused RNA polymerase II into productive elongation is highly regulated, especially at genes that affect human development and disease. To exert control over this rate-limiting step, we designed sequence-specific synthetic transcription elongation factors (Syn-TEFs). These molecules are composed of programmable DNA-binding ligands flexibly tethered to a small molecule that engages the transcription elongation machinery. By limiting activity to targeted loci, Syn-TEFs convert constituent modules from broad-spectrum inhibitors of transcription into gene-specific stimulators. Here we present Syn-TEF1, a molecule that actively enables transcription across repressive GAA repeats that silence frataxin expression in Friedreich's ataxia, a terminal neurodegenerative disease with no effective therapy. The modular design of Syn-TEF1 defines a general framework for developing a class of molecules that license transcription elongation at targeted genomic loci.	[Erwin, Graham S.; Grieshop, Matthew P.; Ali, Asfa; Eguchi, Asuka; Ashraf, Md.; Ansari, Aseem Z.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA; [Qi, Jun; Lawlor, Matthew; Xu, Mousheng; Park, Paul M. C.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kumar, Deepak; Ahmad, Istaq; Srivastava, Achal K.] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Kumar, Deepak; Ahmad, Istaq; Faruq, Mohammed] CSIR, IGIB, Genom & Mol Med, New Delhi, India; [McNally, Anna; Teider, Natalia; Worringer, Katie; Sivasankaran, Rajeev; Bradner, James E.] NIBR, Cambridge, MA 02139 USA; [Syed, Deeba N.; Mukhtar, Hasan] Univ Wisconsin Madison, Dept Dermatol, Madison, WI 53706 USA; [Jeffery, Justin] Univ Wisconsin, Carbone Canc Ctr, Small Anim Imaging Facil, Madison, WI 53792 USA; [Ansari, Aseem Z.] Univ Wisconsin Madison, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ansari, AZ (corresponding author), Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA.; Ansari, AZ (corresponding author), Univ Wisconsin Madison, Genome Ctr Wisconsin, Madison, WI 53706 USA.	azansari@wisc.edu	Ansari, Aseem/AAF-4945-2019; Erwin, Graham/J-1236-2014	Lawlor, Matthew/0000-0003-0700-5763; Erwin, Graham/0000-0002-9286-7626; Grieshop, Matthew/0000-0002-0075-8597; Ahmad, Istaq/0000-0001-8201-0381	NIH [CA133508, GM117362, HL099773, P30 AR066524, GM07215]; W. M. Keck Medical Research Award; Peterson Fellowship; Hilldale scholarship; Science and Engineering Research Board of the Government of India; NATIONAL CANCER INSTITUTE [R01CA133508, P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117362, T32GM007215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Medical Research Award; Peterson Fellowship; Hilldale scholarship; Science and Engineering Research Board of the Government of India; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ansari laboratory, especially D. Bhimsaria, and members of the Raines laboratory, especially T. Smith, for helpful discussions; L. Vanderploeg and E. N. Korkmaz for help with figures; J. Thomson, R. Stewart, J. Bolin, and S. Swanson for help with RNA-seq; A. Kumar, S. Mohapatra, and D. Waseem for early experiments; R. Dolmetsch and A. Kaykas for facilitating the collaboration with the Neuroscience group at NIBR; and S. Brahmachari and A. Agarwal for facilitating the collaboration with the Ataxia group at IGIB. The NIBR team thanks M. Napierala [University of Alabama at Birmingham (UAB)], D. Lynch [Children's Hospital of Philadelphia (CHOP)], and FARA (Friedreich's Ataxia Research Alliance) for making the UAB Friedreich's ataxia patient lines available for use. Friedreich's ataxia patient fibroblasts and iPSC-derived sensory neurons were obtained under a material transfer agreement with CHOP. We thank R. Wade-Martins (University of Oxford) for the luciferase reporter cell lines. This work was supported by NIH grants CA133508, GM117362, and HL099773 and a W. M. Keck Medical Research Award to A.Z.A. and by NIH grant P30 AR066524 to D.N.S. G.S.E. was supported by NIH grant GM07215 and a Peterson Fellowship. M.P.G. was supported by a Hilldale scholarship. A.A. was supported by an Indo-US Postdoctoral Fellowship from the Science and Engineering Research Board of the Government of India. RNA-seq and ChIP-seq data are deposited in the National Center for Biotechnology Information Gene Expression Omnibus under GSE99403. A.Z.A., G.S.E., and M.P.G have filed patent applications relating to the work in this manuscript, including U.S. provisional patent applications 62/478291 and 15/472852, filed 30 March 2016 by the Wisconsin Alumni Research Foundation.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.41; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Eguchi A, 2016, P NATL ACAD SCI USA, V113, pE8257, DOI 10.1073/pnas.1611142114; Eguchi A, 2014, BIOCHEM J, V462, P397, DOI 10.1042/BJ20140400; Erwin GS, 2016, P NATL ACAD SCI USA, V113, pE7418, DOI 10.1073/pnas.1604847113; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Filla A, 1996, AM J HUM GENET, V59, P554; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li YJ, 2015, HUM MOL GENET, V24, P6932, DOI 10.1093/hmg/ddv397; Liszczak GP, 2017, P NATL ACAD SCI USA, V114, P681, DOI 10.1073/pnas.1615723114; Lufino MMP, 2013, HUM MOL GENET, V22, P5173, DOI 10.1093/hmg/ddt370; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Mayer A, 2017, CURR OPIN CELL BIOL, V46, P72, DOI 10.1016/j.ceb.2017.03.002; Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Viger A, 2006, BIOORGAN MED CHEM, V14, P8539, DOI 10.1016/j.bmc.2006.08.028; Yandim C, 2013, J NEUROCHEM, V126, P21, DOI 10.1111/jnc.12254; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	30	63	66	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2017	358	6370					1617	1621		10.1126/science.aan6414	http://dx.doi.org/10.1126/science.aan6414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ6BO	29192133	Green Accepted			2022-12-28	WOS:000418448000066
J	Polishchuk, I; Bracha, AA; Bloch, L; Levy, D; Kozachkevich, S; Etinger-Geller, Y; Kauffmann, Y; Burghammer, M; Giacobbe, C; Villanova, J; Hendler, G; Sun, CY; Giuffre, AJ; Marcus, MA; Kundanati, L; Zaslansky, P; Pugno, NM; Gilbert, PUPA; Katsman, A; Pokroy, B				Polishchuk, Iryna; Bracha, Avigail Aronhime; Bloch, Leonid; Levy, Davide; Kozachkevich, Stas; Etinger-Geller, Yael; Kauffmann, Yaron; Burghammer, Manfred; Giacobbe, Carlotta; Villanova, Julie; Hendler, Gordon; Sun, Chang-Yu; Giuffre, Anthony J.; Marcus, Matthew A.; Kundanati, Lakshminath; Zaslansky, Paul; Pugno, Nicola M.; Gilbert, Pupa U. P. A.; Katsman, Alex; Pokroy, Boaz			Coherently aligned nanoparticles within a biogenic single crystal: A biological prestressing strategy	SCIENCE			English	Article							PHOTORECEPTOR SYSTEM; MOLLUSK SHELLS; CALCITE; FRACTURE; INDENTATION; ORIGIN; GROWTH; PHASE	In contrast to synthetic materials, materials produced by organisms are formed in ambient conditions and with a limited selection of elements. Nevertheless, living organisms reveal elegant strategies for achieving specific functions, ranging from skeletal support to mastication, from sensors and defensive tools to optical function. Using state-of-the-art characterization techniques, we present a biostrategy for strengthening and toughening the otherwise brittle calcite optical lenses found in the brittlestar Ophiocoma wendtii. This intriguing process uses coherent nanoprecipitates to induce compressive stresses on the host matrix, functionally resembling the Guinier-Preston zones known in classical metallurgy. We believe that these calcitic nanoparticles, being rich inmagnesium, segregate during or just after transformation from amorphous to crystalline phase, similarly to segregation behavior from a supersaturated quenched alloy.	[Polishchuk, Iryna; Bracha, Avigail Aronhime; Bloch, Leonid; Levy, Davide; Kozachkevich, Stas; Etinger-Geller, Yael; Kauffmann, Yaron; Katsman, Alex; Pokroy, Boaz] Technion Israel Inst Technol, Dept Mat Sci & Engn, IL-32000 Haifa, Israel; [Polishchuk, Iryna; Bracha, Avigail Aronhime; Bloch, Leonid; Levy, Davide; Kozachkevich, Stas; Etinger-Geller, Yael; Kauffmann, Yaron; Katsman, Alex; Pokroy, Boaz] Technion Israel Inst Technol, Russel Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Bloch, Leonid; Burghammer, Manfred; Giacobbe, Carlotta; Villanova, Julie] European Synchrotron, CS 40220, F-38043 Grenoble 9, France; [Hendler, Gordon] Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA; [Sun, Chang-Yu; Giuffre, Anthony J.; Gilbert, Pupa U. P. A.] Univ Wisconsin Madison, Dept Phys, Chem, Geosci, Madison, WI 53706 USA; [Marcus, Matthew A.] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Kundanati, Lakshminath; Pugno, Nicola M.] Univ Trento, Lab Bioinspired & Graphene Nanomech, Dept Civil Environm & Mech Engn, Via Mesiano 77, I-38123 Trento, Italy; [Zaslansky, Paul] Charite Univ Med Berlin, Dept Restorat & Prevent Dent, Ctr Zahn Mund & Kieferheilkunde, D-14197 Berlin, Germany; [Pugno, Nicola M.] Queen Mary Univ London, Sch Engn & Mat Sci, Mile End Rd, London E1 4NS, England; [Pugno, Nicola M.] Italian Space Agcy, Edoardo Amaldi Fdn, Ket Lab, Via Politecn Snc, I-00133 Rome, Italy; [Bloch, Leonid] Inst Technol Zurich, Ramistr 101, CH-8092 Zurich, Switzerland	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Trento; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London; Agenzia Spaziale Italiana (ASI)	Pokroy, B (corresponding author), Technion Israel Inst Technol, Dept Mat Sci & Engn, IL-32000 Haifa, Israel.; Pokroy, B (corresponding author), Technion Israel Inst Technol, Russel Berrie Nanotechnol Inst, IL-32000 Haifa, Israel.	bpokroy@technion.ac.il	marcus, matthew/P-8023-2019; Bloch, Leonid/AAR-2751-2021; Gilbert, Pupa/A-6299-2010; SUN, CHANG/GXM-3680-2022; zaslansky, paul/AAB-7322-2021; Levy, Davide/B-6699-2011	Bloch, Leonid/0000-0002-9433-7653; Gilbert, Pupa/0000-0002-0139-2099; zaslansky, paul/0000-0002-8714-4992; Levy, Davide/0000-0002-8018-4836; Giacobbe, Carlotta/0000-0003-2988-5992; villanova, julie/0000-0001-6157-2289; Kauffmann, Yaron/0000-0002-0117-6222	Alon Fellowship for Outstanding Young Researchers of the Israeli Council for Higher Education; RBNI Technion; European Commission H under the Graphene Flagship Core 1 [696656, WP14]; European Commission under the Future and Emerging Technologies Proactive "Neurofibres" [732344]; Fondazione Caritro under "Self-Cleaning Glasses" [2016.0278]; NSF [DMR-1603192]; U.S. Department of Energy (DOE) [DE-FG02-07ER15899];  [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1603192] Funding Source: National Science Foundation	Alon Fellowship for Outstanding Young Researchers of the Israeli Council for Higher Education; RBNI Technion; European Commission H under the Graphene Flagship Core 1; European Commission under the Future and Emerging Technologies Proactive "Neurofibres"; Fondazione Caritro under "Self-Cleaning Glasses"; NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Helpful scientific discussions with P. Fratzl are acknowledged with thanks. We also thank M. Kalina for help in preparing the TEM samples and M. D'Incau and H. Gourkar (Anton-Paar Pvt. Ltd. India) for help during some of the microindentation experiments. The x-ray diffraction and nanoCT measurements described in this paper were carried out at beamlines ID13, ID22, and ID16B of the European Synchrotron Radiation Facility (Grenoble, France). This work was primarily supported by the Alon Fellowship for Outstanding Young Researchers of the Israeli Council for Higher Education (B.P.) and the RBNI Technion. N.M.P. is supported by the European Commission H2020 under the Graphene Flagship Core 1 no. 696656 (WP14 "Polymer Composites"), under the Future and Emerging Technologies Proactive "Neurofibres" no. 732344, and by Fondazione Caritro under "Self-Cleaning Glasses" no. 2016.0278 to L.K. P.U.P.A.G. acknowledges NSF grant DMR-1603192 and U.S. Department of Energy (DOE) grant DE-FG02-07ER15899. PEEM experiments were done at the Advanced Light Source, which is a DOE Office of Science User Facility supported by grant DE-AC02-05CH11231. The geological dolomite sample was provided courtesy of R. Slaughter (Univ. of Wisconsin, Geology Museum).	Aichmayer B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015701; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Duparc OBMH, 2010, METALL MATER TRANS A, V41A, P1873, DOI 10.1007/s11661-010-0320-5; EVANS AG, 1976, J AM CERAM SOC, V59, P371, DOI 10.1111/j.1151-2916.1976.tb10991.x; Forien JB, 2015, NANO LETT, V15, P3729, DOI 10.1021/acs.nanolett.5b00143; Fratzl P, 1999, J STAT PHYS, V95, P1429, DOI 10.1023/A:1004587425006; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; GRADY DE, 1979, GEOPHYS RES LETT, V6, P73, DOI 10.1029/GL006i002p00073; HARKER RI, 1955, AM J SCI, V253, P274, DOI 10.2475/ajs.253.5.274; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Kolednik O, 2011, ADV FUNCT MATER, V21, P3634, DOI 10.1002/adfm.201100443; Kunitake ME, 2013, ACTA BIOMATER, V9, P5353, DOI 10.1016/j.actbio.2012.09.030; LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224; Li L, 2015, SCIENCE, V350, P952, DOI 10.1126/science.aad1246; MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3; Pokroy B, 2005, CHEM COMMUN, P2140, DOI 10.1039/b500584a; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Pokroy B, 2009, ADV FUNCT MATER, V19, P1054, DOI 10.1002/adfm.200801201; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Raven JA, 2010, GEOMICROBIOL J, V27, P572, DOI 10.1080/01490451003702990; Studart AR, 2013, ADV FUNCT MATER, V23, P4423, DOI 10.1002/adfm.201300340; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; UNWIN PNT, 1969, ACTA METALL MATER, V17, P1363, DOI 10.1016/0001-6160(69)90154-0; Vogel N, 2015, P NATL ACAD SCI USA, V112, P10845, DOI 10.1073/pnas.1506272112; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Wise SM, 2005, THIN SOLID FILMS, V473, P151, DOI 10.1016/j.tsf.2004.07.075; Zolotoyabko E, 2010, CRYST GROWTH DES, V10, P1207, DOI 10.1021/cg901195t	32	70	74	5	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1294	1298		10.1126/science.aaj2156	http://dx.doi.org/10.1126/science.aaj2156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217569	Green Submitted			2022-12-28	WOS:000417254700056
J	Voelker, R				Voelker, Rebecca			Heart Failure Survey Is a First in FDA's Device Innovation Effort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Voelker, Rebecca] MSJ, Chicago, IL 60601 USA		Voelker, R (corresponding author), MSJ, Chicago, IL 60601 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2071	2071		10.1001/jama.2017.17912	http://dx.doi.org/10.1001/jama.2017.17912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209705				2022-12-28	WOS:000417093500003
J	Clark, J; Zuccala, E; Horton, R				Clark, Jocalyn; Zuccala, Elizabeth; Horton, Richard			Women in science, medicine, and global health: call for papers	LANCET			English	Editorial Material									[Clark, Jocalyn; Zuccala, Elizabeth; Horton, Richard] The Lancet, London EC2Y 5AS, England		Clark, J (corresponding author), The Lancet, London EC2Y 5AS, England.	jocalyn.clark@lancet.com	Zuccala, Elizabeth/HDM-5025-2022	Clark, Jocalyn/0000-0002-8014-3989; Zuccala, Elizabeth/0000-0002-9189-9810				[Anonymous], 2013, NATURE, V495, P5, DOI 10.1038/495005a; [Anonymous], 2017, NATURE, V541, P435, DOI DOI 10.1038/541435B; [Anonymous], 2017, GEND GLOB RES LANDSC; [Anonymous], 2015, DOUBLE JEOPARDY GEND; Dhatt R, 2017, LANCET, V389, P602, DOI 10.1016/S0140-6736(17)30143-5; Edmunds LD, 2016, LANCET, V388, P2948, DOI 10.1016/S0140-6736(15)01091-0; European Research Council, 2016, GEND STAT; Hafkin NJ, 2016, NATL ASSESSMENTS GEN; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Hawkes S, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0249-1; Institute for Gender and the Economy, 2017, GEND EC RES BRIEFS; Jagsi R, 2016, JAMA-J AM MED ASSOC, V315, P2120, DOI 10.1001/jama.2016.2188; Parks AL, 2017, JAMA INTERN MED, V177, P161, DOI 10.1001/jamainternmed.2016.7883; Raymond J, 2013, NATURE, V495, P33, DOI 10.1038/495033a; Rimmer A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3878; Schwalbe N, 2017, LANCET, V390, P733, DOI 10.1016/S0140-6736(17)31939-6; UNESCO, 2015, GLOBAL CITIZENSHIP E; UNFPA, 2017, WORLDS AP REPR HLTH; Vernos I, 2013, NATURE, V495, P39, DOI 10.1038/495039a; Xie Y, 2014, P NATL ACAD SCI USA, V111, P9437, DOI 10.1073/pnas.1407709111	20	45	46	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2423	2424		10.1016/S0140-6736(17)32903-3	http://dx.doi.org/10.1016/S0140-6736(17)32903-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO6UL	29208297				2022-12-28	WOS:000417003400012
J	Mehra, MR				Mehra, Mandeep R.			Heart transplantation at 50	LANCET			English	Editorial Material							DONOR HEARTS; THERAPY		[Mehra, Mandeep R.] Brigham & Womens Hosp, Boston, MA 02492 USA; [Mehra, Mandeep R.] Harvard Med Sch, Boston, MA 02492 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Mehra, MR (corresponding author), Brigham & Womens Hosp, Boston, MA 02492 USA.; Mehra, MR (corresponding author), Harvard Med Sch, Boston, MA 02492 USA.	mmehra@bwh.harvard.edu	Mehra, Mandeep R/G-3484-2013; Mehra, Mandeep R/O-7273-2019	Mehra, Mandeep R/0000-0001-8683-7044; Mehra, Mandeep R/0000-0001-8683-7044	Abbott; Portola	Abbott(Abbott Laboratories); Portola	I have received grants from Abbott (principal investigator, clinical trial in left ventricular assist device); honoraria from Medtronic (steering committee, clinical trial in heart failure), Janssen (Johnson & Johnson) (DSMB clinical trial in heart failure), NupulseCV (Scientific Board left ventricular assist device), and Mesoblast (DSMB clinical trial in heart failure); and consulting fees from Portola (anticoagulation in heart failure). I am Editor in Chief of The Journal of Heart and Lung Transplantation.	Ardehali A, 2015, LANCET, V385, P2577, DOI 10.1016/S0140-6736(15)60261-6; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Dhital KK, 2015, LANCET, V385, P2585, DOI 10.1016/S0140-6736(15)60038-1; Fishman JA, 2017, AM J TRANSPLANT, V17, P2755, DOI 10.1111/ajt.14396; Fishman JA, 2015, AM J TRANSPLANT, V15, P1755, DOI 10.1111/ajt.13236; Goldstein SS, 2017, NEW ENGL J MED, V377, P1693; Halloran PF, 2017, J HEART LUNG TRANSPL, V36, P1192, DOI 10.1016/j.healun.2017.05.029; LEAF A, 1980, NEW ENGL J MED, V302, P1087, DOI 10.1056/NEJM198005083021912; Lindenfeld J, 2004, CIRCULATION, V110, P3858, DOI 10.1161/01.CIR.0000150332.42276.69; Lund LH, 2017, J HEART LUNG TRANSPL, V36, P1037, DOI 10.1016/j.healun.2017.07.019; Madsen JC, 2017, J HEART LUNG TRANSPL, V36, P1299, DOI 10.1016/j.healun.2017.10.003; Mavrogeni SI, 2017, EXPERT REV CARDIOVAS, V15, P307, DOI 10.1080/14779072.2017.1307734; Mehra MR, 2017, J HEART LUNG TRANSPL, V36, P1291, DOI 10.1016/j.healun.2017.10.010; Messer SJ, 2016, J HEART LUNG TRANSPL, V35, P1443, DOI 10.1016/j.healun.2016.07.004; Nair N, 2011, J HEART LUNG TRANSPL, V30, P612, DOI 10.1016/j.healun.2011.02.002; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Trotter PB, 2018, TRANSPLANTATION, V102, P664, DOI 10.1097/TP.0000000000002033; Woolley AE, 2018, J HEART LUNG TRANSPL, V37, P681, DOI 10.1016/j.healun.2017.05.028	19	10	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					E43	E45		10.1016/S0140-6736(17)33093-3	http://dx.doi.org/10.1016/S0140-6736(17)33093-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO6UL	29208305				2022-12-28	WOS:000417003400001
J	Chawla, DS				Chawla, Dalmeet Singh			PSYCHOLOGY Automatic error spotter gains in popularity	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1118	1118		10.1126/science.358.6367.1118	http://dx.doi.org/10.1126/science.358.6367.1118			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191886				2022-12-28	WOS:000416584000014
J	Rynearson, TA				Rynearson, Tatiana A.			OCEANS Navigating in a sea of genes	SCIENCE			English	Editorial Material									[Rynearson, Tatiana A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Rynearson, TA (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	rynearson@uri.edu						Alexander H, 2015, P NATL ACAD SCI USA, V112, pE2182, DOI 10.1073/pnas.1421993112; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Bowman JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135868; Coles VJ, 2017, SCIENCE, V358, P1149, DOI 10.1126/science.aan5712; Coles V.J., 2016, APPROACHES CHALLENGE, P45, DOI DOI 10.1007/978-3-319-30259-1_5; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Mock T, 2016, GLOBAL CHANGE BIOL, V22, P61, DOI 10.1111/gcb.12983; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Ward BB, 2002, P NATL ACAD SCI USA, V99, P10234, DOI 10.1073/pnas.162359199; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	12	0	1	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1129	1130		10.1126/science.aar3431	http://dx.doi.org/10.1126/science.aar3431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191892				2022-12-28	WOS:000416584000020
J	Khera, R; Angraal, S; Couch, T; Welsh, JW; Nallamothu, BK; Girotra, S; Chan, PS; Krumholz, HM				Khera, Rohan; Angraal, Suveen; Couch, Tyler; Welsh, John W.; Nallamothu, Brahmajee K.; Girotra, Saket; Chan, Paul S.; Krumholz, Harlan M.			Adherence to Methodological Standards in Research Using the National Inpatient Sample	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Publicly available data sets hold much potential, but their unique design may require specific analytic approaches. OBJECTIVE To determine adherence to appropriate research practices for a frequently used large public database, the National Inpatient Sample (NIS) of the Agency for Healthcare Research and Quality (AHRQ). DESIGN, SETTING, AND PARTICIPANTS In this observational study of the 1082 studies published using the NIS from January 2015 through December 2016, a representative sample of 120 studies was systematically evaluated for adherence to practices required by AHRQ for the design and conduct of research using the NIS. EXPOSURES None. MAIN OUTCOMES AND MEASURES All studies were evaluated on 7 required research practices based on AHRQ's recommendations and compiled under 3 domains: (1) data interpretation (interpreting data as hospitalization records rather than unique patients); (2) research design (avoiding use in performing state-, hospital-, and physician-level assessments where inappropriate; not using nonspecific administrative secondary diagnosis codes to study in-hospital events); and (3) data analysis (accounting for complex survey design of the NIS and changes in data structure over time). RESULTS Of 120 published studies, 85%(n = 102) did not adhere to 1 or more required practices and 62%(n = 74) did not adhere to 2 or more required practices. An estimated 925 (95% CI, 852-998) NIS publications did not adhere to 1 or more required practices and 696 (95% CI, 596-796) NIS publications did not adhere to 2 or more required practices. A total of 79 sampled studies (68.3%[95% CI, 59.3%-77.3%]) among the 1082 NIS studies screened for eligibility did not account for the effects of sampling error, clustering, and stratification; 62 (54.4%[95% CI, 44.7%-64.0%]) extrapolated nonspecific secondary diagnoses to infer in-hospital events; 45 (40.4%[95% CI, 30.9%-50.0%]) miscategorized hospitalizations as individual patients; 10 (7.1%[95% CI, 2.1%-12.1%]) performed state-level analyses; and 3 (2.9% [95% CI, 0.0%-6.2%]) reported physician-level volume estimates. Of 27 studies (weighted; 218 studies [95% CI, 134-303]) spanning periods of major changes in the data structure of the NIS, 21 (79.7%[95% CI, 62.5%-97.0%]) did not account for the changes. Among the 24 studies published in journals with an impact factor of 10 or greater, 16 (67%) did not adhere to 1 or more practices, and 9 (38%) did not adhere to 2 or more practices. CONCLUSIONS AND RELEVANCE In this study of 120 recent publications that used data from the NIS, the majority did not adhere to required practices. Further research is needed to identify strategies to improve the quality of research using the NIS and assess whether there are similar problems with use of other publicly available data sets.	[Khera, Rohan; Couch, Tyler] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Angraal, Suveen; Welsh, John W.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA; [Girotra, Saket] Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Carver Coll Med, Iowa City, IA 52242 USA; [Chan, Paul S.] St Lukes Mid Amer Heart & Vasc Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO 64110 USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Iowa; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University	Krumholz, HM (corresponding author), 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Khera, Rohan/P-2378-2019; , Harlan/AAI-2875-2020; Khera, Rohan/AAQ-6838-2021; Khera, Rohan/H-9029-2012	Khera, Rohan/0000-0001-9467-6199; Khera, Rohan/0000-0001-9467-6199; Girotra, Saket/0000-0002-4784-4513; Couch, Tyler/0000-0003-2949-035X	National Heart, Lung, and Blood Institute (NHLBI) [5T32HL125247-02]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001105]; NHLBI [K08 HL122527, 1R01HL123980]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123980, T32HL125247, K08HL122527] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Khera is supported by the National Heart, Lung, and Blood Institute (NHLBI) (5T32HL125247-02) and the National Center for Advancing Translational Sciences (UL1TR001105) of the National Institutes of Health. Dr Girotra (K08 HL122527) and Dr Chan (1R01HL123980) are supported by funding from the NHLBI.	[Anonymous], PROD NAT HCUP EST; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Healthcare Cost and Utilization Project, 2016, INTR HCUP NAT INP SA; Healthcare Cost and Utilization Project, 2016, OV NAT NAT INP SAMPL; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2016, HCUP FREQ ASK QUEST; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2008, NIS DESCR DAT EL DRG; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2016, NIS DESCR DAT EL; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality., 2002, CHANG NIS SAMPL WEIG; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2014, NIS DESCR DAT EL; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2016, WHY NIS SHOULD NOT U; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2013, HCUP METH SER METH A; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2011, HCUP METH SER; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2017, HCUPNET HEALTHC COST; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2010, HCUP PUBL SEARCH; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2014, HCUP NAT INP SAMPL R; Healthcare Cost and Utilization Project (HCUP, 2017, EL COM SOFTW VERS 3 EL COM SOFTW VERS 3; Khera R, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003846; Khera R, 2015, CIRCULATION, V132, pE35, DOI 10.1161/CIRCULATIONAHA.114.013342; Motheral B, 2003, VALUE HEALTH, V6, P90, DOI 10.1046/j.1524-4733.2003.00242.x; Shah RU, 2015, J AM COLL CARDIOL, V66, P1973, DOI 10.1016/j.jacc.2015.08.884	20	383	383	4	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2011	2018		10.1001/jama.2017.17653	http://dx.doi.org/10.1001/jama.2017.17653			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183077	Green Accepted, Bronze			2022-12-28	WOS:000416317600022
J	Saunte, DML; Jemec, GBE				Saunte, Ditte Marie Lindhardt; Jemec, Gregor Borut Ernst			Hidradenitis Suppurativa Advances in Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RIFAMPICIN COMBINATION THERAPY; SURGICAL-TREATMENT; CONSECUTIVE PATIENTS; ORAL CLINDAMYCIN; LOCAL EXCISION; CLINICAL-TRIAL; ACNE INVERSA; CASE SERIES; SKIN-GRAFT; MANAGEMENT	IMPORTANCE Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. OBJECTIVE To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. EVIDENCE REVIEW Aliterature search was conducted using PubMed, MEDLINE (Medical Subject Headings [MeSH]), and EMBASE to include recently published treatment studies (searched from September 1, 2011, toMay 1, 2017). Reviews, guidelines, conference abstracts, and studies with less than 10 patients were excluded. Furthermore, internet searches for guidelines on hidradenitis suppurativa using Baidu, Bing, Google, and Qwant browsers were performed. FINDINGS The diagnosis of HS is made by lesion morphology (nodules, abscesses, tunnels, and scars), location (axillae, inframammary folds, groin, perigenital, or perineal), and lesion progression (2 recurrences within 6 months or chronic or persistent lesions for >= 3 months). HS is more common than was previously thought based on epidemiological analysis (0.05%-4.10%). Disability from HS can be significant. Patients with HS may have significant comorbidities (eg, obesity, metabolic syndrome, diabetes, and arthritis) and increased all-cause mortality (incidence rate ratio, 1.35 [95% CI, 1.15-1.59]). Antibiotic treatment with combinations of clindamycin and rifampicin, or ertapenem followed by combination rifampicin, moxifloxacin, and metronidazole for 6 months is effective. Adalimumab is effective in a significant proportion of patients and treatment with IL-1 and IL-12 receptor subunit beta 1 (Rb1) antibodies may also be useful. Tissue-sparing surgical techniques and carbon dioxide laser treatments also are available, but the evidence on clinical outcomes with these approaches is limited. CONCLUSIONS AND RELEVANCE Hidradenitis suppurativa is more common than previously thought and may be treated by an array of pharmacological and surgical techniques. Hidradenitis suppurativa should be considered in the differential diagnosis of nodular lesions or sinus tracts present in the axillae, groin, perineal, and mammillary fold regions.	[Jemec, Gregor Borut Ernst] Zealand Univ Hosp, Dept Dermatol, Sygehusvej 5, DK-4000 Roskilde, Denmark; Univ Copenhagen, Hlth Sci Fac, Copenhagen, Denmark	University of Copenhagen	Jemec, GBE (corresponding author), Zealand Univ Hosp, Dept Dermatol, Sygehusvej 5, DK-4000 Roskilde, Denmark.	gbj@regionsjaelland.dk	Saunte, Ditte Marie l./O-8094-2018	Saunte, Ditte Marie l./0000-0001-7953-1047; Jemec, Gregor/0000-0002-0712-2540	Bayer; AbbVie; Desitin; Pfizer; Galderma; Astellas; Novartis; Leo Pharma; Coloplast; Pierre Fabre; Inflarx; Merck Sharp Dome; Janssen-Cilag; Celgene; UCB; Actelion; Regeneron	Bayer(Bayer AG); AbbVie(AbbVie); Desitin; Pfizer(Pfizer); Galderma; Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Leo Pharma(LEO Pharma); Coloplast; Pierre Fabre; Inflarx; Merck Sharp Dome; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Celgene(Bristol-Myers SquibbCelgene Corporation); UCB(UCB Pharma SA); Actelion; Regeneron(Regeneron)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Saunte reported receiving personal fees from Bayer, AbbVie, Desitin, Pfizer, Galderma, Astellas, Novartis, and Leo Pharma. Dr Jemec reported receiving personal fees from AbbVie, Coloplast, Pfizer, Pierre Fabre, Inflarx, Merck Sharp & Dome, Galderma, Leo Pharma, Novartis, Janssen-Cilag, Celgene, and UCB and grants from Abbvie, Leo Pharma, Actelion, Janssen-Cilag, Regeneron, UCB, and Novartis.	Alavi A, 2015, J AM ACAD DERMATOL, V73, pS55, DOI 10.1016/j.jaad.2015.07.048; Alharbi M, 2014, ANN CHIR PLAST ESTH, V59, P29, DOI 10.1016/j.anplas.2013.10.005; Alharbi Z, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-9; Armyra K, 2017, INT J DERMATOL, V56, P346, DOI 10.1111/ijd.13428; Benson JM, 2011, MABS-AUSTIN, V3, P535, DOI 10.4161/mabs.3.6.17815; Bettoli V, 2014, J EUR ACAD DERMATOL, V28, P125, DOI 10.1111/jdv.12127; Bettoli V, 2016, DERMATOL CLIN, V34, P81, DOI 10.1016/j.det.2015.08.013; Blok JL, 2016, BRIT J DERMATOL, V174, P839, DOI 10.1111/bjd.14338; Blok JL, 2015, J EUR ACAD DERMATOL, V29, P1590, DOI 10.1111/jdv.12952; Boer J, 2010, CLIN EXP DERMATOL, V35, P36, DOI 10.1111/j.1365-2230.2009.03377.x; CLEMMENSEN OJ, 1983, INT J DERMATOL, V22, P325, DOI 10.1111/j.1365-4362.1983.tb02150.x; Deckers IE, 2016, DRUGS, V76, P215, DOI 10.1007/s40265-015-0516-5; DeFazio MV, 2016, ANN PLAS SURG, V77, P217, DOI 10.1097/SAP.0000000000000584; Dessinioti C, 2016, CLIN EXP DERMATOL, V41, P852, DOI 10.1111/ced.12933; Esmann S, 2010, BRIT J DERMATOL, V163, P102, DOI 10.1111/j.1365-2133.2010.09773.x; Fischer AH, 2017, J AM ACAD DERMATOL, V76, P309, DOI 10.1016/j.jaad.2016.08.001; Giatrakos S, 2013, CYTOKINE, V62, P297, DOI 10.1016/j.cyto.2013.03.008; Hotz C, 2016, J INVEST DERMATOL, V136, P1768, DOI 10.1016/j.jid.2016.04.036; Humphries LS, 2016, J PLAST RECONSTR AES, V69, P554, DOI 10.1016/j.bjps.2015.12.004; Hurley HJ, 1996, ROENIGK ROENIGKS DER, V2nd, P623; Ingram JR, 2018, BRIT J DERMATOL, V178, P917, DOI 10.1111/bjd.16101; Ingram JR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010081.pub2; Janse IC, 2017, BRIT J DERMATOL, V176, P1042, DOI 10.1111/bjd.14975; Janse I, 2016, DERMATOL CLIN, V34, P97, DOI 10.1016/j.det.2015.08.007; Janse IC, 2016, ACTA DERM-VENEREOL, V96, P390, DOI 10.2340/00015555-2258; Jemec GBE, 1998, J AM ACAD DERMATOL, V39, P971, DOI 10.1016/S0190-9622(98)70272-5; Jemec GBE, 2016, J MED ECON, V19, P710, DOI 10.3111/13696998.2016.1161636; Jemec GBE, 2015, J AM ACAD DERMATOL, V73, pS4, DOI 10.1016/j.jaad.2015.07.052; Join-Lambert O, 2016, J ANTIMICROB CHEMOTH, V71, P513, DOI 10.1093/jac/dkv361; Kelly G, 2015, BRIT J DERMATOL, V173, P1431, DOI 10.1111/bjd.14075; Kim ES, 2016, AM J CLIN DERMATOL, V17, P545, DOI 10.1007/s40257-016-0220-6; Kimball AB, 2016, J EUR ACAD DERMATOL, V30, P989, DOI 10.1111/jdv.13216; Kimball AB, 2016, NEW ENGL J MED, V375, P422, DOI 10.1056/NEJMoa1504370; Kimball AB, 2012, ANN INTERN MED, V157, P846, DOI 10.7326/0003-4819-157-12-201212180-00004; Kohorst JJ, 2016, DERMATOL SURG, V42, P1030, DOI 10.1097/DSS.0000000000000806; Kromann CB, 2014, BRIT J DERMATOL, V171, P819, DOI 10.1111/bjd.13090; Kromann CB, 2014, ACTA DERM-VENEREOL, V94, P553, DOI 10.2340/00015555-1800; Lipsker D, 2016, DERMATOLOGY, V232, P137, DOI 10.1159/000443878; LOOKINGBILL DP, 1988, J AM ACAD DERMATOL, V18, P31, DOI 10.1016/S0190-9622(88)70004-3; Maeda T, 2015, J PLAST RECONSTR AES, V68, P1268, DOI 10.1016/j.bjps.2015.05.025; Makris GM, 2017, DERMATOL SURG, V43, P107, DOI 10.1097/DSS.0000000000000944; Mehdizadeh A, 2015, J AM ACAD DERMATOL, V73, pS70, DOI 10.1016/j.jaad.2015.07.044; Mendonca CO, 2006, BRIT J DERMATOL, V154, P977, DOI 10.1111/j.1365-2133.2006.07155.x; Mikkelsen PR, 2015, DERMATOL SURG, V41, P255, DOI 10.1097/DSS.0000000000000264; Miller LM, 2016, DERMATOL CLIN, V34, P7, DOI 10.1016/j.det.2015.08.002; Mutaf M, 2014, ANN PLAS SURG, V73, P583, DOI 10.1097/SAP.0b013e3182840831; Nesmith RB, 2013, ANN PLAS SURG, V70, P538, DOI 10.1097/SAP.0b013e31828ea7cb; Onderdijk AJ, 2013, J EUR ACAD DERMATOL, V27, P473, DOI 10.1111/j.1468-3083.2012.04468.x; Ozer I, 2017, DERMATOL THER, V30; Perret LJ, 2014, AUSTRALAS J DERMATOL, V55, P111, DOI 10.1111/ajd.12075; Posch C, 2017, J AM ACAD DERMATOL, V77, P123, DOI 10.1016/j.jaad.2017.01.055; Prens E, 2015, J AM ACAD DERMATOL, V73, pS8, DOI 10.1016/j.jaad.2015.07.045; Riis PT, 2016, J AM ACAD DERMATOL, V75, P1151, DOI 10.1016/j.jaad.2016.06.049; Ring HC, 2017, ACTA DERM-VENEREOL, V97, P208, DOI 10.2340/00015555-2503; Romanowski KS, 2017, J BURN CARE RES, V1; Sampogna F, 2017, ACTA DERM-VENEREOL, V97, P478, DOI 10.2340/00015555-2561; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; Saunte DM, 2015, BRIT J DERMATOL, V173, P1546, DOI 10.1111/bjd.14038; Scheinfeld N, 2016, DERMATOL ONLINE J, V22; Schmidt M, 2015, J PLAST RECONSTR AES, V68, P953, DOI 10.1016/j.bjps.2015.03.002; Shavit E, 2015, J EUR ACAD DERMATOL, V29, P371, DOI 10.1111/jdv.12567; Sotiriou E, 2012, J DRUGS DERMATOL, V11, pS15; Thorlacius L, 2018, BRIT J DERMATOL, V178, P715, DOI 10.1111/bjd.16093; Thorlacius L, 2018, J INVEST DERMATOL, V138, P52, DOI 10.1016/j.jid.2017.09.008; Tzanetakou V, 2016, JAMA DERMATOL, V152, P52, DOI 10.1001/jamadermatol.2015.3903; Utrera-Busquets M, 2016, CLIN EXP DERMATOL, V41, P287, DOI 10.1111/ced.12731; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; van Rappard DC, 2012, BRIT J DERMATOL, V167, P206, DOI 10.1111/j.1365-2133.2012.10807.x; van Rappard DC, 2012, J EUR ACAD DERMATOL, V26, P898, DOI 10.1111/j.1468-3083.2011.04203.x; Vangipuram R, 2016, DERMATOLOGY, V232, P692, DOI 10.1159/000453259; Wollina U, 2017, INT J DERMATOL, V56, P109, DOI 10.1111/ijd.13393; Wollina U, 2012, DERMATOL SURG, V38, P110, DOI 10.1111/j.1524-4725.2011.02157.x; Wormald JCR, 2014, J PLAST RECONSTR AES, V67, P1118, DOI 10.1016/j.bjps.2014.04.032; Yamashita Y, 2014, DERMATOL SURG, V40, P110, DOI 10.1111/dsu.12400; Zouboulis CC, 2015, DERMATOLOGY, V231, P184, DOI 10.1159/000431175	75	196	204	4	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2019	2032		10.1001/jama.2017.16691	http://dx.doi.org/10.1001/jama.2017.16691			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183082				2022-12-28	WOS:000416317600023
J	Slomski, A				Slomski, Anita			Continuous Glucose Monitoring in Pregnant Women With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1968	1968		10.1001/jama.2017.17951	http://dx.doi.org/10.1001/jama.2017.17951			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183071				2022-12-28	WOS:000416317600007
J	Mateos, MV; Dimopoulos, MA; Cavo, M; Suzuki, K; Jakubowiak, A; Knop, S; Doyen, C; Lucio, P; Nagy, Z; Kaplan, P; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Iosava, G; Fujisaki, T; Garg, M; Chiu, C; Wang, J; Carson, R; Crist, W; Deraedt, W; Nguyen, H; Qi, M; San-Miguel, J				Mateos, M. -V.; Dimopoulos, M. A.; Cavo, M.; Suzuki, K.; Jakubowiak, A.; Knop, S.; Doyen, C.; Lucio, P.; Nagy, Z.; Kaplan, P.; Pour, L.; Cook, M.; Grosicki, S.; Crepaldi, A.; Liberati, A. M.; Campbell, P.; Shelekhova, T.; Yoon, S. -S.; Iosava, G.; Fujisaki, T.; Garg, M.; Chiu, C.; Wang, J.; Carson, R.; Crist, W.; Deraedt, W.; Nguyen, H.; Qi, M.; San-Miguel, J.		ALCYONE Trial Investigators	Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; ANTIBODY DARATUMUMAB; INITIAL TREATMENT; DEXAMETHASONE; LENALIDOMIDE; DIAGNOSIS; CRITERIA	BACKGROUND The combination of bortezomib, melphalan, and prednisone is a standard treatment for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem-cell transplantation. Daratumumab has shown efficacy in combination with standard-of-care regimens in patients with relapsed or refractory multiple myeloma. METHODS In this phase 3 trial, we randomly assigned 706 patients with newly diagnosed multiple myeloma who were ineligible for stem-cell transplantation to receive nine cycles of bortezomib, melphalan, and prednisone either alone (control group) or with daratumumab (daratumumab group) until disease progression. The primary end point was progression-free survival. RESULTS At a median follow-up of 16.5 months in a prespecified interim analysis, the 18-month progression-free survival rate was 71.6% (95% confidence interval [CI], 65.5 to 76.8) in the daratumumab group and 50.2% (95% CI, 43.2 to 56.7) in the control group (hazard ratio for disease progression or death, 0.50; 95% CI, 0.38 to 0.65; P<0.001). The overall response rate was 90.9% in the daratumumab group, as compared with 73.9% in the control group (P<0.001), and the rate of complete response or better (including stringent complete response) was 42.6%, versus 24.4% (P<0.001). In the daratumumab group, 22.3% of the patients were negative for minimal residual disease (at a threshold of 1 tumor cell per 105 white cells), as compared with 6.2% of those in the control group (P<0.001). The most common adverse events of grade 3 or 4 were hematologic: neutropenia (in 39.9% of the patients in the daratumumab group and in 38.7% of those in the control group), thrombocytopenia (in 34.4% and 37.6%, respectively), and anemia (in 15.9% and 19.8%, respectively). The rate of grade 3 or 4 infections was 23.1% in the daratumumab group and 14.7% in the control group; the rate of treatment discontinuation due to infections was 0.9% and 1.4%, respectively. Daratumumab-associated infusion-related reactions occurred in 27.7% of the patients. CONCLUSIONS Among patients with newly diagnosed multiple myeloma who were ineligible for stem-cell transplantation, daratumumab combined with bortezomib, melphalan, and prednisone resulted in a lower risk of disease progression or death than the same regimen without daratumumab. The daratumumab-containing regimen was associated with more grade 3 or 4 infections.	Univ Hosp Salamanca, Inst Invest Biomed Salamanca, Salamanca, Spain; [San-Miguel, J.] Clin Univ Navarra, Ctr Invest Med Aplicada, Inst Invest Sanitaria Navarra, Ctr Invest Biomed Red Canc, Pamplona, Spain; [Dimopoulos, M. A.] Natl & Kapodistrian Univ Athens, Athens, Greece; [Cavo, M.] Univ Bologna, Inst Hematol, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Liberati, A. M.] Azienda Osped Santa Maria, Terni, Italy; [Suzuki, K.] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan; [Jakubowiak, A.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Knop, S.] Wurzburg Univ, Med Ctr, Wurzburg, Germany; [Doyen, C.] UCL, Ctr Hosp Univ UCL Namur, Yvoir, Belgium; [Deraedt, W.] Janssen Res & Dev, Beerse, Belgium; [Lucio, P.] Champalimaud Ctr Unknown, Lisbon, Portugal; [Nagy, Z.] Semmelweis Egyet, Budapest, Hungary; [Kaplan, P.] Dnepropetrovsk City Clin Hosp 4, Dnepropetrovsk, Ukraine; [Pour, L.] Univ Hosp Brno, Brno, Czech Republic; [Cook, M.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Garg, M.] Leicester Royal Infirmary Haematol, Leicester, Leics, England; [Grosicki, S.] Silesian Med Univ, Sch Publ Hlth, Dept Canc Prevent, Katowice, Poland; [Crepaldi, A.] Clin Tratamento E, Cuiaba, Brazil; [Campbell, P.] Andrew Love Canc Ctr, Geelong, Vic, Australia; [Shelekhova, T.] Clin Profess Pathol, Saratov, Russia; [Yoon, S. -S.] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Iosava, G.] LTD Medinvent Inst Hlth, Tbilisi, Georgia; [Fujisaki, T.] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan; [Chiu, C.; Carson, R.; Crist, W.; Qi, M.] Janssen Res & Dev, Spring House, PA USA; [Wang, J.; Nguyen, H.] Janssen Res & Dev, Raritan, NJ USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; National & Kapodistrian University of Athens; University of Bologna; Japanese Red Cross Medical Center; University of Tokyo; University of Chicago; University of Chicago Medical Center; University of Wurzburg; Universite Catholique Louvain; Johnson & Johnson; Janssen Pharmaceuticals; Fundacao Champalimaud; Semmelweis University; University Hospital Brno; University of Birmingham; Medical University Silesia; Seoul National University (SNU); Matsuyama Red Cross Hospital; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Mateos, MV (corresponding author), Paseo San Vicente 58, Salamanca 37007, Spain.	mvmateos@usal.es	CAVO, MICHELE/AAK-8274-2020; Grosicki, Sebastian/AAG-2917-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019; martinez, joaquin/AAN-6939-2020; Yoon, Sung-Soo/J-2773-2012; , Van Eygen Koen/AAF-7668-2020; Shelekhova, Tatiana Vladimirovna/B-2812-2014; de Oteyza, Jaime Perez/K-5514-2012; San-Miguel, Jesús F./V-8977-2018; Symeonidis, Argiris/K-2287-2019; Maisnar, Vladimir/Q-8579-2017; Oriol, Albert/K-9923-2017	CAVO, MICHELE/0000-0003-4514-3227; martinez, joaquin/0000-0001-7908-0063; , Van Eygen Koen/0000-0001-8285-906X; de Oteyza, Jaime Perez/0000-0002-8338-2037; San-Miguel, Jesús F./0000-0002-9183-4857; Symeonidis, Argiris/0000-0002-3685-3473; Martin Sanchez, Jesus/0000-0003-4250-4824; Chiu, Christopher W./0000-0001-9744-991X; Maisnar, Vladimir/0000-0003-1738-4920; Garg, Mamta/0000-0002-3560-0132; Grosicki, Sebastian/0000-0003-2644-1050; Hus, Marek/0000-0002-9036-6625; Lucio, Paulo/0000-0003-0175-7534; Encinas, Cristina/0000-0002-9001-9754; Oriol, Albert/0000-0001-6804-2221; Berneman, Zwi/0000-0002-9133-4588; Cook, Mark/0000-0001-8647-9208	Janssen Research and Development; ALCYONE [NCT02195479]	Janssen Research and Development; ALCYONE	Supported by Janssen Research and Development.r Funded by Janssen Research and Development; ALCYONE ClinicalTrials.gov number, NCT02195479.)	Anderson KC, 2016, J NATL COMPR CANC NE, V14, P389, DOI 10.6004/jnccn.2016.0046; Attal M, 2017, NEW ENGL J MED, V376, P1311, DOI 10.1056/NEJMoa1611750; AVETLOISEAU H, 2016, BLOOD, V128; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dimopoulos MA, 2016, NEW ENGL J MED, V375, P1319, DOI 10.1056/NEJMoa1607751; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Howlader NNA, 2020, SEER CANC STAT REV; Krejcik J, 2016, BLOOD, V128, P384, DOI 10.1182/blood-2015-12-687749; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Kumar SK, 2017, J NATL COMPR CANC NE, V15, P230, DOI 10.6004/jnccn.2017.0023; Mateos MV, 2015, HAEMATOLOGICA, V100, P84; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; McCudden C, 2016, CLIN CHEM LAB MED, V54, P1095, DOI 10.1515/cclm-2015-1031; Merz M, 2017, ANN HEMATOL, V96, P987, DOI 10.1007/s00277-017-2991-0; Millennium Pharmaceuticals, 2017, VELC BORT INJ SUBC I; Moreau P, 2017, ANN ONCOL, V28, P52, DOI 10.1093/annonc/mdx096; National Cancer Institute (U.S.), 2009, COMMON TERMINOLOGY C; Overdijk MB, 2016, J IMMUNOL, V197, P807, DOI 10.4049/jimmunol.1501351; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Palumbo A, 2016, NEW ENGL J MED, V375, P754, DOI 10.1056/NEJMoa1606038; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Rajkumar SV, 2016, MAYO CLIN PROC, V91, P101, DOI 10.1016/j.mayocp.2015.11.007; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Song X, 2016, CURR MED RES OPIN, V32, P95, DOI 10.1185/03007995.2015.1105202	29	588	602	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					518	528		10.1056/NEJMoa1714678	http://dx.doi.org/10.1056/NEJMoa1714678			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OX	29231133	Bronze			2022-12-28	WOS:000424335200007
J	de Winter, RJ; Katagiri, Y; Asano, T; Milewski, KP; Lurz, P; Buszman, P; Jessurun, GAJ; Koch, KT; Troquay, RPT; Hamer, BJB; Ophuis, TO; Wohrle, J; Wyderka, R; Cayla, G; Hofma, SH; Levesque, S; Zurakowski, A; Fischer, D; Kosmider, M; Goube, P; Arkenbout, EK; Noutsias, M; Ferrari, MW; Onuma, Y; Wijns, W; Serruys, PW				de Winter, Robbert J.; Katagiri, Yuki; Asano, Taku; Milewski, Krzysztof P.; Lurz, Philipp; Buszman, Pawel; Jessurun, Gillian A. J.; Koch, Karel T.; Troquay, Roland P. T.; Hamer, Bas J. B.; Ophuis, Ton Oude; Woehrle, Jochen; Wyderka, Rafal; Cayla, Guillaume; Hofma, Sjoerd H.; Levesque, Sebastien; Zurakowski, Aleksander; Fischer, Dieter; Kosmider, Maciej; Goube, Pascal; Arkenbout, E. Karin; Noutsias, Michel; Ferrari, Markus W.; Onuma, Yoshinobu; Wijns, William; Serruys, Patrick W.			A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial	LANCET			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ARTERY-DISEASE; BIODEGRADABLE POLYMER; ABSORBABLE POLYMER; BARE METAL; THROMBOSIS; IMPLANTATION; LEADERS	Background MiStent is a drug-eluting stent with a fully absorbable polymer coating containing and embedding a microcrystalline form of sirolimus into the vessel wall. It was developed to overcome the limitation of current durable polymer drug-eluting stents eluting amorphous sirolimus. The clinical effect of MiStent sirolimus-eluting stent compared with a durable polymer drug-eluting stents has not been investigated in a large randomised trial in an all-comer population. Methods We did a randomised, single-blind, multicentre, phase 3 study (DESSOLVE III) at 20 hospitals in Germany, France, Netherlands, and Poland. Eligible participants were any patients aged at least 18 years who underwent percutaneous coronary intervention in a lesion and had a reference vessel diameter of 2.50-3.75 mm. We randomly assigned patients (1: 1) to implantation of either a sirolimus-eluting bioresorbable polymer stent (MiStent) or an everolimus-eluting durable polymer stent (Xience). Randomisation was done by local investigators via web-based software with random blocks according to centre. The primary endpoint was a non-inferiority comparison of a device-oriented composite endpoint (DOCE)-cardiac death, target-vessel myocardial infarction, or clinically indicated target lesion revascularisation-between the groups at 12 months after the procedure assessed by intention-to-treat. A margin of 4.0% was defined for non-inferiority of the MiStent group compared with the Xience group. All participants were included in the safety analyses. This trial is registered with ClinicalTrials. gov, number NCT02385279. Findings Between March 20, and Dec 3, 2015, we randomly assigned 1398 patients with 2030 lesions; 703 patients with 1037 lesions were assigned to MiStent, of whom 697 received the index procedure, and 695 patients with 993 lesions were asssigned to Xience, of whom 690 received the index procedure. At 12 months, the primary endpoint had occurred in 40 patients (5.8%) in the sirolimus-eluting stent group and in 45 patients (6.5%) in the everolimus-eluting stent group (absolute difference -0.8% [95% CI -3.3 to 1.8], p(non-inferiority) = 0.0001). Procedural complications occurred in 12 patients (1.7%) in the sirolimus-eluting stent group and ten patients (1.4%) in the everolimus-eluting stent group; no clinical adverse events could be attributed to these dislodgements through a minimum of 12 months of follow-up. The rate of stent thrombosis, a safety indicator, did not differ between groups and was low in both treatment groups. Interpretation The sirolimus-eluting bioabsorbable polymer stent was non-inferior to the everolimus-eluting durable polymer stent for a device-oriented composite clinical endpoint at 12 months in an all-comer population. MiStent seems a reasonable alternative to other stents in clinical practice	[de Winter, Robbert J.; Katagiri, Yuki; Asano, Taku; Koch, Karel T.] Acad Med Ctr, Amsterdam, Netherlands; [Milewski, Krzysztof P.] Amer Heart Poland SA, Oddzial Kardiol Inwazyjnej Elektrofizjol & Elektr, Tychy, Poland; [Lurz, Philipp] Univ Leipzig, Heart Ctr, Dept Internal Med & Cardiol, Leipzig, Germany; [Buszman, Pawel] Amer Heart Poland, Ctr Cardiovasc Res & Dev, Katowice, Poland; [Jessurun, Gillian A. J.] Treant Zorggrp, Dept Cardiol, Emmen, Netherlands; [Troquay, Roland P. T.] VieCuri Med Ctr Northern Limburg, Venlo, Netherlands; [Hamer, Bas J. B.] Meander Med Ctr, Amersfoort, Netherlands; [Ophuis, Ton Oude] Canisius Wilhelmina Ziekenhuis, Dept Cardiol, Nijmegen, Netherlands; [Woehrle, Jochen] Univ Klinikum Ulm, Ulm, Germany; [Wyderka, Rafal] Zgierskie Ctr Kardiol Med Pro, Zgierz, Poland; [Cayla, Guillaume] Univ Montpellier, CHU Nimes, Dept Cardiol, Montpellier, France; [Hofma, Sjoerd H.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Levesque, Sebastien] CHU Poitiers, Poitiers, France; [Zurakowski, Aleksander] Malopolskie Ctr Sercowo Naczyniowe PAKS, Chrzanow, Poland; [Fischer, Dieter] Univ Klinikum Munster, Munster, Germany; [Kosmider, Maciej] Oddzial Kardiol PAKS, Belchatow, Poland; [Goube, Pascal] CH Sud Francilien Corbeil Essonne, Corbeil Essonnes, France; [Arkenbout, E. Karin] Tergooi Hosp, Dept Cardiol, Blaricum, Netherlands; [Noutsias, Michel] Friedrich Schiller Univ, Dept Cardiol Pneumonol & Intens Care Med, Clin Internal Med 1, Univ Hosp Jena, Jena, Germany; [Ferrari, Markus W.] Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany; [Onuma, Yoshinobu] Erasmus MC, ThoraxCtr, Rotterdam, Netherlands; [Wijns, William] Cardiovasc Res Ctr Aalst, Aalst, Belgium; [Wijns, William] Natl Univ Ireland Galway, Lambe Inst Translat Med, Galway, Ireland; [Wijns, William] CURAM, Galway, Ireland; [Serruys, Patrick W.] Imperial Coll London, Natl Heart & Lung Inst, London, England	University of Amsterdam; Academic Medical Center Amsterdam; Heart Center Leipzig GMBH; Leipzig University; VieCuri Medical Center; Meander Medisch Centrum; Canisius-Wilhelmina Hospital; Ulm University; Universite de Montpellier; CHU de Nimes; Medical Center Leeuwarden; CHU Poitiers; Universite de Poitiers; University of Munster; Centre Hospitalier Sud Francilien; Tergooi Blaricum; Friedrich Schiller University of Jena; Erasmus University Rotterdam; Erasmus MC; Ollscoil na Gaillimhe-University of Galway; Imperial College London	Serruys, PW (corresponding author), Univ London, Imperial Coll, London SW7 2AZ, England.	patrick.w.j.c.serruys@gmail.com	Milewski, Krzysztof/W-9701-2018; Asano, Taku/AAU-5875-2021; Onuma, Yoshinobu/AHB-6273-2022; Buszman, Pawel/AAX-9336-2020; Lurz, Philipp C/B-6558-2009; Noutsias, Michel/AAM-4006-2021	Milewski, Krzysztof/0000-0001-7976-3323; Onuma, Yoshinobu/0000-0001-7702-0649; Lurz, Philipp C/0000-0002-5993-4487; Wijns, William/0000-0002-7267-4376; Noutsias, Michel/0000-0002-9066-5262; Buszman, Pawel/0000-0002-2511-4077; Asano, Taku/0000-0001-5733-3381; Ferrari, Markus/0000-0003-3986-1943	Micell Technologies (Durham, NC, USA); Stentys (Paris, France); European Cardiovascular Research Institute	Micell Technologies (Durham, NC, USA); Stentys (Paris, France); European Cardiovascular Research Institute	The European Cardiovascular Research Institute, Micell Technologies (Durham, NC, USA), and Stentys (Paris, France).	Attizzani GF, 2012, J INVASIVE CARDIOL, V24, P560; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Carlyle WC, 2012, J CONTROL RELEASE, V162, P561, DOI 10.1016/j.jconrel.2012.07.004; Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2013, JACC-CARDIOVASC INTE, V6, P914, DOI 10.1016/j.jcin.2013.05.005; Fulton JL, 2003, POLYMER, V44, P3627, DOI 10.1016/S0032-3861(03)00280-5; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Kereiakes DJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002372; Lansky AJ, 2016, AM J CARDIOL, V117, P532, DOI 10.1016/j.amjcard.2015.11.044; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nakatani S, 2016, EUROINTERVENTION, V12, P1498, DOI 10.4244/EIJY15M10_03; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ormiston J, 2013, JACC-CARDIOVASC INTE, V6, P1026, DOI 10.1016/j.jcin.2013.05.013; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Saez A, 2010, MED DEVICES-EVID RES, V3, P51, DOI 10.2147/MDER.S4422; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Serruys PW, 2007, CIRCULATION, V115, P1433, DOI 10.1161/CIRCULATIONAHA.106.666826; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Tsuchida Keiichi, 2005, EuroIntervention, V1, P266; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Wijns W, 2015, EUROINTERVENTION, V10, P1383, DOI 10.4244/EIJY14M05_03; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	29	61	62	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					431	440		10.1016/S0140-6736(17)33103-3	http://dx.doi.org/10.1016/S0140-6736(17)33103-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OL	29203070				2022-12-28	WOS:000424333600032
J	Cau, A; Beyrand, V; Voeten, DFAE; Fernandez, V; Tafforeau, P; Stein, K; Barsbold, R; Tsogtbaatar, K; Currie, PJ; Godefroit, P				Cau, Andrea; Beyrand, Vincent; Voeten, Dennis F. A. E.; Fernandez, Vincent; Tafforeau, Paul; Stein, Koen; Barsbold, Rinchen; Tsogtbaatar, Khishigjav; Currie, Philip J.; Godefroit, Pascal			Synchrotron scanning reveals amphibious ecomorphology in a new clade of bird-like dinosaurs	NATURE			English	Article							EVOLUTION; THEROPOD; OSTEOLOGY	Maniraptora includes birds and their closest relatives among theropod dinosaurs(1-5). During the Cretaceous period, several maniraptoran lineages diverged from the ancestral coelurosaurian bauplan and evolved novel ecomorphologies, including active flight(2), gigantism(3), cursoriality(4) and herbivory(5). Propagation X-ray phase-contrast synchrotron microtomography of a well-preserved maniraptoran from Mongolia, still partially embedded in the rock matrix, revealed a mosaic of features, most of them absent among non-avian maniraptorans but shared by reptilian and avian groups with aquatic or semiaquatic ecologies(6-14). This new theropod, Halszkaraptor escuilliei gen. et sp. nov., is related to other enigmatic Late Cretaceous maniraptorans from Mongolia(15,16) in a novel clade at the root of Dromaeosauridae(17). This lineage adds an amphibious ecomorphology to those evolved by maniraptorans: it acquired a predatory mode that relied mainly on neck hyperelongation for food procurement, it coupled the obligatory bipedalism of theropods with forelimb proportions that may support a swimming function, and it developed postural adaptations convergent with short-tailed birds.	[Cau, Andrea] Geol & Palaeontol Museum Giovanni Capellini, I-40126 Bologna, Italy; [Beyrand, Vincent; Voeten, Dennis F. A. E.; Fernandez, Vincent; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Beyrand, Vincent; Voeten, Dennis F. A. E.] Palacky Univ, Dept Zool, CS-40220 Olomouc, Czech Republic; [Beyrand, Vincent; Voeten, Dennis F. A. E.] Palacky Univ, Lab Ornithol, CS-40220 Olomouc, Czech Republic; [Stein, Koen] Vrije Univ Brussel, Earth Syst Sci AMGC, B-1050 Brussels, Belgium; [Barsbold, Rinchen] Mongolian Acad Sci, Palaeontol Ctr, Ulaanbaatar 201351, Mongolia; [Tsogtbaatar, Khishigjav] Mongolian Acad Sci, Inst Palaeontol & Geol, Ulaanbaatar 210351, Mongolia; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Godefroit, Pascal] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, B-1000 Brussels, Belgium	European Synchrotron Radiation Facility (ESRF); Palacky University Olomouc; Palacky University Olomouc; Vrije Universiteit Brussel; Mongolian Academy of Sciences; Mongolian Academy of Sciences; University of Alberta; Royal Belgian Institute of Natural Sciences	Cau, A (corresponding author), Geol & Palaeontol Museum Giovanni Capellini, I-40126 Bologna, Italy.	cauand@gmail.com	Stein, Koen HW/G-5731-2015; VOETEN, Dennis/L-8896-2019; Cau, Andrea/ABB-7972-2021; Cau, Andrea/S-8546-2016	VOETEN, Dennis/0000-0002-2090-2824; Cau, Andrea/0000-0001-8761-3720; Tafforeau, Paul/0000-0002-5962-1683; Stein, Koen/0000-0003-4246-3225; Fernandez, Vincent/0000-0002-8315-1458	Willi Hennig Society	Willi Hennig Society	We thank the European Synchrotron Radiation Facility for granting us beam time at ID19 and BM05 beamlines; Y. Pommery for his work on teeth segmentation; T. Hubin for photographs; A. Halamski and D. Madzia for information on Hulsanpes holotype; and M. Auditore for the skeletal reconstructions. U. Lefevre and L. Van Bossuyt took conventional X-ray pictures at the Veterinary School of Liege University. Silhouettes in Fig. 4a were provided by D. Bonadonna and L. Panzarin and are used with their permission. The program TNT was made available by the sponsorship of the Willi Hennig Society.	Balanoff AM, 2012, B AM MUS NAT HIST, P1; Barker CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03671-3; Caldwell MW, 2002, AM J MED GENET, V112, P236, DOI 10.1002/ajmg.10773; Carpenter Kenneth, 2010, Transactions of the Kansas Academy of Science, V113, P1, DOI 10.1660/062.113.0201; Cau A, 2015, PEERJ, V3, DOI 10.7717/peerj.1032; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Foffa D, 2014, NATURWISSENSCHAFTEN, V101, P453, DOI 10.1007/s00114-014-1173-3; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gianechini FA, 2011, ACTA PALAEONTOL POL, V56, P279, DOI 10.4202/app.2009.0127; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Habib M, 2010, BIOL J LINN SOC, V99, P687, DOI 10.1111/j.1095-8312.2010.01372.x; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; Kear BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172759; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; Meylan PA, 1996, J VERTEBR PALEONTOL, V16, P20, DOI 10.1080/02724634.1996.10011280; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Osmolska H., 1982, NEUES JB GEOLOGIE PA, V7, P440; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ribak G, 2004, J EXP BIOL, V207, P2101, DOI 10.1242/jeb.00997; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Thewissen J.G.M., 2007, P310; Turner AH, 2012, B AM MUS NAT HIST, P5; Turner AH, 2011, AM MUS NOVIT, P1, DOI 10.1206/3722.2; Witmer Lawrence M., 2002, P3; Xing LD, 2013, EVOLUTION, V67, P2441, DOI 10.1111/evo.12119; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu X, 2015, NATURE, V521, P70, DOI 10.1038/nature14423; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108	30	74	74	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					395	+		10.1038/nature24679	http://dx.doi.org/10.1038/nature24679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29211712				2022-12-28	WOS:000418559800057
J	Cuculich, PS; Schill, MR; Kashani, R; Mutic, S; Lang, A; Cooper, D; Faddis, M; Gleva, M; Noheria, A; Smith, TW; Hallahan, D; Rudy, Y; Robinson, CG				Cuculich, Phillip S.; Schill, Matthew R.; Kashani, Rojano; Mutic, Sasa; Lang, Adam; Cooper, Daniel; Faddis, Mitchell; Gleva, Marye; Noheria, Amit; Smith, Timothy W.; Hallahan, Dennis; Rudy, Yoram; Robinson, Clifford G.			Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRUCTURAL HEART-DISEASE; RADIOFREQUENCY CATHETER ABLATION; ISCHEMIC CARDIOMYOPATHY; SUBSTRATE ABLATION; MYOCARDIAL-INFARCTION; ARRHYTHMIA; SCAR; VT; TRIAL; SUCCESS	BACKGROUND Recent advances have enabled noninvasive mapping of cardiac arrhythmias with electrocardiographic imaging and noninvasive delivery of precise ablative radiation with stereotactic body radiation therapy (SBRT). We combined these techniques to perform catheter-free, electrophysiology-guided, noninvasive cardiac radioablation for ventricular tachycardia. METHODS We targeted arrhythmogenic scar regions by combining anatomical imaging with noninvasive electrocardiographic imaging during ventricular tachycardia that was induced by means of an implantable cardioverter-defibrillator (ICD). SBRT simulation, planning, and treatments were performed with the use of standard techniques. Patients were treated with a single fraction of 25 Gy while awake. Efficacy was assessed by counting episodes of ventricular tachycardia, as recorded by ICDs. Safety was assessed by means of serial cardiac and thoracic imaging. RESULTS From April through November 2015, five patients with high-risk, refractory ventricular tachycardia underwent treatment. The mean noninvasive ablation time was 14 minutes (range, 11 to 18). During the 3 months before treatment, the patients had a combined history of 6577 episodes of ventricular tachycardia. During a 6-week postablation "blanking period" (when arrhythmias may occur owing to postablation inflammation), there were 680 episodes of ventricular tachycardia. After the 6-week blanking period, there were 4 episodes of ventricular tachycardia over the next 46 patient-months, for a reduction from baseline of 99.9%. A reduction in episodes of ventricular tachycardia occurred in all five patients. The mean left ventricular ejection fraction did not decrease with treatment. At 3 months, adjacent lung showed opacities consistent with mild inflammatory changes, which had resolved by 1 year. CONCLUSIONS In five patients with refractory ventricular tachycardia, noninvasive treatment with electrophysiology-guided cardiac radioablation markedly reduced the burden of ventricular tachycardia.	[Cuculich, Phillip S.; Cooper, Daniel; Faddis, Mitchell; Gleva, Marye; Noheria, Amit; Smith, Timothy W.] Washington Univ, Sch Med, Dept Internal Med, Cardiovasc Div, St Louis, MO 63110 USA; [Schill, Matthew R.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Kashani, Rojano; Mutic, Sasa; Hallahan, Dennis; Robinson, Clifford G.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; [Lang, Adam] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Rudy, Yoram] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Rudy, Yoram] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Rudy, Yoram] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Rudy, Yoram] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rudy, Yoram] Washington Univ, Sch Engn & Appl Sci, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Cuculich, PS (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	pcuculic@wustl.edu	Robinson, Cliff/A-5178-2013; Noheria, Amit/ABD-5463-2021	Robinson, Cliff/0000-0002-1399-9904; Noheria, Amit/0000-0002-9947-3849	Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033343] Funding Source: NIH RePORTER	Barnes-Jewish Hospital Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Barnes-Jewish Hospital Foundation and others.	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Berruezo A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P326, DOI 10.1161/CIRCEP.114.002386; Cochet H, 2013, J CARDIOVASC ELECTR, V24, P419, DOI 10.1111/jce.12052; Cuculich PS, 2011, J AM COLL CARDIOL, V58, P1893, DOI 10.1016/j.jacc.2011.07.029; Curigliano G, 2016, CA-CANCER J CLIN, V66, P310, DOI 10.3322/caac.21341; Cvek J., 2014, CUREUS, V6, pE190, DOI DOI 10.7759/CUREUS.190; Di Biase L, 2015, J AM COLL CARDIOL, V66, P2872, DOI 10.1016/j.jacc.2015.10.026; Di Biase L, 2012, J AM COLL CARDIOL, V60, P132, DOI 10.1016/j.jacc.2012.03.044; Dickfeld T, 2011, CIRC-ARRHYTHMIA ELEC, V4, P172, DOI 10.1161/CIRCEP.110.958744; Dinov B, 2014, CIRCULATION, V129, P728, DOI 10.1161/CIRCULATIONAHA.113.003063; Izquierdo M, 2015, CIRC-ARRHYTHMIA ELEC, V8, P882, DOI 10.1161/CIRCEP.115.002827; Kumar S, 2015, CIRC-ARRHYTHMIA ELEC, V8, P606, DOI 10.1161/CIRCEP.114.002522; Lehmann HI, 2016, SCI REP-UK, V6, DOI 10.1038/srep38895; Loo BW, 2015, CIRC-ARRHYTHMIA ELEC, V8, P748, DOI 10.1161/CIRCEP.115.002765; Marchlinski FE, 2016, J AM COLL CARDIOL, V67, P674, DOI 10.1016/j.jacc.2015.11.041; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Proietti R, 2015, EUROPACE, V17, P461, DOI 10.1093/europace/euu326; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; Romeo MP, 2013, DIAGNOSTIC PATHOLOGY, P24; Sacher F, 2015, J CARDIOVASC ELECTR, V26, P464, DOI 10.1111/jce.12565; Santangeli P, 2017, J AM COLL CARDIOL, V69, P2105, DOI 10.1016/j.jacc.2017.02.044; Sapp JL, 2016, NEW ENGL J MED, V375, P111, DOI 10.1056/NEJMoa1513614; Sharma A, 2010, HEART RHYTHM, V7, P802, DOI 10.1016/j.hrthm.2010.02.010; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Tokuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000072; Tung R, 2015, HEART RHYTHM, V12, P1997, DOI 10.1016/j.hrthm.2015.05.036; Tzou WS, 2015, CIRC-ARRHYTHMIA ELEC, V8, P353, DOI 10.1161/CIRCEP.114.002310; Wang Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002152; Yusuf SW, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/317659; Zhang JJ, 2016, PACE, V39, P781, DOI 10.1111/pace.12882	30	282	296	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2325	2336		10.1056/NEJMoa1613773	http://dx.doi.org/10.1056/NEJMoa1613773			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	29236642	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000417923600005
J	Sundararajan, V; Vogrin, S				Sundararajan, Vijaya; Vogrin, Sara			Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sundararajan, Vijaya; Vogrin, Sara] Univ Melbourne, St Vincents Hosp, Fitzroy, Vic, Australia	St Vincent's Hospital Melbourne; University of Melbourne	Sundararajan, V (corresponding author), Univ Melbourne, St Vincents Hosp, Fitzroy, Vic, Australia.							Chernomordik F, 2017, EUR J PREV CARDIOL, V24, P123, DOI 10.1177/2047487316680692; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					836	836		10.7326/L17-0522	http://dx.doi.org/10.7326/L17-0522			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204618				2022-12-28	WOS:000417135900026
J	Coles, VJ; Stukel, MR; Brooks, MT; Burd, A; Crump, BC; Moran, MA; Paul, JH; Satinsky, BM; Yager, PL; Zielinski, BL; Hood, RR				Coles, V. J.; Stukel, M. R.; Brooks, M. T.; Burd, A.; Crump, B. C.; Moran, M. A.; Paul, J. H.; Satinsky, B. M.; Yager, P. L.; Zielinski, B. L.; Hood, R. R.			Ocean biogeochemistry modeled with emergent trait-based genomics	SCIENCE			English	Article							AMAZON RIVER PLUME; EXPRESSION PATTERNS; TRANSPORT; BIOGEOGRAPHY; METABOLISM; BACTERIA; GENES; SIZE	Marine ecosystem models have advanced to incorporate metabolic pathways discovered with genomic sequencing, but direct comparisons between models and "omics" data are lacking. We developed a model that directly simulates metagenomes and metatranscriptomes for comparison with observations. Model microbes were randomly assigned genes for specialized functions, and communities of 68 species were simulated in the Atlantic Ocean. Unfit organisms were replaced, and the model self-organized to develop community genomes and transcriptomes. Emergent communities from simulations that were initialized with different cohorts of randomly generated microbes all produced realistic vertical and horizontal ocean nutrient, genome, and transcriptome gradients. Thus, the library of gene functions available to the community, rather than the distribution of functions among specific organisms, drove community assembly and biogeochemical gradients in the model ocean.	[Coles, V. J.; Brooks, M. T.; Hood, R. R.] Univ Maryland, Horn Point Lab, Ctr Environm Sci UMCES, POB 775, Cambridge, MD 21613 USA; [Stukel, M. R.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, 117 North Woodward Ave, Tallahassee, FL 32306 USA; [Burd, A.; Moran, M. A.; Satinsky, B. M.; Yager, P. L.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Crump, B. C.; Zielinski, B. L.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Paul, J. H.] Univ S Florida, 140 Seventh Ave South, St Petersburg, FL 33701 USA	University System of Maryland; University of Maryland Center for Environmental Science; State University System of Florida; Florida State University; University System of Georgia; University of Georgia; Oregon State University; State University System of Florida; University of South Florida	Coles, VJ (corresponding author), Univ Maryland, Horn Point Lab, Ctr Environm Sci UMCES, POB 775, Cambridge, MD 21613 USA.	vcoles@umces.edu	Yager, Patricia L/K-8020-2014; Hood, Raleigh/AGW-0453-2022; Coles, Victoria/AAB-3331-2022; Crump, Byron/ABF-3711-2020	Yager, Patricia L/0000-0002-8462-6427; Stukel, Michael/0000-0002-7696-6739; Moran, Mary Ann/0000-0002-0702-8167; Crump, Byron/0000-0001-7062-1273; Satinsky, Brandon/0000-0002-6794-2663; Coles, Victoria/0000-0002-7247-0007; Hood, Raleigh/0000-0002-7248-3481	Natural Environment Research Council; Gordon and Bey Moore Foadation through the "River Ocean Continuum of the Amazon" [GBMF2293, GBMF2928]; National Science Foundation [OCE 0933975]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Bey Moore Foadation through the "River Ocean Continuum of the Amazon"; National Science Foundation(National Science Foundation (NSF))	Sequences from the June 2010 study are available front the National Center for Biotechnology Information Under accession numbers SRP037334 (rnetagenomes), SRP037995 (nonselective metatranscriptomes), and SRP039544 (polyadenylate-selected metatranscriptomes). The model computer code is available at http://sairceforge.net/projects/roca-model/?source-directory Atlantic Meridional-Transect Consortium nutrient data (NER/0/5/2001/00680) were provided by the British Oceanographic Data Centre and supported by the Natural Environment Research Council. Particle concentration, fields were provided by T. Kostadinov. This research was funded by The Gordon and Bey Moore Foadation through the "River Ocean Continuum of the Amazon" project (ROCA: grants GBMF2293 and GBMF2928). Ship time was provided by the National Science Foundation (grant OCE 0933975). V.C. carried out the modeling effort in collaboration, with R.H., M.S., M.A.M., M.B and A.B. "Omics" were mearelred and analyzed by MAN., IP., B.S. B.Z., and B.C., all of whom contributed to the conceptual model development P.Y. led the ANACONDAS ("Amazon iNfluence on the Atlantic: CarbOn export from Nitrogen fixation by DiAtorn Symbioses") /ROCA teams. This is UMCES contribution 5435.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Coles V.J., 2016, APPROACHES CHALLENGE, P45, DOI DOI 10.1007/978-3-319-30259-1_5; Coles VJ, 2013, J GEOPHYS RES-OCEANS, V118, P6894, DOI 10.1002/2013JC008981; Coles VJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001754; Doherty M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00882; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Goes JI, 2014, PROG OCEANOGR, V120, P29, DOI 10.1016/j.pocean.2013.07.010; Hellweger FL, 2014, SCIENCE, V345, P1346, DOI 10.1126/science.1254421; Hood RR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001753; Kostadinov TS, 2010, BIOGEOSCIENCES, V7, P3239, DOI 10.5194/bg-7-3239-2010; Lenski R E, 1998, Int Microbiol, V1, P265; Loick-Wilde N, 2016, LIMNOL OCEANOGR, V61, P460, DOI 10.1002/lno.10227; Maranon E, 2015, ANNU REV MAR SCI, V7, P241, DOI 10.1146/annurev-marine-010814-015955; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; McDonnell AMP, 2010, LIMNOL OCEANOGR, V55, P2085, DOI 10.4319/lo.2010.55.5.2085; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; PASCIAK WJ, 1974, LIMNOL OCEANOGR, V19, P881, DOI 10.4319/lo.1974.19.6.0881; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Reed DC, 2014, P NATL ACAD SCI USA, V111, P1879, DOI 10.1073/pnas.1313713111; SALE P F, 1978, Environmental Biology of Fishes, V3, P85, DOI 10.1007/BF00006310; Satinsky BM, 2017, ISME J, V11, P1852, DOI 10.1038/ismej.2017.46; Satinsky BM, 2014, P NATL ACAD SCI USA, V111, P11085, DOI 10.1073/pnas.1402782111; Smith JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108173; Stukel M. R., 2013, BIOGEOSCI DISCUSS, V10, P13, DOI [10.5194/bgd-10-13931-2013, DOI 10.5194/BGD-10-13931-2013]; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; van der Does M, 2016, ATMOS CHEM PHYS, V16, P13697, DOI 10.5194/acp-16-13697-2016; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Waite A, 1997, MAR ECOL PROG SER, V157, P97, DOI 10.3354/meps157097; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Weber SC, 2017, LIMNOL OCEANOGR, V62, P618, DOI 10.1002/lno.10448; Yoshikawa C, 2013, J GEOPHYS RES-OCEANS, V118, P2520, DOI 10.1002/jgrc.20165; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P5067; Zielinski BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160929	46	77	77	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1149	1154		10.1126/science.aan5712	http://dx.doi.org/10.1126/science.aan5712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191900				2022-12-28	WOS:000416584000033
J	David, M; Rangaraju, M; Raine, A				David, Michael; Rangaraju, Madhav; Raine, Andrew			CLINICAL UPDATES Acquired triggering of the fingers and thumb in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							A1 PULLEY; INJECTION; RELEASE; PART		[David, Michael] Royal Orthopaed Hosp, Birmingham, W Midlands, England; [Rangaraju, Madhav] Princess Rd Surg, Manchester, Lancs, England; [Raine, Andrew] Royal Wolverhampton Hosp Trust, New Cross Hosp, Wolverhampton, England	Royal Orthopaedic Hospital; New Cross Hospital	David, M (corresponding author), Royal Orthopaed Hosp, Birmingham, W Midlands, England.	michaeldavid@nhs.net	David, Michael/O-8635-2019					Abe Y, 2016, J PLAST RECONSTR AES, V69, P270, DOI 10.1016/j.bjps.2015.10.006; Acar MA, 2015, ANN PLAS SURG, V75, P393, DOI 10.1097/SAP.0000000000000233; Al-Qattan MM, 2007, J HAND SURG-EUR VOL, V32E, P521, DOI 10.1016/j.jhse.2007.03.009; Amirfeyz R, 2017, J HAND SURG-EUR VOL, V42, P473, DOI 10.1177/1753193416682917; ANDERSON B, 1991, ARCH INTERN MED, V151, P153, DOI 10.1001/archinte.151.1.153; BARTELL TH, 1991, PLAST RECONSTR SURG, V87, P354, DOI 10.1097/00006534-199102000-00020; Baumgarten KM, 2007, J BONE JOINT SURG AM, V89A, P2604, DOI 10.2106/JBJS.G.00230; Boretto J, 2008, J HAND SURG-EUR VOL, V33E, P260, DOI 10.1177/1753193408087070; Bruijnzeel H, 2012, J HAND SURG-AM, V37A, P1650, DOI 10.1016/j.jhsa.2012.05.014; Cakir M, 2003, CLIN ENDOCRINOL, V59, P162, DOI 10.1046/j.1365-2265.2003.01786.x; Cakmak F, 2012, ARCH ORTHOP TRAUM SU, V132, P685, DOI 10.1007/s00402-011-1440-0; Callegari L, 2011, DRUGS R&D, V11, P137, DOI 10.2165/11591220-000000000-00000; Castellanos J, 2015, J HAND SURG-AM, V40, P121, DOI 10.1016/j.jhsa.2014.09.006; Catalano LW, 2012, ORTHOPEDICS, V35, pE1754, DOI 10.3928/01477447-20121120-20; Cecen GS, 2015, ARCH ORTHOP TRAUM SU, V135, P125, DOI 10.1007/s00402-014-2110-9; Chang EY, 2015, SKELETAL RADIOL, V44, P1201, DOI 10.1007/s00256-015-2172-y; Chao M, 2009, J HAND SURG-EUR VOL, V34E, P522, DOI 10.1177/1753193409100961; Choudhury MM, 2014, J HAND SURG-ASIAN-PA, V19, P393, DOI 10.1142/S0218810414500336; Cigna E, 2013, EUR REV MED PHARMACO, V17, P845; Colbourn J, 2008, J HAND THER, V21, P336, DOI 10.1197/j.jht.2008.05.001; Cordiner-Lawrie S, 2001, J HAND SURG-BRIT EUR, V26, P380, DOI 10.1054/jhsb.2001.0571; Dardas AZ, 2017, J HAND SURG-AM, V42, P227, DOI 10.1016/j.jhsa.2017.02.001; Davatchi F, 2016, INT J RHEUM DIS, V19, P1056, DOI 10.1111/1756-185X.12809; Dierks Ulf, 2008, Tech Hand Up Extrem Surg, V12, P183, DOI 10.1097/BTH.0b013e31817f289a; Drossos K, 2009, J HAND SURG-AM, V34A, P1429, DOI 10.1016/j.jhsa.2009.05.015; Ehrlich A, 2011, 5 MINUTE CLIN CONSUL, P1348; Everding Nathan G, 2015, Hand (N Y), V10, P297, DOI 10.1007/s11552-014-9716-9; Fitzgerald BT, 2005, J HAND SURG-AM, V30A, P479, DOI 10.1016/j.jhsa.2004.10.011; Gorsche R, 1998, J OCCUP ENVIRON MED, V40, P556, DOI 10.1097/00043764-199806000-00008; Goshtasby PH, 2010, J HAND SURG-ASIAN-PA, V15, P81, DOI 10.1142/S0218810410004606; GRIGGS SM, 1995, J HAND SURG-AM, V20A, P787, DOI 10.1016/S0363-5023(05)80432-0; Guerini H, 2008, J ULTRAS MED, V27, P1407, DOI 10.7863/jum.2008.27.10.1407; Gulabi D, 2014, J HAND SURG-EUR VOL, V39, P699, DOI 10.1177/1753193413517992; Gyuricza C, 2009, J HAND SURG-AM, V34A, P1444, DOI 10.1016/j.jhsa.2009.04.037; Hansen RL, 2017, J HAND SURG-AM, V42, P359, DOI 10.1016/j.jhsa.2017.02.011; Health and Social Care Information Centre, 2015, HOSP EP STAT; HEITHOFF SJ, 1988, J HAND SURG-AM, V13A, P567, DOI 10.1016/S0363-5023(88)80097-2; Huang HK, 2015, J HAND SURG-EUR VOL, V40, P735, DOI 10.1177/1753193415590389; Husain Sohail N, 2011, Am J Orthop (Belle Mead NJ), V40, P620; InGumpert E, 2003, BEASLEYS SURG HAND, P372; Jianmongkol S, 2007, J HAND SURG-ASIAN-PA, V12, P79, DOI 10.1142/S0218810407003535; Jongjirasiri Yolchai, 2009, Journal of the Medical Association of Thailand, V92, P41; Jongjirasiri Yolchai, 2007, Journal of the Medical Association of Thailand, V90, P1348; Kameyama M, 2009, J RHEUMATOL, V36, P1686, DOI 10.3899/jrheum.081024; Kasdan M L, 1996, J Ky Med Assoc, V94, P498; Katzman B M, 1999, Am J Orthop (Belle Mead NJ), V28, P703; Kazuki K, 2006, J HAND SURG-ASIAN-PA, V11, P1, DOI 10.1142/S0218810406003115; Kim SJ, 2016, J HAND SURG-EUR VOL, V41, P204, DOI 10.1177/1753193415615076; Koh S, 2010, J HAND SURG-EUR VOL, V35E, P302, DOI 10.1177/1753193409341103; Kumar P, 2009, J HAND SURG-EUR VOL, V34E, P58, DOI 10.1177/1753193408096015; Lange-Riess D, 2009, ARCH ORTHOP TRAUM SU, V129, P1617, DOI 10.1007/s00402-008-0802-8; Lee SK, 2014, J HAND SURG-EUR VOL, V39, P694, DOI 10.1177/1753193413479506; Lindner-Tons S, 1998, J Hand Ther, V11, P206; Liu WC, 2016, KAOHSIUNG J MED SCI, V32, P624, DOI 10.1016/j.kjms.2016.10.004; Lu SC, 2015, ARCH PHYS MED REHAB, V96, P91, DOI 10.1016/j.apmr.2014.09.001; Lundin AC, 2014, SCAND J MED SCI SPOR, V24, P363, DOI 10.1111/j.1600-0838.2012.01514.x; MACDOUGAL B, 1977, PLAST RECONSTR SURG, V59, P260, DOI 10.1097/00006534-197759020-00015; Rojo-Manaute JM, 2012, J ULTRAS MED, V31, P417, DOI 10.7863/jum.2012.31.3.417; MARCK KW, 1987, NETH J SURG, V39, P151; Mol Marianne F, 2013, Hand (N Y), V8, P183, DOI 10.1007/s11552-013-9493-x; Moriya K, 2009, SCAND J PLAST RECONS, V43, P236, DOI 10.1080/02844310701510264; Nanno M, 2014, J NIPPON MED SCH, V81, P269, DOI 10.1272/jnms.81.269; NEWPORT ML, 1990, J HAND SURG-AM, V15A, P748, DOI 10.1016/0363-5023(90)90149-L; Nimigan AS, 2006, AM J PHYS MED REHAB, V85, P36, DOI 10.1097/01.phm.0000184236.81774.b5; Notta A, 1850, ARCH GEN MED, V359, P142; Oh J, 2015, AM J PHYS MED REHAB, V94, pE26, DOI 10.1097/PHM.0000000000000267; Panwar J, 2015, J ULTRASOUND, V18, P79, DOI 10.1007/s40477-014-0140-3; Park J, 2009, J HAND SURG-AM, V34A, P313, DOI 10.1016/j.jhsa.2008.10.006; PATEL MR, 1992, J HAND SURG-AM, V17A, P110, DOI 10.1016/0363-5023(92)90124-8; Peters-Veluthamaningal C, 2008, ANN RHEUM DIS, V67, P1262, DOI 10.1136/ard.2007.073106; Peters-Veluthamaningal C, 2009, COCHRANE DB SYST REV, V359; POPE DF, 1995, J HAND SURG-AM, V20A, P280, DOI 10.1016/S0363-5023(05)80026-7; POSNER MA, 1986, J HAND SURG-AM, V11A, P249, DOI 10.1016/S0363-5023(86)80063-6; Ring D, 2008, J HAND SURG-AM, V33A, P516, DOI 10.1016/j.jhsa.2008.01.001; Rozental TD, 2008, J BONE JOINT SURG AM, V90A, P1665, DOI 10.2106/JBJS.G.00693; Ryzewicz M, 2006, J HAND SURG-AM, V31A, P135, DOI 10.1016/j.jhsa.2005.10.013; Saengnipanthkul S, 2014, J ORTHOP SURG-HONG K, V22, P232, DOI 10.1177/230949901402200225; Salim N, 2012, J HAND SURG-EUR VOL, V37E, P27, DOI 10.1177/1753193411415343; Saremi H, 2016, ARCH BONE JT SURG-AB, V4, P224; Sbernardori MC, 2007, J HAND SURG-EUR VOL, V32E, P556, DOI 10.1016/j.jhse.2007.06.002; Schubert Cornelius, 2013, Hand (N Y), V8, P439, DOI 10.1007/s11552-013-9541-6; Schwaiger Karl, 2017, J Hand Surg Am, V42, pe51, DOI 10.1016/j.jhsa.2016.10.003; Seki Y, 2014, J HAND SURG-ASIAN-PA, V19, P437, DOI 10.1142/S0218810414720320; Sheikh Emran, 2014, Hand (N Y), V9, P340, DOI 10.1007/s11552-014-9603-4; Shinomiya R, 2016, ULTRASOUND MED BIOL, V42, P2203, DOI 10.1016/j.ultrasmedbio.2016.05.015; Spirig A, 2016, ULTRASOUND MED BIOL, V42, P1482, DOI 10.1016/j.ultrasmedbio.2016.02.017; Tagliafico A, 2009, J ULTRAS MED, V28, P1441, DOI 10.7863/jum.2009.28.11.1441; Tanaka Y, 2015, J ORTHOP SCI, V20, P999, DOI 10.1007/s00776-015-0752-2; Tarbhai K, 2012, J HAND SURG-AM, V37A, P243, DOI 10.1016/j.jhsa.2011.10.038; Trezies AJH, 1998, J HAND SURG-BRIT EUR, V23B, P539, DOI 10.1016/S0266-7681(98)80142-3; Valdes K, 2012, J HAND THER, V25, P89, DOI 10.1016/j.jht.2011.09.005; Vance MC, 2012, J HAND SURG-AM, V37A, P1765, DOI 10.1016/j.jhsa.2012.06.007; Wang AA, 2006, J HAND SURG-AM, V31A, P979, DOI 10.1016/j.jhsa.2006.03.022; Wang J, 2013, CLIN ORTHOP RELAT R, V471, P1879, DOI 10.1007/s11999-012-2716-6; Wojahn RD, 2014, J BONE JOINT SURG AM, V96A, P1849, DOI 10.2106/JBJS.N.00004; Wolfe SW, 2016, GREENS OPERATIVE HAN, P1904; YOSIPOVITCH G, 1990, J RHEUMATOL, V17, P951	97	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2017	359								j5285	10.1136/bmj.j5285	http://dx.doi.org/10.1136/bmj.j5285			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MT	29191846				2022-12-28	WOS:000417212300009
J	Wadman, M				Wadman, Meredith			SEXUAL HARASSMENT Boston University geologist fights for his job	SCIENCE			English	News Item																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1114	1114		10.1126/science.358.6367.1114	http://dx.doi.org/10.1126/science.358.6367.1114			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191882				2022-12-28	WOS:000416584000010
J	Cheng, YF; Glaeser, RM; Nogales, E				Cheng, Yifan; Glaeser, Robert M.; Nogales, Eva			How Cryo-EM Became so Hot	CELL			English	Editorial Material							ELECTRON-MICROGRAPHS; RESOLUTION	The Royal Swedish Academy of Sciences awarded the 2017 Nobel Prize for Chemistry to Jacques Dubochet, Joachim Frank, and Richard Henderson for "developing cryoelectron microscopy for the high-resolution structure determination of biomolecules in solution.'' Achieving this goal, which required innovation, persistence, and uncommon physical insight, has broadened horizons for structural studies in molecular and cell biology.	[Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Glaeser, Robert M.; Nogales, Eva] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Glaeser, RM (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	rmglaeser@lbl.gov		Cheng, Yifan/0000-0001-9535-0369	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063072] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM063072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Dashti A, 2014, P NATL ACAD SCI USA, V111, P17492, DOI 10.1073/pnas.1419276111; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Faruqi AR, 2005, NUCL INSTRUM METH A, V546, P170, DOI 10.1016/j.nima.2005.03.023; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; FRANK J, 1975, ULTRAMICROSCOPY, V1, P159, DOI 10.1016/S0304-3991(75)80020-9; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; SAXTON WO, 1977, ULTRAMICROSCOPY, V2, P219; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036	17	42	42	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1229	1231		10.1016/j.cell.2017.11.016	http://dx.doi.org/10.1016/j.cell.2017.11.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195065	Green Accepted, Bronze			2022-12-28	WOS:000417362700002
J	Le Mouel, JP; Fumery, M				Le Mouel, Jean-Philippe; Fumery, Mathurin			Zenker's Diverticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Le Mouel, Jean-Philippe; Fumery, Mathurin] Amiens Univ Hosp, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Le Mouel, JP (corresponding author), Amiens Univ Hosp, Amiens, France.	jeanphilippe.lemouel@wanadoo.fr							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					E31	E31		10.1056/NEJMicm1701620	http://dx.doi.org/10.1056/NEJMicm1701620			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO1VI	29171816				2022-12-28	WOS:000416555000001
J	Rosbash, M				Rosbash, Michael			Life Is an N of 1	CELL			English	Editorial Material																			0	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1241	1245		10.1016/j.cell.2017.11.027	http://dx.doi.org/10.1016/j.cell.2017.11.027			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195068	Bronze			2022-12-28	WOS:000417362700005
J	Subramanian, A; Narayan, R; Corsello, SM; Peck, DD; Natoli, TE; Lu, XD; Gould, J; Davis, JF; Tubelli, AA; Asiedu, JK; Lahr, DL; Hirschman, JE; Liu, ZH; Donahue, M; Julian, B; Khan, M; Wadden, D; Smith, IC; Lam, D; Liberzon, A; Toder, C; Bagul, M; Orzechowski, M; Enache, OM; Piccioni, F; Johnson, SA; Lyons, NJ; Berger, AH; Shamji, AF; Brooks, AN; Vrcic, A; Flynn, C; Rosains, J; Takeda, DY; Hu, R; Davison, D; Lamb, J; Ardlie, K; Hogstrom, L; Greenside, P; Gray, NS; Clemons, PA; Silver, S; Wu, XY; Zhao, WN; Read-Button, W; Wu, XH; Haggarty, SJ; Ronco, LV; Boehm, JS; Schreiber, SL; Doench, JG; Bittker, JA; Root, DE; Wong, B; Golub, TR				Subramanian, Aravind; Narayan, Rajiv; Corsello, Steven M.; Peck, David D.; Natoli, Ted E.; Lu, Xiaodong; Gould, Joshua; Davis, John F.; Tubelli, Andrew A.; Asiedu, Jacob K.; Lahr, David L.; Hirschman, Jodi E.; Liu, Zihan; Donahue, Melanie; Julian, Bina; Khan, Mariya; Wadden, David; Smith, Ian C.; Lam, Daniel; Liberzon, Arthur; Toder, Courtney; Bagul, Mukta; Orzechowski, Marek; Enache, Oana M.; Piccioni, Federica; Johnson, Sarah A.; Lyons, Nicholas J.; Berger, Alice H.; Shamji, Alykhan F.; Brooks, Angela N.; Vrcic, Anita; Flynn, Corey; Rosains, Jacqueline; Takeda, David Y.; Hu, Roger; Davison, Desiree; Lamb, Justin; Ardlie, Kristin; Hogstrom, Larson; Greenside, Peyton; Gray, Nathanael S.; Clemons, Paul A.; Silver, Serena; Wu, Xiaoyun; Zhao, Wen-Ning; Read-Button, Willis; Wu, Xiaohua; Haggarty, Stephen J.; Ronco, Lucienne V.; Boehm, Jesse S.; Schreiber, Stuart L.; Doench, John G.; Bittker, Joshua A.; Root, David E.; Wong, Bang; Golub, Todd R.			A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles	CELL			English	Article							GENE-EXPRESSION; ACQUIRED-RESISTANCE; LUNG-CANCER; DEL(5Q) MDS; INHIBITION; DISCOVERY; PATHWAY; UBIQUITINATION; DEGRADATION; PHA-793887	We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.	[Subramanian, Aravind; Narayan, Rajiv; Corsello, Steven M.; Peck, David D.; Natoli, Ted E.; Lu, Xiaodong; Gould, Joshua; Davis, John F.; Tubelli, Andrew A.; Asiedu, Jacob K.; Lahr, David L.; Hirschman, Jodi E.; Liu, Zihan; Donahue, Melanie; Julian, Bina; Khan, Mariya; Wadden, David; Smith, Ian C.; Lam, Daniel; Liberzon, Arthur; Toder, Courtney; Bagul, Mukta; Orzechowski, Marek; Enache, Oana M.; Piccioni, Federica; Johnson, Sarah A.; Lyons, Nicholas J.; Berger, Alice H.; Shamji, Alykhan F.; Brooks, Angela N.; Vrcic, Anita; Flynn, Corey; Rosains, Jacqueline; Takeda, David Y.; Hu, Roger; Davison, Desiree; Lamb, Justin; Ardlie, Kristin; Hogstrom, Larson; Greenside, Peyton; Gray, Nathanael S.; Clemons, Paul A.; Silver, Serena; Wu, Xiaoyun; Zhao, Wen-Ning; Read-Button, Willis; Wu, Xiaohua; Haggarty, Stephen J.; Ronco, Lucienne V.; Boehm, Jesse S.; Schreiber, Stuart L.; Doench, John G.; Bittker, Joshua A.; Root, David E.; Wong, Bang; Golub, Todd R.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Corsello, Steven M.; Berger, Alice H.; Brooks, Angela N.; Takeda, David Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Corsello, Steven M.; Berger, Alice H.; Brooks, Angela N.; Takeda, David Y.; Gray, Nathanael S.; Zhao, Wen-Ning; Haggarty, Stephen J.; Golub, Todd R.] Harvard Med Sch, Boston, MA 02115 USA; [Gray, Nathanael S.; Golub, Todd R.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Zhao, Wen-Ning; Haggarty, Stephen J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Berger, Alice H.] Univ Washington, Seattle, WA 98195 USA; [Brooks, Angela N.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Rosains, Jacqueline] Seven Bridges Genom, Cambridge, MA 02142 USA; [Lamb, Justin; Read-Button, Willis] Genometry, Cambridge, MA 02139 USA; [Ronco, Lucienne V.] Fulcrum Therapeut, Cambridge, MA 02139 USA; [Greenside, Peyton] Stanford Univ, Palo Alto, CA 94305 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Stanford University	Golub, TR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Golub, TR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Golub, TR (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.	golub@broadinstitute.org	高, 雨莉/HGU-8187-2022; Doench, John G/HCI-9570-2022; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Doench, John/0000-0002-3707-9889; PICCIONI, FEDERICA/0000-0003-1210-3210; Gray, Nathanael/0000-0001-5354-7403; Takeda, David/0000-0002-5986-1169; Corsello, Steven/0000-0002-9929-3709; Enache, Oana/0000-0002-9541-0058	Luminex Corporation; NIH [U54HG006093, U54HL127366, U01HG008699, CA009172, TR001100]; Conquer Cancer Foundation of ASCO Young Investigator Award; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127366] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006093, U01HG008699] Funding Source: NIH RePORTER	Luminex Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conquer Cancer Foundation of ASCO Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Broad Compound Management and the Broad Genetic Perturbation Platform, Harvard Medical School LINCS Center, and LINCS collaborators. P. Tamayo, J. Bradner, and G. Shapiro provided helpful feedback. We thank Luminex Corporation for support with the FlexMap 3D system and Qiagen for assistance with TurboCapture kits. Supported in part by NIH grants U54HG006093 (T.R.G. and A.S.), U54HL127366 (T.R.G. and A. S.) U01HG008699 (T.R.G. and A. S.), CA009172 (S.M.C.), TR001100 (S.M.C.) and the Conquer Cancer Foundation of ASCO Young Investigator Award (S.M.C.). J.L. and W.R.-B are shareholders and employees of Genometry. A. S., R.N., D.D.P., and X.L. are shareholders of Genometry.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Brum AM, 2015, P NATL ACAD SCI USA, V112, P12711, DOI 10.1073/pnas.1501597112; Carlino MS, 2013, MOL CANCER THER, V12, P1332, DOI 10.1158/1535-7163.MCT-13-0011; Churchman ML, 2015, CANCER CELL, V28, P343, DOI 10.1016/j.ccell.2015.07.016; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Dinwiddie MT, 2014, INT J ENV RES PUB HE, V11, P2209, DOI 10.3390/ijerph110202209; Donner Y, 2012, NAT METHODS, V9, P1120, DOI [10.1038/NMETH.2207, 10.1038/nmeth.2207]; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Fortney K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004068; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Illumina Inc, 2007, ILL TECHN B PUB; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jaras M, 2014, J EXP MED, V211, P605, DOI 10.1084/jem.20131033; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lantermann AB, 2015, CANCER RES, V75, P4937, DOI 10.1158/0008-5472.CAN-15-1113; Litichevskiy L., 2017, BIORXIV; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; Locatelli G, 2010, MOL CANCER THER, V9, P1265, DOI 10.1158/1535-7163.MCT-09-1163; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Massard C, 2011, CELL CYCLE, V10, P963, DOI 10.4161/cc.10.6.15075; Muthuswami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077553; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Rohban MH, 2017, ELIFE, V6, DOI 10.7554/eLife.24060; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rovedo MA, 2011, J INVEST DERMATOL, V131, P1442, DOI 10.1038/jid.2011.70; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Schnell SA, 2015, BLOOD, V125, P2806, DOI 10.1182/blood-2014-10-608448; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Singh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150836; Smith I., 2017, BIORXIV; Stockwell SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028568; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tseng GC, 2005, BIOMETRICS, V61, P10, DOI 10.1111/j.0006-341X.2005.031032.x; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wang G., 2011, PLOS ONE, V6; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Yueh MF, 2014, P NATL ACAD SCI USA, V111, P17200, DOI 10.1073/pnas.1419119111; Zhang MY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168935	54	1179	1194	16	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1437	+		10.1016/j.cell.2017.10.049	http://dx.doi.org/10.1016/j.cell.2017.10.049			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195078	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000417362700023
J	Bereciartua, PJ; Cantin, A; Corma, A; Jorda, JL; Palomino, M; Rey, F; Valencia, S; Corcoran, EW; Kortunov, P; Ravikovitch, PI; Burton, A; Yoon, C; Wang, Y; Paur, C; Guzman, J; Bishop, AR; Casty, GL				Bereciartua, Pablo J.; Cantin, Angel; Corma, Avelino; Jorda, Jose L.; Palomino, Miguel; Rey, Fernando; Valencia, Susana; Corcoran, Edward W., Jr.; Kortunov, Pavel; Ravikovitch, Peter I.; Burton, Allen; Yoon, Chris; Wang, Yu; Paur, Charanjit; Guzman, Javier; Bishop, Adeana R.; Casty, Gary L.			Control of zeolite framework flexibility and pore topology for separation of ethane and ethylene	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; ADSORPTIVE SEPARATION; ELECTRON-DIFFRACTION; MOLECULAR-SIEVE; OLEFIN/PARAFFIN SEPARATIONS; DIFFUSION; HYDROCARBONS; MEMBRANES; OLEFINS; TEMPERATURE	The discovery of new materials for separating ethylene from ethane by adsorption, instead of using cryogenic distillation, is a key milestone for molecular separations because of the multiple and widely extended uses of these molecules in industry. This technique has the potential to provide tremendous energy savings when compared with the currently used cryogenic distillation process for ethylene produced through steam cracking. Here we describe the synthesis and structural determination of a flexible pure silica zeolite (ITQ-55). This material can kinetically separate ethylene from ethane with an unprecedented selectivity of similar to 100, owing to its distinctive pore topology with large heart-shaped cages and framework flexibility. Control of such properties extends the boundaries for applicability of zeolites to challenging separations.	[Bereciartua, Pablo J.; Cantin, Angel; Corma, Avelino; Jorda, Jose L.; Palomino, Miguel; Rey, Fernando; Valencia, Susana] Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave Naranjos S-N, E-46022 Valencia, Spain; [Corcoran, Edward W., Jr.; Kortunov, Pavel; Ravikovitch, Peter I.; Burton, Allen; Yoon, Chris; Wang, Yu; Paur, Charanjit; Bishop, Adeana R.; Casty, Gary L.] ExxonMobil Res & Engn Co, 1545 Route 22 East, Annandale, NJ 08801 USA; [Guzman, Javier] ExxonMobil Chem Co, 4500 Bayway Dr, Baytown, TX 77520 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Exxon Mobil Corporation; Exxon Mobil Corporation	Cantin, A; Rey, F (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave Naranjos S-N, E-46022 Valencia, Spain.; Corcoran, EW; Ravikovitch, PI (corresponding author), ExxonMobil Res & Engn Co, 1545 Route 22 East, Annandale, NJ 08801 USA.	acorma@itq.upv.es; frey@itq.upv.es; edward.w.corcoran@exxonmobil.com; peter.ravikovitch@exxonmobil.com	CANOS, AVELINO CORMA/A-3040-2013; Palomino, Miguel/F-9610-2016; Rey, Fernando/C-6778-2011; Jorda, Jose L./D-1334-2009; Valencia, Susana/I-4644-2015; Cantin, Angel/I-4282-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; Palomino, Miguel/0000-0003-2983-1038; Rey, Fernando/0000-0003-3227-5669; Jorda, Jose L./0000-0002-0304-5680; Valencia, Susana/0000-0001-7160-2795; Cantin, Angel/0000-0002-3219-1919; Bereciartua, Pablo J./0000-0002-0136-3191	ExxonMobil Research and Engineering Company; European Research Council [ERC-2014-AdG-671093]; Spanish government [MAT2015-71842-P, SEV-2012-0267, SEV-2016-0683]	ExxonMobil Research and Engineering Company(Exxon Mobil Corporation); European Research Council(European Research Council (ERC)European Commission); Spanish government(Spanish GovernmentEuropean Commission)	We gratefully acknowledge financial support from ExxonMobil Research and Engineering Company, Instituto de Tecnologia Quimica researchers also thank the European Research Council (grant ERC-2014-AdG-671093 "MATching zeolite SYNthiesis with CATalytic activity") and the Spanish government (grants MAT2015-71842-P MINECO/FEDER and Severe Ochea SEV-2012-0267 and SEV-2016-0683) for economic support. Synchrotron powder x-ray diffraction experiments were performed at MSPD beamline at ALBA Synchrotron with the collaboration of ALBA staff. We also thank R. Blanco Gutierrez, H. Deckman, L. Koziol, D. Leta, and K. Stronmaier for useful discussions. Finally; we specially thank the Electron Microscopy Service of the Universitat Politecnica de Valencia and, in particular, M. J. Planes and J. L. Mora for their invaluable support with EDT data acquisition. All data are reported in the main text and supplementary materials. Relevant patents: ES2554648 (B1) (2015), US2016009618 (A1) (2016), US2016008756 (Al) (2016), US2016008753 (A1) (2016), and U02016009563 (A1) (2016).	Aguado S, 2012, J AM CHEM SOC, V134, P14635, DOI 10.1021/ja305663k; Anson A, 2008, CHEM ENG SCI, V63, P4171, DOI 10.1016/j.ces.2008.05.038; Awati RV, 2013, J PHYS CHEM C, V117, P13462, DOI 10.1021/jp402959t; Bachman JE, 2016, NAT MATER, V15, P845, DOI [10.1038/NMAT4621, 10.1038/nmat4621]; Barrett PA, 2003, CHEM COMMUN, P2114, DOI 10.1039/b306440a; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Bohme U, 2013, LANGMUIR, V29, P8592, DOI 10.1021/la401471g; Boulfelfel SE, 2015, J PHYS CHEM C, V119, P15643, DOI 10.1021/acs.jpcc.5b01633; Canos A. Corma, 2015, Patent, Patent No. [ES2554648 (B1), 2554648]; CEN PL, 1990, AICHE J, V36, P789, DOI 10.1002/aic.690360518; Choudary NV, 2002, IND ENG CHEM RES, V41, P2728, DOI 10.1021/ie010546+; Corma A, 2017, CATAL SCI TECHNOL, V7, P12, DOI 10.1039/c6cy01886f; Corma A, 2004, NATURE, V431, P287, DOI 10.1038/nature02909; Gemmi M, 2015, J APPL CRYSTALLOGR, V48, P718, DOI 10.1107/S1600576715004604; Gucuyener C, 2010, J AM CHEM SOC, V132, P17704, DOI 10.1021/ja1089765; Haldoupis E, 2012, CHEMPHYSCHEM, V13, P3449, DOI 10.1002/cphc.201200529; Hartmann M, 2015, LANGMUIR, V31, P12382, DOI 10.1021/acs.langmuir.5b02907; Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5; Jiang JX, 2011, SCIENCE, V333, P1131, DOI 10.1126/science.1208652; Gutierrez-Sevillano JJ, 2016, CHEM-EUR J, V22, P10036, DOI 10.1002/chem.201600983; Karger J., 2012, DIFFUSION NANOPOROUS; Keller G. E., 2005, MAT SEPRATION TECHNO, P87; Keller GE., 1992, SEPARATION PURIFICAT, P59; Kniel L., 1980, ETHYLENE KEYSTONE PE, P14; Koottungal L., 2015, OIL GAS J, P85; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Maghsoudi H, 2016, ADSORPTION, V22, P985, DOI 10.1007/s10450-016-9805-x; Martins VFD, 2016, AICHE J, V62, P2490, DOI 10.1002/aic.15238; Martins VFD, 2015, SEP PURIF TECHNOL, V149, P445, DOI 10.1016/j.seppur.2015.06.012; Mei H, 2002, NEW CARBON MATER, V17, P33; Mofarahi M, 2013, ADSORPTION, V19, P101, DOI 10.1007/s10450-012-9423-1; Mugnaioli E, 2015, Z KRIST-CRYST MATER, V230, P271, DOI 10.1515/zkri-2014-1805; Narin G, 2014, SEP PURIF TECHNOL, V133, P452, DOI 10.1016/j.seppur.2014.06.060; National Research Council, 1998, NMAB4873 NAT RES COU, V487-3; Olson DH, 2004, J PHYS CHEM B, V108, P11044, DOI 10.1021/jp040216d; Palomino M, 2007, CHEM COMMUN, P1233, DOI 10.1039/b700358g; Rege SU, 1998, AICHE J, V44, P799, DOI 10.1002/aic.690440405; Rungta M, 2012, CARBON, V50, P1488, DOI 10.1016/j.carbon.2011.11.019; Ruthven DM, 2007, MICROPOR MESOPOR MAT, V104, P59, DOI 10.1016/j.micromeso.2007.01.005; Sadrameli SM, 2015, FUEL, V140, P102, DOI 10.1016/j.fuel.2014.09.034; Safarik DJ, 1998, IND ENG CHEM RES, V37, P2571, DOI 10.1021/ie970897h; Shi M, 2011, CHEM ENG SCI, V66, P2817, DOI 10.1016/j.ces.2011.03.046; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; Simancas J, 2016, J AM CHEM SOC, V138, P10116, DOI 10.1021/jacs.6b06394; Thommes M, 2015, PURE APPL CHEM, V87, P1051, DOI 10.1515/pac-2014-1117; van Miltenburg A, 2006, CHEM ENG RES DES, V84, P350, DOI 10.1205/cherd05021; Verploegh RJ, 2015, J AM CHEM SOC, V137, P15760, DOI 10.1021/jacs.5b08746; Vidal-Moya JA, 2003, CHEM MATER, V15, P3961, DOI 10.1021/cm034515b; Vidoni A, 2012, IND ENG CHEM RES, V51, P1383, DOI 10.1021/ie202449q; Wang QM, 2002, MICROPOR MESOPOR MAT, V55, P217; Wittcoff H. A., 2005, IND ORGANIC CHEM, P100; YANG RT, 1995, AICHE J, V41, P509, DOI 10.1002/aic.690410309; Yun YF, 2015, IUCRJ, V2, P267, DOI 10.1107/S2052252514028188; Zhang C, 2012, J PHYS CHEM LETT, V3, P2130, DOI 10.1021/jz300855a; Zheng YH, 2015, J MEMBRANE SCI, V475, P303, DOI 10.1016/j.memsci.2014.10.048; Zhu W, 2000, LANGMUIR, V16, P3322, DOI 10.1021/la9914007	56	211	217	59	539	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1068	1071		10.1126/science.aao0092	http://dx.doi.org/10.1126/science.aao0092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170235				2022-12-28	WOS:000416590400043
J	Wahlund, JE; Morooka, MW; Hadid, LZ; Persoon, AM; Farrell, WM; Gurnett, DA; Hospodarsky, G; Kurth, WS; Ye, SY; Andrews, DJ; Edberg, NJT; Eriksson, AI; Vigren, E				Wahlund, J. -E.; Morooka, M. W.; Hadid, L. Z.; Persoon, A. M.; Farrell, W. M.; Gurnett, D. A.; Hospodarsky, G.; Kurth, W. S.; Ye, S. -Y.; Andrews, D. J.; Edberg, N. J. T.; Eriksson, A. I.; Vigren, E.			In situ measurements of Saturn's ionosphere show that it is dynamic and interacts with the rings	SCIENCE			English	Article							ATMOSPHERE	The ionized upper layer of Saturn's atmosphere, its ionosphere, provides a closure of currents mediated by the magnetic field to other electrically charged regions (for example, rings) and hosts ion-molecule chemistry. In 2017, the Cassini spacecraft passed inside the planet's rings, allowing in situ measurements of the ionosphere. The Radio and Plasma Wave Science instrument detected a cold, dense, and dynamic ionosphere at Saturn that interacts with the rings. Plasma densities reached up to 1000 cubic centimeters, and electron temperatures were below 1160 kelvin near closest approach. The density varied between orbits by up to two orders of magnitude. Saturn's A- and B-rings cast a shadow on the planet that reduced ionization in the upper atmosphere, causing a north-south asymmetry.	[Wahlund, J. -E.; Morooka, M. W.; Hadid, L. Z.; Andrews, D. J.; Edberg, N. J. T.; Eriksson, A. I.; Vigren, E.] Swedish Inst Space Phys, Box 537, SE-75121 Uppsala, Sweden; [Persoon, A. M.; Gurnett, D. A.; Hospodarsky, G.; Kurth, W. S.; Ye, S. -Y.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Farrell, W. M.] NASA Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA	University of Iowa; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Wahlund, JE (corresponding author), Swedish Inst Space Phys, Box 537, SE-75121 Uppsala, Sweden.	jan-erik.wahlund@irfu.se	Kurth, William/AAA-7334-2019; Farrell, William/I-4865-2013; Morooka, Michiko/AAO-8594-2020; Hospodarsky, George B/A-7996-2015; Ye, Sheng-Yi/C-4962-2015; Wahlund, Jan-Erik/AAL-6439-2021; Eriksson, Anders I/C-2887-2009	Kurth, William/0000-0002-5471-6202; Morooka, Michiko/0000-0001-9958-0241; Hospodarsky, George B/0000-0001-9200-9878; Ye, Sheng-Yi/0000-0002-3064-1082; Eriksson, Anders I/0000-0003-2926-6761; Gurnett, Don/0000-0003-2403-0282; HADID, Lina/0000-0002-8587-0202; Andrews, David/0000-0002-7933-0322	Swedish National Space Board; NASA [1415150]; Jet Propulsion Laboratory	Swedish National Space Board; NASA(National Aeronautics & Space Administration (NASA)); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA))	The Swedish National Space Board supports the RPWS/Langmuir probe instrument on board Cassini. W.M.F. gratefully acknowledges the Cassini project for internal NASA support. D.A.G., G.H., W.S.K., A.M.P., and S.-Y.Y. were supported by NASA through contract 1415150 with the Jet Propulsion Laboratory. All Cassini RPWS data are archived in the Planetary Data System Planetary Plasma Interaction node at https://pds-ppi.igpp.ucla.edu/search/?t=Saturn&i=RPWS on a prearranged schedule.	Farrell WM, 2017, ICARUS, V292, P48, DOI 10.1016/j.icarus.2017.03.022; Fischer G, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016187; Galand M, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016412; Hedman MM, 2016, ICARUS, V279, P155, DOI 10.1016/j.icarus.2015.09.017; KAISER ML, 1984, J GEOPHYS RES-SPACE, V89, P2371, DOI 10.1029/JA089iA04p02371; Kliore AJ, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013900; KLIORE AJ, 1980, J GEOPHYS RES-SPACE, V85, P5857, DOI 10.1029/JA085iA11p05857; LINDAL GF, 1985, ASTRON J, V90, P1136, DOI 10.1086/113820; Liu HX, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012616; Mendillo M., 2004, GEOPHYS RES LETT, V32; Moore L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027375; Moore L, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013373; Morooka MW, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA017038; Moses JI, 2000, J GEOPHYS RES-PLANET, V105, P7013, DOI 10.1029/1999JE001172; Nagy AF, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011519; NORTHROP TG, 1982, J GEOPHYS RES-SPACE, V87, P6045, DOI 10.1029/JA087iA08p06045; O'Donoghue J, 2013, NATURE, V496, P193, DOI 10.1038/nature12049; Shebanits O, 2013, PLANET SPACE SCI, V84, P153, DOI 10.1016/j.pss.2013.05.021; WAHLUND JE, 1992, J GEOPHYS RES-SPACE, V97, P3019, DOI 10.1029/91JA02438; Xin L., 2006, J GEOPHYS RES, V111	20	32	32	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					66	68		10.1126/science.aao4134	http://dx.doi.org/10.1126/science.aao4134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29229651				2022-12-28	WOS:000419324700067
J	Martin-Duran, JM; Pang, K; Borve, A; Le, HS; Furu, A; Cannon, JT; Jondelius, U; Hejnol, A				Martin-Duran, Jose M.; Pang, Kevin; Borve, Aina; Le, Henrike Semmler; Furu, Anlaug; Cannon, Johanna Taylor; Jondelius, Ulf; Hejnol, Andreas			Convergent evolution of bilaterian nerve cords	NATURE			English	Article							ISODIAMETRA-PULCHRA; REGIONAL SPECIFICATION; SYSTEM CENTRALIZATION; GENE-EXPRESSION; EMBRYOGENESIS; REGENERATION; SUPPORTS; ORIGINS; XENACOELOMORPHA; PHYLOGENIES	It has been hypothesized that a condensed nervous system with a medial ventral nerve cord is an ancestral character of Bilateria. The presence of similar dorsoventral molecular patterns along the nerve cords of vertebrates, flies, and an annelid has been interpreted as support for this scenario. Whether these similarities are generally found across the diversity of bilaterian neuroanatomies is unclear, and thus the evolutionary history of the nervous system is still contentious. Here we study representatives of Xenacoelomorpha, Rotifera, Nemertea, Brachiopoda, and Annelida to assess the conservation of the dorsoventral nerve cord patterning. None of the studied species show a conserved dorsoventral molecular regionalization of their nerve cords, not even the annelid Owenia fusiformis, whose trunk neuroanatomy parallels that of vertebrates and flies. Our findings restrict the use of molecular patterns to explain nervous system evolution, and suggest that the similarities in dorsoventral patterning and trunk neuroanatomies evolved independently in Bilateria.	[Martin-Duran, Jose M.; Pang, Kevin; Borve, Aina; Le, Henrike Semmler; Furu, Anlaug; Hejnol, Andreas] Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5006 Bergen, Norway; [Le, Henrike Semmler] Nat Hist Museum Denmark, Biosystemat Sect, Univ Pk 15, DK-2100 Copenhagen, Denmark; [Cannon, Johanna Taylor; Jondelius, Ulf] Nat Hist Riksmuseet, POB 50007, SE-10405 Stockholm, Sweden	University of Bergen	Hejnol, A (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Thormohlensgate 55, N-5006 Bergen, Norway.	andreas.hejnol@uib.no	Cannon, Johanna/V-3842-2019; Martin-Duran, Jose Maria/L-3505-2017; Jondelius, Ulf/AAF-7943-2020; Hejnol, Andreas/C-5577-2012	Cannon, Johanna/0000-0002-3920-7741; Martin-Duran, Jose Maria/0000-0002-2572-1061; Jondelius, Ulf/0000-0003-2847-2192; Hejnol, Andreas/0000-0003-2196-8507	Sars Core Budget; FP7-PEOPLE-RG; European Research Council Community's Framework Program Horizon; National Science Foundation International Research Fellowship Program Postdoctoral Fellowship; Carlsberg Foundation; Swedish Research Council	Sars Core Budget; FP7-PEOPLE-RG; European Research Council Community's Framework Program Horizon; National Science Foundation International Research Fellowship Program Postdoctoral Fellowship; Carlsberg Foundation(Carlsberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank the staff at the marine stations, current and former members of the Hejnol laboratory, and C. Dunn. The Sars Core Budget, the FP7-PEOPLE-2009-RG, and the European Research Council Community's Framework Program Horizon 2020 to A.H. funded this work. A National Science Foundation International Research Fellowship Program Postdoctoral Fellowship funded K.P. The Carlsberg Foundation funded H.S.L. The Swedish Research Council funded U.J. and J.T.C.	Achatz JG, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-27; Albuixech-Crespo B, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001573; Arendt D, 1999, DEVELOPMENT, V126, P2309; Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242; Arendt D, 2016, NAT REV NEUROSCI, V17, P61, DOI 10.1038/nrn.2015.15; Borve A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-50; Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5; De Mulder K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-69; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; FREEMAN G, 1993, DEV BIOL, V160, P196, DOI 10.1006/dbio.1993.1298; Freeman G, 2000, DEV BIOL, V227, P219, DOI 10.1006/dbio.2000.9857; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Hejnol A, 2016, CURR OPIN GENET DEV, V39, P48, DOI 10.1016/j.gde.2016.05.019; Hejnol A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0045; Hejnol A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-65; Helm C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0690-4; Holland LZ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-27; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaul-Strehlow S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07052-8; Layden MJ, 2016, WIRES DEV BIOL, V5, P408, DOI 10.1002/wdev.222; Li YB, 2017, P NATL ACAD SCI USA, V114, pE6352, DOI 10.1073/pnas.1704194114; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Martin-Duran JM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0005; Martin-Duran JM, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0023-5; Mashanov V.S., 2015, STRUCTURE EVOLUTION, P655, DOI [10.1093/acprof:oso/9780199682201.003.0051, DOI 10.1093/ACPROF:OSO/9780199682201.003.0051]; Mizutani CM, 2008, NAT REV GENET, V9, P663, DOI 10.1038/nrg2417; Moreno E, 2010, EVOL DEV, V12, P258, DOI 10.1111/j.1525-142X.2010.00411.x; Okkema PG, 1997, DEVELOPMENT, V124, P3965; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Raikova OI, 2000, ZOOMORPHOLOGY, V120, P107, DOI 10.1007/s004350000028; Raikova OI, 2016, ORG DIVERS EVOL, V16, P85, DOI 10.1007/s13127-015-0248-0; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Scimone ML, 2014, STEM CELL REP, V3, P339, DOI 10.1016/j.stemcr.2014.06.001; Smart TI, 2009, BIOL BULL-US, V217, P253, DOI 10.1086/BBLv217n3p253; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stolfi A, 2015, NATURE, V527, P371, DOI 10.1038/nature15758; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Vellutini BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32387; Vergara HM, 2017, P NATL ACAD SCI USA, V114, P5878, DOI 10.1073/pnas.1610602114; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Winterbottom EF, 2010, DEVELOPMENT, V137, P2623, DOI 10.1242/dev.047159	50	82	84	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					45	+		10.1038/nature25030	http://dx.doi.org/10.1038/nature25030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29236686	Green Submitted, Green Accepted			2022-12-28	WOS:000419769300026
J	Schuster, SJ; Svoboda, J; Chong, EA; Nasta, SD; Mato, AR; Anak, O; Brogdon, JL; Pruteanu-Malinici, I; Bhoj, V; Landsburg, D; Wasik, M; Levine, BL; Lacey, SF; Melenhorst, JJ; Porter, DL; June, CH				Schuster, Stephen J.; Svoboda, Jakub; Chong, Elise A.; Nasta, Sunita D.; Mato, Anthony R.; Anak, Ozlem; Brogdon, Jennifer L.; Pruteanu-Malinici, Iulian; Bhoj, Vijay; Landsburg, Daniel; Wasik, Mariusz; Levine, Bruce L.; Lacey, Simon F.; Melenhorst, Jan J.; Porter, David L.; June, Carl H.			Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLLICULAR LYMPHOMA; RESPONSE CRITERIA; REMISSIONS; RITUXIMAB; CHEMOTHERAPY; SURVIVAL; EFFICACY; TRIAL; CHOP	BACKGROUND Patients with diffuse large B-cell lymphoma or follicular lymphoma that is refractory to or that relapses after immunochemotherapy and transplantation have a poor prognosis. High response rates have been reported with the use of T cells modified by chimeric antigen receptor (CAR) that target CD19 in B-cell cancers, although data regarding B-cell lymphomas are limited. METHODS We used autologous T cells that express a CD19-directed CAR (CTL019) to treat patients with diffuse large B-cell lymphoma or follicular lymphoma that had relapsed or was refractory to previous treatments. Patients were monitored for response to treatment, toxic effects, the expansion and persistence of CTL019 cells in vivo, and immune recovery. RESULTS A total of 28 adult patients with lymphoma received CTL019 cells, and 18 of 28 had a response (64%; 95% confidence interval [CI], 44 to 81). Complete remission occurred in 6 of 14 patients with diffuse large B-cell lymphoma (43%; 95% CI, 18 to 71) and 10 of 14 patients with follicular lymphoma (71%; 95% CI, 42 to 92). CTL019 cells proliferated in vivo and were detectable in the blood and bone marrow of patients who had a response and patients who did not have a response. Sustained remissions were achieved, and at a median follow-up of 28.6 months, 86% of patients with diffuse large B-cell lymphoma who had a response (95% CI, 33 to 98) and 89% of patients with follicular lymphoma who had a response (95% CI, 43 to 98) had maintained the response. Severe cytokine-release syndrome occurred in 5 patients (18%). Serious encephalopathy occurred in 3 patients (11%); 2 cases were self-limiting and 1 case was fatal. All patients in complete remission by 6 months remained in remission at 7.7 to 37.9 months (median, 29.3 months) after induction, with a sustained reappearance of B cells in 8 of 16 patients and with improvement in levels of IgG in 4 of 10 patients and of IgM in 6 of 10 patients at 6 months or later and in levels of IgA in 3 of 10 patients at 18 months or later. CONCLUSIONS CTL019 cells can be effective in the treatment of relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma. High rates of durable remission were observed, with recovery of B cells and immunoglobulins in some patients. Transient encephalopathy developed in approximately one in three patients and severe cytokine-release syndrome developed in one in five patients.	[Schuster, Stephen J.; Svoboda, Jakub; Chong, Elise A.; Nasta, Sunita D.; Mato, Anthony R.; Landsburg, Daniel; Porter, David L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA; [Schuster, Stephen J.; Svoboda, Jakub; Chong, Elise A.; Nasta, Sunita D.; Mato, Anthony R.; Landsburg, Daniel; Porter, David L.] Univ Penn, Perelman Sch Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA; [Bhoj, Vijay; Wasik, Mariusz; Levine, Bruce L.; Lacey, Simon F.; Melenhorst, Jan J.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Anak, Ozlem] Novartis Pharmaceut, Basel, Switzerland; [Brogdon, Jennifer L.; Pruteanu-Malinici, Iulian] Novartis Inst BioMed Res, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Novartis; Novartis	Schuster, SJ (corresponding author), Univ Penn, Canc Ctr, Perelman Ctr Adv Med, 34th & Civ Ctr Blvd,12th Fl, Philadelphia, PA 19104 USA.	stephen.schuster@uphs.upenn.edu	Melenhorst, Jan/AAW-2546-2020	Melenhorst, Jan/0000-0001-7677-537X	Novartis; NATIONAL CANCER INSTITUTE [R01CA165206] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Novartis and others;	[Anonymous], 2017, AL COP; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Casulo C, 2015, J CLIN ONCOL, V33, P2516, DOI 10.1200/JCO.2014.59.7534; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Crump M, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.7516; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Locke FL, 2017, MOL THER, V25, P285, DOI 10.1016/j.ymthe.2016.10.020; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Neelapu SS, 2017, HEMATOL ONCOL S2, V35; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Salles G, 2017, HAEMATOLOGICA, V102, pE156, DOI 10.3324/haematol.2016.151738; Tan D, 2013, BLOOD, V122, P981, DOI 10.1182/blood-2013-03-491514; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Wang M, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0537-5	27	800	817	8	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2545	2554		10.1056/NEJMoa1708566	http://dx.doi.org/10.1056/NEJMoa1708566			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR0TX	29226764	Green Accepted, Bronze			2022-12-28	WOS:000418777700006
J	Mazer, B				Mazer, Benjamin			CHRISTMAS 2017: TIME AND PLACE Brutalist medicine: a reflection on the architecture of healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mazer, Benjamin] Yale New Haven Med Ctr, Pathol, 20 York St, New Haven, CT 06504 USA; [Mazer, Benjamin] Yale Sch Med, Pathol, New Haven, CT 06510 USA	Yale University; Yale University	Mazer, B (corresponding author), Yale New Haven Med Ctr, Pathol, 20 York St, New Haven, CT 06504 USA.; Mazer, B (corresponding author), Yale Sch Med, Pathol, New Haven, CT 06510 USA.	benjamin.mazer@yale.edu		Mazer, Benjamin/0000-0002-1990-2077					0	0	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5676	10.1136/bmj.j5676	http://dx.doi.org/10.1136/bmj.j5676			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229749				2022-12-28	WOS:000418327000008
J	Sue, K				Sue, Kyle			CHRISTMAS 2017: ALL CREATURES GREAT AND SMALL The science behind "man flu"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INACTIVATED INFLUENZA VACCINE; GENDER-DIFFERENCES; SEX-DIFFERENCES; AGE; TESTOSTERONE; RESPONSES; PREGNANCY		[Sue, Kyle] Mem Univ Newfoundland, Hlth Sci Ctr, Family Med, St John, NF, Canada	Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Sue, K (corresponding author), Mem Univ Newfoundland, Hlth Sci Ctr, Family Med, St John, NF, Canada.	ksue@ualberta.ca	Sue, Kyle/W-4029-2019	Sue, Kyle/0000-0002-0882-1925				Antrobus C., 2012, AUSTR PHARMACIST, V31, P288; Avitsur R, 2011, HORM BEHAV, V59, P257, DOI 10.1016/j.yhbeh.2010.12.002; Baker P, 2014, B WORLD HEALTH ORGAN, V92, P618, DOI 10.2471/BLT.13.132795; Beyer WEP, 1996, EUR J CLIN MICROBIOL, V15, P65, DOI 10.1007/BF01586187; Boynton P., 2006, BMJ-BRIT MED J, V333, P1128, DOI [10.1136/bmj.39041.590556.59, DOI 10.1136/BMJ.39041.590556.59]; Carroll ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-184; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Ericsson Aaron C, 2013, Mo Med, V110, P201; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Guindon G., 2003, CURRENT FUTURE TREND; Hoffmann J, 2015, VACCINE, V33, P6949, DOI 10.1016/j.vaccine.2015.08.044; Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427; Lorenzo ME, 2011, VACCINE, V29, P9246, DOI 10.1016/j.vaccine.2011.09.110; MACINTYRE S, 1993, SOC SCI MED, V36, P15, DOI 10.1016/0277-9536(93)90301-J; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; Pazos MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040502; Peretz J, 2016, AM J PHYSIOL-LUNG C, V310, pL415, DOI 10.1152/ajplung.00398.2015; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Quandelacy TM, 2014, AM J EPIDEMIOL, V179, P156, DOI 10.1093/aje/kwt235; Restif O, 2010, P ROY SOC B-BIOL SCI, V277, P2247, DOI 10.1098/rspb.2010.0188; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Robinson DP, 2014, J VIROL, V88, P4711, DOI 10.1128/JVI.02081-13; Tang JW, 2017, LANCET INFECT DIS, V17, pE320, DOI 10.1016/S1473-3099(17)30238-4; Waldorf KMA, 2008, IMMUNOL INVEST, V37, P631, DOI 10.1080/08820130802205886; Wang XL, 2015, AM J EPIDEMIOL, V182, P335, DOI 10.1093/aje/kwv068; World Health Organization, 2010, SEX GEND INFL; Wyke S, 1998, SOC SCI MED, V46, P901, DOI 10.1016/S0277-9536(97)00217-7; Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	31	19	20	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5560	10.1136/bmj.j5560	http://dx.doi.org/10.1136/bmj.j5560			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229663				2022-12-28	WOS:000418327000006
J	Stokstad, E				Stokstad, Erik			LAST STANDS Foresters and ecologists face off over the future of Europe's oldest forest	SCIENCE			English	Editorial Material																			0	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1240	1243		10.1126/science.358.6368.1240	http://dx.doi.org/10.1126/science.358.6368.1240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217553				2022-12-28	WOS:000417254700017
J	Stone, R				Stone, Richard			NEUROSCIENCE Cuban panel claims stress caused mystery illnesses	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1236	1237		10.1126/science.358.6368.1236	http://dx.doi.org/10.1126/science.358.6368.1236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217550				2022-12-28	WOS:000417254700014
J	George, LA; Sullivan, SK; Giermasz, A; Rasko, JEJ; Samelson-Jones, BJ; Ducore, J; Cuker, A; Sullivan, LM; Majumdar, S; Teitel, J; McGuinn, CE; Ragni, MV; Luk, AY; Hui, D; Wright, JF; Chen, Y; Liu, Y; Wachtel, K; Winters, A; Tiefenbacher, S; Arruda, VR; van der Loo, JCM; Zelenaia, O; Takefman, D; Carr, ME; Couto, LB; Anguela, XM; High, KA				George, L. A.; Sullivan, S. K.; Giermasz, A.; Rasko, J. E. J.; Samelson-Jones, B. J.; Ducore, J.; Cuker, A.; Sullivan, L. M.; Majumdar, S.; Teitel, J.; McGuinn, C. E.; Ragni, M. V.; Luk, A. Y.; Hui, D.; Wright, J. F.; Chen, Y.; Liu, Y.; Wachtel, K.; Winters, A.; Tiefenbacher, S.; Arruda, V. R.; van der Loo, J. C. M.; Zelenaia, O.; Takefman, D.; Carr, M. E.; Couto, L. B.; Anguela, X. M.; High, K. A.			Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AAV VECTOR; IDENTIFICATION; TRANSDUCTION; EXPRESSION; EFFICIENT; EFFICACY; SAFETY; LIVER; PADUA; TRIAL	BACKGROUND The prevention of bleeding with adequately sustained levels of clotting factor, after a single therapeutic intervention and without the need for further medical intervention, represents an important goal in the treatment of hemophilia. METHODS We infused a single-stranded adeno-associated viral (AAV) vector consisting of a bioengineered capsid, liver-specific promoter and factor IX Padua (factor IX-R338L) transgene at a dose of 5x10(11) vector genomes per kilogram of body weight in 10 men with hemophilia B who had factor IX coagulant activity of 2% or less of the normal value. Laboratory values, bleeding frequency, and consumption of factor IX concentrate were prospectively evaluated after vector infusion and were compared with baseline values. RESULTS No serious adverse events occurred during or after vector infusion. Vector-derived factor IX coagulant activity was sustained in all the participants, with a mean (+/- SD) steady-state factor IX coagulant activity of 33.7 +/- 18.5% (range, 14 to 81). On cumulative follow-up of 492 weeks among all the participants (range of follow-up in individual participants, 28 to 78 weeks), the annualized bleeding rate was significantly reduced (mean rate, 11.1 events per year [range, 0 to 48] before vector administration vs. 0.4 events per year [range, 0 to 4] after administration; P = 0.02), as was factor use (mean dose, 2908 IU per kilogram [range, 0 to 8090] before vector administration vs. 49.3 IU per kilogram [range, 0 to 376] after administration; P = 0.004). A total of 8 of 10 participants did not use factor, and 9 of 10 did not have bleeds after vector administration. An asymptomatic increase in liver-enzyme levels developed in 2 participants and resolved with short-term prednisone treatment. One participant, who had substantial, advanced arthropathy at baseline, administered factor for bleeding but overall used 91% less factor than before vector infusion. CONCLUSIONS We found sustained therapeutic expression of factor IX coagulant activity after gene transfer in 10 participants with hemophilia who received the same vector dose. Transgene-derived factor IX coagulant activity enabled the termination of baseline prophylaxis and the near elimination of bleeding and factor use.	[George, L. A.; Samelson-Jones, B. J.; Winters, A.; Arruda, V. R.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [George, L. A.; Samelson-Jones, B. J.; Winters, A.; Arruda, V. R.; van der Loo, J. C. M.; Zelenaia, O.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [George, L. A.; Samelson-Jones, B. J.; Arruda, V. R.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Cuker, A.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Luk, A. Y.; Hui, D.; Wright, J. F.; Chen, Y.; Liu, Y.; Wachtel, K.; Takefman, D.; Carr, M. E.; Couto, L. B.; Anguela, X. M.; High, K. A.] Spark Therapeut, Philadelphia, PA USA; [Sullivan, S. K.] Mississippi Ctr Adv Med, Dept Pediat, Madison, MS USA; [Sullivan, L. M.] Univ Mississippi, Med Sch, Dept Pathol, Jackson, MS USA; [Majumdar, S.] Univ Mississippi, Med Sch, Dept Pediat, Jackson, MS USA; [Giermasz, A.] Univ Calif Davis, Sch Med, Dept Med, Sacramento, CA 95817 USA; [Ducore, J.] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Rasko, J. E. J.] Univ Sydney, Sydney Med Sch, Dept Med, Camperdown, NSW, Australia; [Rasko, J. E. J.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Rasko, J. E. J.] Royal Prince Alfred Hosp, Cell & Mol Therapies, Camperdown, NSW, Australia; [Teitel, J.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Teitel, J.] St Michaels Hosp, Toronto, ON, Canada; [McGuinn, C. E.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Ragni, M. V.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Tiefenbacher, S.] Lab Corp Amer Holdings, Colorado Coagulat, Englewood, CO USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Mississippi; University of Mississippi; University of California System; University of California Davis; University of California System; University of California Davis; University of Sydney; University of Sydney; Centenary Institute; University of Sydney; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	George, LA (corresponding author), Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,Rm 5016, Philadelphia, PA 19106 USA.	georgel@email.chop.edu	Anguela, Xavier/K-9594-2019; McGuinn, Catherine/AHD-6358-2022; High, Katherine A./AAB-9322-2020; Samelson-Jones, Benjamin Jacob/AEW-0628-2022	Anguela, Xavier/0000-0003-2430-8598; Samelson-Jones, Benjamin Jacob/0000-0001-6772-4140; High, Katherine/0000-0002-0805-6223; rasko, John/0000-0003-2975-807X; George, Lindsey/0000-0002-9763-1559	Spark Therapeutics; Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439, P01HL064190, T32HL007150] Funding Source: NIH RePORTER	Spark Therapeutics; Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Spark Therapeutics and Pfizer.	Altman DG, 2001, PRACTICAL STAT MED R, P189; Anguela X, 2015, J THROMB HAEMOST, V13, P324; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Cheung WF, 1996, P NATL ACAD SCI USA, V93, P11068, DOI 10.1073/pnas.93.20.11068; Crudele JM, 2015, BLOOD, V125, P1553, DOI 10.1182/blood-2014-07-588194; Den Uijl IEM, 2011, HAEMOPHILIA, V17, P849, DOI 10.1111/j.1365-2516.2011.02539.x; George LA, 2016, SEMIN HEMATOL, V53, P46, DOI 10.1053/j.seminhematol.2015.10.002; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; High KA, 2016, HUM MOL GENET, V25, pR36, DOI 10.1093/hmg/ddv475; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Leebeek FW, 2016, BLOOD, P128; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Mazepa MA, 2016, BLOOD, V127, P3073, DOI 10.1182/blood-2015-10-675140; Meliani A, 2015, HUM GENE THER METHOD, V26, P45, DOI 10.1089/hgtb.2015.037; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Monahan P, 2015, J THROMB HAEMOST, V13, P87; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Pasi J, 2016, HAEMOPHILIA, V22, P151; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Schuettrumpf J, 2006, MOL THER, V13, P88, DOI 10.1016/j.ymthe.2005.08.004; Simioni P, 2009, NEW ENGL J MED, V361, P1671, DOI 10.1056/NEJMoa0904377; Sommer JM, 2003, MOL THER, V7, P122, DOI 10.1016/S1525-0016(02)00019-9; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Stedman HH, 2014, HUM GENE THER CL DEV, V26, P5; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Sun JJ, 2017, BLOOD, V129, P2161, DOI 10.1182/blood-2016-08-734053; Wagner JA, 1998, LANCET, V351, P1702, DOI 10.1016/S0140-6736(05)77740-0; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021	34	406	424	3	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2215	2227		10.1056/NEJMoa1708538	http://dx.doi.org/10.1056/NEJMoa1708538			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9IL	29211678	Green Accepted, Bronze			2022-12-28	WOS:000417201100005
J	Sugihara, Y; Okada, H				Sugihara, Yuusaku; Okada, Hiroyuki			Pneumatosis Cystoides Intestinalis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sugihara, Yuusaku; Okada, Hiroyuki] Okayama Univ, Grad Sch Med, Okayama, Japan	Okayama University	Sugihara, Y (corresponding author), Okayama Univ, Grad Sch Med, Okayama, Japan.	y.sugi117@gmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2266	2266		10.1056/NEJMicm1701357	http://dx.doi.org/10.1056/NEJMicm1701357			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211667	Green Submitted			2022-12-28	WOS:000417201100009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: If this was cancer there'd be an outcry-but it's mental health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health Public Health England, 2017, 15 MILL PROGR HELP T; Hunt J, 2017, HUFFINGTON POST; McNicoll A, 2016, COMMUNITY CARE, P20; Mental Health First Aid Australia, MHFA COURS EV; Mental Health First Aid England, 2016, MENT HLTH 1 AID ALL; Price C, 2016, PULSE, P4; Royal College of Psychiatrists, 2015, SURV IN PAT ADM CHIL; Silver K, 2017, BBC NEWS	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2017	359								j5407	10.1136/bmj.j5407	http://dx.doi.org/10.1136/bmj.j5407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3ZY	29203467	Bronze, Green Published			2022-12-28	WOS:000417557700001
J	Cartlidge, E				Cartlidge, Edwin			PHYSICS Relativity survives drop test	SCIENCE			English	News Item																			0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1117	1117		10.1126/science.358.6367.1117	http://dx.doi.org/10.1126/science.358.6367.1117			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191885				2022-12-28	WOS:000416584000013
J	Huang, EW; Mendl, CB; Liu, SX; Johnston, S; Jiang, HC; Moritz, B; Devereaux, TP				Huang, Edwin W.; Mendl, Christian B.; Liu, Shenxiu; Johnston, Steve; Jiang, Hong-Chen; Moritz, Brian; Devereaux, Thomas P.			Numerical evidence of fluctuating stripes in the normal state of high-Tc cuprate superconductors	SCIENCE			English	Article							TRANSITION-TEMPERATURE; NEUTRON-SCATTERING; SPIN FLUCTUATIONS; ORDER; CHARGE; EXCITATIONS; DYNAMICS; PHASE; HOLES; MAGNETISM	Upon doping, Mott insulators often exhibit symmetry breaking where charge carriers and their spins organize into patterns known as stripes. For high-transition temperature cuprate superconductors, stripes are widely suspected to exist in a fluctuating form. We used numerically exact determinant quantum Monte Carlo calculations to demonstrate dynamical stripe correlations in the three-band Hubbard model, which represents the local electronic structure of the copper-oxygen plane. Our results, which are robust to varying parameters, cluster size, and boundary conditions, support the interpretation of experimental observations such as the hourglass magnetic dispersion and the Yamada plot of incommensurability versus doping in terms of the physics of fluctuating stripes. These findings provide a different perspective on the intertwined orders emerging from the cuprates' normal state.	[Huang, Edwin W.; Liu, Shenxiu] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Huang, Edwin W.; Mendl, Christian B.; Liu, Shenxiu; Jiang, Hong-Chen; Moritz, Brian; Devereaux, Thomas P.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Huang, Edwin W.; Mendl, Christian B.; Liu, Shenxiu; Jiang, Hong-Chen; Moritz, Brian; Devereaux, Thomas P.] Stanford Univ, Menlo Pk, CA 94025 USA; [Johnston, Steve] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Johnston, Steve] Univ Tennessee, Joint Inst Adv Mat, Knoxville, TN 37996 USA; [Moritz, Brian] Univ North Dakota, Dept Phys & Astrophys, Grand Forks, ND 58202 USA; [Devereaux, Thomas P.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of North Dakota Grand Forks; Stanford University	Huang, EW (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Huang, EW; Devereaux, TP (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.; Huang, EW; Devereaux, TP (corresponding author), Stanford Univ, Menlo Pk, CA 94025 USA.; Devereaux, TP (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	edwinwhuang@gmail.com; tpd@stanford.edu	Moritz, Brian J/D-7505-2015; Mendl, Christian B./N-3409-2016	Moritz, Brian J/0000-0002-3747-8484; Mendl, Christian B./0000-0002-6386-0230; JIANG, HONGCHEN/0000-0003-2842-6591; devereaux, thomas/0000-0001-8072-9237; Huang, Edwin/0000-0002-6250-9529	U. S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; Alexander von Humboldt Foundation via a Feodor Lynen fellowship; University of Tennessee's Science Alliance Joint Directed Research and Development program, a collaboration with Oak Ridge National Laboratory; DOE [DE-AC02-05CH11231]	U. S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Alexander von Humboldt Foundation via a Feodor Lynen fellowship; University of Tennessee's Science Alliance Joint Directed Research and Development program, a collaboration with Oak Ridge National Laboratory; DOE(United States Department of Energy (DOE))	We thank A. Kampf, S. Kivelson, W.-S. Lee, Y. Lee, D. Scalapino, R. Scalettar, J. Tranquada, and J. Zaanen for helpful discussions. Supported by the U. S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract DE-AC02-76SF00515; the Alexander von Humboldt Foundation via a Feodor Lynen fellowship (C.B.M.); and the University of Tennessee's Science Alliance Joint Directed Research and Development program, a collaboration with Oak Ridge National Laboratory (S. J.). Computational work was performed on the Sherlock cluster at Stanford University and on resources of the National Energy Research Scientific Computing Center, supported by DOE under contract DE-AC02-05CH11231. Data supporting this manuscript are stored on the Sherlock cluster at Stanford University and are available from the corresponding author upon request. Source code for the simulations can be found at https://github.com/cmendl/hubbard-dqmc. Sample input files are included for the three-band Hubbard model as studied in this work.	Anissimova S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4467; Chang CC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.116402; Chen CC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177401; Comin R, 2016, ANNU REV CONDEN MA P, V7, P369, DOI 10.1146/annurev-conmatphys-031115-011401; Corboz P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.046402; Cvetkovic V, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/27001; Dai PC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054525; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Eschrig M, 2006, ADV PHYS, V55, P47, DOI 10.1080/00018730600645636; Hager G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075108; Hayden SM, 2004, NATURE, V429, P531, DOI 10.1038/nature02576; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Ichikawa N, 2000, PHYS REV LETT, V85, P1738, DOI 10.1103/PhysRevLett.85.1738; Iglovikov VI, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045110; Jarrell M, 1996, PHYS REP, V269, P133, DOI 10.1016/0370-1573(95)00074-7; Kimura H, 1999, PHYS REV B, V59, P6517, DOI 10.1103/PhysRevB.59.6517; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kung YF, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155166; LeBlanc JPF, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041041; Lee YS, 1999, PHYS REV B, V60, P3643, DOI 10.1103/PhysRevB.60.3643; MACHIDA K, 1989, PHYSICA C, V158, P192, DOI 10.1016/0921-4534(89)90316-X; Matsuda M, 2000, PHYS REV B, V62, P9148, DOI 10.1103/PhysRevB.62.9148; Matsuda M, 2000, PHYS REV B, V61, P4326, DOI 10.1103/PhysRevB.61.4326; Matsuda M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.134515; Mook HA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097004; Muller-Hartmann E, 2002, EUR PHYS J B, V28, P173, DOI 10.1140/epjb/e2002-00219-5; Ramirez AP, 1996, PHYS REV LETT, V76, P3188, DOI 10.1103/PhysRevLett.76.3188; Stock C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024522; Tranquada J. M., 2007, HDB HIGH TEMPERATURE, P6; Tranquada JM, 1999, J PHYS CHEM SOLIDS, V60, P1019, DOI 10.1016/S0022-3697(99)00041-4; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Tranquada JM, 1996, PHYS REV B, V54, P7489, DOI 10.1103/PhysRevB.54.7489; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; Wakimoto S, 2000, PHYS REV B, V61, P3699, DOI 10.1103/PhysRevB.61.3699; Wakimoto S, 1999, PHYS REV B, V60, pR769, DOI 10.1103/PhysRevB.60.R769; Wells BO, 1997, SCIENCE, V277, P1067, DOI 10.1126/science.277.5329.1067; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; White SR, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205112; Xu GY, 2009, NAT PHYS, V5, P642, DOI 10.1038/NPHYS1360; Yamada K, 1998, PHYS REV B, V57, P6165, DOI 10.1103/PhysRevB.57.6165; Zaanen J, 1996, PHYS REV B, V53, P8671, DOI 10.1103/PhysRevB.53.8671; Zaanen J, 2001, PHILOS MAG B, V81, P1485, DOI 10.1080/13642810110051791; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zaliznyak IA, 2000, PHYS REV LETT, V85, P4353, DOI 10.1103/PhysRevLett.85.4353	47	92	93	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1161	+		10.1126/science.aak9546	http://dx.doi.org/10.1126/science.aak9546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191902	Green Submitted			2022-12-28	WOS:000416584000035
J	Jimenez-Alcazar, M; Rangaswamy, C; Panda, R; Bitterling, J; Simsek, YJ; Long, AT; Bilyy, R; Krenn, V; Renne, C; Renne, T; Kluge, S; Panzer, U; Mizuta, R; Mannherz, HG; Kitamura, D; Herrmann, M; Napirei, M; Fuchs, TA				Jimenez-Alcazar, Miguel; Rangaswamy, Chandini; Panda, Rachita; Bitterling, Josephine; Simsek, Yashin J.; Long, Andy T.; Bilyy, Rostyslav; Krenn, Veit; Renne, Christoph; Renne, Thomas; Kluge, Stefan; Panzer, Ulf; Mizuta, Ryushin; Mannherz, Hans Georg; Kitamura, Daisuke; Herrmann, Martin; Napirei, Markus; Fuchs, Tobias A.			Host DNases prevent vascular occlusion by neutrophil extracellular traps	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INNATE IMMUNITY; CELL-DEATH; THROMBOSIS; DEGRADATION; CHROMATIN; BACTERIA; FEATURES	Platelet and fibrin clots occlude blood vessels in hemostasis and thrombosis. Here we report a noncanonical mechanism for vascular occlusion based on neutrophil extracellular traps (NETs), DNA fibers released by neutrophils during inflammation. We investigated which host factors control NETs in vivo and found that two deoxyribonucleases (DNases), DNase1 and DNase1-like 3, degraded NETs in circulation during sterile neutrophilia and septicemia. In the absence of both DNases, intravascular NETs formed clots that obstructed blood vessels and caused organ damage. Vascular occlusions in patients with severe bacterial infections were associated with a defect to degrade NETs ex vivo and the formation of intravascular NET clots. DNase1 and DNase1-like 3 are independently expressed and thus provide dual host protection against deleterious effects of intravascular NETs.	[Jimenez-Alcazar, Miguel; Rangaswamy, Chandini; Panda, Rachita; Bitterling, Josephine; Simsek, Yashin J.; Long, Andy T.; Renne, Thomas; Fuchs, Tobias A.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Martinistr 52, D-20246 Hamburg, Germany; [Bilyy, Rostyslav] Danylo Halytsky Lviv Natl Med Univ, Pekarska St 69, UA-79010 Lvov, Ukraine; [Krenn, Veit] Hlth Care Ctr Histol Cytol & Mol Diagnost, Max Planck Str 5, D-54296 Trier, Germany; [Renne, Christoph] Grp Practice Pathol Wiesbaden, Ludwig Erhard Str 100, D-65199 Wiesbaden, Germany; [Renne, Thomas; Fuchs, Tobias A.] Karolinska Inst, Dept Mol Med & Surg, Solna L1 00, S-17176 Stockholm, Sweden; [Renne, Thomas; Fuchs, Tobias A.] Univ Hosp, Solna L1 00, S-17176 Stockholm, Sweden; [Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, Martinistr 52, D-20246 Hamburg, Germany; [Panzer, Ulf] Univ Med Ctr Hamburg Eppendorf, Med Clin 3, Martinistr 52, D-20246 Hamburg, Germany; [Mizuta, Ryushin; Kitamura, Daisuke] Tokyo Univ Sci, Res Inst Biomed Sci, Yamazaki 2669, Noda, Chiba 2780022, Japan; [Mannherz, Hans Georg; Napirei, Markus] Ruhr Univ Bochum, Fac Med, Dept Anat & Mol Embryol, Univ Str 150, D-44801 Bochum, Germany; [Herrmann, Martin] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Med 3, Univ Klinikum Erlangen, Ulmenweg 18, D-91054 Erlangen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Danylo Halytsky Lviv National Medical University; Max Planck Society; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Tokyo University of Science; Ruhr University Bochum; University of Erlangen Nuremberg	Fuchs, TA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Martinistr 52, D-20246 Hamburg, Germany.; Fuchs, TA (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Solna L1 00, S-17176 Stockholm, Sweden.; Fuchs, TA (corresponding author), Univ Hosp, Solna L1 00, S-17176 Stockholm, Sweden.	t.fuchs@uke.de	Bilyy, Rostyslav/AAH-9636-2020; Herrmann, Martin/A-9597-2013; Mannherz, Hans Georg/HHM-2867-2022; herrmann, martin/AAT-9836-2020; Bilyy, Rostyslav/A-9777-2010	Bilyy, Rostyslav/0000-0002-2344-1349; Herrmann, Martin/0000-0002-0258-2484; Bilyy, Rostyslav/0000-0002-2344-1349; Simsek, Yashin Jakob/0000-0001-8428-1695; Jimenez-Alcazar, Miguel/0000-0003-0179-5573; Rangaswamy, Chandini/0000-0002-7870-7474; Renne, Thomas/0000-0003-4594-5975	German Research Society [KFO 306, FU 742/4-1, SFB 841, INST 152/621-1, SFB 877, INST 257/433-1, SFB 1192, INST 152/692-1, INST 152/686-1]; Stiftung fur Pathobiochemie und Molekulare Diagnostik of the German Society for Clinical Chemistry and Laboratory Medicine; FoRUM-program of the Ruhr-University Bochum [F505-2006]; Hjart Lungfonden [20110500]; Vetenskapsradet [K2013-65X-21462-04-5]; European Research Council [ERC-StG-2012-311575_F-12, PIIF-GA-2013-628264]; Ardea Biosciences, Inc.	German Research Society(German Research Foundation (DFG)); Stiftung fur Pathobiochemie und Molekulare Diagnostik of the German Society for Clinical Chemistry and Laboratory Medicine; FoRUM-program of the Ruhr-University Bochum; Hjart Lungfonden; Vetenskapsradet(Swedish Research Council); European Research Council(European Research Council (ERC)European Commission); Ardea Biosciences, Inc.	We thank A.V. Failla of the Microscope Core Facility, K. Hartmann of the Mouse Pathology Core Facility of the University Medical Center Hamburg-Eppendorf, and V. Vovk of the Lviv National Medical University for their support. This study was supported in part by the German Research Society (KFO 306, FU 742/4-1; SFB 841, INST 152/621-1; SFB 877, INST 257/433-1; SFB 1192, INST 152/692-1, INST 152/686-1), the Stiftung fur Pathobiochemie und Molekulare Diagnostik of the German Society for Clinical Chemistry and Laboratory Medicine, the FoRUM-program of the Ruhr-University Bochum (F505-2006), Hjart Lungfonden (20110500), Vetenskapsradet (K2013-65X-21462-04-5), and the European Research Council (ERC-StG-2012-311575_F-12, PIIF-GA-2013-628264). M.H. acknowledges generous support by Ardea Biosciences, Inc. The data are contained in the manuscript and the supplementary materials.	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Braune SA, 2013, CRIT CARE MED, V41, P1702, DOI 10.1097/CCM.0b013e31828a24a8; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Jimenez-Alcazar M, 2015, J THROMB HAEMOST, V13, P732, DOI 10.1111/jth.12796; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Kumar V., 2009, ROBBINS COTRAN PATHO; Kumar V., 2009, ROBBINS COTRAN PATHO, P43; Leffler J, 2017, J INNATE IMMUN, V9, P12, DOI 10.1159/000450609; Leppkes M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10973; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Mizuta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080223; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	27	314	328	7	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1202	+		10.1126/science.aam8897	http://dx.doi.org/10.1126/science.aam8897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191910				2022-12-28	WOS:000416584000045
J	Bae, T; Tomasini, L; Mariani, J; Zhou, B; Roychowdhury, T; Franjic, D; Pletikos, M; Pattni, R; Chen, BJ; Venturini, E; Riley-Gillis, B; Sestan, N; Urban, AE; Abyzov, A; Vaccarino, FM				Bae, Taejeong; Tomasini, Livia; Mariani, Jessica; Zhou, Bo; Roychowdhury, Tanmoy; Franjic, Daniel; Pletikos, Mihovil; Pattni, Reenal; Chen, Bo-Juen; Venturini, Elisa; Riley-Gillis, Bridget; Sestan, Nenad; Urban, Alexander E.; Abyzov, Alexej; Vaccarino, Flora M.			Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis	SCIENCE			English	Article							DETECTABLE CLONAL MOSAICISM; SOMATIC MUTATIONS; HUMAN BRAIN; STEM-CELLS; GERMLINE MUTATION; CANCER GENOMES; HUMAN NEURONS; NUMBER; DNA; SIGNATURES	Somatic mosaicism in the human brain may alter function of individual neurons. We analyzed genomes of single cells from the forebrains of three human fetuses (15 to 21 weeks postconception) using clonal cell populations. We detected 200 to 400 single-nucleotide variations (SNVs) per cell. SNV patterns resembled those found in cancer cell genomes, indicating a role of background mutagenesis in cancer. SNVs with a frequency of >2% in brain were also present in the spleen, revealing a pregastrulation origin. We reconstructed cell lineages for the first five postzygotic cleavages and calculated a mutation rate of similar to 1.3 mutations per division per cell. Later in development, during neurogenesis, the mutation spectrum shifted toward oxidative damage, and the mutation rate increased. Both neurogenesis and early embryogenesis exhibit substantially more mutagenesis than adulthood.	[Bae, Taejeong; Roychowdhury, Tanmoy; Abyzov, Alexej] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Tomasini, Livia; Mariani, Jessica; Vaccarino, Flora M.] Yale Univ, Child Study Ctr, New Haven, CT 06520 USA; [Zhou, Bo; Pattni, Reenal; Urban, Alexander E.] Stanford Univ, Dept Psychiat, Palo Alto, CA 94305 USA; [Zhou, Bo; Pattni, Reenal; Urban, Alexander E.] Stanford Univ, Dept Genet, Palo Alto, CA 94305 USA; [Franjic, Daniel; Pletikos, Mihovil; Sestan, Nenad; Vaccarino, Flora M.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA; [Chen, Bo-Juen; Venturini, Elisa; Riley-Gillis, Bridget] New York Genome Ctr, New York, NY 10013 USA; [Sestan, Nenad; Vaccarino, Flora M.] Yale Kavli Inst Neurosci, New Haven, CT 06520 USA	Mayo Clinic; Yale University; Stanford University; Stanford University; Yale University	Abyzov, A (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.; Vaccarino, FM (corresponding author), Yale Univ, Child Study Ctr, New Haven, CT 06520 USA.; Vaccarino, FM (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.; Vaccarino, FM (corresponding author), Yale Kavli Inst Neurosci, New Haven, CT 06520 USA.	abyzov.alexej@mayo.edu; flora.vaccarino@yale.edu	Roychowdhury, Tanmoy/AAZ-7889-2021; Abyzov, Alexej/M-4284-2013; Abyzov, Alexej/AAT-4615-2020; Bae, Taejeong/AAW-6003-2021	Bae, Taejeong/0000-0002-4626-3725; Riley-Gillis, Bridget/0000-0001-7338-1156; Pattni, Reenal/0000-0003-4490-731X; Zhou, Bo/0000-0001-6533-7462; Abyzov, Alexej/0000-0001-5405-6729; Vaccarino, Flora/0000-0003-2167-981X	NIH [RR19895, RR029676-01, R01 MH100914, U01 MH106876, U01 MH106874, P50 MH106934, R03 CA191421]; Mayo Clinic Center For Individualized Medicine; NATIONAL CANCER INSTITUTE [R03CA191421] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895, S10RR029676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106874, P50MH106934, R01MH100914, U01MH106876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center For Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the high-performance computing (HPC) facilities operated by the Yale Center for Research Computing and Yale's W. M. Keck Biotechnology Laboratory, as well as their respective staff. This work is also supported by NIH grants RR19895 and RR029676-01, which helped fund the cluster. The sequencing data from this study have been deposited to the NIH National Institute of Mental Health (NIMH) Data Archive (https://data-archive.nimh.nih.gov) under collection ID #2330 and DOI: 10.15154/1410419. This work was funded by the Mayo Clinic Center For Individualized Medicine and by NIH grants R01 MH100914 (F.M.V.), U01 MH106876 (F.M.V., A.A., A.E.U.), U01 MH106874 (N.S.), P50 MH106934 (N.S.), and R03 CA191421 (A.A.). A.A. is also a Visiting Professor at Yale Child Study Center. The supplementary materials contain additional data.	Abyzov A, 2017, GENOME RES, V27, P512, DOI 10.1101/gr.215517.116; Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bacolla A, 2014, GENES-BASEL, V5, P108, DOI 10.3390/genes5010108; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Chen CY, 2017, SCIENCE, V356, P189, DOI 10.1126/science.aak9787; Dong X, 2017, NAT METHODS, V14, P491, DOI [10.1038/NMETH.4227, 10.1038/nmeth.4227]; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Insel TR, 2014, MOL PSYCHIATR, V19, P156, DOI 10.1038/mp.2013.168; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; McConnell MJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal1641; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Moore K. L., 2015, BEFORE WE ARE BORN; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Saini N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006385; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Viel A, 2017, EBIOMEDICINE, V20, P39, DOI 10.1016/j.ebiom.2017.04.022	37	138	140	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					550	+		10.1126/science.aan8690	http://dx.doi.org/10.1126/science.aan8690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29217587	Green Accepted			2022-12-28	WOS:000423795800036
J	Yin, Y; Wu, MY; Zubcevic, L; Borschel, WF; Lander, GC; Lee, SY				Yin, Ying; Wu, Mengyu; Zubcevic, Lejla; Borschel, William F.; Lander, Gabriel C.; Lee, Seok-Yong			Structure of the cold- and menthol-sensing ion channel TRPM8	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; TRPV1 STRUCTURES; K+ CHANNEL; REVEALS; ACTIVATION; DOMAIN; PAIN; MECHANISMS; FEATURES; STIMULI	Transient receptor potential melastatin (TRPM) cation channels are polymodal sensors that are involved in a variety of physiological processes. Within the TRPM family, member 8 (TRPM8) is the primary cold and menthol sensor in humans. We determined the cryo-electron microscopy structure of the full-length TRPM8 from the collared flycatcher at an overall resolution of similar to 4.1 angstroms. Our TRPM8 structure reveals a three-layered architecture. The amino-terminal domain with a fold distinct among known TRP structures, together with the carboxyl-terminal region, forms a large two-layered cytosolic ring that extensively interacts with the transmembrane channel layer. The structure suggests that the menthol-binding site is located within the voltage-sensor-like domain and thus provides a structural glimpse of the design principle of the molecular transducer for cold and menthol sensation.	[Yin, Ying; Zubcevic, Lejla; Borschel, William F.; Lee, Seok-Yong] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Wu, Mengyu; Lander, Gabriel C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Duke University; Scripps Research Institute	Lee, SY (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA.; Lander, GC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	glander@scripps.edu; seok-yong.lee@duke.edu	Zubcevic, Lejla/AAA-6713-2021	Zubcevic, Lejla/0000-0002-1884-9235; Wu, Mengyu/0000-0002-2248-9383; Lander, Gabriel C./0000-0003-4921-1135; Borschel, William/0000-0003-4064-9026	National Institutes of Health [R35NS097241, DP2EB020402]; NIH [S10OD021634]; Protein Data Bank [6BPQ]; EMDB [EMD-7127]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB020402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097241] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Data Bank; EMDB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Cryo-EM data were collected at The Scripps Research Institute (TSRI) electron microscopy facility. We thank Y. Zhang and H. Yang (Duke University) for providing access to their calcium imaging apparatus and guidance to calcium imaging experiments. We thank J.-C. Ducom (TSRI High Performance Computing facility) for computational support, B. Anderson for microscope support, and M. Herzik and S. Chowdhury for helpful discussion and training. We thank Z. Johnson for advice on sample freezing. This work was supported by the National Institutes of Health (grants R35NS097241 to S.-Y.L., DP2EB020402 to G.C.L.). G.C.L is supported as a Searle Scholar and a Pew Scholar. Computational analyses of EM data were performed using shared instrumentation funded by NIH grant S10OD021634. The coordinates are deposited in the Protein Data Bank with the PDB ID 6BPQ, and the electron density maps have been deposited in EMDB with the ID EMD-7127.	Andrews MD, 2015, ACS MED CHEM LETT, V6, P419, DOI 10.1021/ml500479v; Baez D, 2014, CURR TOP MEMBR, V74, P51, DOI 10.1016/B978-0-12-800181-3.00003-8; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Farooqi AA, 2011, IMMUNOGENETICS, V63, P773, DOI 10.1007/s00251-011-0570-4; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hirschi M, 2017, NATURE, V550, P411, DOI 10.1038/nature24055; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Weyer AD, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020037; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	30	163	168	5	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					237	241		10.1126/science.aan4325	http://dx.doi.org/10.1126/science.aan4325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29217583	Green Accepted, Green Submitted			2022-12-28	WOS:000419816600051
J	Murugan, M; Jang, HJ; Park, M; Miller, EM; Cox, J; Taliaferro, JP; Parker, NF; Bhave, V; Hur, H; Liang, YP; Nectow, AR; Pillow, JW; Witten, IB				Murugan, Malavika; Jang, Hee Jae; Park, Michelle; Miller, Ellia M.; Cox, Julia; Taliaferro, Joshua P.; Parker, Nathan F.; Bhave, Varun; Hur, Hong; Liang, Yupu; Nectow, Alexander R.; Pillow, Jonathan W.; Witten, Ilana B.			Combined Social and Spatial Coding in a Descending Projection from the Prefrontal Cortex	CELL			English	Article							FEMALE PRAIRIE VOLES; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; REWARD SEEKING; BEHAVIOR; MEMORY; IDENTIFICATION; TARGET; RAT; HYPOTHALAMUS	Social behaviors are crucial to all mammals. Although the prelimbic cortex (PL, part of medial prefrontal cortex) has been implicated in social behavior, it is not clear which neurons are relevant or how they contribute. We found that PL contains anatomically and molecularly distinct subpopulations that target three downstream regions that have been implicated in social behavior: the nucleus accumbens (NAc), amygdala, and ventral tegmental area. Activation of NAc-projecting PL neurons (PL-NAc), but not the other subpopulations, decreased the preference for a social target. To determine what information PL-NAc neurons convey, we selectively recorded from them and found that individual neurons were active during social investigation, but only in specific spatial locations. Spatially specific manipulation of these neurons bidirectionally regulated the formation of a social-spatial association. Thus, the unexpected combination of social and spatial information within the PL-NAc may contribute to social behavior by supporting social-spatial learning.	[Murugan, Malavika; Jang, Hee Jae; Park, Michelle; Miller, Ellia M.; Cox, Julia; Taliaferro, Joshua P.; Parker, Nathan F.; Bhave, Varun; Nectow, Alexander R.; Pillow, Jonathan W.; Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Park, Michelle; Pillow, Jonathan W.; Witten, Ilana B.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Pillow, Jonathan W.] Princeton Univ, Ctr Stat & Machine Learning, Princeton, NJ 08544 USA; [Hur, Hong; Liang, Yupu] Rockefeller Univ, CCTS Bioinformat Program, New York, NY 10065 USA	Princeton University; Princeton University; Princeton University; Rockefeller University	Witten, IB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Witten, IB (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	iwitten@princeton.edu	Murugan, Malavika/AAB-8060-2019; Core, Vector/CAF-4832-2022	Murugan, Malavika/0000-0003-1300-0379; Bhave, Varun/0000-0003-4442-3454	Pew; McKnight; Sloan Foundation; NIH [DP2 DA035149-01, 5R01MH106689-02, 1F32MH112320-01A1]; SCGB [412733]; NSF GRFP; NARSAD; NCATS NIH CTSA [UL1 TR001866]; McKnight Foundation; Simons Collaboration on the Global Brain [SCGB AWD1004351]; NSF CAREER Award [IIS-1150186]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH112320, R01MH106689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149] Funding Source: NIH RePORTER	Pew; McKnight; Sloan Foundation(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCGB; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NARSAD(NARSAD); NCATS NIH CTSA; McKnight Foundation; Simons Collaboration on the Global Brain; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Engelhard, S. Bolkan, and the rest of the Witten lab for comments and advice on this work; E. Kremer and E. Engel for reagents; and B. Patel for technical assistance. This work was funded by Pew, McKnight, and Sloan Foundation grants to I.B.W., the NIH (DP2 DA035149-01 and 5R01MH106689-02 to I.B.W. and 1F32MH112320-01A1 to J.C.), SCGB (412733 to M.M.), NSF GRFP (to N.F.P.), NARSAD Young Investigator Awards (to A.R.N. and I.B.W.), and NCATS NIH CTSA program (UL1 TR001866 to Y.L. and H.H.). I.B.W. is a New York Stem Cell Foundation-Robertson Investigator. J.W.P. was supported by grants from the McKnight Foundation, Simons Collaboration on the Global Brain (SCGB AWD1004351), and the NSF CAREER Award (IIS-1150186).	Amadei EA, 2017, NATURE, V546, P297, DOI 10.1038/nature22381; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Bishop C.M., 2006, PATTERN RECOGN; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Ekstrand MI, 2014, CELL, V157, P1230, DOI 10.1016/j.cell.2014.03.059; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Felix-Ortiz AC, 2016, NEUROSCIENCE, V321, P197, DOI 10.1016/j.neuroscience.2015.07.041; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kim CK, 2017, CELL, V170, P1013, DOI 10.1016/j.cell.2017.07.020; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Lee E, 2016, J NEUROSCI, V36, P6926, DOI 10.1523/JNEUROSCI.0307-16.2016; Lee J, 2016, NEURON, V90, P1071, DOI 10.1016/j.neuron.2016.05.001; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Ma YY, 2014, NEURON, V83, P1453, DOI 10.1016/j.neuron.2014.08.023; McFarland K, 2003, J NEUROSCI, V23, P3531; Nectow AR, 2017, CELL, V170, P429, DOI 10.1016/j.cell.2017.06.045; Nectow AR, 2017, CELL REP, V19, P655, DOI 10.1016/j.celrep.2017.03.048; Nectow AR, 2015, NAT PROTOC, V10, P1319, DOI 10.1038/nprot.2015.087; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Otchy TM, 2015, NATURE, V528, P358, DOI 10.1038/nature16442; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Park M, 2014, NEURAL COMPUT, V26, P1519, DOI 10.1162/NECO_a_00615; Parker NF, 2016, NAT NEUROSCI, V19, P845, DOI 10.1038/nn.4287; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pearson BL, 2012, BEHAV BRAIN RES, V233, P99, DOI 10.1016/j.bbr.2012.04.040; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Takahashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094657; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; van Kerkhof LWM, 2013, NEUROPSYCHOPHARMACOL, V38, P1899, DOI 10.1038/npp.2013.83; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wong LC, 2016, CURR BIOL, V26, P593, DOI 10.1016/j.cub.2015.12.065; Ye L, 2016, CELL, V165, P1776, DOI 10.1016/j.cell.2016.05.010; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhou P., 2016, ARXIV160507266	52	132	134	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1663	+		10.1016/j.cell.2017.11.002	http://dx.doi.org/10.1016/j.cell.2017.11.002			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29224779	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000418044000021
J	Gostin, LO				Gostin, Lawrence O.			Five Ethical Values to Guide Health System Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Inst Natl & Global Hlth Law, Washington, DC 20057 USA; [Gostin, Lawrence O.] World Hlth Org Collaborating Ctr Publ Hlth Law &, Washington, DC 20057 USA	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Inst Natl & Global Hlth Law, Washington, DC 20057 USA.; Gostin, LO (corresponding author), World Hlth Org Collaborating Ctr Publ Hlth Law &, Washington, DC 20057 USA.	gostin@law.georgetown.edu							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2171	2172		10.1001/jama.2017.18804	http://dx.doi.org/10.1001/jama.2017.18804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234795	Bronze			2022-12-28	WOS:000417822700004
J	Craig, R; Holt, T; Rees, JL				Craig, Richard; Holt, Tim; Rees, Jonathan Lloyd			EASILY MISSED? Acute rotator cuff tears	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER		[Craig, Richard] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford OX3 7LD, England; [Rees, Jonathan Lloyd] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Orthopaed Surg & Musculoskeletal Sci, Oxford OX3 7LD, England; [Holt, Tim] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England	University of Oxford; University of Oxford; University of Oxford	Rees, JL (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Orthopaed Surg & Musculoskeletal Sci, Oxford OX3 7LD, England.	jonathan.rees@ndorms.ox.ac.uk		Rees, Jonathan/0000-0003-1818-5800				Aagaard KE, 2015, ACTA ORTHOP, V86, P558, DOI 10.3109/17453674.2015.1022433; Bak K, 2010, ARTHROSCOPY, V26, P734, DOI 10.1016/j.arthro.2009.11.005; Bateman Marcus, 2016, BMJ Qual Improv Rep, V5, DOI 10.1136/bmjquality.u211254.w4531; Brownson Peter, 2015, Shoulder Elbow, V7, P214, DOI 10.1177/1758573215585656; Gismervik SO, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1400-0; Kulkarni Rohit, 2015, Shoulder Elbow, V7, P135, DOI 10.1177/1758573215576456; Lenza M, 2013, COCHRANE DB SYST REV; Lin YP, 2012, ACTA ORTHOP BELG, V78, P592; Lowe CJM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-228; Mukovozov I, 2013, BONE JOINT RES, V2, P122, DOI 10.1302/2046-3758.27.2000164; Shin SJ, 2012, AM J SPORT MED, V40, P822, DOI 10.1177/0363546511434522; Simank HG, 2006, ARCH ORTHOP TRAUM SU, V126, P235, DOI 10.1007/s00402-005-0034-0; Sorensen AKB, 2007, J SHOULDER ELB SURG, V16, P174, DOI 10.1016/j.jse.2006.06.010	13	14	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5366	10.1136/bmj.j5366	http://dx.doi.org/10.1136/bmj.j5366			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229593				2022-12-28	WOS:000418327000002
J	Barry, M; Talib, Z; Jowell, A; Thompson, K; Moyer, C; Larson, H; Burke, K				Barry, Michele; Talib, Zohray; Jowell, Ashley; Thompson, Kelly; Moyer, Cheryl; Larson, Heidi; Burke, Katherine		Steering Comm Women Leaders	A new vision for global health leadership	LANCET			English	Editorial Material									[Barry, Michele; Jowell, Ashley; Burke, Katherine] Stanford Ctr Innovat Global Hlth, Stanford, CA USA; [Talib, Zohray] George Washington Univ, Dept Gen Internal Med, Washington, DC 20037 USA; [Thompson, Kelly] Women Global Hlth, Hayward, CA USA; [Moyer, Cheryl] Univ Michigan, Dept Learning Hlth Sci, Ann Arbor, MI 48109 USA; [Moyer, Cheryl] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Larson, Heidi] London Sch Hyg & Trop Med, London, England	George Washington University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; London School of Hygiene & Tropical Medicine	Talib, Z (corresponding author), George Washington Univ, Dept Gen Internal Med, Washington, DC 20037 USA.	zmtalib@gmail.com	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583; Jowell, Ashley/0000-0002-6292-5864				Downs JA, 2014, ACAD MED, V89, P1103, DOI 10.1097/ACM.0000000000000369; Gibney E, 2017, NATURE, V549, P143, DOI 10.1038/549143a; Javadi D, 2016, HEALTH SYST REFORM, V2, P229, DOI 10.1080/23288604.2016.1225471; WHO, 2020, GLOB STRAT HUM RES H; Woetzel Jonathan, 2015, ADVANCING WOMENS EQU; World Health Organization, 2016, WORK HLTH GROWTH INV	6	9	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2536	2537		10.1016/S0140-6736(17)33101-X	http://dx.doi.org/10.1016/S0140-6736(17)33101-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29198558	Green Submitted			2022-12-28	WOS:000417493300009
J	Larsson, SC; Traylor, M; Malik, R; Dichgans, M; Burgess, S; Markus, HS				Larsson, Susanna C.; Traylor, Matthew; Malik, Rainer; Dichgans, Martin; Burgess, Stephen; Markus, Hugh S.		CoSTREAM Consortium; Int Genomics Alzheimers Project	Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; VASCULAR RISK-FACTORS; LOCI; METAANALYSIS; DEMENTIA; CONSUMPTION; MECHANISMS; PREVENTION; IDENTIFY	OBJECTIVE To determine which potentially modifiable risk factors, including socioeconomic, lifestyle/dietary, cardiometabolic, and inflammatory factors, are associated with Alzheimer's disease. DESIGN Mendelian randomisation study using genetic variants associated with the modifiable risk factors as instrumental variables. SETTING International Genomics of Alzheimer's Project. PARTICIPANTS 17 008 cases of Alzheimer's disease and 37154 controls. MAIN OUTCOME MEASURES Odds ratio of Alzheimer's per genetically predicted increase in each modifiable risk factor estimated with Mendelian randomisation analysis. RESULTS This study included analyses of 24 potentially modifiable risk factors. A Bonferroni corrected threshold of P=0.002 was considered to be significant, and P<0.05 was considered suggestive of evidence for a potential association. Genetically predicted educational attainment was significantly associated with Alzheimer's. The odds ratios were 0.89 (95% confidence interval 0.84 to 0.93; P=2.4x10(-6)) per year of education completed and 0.74 (0.63 to 0.86; P=8.0x10(-5)) per unit increase in log odds of having completed college/university. The correlated trait intelligence had a suggestive association with Alzheimer's (per genetically predicted 1 SD higher intelligence: 0.73, 0.57 to 0.93; P=0.01). There was suggestive evidence for potential associations between genetically predicted higher quantity of smoking (per 10 cigarettes a day: 0.69, 0.49 to 0.99; P=0.04) and 25-hydroxyvitamin D concentrations (per 20% higher levels: 0.92, 0.85 to 0.98; P=0.01) and lower odds of Alzheimer's and between higher coffee consumption (per one cup a day: 1.26,1.05 to 1.51; P=0.01) and higher odds of Alzheimer's. Genetically predicted alcohol consumption, serum folate, serum vitamin B-12, homocysteine, cardiometabolic factors, and C reactive protein were not associated with Alzheimer's disease. CONCLUSION These results provide support that higher educational attainment is associated with a reduced risk of Alzheimer's disease.	[Larsson, Susanna C.] Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, S-17177 Stockholm, Sweden; [Larsson, Susanna C.; Traylor, Matthew; Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Malik, Rainer; Dichgans, Martin] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Dichgans, Martin] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany; [Burgess, Stephen] Univ Cambridge, Biostat Unit, MRC, Cambridge, England; [Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	Karolinska Institutet; University of Cambridge; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); MRC Biostatistics Unit; University of Cambridge; University of Cambridge	Larsson, SC (corresponding author), Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, S-17177 Stockholm, Sweden.; Larsson, SC (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	susanna.larsson@ki.se	Larsson, Susanna C./F-6065-2015; Dichgans, Martin/HCH-3247-2022	Larsson, Susanna C./0000-0003-0118-0341; Dichgans, Martin/0000-0002-0654-387X; Burgess, Stephen/0000-0001-5365-8760; Malik, Rainer/0000-0001-9212-2520	European Union's Horizon 2020 research and innovation programme [667375]; Swedish Brain Foundation; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [204623/Z/16/Z]; NIHR senior investigator award; MRC [MC_UU_00002/7, MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1, MC_UU_00002/7] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, NF-SI-0512-10019] Funding Source: researchfish	European Union's Horizon 2020 research and innovation programme; Swedish Brain Foundation; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); NIHR senior investigator award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 667375 and the Swedish Brain Foundation. HSM and MT have infrastructural support from the Cambridge University Trusts National Institute for Health Research (NIHR) Biomedical Research Centre. SB is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 204623/Z/16/Z). HSM is supported by a NIHR senior investigator award. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	[Anonymous], 2017, BMJ, V357, pj3170, DOI 10.1136/bmj.j3170; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Benn M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1648; Bennett DA, 2017, HEART, V103, P1400, DOI 10.1136/heartjnl-2016-310605; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2017, EPIDEMIOLOGY, V28, P30, DOI 10.1097/EDE.0000000000000559; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; de la Torre JC, 2013, AM J ALZHEIMERS DIS, V28, P551, DOI 10.1177/1533317513494457; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Grarup N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003530; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Ihle-Hansen H, 2014, INT J STROKE, V9, P932, DOI 10.1111/j.1747-4949.2012.00928.x; Jorgenson E, 2017, MOL PSYCHIATR, V22, P1359, DOI 10.1038/mp.2017.101; Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu QP, 2016, NUTRITION, V32, P628, DOI 10.1016/j.nut.2015.11.015; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Meng XF, 2014, J ALZHEIMERS DIS, V42, P1295, DOI 10.3233/JAD-140954; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mukherjee S, 2015, ALZHEIMERS DEMENT, V11, P1439, DOI 10.1016/j.jalz.2015.05.015; Nordestgaard LT, 2017, J CLIN ENDOCR METAB, V102, P2310, DOI 10.1210/jc.2017-00195; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Ostergaard SD, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001841; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Proitsi P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001713; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shen L, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0063-7; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Staff RT, 2004, BRAIN, V127, P1191, DOI 10.1093/brain/awh144; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Vimaleswaran Karani S, 2013, PLoS Med, V10, pe1001383, DOI 10.1371/journal.pmed.1001383; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548	49	150	150	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5375	10.1136/bmj.j5375	http://dx.doi.org/10.1136/bmj.j5375			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29212772	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000417560100004
J	Wagenbauer, KF; Sigl, C; Dietz, H				Wagenbauer, Klaus F.; Sigl, Christian; Dietz, Hendrik			Gigadalton-scale shape-programmable DNA assemblies	NATURE			English	Article							COMPUTATIONAL DESIGN; PROTEIN COMPLEXES; NANOSCALE SHAPES; ACCURATE DESIGN; FOLDING DNA; ORIGAMI; VIRUS; ARCHITECTURE; RESOLUTION; STATE	Natural biomolecular assemblies such as molecular motors, enzymes, viruses and subcellular structures often form by self-limiting hierarchical oligomerization of multiple subunits(1-3). Large structures can also assemble efficiently from a few components by combining hierarchical assembly and symmetry, a strategy exemplified by viral capsids(4). De novo protein design(5-9) and RNA(10,11) and DNA nanotechnology(12-14) aim to mimic these capabilities, but the bottom-up construction of artificial structures with the dimensions and complexity of viruses and other subcellular components remains challenging. Here we show that natural assembly principles can be combined with the methods of DNA origami(15-24) to produce gigadalton-scale structures with controlled sizes. DNA sequence information is used to encode the shapes of individual DNA origami building blocks, and the geometry and details of the interactions between these building blocks then control their copy numbers, positions and orientations within higher-order assemblies. We illustrate this strategy by creating planar rings of up to 350 nanometres in diameter and with atomic masses of up to 330 megadaltons, micrometre-long, thick tubes commensurate in size to some bacilli, and three-dimensional polyhedral assemblies with sizes of up to 1.2 gigadaltons and 450 nanometres in diameter. We achieve efficient assembly, with yields of up to 90 per cent, by using building blocks with validated structure and sufficient rigidity, and an accurate design with interaction motifs that ensure that hierarchical assembly is self-limiting and able to proceed in equilibrium to allow for error correction. We expect that our method, which enables the self-assembly of structures with sizes approaching that of viruses and cellular organelles, can readily be used to create a range of other complex structures with well defined sizes, by exploiting the modularity and high degree of addressability of the DNA origami building blocks used.	[Wagenbauer, Klaus F.; Sigl, Christian; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany; [Wagenbauer, Klaus F.; Sigl, Christian; Dietz, Hendrik] Tech Univ Munich, Inst Adv Study, Coulombwall 4a, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Coulombwall 4a, D-85748 Garching, Germany.; Dietz, H (corresponding author), Tech Univ Munich, Inst Adv Study, Coulombwall 4a, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	European Research Council Starting Grant [256270]; Deutsche Forschungsgemeinschaft within Gottfried-Wilhelm-Leibniz Program; Excellence Clusters CIPSM (Center for Integrated Protein Science Munich); NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; Bosch Forschungsstiftung	European Research Council Starting Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft within Gottfried-Wilhelm-Leibniz Program; Excellence Clusters CIPSM (Center for Integrated Protein Science Munich); NIM (Nanosystems Initiative Munich); Technische Universitat Munchen (TUM) Institute for Advanced Study; Bosch Forschungsstiftung	We thank A. Neuner and V. Hechtl for technical help, M. Kube and J. Funke for computational assistance, D. van Sinten and S. Welsch from FEI for their support with the Titan Krios, F. Praetorius and B. Kick for scaffold preparation, S. Fraden for discussions, and S. Barth for collecting auxiliary data. We also thank A. Holleitner and M. Altschner for access to the helium-ion microscope. This work was supported by a European Research Council Starting Grant to H.D. (grant agreement number 256270) and the Deutsche Forschungsgemeinschaft through grants provided within the Gottfried-Wilhelm-Leibniz Program, the Excellence Clusters CIPSM (Center for Integrated Protein Science Munich), NIM (Nanosystems Initiative Munich) and the Technische Universitat Munchen (TUM) Institute for Advanced Study. K.F.W. and H.D. are grateful for additional support from the Bosch Forschungsstiftung.	Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; BAN N, 1995, NAT STRUCT BIOL, V2, P882, DOI 10.1038/nsb1095-882; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; BOOY FP, 1994, P NATL ACAD SCI USA, V91, P5652, DOI 10.1073/pnas.91.12.5652; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Funke JJ, 2016, NAT NANOTECHNOL, V11, P47, DOI [10.1038/NNANO.2015.240, 10.1038/nnano.2015.240]; Furini S, 2008, BIOPHYS J, V95, P2265, DOI 10.1529/biophysj.107.127019; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Konijnenberg A, 2015, PROTEIN SCI, V24, P1292, DOI 10.1002/pro.2703; Lai YT, 2014, NAT CHEM, V6, P1065, DOI [10.1038/NCHEM.2107, 10.1038/nchem.2107]; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Leung C, 2014, ELIFE, V3, DOI 10.7554/eLife.04247; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Su T, 2017, ELIFE, V6, DOI 10.7554/eLife.25642; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Tian C, 2014, ANGEW CHEM INT EDIT, V53, P8041, DOI 10.1002/anie.201400377; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388; Wagenbauer KF, 2017, CHEMBIOCHEM, V18, P1873, DOI 10.1002/cbic.201700377; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075	30	240	246	10	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					78	83		10.1038/nature24651	http://dx.doi.org/10.1038/nature24651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219966				2022-12-28	WOS:000417560500046
J	Lane, R				Lane, Richard			Agnes Buzyn: France's Minister for Solidarity and Health	LANCET			English	Biographical-Item																		BUZYN A, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2339	2339		10.1016/S0140-6736(17)32869-6	http://dx.doi.org/10.1016/S0140-6736(17)32869-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN6IX	29185429				2022-12-28	WOS:000416118700013
J	Hu, JZ; Urvoy, A; Vendeiro, Z; Crepel, V; Chen, W; Vuletic, V				Hu, Jiazhong; Urvoy, Alban; Vendeiro, Zachary; Crepel, Valentin; Chen, Wenlan; Vuletic, Vladan			Creation of a Bose-condensed gas of Rb-87 by laser cooling	SCIENCE			English	Article							TONKS-GIRARDEAU GAS; OPTICAL LATTICE; EINSTEIN CONDENSATION; CESIUM ATOMS; GROUND-STATE; COLLISIONS; SUPPRESSION; DEGENERACY; DENSITY; LIGHT	Protocols for attaining quantum degeneracy in atomic gases almost exclusively rely on evaporative cooling, a time-consuming final step associated with substantial atom loss. We demonstrate direct laser cooling of a gas of rubidium-87 (Rb-87) atoms to quantum degeneracy. The method is fast and induces little atom loss. The atoms are trapped in a two-dimensional optical lattice that enables cycles of compression to increase the density, followed by Raman sideband cooling to decrease the temperature. From a starting number of 2000 atoms, 1400 atoms reach quantum degeneracy in 300 milliseconds, as confirmed by a bimodal velocity distribution. The method should be broadly applicable to many bosonic and fermionic species and to systems where evaporative cooling is not possible.	[Hu, Jiazhong; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Res Lab Elect, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hu, JZ; Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	jiazhong@mit.edu; vuletic@mit.edu	Hu, Jiazhong/AAP-2848-2021; Vuletic, Vladan/M-8736-2019	Hu, Jiazhong/0000-0002-2937-4810; Crepel, Valentin/0000-0003-0240-3412; Chen, Wenlan/0000-0003-1521-5365; /0000-0002-9786-0538	NSF; NSF Center for Ultracold Atoms; NASA; Multidisciplinary University Research Initiative grants through the Air Force Office of Scientific Research; Army Research Office; Division Of Physics [1505862] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF Center for Ultracold Atoms(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Multidisciplinary University Research Initiative grants through the Air Force Office of Scientific Research; Army Research Office; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF, NSF Center for Ultracold Atoms, NASA, and Multidisciplinary University Research Initiative grants through the Air Force Office of Scientific Research and the Army Research Office. The authors gratefully acknowledge stimulating discussions with C. Chin, W. Ketterle, R. McConnell, and M. Zwierlein. The data presented in this paper are available upon request to J.H.	ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Bouchoule I, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.031606; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Burnett K, 1996, PHYS REV LETT, V77, P1416, DOI 10.1103/PhysRevLett.77.1416; Castin Y, 1998, PHYS REV LETT, V80, P5305, DOI 10.1103/PhysRevLett.80.5305; DALIBARD J, 1989, J OPT SOC AM B, V6, P2023, DOI 10.1364/JOSAB.6.002023; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Gorlitz A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.130402; Haller E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.230404; Hamann SE, 1998, PHYS REV LETT, V80, P4149, DOI 10.1103/PhysRevLett.80.4149; Han DJ, 2000, PHYS REV LETT, V85, P724, DOI 10.1103/PhysRevLett.85.724; Kerman AJ, 2000, PHYS REV LETT, V84, P439, DOI 10.1103/PhysRevLett.84.439; Ketterle W, 1996, PHYS REV A, V54, P656, DOI 10.1103/PhysRevA.54.656; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Kruger P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.265302; Madison KW, 2001, PHYS REV LETT, V86, P4443, DOI 10.1103/PhysRevLett.86.4443; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; Ruhrig J, 2015, OPT EXPRESS, V23, P5596, DOI 10.1364/OE.23.005596; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Soding J, 1999, APPL PHYS B-LASERS O, V69, P257, DOI 10.1007/s003400050805; Stellmer S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263003; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Vuletic V, 1998, PHYS REV LETT, V81, P5768, DOI 10.1103/PhysRevLett.81.5768; Vuletic V, 1999, PHYS REV LETT, V83, P943, DOI 10.1103/PhysRevLett.83.943; Walker T, 1994, ADV ATOM MOL OPT <D>, V34, P125; Wolf S, 2000, PHYS REV LETT, V85, P4249, DOI 10.1103/PhysRevLett.85.4249	31	51	52	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1078	1080		10.1126/science.aan5614	http://dx.doi.org/10.1126/science.aan5614			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170237	Green Submitted			2022-12-28	WOS:000416590400046
J	Jull, A; Wadham, A; Bullen, C; Parag, V; Kerse, N; Waters, J				Jull, Andrew; Wadham, Angela; Bullen, Chris; Parag, Varsha; Kerse, Ngaire; Waters, Jill			Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULCERS	OBJECTIVE To determine the effect of low dose aspirin on ulcer healing in patients with venous leg ulcers. DESIGN Pragmatic, community based, parallel group, double blind, randomised controlled trial. SETTING Five community nursing centres in New Zealand. PARTICIPANTS 251 adults with venous leg ulcers who could safely be treated with aspirin or placebo: 125 were randomised to aspirin and 126 to placebo. INTERVENTIONS 150 mg oral aspirin daily or matching placebo for up to 24 weeks treatment, with compression therapy as standard background treatment. MAIN OUTCOME MEASURES The primary outcome was time to complete healing of the reference ulcer (largest ulcer if more than one ulcer was present). Secondary outcomes included proportion of participants healed, change in ulcer area, change in health related quality of life, and adverse events. Analysis was by intention to treat. RESULTS The median number of days to healing of the reference ulcer was 77 in the aspirin group and 69 in the placebo group (hazard ratio 0.85, 95% confidence interval 0.64 to 1.13, P=0.25). The number of participants healed at the endpoint was 88 (70%) in the aspirin group and 101 (80%) in the placebo group (risk difference -9.8%, 95% confidence interval -20.4% to 0.9%, P=0.07). Estimated change in ulcer area was 4.1 cm(2) in the aspirin group and 4.8 cm(2) in the placebo group (mean difference -0.7 cm(2), 95% confidence interval -1.9 to 0.5 cm(2), P=0.25). 40 adverse events occurred among 29 participants in the aspirin group and 37 adverse events among 27 participants in the placebo group (incidence rate ratio 1.1, 95% confidence interval 0.7 to 1.7, P=0.71). CONCLUSION Our findings do not support the use of low dose aspirin as adjuvant treatment for venous leg ulcers.	[Jull, Andrew] Univ Auckland, Sch Nursing, Auckland, New Zealand; [Jull, Andrew; Wadham, Angela; Bullen, Chris; Parag, Varsha] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Kerse, Ngaire] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Waters, Jill] Auckland Dist Hlth Board, Adult Long Term Condit & Community Serv, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland District Health Board	Jull, A (corresponding author), Univ Auckland, Sch Nursing, Auckland, New Zealand.; Jull, A (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand.	a.jull@auckland.ac.nz	Kerse, Ngaire/AFF-8119-2022; Bullen, Chris/E-4594-2017; Jull, Andrew/I-1737-2013	Bullen, Chris/0000-0001-6807-2930; Jull, Andrew/0000-0002-8484-3771	Health Research Council (HRC) of New Zealand [14/269]; HRC	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); HRC	The Health Research Council (HRC) of New Zealand was the sole funder of this trial (project grant 14/269). The HRC is a government funded statutory body responsible for managing the government's investment in health research through competitive peer reviewed grants. The HRC had no role in the conduct or analysis of the Aspirin4VLU trial.	BHAGAT K, 1995, CIRCULATION, V92, P2113, DOI 10.1161/01.CIR.92.8.2113; Calonge N, 2009, ANN INTERN MED, V150, P396; Collins L, 2010, AM FAM PHYSICIAN, V81, P989; Carvalho PED, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009432.pub2; Sola ML, 2012, ANN VASC SURG, V26, P620, DOI 10.1016/j.avsg.2011.02.051; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Fagrell B, 1997, J INTERN MED, V241, P349, DOI 10.1046/j.1365-2796.1997.125148000.x; Georgescu A, 2009, J THROMB HAEMOST, V7, P1566, DOI 10.1111/j.1538-7836.2009.03525.x; GOODFIELD MJD, 1986, BRIT J DERMATOL, V115, P521, DOI 10.1111/j.1365-2133.1986.tb05761.x; HANLEY SP, 1981, LANCET, V1, P969; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Iglesias C, 2004, HEALTH TECHNOL ASSES, V8, P1; Jull A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001733.pub2; Jull A, 2008, BRIT J SURG, V95, P175, DOI 10.1002/bjs.6059; Jull A, 2016, J ADV NURS, V72, P669, DOI 10.1111/jan.12864; LAYTON AM, 1994, LANCET, V344, P164, DOI 10.1016/S0140-6736(94)92759-6; Lu XW, 2006, ANGIOLOGY, V57, P321, DOI 10.1177/000331970605700308; Margolis DJ, 2000, AM J MED, V109, P15, DOI 10.1016/S0002-9343(00)00379-X; O'Donnell TF, 2014, J VASC SURG, V60, p3S, DOI 10.1016/j.jvs.2014.04.049; Petherick ES, 2015, FAM PRACT, V32, P374, DOI 10.1093/fampra/cmv013; Rocca Bianca, 2012, Thrombosis, V2012, P376721, DOI 10.1155/2012/376721; Scallon C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006477.pub2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Walker N, 2002, NEW ZEAL MED J, V115, P159	24	18	18	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2017	359								j5157	10.1136/bmj.j5157	http://dx.doi.org/10.1136/bmj.j5157			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WH	29175902	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000416473300001
J	Roberts, ET; Zaslavsky, AM; McWilliams, JM				Roberts, Eric T.; Zaslavsky, Alan M.; McWilliams, J. Michael			The Value-Based Payment Modifier: Program Outcomes and Implications for Disparities	ANNALS OF INTERNAL MEDICINE			English	Article							ACCOUNTABLE CARE ORGANIZATIONS; REGRESSION DISCONTINUITY DESIGNS; SHARED SAVINGS PROGRAM; HEALTH-CARE; PERFORMANCE; RISK; ASSOCIATION; COSTS	Background: When risk adjustment is inadequate and incentives are weak, pay-for-performance programs, such as the Value-Based Payment Modifier (Value Modifier [VM]) implemented by the Centers for Medicare & Medicaid Services, may contribute to health care disparities without improving performance on average. Objective: To estimate the association between VM exposure and performance on quality and spending measures and to assess the effects of adjusting for additional patient characteristics on performance differences between practices serving higher-risk and those serving lower-risk patients. Design: Exploiting the phase-in of the VM on the basis of practice size, regression discontinuity analysis and 2014 Medicare claims were used to estimate differences in practice performance associated with exposure of practices with 100 or more clinicians to full VM incentives (bonuses and penalties) and exposure of practices with 10 or more clinicians to partial incentives (bonuses only). Analyses were repeated with 2015 claims to estimate performance differences associated with a second year of exposure above the threshold of 100 or more clinicians. Performance differences were assessed between practices serving higher-and those serving lower-risk patients after standard Medicare adjustments versus adjustment for additional patient characteristics. Setting: Fee-for-service Medicare. Patients: Random 20% sample of beneficiaries. Measurements: Hospitalization for ambulatory care-sensitive conditions, all-cause 30-day readmissions, Medicare spending, and mortality. Results: No statistically significant discontinuities were found at the threshold of 10 or more or 100 or more clinicians in the relationship between practice size and performance on quality or spending measures in either year. Adjustment for additional patient characteristics narrowed performance differences by 9.2% to 67.9% between practices in the highest and those in the lowest quartile of Medicaid patients and Hierarchical Condition Category scores. Limitation: Observational design and administrative data. Conclusion: The VM was not associated with differences in performance on program measures. Performance differences between practices serving higher-and those serving lower-risk patients were affected considerably by additional adjustments, suggesting a potential for Medicare's pay-for-performance programs to exacerbate health care disparities.	[Roberts, Eric T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, A653 Crabtree Hall,130 De Soto St, Pittsburgh, PA 15261 USA; [Zaslavsky, Alan M.; McWilliams, J. Michael] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McWilliams, JM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu		Roberts, Eric/0000-0002-7439-0799	The Laura and John Arnold Foundation; National Institute on Aging of the National Institutes of Health [P01 AG032952]; Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School; NATIONAL INSTITUTE ON AGING [P30AG024827, P01AG032952] Funding Source: NIH RePORTER	The Laura and John Arnold Foundation; National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grants from the Laura and John Arnold Foundation, National Institute on Aging of the National Institutes of Health (P01 AG032952), and Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School.	Anderson Gerard F, 2015, Issue Brief (Commonw Fund), V20, P1; Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660; Buntin MB, 2017, NEW ENGL J MED, V376, P507, DOI 10.1056/NEJMp1700081; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Center for Medicare and Medicaid Innovation, 2017, CPC PAYM METH BEN AT; Centers for Medicare & Medicaid Services, 2016, PHYS GROUPS RES UPW; Centers for Medicare & Medicaid Services, 2016, TIM PHAS VAL BAS PAY; Centers for Medicare & Medicaid Services, 2015, 2014 MEAS INF PER CA; Centers for Medicare & Medicaid Services, 2015, 2 STEP ATTR MEAS INC; Centers for Medicare & Medicaid Services, 2015, COMP 2016 VAL MOD; Centers for Medicare & Medicaid Services, 2014, FED REGISTER, V79, P67931; Centers for Medicare & Medicaid Services, 2015, 2014 MEAS INF AC CHR; Centers for Medicare & Medicaid Services, 2015, DET METH 2016 VAL MO; Centers for Medicare & Medicaid Services, 2015, 2014 MEAS INF 30 DAY; Centers for Medicare & Medicaid Services, 2015, 2015 VAL BAS PAYM MO; Centers for Medicare & Medicaid Services, 2017, DET METH 2017 VAL MO; Centers for Medicare & Medicaid Services, 2016, MED DAT PROV PRACT S; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P77008; Centers for Medicare & Medicaid Services (CMS) HHS, 2013, Fed Regist, V78, P74229; Centers for Medicare & Medicaid Services; Research Data Assistance Center, 2016, SHAR SAV PROGR ACC C; Centers for Medicare & Medicaid Services; U.S. Department of Health and Human Services, 2016, FED REGISTER, V81, P77338; Chen LM, 2017, JAMA-J AM MED ASSOC, V318, P453, DOI 10.1001/jama.2017.9643; Colla CH, 2017, JAMA INTERN MED, V177, P527, DOI 10.1001/jamainternmed.2016.9122; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; Friedberg MW, 2010, HEALTH AFFAIR, V29, P926, DOI 10.1377/hlthaff.2009.0985; Glied S., 2016, HLTH AFFAIRS BLOG, DOI [10.1377/hblog20160715.055867, DOI 10.1377/HBLOG20160715.055867]; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; Kuye IO, 2013, JAMA INTERN MED, V173, P1100, DOI 10.1001/jamainternmed.2013.845; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Lowes Robert, 2016, MEDSCAPE; McWilliams JM, 2017, ANN INTERN MED, V167, P122, DOI 10.7326/M17-0230; McWilliams JM, 2017, JAMA INTERN MED, V177, P518, DOI 10.1001/jamainternmed.2016.9115; McWilliams JM, 2017, NEW ENGL J MED, V376, P807, DOI 10.1056/NEJMp1612779; McWilliams JM, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI 10.1001/jama.2016.12049; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; National Academies of Sciences Engineering and Medicine, 2016, ACOS GUID MACRA, P25; National Academies of Sciences Engineering and Medicine, 2016, ACC SOC RISK FACT ME; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Peikes D, 2016, EVALUATION COMPREHEN; Pope GC, 2011, EVALUATION CMS HCC R; Rose S, 2016, HEALTH AFFAIR, V35, P440, DOI 10.1377/hlthaff.2015.1026; Ryan AM, 2013, NEW ENGL J MED, V369, P2472, DOI 10.1056/NEJMp1312654; US Department of Health and Human Services, 2016, REP C SOC RISK FACT; VanLare JM, 2012, JAMA-J AM MED ASSOC, V308, P2089, DOI 10.1001/jama.2012.14834; Venkataramani AS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1216	46	71	71	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					255	+		10.7326/M17-1740	http://dx.doi.org/10.7326/M17-1740			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	29181511	Green Accepted			2022-12-28	WOS:000425434000014
J	Uusitupa, M				Uusitupa, Matti			Remission of type 2 diabetes: mission not impossible	LANCET			English	Editorial Material							LIFE-STYLE INTERVENTION; FOLLOW-UP; PREVENTION; OUTCOMES; TRIAL		[Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio 70211, Finland	University of Eastern Finland	Uusitupa, M (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio 70211, Finland.	matti.uusitupa@uef.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020					Gregg EW, 2016, LANCET DIABETES ENDO, V4, P913, DOI 10.1016/S2213-8587(16)30162-0; IDF, 2017, IDF CLIN PRACT REC M; Lean MEJ, 2017, LANCET; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Taylor R, 2018, DIABETOLOGIA, V61, P273, DOI 10.1007/s00125-017-4504-z; Uusitupa MIJ, 1996, ANN MED, V28, P445, DOI 10.3109/07853899608999106; WHO, 2016, GLOB REP PSOR; Wu JHY, 2017, LANCET DIABETES ENDO, V5, P965, DOI [10.1016/S2213-8587(17)30307-8, 10.1016/s2213-8587(17)30307-8]	11	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					515	516		10.1016/S0140-6736(17)33100-8	http://dx.doi.org/10.1016/S0140-6736(17)33100-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV5VB	29221646				2022-12-28	WOS:000424649400005
J	Sinharay, R; Gong, JC; Barratt, B; Ohman-Strickland, P; Ernst, S; Kelly, FJ; Zhang, JF; Collins, P; Cullinan, P; Chung, KF				Sinharay, Rudy; Gong, Jicheng; Barratt, Benjamin; Ohman-Strickland, Pamela; Ernst, Sabine; Kelly, Frank J.; Zhang, Junfeng (Jim); Collins, Peter; Cullinan, Paul; Chung, Kian Fan			Respiratory and cardiovascular responses to walking down a traffic-polluted road compared with walking in a traffic-free area in participants aged 60 years and older with chronic lung or heart disease and age-matched healthy controls: a randomised, crossover study	LANCET			English	Article							DIESEL-EXHAUST INHALATION; PARTICULATE AIR-POLLUTION; OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL STIFFNESS; PHYSICAL-ACTIVITY; TERM EXPOSURE; MATTER PM10; MORTALITY; COHORT; METAANALYSIS	Background Long-term exposure to pollution can lead to an increase in the rate of decline of lung function, especially in older individuals and in those with chronic obstructive pulmonary disease (COPD), whereas shorter-term exposure at higher pollution levels has been implicated in causing excess deaths from ischaemic heart disease and exacerbations of COPD. We aimed to assess the effects on respiratory and cardiovascular responses of walking down a busy street with high levels of pollution compared with walking in a traffic-free area with lower pollution levels in older adults. Methods In this randomised, crossover study, we recruited men and women aged 60 years and older with angiographically proven stable ischaemic heart disease or stage 2 Global initiative for Obstructive Lung Disease (GOLD) COPD who had been clinically stable for 6 months, and age-matched healthy volunteers. Individuals with ischaemic heart disease or COPD were recruited from existing databases or outpatient respiratory and cardiology clinics at the Royal Brompton & Harefield NHS Foundation Trust and age-matched healthy volunteers using advertising and existing databases. All participants had abstained from smoking for at least 12 months and medications were taken as recommended by participants' doctors during the study. Participants were randomly assigned by drawing numbered disks at random from a bag to do a 2 h walk either along a commercial street in London (Oxford Street) or in an urban park (Hyde Park). Baseline measurements of participants were taken before the walk in the hospital laboratory. During each walk session, black carbon, particulate matter (PM) concentrations, ultrafine particles, and nitrogen dioxide (NO2) concentrations were measured. Findings Between October, 2012, and June, 2014, we screened 135 participants, of whom 40 healthy volunteers, 40 individuals with COPD, and 39 with ischaemic heart disease were recruited. Concentrations of black carbon, NO2, PM10, PM2.5, and ultrafine particles were higher on Oxford Street than in Hyde Park. Participants with COPD reported more cough (odds ratio [OR] 1.95, 95% CI 0.96-3.95; p<0.1), sputum (3.15, 1.39-7.13; p<0.05), shortness of breath (1.86, 0.97-3.57; p<0.1), and wheeze (4.00, 1.52-10.50; p<0.05) after walking down Oxford Street compared with Hyde Park. In all participants, irrespective of their disease status, walking in Hyde Park led to an increase in lung function (forced expiratory volume in the first second [FEV1] and forced vital capacity [FVC]) and a decrease in pulse wave velocity (PWV) and augmentation index up to 26 h after the walk. By contrast, these beneficial responses were attenuated after walking on Oxford Street. In participants with COPD, a reduction in FEV1 and FVC, and an increase in R5-20 were associated with an increase in during-walk exposure to NO2, ultrafine particles and PM2.5, and an increase in PWV and augmentation index with NO2 and ultrafine particles. In healthy volunteers, PWV and augmentation index were associated both with black carbon and ultrafine particles. Interpretation Short-term exposure to traffic pollution prevents the beneficial cardiopulmonary effects of walking in people with COPD, ischaemic heart disease, and those free from chronic cardiopulmonary diseases. Medication use might reduce the adverse effects of air pollution in individuals with ischaemic heart disease. Policies should aim to control ambient levels of air pollution along busy streets in view of these negative health effects.	[Sinharay, Rudy; Collins, Peter; Cullinan, Paul; Chung, Kian Fan] Imperial Coll, Natl Heart & Lung Inst, London SW3 6LY, England; [Sinharay, Rudy; Collins, Peter; Cullinan, Paul; Chung, Kian Fan] Imperial Coll, MRC PHE Ctr Environm & Hlth, London, England; [Sinharay, Rudy; Ernst, Sabine; Collins, Peter; Cullinan, Paul; Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, NIHR Biomed Res Unit, London, England; [Gong, Jicheng; Zhang, Junfeng (Jim)] Peking Univ, Coll Environm Sci & Engn, BIC ESAT, Beijing, Peoples R China; [Gong, Jicheng; Zhang, Junfeng (Jim)] Peking Univ, Coll Environm Sci & Engn, SKL ESPC, Beijing, Peoples R China; [Gong, Jicheng; Zhang, Junfeng (Jim)] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Gong, Jicheng; Zhang, Junfeng (Jim)] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Gong, Jicheng; Zhang, Junfeng (Jim)] Duke Kunshan Univ, Kunshan, Peoples R China; [Barratt, Benjamin; Kelly, Frank J.] Kings Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Ohman-Strickland, Pamela] Rutgers State Univ, Rutgers Sch Publ Hlth, New Brunswick, NJ USA	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Peking University; Peking University; Duke University; Duke University; Duke Kunshan University; University of London; King's College London; Rutgers State University New Brunswick	Cullinan, P (corresponding author), Imperial Coll, Natl Heart & Lung Inst, London SW3 6LY, England.	p.cullinan@imperial.ac.uk	Kelly, Frank J/C-6125-2009; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; Gong, Jicheng/AAS-4862-2020; Gong, Jicheng/I-5236-2016	Kelly, Frank J/0000-0003-2558-8392; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; Barratt, Benjamin/0000-0002-5983-0426; Gong, Jicheng/0000-0002-8943-8804; Cullinan, Paul/0000-0002-9314-6468; Ohman Strickland, Pamela/0000-0001-7877-7125	British Heart Foundation; British Heart Foundation [PG/10/82/28608] Funding Source: researchfish; Medical Research Council [MR/L01341X/1] Funding Source: researchfish; Natural Environment Research Council [NE/I008039/1] Funding Source: researchfish; MRC [MR/L01341X/1] Funding Source: UKRI; NERC [NE/I008039/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	British Heart Foundation.	AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; Andersen ZJ, 2015, ENVIRON HEALTH PERSP, V123, P557, DOI 10.1289/ehp.1408698; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Berend N, 2016, RESPIROLOGY, V21, P237, DOI 10.1111/resp.12644; Bickel S, 2014, CHEST, V146, P841, DOI 10.1378/chest.13-1875; Borsboom GJJM, 1999, AM J RESP CRIT CARE, V159, P1163, DOI 10.1164/ajrccm.159.4.9703106; Collier SR, 2010, J STRENGTH COND RES, V24, P2846, DOI 10.1519/JSC.0b013e3181e840e0; Dudenbostel T, 2012, CARDIOL REV, V20, P259, DOI 10.1097/CRD.0b013e31825d0a44; Endes S, 2017, INT J HYG ENVIR HEAL, V220, P1030, DOI 10.1016/j.ijheh.2017.06.001; Guan WJ, 2016, LANCET, V388, P1939, DOI 10.1016/S0140-6736(16)31597-5; Kariisa M, 2015, ARCH ENVIRON OCCUP H, V70, P56, DOI 10.1080/19338244.2014.932753; Koulova A, 2014, CARDIOL REV, V22, P30, DOI 10.1097/CRD.0000000000000000; Laden F, 2006, AM J RESP CRIT CARE; Lagorio Susanna, 2006, Environ Health, V5, P11, DOI 10.1186/1476-069X-5-11; Langrish JP, 2012, J INTERN MED, V272, P224, DOI 10.1111/j.1365-2796.2012.02566.x; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lepeule J, 2014, AM J RESP CRIT CARE, V190, P542, DOI 10.1164/rccm.201402-0350OC; Lundback M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-7; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Mills IC, 2015, BMJ OPEN, V5; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mills NL, 2011, EUR HEART J, V32, P2660, DOI 10.1093/eurheartj/ehr195; Miyata R, 2013, TOXICOL APPL PHARM, V272, P1, DOI 10.1016/j.taap.2013.05.033; Nightingale JA, 2000, AM J RESP CRIT CARE, V162, P161, DOI 10.1164/ajrccm.162.1.9908092; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Peretz A, 2008, ENVIRON HEALTH PERSP, V116, P937, DOI 10.1289/ehp.11027; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rundell KW, 2008, J STRENGTH COND RES, V22, P2, DOI 10.1519/JSC.0b013e31815ef98b; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Strak M, 2010, OCCUP ENVIRON MED, V67, P118, DOI 10.1136/oem.2009.046847; Tainio M, 2016, PREV MED, V87, P233, DOI 10.1016/j.ypmed.2016.02.002; Thurston GD, 2016, ENVIRON HEALTH PERSP, V124, P484, DOI 10.1289/ehp.1509676; Upala S, 2017, INT J CARDIOL, V227, P338, DOI 10.1016/j.ijcard.2016.11.073; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Xie WX, 2015, HEART, V101, P257, DOI 10.1136/heartjnl-2014-306165; Zhu RX, 2013, COPD, V10, P307, DOI 10.3109/15412555.2012.744962	36	212	218	18	150	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2018	391	10118					339	349		10.1016/S0140-6736(17)32643-0	http://dx.doi.org/10.1016/S0140-6736(17)32643-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU5CE	29221643	Green Published, hybrid			2022-12-28	WOS:000423869500029
J	Le, TT; Yang, Y; Tan, C; Suhanovsky, MM; Fulbright, RM; Inman, JT; Li, M; Lee, J; Perelman, S; Roberts, JW; Deaconescu, AM; Wang, MD				Le, Tung T.; Yang, Yi; Tan, Chuang; Suhanovsky, Margaret M.; Fulbright, Robert M., Jr.; Inman, James T.; Li, Ming; Lee, Jaeyoon; Perelman, Sarah; Roberts, Jeffrey W.; Deaconescu, Alexandra M.; Wang, Michelle D.			Mfd Dynamically Regulates Transcription via a Release and Catch-Up Mechanism	CELL			English	Article							REPAIR COUPLING FACTOR; RNA-POLYMERASE; SINGLE-MOLECULE; ESCHERICHIA-COLI; DNA-REPAIR; STRUCTURAL BASIS; ELONGATION; COMPLEXES; REVEALS; PROTEIN	The bacterial Mfd ATPase is increasingly recognized as a general transcription factor that participates in the resolution of transcription conflicts with other processes/roadblocks. This function stems from Mfd's ability to preferentially act on stalled RNA poly-merases (RNAPs). However, the mechanism underlying this preference and the subsequent coordination between Mfd and RNAP have remained elusive. Here, using a novel real-time translocase assay, we unexpectedly discovered that Mfd translocates autonomously on DNA. The speed and processivity of Mfd dictate a "release and catch-up'' mechanism to efficiently patrol DNA for frequently stalled RNAPs. Furthermore, we showed that Mfd prevents RNAP backtracking or rescues a severely backtracked RNAP, allowing RNAP to overcome stronger obstacles. However, if an obstacle's resistance is excessive, Mfd dissociates the RNAP, clearing the DNA for other processes. These findings demonstrate a remarkably delicate coordination between Mfd and RNAP, allowing efficient targeting and recycling of Mfd and expedient conflict resolution.	[Le, Tung T.; Yang, Yi; Tan, Chuang; Inman, James T.; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Le, Tung T.; Yang, Yi; Tan, Chuang; Fulbright, Robert M., Jr.; Inman, James T.; Lee, Jaeyoon; Wang, Michelle D.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Le, Tung T.; Yang, Yi; Tan, Chuang; Fulbright, Robert M., Jr.; Inman, James T.; Lee, Jaeyoon; Wang, Michelle D.] Cornell Univ, LASSP, Ithaca, NY 14853 USA; [Li, Ming] Cornell Univ, Dept Chem, Ithaca, NY 14853 USA; [Roberts, Jeffrey W.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Suhanovsky, Margaret M.; Perelman, Sarah; Deaconescu, Alexandra M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA; [Yang, Yi] Kent Optron, Hopewell Jct, NY 12533 USA; [Li, Ming] AT Kearney, Pudong New Area, 88 Century Ave 34F, Shanghai 200121, Peoples R China	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Cornell University; Brown University	Wang, MD (corresponding author), Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA.; Wang, MD (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.; Wang, MD (corresponding author), Cornell Univ, LASSP, Ithaca, NY 14853 USA.	mwang@physics.cornell.edu	Le, Tung/I-6463-2019; Deaconescu, Alexandra/AAW-8139-2021	Deaconescu, Alexandra/0000-0002-2742-5493; Le, Tung/0000-0002-5481-4080	Howard Hughes Medical Institute; National Science Foundation grant [MCB-0820293]; NIH [T32GM008267, R01GM121975, P20GM103430]; UTRA fellowship from Brown University; National Science Foundation EPSCoR grant [1004057]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430, R01GM121975, T32GM008267] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation grant(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTRA fellowship from Brown University; National Science Foundation EPSCoR grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wang laboratory for critical reading of the manuscript. We especially thank Robert Forties, Jie Ma, Jing Jin, Shanna Moore, Jim Baker, Jessica Killian, and Victoria Dorich for helpful discussion and technical assistance. This work was supported by the Howard Hughes Medical Institute, the National Science Foundation grant (MCB-0820293 to M.D.W.), the NIH (T32GM008267 to M.D.W.; R01GM121975 and P20GM103430 to A.M.D.), and an UTRA fellowship from Brown University (to S.P.). This research is based upon work conducted at the Rhode Island Genomics and the NSF/EPSCoR Proteomics Facility, supported in part by the National Science Foundation EPSCoR grant no. 1004057.	Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; Bai L, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12007; Bai Lu, 2009, P263, DOI 10.1039/9781847559982-00263; Belitsky BR, 2011, J MOL BIOL, V411, P729, DOI 10.1016/j.jmb.2011.06.012; Brennan LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13337; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Candelli A, 2013, BIOPOLYMERS, V99, P611, DOI 10.1002/bip.22225; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Deaconescu AM, 2017, PHOTOCHEM PHOTOBIOL, V93, P268, DOI 10.1111/php.12661; Deaconescu AM, 2012, TRENDS BIOCHEM SCI, V37, P543, DOI 10.1016/j.tibs.2012.09.002; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Deaconescu AM, 2005, ACTA CRYSTALLOGR F, V61, P1062, DOI 10.1107/S1744309105035876; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Garcia-Muse T, 2016, NAT REV MOL CELL BIO, V17, P553, DOI 10.1038/nrm.2016.88; Haines NM, 2014, P NATL ACAD SCI USA, V111, P4037, DOI 10.1073/pnas.1322350111; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Inman JT, 2014, NANO LETT, V14, P6475, DOI 10.1021/nl503009d; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kad NM, 2012, PROG MOL BIOL TRANSL, V110, P1, DOI 10.1016/B978-0-12-387665-2.00001-8; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Koch SJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028103; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Landry MP, 2009, BIOPHYS J, V97, P2128, DOI 10.1016/j.bpj.2009.07.048; Li M, 2015, ELIFE, V4, DOI 10.7554/eLife.06249; Li M, 2012, METHOD ENZYMOL, V513, P29, DOI 10.1016/B978-0-12-391938-0.00002-1; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Mustaev A, 2016, P NATL ACAD SCI USA, V113, P8693, DOI 10.1073/pnas.1601056113; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Proshkin SA, 2016, MOL BIOL+, V50, P332, DOI [10.1134/S0026893316020199, 10.7868/S0026898416020191]; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; SELBY CP, 1993, J BACTERIOL, V175, P7509, DOI 10.1128/JB.175.23.7509-7514.1993; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Shepherd N, 2001, J BACTERIOL, V183, P2527, DOI 10.1128/JB.183.8.2527-2534.2001; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith AJ, 2008, DNA REPAIR, V7, P1670, DOI 10.1016/j.dnarep.2008.06.020; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2012, NUCLEIC ACIDS RES, V40, P10408, DOI 10.1093/nar/gks775; Tetone LE, 2017, P NATL ACAD SCI USA, V114, pE1081, DOI 10.1073/pnas.1616525114; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x	65	40	40	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					344	+		10.1016/j.cell.2017.11.017	http://dx.doi.org/10.1016/j.cell.2017.11.017			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29224782	Green Accepted, Bronze			2022-12-28	WOS:000419840100030
J	Wu, Q; Rauscher, PM; Lang, XL; Wojtecki, RJ; de Pablo, JJ; Hore, MJA; Rowan, SJ				Wu, Qiong; Rauscher, Phillip M.; Lang, Xiaolong; Wojtecki, Rudy J.; de Pablo, Juan J.; Hore, Michael J. A.; Rowan, Stuart J.			Poly[n]catenanes: Synthesis of molecular interlocked chains	SCIENCE			English	Article							SUPRAMOLECULAR POLYMERS; SHAPE-MEMORY; MACROMOLECULES; COVALENT; CATENANE; METALLO; LIGANDS; THERMO; ROUTE; BONDS	As the macromolecular version of mechanically interlocked molecules, mechanically interlocked polymers are promising candidates for the creation of sophisticated molecular machines and smart soft materials. Poly[n]catenanes, where the molecular chains consist solely of interlocked macrocycles, contain one of the highest concentrations of topological bonds. We report, herein, a synthetic approach toward this distinctive polymer architecture in high yield (similar to 75%) via efficient ring closing of rationally designed metallosupramolecular polymers. Light-scattering, mass spectrometric, and nuclear magnetic resonance characterization of fractionated samples support assignment of the high-molar mass product (number-average molar mass similar to 21.4 kilograms per mole) to a mixture of linear poly[7-26]catenanes, branched poly[13-130]catenanes, and cyclic poly[4-7]catenanes. Increased hydrodynamic radius (in solution) and glass transition temperature (in bulk materials) were observed upon metallation with Zn2+.	[Wu, Qiong; Rauscher, Phillip M.; de Pablo, Juan J.; Rowan, Stuart J.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Wu, Qiong; Lang, Xiaolong; Wojtecki, Rudy J.; Hore, Michael J. A.; Rowan, Stuart J.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA; [de Pablo, Juan J.; Rowan, Stuart J.] Argonne Natl Lab, Mat Sci Div, 9700 South Cass Ave, Lemont, IL 60439 USA; [de Pablo, Juan J.; Rowan, Stuart J.] Argonne Natl Lab, Inst Mol Engn, 9700 South Cass Ave, Lemont, IL 60439 USA; [Rowan, Stuart J.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	University of Chicago; Case Western Reserve University; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Rowan, SJ (corresponding author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.; Rowan, SJ (corresponding author), Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.; Rowan, SJ (corresponding author), Argonne Natl Lab, Mat Sci Div, 9700 South Cass Ave, Lemont, IL 60439 USA.; Rowan, SJ (corresponding author), Argonne Natl Lab, Inst Mol Engn, 9700 South Cass Ave, Lemont, IL 60439 USA.; Rowan, SJ (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	stuartrowan@uchicago.edu	Wu, Qiong/AAO-2384-2020; Wu, Qiong/AFC-8913-2022; de Pablo, Juan/AAJ-9161-2021; Hore, Michael J. A./F-7534-2012	Wu, Qiong/0000-0001-8768-7738; Wu, Qiong/0000-0001-8768-7738; Wojtecki, Rudy/0000-0003-0967-5007; Hore, Michael J. A./0000-0003-2571-2111; Rowan, Stuart/0000-0001-8176-0594; Lang, Xiaolong/0000-0001-8161-1388	NSF [CHE 1700847, CHE 1402849, CHE 1151423, DMR-1420709]; University of Chicago Materials Research Science and Engineering Center; Direct For Mathematical & Physical Scien [1700847] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Chicago Materials Research Science and Engineering Center(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank K. Herbert for help with figure design and suggestions on DSC data analysis, P. Agrawal for DOSY measurements; and F. Etheridge for helpful discussions. Special thanks to S. Shang for the picture of her bracelet for Fig. 1A and R. Rauscher for assistance with several figures. This work is funded by the NSF under grants CHE 1700847, CHE 1402849, and CHE 1151423 and by the University of Chicago Materials Research Science and Engineering Center, which is Tingled by the NSF under award number DMR-1420709. Additional data are available in the supplementary materials.	Ahamed BN, 2017, ACS MACRO LETT, V6, P468, DOI 10.1021/acsmacrolett.7b00204; AMABILINO DB, 1994, ANGEW CHEM INT EDIT, V33, P1286, DOI 10.1002/anie.199412861; Amabilino DB, 1997, ANGEW CHEM INT EDIT, V36, P2070, DOI 10.1002/anie.199720701; ASHTON PR, 1989, ANGEW CHEM INT EDIT, V28, P1396, DOI 10.1002/anie.198913961; Berrocal JA, 2015, MACROMOLECULES, V48, P1358, DOI 10.1021/ma502392v; Bielawski CW, 2002, SCIENCE, V297, P2041, DOI 10.1126/science.1075401; Breault GA, 1999, TETRAHEDRON, V55, P5265, DOI 10.1016/S0040-4020(99)00282-3; Burnworth M, 2011, NATURE, V472, P334, DOI 10.1038/nature09963; Cao PF, 2015, MACROMOLECULES, V48, P3825, DOI 10.1021/acs.macromol.5b00470; Chichak KS, 2004, SCIENCE, V304, P1308, DOI 10.1126/science.1096914; Coti KK, 2009, NANOSCALE, V1, P16, DOI 10.1039/b9nr00162j; Danon JJ, 2017, SCIENCE, V355, P159, DOI 10.1126/science.aal1619; Davis JJ, 2010, CHEM COMMUN, V46, P54, DOI 10.1039/b915122b; DIETRICHBUCHECKER CO, 1983, TETRAHEDRON LETT, V24, P5095, DOI 10.1016/S0040-4039(00)94050-4; Endo K, 2004, MACROMOLECULES, V37, P3143, DOI 10.1021/ma021237d; Erbas-Cakmak S, 2015, CHEM REV, V115, P10081, DOI 10.1021/acs.chemrev.5b00146; Fustin CA, 2003, J AM CHEM SOC, V125, P2200, DOI 10.1021/ja0292546; Hamers C, 1998, ADV MATER, V10, P1366, DOI 10.1002/(SICI)1521-4095(199811)10:16<1366::AID-ADMA1366>3.0.CO;2-D; Hamers C, 1998, EUR J ORG CHEM, V1998, P2109; Iwamoto H, 2016, CHEM COMMUN, V52, P319, DOI 10.1039/c5cc07562a; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KRAMER R, 1993, P NATL ACAD SCI USA, V90, P5394, DOI 10.1073/pnas.90.12.5394; Kumpfer JR, 2011, J AM CHEM SOC, V133, P12866, DOI 10.1021/ja205332w; Lahlali H, 2011, ANGEW CHEM INT EDIT, V50, P4151, DOI 10.1002/anie.201100415; Lewis JEM, 2017, CHEM COMMUN, V53, P298, DOI 10.1039/c6cc07377h; Michal BT, 2015, MACROMOLECULES, V48, P3239, DOI 10.1021/acs.macromol.5b00646; Muscat D, 1999, MACROMOLECULES, V32, P1737, DOI 10.1021/ma981077z; Niu ZB, 2009, CHEM REV, V109, P6024, DOI 10.1021/cr900002h; Noda Y, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40509; ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044; Pakula T, 1999, MACROMOLECULES, V32, P6821, DOI 10.1021/ma990248c; Ponnuswamy N, 2012, SCIENCE, V338, P783, DOI 10.1126/science.1227032; Rowan SJ, 2005, FARADAY DISCUSS, V128, P43, DOI 10.1039/b403135k; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Watanabe N, 2004, MACROMOLECULES, V37, P6663, DOI 10.1021/ma048782u; Weidmann J., CHEM COMMUN, V1996, P1243; Weidmann JL, 1999, CHEM-EUR J, V5, P1841, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1841::AID-CHEM1841>3.0.CO;2-Q; Wojtecki RJ, 2013, CHEM SCI, V4, P4440, DOI 10.1039/c3sc52082j; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	40	131	132	11	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1434	1439		10.1126/science.aap7675	http://dx.doi.org/10.1126/science.aap7675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29192134	Green Submitted			2022-12-28	WOS:000417918500042
J	Haffajee, RL; Mello, MM				Haffajee, Rebecca L.; Mello, Michelle M.			Drug Companies' Liability for the Opioid Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Haffajee, Rebecca L.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University; Stanford University	Haffajee, RL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.			Mello, Michelle/0000-0003-2877-4270	NCATS NIH HHS [KL2 TR002241] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2017, PAIN MAN OP EP BAL S; Ausness Richard C., 2014, W VA L REV, V116, P1117; U.S. Senate Homeland Security and Governmental Affairs Committee, 2017, FUEL EP INS THER SYS; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	4	46	46	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2301	2305		10.1056/NEJMp1710756	http://dx.doi.org/10.1056/NEJMp1710756			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP8VG	29236640	Bronze, Green Accepted			2022-12-28	WOS:000417923600001
J	Hu, J; Dziumbla, S; Lin, JH; Bibli, SI; Zukunft, S; de Mos, J; Awwad, K; Fromel, T; Jungmann, A; Devraj, K; Cheng, ZX; Wang, LY; Fauser, S; Eberhart, CG; Sodhi, A; Hammock, BD; Liebner, S; Muller, OJ; Glaubitz, C; Hammes, HP; Popp, R; Fleming, I				Hu, Jiong; Dziumbla, Sarah; Lin, Jihong; Bibli, Sofia-Iris; Zukunft, Sven; de Mos, Julian; Awwad, Khader; Froemel, Timo; Jungmann, Andreas; Devraj, Kavi; Cheng, Zhixing; Wang, Liya; Fauser, Sascha; Eberhart, Charles G.; Sodhi, Akrit; Hammock, Bruce D.; Liebner, Stefan; Mueller, Oliver J.; Glaubitz, Clemens; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid			Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy	NATURE			English	Article							BLOOD-RETINAL BARRIER; VE-CADHERIN; DEPENDENT ENDOCYTOSIS; ENDOTHELIAL-CELLS; ACID; ANGIOGENESIS; ASSOCIATION; CHOLESTEROL; STABILITY; MEMBRANES	Diabetic retinopathy is an important cause of blindness in adults(1,2), and is characterized by progressive loss of vascular cells and slow dissolution of inter-vascular junctions, which result in vascular leakage and retinal oedema(3). Later stages of the disease are characterized by inflammatory cell infiltration, tissue destruction and neovascularization(4,5). Here we identify soluble epoxide hydrolase (sEH) as a key enzyme that initiates pericyte loss and breakdown of endothelial barrier function by generating the diol 19,20-dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid. The expression of sEH and the accumulation of 19,20-dihydroxydocosapentaenoic acid were increased in diabetic mouse retinas and in the retinas and vitreous humour of patients with diabetes. Mechanistically, the diol targeted the cell membrane to alter the localization of cholesterol-binding proteins, and prevented the association of presenilin 1 with N-cadherin and VE-cadherin, thereby compromising pericyte-endothelial cell interactions and inter-endothelial cell junctions. Treating diabetic mice with a specific sEH inhibitor prevented the pericyte loss and vascular permeability that are characteristic of non-proliferative diabetic retinopathy. Conversely, overexpression of sEH in the retinal Muller glial cells of non-diabetic mice resulted in similar vessel abnormalities to those seen in diabetic mice with retinopathy. Thus, increased expression of sEH is a key determinant in the pathogenesis of diabetic retinopathy, and inhibition of sEH can prevent progression of the disease.	[Hu, Jiong; Dziumbla, Sarah; Bibli, Sofia-Iris; Zukunft, Sven; Awwad, Khader; Froemel, Timo; Popp, Ruediger; Fleming, Ingrid] Goethe Univ, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany; [Hu, Jiong; Dziumbla, Sarah; Bibli, Sofia-Iris; Froemel, Timo; Liebner, Stefan; Popp, Ruediger; Fleming, Ingrid] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Berlin, Germany; [Lin, Jihong; Hammes, Hans-Peter] Heidelberg Univ, Univ Med Mannheim, Med Dept 5, Mannheim, Germany; [de Mos, Julian; Glaubitz, Clemens] Goethe Univ, Inst Biophys Chem, Frankfurt, Germany; [de Mos, Julian; Glaubitz, Clemens] Goethe Univ, Ctr Biomol Magnet Resonance, Frankfurt, Germany; [Jungmann, Andreas; Mueller, Oliver J.] Univ Heidelberg Hosp, Internal Med 3, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Jungmann, Andreas; Mueller, Oliver J.] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg, Mannheim, Germany; [Devraj, Kavi; Liebner, Stefan] Goethe Univ, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Cheng, Zhixing; Wang, Liya] Henan Eye Inst, Zhengzhou, Henan, Peoples R China; [Cheng, Zhixing; Wang, Liya] Henan Eye Hosp, Zhengzhou, Henan, Peoples R China; [Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Eberhart, Charles G.; Sodhi, Akrit] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA 95616 USA; [Mueller, Oliver J.] Univ Kiel, Dept Internal Med 3, Arnold Heller Str 3, D-24105 Kiel, Germany	Goethe University Frankfurt; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Goethe University Frankfurt; University of Cologne; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Davis; University of California System; University of California Davis; University of Kiel	Fleming, I (corresponding author), Goethe Univ, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany.; Fleming, I (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Berlin, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Fleming, Ingrid/L-1225-2014; Hammes, Hans-Peter/S-3719-2019; Devraj, Kavi/I-4701-2019; Müller, Oliver/AAA-4399-2021; Bibli, Sofia Iris/AAK-4439-2021; Glaubitz, Clemens/D-5714-2011	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Devraj, Kavi/0000-0002-5005-3413; Müller, Oliver/0000-0001-8223-2638; Glaubitz, Clemens/0000-0002-3554-6586; Hu, Jiong/0000-0001-8266-0886; de Mos, Julian/0000-0003-0103-7078	Deutsche Forschungsgemeinschaft [SFB-TR 23/A6, B7, SFB 1118/C03, GRK 1874/1, 147]; NIEHS [R01 ES002710]; Deutsche Forschungsgemeinschaft Graduate School CLIC; Bayer; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Deutsche Forschungsgemeinschaft Graduate School CLIC(German Research Foundation (DFG)); Bayer(Bayer AG); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank K. Engel-Herbig, K. Bruch, N. Dietrich and I. Winter for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TR 23/A6 and B7, SFB 1118/C03, GRK 1874/1 and Exzellenzcluster 147 'Cardio-Pulmonary Systems') with partial support from NIEHS R01 ES002710. J.dM. was supported by the Deutsche Forschungsgemeinschaft Graduate School CLIC, and J.H. was the recipient of a research award from the Global Ophthalmology Awards Program from Bayer.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barbosa-Sicard E, 2009, J BIOL CHEM, V284, P28156, DOI 10.1074/jbc.M109.054759; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; HAMMES HP, 1991, P NATL ACAD SCI USA, V88, P11555, DOI 10.1073/pnas.88.24.11555; Hu J, 2014, J EXP MED, V211, P281, DOI 10.1084/jem.20131494; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Kovacevic I, 2012, EMBO J, V31, P3309, DOI 10.1038/emboj.2012.176; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Pellissier LP, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.9; Rivera J, 2004, CLIN CHEM, V50, P224, DOI 10.1373/clinchem.2003.025775; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	38	79	81	7	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					248	+		10.1038/nature25013	http://dx.doi.org/10.1038/nature25013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211719	Green Accepted			2022-12-28	WOS:000418029500046
J	Surana, NK; Kasper, DL				Surana, Neeraj K.; Kasper, Dennis L.			Moving beyond microbiome-wide associations to causal microbe identification	NATURE			English	Article							ESCHERICHIA-COLI; CROHNS-DISEASE; BACTERIA; ORGANISMS; LECTIN; HOST	Microbiome-wide association studies have established that numerous diseases are associated with changes in the microbiota(1,2). These studies typically generate a long list of commensals implicated as biomarkers of disease, with no clear relevance to disease pathogenesis(1-5). If the field is to move beyond correlations and begin to address causation, an effective system is needed for refining this catalogue of differentially abundant microbes and to allow subsequent mechanistic studies(1,4). Here we demonstrate that triangulation of microbe-phenotype relationships is an effective method for reducing the noise inherent in microbiota studies and enabling identification of causal microbes. We found that gnotobiotic mice harbouring different microbial communities exhibited differential survival in a colitis model. Co-housing of these mice generated animals that had hybrid microbiotas and displayed intermediate susceptibility to colitis. Mapping of microbe-phenotype relationships in parental mouse strains and in mice with hybrid microbiotas identified the bacterial family Lachnospiraceae as a correlate for protection from disease. Using directed microbial culture techniques, we discovered Clostridium immunis, a previously unknown bacterial species from this family, that-when administered to colitis-prone mice-protected them against colitis-associated death. To demonstrate the generalizability of our approach, we used it to identify several commensal organisms that induce intestinal expression of an antimicrobial peptide. Thus, we have used microbe-phenotype triangulation to move beyond the standard correlative microbiome study and identify causal microbes for two completely distinct phenotypes. Identification of disease-modulating commensals by microbe-phenotype triangulation may be more broadly applicable to human microbiome studies.	[Surana, Neeraj K.; Kasper, Dennis L.] Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Surana, Neeraj K.] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Surana, NK; Kasper, DL (corresponding author), Harvard Med Sch, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Surana, NK (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA.	neeraj.surana@childrens.harvard.edu; dennis_kasper@hms.harvard.edu			Boston Children's Hospital; National Institutes of Health [K08 AI108690, U19 AI109764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109764, K08AI108690] Funding Source: NIH RePORTER	Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Couter for technical assistance; S. Edwards, J. Ramos, and T. Sherpa for assistance with gnotobiotic mice; R. Bronson for review of histology; J. McCoy for editorial assistance; and members of the Kasper laboratory for discussions. Support for this work was provided by a Career Development Award from Boston Children's Hospital (N.K.S.) and National Institutes of Health grants K08 AI108690 (N.K.S.) and U19 AI109764 (N.K.S. and D.L.K.).	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; KANEUCHI C, 1976, INT J SYST BACTERIOL, V26, P195, DOI 10.1099/00207713-26-2-195; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Surana NK, 2014, J CLIN INVEST, V124, P4197, DOI 10.1172/JCI72332; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	31	131	138	3	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					244	+		10.1038/nature25019	http://dx.doi.org/10.1038/nature25019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211710	Green Accepted, Green Submitted			2022-12-28	WOS:000418029500045
J	Tikhomirov, G; Petersen, P; Qian, LL				Tikhomirov, Grigory; Petersen, Philip; Qian, Lulu			Fractal assembly of micrometre-scale DNA origami arrays with arbitrary patterns	NATURE			English	Article							NANOSTRUCTURES	Self-assembled DNA nanostructures(1) enable nanometre-precise patterning that can be used to create programmable molecular machines(2-6) and arrays of functional materials(7-9). DNA origami(10) is particularly versatile in this context because each DNA strand in the origami nanostructure occupies a unique position and can serve as a uniquely addressable pixel. However, the scale of such structures(11-14) has been limited to about 0.05 square micrometres, hindering applications that demand a larger layout(15) and integration with more conventional patterning methods. Hierarchical multistage assembly of simple sets of tiles(16,17) can in principle overcome this limitation, but so far has not been sufficiently robust to enable successful implementation of larger structures using DNA origami tiles. Here we show that by using simple local assembly rules(18) that are modified and applied recursively throughout a hierarchical, multistage assembly process, a small and constant set of unique DNA strands can be used to create DNA origami arrays of increasing size and with arbitrary patterns. We illustrate this method, which we term 'fractal assembly', by producing DNA origami arrays with sizes of up to 0.5 square micrometres and with up to 8,704 pixels, allowing us to render images such as the Mona Lisa and a rooster. We find that self-assembly of the tiles into arrays is unaffected by changes in surface patterns on the tiles, and that the yield of the fractal assembly process corresponds to about 0.95(m-1) for arrays containing m tiles. When used in conjunction with a software tool that we developed that converts an arbitrary pattern into DNA sequences and experimental protocols, our assembly method is readily accessible and will facilitate the construction of sophisticated materials and devices with sizes similar to that of a bacterium using DNA nanostructures.	[Tikhomirov, Grigory; Qian, Lulu] CALTECH, Bioengn, Pasadena, CA 91125 USA; [Petersen, Philip] CALTECH, Biol, Pasadena, CA 91125 USA; [Qian, Lulu] CALTECH, Comp Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Qian, LL (corresponding author), CALTECH, Bioengn, Pasadena, CA 91125 USA.; Qian, LL (corresponding author), CALTECH, Comp Sci, Pasadena, CA 91125 USA.	luluqian@caltech.edu		Tikhomirov, Grigory/0000-0001-6061-3843	BWF grant [1010684]; NIH/NRSA training grant [5 T32 GM07616]; Burroughs Wellcome Fund [1010684]; Faculty Early Career Development Award from NSF [1351081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	BWF grant; NIH/NRSA training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Faculty Early Career Development Award from NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. M. Murray for sharing an acoustic liquid-handling robot and P. W. K. Rothemund for sharing a qPCR machine. We thank E. Winfree and P. W. K. Rothemund for critiques on the manuscript. G.T. was supported by a BWF grant (1010684). P. P. was supported by a NIH/NRSA training grant (5 T32 GM07616). L.Q. was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (1010684) and a Faculty Early Career Development Award from NSF (1351081).	Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Chandran H, 2011, LECT NOTES COMPUT SC, V6937, P64, DOI 10.1007/978-3-642-23638-9_8; Chatterjee G, 2017, NAT NANOTECHNOL, V12, P920, DOI [10.1038/NNANO.2017.127, 10.1038/nnano.2017.127]; Delbruck T., 1995, VISION CHIPS IMPLEME, P139; Doty D, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2380656.2380675; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Knudsen JB, 2015, NAT NANOTECHNOL, V10, P892, DOI [10.1038/NNANO.2015.190, 10.1038/nnano.2015.190]; Lin CX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1070; Lulu Qian, 2014, DNA Computing and Molecular Programming. 20th International Conference, DNA 20. Proceedings: LNCS 8727, P114, DOI 10.1007/978-3-319-11295-4_8; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; Marchi AN, 2014, NANO LETT, V14, P5740, DOI 10.1021/nl502626s; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Nangreave J, 2009, BIOPHYS J, V97, P563, DOI 10.1016/j.bpj.2009.05.013; Park S.H., 2006, ANGEW CHEM, V118, P749; Petersen P., 2017, FRACTILE COMPILER; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Rajendran A, 2011, ACS NANO, V5, P665, DOI 10.1021/nn1031627; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Thubagere AJ, 2017, SCIENCE, V357, DOI 10.1126/science.aan6558; Tikhomirov G, 2017, NAT NANOTECHNOL, V12, P251, DOI [10.1038/NNANO.2016.256, 10.1038/nnano.2016.256]; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zenk J, 2016, J AM CHEM SOC, V138, P3346, DOI 10.1021/jacs.5b10502; Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a	30	254	259	17	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					67	71		10.1038/nature24655	http://dx.doi.org/10.1038/nature24655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29219965				2022-12-28	WOS:000417560500044
J	Blumenthal, DM; Olenski, AR; Tsugawa, Y; Jena, AB				Blumenthal, Daniel M.; Olenski, Andrew R.; Tsugawa, Yusuke; Jena, Anupam B.			Association Between Treatment by Locum Tenens Internal Medicine Physicians and 30-Day Mortality Among Hospitalized Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT SAFETY; SEX-DIFFERENCES; HEART-FAILURE; TEAMWORK; RATES; CARE; READMISSION; DOCTORS	IMPORTANCE Use of locum tenens physicians has increased in the United States, but information about their quality and costs of care is lacking. OBJECTIVE To evaluate quality and costs of care among hospitalized Medicare beneficiaries treated by locum tenens vs non-locum tenens physicians. DESIGN, SETTING, AND PARTICIPANTS A random sample of Medicare fee-for-service beneficiaries hospitalized during 2009-2014 was used to compare quality and costs of hospital care delivered by locum tenens and non-locum tenens internal medicine physicians. EXPOSURES Treatment by locum tenens general internal medicine physicians. MAIN OUTCOMES AND MEASURES The primary outcome was 30-day mortality. Secondary outcomes included inpatient Medicare Part B spending, length of stay, and 30-day readmissions. Differences between locum tenens and non-locum tenens physicians were estimated using multivariable logistic regression models adjusted for beneficiary clinical and demographic characteristics and hospital fixed effects, which enabled comparisons of clinical outcomes between physicians practicing within the same hospital. In prespecified subgroup analyses, outcomes were reevaluated among hospitals with different levels of intensity of locum tenens physician use. RESULTS Of 1 818 873 Medicare admissions treated by general internists, 38 475 (2.1%) received care from a locum tenens physician; 9.3%(4123/44 520) of general internists were temporarily covered by a locum tenens physician at some point. Differences in patient characteristics, demographics, comorbidities, and reason for admission between locum tenens and non-locum tenens physicians were not clinically relevant. Treatment by locum tenens physicians, compared with treatment by non-locum tenens physicians (n = 44 520 physicians), was not associated with a significant difference in 30-day mortality (8.83% vs 8.70%; adjusted difference, 0.14%; 95% CI, -0.18% to 0.45%). Patients treated by locum tenens physicians had significantly higher Part B spending ($1836 vs $1712; adjusted difference, $124; 95% CI, $93 to $154), significantly longer mean length of stay (5.64 days vs 5.21 days; adjusted difference, 0.43 days; 95% CI, 0.34 to 0.52), and significantly lower 30-day readmissions (22.80% vs 23.83%; adjusted difference, -1.00%; 95% CI -1.57% to -0.54%). CONCLUSIONS AND RELEVANCE Among hospitalized Medicare beneficiaries treated by a general internist, there were no significant differences in overall 30-day mortality rates among patients treated by locum tenens compared with non-locum tenens physicians. Additional research may help determine hospital-level factors associated with the quality and costs of care related to locum tenens physicians.	[Blumenthal, Daniel M.] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA; [Blumenthal, Daniel M.] Harvard Med Sch, Boston, MA 02115 USA; [Olenski, Andrew R.] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Tsugawa, Yusuke] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu		Olenski, Andrew/0000-0002-7461-0536; Tsugawa, Yusuke/0000-0002-1937-4833	Office of the Director, National Institutes of Health [1DP5OD017897]; John S. LaDue Memorial Fellowship at Harvard Medical School; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. LaDue Memorial Fellowship at Harvard Medical School; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant 1DP5OD017897 from the Office of the Director, National Institutes of Health (Dr Jena, NIH Early Independence Award). Dr Blumenthal is supported by a grant from the John S. LaDue Memorial Fellowship at Harvard Medical School.	Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Campbell EG, 2010, JT COMM J QUAL PATIE, V36, P319, DOI 10.1016/S1553-7250(10)36048-X; Dietz AS, 2014, J CRIT CARE, V29, P908, DOI 10.1016/j.jcrc.2014.05.025; Doty B, 2009, WORLD J SURG, V33, P228, DOI 10.1007/s00268-008-9820-5; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Filice CE, 2016, MED CARE; Hackman JR., 2002, LEADING TEAMS SETTIN; Huckman RS, 2009, MANAGE SCI, V55, P85, DOI 10.1287/mnsc.1080.0921; Huckman RS, 2006, MANAGE SCI, V52, P473, DOI 10.1287/mnsc.1050.0464; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Jennison T, 2013, INT J SURG, V11, P1141, DOI 10.1016/j.ijsu.2013.09.014; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Lowes R., 2007, MED ECON, V84, P42; Lowes Robert, 2007, Med Econ, V84, ppassim; Lowes Robert, 2007, Med Econ, V84, P40; Mills P, 2008, J AM COLL SURGEONS, V206, P107, DOI 10.1016/j.jamcollsurg.2007.06.281; O'Leary KJ, 2012, J HOSP MED, V7, P48, DOI 10.1002/jhm.970; Patel MR, 2007, AM J MED, V120, P40, DOI 10.1016/j.amjmed.2006.10.008; Poole SR, 1996, PEDIATRICS, V98, P403; Popescu I, 2007, JAMA-J AM MED ASSOC, V297, P2489, DOI 10.1001/jama.297.22.2489; Shah B, 2009, J AM COLL CARDIOL, V53, P416, DOI 10.1016/j.jacc.2008.09.045; Sim AJW, 2011, RURAL REMOTE HEALTH, V11; Simon AB, 2004, J HEALTHC MANAG, V49, P363, DOI 10.1097/00115514-200411000-00005; Speroff T, 2010, QUAL SAF HEALTH CARE, V19, P592, DOI 10.1136/qshc.2009.039511; Tsugawa Y, 2017, JAMA INTERN MED, V177, P675, DOI 10.1001/jamainternmed.2017.0059; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; WENNBERG JE, 1999, DARTMOUTH ATLAS HEAL; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; Xu R, 2013, ANN SURG, V258, P953, DOI 10.1097/SLA.0b013e3182864ffe; Zimlich Rachael, 2014, Med Econ, V91, P58	32	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2119	2129		10.1001/jama.2017.17925	http://dx.doi.org/10.1001/jama.2017.17925			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO7XT	29209722	Green Published, Bronze			2022-12-28	WOS:000417093500017
J	Oshima, Y; Morishima, Y; Ono, K; Hirano, M; Suzuki, K				Oshima, Yasuo; Morishima, Yuko; Ono, Koichi; Hirano, Masaya; Suzuki, Katsunori			Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina	ANNALS OF INTERNAL MEDICINE			English	Letter									[Oshima, Yasuo; Morishima, Yuko; Ono, Koichi; Hirano, Masaya; Suzuki, Katsunori] Amer Coll Phys Japan Chapter, Tokyo, Japan		Oshima, Y (corresponding author), Amer Coll Phys Japan Chapter, Tokyo, Japan.		Oshima, Yasuo/AGN-3291-2022	Oshima, Yasuo/0000-0002-6236-6986				Vogrin S, 2017, ANN INTERN MED, V166, P783, DOI 10.7326/M16-2420	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					836	836		10.7326/L17-0521	http://dx.doi.org/10.7326/L17-0521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204617				2022-12-28	WOS:000417135900025
J	Whyman, JD; Leipzig, RM				Whyman, Jeremy D.; Leipzig, Rosanne M.			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter							OLDER-ADULTS; COHORT		[Whyman, Jeremy D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Leipzig, Rosanne M.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Whyman, JD (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.							Alvarez CA, 2015, BMC GERIATR, V15, DOI 10.1186/1471-2318-15-2; Enthoven WTM, 2016, PHYS THER, V96, P305, DOI 10.2522/ptj.20140525; Maes ML, 2017, THER ADV DRUG SAF, V8, P273, DOI 10.1177/2042098617715381; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Weiner DK, 2003, PAIN MED, V4, P311, DOI 10.1111/j.1526-4637.2003.03042.x	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					834	835		10.7326/L17-0473	http://dx.doi.org/10.7326/L17-0473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204614				2022-12-28	WOS:000417135900023
J	Horton, R				Horton, Richard			Offline: The latent power of doctors	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2425	2425		10.1016/S0140-6736(17)33094-5	http://dx.doi.org/10.1016/S0140-6736(17)33094-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO6UL	29208298				2022-12-28	WOS:000417003400013
J	Zheng, BX; Chung, CM; Corboz, P; Ehlers, G; Qin, MP; Noack, RM; Shi, H; White, SR; Zhang, SW; Chan, GKL				Zheng, Bo-Xiao; Chung, Chia-Min; Corboz, Philippe; Ehlers, Georg; Qin, Ming-Pu; Noack, Reinhard M.; Shi, Hao; White, Steven R.; Zhang, Shiwei; Chan, Garnet Kin-Lic			Stripe order in the underdoped region of the two-dimensional Hubbard model	SCIENCE			English	Article							PHASE-SEPARATION; DENSITY-WAVE; MAGNETISM; HOLES	Competing inhomogeneous orders are a central feature of correlated electron materials, including the high-temperature superconductors. The two-dimensional Hubbard model serves as the canonical microscopic physical model for such systems. Multiple orders have been proposed in the underdoped part of the phase diagram, which corresponds to a regime of maximum numerical difficulty. By combining the latest numerical methods in exhaustive simulations, we uncover the ordering in the underdoped ground state. We find a stripe order that has a highly compressible wavelength on an energy scale of a few kelvin, with wavelength fluctuations coupled to pairing order. The favored filled stripe order is different from that seen in real materials. Our results demonstrate the power of modern numerical methods to solve microscopic models, even in challenging settings.	[Zheng, Bo-Xiao; Chan, Garnet Kin-Lic] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Zheng, Bo-Xiao] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Chung, Chia-Min; White, Steven R.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Corboz, Philippe] Univ Amsterdam, Inst Theoret Phys, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Corboz, Philippe] Univ Amsterdam, Delta Inst Theoret Phys, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Ehlers, Georg; Noack, Reinhard M.] Philipps Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany; [Qin, Ming-Pu; Shi, Hao; Zhang, Shiwei] Coll William & Mary, Dept Phys, Williamsburg, VA 23187 USA	California Institute of Technology; Princeton University; University of California System; University of California Irvine; University of Amsterdam; University of Amsterdam; Philipps University Marburg; William & Mary	Zheng, BX; Chan, GKL (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Zheng, BX (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	boxiao.zheng@gmail.com; gkc1000@gmail.com	White, Steven R/B-4760-2008; Zheng, Bo-Xiao/E-7185-2018; CHUNG, CHIA-MIN/GQP-7497-2022	White, Steven R/0000-0003-3496-0707; Zheng, Bo-Xiao/0000-0003-3983-8006; Corboz, Philippe/0000-0003-1024-1230; CHUNG, CHIA-MIN/0000-0002-6396-0784; Ehlers, Georg/0000-0002-5588-5550	Simons Foundation through the Simons Collaboration on the Many Electron Problem; NSF [DMR-1505406, DMR-1409510, ACI-1053575]; U.S. Department of Energy (DOE) [DE-SC0008627]; Simons Investigators Award; DOE [DE-SC0008624]; DOE Office of Science [DE-AC02-05CH11231]; Oak Ridge Leadership Computing Facility at Oak Ridge National Lab; European Research Council under the European Union's Horizon research and innovation program [677061]; Deutsche Forschringsgemeinschaft (DFG) [NO 314/5-1, FOR 1807]; Direct For Mathematical & Physical Scien [1505406] Funding Source: National Science Foundation; Division Of Materials Research [1409510] Funding Source: National Science Foundation	Simons Foundation through the Simons Collaboration on the Many Electron Problem; NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Simons Investigators Award; DOE(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); Oak Ridge Leadership Computing Facility at Oak Ridge National Lab; European Research Council under the European Union's Horizon research and innovation program; Deutsche Forschringsgemeinschaft (DFG); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Work performed by B.-X.Z. C.-M.C., M.-P.Q., H.S., S.R.W., S.Z., and G.K.-LC. was supported by the Simons Foundation through the Simons Collaboration on the Many Electron Problem. S.R.W. acknowledges suppert from the NSF (DMR-1505406), as do S.Z. and H.S. (DMR-1409510). M.-P.Q. was also supported by the U.S. Department of Energy (DOE) (DE-SC0008627). G.K.-L.C. acknowledges support from a Simons Investigators Award and the DOE (DE-SC0008624). JULIET calculations were carried out at the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by DE-AC02-05CH11231. AFQMC calculations were carried out at the Extreme Science and Engineering Discovery Environment, supported by the NSF (ACI-1053575); at the Oak Ridge Leadership Computing Facility at Oak Ridge National Lab; and at ne computational facilities at the College of William and Mary. P.C. ors supported by the European Research Council under the European Union's Horizon 2020 research and innovation program (grant no. 677061). G.E. and R.M.N. acknowledge support from the Deutsche Forschringsgemeinschaft (DFG) through grant no. NO 314/5-1 in Research Unit FOR 1807. Data used in this work are in the supplementary materials and online at github.com/zhengbx/stripe data The NET calculations were performed with the DMET library, available onhne at bitbucketorg/zhengbx/libdmet. The real-space DIvIRG calculations were performed with ITensor, available online at ITensor.org. Access to the other computer codes can be arranged with the authors upon reasonable request: For the AFQMC code, please contact S.Z., for the hybrid DMRG code, please contact R.M.N., and for the iPEPS code, please contact P.C.	Chang CC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.116402; Chang CC, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.165101; Chou CP, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.060503; Chou CP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134530; CHUBUKOV AV, 1995, PHYS REV B, V51, P12605, DOI 10.1103/PhysRevB.51.12605; Comin R, 2016, ANNU REV CONDEN MA P, V7, P369, DOI 10.1146/annurev-conmatphys-031115-011401; Corboz P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.046402; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Dodaro JF, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.155116; EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; EMERY VJ, 1990, PHYSICA B, V163, P306, DOI 10.1016/0921-4526(90)90196-2; Fradkin E, 2015, REV MOD PHYS, V87, P457, DOI 10.1103/RevModPhys.87.457; Gerber S, 2015, SCIENCE, V350, P949, DOI 10.1126/science.aac6257; Hager G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075108; Himeda A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117001; Hu WJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081110; Jordan J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.250602; Julien MH, 2015, SCIENCE, V350, P914, DOI 10.1126/science.aad3279; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Knizia G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186404; LeBlanc JPF, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041041; MACHIDA K, 1989, PHYSICA C, V158, P192, DOI 10.1016/0921-4534(89)90316-X; Macridin A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.085104; Motruk J, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155139; Nishio Y., ARXIVCONDMAT0401115C; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; POILBLANC D, 1989, PHYS REV B, V39, P9749, DOI 10.1103/PhysRevB.39.9749; Qin MP, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.235119; Raczkowski M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.140505; SCHULZ HJ, 1989, J PHYS-PARIS, V50, P2833, DOI 10.1051/jphys:0198900500180283300; Schuttler H.-B., 2001, ARXIVCONDMAT0104300C; Sorella S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117002; Stoudenmire EM, 2012, ANNU REV CONDEN MA P, V3, P111, DOI 10.1146/annurev-conmatphys-020911-125018; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Verstraete F., 2004, ARXIVCONDMAT0407066C; Vojta M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.104505; White SR, 2003, PHYS REV LETT, V91, DOI [10.1103/PhysRevLett.91.136403, 10.1103/PhysRevLett.136403]; White SR, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220506; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; WHITE SR, 1989, PHYS REV B, V40, P506, DOI 10.1103/PhysRevB.40.506; Wu W, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041105; Xu J, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/50/505601; Yamase H, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.096402; Zaanen J, 2001, PHILOS MAG B, V81, P1485, DOI 10.1080/13642810110051791; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; ZHANG SW, 1995, PHYS REV LETT, V74, P3652, DOI 10.1103/PhysRevLett.74.3652; Zheng BX, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035126	49	257	259	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1155	1160		10.1126/science.aam7127	http://dx.doi.org/10.1126/science.aam7127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191901	Green Submitted, Green Accepted			2022-12-28	WOS:000416584000034
J	Bambach, SK; Lammermann, T				Bambach, Sarah K.; Laemmermann, Tim			Platelets, On Your Marks, Get Set, Migrate!	CELL			English	Editorial Material							DEFENSE	The idea that anucleate platelets display autonomous migration has long been viewed with skepticism. Gaertner et al. provide in vivo evidence that platelets undergo active migration at sites of thrombus formation and in inflamed liver sinusoids. Integrin-dependent migration allows platelets to scavenge and bundle fibrin-bound material, including intravascular bacteria.	[Bambach, Sarah K.; Laemmermann, Tim] Max Planck Inst Immunobiol & Epigenet, Grp Immune Cell Dynam, Freiburg, Germany; [Bambach, Sarah K.] IMPRS MCB, Freiburg, Germany; [Bambach, Sarah K.] Univ Freiburg, Fac Biol, Freiburg, Germany	Max Planck Society; University of Freiburg	Lammermann, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Grp Immune Cell Dynam, Freiburg, Germany.	laemmermann@ie-freiburg.mpg.de	Lämmermann, Tim/AAD-7453-2022	Bambach, Sarah Katharina/0000-0002-3176-4009				Ali RA, 2017, J IMMUNOL, V198, P344, DOI 10.4049/jimmunol.1601178; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; kawa-Ankerhold H., 2017, CELL, V171, P1368; Kraemer BF, 2010, J MOL MED, V88, P1277, DOI 10.1007/s00109-010-0680-8; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Levin Jack, 1997, P63; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; White JG, 2005, PLATELETS, V16, P121, DOI 10.1080/09537100400007390; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1256	1258		10.1016/j.cell.2017.11.026	http://dx.doi.org/10.1016/j.cell.2017.11.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195072	Bronze			2022-12-28	WOS:000417362700009
J	Zhang, J; Pagano, G; Hess, PW; Kyprianidis, A; Ecker, PB; Kaplan, H; Gorshkov, AV; Gong, ZX; Monroe, C				Zhang, J.; Pagano, G.; Hess, P. W.; Kyprianidis, A.; Ecker, P. B.; Kaplan, H.; Gorshkov, A. V.; Gong, Z. -X.; Monroe, C.			Observation of a many-body dynamical phase transition with a 53-qubit quantum simulator	NATURE			English	Article							PROPAGATION; SYSTEMS; IONS	A quantum simulator is a type of quantum computer that controls the interactions between quantum bits (or qubits) in a way that can be mapped to certain quantum many-body problems(1,2). As it becomes possible to exert more control over larger numbers of qubits, such simulators will be able to tackle a wider range of problems, such as materials design and molecular modelling, with the ultimate limit being a universal quantum computer that can solve general classes of hard problems(3). Here we use a quantum simulator composed of up to 53 qubits to study non-equilibrium dynamics in the transverse-field Ising model with long-range interactions. We observe a dynamical phase transition after a sudden change of the Hamiltonian, in a regime in which conventional statistical mechanics does not apply(4). The qubits are represented by the spins of trapped ions, which can be prepared in various initial pure states. We apply a global long-range Ising interaction with controllable strength and range, and measure each individual qubit with an efficiency of nearly 99 per cent. Such high efficiency means that arbitrary many-body correlations between qubits can be measured in a single shot, enabling the dynamical phase transition to be probed directly and revealing computationally intractable features that rely on the long-range interactions and high connectivity between qubits.	[Zhang, J.; Pagano, G.; Hess, P. W.; Kyprianidis, A.; Ecker, P. B.; Kaplan, H.; Gorshkov, A. V.; Gong, Z. -X.; Monroe, C.] Univ Maryland, Joint Quantum Inst, Dept Phys, College Pk, MD 20742 USA; [Zhang, J.; Pagano, G.; Hess, P. W.; Kyprianidis, A.; Ecker, P. B.; Kaplan, H.; Gorshkov, A. V.; Gong, Z. -X.; Monroe, C.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, Dept Phys, College Pk, MD 20742 USA; [Zhang, J.; Pagano, G.; Hess, P. W.; Kyprianidis, A.; Ecker, P. B.; Kaplan, H.; Gorshkov, A. V.; Gong, Z. -X.; Monroe, C.] Natl Inst Stand & Technol, College Pk, MD 20742 USA; [Monroe, C.] IonQ Inc, College Pk, MD 20740 USA; [Gong, Z. -X.] Colorado Sch Mines, Dept Phys, Golden, CO 80401 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Colorado School of Mines	Zhang, J (corresponding author), Univ Maryland, Joint Quantum Inst, Dept Phys, College Pk, MD 20742 USA.; Zhang, J (corresponding author), Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, Dept Phys, College Pk, MD 20742 USA.; Zhang, J (corresponding author), Natl Inst Stand & Technol, College Pk, MD 20742 USA.	jiehang.zhang@gmail.com	Pagano, Guido/B-1750-2018; Monroe, Christopher R/G-8105-2011; Pagano, Guido/ACJ-0744-2022; Gorshkov, Alexey V/A-9848-2008	Pagano, Guido/0000-0002-6760-4015; Pagano, Guido/0000-0002-6760-4015; Gorshkov, Alexey V/0000-0003-0509-3421; Becker, Patrick/0000-0002-7786-9447; Hess, Paul/0000-0003-2985-4221	ARO and AFOSR Atomic and Molecular Physics Programs; AFOSR MURI; IARPA LogiQ programme; ARO MURI; ARL Center for Distributed Quantum Information; NSF Quantum Information Science programme; NSF Physics Frontier Center at JQI; IC Postdoctoral Research Fellowship Program; Direct For Mathematical & Physical Scien [1430094] Funding Source: National Science Foundation	ARO and AFOSR Atomic and Molecular Physics Programs; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); IARPA LogiQ programme; ARO MURI(MURI); ARL Center for Distributed Quantum Information; NSF Quantum Information Science programme; NSF Physics Frontier Center at JQI(National Science Foundation (NSF)); IC Postdoctoral Research Fellowship Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with M. Cetina, L. Duan, A. Polkovnikov, M. Heyl, M. Maghrebi, P. Titum and J. Iosue. This work is supported by the ARO and AFOSR Atomic and Molecular Physics Programs, the AFOSR MURI on Quantum Measurement and Verification, the IARPA LogiQ programme, the ARO MURI on Modular Quantum Systems, the ARL Center for Distributed Quantum Information, the NSF Quantum Information Science programme, and the NSF Physics Frontier Center at JQI. G.P. is supported by the IC Postdoctoral Research Fellowship Program.	BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Barends R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8654; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Brown KR, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052318; Campa A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.040102; Davies PCW, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-30; Debnath S, 2016, NATURE, V536, P63, DOI 10.1038/nature18648; Eisert J, 2015, NAT PHYS, V11, P124, DOI [10.1038/nphys3215, 10.1038/NPHYS3215]; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Flaschner N., 2016, OBSERVATION DYNAMICA; Garttner M, 2017, NAT PHYS, V13, P781, DOI [10.1038/NPHYS4119, 10.1038/nphys4119]; Gong ZX, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.050501; Halimeh JC, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.024302; Hayes D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.140501; Heyl M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135704; Hinrichsen H, 2006, PHYSICA A, V369, P1, DOI 10.1016/j.physa.2006.04.007; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; James DFV, 1998, APPL PHYS B-LASERS O, V66, P181, DOI 10.1007/s003400050373; Jurcevic P, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.080501; Jurcevic P, 2014, NATURE, V511, P202, DOI 10.1038/nature13461; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Kuhr S, 2016, NATL SCI REV, V3, P170, DOI 10.1093/nsr/nww023; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Maghrebi MF, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.023001; Najafi K, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.125139; Neyenhuis B, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700672; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Peschel I., 1999, DENSITY MATRIX RENOR; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Reia SM, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052149; Richerme P, 2014, NATURE, V511, P198, DOI 10.1038/nature13450; Rigol M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110601; Sachdev S., 1999, QUANTUM PHASE TRANSI; Trabesinger A, 2012, NAT PHYS, V8, P263, DOI 10.1038/nphys2258; Yuzbashyan EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097005; Zunkovic B., 2016, DYNAMICAL QUANTUM PH; Zurek WH, 1996, PHYS REP, V276, P177, DOI 10.1016/S0370-1573(96)00009-9	43	565	569	11	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					601	+		10.1038/nature24654	http://dx.doi.org/10.1038/nature24654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189781	Green Accepted, Green Submitted			2022-12-28	WOS:000416520400037
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Let's have a report on what resources the NHS needs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Brennan S, 2017, HLTH SERV J, P359; Donnelly L., 2017, DAILY TELEGRAPH; Ewbank L., 2017, NHS HOSP BED NUMBERS; Richardson J, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4439; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Simpson P, 2017, PUBLIC SPENDING ADUL	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2017	359								j5296	10.1136/bmj.j5296	http://dx.doi.org/10.1136/bmj.j5296			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9ME	29180584	Bronze, Green Published			2022-12-28	WOS:000417210800001
J	Burki, T				Burki, Talha			Scotland to implement alcohol pricing legislation	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2337	2337		10.1016/S0140-6736(17)33041-6	http://dx.doi.org/10.1016/S0140-6736(17)33041-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	29185427				2022-12-28	WOS:000416118700011
J	Goemans, N				Goemans, Nathalie			How glucocorticoids change life in Duchenne muscular dystrophy	LANCET			English	Editorial Material							NATURAL-HISTORY; MORTALITY; THERAPY		[Goemans, Nathalie] Univ Leuven, Univ Hosp Leuven, Neuromusc Reference Ctr Children, KU Leuven,Fac Med,Dept Child Neurol, B-3000 Leuven, Belgium	KU Leuven; University Hospital Leuven	Goemans, N (corresponding author), Univ Leuven, Univ Hosp Leuven, Neuromusc Reference Ctr Children, KU Leuven,Fac Med,Dept Child Neurol, B-3000 Leuven, Belgium.	nathalie.goemans@uzleuven.be						Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014; Goemans N., 2017, LANCET; Griggs RC, 2013, MUSCLE NERVE, V48, P27, DOI 10.1002/mus.23831; Kieny P., 2013, Annals of Physical and Rehabilitation Medicine, V56, P443, DOI 10.1016/j.rehab.2013.06.002; Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Schram G, 2013, J AM COLL CARDIOL, V61, P948, DOI 10.1016/j.jacc.2012.12.008; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409	12	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					406	407		10.1016/S0140-6736(17)32405-4	http://dx.doi.org/10.1016/S0140-6736(17)32405-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29174483				2022-12-28	WOS:000424333600006
J	Cooney, CR; Bright, JA; Capp, EJR; Chira, AM; Hughes, EC; Moody, CJA; Nouri, LO; Varley, ZK; Thomas, GH				Cooney, Christopher R.; Bright, Jen A.; Capp, Elliot J. R.; Chira, Angela M.; Hughes, Emma C.; Moody, Christopher J. A.; Nouri, Lara O.; Varley, Zoe K.; Thomas, Gavin H.			Mega-evolutionary dynamics of the adaptive radiation of birds (vol 542, pg 344, 2017)	NATURE			English	Correction													Thomas, Gavin/AAE-8959-2019					Cooney CR, 2017, NATURE, V542, P344, DOI 10.1038/nature21074	1	1	1	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685								10.1038/nature24665	http://dx.doi.org/10.1038/nature24665			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29186123	Bronze			2022-12-28	WOS:000418559800065
J	Marty, FM; Ljungman, P; Chemaly, RF; Maertens, J; Dadwal, SS; Duarte, RF; Haider, S; Ullmann, AJ; Katayama, Y; Brown, J; Mullane, KM; Boeckh, M; Blumberg, EA; Einsele, H; Snydman, DR; Kanda, Y; DiNubile, MJ; Teal, VL; Wan, H; Murata, Y; Kartsonis, NA; Leavitt, RY; Badshah, C				Marty, F. M.; Ljungman, P.; Chemaly, R. F.; Maertens, J.; Dadwal, S. S.; Duarte, R. F.; Haider, S.; Ullmann, A. J.; Katayama, Y.; Brown, J.; Mullane, K. M.; Boeckh, M.; Blumberg, E. A.; Einsele, H.; Snydman, D. R.; Kanda, Y.; DiNubile, M. J.; Teal, V. L.; Wan, H.; Murata, Y.; Kartsonis, N. A.; Leavitt, R. Y.; Badshah, C.			Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; CARDIOGENIC-SHOCK; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; CULPRIT LESION; OPEN-LABEL; ANGIOPLASTY	BACKGROUND Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV-terminase complex. METHODS In this phase 3, double-blind trial, we randomly assigned CMV-seropositive transplant recipients, 18 years of age or older, in a 2:1 ratio to receive letermovir or placebo, administered orally or intravenously, through week 14 after transplantation; randomization was stratified according to trial site and CMV disease risk. Letermovir was administered at a dose of 480 mg per day (or 240 mg per day in patients taking cyclosporine). Patients in whom clinically significant CMV infection (CMV disease or CMV viremia leading to preemptive treatment) developed discontinued the trial regimen and received anti-CMV treatment. The primary end point was the proportion of patients, among patients without detectable CMV DNA at randomization, who had clinically significant CMV infection through week 24 after transplantation. Patients who discontinued the trial or had missing end-point data at week 24 were imputed as having a primary endpoint event. Patients were followed through week 48 after transplantation. RESULTS From June 2014 to March 2016, a total of 565 patients underwent randomization and received letermovir or placebo beginning a median of 9 days after transplantation. Among 495 patients with undetectable CMV DNA at randomization, fewer patients in the letermovir group than in the placebo group had clinically significant CMV infection or were imputed as having a primary end-point event by week 24 after transplantation (122 of 325 patients [37.5%] vs. 103 of 170 [60.6%], P<0.001). The frequency and severity of adverse events were similar in the two groups overall. Vomiting was reported in 18.5% of the patients who received letermovir and in 13.5% of those who received placebo; edema in 14.5% and 9.4%, respectively; and atrial fibrillation or flutter in 4.6% and 1.0%, respectively. The rates of myelotoxic and nephrotoxic events were similar in the letermovir group and the placebo group. All-cause mortality at week 48 after transplantation was 20.9% among letermovir recipients and 25.5% among placebo recipients. CONCLUSIONS Letermovir prophylaxis resulted in a significantly lower risk of clinically significant CMV infection than placebo. Adverse events with letermovir were mainly of low grade. (Funded by Merck; ClinicalTrials.gov number, NCT02137772; EudraCT number, 2013-003831-31.)	[Marty, F. M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Marty, F. M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Snydman, D. R.] Tufts Med Ctr, Boston, MA USA; [Snydman, D. R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Ljungman, P.] Karolinska Univ Hosp, Stockholm, Sweden; [Ljungman, P.] Karolinska Inst, Stockholm, Sweden; [Chemaly, R. F.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Maertens, J.] Univ Ziekenhuizen Leuven, Leuven, Belgium; [Dadwal, S. S.] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Brown, J.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Duarte, R. F.] Hosp Univ Puerta de Hierro Majadahonda, Madrid, Spain; [Haider, S.] McMaster Univ, Juravinski Hosp, Hamilton, ON, Canada; [Haider, S.] McMaster Univ, Ctr Canc, Hamilton, ON, Canada; [Ullmann, A. J.; Einsele, H.] Univ Klinikum Wurzburg, Wurzburg, Germany; [Katayama, Y.] Hiroshima Red Cross Hosp & Atomic Bomb Survivors, Hiroshima, Japan; [Kanda, Y.] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan; [Mullane, K. M.] Univ Chicago, Chicago, IL 60637 USA; [Boeckh, M.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Blumberg, E. A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [DiNubile, M. J.; Teal, V. L.; Wan, H.; Murata, Y.; Kartsonis, N. A.; Leavitt, R. Y.; Badshah, C.] Merck, Kenilworth, NJ USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Tufts Medical Center; Tufts University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center; KU Leuven; University Hospital Leuven; City of Hope; Stanford University; Hospital Puerta de Hierro-Majadahonda; McMaster University; McMaster University; University of Wurzburg; Jichi Medical University; University of Chicago; Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Merck & Company	Marty, FM (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	fmarty@bwh.harvard.edu	Ljungman, Per/M-4946-2019; DUARTE, Rafael F./Q-5884-2018; Snydman, David R/O-3889-2014; Ullmann, AJ/AAQ-1724-2021; Marty, Francisco M./H-7088-2019; Katayama, Yuta/AAB-7409-2022; Boeckh, Michael/AAA-1607-2022	DUARTE, Rafael F./0000-0002-5240-9815; Snydman, David R/0000-0003-0119-3978; Marty, Francisco M./0000-0002-3708-8734; Katayama, Yuta/0000-0001-5054-9104; 	Merck; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Merck; ClinicalTrials.gov number, NCT02137772; EudraCT number, 2013-003831-31.	De Waha S, 2017, EUR HEART J ACUTE CA; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Henriques JPS, 2016, J AM COLL CARDIOL, V68, P1622, DOI 10.1016/j.jacc.2016.07.744; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Hoebers LP, 2013, EUR J HEART FAIL, V15, P425, DOI 10.1093/eurjhf/hfs182; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Levine GN, 2016, CATHETER CARDIO INTE, V87, P1001, DOI 10.1002/ccd.26325; Ljungman P, 2014, CLIN INFECT DIS, V59, P473, DOI 10.1093/cid/ciu364; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Patel MR, 2017, J AM COLL CARDIOL, V69, P570, DOI 10.1016/j.jacc.2016.10.034; Sanborn TA, 2003, J AM COLL CARDIOL, V42, P1373, DOI 10.1016/S0735-1097(03)01051-9; Sardella G, 2016, J AM COLL CARDIOL, V67, P264, DOI 10.1016/j.jacc.2015.10.082; Smits PC, 2017, NEW ENGL J MED, V376, P1234, DOI 10.1056/NEJMoa1701067; Thiele H, 2016, AM HEART J, V172, P160, DOI 10.1016/j.ahj.2015.11.006; Thiele H, 2015, EUR HEART J, V36, P1223, DOI 10.1093/eurheartj/ehv051; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; van der Schaaf RJ, 2010, AM J CARDIOL, V105, P955, DOI 10.1016/j.amjcard.2009.11.014; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Webb JG, 2003, J AM COLL CARDIOL, V42, P1380, DOI 10.1016/S0735-1097(03)01050-7; Wong SC, 2000, J AM COLL CARDIOL, V36, P1077, DOI 10.1016/S0735-1097(00)00873-1	24	531	546	3	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2017	377	25					2433	2444		10.1056/NEJMoa1706640	http://dx.doi.org/10.1056/NEJMoa1706640			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ5RZ	29211658	Bronze, Green Published			2022-12-28	WOS:000418420000007
J	Seegar, TCM; Killingsworth, LB; Saha, N; Meyer, PA; Patra, D; Zimmerman, B; Janes, PW; Rubinstein, E; Nikolov, DB; Skiniotis, G; Kruse, AC; Blacklow, SC				Seegar, Tom C. M.; Killingsworth, Lauren B.; Saha, Nayanendu; Meyer, Peter A.; Patra, Dhabaleswar; Zimmerman, Brandon; Janes, Peter W.; Rubinstein, Eric; Nikolov, Dimitar B.; Skiniotis, Georgios; Kruse, Andrew C.; Blacklow, Stephen C.			Structural Basis for Regulated Proteolysis by the alpha-Secretase ADAM10	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; TSPANC8 TETRASPANINS; CONVERTING-ENZYME; NOTCH ACTIVATION; BREAST-CANCER; TNF-ALPHA; CLEAVAGE; DISINTEGRIN; METALLOPROTEASE; INHIBITION	Cleavage of membrane-anchored proteins by ADAM (a disintegrin and metalloproteinase) endopeptidases plays a key role in a wide variety of biological signal transduction and protein turnover processes. Among ADAM family members, ADAM10 stands out as particularly important because it is both responsible for regulated proteolysis of Notch receptors and catalyzes the non-amyloidogenic a-secretase cleavage of the Alzheimer's precursor protein (APP). We present here the X-ray crystal structure of the ADAM10 ectodomain, which, together with biochemical and cellular studies, reveals how access to the enzyme active site is regulated. The enzyme adopts an unanticipated architecture in which the C-terminal cysteine-rich domain partially occludes the enzyme active site, preventing unfettered substrate access. Binding of a modulatory antibody to the cysteine-rich domain liberates the catalytic domain from autoinhibition, enhancing enzymatic activity toward a peptide substrate. Together, these studies reveal a mechanism for regulation of ADAM activity and offer a roadmap for its modulation.	[Seegar, Tom C. M.; Killingsworth, Lauren B.; Zimmerman, Brandon; Kruse, Andrew C.; Blacklow, Stephen C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Saha, Nayanendu; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Meyer, Peter A.] Harvard Med Sch, SBGrid Initiat, Boston, MA 02115 USA; [Patra, Dhabaleswar] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Patra, Dhabaleswar] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Janes, Peter W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Rubinstein, Eric] INSERM, Villejuif, France; [Rubinstein, Eric] Univ Paris Sud, Inst Andre Lwoff, Villejuif, France; [Skiniotis, Georgios] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Skiniotis, Georgios] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Monash University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Stanford University; Stanford University	Blacklow, SC (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	stephen_blacklow@hms.harvard.edu	Rubinstein, Eric/B-4650-2019	Rubinstein, Eric/0000-0001-7623-9665; Patra, Dhabaleswar/0000-0001-6520-6972; Janes, Peter/0000-0002-9039-1097; Killingsworth, Lauren/0000-0001-5007-6941; Skiniotis, Georgios/0000-0003-0238-7846	NIH [5 R01 CA092433, 1 R35 CA220340, 5 T32 HL007627, R01 NS038486]; National Institute of General Medical Sciences from NIH [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433, R35CA220340] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences from NIH; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a gift from Edward B. Goodnow to S.C.B., NIH awards 5 R01 CA092433 and 1 R35 CA220340 to S.C.B., 5 T32 HL007627 to T.C.M.S., and R01 NS038486 to D.B.N. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the NIH (P41 GM103403). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrawes MB, 2013, J BIOL CHEM, V288, P25477, DOI 10.1074/jbc.M113.454850; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Atapattu L, 2016, J EXP MED, V213, P1741, DOI 10.1084/jem.20151095; Atapattu L, 2012, J CELL SCI, V125, P6084, DOI 10.1242/jcs.112631; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Feldinger K, 2014, ONCOTARGET, V5, P6633, DOI 10.18632/oncotarget.1955; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jones JC, 2016, ANNU REV PHYSIOL, V78, P243, DOI 10.1146/annurev-physiol-021014-071720; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Liu PCC, 2006, CANCER BIOL THER, V5, P657, DOI 10.4161/cbt.5.6.2708; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger Team, 2010, PYMOL MOL GRAPH SYST; Solomon KA, 1999, J IMMUNOL, V163, P4105; Stawikowska R, 2013, J BIOL CHEM, V288, P22871, DOI 10.1074/jbc.M113.462267; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	58	75	77	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1638	+		10.1016/j.cell.2017.11.014	http://dx.doi.org/10.1016/j.cell.2017.11.014			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29224781	Bronze, Green Accepted			2022-12-28	WOS:000418044000019
J	Simunovic, M				Simunovic, Mijo			Biology and physics rendezvous at the membrane A reductionist model of the cell membrane reveals the physics underlying endocytosis	SCIENCE			English	Editorial Material							CURVATURE-GENERATING PROTEINS; BAR PROTEINS; SCISSION		[Simunovic, Mijo] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Simunovic, Mijo] Univ Chicago, Chicago, IL 60637 USA	Rockefeller University; University of Chicago	Simunovic, M (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.; Simunovic, M (corresponding author), Univ Chicago, Chicago, IL 60637 USA.			Simunovic, Mijo/0000-0001-9394-1552				Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; dArcy Wentworth Thompson, 1917, GROWTH FORM; LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Simunovic M, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.047; Simunovic M, 2016, P NATL ACAD SCI USA, V113, P11226, DOI 10.1073/pnas.1606943113; Simunovic M, 2015, TRENDS CELL BIOL, V25, P780, DOI 10.1016/j.tcb.2015.09.005; Simunovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8219; Simunovic M, 2013, P NATL ACAD SCI USA, V110, P20396, DOI 10.1073/pnas.1309819110; Simunovic M, 2013, BIOPHYS J, V105, P711, DOI 10.1016/j.bpj.2013.06.039	12	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368								10.1126/science.aar2002	http://dx.doi.org/10.1126/science.aar2002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217566	Bronze			2022-12-28	WOS:000417254700048
J	Bould, H; Newbegin, C; Fazel, M; Stewart, A; Stein, A				Bould, Helen; Newbegin, Claudia; Fazel, Mina; Stewart, Anne; Stein, Alan			PRACTICE POINTER Assessment of child or young person with a possible eating disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bould, Helen; Fazel, Mina; Stein, Alan] Warneford Hosp, Dept Psychiat, Oxford, England; [Stewart, Anne] Raglan House, Oxford, England; [Newbegin, Claudia] Pk Med Grp, Newcastle Upon Tyne, Tyne & Wear, England		Bould, H (corresponding author), Warneford Hosp, Dept Psychiat, Oxford, England.	helen.bould@psych.ox.ac.uk		Stein, Alan/0000-0001-8207-2822; Bould, Helen/0000-0001-8163-3210; Fazel, Mina/0000-0001-9342-2365				Konstantakopoulos G, 2011, PSYCHOL MED, V41, P1951, DOI 10.1017/S0033291710002539; Lock J, 2002, CHILD ADOL PSYCH CL, V11, P331, DOI 10.1016/S1056-4993(01)00009-8	2	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5328	10.1136/bmj.j5328	http://dx.doi.org/10.1136/bmj.j5328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29217517	Green Submitted			2022-12-28	WOS:000417560100003
J	DeMichele, A; Yee, D; Esserman, L				DeMichele, Angela; Yee, Douglas; Esserman, Laura			Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[DeMichele, Angela] Univ Penn, Philadelphia, PA 19104 USA; [Yee, Douglas] Univ Minnesota, Minneapolis, MN USA; [Esserman, Laura] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco	DeMichele, A (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.			Yee, Douglas/0000-0002-3387-4009				Begley S., 2017, STAT            0710; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Esserman LJ, 2017, JAMA ONCOL, V3, P1503, DOI 10.1001/jamaoncol.2017.1261; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Knapton, 2017, TELEGRAPH; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Schwartz RS, 2017, NEW ENGL J MED, V376, P2486, DOI 10.1056/NEJMcibr1701388; Yirka B., 2017, MED PRESS       0706	9	56	59	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2287	2289		10.1056/NEJMcibr1711545	http://dx.doi.org/10.1056/NEJMcibr1711545			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211674				2022-12-28	WOS:000417201100015
J	Farquhar, M; van den Eshof, K				Farquhar, Michael; van den Eshof, Kirandeep			CHRISTMAS 2017: TIME AND PLACE Things that go BONG! in the night	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farquhar, Michael; van den Eshof, Kirandeep] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, London, England	Guy's & St Thomas' NHS Foundation Trust	Farquhar, M (corresponding author), Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, London, England.	michael.farquhar@gstt.nhs.uk						Kecklund G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5210; Royal Society for Public Health, 2016, WAK HLTH BEN SLEEP; Sleep Council, 2017, BEING UNC BED DIST Y; Young JS, 2008, J HOSP MED, V3, P473, DOI 10.1002/jhm.372	4	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5615	10.1136/bmj.j5615	http://dx.doi.org/10.1136/bmj.j5615			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29217647				2022-12-28	WOS:000417560100009
J	Kim, HK; Fuchs, G; Wang, SC; Wei, W; Zhang, Y; Park, H; Roy-Chaudhuri, B; Li, P; Xu, JP; Chu, K; Zhang, FJ; Chua, MS; So, S; Zhang, QC; Sarnow, P; Kay, MA				Kim, Hak Kyun; Fuchs, Gabriele; Wang, Shengchun; Wei, Wei; Zhang, Yue; Park, Hyesuk; Roy-Chaudhuri, Biswajoy; Li, Pan; Xu, Jianpeng; Chu, Kirk; Zhang, Feijie; Chua, Mei-Sze; So, Samuel; Zhang, Qiangfeng Cliff; Sarnow, Peter; Kay, Mark A.			A transfer-RNA-derived small RNA regulates ribosome biogenesis	NATURE			English	Article							DIAMOND-BLACKFAN ANEMIA; CELL-PROLIFERATION; NUCLEIC-ACID; FRAGMENTS; REVEALS; GENE; EXPRESSION; PROTEINS; MATURATION; EFFICIENT	Transfer-RNA-derived small RNAs (tsRNAs; also called tRNA-derived fragments) are an abundant class of small non-coding RNAs whose biological roles are not well understood. Here we show that inhibition of a specific tsRNA, LeuCAG3'tsRNA, induces apoptosis in rapidly dividing cells in vitro and in a patient-derived orthotopic hepatocellular carcinoma model in mice. This tsRNA binds at least two ribosomal protein mRNAs (RPS28 and RPS15) to enhance their translation. A decrease in translation of RPS28 mRNA blocks pre-18S ribosomal RNA processing, resulting in a reduction in the number of 40S ribosomal subunits. These data establish a post-transcriptional mechanism that can fine-tune gene expression during different physiological states and provide a potential new target for treating cancer.	[Kim, Hak Kyun; Wang, Shengchun; Zhang, Yue; Park, Hyesuk; Roy-Chaudhuri, Biswajoy; Xu, Jianpeng; Chu, Kirk; Zhang, Feijie; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Kim, Hak Kyun; Wang, Shengchun; Zhang, Yue; Park, Hyesuk; Roy-Chaudhuri, Biswajoy; Xu, Jianpeng; Chu, Kirk; Zhang, Feijie; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Fuchs, Gabriele; Sarnow, Peter] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Wei, Wei; Chua, Mei-Sze; So, Samuel] Stanford Univ, Dept Surg, Asian Liver Ctr, Sch Med, Stanford, CA 94305 USA; [Li, Pan; Zhang, Qiangfeng Cliff] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Ctr Synthet & Syst Biol,MOE Key Lab Bioinformat, Beijing Adv Innovat Ctr Struct Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Fuchs, Gabriele] SUNY Albany, RNA Inst, 1400 Washington Ave, Albany, NY 12222 USA; [Fuchs, Gabriele] SUNY Albany, Dept Biol Sci, 1400 Washington Ave, Albany, NY 12222 USA; [Wang, Shengchun] Medtron Vasc, 3576 Unocal Pl, Santa Rosa, CA 95403 USA; [Zhang, Yue] Stanford Ctr Genom & Personalized Med, 3165 Porter Dr, Palo Alto, CA 94304 USA; [Roy-Chaudhuri, Biswajoy] Impossible Foods Inc, 525 Chesapeake Dr, Redwood City, CA 94063 USA	Stanford University; Stanford University; Stanford University; Stanford University; Tsinghua University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Kay, MA (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	markay@stanford.edu		Sarnow, Peter/0000-0002-2043-2770; Chua, Mei-Sze/0000-0002-3282-4894; Kay, Mark/0000-0002-2799-2615; Fuchs, Gabriele/0000-0002-6838-2100; Li, Pan/0000-0002-6902-5762	National Institutes of Health [R01AI071068, R01DK114483]; Stanford Cancer Institute; CJ Huang Foundation; TS Kwok Liver Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Institute; CJ Huang Foundation; TS Kwok Liver Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sage for HCC tissues from conditional TKO (Rb<SUP>lox/lox</SUP>; p130<SUP>lox/lox</SUP>; p107<SUP>-/-</SUP>) adult mice and liver tissues from p107<SUP>-/-</SUP> mice. This work was supported by grants to M.A.K. from the National Institutes of Health (R01AI071068 and R01DK114483). M.A.K. received support from the Stanford Cancer Institute, and S.S. from the CJ Huang Foundation and the TS Kwok Liver Cancer Foundation.	Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blanco S, 2016, NATURE, V534, P335, DOI 10.1038/nature18282; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; Dianzani I, 2008, HAEMATOL-HEMATOL J, V93, P1601, DOI 10.3324/haematol.2008.000513; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fuchs G, 2011, J MOL BIOL, V410, P118, DOI 10.1016/j.jmb.2011.04.064; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Honda S, 2015, P NATL ACAD SCI USA, V112, pE3816, DOI 10.1073/pnas.1510077112; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Janas MM, 2012, MOL CELL, V46, P171, DOI 10.1016/j.molcel.2012.04.008; Jepsen JS, 2004, OLIGONUCLEOTIDES, V14, P130, DOI 10.1089/1545457041526317; Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Robledo S, 2008, RNA, V14, P1918, DOI 10.1261/rna.1132008; Roy-Chaudhuri B, 2014, NAT STRUCT MOL BIOL, V21, P825, DOI 10.1038/nsmb.2862; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wei W, 2014, ONCOTARGET, V5, P5819, DOI 10.18632/oncotarget.2171; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yan K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010132; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	227	238	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					57	+		10.1038/nature25005	http://dx.doi.org/10.1038/nature25005			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186115	Green Accepted			2022-12-28	WOS:000417560500042
J	Korte, AKM; Vos, JM				Korte, Anna K. M.; Vos, Josephine M.			Ecthyma Gangrenosum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Korte, Anna K. M.; Vos, Josephine M.] Sint Antonius Ziekenhuis, Nieuwegein, Netherlands		Korte, AKM (corresponding author), Sint Antonius Ziekenhuis, Nieuwegein, Netherlands.	ak.korte@antoniusziekenhuis.nl							0	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					E32	E32		10.1056/NEJMicm1702302	http://dx.doi.org/10.1056/NEJMicm1702302			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211664				2022-12-28	WOS:000417201100010
J	Wise, J				Wise, Jacqui			ONCOLOGY Disruptive technologies making cancer care more patient centred	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Cancer Research UK, 2017, BOW SCREEN CAR PARK; Department of Health, 2017, HLTH SEC CHALL NHS D; Independent Cancer Taskforce, ACH WORLD CLASS CANC; NHS England, 2016, ACH WORLD CLASS CANC; Wise J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5450; Wise J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5141	6	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2017	359								j5608	10.1136/bmj.j5608	http://dx.doi.org/10.1136/bmj.j5608			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AQ	29212631				2022-12-28	WOS:000417559500006
J	Li, A; Cornelius, SP; Liu, YY; Wang, L; Barabasi, AL				Li, A.; Cornelius, S. P.; Liu, Y. -Y.; Wang, L.; Barabasi, A. -L.			The fundamental advantages of temporal networks	SCIENCE			English	Article							GENE-EXPRESSION; DYNAMICS; CONTROLLABILITY	Most networked systems of scientific interest are characterized by temporal links, meaning the network's structure changes over time. Link temporality has been shown to hinder many dynamical processes, from information spreading to accessibility, by disrupting network paths. Considering the ubiquity of temporal networks in nature, we ask: Are there any advantages of the networks' temporality? We use an analytical framework to show that temporal networks can, compared to their static counterparts, reach controllability faster, demand orders of magnitude less control energy, and have control trajectories, that are considerably more compact than those characterizing static networks. Thus, temporality ensures a degree of flexibility that would be unattainable in static networks, enhancing our ability to control them.	[Li, A.; Cornelius, S. P.; Barabasi, A. -L.] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Li, A.; Cornelius, S. P.; Barabasi, A. -L.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Li, A.; Wang, L.] Peking Univ, Coll Engn, Ctr Syst & Control, Beijing 100871, Peoples R China; [Cornelius, S. P.; Liu, Y. -Y.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Liu, Y. -Y.; Barabasi, A. -L.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, A. -L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Barabasi, A. -L.] Cent European Univ, Ctr Network Sci, H-1052 Budapest, Hungary	Northeastern University; Northeastern University; Peking University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central European University	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.; Wang, L (corresponding author), Peking Univ, Coll Engn, Ctr Syst & Control, Beijing 100871, Peoples R China.; Barabasi, AL (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Cent European Univ, Ctr Network Sci, H-1052 Budapest, Hungary.	longwang@pku.edu.cn; barabasi@gmail.com	Barabasi, Albert-Laszlo/S-6474-2017; Gao, Y./GWZ-3665-2022; Wang, Long/A-7798-2010; Cornelius, Sean/L-9468-2014	Wang, Long/0000-0001-5600-8157; Li, Aming/0000-0003-4045-8721; Barabasi, Albert/0000-0002-4028-3522; Cornelius, Sean/0000-0001-8697-791X	DARPA Project [W911NF-12-C-002]; Army Research Laboratories (ARL) Network Science (NS) Collaborative Technology Alliance (CTA) grant [ARL NS-CTA W911NF-09-2-0053]; John Templeton Foundation: Mathematical and Physical Sciences grant [PFI-777]; European Commission [FP7 317532, 641191]; NSFC [61375120, 61533001]; China Scholarship Council [201406010195]	DARPA Project; Army Research Laboratories (ARL) Network Science (NS) Collaborative Technology Alliance (CTA) grant; John Templeton Foundation: Mathematical and Physical Sciences grant; European Commission(European CommissionEuropean Commission Joint Research Centre); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	We thank G. Xie, Y. Guan, G. Yan, I. Kovacs, I. Scholtes, M. Angulo, E. Guney, B. Barzel, J. Gao, R. Sinatra, S. Mou, Z. Ji, J. Huang, K. Albrecht, M. Santolini, M. Szell, I. Donnelly, R. Rajaei, S. Aleva, B. Common, and J. De Nicolo for valuable discussions and help. We appreciate J. Wang and X. Peng for supplying the data of dynamic protein-protein interaction networks. We wish to thank M. Gavin and the DARPA Project W911NF-12-C-002 for providing the mobile network datasets. This work is supported by Army Research Laboratories (ARL) Network Science (NS) Collaborative Technology Alliance (CTA) grant ARL NS-CTA W911NF-09-2-0053; the John Templeton Foundation: Mathematical and Physical Sciences grant number PFI-777; European Commission grant numbers FP7 317532 (MULTIPLEX) and 641191 (CIMPLEX). A.L. and L.W. are supported by NSFC (Grants No. 61375120 and No. 61533001). A.L. also acknowledges the support from China Scholarship Council (No. 201406010195). A.-L.B. and S.P.C. conceived the project. All authors designed and performed the research add analyzed the results. A.L. and L.W. performed all the analytical calculations. A.L. performed all the numerical calculations (except the technology network that was analyzed by Y.-Y.L. independently). A.L., and S.P.C. led the writing of the manuscript, Y.-Y.L and L.W. edited the manuscript.	Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Blonder B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020298; Chen GR, 2017, INT J AUTOM COMPUT, V14, P1, DOI 10.1007/s11633-016-1052-9; Chen GR, 2014, INT J CONTROL AUTOM, V12, P221, DOI 10.1007/s12555-014-9001-2; Cohen R., 2010, COMPLEX NETWORKS STR; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Klamka J., 1991, CONTROLLABILITY DYNA, V48; Lentz HHK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118701; Liu YY, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035006; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Posfai M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123055; Rajapakse I, 2011, P NATL ACAD SCI USA, V108, P17257, DOI 10.1073/pnas.1113249108; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Scholtes I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6024; Starnini M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056115; Sun J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208701; Toroczkai Z, 2007, PHYSICA A, V378, P68, DOI 10.1016/j.physa.2006.11.088; Uhlendorf J, 2012, P NATL ACAD SCI USA, V109, P14271, DOI 10.1073/pnas.1206810109; Wang JX, 2013, PROTEOMICS, V13, P301, DOI 10.1002/pmic.201200277; Xie GM, 2002, IEEE T AUTOMAT CONTR, V47, P1401, DOI 10.1109/TAC.2002.801182; Yan G, 2015, NAT PHYS, V11, P779, DOI [10.1038/NPHYS3422, 10.1038/nphys3422]; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015	30	202	212	21	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1042	+		10.1126/science.aai7488	http://dx.doi.org/10.1126/science.aai7488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170233	Green Submitted			2022-12-28	WOS:000416590400037
J	Gaudinski, MR; Houser, KV; Morabito, KM; Hu, ZH; Yamshchikov, G; Rothwell, RS; Berkowitz, N; Mendoza, F; Saunders, JG; Novik, L; Hendel, CS; Holman, LA; Gordon, IJ; Cox, JH; Edupuganti, S; McArthur, MA; Rouphael, NG; Lyke, KE; Cummings, GE; Sitar, S; Bailer, RT; Foreman, BM; Burgomaster, K; Pelc, RS; Gordon, DN; DeMaso, CR; Dowd, KA; Laurencot, C; Schwartz, RM; Mascola, JR; Graham, BS; Pierson, TC; Ledgerwood, JE; Chen, GL				Gaudinski, Martin R.; Houser, Katherine V.; Morabito, Kaitlyn M.; Hu, Zonghui; Yamshchikov, Galina; Rothwell, Ro Shauna; Berkowitz, Nina; Mendoza, Floreliz; Saunders, Jamie G.; Novik, Laura; Hendel, Cynthia S.; Holman, LaSonji A.; Gordon, Ingelise J.; Cox, Josephine H.; Edupuganti, Srilatha; McArthur, Monica A.; Rouphael, Nadine G.; Lyke, Kirsten E.; Cummings, Ginny E.; Sitar, Sandra; Bailer, Robert T.; Foreman, Bryant M.; Burgomaster, Katherine; Pelc, Rebecca S.; Gordon, David N.; DeMaso, Christina R.; Dowd, Kimberly A.; Laurencot, Carolyn; Schwartz, Richard M.; Mascola, John R.; Graham, Barney S.; Pierson, Theodore C.; Ledgerwood, Julie E.; Chen, Grace L.		VRC 319 Study Team; VRC 320 Study Team	Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials	LANCET			English	Article							WEST-NILE-VIRUS; NEUTRALIZING ANTIBODY; INFECTION; TRANSMISSION; BRAZIL; PATHOGENESIS; TRANSFUSION; OUTBREAK; AMERICA; FEVER	Background The Zika virus epidemic and associated congenital infections have prompted rapid vaccine development. We assessed two new DNA vaccines expressing premembrane and envelope Zika virus structural proteins. Methods We did two phase 1, randomised, open-label trials involving healthy adult volunteers. The VRC 319 trial, done in three centres, assessed plasmid VRC5288 (Zika virus and Japanese encephalitis virus chimera), and the VRC 320, done in one centre, assessed plasmid VRC5283 (wild-type Zika virus). Eligible participants were aged 18-35 years in VRC19 and 18-50 years in VRC 320. Participants were randomly assigned 1: 1 by a computer-generated randomisation schedule prepared by the study statistician. All participants received intramuscular injection of 4 mg vaccine. In VRC 319 participants were assigned to receive vaccinations via needle and syringe at 0 and 8 weeks, 0 and 12 weeks, 0, 4, and 8 weeks, or 0, 4, and 20 weeks. In VRC 320 participants were assigned to receive vaccinations at 0, 4, and 8 weeks via single-dose needle and syringe injection in one deltoid or split-dose needle and syringe or needle-free injection with the Stratis device (Pharmajet, Golden, CO, USA) in each deltoid. Both trials followed up volunteers for 24 months for the primary endpoint of safety, assessed as local and systemic reactogenicity in the 7 days after each vaccination and all adverse events in the 28 days after each vaccination. The secondary endpoint in both trials was immunogenicity 4 weeks after last vaccination. These trials are registered with ClinicalTrials.gov, numbers NCT02840487 and NCT02996461. Findings VRC 319 enrolled 80 participants (20 in each group), and VRC 320 enrolled 45 participants (15 in each group). One participant in VRC 319 and two in VRC 320 withdrew after one dose of vaccine, but were included in the safety analyses. Both vaccines were safe and well tolerated. All local and systemic symptoms were mild to moderate. In both studies, pain and tenderness at the injection site was the most frequent local symptoms (37 [46%] of 80 participants in VRC 319 and 36 [80%] of 45 in VRC 320) and malaise and headache were the most frequent systemic symptoms (22 [27%] and 18 [22%], respectively, in VRC 319 and 17 [38%] and 15 [33%], respectively, in VRC 320). For VRC5283, 14 of 14 (100%) participants who received split-dose vaccinations by needle-free injection had detectable positive antibody responses, and the geometric mean titre of 304 was the highest across all groups in both trials. Interpretation VRC5283 was well tolerated and has advanced to phase 2 efficacy testing.	[Gaudinski, Martin R.; Houser, Katherine V.; Morabito, Kaitlyn M.; Yamshchikov, Galina; Rothwell, Ro Shauna; Berkowitz, Nina; Mendoza, Floreliz; Saunders, Jamie G.; Novik, Laura; Hendel, Cynthia S.; Holman, LaSonji A.; Gordon, Ingelise J.; Cox, Josephine H.; Sitar, Sandra; Bailer, Robert T.; Laurencot, Carolyn; Schwartz, Richard M.; Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.; Chen, Grace L.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hu, Zonghui] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Foreman, Bryant M.; Burgomaster, Katherine; Pelc, Rebecca S.; Gordon, David N.; DeMaso, Christina R.; Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Edupuganti, Srilatha; Rouphael, Nadine G.] Emory Sch Med, Emory Vaccine Ctr, Dept Med, Div Infect Dis,Hope Clin, Decatur, GA USA; [McArthur, Monica A.; Lyke, Kirsten E.; Cummings, Ginny E.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; University System of Maryland; University of Maryland Baltimore	Chen, GL (corresponding author), NIAID, Vaccine Res Ctr, Clin Trials Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	grace.chen@nih.gov	Graham, Barney S./AAC-5898-2019; McArthur, Monica/AAD-9682-2019; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; Pelc, Rebecca/0000-0001-5080-4945; Morabito, Kaitlyn/0000-0002-4849-4690; Gaudinski, Martin/0000-0002-3743-5281; Dowd, Kimberly/0000-0003-3641-6852; Cox, Josephine/0000-0003-1301-7373	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001209, ZIAAI005047, ZIAAI005128] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050; BUKOWSKI JF, 1989, J VIROL, V63, P5086, DOI 10.1128/JVI.63.12.5086-5091.1989; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; de Oliveira WK, 2017, LANCET, V390, P861, DOI [10.1016/S0140-6736(17)31368-5, 10.1016/s0140-6736(17)31368-5]; Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4; Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Liang HB, 2016, CELL MOL IMMUNOL, V13, P36, DOI 10.1038/cmi.2015.76; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Pierson TC, 2014, ANNU REV VIROL, V1, P375, DOI 10.1146/annurev-virology-031413-085453; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Sheets RL, 2006, TOXICOL SCI, V91, P620, DOI 10.1093/toxsci/kfj170; Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120; Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1	31	173	178	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					552	562		10.1016/S0140-6736(17)33105-7	http://dx.doi.org/10.1016/S0140-6736(17)33105-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV5VB	29217376	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000424649400032
J	Harper, KL; Sosa, MS; Entenberg, D; Hosseini, H; Cheung, JF; Nobre, R; Avivar-Valderas, A; Nagi, C; Girnius, N; Davis, RJ; Farias, EF; Condeelis, J; Klein, CA; Aguirre-Ghiso, JA				Harper, Kathryn L.; Sosa, Maria Soledad; Entenberg, David; Hosseini, Hedayatollah; Cheung, Julie F.; Nobre, Rita; Avivar-Valderas, Alvaro; Nagi, Chandandaneep; Girnius, Nomeda; Davis, Roger J.; Farias, Eduardo F.; Condeelis, John; Klein, Christoph A.; Aguirre-Ghiso, Julio A.			Mechanism of early dissemination and metastasis in Her2(+) mammary cancer (vol 540, pg 588, 2016)	NATURE			English	Correction													Entenberg, David/AAT-2722-2020	Entenberg, David/0000-0003-0422-7264; Klein, Christoph A./0000-0001-7128-1725; Davis, Roger/0000-0002-0130-1652	NCI NIH HHS [R01 CA109182] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109182] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609	1	7	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688								10.1038/nature24666	http://dx.doi.org/10.1038/nature24666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29236689	Green Accepted, Bronze			2022-12-28	WOS:000423475100058
J	Pangala, SR; Enrich-Prast, A; Basso, LS; Peixoto, RB; Bastviken, D; Hornibrook, ERC; Gatti, LV; Marotta, H; Calazans, LSB; Sakuragui, CM; Bastos, WR; Malm, O; Gloor, E; Miller, JB; Gauci, V				Pangala, Sunitha R.; Enrich-Prast, Alex; Basso, Luana S.; Peixoto, Roberta Bittencourt; Bastviken, David; Hornibrook, Edward R. C.; Gatti, Luciana V.; Marotta, Humberto; Calazans, Luana Silva Braucks; Sakuragui, Cassia Monica; Bastos, Wanderley Rodrigues; Malm, Olaf; Gloor, Emanuel; Miller, John Bharat; Gauci, Vincent			Large emissions from floodplain trees close the Amazon methane budget (vol 552, pg 230, 2017)	NATURE			English	Correction													Miller, John B./AAE-7714-2019; Sakuragui, Cassia/J-8603-2014; Gatti, Luciana Vanni/J-8569-2012; Marotta, Humberto/F-9554-2012; Bastos, Wanderley R/E-9856-2013; Bastos, Wanderley/AAQ-5875-2020; Peixoto, Roberta B/P-6303-2017	Miller, John B./0000-0001-8630-1610; Gatti, Luciana Vanni/0000-0003-4908-8974; Marotta, Humberto/0000-0002-2828-6595; Peixoto, Roberta B/0000-0002-8053-2730	NERC [NE/N015657/1] Funding Source: UKRI; Natural Environment Research Council [NE/N015657/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Pangala SR, 2017, NATURE, V552, P230, DOI 10.1038/nature24639	1	1	1	5	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688								10.1038/nature25191	http://dx.doi.org/10.1038/nature25191			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29236687	Bronze			2022-12-28	WOS:000423475100059
J	Hoggatt, J; Singh, P; Tate, TA; Chou, BK; Datari, SR; Fukuda, S; Liu, LQ; Kharchenko, PV; Schajnovitz, A; Baryawno, N; Mercier, FE; Boyer, J; Gardner, J; Morrow, DM; Scadden, DT; Pelus, LM				Hoggatt, Jonathan; Singh, Pratibha; Tate, Tiffany A.; Chou, Bin-Kuan; Datari, Shruti R.; Fukuda, Seiji; Liu, Liqiong; Kharchenko, Peter V.; Schajnovitz, Amir; Baryawno, Ninib; Mercier, Francois E.; Boyer, Joseph; Gardner, Jason; Morrow, Dwight M.; Scadden, David T.; Pelus, Louis M.			Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell	CELL			English	Article							BONE-MARROW; PROSPECTIVE TRIAL; PROGENITOR CELLS; G-CSF; BLOOD; DONORS; TRANSPLANTATION; PROLIFERATION; PLERIXAFOR; CHEMOKINES	Hematopoietic stem cell transplantation is a potential curative therapy for malignant and nonmalignant diseases. Improving the efficiency of stem cell collection and the quality of the cells acquired can broaden the donor pool and improve patient outcomes. We developed a rapid stem cell mobilization regimen utilizing a unique CXCR2 agonist, GRO beta, and the CXCR4 antagonist AMD3100. A single injection of both agents resulted in stem cell mobilization peaking within 15 min that was equivalent in magnitude to a standard multi-day regimen of granulocyte colony-stimulating factor (G-CSF). Mechanistic studies determined that rapid mobilization results from synergistic signaling on neutrophils, resulting in enhanced MMP-9 release, and unexpectedly revealed genetic polymorphisms in MMP-9 that alter activity. This mobilization regimen results in preferential trafficking of stem cells that demonstrate a higher engraftment efficiency than those mobilized by G-CSF. Our studies suggest a potential new strategy for the rapid collection of an improved hematopoietic graft.	[Hoggatt, Jonathan; Chou, Bin-Kuan; Datari, Shruti R.] Harvard Med Sch, Canc Ctr, Boston, MA 02129 USA; [Hoggatt, Jonathan; Chou, Bin-Kuan; Datari, Shruti R.] Massachusetts Gen Hosp, Ctr Transplantat Sci, Boston, MA 02129 USA; [Hoggatt, Jonathan; Tate, Tiffany A.; Chou, Bin-Kuan; Datari, Shruti R.; Kharchenko, Peter V.; Schajnovitz, Amir; Baryawno, Ninib; Mercier, Francois E.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hoggatt, Jonathan; Tate, Tiffany A.; Schajnovitz, Amir; Baryawno, Ninib; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Singh, Pratibha; Fukuda, Seiji; Liu, Liqiong; Pelus, Louis M.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Kharchenko, Peter V.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Schajnovitz, Amir; Baryawno, Ninib; Mercier, Francois E.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Boyer, Joseph] GlaxoSmithKline, Dept Stat Sci, Collegeville, PA 19426 USA; [Boyer, Joseph; Gardner, Jason; Morrow, Dwight M.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Fukuda, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6930021, Japan; [Gardner, Jason; Morrow, Dwight M.] Magenta Therapeut, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; GlaxoSmithKline; GlaxoSmithKline; Shimane University	Hoggatt, J (corresponding author), Harvard Med Sch, Canc Ctr, Boston, MA 02129 USA.; Hoggatt, J (corresponding author), Massachusetts Gen Hosp, Ctr Transplantat Sci, Boston, MA 02129 USA.; Hoggatt, J; Scadden, DT (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Hoggatt, J; Scadden, DT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Pelus, LM (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.; Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	hoggatt.jonathan@mgh.harvard.edu; david_scadden@harvard.edu; lpelus@iupui.edu	Singh, Pratibha/AAI-9796-2020	Baryawno, Ninib/0000-0001-6054-4163	NIH [R00 HL119559, HL069669, HL096305, R01HL131768, 1S10D012270]; Massachusetts Life Sciences Center; GlaxoSmithKline; NCI [P30 CA082709]; NIDDK [U54 DK106846]; NIAMS [R01AR060332]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119559, R00HL119559, R01HL131768, R01HL096305, U19HL129903, R01HL069669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106846, P30DK049218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Sciences Center; GlaxoSmithKline(GlaxoSmithKline); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Charles P. Lin for development of the in vivo imaging system and Zena Werb and Yung-Ru Zou for providing genetic mice. This work was supported by NIH grant R00 HL119559 to J.H., NIH grants HL069669 and HL096305 to L.M.P., the Massachusetts Life Sciences Center to D.T.S., NIH grant R01HL131768 to P.V.K., and sponsored research from GlaxoSmithKline to L.M.P. and D.T.S. Flow cytometry and mice were partially funded by NCI grant P30 CA082709, NIDDK grant U54 DK106846, NIH instrumentation grant 1S10D012270, and NIAMS grant R01AR060332. J.H., D.T.S., and L.M.P. have filed patent applications. L.M.P was an employee of GSK (SmithKline Beecham) when he discovered and cloned the truncated GROb molecule. J.G., D.M.M., and J.B. were employees of GSK at the time of this work. J.G. and D.M.M. are employees of Magenta Therapeutics. J.H., J. G., D.M.M., and D.T.S. are shareholders for Magenta Therapeutics.	Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Cotignola J, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-10; D'Souza A, 2017, BIOL BLOOD MARROW TR, V23, P1417, DOI 10.1016/j.bbmt.2017.05.035; Devine SM, 2008, BLOOD, V112, P990, DOI 10.1182/blood-2007-12-130179; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fukuda S, 2015, LEUKEMIA, V29, P433, DOI 10.1038/leu.2014.183; Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Giralt S, 2014, BIOL BLOOD MARROW TR, V20, P295, DOI 10.1016/j.bbmt.2013.10.013; Hoggatt Jonathan, 2012, Methods Mol Biol, V904, P49, DOI 10.1007/978-1-61779-943-3_4; Hoggatt J, 2014, METHODS MOL BIOL, V1185, P43, DOI 10.1007/978-1-4939-1133-2_4; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Hoggatt J, 2011, CURR OPIN HEMATOL, V18, P231, DOI 10.1097/MOH.0b013e3283477962; Hosing C, 2011, TRANSFUSION, V51, P1300, DOI 10.1111/j.1537-2995.2011.03176.x; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kaster Elizabeth C, 2014, Health Educ (Muncie), V46, P14; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; King AG, 2001, BLOOD, V97, P1534, DOI 10.1182/blood.V97.6.1534; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luizon MR, 2016, MOL BIOL REP, V43, P463, DOI 10.1007/s11033-016-3993-z; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Niederwieser D, 2016, BONE MARROW TRANSPL, V51, P778, DOI 10.1038/bmt.2016.18; Pantin J, 2017, HAEMATOLOGICA, V102, P600, DOI 10.3324/haematol.2016.147132; Pelus LM, 2004, BLOOD, V103, P110, DOI 10.1182/blood-2003-04-1115; Pulsipher MA, 2013, BLOOD, V121, P197, DOI 10.1182/blood-2012-03-417667; Pulsipher MA, 2009, BLOOD, V113, P3604, DOI 10.1182/blood-2008-08-175323; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Schroeder MA, 2017, BLOOD, V129, P2680, DOI 10.1182/blood-2016-09-739722; Shaughnessy P, 2013, BIOL BLOOD MARROW TR, V19, P1301, DOI 10.1016/j.bbmt.2013.05.008; Suchankova P, 2012, BEHAV BRAIN RES, V228, P232, DOI 10.1016/j.bbr.2011.11.026; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; Switzer GE, 1999, BONE MARROW TRANSPL, V24, P313, DOI 10.1038/sj.bmt.1701884; Tanner RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023609; Tay J, 2017, INT J HEMATOL, V105, P129, DOI 10.1007/s12185-016-2162-4; Tigue CC, 2007, BONE MARROW TRANSPL, V40, P185, DOI 10.1038/sj.bmt.1705722; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vasu S, 2008, BLOOD, V112, P2092, DOI 10.1182/blood-2008-03-143677; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Watters JW, 2003, J APPL PHYSIOL, V95, P1352, DOI 10.1152/japplphysiol.00214.2003; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Williams DA, 2000, BLOOD, V96, P1646	43	63	67	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					191	+		10.1016/j.cell.2017.11.003	http://dx.doi.org/10.1016/j.cell.2017.11.003			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29224778	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000419840100019
J	Panigrahi, P; Parida, S; Nanda, NC; Satpathy, R; Pradhan, L; Chandel, DS; Baccaglini, L; Mohapatra, A; Mohapatra, SS; Misra, PR; Chaudhry, R; Chen, HGH; Johnson, JA; Morris, JG; Paneth, N; Gewolb, IH				Panigrahi, Pinaki; Parida, Sailajanandan; Nanda, Nimai C.; Satpathy, Radhanath; Pradhan, Lingaraj; Chandel, Dinesh S.; Baccaglini, Lorena; Mohapatra, Arjit; Mohapatra, Subhranshu S.; Misra, Pravas R.; Chaudhry, Rama; Chen, Hegang H.; Johnson, Judith A.; Morris, J. Glenn; Paneth, Nigel; Gewolb, Ira H.			A randomized synbiotic trial to prevent sepsis among infants in rural India (vol 548, pg 407, 2017)	NATURE			English	Correction																		Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480	1	5	5	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					238	238		10.1038/nature25006	http://dx.doi.org/10.1038/nature25006			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29186118	Bronze			2022-12-28	WOS:000419794800043
J	Butterfield, GL; Lajoie, MJ; Gustafson, HH; Sellers, DL; Nattermann, U; Ellis, D; Bale, JB; Ke, S; Lenz, GH; Yehdego, A; Ravichandran, R; Pun, SH; King, NP; Baker, D				Butterfield, Gabriel L.; Lajoie, Marc J.; Gustafson, Heather H.; Sellers, Drew L.; Nattermann, Una; Ellis, Daniel; Bale, Jacob B.; Ke, Sharon; Lenz, Garreck H.; Yehdego, Angelica; Ravichandran, Rashmi; Pun, Suzie H.; King, Neil P.; Baker, David			Evolution of a designed protein assembly encapsulating its own RNA genome	NATURE			English	Article							VIRUS; VECTORS; MICROSCOPY; SELECTION; AFFINITY; CAPSIDS; FUSION; PHAGE; HISAT	The challenges of evolution in a complex biochemical environment, coupling genotype to phenotype and protecting the genetic material, are solved elegantly in biological systems by the encapsulation of nucleic acids. In the simplest examples, viruses use capsids to surround their genomes. Although these naturally occurring systems have been modified to change their tropism(1) and to display proteins or peptides(2-4), billions of years of evolution have favoured efficiency at the expense of modularity, making viral capsids difficult to engineer. Synthetic systems composed of non-viral proteins could provide a 'blank slate' to evolve desired properties for drug delivery and other biomedical applications, while avoiding the safety risks and engineering challenges associated with viruses. Here we create synthetic nucleocapsids, which are computationally designed icosahedral protein assemblies(5,6) with positively charged inner surfaces that can package their own full-length mRNA genomes. We explore the ability of these nucleocapsids to evolve virus-like properties by generating diversified populations using Escherichia coli as an expression host. Several generations of evolution resulted in markedly improved genome packaging (more than 133-fold), stability in blood (from less than 3.7% to 71% of packaged RNA protected after 6 hours of treatment), and in vivo circulation time (from less than 5 minutes to approximately 4.5 hours). The resulting synthetic nucleocapsids package one fulllength RNA genome for every 11 icosahedral assemblies, similar to the best recombinant adeno-associated virus vectors(7,8). Our results show that there are simple evolutionary paths through which protein assemblies can acquire virus-like genome packaging and protection. Considerable effort has been directed at 'top-down' modification of viruses to be safe and effective for drug delivery and vaccine applications(1,9,10); the ability to design synthetic nanomaterials computationally and to optimize them through evolution now enables a complementary 'bottom-up' approach with considerable advantages in programmability and control.	[Butterfield, Gabriel L.; Lajoie, Marc J.; Nattermann, Una; Ellis, Daniel; Bale, Jacob B.; Ravichandran, Rashmi; King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Butterfield, Gabriel L.; Lajoie, Marc J.; Nattermann, Una; Ellis, Daniel; Bale, Jacob B.; Ravichandran, Rashmi; King, Neil P.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Butterfield, Gabriel L.; Ellis, Daniel; Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Gustafson, Heather H.; Sellers, Drew L.; Ke, Sharon; Pun, Suzie H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Gustafson, Heather H.; Sellers, Drew L.; Pun, Suzie H.] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Sellers, Drew L.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Nattermann, Una] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Lenz, Garreck H.] Univ Washington, Coll Arts & Sci, Seattle, WA 98195 USA; [Yehdego, Angelica] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@uw.edu	Baker, David/K-8941-2012; Ellis, Daniel/GWN-0700-2022	Baker, David/0000-0001-7896-6217; Gustafson, Heather H./0000-0002-5484-5821; Lenz, Garreck/0000-0002-3233-0763; Bale, Jacob/0000-0003-2444-5875	Howard Hughes Medical Institute; Bill and Melinda Gates Foundation [OPP1118840]; Defense Advanced Research Projects Agency [W911NF-15-1-0645]; NIH [NIH1R01CA177272, NIH1R21NS099654-01A1, NIH5T32HL0071312]; National Science Foundation; Washington Research Foundation Innovation Postdoctoral Fellowship; Cancer Research Institute Irvington Fellowship from the Cancer Research Institute; PHS National Research Service Award from NIGMS [T32GM007270]; NATIONAL CANCER INSTITUTE [R01CA177272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS099654] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Washington Research Foundation Innovation Postdoctoral Fellowship; Cancer Research Institute Irvington Fellowship from the Cancer Research Institute; PHS National Research Service Award from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Chari for RNA-seq advice; S. Bustin for RT-qPCR advice; E. Gray and N. Arroyo for heparinized mouse blood; D. Veesler, J. Kollman and M. Johnson for EM advice; Y. Hsia for DLS advice; C. Walkey, Y. Hsia, G. Rocklin, J. Nelson, A. Chatterjee, S. Kosuri, G. Church, J. Bloom and A. Hessel for suggestions. This work was supported by the Howard Hughes Medical Institute (D.B.), the Bill and Melinda Gates Foundation (D.B. and N.P.K., grant number OPP1118840), the Defense Advanced Research Projects Agency (D.B. and N.P.K., grant number W911NF-15-1-0645), and the NIH (S.H.P., grant number NIH1R01CA177272; D.L.S., grant number NIH1R21NS099654-01A1). G.L.B. was supported by a National Science Foundation Graduate Fellowship. M.J.L. was supported by a Washington Research Foundation Innovation Postdoctoral Fellowship and a Cancer Research Institute Irvington Fellowship from the Cancer Research Institute. H.H.G. was supported by an NIH training grant (NIH5T32HL0071312). U.N. was supported in part by a PHS National Research Service Award (T32GM007270) from NIGMS.	Alvarez P, 2004, J BIOL CHEM, V279, P3375, DOI 10.1074/jbc.M311356200; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Drouin LM, 2016, J VIROL, V90, P8542, DOI 10.1128/JVI.00575-16; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; Hernandez-Garcia A, 2014, NAT NANOTECHNOL, V9, P698, DOI [10.1038/NNANO.2014.169, 10.1038/nnano.2014.169]; Hsia Y, 2016, NATURE, V535, P136, DOI 10.1038/nature18010; Hui DJ, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.29; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lilavivat S, 2012, J AM CHEM SOC, V134, P13152, DOI 10.1021/ja302743g; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Nannenga B. L., 2013, CURR PROTOC PROTEIN; Pascual E, 2015, J VIROL, V89, P2563, DOI 10.1128/JVI.03025-14; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SODERLIND E, 1992, IMMUNOL REV, V130, P109, DOI 10.1111/j.1600-065X.1992.tb01523.x; Sommer JM, 2003, MOL THER, V7, P122, DOI 10.1016/S1525-0016(02)00019-9; Starita Lea M, 2015, Cold Spring Harb Protoc, V2015, P711, DOI 10.1101/pdb.top077503; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081	34	115	117	2	175	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					415	+		10.1038/nature25157	http://dx.doi.org/10.1038/nature25157			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236688	Green Accepted			2022-12-28	WOS:000418559800061
J	Ji, M; Greening, C; Vanwonterghem, I; Carere, CR; Bay, SK; Steen, JA; Montgomery, K; Lines, T; Beardall, J; van Dorst, J; Snape, I; Stott, MB; Hugenholtz, P; Ferrari, BC				Ji, Mukan; Greening, Chris; Vanwonterghem, Inka; Carere, Carlo R.; Bay, Sean K.; Steen, Jason A.; Montgomery, Kate; Lines, Thomas; Beardall, John; van Dorst, Josie; Snape, Ian; Stott, Matthew B.; Hugenholtz, Philip; Ferrari, Belinda C.			Atmospheric trace gases support primary production in Antarctic desert surface soil	NATURE			English	Article							RNA GENE DATABASE; MICROBIAL DIVERSITY; ECOLOGY; GENOMES; POLAR; BACTERIA; ENZYMES; H-2	Cultivation-independent surveys have shown that the desert soils of Antarctica harbour surprisingly rich microbial communities(1-3). Given that phototroph abundance varies across these Antarctic soils(2,4), an enduring question is what supports life in those communities with low photosynthetic capacity(3,5). Here we provide evidence that atmospheric trace gases are the primary energy sources of two Antarctic surface soil communities. We reconstructed 23 draft genomes from metagenomic reads, including genomes from the candidate bacterial phyla WPS-2 and AD3. The dominant community members encoded and expressed high-affinity hydrogenases, carbon monoxide dehydrogenases, and a RuBisCO lineage known to support chemosynthetic carbon fixation(6,7). Soil microcosms aerobically scavenged atmospheric H-2 and CO at rates sufficient to sustain their theoretical maintenance energy and mediated substantial levels of chemosynthetic but not photosynthetic CO2 fixation. We propose that atmospheric H-2, CO2 and CO provide dependable sources of energy and carbon to support these communities, which suggests that atmospheric energy sources can provide an alternative basis for ecosystem function to solar or geological energy sources(8,9). Although more extensive sampling is required to verify whether this process is widespread in terrestrial Antarctica and other oligotrophic habitats, our results provide new understanding of the minimal nutritional requirements for life and open the possibility that atmospheric gases support life on other planets.	[Ji, Mukan; Montgomery, Kate; van Dorst, Josie; Ferrari, Belinda C.] UNSW Sydney, Australian Ctr Astrobiol, Sch Biotechnol & Biomol Sci, Randwick, NSW 2052, Australia; [Greening, Chris; Bay, Sean K.; Lines, Thomas; Beardall, John] Monash Univ, Sch Biol Sci, Ctr Geometr Biol, Clayton, Vic 3800, Australia; [Vanwonterghem, Inka; Steen, Jason A.; Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Carere, Carlo R.; Stott, Matthew B.] GNS Sci, Wairakei Res Ctr, 114 Karetoto Rd, Taupo 3384, New Zealand; [Snape, Ian] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, 203 Channel Highway, Kingston, Tas 7050, Australia	University of New South Wales Sydney; Monash University; University of Queensland; GNS Science - New Zealand; Australian Antarctic Division	Ferrari, BC (corresponding author), UNSW Sydney, Australian Ctr Astrobiol, Sch Biotechnol & Biomol Sci, Randwick, NSW 2052, Australia.	b.ferrari@unsw.edu.au	Ji, Mukan/AAI-5743-2020; Beardall, John/L-5262-2019; Hugenholtz, Philip/AAD-9138-2019; Ferrari, Belinda/AAI-3022-2020; Greening, Chris/J-4408-2019; Bay, Sean/ABC-8400-2020; Vanwonterghem, Inka/Y-5824-2019	Beardall, John/0000-0001-7684-446X; Hugenholtz, Philip/0000-0001-5386-7925; Ferrari, Belinda/0000-0001-5043-3726; Greening, Chris/0000-0001-7616-0594; Bay, Sean/0000-0003-4833-3106; Vanwonterghem, Inka/0000-0002-0150-2622; van Dorst, Josie/0000-0002-9353-8787; Lines, Thomas/0000-0002-6802-7694; Stott, Matthew/0000-0002-2082-9460; Steen, Jason/0000-0003-1351-5815; Ji, Mukan/0000-0001-8139-2875	Bioplatforms Australia, an Australian Antarctic Science project grant [4406]; ARC [FT170100341]; ARC DECRA Fellowship [DE170100310]; ARC DORA and Laureate Fellowship [DP120103498, FL150100038]; Marsden Grant [16-GNS-035]; UNSW Sydney; Centre for Geometric Biology (Monash University); Geothermal Resources of New Zealand research program (GNS Science)	Bioplatforms Australia, an Australian Antarctic Science project grant; ARC(Australian Research Council); ARC DECRA Fellowship(Australian Research Council); ARC DORA and Laureate Fellowship(Australian Research Council); Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); UNSW Sydney; Centre for Geometric Biology (Monash University)(Monash University); Geothermal Resources of New Zealand research program (GNS Science)	We thank the Australian Antarctic Division expedition teams who obtained Antarctic soils and photos used in this study. We also thank S. Siciliano for soil sampling, D. Wilkins for the map, T. Mooney for the Adams Flat photo, M. Chuvochina and A. Oren for etymological advice, and S. Chown for valuable insights. This work was supported by Bioplatforms Australia, an Australian Antarctic Science project grant (4406; awarded to B.C.F., C.G., M.B.S. and I.S.), an ARC Future Fellowship (FT170100341; awarded to B.C.F.), an ARC DECRA Fellowship (DE170100310; awarded to C.G.), an ARC DORA and Laureate Fellowship (DP120103498 and FL150100038; awarded to P.H.), and a Marsden Grant (16-GNS-035; awarded to C.R.C. and C.G.). UNSW Sydney, the Centre for Geometric Biology (Monash University), and the Geothermal Resources of New Zealand research program (GNS Science) also provided funding to support this research.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Berney M, 2014, ENVIRON MICROBIOL, V16, P318, DOI 10.1111/1462-2920.12320; Bissett A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0126-5; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cary SC, 2010, NAT REV MICROBIOL, V8, P129, DOI 10.1038/nrmicro2281; Cavicchioli R, 2015, NAT REV MICROBIOL, V13, P691, DOI 10.1038/nrmicro3549; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Chown SL, 2015, NATURE, V522, P427, DOI 10.1038/nature14505; Conrad R., 1999, Indian Journal of Microbiology, V39, P193; Constant P, 2011, SOIL BIOL BIOCHEM, V43, P1888, DOI 10.1016/j.soilbio.2011.05.009; Constant P, 2010, ENVIRON MICROBIOL, V12, P821, DOI 10.1111/j.1462-2920.2009.02130.x; Darling JA, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140202; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ferrari BC, 2016, ENVIRON MICROBIOL, V18, P1834, DOI 10.1111/1462-2920.13034; Greening C, 2016, ISME J, V10, P761, DOI 10.1038/ismej.2015.153; Greening C, 2015, P NATL ACAD SCI USA, V112, P10497, DOI 10.1073/pnas.1508385112; Greening C, 2015, APPL ENVIRON MICROB, V81, P1190, DOI 10.1128/AEM.03364-14; Grostern A, 2013, ENVIRON MICROBIOL, V15, P3040, DOI 10.1111/1462-2920.12144; Herbold CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4875; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Imelfort M, 2014, PEERJ, V2, DOI 10.7717/peerj.603; Ji M, 2016, POLAR BIOL, V39, P237, DOI 10.1007/s00300-015-1776-y; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Lee KCY, 2013, APPL ENVIRON MICROB, V79, P2484, DOI 10.1128/AEM.03333-12; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lynch RC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00698; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Nielsen UN, 2015, POLAR BIOL, V38, P1391, DOI 10.1007/s00300-015-1703-2; Park SW, 2009, RES MICROBIOL, V160, P159, DOI 10.1016/j.resmic.2008.12.002; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quiza L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00271; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siciliano SD, 2014, SOIL BIOL BIOCHEM, V78, P10, DOI 10.1016/j.soilbio.2014.07.005; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sondergaard D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34212; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tebo BM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00179; TIJHUIS L, 1993, BIOTECHNOL BIOENG, V42, P509, DOI 10.1002/bit.260420415; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Whitman WB, 2016, INT J SYST EVOL MICR, V66, P2108, DOI 10.1099/ijsem.0.000980	55	147	149	13	138	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					400	+		10.1038/nature25014	http://dx.doi.org/10.1038/nature25014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29211716	Green Published, hybrid			2022-12-28	WOS:000418559800058
J	Desai, M; Field, N; Grant, R; McCormack, S				Desai, Monica; Field, Nigel; Grant, Robert; McCormack, Sheena			Recent advances in pre-exposure prophylaxis for HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BONE-MINERAL DENSITY; HIGH-RISK MEN; COST-EFFECTIVENESS; TRANSGENDER WOMEN; UNITED-STATES; ANTIRETROVIRAL PROPHYLAXIS; SERODISCORDANT COUPLES; HETEROSEXUAL MEN; DOUBLE-BLIND; PREVENTION	Although pre-exposure prophylaxis (PrEP)-the use of antiretroviral drugs by noninfected people to prevent the acquisition of HIV-is a promising preventive option, important public health questions remain. Daily oral emtricitabine (FTC)-tenofovir disoproxil fumarate (TDF) is highly efficacious in preventing the acquisition of HIV in people at risk as a result of a range of different types of sexual exposure. There is good evidence of efficacy in women and men, and when men who have sex with men use event based dosing. Studies have been conducted in several countries and epidemics. Because adherence to this treatment varies greatly there are questions about its public health benefit. Oral FTC-TDF is extremely safe, with minimal impact on kidney, bone, or pregnancy outcomes, and there is no evidence that its effectiveness has been reduced by risk compensation during open label and programmatic follow-up. It is too early to assess the impact of this treatment on the incidence of sexually transmitted infections (STIs) at a population level. Many challenges remain. Access to pre-exposure prophylaxis is limited and disparities exist, including those governed by race and sex. Different pricing and access models need to be explored to avoid further widening inequalities. The optimal combination prevention program needs to be defined, and this will depend on local epidemiology, service provision, and cost effectiveness. This review updates the evidence base for pre-exposure prophylaxis regarding its effectiveness, safety, and risk compensation.	[Desai, Monica] Publ Hlth England, IHIV & STI Dept, London NW9 5EQ, England; [Field, Nigel] UCL, Ctr Mol Epidemiol & Translat Res, London WC1E 6BT, England; [Grant, Robert] Univ Calif San Francisco, Sch Med, San Francisco, CA 94115 USA; [Grant, Robert] Gladstone Inst, San Francisco, CA 94115 USA; [Grant, Robert] San Francisco AIDS Fdn, San Francisco, CA 94115 USA; [McCormack, Sheena] UCL, MRC Clin Trials Unit, London, England; [McCormack, Sheena] Chelsea & Westminster Hosp, London SW10 9BH, England	Public Health England; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Medical Research Council Clinical Trials Unit; University of London; University College London; Imperial College London	Desai, M (corresponding author), Publ Hlth England, IHIV & STI Dept, London NW9 5EQ, England.	desai.monica@gmail.com	Field, Nigel/ABG-3948-2020	Field, Nigel/0000-0002-2825-6652	Medical Research Council [MRC_UU_12023/23]; MRC [MC_UU_12023/1] Funding Source: UKRI; Medical Research Council [MC_UU_12023/1, MC_UU_12023/23] Funding Source: researchfish; National Institute for Health Research [CL-2010-18-010, ACF-2008-20-002] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	SMcC was supported by the Medical Research Council (MRC_UU_12023/23).	Aghaizu A, 2016, LANCET HIV, V3, pE431, DOI 10.1016/S2352-3018(16)30037-6; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Antoni AG, 2017, IS ON DEMAND PREP WI; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Baeten J, 2016, INTEGRATED DELIVERY; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Bernard CL, 2016, ANN INTERN MED, V165, P10, DOI 10.7326/M15-2634; British Columbia Centre for Excellence in HIV/ AIDS, 2016, GUIDANCE FOR THE USE; Brown AE, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.25.30553; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Cambiano V, 2015, SEX TRANSM INFECT, V91, pA1, DOI 10.1136/sextrans-2015-052126.1; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; Centers for Disease Control and Prevention, 2014, PREEXPOSURE PROPHYLA; Chen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108742; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen S., 2016, EXPANDING PREP ACCES; Collins S., 2016, HIV TREATMENT BULLET; Dai JY, 2016, J INFECT DIS, V213, P335, DOI 10.1093/infdis/jiv333; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Delpech V, TOWARDS ELIMINATION; Department: Health. Republic of South Africa, 2016, NATIONAL POLICY ON H; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Desai M, 2016, HIV MED, V17, P133, DOI 10.1111/hiv.12285; Deutsch MB, 2015, LANCET HIV, V2, pE512, DOI 10.1016/S2352-3018(15)00206-4; Dolling D, 2014, THIRD JOINT CONFEREN; Dolling DI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1286-4; European AIDS Clinical Society, 2015, GUIDELINES VERSION 8; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; French National Agency for AIDS Research (ANRS), 2015, PRISE EN CHARGE MEDI; Giller RM, 2017, CHANGES IN TRUVADA T; Grant JM, 2016, SOC STUD SCI, V46, P236, DOI 10.1177/0306312716632617; Grant R, 2016, RECOVERY OF BONE MIN; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf LA, 2013, JAIDS-J ACQ IMM DEF, V64, P79, DOI 10.1097/QAI.0b013e31828ece33; Grossman HA, 2016, HIVR4P CONFERENCE; Gulick R, 2016, CONFERENCE ON RETROV, P103; Heffron R, 2014, AIDS, V28, P2771, DOI 10.1097/QAD.0000000000000493; Hoornenborg E, 2017, CONFERENCE ON RETROV, P953; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hosek SG, 2013, J HIV-AIDS SOC SERV, V12, P333, DOI 10.1080/15381501.2013.773575; Hughes G, 2015, FUTURE MICROBIOL, V10, P35, DOI 10.2217/fmb.14.110; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; Karim SSA, 2015, CURR OPIN HIV AIDS, V10, P183, DOI 10.1097/COH.0000000000000147; Kessler J, 2014, AIDS, V28, P2683, DOI 10.1097/QAD.0000000000000460; Kibengo FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074314; Knox DC, 2016, HIV 1 INFECTION WITH; La Direction des Communications du Ministere de la Sante et des Services Sociaux, 2013, AVIS INTERIMAIRE SUR; Lal L, 2017, AIDS, V31, P1709, DOI [10.1097/QAD.0000000000001519, 10.1097/qad.0000000000001519]; Letchumanan M, 2015, ANTIVIR THER, V20, P613, DOI 10.3851/IMP2956; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Martin M, 2015, CONFERENCE ON RETROV; Martin M, 2017, LANCET HIV, V4, pE59, DOI 10.1016/S2352-3018(16)30207-7; Martin M, 2015, AIDS, V29, P819, DOI 10.1097/QAD.0000000000000613; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I, 2016, CONFERENCE ON RETROV; Mirembe BG, 2016, JAIDS-J ACQ IMM DEF, V71, P287, DOI 10.1097/QAI.0000000000000858; Mitchell KM, 2015, AIDS, V29, P2035, DOI 10.1097/QAD.0000000000000798; Mofenson LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002133; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM, 2017, INTERNATIONAL AIDS C; Molina JM, 2016, INTERNATIONAL AIDS C; Montano MA, 2017, CONFERENCE ON RETROV, P979; Mugo NR, 2014, JAMA-J AM MED ASSOC, V312, P362, DOI 10.1001/jama.2014.8735; Mugo Nelly R, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mugwanya KK, 2013, SEX TRANSM INFECT, V89, pA46, DOI 10.1136/sextrans-2013-051184.0144; Mugwanya KK, 2016, JAIDS-J ACQ IMM DEF, V71, P374, DOI 10.1097/QAI.0000000000000868; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Mugwanya KK, 2015, TOP ANTIVIR MED, V23, P451; Mulligan K, 2015, CLIN INFECT DIS, V61, P572, DOI 10.1093/cid/civ324; Murnane PM, 2014, AIDS, V28, P1825, DOI 10.1097/QAD.0000000000000290; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; Nel A, 2016, CONFERENCE ON RETROV; New South Wales, 2017, NSW HIV STRATEGY 201; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Ong K, 2015, POSTER PRESENTATION; Ong KJ, 2015, LANCET, V386, pS16, DOI 10.1016/S0140-6736(15)00854-5; Ouellet E, 2015, CAN J INFECT DIS MED, V26, P23, DOI 10.1155/2015/964512; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Public Health England, 2015, HEALTH PROTECTION RE; Ross EL, 2016, JAIDS-J ACQ IMM DEF, V72, pE61, DOI 10.1097/QAI.0000000000000987; Sagaon-Teyssier L, 2016, AIDS CARE, V28, P48, DOI 10.1080/09540121.2016.1146653; San Francisco Department of Public Health, HIV EPIDEMIOLOGY ANN; Shen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100863; Sivay MV, 2017, JAIDS-J ACQ IMM DEF, V75, P271, DOI 10.1097/QAI.0000000000001374; Thigpen MC, 2011, DAILY ORAL ANTIRETRO; UNAIDS, 2016, FACT SHEET 2016; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Weber S, 2016, AIDS 2016; Whiteman MK, 2016, CONTRACEPTION, V93, P17, DOI 10.1016/j.contraception.2015.07.003; WHO, 2017, WHO IMPLEMENTATION T; WHO, 2016, CONSOLIDATED GUIDANC; Yaylali E, 2016, CONFERENCE ON RETROV	102	65	66	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5011	10.1136/bmj.j5011	http://dx.doi.org/10.1136/bmj.j5011			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KT	29229609	Green Accepted, Green Submitted			2022-12-28	WOS:000418327000001
J	Beaulieu, S; Comby, A; Clergerie, A; Caillat, J; Descamps, D; Dudovich, N; Fabre, B; Geneaux, R; Legare, F; Petit, S; Pons, B; Porat, G; Ruchon, T; Taieb, R; Blanchet, V; Mairesse, Y				Beaulieu, S.; Comby, A.; Clergerie, A.; Caillat, J.; Descamps, D.; Dudovich, N.; Fabre, B.; Geneaux, R.; Legare, F.; Petit, S.; Pons, B.; Porat, G.; Ruchon, T.; Taieb, R.; Blanchet, V.; Mairesse, Y.			Attosecond-resolved photoionization of chiral molecules	SCIENCE			English	Article							PHOTOELECTRON CIRCULAR-DICHROISM; MULTIPHOTON IONIZATION; FANO RESONANCE; DYNAMICS	Chiral light-matter interactions have been investigated for two centuries, leading to the discovery of many chiroptical processes used for discrimination of enantiomers. Whereas most chiroptical effects result from a response of bound electrons, photoionization can produce much stronger chiral signals that manifest as asymmetries in the angular distribution of the photoelectrons along the light-propagation axis. We implemented self-referenced attosecond photoelectron interferometry to measure the temporal profile of the forward and backward electron wave packets emitted upon photoionization of camphor by circularly polarized laser pulses. We measured a delay between electrons ejected forward and backward, which depends on the ejection angle and reaches 24 attoseconds. The asymmetric temporal shape of electron wave packets emitted through an autoionizing state further reveals the chiral character of strongly correlated electronic dynamics.	[Beaulieu, S.; Comby, A.; Clergerie, A.; Descamps, D.; Fabre, B.; Petit, S.; Pons, B.; Blanchet, V.; Mairesse, Y.] Univ Bordeaux, Commissariat Energie Atom & Energies Alternat CEA, Ctr Lasers Intenses & Applicat CELIA, CNRS,UMR5107, F-33405 Talence, France; [Beaulieu, S.; Legare, F.] Inst Natl Rech Sci, Varennes, PQ, Canada; [Caillat, J.; Taieb, R.] UPMC Univ Paris 6, CNRS UMR 7614, Lab Chim Phys Mat & Rayonnement, Sorbonne Univ, F-75252 Paris, France; [Dudovich, N.; Porat, G.] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Geneaux, R.; Ruchon, T.] Univ Paris Saclay, CEA, Lab Interact Dynam & Lasers LIDYL, CNRS,CEA Saclay, F-91191 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; University of Quebec; Institut national de la recherche scientifique (INRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Weizmann Institute of Science; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Beaulieu, S (corresponding author), Univ Bordeaux, Commissariat Energie Atom & Energies Alternat CEA, Ctr Lasers Intenses & Applicat CELIA, CNRS,UMR5107, F-33405 Talence, France.; Beaulieu, S (corresponding author), Inst Natl Rech Sci, Varennes, PQ, Canada.	beaulieus@emt.inrs.ca	Comby, Antoine/V-6431-2018; blanchet, valerie/L-3677-2014; Mairesse, Yann/B-3049-2015; Ruchon, Thierry/AGH-4813-2022; Géneaux, Romain/AAF-1395-2019; Descamps, Dominique/AAC-6571-2019; FABRE, Baptiste/E-3815-2015; pons, bernard/A-6688-2017; Beaulieu, Samuel/AAK-6474-2021; Comby, Antoine/P-4294-2019; Descamps, Dominique/A-6826-2017; Beaulieu, Samuel/E-7208-2017	Comby, Antoine/0000-0002-9541-7110; blanchet, valerie/0000-0002-6464-3879; Mairesse, Yann/0000-0002-9098-7421; Ruchon, Thierry/0000-0001-7933-8933; Géneaux, Romain/0000-0002-3395-6813; Descamps, Dominique/0000-0003-0474-0551; FABRE, Baptiste/0000-0001-9843-8139; pons, bernard/0000-0002-0001-7107; Beaulieu, Samuel/0000-0003-2316-2224; Comby, Antoine/0000-0002-9541-7110; Descamps, Dominique/0000-0003-0474-0551; Beaulieu, Samuel/0000-0003-2316-2224; Caillat, Jeremie/0000-0002-1975-6356	European Research Council under the European Union Horizon research and innovation program [682978 - EXCITERS]; LASERLAB-EUROPE, the European Commission's Seventh Framework Programme [284464]; French National Research Agency [ANR-14-CE32-0014 MISFITS, ANR-14-CE32-0010 XSTASE]; IdEx Bordeaux LAPHIA [ANR-10-IDEX-03-02]; Conseil Regional de Nouvelle-Aquitaine [2.1.3-09010502 COLA2]; LABEX PlasaPar project; program "Investissements d'Avenir" [ANR-11-IDEX-0004-02]; Natural Sciences and Engineering Research Council of Canada Vanier Scholarship;  [ANR-15-CE30-0001-01-CIMBAAD]	European Research Council under the European Union Horizon research and innovation program; LASERLAB-EUROPE, the European Commission's Seventh Framework Programme; French National Research Agency(French National Research Agency (ANR)); IdEx Bordeaux LAPHIA; Conseil Regional de Nouvelle-Aquitaine; LABEX PlasaPar project; program "Investissements d'Avenir"(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council of Canada Vanier Scholarship; 	We thank R. Bouillaud and L. Merzeau for technical assistance and A. L'Huillier for fruitful discussions. This project has received funding from the European Research Council under the European Union Horizon 2020 research and innovation program 682978 - EXCITERS and from LASERLAB-EUROPE, grant 284464, the European Commission's Seventh Framework Programme. We acknowledge the financial support from the French National Research Agency through grants ANR-14-CE32-0014 MISFITS, ANR-14-CE32-0010 XSTASE, and IdEx Bordeaux LAPHIA (ANR-10-IDEX-03-02) and the Conseil Regional de Nouvelle-Aquitaine (2.1.3-09010502 COLA2 project). J.C. and R.T. acknowledge financial support from the LABEX PlasaPar project, the program "Investissements d'Avenir" under the reference ANR-11-IDEX-0004-02, and the program ANR-15-CE30-0001-01-CIMBAAD. S.B. acknowledges the Natural Sciences and Engineering Research Council of Canada Vanier Scholarship. The data presented in the study are available in the SM.	AGOSTINI P, 1979, PHYS REV LETT, V42, P1127, DOI 10.1103/PhysRevLett.42.1127; Argenti L, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.043426; Aseyev SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.223902; Baykusheva D, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4977933; Beaulieu S, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/102002; Beaulieu S., 2016, ARXIV161208764PHYSIC; Beaulieu S, 2016, FARADAY DISCUSS, V194, P325, DOI 10.1039/c6fd00113k; Bowering N, 2001, PHYS REV LETT, V86, P1187, DOI 10.1103/PhysRevLett.86.1187; Busto D., 2017, ARXIV170907639V1PHYS; Catone D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.083001; Cattaneo L., 2016, P INT C ULTR PHEN OP; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Chacon A, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.053427; Comby A, 2016, J PHYS CHEM LETT, V7, P4514, DOI 10.1021/acs.jpclett.6b02065; Dahlstrom JM, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/18/183001; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Garcia GA, 2004, REV SCI INSTRUM, V75, P4989, DOI 10.1063/1.1807578; Gong XC, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.143203; Gruson V, 2016, SCIENCE, V354, P734, DOI 10.1126/science.aah5188; Haessler S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.011404; Heuser S, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.063409; Hockett P, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/9/095602; Hockett P, 2017, J PHYS B-AT MOL OPT, V50, DOI 10.1088/1361-6455/aa7887; Jordan I, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.013404; Kaldun A, 2016, SCIENCE, V354, P738, DOI 10.1126/science.aah6972; Klunder K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.143002; Kotur M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10566; Lehmann CS, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4844295; Lux C, 2015, CHEMPHYSCHEM, V16, P115, DOI 10.1002/cphc.201402643; Lux C, 2012, ANGEW CHEM INT EDIT, V51, P5001, DOI 10.1002/anie.201109035; Meierhenrich U., 2008, AMINO ACIDS ASYMMETR; Naaman R, 2015, ANNU REV PHYS CHEM, V66, P263, DOI 10.1146/annurev-physchem-040214-121554; Nahon L, 2016, PHYS CHEM CHEM PHYS, V18, P12696, DOI 10.1039/c6cp01293k; Nahon L, 2015, J ELECTRON SPECTROSC, V204, P322, DOI 10.1016/j.elspec.2015.04.008; Ossiander M, 2017, NAT PHYS, V13, P280, DOI [10.1038/NPHYS3941, 10.1038/nphys3941]; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Piancastelli MN, 1999, J ELECTRON SPECTROSC, V100, P167, DOI 10.1016/S0368-2048(99)00046-8; Powis I., 2008, ADV CHEM PHYS; Qin F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14465; RITCHIE B, 1976, PHYS REV A, V13, P1411, DOI 10.1103/PhysRevA.13.1411; SCHUMACHER DW, 1994, PHYS REV LETT, V73, P1344, DOI 10.1103/PhysRevLett.73.1344; Skruszewicz S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.043001; Tia M, 2017, J PHYS CHEM LETT, V8, P2780, DOI 10.1021/acs.jpclett.7b01000; Tia M, 2013, J PHYS CHEM LETT, V4, P2698, DOI 10.1021/jz4014129; WIGNER EP, 1955, PHYS REV, V98, P145, DOI 10.1103/PhysRev.98.145; Zipp LJ, 2014, OPTICA, V1, P361, DOI 10.1364/OPTICA.1.000361	46	116	117	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1288	1293		10.1126/science.aao5624	http://dx.doi.org/10.1126/science.aao5624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217568	Green Submitted			2022-12-28	WOS:000417254700055
J	Nachev, V; Winter, Y				Nachev, Vladislav; Winter, York			Response to Comment on "Cognition-mediated evolution of low-quality floral nectars"	SCIENCE			English	Editorial Material							SUGAR COMPOSITION; CHOICE; BEHAVIOR; VOLUME; BATS	Pyke and Waser claim that our virtual pollination ecology model makes unrealistic assumptions and fails to predict observed nectar concentrations of bat flowers and negative correlations between pollinator body size and sugar concentration. In their comment, crucial model features are misrepresented, misunderstood, or ignored. Sensitivity to the supply/demand ratio explains both the equilibrium concentrations and the selection for lower concentrations by larger pollinators.	[Nachev, Vladislav; Winter, York] Humboldt Univ, Berlin, Germany	Humboldt University of Berlin	Winter, Y (corresponding author), Humboldt Univ, Berlin, Germany.	york.winter@charite.de		Winter, York/0000-0002-7828-1872; Nachev, Vladislav/0000-0003-0521-6153				Akre KL, 2014, TRENDS ECOL EVOL, V29, P291, DOI 10.1016/j.tree.2014.03.007; Bogacz R, 2007, PHILOS T R SOC B, V362, P1655, DOI 10.1098/rstb.2007.2059; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Foley BR, 2017, ANIM COGN, V20, P867, DOI 10.1007/s10071-017-1107-5; Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Kromer T, 2008, PLANT BIOLOGY, V10, P502, DOI 10.1111/j.1438-8677.2008.00058.x; MITCHELL RJ, 1990, OECOLOGIA, V83, P238, DOI 10.1007/BF00317758; Nachev V, 2017, SCIENCE, V355, P75, DOI 10.1126/science.aah4219; Nachev V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074144; Nachev V, 2012, ANIM COGN, V15, P393, DOI 10.1007/s10071-011-0465-7; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Pyke GH, 2017, SCIENCE, V358, DOI 10.1126/science.aao1962; Rodriguez-Pena N, 2016, REV MEX BIODIVERS, V87, P465, DOI 10.1016/j.rmb.2016.03.002; Shafir S, 2003, PLANT SYST EVOL, V238, P195, DOI 10.1007/s00606-003-0280-y; Tschapka M, 2007, J TROP ECOL, V23, P385, DOI 10.1017/S0266467407004129; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416	16	1	1	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368							eaao2622	10.1126/science.aao2622	http://dx.doi.org/10.1126/science.aao2622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217543				2022-12-28	WOS:000417254700002
J	Kan, SBJ; Huang, XY; Gumulya, Y; Chen, K; Arnold, FH				Kan, S. B. Jennifer; Huang, Xiongyi; Gumulya, Yosephine; Chen, Kai; Arnold, Frances H.			Genetically programmed chiral organoborane synthesis	NATURE			English	Article							HETEROCYCLIC CARBENE BORANES; DIRECTED EVOLUTION; NONNATURAL REACTIONS; HIGHLY EFFICIENT; HYDROGEN BONDS; CYTOCHROME-C; IN-VIVO; BORON; INSERTION; ENZYMES	Recent advances in enzyme engineering and design have expanded nature's catalytic repertoire to functions that are new to biology(1-3.) However, only a subset of these engineered enzymes can function in living systems(4-7). Finding enzymatic pathways that form chemical bonds that are not found in biology is particularly difficult in the cellular environment, as this depends on the discovery not only of new enzyme activities, but also of reagents that are both sufficiently reactive for the desired transformation and stable in vivo. Here we report the discovery, evolution and generalization of a fully genetically encoded platform for producing chiral organoboranes in bacteria. Escherichia coli cells harbouring wildtype cytochrome c from Rhodothermus marinus(8) (Rma cyt c) were found to form carbon-boron bonds in the presence of borane-Lewis base complexes, through carbene insertion into boron-hydrogen bonds. Directed evolution of Rma cyt c in the bacterial catalyst provided access to 16 novel chiral organoboranes. The catalyst is suitable for gram-scale biosynthesis, providing up to 15,300 turnovers, a turnover frequency of 6,100 h(-1), a 99:1 enantiomeric ratio and 100% chemoselectivity. The enantiopreference of the biocatalyst could also be tuned to provide either enantiomer of the organoborane products. Evolved in the context of whole-cell catalysts, the proteins were more active in the whole-cell system than in purified forms. This study establishes a DNA-encoded and readily engineered bacterial platform for borylation; engineering can be accomplished at a pace that rivals the development of chemical synthetic methods, with the ability to achieve turnovers that are two orders of magnitude (over 400-fold) greater than those of known chiral catalysts for the same class of transformation(9-11). This tunable method for manipulating boron in cells could expand the scope of boron chemistry in living systems.	[Kan, S. B. Jennifer; Huang, Xiongyi; Gumulya, Yosephine; Chen, Kai; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd,MC 210-41, Pasadena, CA 91125 USA	California Institute of Technology	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Huang, Xiongyi/0000-0001-7156-8881; Arnold, Frances H./0000-0002-4027-364X	National Science Foundation, Office of Chemical, Bioengineering, Environmental and Transport Systems SusChEM Initiative [CBET-1403077]; Gordon and Betty Moore Foundation [GBMF2809]; Jacobs Institute for Molecular Engineering for Medicine at Caltech; Ruth L. Kirschstein National Institutes of Health Postdoctoral Fellowship [F32GM125231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM125231] Funding Source: NIH RePORTER	National Science Foundation, Office of Chemical, Bioengineering, Environmental and Transport Systems SusChEM Initiative; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Jacobs Institute for Molecular Engineering for Medicine at Caltech; Ruth L. Kirschstein National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Science Foundation, Office of Chemical, Bioengineering, Environmental and Transport Systems SusChEM Initiative (grant CBET-1403077), the Gordon and Betty Moore Foundation through grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative, and the Jacobs Institute for Molecular Engineering for Medicine at Caltech. X.H. is supported by a Ruth L. Kirschstein National Institutes of Health Postdoctoral Fellowship (F32GM125231). We thank O.F. Brandenberg, S. Brinkmann-Chen, T. Hashimoto, R.D. Lewis, and D.K. Romney for discussions and/or comments on the manuscript, and N.W. Goldberg and A. Zutshi for experimental assistance. We are grateful to S. Virgil, N. Torian, M.K. Takase and L. Henling for analytical support, and H. Gray for providing the pEC86 plasmid.	Argintaru OA, 2013, ANGEW CHEM INT EDIT, V52, P13656, DOI 10.1002/anie.201308036; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; Chen D, 2015, J AM CHEM SOC, V137, P5268, DOI 10.1021/jacs.5b00892; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Cheng QQ, 2013, J AM CHEM SOC, V135, P14094, DOI 10.1021/ja408306a; Coelho PS, 2013, NAT CHEM BIOL, V9, P485, DOI 10.1038/nchembio.1278; Curran DP, 2011, ANGEW CHEM INT EDIT, V50, P10294, DOI 10.1002/anie.201102717; Das BC, 2013, FUTURE MED CHEM, V5, P653, DOI [10.4155/FMC.13.38, 10.4155/fmc.13.38]; Dembitsky VM, 2011, CHEM REV, V111, P209, DOI 10.1021/cr100093b; Elshahawi SI, 2013, P NATL ACAD SCI USA, V110, pE295, DOI 10.1073/pnas.1213892110; Halo TL, 2009, J AM CHEM SOC, V131, P438, DOI 10.1021/ja807872s; Hammer SC, 2017, CURR OPIN GREEN SUST, V7, P23, DOI 10.1016/j.cogsc.2017.06.002; Handa S, 2015, SCIENCE, V349, P1087, DOI 10.1126/science.aac6936; Hernandez KE, 2016, ACS CATAL, V6, P7810, DOI 10.1021/acscatal.6b02550; Hyde S, 2016, ANGEW CHEM INT EDIT, V55, P3785, DOI 10.1002/anie.201511954; Hyster TK, 2016, ANGEW CHEM INT EDIT, V55, P7344, DOI 10.1002/anie.201508816; IRSCHIK H, 1995, J ANTIBIOT, V48, P26, DOI 10.7164/antibiotics.48.26; Jeschek M, 2016, NATURE, V537, P661, DOI 10.1038/nature19114; Jiang QB, 2017, J ORG CHEM, V82, P1951, DOI 10.1021/acs.joc.6b02772; Kan SBJ, 2016, SCIENCE, V354, P1048, DOI 10.1126/science.aah6219; Kanouni T., 2014, Histone Demethylase Inhibitors, Patent No. [W02014/151106, 2014151106]; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kim J, 2015, ANGEW CHEM INT EDIT, V54, P15777, DOI 10.1002/anie.201508861; Leonori D, 2015, ANGEW CHEM INT EDIT, V54, P1082, DOI 10.1002/anie.201407701; Leonori D, 2014, ACCOUNTS CHEM RES, V47, P3174, DOI 10.1021/ar5002473; Li XB, 2013, J AM CHEM SOC, V135, P12076, DOI 10.1021/ja4056245; Mara MW, 2017, SCIENCE, V356, P1276, DOI 10.1126/science.aam6203; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Prier CK, 2017, NAT CHEM, V9, P629, DOI [10.1038/nchem.2783, 10.1038/NCHEM.2783]; Renata H, 2016, J AM CHEM SOC, V138, P12527, DOI 10.1021/jacs.6b06823; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Scopes D., 2012, [US patent, 2012/0289523 A1], Patent No. 20120289523; Stelter M, 2008, BIOCHEMISTRY-US, V47, P11953, DOI 10.1021/bi800999g; Tehfe MA, 2012, ACS MACRO LETT, V1, P92, DOI 10.1021/mz200087g; Tinoco A, 2017, J AM CHEM SOC, V139, P5293, DOI 10.1021/jacs.7b00768; Wolkenstein K, 2015, J AM CHEM SOC, V137, P13460, DOI 10.1021/jacs.5b08191; Wurtemberger-Pietsch S, 2016, DALTON T, V45, P5880, DOI 10.1039/c5dt04106f	38	172	177	6	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					132	+		10.1038/nature24996	http://dx.doi.org/10.1038/nature24996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186119	Green Accepted			2022-12-28	WOS:000417560500057
J	Eisenberg, R; Varmus, H				Eisenberg, Rebecca; Varmus, Harold			Insurance for broad genomic tests in oncology	SCIENCE			English	Editorial Material									[Eisenberg, Rebecca] Univ Michigan, Law Sch, Ann Arbor, MI 48109 USA; [Varmus, Harold] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA	University of Michigan System; University of Michigan; Cornell University	Eisenberg, R (corresponding author), Univ Michigan, Law Sch, Ann Arbor, MI 48109 USA.	rse@umich.edu; varmus@med.cornell.edu			Meyer Cancer Center at Weill Cornell Medicine; William W. Cook Endowment; Elkes Fund of the University of Michigan Law School	Meyer Cancer Center at Weill Cornell Medicine; William W. Cook Endowment; Elkes Fund of the University of Michigan Law School	Supported by funds from the Meyer Cancer Center at Weill Cornell Medicine (to H.V.) and the William W. Cook Endowment and the Elkes Fund of the University of Michigan Law School (to R.S.E.). We acknowledge advice from P. Bach, N. Bagley, J. Baselga, L. Diaz, M. Hamburg, N. Price, R. Sachs, C. Sawyers, M. Seiden, T. Simoncelli, and S. Tunis.	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; [Anonymous], 2016, FED REGISTER, V81, p[73, 113]; Centers for Medicare and Medicaid Services, 2013, LDT AND CLIA FAQS; CMS, 2003, DEC MEM LUNG VOL RED; CMS, 2014, GUID PUBL IND CMS ST; Cohen JP, 2014, J PERS MED, V4, P163, DOI 10.3390/jpm4020163; Foundation Medicine Inc, 2017, FORM 10 Q QUART END, P23; Gray SW, 2014, J CLIN ONCOL, V32, P1317, DOI 10.1200/JCO.2013.52.4298; Green Park Collaborative, 2015, IN MED POL MOD COV G; Guinto J. B., NCCN TRENDS EVALUATI; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lernery S., 2017, NEW ENGL J MED, V377, P1409; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Nowak F, 2012, NAT REV CLIN ONCOL, V9, P479, DOI 10.1038/nrclinonc.2012.42; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; U.S. Department of Health and Human Services (DHHS), 2016, FDA IS ISS MOR POSTM; US Food and Drug Administration, 2017, DISC PAP LAB DEV TES; US Food and Drug Administration, 2014, GUID IND FO IN PRESS	19	15	15	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1133	1134		10.1126/science.aao6708	http://dx.doi.org/10.1126/science.aao6708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191895				2022-12-28	WOS:000416584000023
J	Lyon, J				Lyon, Jeff			Veterans Affairs Creates New Family Support Group	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1967	1967		10.1001/jama.2017.17928	http://dx.doi.org/10.1001/jama.2017.17928			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183055				2022-12-28	WOS:000416317600003
J	Rubin, R				Rubin, Rita			Pet Rats Infect Daughter, Mother With Hantavirus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1969	1969		10.1001/jama.2017.17645	http://dx.doi.org/10.1001/jama.2017.17645			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183085				2022-12-28	WOS:000416317600010
J	Slomski, A				Slomski, Anita			Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1968	1968		10.1001/jama.2017.17953	http://dx.doi.org/10.1001/jama.2017.17953			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183072				2022-12-28	WOS:000416317600008
J	Raskob, GE; van Es, N; Verhamme, P; Carrier, M; Di Nisio, M; Garcia, D; Grosso, MA; Kakkar, AK; Kovacs, MJ; Mercuri, MF; Meyer, G; Segers, A; Shi, MG; Wang, TF; Yeo, E; Zhang, G; Zwicker, JI; Weitz, JI; Buller, HR				Raskob, Gary E.; van Es, Nick; Verhamme, Peter; Carrier, Marc; Di Nisio, Marcello; Garcia, David; Grosso, Michael A.; Kakkar, Ajay K.; Kovacs, Michael J.; Mercuri, Michele F.; Meyer, Guy; Segers, Annelise; Shi, Minggao; Wang, Tzu-Fei; Yeo, Erik; Zhang, George; Zwicker, Jeffrey I.; Weitz, Jeffrey I.; Buller, Harry R.		Hokusai VTE Canc Investigators	Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-K ANTAGONISTS; TREATMENT GUIDELINES; PROPHYLAXIS; MANAGEMENT; THROMBOSIS	BACKGROUND Low-molecular-weight heparin is the standard treatment for cancer-associated venous thromboembolism. The role of treatment with direct oral anticoagulant agents is unclear. METHODS In this open-label, noninferiority trial, we randomly assigned patients with cancer who had acute symptomatic or incidental venous thromboembolism to receive either low-molecular-weight heparin for at least 5 days followed by oral edoxaban at a dose of 60 mg once daily (edoxaban group) or subcutaneous dalteparin at a dose of 200 IU per kilogram of body weight once daily for 1 month followed by dalteparin at a dose of 150 IU per kilogram once daily (dalteparin group). Treatment was given for at least 6 months and up to 12 months. The primary outcome was a composite of recurrent venous thromboembolism or major bleeding during the 12 months after randomization, regardless of treatment duration. RESULTS Of the 1050 patients who underwent randomization, 1046 were included in the modified intention-to-treat analysis. A primary-outcome event occurred in 67 of the 522 patients (12.8%) in the edoxaban group as compared with 71 of the 524 patients (13.5%) in the dalteparin group (hazard ratio, 0.97; 95% confidence interval [CI], 0.70 to 1.36; P = 0.006 for noninferiority; P = 0.87 for superiority). Recurrent venous thromboembolism occurred in 41 patients (7.9%) in the edoxaban group and in 59 patients (11.3%) in the dalteparin group (difference in risk, -3.4 percentage points; 95% CI, -7.0 to 0.2). Major bleeding occurred in 36 patients (6.9%) in the edoxaban group and in 21 patients (4.0%) in the dalteparin group (difference in risk, 2.9 percentage points; 95% CI, 0.1 to 5.6). CONCLUSIONS Oral edoxaban was noninferior to subcutaneous dalteparin with respect to the composite outcome of recurrent venous thromboembolism or major bleeding. The rate of recurrent venous thromboembolism was lower but the rate of major bleeding was higher with edoxaban than with dalteparin. (Funded by Daiichi Sankyo; Hokusai VTE Cancer ClinicalTrials. gov number, NCT02073682.)	[Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, 801 NE 13th St, Oklahoma City, OK 73104 USA; [van Es, Nick; Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Segers, Annelise] Acad Res Org, ITREAS, Amsterdam, Netherlands; [Verhamme, Peter] Univ Hosp Leuven, Dept Vasc Med & Hemostasis, Leuven, Belgium; [Carrier, Marc] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kovacs, Michael J.] Victoria Hosp, London Hlth Sci Ctr, London, ON, Canada; [Yeo, Erik] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Di Nisio, Marcello] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Garcia, David] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Grosso, Michael A.; Mercuri, Michele F.; Shi, Minggao; Zhang, George] Daiichi Sankyo Pharma Dev, Basking Ridge, NJ USA; [Kakkar, Ajay K.] Thrombosis Res Inst, London, England; [Kakkar, Ajay K.] UCL, London, England; [Meyer, Guy] Hop Europeen Georges Pompidou, AP HP, Dept Resp Dis, Paris, France; [Wang, Tzu-Fei] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Zwicker, Jeffrey I.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Boston, MA 02215 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; University Hospital Leuven; University of Ottawa; Ottawa Hospital Research Institute; London Health Sciences Centre; University of Victoria; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; McMaster University; G d'Annunzio University of Chieti-Pescara; University of Washington; University of Washington Seattle; Daiichi Sankyo Company Limited; Thrombosis Research Institute; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; Ohio State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Raskob, GE (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, 801 NE 13th St, Oklahoma City, OK 73104 USA.	gary-raskob@ouhsc.edu	Vandenbriele, Christophe/ABF-7540-2020; Lodigiani, Corrado/AAW-1964-2020; Thijs, Vincent/C-3647-2009; Ruiz-Artacho, PEDRO/I-3100-2018; Beyer-Westendorf, Jan/K-7569-2019; Louzada, Martha L/I-8154-2015; Quere, Isabelle/AAB-8519-2020; Kovacs, Michael/G-3315-2011; Weitz, Jeffrey/AAD-1929-2019; Santamaria, Amparo/AAQ-4410-2021	Vandenbriele, Christophe/0000-0001-5151-6400; Lodigiani, Corrado/0000-0002-9152-9385; Thijs, Vincent/0000-0002-6614-8417; Ruiz-Artacho, PEDRO/0000-0002-5680-9883; Beyer-Westendorf, Jan/0000-0002-6983-9993; Quere, Isabelle/0000-0002-1492-9764; Weitz, Jeffrey/0000-0002-1092-7550; Santamaria, Amparo/0000-0001-7727-880X; Farkas, Katalin/0000-0001-5577-6808; Chan, Noel/0000-0001-9491-6172; Sinnaeve, Peter/0000-0003-4716-5892; van Es, Nick/0000-0001-5256-6346; Font, Carme/0000-0002-3547-7373; Dees, Adriaan/0000-0001-9164-4538	Daiichi Sankyo; Hokusai VTE Cancer	Daiichi Sankyo(Daiichi Sankyo Company Limited); Hokusai VTE Cancer	Funded by Daiichi Sankyo; Hokusai VTE Cancer ClinicalTrials.gov number, NCT02073682.	Ay C, 2017, THROMB HAEMOSTASIS, V117, P219, DOI 10.1160/TH16-08-0615; Bleker SM, 2017, THROMB HAEMOSTASIS, V117, P1944, DOI 10.1160/TH16-12-0946; Farge D, 2013, J THROMB HAEMOST, V11, P56, DOI 10.1111/jth.12070; Francis CW, 2015, J THROMB HAEMOST, V13, P1028, DOI 10.1111/jth.12923; Kahn SR, 2012, THROMB HAEMOSTASIS, V108, P493, DOI 10.1160/TH12-03-0169; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Khorana A A, 2012, J Thromb Haemost, V10, P2602; Khorana AA, 2016, THROMB RES, V145, P51, DOI 10.1016/j.thromres.2016.07.013; Lee AYY, 2015, JAMA-J AM MED ASSOC, V314, P677, DOI 10.1001/jama.2015.9243; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lyman GH, 2015, J ONCOL PRACT, V11, pE442, DOI 10.1200/JOP.2015.004473; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; van Es N, 2015, THROMB HAEMOSTASIS, V114, P1268, DOI 10.1160/TH15-06-0452; van Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04571232, 10.1182/blood-2014-04-571232]	16	835	856	2	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					615	624		10.1056/NEJMoa1711948	http://dx.doi.org/10.1056/NEJMoa1711948			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW0QK	29231094	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000425000000007
J	Laiteerapong, N; Cooper, JM; Skandari, MR; Clarke, PM; Winn, AN; Naylor, RN; Huang, ES				Laiteerapong, N.; Cooper, J. M.; Skandari, M. R.; Clarke, P. M.; Winn, A. N.; Naylor, R. N.; Huang, E. S.			Cost-Effectiveness of Individualized Management of Diabetes Among US Adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Laiteerapong, Neda/ABC-5566-2021; Laiteerapong, Neda/AAO-2596-2020	Laiteerapong, Neda/0000-0003-0124-4325; 					0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					I22	I22		10.7326/P17-9050	http://dx.doi.org/10.7326/P17-9050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29230474				2022-12-28	WOS:000424224300002
J	Paules, CI; Sullivan, SG; Subbarao, K; Fauci, AS				Paules, Catharine I.; Sullivan, Sheena G.; Subbarao, Kanta; Fauci, Anthony S.			Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Paules, Catharine I.; Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sullivan, Sheena G.; Subbarao, Kanta] Peter Doherty Inst Infect & Immun, World Hlth Org Collaborating Ctr Ref & Res Influe, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); World Health Organization	Paules, CI (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Paules, Catharine/0000-0002-9064-6678; Sullivan, Sheena G./0000-0002-0856-0294	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000997] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Sullivan SG, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.43.17-00707; Wu NC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006682; Zost SJ, 2017, P NATL ACAD SCI US	4	143	150	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2018	378	1					7	9		10.1056/NEJMp1714916	http://dx.doi.org/10.1056/NEJMp1714916			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR7BE	29185857	Bronze			2022-12-28	WOS:000419220500012
J	Eichler, FS; Swoboda, KJ; Hunt, AL; Cestari, DM; Rapalino, O				Eichler, Florian S.; Swoboda, Kathryn J.; Hunt, Ann L.; Cestari, Dean M.; Rapalino, Otto			Case 38-2017-A 20-Year-Old Woman with Seizures and Progressive Dystonia Biotin-thiamine-responsive basal ganglia disease due to a homozygous c.1264A -> G (p.Thr422Ala) mutation in SLC19A3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MR-IMAGING FINDINGS; EXOME SEQUENCING REVEALS; NEUROIMAGING FEATURES; MITOCHONDRIAL DISEASE; BRAIN; DEFICIENCY; DIAGNOSIS; CT; ABNORMALITIES; INVOLVEMENT		[Eichler, Florian S.; Swoboda, Kathryn J.; Hunt, Ann L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Eichler, Florian S.; Swoboda, Kathryn J.; Hunt, Ann L.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Cestari, Dean M.] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Rapalino, Otto] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Cestari, Dean M.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Eichler, FS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Eichler, FS (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.			Rapalino, Otto/0000-0002-5038-4183; Swoboda, Kathryn/0000-0002-4593-6342				Albanese A, 2013, MOVEMENT DISORD, V28, P874, DOI 10.1002/mds.25579; Albayram S, 2004, AM J NEURORADIOL, V25, P792; Alfadhel M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-83; Baertling F, 2016, CHILD NERV SYST, V32, P2077, DOI 10.1007/s00381-016-3190-3; Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Bathla G, 2013, CLIN RADIOL, V68, P545, DOI 10.1016/j.crad.2012.05.021; Bekiesinska-Figatowska M, 2013, EUR J RADIOL, V82, P837, DOI 10.1016/j.ejrad.2012.12.006; Bindu PS, 2010, NEUROLOGY, V74, pE12, DOI 10.1212/WNL.0b013e3181ca0101; Blanco M, 2006, AM J NEURORADIOL, V27, P452; Bosley TM, 2014, CAN J NEUROL SCI, V41, P42, DOI 10.1017/S0317167100016243; Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256; BRISMAR J, 1994, BRAIN DEV-JPN, V16, P104, DOI 10.1016/0387-7604(94)90103-1; Brown G, 2014, J INHERIT METAB DIS, V37, P577, DOI 10.1007/s10545-014-9712-9; Cakmakci H, 2010, EUR J RADIOL, V74, pE162, DOI 10.1016/j.ejrad.2009.05.048; Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Debs R, 2010, ARCH NEUROL-CHICAGO, V67, P126, DOI 10.1001/archneurol.2009.293; Fassone Elisa, 2013, BMJ Case Rep, V2013, P200838, DOI 10.1136/bcr-2013-200838; Filatov Alexander, 2011, Top Magn Reson Imaging, V22, P239, DOI 10.1097/RMR.0b013e318296811e; Gerards M, 2013, BRAIN, V136, P882, DOI 10.1093/brain/awt013; Harting I, 2008, J INHERIT METAB DIS, V31, P368, DOI 10.1007/s10545-008-0801-5; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Kassem H, 2014, AM J NEURORADIOL, V35, P1990, DOI 10.3174/ajnr.A3966; Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054; Kitzberger R, 2005, METAB BRAIN DIS, V20, P295, DOI 10.1007/s11011-005-7910-8; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Mohammad SA, 2015, PEDIATR RADIOL, V45, P1696, DOI 10.1007/s00247-015-3395-8; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; Mumtaz HA, 2010, SINGAP MED J, V51, pE69; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Rachinger J, 2002, AM J NEURORADIOL, V23, P1398; Rawal S, 2013, CAN J NEUROL SCI, V40, P259, DOI 10.1017/S0317167100013858; Reuter MS, 2014, AM J MED GENET A, V164, P3162, DOI 10.1002/ajmg.a.36766; Rodriguez-Melendez R, 2003, J NUTR BIOCHEM, V14, P680, DOI 10.1016/j.jnutbio.2003.07.001; Sofou K, 2013, MITOCHONDRION, V13, P364, DOI 10.1016/j.mito.2013.04.008; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; Tabarki B, 2013, NEUROLOGY, V80, P261, DOI 10.1212/WNL.0b013e31827deb4c; Trocello JM, 2013, NEUROLOGY, V81, P1557, DOI 10.1212/WNL.0b013e3182a95883; Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006; van der Knaap MS, 2005, ANN NEUROL, V57, P327, DOI 10.1002/ana.20381; van der Knaap MS, 2001, AM J NEURORADIOL, V22, P541; Vlasova TI, 2005, J NUTR, V135, P42, DOI 10.1093/jn/135.1.42; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216; Zuccoli G, 2015, NEURORADIOLOGY, V57, P973, DOI 10.1007/s00234-015-1568-7	47	2	5	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2376	2385		10.1056/NEJMcpc1706109	http://dx.doi.org/10.1056/NEJMcpc1706109			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	29236641				2022-12-28	WOS:000417923600011
J	Mayers, JR				Mayers, Jared R.			Metabolic markers as cancer clues Changes in branched-chain amino acids may be first sign of certain cancers	SCIENCE			English	Editorial Material							PANCREATIC-CANCER; DRIVEN CANCERS; TUMORS		[Mayers, Jared R.] Brigham & Womens Hosp, Internal Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Mayers, JR (corresponding author), Brigham & Womens Hosp, Internal Med, 75 Francis St, Boston, MA 02115 USA.			Mayers, Jared/0000-0002-8607-1787				American Cancer Society, 2017, CANC FACTS FIG; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Olivares O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16031; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Wigmore SJ, 1997, BRIT J CANCER, V75, P106, DOI 10.1038/bjc.1997.17; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Wolpin BM, 2013, JNCI-J NATL CANCER I, V105, P1027, DOI 10.1093/jnci/djt123; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	18	4	4	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368								10.1126/science.aar2001	http://dx.doi.org/10.1126/science.aar2001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217564				2022-12-28	WOS:000417254700046
J	Yeates, TO; Wheatley, NM				Yeates, Todd O.; Wheatley, Nicole M.			Putting the RuBisCO pieces together Scientists find a way to build the major plant enzyme RuBisCO in bacteria	SCIENCE			English	Editorial Material							RIBULOSE-BISPHOSPHATE CARBOXYLASE; ASSEMBLY CHAPERONE; ESCHERICHIA-COLI; PROTEIN; RAF1; GENE		[Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; UCLA DOE Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE)	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	yeates@mbi.ucla.edu; nwheatley@mbi.ucla.edu						Aigner H, 2017, SCIENCE, V358, P1272, DOI 10.1126/science.aap9221; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Checa SK, 1997, EUR J BIOCHEM, V248, P848, DOI 10.1111/j.1432-1033.1997.00848.x; CLONEY LP, 1992, J BIOL CHEM, V267, P23333; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hauser T, 2015, NAT STRUCT MOL BIOL, V22, P720, DOI 10.1038/nsmb.3062; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; Kato Y, 2004, PLANTA, V220, P97, DOI 10.1007/s00425-004-1328-0; Kolesinski P, 2017, PHOTOSYNTH RES, V132, P135, DOI 10.1007/s11120-017-0336-4; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Wildman SG, 2002, PHOTOSYNTH RES, V73, P243, DOI 10.1023/A:1020467601966	15	3	3	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1253	1254		10.1126/science.aar3107	http://dx.doi.org/10.1126/science.aar3107			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217555				2022-12-28	WOS:000417254700037
J	Saito, F; Hirayasu, K; Satoh, T; Wang, CW; Lusingu, J; Arimori, T; Shida, K; Palacpac, NMQ; Itagaki, S; Iwanaga, S; Takashima, E; Tsuboi, T; Kohyama, M; Suenaga, T; Colonna, M; Takagi, J; Lavstsen, T; Horii, T; Arase, H				Saito, Fumiji; Hirayasu, Kouyuki; Satoh, Takeshi; Wang, Christian W.; Lusingu, John; Arimori, Takao; Shida, Kyoko; Palacpac, Nirianne Marie Q.; Itagaki, Sawako; Iwanaga, Shiroh; Takashima, Eizo; Tsuboi, Takafumi; Kohyama, Masako; Suenaga, Tadahiro; Colonna, Marco; Takagi, Junichi; Lavstsen, Thomas; Horii, Toshihiro; Arase, Hisashi			Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors	NATURE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; CLASS-I MOLECULES; MALARIA PARASITES; CELL-SURFACE; C RECEPTOR; HLA-G; BINDING; RECOGNITION; EXPRESSION; ANTIBODIES	Malaria is among the most serious infectious diseases affecting humans, accounting for approximately half a million deaths each year(1). Plasmodium falciparum causes most life-threatening cases of malaria. Acquired immunity to malaria is inefficient, even after repeated exposure to P. falciparum(2), but the immune regulatory mechanisms used by P. falciparum remain largely unknown. Here we show that P. falciparum uses immune inhibitory receptors to achieve immune evasion. RIFIN proteins are products of a polymorphic multigene family comprising approximately 150-200 genes per parasite genome(3) that are expressed on the surface of infected erythrocytes. We found that a subset of RIFINs binds to either leucocyte immunoglobulin-like receptor B1 (LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAIR1). LILRB1-binding RIFINs inhibit activation of LILRB1-expressing B cells and natural killer (NK) cells. Furthermore, P. falciparum-infected erythrocytes isolated from patients with severe malaria were more likely to interact with LILRB1 than erythrocytes from patients with non-severe malaria, although an extended study with larger sample sizes is required to confirm this finding. Our results suggest that P. falciparum has acquired multiple RIFINs to evade the host immune system by targeting immune inhibitory receptors.	[Saito, Fumiji; Satoh, Takeshi; Kohyama, Masako; Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan; [Hirayasu, Kouyuki; Shida, Kyoko; Kohyama, Masako; Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka 5650871, Japan; [Wang, Christian W.; Lavstsen, Thomas] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Wang, Christian W.; Lavstsen, Thomas] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Lusingu, John] Natl Inst Med Res, Tanga Res Ctr, Tanga, Tanzania; [Arimori, Takao; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Palacpac, Nirianne Marie Q.; Itagaki, Sawako; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 5650871, Japan; [Iwanaga, Shiroh] Mie Univ, Sch Med, Dept Med Zool, Tsu, Mie 5148507, Japan; [Iwanaga, Shiroh] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo 1138510, Japan; [Tsuboi, Takafumi] Ehime Univ, Proteo Sci Ctr, Div Malaria Res, Matsuyama, Ehime 7908577, Japan; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Satoh, Takeshi] Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, Tokyo 1088639, Japan	Osaka University; Osaka University; University of Copenhagen; Rigshospitalet; University of Copenhagen; National Institute of Medical Research; Osaka University; Osaka University; Mie University; Tokyo Medical & Dental University (TMDU); Ehime University; Washington University (WUSTL); University of Tokyo	Arase, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan.; Arase, H (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka 5650871, Japan.	arase@biken.osaka-u.ac.jp	Arase, Hisashi/C-8442-2009; Tsuboi, Takafumi/AAK-6145-2021; Lusingu, John P. A./GSJ-3228-2022	Arase, Hisashi/0000-0002-1153-3166; Palacpac, Nirianne Marie/0000-0003-4098-3972; Wang, Christian/0000-0003-3140-6989; Takashima, Eizo/0000-0001-9070-8499; Tsuboi, Takafumi/0000-0002-7415-1325; Horii, Toshihiro/0000-0002-3000-2045; Lusingu, John P. A./0000-0002-9407-0602; Lavstsen, Thomas/0000-0002-3044-4249; Iwanaga, Shiroh/0000-0002-4394-7267; Arimori, Takao/0000-0002-6063-5572	Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic from the Japan Agency for Medical Research and Development (AMED); Platform Project for Supporting Drug Discovery and Life Science Research from AMED; JSPS KAKENHI [JP16K08839, JP16H05195, JP15K08531]; MEXT KAKENHI [JP26117714, JP23117008, JP24115005]; Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Danish Council for Independent Research grants [1333-00220, 4004-00624B]; Lundbeck Foundation; United States National Institutes of Health [NIH R01HL130678]; Taniguchi Memorial Fellowship program; Grants-in-Aid for Scientific Research [17H04071, 17H05793, 26305009, 15H02545, 17H01420] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130678] Funding Source: NIH RePORTER	Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Platform Project for Supporting Drug Discovery and Life Science Research from AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Senri Life Science Foundation; Kato Memorial Bioscience Foundation; Danish Council for Independent Research grants; Lundbeck Foundation(Lundbeckfonden); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taniguchi Memorial Fellowship program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Mitamura for discussions, K. Saito for mass spectrometry analysis, M. Matsumoto and S. Matsuoka for technical assistance, the Thai and Tanzanian donors and the Japanese Red Cross Society for providing human erythrocytes and human plasma. This work was partly supported by the Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic from the Japan Agency for Medical Research and Development (AMED) (H.A.), the Platform Project for Supporting Drug Discovery and Life Science Research from AMED (J.T.), JSPS KAKENHI grant numbers JP16K08839 (K.H.), JP16H05195 (T.Su.), JP15K08531 (M. K.), MEXT KAKENHI grant numbers JP26117714 (H.A.), JP23117008 (T.T.), JP24115005 (H.A.), the Senri Life Science Foundation (K.H.), the Kato Memorial Bioscience Foundation (K.H.), the Danish Council for Independent Research grants 1333-00220 (C.W.W.) and 4004-00624B (T.L.), The Lundbeck Foundation (T.L.) and the United States National Institutes of Health (NIH R01HL130678, T.L.). F.S was supported by the Taniguchi Memorial Fellowship program.	Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Arumugam TU, 2014, EXPERT REV VACCINES, V13, P75, DOI 10.1586/14760584.2014.861747; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Gomes PS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01617; Hanada K, 2002, J EXP MED, V195, P23, DOI 10.1084/jem.20010724; Hirayasu K, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.54, 10.1038/nmicrobiol.2016.54]; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Hsieh FL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12837; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033326; Janssen CS, 2004, NUCLEIC ACIDS RES, V32, P5712, DOI 10.1093/nar/gkh907; Jiang Y, 2013, INT IMMUNOL, V25, P235, DOI 10.1093/intimm/dxs155; Jin H, 2014, P NATL ACAD SCI USA, V111, P3787, DOI 10.1073/pnas.1401105111; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau CKY, 2015, CELL HOST MICROBE, V17, P118, DOI 10.1016/j.chom.2014.11.007; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; Mkumbaye SI, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1714-2; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mwakalinga SB, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-429; Naji A, 2014, J IMMUNOL, V192, P1536, DOI 10.4049/jimmunol.1300438; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Pieper K, 2017, NATURE, V548, P597, DOI 10.1038/nature23670; Renia L, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00463; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shiratori I, 2005, J IMMUNOL, V175, P4441, DOI 10.4049/jimmunol.175.7.4441; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Tanabe K, 2007, GENE, V397, P153, DOI 10.1016/j.gene.2007.04.033; Trowsdale J, 2015, IMMUNOL REV, V267, P117, DOI 10.1111/imr.12314; Turner L, 2015, INFECT IMMUN, V83, P3096, DOI 10.1128/IAI.00271-15; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Wang CW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-129; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WHO, 2016, WORLD MAL REP 2016; Yam XY, 2017, TRENDS PARASITOL, V33, P309, DOI 10.1016/j.pt.2016.12.012	48	76	79	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					101	+		10.1038/nature24994	http://dx.doi.org/10.1038/nature24994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186116	Green Accepted, Green Submitted			2022-12-28	WOS:000417560500051
J	Nielsen, MP; Shi, XY; Dichtl, P; Maier, SA; Oulton, RF				Nielsen, Michael P.; Shi, Xingyuan; Dichtl, Paul; Maier, Stefan A.; Oulton, Rupert F.			Giant nonlinear response at a plasmonic nanofocus drives efficient four-wave mixing	SCIENCE			English	Article							WAVE-GUIDES; SILICON-CHIP; PHASE; ENHANCEMENT; PROPAGATION; GENERATION; CONVERSION	Efficient optical frequency mixing typically must accumulate over large interaction lengths because nonlinear responses in natural materials are inherently weak. This limits the efficiency of mixing processes owing to the requirement of phase matching. Here, we report efficient four-wave mixing (FWM) over micrometer-scale interaction lengths at telecommunications wavelengths on silicon. We used an integrated plasmonic gap waveguide that strongly confines light within a nonlinear organic polymer. The gap waveguide intensifies light by nanofocusing it to a mode cross-section of a few tens of nanometers, thus generating a nonlinear response so strong that efficient FWM accumulates over wavelength-scale distances. This technique opens up nonlinear optics to a regime of relaxed phase matching, with the possibility of compact, broadband, and efficient frequency mixing integrated with silicon photonics.	[Nielsen, Michael P.; Shi, Xingyuan; Dichtl, Paul; Maier, Stefan A.; Oulton, Rupert F.] Imperial Coll London, Dept Phys, London SW7 2AZ, England	Imperial College London	Oulton, RF (corresponding author), Imperial Coll London, Dept Phys, London SW7 2AZ, England.	r.oulton@imperial.ac.uk	Maier, Stefan/V-2883-2019; oulton, rupert/AAA-8186-2021; Shi, Xingyuan/ABC-2071-2020	Maier, Stefan/0000-0001-9704-7902; Shi, Xingyuan/0000-0002-5115-9121; Dichtl, Paul/0000-0002-3026-5654; Oulton, Rupert/0000-0002-5070-3623; Nielsen, Michael P/0000-0002-0457-7208	U.K. Engineering and Physical Sciences Research Council (EPSRC) [EP/I004343/1, EP/M013812/1]; EPSRC studentships; Natural Sciences and Engineering Research Council of Canada (NSERC) scholarship; EPSRC Career Advancement Fellowship; Marie Curie International Reintegration Grant [PIRG08-GA-2010-277080]; EPSRC [EP/M013812/1, EP/I004343/1, EP/P02520X/1, EP/H000917/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H000917/2, EP/K503381/1, EP/M013812/1, EP/P02520X/1, 1413825, EP/I004343/1] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC studentships(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Sciences and Engineering Research Council of Canada (NSERC) scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); EPSRC Career Advancement Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie International Reintegration Grant(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank J. Nelson for discussions on nonlinear organic polymers. The authors also thank L. Lafone for discussions on plasmonic waveguides. This work was sponsored by the U.K. Engineering and Physical Sciences Research Council (EPSRC; grants EP/I004343/1 and EP/M013812/1). M.P.N. and P.D. were supported by EPSRC studentships. M.P.N. was also supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) scholarship. S.A.M. acknowledges the Lee-Lucas Chair. R.F.O. was supported by an EPSRC Career Advancement Fellowship and Marie Curie International Reintegration Grant (PIRG08-GA-2010-277080). Data requests can be made via dataenquiryEXSS@imperial.ac.uk. M.P.N. and R.F.O. conceived of the experiments. M.P.N. developed the theoretical simulations, fabricated the samples, and conducted the experiments. X.S. prepared the MEH-PPV sample for Z-scan characterisation, which were conducted by M.P.N. and P.D. M.P.N. and R.F.O. cowrote the manuscript. All authors commented on the manuscript.	Aeschlimann M, 2011, SCIENCE, V333, P1723, DOI 10.1126/science.1209206; Aouani H, 2014, NAT NANOTECHNOL, V9, P290, DOI [10.1038/nnano.2014.27, 10.1038/NNANO.2014.27]; Boyer V, 2008, SCIENCE, V321, P544, DOI 10.1126/science.1158275; Cai WS, 2011, SCIENCE, V333, P1720, DOI 10.1126/science.1207858; Ciraci C, 2012, SCIENCE, V337, P1072, DOI 10.1126/science.1224823; Duffin TJ, 2016, OPT LETT, V41, P155, DOI 10.1364/OL.41.000155; FARROW RL, 1992, SCIENCE, V257, P1894, DOI 10.1126/science.257.5078.1894; Foster MA, 2008, NATURE, V456, P81, DOI 10.1038/nature07430; Hales JM, 2010, SCIENCE, V327, P1485, DOI 10.1126/science.1185117; Harutyunyan H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.217403; Ho MC, 2002, J LIGHTWAVE TECHNOL, V20, P469, DOI 10.1109/50.988996; Kachynski AV, 2014, NAT PHOTONICS, V8, P455, DOI 10.1038/nphoton.2014.90; Kravtsov V, 2016, NAT NANOTECHNOL, V11, P459, DOI [10.1038/nnano.2015.336, 10.1038/NNANO.2015.336]; Lafone L, 2014, OPT LETT, V39, P4356, DOI 10.1364/OL.39.004356; Martin SJ, 1999, PHYS REV B, V59, P15133, DOI 10.1103/PhysRevB.59.15133; Melikyan A, 2014, NAT PHOTONICS, V8, P229, DOI [10.1038/NPHOTON.2014.9, 10.1038/nphoton.2014.9]; Nielsen MP, 2016, NANO LETT, V16, P1410, DOI 10.1021/acs.nanolett.5b04931; Renger J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046803; Salem R, 2008, NAT PHOTONICS, V2, P35, DOI 10.1038/nphoton.2007.249; Semple J, 2016, SMALL, V12, P1993, DOI 10.1002/smll.201503110; Shahraam AV, 2009, OPT EXPRESS, V17, P2298, DOI 10.1364/OE.17.002298; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Takesue H, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.031802; Zhao Y, 2017, APL PHOTONICS, V2, DOI 10.1063/1.4973771; Zlatanovic S, 2010, NAT PHOTONICS, V4, P561, DOI 10.1038/NPHOTON.2010.117	26	85	85	6	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1179	1181		10.1126/science.aao1467	http://dx.doi.org/10.1126/science.aao1467			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191907	Green Submitted			2022-12-28	WOS:000416584000040
J	Zhang, HY; Lyden, D				Zhang, Haiying; Lyden, David			CANCER BIOLOGY Bone voyage-Osteoblasts remotely control tumors	SCIENCE			English	Editorial Material							PROGENITOR CELLS; LUNG METASTASIS; MICROENVIRONMENT; GROWTH		[Zhang, Haiying] Weill Cornell Med, Childrens Canc & Blood Fdn Labs, Dept Pediat, Drukier Inst Childrens Hlth,Meyer Canc Ctr, New York, NY 10021 USA; Weill Cornell Med, Childrens Canc & Blood Fdn Labs, Dept Cell & Dev Biol, Drukier Inst Childrens Hlth,Meyer Canc Ctr, New York, NY 10021 USA	Cornell University; Cornell University	Zhang, HY (corresponding author), Weill Cornell Med, Childrens Canc & Blood Fdn Labs, Dept Pediat, Drukier Inst Childrens Hlth,Meyer Canc Ctr, New York, NY 10021 USA.	haz2005@med.cornell.edu; dcl2001@med.cornell.edu						Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Kanaji N, 2014, WORLD J CLIN ONCOL, V5, P197, DOI 10.5306/wjco.v5.i3.197; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Park SI, 2013, CANCER RES, V73, P6574, DOI 10.1158/0008-5472.CAN-12-4692; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008	15	3	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1127	1128		10.1126/science.aar2640	http://dx.doi.org/10.1126/science.aar2640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191891				2022-12-28	WOS:000416584000019
J	D'Silva, J				D'Silva, Jeetha			BMJ AWARDS SOUTH ASIA 2017 Who won in the BMJ Awards South Asia 2017?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						Dar FS, 2015, LIVER TRANSPLANT, V21, P982, DOI 10.1002/lt.24151; DSILVA J, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4542; Hamaluba M, 2015, LANCET INFECT DIS, V15, P405, DOI 10.1016/S1473-3099(15)70007-1; Hettiarachchi K., 2013, SUNDAY TIMES; Sharma P., 2017, MAIL TODAY      0331	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2017	359								j5475	10.1136/bmj.j5475	http://dx.doi.org/10.1136/bmj.j5475			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WH	29175830				2022-12-28	WOS:000416473300006
J	Liu, S; Ullman, TD; Tenenbaum, JB; Spelke, ES				Liu, Shari; Ullman, Tomer D.; Tenenbaum, Joshua B.; Spelke, Elizabeth S.			Ten-month-old infants infer the value of goals from the costs of actions	SCIENCE			English	Article							5-MONTH-OLD INFANTS; RATIONAL ACTION; ACCOUNT; SENSITIVITY; PERCEPTION; OBJECTS; OTHERS	Infants understand that people pursue goals, but how do they learn which goals people prefer? We tested whether infants solve this problem by inverting a mental model of action planning, trading off the costs of acting against the rewards actions bring. After seeing an agent attain two goals equally often at varying costs, infants expected the agent to prefer the goal it attained through costlier actions. These expectations held across three experiments that conveyed cost through different physical path features (height, width, and incline angle), suggesting that an abstract variable-such as "force," "work," or "effort"-supported infants' inferences. We modeled infants' expectations as Bayesian inferences over utility-theoretic calculations, providing a bridge to recent quantitative accounts of action understanding in older children and adults.	[Liu, Shari; Ullman, Tomer D.; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Ullman, Tomer D.; Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Liu, Shari; Ullman, Tomer D.; Tenenbaum, Joshua B.; Spelke, Elizabeth S.] MIT, McGovern Inst Brain Res, CBMM, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, S (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Liu, S (corresponding author), MIT, McGovern Inst Brain Res, CBMM, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shariliu01@g.harvard.edu		Spelke, Elizabeth/0000-0002-6925-3618; /0000-0003-1722-2382; Liu, Shari/0000-0002-7037-5401	CBMM; National Science Foundation Science and Technology Center [CCE-1231216]; National Science Foundation [DGE-1144152]	CBMM; National Science Foundation Science and Technology Center(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	All authors wrote the paper S.L. designed the experiments and collected and analyzed the data under the direction of E.S.S. and T.D.U. built the computational models under the direction of J.B.T. This material is based on work supported by CBMM, funded by National Science Foundation Science and Technology Center award CCE-1231216, and by a National Science Foundation Graduate Research Fellowship under grant DGE-1144152. We thank the families who volunteered to participate and A. Aguirre, R. Guzman, C. Kerwin, N. Kalra, arid H. Tarr for research assistance. All data analyses, and materials from the experiments and models reported in this paper are archived on the Open Science Framework at https://osf.io/mykph.	Baillargeon R, 2016, ANNU REV PSYCHOL, V67, P159, DOI 10.1146/annurev-psych-010213-115033; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Bentham J., 1879, INTRO PRINCIPLES MOR; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 2016, DEV PSYCHOL, V52, P521, DOI 10.1037/dev0000083; Dennett, 1987, INTENTIONAL STANCE; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Heyes CM, 2014, SCIENCE, V344, P1356, DOI 10.1126/science.1243091; Jara-Ettinger J, 2016, TRENDS COGN SCI, V20, P589, DOI 10.1016/j.tics.2016.05.011; Jara-Ettinger J, 2015, COGNITION, V140, P14, DOI 10.1016/j.cognition.2015.03.006; Jern A, 2015, COGNITION, V142, P12, DOI 10.1016/j.cognition.2015.05.006; KIM IK, 1992, J EXP PSYCHOL HUMAN, V18, P385, DOI 10.1037/0096-1523.18.2.385; Kool W, 2017, PSYCHOL SCI, V28, P1321, DOI 10.1177/0956797617708288; Liu S, 2017, COGNITION, V160, P35, DOI 10.1016/j.cognition.2016.12.007; Lucas CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092160; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Luo Y, 2007, COGNITION, V105, P489, DOI 10.1016/j.cognition.2006.10.007; Luo YY, 2009, DEVELOPMENTAL SCI, V12, P142, DOI 10.1111/j.1467-7687.2008.00741.x; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Paulus M, 2012, PSYCHOL RES-PSYCH FO, V76, P760, DOI 10.1007/s00426-011-0385-9; Saxe R, 2006, COGNITION, V101, pB1, DOI 10.1016/j.cognition.2005.10.005; Shenhav A, 2017, ANNU REV NEUROSCI, V40, P99, DOI 10.1146/annurev-neuro-072116-031526; Skerry AE, 2014, COGNITION, V130, P204, DOI 10.1016/j.cognition.2013.11.002; Skerry AE, 2013, P NATL ACAD SCI USA, V110, P18728, DOI 10.1073/pnas.1312322110; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Ullman TD, 2017, TRENDS COGN SCI, V21, P649, DOI 10.1016/j.tics.2017.05.012; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 2009, CURR DIR PSYCHOL SCI, V18, P53, DOI 10.1111/j.1467-8721.2009.01605.x	35	66	66	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1038	1041		10.1126/science.aag2132	http://dx.doi.org/10.1126/science.aag2132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2FN	29170232	Green Submitted, Green Published			2022-12-28	WOS:000416590400036
J	Guo, JT; She, J; Zeng, WZ; Chen, QF; Bai, XC; Jiang, YX				Guo, Jiangtao; She, Ji; Zeng, Weizhong; Chen, Qingfeng; Bai, Xiao-chen; Jiang, Youxing			Structures of the calcium-activated, non-selective cation channel TRPM4	NATURE			English	Article							KINASE; NUCLEOTIDES; SENSITIVITY; VALIDATION; NANODISCS; PROTEIN; SODIUM; DOMAIN	TRPM4 is a calcium-activated, phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2)-modulated, non-selective cation channel that belongs to the family of melastatin-related transient receptor potential (TRPM) channels. Here we present the electron cryo-microscopy structures of the mouse TRPM4 channel with and without ATP. TRPM4 consists of multiple transmembrane and cytosolic domains, which assemble into a three-tiered architecture. The N-terminal nucleotide-binding domain and the C-terminal coiled-coil participate in the tetrameric assembly of the channel; ATP binds at the nucleotide-binding domain and inhibits channel activity. TRPM4 has an exceptionally wide filter but is only permeable to monovalent cations; filter residue Gln973 is essential in defining monovalent selectivity. The S1-S4 domain and the post-S6 TRP domain form the central gating apparatus that probably houses the Ca2+- and PtdIns(4,5)P-2-binding sites. These structures provide an essential starting point for elucidating the complex gating mechanisms of TRPM4 and reveal the molecular architecture of the TRPM family.	[Guo, Jiangtao; She, Ji; Zeng, Weizhong; Chen, Qingfeng; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Guo, Jiangtao; She, Ji; Zeng, Weizhong; Chen, Qingfeng; Bai, Xiao-chen; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Zeng, Weizhong; Chen, Qingfeng; Jiang, Youxing] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; Bai, XC; Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Jiang, YX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	xiaochen.bai@utsouthwestern.edu; youxing.jiang@utsouthwestern.edu	Bai, Xiao-chen/HGV-1244-2022; She, Ji/AAW-6150-2021; chen, qingfeng/J-6844-2017	Bai, Xiao-chen/0000-0002-4234-5686; 	Howard Hughes Medical Institute; National Institutes of Health [GM079179]; Welch Foundation [I-1578]; Cancer Prevention and Research Initiative of Texas; Virginia Murchison Linthicum Scholar in Medical Research fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079179] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Initiative of Texas; Virginia Murchison Linthicum Scholar in Medical Research fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Nguyen for manuscript preparation, J. M. Simard and J. Bryan for providing the TRPM4 clones. Single particle cryo-EM data were collected at the University of Texas Southwestern Medical Center (UTSW) Cryo-Electron Microscopy Facility. We thank D. Nicastro and Z. Chen for support in facility access and data acquisition. Negatively stained sample screening was performed at UTSW Electron Microscopy core. This work was supported in part by the Howard Hughes Medical Institute (Y. J.) and by grants from the National Institutes of Health (GM079179 to Y. J.) and the Welch Foundation (grant I-1578 to Y. J.). X. B. is supported by the Cancer Prevention and Research Initiative of Texas and Virginia Murchison Linthicum Scholar in Medical Research fund.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Baugh L, 2015, TUBERCULOSIS, V95, P142, DOI 10.1016/j.tube.2014.12.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hof T, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0397-4; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Islam M. S., 2011, TRANSIENT RECEPTOR P, P147; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mironov SL, 2008, J PHYSIOL-LONDON, V586, P2277, DOI 10.1113/jphysiol.2007.149021; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Yamaguchi S, 2014, J BIOL CHEM, V289, P35265, DOI 10.1074/jbc.M114.606087; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	59	103	107	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					205	+		10.1038/nature24997	http://dx.doi.org/10.1038/nature24997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211714	Green Accepted			2022-12-28	WOS:000418029500037
J	Sorrentino, V; Omani, MR; Ouchiroud, LM; Beck, JS; Zhang, HB; D'Amico, D; Moullan, N; Potenza, F; Schmid, AW; Rietsch, S; Counts, SE; Auwerx, J				Sorrentino, Vincenzo; Omani, Mario R.; Ouchiroud, Laurent M.; Beck, John S.; Zhang, Hongbo; D'Amico, Davide; Moullan, Norman; Potenza, Francesca; Schmid, Adrien W.; Rietsch, Solene; Counts, Scott E.; Auwerx, Johan			Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; STRESS-RESPONSE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; C-ELEGANS; MODELS; ACTIVATION	Alzheimer's disease is a common and devastating disease characterized by aggregation of the amyloid-beta peptide. However, we know relatively little about the underlying molecular mechanisms or how to treat patients with Alzheimer's disease. Here we provide bioinformatic and experimental evidence of a conserved mitochondrial stress response signature present in diseases involving amyloid-beta proteotoxicity in human, mouse and Caenorhabditis elegans that involves the mitochondrial unfolded protein response and mitophagy pathways. Using a worm model of amyloid-beta proteotoxicity, GMC101, we recapitulated mitochondrial features and confirmed that the induction of this mitochondrial stress response was essential for the maintenance of mitochondrial proteostasis and health. Notably, increasing mitochondrial proteostasis by pharmacologically and genetically targeting mitochondrial translation and mitophagy increases the fitness and lifespan of GMC101 worms and reduces amyloid aggregation in cells, worms and in transgenic mouse models of Alzheimer's disease. Our data support the relevance of enhancing mitochondrial proteostasis to delay amyloid-beta proteotoxic diseases, such as Alzheimer's disease.	[Sorrentino, Vincenzo; Omani, Mario R.; Ouchiroud, Laurent M.; Zhang, Hongbo; D'Amico, Davide; Moullan, Norman; Potenza, Francesca; Rietsch, Solene; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Beck, John S.; Counts, Scott E.] Michigan State Univ, Dept Translat Sci & Mol Med, Dept Family Med, Grand Rapids, MI 49503 USA; [Schmid, Adrien W.] Ecole Polytech Fed Lausanne, Prote Core Facil, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Michigan State University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Inst Bioengn, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	D'Amico, Davide/AAY-6183-2021; Auwerx, Johan/ABE-9307-2021; Schmid, Adrien/CAG-1527-2022; Sorrentino, Vincenzo/R-4403-2018	D'Amico, Davide/0000-0002-8499-9514; Sorrentino, Vincenzo/0000-0002-7212-370X; Auwerx, Johan/0000-0002-5065-5393; Zhang, Hongbo/0000-0002-4081-5752; Schmid, Adrien W./0000-0001-6671-7950; Romani, Mario/0000-0001-9292-8807	NIH Office of Research Infrastructure Programs [P40 OD010440]; 'EPFL Fellows' program - Marie Sklodowska-Curie, Horizon 2020 Grant [665667]; Associazione Italiana per la Ricerca sul Cancro (AIRC); NIH [P01AG014449, R21AG053581, P30 AG053760, R01AG043930]; EPFL; Systems X [SySX.ch2013/153]; Velux Stiftung [1019]; Jebsen Foundation; Swiss National Science Foundation [31003A140780]; NATIONAL INSTITUTE ON AGING [R21AG053581, R01AG043930, P30AG053760, P01AG014449] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 'EPFL Fellows' program - Marie Sklodowska-Curie, Horizon 2020 Grant; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPFL; Systems X; Velux Stiftung; Jebsen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Gonczy and M. Pierron (EPFL) for sharing reagents, the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing worm strains. V.S. is supported by the 'EPFL Fellows' program co-funded by the Marie Sklodowska-Curie, Horizon 2020 Grant agreement (665667). D.D. is supported by a fellowship funded by Associazione Italiana per la Ricerca sul Cancro (AIRC). S.E.C. is supported by NIH grants (P01AG014449, R21AG053581 and P30 AG053760). The research of J.A. is supported by the EPFL, NIH (R01AG043930), Systems X (SySX.ch2013/153), Velux Stiftung (1019), the Jebsen Foundation and the Swiss National Science Foundation (31003A140780).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Askanas Valerie, 2011, Presse Med, V40, pe219, DOI 10.1016/j.lpm.2010.11.024; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Beck JS, 2016, CURR ALZHEIMER RES, V13, P610, DOI 10.2174/1567205013666151221145445; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Corcoran KA, 2002, LEARN MEMORY, V9, P243, DOI 10.1101/lm.51002; Costa R, 2011, J BIOL CHEM, V286, P41647, DOI 10.1074/jbc.M111.274548; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Dember LM, 2006, J AM SOC NEPHROL, V17, P3458, DOI 10.1681/ASN.2006050460; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Gauthier S, 2016, ALZHEIMERS DEMENT, V12, P60, DOI 10.1016/j.jalz.2015.12.003; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20; Herrup K, 2013, ALZHEIMERS DEMENT, V9, P452, DOI 10.1016/j.jalz.2013.01.017; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027; Koopman M, 2016, NAT PROTOC, V11, P1798, DOI 10.1038/nprot.2016.106; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Martire S, 2016, J ALZHEIMERS DIS, V54, P307, DOI 10.3233/JAD-151040; McColl G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-57; Mouchiroud L., 2016, CURR PROTOC NEUROSCI, V77; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Pellegrino MW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0129-1; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Soejitno A, 2015, CNS DRUGS, V29, P487, DOI 10.1007/s40263-015-0257-8; Tiernan CT, 2016, NEUROBIOL AGING, V42, P80, DOI 10.1016/j.neurobiolaging.2016.02.031; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; WONG A, 1995, GENETICS, V139, P1247; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zheng L, 2011, AUTOPHAGY, V7, P1528, DOI 10.4161/auto.7.12.18051; Zhu W, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-53	53	300	309	14	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					187	+		10.1038/nature25143	http://dx.doi.org/10.1038/nature25143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211722	Green Accepted			2022-12-28	WOS:000418029500034
J	Gartlehner, G; Patel, SV; Feltner, C; Weber, RP; Long, R; Mullican, K; Boland, E; Lux, L; Viswanathan, M				Gartlehner, Gerald; Patel, Sheila V.; Feltner, Cynthia; Weber, Rachel Palmieri; Long, Rachel; Mullican, Kelly; Boland, Erin; Lux, Linda; Viswanathan, Meera			Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; DOSE TRANSDERMAL ESTRADIOL; CORONARY-HEART-DISEASE; MILD COGNITIVE IMPAIRMENT; HEALTH INITIATIVE MEMORY; BREAST-CANCER INCIDENCE; BONE-MINERAL DENSITY; REPLACEMENT THERAPY; ESTROGEN/PROGESTIN REPLACEMENT	IMPORTANCE Postmenopausal status coincides with increased risks for chronic conditions such as heart disease, osteoporosis, cognitive impairment, or some types of cancers. Previously, hormone therapy was used for the primary prevention of these chronic conditions. OBJECTIVE To update evidence for the US Preventive Services Task Force on the benefits and harms of hormone therapy in reducing risks for chronic conditions. DATA SOURCES MEDLINE, Cochrane Library, EMBASE, and trial registries from June 1, 2011, through August 1, 2016. Surveillance for new evidence in targeted publications was conducted through July 1, 2017. STUDY SELECTION English-language randomized clinical trials reporting health outcomes. DATA EXTRACTION AND SYNTHESIS Dual review of abstracts, full-text articles, and study quality; meta-analyses when at least 3 similar studies were available. MAIN OUTCOMES AND MEASURES Beneficial or harmful changes in risks for various chronic conditions. RESULTS Eighteen trials (n = 40058; range, 142-16 608; mean age, 53-79 years) were included. Women using estrogen-only therapy compared with placebo had significantly lower risks, per 10000 person-years, for diabetes (-19 cases [95% CI, -34 to -3]) and fractures (-53 cases [95% CI, -69 to -39]). Risks were statistically significantly increased, per 10000 person-years, for gallbladder disease (30 more cases [95% CI, 16 to 48]), stroke (11 more cases [95% CI, 2 to 23]), venous thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI, 880 to 1689]). Women using estrogen plus progestin compared with placebo experienced significantly lower risks, per 10000 person-years, for colorectal cancer (-6 cases [95% CI, -9 to -1]), diabetes (-14 cases [95% CI, -24 to -3), and fractures (-44 cases [95% CI, -71 to -13). Risks, per 10000 person-years, were significantly increased for invasive breast cancer (9 more cases [95% CI, 1 to 19]), probable dementia (22 more cases [95% CI, 4 to 53]), gallbladder disease (21 more cases [95% CI, 10 to 34]), stroke (9 more cases [95% CI, 2 to 19]), urinary incontinence (876 more cases [95% CI, 606 to 1168]), and venous thromboembolism (21 more cases [95% CI, 12 to 33]). CONCLUSIONS AND RELEVANCE Hormone therapy for the primary prevention of chronic conditions in menopausal women is associated with some beneficial effects but also with a substantial increase of risks for harms. The available evidence regarding benefits and harms of early initiation of hormone therapy is inconclusive.	[Gartlehner, Gerald; Patel, Sheila V.; Feltner, Cynthia; Weber, Rachel Palmieri; Long, Rachel; Mullican, Kelly; Boland, Erin; Lux, Linda; Viswanathan, Meera] Univ North Carolina Chapel Hill, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC USA; [Gartlehner, Gerald] Danube Univ Krems, Dept Evidence Based Med & Clin Epidemiol, Krems, Austria; [Patel, Sheila V.; Boland, Erin; Lux, Linda; Viswanathan, Meera] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Feltner, Cynthia; Weber, Rachel Palmieri] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Feltner, Cynthia] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Long, Rachel; Mullican, Kelly] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Danube University Krems; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gartlehner, G (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	ggartlehner@rti.org	Lux, Linda/GPX-3639-2022; Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Weber, Rachel/0000-0001-7119-7734; Patel, Sheila/0000-0002-6508-8803	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the US Preventive Services Task Force (USPSTF).	Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2015, HUMAN DEV REPORT 201; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Boardman HMP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002229.pub4; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Brunner RL, 2005, ARCH INTERN MED, V165, P1976, DOI 10.1001/archinte.165.17.1976; Canonico M, 2014, MENOPAUSE, V21, P214, DOI 10.1097/GME.0b013e31829752e0; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cherry N, 2014, BJOG-INT J OBSTET GY, V121, P700, DOI 10.1111/1471-0528.12598; Cherry N, 2002, LANCET, V360, P2001; Chlebowski RT, 2015, JAMA ONCOL, V1, P296, DOI 10.1001/jamaoncol.2015.0494; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2010, JNCI-J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Culhane NS, 2003, J FAM PRACTICE, V52, P754; Curb JD, 2006, ARCH INTERN MED, V166, P772, DOI 10.1001/archinte.166.7.772; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Espeland MA, 2013, JAMA INTERN MED, V173, P1429, DOI 10.1001/jamainternmed.2013.7727; Espeland MA, 2010, J AM GERIATR SOC, V58, P1263, DOI 10.1111/j.1532-5415.2010.02953.x; Ettinger B, 2004, OBSTET GYNECOL, V104, P443, DOI 10.1097/01.AOG.0000137833.43248.79; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P3618, DOI 10.1210/jc.86.8.3618; Gleason CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001833; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Gramling R, 2009, EPIDEMIOLOGY, V20, P752, DOI 10.1097/EDE.0b013e3181a71279; Greenspan SL, 2005, AM J MED, V118, P1232, DOI 10.1016/j.amjmed.2005.03.004; Harlow SD, 2012, MENOPAUSE, V19, P387, DOI 10.1097/gme.0b013e31824d8f40; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Hendrix SL, 2006, CIRCULATION, V113, P2425, DOI 10.1161/CIRCULATIONAHA.105.594077; Hendrix Susan L, 2003, J Am Osteopath Assoc, V103, pS3; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Hsia J, 2004, CIRCULATION, V109, P620, DOI 10.1161/01.CIR.0000115309.63979.92; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson SR, 2005, OBSTET GYNECOL, V105, P779, DOI 10.1097/01.AOG.0000157116.23249.52; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; McEvoy G.K., 2016, AHFS DRUG INFORM 201; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Nelson HD, 2012, AHRQ PUBLICATION, V12-05167-EF-1; Prentice RL, 2009, AM J EPIDEMIOL, V170, P12, DOI 10.1093/aje/kwp115; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; Resnick SM, 2006, J CLIN ENDOCR METAB, V91, P1802, DOI 10.1210/jc.2005-2097; Resnick Susan M, 2004, Clin Trials, V1, P440, DOI 10.1191/1740774504cn040oa; Resnick SM, 2009, J CLIN ENDOCR METAB, V94, P4152, DOI 10.1210/jc.2009-1340; Ritenbaugh C, 2008, CANCER EPIDEM BIOMAR, V17, P2609, DOI 10.1158/1055-9965.EPI-08-0385; Rocca WA, 2014, MOL CELL ENDOCRINOL, V389, P7, DOI 10.1016/j.mce.2014.01.020; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Steinauer JE, 2005, OBSTET GYNECOL, V106, P940, DOI 10.1097/01.AOG.0000180394.08406.15; Tang JY, 2011, J NATL CANCER I, V103, P1469, DOI 10.1093/jnci/djr333; Tierney MC, 2009, PSYCHONEUROENDOCRINO, V34, P1065, DOI 10.1016/j.psyneuen.2009.02.009; Toh S, 2010, ANN INTERN MED, V152, P211, DOI 10.7326/0003-4819-152-4-201002160-00005; U.S. Food & Drug Administration, MEN MED HELP YOU; US Preventive Services Task Force, 2016, METH PROC; Veerus P, 2006, MATURITAS, V55, P162, DOI 10.1016/j.maturitas.2006.01.012; Vickers MR, 2007, BMJ-BRIT MED J, V335, P239, DOI 10.1136/bmj.39266.425069.AD; Waetjen LE, 2005, OBSTET GYNECOL, V106, P946, DOI 10.1097/01.AOG.0000182576.48290.6d; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; West SL., 2010, AHRQ PUBLICATION; Whitmer RA, 2011, ANN NEUROL, V69, P163, DOI 10.1002/ana.22239; Yaffe K, 2006, ARCH NEUROL-CHICAGO, V63, P945, DOI 10.1001/archneur.63.7.945	83	81	84	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2234	2249		10.1001/jama.2017.16952	http://dx.doi.org/10.1001/jama.2017.16952			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234813	Bronze			2022-12-28	WOS:000417822700021
J	Moskowitz, CS				Moskowitz, Chaya S.			Using Free-Response Receiver Operating Characteristic Curves to Assess the Accuracy of Machine Diagnosis of Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PARADIGM; FROC		[Moskowitz, Chaya S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave,Second Floor, New York, NY 10017 USA	Memorial Sloan Kettering Cancer Center	Moskowitz, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	moskowc1@mskcc.org			National Cancer Institute [P30 CA008748]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by core grant P30 CA008748 to Memorial Sloan Kettering Cancer Center from the National Cancer Institute.	Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Bandos AI, 2009, BIOMETRICS, V65, P247, DOI 10.1111/j.1541-0420.2008.01049.x; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Chakraborty DP, 2013, ACAD RADIOL, V20, P915, DOI 10.1016/j.acra.2013.03.001; Gur D, 2008, ACAD RADIOL, V15, P1312, DOI 10.1016/j.acra.2008.05.006; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; Zou KH, 2012, STAT EVALUATION DIAG	7	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2250	2251		10.1001/jama.2017.18686	http://dx.doi.org/10.1001/jama.2017.18686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234793				2022-12-28	WOS:000417822700022
J	Bae, CJ; Douka, K; Petraglia, MD				Bae, Christopher J.; Douka, Katerina; Petraglia, Michael D.			On the origin of modern humans: Asian perspectives	SCIENCE			English	Review							PLEISTOCENE POPULATION HISTORY; ANATOMICALLY MODERN HUMANS; MODERN HUMAN-BEHAVIOR; HOMO-SAPIENS; SOUTHEAST-ASIA; VOLCANIC WINTER; HUMAN DISPERSAL; INDIAN SUBCONTINENT; NORTHERN AUSTRALIA; HUMAN COLONIZATION	The traditional "out of Africa" model, which posits a dispersal of modern Homo sapiens across Eurasia as a single wave at similar to 60,000 years ago and the subsequent replacement of all indigenous populations, is in need of revision. Recent discoveries from archaeology, hominin paleontology, geochronology, genetics, and paleoenvironmental studies have contributed to a better understanding of the Late Pleistocene record in Asia. Important findings highlighted here include growing evidence for multiple dispersals predating 60,000 years ago in regions such as southern and eastern Asia. Modern humans moving into Asia met Neandertals, Denisovans, mid-Pleistocene Homo, and possibly H. floresiensis, with some degree of interbreeding occurring. These early human dispersals, which left at least some genetic traces in modern populations, indicate that later replacements were not wholesale.	[Bae, Christopher J.] Univ Hawaii Manoa, Dept Anthropol, 2424 Maile Way,346 Saunders Hall, Honolulu, HI 96822 USA; [Douka, Katerina; Petraglia, Michael D.] Max Planck Inst Sci Human Hist, Kahlaische Str 10, D-07743 Jena, Germany; [Douka, Katerina] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, 1-2 South Parks Rd, Oxford OX1 3TG, England; [Petraglia, Michael D.] Smithsonian Inst, Human Origins Program, Natl Museum Nat Hist, Washington, DC 20560 USA	University of Hawaii System; University of Hawaii Manoa; University of Oxford; Smithsonian Institution; Smithsonian National Museum of Natural History	Bae, CJ (corresponding author), Univ Hawaii Manoa, Dept Anthropol, 2424 Maile Way,346 Saunders Hall, Honolulu, HI 96822 USA.; Douka, K; Petraglia, MD (corresponding author), Max Planck Inst Sci Human Hist, Kahlaische Str 10, D-07743 Jena, Germany.; Douka, K (corresponding author), Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, 1-2 South Parks Rd, Oxford OX1 3TG, England.; Petraglia, MD (corresponding author), Smithsonian Inst, Human Origins Program, Natl Museum Nat Hist, Washington, DC 20560 USA.	cjbae@hawaii.edu; douka@shh.mpg.de; petraglia@shh.mpg.de	Douka, Katerina/L-3287-2014; Petraglia, Michael/ABA-9748-2021	Douka, Katerina/0000-0002-0558-0011; , Christopher/0000-0003-2972-7230; Petraglia, Michael/0000-0003-2522-5727	Wenner-Gren Foundation for Anthropological Research; National Geographic Society; U.S. National Science Foundation; Academy of Korean Studies; College of Social Sciences at the University of Hawai'i at Manoa; School of Pacific at the University of Hawai'i at Manoa; Asian Studies at the University of Hawai'i at Manoa; Max Planck Institute for the Science of Human History; European Research Council [ERC-2012-AdG-324139 PALAEOCHRON, ERC-2016-STG-715069 FINDER, ERC-2011-AdG-295719 PALAEODESERTS]	Wenner-Gren Foundation for Anthropological Research; National Geographic Society(National Geographic Society); U.S. National Science Foundation(National Science Foundation (NSF)); Academy of Korean Studies; College of Social Sciences at the University of Hawai'i at Manoa; School of Pacific at the University of Hawai'i at Manoa; Asian Studies at the University of Hawai'i at Manoa; Max Planck Institute for the Science of Human History; European Research Council(European Research Council (ERC)European Commission)	We thank the participants of the Wenner-Gren Symposium "Human Colonization of Asia in the Late Pleistocene" for stimulating and lively discussions in Sintra, Portugal. We acknowledge the support over the years from the Wenner-Gren Foundation for Anthropological Research, the National Geographic Society, the U.S. National Science Foundation, the Academy of Korean Studies, the College of Social Sciences and School of Pacific and Asian Studies at the University of Hawai'i at Manoa (C.J.B.), the Max Planck Institute for the Science of Human History (K.D. and M.D.P,) and the European Research Council [ERC-2012-AdG-324139 PALAEOCHRON and ERC-2016-STG-715069 FINDER (K.D.) and ERC-2011-AdG-295719 PALAEODESERTS (M.D.P.)]. We thank L. Aiello and the anonymous reviewers for their comments and recommendations.	Ackermann RR, 2006, J HUM EVOL, V51, P632, DOI 10.1016/j.jhevol.2006.07.009; Aldenderfer M, 2004, J WORLD PREHIST, V18, P1, DOI 10.1023/B:JOWO.0000038657.79035.9e; Allen J, 2014, AUST ARCHAEOL, P86; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Bae CJ, 2017, CURR ANTHROPOL, V58, pS514, DOI 10.1086/694078; Bae CJ, 2017, CURR ANTHROPOL, V58, pS373, DOI 10.1086/694420; Bae CJ, 2014, QUATERN INT, V354, P169, DOI 10.1016/j.quaint.2014.06.051; Bae CJ, 2012, QUATERN INT, V281, P26, DOI 10.1016/j.quaint.2011.08.044; Bar-Yosef O, 2013, QUATERN INT, V285, P30, DOI 10.1016/j.quaint.2011.07.043; Bar-Yosef O, 2012, QUATERN INT, V269, P9, DOI 10.1016/j.quaint.2011.03.026; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Beyin A., 2006, AFR ARCHAEOL REV, V23, P5, DOI DOI 10.1007/S10437-006-9005-2; Blinkhorn J, 2017, CURR ANTHROPOL, V58, pS463, DOI 10.1086/693462; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Brantingham PJ, 2001, CURR ANTHROPOL, V42, P735, DOI 10.1086/323817; Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Brown S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23559; Buzhilova A, 2017, CURR ANTHROPOL, V58, pS491, DOI 10.1086/694232; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Cartmill Matt., 2009, THE HUMAN LINEAGE; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Davidson Iain, 1992, Archaeology in Oceania, V27, P135; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Derevianko A. P., 2011, CHARACTERISTIC FEATU; Derevianko AP, 2003, ARCHAEOLOGY ETHNOLOG, V3, P27; Erlandson JM, 2015, QUATERN INT, V382, P31, DOI 10.1016/j.quaint.2015.03.046; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Goodall J., 1986, CHIMPANZEES GOMBE PA, DOI [10.1038/546212a, DOI 10.1038/546212A]; Graf KE, 2017, CURR ANTHROPOL, V58, pS583, DOI 10.1086/693388; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; Habgood PJ, 2008, J HUM EVOL, V55, P187, DOI 10.1016/j.jhevol.2007.11.006; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; HOWELLS WW, 1976, J HUM EVOL, V5, P477, DOI 10.1016/0047-2484(76)90088-9; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; Kaifu Y., 2015, EMERGENCE DIVERSITY, P535, DOI DOI 10.1016/J.QUAINT.2013.01.008; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Lahr M. M, 1994, EVOL ANTHROPOL, V3, P48, DOI DOI 10.1002/EVAN.1360030206; Lambeck K, 2011, QUATERNARY SCI REV, V30, P3542, DOI 10.1016/j.quascirev.2011.08.008; Lane CS, 2013, P NATL ACAD SCI USA, V110, P8025, DOI 10.1073/pnas.1301474110; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Liu W, 2010, QUATERN INT, V211, P29, DOI 10.1016/j.quaint.2009.06.017; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Martinon-Torres M, 2017, CURR ANTHROPOL, V58, pS434, DOI 10.1086/694449; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P., 2015, EMERGENCE DIVERSITY, P3; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Michel V, 2016, J HUM EVOL, V101, P101, DOI 10.1016/j.jhevol.2016.07.008; Mondal M, 2016, NAT GENET, V48, P1066, DOI 10.1038/ng.3621; Nakazawa Y, 2017, CURR ANTHROPOL, V58, pS539, DOI 10.1086/694447; Norton CJ, 2010, QUATERN INT, V211, P113, DOI 10.1016/j.quaint.2009.05.002; Norton CJ, 2009, EVOL ANTHROPOL, V18, P247, DOI 10.1002/evan.20235; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Oppenheimer S., 2003, OUT EDEN PEOPLING WO; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Petraglia MD, 2012, QUATERN INT, V258, P119, DOI 10.1016/j.quaint.2011.07.042; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pitulko V, 2017, QUATERNARY SCI REV, V165, P127, DOI 10.1016/j.quascirev.2017.04.004; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; RAMPINO MR, 1992, NATURE, V359, P50, DOI 10.1038/359050a0; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Shen GJ, 2002, J HUM EVOL, V43, P817, DOI 10.1006/jhev.2002.0601; Sikora M, 2017, CURR ANTHROPOL, V58, pS397, DOI 10.1086/694422; Slon V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700186; Smith FH, 2017, QUATERN INT, V450, P126, DOI 10.1016/j.quaint.2016.06.008; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Stringer C, 2017, NATURE, V546, P212, DOI 10.1038/546212a; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Tattersall I., 2015, STRANGE CASE RICKETY; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Tucci S, 2016, NATURE, V538, P179, DOI 10.1038/nature19472; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; WATANABE H, 1985, J ANTHROPOL ARCHAEOL, V4, P1, DOI 10.1016/0278-4165(85)90011-X; Westaway KE, 2017, NATURE, V548, P322, DOI 10.1038/nature23452; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Williams MAJ, 2009, PALAEOGEOGR PALAEOCL, V284, P295, DOI 10.1016/j.palaeo.2009.10.009; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107; Zubova AV, 2017, ARCHAEOL ETHNOL ANTH, V45, P121, DOI 10.17746/1563-0102.2017.45.1.121-134	117	169	176	8	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368							eaai9067	10.1126/science.aai9067	http://dx.doi.org/10.1126/science.aai9067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217544				2022-12-28	WOS:000417254700049
J	Dallilar, Y; Eikenberry, SS; Garner, A; Stelter, RD; Gottlieb, A; Gandhi, P; Casella, P; Dhillon, VS; Marsh, TR; Littlefair, SP; Hardy, L; Fender, R; Mooley, K; Walton, DJ; Fuerst, F; Bachetti, M; Castro-Tirado, AJ; Charcos, M; Edwards, ML; Lasso-Cabrera, NM; Marin-Franch, A; Raines, SN; Ackley, K; Bennett, JG; Cenarro, AJ; Chinn, B; Donoso, HV; Frommeyer, R; Hanna, K; Herlevich, MD; Julian, J; Miller, P; Mullin, S; Murphey, CH; Packham, C; Varosi, F; Vega, C; Warner, C; Ramaprakash, AN; Burse, M; Punnadi, S; Chordia, P; Gerarts, A; Martin, HD; Calero, MM; Scarpa, R; Acosta, SF; Sanchez, WMH; Siegel, B; Perez, FF; Martin, HDV; Losada, JAR; Nunez, A; Tejero, A; Gonzalez, CEM; Rodriguez, CC; Molgo, J; Rodriguez, JE; Caceres, JIF; Garcia, LAR; Lopez, MH; Dominguez, R; Gaggstatter, T; Lavers, AC; Geier, S; Pessev, P; Sarajedini, A				Dallilar, Yigit; Eikenberry, Stephen S.; Garner, Alan; Stelter, Richard D.; Gottlieb, Amy; Gandhi, Poshak; Casella, Piergiorgio; Dhillon, Vik S.; Marsh, Tom R.; Littlefair, Stuart P.; Hardy, Liam; Fender, Rob; Mooley, Kunal; Walton, Dominic J.; Fuerst, Felix; Bachetti, Matteo; Castro-Tirado, A. J.; Charcos, Miguel; Edwards, Michelle L.; Lasso-Cabrera, Nestor M.; Marin-Franch, Antonio; Raines, S. Nicholas; Ackley, Kendall; Bennett, John G.; Cenarro, A. Javier; Chinn, Brian; Donoso, H. Veronica; Frommeyer, Raymond; Hanna, Kevin; Herlevich, Michael D.; Julian, Jeff; Miller, Paola; Mullin, Scott; Murphey, Charles H.; Packham, Chris; Varosi, Frank; Vega, Claudia; Warner, Craig; Ramaprakash, A. N.; Burse, Mahesh; Punnadi, Sujit; Chordia, Pravin; Gerarts, Andreas; De Paz Martin, Hector; Martin Calero, Maria; Scarpa, Riccardo; Acosta, Sergio Fernandez; Hernandez Sanchez, William Miguel; Siegel, Benjamin; Francisco Perez, Francisco; Viera Martin, Himar D.; Rodriguez Losada, Jose A.; Nunez, Agustin; Tejero, Alvaro; Martin Gonzalez, Carlos E.; Cabrera Rodriguez, Cesar; Molgo, Jordi; Esteban Rodriguez, J.; Fernandez Caceres, J. Israel; Rodriguez Garcia, Luis A.; Huertas Lopez, Manuel; Dominguez, Raul; Gaggstatter, Tim; Cabrera Lavers, Antonio; Geier, Stefan; Pessev, Peter; Sarajedini, Ata			A precise measurement of the magnetic field in the corona of the black hole binary V404 Cygni	SCIENCE			English	Article							JET	Observations of binary stars containing an accreting black hole or neutron star often show x-ray emission extending to high energies (>10 kilo-electron volts), which is ascribed to an accretion disk corona of energetic particles akin to those seen in the solar corona. Despite their ubiquity, the physical conditions in accretion disk coronae remain poorly constrained. Using simultaneous infrared, optical, x-ray, and radio observations of the Galactic black hole system V404 Cygni, showing a rapid synchrotron cooling event in its 2015 outburst, we present a precise 461 +/- 12 gauss magnetic field measurement in the corona. This measurement is substantially lower than previous estimates for such systems, providing constraints on physical models of accretion physics in black hole and neutron star binary systems.	[Dallilar, Yigit; Eikenberry, Stephen S.; Garner, Alan; Stelter, Richard D.; Gottlieb, Amy; Charcos, Miguel; Raines, S. Nicholas; Ackley, Kendall; Bennett, John G.; Chinn, Brian; Donoso, H. Veronica; Frommeyer, Raymond; Hanna, Kevin; Herlevich, Michael D.; Julian, Jeff; Miller, Paola; Mullin, Scott; Murphey, Charles H.; Varosi, Frank; Vega, Claudia; Warner, Craig; Sarajedini, Ata] Univ Florida, Bryant Space Sci Ctr 211, Dept Astron, Gainesville, FL 32611 USA; [Gandhi, Poshak] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Casella, Piergiorgio] Ist Nazl Astrofis, Osservatorio Astron Roma, Via Frascati 33, I-00040 Monte Porzio Catone, Italy; [Dhillon, Vik S.; Littlefair, Stuart P.; Hardy, Liam] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Dhillon, Vik S.; Scarpa, Riccardo; Pessev, Peter] Inst Astrofis Canarias, San Cristobal la Laguna 38205, Santa Cruz De T, Spain; [Marsh, Tom R.] Univ Warwick, Dept Phys, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England; [Fender, Rob; Mooley, Kunal] Univ Oxford, Dept Phys, Div Astrophys, Keble Rd, Oxford OX1 3RH, England; [Walton, Dominic J.] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Fuerst, Felix] CALTECH, Space Radiat Lab, Pasadena, CA 91125 USA; [Fuerst, Felix] European Space Astron Ctr, Operat Dept, Madrid, Spain; [Bachetti, Matteo] Ist Nazl Astrofis, Osservatorio Astron Cagliari, Via Sci 5, I-09047 Selargius, Italy; [Castro-Tirado, A. J.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Castro-Tirado, A. J.] Univ Malaga, Unidad Asociada Dept Ingn Sistemas & Automat, E-29071 Malaga, Spain; [Edwards, Michelle L.] Univ Arizona, Large Binocular Telescope Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Lasso-Cabrera, Nestor M.; Marin-Franch, Antonio; Cenarro, A. Javier] Ctr Estudios Fis Cosmos Aragon, Teruel 44001, Aragon, Spain; [Packham, Chris] Univ Texas San Antonio, Dept Phys & Astron, One UTSA Circle, San Antonio, TX 78249 USA; [Packham, Chris] Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan; [Ramaprakash, A. N.; Burse, Mahesh; Punnadi, Sujit; Chordia, Pravin] Interuniv Ctr Astron & Astrophys, Post Bag 4, Pune 411007, Maharashtra, India; [Gerarts, Andreas; De Paz Martin, Hector; Martin Calero, Maria; Scarpa, Riccardo; Acosta, Sergio Fernandez; Hernandez Sanchez, William Miguel; Siegel, Benjamin; Francisco Perez, Francisco; Viera Martin, Himar D.; Rodriguez Losada, Jose A.; Nunez, Agustin; Tejero, Alvaro; Martin Gonzalez, Carlos E.; Cabrera Rodriguez, Cesar; Molgo, Jordi; Esteban Rodriguez, J.; Fernandez Caceres, J. Israel; Rodriguez Garcia, Luis A.; Huertas Lopez, Manuel; Dominguez, Raul; Gaggstatter, Tim; Cabrera Lavers, Antonio; Geier, Stefan; Pessev, Peter] Gran Telescopio Canarias, Cuesta San Jose S-N, E-38712 Brena Baja, La Palma, Spain	State University System of Florida; University of Florida; University of Southampton; Istituto Nazionale Astrofisica (INAF); University of Sheffield; Instituto de Astrofisica de Canarias; University of Warwick; University of Oxford; University of Cambridge; California Institute of Technology; European Space Agency; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Universidad de Malaga; University of Arizona; University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Inter-University Centre for Astronomy & Astrophysics	Dallilar, Y; Eikenberry, SS (corresponding author), Univ Florida, Bryant Space Sci Ctr 211, Dept Astron, Gainesville, FL 32611 USA.	ydallilar@ufl.edu; eiken@ufl.edu	Dhillon, Vikram/AAB-5180-2019; Bachetti, Matteo/AAC-6882-2022; Ramaprakash, Anamparambu/AFS-1521-2022; Fernandez-Acosta, Sergio/AAD-4742-2022; Packham, Christopher/K-4371-2013	Dhillon, Vikram/0000-0003-4236-9642; Bachetti, Matteo/0000-0002-4576-9337; Ramaprakash, Anamparambu/0000-0001-5707-4965; Fernandez-Acosta, Sergio/0000-0003-2733-3406; Eikenberry, Stephen/0000-0002-1332-5061; Stelter, Deno/0000-0003-4549-0210; Raines, Steven Nicholas/0000-0003-3906-2623; Casella, Piergiorgio/0000-0002-0752-3301; Littlefair, Stuart/0000-0001-7221-855X; Ackley, Kendall/0000-0002-8648-0767; Packham, Christopher/0000-0001-7827-5758	University of Florida; National Science Foundation [AST-0352664]; Inter-University Centre for Astronomy and Astrophysics; U.K. Science and Technology Facilities Council [ST/J003697/2]; NASA; Spanish Ministry Project [AYA2015-71718-R]; STFC [ST/L000733/1, ST/M002012/1, ST/P000495/1, ST/M001350/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000733/1, ST/M001350/1, ST/P000495/1, ST/M002012/1] Funding Source: researchfish	University of Florida(University of Florida); National Science Foundation(National Science Foundation (NSF)); Inter-University Centre for Astronomy and Astrophysics; U.K. Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA(National Aeronautics & Space Administration (NASA)); Spanish Ministry Project(Spanish Government); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The near-infrared light curve is based on observations made with the Gran Telescopio Canarias, installed in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias, in the island of La Palma, during science commissioning of CIRCE. Development of CIRCE was supported by the University of Florida and the National Science Foundation (grant AST-0352664), in collaboration with the Inter-University Centre for Astronomy and Astrophysics. The William Herschel Telescope is operated on the island of La Palma by the Isaac Newton Group in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. The ULTRACAM team and P.G. (grant ST/J003697/2) acknowledge the financial support of the U.K. Science and Technology Facilities Council. This research has made use of data obtained with NuSTAR, a project led by the California Institute of Technology, funded by NASA and managed by NASA/Jet Propulsion Laboratory, and has used the NUSTARDAS software package, jointly developed by the Agenzia Spaziale Italiana Science Data Center (Italy) and California Institute of Technology (USA). A.J.C.-T. acknowledges support from the Spanish Ministry Project AYA2015-71718-R. We thank S. Markoff, C. Ceccobello, and T. Maccarone for comments on the scientific discussion. The multiwavelength lightcurves are provided as data file S1, and our derived measurements are listed in table S1. The observational data are available for each instrument: CIRCE at http://astro.ufl.edu/similar to ydallilar/Dallilar17/CIRCEraw; ULTRACAM at https://sotonac-my.sharepoint.com/personal/pg3e14_soton_ac_uk/Documents/Forms/All.aspx?slrid=603d299e%2D704d%2D4000%2Dbf01%2Dc1708c50f62d&RootFolder=%2F personal %2Fpg3e14%5Fsoton%5Fac%5Fuk%2FDocuments%2Fv404&FolderCTID0x012000F83BE7EA86B4FE49B ECFDAA6CEB2B068 (in ULTRACAM pipeline binary format); NuSTAR at https://heasarc.gsfc.nasa.gov/FTP/nustar/data/obs/01/9/90102007011; and AMI at www.tauceti.caltech.edu/kunal/uploads/SWIFT_643949-150625.fits (in radio Flexible Image Transport System format).	Barthelmy S. D., 2015, SWIFT TRIGGER 643949; Belloni TM, 2010, LECT NOTES PHYS, V794, P53, DOI 10.1007/978-3-540-76937-8_3; CASARES J, 1991, MON NOT R ASTRON SOC, V250, P712, DOI 10.1093/mnras/250.4.712; Chaty S, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015589; Cutri R. M., 2003, 2MASS ALL SKY CATALO; Del Santo M, 2013, MON NOT R ASTRON SOC, V430, P209, DOI 10.1093/mnras/sts574; Dhillon VS, 2007, MON NOT R ASTRON SOC, V378, P825, DOI 10.1111/j.1365-2966.2007.11881.x; Eikenberry S. S., 2017, ARXIV170905542ASTROP; Fender R, 2010, LECT NOTES PHYS, V794, P115, DOI 10.1007/978-3-540-76937-8_5; Gandhi P, 2016, MON NOT R ASTRON SOC, V459, P554, DOI 10.1093/mnras/stw571; Gandhi P, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L13; Kimura M, 2016, NATURE, V529, P54, DOI 10.1038/nature16452; Makino F., 1989, 4782 INT ASTR UN; Markoff S, 2003, ASTRON ASTROPHYS, V397, P645, DOI 10.1051/0004-6361:20021497; Markoff S, 2001, ASTRON ASTROPHYS, V372, pL25, DOI 10.1051/0004-6361:20010420; Meier DL, 2001, ASTROPHYS J, V548, pL9, DOI 10.1086/318921; Miller-Jones JCA, 2009, ASTROPHYS J LETT, V706, pL230, DOI 10.1088/0004-637X/706/2/L230; Negoro H., 2015, MAXI GSC DETECTION N; Plotkin RM, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/104; Rodriguez J, 2015, ASTRON ASTROPHYS, V581, DOI 10.1051/0004-6361/201527043; Russell DM, 2013, MON NOT R ASTRON SOC, V429, P815, DOI 10.1093/mnras/sts377; Shahbaz T, 2016, MON NOT R ASTRON SOC, V463, P1822, DOI 10.1093/mnras/stw2171; Spruit HC, 2001, ASTRON ASTROPHYS, V369, P694, DOI 10.1051/0004-6361:20010131; Stawarz L, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/48; Walton DJ, 2017, ASTROPHYS J, V839, DOI 10.3847/1538-4357/aa67e8; Zdziarski AA, 2014, MON NOT R ASTRON SOC, V445, P1321, DOI 10.1093/mnras/stu1835; Zwart JTL, 2008, MON NOT R ASTRON SOC, V391, P1545, DOI 10.1111/j.1365-2966.2008.13953.x	28	20	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1299	1302		10.1126/science.aan0249	http://dx.doi.org/10.1126/science.aan0249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217570	Green Accepted			2022-12-28	WOS:000417254700057
J	Halbertal, D; Ben Shalom, M; Uri, A; Bagani, K; Meltzer, AY; Marcus, I; Myasoedov, Y; Birkbeck, J; Levitov, LS; Geim, AK; Zeldov, E				Halbertal, Dorri; Ben Shalom, Moshe; Uri, Aviram; Bagani, Kousik; Meltzer, Alexander Y.; Marcus, Ido; Myasoedov, Yuri; Birkbeck, John; Levitov, Leonid S.; Geim, Andre K.; Zeldov, Eli			Imaging resonant dissipation from individual atomic defects in graphene	SCIENCE			English	Article							TRANSPORT	Conversion of electric current into heat involves microscopic processes that operate on nanometer length scales and release minute amounts of power. Although central to our understanding of the electrical properties of materials, individual mediators of energy dissipation have so far eluded direct observation. Using scanning nanothermometry with submicrokelvin sensitivity, we visualized and controlled phonon emission from individual atomic-scale defects in graphene. The inferred electron-phonon "cooling power spectrum" exhibits sharp peaks when the Fermi level comes into resonance with electronic quasi-bound states at such defects. Rare in the bulk but abundant at graphene's edges, switchable atomic-scale phonon emitters provide the dominant dissipation mechanism. Our work offers insights for addressing key materials challenges in modern electronics and enables control of dissipation at the nanoscale.	[Halbertal, Dorri; Uri, Aviram; Bagani, Kousik; Meltzer, Alexander Y.; Marcus, Ido; Myasoedov, Yuri; Zeldov, Eli] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel; [Ben Shalom, Moshe; Birkbeck, John; Geim, Andre K.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Ben Shalom, Moshe; Birkbeck, John; Geim, Andre K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Levitov, Leonid S.] MIT, Dept Phys, Cambridge, MA 02139 USA	Weizmann Institute of Science; University of Manchester; University of Manchester; Massachusetts Institute of Technology (MIT)	Halbertal, D; Zeldov, E (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel.; Ben Shalom, M (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England.; Ben Shalom, M (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	dorri.halbertal@weizmann.ac.il; moshebs@tauex.tau.ac.il; eli.zeldov@weizmann.ac.il	Geim, Andre K/J-7888-2012; Ben Shalom, Moshe/ABC-3999-2021; Zeldov, Eli/K-1546-2012	Geim, Andre K/0000-0003-2861-8331; Birkbeck, John/0000-0002-6916-4375; Ben Shalom, Moshe/0000-0001-5781-0037; Halbertal, Dorri/0000-0002-1665-0724; Zeldov, Eli/0000-0002-8200-4974; Levitov, Leonid/0000-0002-4268-731X; Myasoedov, Yuri/0000-0002-1421-4849	Minerva Foundation; German Federal Ministry of Education and Research; NSF/DMR-BSF Binational Science Foundation (BSF) [2015653]; NSF [1609519]; Weizmann-UK Making Connections Programme; Rosa and Emilio Segre Research Award; Lloyd's Register Foundation; European Research Council ARTIMATTER project (ERC-ADG); MISTI (MIT International Science and Technology Initiatives) MIT-Israel Seed Fund; EPSRC [EP/K005014/1, EP/N010345/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N010345/1] Funding Source: researchfish	Minerva Foundation; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NSF/DMR-BSF Binational Science Foundation (BSF); NSF(National Science Foundation (NSF)); Weizmann-UK Making Connections Programme; Rosa and Emilio Segre Research Award; Lloyd's Register Foundation; European Research Council ARTIMATTER project (ERC-ADG); MISTI (MIT International Science and Technology Initiatives) MIT-Israel Seed Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. E. Huber for the SOT readout setup and M. Solodky for assistance with data analysis. This work was supported by the Minerva Foundation with funding from the German Federal Ministry of Education and Research; NSF/DMR-BSF Binational Science Foundation (BSF) grant no. 2015653 and NSF grant no. 1609519; the Weizmann-UK Making Connections Programme; and a Rosa and Emilio Segre Research Award. A.K.G. and M.B.S. acknowledge support from the Lloyd's Register Foundation and the European Research Council ARTIMATTER project (ERC-2012-ADG). L.S.L. and E.Z. acknowledge the support of the MISTI (MIT International Science and Technology Initiatives) MIT-Israel Seed Fund. Data presented in this paper can be obtained from the corresponding authors upon reasonable request. A patent describing the dissipation imaging technique has been submitted (WO 2016/142945).	Allen MT, 2016, NAT PHYS, V12, P128, DOI [10.1038/NPHYS3534, 10.1038/nphys3534]; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Bischoff D, 2015, APPL PHYS REV, V2, DOI 10.1063/1.4926448; Bistritzer R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206410; Boukhvalov DW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035427; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chae J, 2012, NANO LETT, V12, P1839, DOI 10.1021/nl2041222; Dauber J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866289; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Finkler A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4731656; Garcia AGF, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085446; Gonzalez-Herrero H, 2016, SCIENCE, V352, P437, DOI 10.1126/science.aad8038; Halbertal D, 2016, NATURE, V539, P407, DOI 10.1038/nature19843; Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801; Jung SY, 2011, NAT PHYS, V7, P245, DOI 10.1038/NPHYS1866; Mao JH, 2016, NAT PHYS, V12, P545, DOI [10.1038/nphys3665, 10.1038/NPHYS3665]; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Menges F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.205901; Ni ZH, 2010, NANO LETT, V10, P3868, DOI 10.1021/nl101399r; Pereira VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036801; Shytov AV, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.016806; Song JCW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106602; Tao CG, 2011, NAT PHYS, V7, P616, DOI [10.1038/NPHYS1991, 10.1038/nphys1991]; Titov M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.076802; Tse WK, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235406; Vasyukov D, 2013, NAT NANOTECHNOL, V8, P639, DOI [10.1038/nnano.2013.169, 10.1038/NNANO.2013.169]; Wehling TO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085428; Wong D, 2015, NAT NANOTECHNOL, V10, P949, DOI [10.1038/NNANO.2015.188, 10.1038/nnano.2015.188]; Zhu MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14552	30	56	56	8	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1303	1306		10.1126/science.aan0877	http://dx.doi.org/10.1126/science.aan0877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217571	Green Published, Green Submitted			2022-12-28	WOS:000417254700058
J	Popkirov, S; Wessely, S; Nicholson, TR; Carson, AJ; Stone, J				Popkirov, Stoyan; Wessely, Simon; Nicholson, Timothy R.; Carson, Alan J.; Stone, Jon			Different shell, same shock	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Popkirov, Stoyan] Ruhr Univ Bochum, Dept Neurol, Univ Hosp Knappschaftskrankenhaus, Bochum, Germany; [Wessely, Simon] Kings Coll London, Dept Psychol Med, Kings Ctr Mil Hlth Res, London, England; [Nicholson, Timothy R.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Sect Cognit Neuropsychiat, London, England; [Carson, Alan J.; Stone, Jon] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	Ruhr University Bochum; University of London; King's College London; University of London; King's College London; University of Edinburgh	Popkirov, S (corresponding author), Ruhr Univ Bochum, Dept Neurol, Univ Hosp Knappschaftskrankenhaus, Bochum, Germany.	popkirov@gmail.com	Stone, Jon/C-3119-2014	Stone, Jon/0000-0001-9829-8092; Nicholson, Timothy/0000-0002-2350-2332; Wessely, Simon Charles/0000-0002-6743-9929; Popkirov, Stoyan/0000-0001-6168-0036	FoRUM Forschungsreferat (research office) of the Medical Faculty of the Ruhr-University Bochum, Germany; National Institute for Health Research [CS-2014-14-016, CL-2009-17-006] Funding Source: researchfish	FoRUM Forschungsreferat (research office) of the Medical Faculty of the Ruhr-University Bochum, Germany; National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. SP is supported by a scholarship for from the FoRUM Forschungsreferat (research office) of the Medical Faculty of the Ruhr-University Bochum, Germany.	Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Hallett M, 2016, FUNCTIONAL NEUROLOGI; Jones E, 2005, SHELL SHOCK PTSD MIL; Jones E, 2012, J HIST MED ALL SCI, V67, P345, DOI 10.1093/jhmas/jrr015; Kleinman A, 1988, ILLNESS NARRATIVES S; Lerner Paul, 2003, HYSTERICAL MEN WAR P; Linden S., 2016, THEY CALLED IT SHELL; Linden SC, 2013, J HIST MED ALL SCI, V68, P627, DOI 10.1093/jhmas/jrs024; Mentzos S., 2015, HYSTERIE PSYCHODYNAM; Moscovich M, 2013, TREMOR OTHER HYPERK, V3, DOI 10.7916/D89023HJ; Nonne M, 1917, Z GESAMTE NEUROL PSY, V37, P191, DOI 10.1007/BF02917386; Nonne M., 1971, ANFANG ZIE MEINES LE; Reynolds J R, 1869, Br Med J, V2, P483	13	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2017	359								j5621	10.1136/bmj.j5621	http://dx.doi.org/10.1136/bmj.j5621			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8OI	29222085				2022-12-28	WOS:000417904000005
J	Cutting, GR				Cutting, Garry R.			Treating Specific Variants Causing Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IVACAFTOR; MUTATION; LUMACAFTOR; THERAPY; TRIAL		[Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Miller Res Bldg,733 N Broadway,Room 559, Baltimore, MD 21205 USA	Johns Hopkins University	Cutting, GR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Miller Res Bldg,733 N Broadway,Room 559, Baltimore, MD 21205 USA.	gcutting@jhmi.edu			National Institutes of Health [R01 DK44009]; US Cystic Fibrosis Foundation [CUTTIN13A1, CUTTIN15XX]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Cystic Fibrosis Foundation	This work was supported by grants from the National Institutes of Health (R01 DK44009) and the US Cystic Fibrosis Foundation (CUTTIN13A1 and CUTTIN15XX).	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Durmowicz T, 2017, NOVEL APPROACH ALLOW; Griesenbach U, 2013, HUM MOL GENET, V22, pR52, DOI 10.1093/hmg/ddt372; Guevara MT, 2017, EXPERT OPIN DRUG SAF, V16, P1305, DOI 10.1080/14740338.2017.1372419; Konstan MW, 2017, LANCET RESP MED, V5, P107, DOI 10.1016/S2213-2600(16)30427-1; Sawicki GS, 2015, AM J RESP CRIT CARE, V192, P836, DOI 10.1164/rccm.201503-0578OC; Schultz NM, 2015, AM J RESP CRIT CARE, V191; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2130	2131		10.1001/jama.2017.16823	http://dx.doi.org/10.1001/jama.2017.16823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209709				2022-12-28	WOS:000417093500018
J	Oliver, D				Oliver, David			David Oliver: Seven day service standards in NHS hospitals: thorny problem or blooming success?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Brennan S, 2017, HLTH SERV J, V14; NHS England, 2017, MEAS OUR PROGR; Oliver D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2948; Royal College of Physicians, 2017, 2016 17 CENS UK CONS; Royal College of Physicians, 2016, UND UND OV NHS 2016; Royal College of Radiologists, 2016, LAT WORKF CENS HIGHL	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2017	359								j5552	10.1136/bmj.j5552	http://dx.doi.org/10.1136/bmj.j5552			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AL	29208735	Green Published, Bronze			2022-12-28	WOS:000417559000007
J	Zarocostas, J				Zarocostas, John			Peter Sands appointed head of the Global fund	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2338	2338		10.1016/S0140-6736(17)33042-8	http://dx.doi.org/10.1016/S0140-6736(17)33042-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	29185428				2022-12-28	WOS:000416118700012
J	Hickey, M; Szabo, RA; Hunter, MS				Hickey, Martha; Szabo, Rebecca A.; Hunter, Myra S.			Non-hormonal treatments for menopausal symptoms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VASOMOTOR SYMPTOMS; MANAGEMENT; WOMEN		[Hickey, Martha; Szabo, Rebecca A.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Hickey, Martha; Szabo, Rebecca A.] Royal Womens Hosp, Parkville, Vic, Australia; [Szabo, Rebecca A.] Univ Melbourne, Dept Med Educ, Parkville, Vic, Australia; [Hunter, Myra S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of Melbourne; University of Melbourne; University of London; King's College London	Hickey, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia.; Hickey, M (corresponding author), Royal Womens Hosp, Parkville, Vic, Australia.	Hickeym@unimelb.edu.au		Szabo, Rebecca/0000-0002-7426-0978				[Anonymous], 2016, Obstet Gynecol, V127, pe93, DOI 10.1097/AOG.0000000000001351; Archer DF, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.877; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Avis NE, 2009, MENOPAUSE, V16, P442, DOI 10.1097/gme.0b013e3181948dd0; Ayers B, 2013, CLIMACTERIC, V16, P235, DOI 10.3109/13697137.2012.688078; Ayers B, 2012, MENOPAUSE, V19, P749, DOI 10.1097/gme.0b013e31823fe835; Ayers B, 2010, MATURITAS, V65, P28, DOI 10.1016/j.maturitas.2009.10.016; Barton DL, 2010, J CLIN ONCOL, V28, P3278, DOI 10.1200/JCO.2009.26.6379; Barton DL, 1998, J CLIN ONCOL, V16, P495, DOI 10.1200/JCO.1998.16.2.495; Biglia N, 2009, CLIMACTERIC, V12, P310, DOI 10.1080/13697130902736921; Boekhout AH, 2011, J CLIN ONCOL, V29, P3862, DOI 10.1200/JCO.2010.33.1298; Caan B, 2015, MENOPAUSE, V22, P607, DOI [10.1097/gme.0000000000000364, 10.1097/GME.0000000000000364]; Carmody JF, 2011, MENOPAUSE, V18, P611, DOI 10.1097/gme.0b013e318204a05c; Carpenter JS, 2015, CLIMACTERIC, V18, P859, DOI 10.3109/13697137.2015.1083003; Carpenter JS, 2013, J GEN INTERN MED, V28, P193, DOI 10.1007/s11606-012-2202-6; Cella D, 2006, BREAST CANCER RES TR, V100, P273, DOI 10.1007/s10549-006-9260-6; Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Daley Amanda, 2014, Cochrane Database Syst Rev, pCD006108, DOI 10.1002/14651858.CD006108.pub4; Davis SR, 2014, MENOPAUSE, V21, P1075, DOI [10.1097/GME.0000000000000219, 10.1097/gme.0000000000000219]; Dodin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007410.pub2; Drewe J, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0808-y; Duffy OK, 2012, BJOG-INT J OBSTET GY, V119, P554, DOI 10.1111/j.1471-0528.2012.03276.x; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Edwards D, 2016, CLIMACTERIC, V19, P151, DOI 10.3109/13697137.2015.1124259; Ee C, 2017, MENOPAUSE, V24, P980, DOI 10.1097/GME.0000000000000850; Ee C, 2016, ANN INTERN MED, V164, P146, DOI 10.7326/M15-1380; Elkins G, 2008, J CLIN ONCOL, V26, P5022, DOI 10.1200/JCO.2008.16.6389; Elkins GR, 2013, MENOPAUSE, V20, P291, DOI [10.1097/GME.0b013e31826ce3ed, 10.1097/gme.0b013e31826ce3ed]; Ensrud KE, 2015, SLEEP, V38, P97, DOI 10.5665/sleep.4332; Franco OH, 2016, JAMA-J AM MED ASSOC, V315, P2554, DOI 10.1001/jama.2016.8012; Freeman EW, 2011, JAMA-J AM MED ASSOC, V305, P267, DOI 10.1001/jama.2010.2016; Ganz PA, 2016, LANCET, V387, P857, DOI 10.1016/S0140-6736(15)01169-1; Gartoulla P, 2015, MATURITAS, V81, P487, DOI 10.1016/j.maturitas.2015.06.004; Goetsch MF, 2015, J CLIN ONCOL, V33, P3394, DOI 10.1200/JCO.2014.60.7366; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Harlow SD, 2012, MENOPAUSE, V19, P387, DOI 10.1097/gme.0b013e31824d8f40; Hervik JB, 2016, BREAST CANCER RES TR, V160, P223, DOI 10.1007/s10549-016-4002-x; Hickey M, 2016, MENOPAUSE, V23, P1287, DOI 10.1097/GME.0000000000000712; Hickey M, 2016, BREAST CANCER RES TR, V158, P79, DOI 10.1007/s10549-016-3865-1; Islam MR, 2015, CLIMACTERIC, V18, P157, DOI 10.3109/13697137.2014.937689; Joffe H, 2014, JAMA INTERN MED, V174, P1058, DOI 10.1001/jamainternmed.2014.1891; Joffe H, 2010, MENOPAUSE, V17, P908, DOI 10.1097/gme.0b013e3181dbee1b; Johns C, 2016, BREAST CANCER RES TR, V156, P415, DOI 10.1007/s10549-016-3765-4; Kendall A, 2006, ANN ONCOL, V17, P584, DOI 10.1093/annonc/mdj127; Lambert MNT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176590; Leach MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007244.pub2; Lee YK, 2011, OBSTET GYNECOL, V117, P922, DOI 10.1097/AOG.0b013e3182118790; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Loprinzi CL, 2010, J CLIN ONCOL, V28, P641, DOI 10.1200/JCO.2009.24.5647; Loprinzi CL, 2002, J CLIN ONCOL, V20, P1578, DOI 10.1200/JCO.20.6.1578; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Lumsden MA, 2016, JAMA INTERN MED, V176, P1205, DOI 10.1001/jamainternmed.2016.2761; Mann E, 2012, LANCET ONCOL, V13, P309, DOI 10.1016/S1470-2045(11)70364-3; Manson JE, 2015, MENOPAUSE, V22, P247, DOI [10.1097/gme.0000000000000373, 10.1097/GME.0000000000000373]; Marino JL, 2014, MENOPAUSE, V21, P267, DOI 10.1097/GME.0b013e3182976f46; Melisko ME, 2017, JAMA ONCOL, V3, P313, DOI 10.1001/jamaoncol.2016.3904; Mintziori G, 2015, MATURITAS, V81, P410, DOI 10.1016/j.maturitas.2015.04.009; NACHTIGALL LE, 1994, FERTIL STERIL, V61, P178; National Institute for Health and Care Excellence, 2017, EARL LOC ADV BREAST; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; Newton KM, 2014, MENOPAUSE, V21, P339, DOI 10.1097/GME.0b013e31829e4baa; Perrone G, 2013, GYNECOL OBSTET INVES, V76, P38, DOI 10.1159/000351104; Politi MC, 2008, J GEN INTERN MED, V23, P1507, DOI 10.1007/s11606-008-0655-4; Posadzki P, 2013, MATURITAS, V75, P34, DOI 10.1016/j.maturitas.2013.02.005; Prague JK, 2017, LANCET, V389, P1809, DOI 10.1016/S0140-6736(17)30823-1; Rada G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004923.pub2; Reed SD, 2014, OBSTET GYNECOL, V124, P233, DOI 10.1097/AOG.0000000000000386; Reynolds F, 2002, MATURITAS, V42, P201, DOI 10.1016/S0378-5122(02)00082-8; Roberts H, 2016, MATURITAS, V86, P53, DOI 10.1016/j.maturitas.2016.01.007; Saensak S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008582.pub2; Santoro N, 2017, MENOPAUSE, V24, P238, DOI 10.1097/GME.0000000000000756; Shams T, 2014, J GEN INTERN MED, V29, P204, DOI 10.1007/s11606-013-2535-9; Sokol ER, 2017, MENOPAUSE, V24, P810, DOI 10.1097/GME.0000000000000839; Song S, 2018, AUST NZ J OBSTET GYN, V58, P148, DOI 10.1111/ajo.12735; Stearns V, 2005, J CLIN ONCOL, V23, P6919, DOI 10.1200/JCO.2005.10.081; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827; Stefanopoulou E, 2013, MENOPAUSE, V20, P1133, DOI [10.1097/gme.0b013e3182894f6d, 10.1097/GME.0b013e3182894f6d]; Sternfeld B, 2014, MENOPAUSE, V21, P330, DOI 10.1097/GME.0b013e31829e4089; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236; Vincent AJ, 2015, CLIMACTERIC, V18, P690, DOI 10.3109/13697137.2014.996749; Woyka Jane, 2017, Post Reprod Health, V23, P71, DOI 10.1177/2053369117711646; Xu QY, 2014, MATURITAS, V79, P401, DOI 10.1016/j.maturitas.2014.09.011; Zeleke BM, 2016, FERTIL STERIL, V105, P149, DOI 10.1016/j.fertnstert.2015.09.017; Zhu XS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009023.pub2; 2015, MENOPAUSE, V22, P1155, DOI DOI 10.1097/GME.0000000000000546	85	31	32	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2017	359								j5101	10.1136/bmj.j5101	http://dx.doi.org/10.1136/bmj.j5101			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WG	29170264				2022-12-28	WOS:000416472900002
J	Howard, S				Howard, Sally			After 50 years of legal abortion in Great Britain, calls grow for further liberalisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						[Anonymous], 2007, BBC NEWS; [Anonymous], 2006, TERMINATION PREGNANC; Bloomer F, 2014, CULT HEALTH SEX, V16, P366, DOI 10.1080/13691058.2014.886724; Bury L, 2015, YOUNG WOMENS EXPERIE; Department of Health, 2015, AB STAT ENGL WAL; ESRC Northern Ireland Access Research Knowledge, 2016, ESRC NO IR ACC RES K; Greening J, 2017, ACCESS ABORTION SERV; Guttmacher Institute, 2015, FACTS IND AB WORLDW; MacBain JE, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5098; Matthews S, 2017, MAIL ONLINE; Office for National Statistics, 2015, STAT B BIRTHS PAR CH; Open University University of Oxford, 2017, MY BOD MY LIF REAL S; Purcell C, 2014, PERSPECT SEX REPRO H, V46, P101, DOI 10.1363/46e1214; Royal College of Midwives, 2016, POS STAT AB; Stone N, 2011, J FAM PLAN REPROD H, V37, P209, DOI 10.1136/jfprhc-2011-0063; Taylor EA, 2017, NATCEN          0803; Temkin J, 1974, Mod Law Rev, V37, P657; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; World Health Organization, PREV UNS AB	19	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2017	359								j5278	10.1136/bmj.j5278	http://dx.doi.org/10.1136/bmj.j5278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WG	29170242				2022-12-28	WOS:000416472900007
J	Van de Beek, D; Brouwer, MC				Van de Beek, Diederik; Brouwer, Matthijs C.			Atraumatic lumbar puncture needles: practice needs to change	LANCET			English	Editorial Material							HEADACHE; PERFORM		[Van de Beek, Diederik; Brouwer, Matthijs C.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam Neurosci, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam Neurosci, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; Brouwer, Matthijs/0000-0001-7775-7843				Arevalo-Rodriguez I, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009199.pub3; Arevalo-Rodriguez I, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010807.pub2; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; CARBAAT PAT, 1981, LANCET, V2, P1133; Davis A, 2014, EUR J NEUROL, V21, P305, DOI 10.1111/ene.12307; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; Evans RW, 2000, NEUROLOGY, V55, P909, DOI 10.1212/WNL.55.7.909; Moisset X, 2016, EUR NEUROL, V76, P8, DOI 10.1159/000447452; Nath S, 2018, LANCET, V391, P1197, DOI 10.1016/S0140-6736(17)32451-0; National Health Service Digital, 2017, HOSP ACC EM ACT 2015; Peralta F, 2015, ANESTH ANALG, V121, P451, DOI 10.1213/ANE.0000000000000802; Straus SE, 2006, JAMA-J AM MED ASSOC, V296, P2012, DOI 10.1001/jama.296.16.2012	12	4	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1128	1129		10.1016/S0140-6736(17)32480-7	http://dx.doi.org/10.1016/S0140-6736(17)32480-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GA2MF	29223693				2022-12-28	WOS:000428156100009
J	Kimura, T				Kimura, Takeshi			MiStent: just another example of non-inferiority?	LANCET			English	Editorial Material							EVEROLIMUS-ELUTING STENT; CORONARY STENTS; TRIAL; OUTCOMES		[Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Kyoto University	Kimura, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	taketaka@kuhp.kyoto-ua.ac.jp						Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; de Winter RJ, 2017, LANCET; Habara S, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004449; Kereiakes DJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002372; Lansky AJ, 2016, AM J CARDIOL, V117, P532, DOI 10.1016/j.amjcard.2015.11.044; Natsuaki M, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002817; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Sipahi I, 2014, JAMA INTERN MED, V174, P223, DOI 10.1001/jamainternmed.2013.12844; Windecker S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001441	11	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					403	404		10.1016/S0140-6736(17)33079-9	http://dx.doi.org/10.1016/S0140-6736(17)33079-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29203071				2022-12-28	WOS:000424333600004
J	Dalin, C; Wada, Y; Kastner, T; Puma, MJ				Dalin, Carole; Wada, Yoshihide; Kastner, Thomas; Puma, Michael J.			Groundwater depletion embedded in international food trade (vol 543, pg 700, 2017)	NATURE			English	Correction													Kastner, Thomas/C-6346-2012; Wada, Yoshihide/F-3595-2012	Kastner, Thomas/0000-0002-8155-136X; Wada, Yoshihide/0000-0003-4770-2539				Dalin C, 2017, NATURE, V543, P700, DOI 10.1038/nature21403	1	4	4	6	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					366	366		10.1038/nature24664	http://dx.doi.org/10.1038/nature24664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29186114	Bronze			2022-12-28	WOS:000423475100057
J	Sachs, N; de Ligt, J; Kopper, O; Gogola, E; Bounova, G; Weeber, F; Balgobind, AV; Wind, K; Gracanin, A; Begthel, H; Korving, J; van Boxtel, R; Duarte, AA; Lelieveld, D; van Hoeck, A; Ernst, RF; Blokzijl, F; Nijman, IJ; Hoogstraat, M; van de Ven, M; Egan, DA; Zinzalla, V; Moll, J; Boj, SF; Voest, EE; Wessels, L; van Diest, PJ; Rottenberg, S; Vries, RGJ; Cuppen, E; Clevers, H				Sachs, Norman; de Ligt, Joep; Kopper, Oded; Gogola, Ewa; Bounova, Gergana; Weeber, Fleur; Balgobind, Anjali Vanita; Wind, Karin; Gracanin, Ana; Begthel, Harry; Korving, Jeroen; van Boxtel, Ruben; Duarte, Alexandra Alves; Lelieveld, Daphne; van Hoeck, Arne; Ernst, Robert Frans; Blokzijl, Francis; Nijman, Isaac Johannes; Hoogstraat, Marlous; van de Ven, Marieke; Egan, David Anthony; Zinzalla, Vittoria; Moll, Jurgen; Boj, Sylvia Fernandez; Voest, Emile Eugene; Wessels, Lodewyk; van Diest, Paul Joannes; Rottenberg, Sven; Vries, Robert Gerhardus Jacob; Cuppen, Edwin; Clevers, Hans			A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity	CELL			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; COPY NUMBER; R/BIOCONDUCTOR PACKAGE; MUTATIONAL PROCESSES; SOMATIC MUTATION; STEM-CELLS; IN-VITRO; EXPRESSION; GENOME; MODELS	Breast cancer (BC) comprises multiple distinct subtypes that differ genetically, pathologically, and clinically. Here, we describe a robust protocol for long-term culturing of human mammary epithelial organoids. Using this protocol, >100 primary and metastatic BC organoid lines were generated, broadly recapitulating the diversity of the disease. BC organoid morphologies typically matched the histopathology, hormone receptor status, and HER2 status of the original tumor. DNA copy number variations as well as sequence changes were consistent within tumor-organoid pairs and largely retained even after extended passaging. BC organoids furthermore populated all major gene-expression-based classification groups and allowed in vitro drug screens that were consistent with in vivo xeno-transplantations and patient response. This study describes a representative collection of well-characterized BC organoids available for cancer research and drug development, as well as a strategy to assess in vitro drug response in a personalized fashion.	[Sachs, Norman; Kopper, Oded; Wind, Karin; Gracanin, Ana; Begthel, Harry; Korving, Jeroen; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Sachs, Norman; Kopper, Oded; Wind, Karin; Gracanin, Ana; Begthel, Harry; Korving, Jeroen; Clevers, Hans] Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Sachs, Norman; Balgobind, Anjali Vanita; Boj, Sylvia Fernandez; Vries, Robert Gerhardus Jacob] Fdn Hubrecht Organoid Technol HUB, Yalelaan 62, NL-3584 CM Utrecht, Netherlands; [de Ligt, Joep; van Boxtel, Ruben; van Hoeck, Arne; Ernst, Robert Frans; Blokzijl, Francis; Nijman, Isaac Johannes; Cuppen, Edwin] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Univ Weg 100, NL-3584 CG Utrecht, Netherlands; [Gogola, Ewa; Duarte, Alexandra Alves; Wessels, Lodewyk; Rottenberg, Sven] Netherlands Canc Inst, Div Mol Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Bounova, Gergana; Hoogstraat, Marlous] Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Weeber, Fleur; Voest, Emile Eugene] Netherlands Canc Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Lelieveld, Daphne; Egan, David Anthony] Univ Med Ctr, Cell Screening Core, Dept Cell Biol, Ctr Mol Med, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [van de Ven, Marieke] Netherlands Canc Inst, MCCA, Preclin Intervent Unit, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [van Diest, Paul Joannes] Univ Med Ctr Utrecht, Dept Pathol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Rottenberg, Sven] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Langgassstr 122, CH-3012 Bern, Switzerland; [Sachs, Norman; de Ligt, Joep; Kopper, Oded; Bounova, Gergana; van Boxtel, Ruben; van Hoeck, Arne; Ernst, Robert Frans; Blokzijl, Francis; Nijman, Isaac Johannes; Boj, Sylvia Fernandez; Wessels, Lodewyk; Vries, Robert Gerhardus Jacob; Cuppen, Edwin; Clevers, Hans] Canc Genom Netherlands, Oncode Inst, NL-3584 CG Utrecht, Netherlands; [Zinzalla, Vittoria; Moll, Jurgen] Boehringer Ingelheim RCV GmbH & Co KG, Pharmacol & Translat Res, Dr Boehringer Gasse 5-11, A-1121 Vienna, Austria; [Wessels, Lodewyk] Delft Univ Technol, Fac EEMCS, Delft, Netherlands; [Sachs, Norman] Vertex Pharmaceut Inc, San Diego, CA 92121 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Bern; Boehringer Ingelheim; Delft University of Technology; Vertex Pharmaceuticals	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.; Clevers, H (corresponding author), Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.; Clevers, H (corresponding author), Canc Genom Netherlands, Oncode Inst, NL-3584 CG Utrecht, Netherlands.	h.clevers@hubrecht.eu	Hoogstraat, Marlous/ABD-2968-2021; Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; van Boxtel, Ruben/0000-0003-1285-2836; de Ligt, Joep/0000-0002-0348-419X; Van Hoeck, Arne/0000-0002-6570-1452; Gogola, Ewa/0000-0002-5733-770X; Hoogstraat, Marlous/0000-0002-4916-1177; Rottenberg, Sven/0000-0003-2044-9844	Hubrecht Institute, Utrecht University; UMC Utrecht Center for Molecular Medicine; MKMD grant [114021012]; Netherlands Organization for Scientific Research (NWO-ZonMw) [114021012, 91615182]; Stand Up to Cancer International Translational Cancer Research Grant (a program of the Entertainment Industry Foundation); Stichting Vrienden van Hubrecht [2012.010]; Cancer Genomic Center, Pink Ribbon [2014-186]; Boehringer-Ingelheim RCV GmbH Co KG [141947]; Boehringer-Ingelheim RCV GmbH Co KG	Hubrecht Institute, Utrecht University; UMC Utrecht Center for Molecular Medicine; MKMD grant; Netherlands Organization for Scientific Research (NWO-ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Stand Up to Cancer International Translational Cancer Research Grant (a program of the Entertainment Industry Foundation); Stichting Vrienden van Hubrecht; Cancer Genomic Center, Pink Ribbon; Boehringer-Ingelheim RCV GmbH Co KG; Boehringer-Ingelheim RCV GmbH Co KG	We thank all patients participating in this study as well as the teams approaching patients for consent and collecting tissue. We thank Tulay Bayram for supporting regulatory affairs. We acknowledge the Hubrecht Imaging Center for providing imaging support. We thank the Utrecht Sequencing Facility (USF) for providing the sequencing data and service. USF is subsidized by the Hubrecht Institute, Utrecht University, and the UMC Utrecht Center for Molecular Medicine. This work was funded by MKMD grant 114021012 and grants from the Netherlands Organization for Scientific Research (NWO-ZonMw 91615182 and 114021012), a Stand Up to Cancer International Translational Cancer Research Grant (a program of the Entertainment Industry Foundation administered by the AACR), Stichting Vrienden van Hubrecht (2012.010), the Cancer Genomic Center, Pink Ribbon (grant 2014-186), and Boehringer-Ingelheim RCV GmbH & Co KG (contract 141947). N.S., A.G., S.F.B., and H.C. are inventors on patent applications/patents for organoid culture. S.F.B. and R.G.J.V. are full-time employees of the Foundation Hubrecht Organoid Technology (HUB), which holds the exclusive license of organoid technology patents. V.Z. and J.M. are full-time employees of Boehringer-Ingelheim RCV GmbH & Co KG. This work was supported in part by Boehringer-Ingelheim RCV GmbH & Co KG.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ali HR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0431-1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blokzijl F., 2016, MUTATIONAL PATTERNS; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Borst-Eilers E., 1998, WET MED WETENSCHAPPE; Brennan M, 2015, ADV EXP MED BIOL, V867, P327, DOI 10.1007/978-94-017-7215-0_20; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Christgen M, 2016, PATHOL RES PRACT, V212, P583, DOI 10.1016/j.prp.2016.05.002; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Dai XF, 2016, J CANCER, V7, P1281, DOI 10.7150/jca.13141; Danielsen HE, 2016, NAT REV CLIN ONCOL, V13, P291, DOI 10.1038/nrclinonc.2015.208; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479; Elston C W, 2002, Histopathology, V41, P154; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korhonen T, 2013, BREAST, V22, P1119, DOI 10.1016/j.breast.2013.06.001; Lanzerath D., 2016, EUREC BACKGROUND; Lanzerath D., 2011, EUREC INFORM GERMANY; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Leek J.T., 2017, SVA SURROGATE VARIAB; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lorsch JR, 2014, SCIENCE, V346, P1452, DOI 10.1126/science.1259110; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Neal JT, 2016, ANNU REV PATHOL-MECH, V11, P199, DOI 10.1146/annurev-pathol-012615-044249; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sato T, 2015, CELL, V161, DOI 10.1016/j.cell.2015.06.028; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmidt M, 2016, ONCOL RES TREAT, V39, P102, DOI 10.1159/000444409; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soysal SD, 2015, PATHOBIOLOGY, V82, P142, DOI 10.1159/000430499; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stein CK, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0478-3; Stewart B. W., 2003, World Cancer Report; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; van de Vijver M., 2012, WHO CLASSIFICATION T; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Wansbury O, 2008, J INVEST DERMATOL, V128, P1009, DOI 10.1038/sj.jid.5701118; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zardavas D, 2013, NAT REV CLIN ONCOL, V10, P191, DOI 10.1038/nrclinonc.2013.29	76	736	782	38	241	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					373	+		10.1016/j.cell.2017.11.010	http://dx.doi.org/10.1016/j.cell.2017.11.010			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29224780	Bronze			2022-12-28	WOS:000419840100032
J	Sommers, BD; Kesselheim, AS				Sommers, Benjamin D.; Kesselheim, Aaron S.			Massachusetts' Proposed Medicaid Reforms - Cheaper Drugs and Better Coverage?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sommers, Benjamin D.] Harvard Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Harvard Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							[Anonymous], 2017, MASSHEALTH SECT 1115; [Anonymous], 2014, MED DEM HHSS APPR PR; Medicaid and CHIP Payment and Access Commission (MACPAC), 2016, MED SPEND PRESCR DRU; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275	5	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					109	111		10.1056/NEJMp1714824	http://dx.doi.org/10.1056/NEJMp1714824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29236573				2022-12-28	WOS:000419971600004
J	Wong, A; Lin, Q; Griffin, S; Nicholls, A; Regalbuto, JR				Wong, A.; Lin, Q.; Griffin, S.; Nicholls, A.; Regalbuto, J. R.			Synthesis of ultrasmall, homogeneously alloyed, bimetallic nanoparticles on silica supports	SCIENCE			English	Article							STRONG ELECTROSTATIC ADSORPTION; COBALT PHYLLOSILICATE; CATALYSTS; METAL; IMPREGNATION; OXIDES; NOBLE; PH	Supported nanoparticles containing more than one metal have a variety of applications in sensing, catalysis, and biomedicine. Common synthesis techniques for this type of material often result in large, unalloyed nanoparticles that lack the interactions between the two metals that give the particles their desired characteristics. We demonstrate a relatively simple, effective, generalizable method to produce highly dispersed, well-alloyed bimetallic nanoparticles. Ten permutations of noble and base metals (platinum, palladium, copper, nickel, and cobalt) were synthesized with average particle sizes from 0.9 to 1.4 nanometers, with tight size distributions. High-resolution imaging and x-ray analysis confirmed the homogeneity of alloying in these ultrasmall nanoparticles.	[Wong, A.; Lin, Q.; Griffin, S.; Regalbuto, J. R.] Univ South Carolina, Dept Chem Engn, Columbia, SC 29208 USA; [Nicholls, A.] Univ Illinois, Res Resource Ctr East, Chicago, IL 60607 USA	University of South Carolina System; University of South Carolina Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Regalbuto, JR (corresponding author), Univ South Carolina, Dept Chem Engn, Columbia, SC 29208 USA.	regalbuj@cec.sc.edu		Wong, Andrew/0000-0002-9385-9409	NSF [CBET 1160023, IIP 1464630]; NSF [CBET 1160023, IIP 1464630]	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Supported by NSF grants CBET 1160023 and IIP 1464630. All data are repented in :he main text and supplement.	An K, 2015, CATAL LETT, V145, P233, DOI 10.1007/s10562-014-1399-x; BRUNELLE JP, 1978, PURE APPL CHEM, V50, P1211, DOI 10.1351/pac197850091211; Cho HR, 2015, CATAL TODAY, V246, P143, DOI 10.1016/j.cattod.2014.09.029; D'Souza L, 2010, STUD SURF SCI CATAL, V175, P715, DOI 10.1016/S0167-2991(10)75143-0; Feltes TE, 2010, J CATAL, V270, P95, DOI 10.1016/j.jcat.2009.12.012; Hasse B, 2015, CATAL TODAY, V249, P30, DOI 10.1016/j.cattod.2014.10.049; HEISE MS, 1985, J COLLOID INTERF SCI, V107, P237, DOI 10.1016/0021-9797(85)90167-5; Hueso JL, 2013, RSC ADV, V3, P10427, DOI 10.1039/c3ra40774h; Jiao L, 2008, J CATAL, V260, P329, DOI 10.1016/j.jcat.2008.09.022; Job N, 2010, CATAL TODAY, V150, P119, DOI 10.1016/j.cattod.2009.06.022; Kyriakidou EA, 2016, J CATAL, V344, P749, DOI 10.1016/j.jcat.2016.08.018; Lambert S, 2009, J CATAL, V261, P23, DOI 10.1016/j.jcat.2008.10.014; Liu Y, 2011, CHEM MATER, V23, P4199, DOI 10.1021/cm2014785; Loaiza-Gil A, 2005, J MOL CATAL A-CHEM, V228, P339, DOI 10.1016/j.molcata.2004.09.071; Mager N, 2016, PHYS CHEM CHEM PHYS, V18, P32210, DOI 10.1039/c6cp05314a; Mankad NP, 2016, CHEM-EUR J, V22, P5822, DOI 10.1002/chem.201505002; O'Connell K, 2015, CATAL LETT, V145, P777, DOI 10.1007/s10562-015-1479-6; Regalbuto J. R., 2016, CATALYST PREPARATION; Riyapan S, 2016, CATAL SCI TECHNOL, V6, P5608, DOI 10.1039/c6cy00121a; Samad JE, 2016, J CATAL, V342, P203, DOI 10.1016/j.jcat.2016.08.004; SANTHANAM N, 1994, CATAL TODAY, V21, P141, DOI 10.1016/0920-5861(94)80040-5; Schreier M, 2004, J CATAL, V225, P190, DOI 10.1016/j.jcat.2004.03.034; Siani A, 2006, LANGMUIR, V22, P5160, DOI 10.1021/la053476a; Sinfelt J. H., 1977, BIMETALLIC CATALYSTS; Soled S., 2009, SYNTHESIS SOLID CATA, P353; Soled S, 2015, SCIENCE, V350, P1171, DOI 10.1126/science.aad2204; Spieker WA, 2001, CHEM ENG SCI, V56, P3491, DOI 10.1016/S0009-2509(01)00052-5; Trujillano R, 2008, J PHYS CHEM C, V112, P18551, DOI 10.1021/jp806556c; van de Water LGA, 2005, J PHYS CHEM B, V109, P14513, DOI 10.1021/jp051037e; Zecevic J, 2015, NATURE, V528, P245, DOI 10.1038/nature16173; Zhang LY, 2014, CHEMCATCHEM, V6, P2600, DOI 10.1002/cctc.201402175; Zhong C. J, 2013, COMPREHENSIVE INORGA, P75; Zhou B., 2003, NANOTECHNOLOGY CATAL, V1	33	201	204	50	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1427	1430		10.1126/science.aao6538	http://dx.doi.org/10.1126/science.aao6538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29170281				2022-12-28	WOS:000417918500040
J	Amin-Wetzel, N; Saunders, RA; Kamphuis, MJ; Rato, C; Preissler, S; Harding, HP; Ron, D				Amin-Wetzel, Niko; Saunders, Reuben A.; Kamphuis, Maarten J.; Rato, Claudia; Preissler, Steffen; Harding, Heather P.; Ron, David			A J-Protein Co-chaperone Recruits BiP to Monomerize IRE1 and Repress the Unfolded Protein Response	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SHOCK GENE-EXPRESSION; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; ESCHERICHIA-COLI; MOLECULAR-BASIS; ATPASE ACTIVITY; KINASE	When unfolded proteins accumulate in the endoplasmic reticulum (ER), the unfolded protein response (UPR) increases ER-protein-folding capacity to restore protein-folding homeostasis. Unfolded proteins activate UPR signaling across the ER membrane to the nucleus by promoting oligomerization of IRE1, a conserved transmembrane ER stress receptor. However, the coupling of ER stress to IRE1 oligomerization and activation has remained obscure. Here, we report that the ER luminal co-chaperone ERdj4/DNAJB9 is a selective IRE1 repressor that promotes a complex between the luminal Hsp70 BiP and the luminal stress-sensing domain of IRE1 alpha (IRE1(LD)). In vitro, ERdj4 is required for complex formation between BiP and IRE1(LD). ERdj4 associates with IRE1(LD) and recruits BiP through the stimulation of ATP hydrolysis, forcibly disrupting IRE1 dimers. Unfolded proteins compete for BiP and restore IRE1(LD) to its default, dimeric, and active state. These observations establish BiP and its J domain co-chaperones as key regulators of the UPR.	[Amin-Wetzel, Niko; Saunders, Reuben A.; Kamphuis, Maarten J.; Rato, Claudia; Preissler, Steffen; Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Ron, D (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England.	dr360@medschl.cam.ac.uk		Preissler, Steffen/0000-0001-7936-9836; Rato, Claudia/0000-0002-3971-046X; Amin-Wetzel, Niko/0000-0002-4640-3724; Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974	Wellcome Trust [Wellcome 200848/Z/16/Z, Wellcome 100140]; Medical Research Council; Churchill Scholarship; VSB Fonds; Medical Research Council [1358405] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Churchill Scholarship; VSB Fonds; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the CIMR flow cytometry core facility team (Reiner Schulte, Michal Maj, and Chiara Cossetti) for assistance with FACS, the Huntington lab for access to the Octet machine, and Lukas Rohland for purifying GRP170. This work was supported by Wellcome Trust Principal Research Fellowship to D.R. (Wellcome 200848/Z/16/Z), a Wellcome Trust Strategic Award to the Cambridge Institute for Medical Research (Wellcome 100140), a Medical Research Council Doctoral Training Partnership stipend (N.A.-W.), a Churchill Scholarship (R.A.S.), and a scholarship from VSB Fonds (M.J.K.).	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Avezov E, 2013, J CELL BIOL, V201, P337, DOI 10.1083/jcb.201211155; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrara M, 2015, EMBO J, V34, P1589, DOI 10.15252/embj.201489183; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Crespillo-Casado A, 2017, ELIFE, V6, DOI 10.7554/eLife.26109; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; De Los Rios P, 2014, ELIFE, V3, DOI 10.7554/eLife.02218; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Fritz JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107473; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karagoz GE, 2017, ELIFE, V6, DOI 10.7554/eLife.30700; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; MORI K, 1993, CELL, V74, P743; NG DTW, 1992, MOL BIOL CELL, V3, P143, DOI 10.1091/mbc.3.2.143; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Sekine Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166278; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Sundaram A, 2017, ELIFE, V6, DOI 10.7554/eLife.27187; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; WALL D, 1994, J BIOL CHEM, V269, P5446; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	61	128	140	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1625	+		10.1016/j.cell.2017.10.040	http://dx.doi.org/10.1016/j.cell.2017.10.040			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29198525	Green Published, hybrid			2022-12-28	WOS:000418044000018
J	Blount, T; Hartsell, A				Blount, Thomas; Hartsell, Angela			Tubular Opacities in the Gastrointestinal Tract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blount, Thomas; Hartsell, Angela] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Blount, T (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	thomas.blount@unchealth.unc.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2375	2375		10.1056/NEJMicm1703094	http://dx.doi.org/10.1056/NEJMicm1703094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP8VG	29236643				2022-12-28	WOS:000417923600009
J	Filer, D; Thompson, MA; Takhaveev, V; Dobson, AJ; Kotronaki, I; Green, JWM; Heinemann, M; Tullet, JMA; Alic, N				Filer, Danny; Thompson, Maximillian A.; Takhaveev, Vakil; Dobson, Adam J.; Kotronaki, Ilektra; Green, James W. M.; Heinemann, Matthias; Tullet, Jennifer M. A.; Alic, Nazif			RNA polymerase III limits longevity downstream of TORC1	NATURE			English	Article							LIFE-SPAN EXTENSION; DROSOPHILA; RAPAMYCIN; TRANSCRIPTION; EXPRESSION; SYSTEM; YEAST; ACID; BETA	Three distinct RNA polymerases transcribe different classes of genes in the eukaryotic nucleus(1). RNA polymerase (Pol) III is the essential, evolutionarily conserved enzyme that generates short, non-coding RNAs, including tRNAs and 5S rRNA(2). The historical focus on transcription of protein-coding genes has left the roles of Pol III in organismal physiology relatively unexplored. Target of rapamycin kinase complex 1 (TORC1) regulates Pol III activity, and is also an important determinant of longevity(3). This raises the possibility that Pol III is involved in ageing. Here we show that Pol III limits lifespan downstream of TORC1. We find that a reduction in Pol III extends chronological lifespan in yeast and organismal lifespan in worms and flies. Inhibiting the activity of Pol III in the gut of adult worms or flies is sufficient to extend lifespan; in flies, longevity can be achieved by Pol III inhibition specifically in intestinal stem cells. The longevity phenotype is associated with amelioration of age-related gut pathology and functional decline, dampened protein synthesis and increased tolerance of proteostatic stress. Pol III acts on lifespan downstream of TORC1, and limiting Pol III activity in the adult gut achieves the full longevity benefit of systemic TORC1 inhibition. Hence, Pol III is a pivotal mediator of this key nutrient-signalling network for longevity; the growth-promoting anabolic activity of Pol III mediates the acceleration of ageing by TORC1. The evolutionary conservation of Pol III affirms its potential as a therapeutic target.	[Filer, Danny; Dobson, Adam J.; Kotronaki, Ilektra; Alic, Nazif] UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England; [Thompson, Maximillian A.; Green, James W. M.; Tullet, Jennifer M. A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Takhaveev, Vakil; Heinemann, Matthias] Univ Groningen, Mol Syst Biol, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of London; University College London; University of Kent; University of Groningen	Alic, N (corresponding author), UCL, Inst Healthy Ageing, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.; Tullet, JMA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	j.m.a.tullet@kent.ac.uk; n.alic@ucl.ac.uk	Heinemann, Matthias/B-9421-2008; Alic, Nazif/B-4665-2009	Heinemann, Matthias/0000-0002-5512-9077; Dobson, Adam/0000-0003-1541-927X; Thompson, Maximilian/0000-0003-1349-4735; Alic, Nazif/0000-0003-0356-6600; Takhaveev, Vakil/0000-0002-3474-5241; Tullet, Jennifer/0000-0002-2037-526X	NIH Office of Research Infrastructure Programs [P40 OD010440]; Biotechnology and Biological Sciences Research Council [BB/M029093/1]; Royal Society [RG140694, RG140122]; Medical Research Council [MR/L018802/1]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [642738]; UCL Impact PhD studentship; BBSRC [BB/M029093/1] Funding Source: UKRI; MRC [MR/L018802/1] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); UCL Impact PhD studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Grewal, B. Ohlstein, L. Partridge and S. Pletcher for fly lines; C. Bouchoux and F. Uhlmann for yeast reagents; G. Juhasz and A. Teleman for antibodies; E. Bolukbasi and L. Partridge for the Flag-tagged dTor construct and S2 cells; M. Hill and D. Ivanov for help with RNA-seq analysis; L. Conder, A. Garaeva, D. Mostapha, G. Phillips and P. van der Poel for technical assistance, and M. Piper, J. Bahler and the IHA members for support, comments and critical reading of the manuscript. Reagents were obtained from Developmental Studies Hybridoma Bank, Vienna Drosophila Resource Centre, Bloomington Stock Center and the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was funded in part by Biotechnology and Biological Sciences Research Council grant BB/M029093/1, Royal Society grant RG140694 and Medical Research Council grant MR/L018802/1 to N.A., and Royal Society grant RG140122 to J.M.A.T. M.H. and V.T. received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 642738. D.F. is a recipient of the UCL Impact PhD studentship.	Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Arimbasseri AG, 2016, TRENDS BIOCHEM SCI, V41, P546, DOI 10.1016/j.tibs.2016.03.003; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Fan XL, 2015, ONCOTARGET, V6, P35274, DOI 10.18632/oncotarget.5895; FRENDEWEY D, 1985, J BIOL CHEM, V260, P449; Gelino S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006135; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Grewal SS, 2015, BBA-GENE REGUL MECH, V1849, P898, DOI 10.1016/j.bbagrm.2014.12.005; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huberts DHEW, 2013, NAT PROTOC, V8, P1019, DOI 10.1038/nprot.2013.060; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Nagy P, 2014, AUTOPHAGY, V10, P453, DOI 10.4161/auto.27442; Niccoli T, 2016, CURR BIOL, V26, P2291, DOI [10.1016/j.cub.2016.07.017, 10.1016/j.cub.2016.09.018]; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Papagiannakis A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04791-6; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rideout EJ, 2012, P NATL ACAD SCI USA, V109, P1139, DOI 10.1073/pnas.1113311109; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Tsokanos FF, 2016, EMBO J, V35, P1058, DOI 10.15252/embj.201593118; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	48	55	56	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					263	+		10.1038/nature25007	http://dx.doi.org/10.1038/nature25007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29186112	Green Accepted, Green Published			2022-12-28	WOS:000418029500049
J	Hurley, R				Hurley, Richard			CHRISTMAS 2017: THE BMJ APPEAL The BMJ charity appeal Christmas 2017: help MSF bring essential healthcare to millions of people in war torn Yemen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2017	359								j5722	10.1136/bmj.j5722	http://dx.doi.org/10.1136/bmj.j5722			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KW	29233810				2022-12-28	WOS:000418327300003
J	Loomis, I				Loomis, Ilima			ORBITAL DEBRIS NASA sensor to study space junk the size of dust	SCIENCE			English	News Item																			0	1	1	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1234	1234		10.1126/science.358.6368.1234	http://dx.doi.org/10.1126/science.358.6368.1234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217548				2022-12-28	WOS:000417254700012
J	Weinstein, AM				Weinstein, Aliyah M.			An unexpected career resource	SCIENCE			English	Editorial Material									[Weinstein, Aliyah M.] Univ Pittsburgh, Sch Med, Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinstein, AM (corresponding author), Univ Pittsburgh, Sch Med, Immunol, Pittsburgh, PA 15260 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1350	1350		10.1126/science.358.6368.1350	http://dx.doi.org/10.1126/science.358.6368.1350			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217580				2022-12-28	WOS:000417254700068
J	Deeming, DC				Deeming, D. Charles			PALEONTOLOGY How pterosaurs bred	SCIENCE			English	Editorial Material							LIFE-HISTORY; EGG; EGGSHELL; INSIGHT		[Deeming, D. Charles] Univ Lincoln, Sch Life Sci, Joseph Banks Labs, Brayford Pool LN6 7DL, Lincs, England	University of Lincoln	Deeming, DC (corresponding author), Univ Lincoln, Sch Life Sci, Joseph Banks Labs, Brayford Pool LN6 7DL, Lincs, England.	cdeeming@lincoln.ac.uk						Carpenter K., 1999, EGGS NESTS BABY DINO; Chiappe LM, 2004, NATURE, V432, P571, DOI 10.1038/432571a; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Deeming D.C., 2004, P1; Erickson GM, 2017, P NATL ACAD SCI USA, V114, P540, DOI 10.1073/pnas.1613716114; Ji Q, 2004, NATURE, V432, P572, DOI 10.1038/432572a; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Prondvai E, 2014, PALEOBIOLOGY, V40, P288, DOI 10.1666/13030; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Wang XL, 2015, AN ACAD BRAS CIENC, V87, P1599, DOI 10.1590/0001-3765201520150364; Wang XL, 2014, CURR BIOL, V24, P1323, DOI 10.1016/j.cub.2014.04.054; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a	13	6	12	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1124	1125		10.1126/science.aao6493	http://dx.doi.org/10.1126/science.aao6493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191889	Green Submitted			2022-12-28	WOS:000416584000017
J	Wang, XL; Kellner, AWA; Jiang, SX; Cheng, X; Wang, Q; Ma, YX; Paidoula, Y; Rodrigues, T; Chen, H; Sayao, JM; Li, N; Zhang, JL; Bantim, RAM; Meng, X; Zhang, XJ; Qiu, R; Zhou, ZH				Wang, Xiaolin; Kellner, Alexander W. A.; Jiang, Shunxing; Cheng, Xin; Wang, Qiang; Ma, Yingxia; Paidoula, Yahefujiang; Rodrigues, Taissa; Chen, He; Sayao, Juliana M.; Li, Ning; Zhang, Jialiang; Bantim, Renan A. M.; Meng, Xi; Zhang, Xinjun; Qiu, Rui; Zhou, Zhonghe			Egg accumulation with 3D embryos provides insight into the life history of a pterosaur	SCIENCE			English	Article							FILTER-FEEDER PTEROSAUR; PTERODAUSTRO-GUINAZUI; SKELETON FORMATION; CENTRAL ARGENTINA; PATTERNS; PTERODACTYLOIDEA; PALEONTOLOGY; OSSIFICATION; REPTILIA; EGGSHELL	Fossil eggs and embryos that provide unique information about the reproduction and early growth of vertebrates are exceedingly rare, particularly for pterosaurs. Here we report on hundreds of three-dimensional (3D) eggs of the species Hamipterus tianshanensis from a Lower Cretaceous site in China, 16 of which contain embryonic remains. Computed tomography scanning, osteohistology, and micropreparation reveal that some bones lack extensive ossification in potentially late-term embryos, suggesting that hatchlings might have been flightless and less precocious than previously assumed. The geological context, including at least four levels with embryos and eggs, indicates that this deposit was formed by a rare combination of events, with storms acting on a nesting ground. This discovery supports colonial nesting behavior and potential nesting site fidelity in the Pterosauria.	[Wang, Xiaolin; Jiang, Shunxing; Cheng, Xin; Wang, Qiang; Chen, He; Li, Ning; Zhang, Jialiang; Meng, Xi; Zhang, Xinjun; Qiu, Rui; Zhou, Zhonghe] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Wang, Xiaolin; Chen, He; Zhang, Jialiang; Zhang, Xinjun; Qiu, Rui; Zhou, Zhonghe] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Kellner, Alexander W. A.] Univ Fed do Rio de Janeiro, Lab Systemat & Taphonomy Fossil Vertebrates, Dept Geol & Paleontol, Museu Nacl, BR-20940040 Rio De Janeiro, Brazil; [Ma, Yingxia; Paidoula, Yahefujiang] Hami Museum, Hami 839000, Peoples R China; [Rodrigues, Taissa] Univ Fed Espirito Santo, Lab Paleontol, Dept Ciencias Biol, Ctr Ciencias Humanas & Nat, BR-29075910 Vitoria, ES, Brazil; [Sayao, Juliana M.; Bantim, Renan A. M.] Univ Fed Pernambuco, Lab Biodiversidade Nordeste, Ctr Acad Vitoria, Alto Reservatorio St S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universidade Federal do Espirito Santo; Universidade Federal de Pernambuco	Wang, XL (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.; Wang, XL (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Kellner, AWA (corresponding author), Univ Fed do Rio de Janeiro, Lab Systemat & Taphonomy Fossil Vertebrates, Dept Geol & Paleontol, Museu Nacl, BR-20940040 Rio De Janeiro, Brazil.	wangxiaolin@ivpp.ac.cn; kellner@mn.ufrj.br	CHENG, XIN/G-5664-2018; Jiang, Shunxing/R-9013-2016; Kellner, Alexander/ABE-9591-2020; Rodrigues, Taissa/H-1220-2012; Bantim, Renan/J-4076-2014	CHENG, XIN/0000-0003-1415-1152; Jiang, Shunxing/0000-0002-7524-1525; Kellner, Alexander/0000-0001-7174-9447; Rodrigues, Taissa/0000-0001-7918-1358; Wang, Xiaolin/0000-0003-2205-2103	National Natural Science Foundation of China [41572020, 41688103, 41602011, 91514302, 40825005]; Strategic Priority Research Program (B) of CAS [XDB18000000]; Hundred Talents Project of CAS; Excavation Funding and Emphatic Deployed Project of IVPP, CAS; Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES) [67678254]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [460784/2014-5, 304780/2013-8]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) [E-26/202.893/2015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program (B) of CAS; Hundred Talents Project of CAS; Excavation Funding and Emphatic Deployed Project of IVPP, CAS(Chinese Academy of Sciences); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	We thank L. Xiang, H.-J. Zhou, and R.-J. Wang [Institute of Vertebrate Paleontology and Paleoanthropology, Chinese Academy of Sciences (CAS)] for the preparation of the specimens, W. Gao for photography, A.-J. Shi for line drawings, and Y.-M. Hou and P.-F. Yin for help with the CT scan and reconstruction (IVPP). We are also indebted to Y. Li, L. Xiang, Q.-G. Liu, R.-J. Wang, H.-J. Zhou, W. Gao, H.-Q. Shou (IVPP), and G.-L. Wu, B.-L. Guan, H.-M. Wu, Q.-J. Li, H.-Y. Chen, F. Yan, Y.-L. Tian, Z.-J. Yin, H.-P. Dai, and J. Tong (Hami) for assistance in the field work. This study was supported by the National Natural Science Foundation of China (41572020, 41688103, 41602011, 91514302, and 40825005), the Strategic Priority Research Program (B) of CAS (XDB18000000), the Hundred Talents Project of CAS, the Excavation Funding and Emphatic Deployed Project of IVPP, CAS. T.R. acknowledges funding from the Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES no. 67678254) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq no. 460784/2014-5); and A.W.A.K. from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Rio de Janeiro (FAPERJ no. E-26/202.893/2015) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq no. 304780/2013-8). All specimens are housed at the Institute of Vertebrate Paleontology and Paleoanthropology in Beijing, China.	Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Carpenter K., 1994, DINOSAUR EGGS BABIES; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2004, NATURE, V432, P571, DOI 10.1038/432571a; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Grellet-Tinner G, 2014, GEOSCI FRONT, V5, P759, DOI 10.1016/j.gsf.2014.05.002; Hirsch KF, 1996, J VERTEBR PALEONTOL, V16, P752, DOI 10.1080/02724634.1996.10011363; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Ji Q, 2004, NATURE, V432, P572, DOI 10.1038/432572a; Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Kellner AWA, 2013, AN ACAD BRAS CIENC, V85, P113, DOI 10.1590/S0001-37652013000100009; Marti DM, 2014, CURR BIOL, V24, pR615, DOI 10.1016/j.cub.2014.05.040; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; RIEPPEL O, 1994, J HERPETOL, V28, P145, DOI 10.2307/1564613; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; Schleich H.H., 1988, REPTILE EGG SHELLS S; Stark M. J., 1998, AVIAN GROWTH DEV EVO; Steel Lorna, 2008, Zitteliana Reihe B, V28, P109; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Wang XL, 2015, AN ACAD BRAS CIENC, V87, P1599, DOI 10.1590/0001-3765201520150364; Wang XL, 2014, CURR BIOL, V24, P1323, DOI 10.1016/j.cub.2014.04.054; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; WESTERGAARD B, 1987, J ZOOL, V212, P191, DOI 10.1111/j.1469-7998.1987.tb05984.x; Zhou ZH, 2004, SCIENCE, V306, P653, DOI 10.1126/science.1100000	26	17	17	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1197	1201		10.1126/science.aan2329	http://dx.doi.org/10.1126/science.aan2329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191909				2022-12-28	WOS:000416584000044
J	Engelhardt, KE; Barnard, C; Bilimoria, KY				Engelhardt, Kathryn E.; Barnard, Cynthia; Bilimoria, Karl Y.			Wrong-Site Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Engelhardt, Kathryn E.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Engelhardt, Kathryn E.; Bilimoria, Karl Y.] Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA; [Barnard, Cynthia] Northwestern Univ, Chicago, IL 60611 USA	Medical University of South Carolina; Northwestern University; Feinberg School of Medicine; Northwestern University	Bilimoria, KY (corresponding author), Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu			American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	American College of Surgeons; American Board of Surgeons; Accreditation Council for Graduate Medical Education	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bilimoria reports receipt of grants from the American College of Surgeons, the American Board of Surgeons, and the Accreditation Council for Graduate Medical Education and personal fees from the American College of Surgeons. No other disclosures were reported.	[Anonymous], 2016, COMPR ACCR MAN HOSP; Destino LA, 2016, JT COMM J QUAL PATIE, V42, P99, DOI 10.1016/S1553-7250(16)42012-X; Hempel S, 2015, JAMA SURG, V150, P796, DOI 10.1001/jamasurg.2015.0301; Kwaan MR, 2006, ARCH SURG-CHICAGO, V141, P353, DOI 10.1001/archsurg.141.4.353; Levinson W, 2016, JAMA-J AM MED ASSOC, V316, P764, DOI 10.1001/jama.2016.9136	5	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2033	2034		10.1001/jama.2017.17177	http://dx.doi.org/10.1001/jama.2017.17177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183079				2022-12-28	WOS:000416317600024
J	Nath, S; Koziarz, A; Badhiwala, JH; Alhazzani, W; Jaeschke, R; Sharma, S; Banfield, L; Shoamanesh, A; Singh, S; Nassiri, F; Oczkowski, W; Belley-Cote, E; Truant, R; Reddy, K; Meade, MO; Farrokhyar, F; Bala, MM; Alshamsi, F; Krag, M; Etxeandia-Ikobaltzeta, I; Kunz, R; Nishida, O; Matouk, C; Selim, M; Rhodes, A; Hawryluk, G; Almenawer, SA				Nath, Siddharth; Koziarz, Alex; Badhiwala, Jetan H.; Alhazzani, Waleed; Jaeschke, Roman; Sharma, Sunjay; Banfield, Laura; Shoamanesh, Ashkan; Singh, Sheila; Nassiri, Farshad; Oczkowski, Wieslaw; Belley-Cote, Emilie; Truant, Ray; Reddy, Kesava; Meade, Maureen O.; Farrokhyar, Forough; Bala, Malgorzata M.; Alshamsi, Fayez; Krag, Mette; Etxeandia-Ikobaltzeta, Itziar; Kunz, Regina; Nishida, Osamu; Matouk, Charles; Selim, Magdy; Rhodes, Andrew; Hawryluk, Gregory; Almenawer, Saleh A.			Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis	LANCET			English	Review							TRIAL SEQUENTIAL-ANALYSIS; SPINAL NEEDLES; DURAL PUNCTURE; HEADACHE; STANDARD; COST	Background Atraumatic needles have been proposed to lower complication rates after lumbar puncture. However, several surveys indicate that clinical adoption of these needles remains poor. We did a systematic review and meta-analysis to compare patient outcomes after lumbar puncture with atraumatic needles and conventional needles. Methods In this systematic review and meta-analysis, we independently searched 13 databases with no language restrictions from inception to Aug 15, 2017, for randomised controlled trials comparing the use of atraumatic needles and conventional needles for any lumbar puncture indication. Randomised trials comparing atraumatic and conventional needles in which no dural puncture was done (epidural injections) or without a conventional needle control group were excluded. We screened studies and extracted data from published reports independently. The primary outcome of postdural-puncture headache incidence and additional safety and efficacy outcomes were assessed by random-effects and fixed-effects meta-analysis. This study is registered with the International Prospective Register of Systematic Reviews, number CRD42016047546. Findings We identified 20 241 reports; after exclusions, 110 trials done between 1989 and 2017 from 29 countries, including a total of 31 412 participants, were eligible for analysis. The incidence of postdural-puncture headache was significantly reduced from 11.0% (95% CI 9.1-13.3) in the conventional needle group to 4.2% (3.3-5.2) in the atraumatic group (relative risk 0.40, 95% CI 0.34-0.47, p<0.0001; I-2=45.4%). Atraumatic needles were also associated with significant reductions in the need for intravenous fluid or controlled analgesia (0.44, 95% CI 0.29-0.64; p<0.0001), need for epidural blood patch (0.50, 0.33-0.75; p=0.001), any headache (0.50, 0.43-0.57; p<0.0001), mild headache (0.52, 0.38-0.70; p<0.0001), severe headache (0.41, 0.28-0.59; p<0.0001), nerve root irritation (0.71, 0.54-0.92; p=0.011), and hearing disturbance (0.25, 0.11-0.60; p=0.002). Success of lumbar puncture on first attempt, failure rate, mean number of attempts, and the incidence of traumatic tap and backache did not differ significantly between the two needle groups. Prespecified subgroup analyses of postdural-puncture headache revealed no interactions between needle type and patient age, sex, use of prophylactic intravenous fluid, needle gauge, patient position, indication for lumbar puncture, bed rest after puncture, or clinician specialty. These results were rated high-quality evidence as examined using the grading of recommendations assessment, development, and evaluation. Interpretation Among patients who had lumbar puncture, atraumatic needles were associated with a decrease in the incidence of postdural-puncture headache and in the need for patients to return to hospital for additional therapy, and had similar efficacy to conventional needles. These findings offer clinicians and stakeholders a comprehensive assessment and high-quality evidence for the safety and efficacy of atraumatic needles as a superior option for patients who require lumbar puncture. Funding None.	[Nath, Siddharth; Koziarz, Alex; Sharma, Sunjay; Singh, Sheila; Reddy, Kesava; Almenawer, Saleh A.] Hamilton Hlth Sci, Div Neurosurg, Hamilton, ON L8S 4L8, Canada; [Alhazzani, Waleed; Jaeschke, Roman; Belley-Cote, Emilie; Meade, Maureen O.] Hamilton Hlth Sci, Div Crit Care, Hamilton, ON, Canada; [Banfield, Laura] Hamilton Hlth Sci, Hlth Sci Lib, Hamilton, ON, Canada; [Shoamanesh, Ashkan; Oczkowski, Wieslaw] Hamilton Hlth Sci, Div Neurol, Hamilton, ON, Canada; [Shoamanesh, Ashkan; Oczkowski, Wieslaw] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Truant, Ray] Hamilton Hlth Sci, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Farrokhyar, Forough; Etxeandia-Ikobaltzeta, Itziar] Hamilton Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Almenawer, Saleh A.] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Badhiwala, Jetan H.; Nassiri, Farshad] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Bala, Malgorzata M.] Jagiellonian Univ, Dept Hyg & Dietet, Krakow, Poland; [Alshamsi, Fayez] United Arab Emirates Univ, Dept Internal Med, Al Ain, U Arab Emirates; [Krag, Mette] Copenhagen Univ Hosp, Dept Intens Care, Copenhagen, Denmark; [Kunz, Regina] Univ Hosp Basel, Evidence Based Insurance Med, Basel, Switzerland; [Nishida, Osamu] Fujita Hlth Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Toyoake, Aichi, Japan; [Matouk, Charles] Yale Univ, Dept Neurosurg, New Haven, CT USA; [Selim, Magdy] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA; [Rhodes, Andrew] Univ London, St Georges Hosp, Dept Anaesthesia & Intens Care, London, England; [Hawryluk, Gregory] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; University of Toronto; Jagiellonian University; United Arab Emirates University; University of Copenhagen; University of Basel; Fujita Health University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; St Georges University London; University of London; Utah System of Higher Education; University of Utah	Almenawer, SA (corresponding author), Hamilton Hlth Sci, Div Neurosurg, Hamilton, ON L8S 4L8, Canada.; Almenawer, SA (corresponding author), McMaster Univ, Hamilton, ON L8S 4L8, Canada.	almenawers@gmail.com	Rhodes, Andrew/G-4265-2011; Sharma, Sunjay/AAR-7129-2021; Matouk, Charles/AAF-7694-2019; ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; Reddy, Kesava/AAR-8866-2021; Alshamsi, Fayez/AAZ-5713-2021; shoamanesh, ashkan/AHE-1772-2022; Singh, Sheila K/W-2799-2018; Shoamanesh, Ashkan/AAS-4682-2021; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022; Farrokhyar, Forough/AAQ-6005-2021; Nath, Siddharth/O-5872-2018	Rhodes, Andrew/0000-0002-8737-574X; Sharma, Sunjay/0000-0001-7826-9075; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Alshamsi, Fayez/0000-0002-9121-4279; Singh, Sheila K/0000-0003-1272-5300; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Farrokhyar, Forough/0000-0001-9928-9016; Nath, Siddharth/0000-0003-4520-7163; Krag, Mette/0000-0002-5246-8727				Arendt K, 2009, NEUROLOGIST, V15, P17, DOI 10.1097/NRL.0b013e318184f476; Arevalo-Rodriguez I, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010807.pub2; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Birnbach DJ, 2001, HEADACHE, V41, P385, DOI 10.1046/j.1526-4610.2001.111006385.x; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Calthorpe N, 2004, ANAESTHESIA, V59, P1231, DOI 10.1111/j.1365-2044.2004.03976.x; CELLENO D, 1993, REGION ANESTH, V18, P218; Dakka Y, 2011, NEUROLOGY, V77, P71, DOI 10.1212/WNL.0b013e318220abc0; Davis A, 2016, Pract Neurol, V16, P18, DOI 10.1136/practneurol-2014-001055; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engedal TS, 2015, CLIN NEUROL NEUROSUR, V130, P74, DOI 10.1016/j.clineuro.2014.12.020; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; HALPERN S, 1994, ANESTHESIOLOGY, V81, P1376, DOI 10.1097/00000542-199412000-00012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holst D, 1998, ANESTH ANALG, V87, P1331; Lavi R, 2006, NEUROLOGY, V67, P1492, DOI 10.1212/01.wnl.0000240054.40274.8a; Liberati A, 2009, BMJ, V339, pb2700; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Moisset X, 2016, EUR NEUROL, V76, P8, DOI 10.1159/000447452; Nath S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014478; Nguyen DT, 2014, OPEN J ANESTHESIOL, V4, P244, DOI DOI 10.4236/OJANES.2014.410037; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Strupp M, 2001, NEUROLOGY, V57, P2310, DOI 10.1212/WNL.57.12.2310; Tung CE, 2012, NEUROLOGY, V78, P109, DOI 10.1212/WNL.0b013e31823efca9; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0315-7; Xu H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006527; Zhang D, 2016, HEADACHE, V56, P501, DOI 10.1111/head.12745; Zhang YC, 2014, ACAD RADIOL, V21, P612, DOI 10.1016/j.acra.2014.01.021	34	78	82	2	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2018	391	10126					1197	1204		10.1016/S0140-6736(17)32451-0	http://dx.doi.org/10.1016/S0140-6736(17)32451-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA2MF	29223694				2022-12-28	WOS:000428156100031
J	Zannad, F				Zannad, Faiez			Rising incidence of heart failure demands action	LANCET			English	Editorial Material							BURDEN		[Zannad, Faiez] Univ Lorraine, CHRU Nancy, INSERM, Ctr Invest Clin 1433, Nancy, France; [Zannad, Faiez] Univ Lorraine, CHRU Nancy, Inserm U1116, Nancy, France; [Zannad, Faiez] FIGHT HF, Nancy, France; [Zannad, Faiez] F CRIN INI CRCT, Nancy, France	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Zannad, F (corresponding author), Univ Lorraine, CHRU Nancy, INSERM, Ctr Invest Clin 1433, Nancy, France.; Zannad, F (corresponding author), Univ Lorraine, CHRU Nancy, Inserm U1116, Nancy, France.; Zannad, F (corresponding author), FIGHT HF, Nancy, France.; Zannad, F (corresponding author), F CRIN INI CRCT, Nancy, France.	f.zannad@chru-nancy.fr	Zannad, Faiez/K-4649-2019		Janssen; Bayer; Pfizer; Novartis; Boston Scientific; Resmed; Takeda; General Electric; Boehringer Ingelheim; CVRx; AstraZeneca; Amgen; Relypsa; ZS Pharma ZS9; Roche Diagnostics; Vifor Fresenius	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bayer(Bayer AG); Pfizer(Pfizer); Novartis(Novartis); Boston Scientific(Boston Scientific); Resmed; Takeda(Takeda Pharmaceutical Company Ltd); General Electric(General Electric); Boehringer Ingelheim(Boehringer Ingelheim); CVRx; AstraZeneca(AstraZeneca); Amgen(Amgen); Relypsa; ZS Pharma ZS9; Roche Diagnostics; Vifor Fresenius	I have received steering committee fees from Janssen for the COMMANDER-HF trial (co-chair, rivaroxaban in heart failure), Bayer for the ARTS-HF trials (co-chair, finerenone in heart failure), Pfizer (co-chair, eplerenone trials in heart failure), Novartis for the PARAGON trials (member, sacubutril/valsartan in heart failure), Boston Scientific for the NECTAR HF trial (vagal modulation in heart failure), Resmed for the SERVE-HF trial (member, ASV in heart failure and sleep apnoea), Takeda for the EXAMINE trial (member, alogliptin in diabetes), General Electric for the ADMIRE-HF trial (co-chair, MIBG imaging in heart failure), Boehringer Ingelheim for the EMPEROR trial (co-chair, empagliflozin in heart failure), CVRx for the BEAT-HF trial (baroreflex), and AstraZeneca for the AURORA trial (member, rosuvastatin in end-stage renal disease); and consulting fees from Amgen for heart failure pipeline, Quantum Genomics for QG001 in heart failure early development, Relypsa for patiromer for hyperkalaemia, ZS Pharma ZS9 in hyperkalaemia, AstraZeneca for new diabetes medications, Roche Diagnostics for biomarker programme developments, and Vifor Fresenius for patiromer for hyperkalaemia. I am co-founder owning equity of Cardiorenal, a start-up company for home monitoring solutions in heart failure, and founder owning equity of CVCT, a company advising about scientific organisation of meetings.	Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Conrad N, 2017, LANCET; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Farmakis D, 2016, INT J CARDIOL, V203, P279, DOI 10.1016/j.ijcard.2015.10.172; Ferreira JP, 2018, ESC HEART FAIL, V5, P139, DOI 10.1002/ehf2.12218; Fitchett D, 2016, EUR HEART J, V37, P1526, DOI 10.1093/eurheartj/ehv728; Fordyce CB, 2015, J AM COLL CARDIOL, V65, P1567, DOI 10.1016/j.jacc.2015.03.016; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Leong DP, 2017, CIRC RES, V121, P695, DOI 10.1161/CIRCRESAHA.117.311849; Packer M, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004332; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Zannad F, 2017, HEART, V103, P1156, DOI 10.1136/heartjnl-2017-311191	12	40	42	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					518	519		10.1016/S0140-6736(17)32873-8	http://dx.doi.org/10.1016/S0140-6736(17)32873-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV5VB	29174291	hybrid			2022-12-28	WOS:000424649400007
J	Laiteerapong, N; Cooper, JM; Skandari, MR; Clarke, PM; Winn, AN; Naylor, RN; Huang, ES				Laiteerapong, Neda; Cooper, Jennifer M.; Skandari, M. Reza; Clarke, Philip M.; Winn, Aaron N.; Naylor, Rochelle N.; Huang, Elbert S.			Individualized Glycemic Control for U. S. Adults With Type 2 Diabetes A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; LIFETIME HEALTH OUTCOMES; CARDIOVASCULAR OUTCOMES; OLDER PATIENTS; SEVERE HYPOGLYCEMIA; UTILITY VALUES; UNITED-STATES; FOLLOW-UP; RISK; COMPLICATIONS	Background: Intensive glycemic control in type 2 diabetes (glycated hemoglobin [HbA(1c)] level <7%) is an established, costeffective standard of care. However, guidelines recommend individualizing goals on the basis of age, comorbidity, diabetes duration, and complications. Objective: To estimate the cost-effectiveness of individualized control versus uniform intensive control (HbA(1c) level <7%) for the U.S. population with type 2 diabetes. Design: Patient-level Monte Carlo-based Markov model. Data Sources: National Health and Nutrition Examination Survey 2011-2012. Target Population: The approximately 17.3 million persons in the United States with diabetes diagnosed at age 30 years or older. Time Horizon: Lifetime. Perspective: Health care sector. Intervention: Individualized versus uniform intensive glycemic control. Outcome Measures: Average lifetime costs, life-years, and quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Individualized control saved $13 547 per patient compared with uniform intensive control ($105 307 vs. $118 854), primarily due to lower medication costs ($34 521 vs. $48 763). Individualized control decreased life expectancy (20.63 vs. 20.73 years) due to an increase in complications but produced more QALYs (16.68 vs. 16.58) due to fewer hypoglycemic events and fewer medications. Results of Sensitivity Analysis: Individualized control was cost-saving and generated more QALYs compared with uniform intensive control, except in analyses where the disutility associated with receiving diabetes medications was decreased by at least 60%. Limitation: The model did not account for effects of early versus later intensive glycemic control. Conclusion: Health policies and clinical programs that encourage an individualized approach to glycemic control for U.S. adults with type 2 diabetes reduce costs and increase quality of life compared with uniform intensive control. Additional research is needed to confirm the risks and benefits of this strategy.	[Laiteerapong, Neda; Skandari, M. Reza; Naylor, Rochelle N.; Huang, Elbert S.] Univ Chicago, Dept Med, 5841 South Maryland Ave, Chicago, IL 60637 USA; [Clarke, Philip M.] Univ Melbourne, Ctr Hlth Policy, Sch Populat & Global Hlth, Melbourne, Vic 3053, Australia; Univ N Carolina, Chapel Hill, NC USA; [Cooper, Jennifer M.] Northwestern Univ, 633 North St Clair St,Suite 1800, Chicago, IL 60611 USA; [Winn, Aaron N.] Med Coll Wisconsin, Sch Pharm, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	University of Chicago; University of Melbourne; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Medical College of Wisconsin	Laiteerapong, N (corresponding author), Univ Chicago, Dept Med, 5841 South Maryland Ave, Chicago, IL 60637 USA.	nlaiteer@medicine.bsd.uchicago.edu	Laiteerapong, Neda/AAO-2596-2020; Laiteerapong, Neda/ABC-5566-2021	Laiteerapong, Neda/0000-0003-0124-4325; Winn, Aaron/0000-0003-2906-3913	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23 DK092783, K24 DK105340]; NIDDK Chicago Center for Diabetes Translation Research at the University of Chicago [P30 DK092949]; Royster Society of Fellows at the University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK105340, P30DK092949] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK Chicago Center for Diabetes Translation Research at the University of Chicago; Royster Society of Fellows at the University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Laiteerapong was supported by grant K23 DK092783 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Huang is supported by grant K24 DK105340 from the NIDDK. Drs. Laiteerapong and Huang are members of the NIDDK Chicago Center for Diabetes Translation Research at the University of Chicago (P30 DK092949). Dr. Winn was supported by the Royster Society of Fellows at the University of North Carolina at Chapel Hill.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; [Anonymous], 2011, RED BOOK PHARM FUND; Basu A, 2007, MED DECIS MAKING, V27, P112, DOI 10.1177/0272989X06297393; Basu S, 2016, LANCET DIABETES ENDO, V4, P922, DOI 10.1016/S2213-8587(16)30270-4; Beaudet A, 2014, VALUE HEALTH, V17, P462, DOI 10.1016/j.jval.2014.03.003; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; Brown SES, 2008, J AM GERIATR SOC, V56, P1183, DOI 10.1111/j.1532-5415.2008.01757.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chew EY, 2016, DIABETES CARE, V39, P1089, DOI 10.2337/dc16-0024; Chin MH, 2008, MED CARE, V46, P275, DOI 10.1097/MLR.0b013e318158af40; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Edridge CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126427; Elbasha EH, 2016, PHARMACOECONOMICS, V34, P13, DOI 10.1007/s40273-015-0337-0; Fairchild PC, 2017, J GEN INTERN MED, V32, P49, DOI 10.1007/s11606-016-3871-3; Fu AZ, 2008, MED CARE, V46, P984, DOI 10.1097/MLR.0b013e3181791a9c; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Ginde AA, 2008, DIABETES CARE, V31, P511, DOI 10.2337/dc07-1790; Hanmer J, 2010, J CLIN EPIDEMIOL, V63, P331, DOI 10.1016/j.jclinepi.2009.06.013; Hayes AJ, 2013, DIABETOLOGIA, V56, P1925, DOI 10.1007/s00125-013-2940-y; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Laiteerapong N, 2013, DIABETES CARE, V36, P84, DOI 10.2337/dc11-2344; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Lundqvist A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110235; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; McEwan P, 2015, MED DECIS MAKING, V35, P660, DOI 10.1177/0272989X14565821; McEwan P, 2014, VALUE HEALTH, V17, P714, DOI 10.1016/j.jval.2014.07.007; McEwan P, 2015, COST EFFECT RESOUR A, V13, DOI 10.1186/s12962-015-0038-8; McIntosh Brendan, 2011, Open Med, V5, pe35; Mearns ES, 2015, DIABETIC MED, V32, P1530, DOI 10.1111/dme.12837; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Palmer AJ, 2013, VALUE HEALTH, V16, P670, DOI 10.1016/j.jval.2013.01.002; Pathak RD, 2016, DIABETES CARE, V39, P363, DOI 10.2337/dc15-0858; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Ward Alex, 2014, J Med Econ, V17, P176, DOI 10.3111/13696998.2014.882843; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	51	20	22	2	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					170	+		10.7326/M17-0537	http://dx.doi.org/10.7326/M17-0537			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29230472	Green Accepted			2022-12-28	WOS:000424224300005
J	Farquhar, CM; Liu, E; Armstrong, S; Arroll, N; Lensen, S; Brown, J				Farquhar, Cynthia M.; Liu, Emily; Armstrong, Sarah; Arroll, Nicola; Lensen, Sarah; Brown, Julie			Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial	LANCET			English	Article							MALE SUBFERTILITY; COUPLES; PREDICTION; CLOMIPHENE; IUI	Background Women with unexplained infertility are often offered intrauterine insemination (IUI) with ovarian stimulation as an alternative to in-vitro fertilisation (IVF). However, little evidence exists that IUI is an effective treatment. In 2013, the UK National Institute for Health and Care Excellence recommended that IUI should not be routinely offered for couples with unexplained infertility. Methods For this pragmatic, open-label, randomised, controlled, two-centre study, we enrolled women attending two fertility clinics in New Zealand with unexplained infertility and an unfavourable prognosis of natural conception. Participants were randomly assigned (1: 1) using a computer-generated randomisation sequence, prepared by an independent statistician, to either three cycles of IUI with ovarian stimulation (with either oral clomifene citrate [50-150 mg, days 2-6] or oral letrozole [2.5-7.5 mg, days 2-6], with choice of ovarian stimulation made by the clinic) or three cycles of expectant management (couples advised to be sexually active around the likely time of ovulation and provided with a diary to record the first day of each menstrual cycle and dates of sexual activity) in blocks of four, six, and ten, without stratification. The participating couple and the clinicians were informed of treatment allocation. The primary outcome was cumulative livebirth rate in the intention-to-treat population. The safety analyses were done in the intention-to-treat population. This study was prospectively registered with the Australian and New Zealand Clinical Trials Register, number ACTRN12612001025820. Findings Between March 12, 2013, and May 12, 2016, we randomly assigned 101 women to IUI with ovarian stimulation and 100 to expectant management, all of whom were included in the primary efficacy analysis and safety analyses. Women assigned to IUI had a higher cumulative livebirth rate than women assigned to expectant management (31 [31%] livebirths among 101 women vs nine [9%] livebirths among 100 women; risk ratio [RR] 3.41, 95% CI 1.71-6.79; p=0.0003). Of 31 livebirths in the IUI group, 23 resulted from IUI cycles and eight were conceived without assistance before or between IUI cycles. Of nine livebirths in the expectant management group, one patient was pregnant from IUI with ovarian stimulation at study entry and one had received off-protocol treatment (IVF). Two sets of twins were born, both in the IUI group (one from a cancelled cycle for over-response). Interpretation IUI with ovarian stimulation is a safe and effective treatment for women with unexplained infertility and an unfavourable prognosis for natural conception.	[Farquhar, Cynthia M.; Armstrong, Sarah; Arroll, Nicola; Lensen, Sarah; Brown, Julie] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1101, New Zealand; [Farquhar, Cynthia M.; Liu, Emily; Armstrong, Sarah] Auckland Dist Hlth Board, Fertil Plus, Auckland, New Zealand	University of Auckland; Auckland District Health Board	Farquhar, CM (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1101, New Zealand.	c.farquhar@auckland.ac.nz			Auckland Medical Research Foundation; Evelyn Bond Fund of Auckland District Health Board; Mercia Barnes Trust of Royal Australian and New Zealand College of Obstetricians and Gynaecologists; Maurice and Phyllis Paykel Trust; Nurture Foundation for Reproductive Research	Auckland Medical Research Foundation; Evelyn Bond Fund of Auckland District Health Board; Mercia Barnes Trust of Royal Australian and New Zealand College of Obstetricians and Gynaecologists; Maurice and Phyllis Paykel Trust; Nurture Foundation for Reproductive Research	Auckland Medical Research Foundation, Evelyn Bond Fund of Auckland District Health Board, Mercia Barnes Trust of Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Maurice and Phyllis Paykel Trust, and The Nurture Foundation for Reproductive Research.	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Bensdorp AJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7771; Besselink DE, 2008, COCHRANE DB SYST REV, V2; Bhattacharya S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a716; Boomsma CM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004507.pub3; Calhaz-Jorge C, 2016, HUM REPROD, V31, P1638, DOI 10.1093/humrep/dew151; Cantineau AE, 2014, COCHRANE DB SYST REV, V12; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Diamond MP, 2015, NEW ENGL J MED, V373, P1230, DOI 10.1056/NEJMoa1414827; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Hollis S, 1999, BMJ; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; Kim D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007588; Kyrou D, 2010, HUM REPROD, V25, P2501, DOI 10.1093/humrep/deq223; Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218; Macaldowie A, 2016, ASSISTED REPROD TECH; Merviel P, 2010, FERTIL STERIL, V93, P79, DOI 10.1016/j.fertnstert.2008.09.058; Ombelet W, 2014, REPROD BIOMED ONLINE, V28, P300, DOI 10.1016/j.rbmo.2013.10.023; Pennings G, 2007, HUM REPROD, V22, P2075, DOI 10.1093/humrep/dem158; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS111; Reindollar RH, 2010, FERTIL STERIL, V94, P888, DOI 10.1016/j.fertnstert.2009.04.022; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; Tjon-Kon-Fat RI, 2016, HUM REPROD, V31, P2665, DOI 10.1093/humrep/dew241; Tjon-Kon-Fat RI, 2015, HUM REPROD, V30, P2331, DOI 10.1093/humrep/dev193; van Rumste MME, 2008, HUM REPROD UPDATE, V14, P563, DOI 10.1093/humupd/dmn034; Veltman-Verhulst SM, 2012, COCHRANE DB SYST REV, V4; Zegers-Hochschild F, 2006, HUM REPROD, V21, P1968, DOI 10.1093/humrep/del171	28	55	57	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					441	450		10.1016/S0140-6736(17)32406-6	http://dx.doi.org/10.1016/S0140-6736(17)32406-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV1OL	29174128				2022-12-28	WOS:000424333600033
J	Paulino, C; Kalienkova, V; Lam, AKM; Neldner, Y; Dutzler, R				Paulino, Cristina; Kalienkova, Valeria; Lam, Andy K. M.; Neldner, Yvonne; Dutzler, Raimund			Activation mechanism of the calcium-activated chloride channel TMEM16A revealed by cryo-EM	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; INDEPENDENT ACTIVATION; MODEL; PERMEATION; REFINEMENT; EXPRESSION; MICROSCOPY; SCRAMBLASE; PROGRAM; VOLTAGE	The calcium-activated chloride channel TMEM16A is a ligand-gated anion channel that opens in response to an increase in intracellular Ca2+ concentration(1-3). The protein is broadly expressed(4) and contributes to diverse physiological processes, including transepithelial chloride transport and the control of electrical signalling in smooth muscles and certain neurons(5-7). As a member of the TMEM16 (or anoctamin) family of membrane proteins, TMEM16A is closely related to paralogues that function as scramblases, which facilitate the bidirectional movement of lipids across membranes(8-11). The unusual functional diversity of the TMEM16 family and the relationship between two seemingly incompatible transport mechanisms has been the focus of recent investigations. Previous breakthroughs were obtained from the X-ray structure of the lipid scramblase of the fungus Nectria haematococca (nhTMEM16)(12,13), and from the cryo-electron microscopy structure of mouse TMEM16A at 6.6 A (ref. 14). Although the latter structure disclosed the architectural differences that distinguish ion channels from lipid scramblases, its low resolution did not permit a detailed molecular description of the protein or provide any insight into its activation by Ca2+. Here we describe the structures of mouse TMEM16A at high resolution in the presence and absence of Ca2+. These structures reveal the differences between ligand-bound and ligand-free states of a calcium-activated chloride channel, and when combined with functional experiments suggest a mechanism for gating. During activation, the binding of Ca2+ to a site located within the transmembrane domain, in the vicinity of the pore, alters the electrostatic properties of the ion conduction path and triggers a conformational rearrangement of an a-helix that comes into physical contact with the bound ligand, and thereby directly couples ligand binding and pore opening. Our study describes a process that is unique among channel proteins, but one that is presumably general for both functional branches of the TMEM16 family.	[Paulino, Cristina; Kalienkova, Valeria; Lam, Andy K. M.; Neldner, Yvonne; Dutzler, Raimund] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Paulino, Cristina] Univ Groningen, Dept Struct Biol, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands	University of Zurich; University of Groningen	Dutzler, R (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	dutzler@bioc.uzh.ch	Paulino, Cristina/A-2192-2016; Kalienkova, Valeria/A-9863-2019; Kalienkova, Valeriia/AAJ-2736-2020; Paulino, Cristina/ABB-7205-2021	Paulino, Cristina/0000-0001-7017-109X; Kalienkova, Valeria/0000-0002-4143-6172; Kalienkova, Valeriia/0000-0002-4143-6172; Paulino, Cristina/0000-0001-7017-109X; Lam, Andy/0000-0002-2983-3044	European Research Council [339116]; University of Zurich; Maxi foundation	European Research Council(European Research Council (ERC)European Commission); University of Zurich; Maxi foundation	We thank O. Medalia and M. Eibauer, the Center for Microscopy and Image Analysis (ZMB) of the University of Zurich, and the Maxi foundation for support and access to electron microscopes. J. D. Walter is acknowledged for comments on the manuscript and all members of the Dutzler laboratory for help at various stages of the project. This research was supported by a grant from the European Research Council (number 339116, AnoBest). C.P. was supported by a postdoctoral fellowship (Forschungskredit) of the University of Zurich.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Betto G, 2014, J GEN PHYSIOL, V143, P703, DOI 10.1085/jgp.201411182; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Brunner JD, 2016, CURR OPIN STRUC BIOL, V39, P61, DOI 10.1016/j.sbi.2016.05.020; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Contreras JE, 2010, BIOPHYS J, V99, P2863, DOI 10.1016/j.bpj.2010.08.053; Cruz-Rangel S, 2017, J PHYSIOL-LONDON, V595, P1515, DOI 10.1113/JP273111; Cruz-Rangel S, 2015, J PHYSIOL-LONDON, V593, P5283, DOI 10.1113/JP271256; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wood C, 2015, ACTA CRYSTALLOGR D, V71, P123, DOI 10.1107/S1399004714018070; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	53	153	156	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					421	+		10.1038/nature24652	http://dx.doi.org/10.1038/nature24652			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236691	Green Accepted			2022-12-28	WOS:000418559800062
J	Bullman, S; Pedamallu, CS; Sicinska, E; Claney, TE; Zhang, XY; Cai, DN; Neuberg, D; Huang, K; Guevara, F; Nelson, T; Chipashvili, O; Hagan, T; Walker, M; Ramachandran, A; Diosdado, B; Serna, G; Mulet, N; Landolfi, S; Cajal, SRY; Fasani, R; Aguirre, AJ; Ng, K; Elez, E; Ogino, S; Tabernero, J; Fuchs, CS; Hahn, WC; Nuciforo, P; Meyerson, M				Bullman, Susan; Pedamallu, Chandra S.; Sicinska, Ewa; Claney, Thomas E.; Zhang, Xiaoyang; Cai, Diana; Neuberg, Donna; Huang, Katherine; Guevara, Fatima; Nelson, Timothy; Chipashvili, Otari; Hagan, Timothy; Walker, Mark; Ramachandran, Aruna; Diosdado, Begona; Serna, Garazi; Mulet, Nuria; Landolfi, Stefania; Ramon y Cajal, Santiago; Fasani, Roberta; Aguirre, Andrew J.; Ng, Kimmie; Elez, Elena; Ogino, Shuji; Tabernero, Josep; Fuchs, Charles S.; Hahn, William C.; Nuciforo, Paolo; Meyerson, Matthew			Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer	SCIENCE			English	Article							MOLECULAR-FEATURES; NUCLEATUM; COLON; TUMORIGENESIS; CARCINOGENESIS; INFLAMMATION; ASSOCIATION; MICROBIOTA; BINDING; CELLS	Colorectal cancers comprise a complex mixture of malignant cells, nontransformed cells, and microorganisms. Fusobacterium nucleatum is among the most prevalent bacterial species in colorectal cancer tissues. Here we show that colonization of human colorectal cancers with Fusobacterium and its associated microbiome-including Bacteroides, Selenomonas, and Prevotella species-is maintained in distal metastases, demonstrating microbiome stability between paired primary and metastatic tumors. In situ hybridization analysis revealed that Fusobacterium is predominantly associated with cancer cells in the metastatic lesions. Mouse xenografts of human primary colorectal adenocarcinomas were found to retain viable Fusobacterium and its associated microbiome through successive passages. Treatment of mice bearing a colon cancer xenograft with the antibiotic metronidazole reduced Fusobacterium load, cancer cell proliferation, and overall tumor growth. These observations argue for further investigation of antimicrobial interventions as a potential treatment for patients with Fusobacterium-associated colorectal cancer.	[Bullman, Susan; Pedamallu, Chandra S.; Sicinska, Ewa; Zhang, Xiaoyang; Cai, Diana; Neuberg, Donna; Guevara, Fatima; Nelson, Timothy; Chipashvili, Otari; Hagan, Timothy; Ramachandran, Aruna; Diosdado, Begona; Aguirre, Andrew J.; Ng, Kimmie; Ogino, Shuji; Hahn, William C.; Meyerson, Matthew] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bullman, Susan; Pedamallu, Chandra S.; Zhang, Xiaoyang; Cai, Diana; Huang, Katherine; Walker, Mark; Ramachandran, Aruna; Diosdado, Begona; Aguirre, Andrew J.; Hahn, William C.; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Claney, Thomas E.; Aguirre, Andrew J.; Ogino, Shuji; Hahn, William C.; Meyerson, Matthew] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Serna, Garazi; Mulet, Nuria; Landolfi, Stefania; Ramon y Cajal, Santiago; Fasani, Roberta; Elez, Elena; Tabernero, Josep; Nuciforo, Paolo] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, CIBERONC, Barcelona, Spain; [Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Fuchs, Charles S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Meyerson, M (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.; Meyerson, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Meyerson, M (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Ramon y Cajal, Santiago/H-4955-2016; Miquel, Josep Maria/AAG-3508-2019; Nuciforo, Paolo/Q-2885-2019; Élez, Elena/AAH-2945-2019; Tabernero, Josep/AAG-5026-2019; Pedamallu, Chandra Sekhar/AAV-6745-2020; Serna Alonso, Garazi/AGZ-9173-2022; Pedamallu, Chandra Sekhar/AAV-6723-2020	Ramon y Cajal, Santiago/0000-0002-3867-1390; Tabernero, Josep/0000-0002-2495-8139; Elez, Elena/0000-0002-4653-6324; Serna, Garazi/0000-0003-2666-0982; Nelson, Timothy/0000-0001-7784-9211; Neuberg, Donna/0000-0003-2566-3145; Bullman, Susan/0000-0002-7713-0810; Ogino, Shuji/0000-0002-3909-2323; Landolfi, Stefania/0000-0002-1059-635X; Walker, Mark/0000-0001-6613-4560; fasani, roberta/0000-0003-1630-9988; Meyerson, Matthew/0000-0002-9133-8108; Nuciforo, Paolo/0000-0003-1380-0990	NIH [R35 CA197568, R35 CA197735, K07 CA148894, R01 CA118553, R01 CA169141]; Dana-Farber/Harvard Cancer Center GI SPORE P50 grant [CA 127003]; American Cancer Society Research Professorship; Hale Family Center for Pancreatic Cancer; Project P Fund for Colorectal Cancer Research; Stand-up-to Cancer (Colorectal Cancer Dream Team) the Chambers Family Fund for Colorectal Cancer Research; Team Perry Fund; Clark Family Fund for GI Cancer Research; Prevent Cancer Foundation Figdor Family Fellowship; Cellex Private Foundation; Banco Bilbao Vizcaya Argentaria Foundation; Eli Lilly Genentech; Merck; Sanofi; Five Prime Therapeutics; Merrimack Pharmaceuticals; Bayer; Agios Pharmaceuticals; Lair Oncology; KEW Group; National Center for Biotechnology Information (NCBI) [PRINA362951]; NATIONAL CANCER INSTITUTE [R01CA205406, R01CA169141, R35CA197568, K07CA148894, R35CA197735, P50CA127003, R01CA118553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR001102] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center GI SPORE P50 grant; American Cancer Society Research Professorship(American Cancer Society); Hale Family Center for Pancreatic Cancer; Project P Fund for Colorectal Cancer Research; Stand-up-to Cancer (Colorectal Cancer Dream Team) the Chambers Family Fund for Colorectal Cancer Research; Team Perry Fund; Clark Family Fund for GI Cancer Research; Prevent Cancer Foundation Figdor Family Fellowship; Cellex Private Foundation; Banco Bilbao Vizcaya Argentaria Foundation; Eli Lilly Genentech; Merck(Merck & Company); Sanofi(Sanofi-Aventis); Five Prime Therapeutics; Merrimack Pharmaceuticals; Bayer(Bayer AG); Agios Pharmaceuticals; Lair Oncology; KEW Group; National Center for Biotechnology Information (NCBI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIH grants (R35 CA197568 to M.M. R35 CA197735 to S.O., K07 CA148894 to K.N., and R01 CA118553 and R01 CA169141 to C.S.F.) and Dana-Farber/Harvard Cancer Center GI SPORE P50 grant CA 127003 to C.S.F. (this grant also supports S.B., A.J.A., W.C.H., KN., and S.O.). In addition, M.M. is supported by an American Cancer Society Research Professorship; W.C.H. is supported by the Hale Family Center for Pancreatic Cancer; C.S.F. is supported by the Project P Fund for Colorectal Cancer Research, Stand-up-to Cancer (Colorectal Cancer Dream Team) the Chambers Family Fund for Colorectal Cancer Research, the Team Perry Fund and the Clark Family Fund for GI Cancer Research; S.B. is supported by a Prevent Cancer Foundation Figdor Family Fellowship; G.S. N.M. E.E., P.N., and J.T. are supported by the Cellex Private Foundation; and P.N. is supported by the Banco Bilbao Vizcaya Argentaria Foundation. M.M. is on the Scientific Advisory Board of and holds stock in OrigiMed, biotechnology company that provides sequencing information for cancer diagnostics. C.S.F. is on the Board of CytomX Therapeutics, a biotechnology company that is developing therapeutic antibodies for cancer, and is a paid consultant for Eli Lilly Genentech, Merck, Sanofi, Five Prime Therapeutics, Merrimack Pharmaceuticals, Bayer, Agios Pharmaceuticals, Lair Oncology, and KEW Group. M.M. and S.B. are inventors or, U.S. Provisional Patent Application, no. 62/534,672, submitted no the Broad Institute and Dana-Farber Cancer Institute, that covers targeting of Fusobacterium for treatment of colorectal cancer. All raw sequencing data from this study can, be accessed at the National Center for Biotechnology Information (NCBI) under the bioproject PRINA362951. Bacterial whole-genome sequences have been deposited at DNA Data Bank of Japan European Nucleotide Archiye/GenBank, with the following NCBI accession, GenBank assembly accession, and BioSample numbers, respectively: F. necrophorum subsp. funduliforme P1_CP patient P1 primary colorectal tumor (NPNF00000000, GCA_002761995.1, and SAMN07448029), F. necrophorum subsp. funduliforme P1 LM patient PI liver metastasis (NPNE00000000, GCA_002762025.1 and SAMN07448030), F. nucleatum subsp. animalis P2_CP patient P2 primary colorectal tumor (NPND00000000, GA_002762005.1, and SAMN07448031), and F nucleatum subsp. animalis P2 LM patient P2 liver metastasis (NPNC00000000, GCA_002762015.1 and SAMN07448032).	Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen YY, 2017, ONCOTARGET, V8, P31705, DOI 10.18632/oncotarget.15992; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Holt RA, 2017, GASTROENTEROLOGY, V152, P694, DOI 10.1053/j.gastro.2017.01.024; Hope ME, 2005, FEMS MICROBIOL LETT, V244, P1, DOI 10.1016/j.femsle.2005.01.029; Ito M, 2015, INT J CANCER, V137, P1258, DOI 10.1002/ijc.29488; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Li YY, 2016, WORLD J GASTROENTERO, V22, P3227, DOI 10.3748/wjg.v22.i11.3227; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Mima K, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.53; Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Tomkovich S, 2017, CANCER RES, V77, P2620, DOI 10.1158/0008-5472.CAN-16-3472; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018; Yu JH, 2016, INT J CANCER, V139, P1318, DOI 10.1002/ijc.30168; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Yu YN, 2015, ONCOTARGET, V6, P32013, DOI 10.18632/oncotarget.5166	30	605	634	20	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2017	358	6369					1443	+		10.1126/science.aal5240	http://dx.doi.org/10.1126/science.aal5240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP8TH	29170280	Green Accepted			2022-12-28	WOS:000417918500044
J	Skrott, Z; Mistrik, M; Andersen, KK; Friis, S; Majera, D; Gursky, J; Ozdian, T; Bartkova, J; Turi, Z; Moudry, P; Kraus, M; Michalova, M; Vaclavkova, J; Dzubak, P; Vrobel, I; Pouckova, P; Sedlacek, J; Miklovicova, A; Kutt, A; Li, J; Mattova, J; Driessen, C; Dou, QP; Olsen, J; Hajduch, M; Cvek, B; Deshaies, RJ; Bartek, J				Skrott, Zdenek; Mistrik, Martin; Andersen, Klaus Kaae; Friis, Soren; Majera, Dusana; Gursky, Jan; Ozdian, Tomas; Bartkova, Jirina; Turi, Zsofia; Moudry, Pavel; Kraus, Marianne; Michalova, Martina; Vaclavkova, Jana; Dzubak, Petr; Vrobel, Ivo; Pouckova, Pavla; Sedlacek, Jindrich; Miklovicova, Andrea; Kutt, Anne; Li, Jing; Mattova, Jana; Driessen, Christoph; Dou, Q. Ping; Olsen, Jorgen; Hajduch, Marian; Cvek, Boris; Deshaies, Raymond J.; Bartek, Jiri			Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4	NATURE			English	Article							VALOSIN-CONTAINING PROTEIN; BREAST-CANCER; ANTIALCOHOLISM DRUG; PROTEASOME ACTIVITY; POOR-PROGNOSIS; CELL-DEATH; AAA-ATPASE; INHIBITION; EXPRESSION; DEGRADATION	Cancer incidence is rising and this global challenge is further exacerbated by tumour resistance to available medicines. A promising approach to meet the need for improved cancer treatment is drug repurposing. Here we highlight the potential for repurposing disulfiram (also known by the trade name Antabuse), an old alcohol-aversion drug that has been shown to be effective against diverse cancer types in preclinical studies. Our nationwide epidemiological study reveals that patients who continuously used disulfiram have a lower risk of death from cancer compared to those who stopped using the drug at their diagnosis. Moreover, we identify the ditiocarb-copper complex as the metabolite of disulfiram that is responsible for its anti-cancer effects, and provide methods to detect preferential accumulation of the complex in tumours and candidate biomarkers to analyse its effect on cells and tissues. Finally, our functional and biophysical analyses reveal the molecular target of disulfiram's tumour-suppressing effects as NPL4, an adaptor of p97 (also known as VCP) segregase, which is essential for the turnover of proteins involved in multiple regulatory and stress-response pathways in cells.	[Skrott, Zdenek; Mistrik, Martin; Majera, Dusana; Gursky, Jan; Ozdian, Tomas; Turi, Zsofia; Moudry, Pavel; Michalova, Martina; Vaclavkova, Jana; Dzubak, Petr; Vrobel, Ivo; Hajduch, Marian] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Andersen, Klaus Kaae; Friis, Soren; Bartkova, Jirina; Kutt, Anne; Olsen, Jorgen; Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Bartkova, Jirina; Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, Sci Life Lab, Stockholm, Sweden; [Kraus, Marianne; Driessen, Christoph] Kantonsspital St Gallen, Dept Oncol Hematol, St Gallen, Switzerland; [Pouckova, Pavla; Mattova, Jana] Charles Univ Prague, Inst Biophys & Informat, Fac Med 1, Prague 12000 2, Czech Republic; [Sedlacek, Jindrich; Cvek, Boris] Palacky Univ, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Miklovicova, Andrea] Psychiat Hosp, Sternberk 78501, Czech Republic; [Li, Jing; Deshaies, Raymond J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Guangzhou Med Univ, Sch Basic Med Sci, Affiliated Tumor Hosp, Guangzhou 511436, Guangdong, Peoples R China; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Cvek, Boris] Palacky Univ, Olomouc Univ, Social Hlth Inst, Olomouc, Czech Republic; [Deshaies, Raymond J.] Amgen Inc, Thousand Oaks, CA 91320 USA	Palacky University Olomouc; Danish Cancer Society; Karolinska Institutet; Kantonsspital St. Gallen; Charles University Prague; Palacky University Olomouc; California Institute of Technology; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Guangzhou Medical University; California Institute of Technology; Howard Hughes Medical Institute; Palacky University Olomouc; Amgen	Bartek, J (corresponding author), Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark.; Bartek, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, Sci Life Lab, Stockholm, Sweden.; Cvek, B (corresponding author), Palacky Univ, Dept Cell Biol & Genet, Olomouc, Czech Republic.; Deshaies, RJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Deshaies, RJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	cvekb@seznam.cz; deshaies@caltech.edu; jb@cancer.dk	Cvek, Boris/AAT-6420-2021; Humajova, Jana/P-9378-2017; MAJERA, Dusana/U-1079-2019; Hajduch, Marian/J-4015-2014; Dzubak, Petr/D-2175-2013; driessen, christoph/F-7061-2016	Cvek, Boris/0000-0001-8238-3890; Humajova, Jana/0000-0001-8099-6781; Hajduch, Marian/0000-0002-4834-908X; Mistrik, Martin/0000-0002-2321-0348; Vrobel, Ivo/0000-0001-7728-1865; Ozdian, Tomas/0000-0002-5756-6297; Dzubak, Petr/0000-0002-3098-5969; driessen, christoph/0000-0002-1124-7303; Medvedikova, Martina/0000-0002-2382-7997; Skrott, Zdenek/0000-0001-6004-3609	Kellner Family Foundation; Czech National Program of Sustainability; Grant Agency of the Czech Republic; MEYS CR project Czech-BioImaging; Czech Health Research Council; Danish Cancer Society; Danish National Research Foundation (project CARD); Danish Council for Independent Research; Novo Nordisk Foundation; Czech Cancer League; Swedish Research Council; Cancerfonden of Sweden; European Commission (EATRIS); Czech Ministry of Education, youth and sports (OPVKCZ); Cancer Research Czech Republic; Howard Hughes Medical Institute; Lundbeck Foundation [R93-2011-8990] Funding Source: researchfish; The Danish Cancer Society [R124-A7785] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA164803] Funding Source: NIH RePORTER	Kellner Family Foundation; Czech National Program of Sustainability; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MEYS CR project Czech-BioImaging; Czech Health Research Council; Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation (project CARD); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Czech Cancer League; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden of Sweden; European Commission (EATRIS)(European Commission); Czech Ministry of Education, youth and sports (OPVKCZ); Cancer Research Czech Republic; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Lundbeck Foundation(Lundbeckfonden); The Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Skvor, M. Zadinova, J. Vecerka and D. Dolezal for help with animal experiments, Jana Vrbkova for statistical analysis, D. Fridecky and T. Adam for help with HPLC, I. Protivankova and M. Gronvig Nielsen for technical assistance. This work was supported by grants from the Kellner Family Foundation, Czech National Program of Sustainability, Grant Agency of the Czech Republic, MEYS CR project Czech-BioImaging, the Czech Health Research Council, of the Danish Cancer Society, the Danish National Research Foundation (project CARD), the Danish Council for Independent Research, the Novo Nordisk Foundation, the Czech Cancer League, the Swedish Research Council, Cancerfonden of Sweden, the European Commission (EATRIS), the Czech Ministry of Education, youth and sports (OPVKCZ), Cancer Research Czech Republic and the Howard Hughes Medical Institute.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allensworth JL, 2015, MOL ONCOL, V9, P1155, DOI 10.1016/j.molonc.2015.02.007; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; [Anonymous], 2021, LANG ENV STAT COMP; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Auner HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074415; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Collins FS, 2011, NAT REV DRUG DISCOV, V10, P397, DOI 10.1038/nrd3461; Cui Y, 2015, TUMOR BIOL, V36, P9919, DOI 10.1007/s13277-015-3748-9; Cvek B, 2011, CURR CANCER DRUG TAR, V11, P332, DOI 10.2174/156800911794519806; Cvek B, 2008, J MED CHEM, V51, P6256, DOI 10.1021/jm8007807; Cvek B, 2012, DRUG DISCOV TODAY, V17, P409, DOI 10.1016/j.drudis.2011.12.010; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; DUFOUR P, 1993, BIOTHERAPY, V6, P9, DOI 10.1007/BF01877380; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Holdgate Geoffrey, 2013, Methods Mol Biol, V1008, P327, DOI 10.1007/978-1-62703-398-5_12; Iljin K, 2009, CLIN CANCER RES, V15, P6070, DOI 10.1158/1078-0432.CCR-09-1035; Jin M, 2013, ANN ONCOL, V24, P807, DOI 10.1093/annonc/mds508; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lass A, 2008, EXP CELL RES, V314, P2715, DOI 10.1016/j.yexcr.2008.06.008; Li JM, 2014, MOL CELL BIOL, V34, P335, DOI 10.1128/MCB.01190-13; Li Y, 2015, CANCER LETT, V369, P86, DOI 10.1016/j.canlet.2015.07.029; Liu P, 2014, ONCOTARGET, V5, P7471, DOI 10.18632/oncotarget.2166; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lovborg H, 2006, INT J CANCER, V118, P1577, DOI 10.1002/ijc.21534; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nechushtan H, 2015, ONCOLOGIST, V20, P366, DOI 10.1634/theoncologist.2014-0424; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.442; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Riemer A., CELL CYCLE, V13; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Safi R, 2014, CANCER RES, V74, P5819, DOI 10.1158/0008-5472.CAN-13-3527; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shen ML, 2001, BIOCHEM PHARMACOL, V61, P537, DOI 10.1016/S0006-2952(00)00586-4; Soriano GP, 2016, LEUKEMIA, V30, P2198, DOI 10.1038/leu.2016.102; Suzuki Y, 1997, BBA-GEN SUBJECTS, V1335, P242, DOI 10.1016/S0304-4165(97)00027-5; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vorackova I, 2011, PROTEIN EXPRES PURIF, V79, P88, DOI 10.1016/j.pep.2011.04.022; Yamamoto S, 2004, CLIN CANCER RES, V10, P651, DOI 10.1158/1078-0432.CCR-1576-03; Yip NC, 2011, BRIT J CANCER, V104, P1564, DOI 10.1038/bjc.2011.126; Zha J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-163	53	349	363	34	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					194	+		10.1038/nature25016	http://dx.doi.org/10.1038/nature25016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FQ0FK	29211715	Green Accepted			2022-12-28	WOS:000418029500035
J	Collen, M				Collen, Mark			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter							NONSTEROIDAL ANTIINFLAMMATORY DRUGS											Bello AE, 2014, DRUG SAFETY, V37, P897, DOI 10.1007/s40264-014-0207-2; Berenson Alex, 2004, NY TIMES; Collen Mark, 2014, J Pain Palliat Care Pharmacother, V28, P152, DOI 10.3109/15360288.2014.911237; Harirforoosh S, 2013, J PHARM PHARM SCI, V16, P821, DOI 10.18433/J3VW2F; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	5	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					832	833		10.7326/L17-0470	http://dx.doi.org/10.7326/L17-0470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204611				2022-12-28	WOS:000417135900020
J	Voelker, R				Voelker, Rebecca			Treatment for Aggressive Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Voelker, Rebecca] MSJ, Chicago, IL 60601 USA		Voelker, R (corresponding author), MSJ, Chicago, IL 60601 USA.								0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2071	2071		10.1001/jama.2017.18306	http://dx.doi.org/10.1001/jama.2017.18306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209707				2022-12-28	WOS:000417093500005
J	[Anonymous]				[Anonymous]			"Hopefully..." (Reprinted from JAMA vol 202, pg 982, 1967)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1967, JAMA-J AM MED ASSOC, V202, P982	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2145	2145		10.1001/jama.2017.10497	http://dx.doi.org/10.1001/jama.2017.10497			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209710				2022-12-28	WOS:000417093500030
J	Emerson, C; James, S; Littler, K; Randazzo, F				Emerson, Claudia; James, Stephanie; Littler, Katherine; Randazzo, Filippo (Fil)			Principles for gene drive research	SCIENCE			English	Editorial Material									[Emerson, Claudia] McMaster Univ, Inst Eth & Policy Innovat, Hamilton, ON L8S 4L8, Canada; [James, Stephanie] Fdn Natl Inst Hlth, North Bethesda, MD 20852 USA; [Littler, Katherine] Wellcome Trust Res Labs, London NW1 2BE, England; [Randazzo, Filippo (Fil)] Bill & Melinda Gates Fdn, Washington, DC 20005 USA	McMaster University; Bill & Melinda Gates Foundation	James, S (corresponding author), Fdn Natl Inst Hlth, North Bethesda, MD 20852 USA.	sjames@fnih.org			Bill & Melinda Gates Foundation; Open Philanthropy Project; Canadian Institutes of Health Research (CIHR); Commonwealth Scientific and Industrial Research Organization (CSIRO); Foundation for the National Institutes of Health (FNIH); Health Research Council of New Zealand; Indian Council of Medical Research (ICMR); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Pasteur; National Health and Medical Research Council of Australia; Tata Trusts; Wellcome Trust	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Open Philanthropy Project; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Foundation for the National Institutes of Health (FNIH); Health Research Council of New Zealand(Health Research Council of New Zealand); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Tata Trusts; Wellcome Trust(Wellcome TrustEuropean Commission)	Institutions and signatories to the principles for sponsors and supporters of gene drive research (in alphabetical order): Bill & Melinda Gates Foundation, Trevor Mundel; Canadian Institutes of Health Research (CIHR). Paul Lasko: Commonwealth Scientific and Industrial Research Organization (CSIRO), Jack Steele; Foundation for the National Institutes of Health (FNIH). Maria Freire: Fundacao Oswaldo Cruz (Fiocruz). Marco Aurelio Krieger; Health Research Council of New Zealand, Kathryn McPherson; Indian Council of Medical Research (ICMR), Soumya Swaminathan; Institut National de la Sante et de la Recherche Medicale (Inserm), Yves Levy; Institut Pasteur, Christian Brechot; National Health and Medical Research Council of Australia, Anne Kelso: Open Philanthropy Project. Nick Beckstead and Alexander Berger; Tata Trusts, R. Venkataramanan; Wellcome Trust, Jeremy Farrar.	Callaway E., 2016, NAT BIOTECHNOL, DOI [10.1038/nature.2016.21216, DOI 10.1038/NATURE.2016.21216]; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hammond AM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007039; Harvey-Samuel T, 2017, BIOL INVASIONS, V19, P1683, DOI 10.1007/s10530-017-1384-6; Kaebnick GE, 2016, SCIENCE, V354, P710, DOI 10.1126/science.aah5125; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI; Presidential Commission for the Study of Bioethical Issues (PCBE), NEW DIR ETH SYNTH BI; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112; WHO, 2016, WORLD MAL REP 2016	12	42	42	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1135	1136		10.1126/science.aap9026	http://dx.doi.org/10.1126/science.aap9026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191896	Green Published			2022-12-28	WOS:000416584000024
J	Hand, E; McEwen, A				Hand, Eric; McEwen, Alfred			PLANETARY SCIENCE A wet blanket for theories of liquid water on Mars	SCIENCE			English	News Item									[McEwen, Alfred] Univ Arizona, Tucson, AZ 85721 USA	University of Arizona	McEwen, A (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.								0	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1119	1119		10.1126/science.358.6367.1119	http://dx.doi.org/10.1126/science.358.6367.1119			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191887				2022-12-28	WOS:000416584000015
J	Pain, E				Pain, Elisabeth			Being out in STEM	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1214	1214		10.1126/science.358.6367.1214	http://dx.doi.org/10.1126/science.358.6367.1214			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191912				2022-12-28	WOS:000416584000047
J	Bernien, H; Schwartz, S; Keesling, A; Levine, H; Omran, A; Pichler, H; Choi, SW; Zibrov, AS; Endres, M; Greiner, M; Vuletic, V; Lukin, MD				Bernien, Hannes; Schwartz, Sylvain; Keesling, Alexander; Levine, Harry; Omran, Ahmed; Pichler, Hannes; Choi, Soonwon; Zibrov, Alexander S.; Endres, Manuel; Greiner, Markus; Vuletic, Vladan; Lukin, Mikhail D.			Probing many-body dynamics on a 51-atom quantum simulator	NATURE			English	Article							RANGE INTERACTIONS	Controllable, coherent many-body systems can provide insights into the fundamental properties of quantum matter, enable the realization of new quantum phases and could ultimately lead to computational systems that outperform existing computers based on classical approaches. Here we demonstrate a method for creating controlled many-body quantum matter that combines deterministically prepared, reconfigurable arrays of individually trapped cold atoms with strong, coherent interactions enabled by excitation to Rydberg states. We realize a programmable Ising-type quantum spin model with tunable interactions and system sizes of up to 51 qubits. Within this model, we observe phase transitions into spatially ordered states that break various discrete symmetries, verify the high-fidelity preparation of these states and investigate the dynamics across the phase transition in large arrays of atoms. In particular, we observe robust manybody dynamics corresponding to persistent oscillations of the order after a rapid quantum quench that results from a sudden transition across the phase boundary. Our method provides a way of exploring many-body phenomena on a programmable quantum simulator and could enable realizations of new quantum algorithms.	[Bernien, Hannes; Schwartz, Sylvain; Keesling, Alexander; Levine, Harry; Omran, Ahmed; Pichler, Hannes; Choi, Soonwon; Zibrov, Alexander S.; Greiner, Markus; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Schwartz, Sylvain; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Schwartz, Sylvain; Vuletic, Vladan] MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Pichler, Hannes] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys, 60 Garden St, Cambridge, MA 02138 USA; [Endres, Manuel] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology	Greiner, M; Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Vuletic, V (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Vuletic, V (corresponding author), MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	greiner@physics.harvard.edu; vuletic@mit.edu; lukin@fas.harvard.edu	Vuletic, Vladan/M-8736-2019; Omran, Ahmed/AHH-4541-2022; Pichler, Hannes/AAC-9665-2022; Bernien, Hannes/AAM-5598-2020	Omran, Ahmed/0000-0002-2253-0278; Pichler, Hannes/0000-0003-2144-536X; Bernien, Hannes/0000-0002-1950-7368; Levine, Harry/0000-0001-8270-3233	NSF; CUA; ARO; Vannevar Bush Faculty Fellowship; Netherlands Organization for Scientific Research (NWO); German Research Foundation (DFG); European Union under the Marie Sklodowska Curie Individual Fellowship Programme [658253]; National Science Foundation (NSF) through Institute for Theoretical Atomic Molecular and Optical Physics (ITAMP) at Harvard University; Smithsonian Astrophysical Observatory; National Defense Science and Engineering Graduate (NDSEG) Fellowship; Direct For Mathematical & Physical Scien [1506284] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); CUA; ARO; Vannevar Bush Faculty Fellowship; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation (DFG)(German Research Foundation (DFG)); European Union under the Marie Sklodowska Curie Individual Fellowship Programme; National Science Foundation (NSF) through Institute for Theoretical Atomic Molecular and Optical Physics (ITAMP) at Harvard University(National Science Foundation (NSF)); Smithsonian Astrophysical Observatory(Smithsonian InstitutionHarvard-Smithsonian Center for Astrophysics); National Defense Science and Engineering Graduate (NDSEG) Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank E. Demler, A. Chandran, S. Sachdev, A. Vishwanath, P. Zoller, P. Silvi, T. Pohl, M. Knap, M. Fleischhauer, S. Hofferberth and A. Harrow for discussions. This work was supported by NSF, CUA, ARO, and a Vannevar Bush Faculty Fellowship. H.B. acknowledges support by a Rubicon Grant of the Netherlands Organization for Scientific Research (NWO). A.O. acknowledges support by a research fellowship from the German Research Foundation (DFG). S.S. acknowledges funding from the European Union under the Marie Sklodowska Curie Individual Fellowship Programme H2020-MSCA-IF-2014 (project number 658253). H. P. acknowledges support by the National Science Foundation (NSF) through a grant at the Institute for Theoretical Atomic Molecular and Optical Physics (ITAMP) at Harvard University and the Smithsonian Astrophysical Observatory. H.L. acknowledges support by the National Defense Science and Engineering Graduate (NDSEG) Fellowship.	Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Azurenko AM, 2017, NATURE, V545, P462, DOI 10.1038/nature22362; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Baxter R. J., 2007, EXACTLY SOLVED MODEL; Beterov II, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052504; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Chandran A, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.235122; D'Alessio L, 2016, ADV PHYS, V65, P239, DOI 10.1080/00018732.2016.1198134; Daley AJ, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/04/P04005; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Dudin YO, 2012, NAT PHYS, V8, P790, DOI [10.1038/NPHYS2413, 10.1038/nphys2413]; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Farhi E., 2016, PREPRINT; Feiguin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160409; Fendley P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075106; Fox L, 2003, COMPUTATIONAL MODELS, V15, P1; Garttner M, 2017, NAT PHYS, V13, P781, DOI [10.1038/NPHYS4119, 10.1038/nphys4119]; Glaz J, 1999, J STAT PLAN INFER, V82, P251, DOI 10.1016/S0378-3758(99)00047-6; Hall J. L., 1993, LASER MANIPULATION A, P671; HUSE DA, 1984, PHYS REV B, V29, P239, DOI 10.1103/PhysRevB.29.239; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Johansson JR, 2012, COMPUT PHYS COMMUN, V183, P1760, DOI 10.1016/j.cpc.2012.02.021; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13317; Kuhr S, 2016, NATL SCI REV, V3, P170, DOI 10.1093/nsr/nww023; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lechner W, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500838; Lesanovsky I, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.041601; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; McMahon PL, 2016, SCIENCE, V354, P614, DOI 10.1126/science.aah5178; Moessner R, 2011, SPRINGER SER SOLID-S, V164, P437; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Petrosyan D, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/8/084003; Pichler H, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041033; Pohl T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043002; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Richerme P, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012334; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Sachdev S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075128; Sachdev S., 2009, QUANTUM PHASE TRANSI; Saffman M, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/20/202001; Schachenmayer J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103044; Schauss P, 2015, SCIENCE, V347, P1455, DOI 10.1126/science.1258351; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Schiulaz M, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.184202; Schollwock U, 2011, ANN PHYS-NEW YORK, V326, P96, DOI 10.1016/j.aop.2010.09.012; Singer K, 2005, J PHYS B-AT MOL OPT, V38, pS295, DOI 10.1088/0953-4075/38/2/021; Song C, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.180511; Swingle B, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.040302; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Vidal G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040502; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502; Zeiher J., 2017, PREPRINT; Zeiher J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031015; Zurek WH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.105701	62	1066	1070	13	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					579	+		10.1038/nature24622	http://dx.doi.org/10.1038/nature24622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO1KW	29189778	Green Submitted, Green Accepted			2022-12-28	WOS:000416520400033
J	Roth, DE; Leung, M; Mesfin, E; Qamar, H; Watterworth, J; Papp, E				Roth, Daniel E.; Leung, Michael; Mesfin, Elnathan; Qamar, Huma; Watterworth, Jessica; Papp, Eszter			Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MISSING OUTCOME DATA; D DEFICIENCY; METAANALYSIS; CALCIUM; RISK; MASS	OBJECTIVES To estimate the effects of vitamin D supplementation during pregnancy on 11 maternal and 27 neonatal/infant outcomes; to determine frequencies at which trial outcome data were missing, unreported, or inconsistently reported; and to project the potential contributions of registered ongoing or planned trials. DESIGN Systematic review and meta-analysis of randomised controlled trials; systematic review of registered but unpublished trials. DATA SOURCES Medline, Embase, PubMed, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials from inception to September 2017; manual searches of reference lists of systematic reviews identified in the electronic search; and online trial registries for unpublished, ongoing, or planned trials. ELIGIBILITY CRITERIA FOR STUDY SELECTION Trials of prenatal vitamin D supplementation with randomised allocation and control groups administered placebo, no vitamin D, or vitamin D <= 600 IU/day (or its equivalent), and published in a peer reviewed journal. RESULTS 43 trials (8406 participants) were eligible for meta-analyses. Median sample size was 133 participants. Vitamin D increased maternal/cord serum concentration of 25-hydroxyvitamin D, but the dose-response effect was weak. Maternal clinical outcomes were rarely ascertained or reported, but available data did not provide evidence of benefits. Overall, vitamin D increased mean birth weight of 58.33 g (95% confidence interval 18.88 g to 97.78 g; 37 comparisons) and reduced the risk of small for gestational age births (risk ratio 0.60, 95% confidence interval 0.40 to 0.90; seven comparisons), but findings were not robust in sensitivity and subgroup analyses. There was no effect on preterm birth (1.0, 0.77 to 1.30; 15 comparisons). There was strong evidence that prenatal vitamin D reduced the risk of offspring wheeze by age 3 years (0.81, 0.67 to 0.98; two comparisons). For most outcomes, meta-analyses included data from a minority of trials. Only eight of 43 trials (19%) had an overall low risk of bias. Thirty five planned/ongoing randomised controlled trials could contribute 12 530 additional participants to future reviews. CONCLUSIONS Most trials on prenatal vitamin D published by September 2017 were small and of low quality. The evidence to date seems insufficient to guide clinical or policy recommendations. Future trials should be designed and powered to examine clinical endpoints, including maternal conditions related to pregnancy (such as pre-eclampsia), infant growth, and respiratory outcomes.	[Roth, Daniel E.] Hosp Sick Children, Dept Paediat, Toronto, ON, Canada; [Roth, Daniel E.] Univ Toronto, Toronto, ON, Canada; [Roth, Daniel E.; Leung, Michael; Mesfin, Elnathan; Qamar, Huma; Watterworth, Jessica; Papp, Eszter] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Roth, Daniel E.; Leung, Michael; Mesfin, Elnathan; Qamar, Huma; Watterworth, Jessica; Papp, Eszter] Hosp Sick Children, SickKids Res Inst, Toronto, ON, Canada; [Roth, Daniel E.; Qamar, Huma; Watterworth, Jessica] Univ Toronto, Dept Nutr Sci, Fac Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Roth, DE (corresponding author), Hosp Sick Children, Dept Paediat, Toronto, ON, Canada.; Roth, DE (corresponding author), Univ Toronto, Toronto, ON, Canada.; Roth, DE (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.; Roth, DE (corresponding author), Hosp Sick Children, SickKids Res Inst, Toronto, ON, Canada.; Roth, DE (corresponding author), Univ Toronto, Dept Nutr Sci, Fac Med, Toronto, ON, Canada.	daniel.roth@sickkids.ca	Watterworth, Jessica/F-9493-2019	Watterworth, Jessica/0000-0002-6571-1968	Hospital for Sick Children	Hospital for Sick Children	This work was supported by the Hospital for Sick Children through support to DER.	Aghajafari F., 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F1169, 10.1136/bmj.f1169]; Akl EA, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0083-6; Alexander DD, 2016, AM J CLIN NUTR, V103, P683, DOI 10.3945/ajcn.115.130005; Asemi Z, 2013, J NUTR, V143, P1432, DOI 10.3945/jn.113.177550; Bellido T, 2010, J CELL BIOCHEM, V111, P1, DOI 10.1002/jcb.22660; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; Cooper C, 2016, LANCET DIABETES ENDO, V4, P393, DOI 10.1016/S2213-8587(16)00044-9; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Eckhardt CL, 2015, ANN HUM BIOL, V42, P215, DOI 10.3109/03014460.2014.954616; EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789; Finch SL, 2010, J NUTR, V140, P1574, DOI 10.3945/jn.109.113977; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Gagnier JJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-111; Harrington J, 2014, PEDIATR RES, V76, P302, DOI 10.1038/pr.2014.83; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Harvey NC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-13; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210; Ioannidis JPA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h72; Ioannidis JPA, RETRACTION WATCH; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; Mavridis D, 2014, EVID-BASED MENT HEAL, V17, P85, DOI 10.1136/eb-2014-101900; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Munns CF, 2016, HORM RES PAEDIAT, V85, P83, DOI [10.1159/000443136, 10.1210/jc.2015-2175]; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Roth DE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0825-8; Roth DE, 2013, NUTRIENTS, V5, P788, DOI 10.3390/nu5030788; Rummens K, 2002, CALCIFIED TISSUE INT, V71, P364, DOI 10.1007/s00223-001-2125-4; Sablok A, 2015, CLIN ENDOCRINOL, V83, P536, DOI 10.1111/cen.12751; Seamans KM, 2009, AM J CLIN NUTR, V89, p1997S, DOI 10.3945/ajcn.2009.27230D; Thorne-Lyman A, 2012, PAEDIATR PERINAT EP, V26, P75, DOI 10.1111/j.1365-3016.2012.01283.x; Vahdaninia M, 2017, J ALLER CL IMM-PRACT, V5, P771, DOI 10.1016/j.jaip.2016.09.024; WHO, 2022, WHO RECOMMENDATIONS; Zhang RH, 2017, AM J CLIN NUTR, V105, P810, DOI 10.3945/ajcn.116.140392	46	133	135	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2017	359								j5237	10.1136/bmj.j5237	http://dx.doi.org/10.1136/bmj.j5237			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MJ	29187358	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000417211300001
J	Day, JO; Bhatt, P				Day, Jacob O.; Bhatt, Pragnesh			A man with paraesthesia, headache, and vertigo	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Day, Jacob O.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Bhatt, Pragnesh] Aberdeen Royal Infirm, Aberdeen, Scotland	University of Exeter; University of Aberdeen	Day, JO (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England.	jacobday@doctors.org.uk		Day, Jacob/0000-0002-6020-510X				Arnautovic A, 2015, J NEUROSURG-PEDIATR, V15, P161, DOI 10.3171/2014.10.PEDS14295; Doberstein Cody A, 2017, R I Med J (2013), V100, P47; Mueller Diane M, 2004, J Am Acad Nurse Pract, V16, P134; NEWMAN PK, 1981, J NEUROL NEUROSUR PS, V44, P964, DOI 10.1136/jnnp.44.11.964	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2017	359								j5165	10.1136/bmj.j5165	http://dx.doi.org/10.1136/bmj.j5165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WG	29170263				2022-12-28	WOS:000416472900004
J	Marques, ETA; Burke, DS				Marques, Ernesto T. A.; Burke, Donald S.			Tradition and innovation in development of a Zika vaccine	LANCET			English	Editorial Material							VIRUS		[Marques, Ernesto T. A.; Burke, Donald S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Marques, Ernesto T. A.; Burke, Donald S.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Marques, Ernesto T. A.] FIOCRUZ Pernambuco, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz	Marques, ETA (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.; Marques, ETA (corresponding author), FIOCRUZ Pernambuco, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.	marques@pitt.edu	Marques, Ernesto T. A/L-4967-2013	Marques, Ernesto T. A/0000-0003-3826-9358				[Anonymous], 2017, LANCET INFECT DIS, V17, P1003, DOI 10.1016/S1473-3099(17)30534-0; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693; Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9; PARDOLL DM, 1995, IMMUNITY, V3, P165, DOI 10.1016/1074-7613(95)90085-3; Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079; Salk JE, 1955, AM J PUBLIC HEALTH N, V45, P151, DOI 10.2105/AJPH.45.2.151; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36	12	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					516	517		10.1016/S0140-6736(17)33107-0	http://dx.doi.org/10.1016/S0140-6736(17)33107-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV5VB	29217377	Bronze			2022-12-28	WOS:000424649400006
J	Li, X; Lu, JP; Hu, S; Cheng, KK; De Maeseneer, J; Meng, QY; Mossialos, E; Xu, DR; Yip, W; Zhang, HZ; Krumholz, HM; Jiang, LX; Hu, SS				Li, Xi; Lu, Jiapeng; Hu, Shuang; Cheng, K. K.; De Maeseneer, Jan; Meng, Qingyue; Mossialos, Elias; Xu, Dong Roman; Yip, Winnie; Zhang, Hongzhao; Krumholz, Harlan M.; Jiang, Lixin; Hu, Shengshou			The primary health-care system in China	LANCET			English	Review							RATIONAL DRUG-USE; JOB-SATISFACTION; VILLAGE DOCTORS; HUBEI PROVINCE; WESTERN CHINA; URBAN CHINA; RURAL CHINA; REFORM; QUALITY; FACILITIES	China has made remarkable progress in strengthening its primary health-care system. Nevertheless, the system still faces challenges in structural characteristics, incentives and policies, and quality of care, all of which diminish its preparedness to care for a fifth of the world's population, which is ageing and which has a growing prevalence of chronic non-communicable disease. These challenges include inadequate education and qualifications of its workforce, ageing and turnover of village doctors, fragmented health information technology systems, a paucity of digital data on everyday clinical practice, financial subsidies and incentives that do not encourage cost savings and good performance, insurance policies that hamper the efficiency of care delivery, an insufficient quality measurement and improvement system, and poor performance in the control of risk factors (such as hypertension and diabetes). As China deepens its health-care reform, it has the opportunity to build an integrated, cooperative primary health-care system, generating knowledge from practice that can support improvements, and bolstered by evidence-based performance indicators and incentives.	[Li, Xi; Lu, Jiapeng; Hu, Shuang; Zhang, Hongzhao; Jiang, Lixin; Hu, Shengshou] Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China; [Li, Xi; Lu, Jiapeng; Hu, Shuang; Zhang, Hongzhao; Jiang, Lixin; Hu, Shengshou] Peking Union Med Coll, Beijing 100037, Peoples R China; [Cheng, K. K.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Cheng, K. K.] Peking Univ, Hlth Sci Ctr, Gen Practice Dev & Res Ctr, Beijing, Peoples R China; [Meng, Qingyue] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing, Peoples R China; [De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, Ghent, Belgium; [Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Xu, Dong Roman] Sun Yat Sen Univ, Sch Publ Hlth, Sun Yat Sen Global Hlth Inst, Guangzhou, Guangdong, Peoples R China; [Yip, Winnie] Harvard T H Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Birmingham; Peking University; Peking University; Ghent University; University of London; London School Economics & Political Science; Sun Yat Sen University; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Yale University	Hu, SS (corresponding author), Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.; Hu, SS (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	huss@fuwaihospital.org	Cheng, Kar/AAL-8899-2021; Xu, Dong/Z-1502-2019; , Harlan/AAI-2875-2020; Mossialos, Elias/ABE-1301-2021	Cheng, Kar/0000-0002-1516-1857; Xu, Dong/0000-0001-7438-632X; Li, Xi/0000-0003-2249-688X	Chinese Academy of Medical Sciences Innovation Fund for Medical Science [2017-I2M-1-003, 2017-I2M-2-002, 2016-12M-2-004, 2016-12M-1-006]; China National Development and Reform Commission of China; Ministry of Finance; National Health and Family Planning Commission of China; China-WHO Biennial Collaborative Projects [2016/664424-0]; Ministry of Science and Technology of China [2015BAI12B01, 2015BAI12B02]; National Health and Family Planning Commission of China [201502009]; Ministry of Education of China [B16005]; Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities [2017330003]	Chinese Academy of Medical Sciences Innovation Fund for Medical Science; China National Development and Reform Commission of China; Ministry of Finance; National Health and Family Planning Commission of China; China-WHO Biennial Collaborative Projects; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Health and Family Planning Commission of China; Ministry of Education of China(Ministry of Education, China); Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank the multiple contributions made by study teams at the National Center for Cardiovascular Diseases, and all the local sites in the collaborative network in the realms of study design and operations, particularly data collection by Meng Su, Na Tian, Yaping Cao, Chongxin Chen, Jianlan Cui, Xin Sun, Wei Xu, and Bo Gu. We thank Sir Richard Peto (University of Oxford), George Mensah (National Institutes of Health), and Qiuli Zhang (University of Edinburgh) for their support in study design. We thank Yun Wang (Harvard T H Chan School of Public Health), Sebastian Salas-Vega and Anwen Zhang (London School of Economics and Political Science), and Weiyan Jian and Xi Yao (Peking University Health Science Center) for their support in data cleaning and analysis. We thank BeiBei Yuan, Dan Wang, and Huiwen Li (Peking University Health Science Center) and Xinghe Huang (National Center for Cardiovascular Diseases), who searched the published work, extracted data, and summarised findings. We thank Steven DeMaio, Pranammya Dey, and Khurram Nasir for their advice and editing. This project was partly supported by the Chinese Academy of Medical Sciences Innovation Fund for Medical Science (2017-I2M-1-003, 2017-I2M-2-002, 2016-12M-2-004, 2016-12M-1-006), the Entrusted Project from the China National Development and Reform Commission of China, the Major Public Health Service Project from the Ministry of Finance and National Health and Family Planning Commission of China, the China-WHO Biennial Collaborative Projects 2016-2017 (2016/664424-0), the National Key Technology R&D Program (2015BAI12B01, 2015BAI12B02) from the Ministry of Science and Technology of China, the Research Special Fund for Public Welfare Industry of Health (201502009) from the National Health and Family Planning Commission of China, the 111 Project from the Ministry of Education of China (B16005), and the Peking Union Medical College Youth Fund and the Fundamental Research Funds for the Central Universities (2017330003). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Alabousi M, 2017, CAN J CARDIOL, V33, P393, DOI 10.1016/j.cjca.2016.07.005; ALDERSON MR, 1967, BRIT J PREV SOC MED, V21, P1; Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; [Anonymous], 2017, LANCET, V389, P226, DOI 10.1016/S0140-6736(17)30134-4; [Anonymous], 1978, LANCET, V2, P1040; [Anonymous], EC RES REF; [Anonymous], CHIN HLTH EC; Barber SL, 2011, INT J HEALTH PLAN M, V26, P339, DOI 10.1002/hpm.1109; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cao Y, 2012, CHIN HLTH EC, V11, P54; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; China Food and Drug Administration, 2012, COMM IMPL TRAD CHIN; China national health development research center, 2015, RES HEALTHC REF; China Union Medical Press, 2017, CHIN HLTH FAM PLANN; CPC Central Committee State Council., 2016, PLAN HLTH CHIN 2030; Cui WY, 2008, B WORLD HEALTH ORGAN, V86, P914, DOI 10.2471/BLT.08.021208; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073438; [丁洁卫 Ding Jiewei], 2010, [中国药房, China Pharmacy], V21, P1913; Dong LF, 2011, FAM PRACT, V28, P63, DOI 10.1093/fampra/cmq077; Duckett J., 2012, CHINESE STATES RETRE; Fang PQ, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0084-4; Ge CX, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-884; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gong YH, 2016, HEALTH POLICY PLANN, V31, P21, DOI 10.1093/heapol/czv008; Hu J, 2016, HEALTH POLICY, V120, P519, DOI 10.1016/j.healthpol.2016.03.014; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; [黄玉珊 Huang Yushan], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P293; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Jia H, 2015, CHIN HLTH SERV MANAG, V7, P525; Jiang Q, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-324; Kringos DS, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-81; Kuang L, 2015, FAM PRACT, V32, P557, DOI 10.1093/fampra/cmv064; Li JH, 2016, INT J QUAL HEALTH C, V28, P346, DOI 10.1093/intqhc/mzw038; Li Y, 2015, THEORY PRACTICE ED, P13; Li ZJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S9; [刘彩玲 Liu Cailing], 2014, [中国全科医学, Chinese General Practice], V17, P2561; Liu CX, 2015, J EVAL CLIN PRACT, V21, P597, DOI 10.1111/jep.12343; Liu L, 2009, CHINESE HLTH EC, V4, P45; Lu J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010200corr1; Lu J, 2017, LANCET; [罗艳 Luo Yan], 2013, [中国全科医学, Chinese General Practice], V16, P377; Luo ZN, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-77; McCollum R, 2014, INT J HEALTH PLAN M, V29, pE107, DOI 10.1002/hpm.2165; MEE (China), 2007, NAT POLL ENV HLTH RI, V1st; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Meng QY, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-24; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Finance of the People's Republic of China, 2014, MAN SUBS IMPL NAT ES; Ministry of Health, 2015, REG MAN NAT ESS DRUG; Ministry of Health, 2012, NAT ESS DRUG LIST VE; Ministry of Health National Development and Reform Commission Ministry of Industry and Information Technology, 2009, OP EST NAT ESS DRUG; Ministry of health of the people's republic of China, 2010, CHIN HLTH STAT YB 20; Ministry of Health of the People's Republic of China, 2002, CHIN NUTR HLTH SURV; Ministry of Health of the People's Republic of China, 2011, CHIN PUBL HLTH STAT; Ministry of Health Treasury Department State Administration of Traditional Chinese Medicine, 2016, ANN NAT BAS PUBL HLT; National Bureau of Statistics of China, 2017, CHIN STAT YB 2016; National Health and Family Planning Commission of the People's Republic of China, 2017, 2017 CHIN HLTH FAM P; Ouyang T, 2010, THESIS, P17; Policy Research Department of Ministry of Health, 1983, HLTH NEWS; Qi J, 2012, THESIS, P15; Shi LY, 2014, PRIM HEALTH CARE RES, V15, P46, DOI 10.1017/S1463423612000692; Song K, 2014, THESIS, P63; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; State Council of the People's Republic of China, 2009, OP DEEP HLTH CAR REF; State Council of the People's Republic of China, 2016, OP INT BAS HLTH INS; State Council of the People's Republic of China, 2013, OP CONS IMPR ESS DRU; Su M, 2017, LANCET; Sylvia S, 2015, HEALTH POLICY PLANN, V30, P322, DOI 10.1093/heapol/czu014; Tang SF, 2015, INT J ENV RES PUB HE, V12, P11579, DOI 10.3390/ijerph120911579; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tang Shu-nv, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P445; Tian L, 2015, THESIS, P38; Wagstaff A, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7982-0; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Wang R., 2014, THESIS YUNNAN U KUNM, P11; World Health Organization, 2006, US IND MEAS COUNTR P; Wu D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006431; Wu R, 2014, THESIS, P2; Xiao YH, 2016, INT J ANTIMICROB AG, V48, P409, DOI 10.1016/j.ijantimicag.2016.06.017; Xu L, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1970-z; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yang Z, 2014, THESIS, P4; Yao Q, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0186-7; [姚卫光 YAO Weiguang], 2011, [中国全科医学, Chinese General Practice], V14, P1779; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Yin X, 2015, MED CARE, V53, P888, DOI 10.1097/MLR.0000000000000414; Yin XX, 2013, J ANTIMICROB CHEMOTH, V68, P2445, DOI 10.1093/jac/dkt223; Ying G, 2010, CHIN HLTH SERV MANAG, V10, P665; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip W, 2014, HEALTH AFFAIR, V33, P502, DOI 10.1377/hlthaff.2013.0702; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0; Zhang H, 2015, CHIN HLTH SERV MANAG, V5, P370; Zhang H Y, 2016, Beijing Da Xue Xue Bao Yi Xue Ban, V48, P472; [张凯 Zhang Kai], 2010, [中国全科医学, Chinese General Practice], V13, P3837; Zhang L, 2012, CHIN HLTH EC, V10, P54; Zhang MJ, 2016, INT J QUAL HEALTH C, V28, P14, DOI 10.1093/intqhc/mzv111; [张培芳 Zhang Peifang], 2014, [中国全科医学, Chinese General Practice], V17, P2579; Zhang XP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0492-6; Zhang XY, 2016, AUST HEALTH REV, V40, P225, DOI 10.1071/AH15205; Zhang Y, 2013, CHIN GEN PRACT; Zhang Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0649-3; [张越 Zhang Yue], 2016, [中国全科医学, Chinese General Practice], V19, P766; Zhao W, 2012, CHIN HLTH EC, V12, P60; Zhou XD, 2014, SOC SCI MED, V117, P134, DOI 10.1016/j.socscimed.2014.07.040; Zhu JJ, 2012, TECTONOPHYSICS, V554, P18, DOI 10.1016/j.tecto.2012.05.027	109	399	411	72	442	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2584	2594		10.1016/S0140-6736(17)33109-4	http://dx.doi.org/10.1016/S0140-6736(17)33109-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29231837	Green Submitted			2022-12-28	WOS:000417493300027
J	Duffy, DM				Duffy, Dorothy M.			Coherent nanoparticles in calcite A toughening strategy known to metallurgists is also used by the brittlestar	SCIENCE			English	Editorial Material							ALUMINUM-COPPER ALLOYS; MOTHER; PEARL		[Duffy, Dorothy M.] UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England; [Duffy, Dorothy M.] UCL, London Ctr Nanotechnol, Gower St, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Duffy, DM (corresponding author), UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England.; Duffy, DM (corresponding author), UCL, London Ctr Nanotechnol, Gower St, London WC1E 6BT, England.	d.duffy@ucl.ac.uk	duffy, dorothy M/C-1570-2008					Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Guinier A, 1938, NATURE, V142, P569, DOI 10.1038/142569b0; Polishchuk I, 2017, SCIENCE, V358, P1294, DOI 10.1126/science.aaj2156; Preston GD, 1938, PROC R SOC LON SER-A, V167, P0526, DOI 10.1098/rspa.1938.0152; Ringer SP, 2000, MATER CHARACT, V44, P101, DOI 10.1016/S1044-5803(99)00051-0; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	9	9	10	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1254	1255		10.1126/science.aaq0111	http://dx.doi.org/10.1126/science.aaq0111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217556				2022-12-28	WOS:000417254700038
J	Kelly, NP; Gerhard-Herman, M; Desai, AS; Miller, AL; Loscalzo, J				Kelly, Noreen P.; Gerhard-Herman, Marie; Desai, Akshay S.; Miller, Amy L.; Loscalzo, Joseph			An Unusual Cause of Leg Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GIANT-CELL ARTERITIS; POLYMYALGIA-RHEUMATICA; MANAGEMENT		[Miller, Amy L.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021; Desai, Akshay/ABE-7250-2020		Novartis; Abbott; Relypsa; AstraZeneca; DalCor Pharmaceuticals; Janssen	Novartis(Novartis); Abbott(Abbott Laboratories); Relypsa; AstraZeneca(AstraZeneca); DalCor Pharmaceuticals; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Desai reports receiving a grant from Novartis and consulting fees from Novartis, Abbott, Relypsa, AstraZeneca, DalCor Pharmaceuticals, and Janssen. No other potential conflict of interest relevant to this article was reported.	ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Buttgereit F, 2016, JAMA-J AM MED ASSOC, V315, P2442, DOI 10.1001/jama.2016.5444; Chatterjee S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0498-z; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE686, DOI 10.1161/CIR.0000000000000470; Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Stone JH, 2017, NEW ENGL J MED, V377, P317, DOI 10.1056/NEJMoa1613849; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]	8	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2267	2272		10.1056/NEJMcps1703534	http://dx.doi.org/10.1056/NEJMcps1703534			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211675				2022-12-28	WOS:000417201100011
J	Zliobaite, I; Fortelius, M; Stenseth, NC				Zliobaite, Indre; Fortelius, Mikael; Stenseth, Nils C.			Reconciling taxon senescence with the Red Queen's hypothesis	NATURE			English	Article							PREDICTING EXTINCTION; MASS EXTINCTIONS; MAMMALS; OCCUPANCY; EVOLUTION; MACROEVOLUTIONARY; ECOSYSTEMS; PHYLOGENY; CLIMATE; MODELS	In the fossil record, taxa exhibit a regular pattern of waxing and waning of occupancy, range or diversity between their origin and extinction. This pattern appears to contradict the law of constant extinction(1), which states that the probability of extinction in a given taxon is independent of that taxon's age. It is nevertheless well established for species, genera and higher taxa of terrestrial mammals(2-4), marine invertebrates(5-7), marine microorganisms(8), and recent Hawaiian clades of animals and plants(9). Here we show that the apparent contradiction between a stochastically constant extinction rate and the seemingly deterministic waxing and waning pattern of taxa disappears when we consider their peak of expansion rather than their final extinction. To a first approximation, we find that biotic drivers of evolution pertain mainly to the peak of taxon expansion, whereas abiotic drivers mainly apply to taxon extinction. The Red Queen's hypothesis(1), which emphasizes biotic interactions, was originally proposed as an explanation of the law of constant extinction. Much effort has since been devoted to determining how this hypothesis, emphasizing competition for resources, relates to the effects of environmental change. One proposed resolution is that biotic and abiotic processes operate at different scales(10). By focusing attention on taxon expansion rather than survival, we resolve an apparent contradiction between the seemingly deterministic waxing and waning patterns over time and the randomness of extinction that the Red Queen's hypothesis implies.	[Zliobaite, Indre; Fortelius, Mikael] Univ Helsinki, Dept Geosci & Geog, POB 64, FI-00014 Helsinki, Finland; [Zliobaite, Indre; Fortelius, Mikael; Stenseth, Nils C.] Univ Oslo, Ctr Ecol & Evolutionary Synth CEES, Dept Biosci, POB 1066 Blindern, NO-0316 Oslo, Norway; [Zliobaite, Indre] Univ Helsinki, Dept Comp Sci, POB 64, FI-00014 Helsinki, Finland	University of Helsinki; University of Oslo; University of Helsinki	Zliobaite, I (corresponding author), Univ Helsinki, Dept Geosci & Geog, POB 64, FI-00014 Helsinki, Finland.; Zliobaite, I (corresponding author), Univ Oslo, Ctr Ecol & Evolutionary Synth CEES, Dept Biosci, POB 1066 Blindern, NO-0316 Oslo, Norway.; Zliobaite, I (corresponding author), Univ Helsinki, Dept Comp Sci, POB 64, FI-00014 Helsinki, Finland.	indre.zliobaite@heslinki.fi		Fortelius, Mikael/0000-0002-4851-783X; Zliobaite, Indre/0000-0003-2427-5407	Finnish Academy (ECHOES project); Alexander von Humboldt Foundation; Research Council of Norway via CEES	Finnish Academy (ECHOES project); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Research Council of Norway via CEES(Research Council of Norway)	I.Z. and M.F. acknowledge funding from the Finnish Academy (ECHOES project). M.F. was the recipient of a research award from the Alexander von Humboldt Foundation. N.C.S. has been funded by the Research Council of Norway via CEES. We thank H. Mannila for seminal explorations of the law as well as members of the Bjorn Kurten Club (University of Helsinki) and participants of the workshops on 'Biotic Drivers of Macroevolution' organized by CEES (Colloquium 4) for discussions on macroevolution. This Letter is a contribution from the Valio Armas Korvenkontio Unit of Dental Anatomy in Relation to Evolutionary Theory. We miss L. Van Valen and are grateful for the discussions we had with him over many years.	[Anonymous], 1861, ORIGIN SPECIES MEANS; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Carotenuto F, 2010, PALEOBIOLOGY, V36, P399, DOI 10.1666/09059.1; Cornette JL, 2004, P NATL ACAD SCI USA, V101, P187, DOI 10.1073/pnas.2637009100; Eldredge N., 1972, P82; Eronen JT, 2010, EVOL ECOL RES, V12, P217; Eronen JT, 2011, EVOLUTION, V65, P1514, DOI 10.1111/j.1558-5646.2011.01220.x; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Foote M, 2007, SCIENCE, V318, P1131, DOI 10.1126/science.1146303; Fortelius M, 2002, EVOL ECOL RES, V4, P1005; Fortelius M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0232; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Hannisdal B., P R SOC LOND B, V284; Hull PM, 2015, NATURE, V528, P345, DOI 10.1038/nature16160; Jernvall J, 2004, AM NAT, V164, P614, DOI 10.1086/424967; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; Lim JY, 2017, NATURE, V543, P710, DOI 10.1038/nature21675; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; Liu LP, 2012, P ROY SOC B-BIOL SCI, V279, P2793, DOI 10.1098/rspb.2012.0211; Marshall CR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0165; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Pigot AL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001260; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Quental TB, 2013, SCIENCE, V341, P290, DOI 10.1126/science.1239431; Raia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep30965; Rannikko J, 2017, PALAEOGEOGR PALAEOCL, V487, P187, DOI 10.1016/j.palaeo.2017.08.033; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sepkoski D., 2012, REREADING FOSSIL REC, P77; Shanahan T, 2011, STUD HIST PHI PART C, V42, P60, DOI 10.1016/j.shpsc.2010.11.013; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Steininger F. F, 1996, EVOLUTION W EURASIAN, P7; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Tietje M, 2013, J BIOGEOGR, V40, P790, DOI 10.1111/jbi.12030; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Van valen L, 1976, EVOL THEORY, V1, P179; van Valen L.M., 1980, Evolutionary Theory, V4, P289; Vermeij GJ, 2013, PALEOBIOLOGY, V39, P560, DOI 10.1666/13009; Voje KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0186; Zliobaite I, 2016, P NATL ACAD SCI USA, V113, P12751, DOI 10.1073/pnas.1609409113	42	39	40	7	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2017	552	7683					92	+		10.1038/nature24656	http://dx.doi.org/10.1038/nature24656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP4BA	29186124	Green Submitted			2022-12-28	WOS:000417560500049
J	Olson, OC; Quail, DF; Joyce, JA				Olson, Oakley C.; Quail, Daniela F.; Joyce, Johanna A.			Obesity and the tumor microenvironment	SCIENCE			English	Editorial Material							CANCER PROGRESSION; INFLAMMATION; DIET; MICE		[Olson, Oakley C.; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Quail, Daniela F.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ, Canada	Ludwig Institute for Cancer Research; University of Lausanne; McGill University	Quail, DF (corresponding author), McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ, Canada.	daniela.quail@mcgill.ca; johanna@joycelab.org		Olson, Oakley/0000-0002-0716-5380				Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467; Bordonaro M, 2015, J CANCER, V6, P825, DOI 10.7150/jca.12352; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Incio J, 2016, CANCER DISCOV, V6, P852, DOI 10.1158/2159-8290.CD-15-1177; Kolb R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13007; Laurent V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10230; Li RF, 2014, CELL METAB, V19, P702, DOI 10.1016/j.cmet.2014.03.012; Mirsoian A, 2014, J EXP MED, V211, P2373, DOI 10.1084/jem.20140116; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Seo BR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010467; Stefan N, 2017, CELL METAB, V26, P292, DOI 10.1016/j.cmet.2017.07.008	15	45	47	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1130	1131		10.1126/science.aao5801	http://dx.doi.org/10.1126/science.aao5801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191893				2022-12-28	WOS:000416584000021
J	Goadsby, PJ; Reuter, U; Hallstrom, Y; Broessner, G; Bonner, JH; Zhang, F; Sapra, S; Picard, H; Mikol, DD; Lenz, RA				Goadsby, Peter J.; Reuter, Uwe; Hallstrom, Yngve; Broessner, Gregor; Bonner, Jo H.; Zhang, Feng; Sapra, Sandhya; Picard, Hernan; Mikol, Daniel D.; Lenz, Robert A.			A Controlled Trial of Erenumab for Episodic Migraine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE-RELATED PEPTIDE; DOUBLE-BLIND; PREVENTION; SAFETY; CGRP; PREVALENCE; ANTAGONIST; EFFICACY; PHASE-2; HUMANS	BACKGROUND We tested erenumab, a fully human monoclonal antibody that inhibits the calcitonin gene-related peptide receptor, for the prevention of episodic migraine. METHODS We randomly assigned patients to receive a subcutaneous injection of either erenumab, at a dose of 70 mg or 140 mg, or placebo monthly for 6 months. The primary end point was the change from baseline to months 4 through 6 in the mean number of migraine days per month. Secondary end points were a 50% or greater reduction in mean migraine days per month, change in the number of days of use of acute migraine-specific medication, and change in scores on the physical-impairment and everyday-activities domains of the Migraine Physical Function Impact Diary (scale transformed to 0 to 100, with higher scores representing greater migraine burden on functioning). RESULTS A total of 955 patients underwent randomization: 317 were assigned to the 70-mg erenumab group, 319 to the 140-mg erenumab group, and 319 to the placebo group. The mean number of migraine days per month at baseline was 8.3 in the overall population; by months 4 through 6, the number of days was reduced by 3.2 in the 70-mg erenumab group and by 3.7 in the 140-mg erenumab group, as compared with 1.8 days in the placebo group (P<0.001 for each dose vs. placebo). A 50% or greater reduction in the mean number of migraine days per month was achieved for 43.3% of patients in the 70-mg erenumab group and 50.0% of patients in the 140-mg erenumab group, as compared with 26.6% in the placebo group (P<0.001 for each dose vs. placebo), and the number of days of use of acute migraine-specific medication was reduced by 1.1 days in the 70-mg erenumab group and by 1.6 days in the 140-mg erenumab group, as compared with 0.2 days in the placebo group (P<0.001 for each dose vs. placebo). Physical-impairment scores improved by 4.2 and 4.8 points in the 70-mg and 140-mg erenumab groups, respectively, as compared with 2.4 points in the placebo group (P<0.001 for each dose vs. placebo), and everyday-activities scores improved by 5.5 and 5.9 points in the 70-mg and 140-mg erenumab groups, respectively, as compared with 3.3 points in the placebo group (P<0.001 for each dose vs. placebo). The rates of adverse events were similar between erenumab and placebo. CONCLUSIONS Erenumab administered subcutaneously at a monthly dose of 70 mg or 140 mg significantly reduced migraine frequency, the effects of migraines on daily activities, and the use of acute migraine-specific medication over a period of 6 months. The long-term safety and durability of the effect of erenumab require further study.	[Goadsby, Peter J.] Kings Coll Hosp London, Wellcome Trust Kings Clin Res Facil, Natl Inst Hlth Res, London, England; [Reuter, Uwe] Charite, Dept Neurol, Berlin, Germany; [Hallstrom, Yngve] St Goran Hosp, Neuro Ctr, Stockholm, Sweden; [Broessner, Gregor] Med Univ Innsbruck, Dept Neurol, Headache Outpatient Clin, Innsbruck, Austria; [Bonner, Jo H.] Mercy Res, St Louis, MO USA; [Zhang, Feng] Amgen Inc, Dept Global Biostat Sci, Thousand Oaks, CA USA; [Sapra, Sandhya] Amgen Inc, Dept Global Hlth Econ, Thousand Oaks, CA USA; [Picard, Hernan; Mikol, Daniel D.; Lenz, Robert A.] Amgen Inc, Dept Global Dev, Thousand Oaks, CA USA	King's College Hospital NHS Foundation Trust; King's College Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Innsbruck; Amgen; Amgen; Amgen	Goadsby, PJ (corresponding author), Kings Coll London, Kings Coll Hosp, Wellcome Fdn Bldg, London SE5 9PJ, England.	peter.goadsby@kcl.ac.uk	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904; Reuter, Uwe/0000-0002-8527-0725	Amgen; Novartis; STRIVE ClinicalTrials [NCT02456740]	Amgen(Amgen); Novartis(Novartis); STRIVE ClinicalTrials	Funded by Amgen and Novartis; STRIVE ClinicalTrials. gov number, NCT02456740.	Adelman J, 2008, PAIN MED, V9, P175, DOI 10.1111/j.1526-4637.2007.00389.x; [Anonymous], 1998, STAT PRINCIPLES CLIN; [Anonymous], 2015, LANCET NEUROL, V14, P1081; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; Charles A, 2013, CURR OPIN NEUROL, V26, P235, DOI 10.1097/WCO.0b013e32836085f4; Connor KM, 2009, NEUROLOGY, V73, P970, DOI 10.1212/WNL.0b013e3181b87942; Diener HC, 2011, CEPHALALGIA, V31, P573, DOI 10.1177/0333102410388435; Dodick DW, 2014, LANCET NEUROL, V13, P885, DOI 10.1016/S1474-4422(14)70128-0; Goadsby PJ, 2010, LANCET NEUROL, V9, P285, DOI 10.1016/S1474-4422(10)70005-3; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hepp Z, 2015, CEPHALALGIA, V35, P478, DOI 10.1177/0333102414547138; Hewitt DJ, 2011, CEPHALALGIA, V31, P712, DOI 10.1177/0333102411398399; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2016, HEADACHE, V56, P1280, DOI 10.1111/head.12878; Marcus R, 2014, CEPHALALGIA, V34, P114, DOI 10.1177/0333102413500727; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Shi LC, 2016, J PHARMACOL EXP THER, V356, P223, DOI 10.1124/jpet.115.227793; Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Sun H, 2016, LANCET NEUROL, V15, P382, DOI 10.1016/S1474-4422(16)00019-3; Tepper S, 2017, LANCET NEUROL, V16, P425, DOI 10.1016/S1474-4422(17)30083-2; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233	26	449	464	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2123	2132		10.1056/NEJMoa1705848	http://dx.doi.org/10.1056/NEJMoa1705848			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO1VI	29171821	Green Published, Bronze			2022-12-28	WOS:000416555000006
J	Qian, G; Zhou, CC				Qian, Ge; Zhou, Chong-Chen			SPOT DIAGNOSIS A child with nail changes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Qian, Ge; Zhou, Chong-Chen] Zhengzhou Univ, Affiliated Childrens Hosp, Dept Dermatol, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhou, CC (corresponding author), Zhengzhou Univ, Affiliated Childrens Hosp, Dept Dermatol, Zhengzhou, Henan, Peoples R China.	519111170@qq.com						Ceyhan AM, 2010, J DERMATOL, V37, P188, DOI 10.1111/j.1346-8138.2009.00744.x; Chu DH, 2014, PEDIATR CLIN N AM, V61, P293, DOI 10.1016/j.pcl.2013.11.005; Hardin J, 2015, BRIT J DERMATOL, V172, P592, DOI 10.1111/bjd.13339; Mohrenschlager M, 2003, BRIT MED J, V326, P105	4	0	0	4	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5192	10.1136/bmj.j5192	http://dx.doi.org/10.1136/bmj.j5192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29192001				2022-12-28	WOS:000417211800003
J	Schneider, G; Mooser, A; Bohman, M; Schon, N; Harrington, J; Higuchi, T; Nagahama, H; Sellner, S; Smorra, C; Blaum, K; Matsuda, Y; Quint, W; Walz, J; Ulmer, S				Schneider, Georg; Mooser, Andreas; Bohman, Matthew; Schoen, Natalie; Harrington, James; Higuchi, Takashi; Nagahama, Hiroki; Sellner, Stefan; Smorra, Christian; Blaum, Klaus; Matsuda, Yasuyuki; Quint, Wolfgang; Walz, Jochen; Ulmer, Stefan			Double-trap measurement of the proton magnetic moment at 0.3 parts per billion precision	SCIENCE			English	Article							PENNING TRAP; ELECTRON; CPT; TESTS; ION	Precise knowledge of the fundamental properties of the proton is essential for our understanding of atomic structure as well as for precise tests of fundamental symmetries. We report on a direct high-precision measurement of the magnetic moment mu(p) of the proton in units of the nuclear magneton mu(N). The result, mu(p) = 2.79284734462 (+/-0.00000000082) mu(N), has a fractional precision of 0.3 parts per billion, improves the previous best measurement by a factor of 11, and is consistent with the currently accepted value. This was achieved with the use of an optimized double-Penning trap technique. Provided a similar measurement of the antiproton magnetic moment can be performed, this result will enable a test of the fundamental symmetry between matter and antimatter in the baryonic sector at the 10(-10) level.	[Schneider, Georg; Schoen, Natalie; Walz, Jochen] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Schneider, Georg; Mooser, Andreas; Bohman, Matthew; Higuchi, Takashi; Nagahama, Hiroki; Sellner, Stefan; Smorra, Christian; Ulmer, Stefan] RIKEN, Ulmer Fundamental Symmetries Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Bohman, Matthew; Harrington, James; Blaum, Klaus] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Higuchi, Takashi; Matsuda, Yasuyuki] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Quint, Wolfgang] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Walz, Jochen] Helmholtz Inst Mainz, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; RIKEN; Max Planck Society; University of Tokyo; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Schneider, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.; Schneider, G (corresponding author), RIKEN, Ulmer Fundamental Symmetries Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	georg.schneider@uni-mainz.de	Matsuda, Yasuyuki/C-3007-2008; Ulmer, Stefan/AAC-8087-2022; Higuchi, Takashi/C-4571-2017	Matsuda, Yasuyuki/0000-0002-9847-3791; Ulmer, Stefan/0000-0002-4185-4147; Higuchi, Takashi/0000-0003-3281-4669; Smorra, Christian/0000-0001-5584-7960; Schon, Natalie/0000-0002-5357-7642	Helmholtz-Gemeinschaft; RIKEN Initiative Research Unit Program; RIKEN Pioneering Project Funding; RIKEN FPR Funding; RIKEN IRA Program; Max Planck Society; European Research Council [290870-MEFUCO]	Helmholtz-Gemeinschaft(Helmholtz Association); RIKEN Initiative Research Unit Program; RIKEN Pioneering Project Funding; RIKEN FPR Funding; RIKEN IRA Program; Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	Supported by the Helmholtz-Gemeinschaft, the RIKEN Initiative Research Unit Program, the RIKEN Pioneering Project Funding, the RIKEN FPR Funding, the RIKEN IRA Program, the Max Planck Society and European Research Council advanced grant 290870-MEFUCO. Data are available upon request to the Corresponding author.	Abe K, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.012004; Ahmadi M, 2017, NATURE, V541, P506, DOI 10.1038/nature21040; Bennett GW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.091602; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Beyer A, 2017, SCIENCE, V358, P79, DOI 10.1126/science.aah6677; Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; BROWN LS, 1985, ANN PHYS-NEW YORK, V159, P62, DOI 10.1016/0003-4916(85)90192-7; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; CORNELL EA, 1990, PHYS REV A, V41, P312, DOI 10.1103/PhysRevA.41.312; DEHMELT H, 1973, B AM PHYS SOC, V18, P727; Dehmelt H, 1999, PHYS REV LETT, V83, P4694, DOI 10.1103/PhysRevLett.83.4694; DiSciacca J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153001; GABRIELSE G, 1988, J APPL PHYS, V63, P5143, DOI 10.1063/1.340416; GABRIELSE G, 1989, INT J MASS SPECTROM, V88, P319, DOI 10.1016/0168-1176(89)85027-X; Haffner H, 2003, EUR PHYS J D, V22, P163, DOI 10.1140/epjd/e2003-00012-2; HEINZEN DJ, 1990, PHYS REV A, V42, P2977, DOI 10.1103/PhysRevA.42.2977; Heiss F, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.033001; Ketter J, 2014, INT J MASS SPECTROM, V358, P1, DOI 10.1016/j.ijms.2013.10.005; Mohr PJ, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035009; Mooser A, 2014, NATURE, V509, P596, DOI 10.1038/nature13388; Mooser A, 2013, PHYS LETT B, V723, P78, DOI 10.1016/j.physletb.2013.05.012; Mooser A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140405; Nagahama H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14084; Nagahama H, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4967493; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Porto JV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023403; Rodegheri CC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063011; SCHWINGENHEUER B, 1995, PHYS REV LETT, V74, P4376, DOI 10.1103/PhysRevLett.74.4376; Smorra C, 2017, PHYS LETT B, V769, P1, DOI 10.1016/j.physletb.2017.03.024; Smorra C, 2015, EUR PHYS J-SPEC TOP, V224, P3055, DOI 10.1140/epjst/e2015-02607-4; Smorra C, 2015, INT J MASS SPECTROM, V389, P10, DOI 10.1016/j.ijms.2015.08.007; Ulmer S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.253001; WINELAND DJ, 1975, J APPL PHYS, V46, P919, DOI 10.1063/1.321602; WINKLER PF, 1972, PHYS REV A, V5, P83, DOI 10.1103/PhysRevA.5.83	34	52	52	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1081	+		10.1126/science.aan0207	http://dx.doi.org/10.1126/science.aan0207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170238				2022-12-28	WOS:000416590400047
J	Williams, R; Alexander, G; Armstrong, I; Baker, A; Bhala, N; Camps-Walsh, G; Cramp, ME; de Lusignan, S; Day, N; Dhawan, A; Dillon, J; Drummond, C; Dyson, J; Foster, G; Gilmore, I; Hudson, M; Kelly, D; Langford, A; McDougall, N; Meier, P; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rolfe, L; Rice, P; Rutter, H; Sheron, N; Taylor, A; Thompson, J; Thorburn, D; Verne, J; Wass, J; Yeoman, A				Williams, Roger; Alexander, Graeme; Armstrong, Iain; Baker, Alastair; Bhala, Neeraj; Camps-Walsh, Ginny; Cramp, Matthew E.; de Lusignan, Simon; Day, Natalie; Dhawan, Anil; Dillon, John; Drummond, Colin; Dyson, Jessica; Foster, Graham; Gilmore, Ian; Hudson, Mark; Kelly, Deirdre; Langford, Andrew; McDougall, Neil; Meier, Petra; Moriarty, Kieran; Newsome, Philip; O'Grady, John; Pryke, Rachel; Rolfe, Liz; Rice, Peter; Rutter, Harry; Sheron, Nick; Taylor, Alison; Thompson, Jeremy; Thorburn, Douglas; Verne, Julia; Wass, John; Yeoman, Andrew			Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK	LANCET			English	Article							ENGLAND	This report contains new and follow-up metric data relating to the eight main recommendations of the Lancet Standing Commission on Liver Disease in the UK, which aim to reduce the unacceptable harmful consequences of excess alcohol consumption, obesity, and viral hepatitis. For alcohol, we provide data on alcohol dependence, damage to families, and the documented increase in alcohol consumption since removal of the above-inflation alcohol duty escalator. Alcoholic liver disease will shortly overtake ischaemic heart disease with regard to years of working life lost. The rising prevalence of overweight and obesity, affecting more than 60% of adults in the UK, is leading to an increasing liver disease burden. Favourable responses by industry to the UK Government's soft drinks industry levy have been seen, but the government cannot continue to ignore the number of adults being affected by diabetes, hypertension, and liver disease. New direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection have reduced mortality and the number of patients requiring liver transplantation, but more screening campaigns are needed for identification of infected people in high-risk migrant communities, prisons, and addiction centres. Provision of care continues to be worst in regions with the greatest socioeconomic deprivation, and deficiencies exist in training programmes in hepatology for specialist registrars. Firm guidance is needed for primary care on the use of liver blood tests in detection of early disease and the need for specialist referral. This report also brings together all the evidence on costs to the National Health Service and wider society, in addition to the loss of tax revenue, with alcohol misuse in England and Wales costing 21 pound billion a year (possibly up to 52 pound billion) and obesity costing 27 pound billion a year (treasury estimates are as high as 46 pound billion). Voluntary restraints by the food and drinks industry have had little effect on disease burden, and concerted regulatory and fiscal action by the UK Government is essential if the scale of the medical problem, with an estimated 63 000 preventable deaths over the next 5 years, is to be addressed.	[Williams, Roger; Day, Natalie] Inst Hepatol, Fdn Liver Res, London SE5 9NT, England; [Alexander, Graeme] British Assoc Study Liver, Lichfield, Staffs, England; [Armstrong, Iain; Rolfe, Liz; Verne, Julia] Publ Hlth England, London, England; [Bhala, Neeraj] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England; [Camps-Walsh, Ginny] Med Mkt Consultants, Oxford, England; [Cramp, Matthew E.] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England; [Cramp, Matthew E.] Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England; [de Lusignan, Simon] Univ Surrey, Royal Coll Gen Practitioners, Res & Surveillance Ctr, Guildford, Surrey, England; [Baker, Alastair; Dhawan, Anil; O'Grady, John] Kings Coll Hosp London, London, England; [Dillon, John] Univ Dundee, Med Res Inst, Dundee, Scotland; [Drummond, Colin] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Dyson, Jessica; Hudson, Mark] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Foster, Graham] Queen Mary Univ London, London, England; [Gilmore, Ian] Univ Liverpool, Liverpool, Merseyside, England; [Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Langford, Andrew] British Liver Trust, Bournemouth, Dorset, England; [McDougall, Neil] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Meier, Petra] Univ Sheffield, Sect Publ Hlth, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Moriarty, Kieran] Royal Bolton Hosp, Bolton, England; [Newsome, Philip] Univ Birmingham, Biomed Res Ctr, NIHR, Birmingham, W Midlands, England; [Pryke, Rachel] Winyates Hlth Ctr, Redditch, England; [Rice, Peter] Scottish Hlth Act Alcohol Problems, Edinburgh, Midlothian, Scotland; [Rutter, Harry] London Sch Hyg & Trop Med, London, England; [Sheron, Nick] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Taylor, Alison] Childrens Liver Dis Fdn, Birmingham, W Midlands, England; [Thompson, Jeremy] Fulcrum Practice, Middlesbrough, Cleveland, England; [Thorburn, Douglas] Royal Free Hosp, London, England; [Wass, John] Univ Oxford, Oxford, England; [Yeoman, Andrew] Aneurin Bevan Univ Hlth Board, Newport, Shrops, England	University of London; University College London; Public Health England; University of Birmingham; University of Plymouth; University of Plymouth; University of Surrey; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Dundee; University of London; King's College London; Newcastle Freeman Hospital; Newcastle University - UK; University of London; Queen Mary University London; University of Liverpool; University of Birmingham; University of Sheffield; Royal Bolton Hospital; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Oxford	Williams, R (corresponding author), Inst Hepatol, Fdn Liver Res, London SE5 9NT, England.	r.williams@researchinliver.org.uk	Newsome, Philip N/D-4495-2018; Meier, Petra/P-7504-2019; Rutter, Harry/HCI-8765-2022; Drummond, Colin/O-9141-2019; Meier, Petra S/L-7387-2017	Newsome, Philip N/0000-0001-6085-3652; Meier, Petra/0000-0001-5354-1933; Drummond, Colin/0000-0001-9379-5452; Meier, Petra S/0000-0001-5354-1933; Dillon, John/0000-0002-2164-4476; Bhala, Neeraj/0000-0003-2502-1177; Rutter, Harry/0000-0002-9322-0656; Foster, Graham/0000-0002-3704-386X; Sheron, Nick/0000-0001-5232-8292	NIHR Collaborations for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; NIHR South London; Maudsley NHS Foundation Trust Biomedical Research Centre; NIHR Senior Investigator award; MRC [G0701681, G0701818] Funding Source: UKRI	NIHR Collaborations for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; NIHR South London; Maudsley NHS Foundation Trust Biomedical Research Centre; NIHR Senior Investigator award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all those who attended meetings of the working groups of the Commission or contributed data or other content to this report, including Colin Angus (Sheffield Alcohol Research Group, University of Sheffield), Joanne Bosanquet, Clive Henn (Public Health England), Richard Aspinall (Queen Alexandra Hospital, Portsmouth), Alastair Baker, Marianne Samyn (King's College Hospital NHS Foundation Trust), Rachel Batterham, Alastair O'Brien (University College London Hospital), Ana Correa (RCGP Research and Surveillance Centre, Department of Clinical and Experimental Medicine, University of Surrey), Richard Gardner (British Society of Gastroenterology), Katherine Brown (Institute of Alcohol Studies), Suzanne Davison (Leeds Teaching Hospital NHS Trust), James Ferguson (Queen Elizabeth Hospital, Birmingham), Filipa Ferreira (University of Surrey), Michael Glynn (Barts Health NHS Trust), Jonny Greenberg, Jan Maly (Incisive Health), Lynda Greenslade (Royal Free Hospital), Helen Jarvis (RCGP and British Liver Trust), Stephen Liversedge (Bolton Clinical Commissioning Group), Mead Mathews (St Mary's Surgery, Southampton), Alastair MacGilchrist (Edinburgh Royal Infirmary), Martin McKee (London School of Hygiene & Tropical Medicine), Darius Mirza (Queen Elizabeth Hospital and Birmingham Children's Hospital), Zulfiquar Mirza (Chelsea and Westminster Hospital NHS Foundation Trust), Stephen Ryder (Nottingham University NHS Trust), Jeremy Shearman (Royal College of Physicians), Jyotsna Vohra (Cancer Research UK), Ben Windsor-Shellard (Office for National Statistics), Ivelina Yonova (Surrey GP practice liaison officer), and Elisa Allen (NHS Blood and Transplant, Statistics and Clinical Studies). We thank Norgine for their unrestricted grant to the Foundation for Liver Research, which has enabled the Commission to work with Incisive Health in bringing the work of the Commission to the attention of Parliament and in producing the report on the Financial Costs of Liver Disease. CD is part funded by NIHR Collaborations for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust and the NIHR South London and Maudsley NHS Foundation Trust Biomedical Research Centre, and is in receipt of an NIHR Senior Investigator award. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Ahmad Ahmir, 2014, JRSM Open, V5, p2042533313512479, DOI [10.1177/2042533313517689, 10.1177/2042533313512479]; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; British Liver Trust, LOV YOUR LIV BRIT LI; British Soceity of Gastroenterology, BRIT SOC GASTR TRAIN; Burton R, 2017, LANCET, V389, P1558, DOI 10.1016/S0140-6736(16)32420-5; Cabinet Office Department of Health HM Treasury Prime Minister's Office, 2016, CHILDH OB PLAN ACT; Correa A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011092; Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013; de Lusignan Simon, 2005, Inform Prim Care, V13, P65; Department of Health, HOSP INP SYST; Department of Health Ireland, 2015, PUBL HLTH ALC BILL; Department of Health Public Health England, NEXT STAG WORLD LEAD; Drummond C, 2009, SCOTTISH ALCOHOL NEE; Ells LJ, 2015, ARCH DIS CHILD, V100, P631, DOI 10.1136/archdischild-2014-307036; Fear N, 2016, MENTAL HLTH WELLBEIN, P238; Foundation for Liver Research, 2017, FIN CAS ACT LIV DIS; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; HM Revenue and Customs, 2016, POL PAP SOFT DRINK; HMRC, HMRC ALC B; Home Office, DRUG STRAT 2017; ISD Scotland, 2017, NAT DRUG ALC TREATM; ISD Scotland, SMR DAT; Joshi D, 2017, J HEPATOL, V66, P631, DOI 10.1016/j.jhep.2016.11.013; Lal A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002326; Livingstone G, LANCET; NHS Digital, 2017, STAT ALC; NHS Digital, 2016, NAT CHILD MEAS PROGR; NHS Digital, HOSP EP STAT; NHS Digital, 2017, STAT OBESITY PHYS AC; NHS England, COMM QUAL INN; NHS Wales Informatics Service, PEDW DAT ONL; NICE, 2017, LIV DIS QUAL STAND; Northern Ireland Executive, 2016, HLTH SURV NI 2015 16; O'Shaughnessy JR, WRITTEN QUESTION HL5; OECD, 2015, TACKL HARMF ALC US; Office for National Statistics, 20 CENT MORT FIL 190; Office for National Statistics, ALC SPEC DEATHS UK S; Office for National Statistics, 21 CENT MORT FIL DEA; Perkins C, UNDERSTANDING ALCOHO; PHE, UNL AN HIV VIR HEP M; PHE, 2017, HEP C UK 2017 REP WO; PHE, 2016, LOC HLTH CAR PLANN M; PHE, 2016, AD SUBST MIS STAT NA; PHE, COV VACC EV RAP COVE; PHE NHS RightCare, 2017, 2 ATL VAR NHS DIAGN; Pryce R., 2017, ESTIMATES ALCOHOL DE; Public Health England (PHE), 2017, SUG RED ACH 20; Public Health Wales, 2017, NAT IMM UPT DAT; Royal College of General Practitioners (RCGP), LIV DIS TOOLK; Royal College of Physicians, IMPR QUAL LIV SERV; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283; UK Department of Health, 2016, UK CHIEF MED OFF LOW; WHO, GLOB HLTH SECT STRAT; Williams R, 2017, LANCET, V389, P2053, DOI 10.1016/S0140-6736(16)32234-6; Williams R, 2015, LANCET, V386, P2098, DOI 10.1016/S0140-6736(15)00680-7; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; World Health Organization, 2010, GLOB STRAT RED HARMF; Yellow Alert, JAUND NEWB BAB	59	100	101	1	62	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1097	1107		10.1016/S0140-6736(17)32866-0	http://dx.doi.org/10.1016/S0140-6736(17)32866-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ4TP	29198562	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000427585100028
J	Connors, JM; Jurczak, W; Straus, DJ; Ansell, SM; Kim, WS; Gallamini, A; Younes, A; Alekseev, S; Illes, A; Picardi, M; Lech-Maranda, E; Oki, Y; Feldman, T; Smolewski, P; Savage, KJ; Bartlett, NL; Walewski, J; Chen, R; Ramchandren, R; Zinzani, PL; Cunningham, D; Rosta, A; Josephson, NC; Song, E; Sachs, J; Liu, R; Jolin, HA; Huebner, D; Radford, J				Connors, J. M.; Jurczak, W.; Straus, D. J.; Ansell, S. M.; Kim, W. S.; Gallamini, A.; Younes, A.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Oki, Y.; Feldman, T.; Smolewski, P.; Savage, K. J.; Bartlett, N. L.; Walewski, J.; Chen, R.; Ramchandren, R.; Zinzani, P. L.; Cunningham, D.; Rosta, A.; Josephson, N. C.; Song, E.; Sachs, J.; Liu, R.; Jolin, H. A.; Huebner, D.; Radford, J.		ECHELON-1Study Grp	Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COOPERATIVE-ONCOLOGY-GROUP; RESPONSE CRITERIA; PROGNOSTIC SCORE; OPEN-LABEL; ABVD; DISEASE; TOXICITY; TRIAL; INTERGROUP	BACKGROUND Brentuximab vedotin is an anti-CD30 antibody-drug conjugate that has been approved for relapsed and refractory Hodgkin's lymphoma. METHODS We conducted an open-label, multicenter, randomized phase 3 trial involving patients with previously untreated stage III or IV classic Hodgkin's lymphoma, in which 664 were assigned to receive brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) and 670 were assigned to receive doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). The primary end point was modified progression-free survival (the time to progression, death, or noncomplete response and use of subsequent anticancer therapy) as adjudicated by an independent review committee. The key secondary end point was overall survival. RESULTS At a median follow-up of 24.9 months, 2-year modified progression-free survival rates in the A+AVD and ABVD groups were 82.1% (95% confidence interval [CI], 78.7 to 85.0) and 77.2% (95% CI, 73.7 to 80.4), respectively, a difference of 4.9 percentage points (hazard ratio for an event of progression, death, or modified progression, 0.77; 95% CI, 0.60 to 0.98; P = 0.03). There were 28 deaths with A+AVD and 39 with ABVD (hazard ratio for interim overall survival, 0.72 [95% CI, 0.44 to 1.17]; P = 0.19). All secondary efficacy end points trended in favor of A+AVD. Neutropenia occurred in 58% of the patients receiving A+AVD and in 45% of those receiving ABVD; in the A+AVD group, the rate of febrile neutropenia was lower among the 83 patients who received primary prophylaxis with granulocyte colony-stimulating factor than among those who did not (11% vs. 21%). Peripheral neuropathy occurred in 67% of patients in the A+AVD group and in 43% of patients in the ABVD group; 67% of patients in the A+AVD group who had peripheral neuropathy had resolution or improvement at the last follow-up visit. Pulmonary toxicity of grade 3 or higher was reported in less than 1% of patients receiving A+AVD and in 3% of those receiving ABVD. Among the deaths that occurred during treatment, 7 of 9 in the A+AVD group were associated with neutropenia and 11 of 13 in the ABVD group were associated with pulmonary-related toxicity. CONCLUSIONS A+AVD had superior efficacy to ABVD in the treatment of patients with advanced-stage Hodgkin's lymphoma, with a 4.9 percentage-point lower combined risk of progression, death, or noncomplete response and use of subsequent anticancer therapy at 2 years.	[Connors, J. M.; Savage, K. J.] Univ British Columbia, Vancouver, BC, Canada; [Connors, J. M.; Savage, K. J.] British Columbia Canc Agcy Ctr Lymphoid Canc, Dept Med Oncol, Vancouver, BC, Canada; [Jurczak, W.] Jagiellonian Univ, Dept Hematol, Krakow, Poland; [Lech-Maranda, E.] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland; [Lech-Maranda, E.] Ctr Postgrad Med Educ, Dept Hematol & Transfus Med, Warsaw, Poland; [Smolewski, P.] Med Univ Lodz, Dept Expt Hematol, Lodz, Poland; [Walewski, J.] Maria Sklodowska Curie Memorial Inst, Dept Lymphoid Malignancy, Warsaw, Poland; [Walewski, J.] Oncol Ctr, Warsaw, Poland; [Straus, D. J.; Younes, A.] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA; [Ansell, S. M.] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA; [Kim, W. S.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol, Seoul, South Korea; [Gallamini, A.] Antoine Lacassagne Canc Ctr, Res Innovat & Stat, Nice, France; [Alekseev, S.] Petrov Res Inst Oncol, St Petersburg, Russia; [Illes, A.] Univ Debrecen, Fac Med, Dept Hematol, Debrecen, Hungary; [Rosta, A.] Natl Inst Oncol, Dept Hematol, Budapest, Hungary; [Picardi, M.] Federico II Univ Hosp, Dept Adv Biomed Sci, Naples, Italy; [Zinzani, P. L.] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy; [Oki, Y.] MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA; [Feldman, T.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Bartlett, N. L.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Chen, R.] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Ramchandren, R.] Barbara Ann Karmanos Canc Ctr, Dept Hematol & Oncol, Detroit, MI USA; [Cunningham, D.] Royal Marsden NHS Fdn Trust, Gastrointestinal & Lymphoma Unit, Sutton, Surrey, England; [Radford, J.] Univ Manchester & Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Med Oncol, Manchester, Lancs, England; [Josephson, N. C.; Song, E.] Seattle Genet, Dept Clin Dev, Bothell, WA USA; [Sachs, J.; Jolin, H. A.; Huebner, D.] Millennium Pharmaceut Inc, Oncol Clin Res, Cambridge, MA USA; [Liu, R.] Millennium Pharmaceut Inc, Global Biostat, Cambridge, MA USA	University of British Columbia; Jagiellonian University; Collegium Medicum Jagiellonian University; Centre of Postgraduate Medical Education - Poland; Medical University Lodz; Maria Sklodowska-Curie National Research Institute of Oncology; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Sungkyunkwan University (SKKU); Samsung Medical Center; UNICANCER; Centre Antoine Lacassagne; N.N. Petrov Research Institute of Oncology; University of Debrecen; National Institute of Oncology Hungary; University of Naples Federico II; University of Bologna; University of Texas System; UTMD Anderson Cancer Center; Hackensack University Medical Center; Washington University (WUSTL); City of Hope; Barbara Ann Karmanos Cancer Institute; Royal Marsden NHS Foundation Trust; Christie NHS Foundation Trust; University of Manchester; Seattle Genetics; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Connors, JM (corresponding author), British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada.	jconnors@bccancer.bc.ca	Jurczak, Wojciech/ABB-2136-2020; Jurczak, Wojciech/AAV-7973-2020; Luminari, Stefano/J-5916-2014; Jurczak, Wojciech/M-1625-2019; Connors, Joseph/AAF-5284-2019; Walewski, Jan/ABC-9523-2020; Lech-Maranda, Ewa/AAH-5474-2020; Santoro, Armando/J-9594-2018; Specht, Lena/J-6422-2019; Jurczak, Wojciech/L-7645-2019; Savage, Kerry/HCH-5539-2022; Radford, John A/N-1331-2015; Garcia-Sanz, Ramon/B-7986-2017; ZINZANI, PIER LUIGI/J-9182-2016	Jurczak, Wojciech/0000-0003-1879-8084; Jurczak, Wojciech/0000-0003-1879-8084; Luminari, Stefano/0000-0001-8446-2285; Connors, Joseph/0000-0002-1361-7531; Lech-Maranda, Ewa/0000-0001-9592-0851; Santoro, Armando/0000-0003-1709-9492; Specht, Lena/0000-0002-6902-2190; Radford, John A/0000-0001-7898-2786; Briones Meijide, Javier/0000-0003-2750-3735; Kuliczkowski, Kazimierz/0000-0001-6812-1421; Garcia-Sanz, Ramon/0000-0003-4120-2787; Bartlett, Nancy/0000-0001-8470-394X; Cunningham, David/0000-0001-5158-1069; Smolewski, Piotr/0000-0003-2700-3343; Warzocha, Krzysztof/0000-0002-2396-3905; Robak, Tadeusz/0000-0002-3411-6357; Stroyakovskiy, Daniil/0000-0003-1973-1092; ZINZANI, PIER LUIGI/0000-0002-2112-2651; Walewski, Jan/0000-0003-4247-2674; Greenwood, Matthew/0000-0002-3667-2613	Millennium Pharmaceuticals; Seattle Genetics; Amgen; Bayer Healthcare; Bristol-Myers Squibb; Cephalon; F. Hoffmann-La Roche; Genentech; Janssen; Lilly; Merck; NanoString Technologies; Takeda; Pharmacyclics; Acerta; Pfizer; Celtrion; Gilead; TG Therapeutics; MorphoSys; Sandoz Novartis; Servier; Nordic Nanovector; Spectrum; LAM Therapeutics; Celldex; Affimed; Regeneron; Novartis; Celgene; Johnson Johnson; Kyowa Hakko Kirin; Mundipharma; Roche; Celltrion; Eisa; Janssen-Cilag; AbbVie; Teva Pharmaceuticals; Immune Design; Forty Seven; AstraZeneca; Kite; GSK/Novartis; Teva; Boehringer Ingelheim; Karyopham; Ariad; Sanofi; Bayer; TG Pharmaceuticals; Merrimack; Medimmune; Merck Serono; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Seattle Genetics; Amgen(Amgen); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); Cephalon; F. Hoffmann-La Roche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); Merck(Merck & Company); NanoString Technologies; Takeda(Takeda Pharmaceutical Company Ltd); Pharmacyclics; Acerta; Pfizer(Pfizer); Celtrion; Gilead(Gilead Sciences); TG Therapeutics; MorphoSys; Sandoz Novartis; Servier(Servier); Nordic Nanovector; Spectrum; LAM Therapeutics; Celldex; Affimed; Regeneron(Regeneron); Novartis(Novartis); Celgene(Bristol-Myers SquibbCelgene Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Mundipharma; Roche(Roche Holding); Celltrion; Eisa; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AbbVie(AbbVie); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Immune Design; Forty Seven; AstraZeneca(AstraZeneca); Kite; GSK/Novartis; Teva(Teva Pharmaceutical Industries); Boehringer Ingelheim(Boehringer Ingelheim); Karyopham; Ariad; Sanofi; Bayer(Bayer AG); TG Pharmaceuticals; Merrimack; Medimmune(AstraZenecaMedimmune); Merck Serono(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceuticals, and Seattle Genetics.; Dr. Connors reports receiving grant support from Amgen, Bayer Healthcare, Bristol-Myers Squibb, Cephalon, F. Hoffmann-La Roche, Genentech, Janssen, Lilly, Merck, NanoString Technologies, Seattle Genetics, and Takeda; Dr. Jurczak, receiving grant support from Janssen, Pharmacyclics, Acerta, Pfizer, Celtrion, Gilead, TG Therapeutics, and Merck, grant support and consulting fees from MorphoSys and Sandoz Novartis, and consulting fees from Servier, Nordic Nanovector, and Spectrum; Dr. Straus, receiving honoraria from DAVA Oncology; Dr. Ansell, receiving grant support from Millennium Pharmaceuticals, Bristol-Myers Squibb, Seattle Genetics, LAM Therapeutics, Celldex, Affimed, Merck, and Regeneron; Dr. Kim, receiving grant support from Millennium Pharmaceuticals, Novartis, Merck, Celgene, Johnson & Johnson, Kyowa Hakko Kirin, and Mundipharma, and grant support and honoraria from Roche, Celltrion, and Eisa; Dr. Gallamini, receiving grant support and consulting fees from Millennium Pharmaceuticals; Dr. Younes, receiving honoraria from Millennium Pharmaceuticals, Seattle Genetics, Merck, and Bristol-Myers Squibb; Dr. Illes, receiving advisory board fees from Millennium Pharmaceuticals, Novartis, Janssen, Roche, and Celgene; Dr. Lech-Maranda, receiving lecture fees from Roche, Novartis, Gilead, and Bristol-Myers Squibb, advisory board fee from Janssen-Cilag, AbbVie, and Teva Pharmaceuticals, and lecture fees and advisory board fees from Amgen; Dr. Feldman, receiving honoraria from Seattle Genetics, Celgene, AbbVie, Pharmacyclics, Janssen, and Kite Pharma, and consulting fees from Bristol-Myers Squibb; Dr. Smolewski, receiving fees for participating in a clinical study as an investigator from Roche; Dr. Savage, receiving consulting fees and honoraria from Seattle Genetics, Merck, Bristol-Myers Squibb, Servier, Gilead, and Novartis, honoraria from Millennium Pharmaceuticals, and grant support from Roche; Dr. Bartlett, receiving grant support from Millennium Pharmaceuticals, Celgene, Genentech, Merck, Bristol-Myers Squibb, Immune Design, Forty Seven, Affimed, Janssen, Pharmacyclics, AstraZeneca, Novartis, and Gilead, and grant support and advisory board fees from Seattle Genetics, Pfizer, and Kite; Dr. Walewski, receiving grant support, lecture fees, consulting fees, and travel support from Roche, Celgene, and Janssen-Cilag, grant support, consulting fees, and lecture fees from Mundipharma, grant support from GSK/Novartis, lecture fees, consulting fees, and travel support from Takeda, consulting fees and lecture fees from Teva and Servier, consulting fees from Boehringer Ingelheim, Karyopham, and Ariad, lecture fees and travel support from Gilead, and grant support, lecture fees and travel support from Sanofi; Dr. Chen, grant support, consulting fees, and honoraria from Seattle Genetics, grant support and consulting fees from Bristol-Myers Squibb and Pharmacyclics, honoraria from Genentech, and consulting fees and honoraria from Merck; Dr. Zinzani, receiving advisory board fees from Millennium Pharmaceuticals, Roche, Celgene, Janssen, Gilead, Bayer, Merck, Servier, and TG Pharmaceuticals; Dr. Cunningham, receiving grant support, paid to his institution, from AstraZeneca, Amgen, Bayer, Celgene, Merrimack, Medimmune, Merck Serono, and Sanofi; Dr. Josephson, being employed by and owning stock in Seattle Genetics; Dr. Song, being employed by Seattle Genetics; Dr. Sachs, being employed by Unum Therapeutics, and being previously employed by Millennium Pharmaceuticals; Dr. Liu, being employed by Millennium Pharmaceuticals; Dr.; Jolin, being employed by Millennium Pharmaceuticals; Dr. Huebner, being previously employed by Millennium Pharmaceuticals; and Dr. Radford, receiving grant support from Takeda, Bristol-Myers Squibb, Seattle Genetics, and Novartis, and holding shares in GSK and AstraZeneca. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2016, ADCETRIS BRENTUXIMA; Barnes JA, 2011, ANN ONCOL, V22, P910, DOI 10.1093/annonc/mdq549; Borchmann P, 2017, HAEMATOLOGICA, V102, P24; Borchmann P, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.580.580; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Canellos GP, 2004, J CLIN ONCOL, V22, P1532, DOI 10.1200/JCO.2004.99.010; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Carde P, 2016, J CLIN ONCOL, V34, P2028, DOI 10.1200/JCO.2015.64.5648; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Connors JM, 2017, BLOOD, V130, P1375, DOI 10.1182/blood-2017-05-784678; Engert A, 2005, J CLIN ONCOL, V23, P5052, DOI 10.1200/JCO.2005.11.080; Engert A, 2016, J CLIN ONCOL, V34, P1167, DOI 10.1200/JCO.2015.64.8683; Engert A, 2012, LANCET, V379, P1791, DOI 10.1016/S0140-6736(11)61940-5; Gordon LI, 2013, J CLIN ONCOL, V31, P684, DOI 10.1200/JCO.2012.43.4803; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Johnson P, 2016, NEW ENGL J MED, V374, P2419, DOI 10.1056/NEJMoa1510093; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Martin WG, 2005, J CLIN ONCOL, V23, P7614, DOI 10.1200/JCO.2005.02.7243; Matasar MJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv018; Meignan M, 2010, LEUKEMIA LYMPHOMA, V51, P2171, DOI 10.3109/10428194.2010.529208; Ng AK, 2016, SEMIN HEMATOL, V53, P209, DOI 10.1053/j.seminhematol.2016.05.008; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; SCHWAB U, 1982, NATURE, V299, P65, DOI 10.1038/299065a0; Shenoy P, 2011, ADV HEMATOL, V2011, DOI DOI 10.1155/2011/725219; Spaepen K, 2001, BRIT J HAEMATOL, V115, P272, DOI 10.1046/j.1365-2141.2001.03169.x; Younes A, 2013, LANCET ONCOL, V14, P1348, DOI 10.1016/S1470-2045(13)70501-1	26	398	415	5	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					331	344		10.1056/NEJMoa1708984	http://dx.doi.org/10.1056/NEJMoa1708984			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29224502	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000423233400006
J	Jagsi, R				Jagsi, Reshma			Sexual Harassment in Medicine - #MeToo	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISCRIMINATION; METAANALYSIS		[Jagsi, Reshma] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jagsi, R (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Ilies R, 2003, PERS PSYCHOL, V56, P607, DOI 10.1111/j.1744-6570.2003.tb00752.x; Jagsi R, 2016, JAMA-J AM MED ASSOC, V315, P2120, DOI 10.1001/jama.2016.2188; McDonald P, 2012, INT J MANAG REV, V14, P1, DOI 10.1111/j.1468-2370.2011.00300.x; Zillman Claire., 2017, FORTUNE	5	94	95	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					209	211		10.1056/NEJMp1715962	http://dx.doi.org/10.1056/NEJMp1715962			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29236567				2022-12-28	WOS:000422888400002
J	Liu, NA; Lee, CH; Swigut, T; Grow, E; Gu, B; Bassik, MC; Wysocka, J				Liu, Nian; Lee, Cameron H.; Swigut, Tomek; Grow, Edward; Gu, Bo; Bassik, Michael C.; Wysocka, Joanna			Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators	NATURE			English	Article							MARIE-TOOTH DISEASE; TRANSPOSABLE ELEMENTS; RETROTRANSPOSITION; PATHWAYS; GENE	Transposable elements, also known as transposons, are now recognized not only as parasitic DNA, the spread of which in the genome must be controlled by the host, but also as major players in genome evolution and regulation(1-6). Long interspersed element-1 (LINE-1, also known as L1), the only currently autonomous mobile transposon in humans, occupies 17% of the genome and generates inter-and intra-individual genetic variation, in some cases resulting in disease(1-7). However, how L1 activity is controlled and the function of L1s in host gene regulation are not completely understood. Here we use CRISPR-Cas9 screening strategies in two distinct human cell lines to provide a genome-wide survey of genes involved in the control of L1 retrotransposition. We identify functionally diverse genes that either promote or restrict L1 retrotransposition. These genes, which are often associated with human diseases, control the L1 life cycle at the transcriptional or the post-transcriptional level in a manner that can depend on the endogenous L1 nucleotide sequence, underscoring the complexity of L1 regulation. We further investigate the restriction of L1 by the protein MORC2 and by the human silencing hub (HUSH) complex subunits MPP8 and TASOR(8). HUSH and MORC2 can selectively bind evolutionarily young, full-length L1s located within transcriptionally permissive euchromatic environments, and promote deposition of histone H3 Lys9 trimethylation (H3K9me3) for transcriptional silencing. Notably, these silencing events often occur within introns of transcriptionally active genes, and lead to the downregulation of host gene expression in a HUSH-, MORC2-, and L1-dependent manner. Together, these results provide a rich resource for studies of L1 retrotransposition, elucidate a novel L1 restriction pathway and illustrate how epigenetic silencing of transposable elements rewires host gene expression programs.	[Liu, Nian; Swigut, Tomek; Gu, Bo; Wysocka, Joanna] Stanford Univ, Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Lee, Cameron H.; Grow, Edward; Bassik, Michael C.] Stanford Univ, Stanford Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bassik, Michael C.] Stanford Univ, Stanford Sch Med, Stanford Univ Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Sch Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Stanford Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA; [Grow, Edward] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wysocka, J (corresponding author), Stanford Univ, Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Stanford Sch Med, Dept Genet, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Stanford Sch Med, Stanford Univ Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Stanford Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA.	bassik@stanford.edu; wysocka@stanford.edu	Lee, Cameron/U-6605-2019	Swigut, Tomek/0000-0002-7649-6781; Liu, Nian/0000-0001-7246-7732	Jane Coffin Childs Memorial Fund for Medical Research; National Science Foundation [DGE-114747]; National Institutes of Health (NIH) [R01HG008150, 1UM1HG009436-01, 1DP2HD084069-01, R01 GM112720]; Stinehart Reed Award; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112720, T32GM007790] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stinehart Reed Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Moran for the LRE-GFP plasmid and A. Engel for the codon-optimized L1 construct; D. Fuentes, A. Spencley, R. Srinivasan, J. Mohammed, V. Bajpai, K. Tsui, G. Hess, D. Morgens and G. Cornelis for assistance and discussions; K. Cimprich, A. Fire and A. Urban for comments on the manuscript; and L. Bruhn, S. Altschuler, B. Borgo, P. Sheffield and C. Carstens (Agilent) for discussions and oligonucleotide synthesis. This work was funded by grants from the Jane Coffin Childs Memorial Fund for Medical Research (N.L.), National Science Foundation DGE-114747 (C.H.L.), National Institutes of Health (NIH) R01HG008150, 1UM1HG009436-01 and NIH 1DP2HD084069-01 (M.C.B.), NIH R01 GM112720, Stinehart Reed Award and Howard Hughes Medical Institute (J.W.).	Albulym OM, 2016, ANN NEUROL, V79, P419, DOI 10.1002/ana.24575; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bregnard C, 2016, EBIOMEDICINE, V8, P184, DOI 10.1016/j.ebiom.2016.05.005; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Carreira PE, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0076-6; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Doucet AJ, 2015, MOL CELL, V60, P728, DOI 10.1016/j.molcel.2015.10.012; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gasior SL, 2008, DNA REPAIR, V7, P983, DOI 10.1016/j.dnarep.2008.02.006; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nemeth AH, 2000, AM J HUM GENET, V67, P1320, DOI 10.1016/S0002-9297(07)62962-0; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pastor WA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6795; Philippe C, 2016, ELIFE, V5, DOI 10.7554/eLife.13926; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schottmann G, 2016, BRAIN, V139, DOI 10.1093/brain/aww252; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; Taylor MS, 2013, CELL, V155, P1034, DOI 10.1016/j.cell.2013.10.021; Tchasovnikarova IA, 2017, NAT GENET, V49, P1035, DOI 10.1038/ng.3878; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227; Wagstaff BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019672	42	136	139	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					228	+		10.1038/nature25179	http://dx.doi.org/10.1038/nature25179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29211708	Green Accepted			2022-12-28	WOS:000419794800041
J	Nuzzo, JB; Cicero, AJ; Inglesby, TV				Nuzzo, Jennifer B.; Cicero, Anita J.; Inglesby, Thomas V.			The Importance of Continued US Investment to Sustain Momentum Toward Global Health Security	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nuzzo, Jennifer B.; Cicero, Anita J.; Inglesby, Thomas V.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hlth Secur, Baltimore, MD USA; [Nuzzo, Jennifer B.; Cicero, Anita J.; Inglesby, Thomas V.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nuzzo, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 621 E Pratt St,Ste 210, Baltimore, MD 21202 USA.	jnuzzo1@jhu.edu			GHSA; CDC	GHSA; CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. From March to September 2016, Ms Cicero's employer, the Center for Health Security received GHSA funding for a CDC-sponsored project in Benin and Togo, and Ms Cicero was partially supported by that project. No other disclosures were reported.	Global Health Security Agenda, ADV GLOB HLTH SEC AG; Kandel N, 2017, LANCET GLOB HEALTH, V5, pE857, DOI 10.1016/S2214-109X(17)30264-4; Katz R, 2015, LANCET GLOB HEALTH, V3, pE352, DOI 10.1016/S2214-109X(15)00025-X; United States Centers for Disease Control and Prevention (CDC), CONT PUBL HLTH THREA; United States Centers for Disease Control and Prevention (CDC), ADVANCING THE GLOBAL; [United States Department of State Secretary of State RexW], 2017, TILL GRAND CHALL ANN; US (United States White House Office of the Press Secretary), 2014, GLOB HLTH SEC AG GET	7	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2423	2424		10.1001/jama.2017.17188	http://dx.doi.org/10.1001/jama.2017.17188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29192316				2022-12-28	WOS:000418720700015
J	Sachs, RE; Ginsburg, PB; Goldman, DP				Sachs, Rachel E.; Ginsburg, Paul B.; Goldman, Dana P.			Encouraging New Uses for Old Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sachs, Rachel E.] Washington Univ, Sch Law, St Louis, MO USA; [Ginsburg, Paul B.] Brookings Inst, Leonard D Schaeffer Hlth Policy Studies, Washington, DC 20036 USA; [Ginsburg, Paul B.] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Goldman, Dana P.] Univ Southern Calif, Publ Policy Pharm & Econ, Verna & Peter Dauterive Hall,635 Downey Way, Los Angeles, CA 90089 USA	Washington University (WUSTL); Brookings Institution; University of Southern California; University of Southern California	Goldman, DP (corresponding author), Univ Southern Calif, Publ Policy Pharm & Econ, Verna & Peter Dauterive Hall,635 Downey Way, Los Angeles, CA 90089 USA.	dana.goldman@usc.edu	Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	Brookings Institution; USC-Brookings Schaeffer Initiative for Health Policy; Schaeffer Center for Health Policy and Economics	Brookings Institution; USC-Brookings Schaeffer Initiative for Health Policy; Schaeffer Center for Health Policy and Economics	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Sachs reported receiving grants from the Brookings Institution. Dr Ginsburg reported receiving grants from USC-Brookings Schaeffer Initiative for Health Policy. Dr Goldman reported receiving grants from the Schaeffer Center for Health Policy and Economics, and serves a consultant to Precision Health Economics, a health care consultancy that provides services to the life sciences industry, and holds equity in its parent company, Precision Medicine Group.	Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Prakash S, TIMELINE RISE FALL V; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Zissimopoulos JM, 2017, JAMA NEUROL, V74, P225, DOI [10.1001/jamaneurol.2016.3783, 10.1001/ja]	4	23	24	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2017	318	24					2421	2422		10.1001/jama.2017.17535	http://dx.doi.org/10.1001/jama.2017.17535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ9ZO	29204602				2022-12-28	WOS:000418720700014
J	Chou, R; Korthuis, PT; McCarty, D; Coffin, PO; Griffin, JC; Davis-O'Reilly, C; Grusing, S; Daya, M				Chou, Roger; Korthuis, P. Todd; McCarty, Dennis; Coffin, Phillip O.; Griffin, Jessica C.; Davis-O'Reilly, Cynthia; Grusing, Sara; Daya, Mohamud			Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							INTRAMUSCULAR NALOXONE; PREHOSPITAL TREATMENT; INTRANASAL NALOXONE; UNITED-STATES; DEATHS; EPIDEMIC; REFUSAL; TRIAL	Background: Naloxone is effective for reversing opioid overdose, but optimal strategies for out-of-hospital use are uncertain. Purpose: To synthesize evidence on 1) the effects of naloxone route of administration and dosing for suspected opioid overdose in out-of-hospital settings on mortality, reversal of overdose, and harms, and 2) the need for transport to a health care facility after reversal of overdose with naloxone. Data Sources: Ovid MEDLINE (1946 through September 2017), PsycINFO, Cochrane Central Register of Controlled Trials, CINAHL, U.S. Food and Drug Administration (FDA) materials, and reference lists. Study Selection: English-language cohort studies and randomized trials that compared different doses of naloxone, administration routes, or transport versus nontransport after reversal of overdose with naloxone. Main outcomes were mortality, reversal of overdose, recurrence of overdose, and harms. Data Extraction: Dual extraction and quality assessment of individual studies; consensus assessment of overall strength of evidence (SOE). Data Synthesis: Of 13 eligible studies, 3 randomized controlled trials and 4 cohort studies compared different administration routes. At the same dose (2 mg), 1 trial found similar efficacy between higher-concentration intranasal naloxone (2 mg/mL) and intramuscular naloxone, and 1 trial found that lowerconcentration intranasal naloxone (2 mg/5 mL) was less effective than intramuscular naloxone but was associated with decreased risk for agitation (low SOE). Evidence was insufficient to evaluate other comparisons of route of administration. Six uncontrolled studies reported low rates of death and serious adverse events (0% to 1.25%) in nontransported patients after successful naloxone treatment. Limitation: There were few studies, all had methodological limitations, and none evaluated FDA-approved autoinjectors or highly concentrated intranasal formulations. Conclusion: Higher-concentration intranasal naloxone (2 mg/mL) seems to have efficacy similar to that of intramuscular naloxone for reversal of opioid overdose, with no difference in adverse events. Nontransport after reversal of overdose with naloxone seems to be associated with a low rate of serious harms, but no study evaluated risks of transport versus nontransport.	[Chou, Roger; Korthuis, P. Todd; McCarty, Dennis; Griffin, Jessica C.; Davis-O'Reilly, Cynthia; Grusing, Sara; Daya, Mohamud] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [Coffin, Phillip O.] San Francisco Dept Publ Hlth, 25 Ness Ave,Suite 500, San Francisco, CA 94102 USA	Oregon Health & Science University; San Francisco Department of Public Health	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu	Daya, Mohamud R/A-9322-2012; Coffin, Phillip O/G-3286-2012	Coffin, Phillip O/0000-0002-3891-6570; Chou, Roger/0000-0001-9889-8610; Korthuis, Philip/0000-0001-5556-3597	Agency for Healthcare Research and Quality [PROSPERO: CRD42016053891]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42016053891)	Amphastar Pharmaceuticals, 2016, NAL M JOINT M AN AN; Amphastar Pharmaceuticals, 2016, FDA ADV COMM BRIEF M; [Anonymous], [No title captured]; Boyd JJ, 2006, ACTA ANAESTH SCAND, V50, P1266, DOI 10.1111/j.1399-6576.2006.01172.x; Brodt E, AHRQ PUBLICATION; Dailey M, SOC AC EM MED 2017 O; Fiore K., 2016, MEDPAGE TODAY; Frank RG, 2017, NEW ENGL J MED, V376, P605, DOI 10.1056/NEJMp1615145; Galati SA, 2013, CLIN REV EVZIO NALOX; Graham E, 2016, CRD42016053891; Insys Development Company, 2016, NAL TREATM OP OV; Kaleo, 2016, JOINT M AN AN DRUG P; Kelly AM, 2005, MED J AUSTRALIA, V182, P24, DOI 10.5694/j.1326-5377.2005.tb06550.x; Kerr D, 2009, ADDICTION, V104, P2067, DOI 10.1111/j.1360-0443.2009.02724.x; Krieter P, 2016, J CLIN PHARMACOL, V56, P1243, DOI 10.1002/jcph.759; Lavonas EJ, 2015, CIRCULATION, V132, pS501, DOI 10.1161/CIR.0000000000000264; Levine M, 2016, PREHOSP EMERG CARE, V20, P566, DOI 10.3109/10903127.2016.1142626; Merlin MA, 2010, AM J EMERG MED, V28, P296, DOI 10.1016/j.ajem.2008.12.009; National Association of State EMS Officials, NATIONAL MODEL EMS C; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Robertson TM, 2009, PREHOSP EMERG CARE, V13, P512, DOI 10.1080/10903120903144866; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Rudolph SS, 2011, RESUSCITATION, V82, P1414, DOI 10.1016/j.resuscitation.2011.06.027; Sabzghabaee AM, 2014, ARCH MED SCI, V10, P309, DOI 10.5114/aoms.2014.42584; Schumann H, 2008, CLIN TOXICOL, V46, P501, DOI 10.1080/15563650701877374; Somerville NJ, 2017, MMWR-MORBID MORTAL W, V66, P382, DOI 10.15585/mmwr.mm6614a2; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Sutter ME, 2017, ACAD EMERG MED, V24, P106, DOI 10.1111/acem.13034; Tomassoni AJ, 2017, MMWR-MORBID MORTAL W, V66, P107, DOI 10.15585/mm6604a4; U. S. Department of Health and Human Services, 2017, OV INF EXP MED ASS 1; U. S. Department of Health and Human Services, 2016, OV INF HIV HCV REL 1; U. S. Food and Drug Administration, 2016, 2016 M MAT AN AN DRU; U. S. Food and Drug Administration, 2016, FDA BRIEF DOC JINT M; U. S. Food and Drug Administration, 2016, FDA ADV COMM MOST AP; U. S. Preventive Services Task Force, 2015, US PREV SERVTASK FOR; Vilke G M, 1999, Prehosp Emerg Care, V3, P183, DOI 10.1080/10903129908958933; Vilke GM, 2003, ACAD EMERG MED, V10, P893, DOI 10.1197/aemj.10.8.893; Wampler DA, 2011, PREHOSP EMERG CARE, V15, P320, DOI 10.3109/10903127.2011.569854; Wanger K, 1998, ACAD EMERG MED, V5, P293, DOI 10.1111/j.1553-2712.1998.tb02707.x; Wermeling DP, 2013, DRUG DELIV TRANSL RE, V3, P63, DOI 10.1007/s13346-012-0092-0; WHO, 2014, COMM MAN OP OV; Willman MW, 2017, CLIN TOXICOL, V55, P81, DOI 10.1080/15563650.2016.1253846	43	38	39	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2017	167	12					867	+		10.7326/M17-2224	http://dx.doi.org/10.7326/M17-2224			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ3SD	29181532				2022-12-28	WOS:000418276000015
J	Kaminski, M				Kaminski, Martin			An Anglo-American medical lexicon	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kaminski, Martin] Tufts Univ, Sch Med, Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Kaminski, M (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA.	mkaminski@tuftsmedicalcenter.org							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2017	359								j5567	10.1136/bmj.j5567	http://dx.doi.org/10.1136/bmj.j5567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8OI	29222083				2022-12-28	WOS:000417904000002
J	Murphy, DR; Schneider, MJ; Bise, CG; Justice, B				Murphy, Donald R.; Schneider, Michael J.; Bise, Christopher G.; Justice, Brian			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter									[Murphy, Donald R.] Brown Univ, Care New England Hlth Syst, Providence, RI 02912 USA; [Murphy, Donald R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Schneider, Michael J.; Bise, Christopher G.] Univ Pittsburgh, Pittsburgh, PA USA; [Justice, Brian] Excellus BlueCross BlueShield, Rochester, NY USA	Brown University; Care New England; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Murphy, DR (corresponding author), Brown Univ, Care New England Hlth Syst, Providence, RI 02912 USA.; Murphy, DR (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.			Bise, Christopher/0000-0002-3714-5671				Goff I, 2016, CLIN RHEUMATOL, V35, P507, DOI 10.1007/s10067-014-2767-z; Murphy DR, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-17; Paskowski I, 2011, J MANIP PHYSIOL THER, V34, P98, DOI 10.1016/j.jmpt.2010.12.004; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Verbeek J, 2004, SPINE, V29, P2309, DOI 10.1097/01.brs.0000142007.38256.7f	5	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					833	834		10.7326/L17-0471	http://dx.doi.org/10.7326/L17-0471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204612				2022-12-28	WOS:000417135900021
J	Smith, RB; Fecht, D; Gulliver, J; Beevers, SD; Dajnak, D; Blangiardo, M; Ghosh, RE; Hansell, AL; Kelly, FJ; Anderson, HR; Toledano, MB				Smith, Rachel B.; Fecht, Daniela; Gulliver, John; Beevers, Sean D.; Dajnak, David; Blangiardo, Marta; Ghosh, Rebecca E.; Hansell, Anna L.; Kelly, Frank J.; Anderson, H. Ross; Toledano, Mireille B.			Impact of London's road traffic air and noise pollution on birth weight: retrospective population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINE PARTICULATE MATTER; LOS-ANGELES-COUNTY; FULL-TERM INFANTS; AMBIENT-TEMPERATURE; GESTATIONAL-AGE; FETAL-GROWTH; EXPOSURE; PREGNANCY; PRETERM; RISK	Objective To investigate the relation between exposure to both air and noise pollution from road traffic and birth weight outcomes. Design Retrospective population based cohort study. Setting Greater London and surrounding counties up to the M25 motorway (2317 km(2)), UK, from 2006 to 2010. Participants 540 365 singleton term live births. Main outcome measures Term low birth weight (LBW), small for gestational age (SGA) at term, and term birth weight. Results Average air pollutant exposures across pregnancy were 41 mu g/m(3) nitrogen dioxide (NO2), 73 mu g/m(3) nitrogen oxides (NOx), 14 mu g/m(3) particulate matter with aerodynamic diameter <2.5 mu m (PM2.5), 23 mu g/m(3) particulate matter with aerodynamic diameter <10 mu m (PM10), and 32 mu g/m(3) ozone (O-3). Average daytime (L-Aeq,L-16hr) and night-time (L-night) road traffic A-weighted noise levels were 58 dB and 53 dB respectively. Interquartile range increases in NO2, NOx, PM2.5, PM10, and source specific PM2.5 from traffic exhaust (PM2.5 traffic exhaust) and traffic non-exhaust (brake or tyre wear and resuspension) (PM2.5 traffic non-exhaust) were associated with 2% to 6% increased odds of term LBW, and 1% to 3% increased odds of term SGA. Air pollutant associations were robust to adjustment for road traffic noise. Trends of decreasing birth weight across increasing road traffic noise categories were observed, but were strongly attenuated when adjusted for primary traffic related air pollutants. Only PM2.5 traffic (exhaust) and PM2.5 were consistently associated with increased risk of term LBW after adjustment for each of the other air pollutants. It was estimated that 3% of term LBW cases in London are directly attributable to residential exposure to PM2.5 > 13.8 mu g/m(3) during pregnancy. Conclusions The findings suggest that air pollution from road traffic in London is adversely affecting fetal growth. The results suggest little evidence for an independent exposure-response effect of traffic related noise on birth weight outcomes.	[Smith, Rachel B.; Gulliver, John; Blangiardo, Marta; Toledano, Mireille B.] Imperial Coll London, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England; [Smith, Rachel B.; Hansell, Anna L.; Kelly, Frank J.; Toledano, Mireille B.] Kings Coll London, NIHR HPRU Hlth Impact Environm Hazards, London, England; [Fecht, Daniela; Ghosh, Rebecca E.; Hansell, Anna L.] Imperial Coll London, UK Small Area Hlth Stat Unit, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, London, England; [Beevers, Sean D.; Dajnak, David; Kelly, Frank J.; Anderson, H. Ross] Kings Coll London, Fac Life Sci & Med, Environm Res Grp, MRC PHE Ctr Environm & Hlth, London, England; [Anderson, H. Ross] St Georges Univ London, Populat Hlth Res Inst, London, England	Imperial College London; University of London; King's College London; Imperial College London; University of London; King's College London; St Georges University London	Toledano, MB (corresponding author), Imperial Coll London, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England.; Toledano, MB (corresponding author), Kings Coll London, NIHR HPRU Hlth Impact Environm Hazards, London, England.	m.toledano@imperial.ac.uk	Kelly, Frank/ABG-3411-2021; Kelly, Frank J/C-6125-2009; Anderson, Hugh R/A-7417-2016	Kelly, Frank/0000-0003-2558-8392; Kelly, Frank J/0000-0003-2558-8392; Hansell, Anna/0000-0001-9904-7447; Fecht, Daniela/0000-0002-0738-0013; Smith, Rachel/0000-0003-4000-2919; Ghosh, Rebecca/0000-0001-6009-3040; Gulliver, John/0000-0003-3423-2013	UK Natural Environment Research Council; Medical Research Council (MRC); Economic and Social Research Council; Department of Environment, Food and Rural Affairs; Department of Health (DH) through the cross research council Environmental Exposures & Health Initiative [NE/I00789X/1, NE/I008039/1]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King's College London; PHE as part of the MRC-PHE Centre for Environment and Health; UK MRC [MR/L01341X/1]; Public Health England (PHE); MRC [G0801056, MR/L01341X/1] Funding Source: UKRI; NERC [NE/I008039/1, NE/I00789X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1, G0801056, G0801056B] Funding Source: researchfish; Natural Environment Research Council [NE/I00789X/1, NE/I008039/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Department of Health (DH) through the cross research council Environmental Exposures & Health Initiative; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King's College London; PHE as part of the MRC-PHE Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England (PHE); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council, Medical Research Council (MRC), Economic and Social Research Council, Department of Environment, Food and Rural Affairs, and Department of Health (DH) (NE/I00789X/1, NE/I008039/1) through the cross research council Environmental Exposures & Health Initiative. The research was part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact of Environmental Hazards at King's College London in partnership with Public Health England (PHE). The work of the UK SAHSU is funded by PHE as part of the MRC-PHE Centre for Environment and Health, funded also by the UK MRC (MR/L01341X/1). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, PHE, or DH. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication.	[Anonymous], 2016, BIRTH TRENDS LONDON; [Anonymous], 2010, LONDON ATMOSPHERIC E; [Anonymous], 2016, BIRTHS MOTHERS USUAL; ARBUCKLE TE, 1993, OBSTET GYNECOL, V81, P39; Arroyo V, 2016, ENVIRON RES, V145, P162, DOI 10.1016/j.envres.2015.11.034; Auger N, 2014, EPIDEMIOLOGY, V25, P344, DOI 10.1097/EDE.0000000000000074; Basu R, 2014, ENVIRON RES, V128, P42, DOI 10.1016/j.envres.2013.10.008; Basu R, 2010, AM J EPIDEMIOL, V172, P1108, DOI 10.1093/aje/kwq170; Beevers S, TRAFFIC PROJECT SUPP; Beevers SD, 2013, J EXPO SCI ENV EPID, V23, P647, DOI 10.1038/jes.2013.6; Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P1118, DOI 10.1289/ehp.9759; Bell ML, 2010, EPIDEMIOLOGY, V21, P884, DOI 10.1097/EDE.0b013e3181f2f405; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Clemente DBP, 2016, ENVIRON HEALTH PERSP, V124, P659, DOI 10.1289/ehp.1408981; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dadvand P, 2014, EPIDEMIOLOGY, V25, P518, DOI 10.1097/EDE.0000000000000107; Darrow LA, 2011, ENVIRON HEALTH PERSP, V119, P731, DOI 10.1289/ehp.1002785; Douglas P, 2016, INT J HYG ENVIR HEAL, V219, P372, DOI 10.1016/j.ijheh.2016.03.004; Gehring U, 2014, EPIDEMIOLOGY, V25, P351, DOI 10.1097/EDE.0000000000000073; Graham JCC, 2007, 463 DEP WORK PENS RE; Gulliver J, 2015, ENVIRON MODELL SOFTW, V74, P183, DOI 10.1016/j.envsoft.2014.12.022; Ha SD, 2017, ENVIRON RES, V155, P394, DOI 10.1016/j.envres.2017.02.021; Hjortebjerg D, 2016, ENVIRON INT, V95, P1, DOI 10.1016/j.envint.2016.07.003; Lamichhane Dirga Kumar, 2015, Environ Health Toxicol, V30, pe2015011, DOI 10.5620/eht.e2015011; Laurent O, 2016, ENVIRON INT, V92-93, P471, DOI 10.1016/j.envint.2016.04.034; Laurent O, 2014, ENVIRON RES, V134, P488, DOI 10.1016/j.envres.2014.05.003; Lim Jung Sub, 2014, Ann Pediatr Endocrinol Metab, V19, P146, DOI 10.6065/apem.2014.19.3.146; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Moser Kath, 2008, Health Stat Q, P15; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Nieuwenhuijsen MJ, 2008, ENVIRON HEALTH PERSP, V116, P216, DOI 10.1289/ehp.10636; Norris T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006743; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Palagini L, 2014, SLEEP MED, V15, P853, DOI 10.1016/j.sleep.2014.02.013; Pan H, 2011, VERSION, V2, P54; Rich DQ, 2015, ENVIRON HEALTH PERSP, V123, P880, DOI 10.1289/ehp.1408795; Ristovska G, 2014, INT J ENV RES PUB HE, V11, P7931, DOI 10.3390/ijerph110807931; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royal College of Physicians, 2016, EV BREATH WE TAK LIF; Salihu HM, 2012, MATERN CHILD HLTH J, V16, P1679, DOI 10.1007/s10995-011-0868-8; Schembari A, 2015, ENVIRON HEALTH PERSP, V123, P1208, DOI 10.1289/ehp.1408675; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Smith RB, 2016, ENVIRON HEALTH PERSP, V124, P681, DOI 10.1289/ehp.1409480; Stansfeld SA, 2015, INT J ENV RES PUB HE, V12, P12735, DOI 10.3390/ijerph121012735; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Sun XL, 2016, ENVIRON POLLUT, V211, P38, DOI 10.1016/j.envpol.2015.12.022; Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7; Tin W, 1997, BRIT J OBSTET GYNAEC, V104, P180, DOI 10.1111/j.1471-0528.1997.tb11041.x; Toledano MB, 2005, ENVIRON HEALTH PERSP, V113, P225, DOI 10.1289/ehp.7111; Tunstall H, 2010, SOC SCI MED, V71, P786, DOI 10.1016/j.socscimed.2010.04.013; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; van den Hooven EH, 2012, ENVIRON HEALTH PERSP, V120, P1753, DOI 10.1289/ehp.1204918; WHO (WorldHealthOrganization), 2009, NIGHT NOIS GUID EUR; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; World Health Organisation, 2016, INT CLASS DIS REL HL; Wu TN, 1996, AM J EPIDEMIOL, V143, P792	60	95	99	5	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2017	359								j5299	10.1136/bmj.j5299	http://dx.doi.org/10.1136/bmj.j5299			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP4AL	29208602	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000417559000002
J	Bui, DT; Chua, KJ; Gordon, JM				Duc Thuan Bui; Chua, Kian Jon; Gordon, Jeffrey M.			Comment on "Water harvesting from air with metal-organic frameworks powered by natural sunlight"	SCIENCE			English	Editorial Material							THERMODYNAMIC PERSPECTIVE; SYSTEM	Kim et al. (Reports, 28 April 2017, p. 430) presented results for the solar-driven harvesting of water from air via metal-organic frameworks as a prodigious potential advance toward remedying global water shortages. Basic thermodynamics and a survey of multiple off-the-shelf technologies show that their approach is vastly inferior in efficiency (and thereby in feasibility) to available alternatives.	[Duc Thuan Bui; Chua, Kian Jon] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore; [Gordon, Jeffrey M.] Ben Gurion Univ Negev, Dept Solar Energy & Environm Phys, Jacob Blaustein Inst Desert Res, Sede Boqer Campus, IL-84990 Sede Boqer, Israel	National University of Singapore; Ben Gurion University	Gordon, JM (corresponding author), Ben Gurion Univ Negev, Dept Solar Energy & Environm Phys, Jacob Blaustein Inst Desert Res, Sede Boqer Campus, IL-84990 Sede Boqer, Israel.	jeff@bgu.ac.il	Chua, Kian Jon Ernest/D-1502-2009	Chua, Kian Jon Ernest/0000-0001-9293-7471; Bui, Duc Thuan/0000-0002-6040-9145				Bergmair D, 2014, DESALINATION, V339, P26, DOI 10.1016/j.desal.2014.02.007; Bui DT, 2017, ENERGY, V132, P106, DOI 10.1016/j.energy.2017.05.075; Gad HE, 2001, RENEW ENERG, V22, P541, DOI 10.1016/S0960-1481(00)00112-9; Gordon JM, 2016, DESALINATION, V386, P13, DOI 10.1016/j.desal.2016.02.030; Hamed AM, 2000, RENEW ENERG, V19, P625, DOI 10.1016/S0960-1481(99)00068-3; Kabeel AE, 2007, RENEW ENERG, V32, P157, DOI 10.1016/j.renene.2006.01.015; Kim H, 2017, SCIENCE, V356, P430, DOI 10.1126/science.aam8743; Lee J, 2012, INT J REFRIG, V35, P1940, DOI 10.1016/j.ijrefrig.2012.07.009; Li J, 2007, DESALINATION, V212, P123, DOI 10.1016/j.desal.2006.10.006; Mitsubishi Plastics Inc.,, 2011, ZEOL WAT VAP ADS AQS; Oh SJ, 2016, ENERG BUILDINGS, V127, P183, DOI 10.1016/j.enbuild.2016.05.073; Skywater Corp, 2017, MOD SKYW 300; SunToWater Technologies LLC, 2017, 2 STAG DES SYST; TerraLab USA, 2017, MOD WB12 WB 25 WB75; Watair Inc, 2012, MOD CI 7500; Water-Gen Ltd, 2016, MOD GEN 350G	16	9	9	18	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367								10.1126/science.aao0791	http://dx.doi.org/10.1126/science.aao0791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191876				2022-12-28	WOS:000416584000001
J	Silberstein, SD; Dodick, DW; Bigal, ME; Yeung, PP; Goadsby, PJ; Blankenbiller, T; Grozinski-Wolff, M; Yang, RH; Ma, YJ; Aycardi, E				Silberstein, Stephen D.; Dodick, David W.; Bigal, Marcelo E.; Yeung, Paul P.; Goadsby, Peter J.; Blankenbiller, Tricia; Grozinski-Wolff, Melissa; Yang, Ronghua; Ma, Yuju; Aycardi, Ernesto			Fremanezumab for the Preventive Treatment of Chronic Migraine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED PHASE; DOUBLE-BLIND; CGRP; ONABOTULINUMTOXINA; TOLERABILITY; MEDICATIONS; TEV-48125; ANTIBODY; SAFETY; BURDEN	BACKGROUND Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investigated as a preventive treatment for migraine. We compared two fremanezumab dose regimens with placebo for the prevention of chronic migraine. METHODS In this phase 3 trial, we randomly assigned patients with chronic migraine (defined as headache of any duration or severity on >= 15 days per month and migraine on >= 8 days per month) in a 1:1:1 ratio to receive fremanezumab quarterly (a single dose of 675 mg at baseline and placebo at weeks 4 and 8), fremanezumab monthly (675 mg at baseline and 225 mg at weeks 4 and 8), or matching placebo. Both fremanezumab and placebo were administered by means of subcutaneous injection. The primary end point was the mean change from baseline in the average number of headache days (defined as days in which headache pain lasted >= 4 consecutive hours and had a peak severity of at least a moderate level or days in which acute migraine-specific medication [triptans or ergots] was used to treat a headache of any severity or duration) per month during the 12 weeks after the first dose. RESULTS Of 1130 patients enrolled, 376 were randomly assigned to fremanezumab quarterly, 379 to fremanezumab monthly, and 375 to placebo. The mean number of baseline headache days (as defined above) per month was 13.2, 12.8, and 13.3, respectively. The least-squares mean (+/- SE) reduction in the average number of headache days per month was 4.3 +/- 0.3 with fremanezumab quarterly, 4.6 +/- 0.3 with fremanezumab monthly, and 2.5 +/- 0.3 with placebo (P<0.001 for both comparisons with placebo). The percentage of patients with a reduction of at least 50% in the average number of headache days per month was 38% in the fremanezumab-quarterly group, 41% in the fremanezu-mab-monthly group, and 18% in the placebo group (P<0.001 for both comparisons with placebo). Abnormalities of hepatic function occurred in 5 patients in each fremanezumab group (1%) and 3 patients in the placebo group (<1%). CONCLUSIONS Fremanezumab as a preventive treatment for chronic migraine resulted in a lower frequency of headache than placebo in this 12-week trial. Injection-site reactions to the drug were common. The long-term durability and safety of fremanezumab require further study.	[Silberstein, Stephen D.] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA; [Bigal, Marcelo E.; Yeung, Paul P.; Blankenbiller, Tricia; Grozinski-Wolff, Melissa; Yang, Ronghua; Ma, Yuju; Aycardi, Ernesto] Teva Pharmaceut, Frazer, PA USA; [Dodick, David W.] Mayo Clin Arizona, Phoenix, AZ USA; [Goadsby, Peter J.] Kings Coll London, Natl Inst Hlth Res, Wellcome Trust Kings Clin Res Facil, London, England	Jefferson University; Mayo Clinic; Mayo Clinic Phoenix; University of London; King's College London	Silberstein, SD (corresponding author), Jefferson Headache Ctr, 900 Walnut St,2nd Fl,Suite 200, Philadelphia, PA 19107 USA.	silberstein@jefferson.edu	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904	Teva Pharmaceuticals; Alder BioPharmaceuticals; Allergan; Amgen; Automatic Technologies; Avanir Pharmaceuticals; Curelator; Depomed; Dr. Reddy's Laboratories; electroCore; Eli Lilly; eNeura; Insys Therapeutics; Supernus Pharmaceuticals; Theranica Bio-Electronics; Trigemina; Acorda Therapeutics; Biocentric; Biohaven; Boston Scientific; Charleston Laboratories; CoLucid Pharmaceuticals; Ladenburg Thalmann; Magellan; Merck; Neuro Assessment Systems; Pfizer; Promius Pharma; Tonix Pharmaceuticals; Xenon Pharmaceuticals; Zosano Pharma; Akita Biomedical; Alder Bio-Pharmaceuticals; Cipla; Novartis; Quest Diagnostics; Scion Pharmaceuticals	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Alder BioPharmaceuticals; Allergan(AbbVieAllergan); Amgen(Amgen); Automatic Technologies; Avanir Pharmaceuticals; Curelator; Depomed; Dr. Reddy's Laboratories; electroCore; Eli Lilly(Eli Lilly); eNeura; Insys Therapeutics; Supernus Pharmaceuticals; Theranica Bio-Electronics; Trigemina; Acorda Therapeutics; Biocentric; Biohaven; Boston Scientific(Boston Scientific); Charleston Laboratories; CoLucid Pharmaceuticals; Ladenburg Thalmann; Magellan; Merck(Merck & Company); Neuro Assessment Systems; Pfizer(Pfizer); Promius Pharma(Dexcel Pharma); Tonix Pharmaceuticals; Xenon Pharmaceuticals; Zosano Pharma(Dexcel Pharma); Akita Biomedical; Alder Bio-Pharmaceuticals; Cipla; Novartis(Novartis); Quest Diagnostics; Scion Pharmaceuticals	Supported by Teva Pharmaceuticals.; Dr. Silberstein reports receiving consulting fees from Alder BioPharmaceuticals, Allergan, Amgen, Automatic Technologies, Avanir Pharmaceuticals, Curelator, Depomed, Dr. Reddy's Laboratories, electroCore, Eli Lilly, eNeura, Insys Therapeutics, Supernus Pharmaceuticals, Teva Pharmaceuticals, Theranica Bio-Electronics, and Trigemina; Dr. Dodick, receiving consulting fees from Acorda Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, Automatic Technologies, Biocentric, Biohaven, Boston Scientific, Charleston Laboratories, CoLucid Pharmaceuticals, Dr. Reddy's Laboratories, Eli Lilly, eNeura, Insys Therapeutics, Ladenburg Thalmann, Magellan, Merck, Neuro Assessment Systems, Pfizer, Promius Pharma, Teva Pharmaceuticals, Tonix Pharmaceuticals, Trigemina, Xenon Pharmaceuticals, and Zosano Pharma, owning stock options in Epien Medical, Mobile Health, and Nocira, and serving on the board of King-Devick Test; Dr. Bigal, being an employee of Teva Pharmaceuticals; Dr. Yeung, being an employee of Teva Pharmaceuticals; Dr. Goadsby, receiving consulting fees from Akita Biomedical, Alder Bio-Pharmaceuticals, Avanir Pharmaceuticals, Cipla, Dr. Reddy's Laboratories, electroCore, Novartis, Pfizer, Quest Diagnostics, Scion Pharmaceuticals, and Teva Pharmaceuticals, receiving consulting fees and grant support from Allergan, Amgen, Eli Lilly, and eNeura, receiving consulting fees from and holding stock options in Trigemina, and holding a patent, licensed to eNeura, for "Methods and systems for preventative migraine headache treatment" (WO2016090333 A1); Ms. Blankenbiller, being an employee of Teva Pharmaceuticals; Ms. GrozinskiWolff, being an employee of Teva Pharmaceuticals; Dr. Yang, being an employee of Teva Pharmaceuticals; Ms. Ma, being an employee of Teva Pharmaceuticals; and Dr. Aycardi, being an employee of Teva Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.; We thank the patients who participated in this trial and their families; all the investigators, site personnel, and coordinating investigators; and Rhonda Charles, Ph.D. (Chameleon Communications International with funding from Teva Pharmaceuticals), for editorial assistance with an earlier version of the manuscript.	Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2016, NEUROLOGY, V87, P41, DOI 10.1212/WNL.0000000000002801; Bigal ME, 2015, LANCET NEUROL, V14, P1091, DOI 10.1016/S1474-4422(15)00245-8; Bigal ME, 2014, CEPHALALGIA, V34, P483, DOI 10.1177/0333102413517775; Blumenfeld AM, 2013, HEADACHE, V53, P644, DOI 10.1111/head.12055; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hepp Z, 2015, CEPHALALGIA, V35, P478, DOI 10.1177/0333102414547138; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2015, HEADACHE, V55, P103, DOI 10.1111/head.12505_2; Manack AN, 2011, CURR PAIN HEADACHE R, V15, P70, DOI 10.1007/s11916-010-0157-z; Pellesi L, 2017, CLIN PHARM DRUG DEV; Rendas-Baum R, 2014, HEALTH QUAL LIFE OUT, V12, P1, DOI [10.1186/s12955-014-0117-0, DOI 10.1186/s12955-014-0117-0, DOI 10.1186/S12955-014-0117-0]; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Walter S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0476-1	20	367	382	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2113	2122		10.1056/NEJMoa1709038	http://dx.doi.org/10.1056/NEJMoa1709038			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO1VI	29171818	Green Published, Bronze			2022-12-28	WOS:000416555000005
J	Goodwin, ML				Goodwin, Matthew L.			Salt of the Earth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goodwin, Matthew L.] Univ Utah, Dept Orthopaed, 590 Wakara Way, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Goodwin, ML (corresponding author), Univ Utah, Dept Orthopaed, 590 Wakara Way, Salt Lake City, UT 84108 USA.	matthewlgoodwin@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1977	1978		10.1001/jama.2017.15843	http://dx.doi.org/10.1001/jama.2017.15843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183081				2022-12-28	WOS:000416317600015
J	Rubin, R				Rubin, Rita			Suicide Rates Higher in Rural Areas for Most Demographic Groups	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1969	1969		10.1001/jama.2017.17273	http://dx.doi.org/10.1001/jama.2017.17273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183084				2022-12-28	WOS:000416317600011
J	Slomski, A				Slomski, Anita			Psychosocial Intervention Improves Adherence to Antidepressants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1968	1968		10.1001/jama.2017.17955	http://dx.doi.org/10.1001/jama.2017.17955			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183073				2022-12-28	WOS:000416317600009
J	Sow, C; Yonezawa, S; Kitamura, S; Oka, T; Kuroki, K; Nakamura, F; Maeno, Y				Sow, Chanchal; Yonezawa, Shingo; Kitamura, Sota; Oka, Takashi; Kuroki, Kazuhiko; Nakamura, Fumihiko; Maeno, Yoshiteru			RETRACTED: Current-induced strong diamagnetism in the Mott insulator Ca2RuO4 (Retracted article. See vol. 368, pg. 376, 2020)	SCIENCE			English	Article; Retracted Publication							TRANSITION	Mott insulators can host a surprisingly diverse set of quantum phenomena when their frozen electrons are perturbed by various stimuli. Superconductivity, metal-insulator transition, and colossal magnetoresistance induced by element substitution, pressure, and magnetic field are prominent examples. Here we report strong diamagnetism in the Mott insulator calcium ruthenate (Ca2RuO4) induced by dc electric current. The application of a current density of merely 1 ampere per centimeter squared induces diamagnetism stronger than that in other nonsuperconducting materials. This change is coincident with changes in the transport properties as the system becomes semimetallic. These findings suggest that dc current may be a means to control the properties of materials in the vicinity of a Mott insulating transition.	[Sow, Chanchal; Yonezawa, Shingo; Maeno, Yoshiteru] Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan; [Kitamura, Sota] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Kitamura, Sota; Oka, Takashi] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Oka, Takashi] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Kuroki, Kazuhiko] Osaka Univ, Grad Sch Sci, Dept Phys, Osaka 5600043, Japan; [Nakamura, Fumihiko] Kurume Inst Technol, Dept Educ & Creat Engn, Fukuoka 8300052, Japan	Kyoto University; University of Tokyo; Max Planck Society; Max Planck Society; Osaka University	Sow, C; Maeno, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Phys, Kyoto 6068502, Japan.	chanchal@scphys.kyoto-u.ac.jp; maeno@scphys.kyoto-u.ac.jp	Oka, Takashi/C-4350-2011; Kitamura, Sota/N-6794-2018; Yonezawa, Shingo/J-2317-2016	Oka, Takashi/0000-0002-2235-6775; Kitamura, Sota/0000-0003-3083-2353; Yonezawa, Shingo/0000-0002-7476-3604; Oka, Takashi/0000-0003-1746-5368	Japan Society for the Promotion of Science (JSPS) [JP26247060, JP15H05852, JP15K21717, JP17H06136]; JSPS; Japan Science and Technology Agency (JST) [2015-PM12-05-01]; JSPS International Research Fellowship [JP17F17027]; Advanced Leading Graduate Course for Photon Science (ALPS); Grants-in-Aid for Scientific Research [15H02113, 15K21717] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JSPS International Research Fellowship; Advanced Leading Graduate Course for Photon Science (ALPS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge discussions with J. G. Bednorz. We also acknowledge technical support from M. P. Jimenez-Segura. This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (nos. JP26247060, JP15H05852, JP15K21717, and JP17H06136), the JSPS Core-to-Core program and the Impulsing Paradigm Change through Disruptive Technologies Program (ImPACT) from Japan Science and Technology Agency (JST) (grant no. 2015-PM12-05-01). C.S. acknowledges the support of the JSPS International Research Fellowship (grant no. JP17F17027). S.K. acknowledges the support of the Advanced Leading Graduate Course for Photon Science (ALPS). All the relevant data are available upon request from the authors.	Ajisaka S, 2009, PROG THEOR PHYS, V121, P1289, DOI 10.1143/PTP.121.1289; Alexander CS, 1999, PHYS REV B, V60, pR8422, DOI 10.1103/PhysRevB.60.R8422; Braden M, 1998, PHYS REV B, V58, P847, DOI 10.1103/PhysRevB.58.847; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Friedt O, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.174432; FUKUYAMA H, 1971, PROG THEOR PHYS, V45, P704, DOI 10.1143/PTP.45.704; Fuseya Y, 2015, J PHYS SOC JPN, V84, DOI 10.7566/JPSJ.84.012001; Konik RM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086407; Kubota M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.026401; Landau L, 1930, Z PHYS, V64, P629, DOI 10.1007/BF01397213; Liu Y, 2016, J MAGN MAGN MATER, V408, P73, DOI 10.1016/j.jmmm.2016.01.100; Maeno Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011009; Mitra A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.220404; Mizokawa T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132410; Nakamura F, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.220402; Nakamura F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02536; Nakatsuji S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.146401; Nakatsuji S, 2000, PHYS REV LETT, V84, P2666, DOI 10.1103/PhysRevLett.84.2666; Nakatsuji S, 1997, J PHYS SOC JPN, V66, P1868, DOI 10.1143/JPSJ.66.1868; Nakatsuji S, 2000, PHYS REV B, V62, P6458, DOI 10.1103/PhysRevB.62.6458; Narlikar A. V., 1995, STUDIES HIGH TEMPERA, V14; Okazaki R, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.103702; Ren Y, 1998, NATURE, V396, P441, DOI 10.1038/24802; Ren Y, 2000, PHYS REV B, V62, P6577, DOI 10.1103/PhysRevB.62.6577; Shoenberg D., 1936, P R SOC LONDON, V156, P701, DOI [10.1098/rspa.1936.0176, DOI 10.1098/RSPA.1936.0176]; Steffens P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.094104; Yang KY, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174501; Zegkinoglou I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136401; Zhu ZW, 2012, NAT PHYS, V8, P89, DOI 10.1038/nphys2111	30	34	33	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1084	1087		10.1126/science.aah4297	http://dx.doi.org/10.1126/science.aah4297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170239	Green Submitted			2022-12-28	WOS:000416590400048
J	Williams, JG; Bachman, MW; Lyons, MD; Currie, BB; Brown, LH; Jones, AW; Cabanas, JG; Kronhaus, AK; Myers, JB				Williams, Jefferson G.; Bachman, Michael W.; Lyons, Michael D.; Currie, Benjamin B.; Brown, Lawrence H.; Jones, A. Wooten; Cabanas, Jose G.; Kronhaus, Alan K.; Myers, J. Brent			Improving Decisions About Transport to the Emergency Department for Assisted Living Residents Who Fall	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER-PEOPLE; CARE; RADIOGRAPHY; VALIDATION; POLICY	Background: Residents of assisted living facilities who fall may not be seriously ill or injured, but policies often require immediate transport to an emergency department regardless of the patient's condition. Objective: To determine whether unnecessary transport can be avoided. Design: Prospective cohort study. Setting: One large county with a single system of emergency medical services. Participants: Convenience sample of residents in 22 assisted living facilities served by 1 group of primary care physicians. Intervention: Paramedics providing emergency medical services followed a protocol that included consulting with a physician by telephone. Measurements: The number of transports after a fall and the number of time-sensitive conditions in nontransported patients. Results: Of the 1473 eligible residents, 953 consented to participate in the study (mean age, 86 years; 76% female) and 359 had 840 falls in 43 months. The protocol recommended non-transport after 553 falls. Eleven of these patients had a timesensitive condition. At least 7 of them received appropriate care: 4 requested and received transport despite the protocol recommendation, and 3 had minor injuries that were successfully managed on site. Three additional patients had fractures that were diagnosed by outpatient radiography. The final patient developed vomiting and diarrhea, started palliative care, and died 60 hours after the fall. At least 549 of the 553 patients (99.3% [95% CI, 98.2% to 99.8%]) with a protocol recommendation for non-transport received appropriate care. Limitation: The resources required for this program will preclude use in some locations. Conclusion: Shared decision making between paramedics and primary care physicians can prevent transport to the emergency department for many residents of assisted living facilities who fall.	[Williams, Jefferson G.; Bachman, Michael W.; Lyons, Michael D.; Currie, Benjamin B.; Cabanas, Jose G.; Myers, J. Brent] Wake Cty Emergency Med Serv, 331 South McDowell St, Raleigh, NC 27601 USA; Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Brown, Lawrence H.] Univ Texas Austin, Emergency Med Program, Dept Surg & Perioperat Care, Dell Med Sch, 1400 North I-35,Suite 2-230, Austin, TX 78754 USA; James Cook Univ, Mt Isa Ctr Rural & Remote Hlth, Townsville, Qld, Australia; East Carolina Univ, Brody Sch Med, Greenville, NC USA; Doctors Making Housecalls, Durham, NC USA; [Jones, A. Wooten] 406 Lancelot Dr, Greenville, NC 27858 USA; [Kronhaus, Alan K.] 2511 Old Cornwallis Rd,Suite 200, Durham, NC 27713 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; University of Texas Austin; James Cook University; University of North Carolina; East Carolina University	Williams, JG (corresponding author), Wake Cty Emergency Med Serv, 331 South McDowell St, Raleigh, NC 27601 USA.	jeff.williams@wakegov.com		Brown, Lawrence/0000-0002-5940-1840				Abualenain J, 2013, ANN EMERG MED, V61, P638, DOI 10.1016/j.annemergmed.2013.01.016; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Brown LH, 2009, PREHOSP EMERG CARE, V13, P516, DOI 10.1080/10903120903144809; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Centers for Disease Control and Prevention, 2011, WISQARS LEAD CAUS NO; Centers for Disease Control and Prevention, NONF INJ DAT; Centers for Medicare & Medicaid Services, OV MED PHYS FEE SCHE; Cone DC, 2013, PREHOSP EMERG CARE, V17, P51, DOI 10.3109/10903127.2012.717168; Halter M, 2011, EMERG MED J, V28, P44, DOI 10.1136/emj.2009.079566; Hastings SN, 2007, J GEN INTERN MED, V22, P1527, DOI 10.1007/s11606-007-0343-9; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Institute for Healthcare Improvement, 2017, IHI TRIPL AIM IN; Kellermann AL, 2011, NEW ENGL J MED, V364, P2278, DOI 10.1056/NEJMp1101544; Martinez R, 2010, ACAD EMERG MED, V17, P1346, DOI 10.1111/j.1553-2712.2010.00945.x; Morganti KG, 2014, ANN EMERG MED, V63, P615, DOI 10.1016/j.annemergmed.2013.09.025; Munjal K, 2013, JAMA-J AM MED ASSOC, V309, P667, DOI 10.1001/jama.2012.211273; Myers JB, 2013, MOB INT HEALTHC SUMM; Ojo Peter, 2009, Conn Med, V73, P139; Simpson PM, 2014, PREHOSP EMERG CARE, V18, P342, DOI 10.3109/10903127.2013.864355; Simpson PM, 2014, PREHOSP EMERG CARE, V18, P185, DOI 10.3109/10903127.2013.856504; SINGAL BM, 1992, ANN EMERG MED, V21, P802, DOI 10.1016/S0196-0644(05)81025-X; Siracuse JJ, 2012, AM J SURG, V203, P335, DOI 10.1016/j.amjsurg.2011.09.018; Snooks HA, 2004, EMERG MED J, V21, P212, DOI 10.1136/emj.2003.005199; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Weiss Steven J, 2003, Prehosp Emerg Care, V7, P79, DOI 10.1080/10903120390937148; Williams JG, 2015, PREHOSP EMERG CARE, V19, P68, DOI 10.3109/10903127.2014.936631	27	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					179	+		10.7326/M17-0969	http://dx.doi.org/10.7326/M17-0969			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CU	29230475				2022-12-28	WOS:000424224300006
J	Pellegrini, AFA; Ahlstrom, A; Hobbie, SE; Reich, PB; Nieradzik, LP; Staver, AC; Scharenbroch, BC; Jumpponen, A; Anderegg, WRL; Randerson, JT; Jackson, RB				Pellegrini, Adam F. A.; Ahlstrom, Anders; Hobbie, Sarah E.; Reich, Peter B.; Nieradzik, Lars P.; Staver, A. Carla; Scharenbroch, Bryant C.; Jumpponen, Ari; Anderegg, William R. L.; Randerson, James T.; Jackson, Robert B.			Fire frequency drives decadal changes in soil carbon and nitrogen and ecosystem productivity	NATURE			English	Article							TERRESTRIAL ECOSYSTEMS; PONDEROSA PINE; FOREST; VEGETATION; ACCUMULATION; METAANALYSIS; LIMITATION; RECOVERY; WILDFIRE; SAVANNA	Fire frequency is changing globally and is projected to affect the global carbon cycle and climate(1-3). However, uncertainty about how ecosystems respond to decadal changes in fire frequency makes it difficult to predict the effects of altered fire regimes on the carbon cycle; for instance, we do not fully understand the long-term effects of fire on soil carbon and nutrient storage, or whether fire-driven nutrient losses limit plant productivity(4,5). Here we analyse data from 48 sites in savanna grasslands, broadleaf forests and needleleaf forests spanning up to 65 years, during which time the frequency of fires was altered at each site. We find that frequently burned plots experienced a decline in surface soil carbon and nitrogen that was non-saturating through time, having 36 per cent (+/- 13 per cent) less carbon and 38 per cent (+/- 16 per cent) less nitrogen after 64 years than plots that were protected from fire. Fire-driven carbon and nitrogen losses were substantial in savanna grasslands and broadleaf forests, but not in temperate and boreal needleleaf forests. We also observe comparable soil carbon and nitrogen losses in an independent field dataset and in dynamic model simulations of global vegetation. The model study predicts that the long-term losses of soil nitrogen that result from more frequent burning may in turn decrease the carbon that is sequestered by net primary productivity by about 20 per cent of the total carbon that is emitted from burning biomass over the same period. Furthermore, we estimate that the effects of changes in fire frequency on ecosystem carbon storage may be 30 per cent too low if they do not include multidecadal changes in soil carbon, especially in drier savanna grasslands. Future changes in fire frequency may shift ecosystem carbon storage by changing soil carbon pools and nitrogen limitations on plant growth, altering the carbon sink capacity of frequently burning savanna grasslands and broadleaf forests.	[Pellegrini, Adam F. A.; Ahlstrom, Anders; Jackson, Robert B.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Ahlstrom, Anders] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Western Sydney Univ, Hawkesbury Inst Environm, Sydney, NSW, Australia; [Nieradzik, Lars P.] Lund Univ, Ctr Environm & Climate Res, CEC, Lund, Sweden; [Staver, A. Carla] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Scharenbroch, Bryant C.] Univ Wisconsin, Coll Nat Resources, Stevens Point, WI 54481 USA; [Jumpponen, Ari] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Anderegg, William R. L.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Randerson, James T.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Jackson, Robert B.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Jackson, Robert B.] Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA	Stanford University; Lund University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; Lund University; Yale University; University of Wisconsin System; University of Wisconsin Stevens Point; Kansas State University; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; Stanford University; Stanford University	Pellegrini, AFA (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.	afapelle@stanford.edu	Randerson, James/Y-2550-2019; Ahlström, Anders/F-3215-2017; Pellegrini, Adam FA/AAI-4374-2021; Ahlström, Anders/AAC-6716-2019	Randerson, James/0000-0001-6559-7387; Ahlström, Anders/0000-0003-1642-0037; Pellegrini, Adam FA/0000-0003-0418-4129; Ahlström, Anders/0000-0003-1642-0037; Jackson, Robert/0000-0001-8846-7147; Reich, Peter/0000-0003-4424-662X	National Oceanic and Atmospheric Administration (NOAA) Climate and Global Change Postdoctoral Fellowship; Gordon and Betty Moore Foundation; ModElling the Regional and Global Earth system (MERGE); Department of Energy Office of Science Biological and Environmental Research	National Oceanic and Atmospheric Administration (NOAA) Climate and Global Change Postdoctoral Fellowship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); ModElling the Regional and Global Earth system (MERGE); Department of Energy Office of Science Biological and Environmental Research(United States Department of Energy (DOE))	We thank all authors of the studies used in the meta-analysis; the Cedar Creek Long Term Ecological Research programme; The Morton Arboretum Center for Tree Science programme; and J. Harden, L. Hedin, S. Pacala and M. Turner for providing feedback. Funding was provided by a National Oceanic and Atmospheric Administration (NOAA) Climate and Global Change Postdoctoral Fellowship (to A.F.A.P.); the Gordon and Betty Moore Foundation (R.B.J.); the ModElling the Regional and Global Earth system (MERGE) (L.P.N.); and the Department of Energy Office of Science Biological and Environmental Research (J.T.R.).	Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Boerner REJ, 2009, ECOL APPL, V19, P338, DOI 10.1890/07-1767.1; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Debano L.F., 1998, FIRE EFFECTS ECOSYST; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; DeLuca TH, 2008, FRONT ECOL ENVIRON, V6, P18, DOI 10.1890/070070; DeLuca TH, 2006, ECOLOGY, V87, P2511, DOI 10.1890/0012-9658(2006)87[2511:FFANTI]2.0.CO;2; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; KNAPP AK, 1986, BIOSCIENCE, V36, P662, DOI 10.2307/1310387; Knorr W, 2016, NAT CLIM CHANGE, V6, P781, DOI [10.1038/NCLIMATE2999, 10.1038/nclimate2999]; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; McKee W.H., 1982, CHANGES SOIL FERTILI; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; Newland JA, 2000, CAN J FOREST RES, V30, P274, DOI 10.1139/cjfr-30-2-274; Pellegrini AFA, 2015, ECOLOGY, V96, P1275, DOI 10.1890/14-1158.1; Pellegrini AFA, 2014, ECOLOGY, V95, P342, DOI 10.1890/13-0290.1; RAMAKRISHNAN PS, 1981, PLANT SOIL, V60, P41, DOI 10.1007/BF02377111; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Reich PB, 2001, ECOLOGY, V82, P1703; Ricklefs R.E., 2008, EC NATURE; Santin C, 2016, GLOBAL CHANGE BIOL, V22, P76, DOI 10.1111/gcb.12985; Smith B, 2014, BIOGEOSCIENCES, V11, P2027, DOI 10.5194/bg-11-2027-2014; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.2307/3060925; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	30	225	237	56	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					194	198		10.1038/nature24668	http://dx.doi.org/10.1038/nature24668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29227988				2022-12-28	WOS:000419794800034
J	Wartewig, T; Kurgyis, Z; Keppler, S; Pechloff, K; Hameister, E; Ollinger, R; Maresch, R; Buch, T; Steiger, K; Winter, C; Rad, R; Ruland, J				Wartewig, Tim; Kurgyis, Zsuzsanna; Keppler, Selina; Pechloff, Konstanze; Hameister, Erik; Ollinger, Rupert; Maresch, Roman; Buch, Thorsten; Steiger, Katja; Winter, Christof; Rad, Roland; Ruland, Jurgen			PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis (vol 552, pg 121, 2017)	NATURE			English	Correction													Buch, Thorsten/P-1659-2019; Winter, Christof/AAF-1860-2020; Ruland, Jürgen/Q-6680-2018; Winter, Christof/A-1887-2011	Buch, Thorsten/0000-0002-2236-9074; Winter, Christof/0000-0002-0253-9056; Ruland, Jürgen/0000-0002-8381-3597; Winter, Christof/0000-0002-0253-9056; Keppler, Selina Jessica/0000-0002-9010-8044				Wartewig T, 2017, NATURE, V552, P121, DOI 10.1038/nature24649	1	6	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687								10.1038/nature25142	http://dx.doi.org/10.1038/nature25142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29186126	Bronze			2022-12-28	WOS:000419794800045
J	Raiteri, CM; Villata, M; Acosta-Pulido, JA; Agudo, I; Arkharov, AA; Bachev, R; Baida, GV; Benitez, E; Borman, GA; Boschin, W; Bozhilov, V; Butuzova, MS; Calcidese, P; Carnerero, MI; Carosati, D; Casadio, C; Castro-Segura, N; Chen, WP; Damljanovic, G; D'Ammando, F; Di Paola, A; Echevarria, J; Efimova, NV; Ehgamberdiev, SA; Espinosa, C; Fuentes, A; Giunta, A; Gomez, JL; Grishina, TS; Gurwell, MA; Hiriart, D; Jermak, H; Jordan, B; Jorstad, SG; Joshi, M; Kopatskaya, EN; Kuratov, K; Kurtanidze, OM; Kurtanidze, SO; Lahteenmaki, A; Larionov, VM; Larionova, EG; Larionova, LV; Lazaro, C; Lin, CS; Malmrose, MP; Marscher, AP; Matsumoto, K; McBreen, B; Michel, R; Mihov, B; Minev, M; Mirzaqulov, DO; Mokrushina, AA; Molina, SN; Moody, JW; Morozova, DA; Nazarov, SV; Nikolashvili, MG; Ohlert, JM; Okhmat, DN; Ovcharov, E; Pinna, F; Polakis, TA; Protasio, C; Pursimo, T; Redondo-Lorenzo, FJ; Rizzi, N; Rodriguez-Coira, G; Sadakane, K; Sadun, AC; Samal, MR; Savchenko, SS; Semkov, E; Skiff, BA; Slavcheva-Mihova, L; Smith, PS; Steele, IA; Strigachev, A; Tammi, J; Thum, C; Tornikoski, M; Troitskaya, YV; Troitsky, IS; Vasilyev, AA; Vince, O				Raiteri, C. M.; Villata, M.; Acosta-Pulido, J. A.; Agudo, I.; Arkharov, A. A.; Bachev, R.; Baida, G. V.; Benitez, E.; Borman, G. A.; Boschin, W.; Bozhilov, V.; Butuzova, M. S.; Calcidese, P.; Carnerero, M. I.; Carosati, D.; Casadio, C.; Castro-Segura, N.; Chen, W. -P.; Damljanovic, G.; D'Ammando, F.; Di Paola, A.; Echevarria, J.; Efimova, N. V.; Ehgamberdiev, Sh. A.; Espinosa, C.; Fuentes, A.; Giunta, A.; Gomez, J. L.; Grishina, T. S.; Gurwell, M. A.; Hiriart, D.; Jermak, H.; Jordan, B.; Jorstad, S. G.; Joshi, M.; Kopatskaya, E. N.; Kuratov, K.; Kurtanidze, O. M.; Kurtanidze, S. O.; Lahteenmaki, A.; Larionov, V. M.; Larionova, E. G.; Larionova, L. V.; Lazaro, C.; Lin, C. S.; Malmrose, M. P.; Marscher, A. P.; Matsumoto, K.; McBreen, B.; Michel, R.; Mihov, B.; Minev, M.; Mirzaqulov, D. O.; Mokrushina, A. A.; Molina, S. N.; Moody, J. W.; Morozova, D. A.; Nazarov, S. V.; Nikolashvili, M. G.; Ohlert, J. M.; Okhmat, D. N.; Ovcharov, E.; Pinna, F.; Polakis, T. A.; Protasio, C.; Pursimo, T.; Redondo-Lorenzo, F. J.; Rizzi, N.; Rodriguez-Coira, G.; Sadakane, K.; Sadun, A. C.; Samal, M. R.; Savchenko, S. S.; Semkov, E.; Skiff, B. A.; Slavcheva-Mihova, L.; Smith, P. S.; Steele, I. A.; Strigachev, A.; Tammi, J.; Thum, C.; Tornikoski, M.; Troitskaya, Yu. V.; Troitsky, I. S.; Vasilyev, A. A.; Vince, O.			Blazar spectral variability as explained by a twisted inhomogeneous jet	NATURE			English	Article							EXTRAGALACTIC RADIO-SOURCES; PARTICLE-ACCELERATION; RELATIVISTIC JETS; COMPARISON STARS; WEBT CAMPAIGN; HELICAL JETS; PHOTOMETRY; OUTBURST; OBJECTS; ORIGIN	Blazars are active galactic nuclei, which are powerful sources of radiation whose central engine is located in the core of the host galaxy. Blazar emission is dominated by non-thermal radiation from a jet that moves relativistically towards us, and therefore undergoes Doppler beaming(1). This beaming causes flux enhancement and contraction of the variability timescales, so that most blazars appear as luminous sources characterized by noticeable and fast changes in brightness at all frequencies. The mechanism that produces this unpredictable variability is under debate, but proposed mechanisms include injection, acceleration and cooling of particles(2), with possible intervention of shock waves(3,4) or turbulence(5). Changes in the viewing angle of the observed emitting knots or jet regions have also been suggested as an explanation of flaring events(6-10) and can also explain specific properties of blazar emission, such as intra-day variability(11,) quasi-periodicity(12,13) and the delay of radio flux variations relative to optical changes(14). Such a geometric interpretation, however, is not universally accepted because alternative explanations based on changes in physical conditions-such as the size and speed of the emitting zone, the magnetic field, the number of emitting particles and their energy distribution-can explain snapshots of the spectral behaviour of blazars in many cases(15,16). Here we report the results of optical-to-radio-wavelength monitoring of the blazar CTA 102 and show that the observed long-term trends of the flux and spectral variability are best explained by an inhomogeneous, curved jet that undergoes changes in orientation over time. We propose that magnetohydrodynamic instabilities(17) or rotation of the twisted jet(6) cause different jet regions to change their orientation and hence their relative Doppler factors. In particular, the extreme optical outburst of 2016-2017 (brightness increase of six magnitudes) occurred when the corresponding emitting region had a small viewing angle. The agreement between observations and theoretical predictions can be seen as further validation of the relativistic beaming theory.	[Raiteri, C. M.; Villata, M.; Carnerero, M. I.] INAF, Osservatorio Astrofis Torino, I-10025 Pino Torinese, Italy; [Acosta-Pulido, J. A.; Boschin, W.; Lazaro, C.; Pinna, F.; Protasio, C.; Redondo-Lorenzo, F. J.; Rodriguez-Coira, G.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Acosta-Pulido, J. A.; Boschin, W.; Castro-Segura, N.; Lazaro, C.; Pinna, F.; Protasio, C.; Redondo-Lorenzo, F. J.; Rodriguez-Coira, G.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Agudo, I.; Casadio, C.; Fuentes, A.; Gomez, J. L.; Molina, S. N.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Arkharov, A. A.; Efimova, N. V.; Larionov, V. M.; Mokrushina, A. A.] Pulkovo Observ, St Petersburg 196140, Russia; [Bachev, R.; Mihov, B.; Semkov, E.; Slavcheva-Mihova, L.; Strigachev, A.] Bulgarian Acad Sci, Inst Astron, Sofia 1784, Bulgaria; [Bachev, R.; Mihov, B.; Semkov, E.; Slavcheva-Mihova, L.; Strigachev, A.] Bulgarian Acad Sci, NAO, Sofia 1784, Bulgaria; [Baida, G. V.; Borman, G. A.; Butuzova, M. S.; Nazarov, S. V.; Okhmat, D. N.] RAS, Crimean Astrophys Observ, Nauchny 298409, Russia; [Benitez, E.; Echevarria, J.; Espinosa, C.; Hiriart, D.; Michel, R.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City, DF, Mexico; [Boschin, W.; Carosati, D.] INAF, TNG Fdn Galileo Galilei, E-38712 La Palma, Spain; [Bozhilov, V.; Minev, M.; Ovcharov, E.] Univ Sofia, Fac Phys, Dept Astron, BG-1164 Sofia, Bulgaria; [Calcidese, P.] Osservatorio Astronom Reg Autonoma Valle Aosta, I-11020 Nus, Italy; [Carosati, D.] EPT Observ, E-38780 La Palma, Spain; [Casadio, C.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Castro-Segura, N.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Chen, W. -P.; Lin, C. S.; Samal, M. R.] Natl Cent Univ, Grad Inst Astron, Jhongli 32001, Taoyuan County, Taiwan; [Damljanovic, G.; Vince, O.] Astron Observ, Belgrade 11060, Serbia; [D'Ammando, F.] Univ Bologna, Dipartimento Fis & Astron, I-40129 Bologna, Italy; [D'Ammando, F.] INAF, Inst Radioastron, I-40129 Bologna, Italy; [Di Paola, A.; Giunta, A.] INAF, Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Ehgamberdiev, Sh. A.; Mirzaqulov, D. O.] Ulugh Beg Astron Inst, Maidanak Observ, Tashkent 100052, Uzbekistan; [Grishina, T. S.; Jorstad, S. G.; Kopatskaya, E. N.; Larionov, V. M.; Larionova, E. G.; Larionova, L. V.; Mokrushina, A. A.; Morozova, D. A.; Savchenko, S. S.; Troitskaya, Yu. V.; Troitsky, I. S.; Vasilyev, A. A.] St Petersburg State Univ, Astron Inst, St Petersburg 198504, Russia; [Gurwell, M. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Jermak, H.; Steele, I. A.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool L3 5RF, Merseyside, England; [Jordan, B.] Dublin Inst Adv Studies, Sch Cosm Phys, Dublin, Ireland; [Jorstad, S. G.; Joshi, M.; Malmrose, M. P.; Marscher, A. P.] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Kuratov, K.] Al Farabi Kazakh Natl Univ, NNLOT, Alma Ata, Kazakhstan; [Kuratov, K.] Fesenkov Astrophys Inst, Alma Ata, Kazakhstan; [Kurtanidze, O. M.; Kurtanidze, S. O.; Nikolashvili, M. G.] Abastumani Observ, Abastumani 0301, Georgia; [Kurtanidze, O. M.] Kazan Fed Univ, Engelhardt Astron Observ, Tatarstan, Russia; [Kurtanidze, O. M.] Heidelberg Univ, Zentrum Astron, Landessternwarte, D-69117 Heidelberg, Germany; [Kurtanidze, O. M.] Guangzhou Univ, Ctr Astrophys, Guangzhou 510006, Guangdong, Peoples R China; [Lahteenmaki, A.; Tammi, J.; Tornikoski, M.] Aalto Univ, Metsahovi Radio Observ, FI-02540 Kylmala, Finland; [Lahteenmaki, A.] Aalto Univ, Dept Elect & Nanoengn, FI-00076 Aalto, Finland; [Lahteenmaki, A.] Tartu Observ, EE-61602 Toravere, Estonia; [Matsumoto, K.; Sadakane, K.] Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan; [McBreen, B.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Moody, J. W.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Ohlert, J. M.] Astron Stiftung Trebur, Michael Adrian Observatorium, D-65468 Trebur, Germany; [Ohlert, J. M.] Tech Hsch Mittelhessen, Univ Appl Sci, D-61169 Friedberg, Germany; [Polakis, T. A.] Command Module Observ, Tempe, AZ USA; [Pursimo, T.] Nord Opt Telescope, E-38700 Santa Cruz De La Palma, Spain; [Rizzi, N.] Osservatorio Astron Sirio, I-70013 Castellana Grotte, Italy; [Sadun, A. C.] Univ Colorado, Dept Phys, Denver, CO 80217 USA; [Skiff, B. A.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; [Smith, P. S.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Thum, C.] Inst Radio Astron Millimetr, E-18012 Granada, Spain	Istituto Nazionale Astrofisica (INAF); Instituto de Astrofisica de Canarias; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Pulkovo Observatory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Russian Academy of Sciences; Universidad Nacional Autonoma de Mexico; Istituto Nazionale Astrofisica (INAF); Bulgarian Academy of Sciences; University of Sofia; Max Planck Society; University of Southampton; National Central University; University of Bologna; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Academy of Sciences of Uzbekistan; Ulugh Beg Astronomical Institute (UBAI); Saint Petersburg State University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Liverpool John Moores University; Dublin Institute for Advanced Studies; Boston University; Al-Farabi Kazakh National University; National Nanotechnology Laboratory of Open Type in Kazakhstan; Fesenkov Astrophysical Institute; Ilia State University; Kazan Federal University; Ruprecht Karls University Heidelberg; Guangzhou University; Aalto University; Aalto University; University of Tartu; Tartu Observatory; Osaka University of Education; University College Dublin; Brigham Young University; University of Colorado System; University of Colorado Denver; University of Arizona	Raiteri, CM; Villata, M (corresponding author), INAF, Osservatorio Astrofis Torino, I-10025 Pino Torinese, Italy.	raiteri@oato.inaf.it; villata@oato.inaf.it	Lähteenmäki, Anne/L-5987-2013; Troitskaya, Yuliya/N-2222-2015; Morozova, Daria/H-1298-2013; Pursimo, tapio/GLQ-7782-2022; Larionova, Elena/AAK-9274-2021; Savchenko, Sergey S/J-2956-2013; Kopatskaya, Evgenia/AAN-1057-2021; Butuzova, Marina/R-7894-2017; Vasilyev, Andrey A/H-9121-2013; Jorstad, Svetlana/AAM-3279-2021; Butuzova, Marina/AGK-8488-2022; Tammi, Joni/G-2959-2012; Efimova, Natalia V/I-2196-2013; Savchenko, Sergey/O-2498-2019; Mirzaqulov, Davron/ABB-9232-2020; Bozhilov, Vladimir/AAA-6355-2021; Efimova, Natalia Vladimirovna/HDM-7482-2022; Bozhilov, Vladimir/R-6979-2019; Acosta-Pulido, Jose A./AAA-4704-2019; Ehgamberdiev, Shuhrat/ABC-3749-2020; Pinna, Francesca/AAC-7919-2021; Fuentes, Antonio/R-3900-2019; Tammi, Joni/AAQ-1113-2021; Grishina, Tatiana/H-6873-2013; Casadio, Carolina/AAH-5524-2021; Samal, Manash/AAE-9493-2020; Larionov, Valeri/H-1349-2013; Troitskiy, Ivan/K-7979-2013; Gomez, Jose L./C-4195-2008; Agudo, Ivan/G-1701-2015	Troitskaya, Yuliya/0000-0002-9907-9876; Morozova, Daria/0000-0002-9407-7804; Larionova, Elena/0000-0002-2471-6500; Savchenko, Sergey S/0000-0003-4147-3851; Kopatskaya, Evgenia/0000-0001-9518-337X; Butuzova, Marina/0000-0001-7307-2193; Vasilyev, Andrey A/0000-0002-8293-0214; Jorstad, Svetlana/0000-0001-6158-1708; Butuzova, Marina/0000-0001-7307-2193; Tammi, Joni/0000-0002-9164-2695; Efimova, Natalia V/0000-0002-8071-4753; Savchenko, Sergey/0000-0003-4147-3851; Mirzaqulov, Davron/0000-0003-0570-6531; Efimova, Natalia Vladimirovna/0000-0002-8071-4753; Bozhilov, Vladimir/0000-0002-3117-7197; Pinna, Francesca/0000-0001-5965-3530; Fuentes, Antonio/0000-0002-8773-4933; Tammi, Joni/0000-0002-9164-2695; Grishina, Tatiana/0000-0002-3953-6676; Casadio, Carolina/0000-0003-1117-2863; Samal, Manash/0000-0002-9431-6297; Larionov, Valeri/0000-0002-4640-4356; Ehgamberdiev, Shuhrat/0000-0001-9730-3769; Raiteri, Claudia Maria/0000-0003-1784-2784; Gurwell, Mark/0000-0003-0685-3621; Troitskiy, Ivan/0000-0002-4218-0148; Tornikoski, Merja/0000-0003-1249-6026; Gomez, Jose L./0000-0003-4190-7613; Kurtanidze, Omar/0000-0001-5385-0576; Jermak, Helen/0000-0002-1197-8501; Kurtanidze, Sofia/0000-0002-0319-5873; Minev, Milen/0000-0002-5702-5095; Nikolashvili, Mariam/0000-0003-0408-7177; Agudo, Ivan/0000-0002-3777-6182; Lazaro Hernando, Carlos/0000-0002-2245-8528; Villata, Massimo/0000-0003-1743-6946; Castro Segura, Noel/0000-0002-5870-0443; Hiriart, David/0000-0002-4711-7658; Benitez, Erika/0000-0003-1018-2613; Espinosa-Ponce, Carlos/0000-0002-9658-8886; D'Ammando, Filippo/0000-0001-7618-7527; Acosta-Pulido, Jose A./0000-0002-0433-9656; Carnerero Martin, Maria Isabel/0000-0001-5843-5515; Di Paola, Andrea/0000-0002-2189-8644; Rodriguez-Coira, Gustavo/0000-0002-4177-6433	STFC [ST/M003035/1, ST/P006892/1, ST/F007159/1, ST/P002218/1, 1860195] Funding Source: UKRI; Science and Technology Facilities Council [ST/F007159/1, ST/M003035/1, ST/P006892/1, ST/M000966/1, ST/P002218/1] Funding Source: researchfish; Division Of Astronomical Sciences [1615796] Funding Source: National Science Foundation	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Abdo AA, 2010, NATURE, V463, P919, DOI 10.1038/nature08841; Agudo I, 2010, ASTROPHYS J SUPPL S, V189, P1, DOI 10.1088/0067-0049/189/1/1; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; Britzen S, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201629999; CAMENZIND M, 1992, ASTRON ASTROPHYS, V255, P59; Casadio C, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/51; Doroshenko VT, 2013, ASTROPHYSICS+, V56, P343, DOI 10.1007/s10511-013-9290-9; Fromm C. M., 2013, A A, V557, P105; Ghisellini G, 2005, ASTRON ASTROPHYS, V432, P401, DOI 10.1051/0004-6361:20041404; Ghisellini G, 2009, MON NOT R ASTRON SOC, V397, P985, DOI 10.1111/j.1365-2966.2009.15007.x; Ghisellini G, 2002, ASTRON ASTROPHYS, V386, P833, DOI 10.1051/0004-6361:20020275; Gurwell MA, 2007, ASTR SOC P, V375, P234; HUFNAGEL BR, 1992, ASTROPHYS J, V386, P473, DOI 10.1086/171033; IMPEY CD, 1988, ASTRON J, V95, P307, DOI 10.1086/114638; Jordi K, 2006, ASTRON ASTROPHYS, V460, P339, DOI 10.1051/0004-6361:20066082; Jorstad SG, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/147; Larionov VM, 2016, MON NOT R ASTRON SOC, V461, P3047, DOI 10.1093/mnras/stw1516; Larionov VM, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913536; Lyutikov M, 2017, MON NOT R ASTRON SOC, V467, P3876, DOI 10.1093/mnras/stx359; Malmrose MP, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/116; Marcotulli L, 2017, ASTROPHYS J, V839, DOI 10.3847/1538-4357/aa6a17; Marscher AP, 2008, NATURE, V452, P966, DOI 10.1038/nature06895; Massaro E, 2004, ASTRON ASTROPHYS, V413, P489, DOI 10.1051/0004-6361:20031558; Mignone A, 2010, MON NOT R ASTRON SOC, V402, P7, DOI 10.1111/j.1365-2966.2009.15642.x; Ostorero L, 2004, ASTRON ASTROPHYS, V419, P913, DOI 10.1051/0004-6361:20035813; Perucho M, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/55; Raiteri CM, 2014, MON NOT R ASTRON SOC, V442, P629, DOI 10.1093/mnras/stu886; Raiteri CM, 1998, ASTRON ASTROPHYS SUP, V130, P495, DOI 10.1051/aas:1998420; Rieger FM, 2004, ASTROPHYS J, V615, pL5, DOI 10.1086/426018; Savolainen T, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913740; Sikora M, 2001, ASTROPHYS J, V554, P1, DOI 10.1086/321329; Sikora M, 2016, MON NOT R ASTRON SOC, V457, P1352, DOI 10.1093/mnras/stw107; SIMONETTI JH, 1985, ASTROPHYS J, V296, P46, DOI 10.1086/163418; Terasranta H, 1998, ASTRON ASTROPHYS SUP, V132, P305, DOI 10.1051/aas:1998297; Tramacere A, 2009, ASTRON ASTROPHYS, V501, P879, DOI 10.1051/0004-6361/200810865; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Villata M, 2006, ASTRON ASTROPHYS, V453, P817, DOI 10.1051/0004-6361:20064817; Villata M, 1999, ASTRON ASTROPHYS, V347, P30; Villata M, 2009, ASTRON ASTROPHYS, V501, P455, DOI 10.1051/0004-6361/200912065	40	80	82	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					374	+		10.1038/nature24623	http://dx.doi.org/10.1038/nature24623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29211720	Green Accepted			2022-12-28	WOS:000418559800052
J	Yang, HJ; Jiang, XL; Li, BR; Yang, HJ; Miller, M; Yang, A; Dhar, A; Pavletich, NP				Yang, Haijuan; Jiang, Xiaolu; Li, Buren; Yang, Hyo J.; Miller, Meredith; Yang, Angela; Dhar, Ankita; Pavletich, Nikola P.			Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40	NATURE			English	Article							CRYO-EM STRUCTURE; P70 S6 KINASE; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX; RAPTOR; SUBSTRATE; TOR; MUTATIONS; PHOSPHORYLATION	The mechanistic target of rapamycin complex 1 (mTORC1) controls cell growth and metabolism in response to nutrients, energy levels, and growth factors. It contains the atypical kinase mTOR and the RAPTOR subunit that binds to the Tor signalling sequence (TOS) motif of substrates and regulators. mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain) and inhibited by PRAS40. Here we present the 3.0 angstrom cryo-electron microscopy structure of mTORC1 and the 3.4 angstrom structure of activated RHEB-mTORC1. RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis. Cancer-associated hyperactivating mutations map to structural elements that maintain the inactive state, and we provide biochemical evidence that they mimic RHEB relieving auto-inhibition. We also present crystal structures of RAPTOR-TOS motif complexes that define the determinants of TOS recognition, of an mTOR FKBP12-rapamycin-binding (FRB) domain-substrate complex that establishes a second substrate-recruitment mechanism, and of a truncated mTOR-PRAS40 complex that reveals PRAS40 inhibits both substrate-recruitment sites. These findings help explain how mTORC1 selects its substrates, how its kinase activity is controlled, and how it is activated by cancer-associated mutations.	[Yang, Haijuan; Jiang, Xiaolu; Li, Buren; Yang, Hyo J.; Miller, Meredith; Yang, Angela; Dhar, Ankita; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Jiang, Xiaolu; Yang, Hyo J.; Miller, Meredith; Yang, Angela; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.; Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	pavletin@mskcc.org		Yang, Hyo/0000-0001-5279-3194	Howard Hughes Medical Institute; National Institutes of Health [CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064644, P41GM103310] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the Advanced Photon Source, the New York Structural Biology Center Simons Electron Microscopy Center, the Howard Hughes Medical Institute Cryo-EM facility, the Memorial Sloan Kettering Cancer Center Cryo-EM facility, and Subangstrom for help with data collection. This work was supported by the Howard Hughes Medical Institute and National Institutes of Health grant CA008748.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Baretic D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11016; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Ginalski K, 2004, TRENDS BIOCHEM SCI, V29, P522, DOI 10.1016/j.tibs.2004.08.006; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Klink TA, 2008, J BIOMOL SCREEN, V13, P476, DOI 10.1177/1087057108319864; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Michels AA, 2011, BIOCHEM SOC T, V39, P487, DOI 10.1042/BST0390487; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang HR, 2016, PROTEIN CELL, V7, P878, DOI 10.1007/s13238-016-0346-6; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	54	227	232	6	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					368	+		10.1038/nature25023	http://dx.doi.org/10.1038/nature25023			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236692	Green Submitted, Green Accepted			2022-12-28	WOS:000418559800051
J	Stern, S; Kirst, C; Bargmann, CI				Stern, Shay; Kirst, Christoph; Bargmann, Cornelia I.			Neuromodulatory Control of Long-Term Behavioral Patterns and Individuality across Development	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; DROSOPHILA-MELANOGASTER; SEROTONIN RECEPTOR; FORAGING BEHAVIOR; GENE-EXPRESSION; EXPERIENCE; CIRCUIT; CLONING; VARIABILITY	Animals generate complex patterns of behavior across development that may be shared or unique to individuals. Here, we examine the contributions of developmental programs and individual variation to behavior by monitoring single Caenorhabditis elegans nematodes over their complete developmental trajectories and quantifying their behavior at high spatiotemporal resolution. These measurements reveal reproducible trajectories of spontaneous foraging behaviors that are stereotyped within and between developmental stages. Dopamine, serotonin, the neuropeptide receptor NPR-1, and the TGF-beta peptide DAF-7 each have stage-specific effects on behavioral trajectories, implying the existence of a modular temporal program controlled by neuromodulators. In addition, a fraction of individuals within isogenic populations raised in controlled environments have consistent, non-genetic behavioral biases that persist across development. Several neuromodulatory systems increase or decrease the degree of non-genetic individuality to shape sustained patterns of behavior across the population.	[Stern, Shay; Bargmann, Cornelia I.] Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA; [Kirst, Christoph] Rockefeller Univ, Ctr Phys & Biol, New York, NY 10065 USA; [Kirst, Christoph] Rockefeller Univ, Kavli Neural Syst Inst, New York, NY 10065 USA; [Bargmann, Cornelia I.] Chan Zuckerberg Initiat, Palo Alto, CA 94301 USA	Rockefeller University; Rockefeller University; Rockefeller University	Bargmann, CI (corresponding author), Rockefeller Univ, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.; Bargmann, CI (corresponding author), Chan Zuckerberg Initiat, Palo Alto, CA 94301 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618	EGL Charitable Foundation; Human Frontiers Science Program [LT000933/2014]; Howard Hughes Medical Institute	EGL Charitable Foundation; Human Frontiers Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Caenorhabditis Genetics Center (CGC) for strains; David Jordan, Stanislas Leibler, Steve Flavell, and Alejandro Lopez for advice and discussions; and the members of our laboratory for comments on the manuscript. C.K. was supported by the Kavli Foundation. S.S. was supported by the EGL Charitable Foundation and the Human Frontiers Science Program (LT000933/2014). This work was supported by the Howard Hughes Medical Institute, of which C.I.B. was an investigator.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Ben Arous J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007584; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Carre-Pierrat Maite, 2006, Invertebrate Neuroscience, V6, P189, DOI 10.1007/s10158-006-0033-z; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chase Daniel L, 2007, WormBook, P1; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; COOPER WS, 1982, J THEOR BIOL, V94, P135, DOI 10.1016/0022-5193(82)90336-8; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Entchev EV, 2015, ELIFE, V4, DOI 10.7554/eLife.06259; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Garland EJ, 2015, J CAN ACAD CHILD ADO, V25, P4; Greene JS, 2016, NATURE, V539, P254, DOI 10.1038/nature19848; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Hamdan FF, 1999, J NEUROCHEM, V72, P1372, DOI 10.1046/j.1471-4159.1999.721372.x; Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; Jin X, 2016, CELL, V164, P632, DOI 10.1016/j.cell.2016.01.007; Jordan D, 2013, P NATL ACAD SCI USA, V110, P14018, DOI 10.1073/pnas.1308282110; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; NOTTEBOH.F, 1968, IBIS, V110, P549, DOI 10.1111/j.1474-919X.1968.tb00063.x; Olde B, 1997, J MOL NEUROSCI, V8, P53, DOI 10.1007/BF02736863; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Omura DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038649; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Rehm KJ, 2008, J NEUROSCI, V28, P9828, DOI 10.1523/JNEUROSCI.2328-08.2008; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Sandler O, 2015, NATURE, V519, P468, DOI 10.1038/nature14318; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Shannonhouse JL, 2016, PROG NEURO-PSYCHOPH, V69, P19, DOI 10.1016/j.pnpbp.2016.04.001; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; Song BM, 2013, ELIFE, V2, DOI 10.7554/eLife.00329; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Truman JW, 2005, VITAM HORM, V73, P1, DOI 10.1016/S0083-6729(05)73001-6; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Wenzel D, 2011, GENESIS, V49, P647, DOI 10.1002/dvg.20762; Wigglesworth VB, 1936, Q J MICROSC SCI, V79, P91; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366	74	54	54	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2017	171	7					1649	+		10.1016/j.cell.2017.10.041	http://dx.doi.org/10.1016/j.cell.2017.10.041			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FQ0KF	29198526	Bronze			2022-12-28	WOS:000418044000020
J	Linos, E; Admassu, N; Sabry-Elnaggar, H; Li, PMMC; Choo, E				Linos, Eleni; Admassu, Natnaelle; Sabry-Elnaggar, Hala; Li, Peter M. M. C.; Choo, Esther			CHRISTMAS 2017: THE LIVES OF DOCTORS Doctor fails: early warning signs of physician fatigue?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSOCIATION; SAFETY		[Linos, Eleni] Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco, CA 94143 USA; [Admassu, Natnaelle] Univ Calif Berkeley, UC Berkeley UC San Francisco Joint Med Program, Berkeley, CA USA; [Sabry-Elnaggar, Hala] Stanford Med, Phys Moms Grp, Stanford, CA USA; [Li, Peter M. M. C.] Stanford Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Choo, Esther] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Oregon Health & Science University	Linos, E (corresponding author), Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco, CA 94143 USA.	eleni.linos@ucsf.edu		Choo, Esther/0000-0001-8847-5745	NATIONAL CANCER INSTITUTE [DP2CA225433] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adesoye T, 2017, JAMA INTERN MED, V177, P1033, DOI 10.1001/jamainternmed.2017.1394; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Sokol DK, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4906; Stone MD, 2000, SURGERY, V128, P465, DOI 10.1067/msy.2000.108048; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; West CP, 2012, MAYO CLIN PROC, V87, P1138, DOI 10.1016/j.mayocp.2012.07.021	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2017	359								j5503	10.1136/bmj.j5503	http://dx.doi.org/10.1136/bmj.j5503			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ4KW	29233842	Green Published			2022-12-28	WOS:000418327300001
J	Service, RF				Service, Robert F.			MATERIALS RESEARCH Bioelectronics herald the rise of the cyborg	SCIENCE			English	News Item																			0	3	3	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1233	1234		10.1126/science.358.6368.1233	http://dx.doi.org/10.1126/science.358.6368.1233			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217547				2022-12-28	WOS:000417254700011
J	Yasuda, K; Mogi, M; Yoshimi, R; Tsukazaki, A; Takahashi, KS; Kawasaki, M; Kagawa, F; Tokura, Y				Yasuda, K.; Mogi, M.; Yoshimi, R.; Tsukazaki, A.; Takahashi, K. S.; Kawasaki, M.; Kagawa, F.; Tokura, Y.			Quantized chiral edge conduction on domain walls of a magnetic topological insulator	SCIENCE			English	Article							GRAPHENE; FERROMAGNETISM; STATE	Electronic ordering in magnetic and dielectric materials forms domains with different signs of order parameters. The control of configuration and motion of the domain walls (DWs) enables nonvolatile responses against minute external fields. Here, we realize chiral edge states (CESs) on the magnetic DWs of a magnetic topological insulator. We design and fabricate the magnetic domains in the quantum anomalous Hall state with the tip of a magnetic force microscope and prove the existence of the chiral one-dimensional edge conduction along the prescribed DWs through transport measurements. The proof-of-concept devices based on reconfigurable CESs and Landauer-Buttiker formalism are realized for multiple-domain configurations with well-defined DW channels. Our results may lead to the realization of low-power-consumption spintronic devices.	[Yasuda, K.; Mogi, M.; Kawasaki, M.; Tokura, Y.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Yasuda, K.; Mogi, M.; Kawasaki, M.; Tokura, Y.] Univ Tokyo, QPEC, Tokyo 1138656, Japan; [Yoshimi, R.; Takahashi, K. S.; Kawasaki, M.; Kagawa, F.; Tokura, Y.] RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan; [Tsukazaki, A.] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Takahashi, K. S.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; University of Tokyo; RIKEN; Tohoku University; Japan Science & Technology Agency (JST)	Yasuda, K; Tokura, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.; Yasuda, K; Tokura, Y (corresponding author), Univ Tokyo, QPEC, Tokyo 1138656, Japan.; Tokura, Y (corresponding author), RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan.	yasuda@cmr.t.u-tokyo.ac.jp; tokura@riken.jp	Kagawa, Fumitaka/A-2824-2014; Ishida, Mari/AAU-3379-2020; Yoshimi, Ryutaro/E-8907-2016; Yoshimi, Ryutaro/AAM-3895-2021; Tsukazaki, Atsushi/C-3972-2008; Tokura, Yoshinori/C-7352-2009; Yasuda, Kenji/AAA-9632-2022; TAKAHASHI, Kei/B-2498-2013; Kawasaki, Masashi/B-5826-2008; Yoshimi, Ryutaro/GRS-3242-2022	Kagawa, Fumitaka/0000-0002-1763-6799; Yoshimi, Ryutaro/0000-0001-6200-9375; Yoshimi, Ryutaro/0000-0001-6200-9375; Tokura, Yoshinori/0000-0002-2732-4983; Yasuda, Kenji/0000-0003-4894-0205; Yoshimi, Ryutaro/0000-0001-6200-9375; Tsukazaki, Atsushi/0000-0003-0251-063X; Mogi, Masataka/0000-0003-4193-1787	Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) on "Quantum Science on Strong Correlation"; Council for Science and Technology Policy; JSPS KAKENHI [16J03476, 24224009, 24226002, JP15H05853]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [JPMJCR16F1]; Grants-in-Aid for Scientific Research [16J03476] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) on "Quantum Science on Strong Correlation"; Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Kawamura for fruitful discussions. This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) on "Quantum Science on Strong Correlation" initiated by the Council for Science and Technology Policy and by JSPS KAKENHI (no. 16J03476, no. 24224009, no. 24226002, and no. JP15H05853) and by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (no. JPMJCR16F1). All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials. Additional data requests should be addressed to the corresponding authors. M.K. and Y.T. conceived the project. K.Y., M.M., and R.Y. grew the topological insulator heterostructures and performed device fabrication with the help of A.T. and K.S.T. K.Y. and F.K. conducted the MFM measurement and analyzed the data. K.Y., A.T., M.K., F.K., and Y.T. jointly discussed the result and wrote the manuscript with contributions from all authors.	Abanin DA, 2007, SCIENCE, V317, P641, DOI 10.1126/science.1144672; Akhmerov AR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216404; BUTTIKER M, 1988, PHYS REV B, V38, P9375, DOI 10.1103/PhysRevB.38.9375; Catalan G, 2012, REV MOD PHYS, V84, P119, DOI 10.1103/RevModPhys.84.119; Chang CZ, 2015, NAT MATER, V14, P473, DOI [10.1038/nmat4204, 10.1038/NMAT4204]; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; Checkelsky JG, 2014, NAT PHYS, V10, P731, DOI [10.1038/NPHYS3053, 10.1038/nphys3053]; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; Feng Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.126801; Fu L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216403; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Kou XF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9474; Kou XF, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.137201; Ma EY, 2015, SCIENCE, V350, P538, DOI 10.1126/science.aac8289; Malozemoff A P, 1979, MAGNETIC DOMAIN WALL, V1st, P7; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Mogi M, 2017, NAT MATER, V16, P516, DOI [10.1038/NMAT4855, 10.1038/nmat4855]; Mogi M, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4935075; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Ozyilmaz B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.166804; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Seidel J, 2009, NAT MATER, V8, P229, DOI [10.1038/NMAT2373, 10.1038/nmat2373]; Tserkovnyak Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187201; Ueda K, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075127; Upadhyaya P, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.020411; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang J, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.085106; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yang QY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501482; Yasuda K, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.137204; Yeats AL, 2017, P NATL ACAD SCI USA, V114, P10379, DOI 10.1073/pnas.1713458114; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485	33	81	81	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1311	1314		10.1126/science.aan5991	http://dx.doi.org/10.1126/science.aan5991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217573	Green Submitted			2022-12-28	WOS:000417254700060
J	Evans, MJ				Evans, Margaret Jane			Perinatal pathologists have a vital role in stillbirth review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Evans, Margaret Jane] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Evans, MJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland.	margaretjanee@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2017	359								j5620	10.1136/bmj.j5620	http://dx.doi.org/10.1136/bmj.j5620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AQ	29212763				2022-12-28	WOS:000417559500007
J	Hwang, TJ; Darrow, JJ; Kesselheim, AS				Hwang, Thomas J.; Darrow, Jonathan J.; Kesselheim, Aaron S.			The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hwang, Thomas J.; Darrow, Jonathan J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Darrow, J J/R-8365-2019	Darrow, J J/0000-0002-7351-4243; Hwang, Thomas/0000-0003-0717-1497	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	Laura and John Arnold Foundation; Harvard Program in Therapeutic Science; Engelberg Foundation	This work was supported by grants from the Laura and John Arnold Foundation (Dr Kesselheim) and Harvard Program in Therapeutic Science (Dr Kesselheim) and the Engelberg Foundation (Dr Kesselheim).	[Anonymous], GUID IND EXP PROGR S; Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V315, P1516, DOI 10.1001/jama.2015.16984; Krishnamurti T, 2015, JAMA INTERN MED, V175, P1856, DOI 10.1001/jamainternmed.2015.5355; U. S. Food and Drug Administration, NOV DRUG APPR 2016	5	53	53	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2137	2138		10.1001/jama.2017.14896	http://dx.doi.org/10.1001/jama.2017.14896			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209711	Green Published, Bronze			2022-12-28	WOS:000417093500020
J	Vucina, I				Vucina, Ivan			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter									[Vucina, Ivan] Univ Chile, Clin Las Condes, Santiago, Chile	Clinica Las Condes; Universidad de Chile	Vucina, I (corresponding author), Univ Chile, Clin Las Condes, Santiago, Chile.							Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					833	833		10.7326/L17-0474	http://dx.doi.org/10.7326/L17-0474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204615				2022-12-28	WOS:000417135900027
J	Vallee, M; Ampuero, JP; Juhel, K; Bernard, P; Montagner, JP; Barsuglia, M				Vallee, Martin; Ampuero, Jean Paul; Juhel, Kevin; Bernard, Pascal; Montagner, Jean-Paul; Barsuglia, Matteo			Observations and modeling of the elastogravity signals preceding direct seismic waves	SCIENCE			English	Article							TRANSIENT GRAVITY PERTURBATIONS; SOURCE TIME FUNCTIONS; FOCAL MECHANISM; HALF-SPACE; EARTHQUAKES; RUPTURE; FAULTS; SHEAR	After an earthquake, the earliest deformation signals are not expected to be carried by the fastest (P) elastic waves but by the speed-of-light changes of the gravitational field. However, these perturbations are weak and, so far, their detection has not been accurate enough to fully understand their origins and to use them for a highly valuable rapid estimate of the earthquake magnitude. We show that gravity perturbations are particularly well observed with broadband seismometers at distances between 1000 and 2000 kilometers from the source of the 2011, moment magnitude 9.1, Tohoku earthquake. We can accurately model them by a new formalism, taking into account both the gravity changes and the gravity-induced motion. These prompt elastogravity signals open the window for minute time-scale magnitude determination for great earthquakes.	[Vallee, Martin; Juhel, Kevin; Bernard, Pascal; Montagner, Jean-Paul] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, CNRS, Paris, France; [Ampuero, Jean Paul] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [Barsuglia, Matteo] Univ Paris Diderot, Commissariat Energie Atom & Energies Alternat, Sorbonne Paris Cite,Irfu, AstroParticule & Cosmol,CNRS,IN2P3,Observ Paris, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA	Vallee, M (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, CNRS, Paris, France.	vallee@ipgp.fr	Montagner, Jean-Paul/A-8733-2011; Ampuero, Jean Paul/N-3348-2013; bernard, pascal/B-4828-2015; Vallee, Martin/K-5192-2012; Juhel, Kevin/G-6088-2018	Montagner, Jean-Paul/0000-0001-9958-3012; Ampuero, Jean Paul/0000-0002-4827-7987; Vallee, Martin/0000-0001-8049-4634; Juhel, Kevin/0000-0003-0881-6904	GEOSCOPE program; CNRS Institute for Earth Sciences and Astronomy; IPGP; UnivEarthS Labex program at Sorbonne Paris Cite [ANR-10-LABX-0023, ANR-11-IDEX-0005-02]; Agence Nationale de la Recherche [ANR-14-CE03-0014-01]	GEOSCOPE program; CNRS Institute for Earth Sciences and Astronomy; IPGP; UnivEarthS Labex program at Sorbonne Paris Cite; Agence Nationale de la Recherche(French National Research Agency (ANR))	We are grateful to the developers of AXITRA, and more specifically to O. Coutant for making his code publicly available, both in the moment tensor and in the single-force configurations. We thank engineers involved in the installation, maintenance, and data distribution of broadband seismic stations. High-quality signals come from the Global Seismograph Network (https://doi.org/10.7914/SN/IU), New China Digital Seismograph Network (https://doi.org/10.7914/SN/IC), National Research Institute for Earth Science and Disaster Resilience /F-net, GEOSCOPE (https://doi.org/10.18715/GEOSCOPE.G), and Northeast China Extended Seismic Array (https://doi.org/10.7914/SN/YP_2009) networks, all publicly available at the IRIS data management center (http://ds.iris.edu/ds/nodes/dmc/), Institut de Physique du Globe de Paris (IPGP) data center (http://datacenter.ipgp.fr/), or the F-net data center (www.fnet.bosai.go.jp/top.php). Global Centroid-Moment-Tensor Project (www.globalcmt.org/) source parameters of the Tohoku earthquake were very valuable for this study. The careful reviews of three anonymous reviewers were very valuable to clarify observational and theoretical aspects of the initial manuscript. We acknowledge T. Heaton for stimulating discussions that pushed us to carefully study the role of the gravity-induced acceleration. J. Harms provided valuable comments on the relationships between gravity and elastic perturbations. Most numerical computations were performed on the S-CAPAD platform, IPGP, France. We acknowledge the financial support from the GEOSCOPE program (funded by CNRS Institute for Earth Sciences and Astronomy and IPGP), the UnivEarthS Labex program at Sorbonne Paris Cite (ANR-10-LABX-0023 and ANR-11-IDEX-0005-02), and the Agence Nationale de la Recherche through grant ANR-14-CE03-0014-01. Seismic Analysis Code (http://ds.iris.edu/ds/nodes/dmc/software/downloads/sac/) and Generic Mapping Tools (http://gmt.soest.hawaii.edu/projects/gmt) free software packages were used for data processing and figure preparation.	Ando M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.161101; BOUCHON M, 1981, B SEISMOL SOC AM, V71, P959; Cotton F, 1997, GEOPHYS J INT, V128, P676, DOI 10.1111/j.1365-246X.1997.tb05328.x; Dahlen F. A, 1998, THEORETICAL GLOBAL S; Delouis B, 2014, B SEISMOL SOC AM, V104, P1479, DOI 10.1785/0120130151; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Geiger R., 2017, OVERVIEW GRAVITATION; Harms J, 2016, GEOPHYS J INT, V205, P1153, DOI 10.1093/gji/ggw076; Harms J, 2015, GEOPHYS J INT, V201, P1416, DOI 10.1093/gji/ggv090; Heaton TH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01348-z; Hohensee M, 2011, GEN RELAT GRAVIT, V43, P1905, DOI 10.1007/s10714-010-1118-x; Houston H, 2001, J GEOPHYS RES-SOL EA, V106, P11137, DOI 10.1029/2000JB900468; Imanishi Y, 2004, SCIENCE, V306, P476, DOI 10.1126/science.1101875; Kanamori H, 2008, GEOPHYS J INT, V175, P222, DOI 10.1111/j.1365-246X.2008.03887.x; Matsuo K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049018; McManus DJ, 2017, CLASSICAL QUANT GRAV, V34, DOI 10.1088/1361-6382/aa7103; Montagner JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13349; Moody MV, 2002, REV SCI INSTRUM, V73, P3957, DOI 10.1063/1.1511798; Okada Y., 2011, PRELIMINARY REPORT 2; OKUBO S, 1992, J GEOPHYS RES-SOL EA, V97, P7137, DOI 10.1029/92JB00178; Paik J. H., 2016, CLASSICAL QUANT GRAV, V33; Pasyanos ME, 1996, B SEISMOL SOC AM, V86, P1255; Vallee M, 2011, GEOPHYS J INT, V184, P338, DOI 10.1111/j.1365-246X.2010.04836.x; Vallee M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3606; Ye LL, 2016, J GEOPHYS RES-SOL EA, V121, P826, DOI 10.1002/2015JB012426	25	45	50	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1164	1167		10.1126/science.aao0746	http://dx.doi.org/10.1126/science.aao0746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191903				2022-12-28	WOS:000416584000036
J	Wilson, ASS; Hill, MS; Mahon, MF; Dinoi, C; Maron, L				Wilson, Andrew S. S.; Hill, Michael S.; Mahon, Mary F.; Dinoi, Chiara; Maron, Laurent			Organocalcium-mediated nucleophilic alkylation of benzene	SCIENCE			English	Article							SOLUBLE CALCIUM HYDRIDE; HEAVY GRIGNARD-REAGENTS; COMPLEXES; POLYMERIZATION; SUBSTITUTION; STRONTIUM; HYDROGEN; CLUSTER; ARENES; LIGAND	The electrophilic aromatic substitution of a C-H bond of benzene is one of the archetypal transformations of organic chemistry. In contrast, the electron-rich p-system of benzene is highly resistant to reactions with electron-rich and negatively charged organic nucleophiles. Here, we report that this previously insurmountable electronic repulsion may be overcome through the use of sufficiently potent organocalcium nucleophiles. Calcium n-alkyl derivatives-synthesized by reaction of ethene, but-1-ene, and hex-1-ene with a dimeric calcium hydride-react with protio and deutero benzene at 60 degrees C through nucleophilic substitution of an aromatic C-D/H bond. These reactions produce the n-alkyl benzenes with regeneration of the calcium hydride. Density functional theory calculations implicate an unstabilized Meisenheimer complex in the C-H activation transition state.	[Wilson, Andrew S. S.; Hill, Michael S.; Mahon, Mary F.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Dinoi, Chiara; Maron, Laurent] Univ Toulouse, 135 Ave Rangueil, F-31077 Toulouse, France; [Dinoi, Chiara; Maron, Laurent] Univ Toulouse III Paul Sabatier, CNRS, Inst Natl Sci Appl, UMR 5215,LPCNO, 135 Ave Rangueil, F-31077 Toulouse, France	University of Bath; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Hill, MS (corresponding author), Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.; Maron, L (corresponding author), Univ Toulouse, 135 Ave Rangueil, F-31077 Toulouse, France.; Maron, L (corresponding author), Univ Toulouse III Paul Sabatier, CNRS, Inst Natl Sci Appl, UMR 5215,LPCNO, 135 Ave Rangueil, F-31077 Toulouse, France.	m.s.hill@bath.ac.uk; maron@irsamc.ups-tlsc.fr	; Hill, Michael/I-5324-2014	Laurent, Maron/0000-0003-2653-8557; Wilson, Andrew/0000-0003-3972-9571; Hill, Michael/0000-0001-9784-9649	University of Bath; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [1500016] Funding Source: researchfish	University of Bath; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the University of Bath and the Engineering and Physical Sciences Research Council for funding of a Doctoral Training Partnership Ph.D. studentship (A.S.S.W.). The crystallographic data for compounds 6, 7, 8, 9, and 6-d have been deposited with the Cambridge Crystallographic Data Centre as entries 1565865 to 1565869, respectively. All other experimental data are presented in the supplementary materials. Data file S1 contains the Cartesian coordinates for the calculated structures described in this study. Data file S2 contains the Cartesian coordinates of the transition state for the alternative sigma-bond metathesis pathway that was located +29.7 kcal mol<SUP>-1</SUP> higher in energy than the metathesis transition state (TSHI) illustrated in Fig. 5.	Ashdown AA, 1927, IND ENG CHEM, V19, P1063, DOI 10.1021/ie50213a037; Beckmann E., 1905, CHEM BER, V38, P904; Calloway NO, 1935, CHEM REV, V17, P327, DOI 10.1021/cr60058a002; Causero A, 2017, DALTON T, V46, P1822, DOI 10.1039/c6dt04659b; Causero A, 2016, ORGANOMETALLICS, V35, P3350, DOI 10.1021/acs.organomet.6b00566; Chupakhin ON, 2016, TETRAHEDRON LETT, V57, P2665, DOI 10.1016/j.tetlet.2016.04.084; CLOKE FGN, 1991, J CHEM SOC CHEM COMM, P724, DOI 10.1039/c39910000724; Coles MP, 2009, ORGANOMETALLICS, V28, P1579, DOI 10.1021/om8011618; Crimmin MR, 2010, NEW J CHEM, V34, P1572, DOI 10.1039/c0nj00042f; Crimmin MR, 2008, CHEM-EUR J, V14, P11292, DOI 10.1002/chem.200801957; Eaborn C, 1997, CHEM COMMUN, P1961, DOI 10.1039/a703972g; Feil F, 2000, ORGANOMETALLICS, V19, P5010, DOI 10.1021/om0006209; Friedel C., 1877, CR HEBD ACAD SCI, V84, P1392; Gilman H, 1926, J AM CHEM SOC, V48, P2463, DOI 10.1021/ja01420a038; Harder S, 2002, ORGANOMETALLICS, V21, P2268, DOI 10.1021/om020092w; Harder S, 2001, ANGEW CHEM INT EDIT, V40, P4261, DOI 10.1002/1521-3773(20011119)40:22<4261::AID-ANIE4261>3.0.CO;2-J; Harder S, 2001, ORGANOMETALLICS, V20, P1044, DOI 10.1021/om000945p; Harder S, 2006, ANGEW CHEM INT EDIT, V45, P3474, DOI 10.1002/anie.200601013; Harder S, 2010, CHEM REV, V110, P3852, DOI 10.1021/cr9003659; Hill MS, 2016, CHEM SOC REV, V45, P972, DOI 10.1039/c5cs00880h; Hill MS, 2010, CHEM COMMUN, V46, P2498, DOI 10.1039/b923172b; Izod K, 2015, ORGANOMETALLICS, V34, P2406, DOI 10.1021/om501183p; Jochmann P, 2012, ANGEW CHEM INT EDIT, V51, P4452, DOI 10.1002/anie.201200690; Kennedy AR, 2002, J ORGANOMET CHEM, V648, P288, DOI 10.1016/S0022-328X(01)01480-2; Kohler M, 2016, ORGANOMETALLICS, V35, P242, DOI 10.1021/acs.organomet.5b00956; Kovalev IS, 2015, RUSS CHEM REV+, V84, P1191, DOI 10.1070/RCR4462; Leich V, 2015, INORG CHEM, V54, P4927, DOI 10.1021/acs.inorgchem.5b00527; Makosza M, 2010, CHEM SOC REV, V39, P2855, DOI 10.1039/b822559c; Nightingale DV, 1939, CHEM REV, V25, P329, DOI 10.1021/cr60082a001; Piesik DFJ, 2007, EUR J INORG CHEM, P5652, DOI 10.1002/ejic.200700802; Schuhknecht D, 2017, ANGEW CHEM INT EDIT, V56, P12367, DOI 10.1002/anie.201706848; Smith M. B., 2007, ADV ORGANIC CHEM REA; Spielmann J, 2007, CHEM-EUR J, V13, P8928, DOI 10.1002/chem.200701028; Spielmann J, 2008, ANGEW CHEM INT EDIT, V47, P9434, DOI 10.1002/anie.200804657; Werkema EL, 2010, DALTON T, V39, P6648, DOI 10.1039/b918103b; Westerhausen M, 2007, CHEM-EUR J, V13, P6292, DOI 10.1002/chem.200700558; Westerhausen M, 2007, ANGEW CHEM INT EDIT, V46, P1950, DOI 10.1002/anie.200604192; Westerhausen M, 2017, CHEM-EUR J, V23, P1456, DOI 10.1002/chem.201603786; Wheland GW, 1942, J AM CHEM SOC, V64, P900, DOI 10.1021/ja01256a047; Yan K, 2009, J AM CHEM SOC, V131, P15110, DOI 10.1021/ja9070865	40	125	127	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1168	1171		10.1126/science.aao5923	http://dx.doi.org/10.1126/science.aao5923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191904	Green Submitted			2022-12-28	WOS:000416584000037
J	Shapiro, MD; Miles, J; Tavori, H; Fazio, S				Shapiro, Michael D.; Miles, Joshua; Tavori, Hagai; Fazio, Sergio			Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor	ANNALS OF INTERNAL MEDICINE			English	Letter									[Shapiro, Michael D.; Miles, Joshua; Tavori, Hagai; Fazio, Sergio] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Shapiro, MD (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	shapirmi@ohsu.edu	Tavori, Hagai/AAS-9079-2021; Shapiro, Michael D./S-9851-2018	Shapiro, Michael D./0000-0002-9071-3287; Miles, Joshua/0000-0003-0022-1965	National Institutes of Health (National Heart, Lung, and Blood Institute) R01 grant [HL-132985]	National Institutes of Health (National Heart, Lung, and Blood Institute) R01 grant	Partially supported by National Institutes of Health (National Heart, Lung, and Blood Institute) R01 grant HL-132985 (Dr. Fazio).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592	4	27	27	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					376	379		10.7326/M17-2485	http://dx.doi.org/10.7326/M17-2485			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29181527				2022-12-28	WOS:000426632600016
J	Lean, MEJ; Leslie, WS; Barnes, AC; Brosnahan, N; Thom, G; McCombie, L; Peters, C; Zhyzhneuskaya, S; Al-Mrabeh, A; Hollingsworth, KG; Rodrigues, AM; Rehackova, L; Adamson, AJ; Sniehotta, FF; Mathers, JC; Ross, HM; McIlvenna, Y; Stefanetti, R; Trenell, M; Welsh, P; Kean, S; Ford, I; McConnachie, A; Sattar, N; Taylor, R				Lean, Michael E. J.; Leslie, Wilma S.; Barnes, Alison C.; Brosnahan, Naomi; Thom, George; McCombie, Louise; Peters, Carl; Zhyzhneuskaya, Sviatlana; Al-Mrabeh, Ahmad; Hollingsworth, Kieren G.; Rodrigues, Angela M.; Rehackova, Lucia; Adamson, Ashley J.; Sniehotta, Falko F.; Mathers, John C.; Ross, Hazel M.; McIlvenna, Yvonne; Stefanetti, Renae; Trenell, Michael; Welsh, Paul; Kean, Sharon; Ford, Ian; McConnachie, Alex; Sattar, Naveed; Taylor, Roy			Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial	LANCET			English	Article							LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; GASTRIC BYPASS; FOLLOW-UP; ASSOCIATION; MELLITUS; TRIACYLGLYCEROL; DIET	Background Type 2 diabetes is a chronic disorder that requires lifelong treatment. We aimed to assess whether intensive weight management within routine primary care would achieve remission of type 2 diabetes. Methods We did this open-label, cluster-randomised trial (DiRECT) at 49 primary care practices in Scotland and the Tyneside region of England. Practices were randomly assigned (1: 1), via a computer-generated list, to provide either a weight management programme (intervention) or best-practice care by guidelines (control), with stratification for study site (Tyneside or Scotland) and practice list size (>5700 or <= 5700). Participants, carers, and research assistants who collected outcome data were aware of group allocation; however, allocation was concealed from the study statistician. We recruited individuals aged 20-65 years who had been diagnosed with type 2 diabetes within the past 6 years, had a body-mass index of 27-45 kg/m(2), and were not receiving insulin. The intervention comprised withdrawal of antidiabetic and antihypertensive drugs, total diet replacement (825-853 kcal/day formula diet for 3-5 months), stepped food reintroduction (2-8 weeks), and structured support for long-term weight loss maintenance. Co-primary outcomes were weight loss of 15 kg or more, and remission of diabetes, defined as glycated haemoglobin (HbA(1c)) of less than 6.5% (<48 mmol/mol) after at least 2 months off all antidiabetic medications, from baseline to 12 months. These outcomes were analysed hierarchically. This trial is registered with the ISRCTN registry, number 03267836. Findings Between July 25, 2014, and Aug 5, 2017, we recruited 306 individuals from 49 intervention (n= 23) and control (n= 26) general practices; 149 participants per group comprised the intention-to-treat population. At 12 months, we recorded weight loss of 15 kg or more in 36 (24%) participants in the intervention group and no participants in the control group (p<0.0001). Diabetes remission was achieved in 68 (46%) participants in the intervention group and six (4%) participants in the control group (odds ratio 19.7, 95% CI 7.8-49.8; p<0.0001). Remission varied with weight loss in the whole study population, with achievement in none of 76 participants who gained weight, six (7%) of 89 participants who maintained 0-5 kg weight loss, 19 (34%) of 56 participants with 5-10 kg loss, 16 (57%) of 28 participants with 10-15 kg loss, and 31 (86%) of 36 participants who lost 15 kg or more. Mean bodyweight fell by 10.0 kg (SD 8.0) in the intervention group and 1.0 kg (3.7) in the control group (adjusted difference -8.8 kg, 95% CI -10.3 to -7.3; p<0.0001). Quality of life, as measured by the EuroQol 5 Dimensions visual analogue scale, improved by 7.2 points (SD 21.3) in the intervention group, and decreased by 2.9 points (15.5) in the control group (adjusted difference 6.4 points, 95% CI 2.5-10.3; p=0.0012). Nine serious adverse events were reported by seven (4%) of 157 participants in the intervention group and two were reported by two (1%) participants in the control group. Two serious adverse events (biliary colic and abdominal pain), occurring in the same participant, were deemed potentially related to the intervention. No serious adverse events led to withdrawal from the study. Interpretation Our findings show that, at 12 months, almost half of participants achieved remission to a non-diabetic state and off antidiabetic drugs. Remission of type 2 diabetes is a practical target for primary care.	[Lean, Michael E. J.; Leslie, Wilma S.; Brosnahan, Naomi; Thom, George; McCombie, Louise] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med Dent & Nursing, Human Nutr, Glasgow, Lanark, Scotland; [McIlvenna, Yvonne] Univ Glasgow, Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Kean, Sharon; Ford, Ian; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Welsh, Paul; Sattar, Naveed] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Welsh, Paul; Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Barnes, Alison C.; Adamson, Ashley J.; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Rodrigues, Angela M.; Rehackova, Lucia; Sniehotta, Falko F.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Peters, Carl; Zhyzhneuskaya, Sviatlana; Al-Mrabeh, Ahmad; Hollingsworth, Kieren G.; Taylor, Roy] Newcastle Univ, Inst Cellular Med, Newcastle Magnet Resonance Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Trenell, Michael] Newcastle Univ, Move Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Stefanetti, Renae] Newcastle Univ, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Stefanetti, Renae] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Ross, Hazel M.] Counterweight, Corby, Northants, England	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Taylor, R (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Magnet Resonance Ctr, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.	roy.taylor@newcastle.ac.uk	Sniehotta, Falko F/C-5481-2008; Sniehotta, Falko/ABF-7131-2021; Ford, Ian/ABE-6145-2020; Welsh, Paul/H-5249-2019	Sniehotta, Falko F/0000-0003-1738-4269; Sniehotta, Falko/0000-0003-1738-4269; Welsh, Paul/0000-0002-7970-3643; Trenell, Michael/0000-0001-8253-5620; Stefanetti, Renae/0000-0001-6402-6435; Brosnahan, Naomi/0000-0002-3354-1060; Thom, George/0000-0002-8871-9524; Adamson, Ashley/0000-0003-3735-2846	Diabetes UK; ESRC [ES/K007688/1] Funding Source: UKRI; MRC [G0700718, G1100160, MR/L016354/1] Funding Source: UKRI; Medical Research Council [MR/L016354/1, MR/K02325X/1B, G0700718, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001, NF-SI-0617-10156] Funding Source: researchfish	Diabetes UK(Diabetes UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Diabetes UK.	Arun CS, 2004, DIABETOLOGIA, V47, P1380, DOI 10.1007/s00125-004-1473-9; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Finer S, 2017, LANCET DIABETES ENDO; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P913, DOI 10.1016/S2213-8587(16)30162-0; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lean M, 2013, BRIT J GEN PRACT, V63, pE115, DOI 10.3399/bjgp13X663073; Leslie WS, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0406-2; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lingvay I, 2013, DIABETES CARE, V36, P2741, DOI 10.2337/dc12-2316; McCombie L, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4030; Meier JJ, 2006, DIABETES CARE, V29, P1554, DOI 10.2337/dc06-0392; National Institute for Health and Care Excellence, 2015, TYP 2 DIAB AD MAN; Pinnick K, 2010, J CELL BIOCHEM, V109, P683, DOI 10.1002/jcb.22445; Public Health England National Cardiovascular Intelligence Network, 2016, 3 8 MILL PEOPL ENGL; Rehackova L, 2017, DIABETIC MED, V34, P1554, DOI 10.1111/dme.13426; Ross H, 2017, COUNTERWEIGHT PLUS I; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Scottish Intercollegiate Guidelines Network, 2010, MAN DIAB NAT CLIN GU; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Steven S, 2016, DIABETES CARE, V39, P158, DOI 10.2337/dc15-0750; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7; Taylor R, 2017, DIABETOLOGIA; Uusitupa MIJ, 1996, ANN MED, V28, P445, DOI 10.3109/07853899608999106; van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533; Vecht J, 1997, SCAND J GASTROENTERO, V32, P21; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; White MG, 2016, DIABETES CARE, V39, P2080, DOI 10.2337/dc16-0619; WHO, 2016, GLOB REP PSOR; WING RR, 1991, ARCH INTERN MED, V151, P1334, DOI 10.1001/archinte.151.7.1334; Wright AK, 2017, DIABETES CARE, V40, P338, DOI 10.2337/dc16-1616	35	754	789	14	185	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2018	391	10120					541	551		10.1016/S0140-6736(17)33102-1	http://dx.doi.org/10.1016/S0140-6736(17)33102-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV5VB	29221645	Green Published, Green Accepted			2022-12-28	WOS:000424649400031
J	Nandi, A; El-Toukhy, T				Nandi, Anupa; El-Toukhy, Tarek			Stimulated intrauterine insemination for unexplained subfertility	LANCET			English	Editorial Material							IN-VITRO FERTILIZATION; SINGLE EMBRYO-TRANSFER; PATIENTS PREFERENCES; COUPLES; TRIAL; PROGNOSIS		[Nandi, Anupa; El-Toukhy, Tarek] Guys & St Thomas Hosp, Assisted Concept Unit, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Nandi, A (corresponding author), Guys & St Thomas Hosp, Assisted Concept Unit, London SE1 9RT, England.	anupa.nandi@gmail.com	Nandi, Anupa/C-9129-2014	Nandi, Anupa/0000-0001-5181-8556				Bensdorp AJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7771; Bhattacharya S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a716; Custers IM, 2011, FERTIL STERIL, V96, P1107, DOI 10.1016/j.fertnstert.2011.08.005; Farquhar CM, 2017, LANCET; Goldman MB, 2014, FERTIL STERIL, V101, P1574, DOI 10.1016/j.fertnstert.2014.03.012; Malchau SS, 2014, FERTIL STERIL, V102, P1110, DOI 10.1016/j.fertnstert.2014.06.034; Nandi A, 2017, FERTIL STERIL, V107, P1329, DOI 10.1016/j.fertnstert.2017.03.028; National Institute for Health and Clinical Excellence, 2013, FERT ASS TREATM PEOP; Smith S., 2003, JAMA-J AM MED ASSOC, V290, P17; Steures P, 2005, HUM REPROD, V20, P752, DOI 10.1093/humrep/deh673; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; van Weert JM, 2007, REPROD BIOMED ONLINE, V15, P422, DOI 10.1016/S1472-6483(10)60368-9	12	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2018	391	10119					404	405		10.1016/S0140-6736(17)33038-6	http://dx.doi.org/10.1016/S0140-6736(17)33038-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OL	29174130				2022-12-28	WOS:000424333600005
J	Waldron, A; Miller, DC; Redding, D; Mooers, A; Kuhn, TS; Nibbelink, N; Roberts, JT; Tobias, JA; Gittleman, JL				Waldron, Anthony; Miller, Daniel C.; Redding, Dave; Mooers, Arne; Kuhn, Tyler S.; Nibbelink, Nate; Roberts, J. Timmons; Tobias, Joseph A.; Gittleman, John L.			Reductions in global biodiversity loss predicted from conservation spending (vol 551, pg 364, 2017)	NATURE			English	Correction																		Waldron A, 2017, NATURE, V551, P364, DOI 10.1038/nature24295	1	0	0	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					530	530		10.1038/nature25017	http://dx.doi.org/10.1038/nature25017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1GX	29236690	Bronze			2022-12-28	WOS:000428064700001
J	Secemsky, EA; Schermerhorn, M; Carroll, BJ; Kennedy, KF; Shen, CY; Valsdottir, LR; Landon, B; Yeh, RW				Secemsky, Eric A.; Schermerhorn, Marc; Carroll, Brett J.; Kennedy, Kevin F.; Shen, Changyu; Valsdottir, Linda R.; Landon, Bruce; Yeh, Robert W.			Readmissions After Revascularization Procedures for Peripheral Arterial Disease A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY IMPROVEMENT PROGRAM; LOWER-EXTREMITY BYPASS; AMERICAN-COLLEGE; RISK-FACTORS; 30-DAY READMISSION; REDUCTION PROGRAM; RATES; SURGERY	Background: Limited data suggest high rates of unplanned re-hospitalization after endovascular and surgical revascularization for peripheral arterial disease. However, the overall burden of readmissions has not been comprehensively explored. Objective: To evaluate nationwide readmissions after peripheral arterial revascularization for peripheral arterial disease and to assess whether readmission risk varies among hospitals. Design: Retrospective cohort study. Setting: 1085 U.S. acute care hospitals participating in the Nationwide Readmissions Database. Patients: 61 969 unweighted hospitalizations of patients with peripheral arterial disease who had peripheral arterial revascularization and were discharged alive between 1 January and 30 November 2014. Measurements: 30-day readmission rates, causes, and costs of unplanned rehospitalizations after peripheral arterial revascularization; 30-day risk-standardized readmission rates (RSRRs), calculated using hierarchical logistic regression, to assess for heterogeneity of readmission risk between hospitals. Results: Among 61 969 hospitalizations of patients with peripheral arterial disease who were discharged alive after peripheral arterial revascularization, the 30-day nonelective readmission rate was 17.6%. The most common cause of readmission was procedural complications (28.0%), followed by sepsis (8.3%) and complications due to diabetes mellitus (7.5%). Among rehospitalized patients, 21.0% underwent a subsequent peripheral arterial revascularization or lower extremity amputation, 4.6% died, and the median cost of a readmission was $11 013. Thirty-day RSRRs varied from 10.0% to 27.3% (interquartile range, 16.6% to 18.8%). Limitation: Inability to distinguish out-of-hospital deaths after discharge and potential misclassification bias due to use of billing codes to ascertain diagnoses and interventions. Conclusion: More than 1 in 6 patients with peripheral arterial disease who undergo peripheral arterial revascularization have unplanned readmission within 30 days, with high associated mortality risks and costs. Procedure-and patient-related factors were the primary reasons for readmission. Readmission rates varied moderately between institutions after hospital case mix was accounted for, suggesting that differences in hospital quality may only partially account for readmission.	[Secemsky, Eric A.] Massachusetts Gen Hosp, 55 Fruit St,GRB 8-852E, Boston, MA 02114 USA; [Schermerhorn, Marc] Beth Israel Deaconess Med Ctr, 110 Francis St,Suite 5B, Boston, MA 02215 USA; [Carroll, Brett J.] Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Floor 3, Boston, MA 02215 USA; [Kennedy, Kevin F.] 30 West Pershing Rd,Suite 210, Kansas City, MO 64108 USA; [Shen, Changyu; Valsdottir, Linda R.; Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA; [Landon, Bruce] Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Shapiro 6,South Suite, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave,4th Floor, Boston, MA 02215 USA.	ryeh@bidmc.harvard.edu	Yeh, Robert/AAJ-3463-2020		Smith Center for Outcomes Research in Cardiology; Beth Israel Deaconess Medical Center	Smith Center for Outcomes Research in Cardiology; Beth Israel Deaconess Medical Center	By the Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center.	[Anonymous], 2017, HCUP CLIN CLASS SOFT; [Anonymous], 2017, HCUP ELIXH COM SOFTW; [Anonymous], 2007, C PROM GREAT EFF MED; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Centers for Medicare & Medicaid Services, READM RED PROGR HRRP; Davenport DL, 2014, J VASC SURG, V60, P1266, DOI 10.1016/j.jvs.2014.05.051; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Gonzalez AA, 2016, ANN VASC SURG, V35, P130, DOI 10.1016/j.avsg.2016.01.054; Goodney PP, 2013, J VASC SURG, V57, P1471, DOI 10.1016/j.jvs.2012.11.068; Goodney PP, 2012, CIRC-CARDIOVASC QUAL, V5, P94, DOI 10.1161/CIRCOUTCOMES.111.962233; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Vogel TR, 2013, J VASC SURG, V58, P90, DOI 10.1016/j.jvs.2012.12.031; Wasfy JH, 2017, ANN INTERN MED, V166, P324, DOI 10.7326/M16-0185; Yale New Haven Health Services Corporation/Center for Outcomes Research Evaluation, 2017, 2017 COND SPEC MEAS; Zhang JQ, 2014, J VASC SURG, V59, P1331, DOI 10.1016/j.jvs.2013.12.032	21	33	33	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					93	+		10.7326/M17-1058	http://dx.doi.org/10.7326/M17-1058			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29204656				2022-12-28	WOS:000424096600013
J	Ronco, G; Franceschi, S				Ronco, Guglielmo; Franceschi, Silvia			Cervical Cancer Screening: The Transformational Role of Routine Human Papillomavirus Testing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION; NEOPLASIA		[Ronco, Guglielmo] City Hlth & Sci, Turin, Italy; [Franceschi, Silvia] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France; [Ronco, Guglielmo] Via Cavour 31, I-10123 Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; World Health Organization; International Agency for Research on Cancer (IARC)	Ronco, G (corresponding author), Via Cavour 31, I-10123 Turin, Italy.	guglielmo.ronco@cpo.it	franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071				Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Castle PE, 2018, ANN INTERN MED, V168, P20, DOI 10.7326/M17-1609; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	10	6	6	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2018	168	1					75	+		10.7326/M17-2872	http://dx.doi.org/10.7326/M17-2872			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR5SO	29181508				2022-12-28	WOS:000419126700012
J	Li, XL; Selesnick, R; Schiller, Q; Zhang, K; Zhao, H; Baker, DN; Temerin, MA				Li, Xinlin; Selesnick, Richard; Schiller, Quintin; Zhang, Kun; Zhao, Hong; Baker, Daniel N.; Temerin, Michael A.			Measurement of electrons from albedo neutron decay and neutron density in near-Earth space	NATURE			English	Article							RADIATION BELT ELECTRONS; COSMIC-RAY ALBEDO; DIFFUSION; FIELDS	The Galaxy is filled with cosmic-ray particles, mostly protons with kinetic energies greater than hundreds of megaelectronvolts. Around Earth, trapped energetic protons, electrons and other particles circulate at altitudes from about 500 to 40,000 kilometres in the Van Allen radiation belts. Soon after these radiation belts were discovered six decades ago, it was recognized that the main source of inner-belt protons (with kinetic energies of tens to hundreds of megaelectronvolts) is cosmic-ray albedo neutron decay (CRAND)(1). In this process, cosmic rays that reach the upper atmosphere interact with neutral atoms to produce albedo neutrons, which, being prone to beta-decay, are a possible source of geomagnetically trapped protons and electrons. These protons would retain most of the kinetic energy of the neutrons, while the electrons would have lower energies, mostly less than one megaelectronvolt. The viability of CRAND as an electron source has, however, been uncertain, because measurements have shown that the electron intensity in the inner Van Allen belt can vary greatly, while the neutron-decay rate should be almost constant(2,3). Here we report measurements of relativistic electrons near the inner edge of the inner radiation belt. We demonstrate that the main source of these electrons is indeed CRAND, and that this process also contributes to electrons in the inner belt elsewhere. Furthermore, measurement of the intensity of electrons generated by CRAND provides an experimental determination of the neutron density in near-Earth space-2 x 10(-9) per cubic centimetre-confirming theoretical estimates(4).	[Li, Xinlin; Zhang, Kun; Zhao, Hong; Baker, Daniel N.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Li, Xinlin; Zhang, Kun] Univ Colorado, Ann & HJ Smead Dept Aerosp Engn Sci, Boulder, CO 80309 USA; [Selesnick, Richard] US Air Force, Res Lab, Space Vehicles Directorate, Kirtland AFB, NM 87117 USA; [Schiller, Quintin] NASA, Goddard Space Flight Ctr, Heliophys Lab, Greenbelt, MD 20771 USA; [Temerin, Michael A.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Defense; United States Air Force; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley	Li, XL (corresponding author), Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA.; Li, XL (corresponding author), Univ Colorado, Ann & HJ Smead Dept Aerosp Engn Sci, Boulder, CO 80309 USA.	lix@lasp.colorado.edu	Zhang, Kun/AFV-4868-2022	Zhang, Kun/0000-0003-0393-9833; LI, XINLIN/0000-0002-1683-3192; ZHAO, HONG/0000-0001-8292-7691	National Science Foundation (NSF) [AGS 1443749]; NASA/Radiation Belt Storm Probes (RBSP)-Energetic particle, Composition and Thermal plasma (ECT) through Johns Hopkins University (JHU)/Applied Physics Laboratory (APL) under prime NASA [967399, NAS5-01072]; Div Atmospheric & Geospace Sciences [1443749] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NASA/Radiation Belt Storm Probes (RBSP)-Energetic particle, Composition and Thermal plasma (ECT) through Johns Hopkins University (JHU)/Applied Physics Laboratory (APL) under prime NASA; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported in part by the National Science Foundation (NSF) CubeSat Program, NSF grant AGS 1443749, and NASA/Radiation Belt Storm Probes (RBSP)-Energetic particle, Composition and Thermal plasma (ECT) funding through Johns Hopkins University (JHU)/Applied Physics Laboratory (APL) contract 967399 under prime NASA contract NAS5-01072.	Baker DN, 2014, NATURE, V515, P531, DOI 10.1038/nature13956; Baker DN, 2004, NATURE, V432, P878, DOI 10.1038/nature03116; Barker AB, 2005, SPACE WEATHER, V3, DOI 10.1029/2004SW000118; Boscher D., 2012, INT RAD BELT ENV MOD; HESS WN, 1961, J GEOPHYS RES, V66, P665, DOI 10.1029/JZ066i003p00665; KELLOGG PJ, 1959, NATURE, V183, P1295, DOI 10.1038/1831295a0; LENCHEK AM, 1961, J GEOPHYS RES, V66, P4027, DOI 10.1029/JZ066i012p04027; Li X, 2015, J GEOPHYS RES-SPACE, V120, P1215, DOI 10.1002/2014JA020777; Li X, 2013, J GEOPHYS RES-SPACE, V118, P6489, DOI 10.1002/2013JA019342; Li X, 2012, GEOPHYS MONOGR SER, V199, P385, DOI 10.1029/2012GM001313; Li XL, 2009, SPACE WEATHER, V7, DOI 10.1029/2008SW000418; ROEDERER JG, 1973, J GEOPHYS RES, V78, P133, DOI 10.1029/JA078i001p00133; Sauvaud JA, 2006, PLANET SPACE SCI, V54, P502, DOI 10.1016/j.pss.2005.10.019; Selesnick RS, 2016, J GEOPHYS RES-SPACE, V121, P8417, DOI 10.1002/2016JA022973; Selesnick RS, 2016, J GEOPHYS RES-SPACE, V121, P1969, DOI 10.1002/2015JA022154; Selesnick RS, 2016, J GEOPHYS RES-SPACE, V121, P1249, DOI 10.1002/2015JA022180; Selesnick RS, 2015, J GEOPHYS RES-SPACE, V120, P2912, DOI 10.1002/2014JA020963; Selesnick RS, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017793; Selesnick RS, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009179; SINGER SF, 1958, PHYS REV LETT, V1, P171, DOI 10.1103/PhysRevLett.1.171; Su YJ, 2016, J GEOPHYS RES-SPACE, V121, P8508, DOI 10.1002/2016JA022881	21	41	42	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2017	552	7685					382	+		10.1038/nature24642	http://dx.doi.org/10.1038/nature24642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ7RI	29236693				2022-12-28	WOS:000418559800054
J	Zupan, Z; Evans, A; Couturier, DL; Marteau, TM				Zupan, Zorana; Evans, Alexandra; Couturier, Dominique-Laurent; Marteau, Theresa M.			CHRISTMAS 2017: NATURAL PHENOMENA Wine glass size in England from 1700 to 2017: a measure of our time	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BIAS		[Zupan, Zorana; Evans, Alexandra; Couturier, Dominique-Laurent; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England.	tm388@cam.ac.uk	Zupan, Zorana/AAG-9853-2020	Zupan, Zorana/0000-0002-0763-8192; Couturier, Dominique-Laurent/0000-0001-5774-5036; Evans, Alexandra/0000-0002-4055-7300	National Institute of Health Research Senior Investigator Award [NF-SI-0513-10101]; National Institute for Health Research [NF-SI-0513-10101] Funding Source: researchfish	National Institute of Health Research Senior Investigator Award; National Institute for Health Research(National Institute for Health Research (NIHR))	The research for this article was funded by the National Institute of Health Research Senior Investigator Award (NF-SI-0513-10101), awarded to TMM. The funder had no role in the design, collection, analysis, or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication.	[Anonymous], 1845, LANCET, V45, P214; Berry M, 2014, MORNING ADVERTISER; British Glass, 2013, CONT GLASS MAN AUT P; Dickens C., 1843, CHRISTMAS CAROL; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Geier AB, 2006, PSYCHOL SCI, V17, P521, DOI 10.1111/j.1467-9280.2006.01738.x; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]; Kerr WC, 2009, DRUG ALCOHOL REV, V28, P360, DOI 10.1111/j.1465-3362.2009.00056.x; Moore V, 2014, TELEGRAPH; Newton RG, 1989, CONSERVATION GLASS; Nicholls J., 2009, DRINKING CULTURES CO; Office of National Statistics, 2017, AD DRINK HAB GREAT B; Paul J, 1988, MISTLETOE AND WINE; Pechey Rachel, 2017, BMC Res Notes, V10, P287, DOI 10.1186/s13104-017-2610-0; Pechey R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3068-z; Riedel, 2017, SOMM; Robinson E, 2014, OBES REV, V15, P812, DOI 10.1111/obr.12200; Stead M, 2013, SCOPING FEASIBILITY; Stead M, 2014, ALCOHOL ALCOHOLISM, V49, P317, DOI 10.1093/alcalc/agt178; Stockwell T, 2013, ALCOHOL TOO CHEAP UK; UK Department of Health, 2016, UK CHIEF MED OFF LOW; Van Ittersum K, 2012, J CONSUM RES, V39, P215, DOI 10.1086/662615; Vose RH, 1980, GLASS; Wilcox GB, 2015, INT J ADVERT, V34, P641, DOI 10.1080/02650487.2015.1019961; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zupan Z, 2017, BMC Psychol, V5, P17, DOI 10.1186/s40359-017-0183-2	26	10	10	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2017	359								j5623	10.1136/bmj.j5623	http://dx.doi.org/10.1136/bmj.j5623			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KY	29237588	Green Published, hybrid			2022-12-28	WOS:000418327500007
J	Sundram, S; Ventevogel, P				Sundram, Suresh; Ventevogel, Peter			The mental health of refugees and asylum seekers on Manus Island	LANCET			English	Editorial Material							IMMIGRATION DETENTION; SEEKING ASYLUM		[Sundram, Suresh] Monash Univ, Monash Med Ctr, Dept Psychiat, Sch Clin Sci, Clayton, Vic 3168, Australia; [Ventevogel, Peter] United Nations High Commissioner Refugees, Div Programme Management & Support, Publ Hlth Sect, Geneva, Switzerland	Monash University	Sundram, S (corresponding author), Monash Univ, Monash Med Ctr, Dept Psychiat, Sch Clin Sci, Clayton, Vic 3168, Australia.	suresh.sundram@monash.edu	Mares, Sarah/X-1088-2019; Ventevogel, Peter/D-5831-2015	Mares, Sarah/0000-0002-4514-9111; Ventevogel, Peter/0000-0002-3567-8861; SUNDRAM, SURESH/0000-0002-9674-0227	office of the United Nations High Commissioner for Refugees Regional Representative in Australia; Australian Government Department of Immigration and Border Protection	office of the United Nations High Commissioner for Refugees Regional Representative in Australia; Australian Government Department of Immigration and Border Protection	SS has received consultancy fees and travel support from the office of the United Nations High Commissioner for Refugees Regional Representative in Australia and the Australian Government Department of Immigration and Border Protection. PV is employed full-time by the United Nations High Commissioner for Refugees as their Senior Mental Health Officer.	Adu Krow W, 2013, PROFILE MENTAL HLTH; Amnesty International, 2017, WE GOT BOTT MAN ISL; Coffey GJ, 2010, SOC SCI MED, V70, P2070, DOI 10.1016/j.socscimed.2010.02.042; Creek TG, 2014, INT J HUM RIGHTS, V18, P479, DOI 10.1080/13642987.2014.901967; Doherty Ben, 2017, GUARDIAN; EDWARDS Alice, 2011, BACK BASICS RIGHT LI; Filges T., 2016, RES SOCIAL WORK PRAC; Fox L., 2017, AUSTR BROADCAST 1113; Human Rights Watch, 2017, AUSTR PNG REF FAC UN; Robjant K, 2009, BRIT J PSYCHIAT, V194, P306, DOI 10.1192/bjp.bp.108.053223; Senate Legal and Constitutional Affairs Legislation Committee, 2017, ADD EST IMM BORD PRO; Silove D, 2017, WORLD PSYCHIATRY, V16, P130, DOI 10.1002/wps.20438; Steel Z, 2006, BRIT J PSYCHIAT, V188, P58, DOI 10.1192/bjp.bp.104.007864; Steel Z, 2004, AUST NZ J PUBL HEAL, V28, P527, DOI 10.1111/j.1467-842X.2004.tb00042.x; The Senate Legal and Constitutional Affairs References Committee, 2014, REP INC MAN ISL DET; United Nations Development Programme, 2016, HUM DEV REP 2016; United Nations High Commissioner for Refugees, 2013, UNHCR REG REPR UNHCR; United Nations High Commissioner for Refugees, 2016, SUBM OFF UN HIGH COM; United Nations High Commissioner for Refugees, 2017, UNHCR WARNS ESC CRIS; United Nations High Commissioner for Refugees, 2017, UNHCR URG HUM APPR M; United Nations High Commissioner for Refugees, 2017, AUSTR URG ENS PROT A; United Nations High Commissioner for Refugees, 2017, UNHCR URG AUSTR STOP; Westcott B., 2017, CNN; Yaxley L., 2017, AUSTR BROADCAST 0522	24	3	3	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2534	2536		10.1016/S0140-6736(17)33051-9	http://dx.doi.org/10.1016/S0140-6736(17)33051-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29191373				2022-12-28	WOS:000417493300008
J	Karp, EM; Eaton, TR; Nogue, VSI; Vorotnikov, V; Biddy, MJ; Tan, ECD; Brandner, DG; Cywar, RM; Liu, RM; Manker, LP; Michener, WE; Gilhespy, M; Skoufa, Z; Watson, MJ; Fruchey, OS; Vardon, DR; Gill, RT; Bratis, AD; Beckham, GT				Karp, Eric M.; Eaton, Todd R.; Sanchez i Nogue, Violeta; Vorotnikov, Vassili; Biddy, Mary J.; Tan, Eric C. D.; Brandner, David G.; Cywar, Robin M.; Liu, Rongming; Manker, Lorenz P.; Michener, William E.; Gilhespy, Michelle; Skoufa, Zinovia; Watson, Michael J.; Fruchey, O. Stanley; Vardon, Derek R.; Gill, Ryan T.; Bratis, Adam D.; Beckham, Gregg T.			Renewable acrylonitrile production	SCIENCE			English	Article							3-HYDROXYPROPIONIC ACID; ESCHERICHIA-COLI; AMMOXIDATION; GLYCEROL; DEHYDRATION; CONVERSION; CATALYSTS; NITRILES; PATHWAY	Acrylonitrile (ACN) is a petroleum-derived compound used in resins, polymers, acrylics, and carbon fiber. We present a process for renewable ACN production using 3-hydroxypropionic acid (3-HP), which can be produced microbially from sugars. The process achieves ACN molar yields exceeding 90% from ethyl 3-hydroxypropanoate (ethyl 3-HP) via dehydration and nitrilation with ammonia over an inexpensive titanium dioxide solid acid catalyst. We further describe an integrated process modeled at scale that is based on this chemistry and achieves near-quantitative ACN yields (98 +/- 2%) from ethyl acrylate. This endothermic approach eliminates runaway reaction hazards and achieves higher yields than the standard propylene ammoxidation process. Avoidance of hydrogen cyanide as a by-product also improves process safety and mitigates product handling requirements.	[Karp, Eric M.; Eaton, Todd R.; Sanchez i Nogue, Violeta; Vorotnikov, Vassili; Biddy, Mary J.; Tan, Eric C. D.; Brandner, David G.; Cywar, Robin M.; Manker, Lorenz P.; Michener, William E.; Vardon, Derek R.; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Liu, Rongming; Gill, Ryan T.; Bratis, Adam D.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Gilhespy, Michelle; Skoufa, Zinovia; Watson, Michael J.] Johnson Matthey Technol Ctr, Billingham TS23 1LB, Cleveland, England; [Fruchey, O. Stanley] MATRIC, S Charleston, WV 25303 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA.	gregg.beckham@nrel.gov	Liu, Rongming/O-5544-2018; Brandner, David G./N-3418-2017; Vardon, Derek/B-8249-2017; Manker, Lorenz/V-4436-2017; Vorotnikov, Vassili/G-9657-2013	Brandner, David G./0000-0003-4296-4855; Karp, Eric/0000-0002-4620-0919; Vardon, Derek/0000-0002-0199-4524; Manker, Lorenz/0000-0002-9886-6974; Vorotnikov, Vassili/0000-0001-9234-1643; Sanchez i Nogue, Violeta/0000-0002-5873-095X; Tan, Eric/0000-0002-9110-2410; Skoufa, Zinovia/0000-0002-0690-4452	U.S. Department of Energy (DOE) Bioenergy Technologies Office [DE-FOA-0000996]; DOE Office of Energy Efficiency and Renewable Energy [DE-AC36-08G028308]	U.S. Department of Energy (DOE) Bioenergy Technologies Office(United States Department of Energy (DOE)); DOE Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	Supported by U.S. Department of Energy (DOE) Bioenergy Technologies Office grant DE-FOA-0000996. Computer time was provided by Extreme Science and Engineering Discovery Environment (XSEDE) allocation MCB-090159 at the Texas Advanced Computing Center and by the National Renewable Energy Laboratory Computational Sciences Center, supported by the DOE Office of Energy Efficiency and Renewable Energy under contract DE-AC36-08G028308. We thank L. Berstis, S. Kim, and P. Kostestkyy for helpful discussions regarding the catalytic mechanism; D. Salvachua and X. Wang regarding bioreactor cultivation; B. Black, K. Ramirez, and M. Reed for analytical assistance; and members of the Renewable Carbon Fiber Consortium for helpful discussions. E.M.K., T.R.E., D.R.V., and G.T.B. are inventors on patent application WO 2017/143124 A1, US 2017/018272 submitted by the Alliance for Sustainable Energy that covers nitrile production from bio-based feedstocks. R.T.G. is a co-inventor on intellectual property related to biological 3-HPA production, which is now owned by Cargill. All data generated in this study are in the supplementary materials. The U.S. Government retains and the publisher, by accepting the article for publication, acknowledges that the U.S. Government retains a nonexclusive, paid up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for U.S. Government purposes.	[Anonymous], 1996, SOH ACR PROC; Biddy MJ, 2016, ACS SUSTAIN CHEM ENG, V4, P3196, DOI 10.1021/acssuschemeng.6b00243; Biddy MJ, 2016, VIETNAMS TUNA EXPORT, DOI DOI 10.2172/1244312; Borodina I, 2015, METAB ENG, V27, P57, DOI 10.1016/j.ymben.2014.10.003; Centi G, 1997, APPL CATAL A-GEN, V157, P143, DOI 10.1016/S0926-860X(97)00013-6; Chauvel A., 1989, PETROCHEMICAL PROCES; Chien IL, 2008, J PROCESS CONTR, V18, P215, DOI 10.1016/j.jprocont.2007.02.006; Choi S, 2015, METAB ENG, V28, P223, DOI 10.1016/j.ymben.2014.12.007; Chu HS, 2015, BIOTECHNOL BIOENG, V112, P356, DOI 10.1002/bit.25444; Decoster D., 2013, Patent WO, Patent No. 2013192451; Dubois J. L., 2010, Patent No. [101636381, CN 101636381]; Epps G.D.V., 1916, J AM CHEM SOC, V38, P2128; Grasselli RK, 1999, CATAL TODAY, V49, P141, DOI 10.1016/S0920-5861(98)00418-0; Grasselli RK, 2016, TOP CATAL, V59, P1651, DOI 10.1007/s11244-016-0679-7; Grasselli RK, 2011, RSC NANOSCI NANOTECH, P96; Grendze M, 2000, US Patent, Patent No. [6146534, 6,146,534]; Itagaki S, 2013, CHEMCATCHEM, V5, P1725, DOI 10.1002/cctc.201300063; Kelly JC, 2015, ENVIRON SCI TECHNOL, V49, P12535, DOI 10.1021/acs.est.5b03192; Kostestkyy P, 2014, CATAL SCI TECHNOL, V4, P3861, DOI 10.1039/c4cy00632a; Le Notre J, 2011, GREEN CHEM, V13, P807, DOI 10.1039/c0gc00805b; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26932; Liebig C, 2013, APPL CATAL B-ENVIRON, V132, P170, DOI 10.1016/j.apcatb.2012.11.035; McCallion J, 1996, CHEM PROCESS, V59, P73; Mekki-Berrada A, 2013, J CATAL, V306, P30, DOI 10.1016/j.jcat.2013.05.032; Guerrero-Perez MO, 2008, CHEMSUSCHEM, V1, P511, DOI 10.1002/cssc.200800023; Orjuela A, 2011, SEP PURIF TECHNOL, V83, P31, DOI 10.1016/j.seppur.2011.08.010; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Park S -J, 2014, CARBON FIBERS; Pasternak S. M., 1973, J APPL CHEM-USSR, V47, P2590; Rathnasingh C, 2012, J BIOTECHNOL, V157, P633, DOI 10.1016/j.jbiotec.2011.06.008; Shaver F. W., 1950, U. S. Patent, Patent No. 2510423; STEVENSON AC, 1951, IND ENG CHEM, V43, P1920, DOI 10.1021/ie50501a012; Sundmacher K., 2002, REACTIVE DISTILLATIO; SUVOROV BV, 1987, J APPL CHEM-USSR+, V60, P643; Tecnon OrbiChem, 2013, CHEM NET FACTS ACR; Thomas J. M., 2015, PRINCIPLES PRACTICE; Werpy T, 2004, TOP VALUE ADDED CHEM, VI, DOI [10.2172/15008859, DOI 10.2172/15008859]	37	84	90	16	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1307	1310		10.1126/science.aan1059	http://dx.doi.org/10.1126/science.aan1059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217572				2022-12-28	WOS:000417254700059
J	Pyke, GH; Waser, NM				Pyke, Graham H.; Waser, Nickolas M.			Comment on "Cognition-mediated evolution of low-quality floral nectars"	SCIENCE			English	Editorial Material							SUGAR COMPOSITION; PLANT; HUMMINGBIRD; VISITORS; FLOWERS	Nachev et al. (Reports, 6 January 2017, p. 75) present dilute nectar in bat-pollinated plants as "paradoxical" because bats prefer concentrated nectar, but paradox disappears with realistic assumptions about nectar evolution. We argue that they make unrealistic assumptions about the cognitive abilities of bat pollinators, invoke Weber's law inappropriately, and cannot predict observed nectar concentrations of bat flowers or negative correlations between pollinator body size and average concentration.	[Pyke, Graham H.] Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia; [Pyke, Graham H.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Pyke, Graham H.; Waser, Nickolas M.] Rocky Mt Biol Labs, Crested Butte, CO 81224 USA; [Waser, Nickolas M.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Waser, Nickolas M.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA	University of Technology Sydney; Macquarie University; University of California System; University of California Riverside; University of Arizona	Pyke, GH (corresponding author), Univ Technol Sydney, Sch Life Sci, Sydney, NSW 2007, Australia.; Pyke, GH (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.; Pyke, GH (corresponding author), Rocky Mt Biol Labs, Crested Butte, CO 81224 USA.	graham.pyke@uts.edu.au	Pyke, Graham H./R-7359-2019	Pyke, Graham H./0000-0002-9760-987X; Waser, Nickolas/0000-0001-8416-5037				Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Nachev V, 2017, SCIENCE, V355, P75, DOI 10.1126/science.aah4219; Perret M, 2001, ANN BOT-LONDON, V87, P267, DOI 10.1006/anbo.2000.1331; Pyke G. H., 2010, ENCY ANIMAL BEHAV, P596, DOI DOI 10.1016/B978-0-08-045337-8.00278-3; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; PYKE GH, 1981, THEOR POPUL BIOL, V20, P326, DOI 10.1016/0040-5809(81)90050-2; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; PYKE GH, 1992, OIKOS, V65, P321, DOI 10.2307/3545025; Pyke GH., 2010, ENCYCL ANIM BEHAV, V2, P601, DOI [DOI 10.1016/B978-0-08-045337-8.00210-2, 10.1016/B978-0-08-045337-8.00210-2]; Pyke GH, 2016, PERSPECT PLANT ECOL, V19, P70, DOI 10.1016/j.ppees.2016.02.004; Pyke GH, 2016, TRENDS ECOL EVOL, V31, P339, DOI 10.1016/j.tree.2016.02.013; Rodriguez-Pena N, 2016, REV MEX BIODIVERS, V87, P465, DOI 10.1016/j.rmb.2016.03.002; Sazima M, 1999, ANN BOT-LONDON, V83, P705, DOI 10.1006/anbo.1999.0876; WASER NM, 1982, OECOLOGIA, V55, P251, DOI 10.1007/BF00384496	14	4	4	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368							eaao1962	10.1126/science.aao1962	http://dx.doi.org/10.1126/science.aao1962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217542				2022-12-28	WOS:000417254700001
J	Morch, LS; Skovlund, CW; Hannaford, PC; Iversen, L; Fielding, S; Lidegaard, O				Morch, Lina S.; Skovlund, Charlotte W.; Hannaford, Philip C.; Iversen, Lisa; Fielding, Shona; Lidegaard, Ojvind			Contemporary Hormonal Contraception and the Risk of Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTROGEN PLUS PROGESTIN; ORAL-CONTRACEPTIVES; REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; LEVONORGESTREL; AGE; ENDOMETRIAL; FORMULATION; DEVICE	BACKGROUND Little is known about whether contemporary hormonal contraception is associated with an increased risk of breast cancer. METHODS We assessed associations between the use of hormonal contraception and the risk of invasive breast cancer in a nationwide prospective cohort study involving all women in Denmark between 15 and 49 years of age who had not had cancer or venous thromboembolism and who had not received treatment for infertility. Nationwide registries provided individually updated information about the use of hormonal contraception, breast-cancer diagnoses, and potential confounders. RESULTS Among 1.8 million women who were followed on average for 10.9 years (a total of 19.6 million person-years), 11,517 cases of breast cancer occurred. As compared with women who had never used hormonal contraception, the relative risk of breast cancer among all current and recent users of hormonal contraception was 1.20 (95% confidence interval [CI], 1.14 to 1.26). This risk increased from 1.09 (95% CI, 0.96 to 1.23) with less than 1 year of use to 1.38 (95% CI, 1.26 to 1.51) with more than 10 years of use (P = 0.002). After discontinuation of hormonal contraception, the risk of breast cancer was still higher among the women who had used hormonal contraceptives for 5 years or more than among women who had not used hormonal contraceptives. Risk estimates associated with current or recent use of various oral combination (estrogen-progestin) contraceptives varied between 1.0 and 1.6. Women who currently or recently used the progestin-only intrauterine system also had a higher risk of breast cancer than women who had never used hormonal contraceptives (relative risk, 1.21; 95% CI, 1.11 to 1.33). The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95% CI, 10 to 16) per 100,000 person-years, or approximately 1 extra breast cancer for every 7690 women using hormonal contraception for 1 year. CONCLUSIONS The risk of breast cancer was higher among women who currently or recently used contemporary hormonal contraceptives than among women who had never used hormonal contraceptives, and this risk increased with longer durations of use; however, absolute increases in risk were small. (Funded by the Novo Nordisk Foundation.)	[Morch, Lina S.; Skovlund, Charlotte W.; Lidegaard, Ojvind] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Dept Gynecol, Copenhagen, Denmark; [Hannaford, Philip C.; Iversen, Lisa] Univ Aberdeen, Inst Appl Hlth Sci, Acad Primary Care, Aberdeen, Scotland; [Fielding, Shona] Univ Aberdeen, Inst Appl Hlth Sci, Med Stat, Aberdeen, Scotland	Rigshospitalet; University of Copenhagen; University of Aberdeen; University of Aberdeen	Morch, LS; Lidegaard, O (corresponding author), Univ Copenhagen, Dept Gynecol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	linamorch@yahoo.dk; oejvind.lidegaard@regionh.dk		Iversen, Lisa/0000-0002-2524-5229; Morch, Lina/0000-0001-6506-2569	Novo Nordisk Foundation; Medical Research Council [MR/M501633/1, MC_PC_13040, MR/K007017/1, MR/M501633/2] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011645] Funding Source: researchfish; MRC [MR/M501633/2, MR/K007017/1] Funding Source: UKRI	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Novo Nordisk Foundation.	Althuis MD, 2003, CANCER CAUSE CONTROL, V14, P151, DOI 10.1023/A:1023006000760; Althuis MD, 2003, BRIT J CANCER, V88, P50, DOI 10.1038/sj.bjc.6600691; Beaber EF, 2014, CANCER RES, V74, P4078, DOI 10.1158/0008-5472.CAN-13-3400; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Dorjgochoo T, 2009, INT J CANCER, V124, P2442, DOI 10.1002/ijc.24232; Dumeaux V, 2005, CANCER CAUSE CONTROL, V16, P537, DOI 10.1007/s10552-004-8024-z; Dumeaux V, 2003, INT J CANCER, V105, P844, DOI 10.1002/ijc.11167; Haimov-Kochman R, 2003, HUM REPROD, V18, P1231, DOI 10.1093/humrep/deg263; Hannaford PC, 2007, BRIT MED J, V335, P651, DOI 10.1136/bmj.39289.649410.55; Hunter DJ, 2010, CANCER EPIDEM BIOMAR, V19, P2496, DOI 10.1158/1055-9965.EPI-10-0747; Iversen L, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.002; Jernstrom H, 2005, EUR J CANCER, V41, P2312, DOI 10.1016/j.ejca.2005.03.035; Kawai M, 2010, CANCER CAUSE CONTROL, V21, P135, DOI 10.1007/s10552-009-9443-7; Kotsopoulos J, 2014, BREAST CANCER RES TR, V143, P579, DOI 10.1007/s10549-013-2823-4; Kumle M, 2002, CANCER EPIDEM BIOMAR, V11, P1375; Lee SY, 2003, INT J CANCER, V105, P390, DOI 10.1002/ijc.11078; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lindh I, 2017, ACTA OBSTET GYN SCAN, V96, P19, DOI 10.1111/aogs.13055; Lockhat FB, 2005, FERTIL STERIL, V83, P398, DOI 10.1016/j.fertnstert.2004.07.961; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Marchbanks PA, 2012, CONTRACEPTION, V85, P342, DOI 10.1016/j.contraception.2011.08.007; Morch LS, 2009, JAMA-J AM MED ASSOC, V302, P298, DOI 10.1001/jama.2009.1052; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Pasqualini JR, 2007, GYNECOL ENDOCRINOL, V23, P32, DOI 10.1080/09513590701585003; Pike MC, 2000, STEROIDS, V65, P659, DOI 10.1016/S0039-128X(00)00122-7; Raudaskoski T, 2002, BJOG-INT J OBSTET GY, V109, P136, DOI 10.1016/S1470-0328(02)01167-9; Rosenberg L, 2009, AM J EPIDEMIOL, V169, P473, DOI 10.1093/aje/kwn360; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Shantakumar S, 2007, AM J EPIDEMIOL, V165, P1187, DOI 10.1093/aje/kwm006; Soini T, 2014, OBSTET GYNECOL, V124, P292, DOI 10.1097/AOG.0000000000000356; Van Hoften C, 2000, INT J CANCER, V87, P591, DOI 10.1002/1097-0215(20000815)87:4<591::AID-IJC20>3.0.CO;2-C; Vessey M, 2013, CONTRACEPTION, V88, P678, DOI 10.1016/j.contraception.2013.08.008; Wilson NM, 2012, ACTA OBSTET GYN SCAN, V91, P810, DOI 10.1111/j.1600-0412.2012.01416.x; Wu MH, 2006, ANN EPIDEMIOL, V16, P223, DOI 10.1016/j.annepidem.2005.02.015	38	218	223	4	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2228	2239		10.1056/NEJMoa1700732	http://dx.doi.org/10.1056/NEJMoa1700732			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9IL	29211679	Bronze, Green Published			2022-12-28	WOS:000417201100006
J	Rosen, R				Rosen, Rebecca			Are disruptive innovators in GP provision strengthening or weakening the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rosen, Rebecca] Nuffield Trust, London, England		Rosen, R (corresponding author), Nuffield Trust, London, England.	rebecca.rosen@nuffieldtrust.org.uk							0	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2017	359								j5470	10.1136/bmj.j5470	http://dx.doi.org/10.1136/bmj.j5470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MJ	29187352				2022-12-28	WOS:000417211300004
J	Pincus, D; Ravi, B; Wasserstein, D; Huang, A; Paterson, JM; Nathens, AB; Kreder, HJ; Jenkinson, RJ; Wodchis, WP				Pincus, Daniel; Ravi, Bheeshma; Wasserstein, David; Huang, Anjie; Paterson, J. Michael; Nathens, Avery B.; Kreder, Hans J.; Jenkinson, Richard J.; Wodchis, Walter P.			Association BetweenWait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; PATIENT; EMERGENCY; DATABASE; OUTCOMES; DELAY	IMPORTANCE Although wait times for hip fracture surgery have been linked to mortality and are being used as quality-of-care indicators worldwide, controversy exists about the duration of the wait that leads to complications. OBJECTIVE To use population-based wait-time data to identify the optimal time window in which to conduct hip fracture surgery before the risk of complications increases. DESIGN, SETTING, AND PARTICIPANTS Population-based, retrospective cohort study of adults undergoing hip fracture surgery between April 1, 2009, and March 31, 2014, at 72 hospitals in Ontario, Canada. Risk-adjusted restricted cubic splines modeled the probability of each complication according to wait-time. The inflection point (in hours) when complications began to increase was used to define early and delayed surgery. To evaluate the robustness of this definition, outcomes among propensity-score matched early and delayed surgical patients were compared using percent absolute risk differences (RDs, with 95% CIs). EXPOSURE Time elapsed from hospital arrival to surgery (in hours). MAIN OUTCOMES AND MEASURES Mortality within 30 days. Secondary outcomes included a composite of mortality or other medical complications (myocardial infarction, deep vein thrombosis, pulmonary embolism, and pneumonia). RESULTS Among 42 230 patients with hip fracture (mean [SD] age, 80.1 years [10.7], 70.5% women) who met study entry criteria, overall mortality at 30 days was 7.0%. The risk of complications increased when wait times were greater than 24 hours, irrespective of the complication considered. Compared with 13 731 propensity-score matched patients who received surgery earlier, 13 731 patients who received surgery after 24 hours had a significantly higher risk of 30-day mortality (898 [6.5%] vs 790 [5.8%];% absolute RD, 0.79; 95% CI, 0.23-1.35) and the composite outcome (1680 [12.2%]) vs 1383 [10.1%];% absolute RD, 2.16; 95% CI, 1.43-2.89). CONCLUSIONS AND RELEVANCE Among adults undergoing hip fracture surgery, increased wait time was associated with a greater risk of 30-day mortality and other complications. A wait time of 24 hours may represent a threshold defining higher risk.	[Pincus, Daniel; Ravi, Bheeshma; Wasserstein, David; Nathens, Avery B.; Kreder, Hans J.; Jenkinson, Richard J.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Pincus, Daniel; Ravi, Bheeshma; Paterson, J. Michael; Nathens, Avery B.; Kreder, Hans J.; Wodchis, Walter P.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Pincus, Daniel; Huang, Anjie; Paterson, J. Michael; Nathens, Avery B.; Kreder, Hans J.; Jenkinson, Richard J.; Wodchis, Walter P.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Ravi, Bheeshma; Wasserstein, David; Nathens, Avery B.; Kreder, Hans J.; Jenkinson, Richard J.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Wodchis, Walter P.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	Pincus, D (corresponding author), Univ Toronto, Div Orthopaed Surg, Dept Surg, 149 Coll St,Room 508-A, Toronto, ON M5T 1P5, Canada.	d.pincus@utoronto.ca	Pincus, Daniel/K-6113-2017; Pincus, Daniel/M-3033-2019	Pincus, Daniel/0000-0003-3783-8205; Pincus, Daniel/0000-0003-3783-8205; wodchis, walter/0000-0003-2494-7031	Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto; Institute for Clinical Evaluative Sciences, an independent research institute - Ontario Ministry of Health and Long-Term Care	Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto; Institute for Clinical Evaluative Sciences, an independent research institute - Ontario Ministry of Health and Long-Term Care	This study was supported by the Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto, and by the Institute for Clinical Evaluative Sciences, an independent research institute funded by the Ontario Ministry of Health and Long-Term Care.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Aggarwal A, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0454-2; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bretherton CP, 2015, BONE JOINT J, V97B, P104, DOI 10.1302/0301-620X.97B1.35041; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Buse GL, 2014, CAN MED ASSOC J, V186, pE52, DOI 10.1503/cmaj.130901; Canadian Institute for Health Information, 2017, WAIT TIM PRIOR PROC; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dy CJ, 2011, J BONE JOINT SURG AM, V93A, P1326, DOI [10.2106/JBJS.I.01132, 10.2106/JBJSJ.01132]; Frood Jennifer, 2010, Healthc Q, V13, P16; Fu MC, 2017, BONE JOINT J, V99B, P1216, DOI 10.1302/0301-620X.99B9.BJJ-2017-0101.R1; Juurlink D, 2006, CANADIAN I HLTH INFO; Kralj B., 2005, MEASURING RURALITY P; Leslie WD, 2010, OSTEOPOROSIS INT, V21, P1317, DOI 10.1007/s00198-009-1080-1; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; McIsaac DI, 2017, CAN MED ASSOC J, V189, pE905, DOI 10.1503/cmaj.160576; Moja L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046175; Nyholm AM, 2015, J BONE JOINT SURG AM, V97A, P1333, DOI 10.2106/JBJS.O.00029; Pincus D, 2012, CLIN PHARMACOL THER, V92, P766, DOI 10.1038/clpt.2012.171; Pincus D, 2017, J BONE JOINT SURG AM, V99, P914, DOI 10.2106/JBJS.16.00788; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Ravi B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3284; Royal College of Physicians, 2015, NAT HIP FRACT DAT AN; Ryan DJ, 2015, J ORTHOP TRAUMA, V29, P343, DOI 10.1097/BOT.0000000000000313; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Sayers A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0825-5; Schilling PL, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.N.01330; Sheehan KJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1018-7; Sheehan KJ, 2016, CAN MED ASSOC J, V188, P1219, DOI 10.1503/cmaj.160522; Sheehan KJ, 2016, J ORTHOP RES, V34, P197, DOI 10.1002/jor.22997; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Uzoigwe CE, 2013, INJURY, V44, P726, DOI 10.1016/j.injury.2012.08.025; Weiner J., 2011, J HOPKINS ACG SYSTEM	36	283	294	4	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					1994	2003		10.1001/jama.2017.17606	http://dx.doi.org/10.1001/jama.2017.17606			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183076	Bronze, Green Published			2022-12-28	WOS:000416317600020
J	Szanto, PB				Szanto, Paul B.			Diagnostic Problems: Guest Editorial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									[Szanto, Paul B.] Cook Cty Inst, Dept Pathol, Chicago, IL 60608 USA; [Szanto, Paul B.] Hektoen Inst Med Res, Chicago, IL 60612 USA		Szanto, PB (corresponding author), Cook Cty Inst, Dept Pathol, Chicago, IL 60608 USA.; Szanto, PB (corresponding author), Hektoen Inst Med Res, Chicago, IL 60612 USA.							LIEBOW AA, 1956, AM J MED, V21, P485, DOI 10.1016/0002-9343(56)90065-1	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2050	2050		10.1001/jama.2017.10496	http://dx.doi.org/10.1001/jama.2017.10496			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN8ZR	29183058				2022-12-28	WOS:000416317600039
J	Jamison, DT; Alwan, A; Mock, CN; Nugent, R; Watkins, D; Adeyi, O; Anand, S; Atun, R; Bertozzi, S; Bhutta, Z; Binagwaho, A; Black, R; Blecher, M; Bloom, BR; Brouwer, E; Bundy, DAP; Chisholm, D; Cieza, A; Cullen, M; Danforth, K; de Silva, N; Debas, HT; Donkor, P; Dua, T; Fleming, KA; Gallivan, M; Garcia, PJ; Gawande, A; Gaziano, T; Gelband, H; Glass, R; Glassman, A; Gray, G; Habte, D; Holmes, KK; Horton, S; Hutton, G; Jha, P; Knaul, FM; Kobusingye, O; Krakauer, EL; Kruk, ME; Lachmann, P; Laxminarayan, R; Levin, C; Looi, LM; Madhav, N; Mahmoud, A; Mbanya, JC; Measham, A; Medina-Mora, ME; Medlin, C; Mills, A; Mills, JA; Montoya, J; Norheim, O; Olson, Z; Omokhodion, F; Oppenheim, B; Ord, T; Patel, V; Patton, GC; Peabody, J; Prabhakaran, D; Qi, JY; Reynolds, T; Ruacan, S; Sankaranarayanan, R; Sepulveda, J; Skolnik, R; Smith, KR; Temmerman, M; Tollman, S; Verguet, S; Walker, DG; Walker, N; Wu, YF; Zhao, K				Jamison, Dean T.; Alwan, Ala; Mock, Charles N.; Nugent, Rachel; Watkins, David; Adeyi, Olusoji; Anand, Shuchi; Atun, Rifat; Bertozzi, Stefano; Bhutta, Zulfiqar; Binagwaho, Agnes; Black, Robert; Blecher, Mark; Bloom, Barry R.; Brouwer, Elizabeth; Bundy, Donald A. P.; Chisholm, Dan; Cieza, Alarcos; Cullen, Mark; Danforth, Kristen; de Silva, Nilanthi; Debas, Haile T.; Donkor, Peter; Dua, Tarun; Fleming, Kenneth A.; Gallivan, Mark; Garcia, Patricia J.; Gawande, Atul; Gaziano, Thomas; Gelband, Hellen; Glass, Roger; Glassman, Amanda; Gray, Glenda; Habte, Demissie; Holmes, King K.; Horton, Susan; Hutton, Guy; Jha, Prabhat; Knaul, Felicia M.; Kobusingye, Olive; Krakauer, Eric L.; Kruk, Margaret E.; Lachmann, Peter; Laxminarayan, Ramanan; Levin, Carol; Looi, Lai Meng; Madhav, Nita; Mahmoud, Adel; Mbanya, Jean Claude; Measham, Anthony; Elena Medina-Mora, Maria; Medlin, Carol; Mills, Anne; Mills, Jody-Anne; Montoya, Jaime; Norheim, Ole; Olson, Zachary; Omokhodion, Folashade; Oppenheim, Ben; Ord, Toby; Patel, Vikram; Patton, George C.; Peabody, John; Prabhakaran, Dorairaj; Qi, Jinyuan; Reynolds, Teri; Ruacan, Sevket; Sankaranarayanan, Rengaswamy; Sepulveda, Jaime; Skolnik, Richard; Smith, Kirk R.; Temmerman, Marleen; Tollman, Stephen; Verguet, Stephane; Walker, Damian G.; Walker, Neff; Wu, Yangfeng; Zhao, Kun			Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition	LANCET			English	Review							MIDDLE-INCOME COUNTRIES; WORLD; CARE	The World Bank is publishing nine volumes of Disease Control Priorities, 3rd edition (DCP3) between 2015 and 2018. Volume 9, Improving Health and Reducing Poverty, summarises the main messages from all the volumes and contains cross-cutting analyses. This Review draws on all nine volumes to convey conclusions. The analysis in DCP3 is built around 21 essential packages that were developed in the nine volumes. Each essential package addresses the concerns of a major professional community (eg, child health or surgery) and contains a mix of intersectoral policies and health-sector interventions. 71 intersectoral prevention policies were identified in total, 29 of which are priorities for early introduction. Interventions within the health sector were grouped onto five platforms (population based, community level, health centre, first-level hospital, and referral hospital). DCP3 defines a model concept of essential universal health coverage (EUHC) with 218 interventions that provides a starting point for country-specific analysis of priorities. Assuming steady-state implementation by 2030, EUHC in lower-middle-income countries would reduce premature deaths by an estimated 4.2 million per year. Estimated total costs prove substantial: about 9.1% of (current) gross national income (GNI) in low-income countries and 5.2% of GNI in lower-middle-income countries. Financing provision of continuing intervention against chronic conditions accounts for about half of estimated incremental costs. For lower-middle-income countries, the mortality reduction from implementing the EUHC can only reach about half the mortality reduction in non-communicable diseases called for by the Sustainable Development Goals. Full achievement will require increased investment or sustained intersectoral action, and actions by finance ministries to tax smoking and polluting emissions and to reduce or eliminate (often large) subsidies on fossil fuels appear of central importance. DCP3 is intended to be a model starting point for analyses at the country level, but country-specific cost structures, epidemiological needs, and national priorities will generally lead to definitions of EUHC that differ from country to country and from the model in this Review. DCP3 is particularly relevant as achievement of EUHC relies increasingly on greater domestic finance, with global developmental assistance in health focusing more on global public goods. In addition to assessing effects on mortality, DCP3 looked at outcomes of EUHC not encompassed by the disability-adjusted life-year metric and related cost-effectiveness analyses. The other objectives included financial protection (potentially better provided upstream by keeping people out of the hospital rather than downstream by paying their hospital bills for them), stillbirths averted, palliative care, contraception, and child physical and intellectual growth. The first 1000 days after conception are highly important for child development, but the next 7000 days are likewise important and often neglected.	[Jamison, Dean T.; Debas, Haile T.; Peabody, John; Sepulveda, Jaime] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Alwan, Ala; Mock, Charles N.; Watkins, David; Brouwer, Elizabeth; Danforth, Kristen; Holmes, King K.; Levin, Carol] Univ Washington, Seattle, WA 98195 USA; [Nugent, Rachel] RTI Int, Seattle, WA USA; [Adeyi, Olusoji; Measham, Anthony] World Bank Grp, Washington, DC USA; [Anand, Shuchi; Cullen, Mark] Stanford Univ, Stanford, CA 94305 USA; [Atun, Rifat; Bloom, Barry R.; Gawande, Atul; Kruk, Margaret E.; Verguet, Stephane] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Bertozzi, Stefano; Olson, Zachary; Smith, Kirk R.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bhutta, Zulfiqar] Aga Khan Univ, Karachi, Pakistan; [Binagwaho, Agnes; Gawande, Atul; Gaziano, Thomas; Krakauer, Eric L.; Patel, Vikram] Harvard Med Sch, Boston, MA USA; [Black, Robert; Walker, Neff] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Blecher, Mark] Natl Treasury South Africa, Cape Town, South Africa; [Bundy, Donald A. P.] Bill & Melinda Gates Fdn, London, England; [Walker, Damian G.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Chisholm, Dan] World Hlth Org, Reg Off Europe, Copenhagen, Denmark; [Cieza, Alarcos; Dua, Tarun; Mills, Jody-Anne; Reynolds, Teri] World Hlth Org, Geneva, Switzerland; [de Silva, Nilanthi] Univ Kelaniya, Kelaniya, Sri Lanka; [Donkor, Peter] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Fleming, Kenneth A.] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA; [Fleming, Kenneth A.; Ord, Toby] Univ Oxford, Oxford, England; [Gallivan, Mark; Madhav, Nita; Oppenheim, Ben] Metabiota, San Francisco, CA USA; [Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Lima, Peru; [Gawande, Atul; Gaziano, Thomas] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Glass, Roger] US Natl Inst Hlth, Fogarty Int Ctr, Bethesda, MD USA; [Glassman, Amanda] Ctr Global Dev, Washington, DC USA; [Gray, Glenda; Tollman, Stephen] Univ Witwatersrand, Johannesburg, South Africa; [Habte, Demissie] Int Clin Epidemiol Network, New Delhi, India; [Horton, Susan] Univ Waterloo, Waterloo, ON, Canada; [Hutton, Guy] UNICEF, New York, NY USA; [Gelband, Hellen; Jha, Prabhat] Univ Toronto, Toronto, ON, Canada; [Knaul, Felicia M.] Univ Miami, Miami, FL USA; [Kobusingye, Olive] Makerere Univ, Sch Med, Kampala, Uganda; [Lachmann, Peter] Univ Cambridge, Cambridge, England; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Looi, Lai Meng] Univ Malaya, Kuala Lumpur, Malaysia; [Mahmoud, Adel; Qi, Jinyuan] Princeton Univ, Princeton, NJ USA; [Mbanya, Jean Claude] Univ Yaounde I, Yaounde, Cameroon; [Elena Medina-Mora, Maria] Natl Inst Psychiat de la Fuente Muniz, Mexico City, DF, Mexico; [Medlin, Carol] Praxis Social Impact Consulting, Washington, DC USA; [Mills, Anne; Prabhakaran, Dorairaj] London Sch Hyg & Trop Med, London, England; [Montoya, Jaime] Univ Philippines, Manila, Philippines; [Norheim, Ole] Univ Bergen, Bergen, Norway; [Omokhodion, Folashade] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Patton, George C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Patton, George C.] Univ Melbourne, Melbourne, Vic, Australia; [Prabhakaran, Dorairaj] Publ Hlth Fdn India, New Delhi, India; [Ruacan, Sevket] Koc Univ, Sch Med, Istanbul, Turkey; [Sankaranarayanan, Rengaswamy] Int Agcy Res Canc, Lyon, France; [Skolnik, Richard] Yale Univ, New Haven, CT USA; [Temmerman, Marleen] Aga Khan Univ East Africa, Nairobi, Kenya; [Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Zhao, Kun] China Natl Hlth Dev Res Ctr, Beijing, Peoples R China	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Research Triangle Institute; The World Bank; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; Aga Khan University; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; World Health Organization; World Health Organization; University Kelaniya; Kwame Nkrumah University Science & Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; Universidad Peruana Cayetano Heredia; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Witwatersrand; University of Waterloo; UNICEF; University of Toronto; University of Miami; Makerere University; University of Cambridge; Universiti Malaya; Princeton University; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of the Philippines System; University of the Philippines Manila; University of Bergen; University of Ibadan; Murdoch Children's Research Institute; University of Melbourne; Public Health Foundation of India; Koc University; World Health Organization; International Agency for Research on Cancer (IARC); Yale University; Peking University	Jamison, DT (corresponding author), Univ Calif San Francisco, San Francisco Global Hlth Sci, San Francisco, CA 94158 USA.	djamison@uw.edu	Madhav, Nita K/J-1343-2018; Lachmann, P J/I-7968-2019; Prabhakaran, Dorairaj/B-4147-2011; Ord, Toby/N-6679-2014; Looi, Lai Meng/A-3382-2009; Medina-Mora, María Elena I/T-5937-2018; Watkins, David/ABC-3783-2020; Looi, Lai Meng/AAB-9403-2019; Patton, George C/B-5246-2013; , Holmes/K-6215-2019; Atun, Rifat/AAH-5537-2021; Norheim, Ole Frithjof/AAC-8771-2020; Kruk, Margaret E/E-3058-2010; Ribeiro, Ana Cristina/HHN-7466-2022; Laxminarayan, Ramanan/ABD-5050-2021; Bhutta, Zulfiqar/L-7822-2015; Mbanya, Jean Claude N/T-5147-2018	Lachmann, P J/0000-0003-2849-3524; Prabhakaran, Dorairaj/0000-0002-3172-834X; Ord, Toby/0000-0003-4644-016X; Looi, Lai Meng/0000-0001-8325-0117; Medina-Mora, María Elena I/0000-0001-9300-0752; Watkins, David/0000-0001-6341-9595; Looi, Lai Meng/0000-0001-8325-0117; Patton, George C/0000-0001-5039-8326; Norheim, Ole Frithjof/0000-0002-5748-5956; Kruk, Margaret E/0000-0002-9549-8432; Ribeiro, Ana Cristina/0000-0002-0493-8376; Tollman, Stephen/0000-0003-0744-7588; Nugent, Rachel/0000-0001-6421-9077; Fleming, Kenneth/0000-0002-3200-1302; Walker, Damian/0000-0003-4568-0970; Madhav, Nita/0000-0001-8077-330X; Bhutta, Zulfiqar/0000-0003-0637-599X; Qi, Jinyuan/0000-0003-1942-392X; cullen, mark/0000-0001-7996-1864; Atun, Rifat/0000-0002-1531-5983; Bertozzi, Stefano M/0000-0002-1723-7085; Mbanya, Jean Claude N/0000-0001-9651-8653; Knaul, Felicia/0000-0002-0512-4788	Bill AMP; Melinda Gates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK101826] Funding Source: NIH RePORTER	Bill AMP; Melinda Gates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Bill & Melinda Gates Foundation funded DCP3 as an element of its Disease Control Priorities Network grant to the University of Washington. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation. Many institutions have made available the time of their staff and they are specifically acknowledged in each volume. The views expressed in this paper are those of individual authors and not of the institutions with which they are affiliated. We acknowledge three institutions that have played key roles in DCP3. One is the World Bank, original home for the DCP series and accomplished publisher of its products. Within the World Bank, Carlos Rossel and Mary Fisk oversaw the editing and publication of the series, and served as important champions for DCP3. The second is the Inter-Academy Medical Panel (IAMP) and its US affiliate, the National Academy of Medicine (NAM). IAMP/NAM have organised a peer-review process to cover chapters in the nine volumes, and they established an Advisory Committee to the Editors, chaired by Anne Mills, of enormous value. The Department of Global Health, University of Washington, has provided a congenial home for DCP for the past 5 years. We acknowledge the intellectual and practical support of the department's two chairs during this period, King Holmes and Judith Wasserheit. We thank Shamelle Richards, Tiffany Wilk, and Nazila Dabestani for their administrative and research support to the production of DCP3. Brianne Adderley has ably served DCP3 as Project Manager since the beginning, and we owe her a very particular thanks. We thank the referees for valuable and constructive comments.	Afshin A., 2017, DIS CONTROL PRIORITI, V5; [Anonymous], 1993, WORLD DEV REP 1993; [Anonymous], GLOBAL HLTH; Bates M.A., 2017, STANFORD SOCIAL INNO; Bazzano LA, 2014, ANN INTERN MED, V161, P309, DOI 10.7326/M14-0180; Bendavid E, DIS CONTROL IN PRESS, V9; Bloom BR, 2006, DIS CONTROL PRIORITI; BOBADILLA J, 1993, DIS CONTROL PRIORITI; Boyle CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140092; Bundy DAP., 2017, DIS CONTROL PRIORITI, V8; Chang AY, DIS CONTROL IN PRESS, V9; Dehghan M., 2017, LANCET; Essue B, DIS CONTROL IN PRESS, V9; EVANS JR, 1981, NEW ENGL J MED, V305, P1117, DOI 10.1056/NEJM198111053051904; Fleming K, DIS CONTROL IN PRESS, V9; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gates B, DIS CONTROL IN PRESS; Ghebreyesus TA, 2017, LANCET GLOB HEALTH, V5, pE839, DOI 10.1016/S2214-109X(17)30295-4; Giedion U, 2017, WHATS WHATS OUT DESI, P30; HARLAN WR, 1984, HLTH INFORM SYSTEMS; Horton S., DIS CONTROL IN PRESS, V9; Jamison D. T., 1984, CHINA HLTH SECTOR; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P390; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, DIS CONTROL IN PRESS, V9; Jamison DT, 2015, LANCET; Krakauer E, DIS CONTROL IN PRESS, V9; Kydland FE, 2013, GLOBAL PROBLEMS, SMART SOLUTIONS: COSTS AND BENEFITS, P701; Landrigan P, 2017, LANCET; Madhav N, DIS CONTROL IN PRESS, V9; Mahmoud A, 2006, DIS CONTROL PRIORITI; Mathers C, DIS CONTROL IN PRESS, V9; Meltzer D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P157; Mills JA, DIS CONTROL IN PRESS, V9; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Ozler B., 2013, LEARN LIVE EXTERNAL; Peabody J, DIS CONTROL IN PRESS, V9; Pradhan E, 2017, DIS CONTROL PRIORITI, V8; Reynolds T, DIS CONTROL IN PRESS, V9; Rumbold B, 2017, LANCET, V390, P712, DOI 10.1016/S0140-6736(17)30931-5; Schaferhoff M, 2015, LANCET, V386, P2436, DOI 10.1016/S0140-6736(15)61161-8; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Summers LH, DIS CONTROL PRIORITI; Trimble EL, 2015, DIS CONTROL PRIORITI, V3; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 POP DIV; Verguet S, DIS CONTROL IN PRESS, V9; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; Watkins DA, DIS CONTROL IN PRESS, V9; Watkins DA, 2017, 20 DCP3 WORLD BANK; Watkins DA, 2017, 21 DCP3 WORLD BANK; Weiser T. G., 2015, Disease control priorities, third edition: Volume 1. Essential surgery, P279; World Bank, 2014, WORLD DEV IND 2014	55	78	79	4	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 17	2018	391	10125					1108	1120		10.1016/S0140-6736(17)32906-9	http://dx.doi.org/10.1016/S0140-6736(17)32906-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ4TP	29179954	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000427585100029
J	Chowell, D; Morris, LGT; Grigg, CM; Weber, JK; Samstein, RM; Makarov, V; Kuo, FS; Kendall, SM; Requena, D; Riaz, N; Greenbaum, B; Carroll, J; Garon, E; Hyman, DM; Zehir, A; Solit, D; Berger, M; Zhou, RH; Rizvi, NA; Chan, TA				Chowell, Diego; Morris, Luc G. T.; Grigg, Claud M.; Weber, Jeffrey K.; Samstein, Robert M.; Makarov, Vladimir; Kuo, Fengshen; Kendall, Sviatoslav M.; Requena, David; Riaz, Nadeem; Greenbaum, Benjamin; Carroll, James; Garon, Edward; Hyman, David M.; Zehir, Ahmet; Solit, David; Berger, Michael; Zhou, Ruhong; Rizvi, Naiyer A.; Chan, Timothy A.			Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy	SCIENCE			English	Article							PD-1 BLOCKADE; HISTOCOMPATIBILITY ANTIGENS; MUTATIONAL LANDSCAPE; METASTATIC MELANOMA; CTLA-4 BLOCKADE; RESISTANCE; THERAPY; MOLECULES; HIV-1; IDENTIFICATION	CD8(+) T cell-dependent killing of cancer cells requires efficient presentation of tumor antigens by human leukocyte antigen class I (HLA-I) molecules. However, the extent to which patient-specific HLA-I genotype influences response to anti-programmed cell death protein 1 or anti-cytotoxic T lymphocyte-associated protein 4 is currently unknown. We determined the HLA-I genotype of 1535 advanced cancer patients treated with immune checkpoint blockade (ICB). Maximal heterozygosity at HLA-I loci ("A," "B," and "C") improved overall survival after ICB compared with patients who were homozygous for at least one HLA locus. In two independent melanoma cohorts, patients with the HLA-B44 supertype had extended survival, whereas the HLA-B62 supertype (including HLA-B*15:01) or somatic loss of heterozygosity at HLA-I was associated with poor outcome. Molecular dynamics simulations of HLA-B*15:01 revealed different elements that may impair CD8(+) T cell recognition of neoantigens. Our results have important implications for predicting response to ICB and for the design of neoantigen-based therapeutic vaccines.	[Chowell, Diego; Samstein, Robert M.; Makarov, Vladimir; Kuo, Fengshen; Kendall, Sviatoslav M.; Riaz, Nadeem; Solit, David; Berger, Michael; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Chowell, Diego; Morris, Luc G. T.; Samstein, Robert M.; Makarov, Vladimir; Kuo, Fengshen; Kendall, Sviatoslav M.; Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, New York, NY 10065 USA; [Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Grigg, Claud M.; Rizvi, Naiyer A.] NewYork Presbyterian Columbia Univ, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USA; [Weber, Jeffrey K.; Zhou, Ruhong] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Requena, David] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, New York, NY 10029 USA; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY 10029 USA; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA; [Carroll, James; Garon, Edward] Univ Calif Los Angeles, David Geffen Sch Med, 2825 Santa Monica Blvd,Suite 200, Santa Monica, CA 90404 USA; [Hyman, David M.; Solit, David] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hyman, David M.; Chan, Timothy A.] Weill Cornell Sch Med, New York, NY 10065 USA; [Zehir, Ahmet; Berger, Michael] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Solit, David; Berger, Michael] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Zhou, Ruhong] Columbia Univ, Dept Chem, New York, NY 10027 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; NewYork-Presbyterian Hospital; International Business Machines (IBM); Rockefeller University; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, New York, NY 10065 USA.; Rizvi, NA (corresponding author), NewYork Presbyterian Columbia Univ, Med Ctr, 177 Ft Washington Ave, New York, NY 10032 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA.; Chan, TA (corresponding author), Weill Cornell Sch Med, New York, NY 10065 USA.	nar2144@cumc.columbia.edu; chant@mskcc.org	Requena, David/AAF-4255-2019; Solit, David B./AAC-5309-2019; Zehir, Ahmet/ABE-7155-2020; Chan, Timothy A/ABD-5850-2021	Zehir, Ahmet/0000-0001-5406-4104; Solit, David/0000-0002-6614-802X; Morris, Luc/0000-0002-4417-2280; Samstein, Robert/0000-0001-6860-2401; Requena, David/0000-0002-5968-1133; Zhou, Ruhong/0000-0001-8624-5591; Kuo, Fengshen/0000-0003-1797-2896; Riaz, Nadeem/0000-0001-9873-5862	NIH/National Cancer Institute Cancer Center Support Grant [P30 CA008748]; NIH [K08 DE024774, 1R01CA205426]; Damon Runyon Cancer Research Foundation; Pershing Square Sohn Cancer Research Alliance; STARR Cancer Consortium; Stand Up 2 Cancer; BMS; NATIONAL CANCER INSTITUTE [P30CA016042, P30CA008748, R01CA205426, R35CA232097, R01CA208403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024774] Funding Source: NIH RePORTER	NIH/National Cancer Institute Cancer Center Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); STARR Cancer Consortium; Stand Up 2 Cancer; BMS(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Data reported in this study are tabulated in the main text and supplementary materials. This work was supported by NIH/National Cancer Institute Cancer Center Support Grant P30 CA008748, NIH grant K08 DE024774 (L.G.T.M), Damon Runyon Cancer Research Foundation (L.G.T.M), Pershing Square Sohn Cancer Research Alliance (T.A.C), STARR Cancer Consortium (T.A.C), Stand Up 2 Cancer (T.A.C), and NIH grant 1R01CA205426 (N.A.R and T.A.C). T.A.C. is a cofounder of Gritstone Oncology. We thank the Chan laboratory and members of the Bristol-Myers Squibb (BMS) biomarker team for helpful and stimulating discussions. We thank all the patients for their participation in the clinical trials, which is critical to improving care. We thank members of the melanoma service at MSK, including J. Wolchok, A. Shoushtari, M. Postow, and M. Callahan for their care of clinical trial patients. We thank members of the Columbia University oncology team for their excellent care of trial patients. We thank J. Sims, J. Havel, Y. Shen, and R. Srivastava for very stimulating discussions and helpful suggestions. We thank the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, the Cycle for Survival, and members of the Molecular Pathology and Diagnostics for their help with MSK-IMPACT sequencing. The data are available at the following accession numbers: dbGAP, phs001041.v1.p1; dbGAP, phs000452.v2.p1; SRA, SRP067938 and SRP090294; dbGAP, phs000980.v1.p1; SRA, PRJNA419415, PRJNA419422, and PRJNA419530; cBioPortal for Cancer Genomics, http://cbioportal.org/msk-impact (37). The results published here are in part based on data generated by a TCGA pilot project established by the National Cancer Institute and National Human Genome Research Institute. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov. T.A.C. receives research funding from BMS. N.A.R. is a consultant/advisory board member for AstraZeneca, BMS, Roche, Merck, Novartis, Lilly, and Pfizer. T.A.C. and N.A.R are cofounders of Gritstone Oncology.	Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; DIBRINO M, 1995, BIOCHEMISTRY-US, V34, P10130, DOI 10.1021/bi00032a005; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gopalakrishnan V., 2017, SCIENCE; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le D. T., 2017, SCIENCE, V356; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Liu P, 2005, NATURE, V437, P159, DOI 10.1038/nature03926; Marsh S. G., 1999, THE HLA FACTSBOOK; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersdorf EW, 2015, NEW ENGL J MED, V373, P599, DOI 10.1056/NEJMoa1500140; PI T. J. T., 2012, HLA DIS ASS; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Routy B., 2017, SCIENCE; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Sims JS, 2016, P NATL ACAD SCI USA, V113, pE3529, DOI 10.1073/pnas.1601012113; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhao F, 2016, CANCER RES, V76, P4347, DOI 10.1158/0008-5472.CAN-16-0008; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	60	543	577	10	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2018	359	6375					582	+		10.1126/science.aao4572	http://dx.doi.org/10.1126/science.aao4572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU4AS	29217585	Green Accepted			2022-12-28	WOS:000423795800044
J	Neelapu, SS; Locke, FL; Bartlett, NL; Lekakis, LJ; Miklos, DB; Jacobson, CA; Braunschweig, I; Oluwole, OO; Siddiqi, T; Lin, Y; Timmerman, JM; Stiff, PJ; Friedberg, JW; Flinn, IW; Goy, A; Hill, BT; Smith, MR; Deol, A; Farooq, U; McSweeney, P; Munoz, J; Avivi, I; Castro, JE; Westin, JR; Chavez, JC; Ghobadi, A; Komanduri, KV; Levy, R; Jacobsen, ED; Witzig, TE; Reagan, P; Bot, A; Rossi, J; Navale, L; Jiang, Y; Aycock, J; Elias, M; Chang, D; Wiezorek, J; Go, WY				Neelapu, S. S.; Locke, F. L.; Bartlett, N. L.; Lekakis, L. J.; Miklos, D. B.; Jacobson, C. A.; Braunschweig, I.; Oluwole, O. O.; Siddiqi, T.; Lin, Y.; Timmerman, J. M.; Stiff, P. J.; Friedberg, J. W.; Flinn, I. W.; Goy, A.; Hill, B. T.; Smith, M. R.; Deol, A.; Farooq, U.; McSweeney, P.; Munoz, J.; Avivi, I.; Castro, J. E.; Westin, J. R.; Chavez, J. C.; Ghobadi, A.; Komanduri, K. V.; Levy, R.; Jacobsen, E. D.; Witzig, T. E.; Reagan, P.; Bot, A.; Rossi, J.; Navale, L.; Jiang, Y.; Aycock, J.; Elias, M.; Chang, D.; Wiezorek, J.; Go, W. Y.			Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHIMERIC-ANTIGEN-RECEPTOR; NON-HODGKINS-LYMPHOMA; TRANSPLANT-ELIGIBLE PATIENTS; CYTOKINE RELEASE SYNDROME; SALVAGE-CHEMOTHERAPY; REMISSIONS; OUTCOMES; LEUKEMIA	BACKGROUND In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after the failure of conventional therapy. METHODS In this multicenter, phase 2 trial, we enrolled 111 patients with diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, or transformed follicular lymphoma who had refractory disease despite undergoing recommended prior therapy. Patients received a target dose of 2x10(6) anti-CD19 CAR T cells per kilogram of body weight after receiving a conditioning regimen of low-dose cyclophosphamide and fludarabine. The primary end point was the rate of objective response (calculated as the combined rates of complete response and partial response). Secondary end points included overall survival, safety, and biomarker assessments. RESULTS Among the 111 patients who were enrolled, axi-cel was successfully manufactured for 110 (99%) and administered to 101 (91%). The objective response rate was 82%, and the complete response rate was 54%. With a median follow-up of 15.4 months, 42% of the patients continued to have a response, with 40% continuing to have a complete response. The overall rate of survival at 18 months was 52%. The most common adverse events of grade 3 or higher during treatment were neutropenia (in 78% of the patients), anemia (in 43%), and thrombocytopenia (in 38%). Grade 3 or higher cytokine release syndrome and neurologic events occurred in 13% and 28% of the patients, respectively. Three of the patients died during treatment. Higher CAR T-cell levels in blood were associated with response. CONCLUSIONS In this multicenter study, patients with refractory large B-cell lymphoma who received CAR T-cell therapy with axi-cel had high levels of durable response, with a safety profile that included myelosuppression, the cytokine release syndrome, and neurologic events.	[Neelapu, S. S.; Westin, J. R.] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Locke, F. L.; Chavez, J. C.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Bartlett, N. L.; Ghobadi, A.] Washington Univ, St Louis, MO USA; [Bartlett, N. L.; Ghobadi, A.] Siteman Canc Ctr, St Louis, MO USA; [Lekakis, L. J.; Komanduri, K. V.] Univ Miami, Miami, FL USA; [Miklos, D. B.; Levy, R.] Stanford Univ, Stanford, CA 94305 USA; [Siddiqi, T.] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Timmerman, J. M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Castro, J. E.] Univ Calif San Diego, San Diego, CA 92103 USA; [Bot, A.; Rossi, J.; Navale, L.; Jiang, Y.; Aycock, J.; Elias, M.; Chang, D.; Wiezorek, J.; Go, W. Y.] Kite Pharma, Santa Monica, CA USA; [Jacobson, C. A.; Jacobsen, E. D.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Braunschweig, I.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Friedberg, J. W.; Reagan, P.] Univ Rochester, Sch Med, Rochester, NY USA; [Oluwole, O. O.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Flinn, I. W.] Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA; [Lin, Y.; Witzig, T. E.] Mayo Clin, Rochester, MN USA; [Stiff, P. J.] Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA; [Goy, A.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Hill, B. T.; Smith, M. R.] Cleveland Clin, Cleveland, OH 44106 USA; [Deol, A.] Wayne State Univ, Karmanos Canc Ctr, Detroit, MI USA; [Farooq, U.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [McSweeney, P.] Colorado Blood Canc Inst, Denver, CO USA; [Munoz, J.] Banner MD Anderson Canc Ctr, Gilbert, AZ USA; [Avivi, I.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel	University of Texas System; UTMD Anderson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; Washington University (WUSTL); Siteman Cancer Center; University of Miami; Stanford University; City of Hope; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Harvard University; Dana-Farber Cancer Institute; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Rochester; Vanderbilt University; Sarah Cannon Research Institute; Tennessee Oncology; Mayo Clinic; Loyola University Chicago; Hackensack University Medical Center; Cleveland Clinic Foundation; Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Iowa; Banner Research; Banner Health; University of Texas System; UTMD Anderson Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Neelapu, SS (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sneelapu@mdanderson.org	Goy, Andre/AHC-0473-2022; Goy, Andre/AAS-4464-2020; Stiff, Patrick/S-2676-2019; Reagan, Patrick/AAN-3314-2020	Goy, Andre/0000-0001-5125-6522; Goy, Andre/0000-0001-5125-6522; Castro, M.D., Januario E./0000-0003-2785-0892; Levy, Ronald/0000-0003-2061-0650; Farooq, Umar/0000-0001-7891-9891; Siddiqi, Tanya/0000-0001-5292-8298; Westin, Jason/0000-0002-1824-2337; Bartlett, Nancy/0000-0001-8470-394X; Lin, Yi/0000-0002-1556-6416	Kite Pharma; Leukemia and Lymphoma Society Therapy Acceleration Program; NATIONAL CANCER INSTITUTE [P30CA016672, K23CA201594] Funding Source: NIH RePORTER	Kite Pharma; Leukemia and Lymphoma Society Therapy Acceleration Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Kite Pharma and the Leukemia and Lymphoma Society Therapy Acceleration Program;	Ardeshna KM, 2005, BRIT J HAEMATOL, V130, P363, DOI 10.1111/j.1365-2141.2005.05603.x; Casulo C, 2015, BLOOD, V125, P40, DOI 10.1182/blood-2014-04-516815; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Crump M, 2017, BLOOD, V130, P1800, DOI 10.1182/blood-2017-03-769620; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dunleavy K, 2015, BLOOD, V125, P33, DOI 10.1182/blood-2014-05-575092; Friedberg JW, 2011, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2011.1.498; Hitz F, 2015, ANN HEMATOL, V94, P1839, DOI 10.1007/s00277-015-2467-z; Josting A, 2000, J CLIN ONCOL, V18, P332, DOI 10.1200/JCO.2000.18.2.332; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Klyuchnikov E, 2014, BONE MARROW TRANSPL, V49, P1, DOI 10.1038/bmt.2013.72; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Locke FL, 2017, MOL THER, V25, P285, DOI 10.1016/j.ymthe.2016.10.020; Matasar MJ, 2013, BLOOD, V122, P499, DOI 10.1182/blood-2012-12-472027; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moskowitz CH, 1999, J CLIN ONCOL, V17, P3776, DOI 10.1200/JCO.1999.17.12.3776; Nagle SJ, 2013, AM J HEMATOL, V88, P890, DOI 10.1002/ajh.23524; Neelapu SS, 2017, NAT REV CLIN ONCOL, DOI 10. 1038/nrclinonc. 2017. 148; Park JH, 2015, J CLIN ONCOL, V33, P651, DOI 10.1200/JCO.2014.57.5472; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Schuster SJ, 2015, BLOOD, V126, P183; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Sehn LH, 2015, BLOOD, V125, P22, DOI 10.1182/blood-2014-05-577189; Seshadri T, 2008, HEMATOLOGY, V13, P261, DOI 10.1179/102453308X343527; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Telio D, 2012, LEUKEMIA LYMPHOMA, V53, P836, DOI 10.3109/10428194.2011.643404; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; *WHO, 2008, WHO CLASS TUM HAEM L; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	35	2564	2663	51	331	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2017	377	26					2531	2544		10.1056/NEJMoa1707447	http://dx.doi.org/10.1056/NEJMoa1707447			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR0TX	29226797	Bronze, Green Accepted			2022-12-28	WOS:000418777700005
J	Teixeira, FK; Okuniewska, M; Malone, CD; Coux, RX; Rio, DC; Lehmann, R				Teixeira, Felipe Karam; Okuniewska, Martyna; Malone, Colin D.; Coux, Remi-Xavier; Rio, Donald C.; Lehmann, Ruth			piRNA-mediated regulation of transposon alternative splicing in the soma and germ line	NATURE			English	Article							DROSOPHILA-MELANOGASTER; HYBRID DYSGENESIS; P-ELEMENT; GENE-EXPRESSION; EPIGENETIC REGULATION; READ ALIGNMENT; CHIP-SEQ; RNA-SEQ; PIWI; MECHANISM	Transposable elements can drive genome evolution, but their enhanced activity is detrimental to the host and therefore must be tightly regulated(1). The Piwi-interacting small RNA (piRNA) pathway is vital for the regulation of transposable elements, by inducing transcriptional silencing or post-transcriptional decay of mRNAs(2). Here we show that piRNAs and piRNA biogenesis components regulate precursor mRNA splicing of P-transposable element transcripts in vivo, leading to the production of the non-transposase-encoding mature mRNA isoform in Drosophila germ cells. Unexpectedly, we show that the piRNA pathway components do not act to reduce transcript levels of the P-element transposon during P-M hybrid dysgenesis, a syndrome that affects germline development in Drosophila(3,4). Instead, splicing regulation is mechanistically achieved together with piRNA-mediated changes to repressive chromatin states, and relies on the function of the Piwi-piRNA complex proteins Asterix (also known as Gtsf1)(5-7) and Panoramix (Silencio)(8,9), as well as Heterochromatin protein 1a (HP1a; encoded by Su(var) 205). Furthermore, we show that this machinery, together with the piRNA Flamenco cluster(10), not only controls the accumulation of Gypsy retrotransposon transcripts(11) but also regulates the splicing of Gypsy mRNAs in cultured ovarian somatic cells, a process required for the production of infectious particles that can lead to heritable transposition events(12,13). Our findings identify splicing regulation as a new role and essential function for the Piwi pathway in protecting the genome against transposon mobility, and provide a model system for studying the role of chromatin structure in modulating alternative splicing during development.	[Teixeira, Felipe Karam; Okuniewska, Martyna; Malone, Colin D.; Coux, Remi-Xavier; Lehmann, Ruth] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Teixeira, Felipe Karam; Okuniewska, Martyna; Malone, Colin D.; Coux, Remi-Xavier; Lehmann, Ruth] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Cell Biol, New York, NY 10016 USA; [Rio, Donald C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Teixeira, Felipe Karam] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Malone, Colin D.] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY 10032 USA	Howard Hughes Medical Institute; New York University; New York University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Cambridge; Columbia University	Teixeira, FK; Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.; Teixeira, FK; Lehmann, R (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst,Dept Cell Biol, New York, NY 10016 USA.	fk319@cam.ac.uk; ruth.lehmann@med.nyu.edu		Coux, Remi-Xavier/0000-0002-6114-2585; Lehmann, Ruth/0000-0002-8454-5651; Karam Teixeira, Felipe/0000-0001-7651-1657	NIH [P30CA016087, R37HD41900, R35-118121-02, NIH R01-097352]; HHWF fellowship; EMBO fellowship; HFSP fellowship; Wellcome Trust [206257/Z/17/Z]; HHMI investigator; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD041900] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097352, R35GM118121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHWF fellowship; EMBO fellowship(European Molecular Biology Organization (EMBO)); HFSP fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); HHMI investigator(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Zamparini and J. Seifert for early discussions and assistance with developmental analysis; L. Barton for assistance with PGC sorting; T. Trcek for advice on RNA FISH; R. Sachidanandam for small RNA analysis assistance; J. Brennecke, P. Andersen and F. Roudier for advice on ChIP; A. Pelisson for early discussions; W. Theurkauf for antibody reagent; Q. Wang for assistance with JUM analysis; P. Macdonald, R. Carthew, E. Lai, P. Zamore, the Vienna Drosophila Resource Center, and the Bloomington Drosophila Stock Center for fly reagents; the NYUMC Genome Technology Center and the NYUMC Cytometry Center, supported by NIH P30CA016087, for sequencing and cell sorting support. C.D.M. was supported by a HHWF fellowship. F.K.T. was supported by EMBO and HFSP fellowships, and is funded by the Wellcome Trust Sir Henry Dale Fellowship (206257/Z/17/Z). R.L. is supported by NIH R37HD41900 and is an HHMI investigator. D.R. is supported by NIH R35-118121-02 and NIH R01-097352.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; BINGHAM PM, 1982, CELL, V29, P995, DOI 10.1016/0092-8674(82)90463-9; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Iwasaki YW, 2016, MOL CELL, V63, P408, DOI 10.1016/j.molcel.2016.06.008; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; KIDWELL MG, 1977, GENETICS, V86, P813; KIDWELL MG, 1979, GENETICS, V92, P1127; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecher P, 1997, J GEN VIROL, V78, P2379; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maimon I., 2011, JOVE-J VIS EXP, V13, P2537; Majumdar S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0004-2014; Malone CD, 2015, CURR OPIN GENET DEV, V34, P88, DOI 10.1016/j.gde.2015.09.003; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Ohtani H, 2013, GENE DEV, V27, P1656, DOI 10.1101/gad.221515.113; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pezic D, 2014, GENE DEV, V28, P1410, DOI 10.1101/gad.240895.114; Quadrana L, 2016, ELIFE, V5, DOI [10.7554/elife.15716, 10.7554/eLife.15716]; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROCHE SE, 1995, GENE DEV, V9, P1278, DOI 10.1101/gad.9.10.1278; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Seifert JRK, 2012, DEVELOPMENT, V139, P2101, DOI 10.1242/dev.078949; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SIEBEL CW, 1990, SCIENCE, V248, P1200, DOI 10.1126/science.2161558; Sienski G, 2015, GENE DEV, V29, P2258, DOI 10.1101/gad.271908.115; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Song SU, 1997, DEVELOPMENT, V124, P2789; Styhler S, 1998, DEVELOPMENT, V125, P1569; Teixeira FK, 2015, NAT CELL BIOL, V17, P689, DOI 10.1038/ncb3165; Trcek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8962; Van Doren M, 1998, CURR BIOL, V8, P243; Wang Q., 2017, BIORXIV; Wang QQ, 2016, P NATL ACAD SCI USA, V113, P5269, DOI 10.1073/pnas.1600936113; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Yu Y, 2015, SCIENCE, V350, P339, DOI 10.1126/science.aab0700; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030; Zhuang JL, 2014, NUCLEIC ACIDS RES, V42, P6826, DOI 10.1093/nar/gku323	54	63	66	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					268	+		10.1038/nature25018	http://dx.doi.org/10.1038/nature25018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211718	Green Accepted, Green Submitted			2022-12-28	WOS:000418029500050
J	Davies, R				Davies, Rachael			Qimin Zhan: driving medical research for better health in China	LANCET			English	Biographical-Item																			0	0	0	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2541	2541		10.1016/S0140-6736(17)33090-8	http://dx.doi.org/10.1016/S0140-6736(17)33090-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29231828				2022-12-28	WOS:000417493300012
J	Bould, H; Newbegin, C; Stewart, A; Stein, A; Fazel, M				Bould, Helen; Newbegin, Claudia; Stewart, Anne; Stein, Alan; Fazel, Mina			CLINICAL UPDATES Eating disorders in children and young people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ANOREXIA-NERVOSA; PSYCHOSOCIAL TREATMENTS; ADOLESCENTS; COMORBIDITY; THERAPY; RISK; CARE		[Bould, Helen; Stein, Alan; Fazel, Mina] Warneford Hosp, Dept Psychiat, Oxford, England; [Stewart, Anne] Raglan House, Oxford, England; [Newbegin, Claudia] Pk Med Grp, Newcastle Upon Tyne, Tyne & Wear, England		Bould, H (corresponding author), Warneford Hosp, Dept Psychiat, Oxford, England.	helen.bould@psych.ox.ac.uk						Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; AssociationAP, 2013, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003385; Bacaltchuk J, 2003, COCHRANE DB SYST REV; Bailey AP, 2014, J EAT DISORD, V2, DOI 10.1186/2050-2974-2-5; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Bulik CM, 2004, J CLIN PSYCHIAT, V65, P1000; Davies S., 2015, ANN REPORT CHIEF MED; de Vos J, 2014, J EAT DISORD, V2, DOI 10.1186/s40337-014-0027-x; Dold M, 2015, PSYCHOTHER PSYCHOSOM, V84, P110, DOI 10.1159/000369978; England N., 2015, ACCESS WAITING TIMES; Facchini M, 2006, INT J CARDIOL, V106, P170, DOI 10.1016/j.ijcard.2005.01.041; Fairburn CG, 2009, AM J PSYCHIAT, V166, P311, DOI 10.1176/appi.ajp.2008.08040608; Fernandez-Aranda F, 2007, AUST NZ J PSYCHIAT, V41, P24, DOI 10.1080/00048670601057718; Fitzpatrick KK, 2011, BMJ CLIN EVIDENCE; Golden NH, 2007, CURR OPIN OBSTET GYN, V19, P434, DOI 10.1097/GCO.0b013e3282eee384; Halmi KA, 2003, INT J EAT DISORDER, V33, P308, DOI 10.1002/eat.10138; Hay P, 2014, AUST NZ J PSYCHIAT, V48, P977, DOI 10.1177/0004867414555814; Hay PJ, 2012, AUST NZ J PSYCHIAT, V46, P1136, DOI 10.1177/0004867412450469; Health NCCfM, 2004, EATING DISORDERS COR; House J, 2012, INT J EAT DISORDER, V45, P949, DOI 10.1002/eat.22065; Keel PK, 2008, J CLIN CHILD ADOLESC, V37, P39, DOI 10.1080/15374410701817832; le Grange D, 2007, ARCH GEN PSYCHIAT, V64, P1049, DOI 10.1001/archpsyc.64.9.1049; Lock J, 2013, TREATMENT MANUAL ANO, V2nd; Lock J, 2015, J CLIN CHILD ADOLESC, V44, P707, DOI 10.1080/15374416.2014.971458; Madden S, 2015, WORLD J PSYCHIATR, V5, P147, DOI 10.5498/wjp.v5.i1.147; Micali N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002646; Mitchell JE, 2013, INT J EAT DISORDER, V46, P470, DOI 10.1002/eat.22104; National Institute for Health and Care, EXC CLIN KNOWL SUMM; National Institute for Health and Care Excellence, 2016, NICE GUID NG43 TRANS; [National Institute for Health and Care Excellence Excellence NIfHaC], 2017, EXC NIFHAC; O'Connor G, 2016, NUTR CLIN PRACT, V31, P681, DOI 10.1177/0884533615627267; Raevuori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104845; Royal College of Psychiatrists, 2012, JUN MARSIPAN MAN REA; Royal College of Psychiatrists, JUN MARSIPAN MAN REA; Salbach-Andrae H, 2008, CHILD PSYCHIAT HUM D, V39, P261, DOI 10.1007/s10578-007-0086-1; Schmidt U, 2007, AM J PSYCHIAT, V164, P591, DOI 10.1176/appi.ajp.164.4.591; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Singhal V, 2014, CURR OPIN ENDOCRINOL, V21, P64, DOI 10.1097/MED.0000000000000026; Smink FRE, 2014, INT J EAT DISORDER, V47, P610, DOI 10.1002/eat.22316; Solmi M, 2016, ACTA PSYCHIAT SCAND, V133, P341, DOI 10.1111/acps.12556; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Treasure J, 2011, BRIT J PSYCHIAT, V199, P5, DOI 10.1192/bjp.bp.110.087585; van Furth EF, 2016, LANCET PSYCHIAT, V3, P706, DOI 10.1016/S2215-0366(16)30147-X; Welch E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0840-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wilksch SM, 2015, PSYCHOL MED, V45, P1811, DOI 10.1017/S003329171400289X; World Health Organization, ICD 11 BET DRAFT FDN; Wu CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001568; Zipfel S, 2015, LANCET PSYCHIAT, V2, P1099, DOI 10.1016/S2215-0366(15)00356-9	52	2	2	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5245	10.1136/bmj.j5245	http://dx.doi.org/10.1136/bmj.j5245			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP4AW	29217505	Green Submitted			2022-12-28	WOS:000417560100001
J	Heneghan, C; Aronson, JK; Goldacre, B; Mahtani, KR; Pluddemann, A; Onakpoya, I				Heneghan, Carl; Aronson, Jeffrey K.; Goldacre, Ben; Mahtani, Kamal R.; Pluddemann, Annette; Onakpoya, Igho			Transvaginal mesh failure: lessons for regulation of implantable devices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VAGINAL MESH; POLYPROPYLENE MESH; COMPLICATIONS; INFECTION; BACTERIA; SURFACE		[Heneghan, Carl; Aronson, Jeffrey K.; Goldacre, Ben; Mahtani, Kamal R.; Pluddemann, Annette; Onakpoya, Igho] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England	University of Oxford	Heneghan, C (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England.	carl.heneghan@phc.ox.ac.uk		Pluddemann, Annette/0000-0003-2101-0390	National Institute for Health Research (NIHR) School of Primary Care; Laura and John Arnold Foundation; asbestos legal case; National Institute for Health Research [CL-2011-13-006] Funding Source: researchfish	National Institute for Health Research (NIHR) School of Primary Care(National Institute for Health Research (NIHR)); Laura and John Arnold Foundation; asbestos legal case; National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood BMJ policy on declaration of interests and declare the following: CH has been an expert witness in a mesh medical device legal case, but took no payment. He has received financial remuneration from an asbestos legal case. He has received expenses in the past from the FDA to attend a working group on device regulation. JKA has published papers and edited textbooks on adverse drug reactions; he has also acted as an expert witness in cases related to adverse drug reactions. BG reports personal fees from intermittent additional personal income from speaking and writing for lay audiences on problems in science and medicine including regulatory shortcomings. CH receives funding from the National Institute for Health Research (NIHR) School of Primary Care. BG receives funding from the Laura and John Arnold Foundation.	Abed H, 2011, INT UROGYNECOL J, V22, P789, DOI 10.1007/s00192-011-1384-5; [Anonymous], 2015, CTVNEWS         0113; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Barski D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/831285; Bezerra CA, 2005, COCHRANE DB SYST REV, V3; Coughlin RW, 1999, J BIOMAT SCI-POLYM E, V10, P827, DOI 10.1163/156856299X00900; Diwadkar GB, 2009, OBSTET GYNECOL, V113, P367, DOI 10.1097/AOG.0b013e318195888d; Fairclough E, 2017, INT UROGYNECOL J, DOI [10.1007/s00192-017-3273-z28150029, DOI 10.1007/S00192-017-3273-Z28150029]; FDA, 2011, UR MESH UPD SAF EFF; FDA, DEV ADV INV DEV EX I; Feiner B, 2010, OBSTET GYNECOL, V115, P325, DOI 10.1097/AOG.0b013e3181cbca4d; Food and Drug Administration HHS, 2016, Fed Regist, V81, P353; Funk MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.008; Ganj FA, 2009, INT UROGYNECOL J, V20, P919, DOI 10.1007/s00192-009-0879-9; Glazener CMA, 2017, LANCET, V389, P381, DOI 10.1016/S0140-6736(16)31596-3; Goldstein HS, 1999, HERNIA, V3, P23, DOI [10.1007/BF01576737, DOI 10.1007/BF01576737]; Heneghan CJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017125; Hilton P, 2008, BJOG-INT J OBSTET GY, V115, P135, DOI 10.1111/j.1471-0528.2007.01557.x; Hong W., 2017, SCOTT IND REV US SAF, V9, P34; Iglesia CB, 2010, OBSTET GYNECOL, V116, P293, DOI 10.1097/AOG.0b013e3181e7d7f8; ISO, BIOL EV MED DEV EV 1; Keltie K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11821-w; Klinge U, 2002, J BIOMED MATER RES, V63, P765, DOI 10.1002/jbm.10449; Maher C, 2016, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.Cd012079, DOI 10.1002/14651858.CD012079]; McCarthy J., 2017, NEWCASTLE HERAL 0203; MHRA, 2017, GUID NOT MHRA CLIN I; MHRA, 2017, NOT BOD MED DEV; National Collaborating Centre for Womens and Childrens Health, 2011, UR INC MAN UR INC WO; Ostergard DR, 2011, INT UROGYNECOL J, V22, P771, DOI 10.1007/s00192-011-1399-y; Ostergard DR, 2010, INT UROGYNECOL J, V21, P1181, DOI 10.1007/s00192-010-1227-9; Salvatore V., 2017, PM LIVE; Sanghani R., 2017, TELEGRAPH; Sedrakyan A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2372; Shah HN, 2012, INDIAN J UROL, V28, P129, DOI 10.4103/0970-1591.98453; Sorenson C, 2014, MILBANK Q, V92, P114, DOI 10.1111/1468-0009.12043; UK Medicines and Healthcare Products Regulatory Agency, 2014, SUMM EV BEN RISKS VA; Vollebregt A, 2009, INT UROGYNECOL J, V20, P1345, DOI 10.1007/s00192-009-0951-5; Ward KL, 2008, BJOG-INT J OBSTET GY, V115, P226, DOI 10.1111/j.1471-0528.2007.01548.x; Wise J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5523	39	38	38	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5515	10.1136/bmj.j5515	http://dx.doi.org/10.1136/bmj.j5515			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29217786	Green Submitted			2022-12-28	WOS:000417560100005
J	Vedantham, S; Goldhaber, SZ; Julian, JA; Kahn, SR; Jaff, MR; Cohen, DJ; Magnuson, E; Razavi, MK; Comerota, AJ; Gornik, HL; Murphy, TP; Lewis, L; Duncan, JR; Nieters, P; Derfler, MC; Filion, M; Gu, CS; Kee, S; Schneider, J; Saad, N; Blinder, M; Moll, S; Sacks, D; Lin, J; Rundback, J; Garcia, M; Razdan, R; VanderWoude, E; Marques, V; Kearon, C				Vedantham, S.; Goldhaber, S. Z.; Julian, J. A.; Kahn, S. R.; Jaff, M. R.; Cohen, D. J.; Magnuson, E.; Razavi, M. K.; Comerota, A. J.; Gornik, H. L.; Murphy, T. P.; Lewis, L.; Duncan, J. R.; Nieters, P.; Derfler, M. C.; Filion, M.; Gu, C. -S.; Kee, S.; Schneider, J.; Saad, N.; Blinder, M.; Moll, S.; Sacks, D.; Lin, J.; Rundback, J.; Garcia, M.; Razdan, R.; VanderWoude, E.; Marques, V.; Kearon, C.		ATTRACT Trial Investigators	Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY IMPROVEMENT GUIDELINES; POSTTHROMBOTIC SYNDROME; COMPRESSION STOCKINGS; VENOUS THROMBOSIS; RANDOMIZED-TRIAL; CLINICAL INVESTIGATIONS; ANTITHROMBOTIC THERAPY; HEPARIN; STREPTOKINASE; OUTCOMES	BACKGROUND The post-thrombotic syndrome frequently develops in patients with proximal deep-vein thrombosis despite treatment with anticoagulant therapy. Pharmacomechanical catheter-directed thrombolysis (hereafter "pharmacomechanical thrombolysis") rapidly removes thrombus and is hypothesized to reduce the risk of the post-thrombotic syndrome. METHODS We randomly assigned 692 patients with acute proximal deep-vein thrombosis to receive either anticoagulation alone (control group) or anticoagulation plus pharmaco-mechanical thrombolysis (catheter-mediated or device-mediated intrathrombus delivery of recombinant tissue plasminogen activator and thrombus aspiration or maceration, with or without stenting). The primary outcome was development of the post-thrombotic syndrome between 6 and 24 months of follow-up. RESULTS Between 6 and 24 months, there was no significant between-group difference in the percentage of patients with the post-thrombotic syndrome (47% in the pharmacomechanical-thrombolysis group and 48% in the control group; risk ratio, 0.96; 95% confidence interval [CI], 0.82 to 1.11; P = 0.56). Pharmacomechanical thrombolysis led to more major bleeding events within 10 days (1.7% vs. 0.3% of patients, P = 0.049), but no significant difference in recurrent venous thromboembolism was seen over the 24-month follow-up period (12% in the pharmacomechanical-thrombolysis group and 8% in the control group, P = 0.09). Moderate-to-severe post-thrombotic syndrome occurred in 18% of patients in the pharmacomechanical-thrombolysis group versus 24% of those in the control group (risk ratio, 0.73; 95% CI, 0.54 to 0.98; P = 0.04). Severity scores for the post-thrombotic syndrome were lower in the pharmacomechanical-thrombolysis group than in the control group at 6, 12, 18, and 24 months of follow-up (P<0.01 for the comparison of the Villalta scores at each time point), but the improvement in quality of life from baseline to 24 months did not differ significantly between the treatment groups. CONCLUSIONS Among patients with acute proximal deep-vein thrombosis, the addition of pharmacomechanical catheter-directed thrombolysis to anticoagulation did not result in a lower risk of the post-thrombotic syndrome but did result in a higher risk of major bleeding.	[Vedantham, S.; Lewis, L.; Duncan, J. R.; Nieters, P.; Derfler, M. C.; Saad, N.; Blinder, M.] Washington Univ, Sch Med, St Louis, MO USA; [Goldhaber, S. Z.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Jaff, M. R.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Julian, J. A.; Filion, M.; Gu, C. -S.; Kearon, C.] McMaster Univ, Hamilton, ON, Canada; [Kahn, S. R.] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada; [Cohen, D. J.; Magnuson, E.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, KS USA; [Razavi, M. K.] St Josephs Vasc Inst, Orange, CA USA; [Kee, S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Comerota, A. J.] Univ Michigan, Ann Arbor, MI 48109 USA; [Gornik, H. L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Murphy, T. P.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Schneider, J.] Cent DuPage Hosp, Winfield, IL USA; [Moll, S.] Univ N Carolina, Chapel Hill, NC USA; [Sacks, D.] Reading Hosp, Reading, PA USA; [Lin, J.] Henry Ford Hosp, Detroit, MI 48202 USA; [Rundback, J.] Holy Name Hosp, Teaneck, NJ USA; [Garcia, M.] Christiana Care Hosp, Newark, DE USA; [Razdan, R.; VanderWoude, E.] St Elizabeths Reg Med Ctr, Lincoln, NE USA; [Marques, V.] Pepin Heart Ctr, Tampa, FL USA	Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; McMaster University; McGill University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Cleveland Clinic Foundation; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of North Carolina; University of North Carolina Chapel Hill; Henry Ford Health System; Henry Ford Hospital; Christiana Care Health System	Vedantham, S (corresponding author), Washington Univ St Louis, Mallinckrodt Inst Radiol, 510 S Kingshighway Blvd, St Louis, MO 63110 USA.	vedanthams@wustl.edu	Lazo-Langner, Alejandro/E-6993-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Yu, Hyeon/0000-0002-4318-2575; Infeld, Margaret/0000-0002-1923-6166	National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, U01HL088476, U01HL088118] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others;	AbuRahma AF, 2001, ANN SURG, V233, P752, DOI 10.1097/00000658-200106000-00004; ARNESEN H, 1982, ACTA MED SCAND, V211, P65; Bashir R, 2014, JAMA INTERN MED, V174, P1494, DOI 10.1001/jamainternmed.2014.3415; Bernstein SL, 2006, AM J EMERG MED, V24, P162, DOI 10.1016/j.ajem.2005.08.007; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Cynamon J, 2006, J VASC INTERV RADIOL, V17, P1043, DOI 10.1097/01.RVI.0000221085.25333.40; Delis KT, 2004, ANN SURG, V239, P118, DOI 10.1097/01.sla.0000103067.10695.74; ELLIOT MS, 1979, BRIT J SURG, V66, P838, DOI 10.1002/bjs.1800661203; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Haig Y, 2016, LANCET HAEMATOL, V3, pE64, DOI 10.1016/S2352-3026(15)00248-3; Hilleman DE, 2008, J VASC INTERV RADIOL, V19, P377, DOI 10.1016/j.jvir.2007.10.027; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lamping DL, 2003, J VASC SURG, V37, P410, DOI 10.1067/mva.2003.152; MARDER VJ, 1977, J LAB CLIN MED, V89, P1018; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Plate G, 1990, Eur J Vasc Surg, V4, P483, DOI 10.1016/S0950-821X(05)80788-1; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Robertson L, 2015, COCHRANE DB SYST REV, V30; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; SEMBA CP, 1994, RADIOLOGY, V191, P487, DOI 10.1148/radiology.191.2.8153327; TURPIE AGG, 1990, CHEST, V97, pS172, DOI 10.1378/chest.97.4_Supplement.172S; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; Vasquez MA, 2010, J VASC SURG, V52, P1387, DOI 10.1016/j.jvs.2010.06.161; Vedantham S, 2006, J VASC INTERV RADIOL, V17, P435, DOI 10.1097/01.RVI.0000197348.57762.15; Vedantham S, 2006, J VASC INTERV RADIOL, V17, P417, DOI 10.1097/01.RVI.0000197359.26571.C2; Vedantham S, 2004, J VASC INTERV RADIOL, V15, P565, DOI 10.1097/01.RVI.0000127894.00553.02; Vedantham S, 2014, J VASC INTERV RADIOL, V25, P1317, DOI 10.1016/j.jvir.2014.04.019; Vedantham S, 2013, AM HEART J, V165, P523, DOI 10.1016/j.ahj.2013.01.024; Ware J, 1994, SF 36 PHYS MENTAL SU; Watson L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002783.pub4	37	351	381	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2240	2252		10.1056/NEJMoa1615066	http://dx.doi.org/10.1056/NEJMoa1615066			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9IL	29211671	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000417201100007
J	Grabowski, MK; Serwadda, DM; Gray, RH; Nakigozi, G; Kigozi, G; Kagaayi, J; Ssekubugu, R; Nalugoda, F; Lessler, J; Lutalo, T; Galiwango, RM; Makumbi, F; Kong, X; Kabatesi, D; Alamo, ST; Wiersma, S; Sewankambo, NK; Tobian, AAR; Laeyendecker, O; Quinn, TC; Reynolds, SJ; Wawer, MJ; Chang, LW				Grabowski, M. K.; Serwadda, D. M.; Gray, R. H.; Nakigozi, G.; Kigozi, G.; Kagaayi, J.; Ssekubugu, R.; Nalugoda, F.; Lessler, J.; Lutalo, T.; Galiwango, R. M.; Makumbi, F.; Kong, X.; Kabatesi, D.; Alamo, S. T.; Wiersma, S.; Sewankambo, N. K.; Tobian, A. A. R.; Laeyendecker, O.; Quinn, T. C.; Reynolds, S. J.; Wawer, M. J.; Chang, L. W.		Rakai Hlth Sciences Program	HIV Prevention Efforts and Incidence of HIV in Uganda	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; RAKAI; ACQUISITION; COVERAGE; PROGRESS; RISK; CARE	BACKGROUND To assess the effect of a combination strategy for prevention of human immunodeficiency virus (HIV) on the incidence of HIV infection, we analyzed the association between the incidence of HIV and the scale-up of antiretroviral therapy (ART) and medical male circumcision in Rakai, Uganda. Changes in population-level viral-load suppression and sexual behaviors were also examined. METHODS Between 1999 and 2016, data were collected from 30 communities with the use of 12 surveys in the Rakai Community Cohort Study, an open, population-based cohort of persons 15 to 49 years of age. We assessed trends in the incidence of HIV on the basis of observed seroconversion data, participant-reported use of ART, participant-reported male circumcision, viral-load suppression, and sexual behaviors. RESULTS In total, 33,937 study participants contributed 103,011 person-visits. A total of 17,870 persons who were initially HIV-negative were followed for 94,427 person-years; among these persons, 931 seroconversions were observed. ART was introduced in 2004, and by 2016, ART coverage was 69% (72% among women vs. 61% among men, P<0.001). HIV viral-load suppression among all HIV-positive persons increased from 42% in 2009 to 75% by 2016 (P<0.001). Male circumcision coverage increased from 15% in 1999 to 59% by 2016 (P<0.001). The percentage of adolescents 15 to 19 years of age who reported never having initiated sex (i.e., delayed sexual debut) increased from 30% in 1999 to 55% in 2016 (P<0.001). By 2016, the mean incidence of HIV infection had declined by 42% relative to the period before 2006 (i.e., before the scale-up of the combination strategy for HIV prevention) - from 1.17 cases per 100 person-years to 0.66 cases per 100 person-years (adjusted incidence rate ratio, 0.58; 95% confidence interval [CI], 0.45 to 0.76); declines were greater among men (adjusted incidence rate ratio, 0.46; 95% CI, 0.29 to 0.73) than among women (adjusted incidence rate ratio, 0.68; 95% CI, 0.50 to 0.94). CONCLUSIONS In this longitudinal study, the incidence of HIV infection declined significantly with the scale-up of a combination strategy for HIV prevention, which provides empirical evidence that interventions for HIV prevention can have a population-level effect. However, additional efforts are needed to overcome disparities according to sex and to achieve greater reductions in the incidence of HIV infection.	[Grabowski, M. K.; Tobian, A. A. R.] Johns Hopkins Sch Med, Dept Pathol, 443 Carnegie Bldg,600 N Wolfe St, Baltimore, MD 21287 USA; [Laeyendecker, O.; Quinn, T. C.; Reynolds, S. J.; Chang, L. W.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21287 USA; [Grabowski, M. K.; Gray, R. H.; Lessler, J.; Kong, X.; Tobian, A. A. R.; Laeyendecker, O.; Quinn, T. C.; Reynolds, S. J.; Wawer, M. J.; Chang, L. W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Laeyendecker, O.; Quinn, T. C.; Reynolds, S. J.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Grabowski, M. K.; Serwadda, D. M.; Gray, R. H.; Nakigozi, G.; Kigozi, G.; Kagaayi, J.; Ssekubugu, R.; Nalugoda, F.; Lutalo, T.; Galiwango, R. M.; Makumbi, F.; Sewankambo, N. K.; Tobian, A. A. R.; Reynolds, S. J.; Wawer, M. J.; Chang, L. W.] Rakai Hlth Sci Program, Entebbe, Uganda; [Kabatesi, D.; Alamo, S. T.; Wiersma, S.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Serwadda, D. M.; Makumbi, F.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Sewankambo, N. K.] Makerere Univ, Sch Med, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rakai Health Sciences Program; Centers for Disease Control & Prevention - USA; Makerere University; Makerere University	Grabowski, MK (corresponding author), Johns Hopkins Sch Med, Dept Pathol, 443 Carnegie Bldg,600 N Wolfe St, Baltimore, MD 21287 USA.	mgrabow2@jhu.edu		Laeyendecker, Oliver/0000-0002-6429-4760; Nabukalu, Dorean/0000-0002-2680-0669; Reynolds, Steven/0000-0002-5403-2759	National Institute of Allergy and Infectious Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070769] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, ZIAAI001040, ZIAAI000361, K01AI125086, R01AI102939, U01AI075115, U01AI100031, R01AI110324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105313, R01MH107275] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the National Institute of Allergy and Infectious Diseases and others.	Alsallaq RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054575; [Anonymous], 2014, NATL POPULATION HOUS; [Anonymous], 2010, SAFE MALE CIRCUMCISI; [Anonymous], 2012, UG DEM HLTH SURV 201; [Anonymous], 2016, CONSOLIDATED GUIDELI, V2nd; [Anonymous], 2014, FAST TRACK END AIDS; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Botswana AIDS impact survey (BAIS) IV, 2013, GAB STAT BOTSW; Chang LW, 2015, AIDS BEHAV, V19, P1742, DOI 10.1007/s10461-015-1159-y; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Grabowski MK, AIDS IN PRESS; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Jose M, 2005, BIOLOGICALS, V33, P9, DOI 10.1016/j.biologicals.2004.10.003; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Karim SSA, 2017, LANCET HIV, V4, pE56, DOI 10.1016/S2352-3018(16)30187-4; Kong XR, 2016, JAMA-J AM MED ASSOC, V316, P182, DOI 10.1001/jama.2016.7292; Kong XR, 2013, AIDS, V27, P662, DOI 10.1097/QAD.0b013e32835c557c; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Nakigozi G, 2015, JAIDS-J ACQ IMM DEF, V70, P75, DOI 10.1097/QAI.0000000000000710; Okano JT, 2016, LANCET HIV, V3, pE507, DOI 10.1016/S2352-3018(16)30174-6; Okano JT, 2016, LANCET INFECT DIS, V16, P789, DOI 10.1016/S1473-3099(16)30022-6; PEPFAR, 2016, PEP 2016 ANN REP C; Santelli JS, 2015, AIDS, V29, P211, DOI 10.1097/QAD.0000000000000533; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Solomon SS, 2016, LANCET HIV, V3, pE183, DOI 10.1016/S2352-3018(16)00019-9; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Williams BG, 2014, R0 ELIMINATION HIV A	38	110	111	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2154	2166		10.1056/NEJMoa1702150	http://dx.doi.org/10.1056/NEJMoa1702150			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO1VI	29171817	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000416555000009
J	Lopez-Lopez, JA; Sterne, JAC; Thom, HHZ; Higgins, JPT; Hingorani, AD; Okoli, GN; Davies, PA; Bodalia, PN; Bryden, PA; Welton, NJ; Hollingworth, W; Caldwell, DM; Savovic, J; Dias, S; Salisbury, C; Eaton, D; Stephens-Boal, A; Sofat, R				Lopez-Lopez, Jose A.; Sterne, Jonathan A. C.; Thom, Howard H. Z.; Higgins, Julian P. T.; Hingorani, Aroon D.; Okoli, George N.; Davies, Philippa A.; Bodalia, Pritesh N.; Bryden, Peter A.; Welton, Nicky J.; Hollingworth, William; Caldwell, Deborah M.; Savovic, Jelena; Dias, Sofia; Salisbury, Chris; Eaton, Diane; Stephens-Boal, Annya; Sofat, Reecha			Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FACTOR XA INHIBITOR; JAPANESE PATIENTS; ANTITHROMBOTIC THERAPY; DABIGATRAN ETEXILATE; WARFARIN; EDOXABAN; SAFETY; APIXABAN; DESIGN; MULTICENTER	OBJECTIVE To compare the efficacy, safety, and cost effectiveness of direct acting oral anticoagulants (DOACs) for patients with atrial fibrillation. DESIGN Systematic review, network meta-analysis, and cost effectiveness analysis. DATA SOURCES Medline, PreMedline, Embase, and The Cochrane Library. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Published randomised trials evaluating the use of a DOAC, vitamin K antagonist, or antiplatelet drug for prevention of stroke in patients with atrial fibrillation. RESULTS 23 randomised trials involving 94 656 patients were analysed: 13 compared a DOAC with warfarin dosed to achieve a target INR of 2.0-3.0. Apixaban 5 mg twice daily (odds ratio 0.79, 95% confidence interval 0.66 to 0.94), dabigatran 150 mg twice daily (0.65, 0.52 to 0.81), edoxaban 60 mg once daily (0.86, 0.74 to 1.01), and rivaroxaban 20 mg once daily (0.88, 0.74 to 1.03) reduced the risk of stroke or systemic embolism compared with warfarin. The risk of stroke or systemic embolism was higher with edoxaban 60 mg once daily (1.33, 1.02 to 1.75) and rivaroxaban 20 mg once daily (1.35, 1.03 to 1.78) than with dabigatran 150 mg twice daily. The risk of all-cause mortality was lower with all DOACs than with warfarin. Apixaban 5 mg twice daily (0.71, 0.61 to 0.81), dabigatran 110 mg twice daily (0.80, 0.69 to 0.93), edoxaban 30 mg once daily (0.46, 0.40 to 0.54), and edoxaban 60 mg once daily (0.78, 0.69 to 0.90) reduced the risk of major bleeding compared with warfarin. The risk of major bleeding was higher with dabigatran 150 mg twice daily than apixaban 5 mg twice daily (1.33, 1.09 to 1.62), rivaroxaban 20 mg twice daily than apixaban 5 mg twice daily (1.45, 1.19 to 1.78), and rivaroxaban 20 mg twice daily than edoxaban 60 mg once daily (1.31, 1.07 to 1.59). The risk of intracranial bleeding was substantially lower for most DOACs compared with warfarin, whereas the risk of gastrointestinal bleeding was higher with some DOACs than warfarin. Apixaban 5 mg twice daily was ranked the highest for most outcomes, and was cost effective compared with warfarin. CONCLUSIONS The network meta-analysis informs the choice of DOACs for prevention of stroke in patients with atrial fibrillation. Several DOACs are of net benefit compared with warfarin. A trial directly comparing DOACs would overcome the need for indirect comparisons to be made through network meta-analysis. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD 42013005324.	[Lopez-Lopez, Jose A.; Sterne, Jonathan A. C.; Thom, Howard H. Z.; Higgins, Julian P. T.; Okoli, George N.; Davies, Philippa A.; Bryden, Peter A.; Welton, Nicky J.; Hollingworth, William; Caldwell, Deborah M.; Savovic, Jelena; Dias, Sofia; Salisbury, Chris] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Oakfield House, Bristol BS8 2BN, Avon, England; [Sterne, Jonathan A. C.; Higgins, Julian P. T.; Welton, Nicky J.] Natl Inst Hlth Res, Bristol Biomed Res Ctr, Oakfield House, Bristol BS8 2BN, Avon, England; [Hingorani, Aroon D.; Sofat, Reecha] UCL, Fac Populat Hlth Sci, London, England; [Davies, Philippa A.; Savovic, Jelena] Univ Hosp Bristol NHS Fdn Trust, NIHR CLAHRC West, Bristol, Avon, England; [Bodalia, Pritesh N.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Bodalia, Pritesh N.] Royal Natl Orthopaed Hosp NHS Trust, London, England; [Eaton, Diane] AntiCoagulat Europe, Bromley, Kent, England; [Stephens-Boal, Annya] Thrombosis UK, Llanwrda, Wales	University of Bristol; University of Bristol; University of London; University College London; University of Bristol; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Sterne, JAC (corresponding author), Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Oakfield House, Bristol BS8 2BN, Avon, England.; Sterne, JAC (corresponding author), Natl Inst Hlth Res, Bristol Biomed Res Ctr, Oakfield House, Bristol BS8 2BN, Avon, England.	jonathan.sterne@bristol.ac.uk	Sterne, Jonathan/Z-3106-2019; López-López, José/Q-9395-2019; Savović, Jelena/O-4107-2019; Salisbury, Chris/C-6724-2008; Dias, Sofia/F-1922-2010; López-López, José Antonio/A-2865-2013; Higgins, Julian PT/H-4008-2011	Sterne, Jonathan/0000-0001-8496-6053; López-López, José/0000-0002-9655-3616; Savović, Jelena/0000-0002-2861-0578; Salisbury, Chris/0000-0002-4378-3960; Dias, Sofia/0000-0002-2172-0221; López-López, José Antonio/0000-0002-9655-3616; Higgins, Julian PT/0000-0002-8323-2514; Welton, Nicky/0000-0003-2198-3205; Sofat, Reecha/0000-0002-0242-6115; Hingorani, Aroon/0000-0001-8365-0081; Hollingworth, William/0000-0002-0840-6254; , Deborah/0000-0001-8014-7480	National Institute for Health Research (NIHR); NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; NIHR [NF-SI-0611-10168]; National Institute for Health Research [NF-SI-0616-10111, NF-SI-0515-10043, NF-SI-0611-10168, 11/92/17, NF-SI-0515-10091] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the National Institute for Health Research (NIHR). Additional time from PAD was supported by the NIHR Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hospitals Bristol NHS Foundation Trust. JACS is funded by NIHR Senior Investigator award NF-SI-0611-10168. The funders were not actively involved in the research process at any stage.	Assiri A, 2013, CLIN THER, V35, P967, DOI 10.1016/j.clinthera.2013.05.011; Boehringer Ingelheim, 2014, DOS RESP STUD DAB ET; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Chung N, 2011, THROMB HAEMOSTASIS, V105, P535, DOI 10.1160/TH10-07-0451; Cohen D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5131; Connolly SJ, 2013, EUR HEART J, V34, P1498, DOI 10.1093/eurheartj/eht039; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cope S, 2015, VALUE HEALTH, V18, P234, DOI 10.1016/j.jval.2014.10.012; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dogliotti A, 2014, HEART, V100, P396, DOI 10.1136/heartjnl-2013-304347; Eikelboom JW, 2010, AM HEART J, V159, P348, DOI 10.1016/j.ahj.2009.08.026; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295; Huisman MV, 2012, THROMB HAEMOSTASIS, V107, P838, DOI 10.1160/TH11-10-0718; KANNEL WB, 1998, AM J CARDIOL, V0082; Kansal AR, 2012, HEART, V98, P573, DOI 10.1136/heartjnl-2011-300646; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Lin L, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.09.008; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR NAT CLIN GU; National Institute for Health and Clinical Excellence, 2014, ATR FIBR MAN ATR FIB; Ogawa S, 2011, CIRC J, V75, P1852, DOI 10.1253/circj.CJ-10-1183; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Potpara TS, 2017, JAMA-J AM MED ASSOC, V317, P1115, DOI 10.1001/jama.2017.1152; Rasmussen LH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7097; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Verheugt FWA, 2015, LANCET, V386, P303, DOI 10.1016/S0140-6736(15)60245-8; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; Wells G, 2012, THERAPEUTIC REV; Yamashita T, 2012, CIRC J, V76, P1840, DOI 10.1253/circj.CJ-11-1140	39	259	263	4	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2017	359								j5058	10.1136/bmj.j5058	http://dx.doi.org/10.1136/bmj.j5058			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MG	29183961	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000417211000001
J	Anderson, RM; Hadjichrysanthou, C; Evans, S; Wong, MM				Anderson, Roy M.; Hadjichrysanthou, Christoforos; Evans, Stephanie; Wong, Mei Mei			Why do so many clinical trials of therapies for Alzheimer's disease fail?	LANCET			English	Editorial Material									[Anderson, Roy M.; Hadjichrysanthou, Christoforos; Evans, Stephanie; Wong, Mei Mei] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Anderson, RM (corresponding author), Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London W2 1PG, England.	roy.anderson@imperial.ac.uk	Evans, Stephanie/AAL-4537-2021	Evans, Stephanie/0000-0002-2345-5249; Anderson, Roy/0000-0002-9528-3175	Janssen Prevention Center, Leiden, the Netherlands; NIA/NIH [U01 AG016976]; NIA [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161, P50 AG047366, P30 AG010129, P50 AG016573, P50 AG016570, P50 AG005131, P50 AG023501, P30 AG035982, P30 AG028383, P30 AG010124, P50 AG005133, P50 AG005142, P30 AG012300, P50 AG005136, P50 AG033514, P50 AG005681, P50 AG047270]; NATIONAL INSTITUTE ON AGING [U01AG016976] Funding Source: NIH RePORTER	Janssen Prevention Center, Leiden, the Netherlands; NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RMA is a non-executive director of and shareholder in GlaxoSmithKline (GSK), which does not produce therapies for Alzheimer's disease, and receives research funding from the Janssen Prevention Center, Leiden, the Netherlands; GSK and Janssen did not contribute in any way to the opinions expressed in this Comment. CH, SE, and MMW declare no competing interests. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIAfunded ADCs: P30 AG019610 (PI Eric Reiman), P30 AG013846 (PI Neil Kowall), P50 AG008702 (PI Scott Small), P50 AG025688 (PI Allan Levey), P50 AG047266 (PI Todd Golde), P30 AG010133 (PI Andrew Saykin), P50 AG005146 (PI Marilyn Albert), P50 AG005134 (PI Bradley Hyman), P50 AG016574 (PI Ronald Petersen), P50 AG005138 (PI Mary Sano), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye), P30 AG010161 (PI David Bennett), P50 AG047366 (PI Victor Henderson), P30 AG010129 (PI Charles DeCarli), P50 AG016573 (PI Frank LaFerla), P50 AG016570 (PI Marie-Francoise Chesselet), P50 AG005131 (PI Douglas Galasko), P50 AG023501 (PI Bruce Miller), P30 AG035982 (PI Russell Swerdlow), P30 AG028383 (PI Linda Van Eldik), P30 AG010124 (PI John Trojanowski), P50 AG005133 (PI Oscar Lopez), P50 AG005142 (PI Helena Chui), P30 AG012300 (PI Roger Rosenberg), P50 AG005136 (PI Thomas Montine), P50 AG033514 (PI Sanjay Asthana), P50 AG005681 (PI John Morris), and P50 AG047270 (PI Stephen Strittmatter).	Abner EL, 2012, INT J ALZHEIMERS DIS, V2012; [Anonymous], 2017, LANCET NEUROL, V16, P97, DOI 10.1016/S1474-4422(16)30395-7; Carroll J, 2017, ANOTHER ALZHEIMERS D; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Gauthier S, 2016, ALZHEIMERS DEMENT; Holford NHG, 2000, ANNU REV PHARMACOL, V40, P209, DOI 10.1146/annurev.pharmtox.40.1.209; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Lawrence E, 2017, J ALZHEIMERS DIS, V59, P1359, DOI 10.3233/JAD-170261; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Ower AK, 2017, EUR J EPIDEMIOL, DOI [10.1007/s10654-017-0326-z, DOI 10.1007/S10654-017-0326-Z.]; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Romero K, 2015, CLIN PHARMACOL THER, V97, P210, DOI 10.1002/cpt.16; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Skinner J, 2012, BRAIN IMAGING BEHAV, V6, P489, DOI 10.1007/s11682-012-9166-3; Vandenberghe R, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0189-7; Vellas B, 2011, LANCET NEUROL, V10, P297, DOI 10.1016/S1474-4422(08)70087-5	17	119	119	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2327	2329		10.1016/S0140-6736(17)32399-1	http://dx.doi.org/10.1016/S0140-6736(17)32399-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	29185425				2022-12-28	WOS:000416118700005
J	Zanchi, C; Giorgio, C; Businelli, C; Barbi, E				Zanchi, Chiara; Giorgio, Cozzi; Businelli, Caterina; Barbi, Egidio			A teenage girl with lower abdominal pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zanchi, Chiara; Giorgio, Cozzi] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Emergency Dept, Trieste, Italy; [Businelli, Caterina] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Obstet & Gynecol, Trieste, Italy; [Barbi, Egidio] Univ Trieste, Trieste, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Trieste	Giorgio, C (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Emergency Dept, Trieste, Italy.	giorgiocozzi@gmail.com	Barbi, Egidio/K-4016-2018; Zanchi, Chiara/K-2850-2018	Barbi, Egidio/0000-0002-6343-846X; Zanchi, Chiara/0000-0001-8513-1963; Cozzi, Giorgio/0000-0002-6427-1366				Balamuth F, 2010, PEDIATR EMERG CARE, V26, P85, DOI 10.1097/PEC.0b013e3181cdf349; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Centers for Disease Prevention and Control, 2015, PELV INFL DIS PID TR; Chandra Anjani, 2005, Vital Health Stat 23, P1; Das BB, 2016, INFECT DRUG RESIST, V9, P191, DOI 10.2147/IDR.S91260; Kreisel K, 2017, MMWR-MORBID MORTAL W, V66, P80, DOI 10.15585/mmwr.mm6603a3; McNicholas C, 2013, SEX TRANSM DIS, V40, P546, DOI 10.1097/OLQ.0b013e31829529eb; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Savaris RF, 2017, COCHRANE DB SYST REV, V359; Savaris RF, 2007, OBSTET GYNECOL, V110, P53, DOI 10.1097/01.AOG.0000268801.90261.27; Solomon M, 2019, PEDIATR EMERG CARE, V35, P389, DOI 10.1097/PEC.0000000000001148; Trent M, 2013, CURR OPIN OBSTET GYN, V25, P350, DOI 10.1097/GCO.0b013e328364ea79; Woods JL, 2013, PEDIATR EMERG CARE, V29, P720, DOI 10.1097/PEC.0b013e318294dd7b	13	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2017	359								j5122	10.1136/bmj.j5122	http://dx.doi.org/10.1136/bmj.j5122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WG	29170355				2022-12-28	WOS:000416472900003
J	Lamichhaney, S; Han, F; Webster, MT; Andersson, L; Grant, BR; Grant, PR				Lamichhaney, Sangeet; Han, Fan; Webster, Matthew T.; Andersson, Leif; Grant, B. Rosemary; Grant, Peter R.			Rapid hybrid speciation in Darwin's finches	SCIENCE			English	Article							TRANSGRESSIVE SEGREGATION; ALLOPATRIC SPECIATION; SECONDARY CONTACT; HYBRIDIZATION; EVOLUTION; GENETICS; LINEAGE	Homoploid hybrid speciation in animals has been inferred frequently from patterns of variation, but few examples have withstood critical scrutiny. Here we report a directly documented example, from its origin to reproductive isolation. An immigrant Darwin's finch to Daphne Major in the Galapagos archipelago initiated a new genetic lineage by breeding with a resident finch (Geospiza fortis). Genome sequencing of the immigrant identified it as a G. conirostris male that originated on Espanola >100 kilometers from Daphne Major. From the second generation onward, the lineage bred endogamously and, despite intense inbreeding, was ecologically successful and showed transgressive segregation of bill morphology. This example shows that reproductive isolation, which typically develops over hundreds of generations, can be established in only three.	[Lamichhaney, Sangeet; Han, Fan; Webster, Matthew T.; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Grant, B. Rosemary; Grant, Peter R.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andersson, Leif] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Andersson, Leif] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Uppsala University; Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station; Princeton University; Harvard University; Harvard University	Lamichhaney, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	leif.andersson@imbim.uu.se	Grant, Peter/HIR-3733-2022	Webster, Matthew/0000-0003-1141-2863; Han, Fan/0000-0002-8091-443X; Grant, Peter/0000-0002-7347-5758	NSF; Knut and Alice Wallenberg Foundation; Swedish Research Council; Uppsala University and Hospital, SciLifeLab	NSF(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University and Hospital, SciLifeLab	The NSF funded the collection of material under permits from the Galapagos and Costa Rica National Parks Services and the Charles Darwin Research Station, in accordance with protocols of Princeton University's Animal Welfare Committee. The project was supported by the Knut and Alice Wallenberg Foundation and the Swedish Research Council. Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLifeLab, and the Swedish Research Council. Computer resources were supplied by Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). We would also like to thank two anonymous reviewers for valuable comments on the paper. The Illumina reads have been submitted to the short reads archive (www.ncbi.nlm.nih.gov/sra) with the accession number PRJNA392917. Raw tree files for constructing Fig. 2A and figs. S4, S5, and S7 have been submitted to the TreeBASE database with submission ID S21803 (http://purl.org/phylo/treebase/phylows/study/TB2:S21803?format=html). P.R.G. and B.R.G. collected the material. P.R.G., B.R.G., and L.A. conceived the study. L.A. and M.T.W. led the bioinformatic analysis of data. S.L. and F.H. performed the bioinformatic analysis. P.R.G., B.R.G., S.L., and L.A. wrote the paper with input from the other authors. All authors approved the manuscript before submission.	Abbott RJ, 2016, MOL ECOL, V25, P2325, DOI 10.1111/mec.13685; Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bolstad GH, 2015, P NATL ACAD SCI USA, V112, P13284, DOI 10.1073/pnas.1505357112; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Grant B.R., 2014, 40 YEARS EVOLUTION D; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0146; Grant PR, 2010, PHILOS T R SOC B, V365, P1065, DOI 10.1098/rstb.2009.0283; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Hermansen JS, 2011, MOL ECOL, V20, P3812, DOI 10.1111/j.1365-294X.2011.05183.x; Kang JH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-25; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Lack D., 1947, DARWINS FINCHES; Lamichhaney S, 2016, SCIENCE, V352, P470, DOI 10.1126/science.aad8786; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Mavarez J, 2008, MOL ECOL, V17, P4181, DOI 10.1111/j.1365-294X.2008.03898.x; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parsons KJ, 2011, EVOL BIOL, V38, P306, DOI 10.1007/s11692-011-9126-7; RATCLIFFE LM, 1983, ANIM BEHAV, V31, P1139, DOI 10.1016/S0003-3472(83)80021-9; RIESEBERG LH, 1995, NATURE, V375, P313, DOI 10.1038/375313a0; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Schumer M, 2014, EVOLUTION, V68, P1553, DOI 10.1111/evo.12399; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Stelkens R, 2009, EVOLUTION, V63, P884, DOI 10.1111/j.1558-5646.2008.00599.x; SWARTH HARRY S., 1931, OCC PAPERS CALIFORNIA ACAD SCI, V18, P1; Yakimowski SB, 2014, AM J BOT, V101, P1247, DOI 10.3732/ajb.1400201	33	202	205	24	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					224	227		10.1126/science.aao4593	http://dx.doi.org/10.1126/science.aao4593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29170277				2022-12-28	WOS:000419816600048
J	Marrone, DP; Spilker, JS; Hayward, CC; Vieira, JD; Aravena, M; Ashby, MLN; Bayliss, MB; Bethermin, M; Brodwin, M; Bothwell, MS; Carlstrom, JE; Chapman, SC; Chen, CC; Crawford, TM; Cunningham, DJM; De Breuck, C; Fassnacht, CD; Gonzalez, AH; Greve, TR; Hezaveh, YD; Lacaille, K; Litke, KC; Lower, S; Ma, J; Malkan, M; Miller, TB; Morningstar, WR; Murphy, EJ; Narayanan, D; Phadke, KA; Rotermund, KM; Sreevani, J; Stalder, B; Stark, AA; Strandet, ML; Tang, M; Weiss, A				Marrone, D. P.; Spilker, J. S.; Hayward, C. C.; Vieira, J. D.; Aravena, M.; Ashby, M. L. N.; Bayliss, M. B.; Bethermin, M.; Brodwin, M.; Bothwell, M. S.; Carlstrom, J. E.; Chapman, S. C.; Chen, Chian-Chou; Crawford, T. M.; Cunningham, D. J. M.; De Breuck, C.; Fassnacht, C. D.; Gonzalez, A. H.; Greve, T. R.; Hezaveh, Y. D.; Lacaille, K.; Litke, K. C.; Lower, S.; Ma, J.; Malkan, M.; Miller, T. B.; Morningstar, W. R.; Murphy, E. J.; Narayanan, D.; Phadke, K. A.; Rotermund, K. M.; Sreevani, J.; Stalder, B.; Stark, A. A.; Strandet, M. L.; Tang, M.; Weiss, A.			Galaxy growth in a massive halo in the first billion years of cosmic history	NATURE			English	Article							STAR-FORMING GALAXIES; STELLAR POPULATION SYNTHESIS; SIMILAR-TO 6; MOLECULAR GAS; ALMA OBSERVATIONS; C II; REDSHIFT DISTRIBUTION; STARBURST GALAXY; HOST GALAXIES; DUSTY	According to the current understanding of cosmic structure formation, the precursors of the most massive structures in the Universe began to form shortly after the Big Bang, in regions corresponding to the largest fluctuations in the cosmic density field(1-3). Observing these structures during their period of active growth and assembly-the first few hundred million years of the Universe-is challenging because it requires surveys that are sensitive enough to detect the distant galaxies that act as signposts for these structures and wide enough to capture the rarest objects. As a result, very few such objects have been detected so far(4,5). Here we report observations of a far-infrared-luminous object at redshift 6.900 (less than 800 million years after the Big Bang) that was discovered in a wide-field survey(6). High-resolution imaging shows it to be a pair of extremely massive star-forming galaxies. The larger is forming stars at a rate of 2,900 solar masses per year, contains 270 billion solar masses of gas and 2.5 billion solar masses of dust, and is more massive than any other known object at a redshift of more than 6. Its rapid star formation is probably triggered by its companion galaxy at a projected separation of 8 kiloparsecs. This merging companion hosts 35 billion solar masses of stars and has a star-formation rate of 540 solar masses per year, but has an order of magnitude less gas and dust than its neighbour and physical conditions akin to those observed in lower-metallicity galaxies in the nearby Universe(7). These objects suggest the presence of a dark-matter halo with a mass of more than 100 billion solar masses, making it among the rarest dark-matter haloes that should exist in the Universe at this epoch.	[Marrone, D. P.; Spilker, J. S.; Litke, K. C.; Tang, M.] Univ Arizona, Steward Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA; [Hayward, C. C.] Flatiron Inst, Ctr Computat Astrophys, 162 Fifth Ave, New York, NY 10010 USA; [Hayward, C. C.; Ashby, M. L. N.; Stark, A. A.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Vieira, J. D.; Lower, S.; Phadke, K. A.; Sreevani, J.] Univ Illinois, Dept Astron, 1002 West Green St, Urbana, IL 61801 USA; [Aravena, M.] Univ Diego Portales, Fac Ingn, Nucleo Astron, Ave Ejercito 441, Santiago, Chile; [Bayliss, M. B.] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bethermin, M.] Aix Marseille Univ, CNRS, LAM, Lab Astrophys Marseille, Marseille, France; [Brodwin, M.] Univ Missouri, Dept Phys & Astron, 5110 Rockhill Rd, Kansas City, MO 64110 USA; [Bothwell, M. S.] Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England; [Bothwell, M. S.] Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England; [Carlstrom, J. E.; Crawford, T. M.] Univ Chicago, Kavli Inst Cosmol Phys, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Dept Phys, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Enrico Fermi Inst, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Carlstrom, J. E.] Univ Chicago, Dept Astron & Astrophys, 5640 South Ellis Ave, Chicago, IL 60637 USA; [Chapman, S. C.; Cunningham, D. J. M.; Miller, T. B.; Rotermund, K. M.] Dalhousie Univ, Halifax, NS, Canada; [Chen, Chian-Chou; De Breuck, C.] European Southern Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany; [Cunningham, D. J. M.] St Marys Univ, Dept Astron & Phys, Halifax, NS, Canada; [Fassnacht, C. D.] Univ Calif Davis, Dept Phys, One Shields Ave, Davis, CA 95616 USA; [Gonzalez, A. H.; Ma, J.; Narayanan, D.] Univ Florida, Bryant Space Sci Ctr, Dept Astron, Gainesville, FL 32611 USA; [Greve, T. R.] UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England; [Hezaveh, Y. D.; Morningstar, W. R.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Lacaille, K.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Malkan, M.] Univ Calif Los Angeles, Dept Phys & Astrophys, Los Angeles, CA 90095 USA; [Murphy, E. J.] Natl Radio Astron Observ, 520 Edgemont Rd, Charlottesville, VA 22903 USA; [Stalder, B.] Large Synopt Survey Telescope, 950 North Cherry Ave, Tucson, AZ 85719 USA; [Strandet, M. L.; Weiss, A.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Strandet, M. L.] Univ Bonn, IMPRS Astron & Astrophys, Bonn, Germany; [Strandet, M. L.] Univ Cologne, IMPRS Astron & Astrophys, Bonn, Germany	University of Arizona; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Illinois System; University of Illinois Urbana-Champaign; University Diego Portales; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Missouri System; University of Missouri Kansas City; University of Cambridge; University of Cambridge; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Dalhousie University; European Southern Observatory; Saint Marys University - Canada; University of California System; University of California Davis; State University System of Florida; University of Florida; University of London; University College London; Stanford University; McMaster University; University of California System; University of California Los Angeles; National Radio Astronomy Observatory (NRAO); Max Planck Society; University of Bonn; University of Bonn; University of Cologne	Marrone, DP (corresponding author), Univ Arizona, Steward Observ, 933 North Cherry Ave, Tucson, AZ 85721 USA.	dmarrone@email.arizona.edu	CHEN, Chian-Chou (TC) 陳建州/ABB-2819-2020; Murphy, Eric/AAE-8450-2021	CHEN, Chian-Chou (TC) 陳建州/0000-0002-3805-0789; Lacaille, Kevin/0000-0001-9870-5663; Aravena, Manuel/0000-0002-6290-3198; Weiss, Axel/0000-0003-4678-3939; Narayanan, Desika/0000-0002-7064-4309; Fassnacht, Christopher/0000-0002-4030-5461; Jarugula, Sreevani/0000-0002-5386-7076; Tang, Mengtao/0000-0001-5940-338X; Phadke, Kedar/0000-0001-7946-557X; Greve, Thomas R./0000-0002-2554-1837; Bayliss, Matthew/0000-0003-1074-4807; Stark, Antony/0000-0002-2718-9996	NASA; NSF [PLR-1248097, PHY-1125897]; Kavli Foundation; Gordon and Betty Moore Foundation [GBMF 947]; US NSF [AST-1312950]; NASA from the Space Telescope Science Institute [HST-GO-14740]; National Radio Astronomy Observatory [SOSPA4-007]; Simons Foundation; A.P. Sloan Foundation Fellowship; STFC [ST/M001172/1] Funding Source: UKRI; Office of Polar Programs (OPP) [1248097] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Kavli Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US NSF(National Science Foundation (NSF)); NASA from the Space Telescope Science Institute; National Radio Astronomy Observatory; Simons Foundation; A.P. Sloan Foundation Fellowship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	ALMA is a partnership of ESO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. This work incorporates observations with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute (STScI) operated by AURA. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. The SPT is supported by the NSF through grant PLR-1248097, with partial support through PHY-1125897, the Kavli Foundation and the Gordon and Betty Moore Foundation grant GBMF 947. Supporting observations were obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, under a cooperative agreement with the NSF on behalf of the Gemini partnership of NSF (USA), NRC (Canada), CONICYT (Chile), Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina) and Ministerio da Ciencia, Tecnologia e Inovacao (Brazil). D.P.M., J.S.S., J.D.V., K.C.L. and J.S. acknowledge support from the US NSF under grant AST-1312950. D.P.M. was partially supported by NASA through grant HST-GO-14740 from the Space Telescope Science Institute. K.C.L. was partially supported by SOSPA4-007 from the National Radio Astronomy Observatory. The Flatiron Institute is supported by the Simons Foundation. J.D.V. acknowledges support from an A.P. Sloan Foundation Fellowship. Y.D.H. is a Hubble fellow.	Ade PAR, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201525830; Aravena M, 2016, MON NOT R ASTRON SOC, V457, P4406, DOI 10.1093/mnras/stw275; Ashby MLN, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/80; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Blain AW, 2003, MON NOT R ASTRON SOC, V338, P733, DOI 10.1046/j.1365-8711.2003.06086.x; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Bouwens RJ, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/34; Brammer GB, 2008, ASTROPHYS J, V686, P1503, DOI 10.1086/591786; Brauher JR, 2008, ASTROPHYS J SUPPL S, V178, P280, DOI 10.1086/590249; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Burgarella D, 2005, MON NOT R ASTRON SOC, V360, P1413, DOI 10.1111/j.1365-2966.2005.09131.x; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Carlstrom JE, 2011, PUBL ASTRON SOC PAC, V123, P568, DOI 10.1086/659879; Casey CM, 2017, ASTROPHYS J, V840, DOI 10.3847/1538-4357/aa6cb1; Casey CM, 2014, PHYS REP, V541, P45, DOI 10.1016/j.physrep.2014.02.009; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cole S, 2008, MON NOT R ASTRON SOC, V383, P546, DOI [10.1111/j.1365-2966.2007.12516.x, 10.1111/j.1365-2966.2007.125l6.x]; Conroy C, 2010, ASTROPHYS J, V712, P833, DOI 10.1088/0004-637X/712/2/833; Conroy C, 2009, ASTROPHYS J, V699, P486, DOI 10.1088/0004-637X/699/1/486; Cooray A, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/40; Cormier D, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201425207; Decarli R, 2017, NATURE, V545, P457, DOI 10.1038/nature22358; Diaz-Santos T, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/68; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Eikenberry S, 2012, PROC SPIE, V8446, DOI 10.1117/12.925679; Ferkinhoff C, 2010, ASTROPHYS J LETT, V714, pL147, DOI 10.1088/2041-8205/714/1/L147; Harrison I, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/07/022; Hayward CC, 2017, MON NOT R ASTRON SOC, V465, P1682, DOI 10.1093/mnras/stw2888; Hezaveh YD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/132; Hezaveh YD, 2016, ASTROPHYS J, V823, DOI 10.3847/0004-637X/823/1/37; Hezaveh YD, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/52; Hook IM, 2004, PUBL ASTRON SOC PAC, V116, P425, DOI 10.1086/383624; Hopwood R, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L4; Inoue AK, 2016, SCIENCE, V352, P1559, DOI 10.1126/science.aaf0714; Laporte N, 2017, ASTROPHYS J LETT, V837, DOI 10.3847/2041-8213/aa62aa; Lebouteiller V, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201218859; Leitherer C, 2002, ASTROPHYS J SUPPL S, V140, P303, DOI 10.1086/342486; Lo Faro B, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/108; Ma JZ, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/88; Mihos JC, 1996, ASTROPHYS J, V464, P641, DOI 10.1086/177353; Miller TB, 2015, MON NOT R ASTRON SOC, V452, P878, DOI 10.1093/mnras/stv1267; Mocanu LM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/61; Noll S, 2009, ASTRON ASTROPHYS, V507, P1793, DOI 10.1051/0004-6361/200912497; Oteo I, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/34; Rawle TD, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/59; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Riechers DA, 2010, ASTROPHYS J LETT, V720, pL131, DOI 10.1088/2041-8205/720/2/L131; Schuster MT, 2006, P SOC PHOTO-OPT INS, V6270, P27020, DOI 10.1117/12.673134; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Spilker JS, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/112; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Strandet ML, 2017, ASTROPHYS J LETT, V842, DOI 10.3847/2041-8213/aa74b0; Strandet ML, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/2/80; Suyu SH, 2006, MON NOT R ASTRON SOC, V371, P983, DOI 10.1111/j.1365-2966.2006.10733.x; Tinker J, 2008, ASTROPHYS J, V688, P709, DOI 10.1086/591439; Venemans BP, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa62ac; Venemans BP, 2016, ASTROPHYS J, V816, DOI 10.3847/0004-637X/816/1/37; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Wang R, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/44; Wang R, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/101; Wang R, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L34; Wang R, 2010, ASTROPHYS J, V714, P699, DOI 10.1088/0004-637X/714/1/699; Warner C, 2013, ASTR SOC P, V475, P79; Warner C, 2012, ASTR SOC P, V461, P53; Watson D, 2015, NATURE, V519, P327, DOI 10.1038/nature14164; Weiss A, 2007, ASTRON ASTROPHYS, V467, P955, DOI 10.1051/0004-6361:20066117; Weiss A, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/88	73	128	128	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2018	553	7686					51	+		10.1038/nature24629	http://dx.doi.org/10.1038/nature24629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4NI	29211721	Green Submitted, Green Published			2022-12-28	WOS:000419769300027
J	Rosenbaum, L				Rosenbaum, Lisa			The Less-Is-More Crusade - Are We Overmedicalizing or Oversimplifying?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMBULANCE REFERRAL PATTERNS; CARE EVIDENCE; HEALTH-CARE; PHYSICIANS; MEDICINE; POLICY											Abaluck J, 2016, AM ECON REV, V106, P3730, DOI 10.1257/aer.20140260; Abelson R, 2010, NY TIMES; Abramson J., 2004, OVERDOSED AM BROKEN; Al-Lamee R, 2017, LANCET; American College of Physicians, CURR ED RES VERS 3 0; [Anonymous], REFL VAR; [Anonymous], 2017, NY TIMES; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Brownlee S., 2007, OVERTREATED WHY TOO; Chandra A., 2012, EC MEETS GEOGRAPHY M; Cooper Z, 2015, 21815 NBER; Desai NR, 2015, JAMA-J AM MED ASSOC, V314, P2045, DOI 10.1001/jama.2015.13764; Doyle J, 2015, BOSTON GLOBE; Doyle JJ, 2017, J HEALTH ECON, V54, P25, DOI 10.1016/j.jhealeco.2017.03.005; Doyle JJ, 2015, J POLIT ECON, V123, P170, DOI 10.1086/677756; Eichenwald K., 2003, NY TIMES; Epstein D, 2017, ATLANTIC; Fred HL, 2016, TEX HEART I J, V43, P4, DOI 10.14503/THIJ-15-5646; Hamblin J, 2017, ATLANTIC; Kahneman D., 2011, THINKING FAST SLOW; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Moghe S., 2015, CNN; OBERMEYER Z, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J239; Spence D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5967; Sullivan K, 2016, HLTH CARE BLOG  0925; Venkatesh AK, 2013, AM J EMERG MED, V31, P1520, DOI 10.1016/j.ajem.2013.07.019; Welch GB, 2016, LESS MED MORE HLTH; Winerman L., 2012, MONITOR PSYCHOL	29	33	34	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2392	2397		10.1056/NEJMms1713248	http://dx.doi.org/10.1056/NEJMms1713248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP8VG	29236644				2022-12-28	WOS:000417923600015
J	Rubin, R				Rubin, Rita			More Than 1 in 5 Working Adults Use Some Form of Tobacco	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2174	2174		10.1001/jama.2017.18931	http://dx.doi.org/10.1001/jama.2017.18931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234816				2022-12-28	WOS:000417822700009
J	Tang, K; Li, ZH; Li, WK; Chen, L				Tang, Kun; Li, Zhihui; Li, Wenkai; Chen, Lincoln			China's Silk Road and global health	LANCET			English	Review							OUTBREAK	In 2013, China proposed its Belt and Road Initiative to promote trade, infrastructure, and commercial associations with 65 countries in Asia, Africa, and Europe. This initiative contains important health components. Simultaneously, China launched an unprecedented overseas intervention against Ebola virus in west Africa, dispatching 1200 workers, including Chinese military personnel. The overseas development assistance provided by China has been increasing by 25% annually, reaching US$7 billion in 2013. Development assistance for health from China has particularly been used to develop infrastructure and provide medical supplies to Africa and Asia. China's contributions to multilateral organisations are increasing but are unlikely to bridge substantial gaps, if any, vacated by other donors; China is creating its own multilateral funds and banks and challenging the existing global architecture. These new investment vehicles are more aligned with the geography and type of support of the Belt and Road Initiative. Our analysis concludes that China's Belt and Road Initiative, Ebola response, development assistance for health, and new investment funds are complementary and reinforcing, with China shaping a unique global engagement impacting powerfully on the contours of global health.	[Tang, Kun] Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing 100191, Peoples R China; [Li, Zhihui] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Li, Wenkai] China Med Board, Beijing, Peoples R China; [Chen, Lincoln] China Med Board, Cambridge, MA USA	Peking University; Harvard University; Harvard T.H. Chan School of Public Health	Tang, K (corresponding author), Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing 100191, Peoples R China.	tangkun@hsc.pku.edu.cn	Tang, Kun/GSD-3218-2022					[Anonymous], 2017, WHATS DRIVING CHINAS; [Anonymous], 2016, EC TIMES; Chan LH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000266; Curran E., 2016, BLOOMBERG; Dieleman J., 2017, FINANCING GLOBAL HLT; Dong Z, 2015, CHINANEWS       0311; European Parliament, 2016, ON BELT ON ROAD OBOR; Gostin LO, 2009, BRIT MED BULL, V90, P7, DOI 10.1093/bmb/ldp014; Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI [10.1162/1535351041747905, DOI 10.1162/1535351041747905]; Horton R, 2017, LANCET, V389, P1086, DOI 10.1016/S0140-6736(17)30761-4; Hu RW, 2017, LANCET GLOB HEALTH, V5, pE752, DOI 10.1016/S2214-109X(17)30250-4; Huang YZ, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600001; Jaspal ZN, PAKISTAN OBSERVER; Kickbusch I., 2012, GOVERNANCE HLTH 21 C; Lampton David M., 2005, POWER SHIFT CHINA AS, P306; Li A, 2016, W ASIAN AFRICAN STUD, V1, P76; Liu L, 2017, DISASTER MED PUBLIC, V11, P262, DOI 10.1017/dmp.2016.103; Liu PL, 2014, LANCET, V384, P793, DOI 10.1016/S0140-6736(14)60725-X; Lu YY, 2016, J ROY ARMY MED CORPS, V162, P198, DOI 10.1136/jramc-2015-000562; Luft Gal, 2016, FOREIGN AFFAIRS; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Luo Y, 2017, J MICROBIOL IMMUNOL, V50, P1, DOI 10.1016/j.jmii.2016.04.003; Monagham A., 2014, GUARDIAN 0110; National Health and Family Planning Commission, 2015, NHFPCS IMPL PLAN BEL; National Health and Family Planning Commission, 2017, BEIJ COMM SILK ROAD; Nikogosian H, 2017, GLOBAL POLICY; Politzer M., 2008, CHINA AFRICA STRONGE; Sen A., 2004, NEW YORK REV BOOKS; SUBBARAO SK, 1988, PARASITOL TODAY, V4, P72, DOI 10.1016/0169-4758(88)90199-8; United Nations Development Programme, 2017, NEW MEANS TRANSF GLO; Wei PF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5717108; Wu G, BUILDING SILK ROAD H; Xu D, 2016, LANCET, V388, P1860, DOI 10.1016/S0140-6736(16)31839-6; Xu XW, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.71	34	50	63	8	124	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2595	2601		10.1016/S0140-6736(17)32898-2	http://dx.doi.org/10.1016/S0140-6736(17)32898-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP3BI	29231838	Bronze, Green Published			2022-12-28	WOS:000417493300028
J	Levine, PB; McKnight, R				Levine, Phillip B.; McKnight, Robin			Firearms and accidental deaths: Evidence from the aftermath of the Sandy Hook school shooting	SCIENCE			English	Article							BACKGROUND CHECKS; INJURIES; CALIFORNIA	Exposure to firearms increased substantially after the December 2012 shooting at Sandy Hook Elementary School in Newtown, Connecticut, where 20 children and 6 adults were killed. Gun sales spiked by 3 million, on the basis of the increase in the number of background checks for firearm purchases. Google searches for buying and cleaning guns increased. We used Vital Statistics mortality data to examine whether a spike in accidental firearm deaths occurred at the same time as the greater exposure to firearms. We also assessed whether the increase in these deaths was larger in those states where the spike in gun sales per capita was larger. We find that an additional 60 deaths overall, including 20 children, resulted from unintentional shootings in the immediate aftermath of Sandy Hook.	[Levine, Phillip B.; McKnight, Robin] Wellesley Coll, Dept Econ, Wellesley, MA 02481 USA; [Levine, Phillip B.; McKnight, Robin] NBER, Cambridge, MA 02138 USA	Wellesley College; National Bureau of Economic Research	Levine, PB (corresponding author), Wellesley Coll, Dept Econ, Wellesley, MA 02481 USA.; Levine, PB (corresponding author), NBER, Cambridge, MA 02138 USA.	plevine@wellesley.edu		Levine, Phillip/0000-0001-7374-3823; McKnight, Robin/0000-0001-7948-6012				Altman Alex, 2012, TIME; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; [Anonymous], 2013, NY TIMES; Barber C, 2011, ACCIDENT ANAL PREV, V43, P724, DOI 10.1016/j.aap.2010.10.018; Depetris-Chauvin E, 2015, J PUBLIC ECON, V130, P66, DOI 10.1016/j.jpubeco.2015.04.008; Duggan M, 2011, REV ECON STAT, V93, P786, DOI 10.1162/REST_a_00120; Fowler KA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3486; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Lang M, 2016, SOUTH ECON J, V83, P45, DOI 10.1002/soej.12134; Lang M, 2013, ECON J, V123, P1085, DOI 10.1111/ecoj.12007; Miller M, 2005, ACCIDENT ANAL PREV, V37, P661, DOI 10.1016/j.aap.2005.02.003; National Center for Health Statistics, MORT FIL ALL COUNT G; Sinauer N, 1996, JAMA-J AM MED ASSOC, V275, P1740; Stark DE, 2017, JAMA-J AM MED ASSOC, V317, P84, DOI 10.1001/jama.2016.16215; Strong BL, 2016, AM J PREV MED, V51, P1084, DOI 10.1016/j.amepre.2016.09.023; Studdert DM, 2017, ANN INTERN MED, V166, P698, DOI 10.7326/M16-1574; Underwood E, 2013, SCIENCE, V339, P381, DOI 10.1126/science.339.6118.381; Wiebe DJ, 2003, ACCIDENT ANAL PREV, V35, P711, DOI 10.1016/S0001-4575(02)00049-0; WINTEMUTE GJ, 1987, JAMA-J AM MED ASSOC, V257, P3107, DOI 10.1001/jama.257.22.3107	19	33	33	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1324	1328		10.1126/science.aan8179	http://dx.doi.org/10.1126/science.aan8179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO9YM	29217576				2022-12-28	WOS:000417254700063
J	Seegert, L				Seegert, Liz			Alex Azar: critics cry "revolving door" as Trump picks pharma executive for top US health job	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												liz@lizseegert.com						[Anonymous], 2017, NOM A AZAR SERVE SEC; Park E, 2016, MEDICAID BLOCK GRANT	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5655	10.1136/bmj.j5655	http://dx.doi.org/10.1136/bmj.j5655			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29217520				2022-12-28	WOS:000417560100012
J	Autier, P; Boniol, M; Koechlin, A; Pizot, C; Boniol, M				Autier, Philippe; Boniol, Magali; Koechlin, Alice; Pizot, Cecile; Boniol, Mathieu			Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE REPLACEMENT THERAPY; CANCER MORTALITY-RATES; BREAST-CANCER; DIGITAL MAMMOGRAPHY; DIAGNOSIS; TRENDS; FILM; IMPLEMENTATION; PERFORMANCE; TRANSITION	OBJECTIVE To analyse stage specific incidence of breast cancer in the Netherlands where women have been invited to biennial mammography screening since 1989 (ages 50-69) and 1997 (ages 70-75), and to assess changes in breast cancer mortality and quantified overdiagnosis. DESIGN Population based study. SETTING Mammography screening programme, the Netherlands. PARTICIPANTS Dutch women of all ages, 1989 to 2012. MAIN OUTCOME MEASURES Stage specific age adjusted incidence of breast cancer from 1989 to 2012. The extra numbers of in situ and stage 1 breast tumours associated with screening were estimated by comparing rates in women aged 50-74 with those in age groups not invited to screening. Overdiagnosis was estimated after subtraction of the lead time cancers. Breast cancer mortality reductions during 2010-12 and overdiagnosis during 2009-11 were computed without (scenario 1) and with (scenario 2) a cohort effect on mortality secular trends. RESULTS The incidence of stage 2-4 breast cancers in women aged 50 or more was 168 per 100 000 in 1989 and 166 per 100 000 in 2012. Screening would be associated with a 5% mortality reduction in scenario 1 and with no influence on mortality in scenario 2. In both scenarios, improved treatments would be associated with 28% reductions in mortality. Overdiagnosis has steadily increased over time with the extension of screening to women aged 70-75 and with the introduction of digital mammography. After deduction of clinical lead time cancers, 32% of cancers found in women invited to screening in 2010-12 and 52% of screen detected cancers would be overdiagnosed. CONCLUSIONS The Dutch mammography screening programme seems to have little impact on the burden of advanced breast cancers, which suggests a marginal effect on breast cancer mortality. About half of screen detected breast cancers would represent overdiagnosis.	[Autier, Philippe; Koechlin, Alice; Boniol, Mathieu] Univ Strathclyde, Inst Global Publ Hlth IPRI, Allee Claude Debussy, F-69130 Lyon, France; [Autier, Philippe; Boniol, Magali; Koechlin, Alice; Pizot, Cecile; Boniol, Mathieu] Int Prevent Res Inst, Lyon, France		Autier, P (corresponding author), Univ Strathclyde, Inst Global Publ Hlth IPRI, Allee Claude Debussy, F-69130 Lyon, France.; Autier, P (corresponding author), Int Prevent Res Inst, Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014	Autier, Philippe/0000-0003-1538-5321	International Prevention Research Institute	International Prevention Research Institute	This work was part of internally supported research projects of the International Prevention Research Institute. No external funding was received for this project. The International Prevention Research Institute had no influence on the methods, data analyses, or discussion.	American Joint Committee on Cancer, 2002, AJCC CANC STAG MAN, P171; [Anonymous], 2009, JOINT REGRESSION PRO; Autier P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154113; Autier P, 2015, J ROY SOC MED, V108, P440, DOI 10.1177/0141076815593403; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Birnbaum J, 2016, ANN INTERN MED, V164, P236, DOI 10.7326/M15-0754; Broeders MJM, 2001, INT J CANCER, V92, P303, DOI 10.1002/1097-0215(200102)9999:9999&lt;::AID-IJC1186&gt;3.0.CO;2-B; COLE P, 1980, JNCI-J NATL CANCER I, V64, P1263; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; de Gelder R, 2008, INT J CANCER, V123, P680, DOI 10.1002/ijc.23540; de Glas NA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5410; Faber A, 2005, BRIT J CLIN PHARMACO, V60, P641, DOI 10.1111/j.1365-2125.2005.02502.x; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Fracheboud J, 2009, NATL EVALUATION BREA; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; GREENWALD P, 1986, YALE J BIOL MED, V59, P561; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Hoff SR, 2012, RADIOLOGY, V264, P378, DOI 10.1148/radiol.12112074; Hofvind S, 2014, RADIOLOGY, V272, P52, DOI 10.1148/radiol.14131502; IARC, 2002, BRE CANC SCREENING; International Union Against Cancer, 2002, TNM CLASSIFICATION M; Jorgensen KJ, 2017, ANN INTERN MED, V166, P313, DOI 10.7326/M16-0270; Louwman WJ, 2008, CANCER CAUSE CONTROL, V19, P97, DOI 10.1007/s10552-007-9075-8; Maaskant AJG, 2009, BREAST CANCER RES TR, V113, P173, DOI 10.1007/s10549-008-9913-8; MORRISON AS, 1991, INT J EPIDEMIOL, V20, P642, DOI 10.1093/ije/20.3.642; Narod SA, 2015, J Cancer Policy, V5, P8, DOI 10.1016/j.jcpo.2015.03.002; Nederend J, 2014, EUR J CANCER, V50, P31, DOI 10.1016/j.ejca.2013.09.018; Nederend J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3091; NETB. NETfBcs, 1990, NAT EV BREAST SCREEN; NETB) NETfBcsitN, 2007, NETB INT REP 2007 MA; Ripping TM, 2015, INT J CANCER, V137, P921, DOI 10.1002/ijc.29452; Sala M, 2015, EUR RADIOL, V25, P850, DOI 10.1007/s00330-014-3431-3; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Soerjomataram I, 2007, J CLIN ONCOL, V25, P5038, DOI 10.1200/JCO.2007.13.7281; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; Tvedskov TF, 2012, DAN MED J, V59; van der Waal D, 2015, EUR J PUBLIC HEALTH, V25, P320, DOI 10.1093/eurpub/cku088; Vanderveen KA, 2006, ANN SURG ONCOL, V13, P1450, DOI 10.1245/s10434-006-9109-6; Vervoort MM, 2004, BRIT J CANCER, V91, P242, DOI 10.1038/sj.bjc.6601969; Walters S, 2013, BRIT J CANCER, V108, P1195, DOI 10.1038/bjc.2013.6; Waterhouse JAH, 1976, CANC INCIDENCE 5 CON, VIII; World Health Organization, 2013, MORT DAT; World Health Organization, 1990, CANC IAFRO CANC CAUS; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427	46	61	67	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2017	359								j5224	10.1136/bmj.j5224	http://dx.doi.org/10.1136/bmj.j5224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AL	29208760	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000417559000001
J	Berwick, DM				Berwick, Donald M.			Moral Choices for Today's Physician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] Inst Healthcare Improvement, 20 Univ Rd,Seventh Floor, Cambridge, MA 02138 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,Seventh Floor, Cambridge, MA 02138 USA.	donberwick@gmail.com						The Sentencing Project, 2016, COL JUST RAC ETHN DI; World Prison Brief, HIGH LOW PRIS POP RA	2	14	15	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2081	2082		10.1001/jama.2017.16254	http://dx.doi.org/10.1001/jama.2017.16254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209725				2022-12-28	WOS:000417093500010
J	Braillon, A				Braillon, Alain			Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Letter							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CLINICAL-TRIAL; STRESS REDUCTION; USUAL CARE		[Braillon, Alain] Univ Hosp, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Braillon, A (corresponding author), Univ Hosp, Amiens, France.							Braillon A, 2017, PAIN, V158, P535, DOI 10.1097/j.pain.0000000000000794; Cherkin DC, 2017, JAMA-J AM MED ASSOC, V317, P642, DOI 10.1001/jama.2016.17814; Cherkin DC, 2016, JAMA-J AM MED ASSOC, V315, P1240, DOI 10.1001/jama.2016.2323; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2017	167	11					831	832		10.7326/L17-0468	http://dx.doi.org/10.7326/L17-0468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO8KS	29204609				2022-12-28	WOS:000417135900018
J	Mariano, RG; McKelvey, K; White, HS; Kanan, MW				Mariano, Ruperto G.; McKelvey, Kim; White, Henry S.; Kanan, Matthew W.			Selective increase in CO2 electroreduction activity at grain-boundary surface terminations	SCIENCE			English	Article							ELECTRON BACKSCATTER DIFFRACTION; HYDROGEN EVOLUTION REACTION; DISLOCATION DENSITY DISTRIBUTIONS; ELECTROCHEMICAL-CELL MICROSCOPY; OXYGEN REDUCTION REACTION; NANOSCALE ELECTROCHEMISTRY; PLATINUM-ELECTRODES; GOLD NANOPARTICLES; CARBON NANOTUBES; STRAIN	Altering amaterial's catalytic properties requires identifying structural features that give rise to active surfaces. Grain boundaries create strained regions in polycrystalline materials by stabilizing dislocations and may provide a way to create high-energy surfaces for catalysis that are kinetically trapped. Although grain-boundary density has previously been correlated with catalytic activity for some reactions, direct evidence that grain boundaries create surfaces with enhanced activity is lacking. We used a combination of bulk electrochemical measurements and scanning electrochemical cell microscopy with submicrometer resolution to show that grain-boundary surface terminations in gold electrodes are more active than grain surfaces for electrochemical carbon dioxide (CO2) reduction to carbon monoxide (CO) but not for the competing hydrogen (H-2) evolution reaction. The catalytic footprint of the grain boundary is commensurate with its dislocation-induced strain field, providing a strategy for broader exploitation of grain-boundary effects in heterogeneous catalysis.	[Mariano, Ruperto G.; Kanan, Matthew W.] Stanford Univ, Dept Chem, 337 Campus Dr, Stanford, CA 94305 USA; [McKelvey, Kim; White, Henry S.] Univ Utah, Dept Chem, 315 S 1400 E, Salt Lake City, UT 84112 USA; [McKelvey, Kim] Trinity Coll Dublin, Sch Chem, Dublin 2, Ireland	Stanford University; Utah System of Higher Education; University of Utah; Trinity College Dublin	Kanan, MW (corresponding author), Stanford Univ, Dept Chem, 337 Campus Dr, Stanford, CA 94305 USA.	mkanan@stanford.edu		Mariano, Rain/0000-0001-6085-3011; Kanan, Matthew/0000-0002-5932-6289; McKelvey, Kim/0000-0002-0686-6898	NSF [CHE-1565945, ECCS-1542152]; Air Force Office of Scientific Research Multidisciplinary Research Program of the University Research Initiative [FA9550-14-1-0003]	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research Multidisciplinary Research Program of the University Research Initiative	This research was supported by NSF (CHE-1565945) and the Air Force Office of Scientific Research Multidisciplinary Research Program of the University Research Initiative (FA9550-14-1-0003). R.M. gratefully acknowledges NSF for a predoctoral fellowship. We thank C. Spence (Gatan, Inc.) for preparation of Ar ion milled samples. EBSD was performed at the Stanford Nano Shared Facilities (SNSF), which is supported by NSF under award ECCS-1542152. All data are reported in the main text and the supplementary materials.	Aaronson BDB, 2013, J AM CHEM SOC, V135, P3873, DOI 10.1021/ja310632k; Abdolvand H, 2016, INT J PLASTICITY, V84, P160, DOI 10.1016/j.ijplas.2016.05.006; BARTH JV, 1990, PHYS REV B, V42, P9307, DOI 10.1103/PhysRevB.42.9307; Bentley CL, 2017, CHEM SCI, V8, P6583, DOI 10.1039/c7sc02545a; Byers JC, 2014, J AM CHEM SOC, V136, P11252, DOI 10.1021/ja505708y; Calcagnotto M, 2010, MAT SCI ENG A-STRUCT, V527, P2738, DOI 10.1016/j.msea.2010.01.004; Chen CH, 2015, ANAL CHEM, V87, P5782, DOI 10.1021/acs.analchem.5b00988; Chen CH, 2014, PHYS CHEM CHEM PHYS, V16, P18545, DOI 10.1039/c4cp01511h; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; Cho JH, 2005, METALL MATER TRANS A, V36A, P3415, DOI 10.1007/s11661-005-0015-5; Choi SI, 2015, CHEMCATCHEM, V7, P2077, DOI 10.1002/cctc.201500094; DINGLEY DJ, 1992, J MATER SCI, V27, P4545, DOI 10.1007/BF01165988; Ebejer N, 2013, ANNU REV ANAL CHEM, V6, P329, DOI 10.1146/annurev-anchem-062012-092650; Feng XF, 2016, ACS CENTRAL SCI, V2, P169, DOI 10.1021/acscentsci.6b00022; Feng XF, 2015, J AM CHEM SOC, V137, P4606, DOI 10.1021/ja5130513; Gsell M, 1998, SCIENCE, V280, P717, DOI 10.1126/science.280.5364.717; Guell AG, 2014, NANO LETT, V14, P220, DOI 10.1021/nl403752e; Guo Y, 2014, ACTA MATER, V76, P1, DOI 10.1016/j.actamat.2014.05.015; Gwak EJ, 2016, NANO LETT, V16, P2497, DOI 10.1021/acs.nanolett.6b00062; Hall AS, 2015, J AM CHEM SOC, V137, P14834, DOI 10.1021/jacs.5b08259; Hansen HA, 2013, J PHYS CHEM LETT, V4, P388, DOI 10.1021/jz3021155; Hassel AW, 1999, ELECTROCHIM ACTA, V44, P3769, DOI 10.1016/S0013-4686(99)00082-1; Hernandez J, 2004, J ELECTROANAL CHEM, V574, P185, DOI 10.1016/j.jelechem.2003.10.039; Hu JR, 2002, MATER CHEM PHYS, V74, P313, DOI 10.1016/S0254-0584(01)00484-9; Huang XQ, 2014, NANO LETT, V14, P3887, DOI 10.1021/nl501137a; Humphreys FJ, 2004, SCRIPTA MATER, V51, P771, DOI 10.1016/j.scriptamat.2004.05.016; Humphreys FJ, 2001, J MATER SCI, V36, P3833, DOI 10.1023/A:1017973432592; Jiang J, 2013, ACTA MATER, V61, P7227, DOI 10.1016/j.actamat.2013.08.027; Kobayashi S, 2016, BEILSTEIN J NANOTECH, V7, P1829, DOI 10.3762/bjnano.7.176; Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249; Littlewood PD, 2011, ACTA MATER, V59, P6489, DOI 10.1016/j.actamat.2011.07.016; Liu M, 2016, NATURE, V537, P382, DOI 10.1038/nature19060; Mavrikakis M, 1998, PHYS REV LETT, V81, P2819, DOI 10.1103/PhysRevLett.81.2819; Nes E, 1997, PROG MATER SCI, V41, P129, DOI 10.1016/S0079-6425(97)00032-7; Perez J, 1998, J PHYS CHEM B, V102, P10931, DOI 10.1021/jp9831987; Radetic T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.085502; Rohrer GS, 2010, MATER SCI TECH-LOND, V26, P661, DOI 10.1179/026708309X12468927349370; Rollett AD, 2004, Z METALLKD, V95, P226, DOI 10.3139/146.017938; Stolyarov VV, 2003, MAT SCI ENG A-STRUCT, V343, P43, DOI 10.1016/S0921-5093(02)00366-0; Sun S, 2000, PHILOS MAG A, V80, P9, DOI 10.1080/01418610008212038; Sun XH, 2015, ACS NANO, V9, P7634, DOI 10.1021/acsnano.5b02986; Tavares MC, 2001, ELECTROCHIM ACTA, V46, P4359, DOI 10.1016/S0013-4686(01)00726-5; TROOST KZ, 1993, APPL PHYS LETT, V62, P1110, DOI 10.1063/1.108758; Ueji R, 2002, ACTA MATER, V50, P4177, DOI 10.1016/S1359-6454(02)00260-4; Ulvestad A, 2015, NANO LETT, V15, P4066, DOI 10.1021/acs.nanolett.5b01104; VALIEV RZ, 1993, MAT SCI ENG A-STRUCT, V168, P141, DOI 10.1016/0921-5093(93)90717-S; Vaudin MD, 2015, ULTRAMICROSCOPY, V148, P94, DOI 10.1016/j.ultramic.2014.09.007; Verdaguer-Casadevall A, 2015, J AM CHEM SOC, V137, P9808, DOI 10.1021/jacs.5b06227; Villert S, 2009, J MICROSC-OXFORD, V233, P290, DOI 10.1111/j.1365-2818.2009.03120.x; Wang CQ, 2016, NANO LETT, V16, P5669, DOI 10.1021/acs.nanolett.6b02317; Watanabe T, 2011, J MATER SCI, V46, P4095, DOI 10.1007/s10853-011-5393-z; Wilkinson AJ, 2010, PHILOS MAG, V90, P1159, DOI 10.1080/14786430903304145; Wuttig A, 2016, P NATL ACAD SCI USA, V113, pE4585, DOI 10.1073/pnas.1602984113; Wuttig A, 2015, ACS CATAL, V5, P4479, DOI 10.1021/acscatal.5b00808	54	314	312	49	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1187	1191		10.1126/science.aao3691	http://dx.doi.org/10.1126/science.aao3691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191908				2022-12-28	WOS:000416584000042
J	Feinmann, J				Feinmann, Jane			CHRISTMAS APPEAL 2017 The BMJ charity appeal Christmas 2017: Mdecins Sans Frontisres' volunteer doctors need your support	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2017	359								j5535	10.1136/bmj.j5535	http://dx.doi.org/10.1136/bmj.j5535			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MO	29191933	Bronze, Green Published			2022-12-28	WOS:000417211800011
J	Vokes, NI; Van Allen, EM				Vokes, Natalie I.; Van Allen, Eliezer M.			Tumor Evolution: A Problem of Histocompatibility	CELL			English	Editorial Material								In this issue of Cell, two articles show that tumor-specific changes in HLA-mediated antigen presentation affect tumor immunogenicity and may play a role in shaping cancer cell survival.	[Vokes, Natalie I.; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Vokes, Natalie I.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Van Allen, Eliezer M.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Van Allen, EM (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA.	eliezerm_vanallen@dfci.harvard.edu			Bristol Myers-Squibb; Novartis; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER	Bristol Myers-Squibb(Bristol-Myers Squibb); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	E.M.V.A. is a consultant for Tango Therapeutics, Genome Medical, and Invitae. E.M.V.A. receives research funding support from Bristol Myers-Squibb and Novartis.	Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Schreiber R. D., 2011, CELL, V331, P1565; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954	6	4	5	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1252	1253		10.1016/j.cell.2017.11.012	http://dx.doi.org/10.1016/j.cell.2017.11.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195070	Green Accepted, Bronze			2022-12-28	WOS:000417362700007
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Telehealth and telecare need a different approach	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Ayling M, 2013, HLTH SERV J, V359; Barlow J, 2012, REMOTE CARE PLC DEV; Burdsey T., 2017, HLTH SERV J, V359; Cartwright M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f653; Department of Health, 2011, WHOL SYST DEM PROGR; Easton J, 2012, HLTH SERV J, V359; Health Innovation Network, 2017, TECHN EN CAR SERV TE; HENDERSON C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1035; Milburn A., 2017, GUARDIAN; Seddon N., 2013, HLTH SERV J, V359	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2017	359								j5108	10.1136/bmj.j5108	http://dx.doi.org/10.1136/bmj.j5108			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9MG	29183911	Bronze, Green Published			2022-12-28	WOS:000417211000002
J	Van Wagoner, RM; Eichner, A; Bhasin, S; Deuster, PA; Eichner, D				Van Wagoner, Ryan M.; Eichner, Amy; Bhasin, Shalender; Deuster, Patricia A.; Eichner, Daniel			Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-ENHANCING DRUGS; PUBLIC-HEALTH; SUPPLEMENTS; STEROIDS; MEN	IMPORTANCE Recent reports have described the increasing use of nonsteroidal selective androgen receptor modulators, which have not been approved by the US Food and Drug Administration (FDA), to enhance appearance and performance. The composition and purity of such products is not known. OBJECTIVE To determine the chemical identity and the amounts of ingredients in dietary supplements and products marketed and sold through the internet as selective androgen receptor modulators and compare the analyzed contents with product labels. DESIGN AND SETTING Web-based searches were performed from February 18, 2016, to March 25, 2016, using the Google search engine on the Chrome and Internet Explorer web browsers to identify suppliers selling selective androgen receptor modulators. The products were purchased and the identities of the compounds and their amounts were determined from April to August 2016 using chain-of-custody and World Anti-Doping Association-approved analytical procedures. Analytical findings were compared against the label information. EXPOSURES Products marketed and sold as selective androgen receptor modulators. MAIN OUTCOMES AND MEASURES Chemical identities and the amount of ingredients in each product marketed and sold as selective androgen receptor modulators. RESULTS Among 44 products marketed and sold as selective androgen receptor modulators, only 23 (52%) contained 1 or more selective androgen receptor modulators (Ostarine, LGD-4033, or Andarine). An additional 17 products (39%) contained another unapproved drug, including the growth hormone secretagogue ibutamoren, the peroxisome proliferator-activated receptor-d agonist GW501516, and the Rev-ErbA agonist SR9009. Of the 44 tested products, no active compound was detected in 4 (9%) and substances not listed on the label were contained in 11 (25%). In only 18 of the 44 products (41%), the amount of active compound in the product matched that listed on the label. The amount of the compounds listed on the label differed substantially from that found by analysis in 26 of 44 products (59%). CONCLUSIONS AND RELEVANCE In this limited investigation involving chemical analyses of 44 products marketed as selective androgen receptor modulators and sold via the internet, most products contained unapproved drugs and substances. Only 52% contained selective androgen receptor modulators and many were inaccurately labeled.	[Van Wagoner, Ryan M.; Eichner, Daniel] Sports Med Res & Testing Lab, Salt Lake City, UT USA; [Eichner, Amy] US Antidoping Agcy, Colorado Springs, CO USA; [Bhasin, Shalender] Harvard Med Sch, Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, Boston, MA USA; [Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Bethesda, MD USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uniformed Services University of the Health Sciences - USA	Bhasin, S (corresponding author), Brigham & Womens Hosp, Res Program Mens Hlth Aging & Metab, 221 Longwood Ave, Boston, MA 02115 USA.	sbhasin@bwh.harvard.edu	Deuster, Patricia A/G-3838-2015	Deuster, Patricia A/0000-0002-7895-0888	Henry M. Jackson Foundation for the Advancement of Military Medicine [HT9404-13-1-0017]	Henry M. Jackson Foundation for the Advancement of Military Medicine	This project was partially funded by Defense Health Program grant HT9404-13-1-0017 (primary investigator: Dr Deuster) through the Henry M. Jackson Foundation for the Advancement of Military Medicine to the US Anti-Doping Agency (primary investigator: Dr A. Eichner).	Abbate V, 2015, DRUG TEST ANAL, V7, P609, DOI 10.1002/dta.1728; Adunsky A, 2011, ARCH GERONTOL GERIAT, V53, P183, DOI 10.1016/j.archger.2010.10.004; Basaria S, 2013, J GERONTOL A-BIOL, V68, P87, DOI 10.1093/gerona/gls078; Brennan BP, 2013, AM J ADDICTION, V22, P158, DOI 10.1111/j.1521-0391.2013.00311.x; Dobs AS, 2013, LANCET ONCOL, V14, P335, DOI 10.1016/S1470-2045(13)70055-X; Gao WQ, 2007, DRUG DISCOV TODAY, V12, P241, DOI 10.1016/j.drudis.2007.01.003; Health Canada, HLTH CAN END IMP SAF; Kao TC, 2012, ANN EPIDEMIOL, V22, P331, DOI 10.1016/j.annepidem.2012.02.013; Manickam R, 2017, BIOCHIMIE, V136, P42, DOI 10.1016/j.biochi.2016.11.010; Pope HG, 2017, JAMA-J AM MED ASSOC, V317, P23, DOI 10.1001/jama.2016.17441; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Thevis M, 2015, RAPID COMMUN MASS SP, V29, P991, DOI 10.1002/rcm.7189; US Food and Drug Administration, WHAT AR UN DRUGS WHY; US Food and Drug Administration, GUID IND LAB HUM PRE; Westerman ME, 2016, MAYO CLIN PROC, V91, P175, DOI 10.1016/j.mayocp.2015.10.027; Williams CT, 2016, NURS CLIN N AM, V51, P1, DOI 10.1016/j.cnur.2015.10.007; World Anti-Doping Agency, 2016 PROH LIST; World Anti-Doping Agency, WADA WORLD ANT COD I; World Anti-Doping Agency Laboratory Expert Group, TD2015IDCR WORLD ANT	20	54	55	3	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2017	318	20					2004	2010		10.1001/jama.2017.17069	http://dx.doi.org/10.1001/jama.2017.17069			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN8ZR	29183075	Bronze, Green Published			2022-12-28	WOS:000416317600021
J	Cubuk, ED; Ivancic, RJS; Schoenholz, SS; Strickland, DJ; Basu, A; Davidson, ZS; Fontaine, J; Hor, JL; Huang, YR; Jiang, Y; Keim, NC; Koshigan, KD; Lefever, JA; Liu, T; Ma, XG; Magagnosc, DJ; Morrow, E; Ortiz, CP; Rieser, JM; Shavit, A; Still, T; Xu, Y; Zhang, Y; Nordstrom, KN; Arratia, PE; Carpick, RW; Durian, DJ; Fakhraai, Z; Jerolmack, DJ; Lee, D; Li, J; Riggleman, R; Turner, KT; Yodh, AG; Gianola, DS; Liu, AJ				Cubuk, E. D.; Ivancic, R. J. S.; Schoenholz, S. S.; Strickland, D. J.; Basu, A.; Davidson, Z. S.; Fontaine, J.; Hor, J. L.; Huang, Y. -R.; Jiang, Y.; Keim, N. C.; Koshigan, K. D.; Lefever, J. A.; Liu, T.; Ma, X. -G.; Magagnosc, D. J.; Morrow, E.; Ortiz, C. P.; Rieser, J. M.; Shavit, A.; Still, T.; Xu, Y.; Zhang, Y.; Nordstrom, K. N.; Arratia, P. E.; Carpick, R. W.; Durian, D. J.; Fakhraai, Z.; Jerolmack, D. J.; Lee, Daeyeon; Li, Ju; Riggleman, R.; Turner, K. T.; Yodh, A. G.; Gianola, D. S.; Liu, Andrea J.			Structure-property relationships from universal signatures of plasticity in disordered solids	SCIENCE			English	Article							MECHANICAL-BEHAVIOR; METALLIC GLASSES; RELAXATION; DYNAMICS; STRENGTH; LIQUIDS; FLOW; DEFORMATION; POLYMERS	When deformed beyond their elastic limits, crystalline solids flow plastically via particle rearrangements localized around structural defects. Disordered solids also flow, but without obvious structural defects. We link structure to plasticity in disordered solids via a microscopic structural quantity, "softness," designed by machine learning to be maximally predictive of rearrangements. Experimental results and computations enabled us to measure the spatial correlations and strain response of softness, as well as two measures of plasticity: the size of rearrangements and the yield strain. All four quantities maintained remarkable commonality in their values for disordered packings of objects ranging from atoms to grains, spanning seven orders of magnitude in diameter and 13 orders of magnitude in elastic modulus. These commonalities link the spatial correlations and strain response of softness to rearrangement size and yield strain, respectively.	[Cubuk, E. D.; Schoenholz, S. S.] Google Brain, Mountain View, CA 94043 USA; [Ivancic, R. J. S.; Schoenholz, S. S.; Basu, A.; Davidson, Z. S.; Ma, X. -G.; Ortiz, C. P.; Rieser, J. M.; Still, T.; Xu, Y.; Jerolmack, D. J.; Yodh, A. G.; Liu, Andrea J.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Strickland, D. J.; Lefever, J. A.; Magagnosc, D. J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Fontaine, J.; Koshigan, K. D.] Univ Lyon, Lab Tribol & Dynam Syst, Ecole Cent Lyon, CNRS,UMR 5513, F-69134 Ecully, France; [Hor, J. L.; Huang, Y. -R.; Shavit, A.; Lee, Daeyeon; Riggleman, R.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Jiang, Y.; Keim, N. C.; Arratia, P. E.; Carpick, R. W.; Turner, K. T.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Keim, N. C.] Calif Polytech State Univ San Luis Obispo, Phys Dept, San Luis Obispo, CA 93407 USA; [Liu, T.; Fakhraai, Z.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Ma, X. -G.] CNRS Solvay UPenn UMI 3254, Complex Assemblies Soft Matter, Bristol, PA 19007 USA; [Morrow, E.] Houghton Coll, Dept Phys, Houghton, NY 14744 USA; [Nordstrom, K. N.] Mt Holyoke Coll, Dept Phys, S Hadley, MA 01075 USA; [Jerolmack, D. J.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Li, Ju] MIT, Dept Nucl Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Gianola, D. S.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Google Incorporated; University of Pennsylvania; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Centrale de Lyon; University of Pennsylvania; University of Pennsylvania; California State University System; California Polytechnic State University San Luis Obispo; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Solvay SA; Mount Holyoke College; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara	Liu, AJ (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.; Gianola, DS (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	gianola@engr.ucsb.edu; ajliu@physics.upenn.edu	FONTAINE, Julien/B-5321-2008; Jiang, Yijie/A-7605-2014; Ivancic, Robert Joseph/AAN-8990-2021; Liu, Andrea/GYD-4759-2022; Li, Ju/A-2993-2008; Xu, Ye/E-7963-2011; Ma, Xiaoguang/ABI-4962-2020	FONTAINE, Julien/0000-0002-9064-4533; Jiang, Yijie/0000-0002-9347-3290; Ivancic, Robert Joseph/0000-0001-9969-2534; Liu, Andrea/0000-0002-2295-2729; Li, Ju/0000-0002-7841-8058; Xu, Ye/0000-0003-4322-244X; Davidson, Zoey/0000-0002-1528-2085; Ma, Xiao-guang/0000-0003-3220-0034; Gianola, Daniel/0000-0003-4660-0805; Lefever, Joel/0000-0003-3423-9661	NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) [DMR-1720530]; Rheology Optical and Electron Microscopy Shared Experimental Facilities; NSF [DMR-1107642, DMR-1305199, DMR-160738, DMREF-1628407, CMMI-1724519, INSPIRE/EAR-134428]; LRSM Research Experience for Undergraduates program; Simons Foundation [327939]; NASA [NNX0800G]; Agence Nationale de la Recherche through the Materials World Network program [ANR0110NS09-01]; American Chemical Society Petroleum Research Fund [ACS-PRF-53948-ND9]; Direct For Mathematical & Physical Scien [1305199] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES023720] Funding Source: NIH RePORTER	NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); Rheology Optical and Electron Microscopy Shared Experimental Facilities; NSF(National Science Foundation (NSF)); LRSM Research Experience for Undergraduates program; Simons Foundation; NASA(National Aeronautics & Space Administration (NASA)); Agence Nationale de la Recherche through the Materials World Network program(French National Research Agency (ANR)); American Chemical Society Petroleum Research Fund(American Chemical Society); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was primarily supported by NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) (DMR-1720530), including its Rheology Optical and Electron Microscopy Shared Experimental Facilities. We thank the Penn Nanoscale Characterization Facility and the Laboratory for Research on the Structure of Matter (LRSM) Computational Facility. Partial support is acknowledged from NSF grants DMR-1107642 (R.W.C.), DMR-1305199 (D.J.D.), DMR-160738 (A.G.Y.), DMREF-1628407 (Z.F.), CMMI-1724519 (D.S.G.), and INSPIRE/EAR-134428 (D.J.J.); the LRSM Research Experience for Undergraduates program (E.M.); Simons Foundation grant 327939 (A.J.L.); NASA grant NNX0800G (A.G.Y.); and Agence Nationale de la Recherche grant ANR0110NS09-01 through the Materials World Network program. N.C.K. and P.E.A. acknowledge the donors of the American Chemical Society Petroleum Research Fund (ACS-PRF-53948-ND9) for partial support. Z.F. acknowledges P. J. Walsh (Penn Chemistry) and students E. Salami-Ranjbaran and K. Cheng for tris(naphthyl)benzene (TNB) synthesis. The authors declare that they have no competing financial interests.	ARGON AS, 1979, MATER SCI ENG, V39, P101, DOI 10.1016/0025-5416(79)90174-5; Ashton DJ, 2009, EUR PHYS J E, V30, P303, DOI 10.1140/epje/i2009-10531-6; Bansal N. P., 1986, HDB GLASS PROPERTIES; Barthelat F, 2011, J MECH PHYS SOLIDS, V59, P829, DOI 10.1016/j.jmps.2011.01.001; Berthier L., 2011, DYNAMICAL HETEROGENE, V150; Brito C, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/L08003; Candelier R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135702; Chen MW, 2008, ANNU REV MATER RES, V38, P445, DOI 10.1146/annurev.matsci.38.060407.130226; Cheng YQ, 2008, ACTA MATER, V56, P5263, DOI 10.1016/j.actamat.2008.07.011; Cubuk ED, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.108001; Cubuk ED, 2016, J PHYS CHEM B, V120, P6139, DOI 10.1021/acs.jpcb.6b02144; Denisov DV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10641; DURIAN DJ, 1991, SCIENCE, V252, P686, DOI 10.1126/science.252.5006.686; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Gidaspow D., 1994, MULTIPLE FLOW FLUIDI, DOI [10.1177/1748895811401979, DOI 10.1177/1748895811401979]; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; Herrmann H., 1998, PHYS DRY GRANULAR ME; Herrmann J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805026; Hiemenz PC, 1986, PRINCIPLES COLLOID S, DOI 10.1201/9781315274287; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Johnson WL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.195501; KOB W, 1994, PHYS REV LETT, V73, P1376, DOI 10.1103/PhysRevLett.73.1376; KOZEY VV, 1994, J MATER RES, V9, P2717, DOI 10.1557/JMR.1994.2717; Nedderman R.M., 1992, STATICS KINEMATICS G; Nielson L. E., 1981, MECH PROPERTIES POLY, V2; Parmenter KE, 1998, J NON-CRYST SOLIDS, V223, P179, DOI 10.1016/S0022-3093(97)00430-4; Patinet S, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.045501; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Rottler J, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042304; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Schoenholz SS, 2016, NAT PHYS, V12, P469, DOI [10.1038/nphys3644, 10.1038/NPHYS3644]; Schoenholz SS, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031014; Schoenholz SS, 2017, P NATL ACAD SCI USA, V114, P263, DOI 10.1073/pnas.1610204114; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Shavit A, 2014, PHYS CHEM CHEM PHYS, V16, P10301, DOI 10.1039/c3cp55330b; Strickland DJ, 2014, P NATL ACAD SCI USA, V111, P18167, DOI 10.1073/pnas.1413900111; Sussman DM, 2017, P NATL ACAD SCI USA, V114, P10601, DOI 10.1073/pnas.1703927114; Tang C, 2015, J APPL PHYS, V118, DOI 10.1063/1.4929875; Trexler MM, 2010, PROG MATER SCI, V55, P759, DOI 10.1016/j.pmatsci.2010.04.002; Uhl JT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16493; VANBEEST BWH, 1990, PHYS REV LETT, V64, P1955, DOI 10.1103/PhysRevLett.64.1955; Zhang L, 2013, ACS NANO, V7, P8043, DOI 10.1021/nn403214p	44	153	156	13	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1033	1037		10.1126/science.aai8830	http://dx.doi.org/10.1126/science.aai8830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2FN	29170231	Green Accepted, Green Published			2022-12-28	WOS:000416590400035
J	Kushel, M				Kushel, Margot			Hepatitis A Outbreak in California - Addressing the Root Cause	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kushel, Margot] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Kushel, Margot] Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Kushel, Margot] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kushel, M (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.; Kushel, M (corresponding author), Zuckerberg San Francisco Gen Hosp, San Francisco, CA 94110 USA.; Kushel, M (corresponding author), Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.			Kushel, Margot/0000-0002-1361-6889				Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Brown RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155065; California Department of Public Health, 2017, HEP OUTBR CAL CDPH W; California Housing Partnership Corporation, 2016, CONFR CAL RENT POV C; Gubits D., 2015, FAMILY OPTIONS STUDY	5	22	22	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					211	213		10.1056/NEJMp1714134	http://dx.doi.org/10.1056/NEJMp1714134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29211622				2022-12-28	WOS:000422888400003
J	Kabeche, L; Nguyen, HD; Buisson, R; Zou, L				Kabeche, Lilian; Nguyen, Hai Dang; Buisson, Remi; Zou, Lee			A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation	SCIENCE			English	Article							REPLICATION STRESS; AURORA-B; CHECKPOINT; PHOSPHORYLATION; SITE; TRANSCRIPTION; INSTABILITY; GENOME; CHK1; RNA	The ataxia telangiectasia mutated and Rad3-related (ATR) kinase is crucial for DNA damage and replication stress responses. Here, we describe an unexpected role of ATR in mitosis. Acute inhibition or degradation of ATR in mitosis induces whole-chromosome missegregation. The effect of ATR ablation is not due to altered cyclin-dependent kinase 1 (CDK1) activity, DNA damage responses, or unscheduled DNA synthesis but to loss of an ATR function at centromeres. In mitosis, ATR localizes to centromeres through Aurora A-regulated association with centromere protein F (CENP-F), allowing ATR to engage replication protein A (RPA)-coated centromeric R loops. As ATR is activated at centromeres, it stimulates Aurora B through Chk1, preventing formation of lagging chromosomes. Thus, a mitosis-specific and R loop-driven ATR pathway acts at centromeres to promote faithful chromosome segregation, revealing functions of R loops and ATR in suppressing chromosome instability.	[Kabeche, Lilian; Nguyen, Hai Dang; Buisson, Remi; Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Charlestown, MA 02129 USA.; Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	zou.lee@mgh.harvard.edu	Buisson, Rémi/AAK-5208-2020	Buisson, Rémi/0000-0002-7196-8209; Kabeche, Lilian/0000-0001-9917-856X; Nguyen, Dang/0000-0002-4200-8778; Zou, Lee/0000-0003-3094-1058	NIH [5T32CA009216-35, T32DK007540, 1K99CA212154]; Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NIH grants [GM076388, CA197779]; NATIONAL CANCER INSTITUTE [R01CA197779, R00CA212154, K99CA212154, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr Massachusetts General Hospital Research Scholar Award; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Compton for H2B-GFP-expressing RPE1 cells, N. Lowndes for the ATR<SUP>-/-</SUP>, AID-ATR DT40 cell line expressing degron-ATR, S. Taylor for the CENP-F C630 expression plasmid, and N. Dyson and members of the Zou and Dyson laboratories for discussions. L.K., H.D.N., and R.B. are supported by NIH fellowships 5T32CA009216-35, T32DK007540, and 1K99CA212154, respectively. L.Z. is the James and Patricia Poitras Endowed Chair in Cancer Research and is supported by the Jim and Ann Orr Massachusetts General Hospital Research Scholar Award. This work is supported by NIH grants (GM076388 and CA197779) to L.Z.	Aze A, 2016, NAT CELL BIOL, V18, P684, DOI 10.1038/ncb3344; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Brown EJ, 2000, GENE DEV, V14, P397; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Eykelenboom JK, 2013, CELL REP, V5, P1095, DOI 10.1016/j.celrep.2013.10.027; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gent JI, 2012, ANNU REV GENET, V46, P443, DOI 10.1146/annurev-genet-110711-155419; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hussein D, 2002, J CELL SCI, V115, P3403; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu Y, 2014, CURR OPIN GENET DEV, V26, P1, DOI 10.1016/j.gde.2014.03.003; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yazinski SA, 2016, ANNU REV GENET, V50, P155, DOI 10.1146/annurev-genet-121415-121658; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	136	137	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2018	359	6371					108	113		10.1126/science.aan6490	http://dx.doi.org/10.1126/science.aan6490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR8KW	29170278	Green Accepted			2022-12-28	WOS:000419324700077
J	Winkler, PA; Huang, YH; Sun, WN; Du, J; Lu, W				Winkler, Paige A.; Huang, Yihe; Sun, Weinan; Du, Juan; Lu, Wei			Electron cryo-microscopy structure of a human TRPM4 channel	NATURE			English	Article							NONSELECTIVE CATION CHANNEL; CRYO-EM STRUCTURE; VANILLOID RECEPTOR-I; ACTIVATION; DOMAIN; EXPRESSION; REVEALS; GENE; DESENSITIZATION; CARDIOMYOCYTES	Ca2+-activated, non-selective (CAN) ion channels sense increases of the intracellular Ca2+ concentration, producing a flux of Na+ and/or K+ ions that depolarizes the cell, thus modulating cellular Ca2+ entry. CAN channels are involved in cellular responses such as neuronal bursting activity and cardiac rhythm. Here we report the electron cryo-microscopy structure of the most widespread CAN channel, human TRPM4, bound to the agonist Ca2+ and the modulator decavanadate. Four cytosolic C-terminal domains form an umbrella-like structure with a coiled-coil domain for the 'pole' and four helical 'ribs' spanning the N-terminal TRPM homology regions (MHRs), thus holding four subunits in a crown-like architecture. We observed two decavanadate-binding sites, one in the C-terminal domain and another in the intersubunit MHR interface. A glutamine in the selectivity filter may be an important determinant of monovalent selectivity. Our structure provides new insights into the function and pharmacology of both the CAN and the TRPM families.	[Winkler, Paige A.; Huang, Yihe; Du, Juan; Lu, Wei] Van Andel Inst, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA; [Sun, Weinan] Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA	Van Andel Institute	Lu, W (corresponding author), Van Andel Inst, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	wei.lu@vai.org		Sun, Weinan/0000-0002-6723-7964	VARI	VARI	Cryo-EM data was collected at the David Van Andel Advanced Cryo-Electron Microscopy Suite in the Van Andel Research Institute (VARI) and we are grateful to G. Zhao and X. Meng for technical support. We thank C. Xu for help with SerialEM, the HPC team at VARI for computational support and D. Nadziejka for proofreading. This work is supported by internal funding from VARI.	Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clemencon B, 2014, PROTEIN EXPRES PURIF, V95, P169, DOI 10.1016/j.pep.2013.11.017; Constantine M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19352; Csanady L, 2004, J GEN PHYSIOL, V123, P743, DOI 10.1085/jgp.200309008; DeLano W.L, PYMOL MOL GRAPHICS S; Demion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115256; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Gregorio-Teruel L, 2015, BIOPHYS J, V109, P529, DOI 10.1016/j.bpj.2015.06.039; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Guinamard R, 2004, J CARDIOVASC ELECTR, V15, P342, DOI 10.1046/j.1540-8167.2004.03477.x; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Hof T, 2016, J PHYSIOL-LONDON, V594, P295, DOI 10.1113/JP271347; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Kraft R, 2005, PFLUG ARCH EUR J PHY, V451, P204, DOI 10.1007/s00424-005-1428-0; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2004, J PHYSIOL-LONDON, V560, P753, DOI 10.1113/jphysiol.2004.070839; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Singharoy A, 2016, ELIFE, V5, DOI 10.7554/eLife.16105; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; VARGA S, 1985, EUR J BIOCHEM, V148, P119, DOI 10.1111/j.1432-1033.1985.tb08815.x; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zheng S., 2016, BIORXIV, DOI http://dx.doi.org/10.1101/061960	59	101	104	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					200	+		10.1038/nature24674	http://dx.doi.org/10.1038/nature24674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211723				2022-12-28	WOS:000418029500036
J	Ting, DSW; Cheung, CYL; Lim, G; Tan, GSW; Quang, ND; Gan, A; Hamzah, H; Garcia-Franco, R; Yeo, IYS; Lee, SY; Wong, EYM; Sabanayagam, C; Baskaran, M; Ibrahim, F; Tan, NC; Finkelstein, EA; Lamoureux, EL; Wong, IY; Bressler, NM; Sivaprasad, S; Varma, R; Jonas, JB; He, MG; Cheng, CY; Cheung, GCM; Aung, T; Hsu, W; Lee, ML; Wong, TY				Ting, Daniel Shu Wei; Cheung, Carol Yim-Lui; Lim, Gilbert; Tan, Gavin Siew Wei; Quang, Nguyen D.; Gan, Alfred; Hamzah, Haslina; Garcia-Franco, Renata; Yeo, Ian Yew San; Lee, Shu Yen; Wong, Edmund Yick Mun; Sabanayagam, Charumathi; Baskaran, Mani; Ibrahim, Farah; Tan, Ngiap Chuan; Finkelstein, Eric A.; Lamoureux, Ecosse L.; Wong, Ian Y.; Bressler, Neil M.; Sivaprasad, Sobha; Varma, Rohit; Jonas, Jost B.; He, Ming Guang; Cheng, Ching-Yu; Cheung, Gemmy Chui Ming; Aung, Tin; Hsu, Wynne; Lee, Mong Li; Wong, Tien Yin			Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAJOR RISK-FACTORS; MACULAR DEGENERATION; SINGAPORE EPIDEMIOLOGY; AUTOMATED DETECTION; GLOBAL PREVALENCE; TELEMEDICINE; CHALLENGES; MANAGEMENT; BARRIERS; COHORT	IMPORTANCE A deep learning system (DLS) is a machine learning technology with potential for screening diabetic retinopathy and related eye diseases. OBJECTIVE To evaluate the performance of a DLS in detecting referable diabetic retinopathy, vision-threatening diabetic retinopathy, possible glaucoma, and age-related macular degeneration (AMD) in community and clinic-based multiethnic populations with diabetes. DESIGN, SETTING, AND PARTICIPANTS Diagnostic performance of a DLS for diabetic retinopathy and related eye diseases was evaluated using 494 661 retinal images. A DLS was trained for detecting diabetic retinopathy (using 76 370 images), possible glaucoma (125 189 images), and AMD(72 610 images), and performance of DLS was evaluated for detecting diabetic retinopathy (using 112 648 images), possible glaucoma (71 896 images), and AMD(35 948 images). Training of the DLS was completed in May 2016, and validation of the DLS was completed in May 2017 for detection of referable diabetic retinopathy (moderate nonproliferative diabetic retinopathy or worse) and vision-threatening diabetic retinopathy (severe nonproliferative diabetic retinopathy orworse) using a primary validation data set in the Singapore National Diabetic Retinopathy Screening Program and 10 multiethnic cohorts with diabetes. EXPOSURES Use of a deep learning system. MAIN OUTCOMES AND MEASURES Area under the receiver operating characteristic curve (AUC) and sensitivity and specificity of the DLS with professional graders (retinal specialists, general ophthalmologists, trained graders, or optometrists) as the reference standard. RESULTS In the primary validation dataset (n = 14 880 patients; 71 896 images; mean [SD] age, 60.2 [2.2] years; 54.6% men), the prevalence of referable diabetic retinopathy was 3.0%; vision-threatening diabetic retinopathy, 0.6%; possible glaucoma, 0.1%; and AMD, 2.5%. The AUC of the DLS for referable diabetic retinopathy was 0.936 (95% CI, 0.925-0.943), sensitivity was 90.5%(95% CI, 87.3%-93.0%), and specificity was 91.6% (95% CI, 91.0%-92.2%). For vision-threatening diabetic retinopathy, AUC was 0.958 (95% CI, 0.956-0.961), sensitivity was 100% (95% CI, 94.1%-100.0%), and specificity was 91.1% (95% CI, 90.7%-91.4%). For possible glaucoma, AUC was 0.942 (95% CI, 0.929-0.954), sensitivity was 96.4%(95% CI, 81.7%-99.9%), and specificity was 87.2%(95% CI, 86.8%-87.5%). For AMD, AUC was 0.931 (95% CI, 0.928-0.935), sensitivity was 93.2%(95% CI, 91.1%-99.8%), and specificity was 88.7%(95% CI, 88.3%-89.0%). For referable diabetic retinopathy in the 10 additional datasets, AUC range was 0.889 to 0.983 (n = 40 752 images). CONCLUSIONS AND RELEVANCE In this evaluation of retinal images from multiethnic cohorts of patients with diabetes, the DLS had high sensitivity and specificity for identifying diabetic retinopathy and related eye diseases. Further research is necessary to evaluate the applicability of the DLS in health care settings and the utility of the DLS to improve vision outcomes.	[Ting, Daniel Shu Wei; Cheung, Carol Yim-Lui; Tan, Gavin Siew Wei; Quang, Nguyen D.; Gan, Alfred; Hamzah, Haslina; Yeo, Ian Yew San; Lee, Shu Yen; Wong, Edmund Yick Mun; Sabanayagam, Charumathi; Baskaran, Mani; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Cheung, Gemmy Chui Ming; Aung, Tin; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ting, Daniel Shu Wei; Tan, Gavin Siew Wei; Yeo, Ian Yew San; Lee, Shu Yen; Wong, Edmund Yick Mun; Sabanayagam, Charumathi; Baskaran, Mani; Ibrahim, Farah; Tan, Ngiap Chuan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Cheung, Gemmy Chui Ming; Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore; [Cheung, Carol Yim-Lui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Lim, Gilbert; Hsu, Wynne; Lee, Mong Li] Natl Univ Singapore, Sch Comp, Singapore, Singapore; [Garcia-Franco, Renata] IAP, Inst Mexicano Oftalmol, Queretaro, Mexico; [Tan, Ngiap Chuan] Singapore Hlth Serv, SingHlth Polyclin, Singapore, Singapore; [Finkelstein, Eric A.] Duke NUS Grad Med Sch, Lien Ctr Palliat Care, Hlth Serv & Syst Res Program, Singapore, Singapore; [Wong, Ian Y.] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [Bressler, Neil M.] Johns Hopkins Wilmer Eye Inst, Baltimore, MD USA; [Sivaprasad, Sobha] Natl Hlth Serv Fdn Trust, Moorfields Eye Hosp, London, England; [Varma, Rohit] Univ Southern Calif, Gayle & Edward Roski Eye Inst, Los Angeles, CA USA; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [He, Ming Guang] Sun Yatsen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China	National University of Singapore; Singapore National Eye Center; National University of Singapore; Chinese University of Hong Kong; National University of Singapore; National University of Singapore; University of Hong Kong; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Southern California; Ruprecht Karls University Heidelberg; Sun Yat Sen University	Wong, TY (corresponding author), Singapore Natl Eye Ctr, 11 Third Hosp Ave, Singapore 168751, Singapore.	wong.tien.yin@snec.com.sg	Wong, Tien Yin/AAC-9724-2020; Cheung, Carol Y./G-7895-2016; Mani, Baskaran/GWZ-8299-2022; Cheng, Ching-Yu/Y-2229-2019; Lamoureux, Ecosse/Z-5482-2019; Sivaprasad, S./D-6876-2015; He, Mingguang/AAY-5239-2020; Sabanayagam, Charumathi/C-1294-2011; Nguyen, Duc Quang/AHC-6430-2022; Cheung, Carol/AAF-1101-2020; Lim, Gilbert/N-7322-2017	Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Sivaprasad, S./0000-0001-8952-0659; He, Mingguang/0000-0002-6912-2810; Sabanayagam, Charumathi/0000-0002-4042-4719; Nguyen, Duc Quang/0000-0001-6919-5211; Cheung, Carol/0000-0002-9672-1819; Lim, Gilbert/0000-0002-5381-9250; Tan, Ngiap-Chuan/0000-0002-5946-1149; Bidwai, Pooja Vishal/0000-0002-3077-4395; Hsu, Wynne/0000-0002-4142-8893; Cheung, Chui Ming Gemmy/0000-0003-3358-3516; Lee, Mong Li/0000-0002-9636-388X	Singapore National Health Innovation Center (NHIC) [NHIC-I2D-1409022]; SingHealth Foundation Research Grant [SHF/FG648S/2015]; Tanoto Foundation; NMRC, MOH [0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008, STaR/2013, CG/SERI/2010]; Biomedical Research Council [08/1/35/19/550, 09/1/35/19/616]; MOH, Singapore [AIC/RPDD/SIDRP/SERI/FY2013/0018, AIC/HPD/FY2016/0912]; National Medical Research Council (NMRC), Ministry of Health (MOH)	Singapore National Health Innovation Center (NHIC); SingHealth Foundation Research Grant(SingHealth); Tanoto Foundation; NMRC, MOH; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); MOH, Singapore(Ministry of Health-Singapore); National Medical Research Council (NMRC), Ministry of Health (MOH)(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This project received funding from National Medical Research Council (NMRC), Ministry of Health (MOH), Singapore National Health Innovation Center (NHIC), Innovation to Develop Grant (NHIC-I2D-1409022); SingHealth Foundation Research Grant (SHF/FG648S/2015), and the Tanoto Foundation; unrestricted donations to the Retina Division, Johns Hopkins University School of Medicine. For the Singapore Epidemiology of Eye Diseases (SEED) study, we received funding from NMRC, MOH (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and STaR/2013; CG/SERI/2010) and Biomedical Research Council (grants 08/1/35/19/550 and 09/1/35/19/616). The Singapore Diabetic Retinopathy Program received funding from the MOH, Singapore (grants AIC/RPDD/SIDRP/SERI/FY2013/0018 and AIC/HPD/FY2016/0912).	Abramoff MD, 2010, OPHTHALMOLOGY, V117, P1147, DOI 10.1016/j.ophtha.2010.03.046; Abramoff MD, 2010, EXPERT REV MED DEVIC, V7, P287, DOI 10.1586/ERD.09.76; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Bhargava M, 2012, SINGAP MED J, V53, P715; Burgess PI, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-157; Chakrabarti R, 2012, EXPERT REV OPHTHALMO, V7, P417, DOI 10.1586/EOP.12.52; Cheung CMG, 2012, CLIN EXP OPHTHALMOL, V40, P727, DOI 10.1111/j.1442-9071.2012.02765.x; Cheung CMG, 2014, OPHTHALMOLOGY, V121, P1598, DOI 10.1016/j.ophtha.2014.02.004; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chew EY, 2015, OPHTHALMOLOGY, V122, P2155, DOI 10.1016/j.ophtha.2015.08.007; Chong YH, 2017, OPHTHALMOLOGY, V124, P336, DOI 10.1016/j.ophtha.2016.11.016; Chua J, 2015, JAMA OPHTHALMOL, V133, P938, DOI 10.1001/jamaophthalmol.2015.1478; Frcophth AT, 2017, OPHTHALMOLOGY, V124, P343, DOI 10.1016/j.ophtha.2016.11.014; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hazin R, 2011, AM J OPHTHALMOL, V152, P723, DOI 10.1016/j.ajo.2011.06.022; Huang OS, 2015, BRIT J OPHTHALMOL, V99, P1614, DOI 10.1136/bjophthalmol-2014-306492; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Klein R, 1991, OPHTHALMOLOGY, V98, P1134; Lamoureux EL, 2012, CLIN EXP OPHTHALMOL, V40, P73, DOI 10.1111/j.1442-9071.2011.02697.x; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lim G, 2014, MAIHA WORKSH 28 AAAI, P34; National Health Service (NHS) Diabetic Eye Screening Programme and Population Screening Programmes, 2015, DIAB EYE SCREEN COMM; Nguyen HV, 2016, OPHTHALMOLOGY, V123, P2571, DOI 10.1016/j.ophtha.2016.08.021; Ren SQ, 2010, J APPL STAT, V37, P1487, DOI 10.1080/02664760903046102; Shi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175966; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Tang FY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02767-0; Ting DSW, 2011, CLIN EXP OPHTHALMOL, V39, P230, DOI 10.1111/j.1442-9071.2010.02446.x; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Ting DSW, 2017, JAMA OPHTHALMOL, V135, P722, DOI 10.1001/jamaophthalmol.2017.1257; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; Ting DSW, 2016, AM J OPHTHALMOL, V164, P128, DOI 10.1016/j.ajo.2015.12.024; Varma R., 2017, AFRICAN AM EYE DIS S; Wang LZZ, 2017, BRIT J OPHTHALMOL, V101, P1352, DOI 10.1136/bjophthalmol-2016-310002; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2016, JAMA-J AM MED ASSOC, V316, P2366, DOI 10.1001/jama.2016.17563; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	40	884	927	46	276	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2017	318	22					2211	2223		10.1001/jama.2017.18152	http://dx.doi.org/10.1001/jama.2017.18152			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP7NR	29234807	Green Published, Bronze			2022-12-28	WOS:000417822700019
J	McMinn, D; Fergusson, SJ; Daly, M				McMinn, D.; Fergusson, S. J.; Daly, M.			Does pride really come before a fall? Longitudinal analysis of older English adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; AGED 65; STRATEGIES; COMMUNITY; PROFILE; BALANCE; FEAR	OBJECTIVE To test whether high levels of reported pride are associated with subsequent falls. DESIGN Secondary analysis of the English Longitudinal Study of Ageing (ELSA) dataset. SETTING Multi-wave longitudinal sample of non-institutionalised older English adults. PARTICIPANTS ELSA cohort of 6415 participants at wave 5 (baseline, 2010/11), of whom 4964 were available for follow-up at wave 7 (follow-up, 2014/15). MAIN OUTCOME MEASURES Self reported pride at baseline (low/moderate/high) and whether the participant had reported having fallen during the two years before follow-up. RESULTS The findings did not support the contention that "pride comes before a fall." Unadjusted estimates indicate that the odds of reported falls were significantly lower for people with high pride levels compared with those who had low pride (odds ratio 0.69, 95% confidence interval 0.58 to 0.81, P<0.001). This association remained after adjustment for age, sex, household wealth, and history of falls (odds ratio 0.81, 0.68 to 0.97, P<0.05). It was partially attenuated after further adjustment for mobility problems, eyesight problems, the presence of a limiting long term illness, a diagnosis of arthritis or osteoporosis, medication use, cognitive function, and pain and depression (odds ratio 0.86, 0.72 to 1.03, P<0.1). Because the confidence interval exceeded 1 in the final model, it remains possible that pride may not be an independent predictor of falls when known risk factors are considered. People with moderate pride did not have lower odds of having fallen than those with low pride in adjusted models. Participants lost to follow-up did not differ from those retained in terms of key variables, and weighting the analyses to account for selective attrition did not produce different results. CONCLUSIONS Contrary to the well known saying " pride comes before a fall," these findings suggest that pride may actually be a protective factor against falling in older adults. Future studies may seek to investigate the mechanisms underpinning this relation.	[McMinn, D.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB25 2ZD, Scotland; [Fergusson, S. J.] Royal Alexandra Hosp, Paisley PA2 9PN, Renfrew, Scotland; [Daly, M.] Univ Stirling, Dept Management Work & Org, Stirling, Scotland	University of Aberdeen; University of Stirling	Daly, M (corresponding author), Univ Stirling, Dept Management Work & Org, Stirling, Scotland.	michael.daly@stir.ac.uk	Daly, Michael/AAD-7703-2019	Daly, Michael/0000-0003-1557-8326				Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Davis JC, 2010, OSTEOPOROSIS INT, V21, P1295, DOI 10.1007/s00198-009-1162-0; Delbaere Kim, 2010, BMJ, V341, pc4165, DOI 10.1136/bmj.; Fortinsky RH, 2009, HEALTH RISK SOC, V11, P341, DOI 10.1080/13698570903015735; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Gale CR, 2016, AGE AGEING, V45, P789, DOI 10.1093/ageing/afw129; Hadjistavropoulos T, 2011, J AGING HEALTH, V23, P3, DOI 10.1177/0898264310378039; Hawk Cheryl, 2006, Chiropr Osteopat, V14, P3, DOI 10.1186/1746-1340-14-3; Karlsson MK, 2013, OSTEOPOROSIS INT, V24, P747, DOI 10.1007/s00198-012-2256-7; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; NICE,, 2013, FALLS OLD PEOPL ASS; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Sekaran NK, 2013, J AM GERIATR SOC, V61, P96, DOI 10.1111/jgs.12071; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Visschedijk JHM, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0158-1; Wang YC, 2012, AGING MENT HEALTH, V16, P763, DOI 10.1080/13607863.2012.678479	20	1	1	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2017	359								j5451	10.1136/bmj.j5451	http://dx.doi.org/10.1136/bmj.j5451			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ4KT	29229614	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000418327000005
J	Horton, R				Horton, Richard			Offline: The tasks facing Dr Tedros	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2538	2538		10.1016/S0140-6736(17)33137-9	http://dx.doi.org/10.1016/S0140-6736(17)33137-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	29231826	Bronze			2022-12-28	WOS:000417493300010
J	Malakoff, D				Malakoff, David			US POLICY Science groups urge changes as Congress nears final tax bill	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1239	1239		10.1126/science.358.6368.1239	http://dx.doi.org/10.1126/science.358.6368.1239			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217552				2022-12-28	WOS:000417254700016
J	Williams, TM; Blackwell, SB; Richter, B; Sinding, MHS; Heide-Jorgensen, MP				Williams, Terrie M.; Blackwell, Susanna B.; Richter, Beau; Sinding, Mikkel-Holger S.; Heide-Jorgensen, Mads Peter			Paradoxical escape responses by narwhals (Monodon monoceros)	SCIENCE			English	Article							FEAR BRADYCARDIA; EXERCISE; COST	Until recent declines in Arctic sea ice levels, narwhals (Monodon monoceros) have lived in relative isolation from human perturbation and sustained predation pressures. The resulting naivety has made this cryptic, deep-diving cetacean highly susceptible to disturbance, although quantifiable effects have been lacking. We deployed a submersible, animal-borne electrocardiograph-accelerometer-depth recorder to monitor physiological and behavioral responses of East Greenland narwhals after release from net entanglement and stranding. Escaping narwhals displayed a paradoxical cardiovascular down-regulation (extreme bradycardia with heart rate <= 4 beats per minute) superimposed on exercise up-regulation (stroke frequency >25 strokes per minute and energetic costs three to six times the resting rate of energy expenditure) that rapidly depleted onboard oxygen stores. We attribute this unusual reaction to opposing cardiovascular signals-from diving, exercise, and neurocognitive fear responses-that challenge physiological homeostasis.	[Williams, Terrie M.; Richter, Beau] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Coastal Biol Bldg,130 McAllister Way, Santa Cruz, CA 95060 USA; [Blackwell, Susanna B.] Greeneridge Sci, 90 Arnold Pl,Suite D, Santa Barbara, CA 93117 USA; [Sinding, Mikkel-Holger S.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Sinding, Mikkel-Holger S.; Heide-Jorgensen, Mads Peter] Greenland Representat, Greenland Inst Nat Resources, Strandgade 91,2, DK-1401 Copenhagen K, Denmark	University of California System; University of California Santa Cruz; University of Copenhagen; Greenland Institute of Natural Resources	Williams, TM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Coastal Biol Bldg,130 McAllister Way, Santa Cruz, CA 95060 USA.	williams@biology.ucsc.edu	; Heide-Jorgensen, Mads Peter/F-6464-2011; Strander Sinding, Mikkel Holger/B-9450-2015	Blackwell, Susanna B./0000-0001-7158-6852; Williams, Terrie/0000-0001-8170-009X; Heide-Jorgensen, Mads Peter/0000-0003-4846-7622; Strander Sinding, Mikkel Holger/0000-0003-1371-219X	Office of Naval Research [N00014-13-1-0808, N00014-17-1-2737]; NSF Instrument Development for Biological Research program [DBI-1255913]; Greenland Institute of Natural Resources; Greenland Ministry of Education, Church, Culture and Gender Equality; Danish Cooperation for the Environment in the Arctic; Carlsberg Foundation; Mineral License and Safety Authority and Environmental Agency for Mineral Resource Activities of Greenland	Office of Naval Research(Office of Naval Research); NSF Instrument Development for Biological Research program; Greenland Institute of Natural Resources; Greenland Ministry of Education, Church, Culture and Gender Equality; Danish Cooperation for the Environment in the Arctic; Carlsberg Foundation(Carlsberg Foundation); Mineral License and Safety Authority and Environmental Agency for Mineral Resource Activities of Greenland	We thank T. Kendall, W. Hagey, R. Gray, J. Olson, and the hunters from Ittoqqortoormiit, Greenland, for field assistance; S. Hammeken, G. Pike, S. Heide-Jorgensen, and H. C. Schmidt for assistance with release operations; M. Edwards for statistical advice; and R. G. Hansen for the map illustration. T. M. W. received funding from the Office of Naval Research (grants N00014-13-1-0808 and N00014-17-1-2737) and the NSF Instrument Development for Biological Research program (grant DBI-1255913). M.P.H.-J. was supported by the Greenland Institute of Natural Resources; the Greenland Ministry of Education, Church, Culture and Gender Equality; the Danish Cooperation for the Environment in the Arctic; the Carlsberg Foundation; and the Mineral License and Safety Authority and Environmental Agency for Mineral Resource Activities of Greenland. The data reported in this paper are tabulated in the supplementary materials and archived in the UCSC Marine Mammal Physiology Project database (available through the corresponding author). We declare no competing financial interests. Data are available on DRYAD (DOI: 10.5061/dryad.4vn11).	Alboni P, 2011, J CARDIOVASC MED, V12, P422, DOI 10.2459/JCM.0b013e328344bcdc; Breed GA, 2017, P NATL ACAD SCI USA, V114, P2628, DOI 10.1073/pnas.1611707114; CAUSBY LA, 1981, COMP BIOCHEM PHYS C, V69, P367, DOI 10.1016/0306-4492(81)90151-9; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; Davis RW, 2012, J COMP PHYSIOL A, V198, P583, DOI 10.1007/s00359-012-0731-4; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Elmegaard SL, 2016, CURR BIOL, V26, pR1175, DOI 10.1016/j.cub.2016.10.020; Ferguson SH, 2010, LITTLE LESS ARCTIC: TOP PREDATORS IN THE WORLDS LARGEST NORTHERN INLAND SEA, HUDSON BAY, P117, DOI 10.1007/978-90-481-9121-5_6; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Gabrielsen Geir Wing, 1995, P95; Hagenaars MA, 2014, NEUROSCI BIOBEHAV R, V47, P165, DOI 10.1016/j.neubiorev.2014.07.021; Heide-Jorgensen MP, 2015, J ZOOL, V297, P54, DOI 10.1111/jzo.12257; Heide-Jorgensen MP, 2013, BIOL CONSERV, V158, P50, DOI 10.1016/j.biocon.2012.08.005; JACOBSEN NK, 1979, J MAMMAL, V60, P343, DOI 10.2307/1379806; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; Kooyman G. L., 1989, DIVERSE DIVERS; Laidre KL, 2006, CAN FIELD NAT, V120, P457, DOI 10.22621/cfn.v120i4.355; MACARTHUR RA, 1989, CAN J ZOOL, V67, P1783, DOI 10.1139/z89-255; McDonald BI, 2014, J EXP BIOL, V217, P1525, DOI 10.1242/jeb.098558; MURDAUGH HV, 1961, CIRC RES, V9, P358, DOI 10.1161/01.RES.9.2.358; Nielsen MR, 2009, POLAR RES, V28, P238, DOI 10.1111/j.1751-8369.2009.00106.x; Ponganis P. J., 2003, BENNETT ELLIOTTS PHY, P211; Reeves RR, 2014, MAR POLICY, V44, P375, DOI 10.1016/j.marpol.2013.10.005; RIDGWAY SH, 1975, NATURE, V256, P37, DOI 10.1038/256037a0; Scholander P. F., 1940, Hvalradets Skrifter, Vno. 22, P1; SMITH EN, 1980, J MAMMAL, V61, P750, DOI 10.2307/1380333; Williams T. M., 2011, MAR MAMMAL SCI, V12, P422; Williams TM, 2008, P R SOC B, V275, P751, DOI 10.1098/rspb.2007.1484; Williams TM, 2017, J EXP BIOL, V220, P1135, DOI 10.1242/jeb.154245; Williams TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7055; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822	32	50	51	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1329	+		10.1126/science.aao2740	http://dx.doi.org/10.1126/science.aao2740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217577				2022-12-28	WOS:000417254700064
J	Dobson, J				Dobson, Juliet			CHRISTMAS 2017: NATURAL PHENOMENA Hospital gardens are making a comeback	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jdobson@bmj.com						Buck D., 2016, GARDENS HLTH IMPLICA; Hickman C, 2013, THERAPEUTIC LANDSCAP; NAYLOR R, 2017, BMJ, V358	3	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2017	359								j5627	10.1136/bmj.j5627	http://dx.doi.org/10.1136/bmj.j5627			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP4AW	29217512				2022-12-28	WOS:000417560100010
J	Rosenbaum, JDS				Rosenbaum, Sara J. D.			Medicaid Coverage for Family Planning - Can the Courts Stop the States from Excluding Planned Parenthood?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara J. D.] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA	George Washington University	Rosenbaum, JDS (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.								0	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2205	2207		10.1056/NEJMp1711490	http://dx.doi.org/10.1056/NEJMp1711490			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO9IL	29211677				2022-12-28	WOS:000417201100001
J	Stevens, DL; Bryant, AE				Stevens, Dennis L.; Bryant, Amy E.			Necrotizing Soft-Tissue Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LABORATORY RISK INDICATOR; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A STREPTOCOCCAL INFECTIONS; TOXIC-SHOCK-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN THERAPY; HYPERBARIC-OXYGEN THERAPY; PRESSURE WOUND THERAPY; FASCIITIS LRINEC SCORE; STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTIONS		Vet Affairs Med Ctr, Boise, ID USA; Univ Washington, Sch Med, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle	Bryant, AE (corresponding author), Vet Affairs Med Ctr, Infect Dis Sect, 500 W Ft St,Mail Stop 151, Boise, ID 83702 USA.	amy.bryant@va.gov			Motif Biosciences; Merck	Motif Biosciences; Merck(Merck & Company)	Dr. Stevens reports receiving grant support from Motif Biosciences; and Dr. Bryant, receiving grant support from Merck. No other potential conflict of interest relevant to this article was reported.	ADAMS EM, 1985, ARCH INTERN MED, V145, P1020, DOI 10.1001/archinte.145.6.1020; Al Alayed K, 2015, INT J INFECT DIS, V36, P15, DOI 10.1016/j.ijid.2015.04.021; Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Anaya DA, 2007, CLIN INFECT DIS, V44, P705, DOI 10.1086/511638; [Anonymous], 2014, CURR PROB SURG, V51, P344, DOI 10.1067/j.cpsurg.2014.06.001; [Anonymous], 2015, MANDELL DOUGLAS BENN; [Anonymous], 1997, MMWR-MORBID MORTAL W, V46, P944; Arif N, 2016, EPIDEMIOL INFECT, V144, P1338, DOI 10.1017/S0950268815002745; Aronoff DM, 2003, MEDICINE, V82, P225, DOI 10.1097/00005792-200307000-00001; Baharestani MM, 2008, OSTOMY WOUND MANAG, V54, P44; Bandyopadhyay Debabrata, 2016, J Emerg Trauma Shock, V9, P1, DOI 10.4103/0974-2700.173862; Bechar J, 2017, ANN ROY COLL SURG, V99, P341, DOI 10.1308/rcsann.2017.0053; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bocking N, 2016, OPEN FORUM INFECT DI, V4, P243; BODEY GP, 1991, CANCER, V67, P1928, DOI 10.1002/1097-0142(19910401)67:7<1928::AID-CNCR2820670718>3.0.CO;2-9; BROGAN TV, 1995, PEDIATR INFECT DIS J, V14, P588, DOI 10.1097/00006454-199507000-00007; Bryant AE, 2016, 2016 IDWEEK; Bucca K, 2013, ANZ J SURG, V83, P365, DOI 10.1111/j.1445-2197.2012.06251.x; Bulger EM, 2014, JAMA SURG, V149, P528, DOI 10.1001/jamasurg.2013.4841; Burner E, 2016, WEST J EMERG MED, V17, P333, DOI 10.5811/westjem.2016.2.29069; Carbonetti F, 2016, RADIOL MED, V121, P106, DOI 10.1007/s11547-015-0575-4; CHELSOM J, 1994, LANCET, V344, P1111, DOI 10.1016/S0140-6736(94)90629-7; Cheng NC, 2011, ANN PLAS SURG, V67, P632, DOI 10.1097/SAP.0b013e31820b372b; Crew JR, 2013, WOUNDS, V25, P272; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Das DK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-348; DeMuri GP, 2017, PEDIATR INFECT DIS J, V36, P342, DOI 10.1097/INF.0000000000001442; Devaney B, 2015, ANAESTH INTENS CARE, V43, P685, DOI 10.1177/0310057X1504300604; Dubos F, 2008, ACTA DERM-VENEREOL, V88, P26, DOI 10.2340/00015555-0333; Fleming A, 1915, LANCET, V2, P638; FREISCHLAG JA, 1985, AM J SURG, V149, P751, DOI 10.1016/S0002-9610(85)80180-X; Glass GE, 2015, ANN ROY COLL SURG, V97, P46, DOI 10.1308/003588414X14055925058553; Hadeed George J, 2016, J Emerg Trauma Shock, V9, P22, DOI 10.4103/0974-2700.173868; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Hamilton SM, 2014, J INFECT DIS, V209, P1429, DOI 10.1093/infdis/jit594; Hamilton SM, 2013, CLIN INFECT DIS, V57, P870, DOI 10.1093/cid/cit282; Hansen MB, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006995; Hawser S, 2015, J CHEMOTHERAPY, V27, P67, DOI 10.1179/1973947814Y.0000000164; Holland MJ, 2009, ANAESTH INTENS CARE, V37, P588, DOI 10.1177/0310057X0903700416; Jabbour G, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0097-y; Jallali N, 2005, AM J SURG, V189, P462, DOI 10.1016/j.amjsurg.2005.01.012; Kadri SS, 2017, CLIN INFECT DIS, V64, P877, DOI 10.1093/cid/ciw871; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Khamnuan P, 2015, INT J GEN MED, V8, P195, DOI 10.2147/IJGM.S82999; Krapp F, 2017, INT J ANTIMICROB AG, V49, P770, DOI 10.1016/j.ijantimicag.2017.01.018; Kulasegaran S, 2016, ANZ J SURG, V86, P826, DOI 10.1111/ans.13232; Lamagni TL, 2008, EMERG INFECT DIS, V14, P202, DOI 10.3201/eid1402.070888; Laupland KB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e60; Lee CY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-5; Lee JY, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-29; Lepoutre A, 2011, J CLIN MICROBIOL, V49, P4094, DOI 10.1128/JCM.00070-11; Leroy S, 2010, CLIN DRUG INVEST, V30, P179, DOI 10.2165/11532890-000000000-00000; Lesko SM, 2003, INT J CLIN PRACT, P50; Lewis JS, 2014, ANTIMICROB AGENTS CH, V58, P1327, DOI 10.1128/AAC.01877-13; Linner A, 2014, CLIN INFECT DIS, V59, P851, DOI 10.1093/cid/ciu449; Luckett WH, 1909, ANN SURG, V50, P605, DOI 10.1097/00000658-190909000-00007; MACLENNAN JD, 1962, BACTERIOL REV, V26, P177, DOI 10.1128/MMBR.26.2_Pt_1-2.177-274.1962; Majeski J, 1997, SOUTHERN MED J, V90, P1065, DOI 10.1097/00007611-199711000-00001; MCHENRY CR, 1995, ANN SURG, V221, P558, DOI 10.1097/00000658-199505000-00013; Meleny FK, 1924, ARCH SURG-CHICAGO, V9, P317, DOI 10.1001/archsurg.1924.01120080083007; Mikaeloff Y, 2008, BRIT J CLIN PHARMACO, V65, P203, DOI 10.1111/j.1365-2125.2007.02997.x; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Naseer U, 2016, EUR J CLIN MICROBIOL, V35, P1639, DOI 10.1007/s10096-016-2704-y; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; Nordqvist G, 2015, INFECT DIS-NOR, V47, P319, DOI 10.3109/00365548.2014.993420; Nuwayhid ZB, 2007, ANN EPIDEMIOL, V17, P878, DOI 10.1016/j.annepidem.2007.05.011; Peng Xiao-min, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P1040; Plum F., 1996, CECIL TXB MED, P2090; Putnam LR, 2016, J PEDIATR SURG, V51, P1022, DOI 10.1016/j.jpedsurg.2016.02.076; Qvist G, 1941, BMJ-BRIT MED J, V1941, P217, DOI 10.1136/bmj.2.4206.217; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Satlin MJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02349-16; Schurr M, 1998, AM J SURG, V175, P213, DOI 10.1016/S0002-9610(97)00297-3; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; Shaw JJ, 2014, SURG INFECT, V15, P328, DOI 10.1089/sur.2012.135; Sims SA, 2016, STREPTOCOCCUS PYOGEN, P19785; STAMENKOVIC I, 1984, NEW ENGL J MED, V310, P1689, DOI 10.1056/NEJM198406283102601; STEVENS D L, 1990, Reviews of Infectious Diseases, V12, P286; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; STEVENS DL, 1987, J INFECT DIS, V155, P220, DOI 10.1093/infdis/155.2.220; STEVENS DL, 1988, WESTERN J MED, V148, P204; STEVENS DL, 1993, CLIN INFECT DIS, V17, P231, DOI 10.1093/clinids/17.2.231; STEVENS DL, 1995, CLIN INFECT DIS, V21, P977, DOI 10.1093/clinids/21.4.977; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Stevens DL, 2008, P 17 LANC INT S STRE; Stewart JC, 1905, J AMER MED ASSOC, V45, P528; Suzuki Kiyozumi, 2016, Nihon Naika Gakkai Zasshi, V105, P99; Tawa A, 2016, CASE REP CRIT CARE, V2016; Tsai YH, 2015, MED PRIN PRACT, V24, P416, DOI 10.1159/000431094; van Stigt SFL, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0080-7; Wall DB, 2000, J AM COLL SURGEONS, V191, P227, DOI 10.1016/S1072-7515(00)00318-5; Wang CC, 2003, ARCH SURG-CHICAGO, V138, P272, DOI 10.1001/archsurg.138.3.272; Weng TC, 2011, J MICROBIOL IMMUNOL, V44, P418, DOI 10.1016/j.jmii.2011.04.012; Willy C, 2012, CHIRURG, V83, P960, DOI 10.1007/s00104-012-2284-z; Wong CH, 2004, CRIT CARE MED, V32, P1535, DOI 10.1097/01.CCM.0000129486.35458.7D; Wong CH, 2003, J BONE JOINT SURG AM, V85A, P1454, DOI 10.2106/00004623-200308000-00005; Wong CJ, 2013, MED CLIN N AM, V97, P721, DOI 10.1016/j.mcna.2013.03.003; Yahav D, 2014, INT J INFECT DIS, V28, P13, DOI 10.1016/j.ijid.2014.05.024; Zachariadou L, 2014, EPIDEMIOL INFECT, V142, P512, DOI 10.1017/S0950268813001386; Zakikhany K, 2011, EUROSURVEILLANCE, V16, P6	100	266	273	5	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2017	377	23					2253	2265		10.1056/NEJMra1600673	http://dx.doi.org/10.1056/NEJMra1600673			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO9IL	29211672				2022-12-28	WOS:000417201100008
J	Hampton, T				Hampton, Tracy			Body-on-a-Chip Reveals Multitissue Interactions During Drug Exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2069	2070		10.1001/jama.2017.17869	http://dx.doi.org/10.1001/jama.2017.17869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209702				2022-12-28	WOS:000417093500002
J	Voelker, R				Voelker, Rebecca			Support for Treating Opioid Addiction With Medication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Voelker, Rebecca] MSJ, Chicago, IL 60601 USA		Voelker, R (corresponding author), MSJ, Chicago, IL 60601 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2017	318	21					2071	2071		10.1001/jama.2017.18240	http://dx.doi.org/10.1001/jama.2017.18240			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO7XT	29209706				2022-12-28	WOS:000417093500004
J	Palmer, BA; Taylor, GJ; Brumfeld, V; Gur, D; Shemesh, M; Elad, N; Osherov, A; Oron, D; Weiner, S; Addadi, L				Palmer, Benjamin A.; Taylor, Gavin J.; Brumfeld, Vlad; Gur, Dvir; Shemesh, Michal; Elad, Nadav; Osherov, Aya; Oron, Dan; Weiner, Steve; Addadi, Lia			The image-forming mirror in the eye of the scallop	SCIENCE			English	Article							STRUCTURAL BASIS; WAVELENGTH DISCRIMINATION; SPECTRAL SENSITIVITY; COLOR-CHANGE; FISH; REFLECTOR; CRYSTALS; RETINAE	Scallops possess a visual system comprising up to 200 eyes, each containing a concave mirror rather than a lens to focus light. The hierarchical organization of the multilayered mirror is controlled for image formation, from the component guanine crystals at the nanoscale to the complex three-dimensional morphology at the millimeter level. The layered structure of the mirror is tuned to reflect the wavelengths of light penetrating the scallop's habitat and is tiled with a mosaic of square guanine crystals, which reduces optical aberrations. The mirror forms images on a double-layered retina used for separately imaging the peripheral and central fields of view. The tiled, off-axis mirror of the scallop eye bears a striking resemblance to the segmented mirrors of reflecting telescopes.	[Palmer, Benjamin A.; Shemesh, Michal; Osherov, Aya; Weiner, Steve; Addadi, Lia] Weizmann Inst Sci, Dept Struct Biol, IL-7610001 Rehovot, Israel; [Taylor, Gavin J.] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Brumfeld, Vlad; Elad, Nadav] Weizmann Inst Sci, Dept Chem Res Support, IL-7610001 Rehovot, Israel; [Gur, Dvir; Shemesh, Michal] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Gur, Dvir; Oron, Dan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Lund University; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Palmer, BA; Addadi, L (corresponding author), Weizmann Inst Sci, Dept Struct Biol, IL-7610001 Rehovot, Israel.	benjamin.palmer@weizmann.ac.il; lia.addadi@weizmann.ac.il	Taylor, Gavin/C-3930-2017; Gur, Dvir/GQQ-8564-2022; Oron, Dan/W-1947-2019; Gur, Dvir/AAO-2705-2020	Taylor, Gavin/0000-0003-4787-9844; Oron, Dan/0000-0003-1582-8532; Gur, Dvir/0000-0002-9140-1621; Addadi, Lia/0000-0003-1693-648X; Elad, Nadav/0000-0001-6222-2280; Osherov, Aya/0000-0002-5563-5121	Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science; Israel Science Foundation [2012\224330*]; Crown Center of Photonics; I-CORE (Israeli Center for Research Excellence) "Circle of Light"; Human Frontiers Cross-Disciplinary Postdoctoral Fellowship; Carl Tryggers Stiftelse [CTS15:38]	Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science; Israel Science Foundation(Israel Science Foundation); Crown Center of Photonics; I-CORE (Israeli Center for Research Excellence) "Circle of Light"; Human Frontiers Cross-Disciplinary Postdoctoral Fellowship; Carl Tryggers Stiftelse	We thank C. Jones of Haven Diving Services for supplying the scallops and for the photographs in Fig. 1, A and B, and A. Hirsch for her help in the analysis of TEM images. We thank B. Geiger for the use of DeltaVision fluorescence microscopy. Electron microscopy studies were supported by the Irving and Cherna Moskowitz Center for Nano and Bio-Nano Imaging at the Weizmann Institute of Science. This work was supported by the Israel Science Foundation (grant 2012\224330*), the Crown Center of Photonics, and the I-CORE (Israeli Center for Research Excellence) "Circle of Light." B.A.P. is the recipient of a Human Frontiers Cross-Disciplinary Postdoctoral Fellowship. G.J.T. is supported by a stipend from Carl Tryggers Stiftelse (CTS15:38). L.A. and S.W. are the incumbents of the Dorothy and Patrick Gorman Professorial Chair of Biological Ultrastructure and the Dr. Trude Burchardt Professorial Chair of Structural Biology, respectively.	ANDERSSON A, 1981, PROTOPLASMA, V107, P361, DOI 10.1007/BF01276836; BARBER VC, 1967, Z ZELLFORSCH MIK ANA, V76, P295, DOI 10.1007/BF00339290; CRONLYDI.JR, 1966, SCIENCE, V151, P345, DOI 10.1126/science.151.3708.345; DENTON EJ, 1989, J MAR BIOL ASSOC UK, V69, P409, DOI 10.1017/S0025315400029507; DENTON EJ, 1971, PROC R SOC SER B-BIO, V178, P43, DOI 10.1098/rspb.1971.0051; Gur D, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201603514; Gur D, 2016, ADV FUNCT MATER, V26, P1393, DOI 10.1002/adfm.201504339; Gur D, 2015, ANGEW CHEM INT EDIT, V54, P12426, DOI 10.1002/anie.201502268; Gur D, 2015, J AM CHEM SOC, V137, P8408, DOI 10.1021/jacs.5b05289; Gur D, 2014, J AM CHEM SOC, V136, P17236, DOI 10.1021/ja509340c; Homberg U, 2002, ARTHROPOD STRUCT DEV, V30, P271, DOI 10.1016/S1467-8039(02)00010-5; Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Jordan TM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0948; Jordan TM, 2012, NAT PHOTONICS, V6, P759, DOI [10.1038/nphoton.2012.260, 10.1038/NPHOTON.2012.260]; Kepler J., 1619, HARMONICES MUNDI; Land M.F., 2012, ANIMAL EYES, P1; LAND MF, 1965, J PHYSIOL-LONDON, V179, P138, DOI 10.1113/jphysiol.1965.sp007653; LAND MF, 1969, J EXP BIOL, V51, P471; LAND MF, 1966, J EXP BIOL, V45, P433; LAND MF, 1966, J EXP BIOL, V45, P83; Levy-Lior A, 2008, CRYST GROWTH DES, V8, P507, DOI 10.1021/cg0704753; Levy-Lior A, 2010, ADV FUNCT MATER, V20, P320, DOI 10.1002/adfm.200901437; Li L, 2015, SCIENCE, V350, P952, DOI 10.1126/science.aad1246; Marshall J, 2007, ARTHROPOD STRUCT DEV, V36, P420, DOI 10.1016/j.asd.2007.01.006; McCray W. P., 2006, GIANT TELESCOPES; MCREYNOLDS JS, 1970, J GEN PHYSIOL, V56, P376, DOI 10.1085/jgp.56.3.376; MICHINOMAE M, 1994, J EXP BIOL, V193, P1; Partridge JC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3223; Poli I. X., 1795, TESTACEA UTRIUSQUE S; SPAGNOLIA T, 1983, MAR BEHAV PHYSIOL, V10, P23, DOI 10.1080/10236248309378605; Speiser DI, 2008, J EXP BIOL, V211, P2066, DOI 10.1242/jeb.017038; Speiser DI, 2016, INTEGR COMP BIOL, V56, P796, DOI 10.1093/icb/icw099; Speiser DI, 2011, J EXP BIOL, V214, P422, DOI 10.1242/jeb.048108; Speiser DI, 2008, AM MALACOL BULL, V26, P27, DOI 10.4003/006.026.0204; Teyssier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7368; Wagner HJ, 2009, CURR BIOL, V19, P108, DOI 10.1016/j.cub.2008.11.061; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420	37	65	65	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1172	+		10.1126/science.aam9506	http://dx.doi.org/10.1126/science.aam9506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191905				2022-12-28	WOS:000416584000038
J	Raja, A; Miller, ES; Flores, EJ; Wakeman, SE; Eng, G				Raja, Ali; Miller, Emily S.; Flores, Efren J.; Wakeman, Sarah E.; Eng, George			Case 37-2017: A 36-Year-Old Man with Unintentional Opioid Overdose	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONCARDIOGENIC PULMONARY-EDEMA; RANDOMIZED CLINICAL-TRIAL; HEROIN OVERDOSE; USE DISORDER; DEPENDENCE; DETOXIFICATION; INCARCERATION; MAINTENANCE; WITHDRAWAL; METHADONE		[Raja, Ali; Miller, Emily S.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Flores, Efren J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Wakeman, Sarah E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Eng, George] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Raja, Ali; Miller, Emily S.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Raja, Ali; Flores, Efren J.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Wakeman, Sarah E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Eng, George] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Raja, A (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.; Raja, A (corresponding author), Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA.; Raja, A (corresponding author), Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA.		Raja, Ali S./AAE-5103-2019	Flores, Efren/0000-0003-1398-0426				[Anonymous], 2017, OP REL INP STAYS EM; Center for Behavioral Health Statistics and Quality, 2014, TREATM EP DAT SET TE; Centers for Disease Control and Prevention, 2016, OP OV DRUG OV DEATH; Chutuape MA, 2001, AM J DRUG ALCOHOL AB, V27, P19, DOI 10.1081/ADA-100103117; Cicero TJ, 2015, NEW ENGL J MED, V373, P1789, DOI 10.1056/NEJMc1505541; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Day E, 2011, J SUBST ABUSE TREAT, V40, P56, DOI 10.1016/j.jsat.2010.08.007; Department of Justice Drug Enforcement Administration, 2016, 2016 NAT DRUG THREAT; Fiellin DA, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.005; HIND CRK, 1990, THORAX, V45, P957, DOI 10.1136/thx.45.12.957; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Liebschutz JM, 2014, JAMA INTERN MED, V174, P1369, DOI 10.1001/jamainternmed.2014.2556; Ling W, 2016, J NEUROIMMUNE PHARM, V11, P394, DOI 10.1007/s11481-016-9663-z; Ling W, 2013, ADDICTION, V108, P1788, DOI 10.1111/add.12266; Maradiaga JA, 2016, J SUBST ABUSE TREAT, V62, P49, DOI 10.1016/j.jsat.2015.11.004; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Massachusetts Department of Public Health, 2017, DAT BRIEF OP REL OV; McGovern B., 2017, BOSTON HERALD; Mell HK, 2006, CLIN TOXICOL, V44, P399, DOI 10.1080/15563650600671803; Nosyk B, 2014, DRUG ALCOHOL DEPEN, V143, P149, DOI 10.1016/j.drugalcdep.2014.07.020; Osler W., 1880, OEDEMA LEFT LUNG MOR, P291; Rich JD, 2015, LANCET, V386, P350, DOI 10.1016/S0140-6736(14)62338-2; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Sedy J, 2008, PHYSIOL RES, V57, P499, DOI 10.33549/physiolres.931432; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Shanahan CW, 2010, J GEN INTERN MED, V25, P803, DOI 10.1007/s11606-010-1311-3; Sigmon SC, 2016, NEW ENGL J MED, V375, P2504, DOI 10.1056/NEJMc1610047; Sporer KA, 2001, CHEST, V120, P1628, DOI 10.1378/chest.120.5.1628; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Sterrett C, 2003, AM J EMERG MED, V21, P32, DOI 10.1053/ajem.2003.50006; US Food and Drug Administration. National Environmental Policy Act; Environmental Assessments for Tobacco Products; Categorical Exclusions, 2015, FED REG; Wakeman SE, 2017, J GEN INTERN MED, V32, P909, DOI 10.1007/s11606-017-4077-z; Wakeman SE, 2016, SUBST ABUS, V37, P635, DOI 10.1080/08897077.2016.1187240; Wang BT, 2014, J ANAL TOXICOL, V38, P672, DOI 10.1093/jat/bku103	34	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2017	377	22					2181	2188		10.1056/NEJMcpc1710563	http://dx.doi.org/10.1056/NEJMcpc1710563			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FO1VI	29171813	Bronze			2022-12-28	WOS:000416555000012
J	Barclay, J; Veeratterapillay, R; Harding, C				Barclay, Jonathan; Veeratterapillay, Rajan; Harding, Chris			Non-antibiotic options for recurrent urinary tract infections in women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barclay, Jonathan; Veeratterapillay, Rajan; Harding, Chris] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Harding, C (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.	chris.harding@nuth.nhs.uk		Harding, Chris/0000-0002-9407-382X	Astellas; Pfizer; Ferring; Allergan; Medtronic	Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Ferring(Ferring Pharmaceuticals); Allergan(AbbVieAllergan); Medtronic(Medtronic)	CH reports speaker fees from Astellas, Pfizer, Ferring, Allergan, Medtronic, and is a member of the advisory boards for American Medical Systems and Pierre Fabre Pharmaceuticals. JB and RV have no conflicts to report.	Albert X, 2004, COCHRANE DB SYST REV, V359; Beerepoot MAJ, 2013, J UROLOGY, V190, P1981, DOI 10.1016/j.juro.2013.04.142; Beerepoot MAJ, 2012, ARCH INTERN MED, V172, P704, DOI 10.1001/archinternmed.2012.777; Bonkat G, 2017, UROLOGICAL INFECT; De Vita D, 2013, INT UROGYNECOL J, V24, P545, DOI 10.1007/s00192-012-1957-y; Flower A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010446.pub2; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Jepson RG, 2008, COCHRANE DB SYST REV, V359; Jepson Ruth G, 2012, Cochrane Database Syst Rev, V10, pCD001321, DOI 10.1002/14651858.CD001321.pub5; Kranjcec B, 2014, WORLD J UROL, V32, P79, DOI 10.1007/s00345-013-1091-6; Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2; Lee BSB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003265.pub3; Lorenzo-Gomez MF, 2013, INT UROGYNECOL J, V24, P127, DOI 10.1007/s00192-012-1853-5; MURRAY BE, 1982, NEW ENGL J MED, V306, P130, DOI 10.1056/NEJM198201213060302; Naber KG, 2009, INT J ANTIMICROB AG, V33, P111, DOI 10.1016/j.ijantimicag.2008.08.011; National Institute for Health Research, 2016, ALTERNATIVE PROPHYLA; O'Kane DB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010745.pub2; Perrotta C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005131.pub2; Schwenger EM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008772.pub2; Scottish Intercollegiate Guidelines Network, 2012, MAN SUSP BACT UR TAR; Wagenlehner FME, 2015, UROL INT, V95, P167, DOI 10.1159/000371894	21	8	8	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2017	359								j5193	10.1136/bmj.j5193	http://dx.doi.org/10.1136/bmj.j5193			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO0WG	29170359	Bronze			2022-12-28	WOS:000416472900005
J	Cahill, N; Sonneveldt, E; Stover, J; Weinberger, M; Williamson, J; Wei, CC; Brown, W; Alkema, L				Cahill, Niamh; Sonneveldt, Emily; Stover, John; Weinberger, Michelle; Williamson, Jessica; Wei, Chuchu; Brown, Win; Alkema, Leontine			Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool	LANCET			English	Article								Background The London Summit on Family Planning in 2012 inspired the Family Planning 2020 (FP2020) initiative and the 120 x 20 goal of having an additional 120 million women and adolescent girls become users of modern contraceptives in 69 of the world's poorest countries by the year 2020. Working towards achieving 120 x 20 is crucial for ultimately achieving the Sustainable Development Goals of universal access and satisfying demand for reproductive health. Thus, a performance assessment is required to determine countries' progress. Methods An updated version of the Family Planning Estimation Tool (FPET) was used to construct estimates and projections of the modern contraceptive prevalence rate (mCPR), unmet need for, and demand satisfied with modern methods of contraception among women of reproductive age who are married or in a union in the focus countries of the FP2020 initiative. We assessed current levels of family planning indicators and changes between 2012 and 2017. A counterfactual analysis was used to assess if recent levels of mCPR exceeded pre-FP2020 expectations. Findings In 2017, the mCPR among women of reproductive age who are married or in a union in the FP2020 focus countries was 45.7% (95% uncertainty interval [UI] 42.4-49.1), unmet need for modern methods was 21.6% (19 .7-23.9), and the demand satisfied with modern methods was 67.9% (64.4-71.1). Between 2012 and 2017 the number of women of reproductive age who are married or in a union who use modern methods increased by 28 . 8 million (95% UI 5.8-52.5). At the regional level, Asia has seen the mCPR among women of reproductive age who are married or in a union grow from 51.0% (95% UI 48.5-53.4) to 51.8% (47.3-56.5) between 2012 and 2017, which is slow growth, particularly when compared with a change from 23 . 9% (22 . 9-25.0) to 28.5% (26.8-30.2) across Africa. At the country level, based on a counterfactual analysis, we found that 61% of the countries that have made a commitment to FP2020 exceeded pre-FP2020 expectations for modern contraceptive use. Country success stories include rapid increases in Kenya, Mozambique, Malawi, Lesotho, Sierra Leone, Liberia, and Chad relative to what was expected in 2012. Interpretation Whereas the estimate of additional users up to 2017 for women of reproductive age who are married or in a union would suggest that the 120 x 20 goal for all women is overly ambitious, the aggregate outcomes mask the diversity in progress at the country level. We identified countries with accelerated progress, that provide inspiration and guidance on how to increase the use of family planning and inform future efforts, especially in countries where progress has been poor. Copyright (c) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Cahill, Niamh; Wei, Chuchu; Alkema, Leontine] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Cahill, Niamh] Univ Coll Dublin, Sch Math & Stat, Dublin, Ireland; [Sonneveldt, Emily; Stover, John] Avenir Hlth, Glastonbury, CT USA; [Weinberger, Michelle; Williamson, Jessica] Avenir Hlth, Washington, DC USA; [Brown, Win] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Massachusetts System; University of Massachusetts Amherst; University College Dublin; Bill & Melinda Gates Foundation	Cahill, N (corresponding author), Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA.	ncahill@umass.edu	Cahill, Niamh/ABF-5291-2021	Cahill, Niamh/0000-0003-3086-550X	Bill & Melinda Gates Foundation; Avenir Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Avenir Health	The Bill & Melinda Gates Foundation, through grant support to the University of Massachusetts Amherst and Avenir Health.	Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Bongaarts J, 2016, NATURE, V530, P409, DOI 10.1038/530409a; Bradley SarahE.K., 2012, DHS ANAL STUDIES; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; Demographic and Health Surveys, 2016, UND UNM NEED GHAN DE; Fabic MS, 2015, LANCET, V385, P1928, DOI 10.1016/S0140-6736(14)61055-2; Festin MPR, 2016, CONTRACEPTION, V94, P289, DOI 10.1016/j.contraception.2016.05.015; FP2020, 2017, FAM PLANN SUMM SUMM; FP2020, 2014, PARTN PROGR ANN PROG; FP2020, 2017, FP2020 WAY AH 2016 2; FP2020, 2016, FP2020 MOM MIDP; Futures Institute, 2014, TRACK20 MON PROGR FA; IPPF, 2016, SUST DEV GOALS FAM P; Keyonzo N, 2015, REPROD HEALTH MATTER, V23, P103, DOI 10.1016/j.rhm.2015.06.010; Mekonnen Y., 2015, EXAMINING DISCREPANC; New JR, 2017, LANCET GLOB HEALTH, V5, pE350, DOI [10.1016/S2214-109X(17)30033-5, 10.1016/s2214-109x(17)30033-5]; New Jin Rou, 2015, FAMILY PLANNING ESTI; Track20, 2017, 7 TECHN EXP MIDT REV; UN Committee on Economic Social and Cultural Rights, GEN COMM NUMB 14 ART; UN Department of Economic and Social Affairs, 2017, POP DIV WORLD CONTR; UN Department of Economic and Social Affairs Population Division, 2013, 20132 US DEP EC SOC; UN Department of Economic and Social Affairs Population Division, EST PROJ NUMB WOM AG; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017	23	82	82	2	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2018	391	10123					870	882		10.1016/S0140-6736(17)33104-5	http://dx.doi.org/10.1016/S0140-6736(17)33104-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX9XF	29217374	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000426463500024
J	Oria, R; Wiegand, T; Escribano, J; Elosegui-Artola, A; Uriarte, JJ; Moreno-Pulido, C; Platzman, I; Delcanale, P; Albertazzi, L; Navajas, D; Trepat, X; Garcia-Aznar, JM; Cavalcanti-Adam, EA; Roca-Cusachs, P				Oria, Roger; Wiegand, Tina; Escribano, Jorge; Elosegui-Artola, Alberto; Jose Uriarte, Juan; Moreno-Pulido, Cristian; Platzman, Ilia; Delcanale, Pietro; Albertazzi, Lorenzo; Navajas, Daniel; Trepat, Xavier; Manuel Garcia-Aznar, Jose; Cavalcanti-Adam, Elisabetta Ada; Roca-Cusachs, Pere			Force loading explains spatial sensing of ligands by cells	NATURE			English	Article							MOTOR-CLUTCH MODEL; EXTRACELLULAR-MATRIX; ADHESION MATURATION; NASCENT ADHESIONS; INTEGRIN LIGANDS; FOCAL ADHESIONS; TRACTION; RIGIDITY; TRANSMISSION; DYNAMICS	Cells can sense the density and distribution of extracellular matrix (ECM) molecules by means of individual integrin proteins and larger, integrin-containing adhesion complexes within the cell membrane. This spatial sensing drives cellular activity in a variety of normal and pathological contexts(1,2). Previous studies of cells on rigid glass surfaces have shown that spatial sensing of ECM ligands takes place at the nanometre scale, with integrin clustering and subsequent formation of focal adhesions impaired when single integrin-ligand bonds are separated by more than a few tens of nanometres(3-6). It has thus been suggested that a crosslinking 'adaptor' protein of this size might connect integrins to the actin cytoskeleton, acting as a molecular ruler that senses ligand spacing directly(3,7-9). Here, we develop gels whose rigidity and nanometrescale distribution of ECM ligands can be controlled and altered. We find that increasing the spacing between ligands promotes the growth of focal adhesions on low-rigidity substrates, but leads to adhesion collapse on more-rigid substrates. Furthermore, disordering the ligand distribution drastically increases adhesion growth, but reduces the rigidity threshold for adhesion collapse. The growth and collapse of focal adhesions are mirrored by, respectively, the nuclear or cytosolic localization of the transcriptional regulator protein YAP. We explain these findings not through direct sensing of ligand spacing, but by using an expanded computational molecular-clutch model(10,11), in which individual integrin-ECM bonds-the molecular clutches-respond to force loading by recruiting extra integrins, up to a maximum value. This generates more clutches, redistributing the overall force among them, and reducing the force loading per clutch. At high rigidity and high ligand spacing, maximum recruitment is reached, preventing further force redistribution and leading to adhesion collapse. Measurements of cellular traction forces and actin flow speeds support our model. Our results provide a general framework for how cells sense spatial and physical information at the nanoscale, precisely tuning the range of conditions at which they form adhesions and activate transcriptional regulation.	[Oria, Roger; Elosegui-Artola, Alberto; Moreno-Pulido, Cristian; Delcanale, Pietro; Albertazzi, Lorenzo; Navajas, Daniel; Trepat, Xavier; Roca-Cusachs, Pere] Barcelona Inst Technol BIST, Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain; [Oria, Roger; Jose Uriarte, Juan; Navajas, Daniel; Trepat, Xavier; Roca-Cusachs, Pere] Univ Barcelona, E-08036 Barcelona, Spain; [Wiegand, Tina; Platzman, Ilia; Cavalcanti-Adam, Elisabetta Ada] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Wiegand, Tina; Platzman, Ilia; Cavalcanti-Adam, Elisabetta Ada] Heidelberg Univ, D-69120 Heidelberg, Germany; [Escribano, Jorge; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza 50018, Spain; [Navajas, Daniel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid 28029, Spain; [Trepat, Xavier] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Trepat, Xavier] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona 08028, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; Max Planck Society; Ruprecht Karls University Heidelberg; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Roca-Cusachs, P (corresponding author), Barcelona Inst Technol BIST, Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.; Roca-Cusachs, P (corresponding author), Univ Barcelona, E-08036 Barcelona, Spain.; Cavalcanti-Adam, EA (corresponding author), Max Planck Inst Med Res, D-69120 Heidelberg, Germany.; Cavalcanti-Adam, EA (corresponding author), Heidelberg Univ, D-69120 Heidelberg, Germany.	Ada.Cavalcanti-Adam@urz.uni-heidelberg.de; rocacusachs@ub.edu	Garcia-Aznar, Jose Manuel/F-8256-2010; Jimenez, Jorge Escribano/AAB-1152-2020; Roca-Cusachs, Pere/D-4309-2009; Trepat, Xavier/I-3912-2015; Cavalcanti-Adam, Elisabetta Ada/ABA-8495-2021; Navajas, Daniel/E-4233-2010; Albertazzi, Lorenzo/E-8323-2013; Elosegui-Artola, Alberto/G-2691-2016	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Jimenez, Jorge Escribano/0000-0001-8928-350X; Roca-Cusachs, Pere/0000-0001-6947-961X; Trepat, Xavier/0000-0002-7621-5214; Navajas, Daniel/0000-0001-7150-9363; Albertazzi, Lorenzo/0000-0002-6837-0812; Cavalcanti-Adam, Elisabetta/0000-0003-0243-1552; Delcanale, Pietro/0000-0001-8235-765X; Elosegui-Artola, Alberto/0000-0003-0644-3294	Spanish Ministry of Economy and Competitiveness [BFU2016-79916-P, BFU2014-52586-REDT, BFU2015-65074-P, D-PI-20-15-64221-C2-1-R, PI14/00280, SAF2016-75241-R, IJCI-2014-19156]; European Commission [SEP-210342844]; Generalitat de Catalunya [2014-SGR-927]; European Research Council [CoG-616480, StG 306571]; Obra Social 'La Caixa'; Fundacio la Marato de TV3 [20133330]; German Science Foundation (DFG) [SFB1129 P15]; EMBO Young Investigator Programme; Juan de la Cierva Fellowship; FI fellowship (Generalitat de Catalunya); Ramon y Cajal Fellowship (Spanish Ministry of Economy and Competitiveness); Max Planck Society; Alexander von Humboldt foundation	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); Obra Social 'La Caixa'(La Caixa Foundation); Fundacio la Marato de TV3; German Science Foundation (DFG)(German Research Foundation (DFG)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); Juan de la Cierva Fellowship; FI fellowship (Generalitat de Catalunya)(Generalitat de Catalunya); Ramon y Cajal Fellowship (Spanish Ministry of Economy and Competitiveness)(Spanish Government); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by the Spanish Ministry of Economy and Competitiveness (grants BFU2016-79916-P and BFU2014-52586-REDT to P.R.-C.; BFU2015-65074-P to X-.T-.; D-PI-20-15-64221-C2-1-R to J.M.G.-A.; PI14/00280 to D.N.; SAF2016-75241-R (MINECO-FEDER) to L.A.), the European Commission (grant agreement SEP-210342844 to X.T. and P.R.-C.), the Generalitat de Catalunya (grant 2014-SGR-927), the European Research Council (CoG-616480 to X.T. and StG 306571 to J.M.G.-A.), Obra Social 'La Caixa', Fundacio la Marato de TV3 (project 20133330 to P.R.-C.), the German Science Foundation (DFG SFB1129 P15 to E.A.C.-A.), and the EMBO Young Investigator Programme. A.E.-A., R.O., and L.A. were supported respectively by a Juan de la Cierva Fellowship (Spanish Ministry of Economy and Competitiveness, fellowship number IJCI-2014-19156), an FI fellowship (Generalitat de Catalunya), and a Ramon y Cajal Fellowship (Spanish Ministry of Economy and Competitiveness). The support of the Max Planck Society and the Alexander von Humboldt foundation (to I.P.) is acknowledged. We thank P. Oakes, J. Spatz, J. L. Jones, M. D. Allen and the members of the P.R.-C. and X.T. laboratories for technical assistance and discussions.	Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Allen MD, 2014, CLIN CANCER RES, V20, P344, DOI 10.1158/1078-0432.CCR-13-1504; Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002; Amschler K, 2014, ACS NANO, V8, P9113, DOI 10.1021/nn502690b; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Bangasser BL, 2013, CELL MOL BIOENG, V6, P449, DOI 10.1007/s12195-013-0296-5; Bangasser BL, 2013, BIOPHYS J, V105, P581, DOI 10.1016/j.bpj.2013.06.027; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; de Beer AGF, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051914; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Litvinov RI, 2012, J BIOL CHEM, V287, P35275, DOI 10.1074/jbc.M112.404848; Liu Y, 2014, NANO LETT, V14, P5539, DOI 10.1021/nl501912g; Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pallarola D, 2014, ADV FUNCT MATER, V24, P943, DOI 10.1002/adfm.201302411; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388	45	153	156	6	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2017	552	7684					219	+		10.1038/nature24662	http://dx.doi.org/10.1038/nature24662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ0FK	29211717	Green Accepted			2022-12-28	WOS:000418029500040
J	Kogar, A; Rak, MS; Vig, S; Husain, AA; Flicker, F; Il Joe, Y; Venema, L; MacDougall, GJ; Chiang, TC; Fradkin, E; van Wezel, J; Abbamonte, P				Kogar, Anshul; Rak, Melinda S.; Vig, Sean; Husain, Ali A.; Flicker, Felix; Il Joe, Young; Venema, Luc; MacDougall, Greg J.; Chiang, Tai C.; Fradkin, Eduardo; van Wezel, Jasper; Abbamonte, Peter			Signatures of exciton condensation in a transition metal dichalcogenide	SCIENCE			English	Article							SEMIMETAL TISE2; STATE; POLARITONS; INSULATOR; PHONONS	Bose condensation has shaped our understanding of macroscopic quantum phenomena, having been realized in superconductors, atomic gases, and liquid helium. Excitons are bosons that have been predicted to condense into either a superfluid or an insulating electronic crystal. Using the recently developed technique of momentum-resolved electron energy-loss spectroscopy (M-EELS), we studied electronic collective modes in the transition metal dichalcogenide semimetal 1T-TiSe2. Near the phase-transition temperature (190 kelvin), the energy of the electronic mode fell to zero at nonzero momentum, indicating dynamical slowing of plasma fluctuations and crystallization of the valence electrons into an exciton condensate. Our study provides compelling evidence for exciton condensation in a three-dimensional solid and establishes M-EELS as a versatile technique sensitive to valence band excitations in quantum materials.	[Kogar, Anshul; Rak, Melinda S.; Vig, Sean; Husain, Ali A.; Il Joe, Young; Venema, Luc; MacDougall, Greg J.; Chiang, Tai C.; Fradkin, Eduardo; Abbamonte, Peter] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Kogar, Anshul; Rak, Melinda S.; Vig, Sean; Husain, Ali A.; Il Joe, Young; Venema, Luc; MacDougall, Greg J.; Chiang, Tai C.; Fradkin, Eduardo; Abbamonte, Peter] Univ Illinois, Seitz Mat Res Lab, Urbana, IL 61801 USA; [Flicker, Felix] Univ Oxford, Rudolph Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [van Wezel, Jasper] Univ Amsterdam, Inst Phys, NL-1098 XH Amsterdam, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Oxford; University of Amsterdam	Abbamonte, P (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.; Abbamonte, P (corresponding author), Univ Illinois, Seitz Mat Res Lab, Urbana, IL 61801 USA.	abbamonte@mrl.illinois.edu	van Wezel, Jasper/B-6779-2008	van Wezel, Jasper/0000-0002-9378-008X; Husain, Ali/0000-0001-9865-9476; Fradkin, Eduardo/0000-0001-6837-463X; MacDougall, Gregory/0000-0002-7490-9650; Flicker, Felix/0000-0002-8362-1384; Vig, Sean/0000-0001-6083-2130	Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF-4542]; U. S. Department of Energy (DOE) Center for Emergent Superconductivity, an Energy Frontier Research Center - DOE Office of Science [DE-AC02-98CH10886]; DOE [DE-FG02-08ER46549, DE-FG02-07ER46453, DE-SC0012368, DE-FG02-07ER46383]; VIDI grant from the Netherlands Organization for Scientific Research (NWO); Lindemann Trust Fellowship of the English Speaking Union; Astor Junior Research Fellowship of New College, University of Oxford	Gordon and Betty Moore Foundation's EPiQS Initiative; U. S. Department of Energy (DOE) Center for Emergent Superconductivity, an Energy Frontier Research Center - DOE Office of Science; DOE(United States Department of Energy (DOE)); VIDI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Lindemann Trust Fellowship of the English Speaking Union; Astor Junior Research Fellowship of New College, University of Oxford	We thank C. M. Varma, A. H. MacDonald, G. Baym, and A. J. Leggett for discussions and I. Bozovic, J. D. Stack, and S. A. Kivelson for feedback on the manuscript. This work was funded by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF-4542. Development of the M-EELS instrument was supported by the U. S. Department of Energy (DOE) Center for Emergent Superconductivity, an Energy Frontier Research Center funded by the DOE Office of Science under award DE-AC02-98CH10886, with equipment provided by DOE grants DE-FG02-08ER46549 and DE-FG02-07ER46453. J.v.W. acknowledges support from a VIDI grant from the Netherlands Organization for Scientific Research (NWO). G. J. M. and E.F. acknowledge support from DOE grant DE-SC0012368. T.C.C. acknowledges support from DOE grant DE-FG02-07ER46383. F.F. acknowledges support from a Lindemann Trust Fellowship of the English Speaking Union and the Astor Junior Research Fellowship of New College, University of Oxford. The data presented in this manuscript are available from the authors upon reasonable request.	Amo A, 2009, NAT PHYS, V5, P805, DOI 10.1038/NPHYS1364; Beekman AJ, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.165115; Calandra M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196406; Cercellier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146403; DISALVO FJ, 1976, PHYS REV B, V14, P4321, DOI 10.1103/PhysRevB.14.4321; Eisenstein JP, 2014, ANNU REV CONDEN MA P, V5, P159, DOI 10.1146/annurev-conmatphys-031113-133832; Flicker F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8034; Fuhrer M. S., 2016, PHYSICS, V9, P80; Groner G., 1994, DENSITY WAVES SOLIDS; HALPERIN BI, 1968, REV MOD PHYS, V40, P755, DOI 10.1103/RevModPhys.40.755; Holt M, 2001, PHYS REV LETT, V86, P3799, DOI 10.1103/PhysRevLett.86.3799; HUGHES HP, 1977, J PHYS C SOLID STATE, V10, pL319, DOI 10.1088/0022-3719/10/11/009; Ibach H., 1982, ELECT ENERGY LOSS SP; KELDYSH LV, 1965, FIZ TVERD TELA+, V6, P2219; Kidd TE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226402; KOHN W, 1970, REV MOD PHYS, V42, P1, DOI 10.1103/RevModPhys.42.1; Kohn W., 1968, MANY BODY PHYSICS, P355; Kotov VN, 2012, REV MOD PHYS, V84, P1067, DOI 10.1103/RevModPhys.84.1067; Leggett AJ, 2008, SCIENCE, V319, P1203, DOI 10.1126/science.1152822; Li G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027404; LIANG WY, 1979, PHILOS MAG B, V39, P133, DOI 10.1080/13642817908246343; LOGAN DE, 1986, BER BUNSEN PHYS CHEM, V90, P575, DOI 10.1002/bbpc.19860900704; Monney C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/075026; MOTT NF, 1961, PHILOS MAG, V6, P287, DOI 10.1080/14786436108243318; NEUENSCHWANDER J, 1990, PHYS REV B, V41, P12693, DOI 10.1103/PhysRevB.41.12693; Pines D., 1999, THEORY QUANTUM LIQUI; POUGET JP, 1991, PHYS REV B, V43, P8421, DOI 10.1103/PhysRevB.43.8421; Rossnagel K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235101; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; SUZUKI N, 1985, J PHYS SOC JPN, V54, P4668, DOI 10.1143/JPSJ.54.4668; TOSATTI E, 1974, SOLID STATE COMMUN, V14, P773, DOI 10.1016/0038-1098(74)90883-7; van Wezel J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165109; Vig S, 2017, SCIPOST PHYS, V3, DOI 10.21468/SciPostPhys.3.4.026; WAKABAYASHI N, 1978, SOLID STATE COMMUN, V28, P923, DOI 10.1016/0038-1098(78)90112-6; Wakisaka Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.026402; Weber F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.266401; WILSON JA, 1978, PHYS REV B, V18, P2866, DOI 10.1103/PhysRevB.18.2866; WILSON JA, 1977, SOLID STATE COMMUN, V22, P551, DOI 10.1016/0038-1098(77)90133-8	40	211	211	21	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1315	+		10.1126/science.aam6432	http://dx.doi.org/10.1126/science.aam6432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217574	Green Submitted			2022-12-28	WOS:000417254700061
J	Zhou, Y; Castonguay, P; Sidhom, EH; Clark, AR; Dvela-Levitt, M; Kim, S; Sieber, J; Wieder, N; Jung, JY; Andreeva, S; Reichardt, J; Dubois, F; Hoffmann, SC; Basgen, JM; Montesinos, MS; Weins, A; Johnson, AC; Lander, ES; Garrett, MR; Hopkins, CR; Greka, A				Zhou, Yiming; Castonguay, Philip; Sidhom, Eriene-Heidi; Clark, Abbe R.; Dvela-Levitt, Moran; Kim, Sookyung; Sieber, Jonas; Wieder, Nicolas; Jung, Ji Yong; Andreeva, Svetlana; Reichardt, Jana; Dubois, Frank; Hoffmann, Sigrid C.; Basgen, John M.; Montesinos, Monica S.; Weins, Astrid; Johnson, Ashley C.; Lander, Eric S.; Garrett, Michael R.; Hopkins, Corey R.; Greka, Anna			A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models	SCIENCE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; NEPHROTIC SYNDROME; PODOCYTES; RATS; HYPERTENSION; CYTOSKELETON; ALBUMINURIA; MICE; FSGS	Progressive kidney diseases are often associated with scarring of the kidney's filtration unit, a condition called focal segmental glomerulosclerosis (FSGS). This scarring is due to loss of podocytes, cells critical for glomerular filtration, and leads to proteinuria and kidney failure. Inherited forms of FSGS are caused by Rac1-activating mutations, and Rac1 induces TRPC5 ion channel activity and cytoskeletal remodeling in podocytes. Whether TRPC5 activity mediates FSGS onset and progression is unknown. We identified a small molecule, AC1903, that specifically blocks TRPC5 channel activity in glomeruli of proteinuric rats. Chronic administration of AC1903 suppressed severe proteinuria and prevented podocyte loss in a transgenic rat model of FSGS. AC1903 also provided therapeutic benefit in a rat model of hypertensive proteinuric kidney disease. These data indicate that TRPC5 activity drives disease and that TRPC5 inhibitors may be valuable for the treatment of progressive kidney diseases.	[Zhou, Yiming; Castonguay, Philip; Sidhom, Eriene-Heidi; Clark, Abbe R.; Dvela-Levitt, Moran; Kim, Sookyung; Sieber, Jonas; Wieder, Nicolas; Jung, Ji Yong; Andreeva, Svetlana; Reichardt, Jana; Dubois, Frank; Montesinos, Monica S.; Weins, Astrid; Greka, Anna] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Zhou, Yiming; Castonguay, Philip; Sidhom, Eriene-Heidi; Clark, Abbe R.; Dvela-Levitt, Moran; Kim, Sookyung; Sieber, Jonas; Wieder, Nicolas; Jung, Ji Yong; Andreeva, Svetlana; Reichardt, Jana; Dubois, Frank; Montesinos, Monica S.; Weins, Astrid; Greka, Anna] Harvard Med Sch, Boston, MA 02115 USA; [Zhou, Yiming; Castonguay, Philip; Sidhom, Eriene-Heidi; Clark, Abbe R.; Dvela-Levitt, Moran; Kim, Sookyung; Sieber, Jonas; Wieder, Nicolas; Montesinos, Monica S.; Lander, Eric S.; Greka, Anna] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Hoffmann, Sigrid C.] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Heidelberg, Germany; [Basgen, John M.] Charles R Drew Univ Sci & Med, Life Sci Inst, Los Angeles, CA 90059 USA; [Weins, Astrid] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Johnson, Ashley C.; Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Hopkins, Corey R.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Gachon University; Ruprecht Karls University Heidelberg; Charles R. Drew University of Medicine & Science; Harvard University; Brigham & Women's Hospital; University of Mississippi; University of Mississippi Medical Center; University of Nebraska System; University of Nebraska Medical Center	Greka, A (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Greka, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Greka, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	agreka@bwh.harvard.edu		Zhou, Yiming/0000-0002-2109-4320; Jung, Ji Yong/0000-0003-1271-8012; Dvela Levitt, Moran/0000-0001-5597-6455; Sidhom, Eriene-Heidi/0000-0002-2658-9672; Wieder, Nicolas/0000-0001-5683-2891; Kim, Sookyung/0000-0001-6674-940X; Sieber, Jonas/0000-0002-4325-4444	NIH [DK095045, DK099465, DK103658, DK083511, DK093746, U54-MD007598, F31CA195701]; National Defense Science and Engineering Graduate fellowship; Deutsche Forschungs Gesellschaft fellowship [WI 4612/1-1]; Broad-Israel Science Foundation Fellowship; Deutsche Forschungs Gesellshaft Collaborative Research Center 1118 grant; NATIONAL CANCER INSTITUTE [F31CA195701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099465, K08DK083511, R01DK103658, R56DK093746, R01DK095045] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; Deutsche Forschungs Gesellschaft fellowship; Broad-Israel Science Foundation Fellowship; Deutsche Forschungs Gesellshaft Collaborative Research Center 1118 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank T. Tickle for guidance on RNA-seq analysis; K. Maeda for technical assistance with the Dahl S rat studies; L. Gaffney for assistance with graphics; and A. Blobaum and X. Zhan for technical assistance with in vivo pharmacokinetics work. This work was funded by NIH grants DK095045, DK099465, DK103658, DK083511, and DK093746 (A.G.); NIH grant U54-MD007598 (J.M.B.); NIH grant DK103658 (C.R.H.); an F31CA195701 fellowship (A.R. C.); a National Defense Science and Engineering Graduate fellowship (E.-H. S.); a Deutsche Forschungs Gesellschaft fellowship WI 4612/1-1 (N.W.); a Broad-Israel Science Foundation Fellowship (M.D.-L.); and a Deutsche Forschungs Gesellshaft Collaborative Research Center 1118 grant (S.C.H.). A.G. has a financial interest in Goldfinch Biopharma, a biotechnology company focused on discovery and development of precision therapies for patients with kidney disease. A. G.'s financial interest in Goldfinch Bio was reviewed and is managed by Brigham and Women's Hospital-Partners HealthCare and the Broad Institute of MIT and Harvard in accordance with their conflict-of-interest policies. E.S.L. is on the Scientific Advisory Board of Third Rock Ventures (TRV), which is a lead investor in Goldfinch Bio. Under his agreement with TRV, his compensation consists solely of stock in TRV-founded companies. This agreement excludes his receiving stock from certain companies, including Goldfinch Bio. Partners HealthCare-Brigham and Women's Hospital, the University of Nebraska Medical Center, and the authors (A.G. and C.R.H.) have filed a patent application (no. 62/555,219) covering AC1903. The TRPC5 inhibitor compound AC1903 is available from C.R.H. (the University of Nebraska Medical Center) under a materials transfer agreement. All RNA-seq data files are deposited at GEO (accession no. GSE103020).	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48; Buvall L, 2017, J AM SOC NEPHROL, V28, P837, DOI 10.1681/ASN.2016040414; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Garrett MR, 2003, J AM SOC NEPHROL, V14, P1175, DOI 10.1097/01.ASN.0000060572.13794.58; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Inrig JK, 2014, AM J KIDNEY DIS, V63, P771, DOI 10.1053/j.ajkd.2013.10.043; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RAPP JP, 1982, HYPERTENSION, V4, P753, DOI 10.1161/01.HYP.4.6.753; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Richter JM, 2014, MOL PHARMACOL, V86, P514, DOI 10.1124/mol.114.093229; Richter JM, 2014, BRIT J PHARMACOL, V171, P158, DOI 10.1111/bph.12436; Riehle M, 2016, J AM SOC NEPHROL, V27, P2771, DOI 10.1681/ASN.2015030318; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Weins A, 2015, AM J PATHOL, V185, P2143, DOI 10.1016/j.ajpath.2015.04.011; Wieder N, 2016, PEDIATR NEPHROL, V31, P1047, DOI 10.1007/s00467-015-3224-1; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Yamada Y, 2011, HYPERTENS RES, V34, P809, DOI 10.1038/hr.2011.34; You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302; Yu HY, 2016, J CLIN INVEST, V126, P1603, DOI 10.1172/JCI87342; Zicha J, 2012, PHYSIOL RES, V61, pS35, DOI 10.33549/physiolres.932363	34	87	93	7	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2017	358	6368					1332	+		10.1126/science.aal4178	http://dx.doi.org/10.1126/science.aal4178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO9YM	29217578	Green Accepted, Green Published			2022-12-28	WOS:000417254700065
J	Engblom, C; Pfirschke, C; Zilionis, R; Martins, JD; Bos, SA; Courties, G; Rickelt, S; Severe, N; Baryawno, N; Faget, J; Savova, V; Zemmour, D; Kline, J; Siwicki, M; Garris, C; Pucci, F; Liao, HW; Lin, YJ; Newton, A; Yaghi, OK; Iwamoto, Y; Tricot, B; Wojtkiewicz, GR; Nahrendorf, M; Cortez-Retamozo, V; Meylan, E; Hynes, RO; Demay, M; Klein, A; Bredella, MA; Scadden, DT; Weissleder, R; Pittet, MJ				Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas; Martins, Janaina Da Silva; Bos, Stijn A.; Courties, Gabriel; Rickelt, Steffen; Severe, Nicolas; Baryawno, Ninib; Faget, Julien; Savova, Virginia; Zemmour, David; Kline, Jaclyn; Siwicki, Marie; Garris, Christopher; Pucci, Ferdinando; Liao, Hsin-Wei; Lin, Yi-Jang; Newton, Andita; Yaghi, Omar K.; Iwamoto, Yoshiko; Tricot, Benoit; Wojtkiewicz, Gregory R.; Nahrendorf, Matthias; Cortez-Retamozo, Virna; Meylan, Etienne; Hynes, Richard O.; Demay, Marie; Klein, Allon; Bredella, Miriam A.; Scadden, David T.; Weissleder, Ralph; Pittet, Mikael J.			Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils	SCIENCE			English	Article							STEM-CELL NICHE; HEMATOPOIETIC STEM; BONE-MARROW; GENE-EXPRESSION; MYELOID CELLS; OSTEOCALCIN EXPRESSION; PROGNOSTIC VALUE; DIFFERENTIATION; LINEAGE; PROGENITORS	Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn(+)) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecF(high) neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn(+) cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecF(high) neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.	[Engblom, Camilla; Pfirschke, Christina; Courties, Gabriel; Kline, Jaclyn; Siwicki, Marie; Garris, Christopher; Pucci, Ferdinando; Liao, Hsin-Wei; Lin, Yi-Jang; Newton, Andita; Yaghi, Omar K.; Iwamoto, Yoshiko; Tricot, Benoit; Wojtkiewicz, Gregory R.; Nahrendorf, Matthias; Cortez-Retamozo, Virna; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA; [Engblom, Camilla; Pfirschke, Christina; Courties, Gabriel; Kline, Jaclyn; Siwicki, Marie; Garris, Christopher; Pucci, Ferdinando; Liao, Hsin-Wei; Lin, Yi-Jang; Newton, Andita; Yaghi, Omar K.; Iwamoto, Yoshiko; Tricot, Benoit; Wojtkiewicz, Gregory R.; Nahrendorf, Matthias; Cortez-Retamozo, Virna; Weissleder, Ralph; Pittet, Mikael J.] Harvard Med Sch, Boston, MA 02114 USA; [Engblom, Camilla; Zemmour, David; Siwicki, Marie; Garris, Christopher; Yaghi, Omar K.] Harvard Med Sch, Grad Program Immunol, Boston, MA 02115 USA; [Zilionis, Rapolas; Savova, Virginia; Klein, Allon; Weissleder, Ralph] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Zilionis, Rapolas] Vilnius Univ, Inst Biotechnol, LT-10257 Vilnius, Lithuania; [Martins, Janaina Da Silva; Demay, Marie] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Bos, Stijn A.; Bredella, Miriam A.; Weissleder, Ralph; Pittet, Mikael J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rickelt, Steffen; Hynes, Richard O.] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Severe, Nicolas; Baryawno, Ninib; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Faget, Julien; Meylan, Etienne] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Zemmour, David] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vilnius University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Harvard Medical School	Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Res Inst, Boston, MA 02114 USA.; Pittet, MJ (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Pittet, MJ (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Pittet, Mikael/ABD-6300-2021; Pucci, Ferdinando/AAT-8239-2020; Faget, Julien/Y-7187-2019; Wojtkiewicz, Gregory/L-3660-2018	Pucci, Ferdinando/0000-0002-1300-9931; Faget, Julien/0000-0003-0848-7135; Rickelt, Steffen/0000-0002-5224-7764; Kline, Jaclyn/0000-0002-6897-5520; Severe, Nicolas/0000-0003-1971-337X; Courties, Gabriel/0000-0002-0003-7407; Meylan, Etienne/0000-0002-0899-2230; Zemmour, David/0000-0002-0990-217X; Wojtkiewicz, Gregory/0000-0002-3148-8411; Baryawno, Ninib/0000-0001-6054-4163	NIH [P30-AR066261, R01-A1084880, R01-0A206890, P50-CA86355, U54-CA126515, CA148180, L54-CA163109, R33-CA212697]; Samana Coy MGH (Massachusetts General Hospital) Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; Howard Hughes Medical Institute; Edward J. Mallinckrodt Jr. Fellowship; Boehringer Ingelheirn Fonds PhD fellowships; Deutsche Forschirgsgemeinschaft [PF809/1-1]; MGH ECOR (Executive Committee on Research) Tosteson Postdoctoral Fellowship; MIT (Massachdsetts Institute of Technology) Ludwig Center for Molecular Oncology Research; National Institute of General Medical Sciences [T32-GM007753]; NATIONAL CANCER INSTITUTE [U54CA163109, R33CA212697, P50CA148110, R01CA206890, U54CA126515, P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samana Coy MGH (Massachusetts General Hospital) Research Scholar Fund; Robert Wenner Award from the Swiss Cancer League; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Edward J. Mallinckrodt Jr. Fellowship; Boehringer Ingelheirn Fonds PhD fellowships; Deutsche Forschirgsgemeinschaft; MGH ECOR (Executive Committee on Research) Tosteson Postdoctoral Fellowship; MIT (Massachdsetts Institute of Technology) Ludwig Center for Molecular Oncology Research; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Harvard Stem Cell Institute for help with FACS sorting; D. Brooks, M. Scott, and M. Boirsein from the Center for Skeletal Research Core (NIH grant P30-AR066261) for mu CT bone analysis services : members of the Hope Babette Tang Histology Facility at the Koch Institute Swanson Biotechnology Center for technical support; M. Wein for helpful discussions and technical assistance; and D. Mathis, C. Benoist, S. Pillai, S. McAllister, and G. Dramff for their input. This work was supported in part by the Samana Coy MGH (Massachusetts General Hospital) Research Scholar Fund, the Robert Wenner Award from the Swiss Cancer League, and NIH grant's R01-A1084880, R01-0A206890, and P50-CA86355 (to M.J.P.); NIH grant U54-CA126515 (to R.W.); NIH grant CA148180 (to D.T.S.); NIH grant L54-CA163109 and the Howard Hughes Medical Institute (to R.O.H.); NIH grant R33-CA212697 and an Edward J. Mallinckrodt Jr. Fellowship (to U.); Boehringer Ingelheirn Fonds PhD fellowships (to C.E. and D.Z.); Deutsche Forschirgsgemeinschaft PF809/1-1 and MGH ECOR (Executive Committee on Research) Tosteson Postdoctoral Fellowship (to C.P.); a postdoctoral fellowship from the MIT (Massachdsetts Institute of Technology) Ludwig Center for Molecular Oncology Research (to S.R.); and award T32-GM007753 from the National Institute of General Medical Sciences (to OEN.). A.K is a founder of, and is on the Scientific Advisory Board of, iCellBio. R.O.H. is a scientific advisor for Genentech and Amgen. C.E., and C.P. are inventors on patent application 62/489,118 filed by MGH that covers the detection and targeting of tumor-promoting neutrophils. Osteoblast RNA-seq data have been deposited to the GEO (Gene Expression Omnibus) repository under the accession number GSE104294.	Abdallah BM, 2011, J BONE MINER RES, V26, P1457, DOI 10.1002/jbmr.346; Ang ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08134; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510; Bozec A, 2010, J CELL BIOL, V190, P1093, DOI 10.1083/jcb.201002111; BROADUS AE, 1988, NEW ENGL J MED, V319, P556; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Coleman R, 2014, ANN ONCOL, V25, P124, DOI 10.1093/annonc/mdu103; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Courties G, 2015, CIRC RES, V116, P407, DOI 10.1161/CIRCRESAHA.116.305207; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Davidson-Pilon C., 2016, LIFELINES SURVIVAL A; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gordon A., 2010, FASTX TOOLKIT VERSIO; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoggatt J, 2016, ANNU REV PATHOL-MECH, V11, P555, DOI 10.1146/annurev-pathol-012615-044414; Huang SH, 2015, CANCER-AM CANCER SOC, V121, P545, DOI 10.1002/cncr.29100; Jiang L, 2015, ONCOTARGET, V6, P9542, DOI 10.18632/oncotarget.3283; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ES, 2016, J BONE MINER RES, V31, P929, DOI 10.1002/jbmr.2783; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mercer N, 2007, MOL CELL BIOCHEM, V306, P87, DOI 10.1007/s11010-007-9557-8; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; Pompe E, 2015, EUR RADIOL, V25, P283, DOI 10.1007/s00330-014-3408-2; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reagan MR, 2016, NAT REV RHEUMATOL, V12, P154, DOI 10.1038/nrrheum.2015.160; Rizzoli R, 2013, OSTEOPOROSIS INT, V24, P2929, DOI 10.1007/s00198-013-2530-3; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; Schmielau J, 2001, CANCER RES, V61, P4756; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Therneau T., 2017, SURVIVAL ANAL VERSIO; Visnjic D, 2001, J BONE MINER RES, V16, P2222, DOI 10.1359/jbmr.2001.16.12.2222; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Watari K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19470; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; WEINREB M, 1990, J BONE MINER RES, V5, P831; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Wu JY, 2009, J BONE MINER RES, V24, P759, DOI [10.1359/JBMR.090225, 10.1359/jbmr.090225]; Wu WC, 2014, P NATL ACAD SCI USA, V111, P4221, DOI 10.1073/pnas.1320753111; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhou Zheng, 2011, Front Biosci (Schol Ed), V3, P768, DOI 10.2741/s185; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	84	179	187	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367							eaal5081	10.1126/science.aal5081	http://dx.doi.org/10.1126/science.aal5081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191879	Green Submitted, Green Accepted			2022-12-28	WOS:000416584000031
J	Qiu, J				Qiu, Jane			ICE ON THE RUN Scientists are unraveling why certain glaciers are prone to surging abruptly-sometimes wiping out people in their path	SCIENCE			English	Editorial Material															International Water Management Institute; European Geosciences Union	International Water Management Institute; European Geosciences Union	Jane Qiu is a science journalist in Beijing. Her trips to Aru, Tibet, and Ny-Alesund on the Svalbard archipelago were supported by journalism fellowships from the International Water Management Institute and the European Geosciences Union, respectively.		0	5	6	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1120	1123		10.1126/science.358.6367.1120	http://dx.doi.org/10.1126/science.358.6367.1120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2DN	29191888				2022-12-28	WOS:000416584000016
J	Stone, R				Stone, Richard			SCIENCE DIPLOMACY Political chill reverses thaw in US-Cuban science	SCIENCE			English	News Item																			0	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2017	358	6367					1115	1115		10.1126/science.358.6367.1115	http://dx.doi.org/10.1126/science.358.6367.1115			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO2DN	29191883				2022-12-28	WOS:000416584000011
J	Kortlever, RM; Sodir, NM; Wilson, CH; Burkhart, DL; Pellegrinet, L; Swigart, LB; Littlewood, TD; Evan, GI				Kortlever, Roderik M.; Sodir, Nicole M.; Wilson, Catherine H.; Burkhart, Deborah L.; Pellegrinet, Luca; Swigart, Lamorna Brown; Littlewood, Trevor D.; Evan, Gerard I.			Myc Cooperates with Ras by Programming Inflammation and Immune Suppression	CELL			English	Article							C-MYC; ONCOGENIC RAS; PROGNOSTIC-SIGNIFICANCE; CHEMOKINE RECEPTORS; CANCER METASTASIS; INDUCED APOPTOSIS; IN-VITRO; CELLS; MACROPHAGES; TUMORS	The two oncogenes KRas and Myc cooperate to drive tumorigenesis, but the mechanism underlying this remains unclear. In a mouse lung model of KRas(G12D)-driven adenomas, we find that co-activation of Myc drives the immediate transition to highly proliferative and invasive adenocarcinomas marked by highly inflammatory, angiogenic, and immunesuppressed stroma. We identify epithelial-derived signaling molecules CCL9 and IL-23 as the principal instructing signals for stromal reprogramming. CCL9 mediates recruitment of macrophages, angiogenesis, and PD-L1-dependent expulsion of T and B cells. IL-23 orchestrates exclusion of adaptive T and B cells and innate immune NK cells. Co-blockade of both CCL9 and IL-23 abrogates Myc-induced tumor progression. Subsequent deactivation of Myc in established adenocarcinomas triggers immediate reversal of all stromal changes and tumor regression, which are independent of CD4(+) CD8(+) T cells but substantially dependent on returning NK cells. We show that Myc extensively programs an immune suppressive stroma that is obligatory for tumor progression.	[Kortlever, Roderik M.; Sodir, Nicole M.; Wilson, Catherine H.; Burkhart, Deborah L.; Pellegrinet, Luca; Littlewood, Trevor D.; Evan, Gerard I.] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Kortlever, Roderik M.; Sodir, Nicole M.; Swigart, Lamorna Brown; Evan, Gerard I.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Kortlever, Roderik M.; Sodir, Nicole M.; Swigart, Lamorna Brown; Evan, Gerard I.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Swigart, Lamorna Brown] Univ Calif San Francisco, Dept Lab Med, 2340 Sutter St, San Francisco, CA 94115 USA	University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Evan, GI (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.; Evan, GI (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Evan, GI (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	gie20@cam.ac.uk	Pellegrinet, Luca/K-8561-2012; Kortlever, Roderik/AAY-9220-2020	Pellegrinet, Luca/0000-0003-2081-8531; Wilson, Catherine/0000-0002-5333-0295; Evan, Gerard/0000-0003-0412-1216; Kortlever, Roderik/0000-0001-5558-2851	NWO-Rubicon from the Netherlands Organisation for Scientific Research [825.08.022]; Cancer Research UK [C4750/A12077, C4750/A19013]; European Research Council [294851]; SU2C/CR UK/Lustgarten/CR UK/Lustgarten Transatlantic Pancreatic Cancer Dream Team [C4750/A22585]; NIH/NCI [2RO1 CA98018]; NATIONAL CANCER INSTITUTE [R01CA098018] Funding Source: NIH RePORTER; Cancer Research UK [22585, 12077, 19013] Funding Source: researchfish	NWO-Rubicon from the Netherlands Organisation for Scientific Research; Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); SU2C/CR UK/Lustgarten/CR UK/Lustgarten Transatlantic Pancreatic Cancer Dream Team; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We thank the members of the Evan laboratory for discussion and advice and Alessandra Perfetto and Irina Pshenichnaya at the University of Cambridge and Fanya Rostker at UCSF Helen Diller Family Cancer Center for expert mouse work assistance and outstanding technical support. The study was supported by NWO-Rubicon 825.08.022 grant from the Netherlands Organisation for Scientific Research to R.M.K. and by program grants to G.I.E. (Cancer Research UK C4750/A12077 and C4750/A19013, NIH/NCI 2RO1 CA98018, European Research Council 294851, and the SU2C/CR UK/Lustgarten/CR UK/Lustgarten Transatlantic Pancreatic Cancer Dream Team C4750/A22585).	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; ALEXANDER WS, 1989, MOL CELL BIOL, V9, P67, DOI 10.1128/MCB.9.1.67; Ancrile BB, 2008, MOL INTERV, V8, P22, DOI 10.1124/mi.8.1.6; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; BORN TL, 1994, MOL CELL BIOL, V14, P5710, DOI 10.1128/MCB.14.9.5710; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Brekken RA, 1998, CANCER RES, V58, P1952; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chang SH, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/21624011.2014.955704; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; COMPERE SJ, 1989, P NATL ACAD SCI USA, V86, P2224, DOI 10.1073/pnas.86.7.2224; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Dang C, 2013, COLD SPRING HARB PER, V3; Dong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023707; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Goc J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26836; Graziano SL, 1999, J CLIN ONCOL, V17, P668, DOI 10.1200/JCO.1999.17.2.668; Igarashi T, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000083; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kimmelman AC, 2015, CLIN CANCER RES, V21, P1828, DOI 10.1158/1078-0432.CCR-14-2425; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Restifo NP, 2010, CANCER CELL, V18, P403, DOI 10.1016/j.ccr.2010.11.002; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; RICHARDSON GE, 1993, SEMIN ONCOL, V20, P105; RODENHUIS S, 1988, CANCER RES, V48, P5738; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seo AN, 2014, BRIT J CANCER, V110, P2688, DOI 10.1038/bjc.2014.218; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Sodir NM, 2011, GENE DEV, V25, P907, DOI 10.1101/gad.2038411; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Teng MWL, 2012, CANCER RES, V72, P3987, DOI 10.1158/0008-5472.CAN-12-1337; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Tran PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002018; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; Tsuneoka M, 2000, ONCOGENE, V19, P115, DOI 10.1038/sj.onc.1203232; Vaque JP, 2005, J BIOL CHEM, V280, P1112, DOI 10.1074/jbc.M409503200; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Wilson CH, 2014, ONCOGENE, V33, P4877, DOI 10.1038/onc.2014.78; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072955; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071	76	254	258	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2017	171	6					1301	+		10.1016/j.cell.2017.11.013	http://dx.doi.org/10.1016/j.cell.2017.11.013			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FP1HP	29195074	hybrid, Green Published			2022-12-28	WOS:000417362700013
J	Walmsley, I				Walmsley, Ian			Quantum interference beyond the fringe	SCIENCE			English	Editorial Material							2 PHOTONS; ENTANGLEMENT		[Walmsley, Ian] Univ Oxford, Dept Phys, Parks Rd, Oxford OX1 3PU, England	University of Oxford	Walmsley, I (corresponding author), Univ Oxford, Dept Phys, Parks Rd, Oxford OX1 3PU, England.	ian.walmsley@physics.ox.ac.uk		Walmsley, Ian/0000-0002-4714-0575				Aaronson S., 2013, THEORY COMPUT, V9, P143, DOI DOI 10.4086/toc.2013.v009a004; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Branning D, 1999, PHYS REV LETT, V83, P955, DOI 10.1103/PhysRevLett.83.955; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Menssen AJ, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.153603; OU ZY, 1990, PHYS REV A, V42, P2957, DOI 10.1103/PhysRevA.42.2957; Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012314; RARITY JG, 1990, PHYS REV LETT, V65, P1348, DOI 10.1103/PhysRevLett.65.1348; SANDERS BC, 1989, PHYS REV A, V40, P2417, DOI 10.1103/PhysRevA.40.2417	11	6	6	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2017	358	6366					1001	1002		10.1126/science.aao3883	http://dx.doi.org/10.1126/science.aao3883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO2FN	29170224				2022-12-28	WOS:000416590400025
J	Pasi, KJ; Rangarajan, S; Georgiev, P; Mant, T; Creagh, MD; Lissitchkov, T; Bevan, D; Austin, S; Hay, CR; Hegemann, I; Kazmi, R; Chowdary, P; Gercheva-Kyuchukova, L; Mamonov, V; Timofeeva, M; Soh, CH; Garg, P; Vaishnaw, A; Akinc, A; Sorensen, B; Ragni, MV				Pasi, K. J.; Rangarajan, S.; Georgiev, P.; Mant, T.; Creagh, M. D.; Lissitchkov, T.; Bevan, D.; Austin, S.; Hay, C. R.; Hegemann, I.; Kazmi, R.; Chowdary, P.; Gercheva-Kyuchukova, L.; Mamonov, V.; Timofeeva, M.; Soh, C. -H.; Garg, P.; Vaishnaw, A.; Akinc, A.; Sorensen, B.; Ragni, M. V.			Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONACOG BETA PEGOL; FACTOR-VIII; INHIBITOR DEVELOPMENT; THROMBIN GENERATION; CLINICAL-TRIALS; FACTOR-IX; PROPHYLAXIS; DEFICIENCY; HEMOSTASIS; CHILDREN	BACKGROUND Current hemophilia treatment involves frequent intravenous infusions of clotting factors, which is associated with variable hemostatic protection, a high treatment burden, and a risk of the development of inhibitory alloantibodies. Fitusiran, an investigational RNA interference (RNAi) therapy that targets antithrombin (encoded by SERPINC1), is in development to address these and other limitations. METHODS In this phase 1 dose-escalation study, we enrolled 4 healthy volunteers and 25 participants with moderate or severe hemophilia A or B who did not have inhibitory alloantibodies. Healthy volunteers received a single subcutaneous injection of fitusiran (at a dose of 0.03 mg per kilogram of body weight) or placebo. The participants with hemophilia received three injections of fitusiran administered either once weekly (at a dose of 0.015, 0.045, or 0.075 mg per kilogram) or once monthly (at a dose of 0.225, 0.45, 0.9, or 1.8 mg per kilogram or a fixed dose of 80 mg). The study objectives were to assess the pharmacokinetic and pharmacodynamic characteristics and safety of fitusiran. RESULTS No thromboembolic events were observed during the study. The most common adverse events were mild injection-site reactions. Plasma levels of fitusiran increased in a dose-dependent manner and showed no accumulation with repeated administration. The monthly regimen induced a dose-dependent mean maximum antithrombin reduction of 70 to 89% from baseline. A reduction in the antithrombin level of more than 75% from baseline resulted in median peak thrombin values at the lower end of the range observed in healthy participants. CONCLUSIONS Once-monthly subcutaneous administration of fitusiran resulted in dose-dependent lowering of the antithrombin level and increased thrombin generation in participants with hemophilia A or B who did not have inhibitory alloantibodies. (Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov number, NCT02035605.)	[Pasi, K. J.] Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England; [Mant, T.] NIHR, Biomed Res Ctr, London, England; [Bevan, D.] Kings Coll London, Guys & St Thomas NHS Fdn Trust, London, England; [Austin, S.] St Georges Healthcare NHS Trust Haemophilia Ctr, London, England; [Chowdary, P.] Royal Free Hosp London, London, England; [Rangarajan, S.] Hampshire Hosp NHS Fdn Trust, Haemophilia Haemostasis & Thrombosis Ctr, Basingstoke, Hants, England; [Mant, T.] Quintiles IMS, Reading, Berks, England; [Creagh, M. D.] Royal Cornwall Hosp NHS Trust, Truro, England; [Hay, C. R.] Manchester Royal Infirm, Manchester, Lancs, England; [Kazmi, R.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Georgiev, P.] Univ Multiprofile Hosp Act Treatment Sveti Georgi, Plovdiv, Bulgaria; [Georgiev, P.] Med Univ Plovdiv, Plovdiv, Bulgaria; [Lissitchkov, T.] Univ Hosp Hematol, Sofia, Bulgaria; [Gercheva-Kyuchukova, L.] Univ Hosp St Marina, Dept Hematol, Varna, Bulgaria; [Hegemann, I.] Univ Hosp Zurich, Zurich, Switzerland; [Mamonov, V.] Natl Res Ctr Hematol, Moscow, Russia; [Timofeeva, M.] Res Inst Hematol & Blood Transfus, Kirov, Russia; [Soh, C. -H.; Garg, P.; Vaishnaw, A.; Akinc, A.; Sorensen, B.] Alnylam Pharmaceut, Cambridge, MA USA; [Sorensen, B.] Codiak Biosci, Woburn, MA USA; [Ragni, M. V.] Univ Pittsburgh, Pittsburgh, PA USA; [Ragni, M. V.] Hemophilia Ctr Western Penn, Pittsburgh, PA USA	University of London; Queen Mary University London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; IQVIA; Royal Cornwall Hospital; University of Manchester; University of Southampton; University Hospital Southampton NHS Foundation Trust; Medical University Plovdiv; Medical University Varna; University of Zurich; University Zurich Hospital; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Kirov Research Institute of Hematology & Blood Transfusiology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pasi, KJ (corresponding author), Royal London Hosp, Haemophilia Ctr, London E1 1BB, England.	k.j.pasi@qmul.ac.uk	Gorodilova, Elena/H-3682-2017; Georgiev, Pencho/AAV-6464-2020; Chowdary, P/I-2623-2012	Gorodilova, Elena/0000-0002-5714-2785; Georgiev, Pencho/0000-0001-5677-6754; Chowdary, P/0000-0002-6690-8586; Laffan, Michael/0000-0002-8268-3268; Rangarajan, Savita/0000-0001-7367-133X; Vettermann, Christian/0000-0003-3794-6441	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov number, NCT02035605.	Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Bolliger D, 2010, THROMB HAEMOSTASIS, V103, P1233, DOI 10.1160/TH09-10-0732; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; den Uijl IEM, 2011, HAEMOPHILIA, V17, P41, DOI 10.1111/j.1365-2516.2010.02383.x; DiMichele D, 2007, BRIT J HAEMATOL, V138, P305, DOI 10.1111/j.1365-2141.2007.06657.x; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P307, DOI 10.1055/s-0029-1222609; Ghosh K, 2001, HAEMOPHILIA, V7, P9, DOI 10.1046/j.1365-2516.2001.00455.x; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gouw SC, 2013, BLOOD, V121, P4046, DOI 10.1182/blood-2012-09-457036; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Lofqvist T, 1997, J INTERN MED, V241, P395, DOI 10.1046/j.1365-2796.1997.130135000.x; Mahdi AJ, 2015, BRIT J HAEMATOL, V169, P768, DOI 10.1111/bjh.13360; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Negrier C, 2016, HAEMOPHILIA, V22, P507, DOI 10.1111/hae.12902; NEGRIER C, 1993, BLOOD, V81, P690; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Oh RC, 2011, AM FAM PHYSICIAN, V84, P1003; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peyvandi F, 2016, J THROMB HAEMOST, V14, P2095, DOI 10.1111/jth.13491; Peyvandi F, 2016, LANCET, V388, P187, DOI 10.1016/S0140-6736(15)01123-X; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shetty S, 2007, BRIT J HAEMATOL, V138, P541, DOI 10.1111/j.1365-2141.2007.06693.x; Skinner MW, 2012, HAEMOPHILIA, V18, P1, DOI 10.1111/j.1365-2516.2012.02822.x; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Young G, 2016, HAEMOPHILIA, V22, P25, DOI 10.1111/hae.13028; Young G, 2016, THROMB RES, V141, P69, DOI 10.1016/j.thromres.2016.02.030	32	578	604	13	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					819	828		10.1056/NEJMoa1616569	http://dx.doi.org/10.1056/NEJMoa1616569			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28691885	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000408626400005
J	Gies, E				Gies, Erica			The real cost of energy	NATURE			English	Editorial Material																			0	14	14	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2017	551	7682					S145	S147						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO1KW	29189819	Bronze			2022-12-28	WOS:000416520400005
